<SEC-DOCUMENT>0001628280-24-008035.txt : 20240229
<SEC-HEADER>0001628280-24-008035.hdr.sgml : 20240229
<ACCEPTANCE-DATETIME>20240229165701
ACCESSION NUMBER:		0001628280-24-008035
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240229
DATE AS OF CHANGE:		20240229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		24704783

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>rdnt-20231231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:rdnt="http://www.radnet.com/20231231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-32">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-33">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-35">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-160">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-161">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-151" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-664">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-151" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="f-666">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-703">http://fasb.org/us-gaap/2023#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="c-14" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-706">http://fasb.org/us-gaap/2023#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-709">http://fasb.org/us-gaap/2023#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1511">http://www.radnet.com/20231231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1512">http://www.radnet.com/20231231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</ix:nonNumeric><ix:nonNumeric contextRef="c-457" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1680">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-457" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="f-1682">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="c-489" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1757">P2Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-12</xbrli:startDate><xbrli:endDate>2023-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-20</xbrli:startDate><xbrli:endDate>2023-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-07</xbrli:startDate><xbrli:endDate>2023-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:GeneralHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-13</xbrli:startDate><xbrli:endDate>2023-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:GeneralHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DRTLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-22</xbrli:startDate><xbrli:endDate>2021-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-24</xbrli:startDate><xbrli:endDate>2021-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:center</xbrli:measure></xbrli:unit><xbrli:unit id="loan"><xbrli:measure>rdnt:loan</xbrli:measure></xbrli:unit><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rdnt:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-30</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rdnt:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rdnt:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="incentiveplan"><xbrli:measure>rdnt:incentivePlan</xbrli:measure></xbrli:unit><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>rdnt:agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:GeneralHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-12</xbrli:startDate><xbrli:endDate>2023-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-12</xbrli:startDate><xbrli:endDate>2023-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="investment"><xbrli:measure>rdnt:investment</xbrli:measure></xbrli:unit><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbitaiIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jointventure"><xbrli:measure>rdnt:jointVenture</xbrli:measure></xbrli:unit><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:LosAngelesImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="location"><xbrli:measure>rdnt:location</xbrli:measure></xbrli:unit><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:LosAngelesImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:LosAngelesImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-04-01</xbrli:startDate><xbrli:endDate>2017-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-04-01</xbrli:startDate><xbrli:endDate>2017-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:BeverlyHillsImagingCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:CCDGLRSServicesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SouthernCaliforniaDiagnosticImagingIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:InglewoodImagingCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RamapoRadiologyAssociatesPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MadisonRadiologyMedicalGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DelawareDiagnosticImagingPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairRadiologicalAssociatesPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ChelseaDignosticRadiologyPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NorthJerseyImagingCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:JointVentureWithCalvertMedicalImagingCentersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:CertainSellerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:BusinessAcquisitionContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:FixedAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:TarzanaMedicalCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:A6.0NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:A6.0NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:OneMonthSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:ThreeMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SixMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-07</xbrli:startDate><xbrli:endDate>2022-10-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-31</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>rdnt:tranche</xbrli:measure></xbrli:unit><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:AILongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HoustonMedicalImagingLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-16</xbrli:startDate><xbrli:endDate>2023-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AntelopeValleyOutpatientImagingCenterLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December&#160;31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF     </span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">     1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For the transition period from    to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"/><td style="width:26.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.322%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">310</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, $.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">Yes</ix:nonNumeric>&#160; &#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.695%"><tr><td style="width:1.0%"/><td style="width:34.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.321%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-26">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.   <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).    &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="f-29">2.1</ix:nonFraction> billion on June&#160;30, 2023 (the last business day of the registrant&#8217;s most recently completed second fiscal quarter) based on the closing price for the common stock on the NASDAQ Global Market on June&#160;30, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on February&#160;27, 2024, was <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">68,475,443</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive proxy statement for the 2024 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.</span></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:80.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">FORM 10-K ITEM</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_13">PART I.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_19">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_22">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item IC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_1309">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_1309">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_25">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_28">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_31">28</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_34">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_37">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">[Reserved]</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_40">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_43">Management&#8217;s Discussion and Analysis of Financial Condition&#160;and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_43">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_46">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_46">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_49">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_49">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_115">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_115">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_118">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_124">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_127">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_130">PART III.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_133">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_133">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_136">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_136">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_139">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_139">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_142">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_142">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_145">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_145">94</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_151">PART IV.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_151">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_151">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_157">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_160">100</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Forward-looking statements can generally be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward looking statements in this annual report include statements or inferences we make about:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expectations concerning domestic and global economic conditions, rates of inflation, or changes in interest rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends in our revenues, operating expenses or capital expenditures, and our financial guidance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expected future market acceptance for our products or services, and our competitive strengths in the markets we serve;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expected timing and potential impact of regulatory changes affecting our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully acquire and integrate new businesses, and achieve expected benefits, synergies or operating results from those acquisitions; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">economic and costs savings anticipated to be derived from our investment in artificial intelligence and machine learning products and solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements relate to the future, they are inherently subject to known and unknown risks, uncertainties and other factors that are difficult to predict and out of our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our actual results, levels of activity, performance or achievements may be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated or implied in our forward-looking statements include factors listed in Item 1 &#8212; &#8220;Business,&#8221; Item 1A&#8212; &#8220;Risk Factors,&#8221; Item 3&#8212; &#8220;Legal Proceedings,&#8221; Item 7 &#8212; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this annual report and in other reports that we file with the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement in this annual report is based on information currently available to us and speaks only as of the date of this report.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this annual report or any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this annual report, except to the extent required by law.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_16"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Business</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. We have been in business since 1985. Our principal business segment is the provision of diagnostic imaging services. At December 31, 2023, we operated, directly or indirectly through joint ventures with hospitals, 366 imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our imaging centers provide physicians with capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Integral to the imaging center business is our software arm headed by our eRad, Inc. subsidiary, which sells computerized systems that distribute, display, store and retrieve digital images. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to develop leading positions in regional markets in order to leverage operational efficiencies. We develop our imaging business through a combination of organic growth and acquisitions. Our scale and density within selected geographies provides close, long-term relationships with key payors, radiology groups and referring physicians. Each of our center-level and regional operations teams is responsible for managing relationships with local physicians and payors, meeting our standards of patient service, and maintaining profitability. We provide training programs, standardized policies and procedures, and sharing of best practices among the physicians in our regional networks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, our majority-owned subsidiary Heart &amp; Lung Imaging Limited, provides teleradiology services for remote interpretation of images on behalf of providers within the framework of the United Kingdom's National Health Service.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also established an Artificial Intelligence (AI) division, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images.  The division is led by our DeepHealth, Inc. subsidiary and includes our acquisitions of Aidence Holding B.V. and Quantib B.V., both based in the Netherlands.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All reports we file with the Securities and Exchange Commission are available free of charge via EDGAR through the SEC website at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We also maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.radnet.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> where we make available, free of charge, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports as soon as reasonably practicable after the material is electronically filed with, or furnished to, the Securities and Exchange Commission. References to our website in this report are provided as a convenience and the information contained on, or otherwise accessible through, the website is not incorporated by reference into, nor does it form a part of this annual report on Form 10-K or any other document that we file with the Securities and Exchange Commission.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Overview</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging involves the use of non-invasive procedures to generate representations of internal anatomy and function that can be recorded on film or digitized for display on a video monitor. Diagnostic imaging procedures facilitate the early diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often minimizing the cost and amount of care for patients. Diagnostic imaging procedures include MRI, CT, PET, nuclear medicine, ultrasound, mammography, X-ray and fluoroscopy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While X-ray remains the most commonly performed diagnostic imaging procedure, the fastest growing and higher margin procedures are MRI, CT and PET. The rapid growth in PET scans is attributable to the increasing recognition of the efficacy of PET scans in the diagnosis and monitoring of cancer. The number of MRI and CT scans performed annually in the United States continues to grow due to their wider acceptance by physicians and payors, an increasing number of applications for their use and a general increase in demand due to the aging population.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there has been rapid development of AI tools for the radiology field. In October 2023, the United States Food &amp; Drug Administration reported it had granted marketing clearance to 405 radiology software products since January 2020.  Modern AI is built by training on large databases to recognize patterns with much higher performance than previously. AI methods are now being employed throughout the imaging industry in a wide variety of ways, such as speeding image acquisition, providing diagnostic assistance, or prioritizing workflows. In addition, AI methods can speed up administrative tasks, such as keeping track of individuals needing procedures on a regular basis (i.e., mammograms, follow-up exams, etc.) and alerting our staff to contact the patient and schedule appointments.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Settings</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging services are typically provided in one of the following settings:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed-site, freestanding outpatient diagnostic centers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These centers range from single-modality to multi-modality centers and are generally not owned by hospitals or clinics. These centers depend upon physician referrals for their patients and generally do not maintain dedicated, contractual relationships with hospitals or clinics. In fact, these centers may compete with hospitals or clinics that have their own imaging systems to provide services to these patients. These centers bill third-party payors, such as managed care organizations, insurance companies, Medicare or Medicaid. All of our wholly-owned centers are in this category.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospitals. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many hospitals provide both inpatient and outpatient diagnostic imaging services, typically on site or at a dedicated center located on or nearby the hospital campus.  These centers can be owned and operated by the hospital and provide imaging services to inpatients as ordered or outpatients through physician referrals. The hospital normally bills third-party payors such as managed care organizations, insurance companies, Medicare or Medicaid. We have entered into joint ventures with certain hospitals to both provide and manage their diagnostic imaging services, allowing them to leverage our industry expertise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mobile Imaging. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While many hospitals own or lease their own equipment, certain hospitals provide diagnostic imaging services by contracting with providers of mobile imaging services. Using specially designed trailers, mobile imaging service providers transport imaging equipment and provide services to hospitals and clinics on a part-time or full-time basis, thus allowing small to mid-size hospitals and clinics that do not have the patient demand to justify fixed on-site access to advanced diagnostic imaging technology. Diagnostic imaging providers contract directly with the hospital or clinic and are typically reimbursed directly by them. We do not provide mobile imaging services.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Modalities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal diagnostic imaging modalities we use at our centers are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MRI.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MRI has become widely accepted as the standard diagnostic tool for a wide and fast-growing variety of clinical applications for soft tissue anatomy, such as those found in the brain, spinal cord, abdomen, heart and interior ligaments of body joints such as the knee. MRI uses a strong magnetic field in conjunction with low energy electromagnetic waves that are processed by a computer to produce high-resolution, three-dimensional, cross-sectional images of body tissue. A typical MRI examination takes from 20 to 45 minutes. MRI systems are designed as either open or closed and have magnetic field strength of 0.2 Tesla to 3.0 Tesla.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CT. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CT provides higher resolution images than conventional X-rays, but generally not as well defined as those produced by MRI. CT uses a computer to direct the movement of an X-ray tube to produce multiple cross-sectional images of a particular organ or area of the body. CT is used to detect tumors and other conditions affecting bones and internal organs. It is also used to detect the occurrence of strokes, hemorrhages and infections. A typical CT examination takes from 15 to 45 minutes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PET.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PET scanning involves the administration of a radiopharmaceutical agent with a positron-emitting isotope and the measurement of the distribution of that isotope to create images for diagnostic purposes. PET scans provide the capability to determine how metabolic activity impacts other aspects of physiology in the disease process by correlating the reading for the PET with other tools such as CT or MRI. PET technology has been found highly effective and appropriate in certain clinical circumstances for the detection and assessment of tumors throughout the body, the evaluation of some cardiac conditions and the assessment of epilepsy seizure sites. The information provided by PET technology often obviates the need to perform further highly invasive or diagnostic surgical procedures.  In addition, we employ combined PET/CT systems that blend the PET and CT imaging modalities into one scanner. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nuclear Medicine.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nuclear medicine uses short-lived radioactive isotopes that release small amounts of radiation that can be recorded by a gamma camera and processed by a computer to produce an image of various anatomical structures or to assess the function of various organs such as the heart, kidneys, thyroid and bones. Nuclear medicine is used primarily to study anatomic and metabolic functions. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">X-ray.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-rays use roentgen rays to penetrate the body and record images of organs and structures on film. Digital X-ray systems add computer image processing capability to traditional X-ray images, which provides faster transmission of images with a higher resolution and the capability to store images more cost-effectively. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ultrasound.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultrasound imaging uses sound waves and their echoes to visualize and locate internal organs. It is particularly useful in viewing soft tissues that do not X-ray well. Ultrasound is used in pregnancy to avoid X-ray exposure as well as in gynecological, urologic, vascular, cardiac and breast applications. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mammography.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mammography is a specialized form of radiology using low dosage X-rays to visualize breast tissue and is the primary screening tool for breast cancer. Mammography procedures and related services assist in the diagnosis of and treatment planning for breast cancer. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluoroscopy.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluoroscopy uses ionizing radiation combined with a video viewing system for real time monitoring of organs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Trends</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the diagnostic imaging services industry will continue to grow as a result of a number of factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Escalating Demand for Healthcare Services from an Aging Population. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. population is expected to trend older over the coming decades.  According to a Pew Research Center report issued January 9, 2024, the number of US residents age over 65 stands at approximately 62 million, representing 18% of the population, and is expected to reach 84 million, or 23% of the total population by 2054.  Because diagnostic imaging use tends to increase as a person ages, we believe the aging population will generate more demand for diagnostic imaging procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Greater Consumer Awareness of and Demand for Preventive Diagnostic Screening. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging, such as elective full-body scans, is increasingly being used as a screening tool for preventive care procedures. Consumer awareness of diagnostic imaging as a less invasive and preventive screening method has added to the growth in diagnostic imaging procedures. We believe that further technological advancements allowing for early diagnosis of diseases and disorders using less invasive procedures will create additional demand for diagnostic imaging.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Effective Applications for Diagnostic Imaging Technology. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New technological developments are expected to extend the clinical uses of diagnostic imaging technology and increase the number of scans performed. Recent technological advancements include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI spectroscopy, which can differentiate malignant from benign lesions;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI angiography, which can produce three-dimensional images of body parts and assess the status of blood vessels;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">enhancements in teleradiology systems, which permit the digital transmission of radiological images from one location to another for interpretation by radiologists at remote locations;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the development of combined PET/CT and PET/MRI scanners, which combine technologies to create a powerful diagnostic imaging system; and</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">use of augmented reality technologies make it possible to create three dimensional images that physicians can examine through virtual reality headsets or print using a three dimensional printer.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional improvements in imaging technologies, contrast agents and scan capabilities are leading to new non-invasive diagnostic imaging applications, including methods of diagnosing blockages in the heart&#8217;s vital coronary arteries, liver metastases, pelvic diseases and vascular abnormalities without exploratory surgery. We believe that the use of the diagnostic capabilities of MRI and other imaging services will continue to increase because they are cost-effective, time-efficient and non-invasive, as compared to alternative procedures, including surgery, and that newer technologies and future technological advancements will further increase the use of imaging services. At the same time, the industry has increasingly used upgrades to existing equipment to expand applications, extend the useful life of existing equipment, improve image quality, reduce image acquisition time and increase the volume of scans that can be performed. We believe the use of equipment upgrades rather than </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equipment replacements will continue, as we do not foresee new imaging technologies on the near-term horizon that will displace MRI, CT or PET as the principal advanced diagnostic imaging modalities.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of Artificial Intelligence. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AI has the potential to significantly change the medical imaging industry.  Current AI applications are aiding in image creation (for example, reducing the time required to perform an MRI scan, or the dose of a CT or PET scan) as well as aiding physicians performing image interpretation. AI appears to be particularly valuable in aiding radiologists reviewing cancer screening exams, where volumes can be high and lesions can be difficult to find, such as in screening mammography. AI can also improve business processes to better effectively serve customers and improve reimbursement and collections accuracy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors include independent imaging operators and smaller regional operators, as well as hospitals and hospital groups that operate their own imaging services.  In addition, some physician practices have established their own diagnostic imaging centers within their group practices. Some of our competitors may now or in the future have access to greater financial resources than we do, which could allow them to establish more centers and provide access to newer, more advanced equipment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete principally on the basis of our reputation, our ability to provide multiple modalities at many of our centers, the location of our centers, the quality of our diagnostic imaging services and technologists and our ability to establish and maintain relationships with healthcare providers and referring physicians. We believe that the following competitive strengths differentiate us from our competition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Scale and Reputation.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we operated, directly or indirectly through joint ventures with hospitals, 366 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;We are the largest operator of freestanding, fixed-site outpatient diagnostic imaging service centers in the United States, based on number of centers and revenue.  Our specific knowledge of our geographic markets drives strong relationships with key payors, radiology groups and referring physicians within our markets.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Comprehensive "Multi-Modality" Diagnostic Imaging Offering.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our centers offer multiple types of imaging procedures, driving strong relationships with referring physicians and payors in our markets and a diversified revenue base. At each of our multi-modality centers, we offer patients and referring physicians one location to serve their needs for multiple procedures. This prevents multiple patient visits or unnecessary travel between locations, increasing patient throughput and decreasing costs and time delays. Our revenue is generated by a broad mix of modalities. We believe our multi-modality strategy lessens our exposure to reimbursement changes in any specific modality.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Competitive Pricing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business focus, scale, resources and access to technology afford us with certain operating efficiencies.  Our size and scale allow us to achieve operating, sourcing and administrative efficiencies, including equipment and medical supply sourcing savings and favorable maintenance contracts from equipment manufacturers and other suppliers. As such, we believe our fees are generally lower than hospital fees for the same services we provide.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Facility Density in Many Highly Populated Areas of the United States. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostic imaging centers are strategically organized into regional networks concentrated in major population centers in seven states, providing a density that offers unique benefits to our patients, our referring physicians, our payors and us. We are able to increase the convenience of our services to patients by implementing scheduling systems within geographic regions, where practical. For example, many of our diagnostic imaging centers within a particular region can access the patient appointment calendars of other centers within the same regional network to efficiently allocate time available and to meet a patient's appointment, date, time, or location preferences. The grouping of our centers within regional networks enables us to easily move technologists and other personnel, as well as equipment, from over-utilized to under-utilized centers on an as-needed basis, and drive referrals. Our organization of referral networks results in increased patient throughput, greater operating efficiencies, better equipment utilization rates and improved response time for our patients. We believe our networks of centers and tailored service offerings for geographic areas drive local physician referrals, make us an attractive candidate for selection as a preferred provider by third-party payors and create economies of scale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Payors and Diversified Payor Mix.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including commercial insurance payors, managed care capitated payors and government payors such as Medicare and Medicaid, mitigating our exposure to unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable and recurring stream of revenue. We believe that third-party payors representing large groups of patients often </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prefer to enter into managed care contracts with providers that offer a broad array of diagnostic imaging services at convenient locations throughout a geographic area.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Experienced and Highly Regarded Radiologists. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracted radiologists have outstanding credentials, strong relationships with referring physicians, and a broad mix of sub-specialties. The collective experience and expertise of these radiologists translates into more accurate and efficient service to patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Experienced and Committed Management Team. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior and executive management teams have created our differentiated approach based on their comprehensive understanding of the diagnostic imaging industry and the dynamics of our regional markets. We have a track record of successful acquisitions and integration of acquired businesses into RadNet, and have managed the business through a variety of economic and reimbursement cycles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Technologically Advanced Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we created an AI division that now hosts the combined efforts of our acquisitions of DeepHealth, Inc., Aidence Holding B.V., and Quantib B.V..</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The division is currently focused on developing improved medical interpretation of scans within the fields of mammography, lung and prostate imaging.  Given the importance of training data in building modern AI applications as well as getting feedback on performance, our combination of vertical integration and scale provide advantages over other AI creators.  Alongside our established subsidiary eRad, Inc., which develops and sells computerized imaging data storage and retrieval systems, we have assembled an industry leading team of software developers to create radiology workflow solutions that improve patient care.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maximize Performance at Our Existing Centers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to enhance our operations and increase scan volume and revenue at our existing centers by expanding physician relationships and increasing the procedure offerings.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus on Profitable Contracting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our contracts with third-party payors, industry vendors and radiology groups, as well as our equipment and real property leases, to determine how we may improve the terms to increase our revenues and reduce our expenses. Because many of our contracts with third party payors are short-term in nature, we can regularly renegotiate these contracts, if necessary. We believe our position as a leading provider of diagnostic imaging services and our long-term relationships with physician groups in our markets enable us to obtain more favorable contract terms than would be available to smaller or less experienced imaging services providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optimize Operating Efficiencies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to maximize our equipment utilization by adding, upgrading and re-deploying equipment where we experience excess demand. We will continue to trim excess operating and general and administrative costs where it is feasible to do so. We may also continue to use, where appropriate, highly trained radiology physician assistants to perform, under appropriate supervision of radiologists, basic services traditionally performed by radiologists. We will continue to upgrade our advanced information technology system to create cost reductions for our centers in areas such as image storage, support personnel and financial management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Networks. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to expand the number of our centers both organically and through targeted acquisitions, using a disciplined approach for evaluating and entering new areas, including consideration of whether we have adequate financial resources to expand. Our current plans are to strengthen our market presence in geographic areas where we currently have existing operations and to expand into neighboring and other areas where we believe we can compete effectively. We perform extensive due diligence before developing a new facility or acquiring an existing facility or entering into a joint venture with a hospital to manage a facility, including surveying local referral sources and radiologists, as well as examining the demographics, reimbursement environment, competitive landscape and intrinsic demand of the geographic market. We generally will only enter new markets where:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there is sufficient patient demand for outpatient diagnostic imaging services;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we believe we can gain significant market share;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we can build key referral relationships or we have already established such relationships; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payors are receptive to our entry into the market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Joint Ventures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our growth strategy we have entered into joint ventures with hospitals, health systems or radiology practices that were formed for the purpose of owning and operating diagnostic imaging centers. We have created a number of joint ventures in key markets with well-established hospital systems to manage additional centers. We intend to continue to expand in established markets through additional joint ventures, particularly with hospital systems. We believe that these joint ventures deepen and expand our strength in markets where we are already established.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Leverage our investment in AI and technology to improve services and operating efficiency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  We have developed  a portfolio of proprietary technologies that stretch from patient-scheduling, to image storage and retrieval, to AI applications that aid in the interpretation of scans in certain fields. We intend to use our substantial investment in technology and AI to create differentiated service offerings in each phase of our business. We are currently developing solutions to improve the quality and consistency of our core imaging services, expand our service offerings, and improve our operating efficiency, ranging from patient intake through billing and collection.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a comprehensive set of imaging services including MRI, CT, PET, nuclear medicine, X-ray, ultrasound, mammography, fluoroscopy and other related procedures. We focus on providing standardized high quality imaging services, regardless of location, to ensure patients, physicians and payors consistency in service and quality. To ensure the high quality of our services, we monitor patient satisfaction, timeliness of services to patients, and delivery of reports to physicians.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key features of our services include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">patient-friendly, non-clinical environments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">a 24-hour turnaround on routine examinations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">interpretations within one to two hours, if needed;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">flexible patient scheduling, including same-day appointments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">extended operating hours, including weekends;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">reports delivered by courier, facsimile or email;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of second opinions and consultations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of sub-specialty interpretations at no additional charge; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">standardized fee schedules by region.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Professionals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we provide services (except Florida and Arizona), a lay person or any entity other than a professional corporation or similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. This doctrine is commonly referred to as the prohibition on the &#8220;corporate practice&#8221; of medicine. In order to comply with this prohibition, we contract with medical groups to provide professional medical services in our centers, including the supervision and interpretation of diagnostic imaging procedures. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with a consolidated medical group (the "Group") which consists of professional corporations owned or controlled by individuals within our senior management that provide professional medical services in Arizona, California, Delaware, Maryland, New Jersey and New York.  At locations where the Group does not provide professional medical services, we have entered into long-term contracts with third-party radiology groups in the area to provide physician services at those centers.  These third-party radiology practice groups maintain full control over the provision of professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers.  Each medical group maintains control over the physicians it employs, and is responsible for staffing the facility with qualified professional medical personnel.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under management agreements with the Group or other third-party radiology practices, we provide the use of our diagnostic imaging equipment, technical and management services, and administration of the non-medical functions of the professional medical practices at our centers, including the provision of non-medical staff, accounting services, billing and collection, medical and office supplies, transcription services, maintenance of medical records, and marketing. As compensation for the services furnished under management contracts with our medical groups, we receive technical fees for the use of our diagnostic imaging equipment and technical services and an agreed percentage of the medical practice billings for, or collections from, services provided at our centers. The medical groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we perform certain management services for a portion of the professional groups with whom we contract who provide professional radiology services at local hospitals. For performing these management services, which include billing, collecting, transcription and medical coding, we receive management fees, that depending on the agreement are calculated at a fixed or variable rate.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees charged for diagnostic imaging services performed at our centers are paid by a diverse mix of payors:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Insurance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, insurance companies reimburse us, directly or indirectly, including through the Group or through the contracted radiology groups, on the basis of agreed upon rates. These rates are negotiated and may differ materially with rates set forth in the Medicare Physician Fee Schedule for the particular service. The patients may be responsible for certain co-payments or deductibles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Care Capitation Agreements.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements that are generally between the medical groups and the payor (which in most cases are large medical groups or Independent Practice Associations), the payor pays a pre-determined amount per-member per-month in exchange for the radiology group providing all necessary covered services to the managed care members included in the agreement. These contracts pass much of the financial risk of providing outpatient diagnostic imaging services, including the risk of over-use, from the payor to the radiology practice group and, as a result of our management agreement with the radiology practice group, to us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that through our comprehensive utilization management, or UM, program we have become highly skilled at assessing and moderating the risks associated with the capitation agreements, so that these agreements are profitable for us. Our UM program is managed by our UM department, which consists of staff who are actively involved with the referring physicians and payor management in both prospective and retrospective review programs. Our UM program includes features such as physician education combined with peer review procedures which are designed to manage our costs while ensuring that patients receive appropriate care.</span></div><div style="text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare/Medicaid.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare is the federal health insurance program for people age 65 or older and people under age 65 with certain disabilities. Medicaid, funded by both the federal government and states, is a state-administered health insurance program for qualifying low-income and medically needy persons. For services for which we bill Medicare directly or indirectly, including through contracted radiologists, we are paid under the Medicare Physician Fee Schedule. Under the Protecting Access to Medicare Act of 2014, Congress introduced a new quality incentive program that, effective January 1, 2016, reduces Medicare payments for certain CT services reimbursed through the Medicare Physician Fee Schedule that are furnished using equipment that does not meet certain dose optimization and management standards. Medicare patients usually pay a 20% co-payment unless they have secondary insurance. Medicaid rates are set by the individual states for each state program and Medicaid patients may be responsible for a modest co-payment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts with Physician Groups and Other Non-Insurance Company Payors.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of our contracts with physician groups and other providers, we do not bill payors, but instead accept agreed upon rates for our radiology services. These rates are typically at or below the rates set forth in the current Medicare Fee Schedule for the particular service. However, we often agree to a specified rate for MRI and CT procedures that is not tied to the Medicare Fee Schedule.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers are primarily located in geographic networks that we refer to as regions. The majority of our centers are multi-modality sites, offering various combinations of MRI, CT, PET, nuclear medicine, ultrasound, X-ray, fluoroscopy services and other related procedures. A portion of our centers are single-modality sites, offering either X-ray or MRI services. Consistent with our regional network strategy, we locate our single-modality centers near multi-modality centers, to help accommodate overflow in targeted demographic areas.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the number of our centers operated directly or managed through joint ventures for each year during the three-year period ended December 31, 2023:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended<br/>December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total centers owned or managed (at beginning of the year)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers added by:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers closed or sold</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total centers owned or managed (at year end)</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table indicates, as of December 31, 2023, the quantity of principal diagnostic equipment available at our imaging centers operated directly or through joint venture investments:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:60.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.851%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Count</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average age of our MRI and CT units is less than five years, and the average age of our PET units is less than four years. The useful life of our MRI, CT and PET units is typically ten years.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our facility acquisitions can be found within Item 7 - &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, as well as Note 4 to our consolidated financial statements included in this annual report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Technology</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters and many of our centers are interconnected through a state-of-the-art information technology system. This system, which is compliant with the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), is comprised of a number of integrated applications and provides a single operating platform for billing and collections, electronic medical records, practice management and image management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This technology has created cost reductions for our centers in areas such as image storage, support personnel and financial management and has further allowed us to optimize the productivity of all aspects of our business by enabling us to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capture patient demographic, history and billing information at point-of-service;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">automatically generate bills and electronically file claims with third-party payors;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">record and store diagnostic report images in digital format;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">digitally transmit in real-time diagnostic images from one location to another, thus enabling networked radiologists to cover larger geographic markets by using the specialized training of other networked radiologists;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform claims, rejection and collection analysis; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform sophisticated financial analysis, such as analyzing cost and profitability, volume, charges, current activity and patient case mix, with respect to each of our managed care contracts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our own Radiology Information System through our team of software development engineers, which is used as our front desk patient tracking system.  Our eRad, Inc., subsidiary develops and sells computerized imaging data storage and retrieval systems.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary goal of our talent management strategy is to attract and retain engaged, talented, and diverse team members to establish RadNet as the employer of choice. We seek to drive performance by enabling effective leadership that results in a positive patient experience delivered by talented and engaged team members. To achieve this, leaders across the enterprise partner to develop and deliver talent and culture programs, create total rewards strategies, and provide efficient and effective people operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the strength of our workforce is critical to the success of our mission to provide comprehensive radiology solutions and change the future of healthcare. We invest in our employees to ensure their confidence and competence in their roles, as well as to provide a path for professional career development. We value an ethical culture where diversity is embraced, good health and safety are promoted, and employees are empowered to share their ideas and opinions. We strive to care for our team members and are concerned about their total well-being.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Headcount and Labor Representation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, we had a total of 7,872 full-time, 569 part-time and 1,847 per diem employees, including those employed by the Group. These numbers include 220 full-time and 89 part-time physicians and 2,429 full-time, 397 part-time and 1,190 per-diem technologists.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity, Inclusion, &amp; Belonging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to creating an inclusive work environment where team members can be their best and authentic selves. With diversity comes a plethora of different perspectives and these different perspectives breed innovative ideas that enable us to lead radiology forward. Our relationship with Jobs.Vision.Success SoCal, a nonprofit, non-sectarian social service agency, is one example of our support and sponsorship of community outreach and enrichment programs for underserved populations. As a foundational practice, all employees are required to complete cultural competence training annually.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Listening</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe in ensuring every team member feels valued, seen, and heard; therefore, we have various avenues for all to share ideas and provide feedback. Piloting initiatives such as the Connections Roadshow and new employee listening platforms enable senior leaders to hear from team members at all levels of the organization to gain insights on various topics including quality, engagement, innovation, customer service, patient focus, diversity, equity, inclusion, and belonging. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Well-being</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We subscribe to the belief that if we take care of our people, they will in turn, take care of our patients. Prioritizing and promoting wellness allows our team members to be their best selves at work and at home. Concerning ourselves with the physical, mental, emotional, and social well-being of each team member enables us to attract and retain top talent. Beyond fair and equitable pay, we offer a wide range of benefit plan options that include, but are not limited to, medical insurance, health savings accounts, family support services, nutrition and exercise programs, and financial education. We evaluate our total well-being packages regularly to remain competitive, align with legislative changes, and respond to the needs of our team members. Based on survey feedback, we recently replaced our wellness platform and introduced Navigate Wellness to better address what our team members care about most. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Talent Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipping our people to perform excellently is one of our top priorities. With companies across the country facing unprecedented, post-pandemic labor shortages, attrition, and turnover, we are doubling down on our People and Culture initiatives. We have established a Talent &amp; Culture Center of Expertise to focus on the employee experience from beginning to end. With a heightened focus on upskilling our existing workforce, our investment in new training and development platforms and piloting a coaching capabilities builder program for our leaders, we are promoting timely and effective feedback that fosters trust, respect, teamwork, growth, and excellence. Furthermore, our tuition reimbursement program encourages team members at all levels of the enterprise to seek additional skills.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and marketing team employs a multi-pronged approach to marketing, including physician, payor and sports marketing programs, each of which are described below:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Marketing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each customer service representative on our physician marketing team is responsible for marketing activity on behalf of one or more centers. The representatives act as a liaison between the facility and referring physicians, holding meetings periodically and on an as-needed basis with them and their staff to present educational programs on new applications and uses of our systems and to address particular patient service issues that have arisen. In our experience, consistent hands-on contact with a referring physician and his or her staff generates goodwill and increases referrals to our centers. The representatives also continually seek to establish referral relationships with new physicians and physician groups. In addition to a base salary, each representative receives a bonus based upon success.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payor Marketing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing team regularly meets with managed care organizations and insurance companies to solicit contracts and meet with existing contracting payors to solidify those relationships. The comprehensiveness of our services, the geographic location of our centers and the reputation of the physicians with whom we contract all serve as tools for obtaining new or repeat business from payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sports Marketing Program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our west coast operations renders in stadium digital X-ray for the following organizations: Los Angeles Clippers, Dodgers, Kings and Lakers. In exchange, we receive season tickets and parking.  Contract lengths vary from yearly up to five years. We also provide radiology services at select imaging centers for the Anaheim Ducks, Los Angeles Angels, Los Angeles  Rams, Oakland Athletics, San Francisco 49ers and student athletes of the University of Southern California. Through our east coast operations, we have entered into sponsorship agreements with the Baltimore Ravens of the National Football League and the Baltimore Orioles of Major League Baseball which permit us to state we are the imaging partner to each organization. Both of those agreements are being renewed through 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suppliers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquire our major diagnostic imaging equipment directly from original equipment manufacturers or through third party financing companies and purchase medical supplies from various national vendors.  Our diagnostic imaging equipment represents a cornerstone investment of the company as it provides our customers the latest in imaging technology.  We employ direct purchase or finance arrangements with such firms as GE, Hologic, Key Equipment, Philips, Siemens and Spectrum for our diagnostic equipment imaging needs.  We seek to establish strong working relationships with our providers, who are of comparable stature and offer similar products, to mitigate the risk that any one supplier becomes unavailable. If we open or acquire additional imaging centers, we may incur material equipment lease obligations.  See Note 9, Leases, in the notes accompanying our consolidated financial statements included in this report for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timely and effective maintenance of our imaging equipment is essential for achieving high utilization rates.  In order to ensure operational efficiency, we have maintenance arrangements with&#160;the various service arms of the original equipment manufacturers that supply our imaging equipment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance and Liability Mitigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain insurance policies with coverage we believe is appropriate in light of the risks attendant to our business and consistent with industry practice. We maintain general liability insurance and professional liability insurance in commercially reasonable amounts. Additionally, we maintain workers&#8217; compensation insurance on all of our employees. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our agreements with physician groups, including the Group, we require the physician group maintain medical malpractice insurance for each physician in the group, with coverage limits of not less than $1.0 million per incident and $3.0 million in the aggregate per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance coverage is placed on a statutory basis and corresponds to individual state&#8217;s requirements. However, adequate liability insurance may not be available to us in the future at acceptable costs or at all. In addition, insurers from which we purchase such insurance may experience financial hardship which would impact their ability to pay covered policyholder claims.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In California our operations benefit from a statutory medical malpractice cap that reduces our liability exposure. California places a $250,000 limit on non-economic damages for medical malpractice cases. The cap applies whether the case is for injury or death, and it allows only one $250,000 recovery in a wrongful death case. Non-economic damages are defined as compensation for pain, suffering, inconvenience, physical impairment, disfigurement and other non-pecuniary injury. No cap applies to economic damages. Other states in which we now operate do not have similar limitations and in those states we believe our insurance coverage to be sufficient.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly regulated, and changes in the regulatory environment could significantly affect our operations in the future. Our ability to operate profitably will depend in part upon us, and the contracted radiology practices and their affiliated physicians, obtaining and maintaining all necessary licenses and other approvals, and operating in compliance with applicable healthcare regulations. We believe that healthcare regulations will continue to change. Therefore, we monitor developments in healthcare law and modify our operations from time to time as the business and regulatory environment changes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facilities Licensing and Certification Laws. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of diagnostic imaging centers are subject to various federal and state laws, regulations and approvals concerning licensing of centers and personnel. In addition, free-standing diagnostic imaging centers that provide services not performed as part of a physician's office must meet Medicare requirements to be certified as an independent diagnostic testing facility before it can be authorized to bill the Medicare program. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we operate, other than Florida and Arizona, a lay person or any entity other than a professional corporation or other similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. The laws of such states also prohibit a lay person or a non-professional entity from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging centers, in a manner that we believe keeps us from engaging in the practice of medicine, exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Government Healthcare Programs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial portion of our revenue from direct billings to governmental healthcare programs, such as Medicare and Medicaid, and private health insurance companies and/or health plans, including but not limited to those participating in the Medicare Advantage program. During the year ended December 31, 2023, approximately 23% of our net service revenue generated at our diagnostic imaging centers was derived from federal government sponsored healthcare programs (Medicare) and 3% from state sponsored programs (Medicaid). As a result, any negative changes in governmental capitation or fee-for-service rates or methods of reimbursement for the services we provide could have a significant adverse impact on our revenue and financial results.  Because governmental healthcare programs generally reimburse on a fee schedule basis rather than on a charge-related basis, we generally cannot increase our revenues from these programs by increasing our fees for the specified services. Moreover, if our costs increase, we may not be able to recover our increased costs from these programs. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government payors have taken and may continue to take steps to control the cost, eligibility for, use, and delivery of healthcare services as a result of budgetary constraints, cost containment pressures and other reasons. We believe that these trends in cost containment will continue. These cost containment measures, and other market changes in non-governmental insurance plans have generally restricted our ability to recover, or shift to non-governmental payors, any increased costs that we experience. Our integrated care business and financial operations may be materially affected by these developments.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Federal Anti-kickback Statute. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law known as the Anti-kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, (i) the referral of a person, (ii) the furnishing or arranging for the furnishing of items or services reimbursable under the Medicare, Medicaid or other governmental programs or (iii) the purchase, lease or order or arranging or recommending purchasing, leasing or ordering of any item or service reimbursable under the Medicare, Medicaid or other governmental programs. Noncompliance with the federal Anti-kickback Statute can result in exclusion from the Medicare, Medicaid or other governmental programs and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Anti-kickback Statute is broad, and it prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. To create better clarity, the Office of the Inspector General of the U.S. Department of Health and Human Services (OIG) has issued regulations as "safe harbor" guidelines which if met in form and substance, will assure healthcare providers that they will not be prosecuted for violation of the Anti&#8211;kickback Statute.  The OIG issued a final rule on November 20, 2020, as part of the Regulatory Sprint to Coordinated Care initiative by the U.S. Department of Health and Human Services that, among other things, established new "safe harbors" under the Anti-kickback Statute for certain value-based compensation arrangements.  Although full compliance with these provisions ensures against prosecution under the federal Anti-kickback Statute, the failure of a transaction or arrangement to fit within a specific safe harbor does not necessarily mean that the transaction or arrangement is illegal or that prosecution under the federal Anti-kickback Statute will be pursued.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although some of our arrangements may not fall within a safe harbor, we believe that such business arrangements do not violate the Anti-kickback Statute because we are careful to structure them to reflect fair value and ensure that the reasons underlying our decision to enter into a business arrangement comport with reasonable interpretations of the Anti-kickback Statute. However, even though we continuously strive to comply with the requirements of the Anti-kickback Statute, liability under the Anti-kickback Statute may still arise because of the intentions or actions of the parties with whom we do business. While we are not aware of any such intentions or actions, we have only limited knowledge regarding the intentions or actions underlying those arrangements. Conduct and business arrangements that do not fully satisfy one of these safe harbor provisions may result in increased scrutiny by government enforcement authorities such as the Office of the Inspector General.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Stark Law.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ethics in Patient Referral Act of 1989, commonly known as the Stark Law, prohibits a physician from referring Medicare patients to an entity providing designated health services in which the physician (or immediate family member) has an ownership or investment interest or with which the physician (or immediate family member) has entered into a compensation arrangement. The Stark Law also prohibits the entity from billing for any such prohibited referral. The penalties for violating the Stark Law include a prohibition on payment by these governmental programs and civil penalties of as much as $15,000 for each violation referral and $100,000 for participation in a circumvention scheme. The regulations governing the Stark Law were also recently amended as part of the Regulatory Sprint to Coordinated Care initiative.  These new regulations, which among other things establish new exceptions for value-based arrangements, were published by the Centers for Medicare &amp; Medicaid Services (CMS) on November 20, 2020.  We believe that, although we receive fees under our service agreements for management and administrative services, we are not in a position to make or influence referrals of patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stark Law, radiology and certain other imaging services and radiation therapy services and supplies are services included in the designated health services subject to the self-referral prohibition. Such services include the professional and technical components of any diagnostic test or procedure using X-rays, ultrasound or other imaging services, CT, MRI, radiation therapy and diagnostic mammography services (but not screening mammography services). PET and nuclear medicine procedures are also included as designated health services under the Stark Law. The Stark Law, however, excludes from designated health services: (i) X-ray, fluoroscopy or ultrasound procedures that require the insertion of a needle, catheter, tube or probe through the skin or into a body orifice; (ii) radiology procedures that are integral to the performance of, and performed during, non-radiological medical procedures; and (iii) invasive or interventional radiology, because the radiology services in these procedures are merely incidental or secondary to another procedure that the physician has ordered.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law provides that a request by a radiologist for diagnostic radiology services or a request by a radiation oncologist for radiation therapy, if such services are furnished by or under the supervision of such radiologist or radiation oncologist pursuant to a consultation requested by another physician, does not constitute a referral by a referring physician. If such requirements are met, the Stark Law self-referral prohibition would not apply to such services. The effect of the Stark Law on the radiology practices, therefore, will depend on the precise scope of services furnished by each such practice&#8217;s radiologists and whether such services derive from consultations or are self-generated.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, other than self-referred patients, all of the services covered by the Stark Law provided by the contracted radiology practices derive from requests for consultation by non-affiliated physicians. Therefore, we believe that the Stark Law is not implicated by the financial relationships between our operations and the contracted radiology practices. In addition, we believe that we have structured our acquisitions of the assets of existing practices, and we intend to structure any future acquisitions, so as not to violate the Anti-kickback Statute, Stark Law and the regulations related to these laws. Specifically, we believe the consideration paid by us to physicians to acquire the tangible and intangible assets associated with their practices is consistent with fair value in arms&#8217; length transactions and is not intended to induce the referral of patients or other business generated by such physicians. Should any such practice be deemed to constitute an arrangement designed to induce the referral of Medicare or Medicaid patients, then our acquisitions could be viewed as possibly violating anti-kickback and anti-referral laws and regulations. A determination of liability under any such laws could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; General. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government embarked on an initiative to audit all Medicare carriers, which are the companies that adjudicate and pay Medicare claims. These audits are expected to intensify governmental scrutiny of individual providers. An unsatisfactory audit of any of our diagnostic imaging centers or contracted radiology practices could result in any or all of the following: significant repayment obligations, exclusion from Medicare, Medicaid or other governmental programs, and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal regulatory and law enforcement authorities have increased enforcement activities with respect to Medicare and Medicaid fraud and abuse regulations and other reimbursement laws and rules, including laws and regulations that govern our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activities and the activities of the radiology practices. The federal government also has increased funding to fight healthcare fraud and is coordinating its enforcement efforts among various agencies, such as the U.S. Department of Justice, the U.S. Department of Health and Human Services Office of Inspector General, and state Medicaid fraud control units. The government may investigate our or the radiology practices&#8217; activities, claims may be made against us or the radiology practices and these increased enforcement activities may directly or indirectly have an adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Anti-kickback and Physician Self-referral Laws. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have adopted laws similar to the federal Anti-kickback Statute and the Stark Law. Some of these state prohibitions apply to services and the referral of patients for healthcare services reimbursed by any source, not only the Medicare and Medicaid programs. Although we believe that we comply with both federal and state anti-kickback laws and self-referral laws, any finding of a violation of these laws could subject us to criminal and civil penalties or possible exclusion from federal or state healthcare programs. Such penalties would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal False Claims Act. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal False Claims Act provides, in part, that the federal government may bring a lawsuit against any person who it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim approved. The federal False Claims Act further provides that a lawsuit thereunder may be initiated in the name of the United States by an individual, a &#8220;whistleblower,&#8221; who is an original source of the allegations. The government has taken the position that claims presented in violation of the federal Anti-kickback Statute or Stark Law may be considered a violation of the federal False Claims Act. Penalties include civil penalties of not less than $5,500 and not more than $11,000 for each false claim, plus three times the amount of damages that the federal government sustained because of the act of that person.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, states are being encouraged to adopt false claims acts similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain whistleblower provisions. Even in instances when a whistleblower action is dismissed with no judgment or settlement, we may incur substantial legal fees and other costs relating to an investigation. Future actions under the False Claims Act may result in significant fines and legal fees, which would adversely affect our financial performance and our ability to operate our business. We believe that we are in compliance with the rules and regulations that apply to the federal False Claims Act as well as its state counterparts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient Protection and Affordable Care Act. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare reform legislation enacted in the first quarter of 2010 by the Patient Protection and Affordable Care Act or PPACA, specifically requires the U.S. Department of Health and Human Services, in computing physician practice expense relative value units, to increase the equipment utilization factor for advanced diagnostic imaging services (such as MRI, CT and PET) from a presumed utilization rate of 50% to 75% over a three year period. The Health Care and Education Reconciliation Act of 2010 (H.R. 4872), or Reconciliation Act, fully implemented the higher utilization rate in the beginning of 2011, eliminating the phase-in approach provided in the PPACA. This utilization rate was further increased to 90% by the American Taxpayer Relief Act of 2012, effective as of January 1, 2014.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aim of increased utilization of diagnostic imaging services is to spread the cost of the equipment and services over a greater number of scans, resulting in a lower cost per scan. These changes precipitated reductions in federal reimbursement for medical imaging, resulting in decreased  revenues per scan for the scans we perform for Medicare beneficiaries. Other changes in reimbursement for services rendered by Medicare Advantage plans may also reduce the revenues we receive for services rendered to Medicare Advantage enrollees.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPACA also required individuals to pay additional taxes if he or she was uninsured during the year (the "Individual Mandate"). On December 22, 2017, the Tax Cuts and Jobs Act was enacted which, among numerous changes to the tax code, repealed the Individual Mandate tax penalty. Repeal of the Individual Mandate may lead to more people being uninsured, and could raise premium rates for insured persons. Such a development could affect reimbursement, coverage, and utilization of diagnostic imaging services in ways that are currently unpredictable.  Other changes to the PPACA (whether through legislation or judicial action), including further rollbacks of the PPACA being sought by congressional and state members of the Republican Party, or expansion of the PPACA (including, but not limited to, the development of a "public option" that would compete with private insurers to offer coverage to both individuals and those with employer sponsored insurance) being sought by the Biden Administration, could have similarly unpredictable effects.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurance Portability and Accountability Act of 1996.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress enacted the Health Insurance Portability and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217; individually identifiable healthcare information. &#160;HIPAA, among other things, amends existing crimes and criminal penalties for Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-government healthcare benefit programs. Under HIPAA, a healthcare benefit program includes any private plan or contract affecting interstate </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commerce under which any medical benefit, item or service is provided. A person or entity that knowingly and willfully obtains the money or property of any healthcare benefit program by means of false or fraudulent representations in connection with the delivery of healthcare services is subject to a fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services to federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, HIPAA requires healthcare providers and their business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;). HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2) substantive security and privacy obligations, including new federal security breach notification requirements to affected individuals, DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many states have enacted comparable privacy and security statutes or regulations that, in some cases, are more stringent than HIPAA requirements. In those cases it may be necessary to modify our operations and procedures to comply with the more stringent state laws, which may entail significant and costly changes for us. We believe that we are in compliance with such state laws and regulations. However, if we fail to comply with applicable state laws and regulations, we could be subject to additional sanctions.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the current HIPAA requirements, as amended by HITECH, and comparable state laws, but we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations of our contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards may result in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs, including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Food and Drug Administration or FDA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has issued the requisite pre-market approval for all of the MRI and CT systems we use.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mammography systems are regulated by the FDA pursuant to the Mammography Quality Standards Act of 1992, as amended by the Mammography Quality Standards Reauthorization Acts of 1998 and 2004 (collectively, the &#8220;MQSA&#8221;). All mammography centers are required to meet the applicable MQSA requirements, including quality standards, be accredited by an approved accreditation body or state agency and certified by the FDA or an FDA-approved certifying state agency. Pursuant to the accreditation process, each facility providing mammography services must comply with certain standards that include, among other things, annual inspection of the facility's equipment, personnel (interpreting physicians, technologists and medical physicists) and practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these MQSA requirements and standards is required to obtain Medicare payment for services provided to beneficiaries and to avoid various sanctions, including monetary penalties, or suspension of certification. Although the Mammography Accreditation Program of the American College of Radiology is an approved accreditation body and currently accredits all of our centers which provide mammography services, and although we anticipate continuing to meet the requirements for accreditation, if we lose such accreditation, the FDA could revoke our certification. Congress has extended Medicare benefits to include coverage of screening mammography but coverage is subject to the facility performing the mammography meeting prescribed quality standards described above. The Medicare requirements to meet the standards apply to diagnostic mammography and image quality examination as well as screening mammography.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Radiologist Licensing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The radiologists providing professional medical services at our centers are subject to licensing and related regulations by the states in which they provide services. As a result, we require the radiology groups with which we contract to require those radiologists to have and maintain appropriate licensure. We do not believe that such laws and regulations will either prohibit or require licensure approval of our business operations, although no assurances can be made that such laws and regulations will not be interpreted to extend such prohibitions or requirements to our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Laws and Regulation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States in which we operate have adopted certain laws and regulations affecting risk assumption in the healthcare industry, including those that subject any physician or physician network engaged in risk-based managed care to comply with applicable insurance laws and regulations. These laws and regulations may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to the contracted radiology practices, limiting their ability to enter into capitated or other risk-sharing managed care arrangements and indirectly affecting our revenue from the contracted practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Matters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities we operate or manage generate hazardous and medical waste subject to federal and state requirements regarding handling and disposal. We believe that the facilities that we operate and manage are currently in compliance in all material respects with applicable federal, state and local statutes and ordinances regulating the handling and disposal of such materials. We do not believe that we will be required to expend any material additional amounts in order to remain in compliance with these laws and regulations or that compliance will materially affect our capital expenditures, earnings or competitive position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance Program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a program to monitor compliance with federal and state laws and regulations applicable to healthcare entities. We have a compliance officer who is charged with implementing and supervising our compliance program, which includes the adoption of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others may report regulatory or ethical concerns to our compliance officer. We believe that our compliance program meets the relevant standards provided by the Office of Inspector General of the Department of Health and Human Services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important part of our compliance program consists of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We also conduct mandatory educational programs designed to familiarize our employees with the regulatory requirements and specific elements of our compliance program.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_19"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Risk Factors</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Economic and Industry Risks </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse changes in general domestic and worldwide economic conditions could adversely affect our operating results, financial condition, and liquidity.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to risk arising from adverse changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of credit markets. Concerns about the systemic impact of potential long-term and wide-spread recession, inflation, energy costs, geopolitical issues, the availability and cost of credit have contributed to increased market volatility and diminished expectations for near-term growth in the United States and many global economies. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Continued turbulence in domestic and international markets and economies may adversely affect our liquidity and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Patients may transition work, leaving insurance programs, or defer non-emergency procedures, which could reduce overall demand for our services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A decline in global economic conditions could also have a significant impact on the financial condition and operations of our third party payors, contracting radiology groups, equipment manufacturers and other suppliers. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A downturn in the economic environment can also lead to increased risk of collection on our accounts receivable,  impairment of goodwill, and increased risk of failure of financial institutions including insurance companies and derivatives counterparties. These and other economic events could materially adversely affect our business, results of operations, financial condition and stock price.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing interest rates or disruption of credit markets could adversely affect our financial condition and liquidity.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In response to recent macroeconomic concerns, the United States and other western countries have implemented monetary policies focused on suppressing inflation, including increasing interest rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate in an industry that requires significant amounts of capital to fund operations, particularly in the  development or acquisition of diagnostic imaging centers and the acquisition of diagnostic imaging equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To meet these capital requirements, we have incurred various indebtedness including senior secured credit facilities and equipment leases.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Most of our indebtedness is borrowed under terms with variable interest rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have purchased, and may in the future purchase, forward swaps or other derivative instruments designed to mitigate the risk of changes in interest rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The use of such hedging activities may not be effective to offset any, or more than a portion, of the adverse financial effects of unfavorable movements in interest rates over the limited time the hedges are in place.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If these market conditions continue, we may experience increased expenses associated with borrowing and resulting decreases in profitability.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, continued disruption in credit markets could render it more difficult for us to timely replace maturing liabilities or to expand credit facilities, which would adversely affect our liquidity and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our labor costs have been, and we expect will continue to be, adversely affected by competition for staffing, the shortage of experienced healthcare professionals, and regulatory activity including changes in minimum wage laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations are dependent on the availability, efforts, abilities and experience of management and medical support personnel. We compete with other healthcare providers in recruiting and retaining qualified employees; however, over the past several years, the healthcare industry has faced considerable workforce challenges, including shortages of skilled personnel and increased wage competition. In some of the regions in which we operate, state or municipalities increased the applicable minimum wage, which has created more competition and, in some cases, higher labor costs. If prevailing wages continue to be driven higher, we could suffer increased employee turnover and increased costs, adversely affecting our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have a substantial number of employees who are paid on a part-time or per diem basis.  In 2023, California mandated minimum wage increases for certain industries, including ours.  As a result, we will experience increased compensation costs for certain of our employees and vendors beginning in 2024. As minimum wage rates increase, related laws and regulations change, and/or inflationary or other pressures increase wage rates, we and our partners may need to increase not only the wage rates of minimum wage employees, but also the wages paid to other hourly or salaried employees. If other states adopt similar minimum wage increases, the effect on our cost of operations would be compounded. In addition, we expect that inflationary pressures will continue to impact our salaries, wages, benefits and other costs.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because the majority of our services are performed under multi-year contracted rates with commercial insurance companies or through government programs such as Medicare and Medicaid, we may be unable to offset these increased labor costs.  Any such increase in costs, without an attendant increase in revenues or offsetting increase in operating efficiency, would reduce profitability and cash flows. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We face various risks related to health epidemics and other outbreaks, which may have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We face various risks related to health epidemics and other outbreaks, that have emerged and could emerge in the future, including:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">restrictions intended to slow the spread of outbreaks, including quarantines, government-mandated actions, stay-at-home orders and other restrictions, have led and may in the future lead to periods where our imaging procedure volumes drop significantly;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">disruptions in supply chains can affect the cost and availability of reagents and other materials needed for certain procedures; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">significant portions of our workforce may be unable to work due to illness, quarantines, facility closures, ineffective remote work arrangements or technology failures or limitations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">general economic downturns as a result of outbreaks may affect demand or pricing for our services; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">volatility in the global capital markets may result in a decrease in the price of our common stock, or an increase in our cost of capital. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Business interruptions due to natural disasters or other external events beyond our control can adversely affect our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations can be impacted by external events beyond our control, such as the effects of earthquakes, fires, floods, severe weather, public health issues, power failures, telecommunication loss, and other natural and man-made events, some of which may be intensified by the effects of climate change and changing weather patterns. Our corporate headquarters and over 100 of our radiology centers are located in California, which is subject to wildfires, blackouts, and potentially damaging earthquakes. In addition, several of our imaging centers located in parts of the east coast have suffered from weather events that caused us to temporarily close centers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These or other similar events could cause disruption or interruption to our operations and significantly impact our employees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any disruption to our services may result in decreases in revenues or increased operating and capital expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Historically, when we have experienced a reduction in business due to inclement weather or external events for a period of time, our operations have returned to a normalized level, but we have not experienced a significant increase of procedures that would fully compensate for the revenues lost during the slower periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changes in the method or rates of third-party reimbursement could have a negative impact on our results</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A significant portion of our business is derived from federal and state reimbursement programs such as Medicare or Medicaid.  From time to time those programs implement changes designed to contain healthcare costs, some of which have resulted in decreased reimbursement rates for diagnostic imaging services that impact our business. On November 16, 2023, Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) released the 2023 Medicare Physician Fee Schedule final rule, which contained significant payment reductions for radiology services, effective January 1, 2024, largely as a result of changes to relative value units, redistributive effects of the CMS proposed clinical labor pricing update and statutorily mandated budget neutrality rules. The January 18, 2024 continuing resolution passed by Congress and signed into law by President Biden did not contain provisions to stop or mitigate these reimbursement cuts. Furthermore, absent further and more permanent intervention from Congress, CMS could propose and impose similar or more significant reimbursement cuts in the months and years ahead</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">One of the principal objectives of health maintenance organizations and preferred provider organizations is to control the cost of healthcare services. Managed care contracting has become very competitive, and reimbursement schedules are at or below Medicare reimbursement levels. The expansion of health maintenance organizations, preferred provider organizations and other managed care organizations within the geographic areas covered by our network could have a negative impact on the utilization and pricing of our services, because these organizations will exert greater control over patients&#8217; access to diagnostic imaging services, the selections of the provider of such services and reimbursement rates for those services. Relatedly, reimbursement rate cuts may be pursued as a cost-saving measure by third party payors resulting from the implementation of the federal No Surprises Act (H.R. 133) and similar insurer-provider payment dispute laws, which also may negatively impact our revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any reduction in the rate that we can charge for our imaging services under these programs will reduce our net revenues and our operating margins per procedure under those reimbursement programs. Unless we can secure additional procedure volumes, increase utilization of our equipment, or change the overall mix of service procedures that we provide, a decline in reimbursement rates will reduce our net revenues and results of operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We experience competition from other diagnostic imaging companies and hospitals, and this competition could adversely affect our revenue and business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The market for diagnostic imaging services is highly competitive. We compete for patients principally on the basis of our reputation, our ability to provide multiple modalities at many of our centers, the location of our centers and the quality of our diagnostic imaging services. Our competitors include independent imaging operators, such as Akumin, Inc., and smaller regional operators, as well as hospitals, clinics and radiology groups that operate their own imaging equipment. Some of our competitors may have, now or in the future, access to greater financial resources than we do and may have access to newer, more advanced equipment. If we are unable to successfully compete, our business and financial condition would be adversely affected.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Technological change in our industry could reduce the demand for our services and require us to incur significant costs to upgrade our equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The development of new technologies or refinements of existing modalities may require us to upgrade and enhance our existing equipment before we may otherwise intend. Many companies currently manufacture diagnostic imaging equipment. Competition among manufacturers for a greater share of the diagnostic imaging equipment market may result in technological advances in the speed and imaging capacity of new equipment. In addition, advances in technology may enable physicians and others to perform diagnostic imaging procedures without us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our scale in both the number of our locations and the number and types of imaging equipment we offer is one of our competitive advantages.  If the development of new technologies accelerates the obsolescence of our current equipment, we may lose some of our competitive advantage.  We may also be required to accelerate the depreciation on existing equipment and incur significant capital expenditures to acquire the new technologies.  We may not have the financial ability to acquire the new or improved equipment and may not be able to maintain a competitive equipment base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Business Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contracted radiology practices terminate their agreements with us, our business could substantially diminish.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our business is substantially dependent on the radiology groups that we contract with to provide medical services at our imaging centers. The radiology groups are party to substantially all of the managed care contracts from which we derive revenue.  Under the terms of our management agreements, the radiology groups are required use their best efforts to provide medical services at our centers as well as any new centers that we open or acquire in their areas of operation. Although our management agreements are for multiple years, the radiology groups have the right to terminate the agreements if we default on our obligations and fail to cure the default. Also, the various radiology groups&#8217; ability to continue performing under the management agreements may be curtailed or eliminated due to the radiology groups&#8217; own financial difficulties, loss of physicians or other circumstances. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If any of our contracted radiology groups cannot perform their obligations to us, we would need to contract with one or more other radiology groups to provide the professional medical services. We may not be able to locate radiology groups willing to provide those services on terms acceptable to us, if at all. In addition, the radiology group&#8217;s relationships with referring physicians are largely responsible for the revenue generated at the centers they service. Any replacement radiology group&#8217;s relationships with referring physicians may not be as extensive as those of the terminated group. The termination of a management agreement with a radiology group could result in both short and long-term loss of revenue and adversely affect our performance and competitive position in the markets served by the departing radiology group.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each of the Group and our third party contracted radiology practices has entered into agreements with its physician shareholders and full-time employed radiologists that generally prohibit those shareholders and radiologists from competing for a period of two to five years within defined geographic regions after they cease to be owners or employees, as applicable. In certain states, like California, a covenant not to compete is enforced in limited circumstances involving the sale of a business. In other states, a covenant not to compete will be enforced only:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent it is necessary to protect a legitimate business interest of the party seeking enforcement;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it does not unreasonably restrain the party against whom enforcement is sought; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it is not contrary to public interest.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforceability of a non-compete covenant is determined by a court based on all of the facts and circumstances of the specific case at the time enforcement is sought. For this reason, it is not possible to predict whether or to what extent a court will enforce the contracted radiology practices&#8217; covenants. The inability of the contracted radiology practices or us to enforce a radiologist&#8217;s non-compete covenants could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on the ability of our contracted radiology practices, including the Group, to hire and retain qualified radiologists.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At times, there has been a shortage of qualified radiologists in some of the regional markets we serve. Competition in recruiting radiologists may make it difficult for our contracted radiology practices to maintain adequate levels of radiologists. If a significant number of radiologists terminate their relationships with our contracted radiology practices and those radiology practices cannot recruit sufficient qualified radiologists to fulfill their obligations under our agreements with them, our ability to maximize the use of our diagnostic imaging centers and our financial results could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are experiencing tighter labor conditions in some of the markets we serve.  As a result our contracting radiological practices have experienced increased salary and professional services expenses.  Increased expenses for the contracting radiological practices, including the Group, impacts our financial results because the management fee we receive from them, which is based on a percentage of their collections, is adjusted annually to take into account their expenses. Neither we, nor our contracted radiology practices, maintain insurance on the lives of any affiliated physicians. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to generate revenue depends in large part on referrals from physicians.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A significant portion of the services that we perform are derived from patient referrals from unaffiliated physicians and other third parties. Those physicians and other third parties do not have any contractual obligation to refer patients to us.  If a sufficiently large number of these physicians and other third parties were to discontinue referring patients to us, our imaging procedure volume would decrease, which would reduce our net revenue and operating margins. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, commercial third-party payors have implemented managed care programs that could limit the ability of physicians to refer patients to us. For example, health maintenance organizations sometimes contract directly with providers </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and require their enrollees to obtain these services exclusively from those contracted providers. Some insurance companies and self-insured employers also limit these services to contracted providers. These &#8220;closed panel&#8221; systems are now common in the managed care environment. Other systems such as preferred physician organizations create an economic disincentive for referrals to providers outside the system&#8217;s designated panel of providers. We seek to be the designated provider under these systems. If we are unable to compete successfully for these managed care contracts, our net revenues and our prospects for growth could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to professional malpractice liability, which could be costly and negatively impact our reputation and  business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The physicians employed by our contracted radiology groups are from time to time subject to malpractice claims. Under the terms of our management agreements with those radiology groups, we structure the relationship in a manner that we believe does not constitute our practice of medicine, or subject us to professional malpractice claims for acts or omissions of physicians employed by the contracted radiology practices. Nevertheless, claims relating to services provided by the contracted radiology practices have been asserted against us in the past and may be asserted against us in the future. In addition, we may be subject to other professional liability claims, including for improper use or malfunction of our diagnostic imaging equipment, or for accidental contamination, or injury from exposure to radiation. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We seek to mitigate this risk through the purchase of professional liability insurance. Any claim made against us that is not fully covered by insurance could be costly to defend, result in a substantial damage award against us and divert the attention of our management from our operations, all of which could have an adverse effect on our financial performance. In addition, successful claims against us may adversely affect our business or reputation. Although California places a $250,000 limit on non-economic damages for medical malpractice cases, no limit applies to economic damages and no such limits exist in the other states in which we provide services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not receive payment from some of our healthcare provider customers because of their financial circumstances.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We contract with commercial insurance and managed care providers to provide diagnostic imaging services to their members. Some of our healthcare provider customers do not have significant financial resources, liquidity or access to capital. If these customers experience financial difficulties they may be unable to pay us for the services that we provide. A significant deterioration in general or local economic conditions could have a material adverse effect on the financial health of certain of our healthcare provider customers. If our health care provider customers suffer financial hardship they could delay or default on their payment obligations to us, reducing our accounts receivable and negatively impacting our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitation fee arrangements could reduce our operating margins.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2023, we derived approximately 9% of our total net revenue from capitation arrangements, and we expect to continue to derive a significant portion of our revenue from capitation arrangements in the future. Under capitation arrangements, the payor pays us a pre-determined amount per-patient per-month, and in exchange we are required to provide all necessary covered services to the patients covered under the arrangement. These contracts pass much of the financial risk of providing diagnostic imaging services, including the risk of over-use, from the payor to us as the provider. Our ability to generate profit from these arrangements is dependent on our ability to correctly forecast demand for services for the patient base, negotiate appropriate pre-determined amounts with the payor and efficiently manage the utilization of those services. If we are not successful in forecasting demand patients or enrollees covered by these contracts require more frequent or extensive care than anticipated, or if we are not efficient in managing the utilization of services under these capitation arrangements, we would incur unanticipated costs not offset by additional revenue, which would reduce operating margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity threats and other disruption or malfunction in our information technology systems could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We rely on information technology systems to process, transmit and store electronic information including legally-protected personal information, such as diagnostic image results and other patient health information, credit card and other financial information, insurance information, and personally identifiable information. A significant portion of the communication between our personnel, patients, business partners, and suppliers depends on information technology. We rely on our information systems to perform functions critical to our ability to operate, including patient scheduling, billing, collections, image storage and image transmission. We also use information technology systems and networks in our operations and supporting departments such as research and development, marketing, accounting, finance, and human resources. The future success and growth of our business depends on streamlined processes made available through information systems, global communications, internet activity and other network processes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information technology system is vulnerable to damage or interruption from:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Cybersecurity attacks and breaches, ransomware and computer viruses, coordinated attacks by hackers, activist entities, organized criminal threat actors, and nation-state sponsored actors, seeking to disrupt operations or misappropriate information;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">technology service provider outages and technology supply chain cyber-security weaknesses; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">power losses, computer systems failures, internet and telecommunications or data network failures, operator negligence, improper operation by or supervision of employees, physical and electronic losses of data and similar events; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">earthquakes, fires, floods and other natural disasters; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">acts of vandalism or theft, misplaced or lost data, programming or human errors and similar events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cybersecurity threats are constantly changing, increasing the difficulty of successfully defending against them or implementing adequate preventive measures. While we maintain multiple layers of security measures and are continuously enhancing our security technologies to address new threats, emerging and advanced cybersecurity threats, including coordinated attacks, require additional layers of security which may disrupt or impact efficiency of operations.  We have in the past experienced unauthorized access to our network and could again face attempts by others to gain unauthorized access to information or to introduce malicious software to disrupt the operation of our information technology systems. While management is not aware of a cybersecurity incident that has had a material effect on our operations, there can be no assurances that a cybersecurity incident that could have a material impact on us will not occur in the future.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, loss of sensitive data and income, reputational harm, and diversion of funds. A successful ransomware or similar attack could disrupt or limit our ability to operate and generate revenue for an extended period of time  including our ability to retrieve patient records, schedule imaging procedures, store and transmit diagnostic images, bill payors or patients, provide customer assistance services, conduct research and development activities, collect, process and prepare company financial information, and manage the administrative aspects of our business, any of which could materially adversely affect our business. Extortion payments may alleviate the negative impact of a ransomware attack, but there is the risk that the threat actor may not destroy the stolen information and we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any such interruption in access, improper access, disclosure, modification, or other loss of information could result in legal claims or proceedings, liability or penalties under laws and regulations that protect the privacy of personal information, such as HIPAA, European data privacy regulations, such as the General Data Protection Regulation, or GDPR, or state privacy regulations, such as the California Consumer Privacy Act. We may be required to comply with state breach notification laws or become subject to mandatory corrective action. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Responding to such incidents could require us to incur significant costs related to rebuilding internal systems, defending against litigation, responding to regulatory inquiries or actions, paying damages, complying with consumer protection laws or taking other remedial steps with respect to third parties. If our data storage system was compromised, it could also give rise to unwanted media attention, materially damage our payor and physician relationships, and harm our business reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we maintain cyber liability insurance, our insurance may not be sufficient to protect against all losses we may incur if we suffer significant or multiple attacks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends in part on our key personnel and loss of key executives could adversely affect our operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our success depends in part on our ability to attract and retain qualified senior and executive management, and managerial and technical personnel. The loss of the services of Dr. Howard G. Berger, our President and Chief Executive Officer, and Norman R. Hames or Stephen M. Forthuber, our Presidents and Chief Operating Officers, West Coast and East Coast, respectively, could hinder our ability to execute our business strategy and have a significant negative impact on our operations. We believe that they could not easily be replaced with executives of equal experience and capabilities, which would adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The future growth of our imaging business is partially dependent on our ability to continue to successfully integrate acquired businesses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have experienced substantial growth through acquisitions that have increased our size, scope and geographic distribution of our imaging center business. During the past three fiscal years, we have completed acquisitions that  have added 45 centers to our fixed-site outpatient diagnostic imaging services.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We may never realize expected synergies or capitalize on expected business opportunities in connection with an acquisition.  Moreover, assumptions underlying estimates of expected cost savings may be inaccurate, or general industry and business conditions may deteriorate. Integrating operations requires significant efforts and expense on our part. Our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">management may have its attention diverted while trying to integrate an acquisition. Personnel may leave or be terminated because of an acquisition. If these factors limit our ability to integrate the operations of an acquisition successfully or on a timely basis, our expectations of future results of operations, including certain cost savings and synergies as a result of the acquisition, may not be met.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not generate the expected benefits from our investment in AI technologies or other new lines of business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that technology advancements including AI will significantly impact diagnostic imaging services in the future.  As part of our growth strategy we have acquired or invested in a number of AI companies and technologies, including DeepHealth, Inc., NuLogix Health, Inc., WhiteRabbit.ai, Aidence Holding B.V. and Quantib B.V. with the expectation that these  AI technologies can be developed into solutions that enhance  the quality of outcomes for patients via improved diagnostic imaging, reduce operating costs, and correspondingly improve our competitive position.  However, the success of our AI investments will depend upon a number of factors, some of which are out of our control, such as:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to effectively integrate the operations of the acquired companies, including retaining key personnel;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timeline and related expenses associated with applying for regulatory approvals necessary for commercialization; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">whether any of our existing or future AI products will receive European CE or U.S. FDA 510(k) clearance or other clearances and or regulatory approvals necessary for commercialization;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">whether our AI solutions will prove effective for improving health care quality, patient services or business procedures;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to successfully commercialize and secure market acceptance of our AI solutions from patients and health care providers; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the development of competing technologies by other companies, and the relative efficacy, cost and ease of use of those technologies. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There is no guarantee that we will receive the anticipated benefits from the investments we have made and may continue to make in the area of AI.  Any failure would result in reduced operating profits and the potential impairment of goodwill related to those investments, which would further impact our profitability.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the future we may acquire companies that create a new line of business. The process of integrating the acquired business, technology, service and research and development component into our business and operations and entry into a new line of business in which we are inexperienced may result in unforeseen operating difficulties and expenditures. In developing a new line of business, we may invest significant time and resources that take away the attention of management that would otherwise be available for ongoing development of our business. In addition, there can be no assurance that our new lines of business will ultimately be successful. The failure to successfully manage these risks in the development and implementation of new lines of business could have a material, adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare and Regulatory Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory framework in which we operate is continually evolving.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we are operating in compliance with applicable federal and state laws, neither our current or anticipated business operations nor the operations of our contracted radiology practices have been the subject of judicial or regulatory interpretation. We cannot assure you that a review of our business by courts or regulatory authorities will not result in a determination that could adversely affect our operations. In addition, healthcare laws and regulations may change significantly in the future in a way that restricts our operations. We continuously monitor these developments and modify our operations from time to time as the regulatory environment changes. We cannot assure you, however, that we will be able to adapt our operations to address new regulations or that new regulations will not adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have enacted statutes or adopted regulations affecting risk assumption in the healthcare industry, including statutes and regulations that subject any physician or physician network engaged in risk-based managed care contracting to comply with applicable insurance laws. These laws, if adopted in the states in which we operate, may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to us and the contracted radiology practices and limit our ability to enter into capitation or other risk-sharing managed care arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by eligibility changes to government and private insurance programs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to potential decreased availability of healthcare through private employers, the number of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will increase the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift in payor mix from managed care and other private payors to government payors as well as an increase in the number of uninsured patients may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease in net revenue. Changes in the eligibility requirements for governmental programs and state decisions on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase patient financial responsibility, resulting in a greater risk of uncollectible receivables. Furthermore, additional changes to, or rollback of, the PPACA, whether through legislation or judicial action, may also affect reimbursement and coverage in ways that are currently unpredictable. These factors and events could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complying with federal and state regulations is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly or indirectly, through the radiology practices with which we contract, subject to extensive regulation by both the federal government and the state governments in which we provide services, including:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Medicare and Medicaid Anti-Kickback Statute, and state anti-kickback prohibitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state billing and claims submission laws and regulations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH, and comparable state laws;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral prohibition commonly known as the Stark Law and state equivalents;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that prohibit the corporate practice of medicine and prohibit similar fee-splitting arrangements;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws governing the approval of healthcare transactions and complying with cost targets, including the California Health Care Quality and Affordability Act and its implementing regulations.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state laws governing the diagnostic imaging and therapeutic equipment we use in our business concerning patient safety, equipment operating specifications and radiation exposure levels; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws governing reimbursement for diagnostic services related to services compensable under workers' compensation rules; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state environmental and health and safety laws.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws and regulations to which we or the radiology practices with which we contract are subject, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment of our operations. Any penalties, damages, fines or curtailment of our operations, individually or in the aggregate, could adversely affect our ability to operate our business and our financial results. The risks of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State and federal anti-kickback and anti-self-referral laws may adversely affect income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various federal and state laws govern financial arrangements among healthcare providers. The federal Anti-Kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, the referral of Medicare, Medicaid, or other federal healthcare program patients, or in return for, or to induce, the purchase, lease or order of items or services that are covered by Medicare, Medicaid, or other federal healthcare programs. Similarly, many state laws prohibit the solicitation, payment or receipt of remuneration in return for, or to induce the referral of patients in private as well as government programs. Violation of these anti-kickback laws may result in substantial civil or criminal penalties for individuals or entities and/or exclusion from federal or state healthcare programs. We believe we are operating in compliance with applicable law and believe that our arrangements with providers would not be found to violate the anti-kickback laws. However, these laws could be interpreted in a manner inconsistent with our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law prohibiting certain physician self-referrals, known as the Stark Law, prohibits a physician from referring Medicare or Medicaid patients to an entity for certain &#8220;designated health services&#8221; if the physician has a prohibited financial relationship with that entity, unless an exception applies. Certain radiology services are considered &#8220;designated health services&#8221; under the Stark Law. Although we believe our operations do not violate the Stark Law, our activities may be challenged. If a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">challenge is successful, it could have an adverse effect on our operations. In addition, legislation may be enacted in the future that further addresses Medicare and Medicaid fraud and abuse or imposes additional regulatory burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Deficit Recovery Act, states enacting false claims statutes similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain qui tam or whistleblower provisions, receive an increased percentage of any recovery from a State Medicaid judgment or settlement. Adoption of new false claims statutes in states where we operate may impose additional burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with various licensure, certification and accreditation standards, we may be subject to loss of licensure, certification or accreditation, which would adversely affect our operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of our diagnostic imaging centers are subject to various federal and state laws, regulations and approvals concerning licensing of personnel, other required certificates for certain types of healthcare facilities and certain medical equipment. In addition, freestanding diagnostic imaging centers that provide services independent of a physician&#8217;s office must be enrolled by Medicare as an independent diagnostic treatment facility, or IDTF, to bill the Medicare program. Medicare carriers have discretion in applying the IDTF requirements and therefore the application of these requirements may vary from jurisdiction to jurisdiction. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, federal legislation requires all suppliers that provide the technical component of diagnostic MRI, PET/CT, CT, and nuclear medicine to be accredited by an accreditation organization designated by CMS (which currently include the American College of Radiology, the Intersocietal Accreditation Commission and the Joint Commission). Our MRI, CT, nuclear medicine, ultrasound and mammography centers are currently accredited by the American College of Radiology. We may not be able to receive the required regulatory approvals or accreditation for any future acquisitions, expansions or replacements, and the failure to obtain these approvals could limit the opportunity to expand our services.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our payors required that the physicians providing imaging services are credentialed, before the payor will commence  payment. We have experienced a slowdown in the credentialing of our physicians over the last several years which has lengthened our billing and collection cycle, and could negatively impact our ability to collect revenue from patients covered by Medicare.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensure and certification. If any facility loses its certification under the Medicare program, then the facility will be ineligible to receive reimbursement from the Medicare and Medicaid programs. For the year ended December 31, 2023, approximately 23% and 3% of our net service fee revenue came from Medicare and various state Medicaid programs, respectively. A change in the applicable certification status of one of our centers could adversely affect our other centers and, in turn, us as a whole. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our agreements with the contracted radiology practices must be structured to avoid the corporate practice of medicine and fee-splitting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of certain states prohibit us from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. These laws are enforced by state courts and regulatory authorities, each with broad discretion. A component of our business has been to enter into management agreements with radiology practices. We provide management, administrative, technical and other non-medical services to the radiology practices in exchange for a service fee typically based on a percentage of the practice&#8217;s revenue. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging centers, in a manner that we believe keeps us from engaging in the practice of medicine or exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting. State laws and enforcement efforts regarding corporate practice of medicine and fee-splitting are often subject to change.  As a consequence, there can be no assurance that our present arrangements with the Group or the physicians providing medical services and medical supervision at our imaging centers will not be challenged, and, if challenged, that they will not be found to violate the corporate practice of medicine or fee splitting prohibitions.  Any violation would subject us to potential damages, injunction and/or civil and criminal penalties or require us to restructure our arrangements in a way that would affect the control or quality of our services and/or change the amounts we receive under our management agreements. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we fail to comply with federal and state privacy and information security laws mandating protection of certain confidential data against disclosure, including cybersecurity attacks, we may be subject to government or private actions.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We must comply with numerous federal and state laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by the federal HITECH Act. Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including foreign state agents. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or to defend against cybersecurity attacks, could subject us to monetary fines, civil suits, civil penalties or criminal sanctions.  We could also be required to disclose the breach publicly, which may damage our business reputation with our patients and vendors and cause a further material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our imaging modalities use radioactive materials, which generate regulated waste and could subject us to liabilities for injuries or violations of environmental and health and safety laws.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our imaging procedures use radioactive materials, which generate medical and other regulated wastes. For example, patients are injected with a radioactive substance before undergoing a PET scan. Storage, use and disposal of these materials and waste products present the risk of accidental environmental contamination and physical injury. We are subject to federal, state and local regulations governing storage, handling and disposal of these materials. We could incur significant costs and the diversion of our management&#8217;s attention in order to comply with current or future environmental and health and safety laws and regulations. Also, we cannot completely eliminate the risk of accidental contamination or injury from these hazardous materials. Although we maintain professional liability insurance coverage in amounts we believe is consistent with industry practice in the event of an accident, we could be held liable for any resulting damages, and any liability could exceed the limits of or fall outside the coverage of our professional liability insurance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we have high fixed costs, lower scan volumes or other decreases revenues could  adversely affect the profitability of our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of our expenses are debt service, depreciation, compensation paid to technologists, salaries, real estate lease expenses and equipment maintenance costs. Because a majority of these expenses are fixed, a relatively small change in our revenue could have a disproportionate effect on our operating and financial results depending on the source of our revenue. Thus, decreased revenue as a result of lower scan volumes, product mix, or reductions in reimbursement rates could result in lower margins, which would materially adversely affect the profitability of our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our substantial debt could adversely affect our financial condition and prevent us from fulfilling our obligations under our outstanding indebtedness.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current substantial indebtedness and any future indebtedness we incur could adversely affect our financial condition. We are highly leveraged. As of December 31, 2023 term loan indebtedness, excluding related discount, was $823.1 million, of which the Barclays credit facility term loans were $678.7 million and the Truist credit facility term loan was $144.4 million. Our substantial indebtedness could also:</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it difficult for us to satisfy our payment obligations with respect to our outstanding indebtedness;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and other general corporate purposes;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expose us to the risk of interest rate increases on our variable rate borrowings, including borrowings under our Barclays and Truist credit facilities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to adverse general economic and industry conditions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds on terms that are satisfactory to us, or at all.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A restriction in our ability to make capital expenditures would restrict our growth and could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations, particularly the initial start-up and development expenses of new diagnostic imaging centers and the acquisition of additional centers and new diagnostic imaging equipment. We incur capital expenditures to, among other things, upgrade and replace equipment for existing centers and expand within our existing markets and enter new markets. If we open or acquire </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">additional imaging centers, we may have to incur material capital lease obligations. To the extent we are unable to generate sufficient cash from our operations, funds are not available under our credit facilities or we are unable to structure or obtain financing through operating leases, finance leases or long-term installment notes, we may be unable to meet the capital expenditure requirements necessary to support the maintenance and continued growth of our operations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may be required to recognize an impairment of our goodwill, other intangible assets, or other long-lived assets, which could have an adverse effect on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">When we acquire businesses we are generally required to allocate the purchase price to various assets including goodwill and other intangible assets. We are required to perform impairment tests for goodwill and other indefinite-lived intangible assets annually and whenever events or circumstances indicate that it is more likely than not that impairment exists.  We are also required to perform an impairment test of definite lived intangible or other long-lived assets when indicators of impairment are present. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have been required to recognize impairment charges in the past, and may again. In September 2023, we determined that an In-process Research and Development ("IPR&amp;D") indefinite-lived intangible asset related to Aidence Holding B.V.'s Ai Veye Lung Nodule and Veye Clinic would not receive FDA approval for sale in the US without a new submission and additional expenditures for rework in the original projected timeline. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the related IPR&amp;D intangible asset and resulted in impairment charges of $3.9 million. A future decline in our operating results, future estimated cash flows and other assumptions could impact our estimated fair values, potentially leading to a material impairment of goodwill, other intangible assets, or other long-lived assets, which could adversely affect our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our credit facilities and instruments governing our other indebtedness restrict certain operations of our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities contain affirmative and negative covenants which restrict, among other things, our ability to:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or make certain other restricted payments or investments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional indebtedness and certain disqualified equity interests;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens (other than permitted liens) securing indebtedness or trade payables;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell certain assets or merge with or into other companies or otherwise dispose of all or substantially all of our assets;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into certain transactions with affiliates;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create restrictions on dividends or other payments by our restricted subsidiaries; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create guarantees of indebtedness by restricted subsidiaries.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these restrictions could affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. A failure to comply with these covenants and restrictions would permit the relevant creditors to declare all amounts borrowed under the applicable agreement governing such indebtedness, together with accrued interest and fees, to be immediately due and payable. If the indebtedness under our credit facilities is accelerated, we may not have sufficient assets to repay amounts due under the credit facilities or on other indebtedness then outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Markets Risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible volatility in our stock price could negatively affect us and our stockholders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock on the NASDAQ Global Market has fluctuated significantly in the past. During the period from January 1, 2021 through December 31, 2023, the trading price of our common stock fluctuated from a high of $38.84 per share to a low of $12.03 per share. In the past, we have experienced a drop in stock price following an announcement of disappointing earnings or earnings guidance. Any such announcement in the future could lead to a similar drop in stock price. The price of our common stock could also be subject to wide fluctuations in the future as a result of a number of other factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expectations as to future financial performance or buy/sell recommendations of securities analysts;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our, or a competitor&#8217;s, announcement of new services, or significant acquisitions, strategic partnerships, joint ventures or capital commitments; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the operating and stock price performance of other comparable companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the U.S. securities markets periodically experience significant price and volume fluctuations. These fluctuations often have been unrelated to the operating performance of companies in these markets. Broad market and industry factors may lead to volatility in the price of our common stock, regardless of our operating performance. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of volatility in the market price of an individual company&#8217;s securities, securities class action litigation often has been instituted against that company. The institution of similar litigation against us could result in substantial costs and a diversion of management&#8217;s attention and resources, which could negatively affect our business, results of operations or financial condition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of the Delaware General Corporation Law and our organizational documents may discourage an acquisition of us.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we could become the subject of an unsolicited attempted takeover of our company. Although an unsolicited takeover could be in the best interests of our stockholders, our organizational documents and the General Corporation Law of the State of Delaware both contain provisions that will impede the removal of directors and may discourage a third-party from making a proposal to acquire us. For example, provisions in our organizational documents:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the board of directors to increase its own size, within the maximum limitations set forth in the bylaws, and fill the resulting vacancies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize the issuance of shares of preferred stock in one or more series without a stockholder vote;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit transfers and/or acquisitions of stock (without consent of the Board of Directors ) that would result in any stockholder owning greater than 5% of the currently outstanding stock resulting in a limitation on net operating loss carryovers, capital loss carryovers, general business credit carryovers, alternative minimum tax credit carryovers and foreign tax credit carryovers, as well as any loss or deduction attributable to a &#8220;net unrealized built-in loss&#8221; within the meaning of Section 382 of the internal revenue code of 1986, as amended.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the Delaware General Corporation Law, which could have the effect of delaying or preventing a change in control.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_22"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Unresolved Staff Comments</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_1309"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Cybersecurity</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Risk Management and Strategy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a healthcare provider, cybersecurity, data protection, safeguarding patient information and the integrity of our information systems is of the utmost priority.  We have developed and maintain a  Cybersecurity and Data Protection Program which aligns with industry-standard frameworks and applicable regulatory requirements, integrates with our overall risk management process, and aims to ensure cybersecurity concerns are a requisite element for decision-making at all levels of our business.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RadNet&#8217;s Cybersecurity and Data Protection Program assesses, identifies and manages threats to our information systems and evaluates cybersecurity risks associated with our vendors and third-party partners.  We are focused on detecting, preventing and responding to cyber threats, maintaining the privacy and protection of sensitive information, and maintaining the durability and resiliency of our information and data processing systems.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approach to designing, operating and measuring the effectiveness of our program leverages experienced internal resources, industry-recognized cybersecurity consultants, assessors, healthcare and industry-specific cybersecurity working groups and threat-intelligence platforms, federal law enforcement and CISA partnerships.  We use these resources and partnerships, along with our internal expertise, to develop specialized insights pertinent to our business&#8217;s cyber-risk, and tailor our cybersecurity strategy to best safeguard our systems and data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We staff an internal cybersecurity team and maintain a third-party managed security operations center which in-concert provide 24x7x365 real-time detection and response.  These teams are always connected and routinely respond to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">perceived threats within minutes.  Time to detect and respond metrics are continuously evaluated for opportunities to enhance our program.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cyber-awareness training and testing is a key component of RadNet&#8217;s Cybersecurity and Data Protection Program.  Every employee is required to complete cyber-related training (including third-parties who access our systems) and successfully complete testing throughout the year in addition to monthly phishing tests.  Furthermore, we require all system users to complete annual Patient Privacy and Patient Data Breach training and testing to meet RadNet compliance standards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We benchmark and evaluate our Cybersecurity and Data Protection Program and data protection maturity against the NIST Cybersecurity Framework and the HIPAA Security Rule.  Consistent with these frameworks, our program includes recurring third-party assessments and a vendor risk management program.  Our vendor risk management program conducts security assessments to determine a risk profile of potential vendors and third-party partners and integrates ongoing monitoring and periodic re-assessments to ensure compliance with RadNet&#8217;s security standards.  RadNet&#8217;s Vendor Risk Management Team works closely with RadNet Legal, Compliance and Operations teams to address data safety, compliance and legal requirements for each of our vendor/partner engagements.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continuously evaluate the practical effectiveness of our cyber-defenses both internally and externally using a combination of technology-based assessments and recurring third-party audits.  Our Critical Incident Response Team periodically conducts cyber-focused tabletop exercises using scenarios drawn from observations of risk indicators and from threat intelligence reports of real-world incidents affecting our industry.  Outcomes and insights from tabletop exercises are used to enhance RadNet&#8217;s Incident Response Plan which is architected following NIST guidelines and reviewed annually and updated periodically as needed.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our program's overall maturity and operational readiness are regularly evaluated internally by RadNet IT Governance and Compliance teams and by independent expert auditors using the NIST's Cybersecurity Framework. Our program, and the results of the evaluation and testing efforts, are regularly reviewed by our senior management and members of our Board of Directors. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybersecurity threats, including previous cybersecurity incidents, have not materially affected our business strategy, results of operations, or financial condition.  However, cybersecurity threats have the potential to interrupt our operations or cause significant financial hardship.  Our risks associated with cybersecurity threats are set forth under &#8220;Risk Factors&#8221; in Part I, Item 1A in this report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Governance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RadNet is committed to appropriate cybersecurity governance and oversight. Our Cybersecurity and Data Protection Program is the principal responsibility of our Chief Information Officer and Chief Information Security Officer, each of whom have over 20 years of experience in information systems, including cybersecurity training and experience. Additionally, RadNet&#8217;s CIO and CISO work closely with our executive management, legal and compliance leaders, and meet regularly to discuss cybersecurity matters and risks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors oversees management's processes for identifying and mitigating risks, including cybersecurity and information security risks. Our Audit Committee of our Board of Directors regularly reviews our technology and cybersecurity program and effectiveness, and internal audits of our program. Our Audit Committee also receives regular cybersecurity updates and education on a broad range of topics, including: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">current cybersecurity landscape and emerging threats; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">status of ongoing cybersecurity initiatives and strategies; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">incident report and learnings from any cybersecurity events; and </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">compliance with regulatory requirements and industry standards. </span></div><div><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_25"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Properties</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters is located in adjoining premises at 1508, 1510 and 1516 Cotner Avenue, Los Angeles, California 90025, and approximately 21,500 square feet is occupied under these leases, which including options, expire June&#160;30, 2027. We also have a regional office of approximately 39,000 square feet in Baltimore, Maryland under a lease, which including options, expires September&#160;30, 2028. In addition, we lease approximately 36,700 square feet of warehouse space nationwide, which expire at various dates, including options, through December&#160;31, 2028. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, we operated directly or indirectly through joint ventures with hospitals, 366 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial lease term varies in length from 5 to 15 years. Factoring in renewal options, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations, usually for one year terms, that are renewable on mutual consent with the landlord. Rental increases can range from 1% to 10% on an annual basis, depending on the location and market conditions where we do business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, total square footage operated directly or indirectly under lease, including medical office, administrative and warehouse locations, was approximately 2.7 million square feet.  All leasing activity described relates solely to our Imaging Center segment, as our AI segment leasing activity is currently immaterial.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_28"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Legal Proceedings</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we are engaged in the defense of lawsuits arising out of the ordinary course of our business. We do not believe that the outcome of our current litigation will have a material adverse impact on our business, financial condition and results of operations. However, the outcome of litigation is inherently uncertain.  If one or more legal matters were resolved against us in a reporting period for amounts above management&#8217;s expectations, our financial condition and operating results could be materially adversely affected.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_31"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mine Safety Disclosures</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Trading Market</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is quoted on the NASDAQ Global Market under the symbol &#8220;RDNT&#8221;.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of  February&#160;27, 2024, the number of holders of record of our common stock was 1,001.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock and we do not expect to pay any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance the growth and development of our business. Our current credit facilities place restrictions on our ability to issue dividends. See discussion under &#8220;Liquidity and Capital Resources&#8221; regarding our current credit facilities. Payment of future dividends, if any, will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements and such other factors as the board of directors deems relevant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the yearly percentage change in cumulative total stockholder return of our common stock during the period from 2018 to 2023 with (i) the cumulative total return of the S&amp;P 500 index and (ii) the cumulative total return of the S&amp;P 500 &#8211; Healthcare Sector index. The comparison assumes $100 was invested on December&#160;31, 2018 in our common stock and in each of the foregoing indices and the reinvestment of dividends through December&#160;29, 2023. The stock price performance on the following graph is not necessarily indicative of future stock price performance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Form 10-K into any filing under the Securities Act or under the Exchange Act, except to the extent that RadNet specifically incorporates this information by reference, and shall not otherwise be deemed filed under the Securities Act or the Exchange Act.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><img src="rdnt-20231231_g1.jpg" alt="1833" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL RETURN PERCENTAGE<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/23</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.61&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.60)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.86&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.46)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.65&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.82&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.45&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.13&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.96)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.06&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:29.975%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEXED RETURNS<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/23</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.61&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.43&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.07&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.15&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.89&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.82&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.07&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.89&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.51&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.00&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2023, we issued 64,569 shares of common stock to settle a milestone contingent liability as part of our purchase of Heart &amp; Lung Imaging Limited. The shares were ascribed a value of $2.3 million. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2023, we issued 56,600 shares of common stock to settle a milestone contingent liability as part of our purchase of Heart &amp; Lung Imaging Limited. The shares were ascribed a value of $1.6 million. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 7, 2023, we issued 113,303 shares of common stock to settle the stock portion of a holdback contingent liability as part of our purchase of Quantib B.V. The shares were ascribed a value of $3.5 million. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2023, we issued 114,227 shares of common stock to settle a holdback contingent liability as part of our purchase of  Aidence Holding B.V. The shares were ascribed a value of $4.0 million. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of the foregoing transactions, the shares of common stock issued without registration on the basis of the exemption for private placement transactions provided by Section 4(a)(2) of the Securities Act.</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_40"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Reserved</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) is intended to help the reader understand the results of operations and financial condition of RadNet, Inc. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes included in this annual report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of diagnostic imaging services in the United States. At December 31, 2023, we operated directly or indirectly through joint ventures with hospitals, 366 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Internationally, our subsidiary Heart &amp; Lung Imaging Limited, provides teleradiology services for remote interpretation of images on behalf of providers within the framework of the United Kingdom's National Health Service.  Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting, in the notes accompanying our consolidated financial statements included in this report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our imaging centers centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients.  Integral to the imaging center business is our software arm headed by eRad, Inc., which sells computerized systems that distribute, display, store and retrieve digital images. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also established an Artificial Intelligence (AI) business, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images.  The division is led by our DeepHealth, Inc. subsidiary and includes our acquisitions of Aidence Holding B.V. and Quantib B.V., both based in the Netherlands.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table shows our imaging centers in operation at year end and revenues for the years ended December 31, 2023, 2022 and 2021:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers in operation</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors and commercial insurance companies, managed care capitated payors, and government payors such as Medicare and Medicaid. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. Our service fee revenue, net of contractual allowances and discounts, implicit price concessions, and revenue under capitation arrangements for the years ended December 31, 2023, 2022 and 2021 are summarized in the following table (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,175&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,279&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,249&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,849&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,082&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,238&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,433&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,045&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when&#160;securing medical care&#160;will result in significant out-of-pocket expenditures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Equity Investments and Joint Venture Activity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion summarizes certain details concerning our acquisition or disposition of centers, our equity investments and our joint venture transactions.  See Note 4, Business Combinations and Related Activity and Note 2,  Summary of Significant Accounting Policies, in the notes accompanying our consolidated financial statements included in this report for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Radiology Imaging Center Asset Acquisitions:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended 2023, 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in many of our markets.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2023:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,689)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison Radiology Medical Group, Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Diagnostic Imaging, P.A.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10,765</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$3,942</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$8,173</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$6,473</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$300</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$50</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(8,173)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#x5E;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#x5E;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,200</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,800</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,877</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,665</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,690</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Dignostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$142,781</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$22,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$7,225</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$106,045</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,325</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(2,145)</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(6,684)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#x5E; IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for  $1.2 million in contingent consideration.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+See detailed description of the Heart &amp; Lung Imaging Limited acquisition below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart &amp; Lung Imaging Limited.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we acquired a 75% controlling interest in Heart &amp; Lung Imaging Limited (&#8220;HLI&#8221;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#8217;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $31.9 million, including: (a) shares of our common stock with a fair value of $6.8 million </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(359,002 shares issued at $19.06 per share), (b) cash of $6.3 million, (c) contingent consideration of $10.8 million ($10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims) and (d) noncontrolling interest of $8.0 million. We recorded $0.6 million in current assets, $15.8 million in intangible assets, $0.6 million current liabilities and $16.2 million in goodwill in connection with this transaction.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 19.0%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we acquired all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on developing artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2&#160;million including (a) 1,117,872 shares of our common stock issued at $26.80 per share with a fair value of $30.0&#160;million (b) cash of $1.8&#160;million, (c) contingent consideration of $11.9&#160;million ($7.4&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $4.5&#160;million) and (d) a settlement of a loan from RadNet of $1.5&#160;million.  In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6&#160;million.  As a result of this transaction, we recorded $1.0&#160;million in current assets, $0.2&#160;million in property and equipment, $27.7&#160;million in intangible assets (including developed technology of $21.1&#160;million and IPR&amp;D of $5.5&#160;million), $3.2&#160;million in current liabilities, a deferred tax liability of $3.5&#160;million, and $22.9&#160;million in goodwill. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.  As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15% to 17%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company originally expected to complete the project following twelve months of acquisition. Subsequently, in September 2023, we determined that the IPR&amp;D related to Aidence's Ai Veye Lung Nodule and Veye Clinic would not achieve FDA approval for sale in the US without a new submission and additional expenditures for rework. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the associated IPR&amp;D intangible asset and resulted in an impairment charge of $3.9&#160;million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated financial statements included with this report.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The useful lives for the developed technology asset was set at 7 years, for customer relationships 5.4 years, and trade names was 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding our AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on developing artificial intelligence powered applications for neurological and prostate imaging scans and reporting.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3&#160;million including (a) 965,058 shares of our common stock  issued at $26.80 per share with a fair value of $25.9&#160;million (b) cash of $11.8&#160;million and (c)  contingent consideration consisting of 113,303 shares with a fair value at the date of close of $3.0&#160;million and cash of $1.6&#160;million both to be released 18 months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $2.4&#160;million in current assets, $0.1&#160;million in property and equipment, $21.3&#160;million in intangible assets (including developed technology of $19.6&#160;million and IPR&amp;D of $0.7&#160;million), $0.7&#160;million in current liabilities, $6.7&#160;million in long-term debt and deferred tax liabilities, and $26.4&#160;million in goodwill.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.  As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 50% to 55%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at seven years, customer relationships three years, and trade names seven years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding our AI capabilities to drive revenue growth.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiaries</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Los Angeles Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of three locations in Los Angeles, California. We contributed the operations of 3 centers to the subsidiary. Cedars-Sinai Medical Center purchased from us a 35% noncontrolling economic interest in LAIG for a cash payment of $5.9 million. As a result of the transaction, we retain a 65% controlling economic interest in LAIG.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frederick County Radiology, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc.  The operation offers multi-modality services out of six locations in Frederick, Maryland.  We contributed the operations of four centers to the enterprise and Frederick Health Hospital, Inc. contributed $5.4 million in fixed assets, $3.0 million in equipment, and  $11.0 million in goodwill.  As a result of the transaction, we recognized a gain of $6.6 million to additional paid in capital and retained a 65% controlling economic interest in FCR and Frederick Health Hospital, Inc. retains an $11.1 million or 35% noncontrolling economic interest in FCR.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Radiology at Capital Region, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022 we formed Advanced Radiology at Capital Region, LLC, a partnership with Dimension Health Corporation, an affiliate of the University of Maryland.  The operation will provide multi-modality services out of two yet to be determined locations in the Largo, Maryland area.  The venture was initially capitalized with nominal amounts of $5.1&#160;thousand for a 51% economic interest from us and $4.9&#160;thousand from Dimension Health Corporation for a 49% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simi Valley Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we formed the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services.  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. We contributed $0.3 million in assets for a 60.0% economic interest and Simi Valley Hospital and Health Services contributed assets totaling $0.1 million for a 40.0% economic interest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Santa Monica Imaging Group, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars-Sinai Medical Center the Santa Monica Imaging Group, LLC ("SMIG"), consisting of two multi-modality imaging centers located in Santa Monica, California with RadNet holding a 40% economic interest and Cedars-Sinai Medical Center holding a 60% economic interest. We account for our share of the venture under the equity method. On January 1, 2019, Cedars-Sinai Medical Center purchased an additional 5% economic interest in SMIG from us and, as a result, our economic interest in SMIG was reduced to 35%.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, we contributed an additional multi-modality imaging center and a newly constructed imaging center located in Beverly Hills, California valued at $27.2 million and purchased an additional economic interest in SMIG for cash payment of $11.3 million. Simultaneously, Cedars-Sinai Medical Center contributed five additional multi-modality imaging centers located in Santa Monica, California. As a result of the transaction, our economic interest in SMIG has been increased to 49%. We recorded a gain of  $16.8 million, within (gain) on contribution of imaging centers into joint venture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our consolidated statement of operations representing the difference between the fair value and carrying value of the business contributed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Following the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contributions to Arizona Diagnostic Radiology Group</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2023 and 2022, we made additional equity contributions of $2.4 million and $1.4 million, respectively, to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022 we contributed eight of our imaging centers to ADRG of $12.7 million and recorded a loss of $0.5 million which was calculated as the difference between the transaction price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $4.5 million of the transaction price as an offset to due to affiliates while the remaining $8.3 million was recorded as investment in joint venture on our balance sheet. We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed. To maintain our 49% economic interest in ADRG, we received a distribution from the partnership of $4.5 million to reduce our overall investment to $8.3 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to net revenue for the years 2023, 2022 and 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swaps</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for  income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO RADNET, INC.</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022 </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grow our imaging center business through a combination of organic growth as well as acquisitions and joint ventures.  In the discussion below same center metrics are based on imaging centers that were in operation throughout the period of January 1, 2022 through December 31, 2023.  Excluded amounts relate to imaging centers that were acquired or divested between January 1, 2022 through December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,604,161</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,425,665</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$178,496</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,465,076</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,372,134</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$92,942</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$139,085</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53,531</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall revenue change was driven by procedure volume growth of 5.7% compared to the same period in the prior year. On a same center basis, the increase in revenue was largely attributable to product mix as advanced radiology procedures of MRI, PET, and CT expanded at combined 7.2% to provide the major portion of the revenue growth.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the twelve months ended December 31, 2023 increased approximately $130.8 million, or 9.7%, from $1.35 billion for the twelve months ended December 31, 2022 to $1.48 billion for the twelve months ended December 31, 2023.  The following table sets forth our cost of operations and total operating expenses for the twelve months ended December 31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860,464&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778,586&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,660&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,150&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,124&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,157&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,036&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240,593&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,808)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,484,314&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353,549&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecommunications, utilities, marketing, travel and other expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160; Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div style="margin-top:5pt;padding-left:31.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:54.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$860,464</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$778,586</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81,878</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$805,096</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$757,989</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47,107</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55,368</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,597</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the prior year, growth in procedure volumes precipitated increases in salary expenses to meet additional professional staffing needs and we increased salaries as we seek to retain our skilled work force in the current tight labor market.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stock-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation decreased $3.6 million, or 17.1%, to approximately $24.6 million for the twelve months ended December 31, 2023 compared to $21.0 million for the twelve months ended December 31, 2022. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Building and equipment rental</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$117,660</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$123,150</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($5,490)</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$104,257</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$113,277</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($9,020)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,403</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,873</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in building and equipment rental was the result of our contribution of  Phoenix, AZ imaging centers in connection with the formation of the Arizona Diagnostic Radiology Group joint venture in November 2022 and from the buyout of radiology equipment lease contracts during the year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Medical supplies</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$86,213</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$68,712</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17,501</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$79,550</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$64,872</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,678</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,663</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,840</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased medical supplies expense was related to the 7.2% growth in advanced radiology volumes noted above, combined with price increases for contrast agents and higher utilization of isotopes employed in PET and CT procedures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other operating expenses</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$282,124</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$249,157</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32,967</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$259,164</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$240,084</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,078</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,960</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,073</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rise in other operating expenses is attributable to additional professional fees associated with our acquisition activity, contractor services, equipment and maintenance and software upgrades all in support of our expansion and increase in procedure volumes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional segment operating and non operating expenses:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$120,776</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$109,524</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,252</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss  on disposal of equipment and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,191</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,506</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($315)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) Loss on contribution of imaging centers into joint venture</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($16,808)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($16,808)</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,185</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($39,621)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47,806</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120.7)%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expenses</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($7,756)</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,467</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($11,223)</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323.7)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,972</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$926</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,046</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.0%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nm=not meaningful</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in depreciation expense was the result of our higher depreciable asset base.  For the year ended  December 31, 2023, we recognized a gain on the contribution of assets into our Santa Monica Imaging Group LLC joint venture.  The non-cash expense associated with the change in fair value of our interest rate swaps for the year ended December </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31, 2023 related to the expiration of our notional $100 million in 2019 swaps and the shorter term on our remaining $400 million notional 2019 swaps.  The gain associated with the non-cash change in fair value of interest rate swaps during the year ended December 31, 2022 was driven by the significant increase in interest rates experienced during the period. Other income for the year ended December 31, 2023 included money market interest income of $10.9 million, offset by an eRad loss on investments of $3.1 million. Other expenses in 2022 included approximately $0.7 million of debt restructuring charges related to the refinancing of our credit facilities with Truist in 2022 and an eRad loss on investments of $2.9 million. See Note 8, Credit Facilities and Notes Payable, in the notes accompanying our consolidated financial statements included in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease abandonment charges</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers to maximize utilization rates. During the end of 2023, we experienced lower utilization at two imaging centers. As a result, we abandoned the leases related to these locations at the end of 2023 and diverted the patients to our other sites in the area. We recorded a charge of approximately $5.1&#160;million in December 2023 related to lease facilities abandonment. The lease abandonment charges include the impairment of associated right-of-use assets of $2.7 million and write off of related leasehold improvements of approximately $2.5 million.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,147</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,147</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,147</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,147</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, we determined that an IPR&amp;D  indefinite-lived intangible asset related to Aidence's Ai Veye Lung Nodule and Veye Clinic would not receive FDA approval for sale in the US without a new submission and additional expenditures for rework in the original projected timeline. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the related IPR&amp;D intangible asset and resulted in impairment charges of $3.9 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:53.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$64,483</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50,841</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,642</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to derivatives*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(9,752)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,806</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to amortization**</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,987</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,693</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Interest Expense***</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71,248</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,342</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30,906</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6%</span></td></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Includes payments from 2019 swaps</span></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Includes noncash amortization of deferred loan costs and discount on issuance of debt</span></div><div style="margin-top:4pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***Includes interest related to our term loans, revolving credit line, notes, and other</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rise in adjusted interest expense is attributable to higher overall loan balances in combination with increased variable interest rates paid on those balances in comparison to the same period in the prior year. During 2022 we refinanced our Truist term loan which added an additional $108.0 million in obligations to our balance sheet in the fourth quarter. Based on recent Federal Reserve interest rate decisions, we expect the effective interest rates on our senior credit facilities, and the related interest expense, to stabilize in the near term. See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> To mitigate our future floating rate interest expense exposure we entered into the 2019 swaps with locked in interest rates for one-month Term SOFR of 1.89% for $100 million of notional value and 1.98% for $400 million of notional value.  We are liable for premium payments to the 2019 swap counterparties if interests rates are below the arranged rates, and receive payments from the 2019 swap counterparties if interest rates exceed the arranged rates.  If interest rates were to theoretically </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reduce to 0%, our maximum premium payment would be the difference between the two swapped rates and 0% then multiplied by the notional value of the swaps, or $1.89 million per year for the $100 million swap and $8.0 million per year for the $400 million swap.  Payments under the 2019 swaps are settled in cash on a monthly basis. During the year ended December 31, 2023, interest rates were above the arranged rates for most of the year and we received payment of $14.5 million in cash payments from our 2019 swap counterparties, which was reported a component of interest expense. See the Derivative Instruments section of Note 2, Summary of Significant Accounting Policies, in the notes accompanying the consolidated financial statements included in this report and Item 7A &#8212;  "Quantitative and Qualitative Disclosure About Market Risk" below for more details on our derivative transactions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:118%">Non-cash change in fair value of interest rate hedge</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">In 2020, we determined that the cash flows from the 2019 swaps did not match the cash flows of our Barclays term loan and were therefore ineffective as cash flow hedges.  Since that time, in accordance with accounting guidelines, all changes in fair value are being recognized in other income and expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">The fair value of the 2019 swaps at December 31, 2023 was a net asset of $15.1 million compared to a net asset of $23.3 million December 31, 2022, resulting in a loss of $8.2 million during the year ended December 31, 2023, which decreased the Company&#8217;s tax provision by $2.1 million.  The significant change in fair value was caused by the expiration of the $100 million swap in October 2023 and the shorter remaining term on the $400 million swap, which offset the increase in market interest rates and the steepening of the yield curve.  The one-month Term SOFR rate at December 31, 2023 was approximately 5.47%, higher than the 4.33% one-month Term SOFR rate at December 31, 2022 and significantly above the 1.98% arranged rate for the $400 million portion of the 2019 swaps.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2023 we recognized equity in earnings from unconsolidated joint ventures of $6.4 million versus $10.4 million for the twelve months ended December 31, 2022, a decrease of $4.0 million or 38.1%. The decrease in equity in earnings from unconsolidated joint ventures was due to the formation of Arizona Diagnostic Radiology Group in November 2022, which operated at a net loss in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to noncontrolling interests</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, our consolidated subsidiaries operated 321 imaging centers of which 85 were not wholly-owned and thus a portion of their operating results were attributable to noncontrolling interests. At December 31, 2022, our consolidated subsidiaries included 318 centers of which 81 were not wholly-owned. As noncontrolling interests only represent a portion of our imaging center business, and excludes our AI segment which generated losses of $21.2 million in 2023, we do not expect changes in net income attributable to noncontrolling interests to correlate with changes in consolidated operating income or pretax income.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2023, we recognized net income attributable to noncontrolling interests of $27.3 million versus $23.0 million for the twelve months ended December 31, 2022, an increase of $4.3 million. The increase in net income attributable to noncontrolling interests was primarily due to the formation of a new majority owned subsidiary, Los Angeles Imaging Group, LLC in September 2023 as described in Note 4 to the consolidated financial statements. We contributed the operations of three centers to Los Angeles Imaging Group, LLC, and Cedars-Sinai Medical Center contributed cash.  Net income attributable to noncontrolling interests was also improved as a result of our acquisition of various interests in 2022, which were able to operate for full twelve months in 2023.  In October 2022, our consolidated joint venture New Jersey Imaging Network, LLC, acquired the assets of Montclair Radiological associates, P.A. In November 2022 we acquired a 75% controlling interest in Heart &amp; Lung Imaging Limited. Additionally in April 2022 we formed a new majority owned subsidiary, Frederick County Radiology, LLC.  See Note 4, Business Combinations and Related Activity, in the notes accompanying our consolidated financial statements included in this report, for a more detailed discussion of these acquisitions.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AI Segment</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022 </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with a current emphasis on breast, prostate, and lung cancer diagnostics.  The  breakdown of revenue and expenses of the segment for the twelve months ended December 31, 2023 and 2022 are as follows:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">             </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.107%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Statement of Operations</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$12,469</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$4,396</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$8,073</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Salaries and Wages</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,168</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,799</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,369</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other operating</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,171</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation &amp; Amort.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,615</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,354</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other operating loss</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,619</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,148</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,470</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21,150)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25,752)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,602</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,402</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(903)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,305</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22,552)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,851)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,299</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,955)</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,395)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,440</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($20,597)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($21,456)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$859</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenues for the AI segment was driven by the launch of new imaging products, including our Enhanced Breast Cancer Detection product which was initially released in 2022 and is being rolled out in certain of our imaging centers.  The increase in operating expenses for the AI segment was primarily related to salary expense as we increased headcount in connection with the commercialization of our initial AI products.  Our net loss for the segment was consistent with the prior year.  We expect that our AI segment will continue to generate net losses over the next several years.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the comparison of results of operations for the year ended December 31, 2022 to the year ended December 31, 2021, for both out Imaging Center and AI segments, please see Item 7 &#8212; "Management's Discussion and Analysis of Financial Condition and Operations" in our Form 10-K for the year ended December 31, 2022, filed with the SEC on March 1, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results. We believe that, in addition to GAAP metrics, non-GAAP metrics such as Adjusted EBITDA assist us in measuring our core operations from period to period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the Company&#8217;s core financial performance against other periods.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures, gain on contribution of imaging centers into joint ventures, and non-cash equity compensation.&#160; Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or one-time events that take place during the period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, or other financial statement data presented in the consolidated financial statements as an indicator of financial performance.  Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation and this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the nearest comparable GAAP financial measure, net income, to Adjusted EBITDA for the years ended December 31, 2023, 2022, and 2021, respectively (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,044&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,483&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,841&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,830&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,391&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,877&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,694&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,529&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,044&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,185&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,621)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,670)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on contribution of imaging centers into joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non operational rent expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Capitalized R&amp;D - DeepHealth Cloud OS &amp; Generative AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs HLH,  Aidence Holding B.V., Quantib B.V, and WhiteRabbit</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment for contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimate related to refund liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,089&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 82pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA Including Losses from AI Segment and Provider Relief Funding</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$232,343</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$192,474</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$218,928</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 82pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment and excluding benefit from Provider Relief Funding</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$232,343</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$192,474</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA Losses from AI segment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,575&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 82pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA excluding Losses from AI Segment and Provider Relief Funding</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$245,108</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$209,049</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$211,940</span></td></tr></table></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table is a reconciliation of GAAP net income for our AI Segment to Adjusted EBITDA for the years ended December 31, 2023, 2022 and 2021 respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.424%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,597)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,456)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,060)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,615&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,354&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,955)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,395)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change to contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of IPR&amp;D intangible asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA AI Segment</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,765)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,575)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,122)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cash we generate from our core operations enables us to fund ongoing operations, our research and development for new products and technologies including our investment in AI, and acquisition or expansion of imaging centers.  We expect to continue to generate positive cash flows from operations for the foreseeable future.  In June 2023, we closed on a public offering of our common stock raising net proceeds, after deducting underwriting discounts, commissions, and expenses, of $245.8 million. Accordingly, we believe that our current sources of funds will provide us with adequate liquidity during the 12-month period following December 31, 2023, as well as in the long-term.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key balance sheet data as of December 31, 2023 and December 31, 2022 and income statement data for the twelve months ended December 31, 2023, 2022 and 2021 (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Data for the period ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,570&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,834&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liability)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,805&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,932)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Statement data for the twelve months ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,630&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to ongoing operations, we invest in the purchase of imaging facilities, the acquisition of equipment, and the acquisition of technology to fund our growth. If economic or global business conditions slowed, we expect that we will be able to adjust the pace of our investment activities.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continually evaluate our cash needs and may decide it is best to raise additional capital or seek alternative financing sources to fund the rapid growth of our business, including through draw-downs on existing or new debt facilities or financing funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> We expect to fund any future capital requirements primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.  We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash for the twelve months ended December 31, in thousands:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,863&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,417&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,491&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,470)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246,949)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221,511)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,635&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,647&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,673&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities for the period ended December&#160;31, 2023 included $261.1 million in net income reconciling adjustments and $40.3 million change in assets and liabilities. The $68.3 million increase in cash provided by operating activities for the year ended December 31, 2023 compared to December 31, 2022 was primarily driven by an increase in income from operations and timing of payment.</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the twelve months ended December 31, 2023 decreased from December 31, 2022 by $45.5 million. The changes included a $119.0 million reduction in purchases of  imaging centers and other AI operations compared to 2022 which included our acquisition of Aidence Holding B.V. and Quantib B.V. for net consideration of $45.2 million and $42.3 million, respectively.  This decrease was offset by an increase in the level of capital expenditures for property and equipment of $57.1 million.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities for the twelve months ended December 31, 2023 related primarily to a secondary public offering of our common stock, offset by payments including prepayments on our term loan, and payments of contingent consideration on recent acquisition transactions.  In June 2023, we closed on a public offering of 8,711,250 shares of our common stock at a price to the public of $29.75 per share, resulting in net proceeds, after deducting underwriting discounts, commissions, and expenses, of $245.8 million.  Payments on term loan debt for the twelve months ended December 31, 2023 were $41.1million. In addition, we made a prepayment of $30.0 million on our term loan to mitigate our exposure on variable interest debt as $100 million of notional value of our 2019 swaps matured in October 2023.  On July 7, 2023, September 20, 2023 and December 12, 2023, we settled contingent liabilities associated with the acquisition related holdbacks and milestones for Quantib B.V. and Heart &amp; Lung Imaging Limited with cash payments totaling $5.5 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.   Amounts remaining to be collected on these agreements were $14.3 million and  $15.4 million at December 31, 2023 and December 31, 2022, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with Truist Bank.  The Barclays credit facilities are comprised of term loans and a revolving credit facility of $195.0 million. The Truist credit facilities relate to our subsidiary New Jersey Imaging Network LLC, and are comprised of a term loan and a revolving credit facility of $50.0 million.  As of December 31, 2023, we were in compliance with all covenants under our credit facilities.  Deferred financing costs on our revolving credit lines at December 31, 2023, net of accumulated amortization, totaled $1.6 million, with $1.1 million related to the Barclays revolving credit facility and $0.5 million related to the Truist revolving credit facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2023 are $813.0 million of total term loan debt (net of unamortized discounts of $10.0 million) displayed below in thousands:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,687&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,041)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,646&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823,062&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,031)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813,031&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays revolving credit facility at December 31, 2023 and had reserved $7.6 million for certain letters of credit.  The remaining $187.4 million of our Barclays revolving credit facility </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was available to draw upon as of  December 31, 2023.  We also had no balance under our $50.0 million Truist revolving credit facility at December 31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon.  For more information on our secured credit facilities see Note 8, Credit Facilities and Notes Payable, in the notes accompanying our consolidated financial statements in this report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Commitments</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future obligations for notes payable, lines of credit, and equipment and building operating leases for the next five years and thereafter include (dollars in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:29.296%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,324&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,431&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,676&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,188&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,454&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,073&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and fees on notes payable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases (1)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,603&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,092&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,400&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,977&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,633&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,594&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938,299&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,223&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes interest component of operating lease obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have service agreements with various vendors under which they have agreed to be responsible for the maintenance and repair of a majority of our equipment for a fee that is based on the type and age of the equipment. Under these agreements, we are committed to minimum payments of approximately $30.5 million in 2024.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this annual report on Form 10-K we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The critical areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;that we receive from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group (as defined in Note 1 Nature of Business included in the notes to our consolidated financial statements), this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATIONS &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $679.5 million and $677.7 million at December 31, 2023 and December 31, 2022, respectively.  Indefinite lived intangible assets were $9.0 million at December 31, 2023 and $24.1 million at December 31, 2022 and are associated with the value of certain trade name intangibles and IPR&amp;D.  Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested goodwill, trade name and IPR&amp;D for impairment&#160;on October 1, 2023. On September 2023, we determined that an IPR&amp;D indefinite-lived intangible asset related to Aidence's Ai Veye Lung Nodule and Veye Clinic would not receive FDA approval for sale in the US without a new submission and additional expenditures for rework in the original projected timeline. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the related IPR&amp;D intangible asset and resulted in impairment charges of $3.9 million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Our annual impairment test as of October 1, 2023 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2023.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3, Recent Accounting Standards, in the notes accompanying the consolidated financial statements included in this report for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information concerning RadNet, Inc., including our consolidated subsidiaries, for each of the years ended December 31, 2023, 2022 and 2021 is included in the consolidated financial statements and notes thereto in this report.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_46"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generate substantially all of our revenues and incur substantially all of our expenses in United States dollars.  As a  result, our financial results are unlikely to be materially affected by changes in foreign currency exchange rates or weak economic conditions in foreign markets.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange risk with respect to revenues and expenses denominated in the Euro, Canadian Dollar, Hungarian Forint and Pound Sterling. We have AI operations in the Netherlands, radiology services in the United Kingdom, and maintain research and development centers in Canada and Hungary. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At December&#160;31, 2023, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against these currencies, would have resulted in an annual increase of approximately $0.3 million in operating expenses. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. We purchased the 2019 swaps to mitigate interest rate risk on a portion of our outstanding term loan debt, as described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We can elect SOFR or Alternative Base Rate interest rate options on amounts outstanding under the Barclay's term loan.  At December 31, 2023, after giving effect to the $400 million notional amount of our 2019 swaps, we had $279.0 million outstanding subject to a SOFR election on our Barclay's term loan, at an effective rate plus applicable margin of 5.38%. A hypothetical 1% increase in the SOFR rates under the Barclay's credit facility would result in an increase of $2.8 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can elect SOFR or Base Rate interest rate options on amounts outstanding under the Truist credit facility. At December 31, 2023, we had $144.4 million outstanding subject to an adjusted SOFR election on our Trust term loan. At December 31, 2023, our effective SOFR rate plus applicable margin was 7.24%. A hypothetical 1% increase in the adjusted SOFR rates under the Truist credit facility would result in an increase of approximately $1.4 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Statements and Supplementary Data</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:164%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of RadNet, Inc. and subsidiaries</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the Company) as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 29, 2024 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Critical Audit Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:16.824%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting for Revenue Recognition</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">the Matter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended December 31, 2023, the Company&#8217;s service fee revenue was $1,463 million. As discussed in Note 2 to the consolidated financial statements, service fee revenue is based upon the estimated amounts the Company expects to be entitled to receive from patients and third-party payors (Medicare, Medicaid, managed care health plans and commercial insurance companies). Estimates of contractual allowances and implicit price concessions associated with third-party payors and any amounts due directly from patients are based upon historical collection experience from such payors. The contractual allowance estimation process is periodically reviewed to consider and incorporate updates to the laws and regulations, changes in business and economic conditions and contractual terms resulting from contract negotiations and renewals. The Company also records estimated implicit price concessions (based primarily on historical collection experience) related to amounts due directly from patients to record these revenues and accounts receivable at the estimated amounts the Company expects to collect.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing management&#8217;s estimates of contractual allowances and implicit price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized in determining related amounts.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Addressed the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Matter in Our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Audit</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls that address the risks of material misstatement relating to the measurement of service fee revenue. This included testing controls related to management&#8217;s review of the significant assumptions and inputs used in the determination of the estimated amount that would be collected for services rendered during the period. We also tested controls over the current and historical data used by management in determining this estimate, including the completeness and accuracy of the data.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated contractual allowances and implicit price concessions, we performed audit procedures that included, among others, assessing methodologies and evaluating the significant assumptions discussed above and testing the completeness and accuracy of the underlying data used by the Company in its estimates. We also assessed the historical accuracy of management&#8217;s estimates as a source of potential corroborative or contrary evidence.<br/></span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-36">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 2007. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-37">Los Angeles, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February 29, 2024</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_55"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-38">342,570</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-39">127,834</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">163,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-41">166,357</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-42">25,342</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">18,971</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">47,657</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-45">54,022</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">579,276</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">367,184</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-48">604,401</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-49">565,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-50">596,032</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-51">603,524</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and right-of-use-assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-52">1,200,433</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-53">1,169,485</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-54">679,463</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-55">677,665</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-56">90,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-57">106,228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="f-58">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="f-59">2,280</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-60">92,710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-61">57,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="f-62">46,333</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="f-63">53,172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-64">2,690,473</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-65">2,433,907</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">342,940</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">369,595</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">15,910</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">23,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">4,647</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">4,021</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">55,981</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">17,974</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">12,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">437,452</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">466,723</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">605,097</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">604,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-80">812,068</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-81">839,344</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-82">15,776</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-83">9,256</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">6,721</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">23,015</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-86">1,877,114</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-87">1,942,455</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RadNet, Inc. stockholders' equity:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-88"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-89">.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-90"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-91">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-92"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-93">67,956,318</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-94"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-95">57,723,125</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2023 and 2022 respectively</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-96">7</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-97">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-98">722,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-99">436,288</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-100">12,484</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-101">20,677</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-102">79,578</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-103">82,622</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-104">630,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-105">332,995</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-106">182,664</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-107">158,457</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-108">813,359</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-109">491,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-110">2,690,473</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-111">2,433,907</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-112">1,463,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-113">1,278,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-114">1,166,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-115">153,433</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-116">152,045</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-117">148,334</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-118">1,616,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-119">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-120">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:fixed-zero" scale="3" id="f-121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:fixed-zero" scale="3" id="f-122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-123">9,110</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-124">1,395,239</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-125">1,264,346</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-126">1,123,274</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:GainLossOnContributionIntoJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-127">16,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:GainLossOnContributionIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:GainLossOnContributionIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-130">5,146</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-132">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-133">128,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-134">115,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-135">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-136">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-137">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-138">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="f-139">3,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-140">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-141">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-142">1,517,933</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-143">1,383,698</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-144">1,241,633</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-145">98,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-146">46,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-147">82,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-148">64,483</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-149">50,841</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-150">48,830</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-151">6,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-152">10,390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-153">10,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swaps</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="f-154">8,185</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="f-155">39,621</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="f-156">21,670</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses" format="ixt:fixed-zero" scale="3" id="f-157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses" scale="3" id="f-158">731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-159">6,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-160"><span style="-sec-ix-hidden:f-161">Other (income) expenses</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-162">6,354</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-163">1,833</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-164">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-165">59,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-166">3,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-167">23,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-168">38,810</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-169">42,969</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-170">58,879</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-171">8,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-172">9,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-173">14,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-174">30,337</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-175">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-176">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-177">27,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-178">22,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-179">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-180">3,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-181">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-182">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-183">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-184">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-185">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET  INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-186">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-187">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-188">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-189">63,580,059</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-190">56,293,336</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-191">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-192">64,658,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-193">57,320,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-194">53,421,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">30,337</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-196">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-197">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-198">4,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-199">3,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-200">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-201">3,576</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-202">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-203">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-204">38,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-205">33,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-206">47,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-207">27,293</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-208">22,958</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-209">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-210">11,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-211">10,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-212">28,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Radnet, Inc.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paid-in</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stockholders'</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-213">51,640,537</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-214">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-215">307,788</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-216">24,051</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-217">117,999</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-218">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-219">92,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-220">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-221">53,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-222">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-223">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-224">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-225">1,212,758</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-226">471,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-227">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-228">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-229">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions and asset purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-230">82,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-231">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-232">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-233">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Release of holdback shares from the purchase of DeepHealth</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-234">91,517</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-235">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-236">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-237">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="f-238">4,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="f-239">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="f-240">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="f-241">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on contribution of assets to majority owned subsidiary</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" scale="3" id="f-242">4</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" scale="3" id="f-243">4</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" scale="3" id="f-244">4</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" scale="3" id="f-245">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" scale="3" id="f-246">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale of economic interests in majority owned subsidiary, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-247">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-248">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-249">7,404</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-250">11,610</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="f-251">2,426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="f-252">2,426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-253">65</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-254">65</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-255">65</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-256">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-257">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-258">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-259">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-260">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-261">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-262">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-263">53,548,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-264">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-265">342,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-266">20,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-267">93,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-268">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-269">117,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-270">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-271">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-272">1</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-273">294</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-274">295</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-275">295</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-276">725,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock to settle DeepHealth contingent consideration </span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-47" decimals="INF" name="rdnt:SharesIssuedSharesSettlementOfContingentConsideration" format="ixt:num-dot-decimal" scale="0" id="f-277">781,577</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-47" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-278">204,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-279">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-280">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-281">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for  acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-282">2,465,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-283">63,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-284">63,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-285">63,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock and share cancellation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-44" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="f-286">26,710</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="f-287">75</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="f-288">75</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="f-289">75</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-290">19,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-291">19,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale of economic interests in majority owned subsidiary, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-292">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-293">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-294">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-295">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-296">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-297">3,943</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-298">3,943</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-299">3,943</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-300">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-301">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-302">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-303">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-304">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-305">22,958</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-306">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-307">57,723,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-308">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-309">436,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-310">20,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-311">82,622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-312">332,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-313">158,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-314">491,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-315">12,424</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-316">142</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-317">142</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-318">142</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-319">1,128,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-64" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-320">37,909</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-321">26,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-322">26,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-323">26,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-324">8,711,250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-325">1</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-326">245,831</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-327">245,832</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-328">245,832</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock in connection with  acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-329">378,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-330">11,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-331">11,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-332">11,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="f-333">35,542</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" format="ixt:fixed-zero" scale="3" id="f-334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" format="ixt:fixed-zero" scale="3" id="f-335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale of economic interests in majority owned subsidiary, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-336">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-337">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-338">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-339">2,885</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-340">2,885</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="f-341">5,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="f-342">5,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-343">4,617</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-344">4,617</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-345">4,617</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-346">3,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-347">3,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-348">3,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="f-349">2</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="3" id="f-350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="f-351">2</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="f-352">1</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="f-353">1</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-354">3,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-355">3,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-356">27,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-357">30,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2023</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-358">67,956,318</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-359">7</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-360">722,750</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-361">12,484</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-362">79,578</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-363">630,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-364">182,664</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-365">813,359</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-366">30,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-367">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-368">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-369">128,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-370">115,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-371">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-372">61,102</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-373">68,847</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-374">73,967</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-375">5,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-377">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-378">9,176</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-379">5,952</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-380">6,260</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and write off of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-381">2,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-382">2,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-383">3,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:GainLossOnContributionIntoJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-384">16,808</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:GainLossOnContributionIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:GainLossOnContributionIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-387">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-388">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-389">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-392">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="f-393">3,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="f-396">3,576</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="f-397">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="f-398">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-399">8,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-400">39,621</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-401">21,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-402">26,785</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-403">23,770</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-404">25,203</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="f-405">3,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="f-406">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="f-407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-408">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-409">30,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-410">5,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-411">8,441</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-412">3,327</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-413">15,777</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-414">1,484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-415">12,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-416">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-417">6,056</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-418">13,356</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-419">19,834</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-420">54,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-421">68,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-422">72,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-423">626</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-424">7,316</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-425">28,319</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-426">15,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-427">49,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-428">9,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-429">220,863</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-430">146,417</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-431">149,491</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of imaging centers and other operations</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="f-432">10,918</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="f-433">129,961</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="f-434">77,691</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-435">176,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-436">119,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-437">137,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-440">5,130</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-441">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-442">3,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-443">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-444">14,035</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-445">1,441</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-446">1,441</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-447">201,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-448">246,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-449">221,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-450">41,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-451">53,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-452">619,529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable other than term loan debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="f-453">2,930</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:fixed-zero" scale="3" id="f-454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="f-455">3,302</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional deferred finance costs on revolving loan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="f-458">938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from debt issuance, net of issuance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="f-459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-460">147,996</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-461">717,307</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-462">5,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="f-463">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-464">2,426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of economic interest in majority owned subsidiary </span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" format="ixt:fixed-zero" scale="3" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" format="ixt:num-dot-decimal" scale="3" id="f-467">13,073</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="f-469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-470">128,300</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-473">128,300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-474">5,121</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-477">5,495</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-478">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-479">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-480">245,832</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-482">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="f-483">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="f-484">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="f-485">488</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-486">195,635</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-487">93,647</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-488">104,673</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-489">292</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-490">113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-491">65</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-492">214,736</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-493">6,772</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-494">32,588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-495">127,834</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-496">134,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-497">102,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-498">342,570</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-499">127,834</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-500">134,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-501">64,695</ix:nonFraction></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-502">39,151</ix:nonFraction></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-503">29,042</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-504">1,587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="f-505">587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-506">1,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="f-507">67.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="f-508">111.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="f-509">63.9</ix:nonFraction> million during the years ended December 31, 2023, 2022 and 2021, respectively, that we had not paid for as of December 31, 2023, 2022 and 2021, respectively. The offsetting amount due was recorded in our consolidated balance sheets under accounts payable, accrued expenses and other.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2023, we issued <ix:nonFraction unitRef="shares" contextRef="c-74" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-510">64,569</ix:nonFraction> shares of common stock to settle the stock contingent liabilities as part of our purchase of Heart &amp; Lung Imaging Limited. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-511">2.3</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2023, we issued <ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-512">56,600</ix:nonFraction> shares of common stock to settle the stock contingent liabilities as part of our purchase of Heart &amp; Lung Imaging Limited. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-513">1.6</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, we made a contribution of a business with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-514">27.2</ix:nonFraction> million to our Santa Monica Imaging Group, LLC joint venture.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 7, 2023, we issued <ix:nonFraction unitRef="shares" contextRef="c-79" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-515">113,303</ix:nonFraction> shares of common stock to settle the stock holdback contingent liabilities as part of our purchase of Quantib B.V.. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-516">3.5</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 13, 2023, we issued <ix:nonFraction unitRef="shares" contextRef="c-81" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-517">144,227</ix:nonFraction> shares of common stock to settle the general holdback contingent liabilities as part of our purchase of Aidence Holding B.V.. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-518">4.0</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2023, we issued a promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-519">19.8</ix:nonFraction> million to acquire radiology equipment previously leased under operating leases.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="c-84" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-520">359,002</ix:nonFraction> shares of common stock to complete our purchase of Heart &amp; Lung Imaging Limited.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-521">6.8</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022  we made a contribution to our joint venture Arizona Diagnostic Radiology Group of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-522">12.7</ix:nonFraction> million in equipment and other assets. We recorded an offset to due to affiliates of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:ProceedsFromDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="f-523">4.5</ix:nonFraction> million to reduce our overall investment to $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-524">8.3</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we received $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-525">8.4</ix:nonFraction> million in fixed assets and equipment from our partner in Frederick County Radiology, LLC.  </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-526">1,141,234</ix:nonFraction> shares of common stock to complete our purchase of Aidence Holding B.V.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-527">30.6</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="c-91" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-528">965,058</ix:nonFraction> shares of common stock to complete our purchase of Quantib B.V. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-529">25.9</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021 we completed our purchase of specific technology assets of DRT LLC in part by issuing <ix:nonFraction unitRef="shares" contextRef="c-93" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" format="ixt:num-dot-decimal" scale="3" id="f-530">15,000</ix:nonFraction> shares of our common stock to complete the transaction.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" format="ixt:num-dot-decimal" scale="6" id="f-531">0.4</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2021, we completed our stock purchase of Tangent Associates LLC by issuing <ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-532">67,658</ix:nonFraction> shares of our common stock to complete the transaction. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="f-533">2.0</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, partnership agreement with Simi Valley Hospital and Health Services. Of the total combined assets of $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-534">0.4</ix:nonFraction>&#160;million, we transferred $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-535">0.3</ix:nonFraction>&#160;million and Simi Valley Hospital and Health Services contributed the remaining $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-536">0.1</ix:nonFraction>&#160;million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 1 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-537" continuedAt="f-537-1" escape="true">NATURE OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="f-537-1" continuedAt="f-537-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2023, we operated directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="c-4" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="f-538">366</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise <ix:nonFraction unitRef="loan" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-539">two</ix:nonFraction> segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting. In June 2023, we completed a public offering of <ix:nonFraction unitRef="shares" contextRef="c-99" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-540">8,711,250</ix:nonFraction> shares of our common stock at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-100" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-541">29.75</ix:nonFraction> per share. The gross proceeds as a result of this public offering was $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="6" id="f-542">259.2</ix:nonFraction>&#160;million before underwriting discounts, commissions, and expenses totaling $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="rdnt:SaleOfStockCost" format="ixt:num-dot-decimal" scale="6" id="f-543">13.4</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc. as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group (the "Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="f-544">205.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="f-545">189.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="f-546">179.6</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the years ended December 31, 2023, 2022, and 2021, respectively and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="f-547">205.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="f-548">189.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="f-549">179.6</ix:nonFraction> million of operating expenses for the years ended December 31, 2023, 2022, and 2021, respectively. RadNet, Inc. recognized $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-550">849.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-551">786.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-552">749.2</ix:nonFraction> million of total billed net service fee revenue for the years ended December 31, 2023, 2022, and 2021, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-537-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31, 2023 and December 31, 2022, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-553">94.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-554">110.3</ix:nonFraction> million, respectively, of accounts receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-555">16.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-556">16.2</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div></ix:continuation><div id="i6e34f25d3bd24e8f8cef4b7925f59439_76"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-557" continuedAt="f-557-1" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-557-1" continuedAt="f-557-2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-558" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-559" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-560" continuedAt="f-560-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the fees for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by the Group as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and co-payment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-2" continuedAt="f-557-3"><ix:continuation id="f-560-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="f-561" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service fee revenues for the years ended December 31, 2023, 2022, and 2021 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-562">897,948</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-563">785,128</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-564">743,462</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-565">363,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-566">311,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-567">280,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-568">43,175</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-569">38,279</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-570">34,731</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-571">47,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-572">51,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-573">44,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-574">42,249</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-575">31,849</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-576">19,398</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-577">17,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-578">22,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-579">19,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-580">18,082</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-581">14,238</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-582">10,525</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-583">20,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-584">19,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-585">12,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-586">153,433</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-587">152,045</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-588">148,334</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-589">1,604,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-590">1,425,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-591">1,313,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-592">12,469</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-593">4,396</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-594">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-595">1,616,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-596">1,430,061</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-597">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020. As part of the CARES act, we received $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="f-598">39.6</ix:nonFraction> million total of accelerated Medicare payments which were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed. Through December 31, 2023, all of the accelerated Medicare payments have been applied to revenue.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-599" continuedAt="f-599-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-599-1">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.</ix:continuation>   Amounts remaining to be collected on these agreements were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="f-600">14.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="f-601">15.4</ix:nonFraction> million at December 31, 2023 and December 31, 2022, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS PAYABLE AND ACCRUED EXPENSES - <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-602" continuedAt="f-602-1" escape="true">Accounts payable and accrued expenses were comprised of the following (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-3" continuedAt="f-557-4"><ix:continuation id="f-602-1"><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"><tr><td style="width:1.0%"/><td style="width:67.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-603">122,888</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-604">102,678</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-605">124,059</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-606">181,574</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-607">71,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-608">62,072</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-609">24,696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-610">23,271</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-611">342,940</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-612">369,595</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-613" continuedAt="f-613-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; We have developed and sell Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-613-1">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.</ix:continuation> </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we recorded approximately $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-614">20.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-615">13.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-616">10.5</ix:nonFraction> million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statements of operations. At December 31, 2023 we had deferred revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-617">1.3</ix:nonFraction> million associated with these sales which we expect to recognize into revenue over the next <ix:nonNumeric contextRef="c-138" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="f-618">12</ix:nonNumeric> months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="f-619" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-620" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. The cash in the financial institution is in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-621" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredChargesPolicyTextBlock" id="f-622" continuedAt="f-622-1" escape="true">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. </ix:nonNumeric>Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-623">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-624">2.3</ix:nonFraction> million for the twelve months ended at December 31, 2023 and 2022, respectively.  See Note 8, Credit Facilities and <ix:continuation id="f-622-1">Notes Payable for more information on our revolving lines of credit.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-625" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from <ix:nonNumeric contextRef="c-139" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-626">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-140" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-627">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="c-141" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-628">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-142" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-629">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-630" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATIONS &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-4" continuedAt="f-557-5"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="f-631" continuedAt="f-631-1" escape="true">GOODWILL AND INDEFINITE LIVED INTANGIBLES</ix:nonNumeric> &#8211; Goodwill totaled $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-632">679.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-633">677.7</ix:nonFraction> million at December 31, 2023 and December 31, 2022, respectively. Indefinite lived intangible assets were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-634">9.0</ix:nonFraction> million at December 31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-635">24.1</ix:nonFraction> million at December 31, 2022 and are associated with the value of certain trade name intangibles and in process research and development ("IPR&amp;D"). <ix:continuation id="f-631-1">Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</ix:continuation>  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested goodwill, trade name and IPR&amp;D for impairment&#160;on October 1, 2023.  In September 2023, we determined that an IPR&amp;D indefinite-lived intangible asset related to Aidence's Ai Veye Lung Nodule and Veye Clinic would not receive FDA approval for sale in the US without a new submission and additional expenditures for rework in the original projected timeline. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the related IPR&amp;D intangible asset and resulted in impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-636">3.9</ix:nonFraction> million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The estimated fair value of the IPR&amp;D intangible asset was determined using the multi-period excess earnings method under the income approach, which estimates the present value of the free cash flows associated with the asset and tax amortization benefit to arrive at the fair value of the asset. Our annual impairment test as of October 1, 2023 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2023.  </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-637" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2023 and December 31, 2021 we recorded lease abandonment of $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-638">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-639">7.1</ix:nonFraction> million, respectively in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-640" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-641" continuedAt="f-641-1" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2023. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-5" continuedAt="f-557-6"><ix:continuation id="f-641-1"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers to maximize utilization rates. We may abandon low utilization leases and divert the patients to nearby centers. During 2023, we experienced lower utilization at two imaging centers. To complete the closure of these locations, we took a lease abandonment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharge" format="ixt:num-dot-decimal" scale="6" id="f-642">5.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharge" format="ixt:num-dot-decimal" scale="6" id="f-643">19.7</ix:nonFraction> million at December 31, 2023 and December 31, 2021, respectively. Of these amounts, $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-644">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-645">12.6</ix:nonFraction> million were related to right-of-use assets impairment and $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-646">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-647">7.1</ix:nonFraction> million were related to the write-off of leasehold improvements for the years ending December 31, 2023 and December 31, 2021.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="rdnt:UninsuredRisksPolicyTextBlock" id="f-648" continuedAt="f-648-1" escape="true">UNINSURED RISKS &#8211; We maintain a high-deductible workers&#8217; compensation insurance policy. </ix:nonNumeric>We have recorded liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-649">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-650">3.9</ix:nonFraction> million at December 31, 2023 and December 31, 2022, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-648-1" continuedAt="f-648-2">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.</ix:continuation> The policy has a deductible which is $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="rdnt:MedicalMalpracticeDeductiblePerIncidence" format="ixt:num-dot-decimal" scale="0" id="f-651">10,000</ix:nonFraction> per incidence for all years covered by this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:continuation id="f-648-2" continuedAt="f-648-3"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2023, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-648-3">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.</ix:continuation> We have recorded liabilities as of December 31, 2023 and 2022 of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="f-652">7.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="f-653">7.4</ix:nonFraction> million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue Shield for a stop loss policy that provides coverage for any claims that exceed $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="INF" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" format="ixt:num-dot-decimal" scale="0" id="f-654">250,000</ix:nonFraction> up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="INF" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" format="ixt:num-dot-decimal" scale="6" id="f-655">1.0</ix:nonFraction> million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:PostemploymentBenefitPlansPolicy" id="f-656" escape="true">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</ix:nonNumeric> We can elect to provide a matching contribution in the amount to a maximum of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-657">1.0</ix:nonFraction>% per <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-658">4.0</ix:nonFraction>% of employee contributions.  We contributed $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:fixed-zero" scale="6" id="f-659">0.0 million</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-660">3.0</ix:nonFraction> million in matching for each of the twelve months ended December 31, 2023 and December 31, 2022.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="f-661" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have <ix:nonFraction unitRef="incentiveplan" contextRef="c-4" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="f-662">one</ix:nonFraction> long-term incentive plan that we adopted in 2006 and which we first amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, third on April 15, 2021 and currently as of April 27, 2023 (the &#8220;Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023. We have reserved <ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-663">20,100,000</ix:nonFraction> shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric. We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options generally vest over <span style="-sec-ix-hidden:f-664">three</span> years to <ix:nonNumeric contextRef="c-152" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-665">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:f-666">five</span> years to <ix:nonNumeric contextRef="c-152" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-667">ten years</ix:nonNumeric> from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-668" continuedAt="f-668-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-6" continuedAt="f-557-7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-668-1">component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</ix:continuation>  <ix:nonNumeric contextRef="c-1" name="rdnt:ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" id="f-669" continuedAt="f-669-1" escape="true">The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2023, 2022 and 2021 is provided below (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-669-1"><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"><tr><td style="width:1.0%"/><td style="width:58.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.957%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="f-670">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" scale="3" id="f-671">65</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="f-672">442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-673">3,943</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-674">4,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-675">4,617</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="f-676">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-677" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER COMPREHENSIVE INCOME (LOSS) &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2023, December 31, 2022, and December 31, 2021 are included in the consolidated statements of comprehensive income.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="f-678" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-679" continuedAt="f-679-1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 swaps</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into <ix:nonFraction unitRef="agreement" contextRef="c-153" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="3" id="f-680">four</ix:nonFraction> forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-681">500,000,000</ix:nonFraction>, consisting of <ix:nonFraction unitRef="agreement" contextRef="c-154" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="f-682">two</ix:nonFraction> agreements of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-683">50,000,000</ix:nonFraction> each and <ix:nonFraction unitRef="agreement" contextRef="c-155" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="f-684">two</ix:nonFraction> agreements of  $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-685">200,000,000</ix:nonFraction> each.  <ix:continuation id="f-679-1" continuedAt="f-679-2"> The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They matured in October 2023 for the two smaller notional and will mature in October 2025 for the two larger notional.</ix:continuation> Under these arrangements, we arranged the 2019 swaps with locked in 1 month Term SOFR rates at <ix:nonFraction unitRef="number" contextRef="c-156" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="f-686">1.89</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-687">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="c-158" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="f-688">1.98</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-689">400,000,000</ix:nonFraction> notional. In October of 2023, the two agreements of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-690">50,000,000</ix:nonFraction> each matured and the remaining 2019 swaps have a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-691">400,000,000</ix:nonFraction> as of December 31, 2023. <ix:continuation id="f-679-2" continuedAt="f-679-3">As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-679-3">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of other accumulated comprehensive income (loss) in the consolidated statement of equity.</ix:continuation>  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-692">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="c-158" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="f-693">1.98</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-694">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="c-156" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="f-695">1.89</ix:nonFraction>% did not match the cash flows for our Barclays term loans and so we determined that they were not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-696">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="f-697">100,000,000</ix:nonFraction> notional was recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-698">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="f-699">0.4</ix:nonFraction> million per month and continuing at approximately $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="f-700">0.3</ix:nonFraction> million per month through October 2025.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-701" continuedAt="f-701-1" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="f-557-7" continuedAt="f-557-8"><ix:continuation id="f-701-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-702">8,185</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-703">Other Income (Expense)</span></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-704">3,576</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-705">39,621</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-706">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-707">3,687</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-708">21,670</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-709">Other Income (Expense)</span></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-710">3,695</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we agreed to pay up to $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="f-711">10.0</ix:nonFraction> million consideration upon the completion of <ix:nonFraction unitRef="loan" contextRef="c-90" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" format="ixt-sec:numwordsen" scale="0" id="f-712">two</ix:nonFraction> identified milestones in RadNet common shares or cash at our election.  The contingency had a fair value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-713">7.2</ix:nonFraction> million on December 31, 2022. The fair value is based on the yield rate of S&amp;P B-rated corporate bonds and the probability of meeting the milestones which were tied to FDA approval of artificial intelligence screening solutions. In September 2023, we determined that the milestones could not be achieved under the contractual terms of the stock purchase agreement because the original submissions of artificial intelligence screening solutions did not receive regulatory clearance. A new submission would be required; and therefore, the probability of the milestones being achieved became zero. Accordingly, management recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="f-714">7.2</ix:nonFraction> million in 2023 representing the change in fair value of contingent consideration within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, there was a general holdback of $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-715">4.0</ix:nonFraction> million for any indemnification claims, which was settled on April 30, 2023 by the issuance of <ix:nonFraction unitRef="shares" contextRef="c-81" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-716">144,227</ix:nonFraction> shares of our common stock.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we agreed to issue <ix:nonNumeric contextRef="c-91" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="f-717">18</ix:nonNumeric> months after acquisition, <ix:nonFraction unitRef="shares" contextRef="c-92" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-718">113,303</ix:nonFraction> shares of our common stock with an initial fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="6" id="f-719">3.0</ix:nonFraction> million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. In addition, there is a general holdback of $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-720">1.6</ix:nonFraction> million to be issued in cash subject to adjustment for any indemnification claims. On July 7, 2023, we settled the stock holdback contingent liabilities by issuing <ix:nonFraction unitRef="shares" contextRef="c-80" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-721">113,303</ix:nonFraction> shares of our common stock at an ascribed value of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-722">3.5</ix:nonFraction> million and also settled the general holdback for $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-723">1.6</ix:nonFraction> million in cash.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Montclair. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-724">1.2</ix:nonFraction> million in contingent consideration which was based on the anticipated achievement of specific EBITDA targets within a defined time frame. In June 2023, we determined that the contingent consideration thresholds were not achieved and, as such, we recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="f-725">1.2</ix:nonFraction> million representing the change in fair value of the contingent consideration within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart &amp; Lung Imaging Limited. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed our acquisition of <ix:nonFraction unitRef="number" contextRef="c-176" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-726">75</ix:nonFraction>% of the equity interests of Heart &amp; Lung Imaging Limited. The purchase included $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-727">10.2</ix:nonFraction> million in contingent milestone consideration and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-728">0.6</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="c-179" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="f-729">24</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in subsequent periods.  The milestone contingencies had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-730">6.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-731">11.1</ix:nonFraction> million as of December 31, 2023 and 2022, respectively.   The contingent consideration is determined by the achievement of a specific number of physician reads. On September 20, 2023, we settled a milestone contingent liability by issuing <ix:nonFraction unitRef="shares" contextRef="c-182" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-732">56,600</ix:nonFraction> shares of our common stock at an ascribed value of $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-733">1.6</ix:nonFraction> million and cash of $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationAsset" format="ixt:num-dot-decimal" scale="6" id="f-734">1.8</ix:nonFraction> million. On December 12, 2023, we settled a milestone contingent liability by issuing <ix:nonFraction unitRef="shares" contextRef="c-183" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-735">64,569</ix:nonFraction> shares of our common stock at an ascribed value of $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="f-736">2.3</ix:nonFraction> million and cash of $<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-737">2.1</ix:nonFraction> million.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="f-738" continuedAt="f-738-1" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular roll-forward of contingent consideration is as follows (amounts in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-738-1" continuedAt="f-738-2"><ix:continuation id="f-557-8" continuedAt="f-557-9"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-9" continuedAt="f-557-10"><ix:continuation id="f-738-2"><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:11.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-739">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-740">4,000</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="f-741">7,158</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="f-742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-743">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-744">3,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" sign="-" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-745">5,110</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="f-746">1,401</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="f-747">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-749">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-191" xsi:nil="true" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" id="f-750"></ix:nonFraction></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="f-751">1,200</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="f-752">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-754">11,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" sign="-" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-755">7,854</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="f-756">2,477</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="f-757">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-758">6,879</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-760">11,453</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="f-761">362</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="f-762">67</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-763">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-764">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-765">4,581</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="f-766">903</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="f-767">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-768">3,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-769">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-770">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="f-772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-773">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-774">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements" format="ixt:num-dot-decimal" scale="3" id="f-775">10,814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="f-776">566</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="f-777">276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-778">11,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at December 31, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-779" continuedAt="f-779-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="f-780" continuedAt="f-780-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-10" continuedAt="f-557-11"><ix:continuation id="f-780-1" continuedAt="f-780-2"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-781">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-782">15,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-783">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-784">15,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-785">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-786">23,302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-787">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-788">23,302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="f-779-1" continuedAt="f-779-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward SOFR curve in 2023 and forward LIBOR curve in 2022. respectively. The forward SOFR curve and forward LIBOR curve are readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><ix:continuation id="f-780-2" continuedAt="f-780-3"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-791">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-792">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs. For Heart &amp; Lung Imaging Limited, the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Heart &amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="rdnt:ScheuldeOfEstimatedFairValuesTableTextBlock" id="f-793" escape="true"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-796">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-797">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. Holdback of <ix:nonFraction unitRef="shares" contextRef="c-92" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-798">113,303</ix:nonFraction> shares of RadNet common stock</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-801">3,709</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-802">3,709</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-805">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-806">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-809">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-810">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs. For Aidence Holding B.V., the milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval. For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="rdnt:ValueOfEstimatedSharesIssuable" scale="0" id="f-811">18.83</ix:nonFraction>) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares. For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame. For Heart &amp; Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads. As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart &amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data, they are classified as Level 3.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-11" continuedAt="f-557-12"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-780-3"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our Barclays Term Loans and Trust Term Loan long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="f-812">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="f-813">824,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="f-814">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="f-815">824,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="f-816">823,063</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="f-817">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="f-818">843,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="f-819">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="f-820">843,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="f-821">864,125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="c-240" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="f-822"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="f-823">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2023 and December 31, 2022, respectively.  Our Truist revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="c-242" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="f-824"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="f-825">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2023 and December 31, 2022, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:continuation id="f-779-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily relate to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations and other notes payable to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-12" continuedAt="f-557-13"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-826" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-827" continuedAt="f-827-1" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></span></div></ix:nonNumeric><ix:continuation id="f-827-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-828">3,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-829">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-830">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-831">63,580,059</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-832">56,293,336</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-833">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-834">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-835">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-836">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-837">63,580,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-838">56,293,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-839">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-840">202,995</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-841">172,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-842">259,539</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options, warrants and holdback shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-843">875,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-844">855,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-845">664,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-846">64,658,299</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-847">57,320,870</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-848">53,421,033</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value associated with contingently issuable shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements" format="ixt:fixed-zero" scale="3" id="f-849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements" scale="3" id="f-850">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements" format="ixt:fixed-zero" scale="3" id="f-851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc's common stockholders for diluted share calculation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-852">3,044</ix:nonFraction></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-853">9,926</ix:nonFraction></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-854">24,727</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-855">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-856">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-857">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-244" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-858">754,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-245" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-859">152,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-246" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-860">47,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight average shares for which the exercise price exceeds the average market price of common stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-247" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-861">70,760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-248" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-249" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsPolicy" id="f-864" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES- Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have <ix:nonFraction unitRef="investment" contextRef="c-4" decimals="INF" name="rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" format="ixt-sec:numwordsen" scale="0" id="f-865">three</ix:nonFraction> equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost as follows:</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-866">1.2</ix:nonFraction> million, represents a <ix:nonFraction unitRef="number" contextRef="c-250" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-867">14.21</ix:nonFraction>% equity interest in the company.  No observable price changes or impairment in our investment was identified as of December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased <ix:nonFraction unitRef="shares" contextRef="c-251" decimals="-5" name="rdnt:EquityMethodInvestmentSharesPurchased" format="ixt:num-dot-decimal" scale="6" id="f-868">2.1</ix:nonFraction> million preferred shares in Turner Imaging Systems for $<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-869">2.0</ix:nonFraction> million.  On January 1, 2019 we funded a convertible promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-870">0.1</ix:nonFraction> million that converted to an additional <ix:nonFraction unitRef="shares" contextRef="c-253" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="f-871">80,000</ix:nonFraction> preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was identified as of December 31, 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-557-13" continuedAt="f-557-14"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired <ix:nonFraction unitRef="shares" contextRef="c-254" decimals="INF" name="rdnt:EquityMethodInvestmentSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-872">2,315,350</ix:nonFraction> shares of Series A Preferred Stock interest at a cost of $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-873">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="f-874">2.5</ix:nonFraction> million in support of its operations. On October 6, 2023, WhiteRabbit.ai Inc. commenced another offering of preferred shares and the Company converted its note receivable outstanding principal and accrued interest in exchange for <ix:nonFraction unitRef="shares" contextRef="c-255" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-875">20,325,203</ix:nonFraction> shares of Series C-1 Preferred Stock at an exchange rate of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-255" decimals="4" name="rdnt:PreferredStockExchangeRatePerShare" scale="0" id="f-876">0.123</ix:nonFraction> per share. No observable price changes or impairment in our investment was identified as of December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-877" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have <ix:nonFraction unitRef="jointventure" contextRef="c-4" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="f-878">13</ix:nonFraction> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="c-256" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="f-879">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-257" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="f-880">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2023.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsTextBlock" id="f-881" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2023 and December 31, 2022 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-882">42,229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-883">9,712</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-884">10,390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-885">4,438</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-886">57,893</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-887">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-888">43,993</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-889">15,603</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-890">92,710</ix:nonFraction>&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the imaging centers underlying these joint ventures of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="f-891">17.9</ix:nonFraction> million , $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="f-892">22.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="f-893">19.6</ix:nonFraction> million for the years ended December 31, 2023, 2022 and 2021, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures. As we have the ability to exercise significant influence over our joint venture entities, we consider them related parties. Amounts transacted between ourselves and the entities in the ordinary course of business are disclosed on our balance sheet in the due from/to affiliate accounts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="f-894" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key financial data for these joint ventures as of December 31, 2023 and 2022, respectively, and for the years ended December 31, 2023, 2022 and 2021, respectively, (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-895">39,819</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-896">39,304</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-897">224,936</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-898">134,694</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-899">46,587</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-900">29,588</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-901">70,834</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-902">37,952</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="f-903">147,334</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="f-904">106,458</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-905">184,194</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-906">145,256</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-907">129,023</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-908">12,968</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-909">21,169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-910">21,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><ix:continuation id="f-557-14"><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2023 and 2022, we made additional equity contributions of $<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="rdnt:EquityMethodInvestmentAdditionalContribution" format="ixt:num-dot-decimal" scale="6" id="f-911">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="rdnt:EquityMethodInvestmentAdditionalContribution" format="ixt:num-dot-decimal" scale="6" id="f-912">1.4</ix:nonFraction> million, respectively, to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we contributed <ix:nonFraction unitRef="center" contextRef="c-87" decimals="INF" name="rdnt:NumberOfAssetsSold" format="ixt-sec:numwordsen" scale="0" id="f-913">eight</ix:nonFraction> of our imaging centers to ADRG of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-914">12.7</ix:nonFraction> million and recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" sign="-" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="6" id="f-915">0.5</ix:nonFraction> million which was calculated as the difference between the sale price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:ProceedsFromDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="f-916">4.5</ix:nonFraction> million of the sale price as an offset to due to affiliates while the remaining $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-917">8.3</ix:nonFraction> million was recorded as investment in joint venture on our balance sheet.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our <ix:nonFraction unitRef="number" contextRef="c-87" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-918">49</ix:nonFraction>% economic interest in ADRG, we received a distribution from the partnership of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:ProceedsFromDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="f-919">4.5</ix:nonFraction> million to reduce our overall investment to $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-920">8.3</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary and sale of economic interest</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Los Angeles Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of <ix:nonFraction unitRef="location" contextRef="c-267" decimals="INF" name="rdnt:NumberOfLocationOfferingMultiModalityServices" format="ixt-sec:numwordsen" id="f-921">three</ix:nonFraction> locations in Los Angeles, California. We contributed the operations of <ix:nonFraction unitRef="center" contextRef="c-267" decimals="INF" name="rdnt:NumberOfCentersContributed" scale="0" id="f-922">3</ix:nonFraction> centers to the subsidiary. Cedars-Sinai Medical Center ("CSMC") purchased from us a <ix:nonFraction unitRef="number" contextRef="c-268" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-923">35</ix:nonFraction>% noncontrolling interest in LAIG for a cash payment of $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:LimitedPartnersContributedCapital" format="ixt:num-dot-decimal" scale="6" id="f-924">5.9</ix:nonFraction> million. As a result of the transaction, we retain a <ix:nonFraction unitRef="number" contextRef="c-269" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-925">65</ix:nonFraction>% controlling economic interest in LAIG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Santa Monica Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed, in conjunction with Cedars-Sinai Medical Center ("CSMC") the Santa Monica Imaging Group, LLC ("SMIG"), consisting of two multi-modality imaging centers located in Santa Monica, California with RadNet holding a <ix:nonFraction unitRef="number" contextRef="c-270" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-926">40</ix:nonFraction>% economic interest and CSMC holding a <ix:nonFraction unitRef="number" contextRef="c-271" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-927">60</ix:nonFraction>% economic interest. RadNet accounted for its share of the venture under the equity method. On January 1, 2019, CSMC purchased an additional <ix:nonFraction unitRef="number" contextRef="c-272" decimals="2" name="rdnt:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" scale="-2" id="f-928">5</ix:nonFraction>% economic interest in SMIG from us and, as a result, of our economic interest in SMIG was reduced to <ix:nonFraction unitRef="number" contextRef="c-273" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-929">35</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, RadNet contributed an additional multi-modality imaging center and a newly constructed imaging center located in Beverly Hills, California valued at $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" name="us-gaap:LimitedPartnersContributedCapital" format="ixt:num-dot-decimal" scale="6" id="f-930">27.2</ix:nonFraction> million and purchased an additional economic interest in SMIG for cash payment of $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-5" name="us-gaap:LimitedPartnersContributedCapital" format="ixt:num-dot-decimal" scale="6" id="f-931">11.3</ix:nonFraction> million. Simultaneously, CSMC contributed five additional multi-modality imaging centers located in Santa Monica, California. As a result of the transaction, our economic interest in SMIG has been increased to <ix:nonFraction unitRef="number" contextRef="c-276" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-932">49</ix:nonFraction>%. We recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="6" id="f-933">16.8</ix:nonFraction> million, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Gain) on contribution of imaging centers into joint venture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, representing the difference between the fair value and carrying value of the business contributed. The related gain on disposal of business was calculated as the difference between the fair value and carrying value of such imaging centers which included equipment, other assets, accrued liabilities, and an allocation of goodwill to such imaging centers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of the imaging centers contributed to SMIG, we used an income approach which is considered a level 3 valuation technique. See Fair Value Measurements above for further detail on the valuation hierarchy. Key assumptions used in measuring the fair value are financial forecasts and a discount rate. We also utilized the cash paid for an additional interest in the joint venture to substantiate the fair value of the contributed assets.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-935" continuedAt="f-935-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="f-934" continuedAt="f-934-1" escape="true">RECENT ACCOUNTING STANDARDS</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-935-1" continuedAt="f-935-2"><ix:continuation id="f-934-1" continuedAt="f-934-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-07 ("ASU 2023-07"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance requires entities to provide enhanced disclosures about significant segment expenses. For entities that have adopted the amendments in ASU 2023-07, the updated guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2023-07 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-09 ("ASU 2023-09"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax (Topic 740) Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to the rate reconciliation and income taxes paid information. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-935-2"><ix:continuation id="f-934-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is currently evaluating the impact of the adoption of ASU 2023-09 on its consolidated financial position and results of operations.</span></div></ix:continuation></ix:continuation><div id="i6e34f25d3bd24e8f8cef4b7925f59439_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="f-936" continuedAt="f-936-1" escape="true">BUSINESS COMBINATIONS AND RELATED ACTIVITY</ix:nonNumeric></span></div><ix:continuation id="f-936-1" continuedAt="f-936-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended 2023, 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California, Delaware, Maryland, New Jersey and New York markets.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-937" continuedAt="f-937-1" escape="true">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-937-1" continuedAt="f-937-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-938">3,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-939">435</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-940">1,689</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-941">3,015</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-942">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="f-943">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-944">1,689</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-945">1,815</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-946">466</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-947">1,184</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-948">1,272</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-949">50</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="f-950">27</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-951">1,184</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-952">2,600</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-953">877</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-954">1,188</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-955">1,658</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-956">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="f-957">15</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-958">1,188</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-959">2,000</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-960">1,663</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-961">3,775</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:Goodwill" scale="3" id="f-962">229</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-963">100</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="f-964">8</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-965">3,775</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison Radiology Medical Group, Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="f-966">250</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-967">100</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-968">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:Goodwill" scale="3" id="f-969">150</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-970">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="f-971">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-972">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Diagnostic Imaging, P.A.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="f-973">600</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-974">401</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="f-975">337</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:Goodwill" scale="3" id="f-976">149</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-977">50</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="f-978">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="f-979">337</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-980">10,765</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-981">3,942</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-982">8,173</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-983">6,473</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-984">300</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="f-985">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-986">8,173</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-936-2" continuedAt="f-936-3"><ix:continuation id="f-937-2" continuedAt="f-937-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#x5E;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-987">8,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-988">2,910</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-989">1,703</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-990">5,271</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-991">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="f-992">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-993">1,703</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#x5E;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-994">4,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-995">2,103</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="f-996">857</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-997">2,697</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="f-998">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="f-999">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="f-1000">857</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-1001">94,877</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1002">16,414</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1003">4,665</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1004">79,690</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-1005">400</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" sign="-" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1006">2,168</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1007">4,124</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-1008">32,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-1009">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-1010">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1011">16,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1012">15,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="f-1013">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-1014">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Diagnostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-1015">2,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-1016">568</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-1017">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1018">2,132</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-1019">100</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="f-1020">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-1021">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="f-1022">104</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="f-1023">20</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-1024">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:Goodwill" scale="3" id="f-1025">55</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="f-1026">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="f-1027">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-1028">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-1029">142,781</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1030">22,015</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1031">7,225</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1032">106,045</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1033">16,325</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" sign="-" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1034">2,145</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1035">6,684</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#x5E; IFRC LLC acquisitions consisted of <ix:nonFraction unitRef="loan" contextRef="c-290" decimals="INF" name="rdnt:BusinessCombinationNumberOfSubsidiariesAcquired" format="ixt-sec:numwordsen" scale="0" id="f-1036">three</ix:nonFraction> subsidiaries of IFRC, <ix:nonFraction unitRef="loan" contextRef="c-291" decimals="INF" name="rdnt:BusinessCombinationNumberOfSubsidiariesAcquired" format="ixt-sec:numwordsen" scale="0" id="f-1037">one</ix:nonFraction> of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for $<ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1038">1.2</ix:nonFraction> million in contingent consideration.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-937-3">+See detailed description of the Heart &amp; Lung Imaging Limited acquisition below.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart &amp; Lung Imaging Limited.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we acquired a <ix:nonFraction unitRef="number" contextRef="c-176" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1039">75</ix:nonFraction>% controlling interest in Heart &amp; Lung Imaging Limited (&#8220;HLI&#8221;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#8217;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-1040">31.9</ix:nonFraction> million, including: i) shares with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="f-1041">6.8</ix:nonFraction> million (<ix:nonFraction unitRef="shares" contextRef="c-179" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1042">359,002</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-176" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="f-1043">19.06</ix:nonFraction> per share), ii) cash of $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-1044">6.3</ix:nonFraction> million, iii) contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1045">10.8</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1046">10.2</ix:nonFraction> million in contingent milestone consideration and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1047">0.6</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="c-179" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="f-1048">24</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1049">8.0</ix:nonFraction> million. We recorded $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1050">0.6</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-1051">15.8</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1052">0.6</ix:nonFraction> million current liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1053">16.2</ix:nonFraction> million in goodwill in connection with this transaction.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of <ix:nonFraction unitRef="number" contextRef="c-292" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-1054">19.0</ix:nonFraction>%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-1055">45.2</ix:nonFraction>&#160;million including i) <ix:nonFraction unitRef="shares" contextRef="c-293" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1056">1,117,872</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="f-1057">26.80</ix:nonFraction> per share with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="f-1058">30.0</ix:nonFraction>&#160;million, ii) cash of $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-1059">1.8</ix:nonFraction>&#160;million, iii) contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1060">11.9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1061">7.4</ix:nonFraction>&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1062">4.5</ix:nonFraction>&#160;million), and iv) a settlement of a loan from RadNet of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1063">1.5</ix:nonFraction>&#160;million.  In addition we paid certain seller closing costs through the issuance of <ix:nonFraction unitRef="shares" contextRef="c-297" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1064">23,362</ix:nonFraction> shares at a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="f-1065">0.6</ix:nonFraction>&#160;million.  As a result of this transaction, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1066">1.0</ix:nonFraction>&#160;million in current assets, $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1067">0.2</ix:nonFraction>&#160;million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-1068">27.7</ix:nonFraction>&#160;million in intangible assets (including developed technology of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-936-3" continuedAt="f-936-4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-1069">21.1</ix:nonFraction>&#160;million and IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-1070">5.5</ix:nonFraction>&#160;million), $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1071">3.2</ix:nonFraction>&#160;million in current liabilities, a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1072">3.5</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1073">22.9</ix:nonFraction>&#160;million in goodwill. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from <ix:nonFraction unitRef="number" contextRef="c-300" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-1074">15</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-301" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-1075">17</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company originally expected to complete the project following twelve months of acquisition. Subsequently, in September 2023, we determined that the In-process Research and Development ("IPR&amp;D") related to Aidence's Ai Veye Lung and Veye Clinic would not achieve FDA approval for sale in the US without a new submission and additional expenditures for rework.  The additional expenditures, delay, and reduction of US sales affected the estimated fair value of the associated IPR&amp;D intangible asset and resulted in impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-1076">3.9</ix:nonFraction>&#160;million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The useful lives for the developed technology asset was set at <ix:nonNumeric contextRef="c-302" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-1077">7</ix:nonNumeric> years, for customer relationships <ix:nonNumeric contextRef="c-303" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-1078">5.4</ix:nonNumeric> years, and trade names was <ix:nonNumeric contextRef="c-304" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-1079">7</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-1080">42.3</ix:nonFraction>&#160;million including i) <ix:nonFraction unitRef="shares" contextRef="c-91" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1081">965,058</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-305" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="f-1082">26.80</ix:nonFraction> per share with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="f-1083">25.9</ix:nonFraction>&#160;million, ii) cash of $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-1084">11.8</ix:nonFraction>&#160;million, and iii)  contingent consideration consisting of <ix:nonFraction unitRef="shares" contextRef="c-306" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1085">113,303</ix:nonFraction> shares with a fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="f-1086">3.0</ix:nonFraction>&#160;million and cash of $<ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1087">1.6</ix:nonFraction>&#160;million both to be released <ix:nonNumeric contextRef="c-91" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="f-1088">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1089">2.4</ix:nonFraction>&#160;million in current assets, $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1090">0.1</ix:nonFraction>&#160;million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-1091">21.3</ix:nonFraction>&#160;million in intangible assets (including developed technology of $<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-1092">19.6</ix:nonFraction>&#160;million and IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-1093">0.7</ix:nonFraction>&#160;million), $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1094">0.7</ix:nonFraction>&#160;million in current liabilities, $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1095">6.7</ix:nonFraction>&#160;million in long-term debt and deferred tax liabilities, and $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1096">26.4</ix:nonFraction>&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from <ix:nonFraction unitRef="number" contextRef="c-310" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-1097">50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-311" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-1098">55</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The useful lives for the developed technology asset was set at <ix:nonNumeric contextRef="c-312" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="f-1099">seven years</ix:nonNumeric>, customer relationships <ix:nonNumeric contextRef="c-313" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="f-1100">three years</ix:nonNumeric>, and trade names <ix:nonNumeric contextRef="c-314" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="f-1101">seven years</ix:nonNumeric>. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-936-4"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed above, for the acquisitions of Aidence and Quantib, the Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiaries</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frederick County Radiology, LLC.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc.  The operation offers multi-modality services out of <ix:nonFraction unitRef="location" contextRef="c-315" decimals="INF" name="rdnt:NumberOfLocationOfferingMultiModalityServices" format="ixt-sec:numwordsen" scale="0" id="f-1102">six</ix:nonFraction> locations in Frederick, Maryland.  We contributed the operations of <ix:nonFraction unitRef="center" contextRef="c-316" decimals="INF" name="rdnt:NumberOfCentersContributed" format="ixt-sec:numwordsen" scale="0" id="f-1103">four</ix:nonFraction> centers to the enterprise and Frederick Health Hospital, Inc.  contributed $<ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1104">5.4</ix:nonFraction> million in fixed assets, $<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1105">3.0</ix:nonFraction> million in equipment, and  $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1106">11.0</ix:nonFraction> million in goodwill.  As a result of the transaction, we recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1107">6.6</ix:nonFraction> million to additional paid in capital and retained a <ix:nonFraction unitRef="number" contextRef="c-320" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-1108">65</ix:nonFraction>% controlling economic interest in FCR and Frederick Health Hospital, Inc. retains an $<ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1109">11.1</ix:nonFraction> million or <ix:nonFraction unitRef="number" contextRef="c-322" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" scale="-2" id="f-1110">35</ix:nonFraction>% noncontrolling economic interest in FCR.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary and sale of ownership interest</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Los Angeles Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023 we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of <ix:nonFraction unitRef="location" contextRef="c-267" decimals="INF" name="rdnt:NumberOfLocationOfferingMultiModalityServices" format="ixt-sec:numwordsen" id="f-1111">three</ix:nonFraction> locations in Los Angeles, California. We contributed the operations of <ix:nonFraction unitRef="center" contextRef="c-267" decimals="INF" name="rdnt:NumberOfCentersContributed" scale="0" id="f-1112">3</ix:nonFraction> centers to the subsidiary. Cedars-Sinai Medical Center purchased from us a <ix:nonFraction unitRef="number" contextRef="c-268" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-1113">35</ix:nonFraction>% noncontrolling economic interest in LAIG for a cash payment of $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:LimitedPartnersContributedCapital" format="ixt:num-dot-decimal" scale="6" id="f-1114">5.9</ix:nonFraction> million. As a result of the transaction, we retain a <ix:nonFraction unitRef="number" contextRef="c-269" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="f-1115">65</ix:nonFraction>% controlling economic interest in LAIG.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tarzana Medical Center, LLC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Effective September 1, 2021 we completed the sale of a <ix:nonFraction unitRef="number" contextRef="c-323" decimals="3" name="rdnt:NoncontrollingInterestPercentOfOwnershipSold" scale="-2" id="f-1116">24.9</ix:nonFraction>% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="rdnt:ProceedsFromSaleOfInterestInMinorityShareholders" format="ixt:num-dot-decimal" scale="6" id="f-1117">13.1</ix:nonFraction> million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from <ix:nonFraction unitRef="number" contextRef="c-324" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-1118">75.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-325" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-1119">50.1</ix:nonFraction>% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $<ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="6" id="f-1120">4.2</ix:nonFraction> million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1121">5.2</ix:nonFraction> million.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1122" continuedAt="f-1122-1" escape="true">SEGMENT REPORTING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1122-1" continuedAt="f-1122-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  We also provide teleradiology services in the United Kingdom though our majority-owned Heart &amp; Lung Imaging Limited subsidiary.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div></ix:continuation><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1122-2" continuedAt="f-1122-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1123" continuedAt="f-1123-1" escape="true"><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:18.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Centers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1124">1,610,707</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1125">5,923</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1127">1,616,630</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1129">6,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1130">6,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1132">1,610,707</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1133">12,469</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1134">6,546</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1135">1,616,630</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:18.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Centers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1136">1,425,665</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1137">4,396</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1139">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1140">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1141">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1144">1,425,665</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1145">4,396</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-1146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1147">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1123-1"><ix:continuation id="f-1122-3" continuedAt="f-1122-4"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1148">1,604,161</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1149">1,425,665</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1150">1,313,662</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1151">12,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1152">4,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1153">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1154">1,616,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1155">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-1156">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1157">1,371,036</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1158">1,240,593</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1159">1,117,941</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1160">24,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1161">23,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1162">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1163">1,395,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1164">1,264,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1165">1,123,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" sign="-" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-1166">16,808</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-1172">16,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:GainOnContributionOfImagingCentersIntoJointVenture" format="ixt:fixed-zero" scale="3" id="f-1174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Lease abandonment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-1175">5,146</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-1176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-1177">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-1178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-1179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-1180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-1181">5,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="f-1182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="f-1183">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1184">120,776</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1185">109,524</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1186">96,174</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1187">7,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1188">6,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-1189">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1190">128,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1191">115,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1192">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1193">2,191</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1194">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1195">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-1196">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-1197">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="f-1198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1199">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1200">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1201">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="f-1202">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-1203">926</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-1204">744</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="f-1205">1,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-1206">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="3" id="f-1207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="f-1208">3,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-1209">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-1210">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1211">119,847</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1212">72,116</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1213">77,882</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1214">21,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1215">25,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1216">4,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1217">98,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1218">46,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="f-1219">73,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="f-1122-4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In the first quarter of 2024, we revised our reportable segments to combine our eRad business, which was included in the Imaging Center segment, with our AI segment to form a new Digital Health reportable segment. As a result of the change, beginning with our Quarterly Report on Form 10-Q for the quarter ending March 31, 2024, we will report our results in these <ix:nonFraction unitRef="loan" contextRef="c-356" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1220">two</ix:nonFraction> reportable segments. The change in reportable segments will be reflected retrospectively.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-1221" continuedAt="f-1221-1" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="f-1221-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="f-1222" continuedAt="f-1222-1" escape="true">The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2022 and December 31, 2023 is provided below (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-1222-1"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"/><td style="width:33.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1223">489,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1224">24,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1225">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1226">120,551</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1227">48,697</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1228">169,248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="f-1229">4,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="3" id="f-1230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="f-1231">4,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="f-1232">106</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="f-1233">147</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="f-1234">41</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1235">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1236">2,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1237">1,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1238">606,483</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1239">71,182</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1240">677,665</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1241">6,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="f-1242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1243">6,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="f-1244">9,235</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="3" id="f-1245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="f-1246">9,235</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-1247">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="f-1248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-1249">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1250">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1251">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1252">2,957</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1253">606,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1254">72,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1255">679,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2023 is $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="f-1256">142.7</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1257">12.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1258">10.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1259">4.4</ix:nonFraction> million for the years ended December 31, 2023, 2022 and 2021, respectively. Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over <ix:nonNumeric contextRef="c-363" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-1260">25</ix:nonNumeric> years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-1261" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1262">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1263">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1264">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1265">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1266">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1267">6,671</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1268">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-364" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1269">7.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="f-1270">946</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="f-1271">714</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="f-1272">427</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="f-1273">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="f-1274">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="f-1275">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1276">2,270</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-365" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1277">3.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1278">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1279">1,104</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="f-1280">981</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="f-1281">797</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="f-1282">764</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1283">10,564</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1284">15,444</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-366" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1285">17.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="f-1286">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="f-1287">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="f-1288">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="f-1289">315</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="f-1290">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="f-1291">164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1292">1,727</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-367" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1293">5.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1294">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1295">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1296">7,745</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1297">7,210</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1298">7,046</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1299">6,117</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1300">43,688</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-368" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1301">5.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="f-1302">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="f-1303">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="f-1304">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="f-1305">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="f-1306">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="f-1307">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-1308">398</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-369" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1309">5.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1310">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1311">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1312">1,882</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1313">1,882</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1314">12,645</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1315">12,283</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1316">11,833</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1317">10,818</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1318">10,505</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1319">32,531</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1320">90,615</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-1321" continuedAt="f-1321-1" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="f-1321-1" continuedAt="f-1321-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-1322" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-1323">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-1324">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1325">714,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1326">649,034</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1327">127,540</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1328">119,467</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1329">47,286</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1330">36,015</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1331">537,853</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-1332">501,963</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment originally acquired under finance/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1333">13,971</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1334">13,971</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1335">1,441,300</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1336">1,320,700</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1337">836,899</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1338">754,739</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1339">604,401</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1340">565,961</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2023  is approximately $<ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1341">42.7</ix:nonFraction> million total of construction in process amounts consisting of $<ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1342">12.2</ix:nonFraction> million in medical equipment, $<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1343">1.9</ix:nonFraction> million in computer and office equipment, $<ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1344">6.0</ix:nonFraction> million in software costs and $<ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1345">22.6</ix:nonFraction> million in leasehold improvements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2022 is approximately $<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1346">73.4</ix:nonFraction> million total of construction in process amounts consisting of $<ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1347">26.6</ix:nonFraction> million in medical equipment, $<ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1348">5.3</ix:nonFraction> million in computer and office equipment, $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1349">0.4</ix:nonFraction> million in software costs and $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="f-1350">41.1</ix:nonFraction> million in leasehold improvements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1321-2">Depreciation and amortization expense of property and equipment, including amortization of equipment under finance leases, for the years ended December 31, 2023, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1351">116.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1352">105.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1353">92.3</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1354" continuedAt="f-1354-1" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="f-1354-1" continuedAt="f-1354-2"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-1355" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022 our term loan debt and other obligations consisted of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1356">678,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1357">714,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on Barclays Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-1358">9,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-1359">11,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Term Loan collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1360">144,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1361">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on Truist Term Loan </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="f-1362">990</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-1363">1,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at <ix:nonFraction unitRef="number" contextRef="c-392" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1364">6.0</ix:nonFraction>%, due 2028, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-3" name="us-gaap:OtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-1365">17,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" name="us-gaap:OtherNotesPayable" format="ixt:fixed-zero" scale="3" id="f-1366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1367">830,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1368">851,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1369">17,974</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1370">12,400</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1371">812,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1372">839,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-1373" continuedAt="f-1373-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands)</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1354-2" continuedAt="f-1354-3"><ix:continuation id="f-1373-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1374">20,324</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1375">22,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1376">22,676</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1377">124,188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1378">650,454</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1379">840,073</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="c-394" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-1380">no</ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1381">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at December 31, 2023 and had reserved an additional $<ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="f-1382">7.6</ix:nonFraction> million for certain letters of credit.  The remaining $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1383">187.4</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2023.  We also had <ix:nonFraction unitRef="usd" contextRef="c-398" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-1384">no</ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1385">50.0</ix:nonFraction> million Truist Revolving Credit Facility, related to our consolidated subsidiary NJIN, at December 31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2023 we were in compliance with all covenants under our credit facilities. On February 1, 2023, we issued a promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1386">19.8</ix:nonFraction> million to acquire radiology equipment previously leased under operating leases.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2023, we entered into the First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement related to our Barclays credit facility (the "Barclays Amendment"), which replaces the interest rate benchmark, from the London Interbank Offered Rate ("LIBOR") to the Secured Overnight Financing Rate ("SOFR") and includes applicable credit spread adjustments of <ix:nonFraction unitRef="number" contextRef="c-400" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1387">0.11448</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1388">0.26161</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-402" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1389">0.42826</ix:nonFraction>% for interest periods of one month, three months, and six months, respectively. The replacement of LIBOR with SOFR and the credit spread adjustments were effective as of March 31, 2023, which was the last day of the last-ending existing interest period of currently outstanding loan bearing interest at LIBOR. Other than the foregoing, the material terms of the Barclays credit facility remained unchanged.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Barclays Restated Credit Agreement") which provides for $<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1390">725.0</ix:nonFraction> million of senior secured first lien term loans (the "Barclays Term Loans") and a $<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1391">195.0</ix:nonFraction> million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the Barclays Term Loans were used to refinance loans outstanding under our prior Barclays credit agreement and provide funding for current and future operations. Total costs of the Barclays Restated Credit Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="f-1392">14.9</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1393">8.8</ix:nonFraction> million capitalized to discount and deferred finance cost, $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1394">4.5</ix:nonFraction> million expensed to debt restructuring costs, $<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1395">1.5</ix:nonFraction> million charged to loss on early extinguishment of debt and $<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" name="us-gaap:AmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="f-1396">0.1</ix:nonFraction> million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the  Barclays Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Truist Restated Credit Agreement") which provides for a $<ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1397">150.0</ix:nonFraction> million of a secured term loan (the "Truist Term Loan") and a $<ix:nonFraction unitRef="usd" contextRef="c-407" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1398">50.0</ix:nonFraction> million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior Truist term loan agreement and provide funding for current and future operations. Total costs of the Truist Restated Credit Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="f-1399">2.7</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1400">2.0</ix:nonFraction> million capitalized to discount and deferred finance cost and $<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1401">0.7</ix:nonFraction> million expensed to loss on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Truist Restated Credit Agreement.</span></div><ix:nonNumeric contextRef="c-1" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="f-1402" continuedAt="f-1402-1" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Truist Restated Credit Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Truist Restated Credit Agreement), plus an applicable margin according to the following schedule:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1354-3" continuedAt="f-1354-4"><ix:continuation id="f-1402-1" continuedAt="f-1402-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-410" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="f-1403">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-411" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1404">2.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-412" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1405">1.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-413" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1406">2.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-413" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1407">0.45</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="c-414" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-1408">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-414" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="f-1409">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-415" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1410">2.25</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-416" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1411">1.25</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-417" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1412">2.25</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-417" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1413">0.40</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="c-418" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-1414">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-418" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="f-1415">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-419" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1416">2.00</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-420" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1417">1.00</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-421" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1418">2.00</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-421" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1419">0.35</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="c-422" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-1420">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-422" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="f-1421">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-423" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1422">1.75</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-424" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1423">0.75</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-425" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1424">1.75</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-425" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1425">0.30</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="c-426" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-1426">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-427" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1427">1.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-428" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1428">0.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-429" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1429">1.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-429" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1430">0.30</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Barclays Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March 31, 2023, the Barclays Term Loans bore interest at either a Eurodollar Rate or an Alternative Base Rate (in each such case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin. The applicable margin for Eurodollar Rate and Alternative Base Rate was <ix:nonFraction unitRef="number" contextRef="c-430" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1431">3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-431" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1432">2</ix:nonFraction>%, respectively, with an effective Eurodollar Rate and the Alternative Base Rate of <ix:nonFraction unitRef="number" contextRef="c-432" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1433">4.63</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-433" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1434">8.00</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Barclays Amendment, effective March 31, 2023, the Barclays Term Loans bear interest either at a SOFR or Alternative Base Rate (in each such case, as defined in the Restated Barclays Credit Agreement) plus an applicable margin. The applicable margin for Eurodollar Rate and Alternative Base Rate was <ix:nonFraction unitRef="number" contextRef="c-430" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1435">3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-431" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1436">2</ix:nonFraction>%, respectively. At December 31, 2023, we have an effective SOFR of <ix:nonFraction unitRef="number" contextRef="c-434" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1437">8.38</ix:nonFraction>%, with an applicable credit spread adjustment of <ix:nonFraction unitRef="number" contextRef="c-434" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1438">0.26161</ix:nonFraction>%, and an Alternative Base Rate of <ix:nonFraction unitRef="number" contextRef="c-435" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1439">10.5</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Restated Credit Agreement provides for quarterly payments of principal for the Barclays Term Loans in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-1440">1.8</ix:nonFraction> million. The  Barclays Term Loans will mature on April 23, 2028 unless otherwise accelerated under the terms of the Barclays Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Term Loan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Term Loan currently bears interest at a three month SOFR election of <ix:nonFraction unitRef="number" contextRef="c-437" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1441">5.33</ix:nonFraction>% plus an applicable margin and fees based on Pricing Level V described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the Truist Term Loan began March 31, 2023 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="6" id="f-1442">1.9</ix:nonFraction> million, representing <ix:nonFraction unitRef="number" contextRef="c-438" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="f-1443">1.00</ix:nonFraction>% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-5" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" format="ixt:num-dot-decimal" scale="6" id="f-1444">0.9</ix:nonFraction> million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the Truist Restated Credit Agreement.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility is a $<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1445">195.0</ix:nonFraction> million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1446">1.1</ix:nonFraction> million at December 31, 2023.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1354-4"><ix:continuation id="f-1402-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin which adjusts depending on our  net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternative Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="c-440" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="f-1447">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-441" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1448">3.25</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-442" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1449">2.25</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="c-443" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="f-1450">3.00</ix:nonFraction>x but &#8804; <ix:nonFraction unitRef="number" contextRef="c-444" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="f-1451">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-445" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1452">3.00</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-446" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1453">2.00</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; <ix:nonFraction unitRef="number" contextRef="c-447" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="f-1454">3.00</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-448" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1455">2.75</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-449" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1456">1.75</ix:nonFraction>%</span></div></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the effective interest rate for borrowings on revolving loans under the Barclays Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="c-397" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1457">10.3</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for SOFR revolving loans which is currently <ix:nonFraction unitRef="number" contextRef="c-450" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1458">3.00</ix:nonFraction>% and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="c-451" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1459">0.125</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Barclays Restated Credit Agreement. In addition, a commitment fee of <ix:nonFraction unitRef="number" contextRef="c-451" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1460">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Barclays Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated with the Truist Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="c-407" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1461">50.0</ix:nonFraction> million are deferred financing costs, net of accumulated amortization, of  $<ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1462">0.5</ix:nonFraction> million at December 31, 2023.  As of December 31, 2023, NJIN had no borrowings under the Truist Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level V as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to prior Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Truist Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2018, under an Amended and Restated Revolving Credit and Term Loan Agreement, our NJIN subsidiary secured a term loan commitment of $<ix:nonFraction unitRef="usd" contextRef="c-453" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1463">60.0</ix:nonFraction> million and established revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="c-454" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1464">30.0</ix:nonFraction> million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Truist Restated Credit Agreement.</span></div></ix:continuation><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-1465" continuedAt="f-1465-1" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1465-1" continuedAt="f-1465-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material lease contracts are for facilities and advanced radiology equipment.  In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from <ix:nonNumeric contextRef="c-455" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1466">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c-456" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1467">15</ix:nonNumeric> years. Including renewal options negotiated with the landlord, we can have a total span of <ix:nonNumeric contextRef="c-455" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-1468">10</ix:nonNumeric> to <ix:nonNumeric contextRef="c-456" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-1469">35</ix:nonNumeric> years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from <ix:nonNumeric contextRef="c-457" name="rdnt:LesseeLeaseTermofContract" format="ixt-sec:duryear" id="f-1470">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c-458" name="rdnt:LesseeLeaseTermofContract" format="ixt-sec:duryear" id="f-1471">8</ix:nonNumeric> years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our incremental borrowing rate used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our incremental borrowing rate is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1465-2" continuedAt="f-1465-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1472" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:60.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.592%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1473">106,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1474">107,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1475">121,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1476">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1477">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1478">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:fixed-zero" scale="3" id="f-1479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:fixed-zero" scale="3" id="f-1480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1481">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1482">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1483">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1484">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2023 and 2021 included $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-1485">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-1486">12.6</ix:nonFraction> million, respectively in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="f-1487" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:61.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1488">101,516</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1489">108,004</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1490">110,288</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="3" id="f-1491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="3" id="f-1492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1493">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="3" id="f-1494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="3" id="f-1495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="f-1496">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1497">55,852</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1498">88,080</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1499">186,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1465-3"><ix:nonNumeric contextRef="c-1" name="rdnt:AssetsAndLiabilitiesLesseeTableTextBlock" id="f-1500" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1501">596,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1502">603,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1503">55,981</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1504">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1505">605,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1506">604,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1507">661,078</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1508">661,724</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1509">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1510">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1511"><span style="-sec-ix-hidden:f-1512">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1513">13,374</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1514">12,171</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="f-1515">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1516">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1517">10.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1518">10.9</ix:nonNumeric></span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1519">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1520">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1521" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:59.904%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.896%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1522">97,603</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1523">92,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1524">91,400</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1525">88,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1526">85,633</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rdnt:LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" format="ixt:num-dot-decimal" scale="3" id="f-1527">482,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1528">938,299</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1529">277,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1530">661,078</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1531">4.6</ix:nonFraction> million.  These operating leases will commence in 2024 with lease terms of <ix:nonNumeric contextRef="c-455" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="f-1532">1</ix:nonNumeric> to <ix:nonNumeric contextRef="c-456" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="f-1533">15</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1534" continuedAt="f-1534-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="f-1534-1" continuedAt="f-1534-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-1535" continuedAt="f-1535-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we have the following income (loss) before income taxes (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-1534-2" continuedAt="f-1534-3"><ix:continuation id="f-1535-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Domestic</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-1536">60,374</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-1537">59,529</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-1538">58,806</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-1539">21,564</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-1540">16,560</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="f-1541">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1542">38,810</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1543">42,969</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1544">58,879</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1545" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1547">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1548">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-1549">3,442</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="f-1550">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-1551">2,191</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-1552">638</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-1553">87</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-1554">18</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:CurrentOtherTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1555">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:CurrentOtherTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1556">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:CurrentOtherTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1557">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1558">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1559">6,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1560">9,831</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1561">2,724</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1562">5,863</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1563">6,902</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1564">1,843</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1565">3,430</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:ForeignCurrencyTranslationAdjustments" format="ixt:fixed-zero" scale="3" id="f-1567">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:ForeignCurrencyTranslationAdjustments" format="ixt:fixed-zero" scale="3" id="f-1568">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:ForeignCurrencyTranslationAdjustments" format="ixt:fixed-zero" scale="3" id="f-1569">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1570">8,473</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1571">9,361</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1572">14,560</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1573" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1574">8,150</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1575">9,023</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1576">12,365</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1577">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="f-1578">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1579">4,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-1580">196</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-1581">305</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-1582">93</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="f-1583">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="f-1584">759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="f-1585">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1586">5,752</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1587">4,821</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1588">4,114</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1589">2,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1590">6,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="f-1591">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1592">5,987</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="f-1593">234</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1594">2,530</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="f-1595">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-1596">1,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-1597">5,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1598">1,083</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-1599">737</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-1600">4</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="f-1601">884</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="f-1602">749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="f-1603">321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax rate adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="f-1604">984</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="f-1605">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="f-1606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:fixed-zero" scale="3" id="f-1607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-1608">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:fixed-zero" scale="3" id="f-1609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1610">8,473</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1611">9,361</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1612">14,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1613" continuedAt="f-1613-1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets and liabilities comprise the following (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1534-3" continuedAt="f-1534-4"><ix:continuation id="f-1613-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1614">43,247</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1615">68,124</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="f-1616">4,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="f-1617">3,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1618">136,097</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1619">142,347</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1620">4,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1621">4,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-1622">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-1623">3,071</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-1624">15,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-1625">6,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1626">9,688</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1627">12,095</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1628">196,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1629">216,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1630">7,851</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1631">9,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1632">42,419</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1633">38,820</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1634">15,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1635">18,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1636">122,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1637">129,802</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOutsideBasisDifference" format="ixt:num-dot-decimal" scale="3" id="f-1638">18,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOutsideBasisDifference" format="ixt:num-dot-decimal" scale="3" id="f-1639">20,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1640">4,761</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1641">9,081</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1642">211,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1643">225,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1644">15,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1645">9,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1646">128.9</ix:nonFraction> million, which is comprised of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1647">63.9</ix:nonFraction> million, which expire at various intervals from the years 2026 to 2037, and had carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1648">65.0</ix:nonFraction> million of net operating losses which do not expire. Federal net operating losses generated in tax years following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  We also had state net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1649">145.3</ix:nonFraction> million, which expire at various intervals from the years 2024 through 2042. As of December 31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1650">24.9</ix:nonFraction> million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code. We also had foreign net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1651">45.8</ix:nonFraction> million, which do not expire and are carried over indefinitely.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2023, we have determined that deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized" format="ixt:num-dot-decimal" scale="6" id="f-1652">196.2</ix:nonFraction> million are more likely-than-not to be realized. We have also determined deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-1653">42.4</ix:nonFraction> million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018. We do not anticipate the results of any open examinations would result in a material change to our financial position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1654" continuedAt="f-1654-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1534-4"><ix:continuation id="f-1654-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1655">4,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1656">5,088</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1657">5,484</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1658">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1659">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1660">317</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="f-1661">62</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-1662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-1663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="f-1664">1,180</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="f-1665">999</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="f-1666">713</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" scale="3" id="f-1667">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="f-1668">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="f-1669">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1670">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1671">4,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1672">5,088</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, we had unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-1673">3.1</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1674">2.5</ix:nonFraction> million will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2023 the Company accrued approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1675">47</ix:nonFraction> thousand of interest and penalties. As of December 31, 2023, accrued interest and penalties amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1676">0.4</ix:nonFraction> million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2021, the Organization for Economic Co-operation and Development ("OECD") announced an inclusive framework on base erosion and profit shifting including Pillar Two Model Rules defining the global minimum tax, which calls for taxation of large multinational corporations at a minimum rate of 15%. Subsequently multiple sets of administrative guidance have been issued. Many non-US tax jurisdictions have either recently enacted legislation to adopt certain components of Pillar Two Model Rules beginning in 2024 (including the European Union Member States) with the adoption of additional components in later years or announced their plans to enact legislation in future years. We are continuing to evaluate the impacts of enacted legislation and pending legislation to enact Pillar Two Model Rules in the jurisdictions that we operate in outside of the US.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 was signed into law on August 9, 2022 to boost domestic semiconductor manufacturing and encourage US research activities.  The act provided a 25% investment credit intended to promote domestic production of semiconductors. This act is not expected to have a material impact for us.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1677" continuedAt="f-1677-1" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="f-1677-1" continuedAt="f-1677-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="incentiveplan" contextRef="c-4" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="f-1678">one</ix:nonFraction> long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, second on March 9, 2017, third on April 15, 2021, and currently as of April 27, 2023 (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023.  We have reserved for issuance under the Restated Plan <ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1679">20,100,000</ix:nonFraction> shares of common stock.  We can issue options (incentive and nonstatutory), performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:f-1680">one</span> to <ix:nonNumeric contextRef="c-458" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1681">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:f-1682">five</span> to <ix:nonNumeric contextRef="c-458" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-1683">ten years</ix:nonNumeric> from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1677-2" continuedAt="f-1677-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1684" continuedAt="f-1684-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the twelve months ended December 31, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Restated Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1685">678,914</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1686">15.72</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-462" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1687">261,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-462" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1688">18.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1689">12,723</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1690">11.11</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled, forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-462" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1691">16,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-462" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1692">17.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1693">911,411</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1694">16.60</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1695">6.22</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1696">16,561,659</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1697">668,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1698">14.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1699">5.24</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-1700">13,387,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2023 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2023. As of December 31, 2023, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="f-1701">1.4</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="c-464" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1702">1.23</ix:nonNumeric> years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;<ix:nonFraction unitRef="shares" contextRef="c-465" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1703">412,434</ix:nonFraction>&#160;options at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-466" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1704">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2023, total unrecognized stock based compensation expense related to non-vested DeepHealth options was insignificant.</span></div><ix:continuation id="f-1684-1"><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:46.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-467" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1705">116,982</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="c-467" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="f-1706"></ix:nonFraction></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-468" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1707">37,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-468" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-469" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1709">79,073</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-469" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-468" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1711">5.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1712">2,749,368</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-469" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1713">76,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-469" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-468" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1715">5.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-1716">2,663,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2023, we have issued a total of <ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1717">8,718,185</ix:nonFraction> RSA&#8217;s of which <ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1718">537,358</ix:nonFraction> were unvested at December 31, 2023. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-1719" continuedAt="f-1719-1" escape="true">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2023:</ix:nonNumeric></span></div><ix:continuation id="f-1719-1" continuedAt="f-1719-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1677-3" continuedAt="f-1677-4"><ix:continuation id="f-1719-2"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-472" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1720">536,767</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-472" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1721">23.84</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1722">825,255</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-470" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1723">21.31</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1724">785,656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-470" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1725">22.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1726">39,008</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-470" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1727">18.31</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1728">537,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-470" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-1729">0.90</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-471" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1730">22.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based on the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2023 we issued <ix:nonFraction unitRef="shares" contextRef="c-473" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1731">50,765</ix:nonFraction> shares relating to these awards, amounting to approximately $<ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-5" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" format="ixt:num-dot-decimal" scale="6" id="f-1732">1.3</ix:nonFraction> million of compensation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSUs with a target award of <ix:nonFraction unitRef="shares" contextRef="c-474" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1733">25,683</ix:nonFraction> shares of our common stock. The PSUs will vest in <ix:nonFraction unitRef="tranche" contextRef="c-474" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="f-1734">two</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="c-474" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1735">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="c-475" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1736">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-476" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1737">200</ix:nonFraction>% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022. In January of 2023, based on the performance condition achieved, the board of directors issued <ix:nonFraction unitRef="shares" contextRef="c-477" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1738">12,843</ix:nonFraction> units with a fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-477" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-1739">29.44</ix:nonFraction> per unit.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we granted certain employees PSUs with a target award of <ix:nonFraction unitRef="shares" contextRef="c-478" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1740">60,685</ix:nonFraction> shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="c-479" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1741">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-480" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1742">200</ix:nonFraction>% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2023 through December 31, 2023. As of December 31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-481" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1743">121,370</ix:nonFraction> shares are expected to vest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSOs to purchase a maximum of <ix:nonFraction unitRef="shares" contextRef="c-482" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1744">111,925</ix:nonFraction> shares of our common stock. The PSOs will vest in <ix:nonFraction unitRef="tranche" contextRef="c-482" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="f-1745">three</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="c-482" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1746">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="c-483" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="f-1747">0</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="c-484" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-1748">111,925</ix:nonFraction> shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022. In January of 2023, based on the performance condition achieved, the board of directors issued <ix:nonFraction unitRef="shares" contextRef="c-485" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1749">27,981</ix:nonFraction> options with a strike price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-485" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-1750">29.44</ix:nonFraction> per share.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we granted certain employees PSOs with a potential to purchase a maximum of <ix:nonFraction unitRef="shares" contextRef="c-486" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1751">235,227</ix:nonFraction> shares of our common stock. The PSOs will vest in <ix:nonFraction unitRef="tranche" contextRef="c-486" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" id="f-1752">three</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="c-486" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1753">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="shares" contextRef="c-487" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="f-1754">0</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="c-488" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-1755">235,227</ix:nonFraction> shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period January 1, 2023 through December 31, 2023. As of December 31, 2023, all <ix:nonFraction unitRef="shares" contextRef="c-488" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-1756">235,227</ix:nonFraction> shares are expected to vest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AI Long Term Incentive Plan shares ("AI LTIPs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a <span style="-sec-ix-hidden:f-1757">two</span> to <ix:nonNumeric contextRef="c-490" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1758">four year</ix:nonNumeric> period, conditioned on continued employment through the vesting periods. We determine the fair value of all AI LTIPs based on the closing price of our common stock on the award date.  </span><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="f-1759" continuedAt="f-1759-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all unvested AI LTIPs activities during the twelve months ended December 31, 2023:</span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1677-4"><ix:continuation id="f-1759-1"><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:61.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.824%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-491" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1760">169,471</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-491" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1761">19.56</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-492" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" id="f-1762">216,460</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-492" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1763">20.24</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-493" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1764">66,309</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-493" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1765">19.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-492" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1766">94,897</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-492" decimals="2" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" scale="0" id="f-1767">19.82</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-494" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1768">224,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-492" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-1769">2.73</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-494" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1770">20.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the <ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1771">20,100,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan at December 31, 2023, there remain <ix:nonFraction unitRef="shares" contextRef="c-495" decimals="INF" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-1772">4,069,349</ix:nonFraction> shares available for future issuance.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1773" continuedAt="f-1773-1" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1773-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposed acquisitions of imaging centers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2023, we acquired Houston Medical Imaging, LLC for a purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-1774">29.0</ix:nonFraction> million. Houston Medical Imaging consists of seven multi modality imaging centers located in Houston, Texas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2024, we acquired Antelope Valley Outpatient Imaging Center, LLC for a purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-1775">3.5</ix:nonFraction> million. Antelope Valley Outpatient Imaging consists of four multi modality imaging centers located in Palmdale, California.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Changes In and Disagreements with Accountants on Accounting and Financial Disclosure</span></td></tr></table></div><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_118"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Controls and Procedures</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of December 31, 2023. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2023 to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Internal control over financial reporting includes policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are transacted in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision of our Principal Executive Officer and Principal Financial Officer, conducted an assessment of the effectiveness of its internal control over financial reporting as of December 31, 2023 based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2023.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young LLP, the Company&#8217;s independent registered public accounting firm, has audited the Company&#8217;s internal control over financial reporting as of December 31, 2023, as stated in their report, which is included below in this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management does not expect that internal controls over financial reporting will prevent or detect all misstatements or incidences of fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The design and implementation of a control system is limited by resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods are subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act)  during the&#160;quarter ended&#160;December&#160;31, 2023,&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Opinion on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited RadNet, Inc. and subsidiaries&#8217; internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), (the COSO criteria). In our opinion, RadNet, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on the COSO criteria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income, equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and our report dated February 29, 2024 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Los Angeles, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February 29, 2024&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9B.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other Information.</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal quarter ended December 31, 2023, none of our directors or executive officers <ix:nonNumeric contextRef="c-498" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1776"><ix:nonNumeric contextRef="c-498" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1777">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-498" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1778"><ix:nonNumeric contextRef="c-498" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1779">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_127"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_130"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_133"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Directors, Executive Officers and Corporate Governance</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 10 will be included under the captions &#8220;Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Corporate Governance,&#8221; and &#8220;Delinquent Section 16(a) Reports&#8221; in our definitive Proxy Statement for the 2024 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year (the &#8220;Proxy Statement&#8221;) and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of financial ethics applicable to our directors, officers and employees which is designed to deter wrongdoing and to promote:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">honest and ethical conduct;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in our other public communications;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">compliance with applicable laws, rules and regulations, including insider trading compliance; and</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">accountability for adherence to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may obtain a copy of our Code of Financial Ethics on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.radnet.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under Investor Relations&#160;&#8212;&#160;Corporate Governance. The Audit Committee is responsible for reviewing the Code of Financial Ethics and amending as necessary. Any amendments will be disclosed on our website.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_136"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Executive Compensation</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 11 will be included under the captions &#8220;Compensation of Directors,&#8221; &#8220;Compensation Committee Report,&#8221; &#8220;Compensation Discussion and Analysis,&#8221; and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_139"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 12 will be included under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_142"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Certain Relationships and Related Transactions, and Director Independence</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 13 will be included under the captions &#8220;Compensation of Directors," "Compensation Committee Report," "Compensation Discussion and Analysis", and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_145"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Accountant Fees and Services</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 14 will be included under the caption &#8220;Fees Paid to Auditors&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="text-align:center"><span><br/></span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_151"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibits and Financial Statements Schedule</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(a) Documents filed as part of this annual report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1) Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The following financial statements are included in this report</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_52">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  (PCAOB ID:<ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-1780">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_52">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_55">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_55">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_58">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_58">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_61">Consolidated Statements of Comprehensive (Loss) Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_61">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_64">Consolidated Statements of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_64">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_67">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i6e34f25d3bd24e8f8cef4b7925f59439_67">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_70">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 to 86</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Financial Statement Schedules</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) Exhibits </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are filed herewith or incorporated by reference herein:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm">Certificate of Incorporation of RadNet, Inc., a Delaware corporation (incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm">xhibit</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm"> 3.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm"> filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">Certificate of Amendment to Certificate of Incorporation of RadNet, Inc., a Delaware corporation, dated September 2, 2008 (incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">xhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">3.2 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">Amended and Restated Bylaws of RadNet, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">filed with</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm"> Form 8-K </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">on February 6, 2020)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822008645/radnet_s3asr.htm">Description of Securities (incorporated by reference the Description of Common Stock contained in the registration statement on Form S-3ASR filed on December 27, 20</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">Equity Incentive Plan, amended and restated as of April </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">27</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm"> (incorporated by reference to Exhibit 99.1 filed with Form S-8 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">re</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">gistration statement </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">August 9, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9902.htm">Form of Incentive Stock Option Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9902.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9902.htm"> filed with Form S-8 registration statement on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9902.htm">August 9, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9902.htm">).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9903.htm">Form of Nonstatutory Stock Option Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.3 filed with Form S-8 registration statement on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9903.htm">August 9, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9903.htm">).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9904.htm">Form of Stock Award Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.4 filed with Form S-8 registration statement on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9904.htm">Aug</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9904.htm">ust 9, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9904.htm">).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9905.htm">Form of Stock Units Agreement (deferred settlement) for the Equity Incentive Plan (incorporated by reference to Exhibit 99.5 filed with Form S-8 registration statement on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9905.htm">August </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9905.htm">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9905.htm">, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005459/radnet_ex9905.htm">).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">Nonqualified Deferred Compensation Plan, effective as of May 5, 2016 (incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">Exh</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">ibit 10.1 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">filed with Form 8-K on May 9, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm">Form of Indemnification Agreement between the Company and each of its officers and directors (incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm">xhibit</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm"> 10.1 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm"> filed with Form 8-K</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm">on June 14, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm">Employment Agreement dated as of April 20, 2023 with Howard G. Berger, M.D. (incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm">xhibit</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm"> 10.1 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm"> filed with </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm"> Form 8-K </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm">on</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002619/radnet_ex1001.htm"> April 26, 2023</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex109-amendmenttoemploym.htm">Amendment to Employment Agreement dated January 1, 2024 with Howard G. Berger, M.D. (filed herewith).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1001.htm">Employment Agreement dated September 1, 2022 with Mark D. Stolper  (incorporated by reference to Exhibit 10.1  filed with</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1001.htm"> Form 8-K on September 2, 2022).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1011-amendmenttoemploy.htm">Amendment to Employment Agreement dated January 1, 2024 with Mark D. Stolper (filed herewith).</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1002.htm">Employment Agreement dated September 1, 2022 with Stephen M. Forthuber (incorporated by reference to Exhibit 10.2  filed with</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1002.htm"> Form 8-K on September 2, 2022).</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.573%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1013-amendmenttoemploy.htm">Amendment to Employment Agreement dated January 1, 2024 with Stephen M. Forthuber (filed herewith).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1003.htm">Employment Agreement dated September 1, 2022 with Norman R. Hames  (incorporated by reference to Exhibit 10.3 filed with </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1003.htm">Form 8-K on September 2, 2022).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1015-amendmenttoemploy.htm">Amendment to Employment Agreement dated January 1, 2024 with Norman R. Hames (filed herewith).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1004.htm">Employment Agreement dated September 1, 2022 with Mital Patel (incorporated by reference to Exhibit 10.4 filed with </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1004.htm">Form 8-K on September 2, 2022).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1017-amendmenttoemploy.htm">Amendment to Employment Agreement dated January 1, 2024 with Mital Patel (filed herewith).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052623000003/davidjkatz_employmentagr.htm">Employment Agreement dated September 1, 2022 with David J. Katz (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052623000003/davidjkatz_employmentagr.htm">incorporated by reference to Exhibit 10.15 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052623000003/davidjkatz_employmentagr.htm">filed with</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052623000003/davidjkatz_employmentagr.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052623000003/davidjkatz_employmentagr.htm"> Form 10-K on March 1, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052623000003/davidjkatz_employmentagr.htm">).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1019-amendmenttoemploy.htm">Amendment to Employment Agreement dated January 1, 2024 with David J. Katz (filed herewith).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823005434/radnet_ex1001.htm">&#160;Employment Agreement dated June 1, 2020 with Gregory Sorensen (incorporated by reference to Exhibit 10.1 filed  with Form 8-K on August 9, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052622000006/radnet-cgordonamendedandre.htm">Amended and Restated Severance Agreement dated February 24, 2022 with Christine Gordon</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504015956/dex1016.htm">Amended and Restated Management and Service Agreement between Radnet Management, Inc. and Beverly Radiology Medical Group III dated January 1, 2004 (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2003).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm">Second Amended and Restated First Lien Credit and Guaranty Agreement, dated as of April 23, 2021, by and among RadNet Management, Inc., a California corporation, RadNet, Inc., a Delaware corporation, certain subsidiaries and affiliates of RadNet Management, Inc., as Guarantors, the Lenders and other financial institutions from time to time party thereto, and Barclays Bank PLC, as Administrative Agent and Collateral Agent (incorporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm">xhibit</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm"> 10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm"> filed with Form 8-K on April 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">irst Amendment to Second Amended and Restated Fir</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">st Lien</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm"> Credit and Guar</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">anty Agreement dated March 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm">, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000168316823002122/radnet_ex1001.htm"> (incorporated by reference to Exhibit 10.1 filed with Form 8-K on April 4, 2023)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2023exhibit211.htm">List of Subsidiaries.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2023exhibit231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6e34f25d3bd24e8f8cef4b7925f59439_163">Power of Attorney (included on signature page attached hereto).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42023exhibit311.htm">CEO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42023exhibit312.htm">CFO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42023exhibit321.htm">CEO Certification pursuant to Section 906.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42023exhibit322.htm">CFO Certification pursuant to Section 906.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.573%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971-radnetincpolicyonrec.htm">RadNet, Inc. Policy on Recovery of Erroneously Awarded Compensation adopted November 8, 2023 (filed herewith).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Calculation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Label Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. &#160;10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_160"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;HOWARD &#160;G. BERGER, M.D .</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., President,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6e34f25d3bd24e8f8cef4b7925f59439_163"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">POWER OF ATTORNEY</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby severally constitutes and appoints Howard G. Berger, M.D. and Mark D. Stolper, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution for him or her and in his or her name, place and stead, in any and all capacities to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of registrant in the capacities and on the dates indicated.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ HOWARD G. BERGER, M.D.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., Director, Chief Executive Officer and President (Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ GREGORY E. SPURLOCK</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gregory E. Spurlock, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ALMA GREGORY SORENSEN</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alma Gregory Sorensen, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID L. SWARTZ</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David L. Swartz, Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.458%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAWRENCE L. LEVITT</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lawrence L. Levitt, Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAURA P. JACOBS</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Laura P. Jacobs, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHRISTINE GORDON</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Christine Gordon, Director</span></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARK D. STOLPER</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper, Chief Financial Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Principal Accounting Officer)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>2
<FILENAME>ex109-amendmenttoemploym.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex109-amendmenttoemploym</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex109-amendmenttoemploym001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex109-amendmenttoemploym001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    AMENDMENT #1 TO EMPLOYMENT AGREEMENT  This Amendment #1 (this &#8220;Amendment&#8221;), made as of the 1st day of January 2024 (the  &#8220;Effective Date&#8221;), to the Employment Agreement, dated as of April 20, 2023 and as amended  (the &#8220;Agreement&#8221;), is by and between Radnet Management, Inc. (the &#8220;Company&#8221;), and Howard  G. Berger, M.D. (&#8220;Employee&#8221;).   W I T N E S E T H:  WHEREAS, the Compensation Committee of the Board of Directors of RadNet, Inc.  approved an increase to Employee&#8217;s Base Compensation effective as of the Effective Date; and   WHEREAS, this Amendment is a written agreement signed by the parties as required by  Section 5.3 of the Agreement with respect to modifying the Agreement.  NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of  which are hereby acknowledged, the parties agree as follows:    1. Base Compensation Change.  Section 2.1 of the Agreement which presently reads  as:   &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $1,500,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices, provided however that BRMG shall each calendar year pay  Employee $500,000 of this Base Compensation amount such that the Company will only  be responsible for the difference of the Base Compensation minus $500,000.&#8221;        is hereby entirely restated to read as follows:  &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $3,000,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices, provided however that BRMG shall each calendar year pay  Employee $1,000,000 of this Base Compensation amount such that the Company will  only be responsible for the difference of the Base Compensation minus $1,000,000.&#8221;  2. Scope.  All other provisions of the Agreement shall continue in full force and  effect as is on and after the Effective Date.  3. Defined Terms.  Except as otherwise defined in this Amendment, the capitalized  terms in this Amendment shall have the same meaning as such terms have in the Agreement.  4.  Governing Law.  The validity, construction and interpretation of this Amendment  shall be governed in all respects by the laws of the State of California applicable to contracts  made and to be performed wholly within that State.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex109-amendmenttoemploym002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex109-amendmenttoemploym002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    5.  Counterparts.  This Amendment may be executed in several counterparts, each of  which shall be deemed to be an original but all of which together will constitute one and the  same instrument.  IN WITNESS WHEREOF, the parties have caused this Amendment to the Agreement to  be duly executed and delivered as of the Effective Date.    Radnet Management, Inc.      By:               Name: David J. Katz     Howard G. Berger, M.D.  Its: Executive Vice President and   Chief Legal Officer and Corporate Secretary    ACKNOWLEDGED AND AGREED:    Beverly Radiology Medical Group III         By:               Howard G. Berger, M.D.                                        </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex109-amendmenttoemploym003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex109-amendmenttoemploym003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      EXHIBIT 1    EMPLOYMENT AGREEMENT        </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>3
<FILENAME>ex1011-amendmenttoemploy.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1011-amendmenttoemploy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex1011-amendmenttoemploy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011-amendmenttoemploy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    AMENDMENT #1 TO EMPLOYMENT AGREEMENT  This Amendment #1 (this &#8220;Amendment&#8221;), made as of the 1st day of January 2024 (the  &#8220;Effective Date&#8221;), to the Employment Agreement, dated as of September 1, 2022 and as  amended (the &#8220;Agreement&#8221;), is by and between Radnet Management, Inc. (the &#8220;Company&#8221;), and  Mark D. Stolper (&#8220;Employee&#8221;).   W I T N E S E T H:  WHEREAS, the Compensation Committee of the Board of Directors of RadNet, Inc.  approved an increase to Employee&#8217;s Base Compensation effective as of the Effective Date; and   WHEREAS, this Amendment is a written agreement signed by the parties as required by  Section 5.3 of the Agreement with respect to modifying the Agreement.  NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of  which are hereby acknowledged, the parties agree as follows:    1. Base Compensation Change.  Section 2.1 of the Agreement which presently reads  as:   &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $575,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;        is hereby entirely restated to read as follows:  &#8220;As of January 1, 2024, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $700,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;.  2. Scope.  All other provisions of the Agreement shall continue in full force and  effect as is on and after the Effective Date.  3. Defined Terms.  Except as otherwise defined in this Amendment, the capitalized  terms in this Amendment shall have the same meaning as such terms have in the Agreement.  4.  Governing Law.  The validity, construction and interpretation of this Amendment  shall be governed in all respects by the laws of the State of California applicable to contracts  made and to be performed wholly within that State.  5.  Counterparts.  This Amendment may be executed in several counterparts, each of  which shall be deemed to be an original but all of which together will constitute one and the  same instrument.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011-amendmenttoemploy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011-amendmenttoemploy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    IN WITNESS WHEREOF, the parties have caused this Amendment to the Agreement to  be duly executed and delivered as of the Effective Date.    Radnet Management, Inc.      By:               Name: Howard G. Berger, M.D.    Mark D. Stolper  Its: President    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011-amendmenttoemploy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011-amendmenttoemploy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      EXHIBIT 1    EMPLOYMENT AGREEMENT      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>4
<FILENAME>ex1013-amendmenttoemploy.htm
<DESCRIPTION>EX-10.13
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1013-amendmenttoemploy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex1013-amendmenttoemploy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1013-amendmenttoemploy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    AMENDMENT #1 TO EMPLOYMENT AGREEMENT  This Amendment #1 (this &#8220;Amendment&#8221;), made as of the 1st day of January 2024 (the  &#8220;Effective Date&#8221;), to the Employment Agreement, dated as of September 1, 2022 and as  amended (the &#8220;Agreement&#8221;), is by and between Radnet Management, Inc. (the &#8220;Company&#8221;), and  Stephen M. Forthuber (&#8220;Employee&#8221;).   W I T N E S E T H:  WHEREAS, the Compensation Committee of the Board of Directors of RadNet, Inc.  approved an increase to Employee&#8217;s Base Compensation effective as of the Effective Date; and   WHEREAS, this Amendment is a written agreement signed by the parties as required by  Section 5.3 of the Agreement with respect to modifying the Agreement.  NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of  which are hereby acknowledged, the parties agree as follows:    1. Base Compensation Change.  Section 2.1 of the Agreement which presently reads  as:   &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $650,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;        is hereby entirely restated to read as follows:  &#8220;As of January 1, 2024, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $800,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;.  2. Scope.  All other provisions of the Agreement shall continue in full force and  effect as is on and after the Effective Date.  3. Defined Terms.  Except as otherwise defined in this Amendment, the capitalized  terms in this Amendment shall have the same meaning as such terms have in the Agreement.  4.  Governing Law.  The validity, construction and interpretation of this Amendment  shall be governed in all respects by the laws of the State of California applicable to contracts  made and to be performed wholly within that State.  5.  Counterparts.  This Amendment may be executed in several counterparts, each of  which shall be deemed to be an original but all of which together will constitute one and the  same instrument.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1013-amendmenttoemploy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1013-amendmenttoemploy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    IN WITNESS WHEREOF, the parties have caused this Amendment to the Agreement to  be duly executed and delivered as of the Effective Date.    Radnet Management, Inc.      By:               Name: Howard G. Berger, M.D.    Stephen M. Forthuber  Its: President    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1013-amendmenttoemploy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1013-amendmenttoemploy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      EXHIBIT 1    EMPLOYMENT AGREEMENT      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>5
<FILENAME>ex1015-amendmenttoemploy.htm
<DESCRIPTION>EX-10.15
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1015-amendmenttoemploy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex1015-amendmenttoemploy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1015-amendmenttoemploy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  AMENDMENT #1 TO EMPLOYMENT AGREEMENT  This Amendment #1 (this &#8220;Amendment&#8221;), made as of the 1st day of January 2024 (the  &#8220;Effective Date&#8221;), to the Employment Agreement, dated as of September 1, 2022 and as  amended (the &#8220;Agreement&#8221;), is by and between Radnet Management, Inc. (the &#8220;Company&#8221;), and  Norman R. Hames (&#8220;Employee&#8221;).   W I T N E S E T H:  WHEREAS, the Compensation Committee of the Board of Directors of RadNet, Inc.  approved an increase to Employee&#8217;s Base Compensation effective as of the Effective Date; and   WHEREAS, this Amendment is a written agreement signed by the parties as required by  Section 5.3 of the Agreement with respect to modifying the Agreement.  NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of  which are hereby acknowledged, the parties agree as follows:    1. Base Compensation Change.  Section 2.1 of the Agreement which presently reads  as:   &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $650,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;        is hereby entirely restated to read as follows:  &#8220;As of January 1, 2024, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $800,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;.  2. Scope.  All other provisions of the Agreement shall continue in full force and  effect as is on and after the Effective Date.  3. Defined Terms.  Except as otherwise defined in this Amendment, the capitalized  terms in this Amendment shall have the same meaning as such terms have in the Agreement.  4.  Governing Law.  The validity, construction and interpretation of this Amendment  shall be governed in all respects by the laws of the State of California applicable to contracts  made and to be performed wholly within that State.  5.  Counterparts.  This Amendment may be executed in several counterparts, each of  which shall be deemed to be an original but all of which together will constitute one and the  same instrument.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1015-amendmenttoemploy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1015-amendmenttoemploy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">IN WITNESS WHEREOF, the parties have caused this Amendment to the Agreement to  be duly executed and delivered as of the Effective Date.    Radnet Management, Inc.      By:               Name: Howard G. Berger, M.D.    Norman R. Hames  Its: President    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1015-amendmenttoemploy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1015-amendmenttoemploy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      EXHIBIT 1    EMPLOYMENT AGREEMENT      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>6
<FILENAME>ex1017-amendmenttoemploy.htm
<DESCRIPTION>EX-10.17
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1017-amendmenttoemploy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex1017-amendmenttoemploy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1017-amendmenttoemploy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    AMENDMENT #1 TO EMPLOYMENT AGREEMENT  This Amendment #1 (this &#8220;Amendment&#8221;), made as of the 1st day of January 2024 (the  &#8220;Effective Date&#8221;), to the Employment Agreement, dated as of September 1, 2022 and as  amended (the &#8220;Agreement&#8221;), is by and between Radnet Management, Inc. (the &#8220;Company&#8221;), and  Mital Patel (&#8220;Employee&#8221;).   W I T N E S E T H:  WHEREAS, the Compensation Committee of the Board of Directors of RadNet, Inc.  approved an increase to Employee&#8217;s Base Compensation effective as of the Effective Date; and   WHEREAS, this Amendment is a written agreement signed by the parties as required by  Section 5.3 of the Agreement with respect to modifying the Agreement.  NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of  which are hereby acknowledged, the parties agree as follows:    1. Base Compensation Change.  Section 2.1 of the Agreement which presently reads  as:   &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $575,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;        is hereby entirely restated to read as follows:  &#8220;As of January 1, 2024, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $750,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;.  2. Scope.  All other provisions of the Agreement shall continue in full force and  effect as is on and after the Effective Date.  3. Defined Terms.  Except as otherwise defined in this Amendment, the capitalized  terms in this Amendment shall have the same meaning as such terms have in the Agreement.  4.  Governing Law.  The validity, construction and interpretation of this Amendment  shall be governed in all respects by the laws of the State of California applicable to contracts  made and to be performed wholly within that State.  5.  Counterparts.  This Amendment may be executed in several counterparts, each of  which shall be deemed to be an original but all of which together will constitute one and the  same instrument.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1017-amendmenttoemploy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1017-amendmenttoemploy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    IN WITNESS WHEREOF, the parties have caused this Amendment to the Agreement to  be duly executed and delivered as of the Effective Date.    Radnet Management, Inc.      By:               Name: Howard G. Berger, M.D.    Mital Patel  Its: President    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1017-amendmenttoemploy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1017-amendmenttoemploy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      EXHIBIT 1    EMPLOYMENT AGREEMENT      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>7
<FILENAME>ex1019-amendmenttoemploy.htm
<DESCRIPTION>EX-10.19
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1019-amendmenttoemploy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex1019-amendmenttoemploy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1019-amendmenttoemploy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    AMENDMENT #2 TO EMPLOYMENT AGREEMENT  This Amendment #2 (this &#8220;Amendment&#8221;), made as of the 1st day of January 2024 (the  &#8220;Effective Date&#8221;), to the Employment Agreement, dated as of September 1, 2022 and as  amended (the &#8220;Agreement&#8221;), is by and between Radnet Management, Inc. (the &#8220;Company&#8221;), and  David J. Katz (&#8220;Employee&#8221;).   W I T N E S E T H:  WHEREAS, the Compensation Committee of the Board of Directors of RadNet, Inc.  approved an increase to Employee&#8217;s Base Compensation effective as of the Effective Date; and   WHEREAS, this Amendment is a written agreement signed by the parties as required by  Section 5.3 of the Agreement with respect to modifying the Agreement.  NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of  which are hereby acknowledged, the parties agree as follows:    1. Base Compensation Change.  Section 2.1 of the Agreement which presently reads  as:   &#8220;As of the Execution Date, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $575,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;        is hereby entirely restated to read as follows:  &#8220;As of January 1, 2024, for the performance of Employee&#8217;s duties hereunder, the  Company shall pay Employee an annual salary of $700,000 (&#8220;Base Compensation&#8221;),  payable (after deducting required withholdings) in accordance with the Company&#8217;s  ordinary payroll practices.&#8221;.  2. Scope.  All other provisions of the Agreement shall continue in full force and  effect as is on and after the Effective Date.  3. Defined Terms.  Except as otherwise defined in this Amendment, the capitalized  terms in this Amendment shall have the same meaning as such terms have in the Agreement.  4.  Governing Law.  The validity, construction and interpretation of this Amendment  shall be governed in all respects by the laws of the State of California applicable to contracts  made and to be performed wholly within that State.  5.  Counterparts.  This Amendment may be executed in several counterparts, each of  which shall be deemed to be an original but all of which together will constitute one and the  same instrument.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1019-amendmenttoemploy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1019-amendmenttoemploy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    IN WITNESS WHEREOF, the parties have caused this Amendment to the Agreement to  be duly executed and delivered as of the Effective Date.    Radnet Management, Inc.      By:               Name: Howard G. Berger, M.D.    David J. Katz  Its: President    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1019-amendmenttoemploy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1019-amendmenttoemploy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      EXHIBIT 1    EMPLOYMENT AGREEMENT      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>8
<FILENAME>a10k2023exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i5f5777fc7152464a88a2be5212bfe0a6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Managed Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management I, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Sub, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Village, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glendale Advanced Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mission Advanced Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Imaging Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Radiology, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Monica Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SoCal MR Site Management, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ventura County Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMIS Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced NA, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services of Delaware, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Diagnostic Radiology Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Imaging Services, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeepHealth, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ide Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Image Medical Corporation</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Rockland Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix Health, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PantheonXT Partners, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiologix, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology Alliance Delivery Systems, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology and Nuclear Medicine Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radsite LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raven Holdings U.S., Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMI Scheduling, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simi Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasure Coast Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Imaging, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Victorville, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scriptsender, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kepdoktor Kft</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging at Timonium Crossing, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Center at St. Joseph Medical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced PET Imaging of Maryland, L.P.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced &#47;Upper Chesapeake Health Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore County Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore Washington Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calvert Medical Imaging Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franklin Imaging, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frederick County Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Baltimore Diagnostic Imaging Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Community Magnetic Imaging Center Limited Partnership</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mount Airy Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radar Medical Systems, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DH AI International Holdings B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging On Call, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Services Company of New York, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Park West Circle Realty, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garden State Radiology Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Diagnostics of New Jersey, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Health Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Network, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eRad, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Rhode Island, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roentgen Reinsurance Company, Ltd</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turks and Caicos</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence UK, Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>a10k2023exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8e7af84e085e40009cf1801030c0ac9f_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">Exhibit 23.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">We consent to the incorporation by reference in the following Registration Statements&#58;      </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">a.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:11.07pt">Registration Statement (Form S-3ASR No. 333-269025) of RadNet, Inc.,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">b.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement (Form S-8 Nos. 333-176324, 333-206311, 333-219824, 333-257638 and 333-273856) pertaining to the RadNet, Inc. Equity Incentive Plan, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">c.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:11.07pt">Registration Statement (Form S-8 No. 333-238874) pertaining to the 2017 Stock Incentive Plan of DeepHealth, Inc.&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">of our reports dated February 29, 2024, with respect to the consolidated financial statements of RadNet, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of RadNet, Inc. and subsidiaries included in this Annual Report (Form 10-K) of RadNet, Inc. for the year ended December 31, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:164%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:164%">Los Angeles, California</font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February 29, 2024</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>q42023exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i5e764e35ede64e71be6c099b701d30da_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February 29, 2024</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>q42023exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i9e0718d1e6cf4e2db45951c2ee0c9479_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February 29, 2024</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>q42023exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iff5e595fbe864732914989c931911cff_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2023, as filed with the Securities and Exchange Commission on February 29, 2024 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>q42023exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i9dc3ebd628dc404fb61d1661efe606a7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2023, as filed with the Securities and Exchange Commission on February 29, 2024 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font><br></font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>14
<FILENAME>ex971-radnetincpolicyonrec.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i75e0a883d8c14a1fbbc217ca564a72e2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RADNET, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLICY ON RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOVEMBER 8, 2023</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">I.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Overview</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy was adopted by the Committee on the Effective Date, and has been ratified by the Board, and the purposes of the Policy are to deter&#58; (i) any financial or accounting irregularities with respect to the Company&#8217;s financial statements and (ii) any intentional or grossly negligent misconduct by any Senior Executive.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">II.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Definitions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Accounting Restatement&#8221; means an accounting restatement of the Company&#8217;s financial statements due to the Company&#8217;s material noncompliance with any financial reporting requirement under U.S. securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Applicable Rules&#8221; means collectively the applicable rules and requirements of Rule 10D-1 and the Exchange. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Board&#8221; means the Board of Directors of the Company, as constituted from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Clawback Incentive Compensation&#8221; means, in connection with an Accounting Restatement and with respect to each individual who served as a Senior Executive at any time during the applicable performance period for any Incentive Compensation (whether or not such Senior Executive is serving at the time the Erroneously Awarded Compensation is required to be recouped by the Company), all Incentive Compensation Received by such Senior Executive (i) after beginning service as a Senior Executive, (ii) while the Company has a class of securities listed on a national securities exchange, and (iii) during the applicable Look-Back Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Committee&#8221; means the Compensation Committee of the Board or such other committee or subcommittee of the Board, if any, duly appointed to administer the Policy and having such powers in each instance as shall be specified by the Board and as specified in Section III of this Policy.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;Company&#8221; means RadNet, Inc., a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Effective Date&#8221; means November 8, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Erroneously Awarded Compensation&#8221; means, with respect to each Senior Executive in connection with an Accounting Restatement, the amount of the Clawback Incentive Compensation that exceeds the amount of the Incentive Compensation that would have been Received had the amount of such Incentive Compensation been calculated based on the restated amounts, as determined by the Committee, calculated by the Committee without regard to any taxes paid. With respect to Incentive Compensation based on (or derived from) TSR or stock price, where the amount of Erroneously </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Awarded Compensation is not subject to mathematical recalculation directly from the information in the applicable Accounting Restatement, the Committee shall determine the amount of Erroneously Awarded Compensation based on a reasonable estimate of the effect of the Accounting Restatement on the TSR or stock price upon which the Incentive Compensation was Received.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;Exchange&#8221; means The Nasdaq Stock Market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Financial Reporting Measure&#8221; means any measure that is determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measure that is derived wholly or in part from such measure, including but not limited to, &#8220;non-GAAP financial measures&#8221; for purposes of Exchange Act Regulation G and Item 10 of Regulation S-K, as well as other measures, metrics and ratios that are not non-GAAP measures, like same store sales. Financial Reporting Measures include but are not limited to the following (and any measures derived from the following)&#58; stock price&#59; TSR&#59; revenues&#59; net income&#59; operating income&#59; profitability of one or more reportable segments&#59; financial ratios (e.g., accounts receivable turnover and inventory turnover rates)&#59; earnings before interest, taxes, depreciation and amortization&#59; funds from operations and adjusted funds from operations&#59; liquidity measures (e.g., working capital, operating cash flow)&#59; return measures (e.g., return on invested capital, return on assets)&#59; earnings measures (e.g., earnings per share)&#59; sales per square foot or same store sales, where sales is subject to an Accounting Restatement&#59; revenue per user, or average revenue per user, where revenue is subject to an Accounting Restatement&#59; cost per employee, where cost is subject to an Accounting Restatement&#59; any of such financial reporting measures relative to a peer group, where the Company&#8217;s financial reporting measure is subject to an Accounting Restatement&#59; and tax basis income. A Financial Reporting Measure need not be presented within the Company&#8217;s financial statements or included in a report or other document filed with the SEC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;Incentive Compensation&#8221; means any compensation granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure, measured on a pre-tax basis.  Incentive Compensation includes, without limitation&#58; any non-equity incentive plan awards that are earned based wholly or in part on satisfying a Financial Reporting Measure performance goal&#59; bonuses paid from a &#8220;bonus pool,&#8221; the size of which is determined based wholly or in part on satisfying a Financial Reporting Measure performance goal&#59; other cash awards based on satisfaction of a Financial Reporting Measure performance goal&#59; restricted stock, restricted stock units, performance share units, stock options, and stock appreciation rights that are granted or become vested based wholly or in part on satisfying a Financial Reporting Measure Performance Goal&#59; and proceeds received upon the sale of shares acquired through an incentive plan that were granted or vested based wholly or in part on satisfying a Financial Reporting Measure performance goal. Incentive Compensation shall also include without limitation any compensation or awards that were granted or received under the Company&#8217;s Equity Incentive Plan or pursuant to any bonus program and this includes incentive awards that have only time-based vesting conditions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">&#8220;Look-Back Period&#8221; means, with respect to an Accounting Restatement, the three completed fiscal years of the Company immediately preceding the Trigger Event and any transition period (that results from a change in the Company&#8217;s fiscal year) within or immediately following those three completed fiscal years (except that a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">transition period that comprises a period of at least nine months shall count as a completed fiscal year).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Policy&#8221; means this Policy on Recovery of Erroneously Awarded Compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Received&#8221; means, with respect to Incentive Compensation, actual or deemed receipt, and Incentive Compensation shall be deemed &#8220;Received&#8221; in the Company&#8217;s fiscal period during which the applicable Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of such Incentive Compensation occurs after the end of that period. If an equity incentive award vests only upon satisfaction of a Financial Reporting Measure performance condition, the award shall be deemed Received in the fiscal period when it vested. Ministerial acts or other conditions necessary to effect issuance or payment, such as calculating the amount earned or obtaining Board approval of payment, do not affect the determination of the date Received.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Rule 10D-1&#8221; means rule 10D-1 of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;SEC&#8221; means the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;Senior Executive&#8221; means any person who was the Company&#8217;s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performed a policy-making function, or any other person who performed similar policy-making functions for the Company and any other &#8220;key employees&#8221; who were designated as a &#8220;Senior Executive&#8221; by the Committee. Executive officers of the Company&#8217;s parents or subsidiaries may be deemed Senior Executives if they perform policy-making functions for the Company. For purposes of this definition, policy-making function is not intended to include policy-making functions that are not significant. All executive officers of the Company identified by the Board pursuant to Item 401(b) of Regulation S-K shall be deemed to be Senior Executives.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.36pt">&#8220;Trigger Event&#8221; means the earliest to occur of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement, in each case regardless of if or when the restated financial statements are filed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;TSR&#8221; means total stockholder return.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">III.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Administration of Policy</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Policy shall be administrated by the Committee.  All questions of interpretation or application of this Policy shall be determined by the Committee.  All Committee decisions shall be final and binding upon all persons and shall be afforded the maximum deference permitted under applicable law.  The Committee is authorized to make all determinations necessary and may authorize and empower any officer or employee of the Company to take any and all actions necessary or appropriate to carry </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">out the purpose and intent of this Policy (other than with respect to any recovery or potential recovery under this Policy involving such officer or employee), appropriate or advisable for the administration of this Policy and the Committee may use any of the Company&#8217;s resources it deems appropriate to recoup Erroneously Awarded Compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Determinations of financial and&#47;or accounting irregularities and&#47;or misconduct (as described in sections IV and V below) for purposes of this Policy shall be made by the Committee independently of, and the Committee shall not be bound by, determinations by management or by any other committee of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the event of an Accounting Restatement, except to the extent permitted by the Applicable Rules or section V, the Committee will generally treat all Senior Executives (including former employees) the same with respect to any recovery actions.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding anything to the contrary herein, the Company shall not be required to recoup Erroneously Awarded Compensation under this Policy if the Committee or a majority of the independent directors serving on the Board, has determined that recovery would be impracticable in accordance with the Applicable Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">This Policy shall be applied to the fullest extent of the law. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company under applicable law (including, without limitation, Section 304 of the U.S. Sarbanes-Oxley Act of 2002, as amended, or Section 954 of the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as amended), pursuant to the terms of any other policy of the Company, pursuant to the terms of any employment agreement, equity award agreement, severance or other agreement, and any other legal remedies available to the Company. Nothing herein, and no recoupment or recovery as contemplated by this Policy, shall (i) limit any claims, damages or other legal remedies the Company or any of its affiliates may have against a Senior Executive arising out of or resulting from any actions or omissions by the Senior Executive or (ii) limit the Company&#8217;s ability to seek recovery, in appropriate circumstances (including circumstances beyond the scope of this Policy) as permitted by applicable law, of any amounts from any employee, whether or not the employee is a Senior Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Notwithstanding the terms of any indemnification or insurance policy or any contractual arrangement with any Senior Executive that may be interpreted to the contrary&#58; (a) the Company shall not indemnify any Senior Executive against (i) the loss of any Erroneously Awarded Compensation that is recouped, repaid, returned or recovered pursuant to the terms of this Policy&#59; or (ii) any claims relating to the Company&#8217;s enforcement of its rights under this Policy&#59; and (b) the Company is prohibited from paying or reimbursing a Senior Executive for the cost of or premiums of any third-party insurance purchased to fund any potential obligations of a Senior Executive under this Policy. Further, the Company shall not enter into any agreement that exempts any Incentive Compensation from the application of this Policy or that waives the Company&#8217;s right to recoup any Erroneously Awarded Compensation, and this Policy shall supersede any such agreement (whether entered into before, on or after the Effective Date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">No members of the Committee, nor any other members of the Board who assist in the administration of this Policy, nor any officer of employee of the Company authorized and empowered by the Committee who assists in the administration of this Policy shall be personally liable for any action, determination or interpretation made with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">respect to this Policy, and each of the foregoing shall be fully indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board or any officer of employee of the Company under applicable law, Company policy or contractual arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Committee or the Board may amend, modify, supplement, restate, rescind, terminate or replace all or any portion of this Policy at any time and from time to time in its sole discretion, including, without limitation, as the Committee or Board deems necessary to reflect and comply with applicable law or any of the Applicable Rules. To the extent of any inconsistency between this Policy and any of the Applicable Rules, the Applicable Rules shall control and this Policy shall be deemed amended to incorporate such Applicable Rules. Notwithstanding anything to the contrary herein, no amendment, modification, supplement, restatement, rescission, termination or replacement of this Policy shall be effective if such amendment, modification, supplement, restatement, rescission, termination or replacement would (after taking into account any actions taken by the Company contemporaneously with such amendment, modification, supplement, restatement, rescission, termination or replacement) cause the Company to violate any of the Applicable Rules or other applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">This Policy shall be binding and enforceable against all Senior Executives and their beneficiaries, heirs, executors, administrators or other legal representatives, to the fullest extent of the law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">To the extent required by the Applicable Rules, the Company shall publicly disclose this Policy and make other Policy related public disclosures.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company shall interpret and administer this Policy to comply with the Applicable Rules. This Policy entirely replaces and supersedes any prior Company policies on recoupment of compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IV.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Accounting Restatements (regardless of Misconduct) that Trigger Recovery</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;A.&#160;&#160;&#160;&#160;Accounting Restatement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Company is required to prepare an Accounting Restatement, the Company shall determine, in accordance with this Policy, the amount of any Erroneously Awarded Compensation for each Senior Executive in connection with such Accounting Restatement, irrespective of any fault, misconduct or responsibility of any Senior Executive for the Accounting Restatement, and thereafter the Company shall reasonably promptly seek to recover such amount of Erroneously Awarded Compensation. In connection with the foregoing, the Committee, which may act in conjunction with the Company&#8217;s Audit Committee, may take all such actions permitted by this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;B.&#160;&#160;&#160;&#160;Recovery</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is Erroneously Awarded Compensation, the Committee shall determine, in its sole discretion, the timing and method(s) for recouping the same, which methods may include, without limitation, one or more of the following&#58; (i) requiring reimbursement of any Erroneously Awarded Compensation&#59; (ii) requiring reimbursement of any equity-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">based compensation awarded&#59; (iii) cancelling outstanding cash or equity-based awards, whether vested or unvested or paid or unpaid&#59; (iv) cancelling or offsetting against any compensation otherwise owed by the Company to the Senior Executive, including any future cash or equity-based awards&#59; (v) requiring the forfeiture of deferred compensation, subject to compliance with Section 409A of the Internal Revenue Code and the regulations promulgated thereunder&#59; (vi) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards&#59; and (vii) pursuing any other reasonable remedies. Subject to compliance with applicable law, the Committee may effect recoupment under this Policy from any amount otherwise payable to a Senior Executive, including amounts payable to such individual under any otherwise applicable Company (or affiliate) plan or program, including base salary, bonuses or commissions and compensation previously deferred by the Senior Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent that the Committee determines to recoup Erroneously Awarded Compensation from a Senior Executive and such Senior Executive fails to repay all Erroneously Awarded Compensation to the Company when due, the Company may take all actions reasonable and appropriate to recover such Erroneously Awarded Compensation from the applicable Senior Executive. The applicable Senior Executive shall be required to reimburse the Company for any and all expenses reasonably incurred (including legal fees) by the Company in recovering such Erroneously Awarded Compensation in accordance with the preceding sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">V.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Misconduct that Triggers Recovery</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;A.&#160;&#160;&#160;&#160;Misconduct</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;Misconduct&#8221; that triggers recovery, or other remedies pursuant to this Policy, occurs when the Committee determines in its sole discretion that any Senior Executive&#8217;s intentional misconduct, gross negligence, or failure to report another Company employee&#8217;s (or other Company service provider&#8217;s) intentional misconduct or gross negligence&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">was a contributing factor or partial factor to the Company having to prepare an Accounting Restatement or restate any of its financial statements filed with the SEC&#59; or </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt">constituted fraud, bribery or any other illegal act (or contributed to another person&#8217;s fraud, bribery or other illegal act) which in each case adversely impacted the Company&#8217;s finances, business and&#47;or reputation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;B.&#160;&#160;&#160;&#160;Remedies for Misconduct</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">After consideration of all the facts and circumstances that the Committee in its sole discretion considers relevant, the Committee shall take such action&#91;s&#93; as it deems to be in the best interests of the Company, necessary to remedy the Misconduct, prevent its recurrence, and impose such discipline on the wrongdoer&#91;s&#93; as is appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The actions the Committee could elect to take against a particular Senior Executive for Misconduct include in addition to those remedies provided by Section IV, without limitation, one or more of the following&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-6-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Reimbursement (or cancellation) of all or a portion of any Incentive Compensation received by (or payable to) such Senior Executive&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt">Cancellation of any and all outstanding restricted stock, restricted stock units, stock options. stock appreciation rights and any other equity compensation awards granted to such Senior Executive&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.01pt">Reimbursement of any gains realized in the exercise of stock options or stock appreciation rights, vesting of or sales of vested, restricted stock, restricted stock units and any other equity compensation awards granted to such Senior Executive, regardless of when issued&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt">Disciplinary actions, up to and including termination of employment (with the concurrence of the Board) of the Senior Executive for cause&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Adjustment of future compensation, including but not limited to equity compensation grants, bonus awards or salary, of the Senior Executive, subject to contractual obligations under applicable employment agreements, if any&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt">The pursuit of any and all remedies available in law and&#47;or equity in any country, including but not limited to an action for breach of fiduciary duty&#59; and&#47;or </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.34pt">The pursuit of such other action as may fit the circumstance of the particular case.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee may take into account penalties or punishments imposed by third parties, such as law enforcement agencies, regulators or other authorities.  The Committee&#8217;s power to determine the appropriate punishment for the wrongdoer&#91;s&#93; is in addition to, and not in replacement of, other remedies imposed by the Company or by such other entities. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-7-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Agreement to the Policy on Recovery of Erroneously Awarded Compensation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This agreement is made as of _____________, 2023 by and between RadNet, Inc., a Delaware corporation (the &#34;Company&#34;), and _____________ (the &#34;Senior Executive&#34;).   In exchange for any Compensation provided (or to be provided) to the Senior Executive, the parties hereby agree to all of the terms of this agreement.  Capitalized terms used in this agreement which are not defined in this agreement shall have the meaning set forth in the Company's Policy on Recovery of Erroneously Awarded Compensation (the &#8220;Policy&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this agreement, &#8220;Compensation&#8221; means any compensation received (or to be received by) or awarded (or to be awarded) under any Company (or Company affiliate) plan, policy or arrangement or on a discretionary basis whether or not pursuant to any plan, which includes without limitation any Incentive Compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Senior Executive agrees to fully abide with and be bound by the terms of the Policy as may be amended, modified, supplemented, and&#47;or restated by the Company from time to time.  A copy of the present form of the Policy has been previously provided to the Senior Executive and the Senior Executive acknowledges that he&#47;she has read and fully understands the Policy.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">In the event it is determined by the Committee or Board that Compensation awarded to, paid to, or Received by the Senior Executive must be recouped or recovered by, or repaid, forfeited or reimbursed to the Company in accordance with the Policy, the Senior Executive will promptly take any action necessary (including without limitation any actions requested by the Company) to effectuate the same. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Policy applies to the Compensation notwithstanding any terms of the plan, policy or agreement under which it is granted or the terms of any employment agreement to which the Senior Executive is a party. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Any future amendments, modifications, supplements, or restatements to or of the Policy, including without limitation any amendments to comply with applicable law, will automatically be applicable to the Senior Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The laws of the State of Delaware, without regard to its conflict of law provisions, shall govern the interpretation and validity of the provisions of this agreement and all questions relating to this agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This agreement shall be binding on the Senior Executive and his&#47;her heirs, successors and legal representatives, and on the Company and its successors. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">If the terms of the Policy and this agreement conflict, the terms of the Policy shall prevail. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">In the event that any provision of this agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this agreement shall continue in full force and effect and shall be interpreted so as reasonably to effect the intent of the parties hereto. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-8-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Any Compensation may be subject to reimbursement, recovery, clawback and&#47;or forfeiture pursuant to applicable law, under circumstances that are different from those applicable under the Policy, and the Senior Executive consents to application of any such reimbursement, recovery, clawback or forfeiture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This agreement, together with the Policy, sets forth the entire understanding of the parties and supersedes all prior agreements, arrangements, and other communications, whether oral or written, pertaining to the subject matter hereof&#59; and this agreement shall not be modified or amended except by written agreement of the Company and the Senior Executive. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company and the Senior Executive have executed this agreement effective as of the day and year first above written.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">____________________________<br>&#91;Name of Senior Executive&#93;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RadNet, Inc.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">____________________________<br>By&#58; <br>Its&#58; </font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SMRH&#58;4895-5565-5751.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-9-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">011524</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04RR-112769</font></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>rdnt-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:97227b0c-cc0e-485b-bbeb-be4e8b957c79,g:17ec1eaf-cfc2-4d82-aff2-f13ccefcfa9a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://www.radnet.com/role/COVERPAGE">
        <link:definition>0000001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AUDITINFORMATION" roleURI="http://www.radnet.com/role/AUDITINFORMATION">
        <link:definition>0000002 - Document - AUDIT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESS" roleURI="http://www.radnet.com/role/NATUREOFBUSINESS">
        <link:definition>0000010 - Disclosure - NATURE OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGSTANDARDS" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS">
        <link:definition>0000012 - Disclosure - RECENT ACCOUNTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITY" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY">
        <link:definition>0000013 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTING" roleURI="http://www.radnet.com/role/SEGMENTREPORTING">
        <link:definition>0000014 - Disclosure - SEGMENT REPORTING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>0000016 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE">
        <link:definition>0000017 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.radnet.com/role/LEASES">
        <link:definition>0000018 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.radnet.com/role/INCOMETAXES">
        <link:definition>0000019 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000020 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS">
        <link:definition>0000021 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>9954472 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables">
        <link:definition>9954473 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGTables" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables">
        <link:definition>9954474 - Disclosure - SEGMENT REPORTING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>9954475 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>9954476 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables">
        <link:definition>9954477 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.radnet.com/role/LEASESTables">
        <link:definition>9954478 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.radnet.com/role/INCOMETAXESTables">
        <link:definition>9954479 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>9954480 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSDetails" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetails">
        <link:definition>9954481 - Disclosure - NATURE OF BUSINESS (Details )</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails">
        <link:definition>9954482 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Net Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details">
        <link:definition>9954483 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information1 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails">
        <link:definition>9954484 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Payable and Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details">
        <link:definition>9954485 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information2 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details">
        <link:definition>9954486 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1">
        <link:definition>9954486 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details">
        <link:definition>9954487 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information4 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails">
        <link:definition>9954488 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Foreign Currency Translation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details">
        <link:definition>9954489 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information5 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails">
        <link:definition>9954490 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details">
        <link:definition>9954491 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information6 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails">
        <link:definition>9954492 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails">
        <link:definition>9954493 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails">
        <link:definition>9954494 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails">
        <link:definition>9954495 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details">
        <link:definition>9954496 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information7 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails">
        <link:definition>9954497 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment in Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details">
        <link:definition>9954498 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information8 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails">
        <link:definition>9954499 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Key Financial Data on Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails">
        <link:definition>9954500 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1">
        <link:definition>9954500 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details">
        <link:definition>9954501 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information9 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails">
        <link:definition>9954502 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Assets and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details">
        <link:definition>9954503 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information1 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details">
        <link:definition>9954504 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information2 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details">
        <link:definition>9954505 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details">
        <link:definition>9954506 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information4 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGDetails" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails">
        <link:definition>9954507 - Disclosure - SEGMENT REPORTING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails">
        <link:definition>9954508 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
        <link:definition>9954509 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails">
        <link:definition>9954510 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Annual Amortization Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails">
        <link:definition>9954511 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTAdditionalInformationDetails" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails">
        <link:definition>9954512 - Disclosure - PROPERTY AND EQUIPMENT - Additional Information (Details )</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails">
        <link:definition>9954513 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails">
        <link:definition>9954514 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Annual Note Payable Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails">
        <link:definition>9954515 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails">
        <link:definition>9954516 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE- Second Amended and Restated First Lien Credit and Guaranty Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
        <link:definition>9954517 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails">
        <link:definition>9954518 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Senior Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails">
        <link:definition>9954519 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails">
        <link:definition>9954520 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails">
        <link:definition>9954521 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Recent Amendments to Prior Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetails" roleURI="http://www.radnet.com/role/LEASESDetails">
        <link:definition>9954522 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseCostDetails" roleURI="http://www.radnet.com/role/LEASESLeaseCostDetails">
        <link:definition>9954523 - Disclosure - LEASES - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalCashFlowsDetails" roleURI="http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails">
        <link:definition>9954524 - Disclosure - LEASES - Supplemental Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalBalanceSheetDetails" roleURI="http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails">
        <link:definition>9954525 - Disclosure - LEASES - Supplemental Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturitiesofOperatingandFinanceLeaseDetails" roleURI="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails">
        <link:definition>9954526 - Disclosure - LEASES - Maturities of Operating and Finance Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturitiesofOperatingandFinanceLeaseDetails_1" roleURI="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1">
        <link:definition>9954526 - Disclosure - LEASES - Maturities of Operating and Finance Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESIncomeLossBeforeIncomeTaxesDetails" roleURI="http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails">
        <link:definition>9954527 - Disclosure - INCOME TAXES - Income (Loss) Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESIncomeTaxExpenseDetails" roleURI="http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails">
        <link:definition>9954528 - Disclosure - INCOME TAXES - Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails" roleURI="http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails">
        <link:definition>9954529 - Disclosure - INCOME TAXES - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954530 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESAdditionalInformationDetails" roleURI="http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails">
        <link:definition>9954531 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESUnrecognizedTaxBenefitDetails" roleURI="http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails">
        <link:definition>9954532 - Disclosure - INCOME TAXES - Unrecognized Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails">
        <link:definition>9954533 - Disclosure - STOCK-BASED COMPENSATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails">
        <link:definition>9954534 - Disclosure - STOCK-BASED COMPENSATION - Outstanding Options and Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails">
        <link:definition>9954535 - Disclosure - STOCK-BASED COMPENSATION - RSU's and LTIPs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>9954536 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_CurrentOtherTaxExpenseBenefit" abstract="false" name="CurrentOtherTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FixedAssetsMember" abstract="true" name="FixedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" abstract="true" name="ThreeMonthsSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" abstract="true" name="SixMonthsSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" abstract="false" name="ScheuldeOfEstimatedFairValuesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" abstract="false" name="BusinessCombinationNumberOfSubsidiariesAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_TangentAssociatesLLCMember" abstract="true" name="TangentAssociatesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_NorthJerseyImagingCenterLLCMember" abstract="true" name="NorthJerseyImagingCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LosAngelesImagingGroupLLCMember" abstract="true" name="LosAngelesImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MontclairRadiologicalAssociatesPAMember" abstract="true" name="MontclairRadiologicalAssociatesPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesPurchased" abstract="false" name="EquityMethodInvestmentSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestPercentOfOwnershipSold" abstract="false" name="NoncontrollingInterestPercentOfOwnershipSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rdnt_QuantibMember" abstract="true" name="QuantibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AcquisitionsAndAssetPurchasesMember" abstract="true" name="AcquisitionsAndAssetPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_OperatingLeaseLeaseAbandonmentCharge" abstract="false" name="OperatingLeaseLeaseAbandonmentCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DevelopedTechnologySoftwareMember" abstract="true" name="DevelopedTechnologySoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_IntersegmentMember" abstract="true" name="IntersegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_TurnerImagingSystemsMember" abstract="true" name="TurnerImagingSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CashHoldbackMember" abstract="true" name="CashHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" abstract="false" name="BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ForeignCurrencyTranslationAdjustments" abstract="false" name="ForeignCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_HoustonMedicalImagingLLCMember" abstract="true" name="HoustonMedicalImagingLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SaleOfStockCost" abstract="false" name="SaleOfStockCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SunTrustMember" abstract="true" name="SunTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BeverlyHillsImagingCenterMember" abstract="true" name="BeverlyHillsImagingCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rdnt_LesseeLeaseTermofContract" abstract="false" name="LesseeLeaseTermofContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ChelseaDignosticRadiologyPCMember" abstract="true" name="ChelseaDignosticRadiologyPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ProperyAndEquipmentNetMember" abstract="false" name="ProperyAndEquipmentNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" abstract="false" name="PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AidenceHoldingBVMember" abstract="true" name="AidenceHoldingBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_DRTLLCMember" abstract="true" name="DRTLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_GainOnContributionOfImagingCentersIntoJointVenture" abstract="false" name="GainOnContributionOfImagingCentersIntoJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberOfLocationOfferingMultiModalityServices" abstract="false" name="NumberOfLocationOfferingMultiModalityServices" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DelawareDiagnosticImagingPAMember" abstract="true" name="DelawareDiagnosticImagingPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rdnt_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" abstract="false" name="ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_FrederickHealthHospitalIncMember" abstract="true" name="FrederickHealthHospitalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" abstract="false" name="NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AIMember" abstract="true" name="AIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SharesIssuedSharesSettlementOfContingentConsideration" abstract="false" name="SharesIssuedSharesSettlementOfContingentConsideration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_MadisonRadiologyMedicalGroupIncMember" abstract="true" name="MadisonRadiologyMedicalGroupIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" abstract="false" name="EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TruistMember" abstract="true" name="TruistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PublicOfferingMember" abstract="true" name="PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HeartAndLungImagingLimitedMember" abstract="true" name="HeartAndLungImagingLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LongTermIncentivePlanSharesMember" abstract="true" name="LongTermIncentivePlanSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_DeepHealthIncMember" abstract="true" name="DeepHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" abstract="false" name="LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rdnt_ContingentMilestoneConsiderationMember" abstract="true" name="ContingentMilestoneConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_OtherSellersMember" abstract="true" name="OtherSellersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TarzanaMedicalCenterLLCMember" abstract="true" name="TarzanaMedicalCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_IFRCLLCSubsidiaryOneMember" abstract="true" name="IFRCLLCSubsidiaryOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" abstract="false" name="GainLossOnExtinguishmentOfDebtAndRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_IFRCLLCSubsidiaryTwoMember" abstract="true" name="IFRCLLCSubsidiaryTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BlueShieldMember" abstract="true" name="BlueShieldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" abstract="false" name="PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" abstract="true" name="BusinessCombinationContingentConsiderationLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_MontclairMember" abstract="true" name="MontclairMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_SouthernCaliforniaDiagnosticImagingIncMember" abstract="true" name="SouthernCaliforniaDiagnosticImagingIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_IFRCLLCMember" abstract="true" name="IFRCLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_WestValleyImagingGroupLLCMember" abstract="true" name="WestValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ComputerandOfficeEquipmentMember" abstract="true" name="ComputerandOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_ValueOfEstimatedSharesIssuable" abstract="false" name="ValueOfEstimatedSharesIssuable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" abstract="false" name="ProceedsFromSaleOfInterestInMinorityShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GeneralHoldbackMember" abstract="true" name="GeneralHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_NumberOfCentersContributed" abstract="false" name="NumberOfCentersContributed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_CovenantNotToCompeteMember" abstract="true" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationMember" abstract="true" name="BusinessAcquisitionContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PatentAndTrademarksMember" abstract="true" name="PatentAndTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_GainLossOnContributionIntoJointVenture" abstract="false" name="GainLossOnContributionIntoJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_UninsuredRisksPolicyTextBlock" abstract="false" name="UninsuredRisksPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_A6.0NotesDue2028Member" abstract="true" name="A6.0NotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AILongTermIncentivePlanSharesMember" abstract="true" name="AILongTermIncentivePlanSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_EarningPerShareBasicAndDilutedAbstract" abstract="true" name="EarningPerShareBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FrederickCountyRadiologyLLCMember" abstract="true" name="FrederickCountyRadiologyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_CCDGLRSServicesIncMember" abstract="true" name="CCDGLRSServicesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LondonInterbankOfferedRateLIBOR1Member" abstract="true" name="LondonInterbankOfferedRateLIBOR1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_CedarsSinaiMedicalCenterMember" abstract="true" name="CedarsSinaiMedicalCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_PatientServicesNetMember" abstract="true" name="PatientServicesNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_WhiteRabbitaiIncMember" abstract="true" name="WhiteRabbitaiIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesAcquired" abstract="false" name="EquityMethodInvestmentSharesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ImagingCentersMember" abstract="true" name="ImagingCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockOptionsMember" abstract="true" name="PerformanceBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionsMember" abstract="true" name="BusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" abstract="false" name="DeferredTaxAssetsTaxBenefitMayNotBeRealized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberOfAssetsSold" abstract="false" name="NumberOfAssetsSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ManagementServiceContractsMember" abstract="true" name="ManagementServiceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_HeartLungImagingLimitedMember" abstract="true" name="HeartLungImagingLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" abstract="false" name="UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_SimiAdventistMember" abstract="true" name="SimiAdventistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" abstract="true" name="JointVentureWithCalvertMedicalImagingCentersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_RamapoRadiologyAssociatesPCMember" abstract="true" name="RamapoRadiologyAssociatesPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" abstract="false" name="DeferredTaxLiabilitiesOutsideBasisDifference" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseLeaseAbandonmentCharges" abstract="false" name="OperatingLeaseLeaseAbandonmentCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingIncomeLossExcludingReliefFunding" abstract="false" name="OperatingIncomeLossExcludingReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" abstract="false" name="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" abstract="true" name="OneMonthSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_PreferredStockExchangeRatePerShare" abstract="false" name="PreferredStockExchangeRatePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_InglewoodImagingCenterLLCMember" abstract="true" name="InglewoodImagingCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentAdditionalContribution" abstract="false" name="EquityMethodInvestmentAdditionalContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RavenHoldingsMember" abstract="true" name="RavenHoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_OperatingExpensesExcludingDepreciationAndAmortization" abstract="false" name="OperatingExpensesExcludingDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AidenceMember" abstract="true" name="AidenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_MedicalMalpracticeDeductiblePerIncidence" abstract="false" name="MedicalMalpracticeDeductiblePerIncidence" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalInsuranceStopLossPolicyClaimAmount" abstract="false" name="MedicalInsuranceStopLossPolicyClaimAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockUnitsMember" abstract="true" name="PerformanceBasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_CertainSellerMember" abstract="true" name="CertainSellerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ERADMember" abstract="true" name="ERADMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ImagingCenterSegmentRevenueMember" abstract="true" name="ImagingCenterSegmentRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" abstract="false" name="ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ThirdPartyMember" abstract="true" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ArizonaDiagnosticsGroupMember" abstract="true" name="ArizonaDiagnosticsGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_SoftwareAndTeleradiologyMember" abstract="true" name="SoftwareAndTeleradiologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_StockHoldbackMember" abstract="true" name="StockHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_SimiValleyImagingGroupLLCMember" abstract="true" name="SimiValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" abstract="true" name="AntelopeValleyOutpatientImagingCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SantaMonicaImagingGroupLLCMember" abstract="true" name="SantaMonicaImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" abstract="false" name="UnrecognizedTaxBenefitsTaxImpactIfRecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" abstract="false" name="AdjustmentToNetIncomeAttributableToAssumedShareSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_DebtInstrumentLeverageRatio" abstract="false" name="DebtInstrumentLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_KeyFinancialDataForJointVentures" abstract="true" name="KeyFinancialDataForJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="ForeignOperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_JointVentureInterestMember" abstract="true" name="JointVentureInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>rdnt-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:97227b0c-cc0e-485b-bbeb-be4e8b957c79,g:17ec1eaf-cfc2-4d82-aff2-f13ccefcfa9a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_77f258df-d9cf-430b-ab77-705417a8eb87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ca52b53c-0feb-4129-b30f-5dde3d8e834b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_77f258df-d9cf-430b-ab77-705417a8eb87" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ca52b53c-0feb-4129-b30f-5dde3d8e834b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_32673764-5eba-491c-87b0-56c30d6b9006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_77f258df-d9cf-430b-ab77-705417a8eb87" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_32673764-5eba-491c-87b0-56c30d6b9006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cadc0a7f-e104-43f5-88a2-8d61e02c8787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_77f258df-d9cf-430b-ab77-705417a8eb87" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cadc0a7f-e104-43f5-88a2-8d61e02c8787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_84b6ef85-f473-4574-bf18-c2fb8b9b4398" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_77f258df-d9cf-430b-ab77-705417a8eb87" xlink:to="loc_us-gaap_NotesPayableCurrent_84b6ef85-f473-4574-bf18-c2fb8b9b4398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_810c6999-d544-434b-8ff1-88edec45e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_77f258df-d9cf-430b-ab77-705417a8eb87" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_810c6999-d544-434b-8ff1-88edec45e82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_beae8452-8e10-450b-8b2f-1df0793384a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_125596cf-7d50-4705-8f06-703eb01e9cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_beae8452-8e10-450b-8b2f-1df0793384a0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_125596cf-7d50-4705-8f06-703eb01e9cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_040d5694-df03-4896-b9ef-3f68d76c3515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_beae8452-8e10-450b-8b2f-1df0793384a0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_040d5694-df03-4896-b9ef-3f68d76c3515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bccd2709-99d2-43ee-8fc3-dcf50688ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_beae8452-8e10-450b-8b2f-1df0793384a0" xlink:to="loc_us-gaap_LiabilitiesCurrent_bccd2709-99d2-43ee-8fc3-dcf50688ccca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_2428e9f7-5083-46f9-826c-19da45f54d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_beae8452-8e10-450b-8b2f-1df0793384a0" xlink:to="loc_us-gaap_LongTermNotesPayable_2428e9f7-5083-46f9-826c-19da45f54d2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b6db197c-d740-4385-91f2-6641770d337d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_beae8452-8e10-450b-8b2f-1df0793384a0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b6db197c-d740-4385-91f2-6641770d337d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_6fb43dc8-af1c-4ac9-ac8f-e7d163d9000f" xlink:href="rdnt-20231231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f021f9e7-4711-4f09-98c0-6516b3cf6694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_6fb43dc8-af1c-4ac9-ac8f-e7d163d9000f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f021f9e7-4711-4f09-98c0-6516b3cf6694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7d2a1f3a-8d21-4e05-af0e-db7c4dbccac8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_6fb43dc8-af1c-4ac9-ac8f-e7d163d9000f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7d2a1f3a-8d21-4e05-af0e-db7c4dbccac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_50a83b6e-d7c5-497a-ab45-29f55ffc9958" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98139cef-fbdb-4674-92d6-610d36f93f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_50a83b6e-d7c5-497a-ab45-29f55ffc9958" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98139cef-fbdb-4674-92d6-610d36f93f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b63ce273-823f-4ed1-a60c-55e34d3d70a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_50a83b6e-d7c5-497a-ab45-29f55ffc9958" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b63ce273-823f-4ed1-a60c-55e34d3d70a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_de6936f5-19b3-4025-aa88-54794e33bb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_50a83b6e-d7c5-497a-ab45-29f55ffc9958" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_de6936f5-19b3-4025-aa88-54794e33bb9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_017fe2f1-29af-4481-87d0-a9d517501232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_50a83b6e-d7c5-497a-ab45-29f55ffc9958" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_017fe2f1-29af-4481-87d0-a9d517501232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d039a595-1a9a-4025-b264-77a54944e368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5716d238-4978-4419-8653-40ccc8c604b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d039a595-1a9a-4025-b264-77a54944e368" xlink:to="loc_us-gaap_Liabilities_5716d238-4978-4419-8653-40ccc8c604b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_266d5390-5371-4d7b-9441-d466225bdac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d039a595-1a9a-4025-b264-77a54944e368" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_266d5390-5371-4d7b-9441-d466225bdac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cc729d52-10af-4342-b84f-29472ca0d15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_us-gaap_AssetsCurrent_cc729d52-10af-4342-b84f-29472ca0d15d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_a9a1aa2c-0731-4f1f-8c24-c71f1b6ea677" xlink:href="rdnt-20231231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_a9a1aa2c-0731-4f1f-8c24-c71f1b6ea677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0ac752fc-8be1-4e49-a76f-da705101c948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_us-gaap_Goodwill_0ac752fc-8be1-4e49-a76f-da705101c948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c0bc4927-98c2-4fe5-96f4-f8353ef54946" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c0bc4927-98c2-4fe5-96f4-f8353ef54946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_04eded37-41e0-44c3-8e1c-c8d06cfe1281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_04eded37-41e0-44c3-8e1c-c8d06cfe1281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_50df7db9-5486-4554-86db-c48a6c58049f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_50df7db9-5486-4554-86db-c48a6c58049f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_173c8d2e-daa3-48fa-87f3-5619d385d986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b8824b5-4548-4d33-b65c-6ae17f644434" xlink:to="loc_us-gaap_DepositsAssets_173c8d2e-daa3-48fa-87f3-5619d385d986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_de1d70fb-e3e0-4c67-9a56-6707742eb8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d8a2b1ef-d128-4356-989f-ee71d5974d28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_de1d70fb-e3e0-4c67-9a56-6707742eb8b6" xlink:to="loc_us-gaap_CommonStockValue_d8a2b1ef-d128-4356-989f-ee71d5974d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1e15f200-1db9-4900-aa02-9fad549d79b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_de1d70fb-e3e0-4c67-9a56-6707742eb8b6" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1e15f200-1db9-4900-aa02-9fad549d79b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_15ccf0ca-20a7-4370-91c5-20a88cb79650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_de1d70fb-e3e0-4c67-9a56-6707742eb8b6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_15ccf0ca-20a7-4370-91c5-20a88cb79650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_167771f0-4039-43c5-94ce-064f9dd6828a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_de1d70fb-e3e0-4c67-9a56-6707742eb8b6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_167771f0-4039-43c5-94ce-064f9dd6828a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e83c6451-734b-4286-a7cf-0c1fd53012c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e69cfafe-8ed1-4e9b-bb3f-db2442966792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e83c6451-734b-4286-a7cf-0c1fd53012c9" xlink:to="loc_us-gaap_StockholdersEquity_e69cfafe-8ed1-4e9b-bb3f-db2442966792" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_254a2eac-5cdd-4142-85fc-e976082618b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e83c6451-734b-4286-a7cf-0c1fd53012c9" xlink:to="loc_us-gaap_MinorityInterest_254a2eac-5cdd-4142-85fc-e976082618b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5a3b3444-0914-4f6b-8a94-8fd4bb20e26d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f92bd1d6-e7ce-4397-b06a-b115b110c5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5a3b3444-0914-4f6b-8a94-8fd4bb20e26d" xlink:to="loc_us-gaap_ProfitLoss_f92bd1d6-e7ce-4397-b06a-b115b110c5f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dd590308-6f46-4592-aab0-b76a91d1fbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5a3b3444-0914-4f6b-8a94-8fd4bb20e26d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dd590308-6f46-4592-aab0-b76a91d1fbd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_79ef846f-fe50-48a8-8f30-54028220f9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:to="loc_us-gaap_SeveranceCosts1_79ef846f-fe50-48a8-8f30-54028220f9a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_0c9ab932-7cc3-4d69-b370-fc09fe9a2c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_0c9ab932-7cc3-4d69-b370-fc09fe9a2c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_3f90453f-3487-41e6-8004-ba62f4abd1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_3f90453f-3487-41e6-8004-ba62f4abd1d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_bc52de01-7d76-445d-b25b-9932756ba7b6" xlink:href="rdnt-20231231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_bc52de01-7d76-445d-b25b-9932756ba7b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_06b1c8a7-4ade-4187-ae58-ba5e51d03162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_06b1c8a7-4ade-4187-ae58-ba5e51d03162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnContributionIntoJointVenture_90914f06-bdfc-4e02-95f7-3e61dbfe5174" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnContributionIntoJointVenture"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_eaa61c2b-8211-4edd-a9c6-f54a61d5487e" xlink:to="loc_rdnt_GainLossOnContributionIntoJointVenture_90914f06-bdfc-4e02-95f7-3e61dbfe5174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b6880090-293d-46f3-85ed-09552605fd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a46a18e-63ca-4a95-b793-5f74212c17b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_b6880090-293d-46f3-85ed-09552605fd1e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a46a18e-63ca-4a95-b793-5f74212c17b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_668eccef-5ac9-46db-9ce8-fdf8510e2c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_b6880090-293d-46f3-85ed-09552605fd1e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_668eccef-5ac9-46db-9ce8-fdf8510e2c30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_21ab93e4-2df5-4518-aa0e-fe52191b2bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d596347-4c59-4f86-a57e-15fe1006f8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_21ab93e4-2df5-4518-aa0e-fe52191b2bbb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d596347-4c59-4f86-a57e-15fe1006f8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_bb7367b6-739e-42da-ae22-3343e92a63f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_21ab93e4-2df5-4518-aa0e-fe52191b2bbb" xlink:to="loc_us-gaap_OperatingExpenses_bb7367b6-739e-42da-ae22-3343e92a63f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_4f91ad53-535c-4ab5-82ab-af30428e599d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_21ab93e4-2df5-4518-aa0e-fe52191b2bbb" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_4f91ad53-535c-4ab5-82ab-af30428e599d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_52004294-7d3b-4007-a7dc-198d4e89dc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_abb14c18-c62d-4fbd-a735-4d5d1acda3af" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_52004294-7d3b-4007-a7dc-198d4e89dc3e" xlink:to="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_abb14c18-c62d-4fbd-a735-4d5d1acda3af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_195a520b-8f20-48d8-b3eb-d39793ff3fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_52004294-7d3b-4007-a7dc-198d4e89dc3e" xlink:to="loc_us-gaap_InterestExpenseDebt_195a520b-8f20-48d8-b3eb-d39793ff3fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f1860eec-8b45-4455-8531-55b5d86f7705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_52004294-7d3b-4007-a7dc-198d4e89dc3e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f1860eec-8b45-4455-8531-55b5d86f7705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b800e5c5-42c1-444b-b9e8-75f7eeeb7ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_52004294-7d3b-4007-a7dc-198d4e89dc3e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b800e5c5-42c1-444b-b9e8-75f7eeeb7ffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_838ceac4-29ca-4f6c-bd0a-e99872034df5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_52004294-7d3b-4007-a7dc-198d4e89dc3e" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_838ceac4-29ca-4f6c-bd0a-e99872034df5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba0bf830-66e5-4e39-9850-51dc812e0528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9b4f994a-e8dd-48b7-a18a-c6584d712176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba0bf830-66e5-4e39-9850-51dc812e0528" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9b4f994a-e8dd-48b7-a18a-c6584d712176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cdfe0e13-f713-476c-a356-d35743646d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba0bf830-66e5-4e39-9850-51dc812e0528" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cdfe0e13-f713-476c-a356-d35743646d3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b1031e30-9d0a-4f51-89db-23b1ca5afaac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_11fc987c-f9fd-4714-86e9-e101bbd41d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b1031e30-9d0a-4f51-89db-23b1ca5afaac" xlink:to="loc_us-gaap_ProfitLoss_11fc987c-f9fd-4714-86e9-e101bbd41d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_11e5d5e1-54b7-43a6-9e94-2982f79c8c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b1031e30-9d0a-4f51-89db-23b1ca5afaac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_11e5d5e1-54b7-43a6-9e94-2982f79c8c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_d614557d-b440-4594-b34b-1ac51b38c177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b1031e30-9d0a-4f51-89db-23b1ca5afaac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_d614557d-b440-4594-b34b-1ac51b38c177" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_3605dbb0-a92a-4fe9-91ad-0e6ed8c2f1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_3605dbb0-a92a-4fe9-91ad-0e6ed8c2f1e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_14fc536e-93c2-456d-98c5-7d61a3929c05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_14fc536e-93c2-456d-98c5-7d61a3929c05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_89606b5b-74ab-4624-b20a-512ab79768b9" xlink:href="rdnt-20231231.xsd#rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_89606b5b-74ab-4624-b20a-512ab79768b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_7db4c063-134d-4ba2-8f89-c87323d48518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_RepaymentsOfDebt_7db4c063-134d-4ba2-8f89-c87323d48518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_515d76b8-1bdd-4ef3-b78c-d7c21dbd939d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_515d76b8-1bdd-4ef3-b78c-d7c21dbd939d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_341ad1da-23a1-4e51-8413-db55315b1a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_341ad1da-23a1-4e51-8413-db55315b1a6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cbefbefe-8f2b-4f46-9ec2-82b761ef8862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cbefbefe-8f2b-4f46-9ec2-82b761ef8862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_18cf5707-18c0-4d16-a71f-c022144dceb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_18cf5707-18c0-4d16-a71f-c022144dceb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2a42ad53-8f7e-4195-b152-f9356c96966a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2a42ad53-8f7e-4195-b152-f9356c96966a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_ec7638a3-f4d9-4e25-bfee-3574875e7b33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_ec7638a3-f4d9-4e25-bfee-3574875e7b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d8ecde4d-aa96-478d-a2d9-191a2d5d64a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d8ecde4d-aa96-478d-a2d9-191a2d5d64a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_78ca79dd-71f0-4ea3-a57d-fb49c1da6327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b5eb79e-0370-468d-a2ab-9ea22d255a2c" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_78ca79dd-71f0-4ea3-a57d-fb49c1da6327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2cf3f77d-9a70-44ee-9f29-94b41780d089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2cf3f77d-9a70-44ee-9f29-94b41780d089" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c365fa45-821a-4a18-86b5-ea237930641c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c365fa45-821a-4a18-86b5-ea237930641c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_811cd55a-62e8-445f-8434-cfa54703976f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_811cd55a-62e8-445f-8434-cfa54703976f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fa45936e-8b3b-4f65-90ed-63247e0bfcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fa45936e-8b3b-4f65-90ed-63247e0bfcf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7a707fed-f263-4598-9d48-21f1b848fea9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7a707fed-f263-4598-9d48-21f1b848fea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_120879c2-d326-4dfd-b197-9425baf1213e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_120879c2-d326-4dfd-b197-9425baf1213e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25acff60-2f1e-4f4b-a646-e77f8e904685" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_ProfitLoss_25acff60-2f1e-4f4b-a646-e77f8e904685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7fe39239-ce1d-4143-9031-64b3354d2ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_ShareBasedCompensation_7fe39239-ce1d-4143-9031-64b3354d2ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4674039d-8f51-400c-a0c1-115c77d5928c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4674039d-8f51-400c-a0c1-115c77d5928c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_1e9864a7-8d28-4986-9936-f2788268ad55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_1e9864a7-8d28-4986-9936-f2788268ad55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_3ddf137e-ecb9-4c81-ac5a-b11138241fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_3ddf137e-ecb9-4c81-ac5a-b11138241fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_78766b24-a557-4921-b386-d575ab9fa986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_78766b24-a557-4921-b386-d575ab9fa986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3108b6d1-ca91-478f-9767-24d9a5903dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3108b6d1-ca91-478f-9767-24d9a5903dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_7020cfcf-eb54-4f9e-99e9-bcdc431d6179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_7020cfcf-eb54-4f9e-99e9-bcdc431d6179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_35c5db96-e34f-4009-814a-9703fcf16f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_35c5db96-e34f-4009-814a-9703fcf16f1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_6f3f9d44-ab18-483f-886a-8bf6ac12a856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_6f3f9d44-ab18-483f-886a-8bf6ac12a856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8593fd0c-cee5-4181-b2eb-f224fef7f632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8593fd0c-cee5-4181-b2eb-f224fef7f632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_16b07219-5df9-40b1-b2c1-bd42b630b8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_16b07219-5df9-40b1-b2c1-bd42b630b8b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_3d17c11f-b36e-4e98-a0f8-fc488d7ff243" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_3d17c11f-b36e-4e98-a0f8-fc488d7ff243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_2e0e9dc6-20ad-4e16-aed9-57a6f6e7e36c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_2e0e9dc6-20ad-4e16-aed9-57a6f6e7e36c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnContributionIntoJointVenture_3a7318e4-590f-4d92-b8cb-a5a996e50c52" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnContributionIntoJointVenture"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d490386-8102-4800-bc92-0ba339313081" xlink:to="loc_rdnt_GainLossOnContributionIntoJointVenture_3a7318e4-590f-4d92-b8cb-a5a996e50c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7edae0a8-9449-4401-bc5f-0a36c3db2995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4fe5cd83-736a-49d2-8105-adf22f4269a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7edae0a8-9449-4401-bc5f-0a36c3db2995" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4fe5cd83-736a-49d2-8105-adf22f4269a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_68d78f76-e150-4018-b38c-608ff87cc9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7edae0a8-9449-4401-bc5f-0a36c3db2995" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_68d78f76-e150-4018-b38c-608ff87cc9cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d7191fc5-54be-47ff-a585-554ed5838e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7edae0a8-9449-4401-bc5f-0a36c3db2995" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d7191fc5-54be-47ff-a585-554ed5838e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32aa0fee-837f-4991-9a23-01a3612f8f06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7edae0a8-9449-4401-bc5f-0a36c3db2995" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32aa0fee-837f-4991-9a23-01a3612f8f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ae4579-0108-4b77-a1eb-db31233767f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_f36670be-f12d-450d-9176-299c84b146cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ae4579-0108-4b77-a1eb-db31233767f7" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_f36670be-f12d-450d-9176-299c84b146cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_a8e1ed6e-a784-4b8d-a3a1-d7e005465dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ae4579-0108-4b77-a1eb-db31233767f7" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_a8e1ed6e-a784-4b8d-a3a1-d7e005465dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_718f141d-ae63-40dc-9f49-10da17253450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ae4579-0108-4b77-a1eb-db31233767f7" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_718f141d-ae63-40dc-9f49-10da17253450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_06968d0a-ebb4-4d77-bafe-11e5478e6321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ae4579-0108-4b77-a1eb-db31233767f7" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_06968d0a-ebb4-4d77-bafe-11e5478e6321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_8f0f5353-fa4f-4f1e-afb3-e6727bb2679b" xlink:href="rdnt-20231231.xsd#rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6ae4579-0108-4b77-a1eb-db31233767f7" xlink:to="loc_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_8f0f5353-fa4f-4f1e-afb3-e6727bb2679b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a55f3b3-b7d7-427d-b2d6-0563a02c7791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4d57fa6f-3737-4936-abd5-3787f11fc60a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a55f3b3-b7d7-427d-b2d6-0563a02c7791" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4d57fa6f-3737-4936-abd5-3787f11fc60a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d622e52b-a84d-40b0-b872-0168afdb2c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a55f3b3-b7d7-427d-b2d6-0563a02c7791" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d622e52b-a84d-40b0-b872-0168afdb2c1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8417fc20-e190-4550-8107-3e7aa26d9ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a55f3b3-b7d7-427d-b2d6-0563a02c7791" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8417fc20-e190-4550-8107-3e7aa26d9ac3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d7ffc7-f7d1-4342-b211-f1a3dd6c13e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8abe9405-7eec-42be-9482-c94c146ea94f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d7ffc7-f7d1-4342-b211-f1a3dd6c13e3" xlink:to="loc_us-gaap_AssetsCurrent_8abe9405-7eec-42be-9482-c94c146ea94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_877bab70-99e5-4831-889c-ca5c08c40c76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d7ffc7-f7d1-4342-b211-f1a3dd6c13e3" xlink:to="loc_us-gaap_AssetsNoncurrent_877bab70-99e5-4831-889c-ca5c08c40c76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3f3bf83e-cb3b-4275-ac27-7d7fe83b3e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d7ffc7-f7d1-4342-b211-f1a3dd6c13e3" xlink:to="loc_us-gaap_LiabilitiesCurrent_3f3bf83e-cb3b-4275-ac27-7d7fe83b3e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_d481f769-98cd-41dd-b688-5238629d8850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d7ffc7-f7d1-4342-b211-f1a3dd6c13e3" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_d481f769-98cd-41dd-b688-5238629d8850" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_42a0c22b-bbc9-44db-a3aa-1f8e9bb0f85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_42a0c22b-bbc9-44db-a3aa-1f8e9bb0f85e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c7681a83-80c7-4edd-9bab-917c06445b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c7681a83-80c7-4edd-9bab-917c06445b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_6d2342f8-dd7c-4422-b479-31b12c5a62b6" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_6d2342f8-dd7c-4422-b479-31b12c5a62b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_79ca30fd-b3be-4a58-8761-3d74ecc52e5e" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_79ca30fd-b3be-4a58-8761-3d74ecc52e5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_177f8255-069c-4896-a94c-bfba4e162928" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_177f8255-069c-4896-a94c-bfba4e162928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8c47c9b8-c890-4b96-b22f-b9d570d3b56e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_33f84c93-91a9-4b1d-8f5e-96c633cae290" xlink:to="loc_us-gaap_Goodwill_8c47c9b8-c890-4b96-b22f-b9d570d3b56e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2834e716-529d-4a50-a9aa-ca209ed78f72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c2b9cf12-039a-4148-8972-bebbadcb5e62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2834e716-529d-4a50-a9aa-ca209ed78f72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c2b9cf12-039a-4148-8972-bebbadcb5e62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d7f286c-710b-4f5f-b8db-c907afe196bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2834e716-529d-4a50-a9aa-ca209ed78f72" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d7f286c-710b-4f5f-b8db-c907afe196bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b5455b28-06d5-4706-b77f-fcbdc4ba0642" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b5455b28-06d5-4706-b77f-fcbdc4ba0642" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d618511d-d9cd-47da-a523-408ebad0589a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d618511d-d9cd-47da-a523-408ebad0589a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a4abf222-c3dd-425b-9abf-e89c2c42087f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a4abf222-c3dd-425b-9abf-e89c2c42087f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ab302e05-8d74-4d5b-829e-9ab74957efa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ab302e05-8d74-4d5b-829e-9ab74957efa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_672249e1-b165-4e38-ad4e-10e5a1de71ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_672249e1-b165-4e38-ad4e-10e5a1de71ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_24f350f6-2e06-48ed-82b9-8b7f816d4dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0b06d78-5975-4b78-ad8f-13fdaa785a42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_24f350f6-2e06-48ed-82b9-8b7f816d4dd8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9aea9622-6399-45a5-b657-e4611fcc0271" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_579c0f1a-76df-4738-9fb5-87f66ea60be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9aea9622-6399-45a5-b657-e4611fcc0271" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_579c0f1a-76df-4738-9fb5-87f66ea60be9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_485b6ffd-ae8b-4086-8b30-b308fbf38223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9aea9622-6399-45a5-b657-e4611fcc0271" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_485b6ffd-ae8b-4086-8b30-b308fbf38223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0d2b0daa-9cf6-4ad2-a829-f329708e1817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_1374cf61-bca9-4a1d-be1e-bcd36b28346b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0d2b0daa-9cf6-4ad2-a829-f329708e1817" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_1374cf61-bca9-4a1d-be1e-bcd36b28346b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d9d9d496-4482-4d9a-8724-23ee9a2fa0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0d2b0daa-9cf6-4ad2-a829-f329708e1817" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d9d9d496-4482-4d9a-8724-23ee9a2fa0cd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_06e52d28-b180-4ccf-9e8e-c691580af0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_563c9781-82e7-42e4-81ba-9ecfe7c2c360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_06e52d28-b180-4ccf-9e8e-c691580af0a5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_563c9781-82e7-42e4-81ba-9ecfe7c2c360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f0e8c622-b83f-4468-bdd9-bdd325dc083c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_06e52d28-b180-4ccf-9e8e-c691580af0a5" xlink:to="loc_us-gaap_LongTermDebtCurrent_f0e8c622-b83f-4468-bdd9-bdd325dc083c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b3daad84-cb50-44e8-b405-583791b50e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_64554787-d3a3-486c-bfcc-dd633c7264fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b3daad84-cb50-44e8-b405-583791b50e8e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_64554787-d3a3-486c-bfcc-dd633c7264fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ae108528-8db4-4279-a505-1066c46e62b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b3daad84-cb50-44e8-b405-583791b50e8e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ae108528-8db4-4279-a505-1066c46e62b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6c1c438a-efa0-443a-ae48-e2f3accac131" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b3daad84-cb50-44e8-b405-583791b50e8e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6c1c438a-efa0-443a-ae48-e2f3accac131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0c69fbc5-b4e8-4bd0-b406-d68e8eef1aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b3daad84-cb50-44e8-b405-583791b50e8e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0c69fbc5-b4e8-4bd0-b406-d68e8eef1aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_34e6f2b1-7114-4076-ab30-30e4f034fd23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b3daad84-cb50-44e8-b405-583791b50e8e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_34e6f2b1-7114-4076-ab30-30e4f034fd23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESLeaseCostDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_04913b96-36d7-4135-a4b4-35e84e81a730" xlink:href="rdnt-20231231.xsd#rdnt_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_431aaec0-370b-448a-b2ad-c8816627ef0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_04913b96-36d7-4135-a4b4-35e84e81a730" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_431aaec0-370b-448a-b2ad-c8816627ef0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ebc1982e-6550-4e4d-9b6b-5d003f9145b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_04913b96-36d7-4135-a4b4-35e84e81a730" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ebc1982e-6550-4e4d-9b6b-5d003f9145b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESSupplementalBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_da87167f-c8fa-412d-a5f9-6f576df0dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a4143d94-6ac7-45f6-9b67-93af2a3625a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_da87167f-c8fa-412d-a5f9-6f576df0dfeb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a4143d94-6ac7-45f6-9b67-93af2a3625a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c4934320-3d98-4e09-9b3c-fc6692c957e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_da87167f-c8fa-412d-a5f9-6f576df0dfeb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c4934320-3d98-4e09-9b3c-fc6692c957e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_3aea0d1c-e26c-4695-b83a-ad8fc15d59b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_85013470-62e4-4591-98d1-ae1fc1c0aa9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_3aea0d1c-e26c-4695-b83a-ad8fc15d59b2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_85013470-62e4-4591-98d1-ae1fc1c0aa9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_8a93f2fe-72db-4741-8a44-b1b9030bf31e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_3aea0d1c-e26c-4695-b83a-ad8fc15d59b2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_8a93f2fe-72db-4741-8a44-b1b9030bf31e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESMaturitiesofOperatingandFinanceLeaseDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_dbc11987-53d3-4864-bc57-8c151a956eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_dbc11987-53d3-4864-bc57-8c151a956eb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a40325f1-f531-4d95-a93e-4c12bdcf029f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a40325f1-f531-4d95-a93e-4c12bdcf029f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d80c7735-f98b-4edc-a63a-c59d57860c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d80c7735-f98b-4edc-a63a-c59d57860c56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_3bb1155a-ccfb-419c-8d4e-b73aa1c81c94" xlink:href="rdnt-20231231.xsd#rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:to="loc_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_3bb1155a-ccfb-419c-8d4e-b73aa1c81c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_eec20c85-4f3f-4753-abac-6a3073ffdfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_eec20c85-4f3f-4753-abac-6a3073ffdfb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b2a2809-10c3-4388-a550-c9662bfe490a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ffa74052-3bbf-4f91-aa7b-f8c60f9a835b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b2a2809-10c3-4388-a550-c9662bfe490a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESMaturitiesofOperatingandFinanceLeaseDetails_1"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c63296ab-0419-423b-a355-491df3fe9c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_84aca93e-cd17-445a-a35f-35f340847ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c63296ab-0419-423b-a355-491df3fe9c1f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_84aca93e-cd17-445a-a35f-35f340847ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c75fc51a-9a75-4125-86c6-cef6d8057491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c63296ab-0419-423b-a355-491df3fe9c1f" xlink:to="loc_us-gaap_OperatingLeaseLiability_c75fc51a-9a75-4125-86c6-cef6d8057491" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESIncomeLossBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ccc8c23a-dcce-4eb9-aa99-7f99a41b5741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4392030b-7314-485f-bfac-760c2337bf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ccc8c23a-dcce-4eb9-aa99-7f99a41b5741" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4392030b-7314-485f-bfac-760c2337bf6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b00f12d6-2a17-4258-93c0-2e5c537e131a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ccc8c23a-dcce-4eb9-aa99-7f99a41b5741" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b00f12d6-2a17-4258-93c0-2e5c537e131a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b3802934-0be6-4da9-a906-960b5a5186e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b3802934-0be6-4da9-a906-960b5a5186e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignCurrencyTranslationAdjustments_4c805d6e-53d1-41e0-9f98-1ac1e2d38b50" xlink:href="rdnt-20231231.xsd#rdnt_ForeignCurrencyTranslationAdjustments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_rdnt_ForeignCurrencyTranslationAdjustments_4c805d6e-53d1-41e0-9f98-1ac1e2d38b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_50ee1a7a-7459-4d6e-9c13-8248af4beaed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_50ee1a7a-7459-4d6e-9c13-8248af4beaed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CurrentOtherTaxExpenseBenefit_1b362291-a771-4bb2-a329-1e178eb4f477" xlink:href="rdnt-20231231.xsd#rdnt_CurrentOtherTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_rdnt_CurrentOtherTaxExpenseBenefit_1b362291-a771-4bb2-a329-1e178eb4f477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_35528888-fdfd-4196-8e66-e0f6e24e2122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_35528888-fdfd-4196-8e66-e0f6e24e2122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bdbcb99b-e82c-4bbe-af84-85ce05ed4e48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bdbcb99b-e82c-4bbe-af84-85ce05ed4e48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9bf14528-6f39-4c54-8508-1dd790ea6729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9bf14528-6f39-4c54-8508-1dd790ea6729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a6e442f7-3969-4b54-aaa3-f36f673748cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_739e7231-8305-4865-8096-6eedd1050fe9" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a6e442f7-3969-4b54-aaa3-f36f673748cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_125f6079-b5bd-40b3-adfc-2badaed873ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_125f6079-b5bd-40b3-adfc-2badaed873ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_2b2e8c9c-1cf6-4e30-bad4-76f66f223faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_2b2e8c9c-1cf6-4e30-bad4-76f66f223faa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bd9f3f27-6da9-426e-bd51-86e6363024d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bd9f3f27-6da9-426e-bd51-86e6363024d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_e90a4e30-4799-4f8e-8c4d-6c1d09c4f9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_e90a4e30-4799-4f8e-8c4d-6c1d09c4f9d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_4d9183c6-d776-47dc-bcfd-ea5f2c64b4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_4d9183c6-d776-47dc-bcfd-ea5f2c64b4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_0f117f50-a76f-4fb9-903a-842c5708dc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_0f117f50-a76f-4fb9-903a-842c5708dc25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_5dd0a7fb-9fb7-4e14-a477-80f7a8da10e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_5dd0a7fb-9fb7-4e14-a477-80f7a8da10e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_c8a96b64-5466-460f-8091-a549a8ae2ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_c8a96b64-5466-460f-8091-a549a8ae2ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_5272995b-906f-479c-9735-b28d5b5650b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_5272995b-906f-479c-9735-b28d5b5650b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e3f87d78-5a82-4231-815c-2828923c9f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e3f87d78-5a82-4231-815c-2828923c9f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8ca4f52b-eddb-4e75-a093-d7aa0ad7f6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8ca4f52b-eddb-4e75-a093-d7aa0ad7f6b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d543067c-1afd-4550-af3e-de05680a89dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c652614f-8f79-4c72-a7ef-3e636a6f4138" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d543067c-1afd-4550-af3e-de05680a89dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_451f7a4c-8a44-416f-aa74-fb685a573814" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1fe98c27-4b4b-42b4-9188-cbd6d855cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_451f7a4c-8a44-416f-aa74-fb685a573814" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1fe98c27-4b4b-42b4-9188-cbd6d855cfe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_31c32347-2bda-430f-8056-0e4862e66be7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_451f7a4c-8a44-416f-aa74-fb685a573814" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_31c32347-2bda-430f-8056-0e4862e66be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_aff59641-184d-473d-bbed-9adffe74b91d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_aff59641-184d-473d-bbed-9adffe74b91d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b731dfc3-d484-43a3-ab0b-05654d2d40ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b731dfc3-d484-43a3-ab0b-05654d2d40ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_7dc18ea8-1743-4319-82de-59b4f4b0ca68" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_7dc18ea8-1743-4319-82de-59b4f4b0ca68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_83cad3b1-d018-486d-b8e8-9f4c78e5c7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_83cad3b1-d018-486d-b8e8-9f4c78e5c7b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_c7a9c77f-0fdb-442e-9ee0-2fc9219ac910" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_c7a9c77f-0fdb-442e-9ee0-2fc9219ac910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_624f7202-677c-4dcc-b7ba-d1370922e1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_624f7202-677c-4dcc-b7ba-d1370922e1e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9b19433a-b3a7-4e05-9555-73cecf0370d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_170b0d82-edc5-49d3-8300-35f5ef99ef6d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9b19433a-b3a7-4e05-9555-73cecf0370d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_f84d9542-790e-4a8d-bf64-946b83a4ec8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_f84d9542-790e-4a8d-bf64-946b83a4ec8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_f910acc6-46ab-43ad-a147-10d745b94401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_f910acc6-46ab-43ad-a147-10d745b94401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_3df9ae25-955f-48ad-82ee-82a09e21bcd7" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_3df9ae25-955f-48ad-82ee-82a09e21bcd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_6b8187c5-7a96-4226-b6dc-7a1a41534efa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_6b8187c5-7a96-4226-b6dc-7a1a41534efa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_0c49c88a-ed14-4ab0-9383-4b8669db2c28" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxLiabilitiesOutsideBasisDifference"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_0c49c88a-ed14-4ab0-9383-4b8669db2c28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e14af9ec-8d03-4059-9ade-19eb9d70cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6d9b4761-ff5c-4fcb-9e2b-f3eac71dabb6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e14af9ec-8d03-4059-9ade-19eb9d70cf1a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>rdnt-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:97227b0c-cc0e-485b-bbeb-be4e8b957c79,g:17ec1eaf-cfc2-4d82-aff2-f13ccefcfa9a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:to="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_78055445-051c-4eb3-bb2c-4dc4d942bdf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:to="loc_us-gaap_RelatedPartyDomain_78055445-051c-4eb3-bb2c-4dc4d942bdf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e5fb999c-6a85-4765-9098-ef273da93c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:to="loc_us-gaap_RelatedPartyDomain_e5fb999c-6a85-4765-9098-ef273da93c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_72b9c449-6fda-46b5-a741-c288d4ef5c89" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_e5fb999c-6a85-4765-9098-ef273da93c5d" xlink:to="loc_srt_AffiliatedEntityMember_72b9c449-6fda-46b5-a741-c288d4ef5c89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:to="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8087958b-ce33-44de-af14-22ae2ed78be8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8087958b-ce33-44de-af14-22ae2ed78be8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_59b7b9e5-514d-4baf-9055-7abb500e5e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_59b7b9e5-514d-4baf-9055-7abb500e5e29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_eb130988-2718-4d25-9f6d-7296f72d7324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_eb130988-2718-4d25-9f6d-7296f72d7324" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cfada7cb-8546-4e6e-a941-42b6c74dc506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cfada7cb-8546-4e6e-a941-42b6c74dc506" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cecb99b0-adcf-4b74-8d50-3c8a3415f58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_AssetsCurrent_cecb99b0-adcf-4b74-8d50-3c8a3415f58c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3f72eaa5-4670-4590-9665-add1494a5d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3f72eaa5-4670-4590-9665-add1494a5d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_66181a50-9353-421b-b237-71cf8fd28e31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_66181a50-9353-421b-b237-71cf8fd28e31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_59c3f550-871e-4a6b-b735-2e75b6688b2b" xlink:href="rdnt-20231231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_59c3f550-871e-4a6b-b735-2e75b6688b2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6114dcd2-a1ab-4185-8546-72d399f1269b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_Goodwill_6114dcd2-a1ab-4185-8546-72d399f1269b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_560f723d-285a-487a-a63c-6b1c48f3b541" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_560f723d-285a-487a-a63c-6b1c48f3b541" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_e70b660e-d69b-4c41-90c7-2c9fa636db9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_e70b660e-d69b-4c41-90c7-2c9fa636db9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_75455453-0d0d-4c20-ba45-1aeac334555b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_75455453-0d0d-4c20-ba45-1aeac334555b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_930d4415-a3b8-407f-8616-842c4ffd55e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_DepositsAssets_930d4415-a3b8-407f-8616-842c4ffd55e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_14f07c98-a7ef-4f68-a21b-9eb2ee19475a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_Assets_14f07c98-a7ef-4f68-a21b-9eb2ee19475a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_85925fef-8a7c-4a20-b79c-8e89e040ea5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_85925fef-8a7c-4a20-b79c-8e89e040ea5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_814fc18a-dfad-4dc7-9bf0-795ac085a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_814fc18a-dfad-4dc7-9bf0-795ac085a0ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_336f1b35-d8a0-4f6a-90a1-c6a51bded0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_336f1b35-d8a0-4f6a-90a1-c6a51bded0a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9ccc27ce-f7da-42ef-8aa5-dfc493f9219f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9ccc27ce-f7da-42ef-8aa5-dfc493f9219f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_0851f818-3300-441a-bc64-d345a34a4937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_NotesPayableCurrent_0851f818-3300-441a-bc64-d345a34a4937" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_16cf638d-8537-4950-8144-88efc96542eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_LiabilitiesCurrent_16cf638d-8537-4950-8144-88efc96542eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5cd5c2a-83f4-4e68-9f79-eea5f8cf5826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5cd5c2a-83f4-4e68-9f79-eea5f8cf5826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_b9158572-d27a-4059-8d63-96e03abe3579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_LongTermNotesPayable_b9158572-d27a-4059-8d63-96e03abe3579" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef865b41-a196-4470-9aae-123e452d17e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef865b41-a196-4470-9aae-123e452d17e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e4cf89ac-11e4-44a1-b272-03724f3b593a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e4cf89ac-11e4-44a1-b272-03724f3b593a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_65a7b7fb-c4ee-4d34-9f20-771a7be66979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_Liabilities_65a7b7fb-c4ee-4d34-9f20-771a7be66979" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:to="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ff50b741-ea0e-44af-b35c-f431b20e7c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_CommonStockValue_ff50b741-ea0e-44af-b35c-f431b20e7c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_648cdfe4-b5ef-41d9-9a5c-6be3498b2f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_648cdfe4-b5ef-41d9-9a5c-6be3498b2f68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_05143439-6253-496c-b486-25fb815eb205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_05143439-6253-496c-b486-25fb815eb205" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c1ef82a-9782-45a6-a42d-1e5f1de60965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c1ef82a-9782-45a6-a42d-1e5f1de60965" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4c037fa8-37a2-44a5-aabd-d2cd06995e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_StockholdersEquity_4c037fa8-37a2-44a5-aabd-d2cd06995e87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_50137e31-023f-468a-a83b-021078836a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:to="loc_us-gaap_MinorityInterest_50137e31-023f-468a-a83b-021078836a01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_06bb1eed-fc89-44d1-af72-1ebe98862d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_06bb1eed-fc89-44d1-af72-1ebe98862d39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_025e7621-96a5-4ebd-907d-0a4f70faeff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_025e7621-96a5-4ebd-907d-0a4f70faeff2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:to="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a08fa854-09fc-4cb4-9c7d-4354a80e1789_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:to="loc_srt_ProductsAndServicesDomain_a08fa854-09fc-4cb4-9c7d-4354a80e1789_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:to="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_a5a15eab-0d22-437d-81cf-dcbe8e04d44b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_a5a15eab-0d22-437d-81cf-dcbe8e04d44b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_7e25736d-0fd8-4a94-b322-1881e2bb57e9" xlink:href="rdnt-20231231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:to="loc_rdnt_CapitationArrangementsMember_7e25736d-0fd8-4a94-b322-1881e2bb57e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_549a5cf7-0664-454f-81d0-46ecb073ba5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_549a5cf7-0664-454f-81d0-46ecb073ba5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_572033a2-caf6-46ff-a743-e111491376ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_572033a2-caf6-46ff-a743-e111491376ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_13006b5a-3b7f-46d1-a013-03ebce5e443f" xlink:href="rdnt-20231231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_13006b5a-3b7f-46d1-a013-03ebce5e443f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnContributionIntoJointVenture_da99b688-fd43-4f40-afa6-e88e7b1cd2e7" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnContributionIntoJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_rdnt_GainLossOnContributionIntoJointVenture_da99b688-fd43-4f40-afa6-e88e7b1cd2e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_452f6fbe-dfab-4714-9f6b-7b913e2d39ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_452f6fbe-dfab-4714-9f6b-7b913e2d39ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dd4806f5-3bc3-4a43-91a0-64a3a0f3e0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dd4806f5-3bc3-4a43-91a0-64a3a0f3e0ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_7a04dc2b-b680-4e38-a785-bc9b0512a16a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_7a04dc2b-b680-4e38-a785-bc9b0512a16a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0a1755d0-268e-4d67-8edd-996c0e73a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_SeveranceCosts1_0a1755d0-268e-4d67-8edd-996c0e73a49f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_eab19547-550c-4332-91dc-cc8c2d3a13bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_OperatingExpenses_eab19547-550c-4332-91dc-cc8c2d3a13bc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9c813d8e-7d5c-40b0-b2d5-961aa9aac61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_OperatingIncomeLoss_9c813d8e-7d5c-40b0-b2d5-961aa9aac61d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_847aa363-212e-433c-9a20-197ec8ae0bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_InterestExpenseDebt_847aa363-212e-433c-9a20-197ec8ae0bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dfbcab87-f0e1-40e5-8f71-3bdc0af64082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dfbcab87-f0e1-40e5-8f71-3bdc0af64082" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fc991012-17cf-4ef5-86db-dba0a7ad6971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fc991012-17cf-4ef5-86db-dba0a7ad6971" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_4b26e906-321b-4db0-8d16-3431ac7a7620" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_4b26e906-321b-4db0-8d16-3431ac7a7620" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_94bc18e5-19c3-49f2-b4a1-4778334cb7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_94bc18e5-19c3-49f2-b4a1-4778334cb7e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_fd1ff07c-4e77-451d-b782-03b4309b386e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_fd1ff07c-4e77-451d-b782-03b4309b386e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50c14343-b449-4110-a376-d6283922c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50c14343-b449-4110-a376-d6283922c4ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ae8a35b-29ac-4de8-a825-cb7e0be3d603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ae8a35b-29ac-4de8-a825-cb7e0be3d603" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f86d067d-4bce-4842-a8aa-057e984f155b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_ProfitLoss_f86d067d-4bce-4842-a8aa-057e984f155b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aeddd0ed-f8d3-45b4-9d8a-121671d49efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aeddd0ed-f8d3-45b4-9d8a-121671d49efe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f2409315-2eab-4823-b56e-3a91e565d5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_NetIncomeLoss_f2409315-2eab-4823-b56e-3a91e565d5a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_39a3f561-6cdb-4294-8eb2-ac8a715ec689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_EarningsPerShareBasic_39a3f561-6cdb-4294-8eb2-ac8a715ec689" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_99370854-eca4-41f9-bec8-fda0e490fe28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_99370854-eca4-41f9-bec8-fda0e490fe28" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:href="rdnt-20231231.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc3c0e90-3935-459e-ac5c-ab860508ec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc3c0e90-3935-459e-ac5c-ab860508ec5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c2cfa01-468c-48d1-832d-837f8bc1aaff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c2cfa01-468c-48d1-832d-837f8bc1aaff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b667795a-376b-4461-bacd-474af50092a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b667795a-376b-4461-bacd-474af50092a5" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3b77a0aa-e863-484b-a415-7e3315795317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3b77a0aa-e863-484b-a415-7e3315795317" xlink:to="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_67196be5-434f-4d30-b7b8-b679508043cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:to="loc_us-gaap_EquityComponentDomain_67196be5-434f-4d30-b7b8-b679508043cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:to="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:to="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fe6b8851-b9cf-409b-8fda-66aec3d44dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_CommonStockMember_fe6b8851-b9cf-409b-8fda-66aec3d44dc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e2763d76-2365-4826-bf2c-4987d0366af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e2763d76-2365-4826-bf2c-4987d0366af1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f32d05b4-a288-4a48-b636-797c1c217bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f32d05b4-a288-4a48-b636-797c1c217bda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a906cd4f-33a0-4c4b-9234-cc9f3736a823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_RetainedEarningsMember_a906cd4f-33a0-4c4b-9234-cc9f3736a823" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_a8c5f6bb-df8c-4dac-82ff-9ddd8092f648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:to="loc_us-gaap_NoncontrollingInterestMember_a8c5f6bb-df8c-4dac-82ff-9ddd8092f648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_47ab8477-5150-4f12-ac90-e4ce3afbb9cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_47ab8477-5150-4f12-ac90-e4ce3afbb9cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8f617d59-291a-4090-a02d-a3fa4c555a70" xlink:href="rdnt-20231231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:to="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8f617d59-291a-4090-a02d-a3fa4c555a70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_d23f91c7-2018-4097-ac8c-45ea89a5f08e" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:to="loc_rdnt_DeepHealthIncMember_d23f91c7-2018-4097-ac8c-45ea89a5f08e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b77a0aa-e863-484b-a415-7e3315795317" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_89410622-9b52-4e2f-b54b-e81b0ab4e14c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_89410622-9b52-4e2f-b54b-e81b0ab4e14c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc7ea99f-41b4-4550-9e85-24bf62708401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc7ea99f-41b4-4550-9e85-24bf62708401" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6a4276b6-bcbb-49df-8112-437e6dd43ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6a4276b6-bcbb-49df-8112-437e6dd43ea4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d54e138a-d35e-4b3d-8dc8-6d6828a548b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d54e138a-d35e-4b3d-8dc8-6d6828a548b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b3f87633-c4b8-46c8-b934-278047a2f978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b3f87633-c4b8-46c8-b934-278047a2f978" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_d659e68d-eda9-4189-bd0f-2922e1bf0dd3" xlink:href="rdnt-20231231.xsd#rdnt_SharesIssuedSharesSettlementOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_d659e68d-eda9-4189-bd0f-2922e1bf0dd3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8162605-8814-40f4-95c6-e4deb7dc0d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8162605-8814-40f4-95c6-e4deb7dc0d02" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9d2ae39e-7120-4ab0-b0ac-6c6ea437f16d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9d2ae39e-7120-4ab0-b0ac-6c6ea437f16d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_a4adbaf2-071c-4381-ad2a-2ecb0c3cbb27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_a4adbaf2-071c-4381-ad2a-2ecb0c3cbb27" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_3f36623c-a854-4eda-a7e7-d4e1b32e8b7e" xlink:href="rdnt-20231231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_3f36623c-a854-4eda-a7e7-d4e1b32e8b7e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fcb00b64-3c8d-44b5-80f7-8163a9dfce67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fcb00b64-3c8d-44b5-80f7-8163a9dfce67" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_182c3262-301c-44a5-ba7e-c56c5cdd8775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_182c3262-301c-44a5-ba7e-c56c5cdd8775" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7d565673-6e24-4219-9ed8-6e3748625374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7d565673-6e24-4219-9ed8-6e3748625374" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cfd0013d-2274-4d17-ac59-012de21d8602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_ProfitLoss_cfd0013d-2274-4d17-ac59-012de21d8602" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_bada90b5-4e38-4716-b866-1606908a47ff" xlink:href="rdnt-20231231.xsd#rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_bada90b5-4e38-4716-b866-1606908a47ff" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fb254b56-56a2-4387-9c19-fc0361eaf72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fb254b56-56a2-4387-9c19-fc0361eaf72b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f19abfb6-904d-4cc2-ae6d-165bc211d8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f19abfb6-904d-4cc2-ae6d-165bc211d8e1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_148d55ea-fd99-4f0e-b292-148f89d2a739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_148d55ea-fd99-4f0e-b292-148f89d2a739" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_483f5885-58ce-4a30-9483-5e01788516ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_483f5885-58ce-4a30-9483-5e01788516ef" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_701bc86f-e63f-4c1e-8313-ba8b82adbd52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_701bc86f-e63f-4c1e-8313-ba8b82adbd52" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_f3bb2d80-de43-440e-9037-3f02bb5677aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_f3bb2d80-de43-440e-9037-3f02bb5677aa" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_be1e9a26-7322-42a5-9cc2-174653bab889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_be1e9a26-7322-42a5-9cc2-174653bab889" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a4b8ec25-ef7d-4604-9cb4-0298e2990c67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockholdersEquityOther_a4b8ec25-ef7d-4604-9cb4-0298e2990c67" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6af77aec-e0dc-4c0d-8ddc-89fde9fa272e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd2d0392-3cfe-4df7-a72a-66c5c8b41f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_164e989f-9f2d-4f9e-98ac-3c382d5de38d" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_AidenceMember_164e989f-9f2d-4f9e-98ac-3c382d5de38d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_1ebf1526-f073-488b-a679-75e84abe6270" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_QuantibMember_1ebf1526-f073-488b-a679-75e84abe6270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember_0a4d6600-9b20-4484-9ba3-581802a046be" xlink:href="rdnt-20231231.xsd#rdnt_DRTLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_DRTLLCMember_0a4d6600-9b20-4484-9ba3-581802a046be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_da74f072-0f87-494e-ae6d-12c5379705c4" xlink:href="rdnt-20231231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_TangentAssociatesLLCMember_da74f072-0f87-494e-ae6d-12c5379705c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartLungImagingLimitedMember_0ee9f8c5-a4f6-46e9-9b76-66b940a63d97" xlink:href="rdnt-20231231.xsd#rdnt_HeartLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_HeartLungImagingLimitedMember_0ee9f8c5-a4f6-46e9-9b76-66b940a63d97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_18d1a09a-37b3-4cfd-b6cc-faad4c8e22dc" xlink:href="rdnt-20231231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_AidenceHoldingBVMember_18d1a09a-37b3-4cfd-b6cc-faad4c8e22dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_65830023-f29c-41b9-a1bb-e7b34ec15f19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_65830023-f29c-41b9-a1bb-e7b34ec15f19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockHoldbackMember_56592527-409d-4885-90fb-0a556dece80e" xlink:href="rdnt-20231231.xsd#rdnt_StockHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:to="loc_rdnt_StockHoldbackMember_56592527-409d-4885-90fb-0a556dece80e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GeneralHoldbackMember_210c2dfc-c7b3-41ec-b738-f110b8d00711" xlink:href="rdnt-20231231.xsd#rdnt_GeneralHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:to="loc_rdnt_GeneralHoldbackMember_210c2dfc-c7b3-41ec-b738-f110b8d00711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1e94fd76-c884-49c9-a3c8-7f6035d6a20a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1e94fd76-c884-49c9-a3c8-7f6035d6a20a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember_6020179a-e2e5-42e2-9923-82b5d37d67e3" xlink:href="rdnt-20231231.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:to="loc_rdnt_SantaMonicaImagingGroupLLCMember_6020179a-e2e5-42e2-9923-82b5d37d67e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_2ca1f127-abac-44ab-8cf9-1c02f0944e15" xlink:href="rdnt-20231231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_2ca1f127-abac-44ab-8cf9-1c02f0944e15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d6a46c3-ef89-492b-a415-b1f0d462b42f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d6a46c3-ef89-492b-a415-b1f0d462b42f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_097de270-7b85-46c2-9d03-663b26a0c928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d6a46c3-ef89-492b-a415-b1f0d462b42f" xlink:to="loc_us-gaap_UnsecuredDebtMember_097de270-7b85-46c2-9d03-663b26a0c928" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c3003f58-6eaa-4cf8-a56e-635bcbfac2be_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:to="loc_dei_EntityDomain_c3003f58-6eaa-4cf8-a56e-635bcbfac2be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:to="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_6080c308-24a0-4e8e-96e7-c55fa438138f" xlink:href="rdnt-20231231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_6080c308-24a0-4e8e-96e7-c55fa438138f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_ed3422f5-c007-450c-ae15-bbdf583c4e0d" xlink:href="rdnt-20231231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_ed3422f5-c007-450c-ae15-bbdf583c4e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_4b502053-dc69-406b-8704-6d42587520ef" xlink:href="rdnt-20231231.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:to="loc_rdnt_SimiAdventistMember_4b502053-dc69-406b-8704-6d42587520ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b4a1b280-d01a-4eea-a481-676205e2ee64_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:to="loc_srt_OwnershipDomain_b4a1b280-d01a-4eea-a481-676205e2ee64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c6e4d20f-a154-4a04-8db5-6727b0dbed8a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:to="loc_srt_OwnershipDomain_c6e4d20f-a154-4a04-8db5-6727b0dbed8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_36462316-e669-4bda-b8f6-9cd951a7bcb1" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_c6e4d20f-a154-4a04-8db5-6727b0dbed8a" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_36462316-e669-4bda-b8f6-9cd951a7bcb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_fced9035-21a8-47c3-b7d9-83b05a6410a0" xlink:href="rdnt-20231231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_fced9035-21a8-47c3-b7d9-83b05a6410a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c011095c-492f-4dba-97d9-47ba86962572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c011095c-492f-4dba-97d9-47ba86962572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_5574cece-04f1-496b-833a-2fdc73b8a948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_5574cece-04f1-496b-833a-2fdc73b8a948" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_959dc4b9-99f3-449d-808b-285b371c93fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_959dc4b9-99f3-449d-808b-285b371c93fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94413670-c488-4f73-8acd-136aa2bd3c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94413670-c488-4f73-8acd-136aa2bd3c3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_05ce1777-916f-45aa-b965-19314e003d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_05ce1777-916f-45aa-b965-19314e003d8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_dc198238-b9a1-491d-aee7-ede920a18f40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_dc198238-b9a1-491d-aee7-ede920a18f40" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_03532a9a-18fa-4efa-b1ec-9ffc4efb7cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_03532a9a-18fa-4efa-b1ec-9ffc4efb7cfe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_35b67d83-fdd1-48b1-a8d7-6e3bb7ca30c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_EquityMethodInvestments_35b67d83-fdd1-48b1-a8d7-6e3bb7ca30c0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9353fae-47e3-43a5-a8e7-f177de7d30c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9353fae-47e3-43a5-a8e7-f177de7d30c3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_f5474ff1-1a64-4148-9bf9-a21c363bd23b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_f5474ff1-1a64-4148-9bf9-a21c363bd23b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_83f1efb4-3fe6-4b28-9b28-83219c911707" xlink:href="rdnt-20231231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_83f1efb4-3fe6-4b28-9b28-83219c911707" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#NATUREOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_daef39da-bee9-4cde-a482-67775a708e31_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:to="loc_srt_ConsolidatedEntitiesDomain_daef39da-bee9-4cde-a482-67775a708e31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2218642f-d96f-4c2c-93b4-0605f611f28b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2218642f-d96f-4c2c-93b4-0605f611f28b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_29f5485e-6575-4166-9e44-26de2770a43d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2218642f-d96f-4c2c-93b4-0605f611f28b" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_29f5485e-6575-4166-9e44-26de2770a43d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8f67255-4b9e-49d8-9299-702340edb5af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:to="loc_us-gaap_EquityComponentDomain_b8f67255-4b9e-49d8-9299-702340edb5af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2401209a-8719-4289-8e16-533734598cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:to="loc_us-gaap_EquityComponentDomain_2401209a-8719-4289-8e16-533734598cfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f89af121-6ebe-42af-9ed9-5d7403abb3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2401209a-8719-4289-8e16-533734598cfb" xlink:to="loc_us-gaap_CommonStockMember_f89af121-6ebe-42af-9ed9-5d7403abb3eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa54d35d-50e6-4eec-931f-e12ffb6e05f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa54d35d-50e6-4eec-931f-e12ffb6e05f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d0559de0-86dc-47e6-bf2d-43e83b5ec8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d0559de0-86dc-47e6-bf2d-43e83b5ec8c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PublicOfferingMember_4f15caa4-0623-4aab-8333-020d761f228f" xlink:href="rdnt-20231231.xsd#rdnt_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d0559de0-86dc-47e6-bf2d-43e83b5ec8c4" xlink:to="loc_rdnt_PublicOfferingMember_4f15caa4-0623-4aab-8333-020d761f228f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_d3c961c9-15c2-4c8f-a108-bb83cce4e0ef" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_rdnt_NumberOfCenters_d3c961c9-15c2-4c8f-a108-bb83cce4e0ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_23d921ba-5bdc-42ac-bd8a-653033cdccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_NumberOfReportableSegments_23d921ba-5bdc-42ac-bd8a-653033cdccd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fbe03a29-64a3-4c5d-9f82-85d95ca256aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fbe03a29-64a3-4c5d-9f82-85d95ca256aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_ce2aca93-c1f2-4acf-9b2d-88081f97661c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_ce2aca93-c1f2-4acf-9b2d-88081f97661c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_2353fd15-a770-4a51-9980-f41851dc4e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_2353fd15-a770-4a51-9980-f41851dc4e5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SaleOfStockCost_2db72bf1-ff30-4a78-9fcb-4e47c230dc5c" xlink:href="rdnt-20231231.xsd#rdnt_SaleOfStockCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_rdnt_SaleOfStockCost_2db72bf1-ff30-4a78-9fcb-4e47c230dc5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_314b4eea-5d23-4769-9579-e135862c39b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_314b4eea-5d23-4769-9579-e135862c39b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_224becb8-48ff-4122-81e1-ee15985aa399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_224becb8-48ff-4122-81e1-ee15985aa399" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_ec3fa892-0546-4c07-adf5-bb6816ab4c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_ec3fa892-0546-4c07-adf5-bb6816ab4c9f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dd222540-d343-403e-8ceb-884f254f828a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_Assets_dd222540-d343-403e-8ceb-884f254f828a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4c43d4f3-ed84-4d59-b738-c7ed8b0c3b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_Liabilities_4c43d4f3-ed84-4d59-b738-c7ed8b0c3b91" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_df2b8eeb-4f97-4014-9752-0e08de6bfc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_df2b8eeb-4f97-4014-9752-0e08de6bfc8a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_969629b8-eff6-4bda-9365-791c49da7463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_EquityMethodInvestments_969629b8-eff6-4bda-9365-791c49da7463" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ba7ed6cc-35a6-48d1-badc-661561882c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ba7ed6cc-35a6-48d1-badc-661561882c03" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f8651f1d-db69-4084-98de-a821427b3e31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f8651f1d-db69-4084-98de-a821427b3e31" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:to="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:to="loc_srt_ProductsAndServicesDomain_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:to="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:to="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_0a225ef2-f989-4eb2-98b8-1d296c317fea" xlink:href="rdnt-20231231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_CommercialInsurance1Member_0a225ef2-f989-4eb2-98b8-1d296c317fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_49a4f328-f86b-4ced-bc47-eec61a247912" xlink:href="rdnt-20231231.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_Medicare1Member_49a4f328-f86b-4ced-bc47-eec61a247912" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_872fa65b-d1d0-4fec-9473-af8baf8f1273" xlink:href="rdnt-20231231.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_Medicaid1Member_872fa65b-d1d0-4fec-9473-af8baf8f1273" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_e4ec6c1c-4297-4257-bd25-ad5f97330922" xlink:href="rdnt-20231231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_e4ec6c1c-4297-4257-bd25-ad5f97330922" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_a1305a59-7148-4122-8b52-360cd5a6f128" xlink:href="rdnt-20231231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_a1305a59-7148-4122-8b52-360cd5a6f128" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_35b19ef4-71a5-4d49-b528-d6d42001ddc0" xlink:href="rdnt-20231231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_HealthCareManagementServiceMember_35b19ef4-71a5-4d49-b528-d6d42001ddc0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareAndTeleradiologyMember_d6db942e-2f59-4010-a572-8ad4c63e7e74" xlink:href="rdnt-20231231.xsd#rdnt_SoftwareAndTeleradiologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_SoftwareAndTeleradiologyMember_d6db942e-2f59-4010-a572-8ad4c63e7e74" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_57b57894-ed16-453d-984a-f0b2244a74a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_us-gaap_HealthCareOtherMember_57b57894-ed16-453d-984a-f0b2244a74a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_238f4327-6760-4c70-9d06-39e2943caf72" xlink:href="rdnt-20231231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_CapitationArrangementsMember_238f4327-6760-4c70-9d06-39e2943caf72" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_4ed4496b-2ac1-4ec5-8a9e-4144f8070f9e" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:to="loc_rdnt_AIMember_4ed4496b-2ac1-4ec5-8a9e-4144f8070f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5186ac8-6d3d-48d9-b68a-08f523ea3856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f8651f1d-db69-4084-98de-a821427b3e31" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5186ac8-6d3d-48d9-b68a-08f523ea3856" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_bb254f03-7c58-43ed-aa63-a7a11c386469_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_bb254f03-7c58-43ed-aa63-a7a11c386469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_3002c31c-40f6-41aa-8cc6-091c9d74fe02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_3002c31c-40f6-41aa-8cc6-091c9d74fe02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_3055c9d5-e87f-432b-9ea9-4544307d75b5" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_3002c31c-40f6-41aa-8cc6-091c9d74fe02" xlink:to="loc_rdnt_COVID19PandemicMember_3055c9d5-e87f-432b-9ea9-4544307d75b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_d2c7ec3e-205c-4bdb-a745-47ab0f8fd2e1" xlink:href="rdnt-20231231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:to="loc_rdnt_AdvanceMedicarePayments_d2c7ec3e-205c-4bdb-a745-47ab0f8fd2e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_84f5b5bd-3f32-4cbe-a113-5b240ffbecab" xlink:href="rdnt-20231231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_84f5b5bd-3f32-4cbe-a113-5b240ffbecab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_41230135-f939-42ab-a25b-f5d35a467289_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:to="loc_srt_ProductsAndServicesDomain_41230135-f939-42ab-a25b-f5d35a467289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_686b2f5d-5efb-43e9-854e-7aea8e29bf96" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:to="loc_srt_ProductsAndServicesDomain_686b2f5d-5efb-43e9-854e-7aea8e29bf96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_78bacd7b-204f-4c95-8649-f7b955881310" xlink:href="rdnt-20231231.xsd#rdnt_PatientServicesNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_686b2f5d-5efb-43e9-854e-7aea8e29bf96" xlink:to="loc_rdnt_PatientServicesNetMember_78bacd7b-204f-4c95-8649-f7b955881310" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_621ef76b-2d00-497d-94d2-8aa010e703b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:to="loc_us-gaap_SegmentDomain_621ef76b-2d00-497d-94d2-8aa010e703b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2f38c123-626b-488b-b6ff-89010e614718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:to="loc_us-gaap_SegmentDomain_2f38c123-626b-488b-b6ff-89010e614718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_a12a3f45-0532-4c30-add3-827a4f6cf4dc" xlink:href="rdnt-20231231.xsd#rdnt_ERADMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2f38c123-626b-488b-b6ff-89010e614718" xlink:to="loc_rdnt_ERADMember_a12a3f45-0532-4c30-add3-827a4f6cf4dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_644af85d-3baf-4f1e-bcbf-fc3497ff746a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:to="loc_srt_RangeMember_644af85d-3baf-4f1e-bcbf-fc3497ff746a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:to="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2939edef-b036-451e-a863-f9857adcc6b4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:to="loc_srt_MinimumMember_2939edef-b036-451e-a863-f9857adcc6b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_664fd4c5-f692-48ae-a067-accd932a17ae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:to="loc_srt_MaximumMember_664fd4c5-f692-48ae-a067-accd932a17ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fb1439e-2242-4ca2-900b-75e8fd041223_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fb1439e-2242-4ca2-900b-75e8fd041223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_e6913b57-3d93-4dfa-8a9e-7fe5970dec27" xlink:href="rdnt-20231231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_e6913b57-3d93-4dfa-8a9e-7fe5970dec27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f662ee28-9355-44da-9358-957969a6d856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f662ee28-9355-44da-9358-957969a6d856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_502aa3a0-6fb0-42f8-b336-4c038725f9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_502aa3a0-6fb0-42f8-b336-4c038725f9d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_c14e9e90-b7b5-485a-b45e-60667b463b64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_c14e9e90-b7b5-485a-b45e-60667b463b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d639195a-b84b-4572-bab4-e319fa4b8d30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d639195a-b84b-4572-bab4-e319fa4b8d30" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1912abc2-b7be-4ebf-928c-430926eb59ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1912abc2-b7be-4ebf-928c-430926eb59ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_66aa87c6-d428-4936-8824-0140dcb39bb5" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:to="loc_rdnt_AidenceMember_66aa87c6-d428-4936-8824-0140dcb39bb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5cb58bf2-ae6f-4672-820f-5a6003c15c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5cb58bf2-ae6f-4672-820f-5a6003c15c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_014087a6-0ae7-4c14-bdb4-6f249376dabd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_ReinsuranceContractAxis_014087a6-0ae7-4c14-bdb4-6f249376dabd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18f223d7-7280-41ef-9954-d7938bacd8d6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18f223d7-7280-41ef-9954-d7938bacd8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_b05e90cb-d67a-445a-8a18-81b4eddfca24" xlink:href="rdnt-20231231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:to="loc_rdnt_BlueShieldMember_b05e90cb-d67a-445a-8a18-81b4eddfca24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:to="loc_srt_RangeMember_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:to="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_90dbbe68-0530-4034-b14b-28b5dc930219" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:to="loc_srt_MinimumMember_90dbbe68-0530-4034-b14b-28b5dc930219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4856e65e-5b89-458d-9cea-d137caf0c73a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:to="loc_srt_MaximumMember_4856e65e-5b89-458d-9cea-d137caf0c73a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a12df55e-b125-4479-8b24-26b8114b4de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_Goodwill_a12df55e-b125-4479-8b24-26b8114b4de4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae0685f5-4fd3-4401-8f2d-3ac2b064bd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae0685f5-4fd3-4401-8f2d-3ac2b064bd9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dc733947-bcf4-404c-9378-8bf268765f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dc733947-bcf4-404c-9378-8bf268765f35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6b56fbb5-2a1e-4699-8133-de658ebebc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6b56fbb5-2a1e-4699-8133-de658ebebc6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_a4a1e62e-c092-4cde-9091-a83e841254b3" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_a4a1e62e-c092-4cde-9091-a83e841254b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_47fd4546-0f0b-40a6-91dd-3fe2988f721e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_47fd4546-0f0b-40a6-91dd-3fe2988f721e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_0ecac555-1e93-440a-abcd-2de98b7525d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_0ecac555-1e93-440a-abcd-2de98b7525d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_310a48b6-daba-4447-99c6-67bdd9688bce" xlink:href="rdnt-20231231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_310a48b6-daba-4447-99c6-67bdd9688bce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_3cb92020-38d2-4688-9f40-79adedc482a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_SelfInsuranceReserve_3cb92020-38d2-4688-9f40-79adedc482a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9d1064c4-f47b-4066-9bb9-e27d5b8c8144" xlink:href="rdnt-20231231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9d1064c4-f47b-4066-9bb9-e27d5b8c8144" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1912abc2-b7be-4ebf-928c-430926eb59ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1912abc2-b7be-4ebf-928c-430926eb59ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_66aa87c6-d428-4936-8824-0140dcb39bb5" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:to="loc_rdnt_AidenceMember_66aa87c6-d428-4936-8824-0140dcb39bb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5cb58bf2-ae6f-4672-820f-5a6003c15c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5cb58bf2-ae6f-4672-820f-5a6003c15c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18f223d7-7280-41ef-9954-d7938bacd8d6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18f223d7-7280-41ef-9954-d7938bacd8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_b05e90cb-d67a-445a-8a18-81b4eddfca24" xlink:href="rdnt-20231231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:to="loc_rdnt_BlueShieldMember_b05e90cb-d67a-445a-8a18-81b4eddfca24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:to="loc_srt_RangeMember_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:to="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_90dbbe68-0530-4034-b14b-28b5dc930219" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:to="loc_srt_MinimumMember_90dbbe68-0530-4034-b14b-28b5dc930219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4856e65e-5b89-458d-9cea-d137caf0c73a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:to="loc_srt_MaximumMember_4856e65e-5b89-458d-9cea-d137caf0c73a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a12df55e-b125-4479-8b24-26b8114b4de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_Goodwill_a12df55e-b125-4479-8b24-26b8114b4de4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae0685f5-4fd3-4401-8f2d-3ac2b064bd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae0685f5-4fd3-4401-8f2d-3ac2b064bd9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dc733947-bcf4-404c-9378-8bf268765f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dc733947-bcf4-404c-9378-8bf268765f35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6b56fbb5-2a1e-4699-8133-de658ebebc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6b56fbb5-2a1e-4699-8133-de658ebebc6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_a4a1e62e-c092-4cde-9091-a83e841254b3" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_a4a1e62e-c092-4cde-9091-a83e841254b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_47fd4546-0f0b-40a6-91dd-3fe2988f721e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_47fd4546-0f0b-40a6-91dd-3fe2988f721e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_0ecac555-1e93-440a-abcd-2de98b7525d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_0ecac555-1e93-440a-abcd-2de98b7525d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_310a48b6-daba-4447-99c6-67bdd9688bce" xlink:href="rdnt-20231231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_310a48b6-daba-4447-99c6-67bdd9688bce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_3cb92020-38d2-4688-9f40-79adedc482a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_SelfInsuranceReserve_3cb92020-38d2-4688-9f40-79adedc482a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9d1064c4-f47b-4066-9bb9-e27d5b8c8144" xlink:href="rdnt-20231231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9d1064c4-f47b-4066-9bb9-e27d5b8c8144" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:to="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cead0a4b-3aec-4cdb-b408-415b53a1cb01_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:to="loc_srt_RangeMember_cead0a4b-3aec-4cdb-b408-415b53a1cb01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:to="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_454eb6f5-21cb-4310-b937-9d270612176f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:to="loc_srt_MinimumMember_454eb6f5-21cb-4310-b937-9d270612176f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_411ccc6c-1056-45e4-8b97-4bda61751e87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:to="loc_srt_MaximumMember_411ccc6c-1056-45e4-8b97-4bda61751e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:to="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_47e4d74c-8659-4a4a-b690-c3a074dfef93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:to="loc_us-gaap_PlanNameDomain_47e4d74c-8659-4a4a-b690-c3a074dfef93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d221b969-b14e-41b2-afa9-c3b0521698b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:to="loc_us-gaap_PlanNameDomain_d221b969-b14e-41b2-afa9-c3b0521698b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_0290aa07-63c7-478d-87b2-cd7f1f70db61" xlink:href="rdnt-20231231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d221b969-b14e-41b2-afa9-c3b0521698b2" xlink:to="loc_rdnt_RestatedPlanMember_0290aa07-63c7-478d-87b2-cd7f1f70db61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_fb001c1e-a052-42d6-a3a1-4748fddf074f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_fb001c1e-a052-42d6-a3a1-4748fddf074f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c454192e-0538-4e1e-9472-ab4870a74a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c454192e-0538-4e1e-9472-ab4870a74a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_06cbf8f4-de32-4bfa-a40f-35dcd3336027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_06cbf8f4-de32-4bfa-a40f-35dcd3336027" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_21934f20-5322-4ea1-862a-c507208aaa82" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_21934f20-5322-4ea1-862a-c507208aaa82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0728d3fc-6365-477e-97d8-15152827829f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0728d3fc-6365-477e-97d8-15152827829f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e0670a69-c8e6-40f9-83e1-53e4a9cc5406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e0670a69-c8e6-40f9-83e1-53e4a9cc5406" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2dcf2463-2c3b-4141-afc3-4924267e277f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2dcf2463-2c3b-4141-afc3-4924267e277f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_22d747e9-2a31-4abe-b136-f4338c7768e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_22d747e9-2a31-4abe-b136-f4338c7768e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_17d6c532-e108-49ab-bf32-296338b322da" xlink:href="rdnt-20231231.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:to="loc_rdnt_A2019SWAPSMember_17d6c532-e108-49ab-bf32-296338b322da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_54239f54-7075-4771-b2b6-854d6de7f926" xlink:href="rdnt-20231231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:to="loc_rdnt_A2019SWAPS1Member_54239f54-7075-4771-b2b6-854d6de7f926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_edad3053-4907-4934-84ce-02b586d60adf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_edad3053-4907-4934-84ce-02b586d60adf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_68da5503-9ae6-44e4-853d-896584f7b145" xlink:href="rdnt-20231231.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:to="loc_rdnt_October2023Member_68da5503-9ae6-44e4-853d-896584f7b145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_2c1d68e8-7a50-4534-8b26-946c27103201" xlink:href="rdnt-20231231.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:to="loc_rdnt_October2025Member_2c1d68e8-7a50-4534-8b26-946c27103201" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d2d1681-be81-438d-bdae-bb690bf150c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d2d1681-be81-438d-bdae-bb690bf150c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7f4ac293-ec37-4609-8103-e262e12ae653" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d2d1681-be81-438d-bdae-bb690bf150c7" xlink:to="loc_us-gaap_InterestRateSwapMember_7f4ac293-ec37-4609-8103-e262e12ae653" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f4c243ac-e3de-4526-adc5-a00ca880a5f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:to="loc_us-gaap_VariableRateDomain_f4c243ac-e3de-4526-adc5-a00ca880a5f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21ca32bd-c448-47a4-b9ae-629a1f1da3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:to="loc_us-gaap_VariableRateDomain_21ca32bd-c448-47a4-b9ae-629a1f1da3fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LondonInterbankOfferedRateLIBOR1Member_11615878-3f25-49f6-9ec1-6ef6932d99ab" xlink:href="rdnt-20231231.xsd#rdnt_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21ca32bd-c448-47a4-b9ae-629a1f1da3fc" xlink:to="loc_rdnt_LondonInterbankOfferedRateLIBOR1Member_11615878-3f25-49f6-9ec1-6ef6932d99ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0369063-13d1-43e0-8ee6-f01d91678f51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:to="loc_us-gaap_EquityComponentDomain_a0369063-13d1-43e0-8ee6-f01d91678f51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_383ad4f7-67e4-4c1c-86ad-c874dd6d7650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:to="loc_us-gaap_EquityComponentDomain_383ad4f7-67e4-4c1c-86ad-c874dd6d7650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1cf1b439-91a2-4268-82c8-12d0f41dfc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_383ad4f7-67e4-4c1c-86ad-c874dd6d7650" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1cf1b439-91a2-4268-82c8-12d0f41dfc25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_98f9e775-2a45-49bc-a1b7-9ca49f0246c8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_98f9e775-2a45-49bc-a1b7-9ca49f0246c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f1076cf6-20b7-4a74-af38-f27992f5454a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f1076cf6-20b7-4a74-af38-f27992f5454a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c8eb9b55-4236-47cc-85d1-0365fc022663" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f1076cf6-20b7-4a74-af38-f27992f5454a" xlink:to="loc_srt_ScenarioForecastMember_c8eb9b55-4236-47cc-85d1-0365fc022663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_1b4dd2cc-b637-4900-a0c9-88c6fc5de8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_1b4dd2cc-b637-4900-a0c9-88c6fc5de8a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d2432e96-c5e1-4481-97a5-84c78834ddba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d2432e96-c5e1-4481-97a5-84c78834ddba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_603b512d-68ab-4bf5-bcbf-fcb9b58075a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_603b512d-68ab-4bf5-bcbf-fcb9b58075a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2028228b-0415-48ac-84ea-3c5f41650dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_StockholdersEquity_2028228b-0415-48ac-84ea-3c5f41650dd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_21895e85-4ea0-4de5-8550-2a863e78a6cd" xlink:href="rdnt-20231231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_21895e85-4ea0-4de5-8550-2a863e78a6cd" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_23e3e188-5d7f-445a-b3cb-e1e634c2a170_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_23e3e188-5d7f-445a-b3cb-e1e634c2a170_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6a6f387d-9f00-4f71-a781-1159846f51d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6a6f387d-9f00-4f71-a781-1159846f51d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6a35ceea-b7d4-48d1-bf04-9b076f4d0b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6a6f387d-9f00-4f71-a781-1159846f51d3" xlink:to="loc_us-gaap_InterestRateSwapMember_6a35ceea-b7d4-48d1-bf04-9b076f4d0b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f80f8287-3b3b-4625-bd5a-0c7eed5ddc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f80f8287-3b3b-4625-bd5a-0c7eed5ddc6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ec439680-1bfe-4277-bf0d-fd1240dc4fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f80f8287-3b3b-4625-bd5a-0c7eed5ddc6d" xlink:to="loc_us-gaap_InterestExpenseMember_ec439680-1bfe-4277-bf0d-fd1240dc4fb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5cc68106-3b6e-449b-9352-0adaa53c7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5cc68106-3b6e-449b-9352-0adaa53c7efc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_40f7873e-1bfa-4c90-80e9-b44652c67d55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_40f7873e-1bfa-4c90-80e9-b44652c67d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_261e41db-59b7-4342-a81a-6c7d8c8f9d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_261e41db-59b7-4342-a81a-6c7d8c8f9d43" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_46ab2f94-e215-4213-bc9e-8688579a7ff6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_46ab2f94-e215-4213-bc9e-8688579a7ff6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_7bfbe2c7-70e2-4a02-bfe2-b6814dbd0157" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_AidenceMember_7bfbe2c7-70e2-4a02-bfe2-b6814dbd0157" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_e4f62bf1-ebe5-4204-b381-5d88a36a861a" xlink:href="rdnt-20231231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_AidenceHoldingBVMember_e4f62bf1-ebe5-4204-b381-5d88a36a861a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_3e58507f-74fb-47f5-bea2-31da1045f0c5" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_QuantibMember_3e58507f-74fb-47f5-bea2-31da1045f0c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_6f31de6b-8d98-4aa3-b45e-b2c4db65da6d" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_MontclairMember_6f31de6b-8d98-4aa3-b45e-b2c4db65da6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_98a72e1b-68ca-4a0d-86b9-0c52bc606f0a" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_98a72e1b-68ca-4a0d-86b9-0c52bc606f0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_2301dc2c-c8d6-4efa-a610-cb73d0972255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_2301dc2c-c8d6-4efa-a610-cb73d0972255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_a62f02b8-f92e-4f8e-9c1a-17ba61da7605" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_a62f02b8-f92e-4f8e-9c1a-17ba61da7605" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_01182365-bfc5-4136-98bc-d31bf6829acc" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_CashHoldbackMember_01182365-bfc5-4136-98bc-d31bf6829acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GeneralHoldbackMember_da005e5d-b82e-4281-aae6-51affd448d57" xlink:href="rdnt-20231231.xsd#rdnt_GeneralHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_GeneralHoldbackMember_da005e5d-b82e-4281-aae6-51affd448d57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockHoldbackMember_311ef255-2033-4bad-a360-ce1f27362f50" xlink:href="rdnt-20231231.xsd#rdnt_StockHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_StockHoldbackMember_311ef255-2033-4bad-a360-ce1f27362f50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7ee99a27-015a-4c79-82b7-b36afec86475" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7ee99a27-015a-4c79-82b7-b36afec86475" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_69b08684-eb7b-4f4c-9aac-bd1b132dbf2b" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_69b08684-eb7b-4f4c-9aac-bd1b132dbf2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbfdcd20-f108-47de-b3ad-f22b72ed9774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbfdcd20-f108-47de-b3ad-f22b72ed9774" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_127c9d95-c6cd-4d2f-8fba-fc3a155abcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_127c9d95-c6cd-4d2f-8fba-fc3a155abcfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5fefbed5-0c43-4d0c-92d5-b629911cce4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5fefbed5-0c43-4d0c-92d5-b629911cce4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6bff1f86-7c81-444e-bec2-a2a69ef50ef2" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6bff1f86-7c81-444e-bec2-a2a69ef50ef2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d7165ca4-8459-438c-a4d6-144ce04c1c1f" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d7165ca4-8459-438c-a4d6-144ce04c1c1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_5dab09f6-df3a-4220-a3cc-6f294ac5b43c" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_5dab09f6-df3a-4220-a3cc-6f294ac5b43c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ed44a32e-4728-4159-8d48-1a0ee79909c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ed44a32e-4728-4159-8d48-1a0ee79909c0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_5da7250e-0bbd-4ac0-972a-3f313647831f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_5da7250e-0bbd-4ac0-972a-3f313647831f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_cecfc67e-2fcd-419c-ba0b-65150af95dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_cecfc67e-2fcd-419c-ba0b-65150af95dec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b25c6fbe-e967-47f6-92dc-4beaec188935" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b25c6fbe-e967-47f6-92dc-4beaec188935" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_5c79ccb5-e1b1-4d62-8c07-aeb1de7f6393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_5c79ccb5-e1b1-4d62-8c07-aeb1de7f6393" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_96e42a63-e667-48dc-9af6-fb8ccf82e2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_96e42a63-e667-48dc-9af6-fb8ccf82e2bf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c53a82e-a0f4-45a5-9090-8c379c423f5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c53a82e-a0f4-45a5-9090-8c379c423f5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_85075a32-3a0f-4bf4-9e24-0451e92f966a" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_AidenceMember_85075a32-3a0f-4bf4-9e24-0451e92f966a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_b7a0c4eb-c675-4327-a75e-67f298b5a9c5" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_QuantibMember_b7a0c4eb-c675-4327-a75e-67f298b5a9c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_31bb8117-f617-4b2d-9b6c-0e5b9fea82a2" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_MontclairMember_31bb8117-f617-4b2d-9b6c-0e5b9fea82a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_1d005c5e-40e8-427c-8668-90f995c59327" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_1d005c5e-40e8-427c-8668-90f995c59327" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_96e42a63-e667-48dc-9af6-fb8ccf82e2bf" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a5aa47b-f29a-4153-8fbb-b4abe36a28c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a5aa47b-f29a-4153-8fbb-b4abe36a28c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_64368b9d-0300-4507-a131-80166d81df85" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_64368b9d-0300-4507-a131-80166d81df85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc67f370-048d-4c1a-b7b6-e16991ac4f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc67f370-048d-4c1a-b7b6-e16991ac4f1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_49ae6bf6-30ef-443c-84a1-9bd87a3a1c76" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_49ae6bf6-30ef-443c-84a1-9bd87a3a1c76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_041f5a34-5004-46ae-a24a-6703b03e4400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8959a45d-9c95-454c-a25b-a0d513259a4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8959a45d-9c95-454c-a25b-a0d513259a4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d7b38f7f-5488-4c55-a158-249ccf30c6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d7b38f7f-5488-4c55-a158-249ccf30c6e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf8491d4-945b-480b-b6c4-bb39949f1d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d7b38f7f-5488-4c55-a158-249ccf30c6e0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf8491d4-945b-480b-b6c4-bb39949f1d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8140d348-515d-4329-b0fa-b6a04a47d2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf8491d4-945b-480b-b6c4-bb39949f1d32" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8140d348-515d-4329-b0fa-b6a04a47d2f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77bdf4c2-747a-48ed-bbc6-ea6f03f50622_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77bdf4c2-747a-48ed-bbc6-ea6f03f50622_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b2c440d9-3158-4446-b80b-3ba0b58ddc44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b2c440d9-3158-4446-b80b-3ba0b58ddc44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_26107671-f9d6-40d9-9015-eb01cbb7315e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_26107671-f9d6-40d9-9015-eb01cbb7315e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cd1a8397-e6e4-45b8-91be-31ececfdb318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cd1a8397-e6e4-45b8-91be-31ececfdb318" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1279b212-4623-4f23-b21b-f52883ad2ffa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1279b212-4623-4f23-b21b-f52883ad2ffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1fa4ee3-a888-4bda-859d-c94275aa25c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1fa4ee3-a888-4bda-859d-c94275aa25c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cf3e09a4-b636-4ce6-a330-4e3780641a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1fa4ee3-a888-4bda-859d-c94275aa25c2" xlink:to="loc_us-gaap_InterestRateSwapMember_cf3e09a4-b636-4ce6-a330-4e3780641a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c32875e-89ad-4778-a193-4bf251ce5576_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c32875e-89ad-4778-a193-4bf251ce5576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_58ed104d-dff8-4ed4-8c49-7a770bf397c5" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_AidenceMember_58ed104d-dff8-4ed4-8c49-7a770bf397c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_bcdb834c-e144-4356-977e-14168ad8ef18" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_QuantibMember_bcdb834c-e144-4356-977e-14168ad8ef18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_51eeee52-3dbc-4db4-a0a0-be34fde1719d" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_MontclairMember_51eeee52-3dbc-4db4-a0a0-be34fde1719d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_034e6958-b27f-429b-88e2-110af200ed2a" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_034e6958-b27f-429b-88e2-110af200ed2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_62091312-2a3f-402d-9eba-cc16749f1097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_DerivativeAssets_62091312-2a3f-402d-9eba-cc16749f1097" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7c049d2d-3d5e-4a9b-8380-a608a1291fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_DerivativeLiabilities_7c049d2d-3d5e-4a9b-8380-a608a1291fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_7b4f2927-4203-474f-be06-f6ff3ea7ba6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_7b4f2927-4203-474f-be06-f6ff3ea7ba6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_b3f56280-52f4-4683-92df-2b38f9f35b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_7b4f2927-4203-474f-be06-f6ff3ea7ba6b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_b3f56280-52f4-4683-92df-2b38f9f35b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_2e82d54e-4ce2-4a8d-b0b7-61882621e5f2" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_2e82d54e-4ce2-4a8d-b0b7-61882621e5f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ValueOfEstimatedSharesIssuable_8a776c90-a763-480c-971a-8cfd54b4799d" xlink:href="rdnt-20231231.xsd#rdnt_ValueOfEstimatedSharesIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_rdnt_ValueOfEstimatedSharesIssuable_8a776c90-a763-480c-971a-8cfd54b4799d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b34c2d57-c447-47fb-8968-c610d51d8f9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b34c2d57-c447-47fb-8968-c610d51d8f9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0a63d162-e319-4744-b52a-dbcccdbe8ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0a63d162-e319-4744-b52a-dbcccdbe8ee8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b37b727f-707e-4d81-92d8-8a49a1c19d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b37b727f-707e-4d81-92d8-8a49a1c19d9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_55b078d1-93a6-4af9-995e-a9e2e7e7fbce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_55b078d1-93a6-4af9-995e-a9e2e7e7fbce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c275d2e7-4f57-480a-84a6-90f1fe354e2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c275d2e7-4f57-480a-84a6-90f1fe354e2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8eb6f34a-52bc-400c-9e56-fc0b667026df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8eb6f34a-52bc-400c-9e56-fc0b667026df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cb8b93fd-9061-40f2-bfe0-22d16354b4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8eb6f34a-52bc-400c-9e56-fc0b667026df" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cb8b93fd-9061-40f2-bfe0-22d16354b4b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a36137d-6153-4007-a301-5067fbaa37ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cb8b93fd-9061-40f2-bfe0-22d16354b4b1" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a36137d-6153-4007-a301-5067fbaa37ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9b9af29-54ef-4115-880d-d2a7274a039d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9b9af29-54ef-4115-880d-d2a7274a039d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_e5f6fccd-0e35-42a1-ae12-c9120b2870dc" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:to="loc_rdnt_BarclaysMember_e5f6fccd-0e35-42a1-ae12-c9120b2870dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_5812881f-2328-42ca-913c-0e39f425df7a" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:to="loc_rdnt_TruistMember_5812881f-2328-42ca-913c-0e39f425df7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e34d4ec6-c55b-4391-ab70-781b9c56858a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e34d4ec6-c55b-4391-ab70-781b9c56858a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e164795e-7abb-4a68-87d8-89aa69a60370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:to="loc_us-gaap_LineOfCredit_e164795e-7abb-4a68-87d8-89aa69a60370" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_72c0f3d5-a60e-41e0-9c11-79ab916221ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_72c0f3d5-a60e-41e0-9c11-79ab916221ad" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_187d0813-1bc3-4ae9-8aee-586d30b430a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_187d0813-1bc3-4ae9-8aee-586d30b430a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c60a5aff-393a-45f3-80e2-258c8ec39c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c60a5aff-393a-45f3-80e2-258c8ec39c52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fb408488-2b7b-4514-a641-d807272749f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:to="loc_us-gaap_CommonStockMember_fb408488-2b7b-4514-a641-d807272749f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_5142c4f6-fc61-4e6d-8ff3-0ee1c4c3e4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_72c0f3d5-a60e-41e0-9c11-79ab916221ad" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_5142c4f6-fc61-4e6d-8ff3-0ee1c4c3e4ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a961082-ae7f-41f0-927a-6c0cd924371f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_5142c4f6-fc61-4e6d-8ff3-0ee1c4c3e4ce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a961082-ae7f-41f0-927a-6c0cd924371f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4d2bc705-7584-43ed-b331-1ce050cd0286_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4d2bc705-7584-43ed-b331-1ce050cd0286_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_9181ec45-1026-49ab-ac04-4fee5c5d5e97" xlink:href="rdnt-20231231.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:to="loc_rdnt_MedicVisionMember_9181ec45-1026-49ab-ac04-4fee5c5d5e97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_f927f525-21be-4898-8370-bd233f915ab5" xlink:href="rdnt-20231231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:to="loc_rdnt_TurnerImagingSystemsMember_f927f525-21be-4898-8370-bd233f915ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember_55d58a58-27b1-4dbf-89a3-67e8acc68e40" xlink:href="rdnt-20231231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:to="loc_rdnt_WhiteRabbitaiIncMember_55d58a58-27b1-4dbf-89a3-67e8acc68e40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6c1ddb92-9eb8-4021-859d-25ef32c6964c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6c1ddb92-9eb8-4021-859d-25ef32c6964c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a551f9e6-fc92-42ca-a7f6-b23317f69b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a551f9e6-fc92-42ca-a7f6-b23317f69b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_16fafa62-a6c0-439a-b12c-52756510ed4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a551f9e6-fc92-42ca-a7f6-b23317f69b93" xlink:to="loc_us-gaap_CommercialPaperMember_16fafa62-a6c0-439a-b12c-52756510ed4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2a0a9d59-110e-4f43-a0c0-6b6073d9b497_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:to="loc_us-gaap_ClassOfStockDomain_2a0a9d59-110e-4f43-a0c0-6b6073d9b497_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d76fa8ed-b134-44fa-9959-d510f4c2ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:to="loc_us-gaap_ClassOfStockDomain_d76fa8ed-b134-44fa-9959-d510f4c2ca89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_975b982d-b176-47c6-ad13-efadf528d3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d76fa8ed-b134-44fa-9959-d510f4c2ca89" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_975b982d-b176-47c6-ad13-efadf528d3b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ced21281-92dc-4265-8ea5-113f1b15d078_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ced21281-92dc-4265-8ea5-113f1b15d078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d454cd8-914d-4790-90cd-1d36d4087525" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d454cd8-914d-4790-90cd-1d36d4087525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_08b408a2-085c-4c66-ab38-1af1aeef5d53" xlink:href="rdnt-20231231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d454cd8-914d-4790-90cd-1d36d4087525" xlink:to="loc_rdnt_DignityHealthMember_08b408a2-085c-4c66-ab38-1af1aeef5d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9125dd51-2fc1-4d5c-84fa-c47257436d10_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:to="loc_srt_RangeMember_9125dd51-2fc1-4d5c-84fa-c47257436d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:to="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d6edc945-dce6-4a52-a8dc-4d3326bbe209" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:to="loc_srt_MinimumMember_d6edc945-dce6-4a52-a8dc-4d3326bbe209" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba046d6b-5dfd-4742-b177-64a6b225aadb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:to="loc_srt_MaximumMember_ba046d6b-5dfd-4742-b177-64a6b225aadb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_172c5d02-a4ad-4a49-b793-1adde84c244a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_172c5d02-a4ad-4a49-b793-1adde84c244a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2d05ce66-6373-4d5b-8c7f-78ae536cd339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2d05ce66-6373-4d5b-8c7f-78ae536cd339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_f62c5106-923d-49d6-9254-89e5890cfe2d" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2d05ce66-6373-4d5b-8c7f-78ae536cd339" xlink:to="loc_rdnt_JointVentureMember_f62c5106-923d-49d6-9254-89e5890cfe2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3a16856d-9e9f-4615-897e-8644d2cb86ab_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:to="loc_dei_EntityDomain_3a16856d-9e9f-4615-897e-8644d2cb86ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_60b40247-a354-4888-b2da-773090ec5e88" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:to="loc_dei_EntityDomain_60b40247-a354-4888-b2da-773090ec5e88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_b8058f46-ed41-4870-9ea1-7d957b75eeb6" xlink:href="rdnt-20231231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_60b40247-a354-4888-b2da-773090ec5e88" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_b8058f46-ed41-4870-9ea1-7d957b75eeb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9f52dc4e-1cf9-45c4-a80c-16151f63e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9f52dc4e-1cf9-45c4-a80c-16151f63e3b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_f1205a4c-98c6-4c0a-89a8-b3a776d06ae9" xlink:href="rdnt-20231231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_f1205a4c-98c6-4c0a-89a8-b3a776d06ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_963e8bb3-313a-422e-a31b-1ebde51327ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_963e8bb3-313a-422e-a31b-1ebde51327ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4212057e-cf6b-4410-9f13-b775ac0afc29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4212057e-cf6b-4410-9f13-b775ac0afc29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_2d44eb91-ab27-43d6-9046-b79a0c95a315" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_2d44eb91-ab27-43d6-9046-b79a0c95a315" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_4525b63b-0148-485c-aad1-914b72f3e5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_4525b63b-0148-485c-aad1-914b72f3e5a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_8f166383-04f4-4f08-b7d1-f08a4a0b287d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_ShortTermBorrowings_8f166383-04f4-4f08-b7d1-f08a4a0b287d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1ca0f10a-a7d2-476d-b1db-e2ce066fb5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1ca0f10a-a7d2-476d-b1db-e2ce066fb5ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesAcquired_6a75f28c-7139-4294-92c1-feaeca18f47b" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_EquityMethodInvestmentSharesAcquired_6a75f28c-7139-4294-92c1-feaeca18f47b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_88a087f0-375f-495e-a44a-bfd06a359099" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_88a087f0-375f-495e-a44a-bfd06a359099" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6a7c667c-b2b2-45fb-8597-41cb86edda8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6a7c667c-b2b2-45fb-8597-41cb86edda8a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PreferredStockExchangeRatePerShare_2af9a8a2-2388-43ac-9e68-2079d9836859" xlink:href="rdnt-20231231.xsd#rdnt_PreferredStockExchangeRatePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_PreferredStockExchangeRatePerShare_2af9a8a2-2388-43ac-9e68-2079d9836859" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_06f86770-0cbe-48ec-8248-cfece0795c0d" xlink:href="rdnt-20231231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_06f86770-0cbe-48ec-8248-cfece0795c0d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_6a144f02-fc22-4a4f-babe-426ccd6c5e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_6a144f02-fc22-4a4f-babe-426ccd6c5e7c" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e7047c91-6e3f-423c-859c-b6f063f5b52e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e7047c91-6e3f-423c-859c-b6f063f5b52e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1748c5cc-8a93-41ac-9332-acf4941fa0a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1748c5cc-8a93-41ac-9332-acf4941fa0a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_e3aec82c-68cc-42e8-bc06-07d6fd4dc64b" xlink:href="rdnt-20231231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1748c5cc-8a93-41ac-9332-acf4941fa0a3" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_e3aec82c-68cc-42e8-bc06-07d6fd4dc64b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_b2f5a9d2-0e2b-437f-879a-0486ea4955c4" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_rdnt_ManagementServiceFees_b2f5a9d2-0e2b-437f-879a-0486ea4955c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution_56112a4f-1eb4-43c1-8bea-84b0e7270bc7" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_rdnt_EquityMethodInvestmentAdditionalContribution_56112a4f-1eb4-43c1-8bea-84b0e7270bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold_c094796a-be60-4197-a86b-144c4867b3ea" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_rdnt_NumberOfAssetsSold_c094796a-be60-4197-a86b-144c4867b3ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_832313b9-5630-48cf-930e-fbc7f31cf53c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_832313b9-5630-48cf-930e-fbc7f31cf53c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_76db6160-ff09-48c6-879a-b197351f12c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_76db6160-ff09-48c6-879a-b197351f12c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_67ae1a6b-b054-4157-987f-2d77a8202ead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_67ae1a6b-b054-4157-987f-2d77a8202ead" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_caa27697-badf-43a6-9636-89f73505e66c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_EquityMethodInvestments_caa27697-badf-43a6-9636-89f73505e66c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5935e3b4-ecf1-40e3-a12d-ec6f109d7e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5935e3b4-ecf1-40e3-a12d-ec6f109d7e9a" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c76c1ba5-abd1-42df-9c61-302cfb693ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c76c1ba5-abd1-42df-9c61-302cfb693ec5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_4ad40992-0e83-463c-8e0c-ea0fdaa5813a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_4ad40992-0e83-463c-8e0c-ea0fdaa5813a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3e678080-71dc-4149-9759-e35ae6122d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3e678080-71dc-4149-9759-e35ae6122d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fa9faf99-1be4-4ec7-acda-373fc68b0066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3e678080-71dc-4149-9759-e35ae6122d3b" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fa9faf99-1be4-4ec7-acda-373fc68b0066" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7e82915a-e170-4fb0-8252-c6eba495b848_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7e82915a-e170-4fb0-8252-c6eba495b848_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ce12727e-98f5-4ee6-9d2b-0d2095b50ee3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ce12727e-98f5-4ee6-9d2b-0d2095b50ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember_edeb3f8b-ce9b-47dd-8845-7b581e224ec6" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ce12727e-98f5-4ee6-9d2b-0d2095b50ee3" xlink:to="loc_rdnt_JointVentureInterestMember_edeb3f8b-ce9b-47dd-8845-7b581e224ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:href="rdnt-20231231.xsd#rdnt_KeyFinancialDataForJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c76c1ba5-abd1-42df-9c61-302cfb693ec5" xlink:to="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_69c73a22-43b0-4f69-9cf4-8dcef81bbc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_AssetsCurrent_69c73a22-43b0-4f69-9cf4-8dcef81bbc0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_37dca1de-9c77-4453-a403-5aa54779c443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_AssetsNoncurrent_37dca1de-9c77-4453-a403-5aa54779c443" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6140a1de-b299-4436-843e-ad08356c8f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_LiabilitiesCurrent_6140a1de-b299-4436-843e-ad08356c8f2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_e36d1a01-3e16-4d51-abb7-c4fc28271f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_e36d1a01-3e16-4d51-abb7-c4fc28271f68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_b7c6b785-9ac4-4722-aec8-90513a840f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_b7c6b785-9ac4-4722-aec8-90513a840f8b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e2378ee7-268c-44df-aef2-6511b78654de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_Revenues_e2378ee7-268c-44df-aef2-6511b78654de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0525d12-a50d-4da0-b7a8-fca3d4082459" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_ProfitLoss_a0525d12-a50d-4da0-b7a8-fca3d4082459" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5ba1e3b5-9d96-4e4d-8d26-b07f2ff93dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5ba1e3b5-9d96-4e4d-8d26-b07f2ff93dfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7d2fd43a-a584-45ac-a962-0eca83e9c20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7d2fd43a-a584-45ac-a962-0eca83e9c20c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1cc324a4-01b2-477c-a608-e5df9d05ea11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1cc324a4-01b2-477c-a608-e5df9d05ea11" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7d2fd43a-a584-45ac-a962-0eca83e9c20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7d2fd43a-a584-45ac-a962-0eca83e9c20c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1cc324a4-01b2-477c-a608-e5df9d05ea11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1cc324a4-01b2-477c-a608-e5df9d05ea11" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:to="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a384b39f-e326-4dfd-879b-6dcec3cb0288_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:to="loc_srt_OwnershipDomain_a384b39f-e326-4dfd-879b-6dcec3cb0288_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:to="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LosAngelesImagingGroupLLCMember_23453fb5-b2c8-4dfb-84da-847497d5e1c4" xlink:href="rdnt-20231231.xsd#rdnt_LosAngelesImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:to="loc_rdnt_LosAngelesImagingGroupLLCMember_23453fb5-b2c8-4dfb-84da-847497d5e1c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember_72281f2f-fe21-41fa-986e-885efc49e7da" xlink:href="rdnt-20231231.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:to="loc_rdnt_SantaMonicaImagingGroupLLCMember_72281f2f-fe21-41fa-986e-885efc49e7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyHillsImagingCenterMember_3f7033e5-4c81-4aa9-b70f-083cd634743c" xlink:href="rdnt-20231231.xsd#rdnt_BeverlyHillsImagingCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:to="loc_rdnt_BeverlyHillsImagingCenterMember_3f7033e5-4c81-4aa9-b70f-083cd634743c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:to="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e8e83d93-b71f-44db-a42b-5eb135324a38_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:to="loc_dei_EntityDomain_e8e83d93-b71f-44db-a42b-5eb135324a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_95a8ddb1-b95e-404c-9776-943c42790a67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:to="loc_dei_EntityDomain_95a8ddb1-b95e-404c-9776-943c42790a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_a980b77c-dcd0-4cd4-a8e3-7fdc6663ccbc" xlink:href="rdnt-20231231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_95a8ddb1-b95e-404c-9776-943c42790a67" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_a980b77c-dcd0-4cd4-a8e3-7fdc6663ccbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_70c1c844-9f7c-41c2-8a37-c181f73e3edc" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_70c1c844-9f7c-41c2-8a37-c181f73e3edc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed_bc481ae4-6740-467f-89c5-93f83e55aaa5" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_rdnt_NumberOfCentersContributed_bc481ae4-6740-467f-89c5-93f83e55aaa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8594ada2-343d-4d7c-9ee2-d147a96d984b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8594ada2-343d-4d7c-9ee2-d147a96d984b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersContributedCapital_ed9fe4ec-a3a5-4aa2-a6ad-8f35ec351195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersContributedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_LimitedPartnersContributedCapital_ed9fe4ec-a3a5-4aa2-a6ad-8f35ec351195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_e0a40103-9a76-4c67-b8cd-4cd96f6d911d" xlink:href="rdnt-20231231.xsd#rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_e0a40103-9a76-4c67-b8cd-4cd96f6d911d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_39c0b2af-f575-4de1-a713-18e1f5a66d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_39c0b2af-f575-4de1-a713-18e1f5a66d35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6b1960e9-7c98-430d-b7a9-8945e16b8807" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6b1960e9-7c98-430d-b7a9-8945e16b8807" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_99985f85-d6b3-40f1-b422-b4012c30ed46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_99985f85-d6b3-40f1-b422-b4012c30ed46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CCDGLRSServicesIncMember_51b50cf7-a55e-4ec7-aa40-641a8d7a24a7" xlink:href="rdnt-20231231.xsd#rdnt_CCDGLRSServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_CCDGLRSServicesIncMember_51b50cf7-a55e-4ec7-aa40-641a8d7a24a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_dcd17b68-7d8f-4e39-a53d-ee64f1454ae4" xlink:href="rdnt-20231231.xsd#rdnt_SouthernCaliforniaDiagnosticImagingIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_dcd17b68-7d8f-4e39-a53d-ee64f1454ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InglewoodImagingCenterLLCMember_d3d8644a-9724-4f04-b06d-e26a5cf16e40" xlink:href="rdnt-20231231.xsd#rdnt_InglewoodImagingCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_InglewoodImagingCenterLLCMember_d3d8644a-9724-4f04-b06d-e26a5cf16e40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamapoRadiologyAssociatesPCMember_86790728-95af-4f44-ba78-e19512105d00" xlink:href="rdnt-20231231.xsd#rdnt_RamapoRadiologyAssociatesPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_RamapoRadiologyAssociatesPCMember_86790728-95af-4f44-ba78-e19512105d00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MadisonRadiologyMedicalGroupIncMember_8d4ec440-1b88-40d2-bbeb-cc86d823909d" xlink:href="rdnt-20231231.xsd#rdnt_MadisonRadiologyMedicalGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_MadisonRadiologyMedicalGroupIncMember_8d4ec440-1b88-40d2-bbeb-cc86d823909d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DelawareDiagnosticImagingPAMember_8dd44242-bbd9-43d9-9a97-97a7b6044a14" xlink:href="rdnt-20231231.xsd#rdnt_DelawareDiagnosticImagingPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_DelawareDiagnosticImagingPAMember_8dd44242-bbd9-43d9-9a97-97a7b6044a14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryOneMember_f60dc3ef-6517-43bc-8521-d700d7bcecf0" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCSubsidiaryOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_IFRCLLCSubsidiaryOneMember_f60dc3ef-6517-43bc-8521-d700d7bcecf0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryTwoMember_5ce655e5-7a4e-4c04-adeb-d90c52bfc82d" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCSubsidiaryTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_IFRCLLCSubsidiaryTwoMember_5ce655e5-7a4e-4c04-adeb-d90c52bfc82d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairRadiologicalAssociatesPAMember_3840e238-b05d-4e12-a728-e1117aae9ba4" xlink:href="rdnt-20231231.xsd#rdnt_MontclairRadiologicalAssociatesPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_MontclairRadiologicalAssociatesPAMember_3840e238-b05d-4e12-a728-e1117aae9ba4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_4f23fdce-efbf-4748-ab6c-fc98adb691fe" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_4f23fdce-efbf-4748-ab6c-fc98adb691fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ChelseaDignosticRadiologyPCMember_2947f360-b492-4b43-9b0f-4497b45e7ab9" xlink:href="rdnt-20231231.xsd#rdnt_ChelseaDignosticRadiologyPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_ChelseaDignosticRadiologyPCMember_2947f360-b492-4b43-9b0f-4497b45e7ab9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NorthJerseyImagingCenterLLCMember_e31b1429-c179-4da9-9aed-074aefb2791f" xlink:href="rdnt-20231231.xsd#rdnt_NorthJerseyImagingCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_NorthJerseyImagingCenterLLCMember_e31b1429-c179-4da9-9aed-074aefb2791f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember_7e2edf47-45e7-46a1-b8e9-a7ca8e386025" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_IFRCLLCMember_7e2edf47-45e7-46a1-b8e9-a7ca8e386025" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_066cac35-9beb-403f-8137-59e9c2d359ca" xlink:href="rdnt-20231231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_TangentAssociatesLLCMember_066cac35-9beb-403f-8137-59e9c2d359ca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_60a585cb-b1d5-4b9d-aa59-d72343c1041e" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_BusinessAcquisitionsMember_60a585cb-b1d5-4b9d-aa59-d72343c1041e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:to="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_50186a3d-7dbe-407e-b5fa-de9bf7875518_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:to="loc_dei_EntityDomain_50186a3d-7dbe-407e-b5fa-de9bf7875518_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e9478ddc-fc59-4268-832a-b8dfe89a7a7b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:to="loc_dei_EntityDomain_e9478ddc-fc59-4268-832a-b8dfe89a7a7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d14fb047-234e-4aed-81a8-5832e1af80ff" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e9478ddc-fc59-4268-832a-b8dfe89a7a7b" xlink:to="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d14fb047-234e-4aed-81a8-5832e1af80ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5682bcc-fa91-4e72-a7e6-3efc336d9595" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5682bcc-fa91-4e72-a7e6-3efc336d9595" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_388d039b-6ab6-4982-a656-afb288380812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_388d039b-6ab6-4982-a656-afb288380812" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_d5ecc61f-6736-4f69-aadc-1fa7df429618" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_d5ecc61f-6736-4f69-aadc-1fa7df429618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebe86fbe-85f7-48cb-a6c2-5a3c5084f1da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_Goodwill_ebe86fbe-85f7-48cb-a6c2-5a3c5084f1da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d2c7d423-f8a0-4268-80cb-516fa175090c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d2c7d423-f8a0-4268-80cb-516fa175090c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_fe7e2346-ee20-49b0-a92a-a800a2be2b65" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_fe7e2346-ee20-49b0-a92a-a800a2be2b65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_d32f0a73-b71e-473d-a9be-add3575be28c" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_d32f0a73-b71e-473d-a9be-add3575be28c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_83f58c3a-2f91-4548-8495-8d94b7866a16" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationNumberOfSubsidiariesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_83f58c3a-2f91-4548-8495-8d94b7866a16" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23520433-aa91-4402-b71d-ba992c076e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23520433-aa91-4402-b71d-ba992c076e1e" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b27a8f7-277c-445f-94fb-6d6f6f26268a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b27a8f7-277c-445f-94fb-6d6f6f26268a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9909994-e708-453b-b19b-5cd823fd97a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9909994-e708-453b-b19b-5cd823fd97a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_549d83cd-76b0-4f98-95b9-6b46f47e65d8" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9909994-e708-453b-b19b-5cd823fd97a2" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_549d83cd-76b0-4f98-95b9-6b46f47e65d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f0417080-7c79-48e7-b3cf-1e5d667673e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f0417080-7c79-48e7-b3cf-1e5d667673e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_c4044948-17ab-49d5-9b31-3c65d087dc43" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_c4044948-17ab-49d5-9b31-3c65d087dc43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_1f1e20bf-f283-4ef8-88bd-96c216e42cc6" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:to="loc_rdnt_CashHoldbackMember_1f1e20bf-f283-4ef8-88bd-96c216e42cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_69912a4e-700a-4207-a7e7-bdd1d915b969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_69912a4e-700a-4207-a7e7-bdd1d915b969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_904f917c-1a4f-437d-8725-e2633a5fac55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_69912a4e-700a-4207-a7e7-bdd1d915b969" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_904f917c-1a4f-437d-8725-e2633a5fac55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_846c4823-669c-4262-b5dc-b6d43629a1bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:to="loc_us-gaap_ValuationTechniqueDomain_846c4823-669c-4262-b5dc-b6d43629a1bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_83a71a0b-7d47-4e57-9ddc-fdb60beaa879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:to="loc_us-gaap_ValuationTechniqueDomain_83a71a0b-7d47-4e57-9ddc-fdb60beaa879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_c9a621a1-7250-4bbd-b30c-a58c36b1073e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_83a71a0b-7d47-4e57-9ddc-fdb60beaa879" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_c9a621a1-7250-4bbd-b30c-a58c36b1073e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9200232b-5ab0-47c8-9fff-2004b3eacb42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9200232b-5ab0-47c8-9fff-2004b3eacb42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9c61424-c5a6-485c-94fc-e604615dca14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9c61424-c5a6-485c-94fc-e604615dca14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5d566dcc-de3e-4b07-9699-0412829a727a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5d566dcc-de3e-4b07-9699-0412829a727a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a707532d-679c-431a-bc08-16d4ed91a441" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a707532d-679c-431a-bc08-16d4ed91a441" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1bf4a110-577a-4061-9a23-71ed9d631c67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1bf4a110-577a-4061-9a23-71ed9d631c67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_55b9b603-5a09-44e8-ac4a-847f7a73042e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_55b9b603-5a09-44e8-ac4a-847f7a73042e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1afb242b-0496-4e33-92d4-bd54058fb4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1afb242b-0496-4e33-92d4-bd54058fb4e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_079a1fd0-396b-4fd3-bd7e-f84ad9b90087" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_079a1fd0-396b-4fd3-bd7e-f84ad9b90087" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_3a8c8d82-afec-4e99-b846-8ea5a4d255dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_3a8c8d82-afec-4e99-b846-8ea5a4d255dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_19bd9cb7-ff76-4122-9d49-1642590c8273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_19bd9cb7-ff76-4122-9d49-1642590c8273" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c8f19ee3-3843-4ba8-b232-a823600aff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c8f19ee3-3843-4ba8-b232-a823600aff3f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2fef69e8-0b5e-4e03-8dfd-98dcab4084b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2fef69e8-0b5e-4e03-8dfd-98dcab4084b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9d8b08ea-b896-4d85-a8b2-33c6a0b25512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_Goodwill_9d8b08ea-b896-4d85-a8b2-33c6a0b25512" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_250910c8-8381-44a8-a61c-d8590da984a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_250910c8-8381-44a8-a61c-d8590da984a4" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e38f20-2d56-4a79-8ab8-b7873dfbd437_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e38f20-2d56-4a79-8ab8-b7873dfbd437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b4787e3-8f3a-4d5b-8183-5aea715069e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b4787e3-8f3a-4d5b-8183-5aea715069e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_3e20f849-43af-4873-a56e-c43f33936b3a" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b4787e3-8f3a-4d5b-8183-5aea715069e3" xlink:to="loc_rdnt_AidenceMember_3e20f849-43af-4873-a56e-c43f33936b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b9a0c443-5f0b-473d-8ded-59039675aa0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b9a0c443-5f0b-473d-8ded-59039675aa0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_45882933-4467-45fd-a45d-0edac065031a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_45882933-4467-45fd-a45d-0edac065031a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_7ab216de-823b-489f-a0b7-a777012a19e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_7ab216de-823b-489f-a0b7-a777012a19e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4fc1843d-f43b-4576-8406-2dfdcf3d03f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4fc1843d-f43b-4576-8406-2dfdcf3d03f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_163d387e-c30d-43f0-9aba-0badd91ff613" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_TradeNamesMember_163d387e-c30d-43f0-9aba-0badd91ff613" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e50053c0-08e6-478a-a1d7-451b152c16de_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:to="loc_srt_RangeMember_e50053c0-08e6-478a-a1d7-451b152c16de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:to="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_589e687b-3f9d-41c6-86cb-1084da41b98b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:to="loc_srt_MinimumMember_589e687b-3f9d-41c6-86cb-1084da41b98b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1a7f4daf-015b-4200-acf1-130b07f3dcf8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:to="loc_srt_MaximumMember_1a7f4daf-015b-4200-acf1-130b07f3dcf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_17810235-7e88-4c99-a6f5-37e2e3d779a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_17810235-7e88-4c99-a6f5-37e2e3d779a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_99861889-af9d-4e7a-b177-480b189787d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_99861889-af9d-4e7a-b177-480b189787d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_02510946-14a9-4817-bd7c-8ea95e9e9c73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_99861889-af9d-4e7a-b177-480b189787d4" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_02510946-14a9-4817-bd7c-8ea95e9e9c73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_e3a130c3-dbc0-438e-9015-7ccd4c936158_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:to="loc_us-gaap_ValuationTechniqueDomain_e3a130c3-dbc0-438e-9015-7ccd4c936158_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_24e7bb56-3de3-4c31-92da-5d7c1f2927c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:to="loc_us-gaap_ValuationTechniqueDomain_24e7bb56-3de3-4c31-92da-5d7c1f2927c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_ee410f36-d6b9-49ea-bbf2-ffa386144362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_24e7bb56-3de3-4c31-92da-5d7c1f2927c8" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_ee410f36-d6b9-49ea-bbf2-ffa386144362" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8e472bfc-4feb-4858-9f85-7af15333b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8e472bfc-4feb-4858-9f85-7af15333b87d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_730c8627-702a-4d1d-b796-485b21b6cdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_730c8627-702a-4d1d-b796-485b21b6cdb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f9ee72e-33f6-4b71-a834-780350634042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f9ee72e-33f6-4b71-a834-780350634042" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8769604e-5b43-4fcb-9daa-4f37647e42da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_Goodwill_8769604e-5b43-4fcb-9daa-4f37647e42da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d97b5686-3cb8-4f92-b07c-2ed88de94c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d97b5686-3cb8-4f92-b07c-2ed88de94c9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_53498495-ce4a-4853-804d-8f446c82e3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_53498495-ce4a-4853-804d-8f446c82e3c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6e3e05ba-b380-46a3-95bb-506893ff0745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6e3e05ba-b380-46a3-95bb-506893ff0745" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_409a3215-89c6-4476-8913-85eea2ec139b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_409a3215-89c6-4476-8913-85eea2ec139b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_811e37f5-6345-4769-9e67-ae77e5899d26" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:to="loc_rdnt_QuantibMember_811e37f5-6345-4769-9e67-ae77e5899d26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_dd8d04fe-9310-4b58-a258-e14e8842a7da" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_dd8d04fe-9310-4b58-a258-e14e8842a7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_cba29583-b777-484f-b106-37f26c035d04" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:to="loc_rdnt_AidenceMember_cba29583-b777-484f-b106-37f26c035d04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c6fe91f8-e644-4421-9199-655bb9b0b7a2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c6fe91f8-e644-4421-9199-655bb9b0b7a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember_ec190688-aafe-42ca-9404-3ed53aaefb4f" xlink:href="rdnt-20231231.xsd#rdnt_OtherSellersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:to="loc_rdnt_OtherSellersMember_ec190688-aafe-42ca-9404-3ed53aaefb4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember_37491f6d-4331-4584-b7da-09ced4b8968f" xlink:href="rdnt-20231231.xsd#rdnt_CertainSellerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:to="loc_rdnt_CertainSellerMember_37491f6d-4331-4584-b7da-09ced4b8968f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_cf8df255-04f8-44ce-a566-cc9db941d5a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_cf8df255-04f8-44ce-a566-cc9db941d5a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_7a8d7d89-0d7d-4da5-bf7d-2e12c367de2a" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_7a8d7d89-0d7d-4da5-bf7d-2e12c367de2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_1711d5e7-6172-415d-b1b9-88be6f39a17f" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:to="loc_rdnt_CashHoldbackMember_1711d5e7-6172-415d-b1b9-88be6f39a17f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_a4935519-c832-4e99-bb1f-95c8a85e633f" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_a4935519-c832-4e99-bb1f-95c8a85e633f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_372d740b-56af-460a-9b15-51c39988b796_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_372d740b-56af-460a-9b15-51c39988b796_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_77d18dfd-c2fa-413b-b04b-0e5f9b83510c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_77d18dfd-c2fa-413b-b04b-0e5f9b83510c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a6895803-ced6-4347-9353-517e6095eaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a6895803-ced6-4347-9353-517e6095eaf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_90f06a99-9734-4381-97dd-12b2a88f8fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_90f06a99-9734-4381-97dd-12b2a88f8fd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1a200092-c79d-4135-abb4-f0623cba01a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_TradeNamesMember_1a200092-c79d-4135-abb4-f0623cba01a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2ad386a4-7d24-4246-800e-2adec6ccdda0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:to="loc_srt_RangeMember_2ad386a4-7d24-4246-800e-2adec6ccdda0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:to="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db60e217-f07b-4f89-bfee-56366e5460de" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:to="loc_srt_MinimumMember_db60e217-f07b-4f89-bfee-56366e5460de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ef185e60-6853-495e-a8da-43dabcd385a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:to="loc_srt_MaximumMember_ef185e60-6853-495e-a8da-43dabcd385a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0b4c4906-d96d-4024-8fed-5ee5f5d5d399_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0b4c4906-d96d-4024-8fed-5ee5f5d5d399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_749c16fb-e1fe-40c0-8f37-c0f9078ec227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_749c16fb-e1fe-40c0-8f37-c0f9078ec227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_6c5f3d32-531b-4f75-acc0-d8a14d343c84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_749c16fb-e1fe-40c0-8f37-c0f9078ec227" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_6c5f3d32-531b-4f75-acc0-d8a14d343c84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_98286e6d-ee8c-4fda-be51-89598bac649e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:to="loc_us-gaap_ValuationTechniqueDomain_98286e6d-ee8c-4fda-be51-89598bac649e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_3a5d8c95-10e8-485d-a4da-4a9bb1b9647f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:to="loc_us-gaap_ValuationTechniqueDomain_3a5d8c95-10e8-485d-a4da-4a9bb1b9647f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_8d0607de-3819-4550-b4de-869598aaa082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_3a5d8c95-10e8-485d-a4da-4a9bb1b9647f" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_8d0607de-3819-4550-b4de-869598aaa082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_efbda5b8-4951-4fb4-9767-2fb13a0a1239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_efbda5b8-4951-4fb4-9767-2fb13a0a1239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3af50f58-8c27-44fe-8b3a-df9449a556ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3af50f58-8c27-44fe-8b3a-df9449a556ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02cf9052-5bbc-46ad-aafe-38b16d56a875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02cf9052-5bbc-46ad-aafe-38b16d56a875" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_03081184-e90c-413f-bb62-9c974700f5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_03081184-e90c-413f-bb62-9c974700f5fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_bcda18f7-57c7-4291-904e-315bbe6ff72d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_bcda18f7-57c7-4291-904e-315bbe6ff72d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_931cddb1-6a1e-4d55-8d51-fb56e7a627fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_931cddb1-6a1e-4d55-8d51-fb56e7a627fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbc80fc0-56fe-424b-9cf2-6a93cbb73bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbc80fc0-56fe-424b-9cf2-6a93cbb73bbb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_2aa4e88b-9fa3-42e9-881f-a604f5f6f37e" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_2aa4e88b-9fa3-42e9-881f-a604f5f6f37e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d4f38e2a-3ce4-4b6c-ade8-1b45d3f0f765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d4f38e2a-3ce4-4b6c-ade8-1b45d3f0f765" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2b572b60-0d3b-4a76-a9f1-346fd414b580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2b572b60-0d3b-4a76-a9f1-346fd414b580" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_26cc3f82-342b-4bda-bc6c-86b44b72c5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_26cc3f82-342b-4bda-bc6c-86b44b72c5ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9334b3e2-5c65-4f53-9142-bb16b40aa829" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9334b3e2-5c65-4f53-9142-bb16b40aa829" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c755374-d095-4cec-93df-5eb924be812d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_Goodwill_9c755374-d095-4cec-93df-5eb924be812d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_26d6912b-3b76-40e9-8b68-862de12b4292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_26d6912b-3b76-40e9-8b68-862de12b4292" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_aef0a9d3-4f1b-4a33-b470-175dbaa5f2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_aef0a9d3-4f1b-4a33-b470-175dbaa5f2b4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06191695-bf52-4cfa-b36d-a4ed2f07f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06191695-bf52-4cfa-b36d-a4ed2f07f7bf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2612cf61-536f-45a5-b742-1f21d2c1a6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2612cf61-536f-45a5-b742-1f21d2c1a6ee" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbdd1060-ee9b-4e00-8612-897ed84c030e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbdd1060-ee9b-4e00-8612-897ed84c030e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_54b345b0-6a4c-4ba8-8be7-a4527fe60234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_54b345b0-6a4c-4ba8-8be7-a4527fe60234" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_d425e4b3-34d2-416b-98d9-b88bbf803bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_d425e4b3-34d2-416b-98d9-b88bbf803bf3" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c1f1d7fa-06ac-49a9-9319-a286e53cf42e_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:to="loc_dei_EntityDomain_c1f1d7fa-06ac-49a9-9319-a286e53cf42e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:to="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_46b5b767-3f2b-4ca1-942c-dd8c59ae0de6" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_46b5b767-3f2b-4ca1-942c-dd8c59ae0de6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_97ab895d-9989-4b9f-aaa7-69f72c79494b" xlink:href="rdnt-20231231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_97ab895d-9989-4b9f-aaa7-69f72c79494b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_83c1d7e0-01d4-4ac1-a127-6584cf35f296" xlink:href="rdnt-20231231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_83c1d7e0-01d4-4ac1-a127-6584cf35f296" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3f6838e7-391c-429a-9a7e-530f05c9ccfa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3f6838e7-391c-429a-9a7e-530f05c9ccfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6fe8fb51-ed4b-4cce-896f-e3f503693e35" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6fe8fb51-ed4b-4cce-896f-e3f503693e35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_c1005954-de75-4a01-b61d-f21acd3a2caf" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fe8fb51-ed4b-4cce-896f-e3f503693e35" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_c1005954-de75-4a01-b61d-f21acd3a2caf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_98f030af-2a14-4bbc-9938-ea5e3562b36a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:to="loc_srt_OwnershipDomain_98f030af-2a14-4bbc-9938-ea5e3562b36a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:to="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_8d0cb4af-e765-4164-9370-fe1d46ab2d5c" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_8d0cb4af-e765-4164-9370-fe1d46ab2d5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LosAngelesImagingGroupLLCMember_d12d41a8-722f-4c0e-b39a-8902655376f8" xlink:href="rdnt-20231231.xsd#rdnt_LosAngelesImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:to="loc_rdnt_LosAngelesImagingGroupLLCMember_d12d41a8-722f-4c0e-b39a-8902655376f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_46439d91-2edd-43f8-8474-168b5e2f3f24" xlink:href="rdnt-20231231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_46439d91-2edd-43f8-8474-168b5e2f3f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f74dae32-69b8-416e-9f14-933aad2df72a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f74dae32-69b8-416e-9f14-933aad2df72a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FixedAssetsMember_887062b1-3fe2-42dd-99c7-adc5fcdbe45f" xlink:href="rdnt-20231231.xsd#rdnt_FixedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:to="loc_rdnt_FixedAssetsMember_887062b1-3fe2-42dd-99c7-adc5fcdbe45f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_9d10da78-5828-46d7-b399-585b44ba535f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:to="loc_us-gaap_EquipmentMember_9d10da78-5828-46d7-b399-585b44ba535f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:to="loc_us-gaap_EquityComponentDomain_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6a0704f1-4117-4fc7-a2b9-b5f244ed9d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:to="loc_us-gaap_EquityComponentDomain_6a0704f1-4117-4fc7-a2b9-b5f244ed9d4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_425470a7-1c18-46dd-a9f8-65b07a7325ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6a0704f1-4117-4fc7-a2b9-b5f244ed9d4d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_425470a7-1c18-46dd-a9f8-65b07a7325ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4ac8857b-661c-4faf-9f91-b2c29b48472f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4ac8857b-661c-4faf-9f91-b2c29b48472f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_68988eb5-07d7-4126-b008-7134d16f549a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_68988eb5-07d7-4126-b008-7134d16f549a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_08940456-4076-4397-9cfd-a9437149f2dc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_68988eb5-07d7-4126-b008-7134d16f549a" xlink:to="loc_srt_SubsidiariesMember_08940456-4076-4397-9cfd-a9437149f2dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:to="loc_us-gaap_AssetAcquisitionDomain_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_920db4a1-ed25-4b2a-8a30-a547828c0c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:to="loc_us-gaap_AssetAcquisitionDomain_920db4a1-ed25-4b2a-8a30-a547828c0c3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember_af2c6350-bac9-4604-a4b2-d3617828a64f" xlink:href="rdnt-20231231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_920db4a1-ed25-4b2a-8a30-a547828c0c3c" xlink:to="loc_rdnt_TarzanaMedicalCenterLLCMember_af2c6350-bac9-4604-a4b2-d3617828a64f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_e2ac22cc-3123-4f0e-89fa-e421a1799044" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_e2ac22cc-3123-4f0e-89fa-e421a1799044" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed_0f37621a-7f72-4633-8ec0-1c87f948104c" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_NumberOfCentersContributed_0f37621a-7f72-4633-8ec0-1c87f948104c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_507547a1-85d0-49df-bb72-0e4c230e5390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_507547a1-85d0-49df-bb72-0e4c230e5390" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_519eef36-9705-4154-8930-36393ec18f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_Goodwill_519eef36-9705-4154-8930-36393ec18f4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5cb327d8-7510-4636-985a-3c91d9e70871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5cb327d8-7510-4636-985a-3c91d9e70871" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_08fc163b-3925-4d82-a245-3df530350412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_08fc163b-3925-4d82-a245-3df530350412" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fbfa9ff3-faaa-4992-9c67-d1a2000f6966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_EquityMethodInvestments_fbfa9ff3-faaa-4992-9c67-d1a2000f6966" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_2e289f6a-771e-46d4-a409-b222fe8047c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_2e289f6a-771e-46d4-a409-b222fe8047c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersContributedCapital_8cd4a39c-a1ae-467c-8329-a5250927832c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersContributedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_LimitedPartnersContributedCapital_8cd4a39c-a1ae-467c-8329-a5250927832c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_c6c19c53-0c06-41c7-b5dd-5505ea14b35b" xlink:href="rdnt-20231231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_c6c19c53-0c06-41c7-b5dd-5505ea14b35b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_f08c1d8b-6163-4319-a310-336cc56bec70" xlink:href="rdnt-20231231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_f08c1d8b-6163-4319-a310-336cc56bec70" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_6478e1e6-6bab-4eeb-a778-b7f8ea3e4e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_6478e1e6-6bab-4eeb-a778-b7f8ea3e4e1a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_b614fa63-916e-4d1f-93a9-2d98abcf96c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_b614fa63-916e-4d1f-93a9-2d98abcf96c0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_41346a02-3fc2-40a4-b3db-ae4d16f321b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_41346a02-3fc2-40a4-b3db-ae4d16f321b7" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SEGMENTREPORTINGDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_52a6aa96-bcb6-4822-a3e8-68f74c99f326_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:to="loc_srt_ConsolidationItemsDomain_52a6aa96-bcb6-4822-a3e8-68f74c99f326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:to="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dd6d1f2a-78d0-4d9a-9830-9eb5a21f8dce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:to="loc_us-gaap_OperatingSegmentsMember_dd6d1f2a-78d0-4d9a-9830-9eb5a21f8dce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_c3be91eb-dc83-4957-8411-5150b16e17a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:to="loc_us-gaap_IntersegmentEliminationMember_c3be91eb-dc83-4957-8411-5150b16e17a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_13f491ca-88cd-4b56-92d6-86e07e681277_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:to="loc_us-gaap_SegmentDomain_13f491ca-88cd-4b56-92d6-86e07e681277_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:to="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_9ef2e964-0f17-46b8-a46c-cd7d958b34d0" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:to="loc_rdnt_ImagingCentersMember_9ef2e964-0f17-46b8-a46c-cd7d958b34d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_9ec820c8-532b-42ab-bdf6-0a2c11fd3d7d" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:to="loc_rdnt_AIMember_9ec820c8-532b-42ab-bdf6-0a2c11fd3d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_62fc2897-0d19-4cac-84d5-94917b59b964_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:to="loc_us-gaap_SubsegmentsDomain_62fc2897-0d19-4cac-84d5-94917b59b964_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:to="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThirdPartyMember_2c1b4d6f-ac8e-4575-99d2-7382a237b680" xlink:href="rdnt-20231231.xsd#rdnt_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:to="loc_rdnt_ThirdPartyMember_2c1b4d6f-ac8e-4575-99d2-7382a237b680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IntersegmentMember_ca24ef10-c684-4d9f-bfd3-6752bc120a33" xlink:href="rdnt-20231231.xsd#rdnt_IntersegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:to="loc_rdnt_IntersegmentMember_ca24ef10-c684-4d9f-bfd3-6752bc120a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_26f2003b-3558-451e-a6ea-f51331ec0b55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_26f2003b-3558-451e-a6ea-f51331ec0b55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_a8e4b927-c24e-462d-a63e-89402f331b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_a8e4b927-c24e-462d-a63e-89402f331b0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_037ce62e-77d9-4682-b1ca-5e521214bda5" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_a8e4b927-c24e-462d-a63e-89402f331b0e" xlink:to="loc_rdnt_COVID19PandemicMember_037ce62e-77d9-4682-b1ca-5e521214bda5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7e2a3b03-b7de-405a-9667-bf391e08da45_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7e2a3b03-b7de-405a-9667-bf391e08da45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7c5ad7a2-fb21-42f5-9d69-82aa621a60a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7c5ad7a2-fb21-42f5-9d69-82aa621a60a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_03517311-12b5-439e-8230-d91360a71df7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_7c5ad7a2-fb21-42f5-9d69-82aa621a60a0" xlink:to="loc_srt_ScenarioForecastMember_03517311-12b5-439e-8230-d91360a71df7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a5ea0dcd-0e73-4d9e-8ba0-6f7ac4777415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_Revenues_a5ea0dcd-0e73-4d9e-8ba0-6f7ac4777415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_3102e986-d716-4ca1-b7f1-f502cdad96ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_3102e986-d716-4ca1-b7f1-f502cdad96ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_b6211886-c53b-4361-844e-aa621d477de4" xlink:href="rdnt-20231231.xsd#rdnt_GainOnContributionOfImagingCentersIntoJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_b6211886-c53b-4361-844e-aa621d477de4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_557b964a-9e2e-43a5-86ac-0ed1708841dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_557b964a-9e2e-43a5-86ac-0ed1708841dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_027e8e0d-06c3-4a20-892c-f0907a97d9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_027e8e0d-06c3-4a20-892c-f0907a97d9a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1a85b19d-9d6a-468f-8a8f-4d4c88066c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1a85b19d-9d6a-468f-8a8f-4d4c88066c8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_6d58a67a-0165-430a-aa09-ac0a72ecd410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_SeveranceCosts1_6d58a67a-0165-430a-aa09-ac0a72ecd410" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_2c039481-ca30-4d84-8015-8104255431d9" xlink:href="rdnt-20231231.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_2c039481-ca30-4d84-8015-8104255431d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_de2be495-8bac-4229-8875-8a01ff9e74dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_NumberOfReportableSegments_de2be495-8bac-4229-8875-8a01ff9e74dc" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_82f500c0-0b76-4f7b-b0ad-142fe15bfb07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_82f500c0-0b76-4f7b-b0ad-142fe15bfb07" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7977b23d-e213-4e34-b0d1-27f90c11c229_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:to="loc_us-gaap_SegmentDomain_7977b23d-e213-4e34-b0d1-27f90c11c229_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:to="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_6a09ed5c-031d-4f49-bd9b-a1ef8df578d1" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:to="loc_rdnt_ImagingCentersMember_6a09ed5c-031d-4f49-bd9b-a1ef8df578d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_28d793e4-f116-44ae-bf02-71d1987ce8fd" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:to="loc_rdnt_AIMember_28d793e4-f116-44ae-bf02-71d1987ce8fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_82f500c0-0b76-4f7b-b0ad-142fe15bfb07" xlink:to="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0178bf15-a177-4d39-92f7-0eb8461bdab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_Goodwill_0178bf15-a177-4d39-92f7-0eb8461bdab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e48fb9a0-ee39-409f-a809-b9ca9f677988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e48fb9a0-ee39-409f-a809-b9ca9f677988" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_42f23ff6-4b8d-4e14-9972-5b926982250b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_42f23ff6-4b8d-4e14-9972-5b926982250b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1669a128-e2c8-493b-8178-8f5ec3fefcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1669a128-e2c8-493b-8178-8f5ec3fefcd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_082e584d-e7a6-42da-9e52-5f5a9a3f3c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_082e584d-e7a6-42da-9e52-5f5a9a3f3c96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c625792e-0995-46c1-a4ad-f4ac5b27df63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e1047f6-5935-45ea-a03f-68f669bac9a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e1047f6-5935-45ea-a03f-68f669bac9a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_936286d6-aab7-4b25-9d44-c501cff7e994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_936286d6-aab7-4b25-9d44-c501cff7e994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_aac1732c-ad8c-48d3-9011-97ca71e09ca2" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_936286d6-aab7-4b25-9d44-c501cff7e994" xlink:to="loc_rdnt_ManagementServiceContractsMember_aac1732c-ad8c-48d3-9011-97ca71e09ca2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3ef97539-799e-41ce-bce0-8eca0e10d339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3ef97539-799e-41ce-bce0-8eca0e10d339" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_88ba231f-5b15-4b60-91e6-fe316ab2ef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_AdjustmentForAmortization_88ba231f-5b15-4b60-91e6-fe316ab2ef2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f523c26b-ccc6-4cd1-9c86-ff0fc53dc52f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f523c26b-ccc6-4cd1-9c86-ff0fc53dc52f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52f1ec4f-ab20-479a-9d95-725996442aa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52f1ec4f-ab20-479a-9d95-725996442aa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_8c359512-2881-4ee5-b57e-fa5f516830bc" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_ManagementServiceContractsMember_8c359512-2881-4ee5-b57e-fa5f516830bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_64eaa4cb-c5a2-4c9f-b890-ddf9cc1d369d" xlink:href="rdnt-20231231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_CovenantNotToCompeteMember_64eaa4cb-c5a2-4c9f-b890-ddf9cc1d369d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3789e845-e7d0-46a4-8681-bb04ac2a2f97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3789e845-e7d0-46a4-8681-bb04ac2a2f97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember_b01ea4ab-b418-4ae4-929e-07cdc4022585" xlink:href="rdnt-20231231.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_PatentAndTrademarksMember_b01ea4ab-b418-4ae4-929e-07cdc4022585" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember_cb47b8ed-2590-4976-a4c1-666d5ca0214f" xlink:href="rdnt-20231231.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_DevelopedTechnologySoftwareMember_cb47b8ed-2590-4976-a4c1-666d5ca0214f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_05d201fa-2e56-4e91-9a8a-8fd87b6ec0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_us-gaap_TradeNamesMember_05d201fa-2e56-4e91-9a8a-8fd87b6ec0b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f026f911-d039-4b0c-80b4-e0155927550c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f026f911-d039-4b0c-80b4-e0155927550c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5f9cb198-51f9-4ee0-89f1-4d46d707dd22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5f9cb198-51f9-4ee0-89f1-4d46d707dd22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0df427b1-f56b-4cdf-ad7d-171f189fe15c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0df427b1-f56b-4cdf-ad7d-171f189fe15c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_077a1a8d-705b-4ba1-97bc-6a426a228652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_077a1a8d-705b-4ba1-97bc-6a426a228652" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_68b210bf-7a85-4bbe-923b-ea00a081e71e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_68b210bf-7a85-4bbe-923b-ea00a081e71e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_33b2f0dd-dfa5-4a87-9226-c2eb92d3e72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_33b2f0dd-dfa5-4a87-9226-c2eb92d3e72b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c49c2fd-d2fc-4512-95e1-ded3ea53ae22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c49c2fd-d2fc-4512-95e1-ded3ea53ae22" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cd18cbbe-f9d9-4247-a1c8-d8f30521567d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cd18cbbe-f9d9-4247-a1c8-d8f30521567d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_fb2203c8-71fa-4f80-bc21-e50b71dc8cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_fb2203c8-71fa-4f80-bc21-e50b71dc8cc5" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ba98479-cbed-41b9-a00c-9924c9bdf100_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5ba98479-cbed-41b9-a00c-9924c9bdf100_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_58d43317-629a-4f12-9dac-991acb56bf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:to="loc_us-gaap_TradeNamesMember_58d43317-629a-4f12-9dac-991acb56bf1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e7da53cf-ff18-42d9-8692-3b16ef26bc19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e7da53cf-ff18-42d9-8692-3b16ef26bc19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_76455f7f-6fe5-41ba-9806-e36bda881336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_fb2203c8-71fa-4f80-bc21-e50b71dc8cc5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_76455f7f-6fe5-41ba-9806-e36bda881336" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_388f5e2b-5dfd-4635-8af7-11127d451e0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_388f5e2b-5dfd-4635-8af7-11127d451e0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_edd4783c-3090-491a-8891-288b0b035972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_LandMember_edd4783c-3090-491a-8891-288b0b035972" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d0630e1c-4a52-4e68-b245-04ff7dea322e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_EquipmentMember_d0630e1c-4a52-4e68-b245-04ff7dea322e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f82fb4bc-1db6-4941-9ac3-1423596b8020" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f82fb4bc-1db6-4941-9ac3-1423596b8020" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e9fe31a0-078e-4458-b674-073e5689218a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e9fe31a0-078e-4458-b674-073e5689218a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_503cf5ef-7819-49a1-8a44-312686f2796f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_503cf5ef-7819-49a1-8a44-312686f2796f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_29006341-df40-47bd-9052-71036494a802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_29006341-df40-47bd-9052-71036494a802" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2f7d0a6a-dae0-43af-a510-a6937749d336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2f7d0a6a-dae0-43af-a510-a6937749d336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_56f46ca0-1b69-4ebd-a7ee-488cfff48b89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_56f46ca0-1b69-4ebd-a7ee-488cfff48b89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_b2450b0d-1c01-428c-a8ac-183f0361491a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_b2450b0d-1c01-428c-a8ac-183f0361491a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4e630598-d3c9-4a2f-963d-6aaeb613a7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4e630598-d3c9-4a2f-963d-6aaeb613a7db" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENTAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd6b9b39-b306-4bf7-960f-945eb20455cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd6b9b39-b306-4bf7-960f-945eb20455cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8c1f253a-3c42-4e18-83ff-26c4c7b21e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_us-gaap_ConstructionInProgressMember_8c1f253a-3c42-4e18-83ff-26c4c7b21e63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_ba2627f7-d81a-449d-81b0-6a9f95a0136f" xlink:href="rdnt-20231231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_rdnt_MedicalEquipmentMember_ba2627f7-d81a-449d-81b0-6a9f95a0136f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_a7232879-7414-4777-b4f0-c99dc293ff7d" xlink:href="rdnt-20231231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_a7232879-7414-4777-b4f0-c99dc293ff7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_a9dc604a-8f0b-4fc7-b1c0-98c5b6de9c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_a9dc604a-8f0b-4fc7-b1c0-98c5b6de9c70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_442d3965-d480-4adc-863a-52fcb4b23f73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_442d3965-d480-4adc-863a-52fcb4b23f73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c56511a9-308f-496d-a668-ad0fcb8a335b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c56511a9-308f-496d-a668-ad0fcb8a335b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_4b490a14-b7b5-40dd-a9ce-7673bfbc2f55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_ConstructionInProgressGross_4b490a14-b7b5-40dd-a9ce-7673bfbc2f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ed91fdc1-1132-4a9f-ba62-2af45bef7d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_DepreciationAndAmortization_ed91fdc1-1132-4a9f-ba62-2af45bef7d43" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c76dc255-2758-4d7e-bc9a-f2318a03500f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c76dc255-2758-4d7e-bc9a-f2318a03500f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_7060989d-e735-470a-b81d-991e309a3dd7" xlink:href="rdnt-20231231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:to="loc_rdnt_TermLoanMember_7060989d-e735-470a-b81d-991e309a3dd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f108d174-aa1d-4d94-9297-fea86610677d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:to="loc_us-gaap_SecuredDebtMember_f108d174-aa1d-4d94-9297-fea86610677d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:to="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a18d960a-8728-4995-9fe1-cc18fce1268e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a18d960a-8728-4995-9fe1-cc18fce1268e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_ad3f5a9d-1e12-488c-b319-e0a9000f60e2" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:to="loc_rdnt_FirstLienTermLoanMember_ad3f5a9d-1e12-488c-b319-e0a9000f60e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_a62ad858-f2ea-4527-9339-1f7a91916c3d" xlink:href="rdnt-20231231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:to="loc_rdnt_RestatedAgreementMember_a62ad858-f2ea-4527-9339-1f7a91916c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A6.0NotesDue2028Member_f1908311-ac32-460b-874a-e22b9e94925f" xlink:href="rdnt-20231231.xsd#rdnt_A6.0NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:to="loc_rdnt_A6.0NotesDue2028Member_f1908311-ac32-460b-874a-e22b9e94925f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88bd121d-5b50-4ca4-92e4-f5f050f3d832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88bd121d-5b50-4ca4-92e4-f5f050f3d832" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_76809db8-1f28-4f48-8eab-17dfe93c9b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebt_76809db8-1f28-4f48-8eab-17dfe93c9b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_52c7fd7d-56d9-4587-98d0-ff3f64584301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_52c7fd7d-56d9-4587-98d0-ff3f64584301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNotesPayable_7ad6d171-e77e-4153-bb54-a901c3303147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_OtherNotesPayable_7ad6d171-e77e-4153-bb54-a901c3303147" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8f6cf781-7fb9-4eb2-bc57-632c01d00a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f61256f5-3b44-40b0-b75c-89b496ef475e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebtCurrent_f61256f5-3b44-40b0-b75c-89b496ef475e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_aaeed584-903a-4130-b844-aea5697e1a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_aaeed584-903a-4130-b844-aea5697e1a0f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eee9e727-7f9f-4531-9932-a74efaa1ed3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:to="loc_us-gaap_CreditFacilityDomain_eee9e727-7f9f-4531-9932-a74efaa1ed3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1b4bbc9e-2b00-492e-affd-3e9acbe729b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:to="loc_us-gaap_CreditFacilityDomain_1b4bbc9e-2b00-492e-affd-3e9acbe729b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a3d4a323-1074-49e2-a630-f2bf847eaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1b4bbc9e-2b00-492e-affd-3e9acbe729b2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a3d4a323-1074-49e2-a630-f2bf847eaa85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_096f57ba-514c-48e9-bc03-41d141667110" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_096f57ba-514c-48e9-bc03-41d141667110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_fa9e981d-f193-47e8-b677-de9e66c0b566" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_fa9e981d-f193-47e8-b677-de9e66c0b566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_48e2916b-9561-4b6f-8c6a-85ed32458eb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_48e2916b-9561-4b6f-8c6a-85ed32458eb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_8fd34656-f4eb-4402-b6bb-c0be3e9aa5a3" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:to="loc_rdnt_BarclaysMember_8fd34656-f4eb-4402-b6bb-c0be3e9aa5a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_6d2388ad-2f4e-4b9d-b7f9-d0c194544ed6" xlink:href="rdnt-20231231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:to="loc_rdnt_SunTrustMember_6d2388ad-2f4e-4b9d-b7f9-d0c194544ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e9703852-28d6-43b2-8400-ec5ec5c4e314_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e9703852-28d6-43b2-8400-ec5ec5c4e314_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_24fb3e88-5d5f-4cda-a472-488b87e96bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_24fb3e88-5d5f-4cda-a472-488b87e96bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_5d72c4ba-41ff-4708-a5bc-64caed93344e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24fb3e88-5d5f-4cda-a472-488b87e96bbb" xlink:to="loc_us-gaap_LineOfCreditMember_5d72c4ba-41ff-4708-a5bc-64caed93344e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:to="loc_us-gaap_VariableRateDomain_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:to="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a807a10e-b752-4a22-97bd-3370093d8f3d" xlink:href="rdnt-20231231.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:to="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a807a10e-b752-4a22-97bd-3370093d8f3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_c118f2ab-cfd5-4b51-ab6a-06887e61d08e" xlink:href="rdnt-20231231.xsd#rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:to="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_c118f2ab-cfd5-4b51-ab6a-06887e61d08e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_0181d982-4788-4075-b03b-3ea776519593" xlink:href="rdnt-20231231.xsd#rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:to="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_0181d982-4788-4075-b03b-3ea776519593" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f844fdd1-b14c-4c23-b18f-7e70488cc732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCredit_f844fdd1-b14c-4c23-b18f-7e70488cc732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d8d972a7-bf5e-45bb-8ff7-4ccc17c5f84a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d8d972a7-bf5e-45bb-8ff7-4ccc17c5f84a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4939f350-81a6-4037-b7f2-64df0580d6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4939f350-81a6-4037-b7f2-64df0580d6c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c6faa8bf-f6ee-4fc4-aea7-32233d4f0341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c6faa8bf-f6ee-4fc4-aea7-32233d4f0341" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34017b75-d284-4465-8e35-ef16c69fb9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34017b75-d284-4465-8e35-ef16c69fb9e7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8e58a50b-d247-4121-bbb9-954475f2583d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8e58a50b-d247-4121-bbb9-954475f2583d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_249702d2-b72b-49cf-b297-a6d7651fc3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:to="loc_us-gaap_MediumTermNotesMember_249702d2-b72b-49cf-b297-a6d7651fc3f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9f092a27-7891-47d0-ba1f-18723271a0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:to="loc_us-gaap_LineOfCreditMember_9f092a27-7891-47d0-ba1f-18723271a0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_16695ea2-745d-4ade-b574-102addd81dae" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_16695ea2-745d-4ade-b574-102addd81dae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d9d437b2-c023-43cf-846a-11081da51736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:to="loc_us-gaap_CreditFacilityDomain_d9d437b2-c023-43cf-846a-11081da51736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7f950ec0-8870-423c-9f77-3d659bb00006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:to="loc_us-gaap_CreditFacilityDomain_7f950ec0-8870-423c-9f77-3d659bb00006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1ea12cf0-29e1-4a50-9376-21ba9d39ca4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7f950ec0-8870-423c-9f77-3d659bb00006" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1ea12cf0-29e1-4a50-9376-21ba9d39ca4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_34f0abe9-244a-4bba-8d6a-f9216b19733b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_34f0abe9-244a-4bba-8d6a-f9216b19733b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b89debc1-bc80-4c50-9116-64bea959d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b89debc1-bc80-4c50-9116-64bea959d9e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_dc5451d3-317d-4c91-b432-85d2b1302b4f" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b89debc1-bc80-4c50-9116-64bea959d9e1" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_dc5451d3-317d-4c91-b432-85d2b1302b4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c078bf29-7aa7-48a5-a396-a7429d226b3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c078bf29-7aa7-48a5-a396-a7429d226b3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_aebba7cf-241e-4a89-b3e8-375ff22ced80" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:to="loc_rdnt_BarclaysMember_aebba7cf-241e-4a89-b3e8-375ff22ced80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_6e6a8528-61cc-4765-a38d-7dfadf40121c" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:to="loc_rdnt_TruistMember_6e6a8528-61cc-4765-a38d-7dfadf40121c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_45cdaa03-b52d-4e2b-9c93-33e6417d6c31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_LineOfCredit_45cdaa03-b52d-4e2b-9c93-33e6417d6c31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c57cb353-d7b4-488f-a9b9-e554d541b294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c57cb353-d7b4-488f-a9b9-e554d541b294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_cbe11fa6-f34c-46ea-a62f-13da76b28dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_cbe11fa6-f34c-46ea-a62f-13da76b28dd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_8cfe9839-b7bc-42d4-8cfd-b594a9de21d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_8cfe9839-b7bc-42d4-8cfd-b594a9de21d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b005f3f8-86da-4ba8-a9c3-e4e7b3b85d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b005f3f8-86da-4ba8-a9c3-e4e7b3b85d02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f62387a-0016-475d-b065-692732cf9c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f62387a-0016-475d-b065-692732cf9c56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_b4a5e102-e6b5-4541-9023-759a971e447e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_b4a5e102-e6b5-4541-9023-759a971e447e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4f8afa41-1251-4990-b0bc-6a909b71ecea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:to="loc_us-gaap_CreditFacilityDomain_4f8afa41-1251-4990-b0bc-6a909b71ecea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_27e7fb5d-3cf3-4983-869e-6665eab3814a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:to="loc_us-gaap_CreditFacilityDomain_27e7fb5d-3cf3-4983-869e-6665eab3814a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_dfd65103-10a4-4c97-ad0e-931822129e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_27e7fb5d-3cf3-4983-869e-6665eab3814a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_dfd65103-10a4-4c97-ad0e-931822129e2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_176a22de-9486-4288-9be8-2767f8cefdbb_default" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:to="loc_rdnt_LeverageRatioDomain_176a22de-9486-4288-9be8-2767f8cefdbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:to="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_301fb674-acd0-46da-9791-dd7dea6e5e92" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIMember_301fb674-acd0-46da-9791-dd7dea6e5e92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_86a82aca-af8e-45bd-b4fc-e44d5bbe7995" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIIMember_86a82aca-af8e-45bd-b4fc-e44d5bbe7995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_e1920ae8-19e1-41a1-aea5-c03e709fe584" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIIIMember_e1920ae8-19e1-41a1-aea5-c03e709fe584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_a5d4478e-7dd0-4ec0-b329-e96d721b9249" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIVMember_a5d4478e-7dd0-4ec0-b329-e96d721b9249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_c7c163b5-074c-41fa-a96c-7d4508184a8b" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelVMember_c7c163b5-074c-41fa-a96c-7d4508184a8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ef578917-1b4b-494a-bf43-a9db3c17ccad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ef578917-1b4b-494a-bf43-a9db3c17ccad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b1d8bffb-1199-4b42-8aaf-4a69abad73de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b1d8bffb-1199-4b42-8aaf-4a69abad73de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_2de76d6e-c891-477c-8522-6ddcafb82fc2" xlink:href="rdnt-20231231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1d8bffb-1199-4b42-8aaf-4a69abad73de" xlink:to="loc_rdnt_RestatedAgreementMember_2de76d6e-c891-477c-8522-6ddcafb82fc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_353bfdc0-1309-44f2-99db-fe849f8c84ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:to="loc_us-gaap_VariableRateDomain_353bfdc0-1309-44f2-99db-fe849f8c84ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:to="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_3ef9c03b-a8cb-4b8c-a570-7b6ed8141ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:to="loc_us-gaap_EurodollarMember_3ef9c03b-a8cb-4b8c-a570-7b6ed8141ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_8744f201-4359-4da8-9199-278a285072da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:to="loc_us-gaap_BaseRateMember_8744f201-4359-4da8-9199-278a285072da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_4e19d701-b55b-4f19-a27a-110961e6421b" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_4e19d701-b55b-4f19-a27a-110961e6421b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_3c105937-8026-4c9d-9e7f-05faafc46113" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_3c105937-8026-4c9d-9e7f-05faafc46113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1bdfb852-43f7-4a73-b5ac-b78bee74f0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1bdfb852-43f7-4a73-b5ac-b78bee74f0f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_eba47662-6e26-4242-9a71-9f18a0510347" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_eba47662-6e26-4242-9a71-9f18a0510347" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a8cf1367-2a90-4931-b34c-33ec6e73bc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a8cf1367-2a90-4931-b34c-33ec6e73bc0f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6530471-ddc2-43e7-af4f-29478498bb9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:to="loc_us-gaap_CreditFacilityDomain_d6530471-ddc2-43e7-af4f-29478498bb9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3dab0968-f0f8-4523-a138-d14c054ebda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:to="loc_us-gaap_CreditFacilityDomain_3dab0968-f0f8-4523-a138-d14c054ebda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_bde7d04c-5e5d-46d2-ac12-afd2a7b8965e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3dab0968-f0f8-4523-a138-d14c054ebda4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_bde7d04c-5e5d-46d2-ac12-afd2a7b8965e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4650056e-a798-4a8b-92c9-1cb70dd3b7c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4650056e-a798-4a8b-92c9-1cb70dd3b7c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_a66dd23c-017e-4116-8f94-a7f09ac3c6ca" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_a66dd23c-017e-4116-8f94-a7f09ac3c6ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_52cb7487-2b40-4399-a2ec-422f1a59c261" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:to="loc_rdnt_FirstLienTermLoanMember_52cb7487-2b40-4399-a2ec-422f1a59c261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f8b11d8e-8e16-447e-91fb-57aec4c80294_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f8b11d8e-8e16-447e-91fb-57aec4c80294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e3ab51a1-da94-40d9-bd95-eb04f9f504c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:to="loc_us-gaap_LineOfCreditMember_e3ab51a1-da94-40d9-bd95-eb04f9f504c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_bd75d2fc-7156-4e50-865b-7dc1c738256a" xlink:href="rdnt-20231231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:to="loc_rdnt_TermLoanMember_bd75d2fc-7156-4e50-865b-7dc1c738256a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_d7007d81-7a82-4dfe-ae24-f1e35da695f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:to="loc_us-gaap_MediumTermNotesMember_d7007d81-7a82-4dfe-ae24-f1e35da695f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f320f67f-890e-41c5-82c6-62230ad1231d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:to="loc_us-gaap_VariableRateDomain_f320f67f-890e-41c5-82c6-62230ad1231d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:to="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_7d78d213-4b95-45ea-80d9-156059763360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_us-gaap_EurodollarMember_7d78d213-4b95-45ea-80d9-156059763360" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_7c90fbd3-8a4c-4c13-a1c9-26d58a4be414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_us-gaap_BaseRateMember_7c90fbd3-8a4c-4c13-a1c9-26d58a4be414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_505fa60a-69a4-41cd-a8f4-5134ebd5446a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_505fa60a-69a4-41cd-a8f4-5134ebd5446a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_07b6c5c1-6dd3-4864-9d7c-31b2d5deeed0" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_07b6c5c1-6dd3-4864-9d7c-31b2d5deeed0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a4f53956-541f-4e04-aae4-9023f293ab54" xlink:href="rdnt-20231231.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a4f53956-541f-4e04-aae4-9023f293ab54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_e4369a86-e47b-4cee-99de-2639407ceba2_default" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:to="loc_rdnt_LeverageRatioDomain_e4369a86-e47b-4cee-99de-2639407ceba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_275f0485-4e4a-4085-ac59-6a7f07c6dca1" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:to="loc_rdnt_LeverageRatioDomain_275f0485-4e4a-4085-ac59-6a7f07c6dca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_7547dfa9-9263-46ac-b346-24dc031ead20" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_275f0485-4e4a-4085-ac59-6a7f07c6dca1" xlink:to="loc_rdnt_LeverageRatioThreeMember_7547dfa9-9263-46ac-b346-24dc031ead20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2a67a982-70d2-452c-940f-bb086bf3e7de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2a67a982-70d2-452c-940f-bb086bf3e7de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_5db4a32b-9590-4ebc-b3f2-fa0a0664b62f" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:to="loc_rdnt_BarclaysMember_5db4a32b-9590-4ebc-b3f2-fa0a0664b62f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_d7cbf86f-00d3-4a5a-b82f-576e99def4ea" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:to="loc_rdnt_TruistMember_d7cbf86f-00d3-4a5a-b82f-576e99def4ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c24aa074-a70f-438f-a7f1-53ce489afafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c24aa074-a70f-438f-a7f1-53ce489afafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_2d6bee12-953b-4d3e-9e17-7bb202e93f2b" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_2d6bee12-953b-4d3e-9e17-7bb202e93f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b009cbe-3337-45f2-97ee-70457773cc61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b009cbe-3337-45f2-97ee-70457773cc61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6ca204f6-92a4-48dc-9f42-fa00617e99a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6ca204f6-92a4-48dc-9f42-fa00617e99a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_e2172496-d667-493c-899d-d6dae0188932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_e2172496-d667-493c-899d-d6dae0188932" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_dbfa7f26-b158-4ade-a6de-caac7eff4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_dbfa7f26-b158-4ade-a6de-caac7eff4ab4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_4ef532ba-0d78-4cbb-a30c-a3aeb0f23048" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_4ef532ba-0d78-4cbb-a30c-a3aeb0f23048" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_1d886c2f-701a-448b-b72f-37993abbc4d7" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_1d886c2f-701a-448b-b72f-37993abbc4d7" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a5119b49-b4ea-472f-bf75-a19540e85f91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:to="loc_us-gaap_CreditFacilityDomain_a5119b49-b4ea-472f-bf75-a19540e85f91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:to="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_87f98a23-f26f-4aee-91c2-cbd99ffaa546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_87f98a23-f26f-4aee-91c2-cbd99ffaa546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_75c34e7e-091f-416b-8e74-90fbdff19a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:to="loc_us-gaap_LetterOfCreditMember_75c34e7e-091f-416b-8e74-90fbdff19a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a6e3a80e-9136-43d2-8f52-954640a151ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a6e3a80e-9136-43d2-8f52-954640a151ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0729eea4-09c2-48a6-a9a7-0e81879b6341" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0729eea4-09c2-48a6-a9a7-0e81879b6341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_6852491a-74cc-4ac5-90fa-d39c97097a36" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_6852491a-74cc-4ac5-90fa-d39c97097a36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1a5f784-b4e3-4200-8125-723bab1fa9cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1a5f784-b4e3-4200-8125-723bab1fa9cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_9cae78b2-b716-4a9f-83af-be95b4f0f30b" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:to="loc_rdnt_BarclaysMember_9cae78b2-b716-4a9f-83af-be95b4f0f30b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_bbc0cd5a-c692-4aaa-8303-def833605bcd" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:to="loc_rdnt_TruistMember_bbc0cd5a-c692-4aaa-8303-def833605bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_abf2f5b7-5fc9-46b2-9153-55cfb7ac5dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:to="loc_us-gaap_LineOfCreditMember_abf2f5b7-5fc9-46b2-9153-55cfb7ac5dcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_0bb14f65-d8b9-49e6-87dc-63d68d4548e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:to="loc_us-gaap_LetterOfCreditMember_0bb14f65-d8b9-49e6-87dc-63d68d4548e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_00017082-64c3-4287-b4af-6f7795ab47bb_default" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:to="loc_rdnt_LeverageRatioDomain_00017082-64c3-4287-b4af-6f7795ab47bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:to="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_897f9c72-1d68-4735-94e5-89e946d333a7" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:to="loc_rdnt_LeverageRatioThreeMember_897f9c72-1d68-4735-94e5-89e946d333a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_6ac16e07-89c6-4d3c-b86d-c4c001dbca4b" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:to="loc_rdnt_LeverageRatioOneMember_6ac16e07-89c6-4d3c-b86d-c4c001dbca4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_6abc564c-4286-4704-98a1-76738b418bba" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:to="loc_rdnt_LeverageRatioTwoMember_6abc564c-4286-4704-98a1-76738b418bba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_419d742a-864a-4936-8006-c61a3835c8b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:to="loc_us-gaap_VariableRateDomain_419d742a-864a-4936-8006-c61a3835c8b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e602c6cb-d780-4231-94bc-6159a8b733f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:to="loc_us-gaap_VariableRateDomain_e602c6cb-d780-4231-94bc-6159a8b733f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_cc97b8bd-3e1a-4144-856f-a2badb5d6fba" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e602c6cb-d780-4231-94bc-6159a8b733f4" xlink:to="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_cc97b8bd-3e1a-4144-856f-a2badb5d6fba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28ba6d0d-c1f4-43ac-a814-01f01413217a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28ba6d0d-c1f4-43ac-a814-01f01413217a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_175830a4-14c9-449f-9f44-a2d1c59aa29e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_175830a4-14c9-449f-9f44-a2d1c59aa29e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b274726f-315c-4452-acb2-ce767813eb47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b274726f-315c-4452-acb2-ce767813eb47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_62cc8cbf-baed-4f28-9b36-84d21acd57b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_62cc8cbf-baed-4f28-9b36-84d21acd57b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9aa64a06-c8c8-434c-b4bc-0be66b412109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9aa64a06-c8c8-434c-b4bc-0be66b412109" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_476dc12a-7f04-4f97-a65d-c9f4aef9d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_476dc12a-7f04-4f97-a65d-c9f4aef9d98c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_29cf389c-391b-40d6-998c-0df4b773c11d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_29cf389c-391b-40d6-998c-0df4b773c11d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99d2cab4-d168-402f-91ad-14894a31a5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99d2cab4-d168-402f-91ad-14894a31a5c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d114a1d3-0e0f-4a06-a328-d71c197aaeed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d2cab4-d168-402f-91ad-14894a31a5c3" xlink:to="loc_us-gaap_LineOfCreditMember_d114a1d3-0e0f-4a06-a328-d71c197aaeed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_28492070-838c-4c2a-9d63-983f8d9d0843_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:to="loc_us-gaap_CreditFacilityDomain_28492070-838c-4c2a-9d63-983f8d9d0843_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7fbe69ba-740e-40ed-a716-fb5eefa08168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:to="loc_us-gaap_CreditFacilityDomain_7fbe69ba-740e-40ed-a716-fb5eefa08168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d1552170-9450-4e8d-ba79-d58cee2aa491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7fbe69ba-740e-40ed-a716-fb5eefa08168" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d1552170-9450-4e8d-ba79-d58cee2aa491" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:to="loc_us-gaap_VariableRateDomain_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:to="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_f50a16ca-8497-4a81-acdc-6427c34b7384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:to="loc_us-gaap_EurodollarMember_f50a16ca-8497-4a81-acdc-6427c34b7384" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_fac82e28-c021-4966-aa71-a8bc74227f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:to="loc_us-gaap_BaseRateMember_fac82e28-c021-4966-aa71-a8bc74227f36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_5beff012-5db2-4141-8893-c338c3033518" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:to="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_5beff012-5db2-4141-8893-c338c3033518" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c0406e3c-c933-423e-b897-1f20a5777cf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c0406e3c-c933-423e-b897-1f20a5777cf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f245012e-fa74-4a5b-9c15-8ff47031ac7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f245012e-fa74-4a5b-9c15-8ff47031ac7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_646c8b39-a935-42cc-ba2f-475e462e63e5" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f245012e-fa74-4a5b-9c15-8ff47031ac7d" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_646c8b39-a935-42cc-ba2f-475e462e63e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_fd86a6e9-48ee-458f-8b56-3efef84027c6_default" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:to="loc_rdnt_LeverageRatioDomain_fd86a6e9-48ee-458f-8b56-3efef84027c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:to="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_e64759f3-3ce4-4e31-bc6a-35871245faca" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:to="loc_rdnt_LeverageRatioOneMember_e64759f3-3ce4-4e31-bc6a-35871245faca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_b601179d-9cfc-4f22-866c-82d26e8a5496" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:to="loc_rdnt_LeverageRatioTwoMember_b601179d-9cfc-4f22-866c-82d26e8a5496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_1952dc0c-219a-4b68-95eb-de1d7b46fe6e" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:to="loc_rdnt_LeverageRatioThreeMember_1952dc0c-219a-4b68-95eb-de1d7b46fe6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c13dd28a-f833-4947-831f-a403f75bb449_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:to="loc_srt_RangeMember_c13dd28a-f833-4947-831f-a403f75bb449_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:to="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7b2b2bf3-38cb-4160-8b92-980cafcd374c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:to="loc_srt_MinimumMember_7b2b2bf3-38cb-4160-8b92-980cafcd374c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b38b290-6e0a-4cc5-88e2-08265fa7f622" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:to="loc_srt_MaximumMember_8b38b290-6e0a-4cc5-88e2-08265fa7f622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_6dd61845-7dd6-4f19-9609-316215b3acf1" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_6dd61845-7dd6-4f19-9609-316215b3acf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f4c2cb77-c763-47bd-852d-59d6cb73b5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f4c2cb77-c763-47bd-852d-59d6cb73b5cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1f7ba788-6a38-4a13-9073-dee94b2bd8d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:to="loc_us-gaap_CreditFacilityDomain_1f7ba788-6a38-4a13-9073-dee94b2bd8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fdb21b5b-63ac-4d38-9b4e-4c87246e0547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:to="loc_us-gaap_CreditFacilityDomain_fdb21b5b-63ac-4d38-9b4e-4c87246e0547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6cf692eb-7204-4f40-bbc7-a95565d7b812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fdb21b5b-63ac-4d38-9b4e-4c87246e0547" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6cf692eb-7204-4f40-bbc7-a95565d7b812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_4c10456e-a473-4736-87d8-3ffc9f9eba2d" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_4c10456e-a473-4736-87d8-3ffc9f9eba2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_62cad816-be68-40c9-a533-0a2d3764395e" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_62cad816-be68-40c9-a533-0a2d3764395e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2226af5c-dee4-428d-86ec-8b03bb3965b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2226af5c-dee4-428d-86ec-8b03bb3965b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_037538aa-a0cb-4aee-b5da-119373b2158a" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:to="loc_rdnt_BarclaysMember_037538aa-a0cb-4aee-b5da-119373b2158a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_b940ba53-ad8e-4b49-80f4-6d785bae4a4e" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:to="loc_rdnt_TruistMember_b940ba53-ad8e-4b49-80f4-6d785bae4a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_50cf44fd-c1e8-48d0-9706-daf8c5f980af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_50cf44fd-c1e8-48d0-9706-daf8c5f980af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_aef10bba-7172-4056-8d7e-8e75a433dd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:to="loc_us-gaap_LineOfCreditMember_aef10bba-7172-4056-8d7e-8e75a433dd8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_6a3a045d-bd97-484f-a385-054ea81dbbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:to="loc_us-gaap_MediumTermNotesMember_6a3a045d-bd97-484f-a385-054ea81dbbbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_1b2e6dc8-ab9b-4842-b727-995a98b0052f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_1b2e6dc8-ab9b-4842-b727-995a98b0052f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_243e6742-af23-4c51-b088-98f1405ce252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_243e6742-af23-4c51-b088-98f1405ce252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_4615261b-bb79-4c1b-b6ce-2598e74e30c7" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_243e6742-af23-4c51-b088-98f1405ce252" xlink:to="loc_rdnt_COVID19PandemicMember_4615261b-bb79-4c1b-b6ce-2598e74e30c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_40c5e951-27d2-4ce4-847f-fcc815073dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_40c5e951-27d2-4ce4-847f-fcc815073dd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_85048973-5632-4caa-853a-95e2ce968d58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_LineOfCredit_85048973-5632-4caa-853a-95e2ce968d58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d88cf045-cd84-4f89-bf05-fee9c2726ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d88cf045-cd84-4f89-bf05-fee9c2726ae6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4868328c-3b17-4378-8537-852677d99a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4868328c-3b17-4378-8537-852677d99a82" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:to="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c245d62-1bab-40b2-8b74-25c0b9dacc6c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:to="loc_srt_RangeMember_7c245d62-1bab-40b2-8b74-25c0b9dacc6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:to="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ce227269-d360-4750-9075-83daace51c46" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:to="loc_srt_MinimumMember_ce227269-d360-4750-9075-83daace51c46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cbda833-2bc1-4b46-94cd-03e70803b158" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:to="loc_srt_MaximumMember_5cbda833-2bc1-4b46-94cd-03e70803b158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed6b2140-ea81-444c-bd4c-f9af256c230d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed6b2140-ea81-444c-bd4c-f9af256c230d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_17d18b85-c1e6-45d1-8cc4-e8c892e49657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_17d18b85-c1e6-45d1-8cc4-e8c892e49657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_ba67e2ff-3d63-42a9-8db0-99b0ba910500" xlink:href="rdnt-20231231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_rdnt_LesseeLeaseTermofContract_ba67e2ff-3d63-42a9-8db0-99b0ba910500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_a4ce6b08-9384-4217-b38c-6ab9c22a6453" xlink:href="rdnt-20231231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_a4ce6b08-9384-4217-b38c-6ab9c22a6453" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_58d0fc42-b830-403d-a4da-b8d9685dd09d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_58d0fc42-b830-403d-a4da-b8d9685dd09d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65e19ea0-def6-4b4d-adf0-a137f3f8e460_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65e19ea0-def6-4b4d-adf0-a137f3f8e460_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_627558cf-837f-48f8-9952-9bc2aa86eb70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_627558cf-837f-48f8-9952-9bc2aa86eb70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_e3321ba0-3d5d-4d97-8bd6-695500beac32" xlink:href="rdnt-20231231.xsd#rdnt_RavenHoldingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_627558cf-837f-48f8-9952-9bc2aa86eb70" xlink:to="loc_rdnt_RavenHoldingsMember_e3321ba0-3d5d-4d97-8bd6-695500beac32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c773ffde-dceb-4523-a1b4-17633c1334ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c773ffde-dceb-4523-a1b4-17633c1334ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9cd69733-bfb3-47ce-ad03-9d4d4fa65f77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:to="loc_us-gaap_DomesticCountryMember_9cd69733-bfb3-47ce-ad03-9d4d4fa65f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d660e612-cd92-4db1-a644-f63e47e21472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d660e612-cd92-4db1-a644-f63e47e21472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_974ff3db-50cf-4b0a-8fcb-b945e0077082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_974ff3db-50cf-4b0a-8fcb-b945e0077082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a9d60bb8-e789-43d7-8fa6-3ab4e2bc4dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a9d60bb8-e789-43d7-8fa6-3ab4e2bc4dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f01e2cf2-0056-412a-8afb-dcc83c308919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f01e2cf2-0056-412a-8afb-dcc83c308919" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_6088f258-86ee-4a7d-9669-ba27670a87dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_OperatingLossCarryforwards_6088f258-86ee-4a7d-9669-ba27670a87dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_b65db217-ac62-4b65-af13-d8f609fdaf04" xlink:href="rdnt-20231231.xsd#rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_b65db217-ac62-4b65-af13-d8f609fdaf04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_d45ff4f5-3ac0-4f56-9d22-549138ec4929" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_d45ff4f5-3ac0-4f56-9d22-549138ec4929" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_d0934ad2-2a2a-4451-a445-8c8fcbcb5c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_d0934ad2-2a2a-4451-a445-8c8fcbcb5c7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_310a23ea-793e-4dc8-94a6-4a61efdbf465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_310a23ea-793e-4dc8-94a6-4a61efdbf465" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_033167ad-cccd-4c1b-8e51-45ed9f1bec2e" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_033167ad-cccd-4c1b-8e51-45ed9f1bec2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_61fec4e5-acdc-4f46-8378-76e8742c6209" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_61fec4e5-acdc-4f46-8378-76e8742c6209" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a526536b-003e-48bc-b990-a70ca4a64109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a526536b-003e-48bc-b990-a70ca4a64109" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1786b1d-744e-4024-baec-4b90721d7d5c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:to="loc_srt_RangeMember_d1786b1d-744e-4024-baec-4b90721d7d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:to="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c4010a2-cd5d-4354-9e17-bbf8a21c5a7d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:to="loc_srt_MinimumMember_0c4010a2-cd5d-4354-9e17-bbf8a21c5a7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01be6c57-bb70-45d5-a77a-dc63d6fa754f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:to="loc_srt_MaximumMember_01be6c57-bb70-45d5-a77a-dc63d6fa754f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4587acd2-adc7-4030-969e-6adb47b97b8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4587acd2-adc7-4030-969e-6adb47b97b8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_be7f08c4-df8e-4567-af7c-1b3d08d80483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_us-gaap_RestrictedStockMember_be7f08c4-df8e-4567-af7c-1b3d08d80483" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_3238726a-d17c-47ea-9f63-b8f5c57e6502" xlink:href="rdnt-20231231.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_FutureServiceMember_3238726a-d17c-47ea-9f63-b8f5c57e6502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a7febb45-f419-4a8e-81f8-f06b148e76c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a7febb45-f419-4a8e-81f8-f06b148e76c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_15e201ae-9ffb-4f07-b9aa-e79dc784703b" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_15e201ae-9ffb-4f07-b9aa-e79dc784703b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_d665099e-2bb4-4a92-b5d9-884b135385de" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_d665099e-2bb4-4a92-b5d9-884b135385de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_87f3d6b4-e2e5-4ae1-8a85-3d3d125d5520" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_87f3d6b4-e2e5-4ae1-8a85-3d3d125d5520" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45212cc0-f57a-4aba-aef5-ff0dbda76825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45212cc0-f57a-4aba-aef5-ff0dbda76825" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_c698d657-68bf-482b-aabf-5b5f09eaf860" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45212cc0-f57a-4aba-aef5-ff0dbda76825" xlink:to="loc_rdnt_DeepHealthIncMember_c698d657-68bf-482b-aabf-5b5f09eaf860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:to="loc_us-gaap_PlanNameDomain_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_07e6f216-87be-4557-b491-9fdccb4cf492" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:to="loc_us-gaap_PlanNameDomain_07e6f216-87be-4557-b491-9fdccb4cf492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_3f574937-1792-4a8d-a100-acdd38cba7bd" xlink:href="rdnt-20231231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_07e6f216-87be-4557-b491-9fdccb4cf492" xlink:to="loc_rdnt_RestatedPlanMember_3f574937-1792-4a8d-a100-acdd38cba7bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0b0624db-ff63-4b30-b96c-bd0ea2de5d24_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0b0624db-ff63-4b30-b96c-bd0ea2de5d24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46740adc-e7b9-4cea-a13b-f17bf3e4d493" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46740adc-e7b9-4cea-a13b-f17bf3e4d493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f1494be9-3d0d-45b4-8493-a12518bd2d01" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46740adc-e7b9-4cea-a13b-f17bf3e4d493" xlink:to="loc_srt_DirectorMember_f1494be9-3d0d-45b4-8493-a12518bd2d01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_cbf2afe3-b311-4893-89e0-22231847001b" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_cbf2afe3-b311-4893-89e0-22231847001b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8a564619-285e-479d-ada1-12a4e84326ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8a564619-285e-479d-ada1-12a4e84326ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c5c312aa-5f1b-4889-8f8a-38759bb02067" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c5c312aa-5f1b-4889-8f8a-38759bb02067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_99149eae-bbb9-4464-b55f-a4b03f60f929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_99149eae-bbb9-4464-b55f-a4b03f60f929" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d4c7b659-03dd-4ae7-815c-74d6b1758e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d4c7b659-03dd-4ae7-815c-74d6b1758e4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c862ce4f-2fb3-401c-922a-8974a9575aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c862ce4f-2fb3-401c-922a-8974a9575aa0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8e405aa9-62de-49d1-812b-dc5eced74b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8e405aa9-62de-49d1-812b-dc5eced74b23" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15500f60-70c4-46cf-bf5d-948d5e607022" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15500f60-70c4-46cf-bf5d-948d5e607022" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e475fb4b-2113-4c12-a365-2e12a81c5869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e475fb4b-2113-4c12-a365-2e12a81c5869" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db1f0786-0470-4975-8a78-d82a1265e534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db1f0786-0470-4975-8a78-d82a1265e534" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_8fcb13b6-ee06-48ce-96de-435d20cc7c7c" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_8fcb13b6-ee06-48ce-96de-435d20cc7c7c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19247710-8ca0-4ae1-8afb-8947aba22341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19247710-8ca0-4ae1-8afb-8947aba22341" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_bc429454-6e14-4de8-bfbb-7132740a8145" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_bc429454-6e14-4de8-bfbb-7132740a8145" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9ecda032-22ac-42dd-b48e-c2833b7c19c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9ecda032-22ac-42dd-b48e-c2833b7c19c3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_b1e2549f-11cf-42af-8206-6aa246676f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharesIssued_b1e2549f-11cf-42af-8206-6aa246676f67" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_41852d46-34ee-48c8-9f34-8f0739d41483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_41852d46-34ee-48c8-9f34-8f0739d41483" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_46fa6877-6931-49ef-bc36-47213467e392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_46fa6877-6931-49ef-bc36-47213467e392" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_83d76477-93bb-4256-8f25-be5fac456cef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_83d76477-93bb-4256-8f25-be5fac456cef" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_9b2167d2-4c20-4526-83e2-0864f5bae8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_9b2167d2-4c20-4526-83e2-0864f5bae8aa" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0eb22b0-e307-419b-8927-5cbd60c8a546_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0eb22b0-e307-419b-8927-5cbd60c8a546_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dea95c8e-8fd2-4432-8134-17ef03d06872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dea95c8e-8fd2-4432-8134-17ef03d06872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_aff81830-9cd5-4e3a-8272-e1abba1e00fa" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dea95c8e-8fd2-4432-8134-17ef03d06872" xlink:to="loc_rdnt_DeepHealthIncMember_aff81830-9cd5-4e3a-8272-e1abba1e00fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:to="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06535a53-6eb9-42d8-9598-ce228f47a804_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06535a53-6eb9-42d8-9598-ce228f47a804_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_888c4467-0eed-434e-be2f-4f90cf81d8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_888c4467-0eed-434e-be2f-4f90cf81d8cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_2537e0ca-0762-49b8-89a0-7d2bfadd860a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_888c4467-0eed-434e-be2f-4f90cf81d8cd" xlink:to="loc_us-gaap_StockOptionMember_2537e0ca-0762-49b8-89a0-7d2bfadd860a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3172a448-33ed-4e68-b454-5a703dedb108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3172a448-33ed-4e68-b454-5a703dedb108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_13dc2467-e9d6-46f2-bda0-e117a5a674f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_13dc2467-e9d6-46f2-bda0-e117a5a674f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_51d19ea2-85a2-40ac-8930-417871d64599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_51d19ea2-85a2-40ac-8930-417871d64599" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8812c6e9-4c03-4b43-aa43-b5c3d54ed889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8812c6e9-4c03-4b43-aa43-b5c3d54ed889" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7b7547f-284a-4e1b-a7d3-dfcc1d15db78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2787e90e-bdb2-4239-943a-d44a225cc04a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2787e90e-bdb2-4239-943a-d44a225cc04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16f1d66f-6237-447e-b2fd-b6c90b770057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16f1d66f-6237-447e-b2fd-b6c90b770057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b623262c-118e-4f2b-b85d-4ec95737aebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b623262c-118e-4f2b-b85d-4ec95737aebf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_868994d8-7dc5-48ed-aea1-887653162dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_868994d8-7dc5-48ed-aea1-887653162dc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_91c8684a-33af-4fbf-b085-33dc69a90738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_91c8684a-33af-4fbf-b085-33dc69a90738" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_48b55853-cd38-49ea-b986-35a5d19fac61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e4711bdd-3785-47a1-bbcf-283ca51a90c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e4711bdd-3785-47a1-bbcf-283ca51a90c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:href="rdnt-20231231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6d6dd4f0-2a14-4e7c-a606-899417e0bf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6d6dd4f0-2a14-4e7c-a606-899417e0bf1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_fe1779a4-2443-4269-86ef-d7a683b5cf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_fe1779a4-2443-4269-86ef-d7a683b5cf7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:href="rdnt-20231231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_29b89ceb-97de-4b56-91ca-fcb7535e6785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_29b89ceb-97de-4b56-91ca-fcb7535e6785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1768cf3-9e85-47a4-845b-1ae85007fa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1768cf3-9e85-47a4-845b-1ae85007fa7a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:to="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4656c0ff-80ec-439a-bf56-f57094f68a22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4656c0ff-80ec-439a-bf56-f57094f68a22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d9c11cf1-a53e-458e-bb2f-f13e8f0c0748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_us-gaap_RestrictedStockMember_d9c11cf1-a53e-458e-bb2f-f13e8f0c0748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_976b9056-cad4-469b-a0d5-99feb85de380" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_976b9056-cad4-469b-a0d5-99feb85de380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_ea2ec59b-77fd-48a9-b38f-7ed5077fa622" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_ea2ec59b-77fd-48a9-b38f-7ed5077fa622" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_1f9c5938-5ed1-4076-ad7f-4198e5de88c6" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_1f9c5938-5ed1-4076-ad7f-4198e5de88c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AILongTermIncentivePlanSharesMember_43fd4710-83dc-4310-a841-52c8e50c237c" xlink:href="rdnt-20231231.xsd#rdnt_AILongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_AILongTermIncentivePlanSharesMember_43fd4710-83dc-4310-a841-52c8e50c237c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:to="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c31a8169-8fd9-4efa-b989-06871a805edd_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:to="loc_srt_RangeMember_c31a8169-8fd9-4efa-b989-06871a805edd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:to="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8e979df1-e05a-46c5-9a8f-32786bfe4a3d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:to="loc_srt_MinimumMember_8e979df1-e05a-46c5-9a8f-32786bfe4a3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2f1da66b-448d-44f4-a45f-8df877cf7a34" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:to="loc_srt_MaximumMember_2f1da66b-448d-44f4-a45f-8df877cf7a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3662490d-f590-4011-8873-ec70d3b4608e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3662490d-f590-4011-8873-ec70d3b4608e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1906a821-bbef-4716-ad0d-81b73d6914d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1906a821-bbef-4716-ad0d-81b73d6914d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_acd13342-3a84-4021-bb36-bb4277d1a370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_acd13342-3a84-4021-bb36-bb4277d1a370" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f0a7be73-1973-4672-b219-d2af795af2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f0a7be73-1973-4672-b219-d2af795af2b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_534c3c16-d18f-40d0-bacf-6423f23901ff" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_534c3c16-d18f-40d0-bacf-6423f23901ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_00ffbe86-eb9c-49da-9e52-348aee72bc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_82e731cb-5cd5-4ddd-9779-b10da2ab7410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_82e731cb-5cd5-4ddd-9779-b10da2ab7410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fe313e91-50e2-419f-a02a-6709bfa6f6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fe313e91-50e2-419f-a02a-6709bfa6f6fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5fd317db-6060-40f4-867e-5d348489b325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5fd317db-6060-40f4-867e-5d348489b325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_711b38ee-663a-4769-9288-ade0bbc7044e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_711b38ee-663a-4769-9288-ade0bbc7044e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a48242e3-0640-4e36-b7f0-51e1536c5a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a48242e3-0640-4e36-b7f0-51e1536c5a18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_4781fb7a-e287-42af-bbd3-7b7d7411a53c" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_4781fb7a-e287-42af-bbd3-7b7d7411a53c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1b4a4b7d-fcdc-4a23-a179-074a0f42c620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_87881ff0-9ea9-4c8f-b647-3612cee0b1c0" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_87881ff0-9ea9-4c8f-b647-3612cee0b1c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c64caa06-d9da-468e-9708-64341d9a3675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c64caa06-d9da-468e-9708-64341d9a3675" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8cd223ad-afc4-4f6d-9fd8-0e51c8e176f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8cd223ad-afc4-4f6d-9fd8-0e51c8e176f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_984c2a1d-2b9e-4853-b484-ed37642e5eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_984c2a1d-2b9e-4853-b484-ed37642e5eaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8cdcdecf-c700-4ae2-afc6-7d808cf4232f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8cdcdecf-c700-4ae2-afc6-7d808cf4232f" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_32e38438-b830-467f-878f-bbdf5c5c4152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_32e38438-b830-467f-878f-bbdf5c5c4152" xlink:to="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0794c7d8-b0e1-4be7-94f2-10df05fc8907_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0794c7d8-b0e1-4be7-94f2-10df05fc8907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HoustonMedicalImagingLLCMember_3d0893f3-0ae4-4b78-b342-e7cce066bfcd" xlink:href="rdnt-20231231.xsd#rdnt_HoustonMedicalImagingLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:to="loc_rdnt_HoustonMedicalImagingLLCMember_3d0893f3-0ae4-4b78-b342-e7cce066bfcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_617e69ad-1495-4345-a865-8ed3047eeb50" xlink:href="rdnt-20231231.xsd#rdnt_AntelopeValleyOutpatientImagingCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:to="loc_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_617e69ad-1495-4345-a865-8ed3047eeb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7e61dd6d-641b-4e8a-970d-d29cf1090449_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7e61dd6d-641b-4e8a-970d-d29cf1090449_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15aa6332-188d-45f3-8f1a-2b894fc4a990" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15aa6332-188d-45f3-8f1a-2b894fc4a990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2031e2bc-3f04-4f4f-b41c-95d3101cfcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15aa6332-188d-45f3-8f1a-2b894fc4a990" xlink:to="loc_us-gaap_SubsequentEventMember_2031e2bc-3f04-4f4f-b41c-95d3101cfcf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a04c3da9-ee52-4399-bf9c-57de5dc3bf89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_32e38438-b830-467f-878f-bbdf5c5c4152" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a04c3da9-ee52-4399-bf9c-57de5dc3bf89" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_c3f5cd2d-623d-47f0-aa99-19cfee5f847d" xlink:href="rdnt-20231231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_c3f5cd2d-623d-47f0-aa99-19cfee5f847d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockOptionMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_73711d36-616b-4351-9512-c302917f3f21" xlink:href="rdnt-20231231.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_FutureServiceMember_73711d36-616b-4351-9512-c302917f3f21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_bce679fb-ac7a-49c0-a06c-98e905d7077d" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_bce679fb-ac7a-49c0-a06c-98e905d7077d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_3d3f516e-2aef-46d5-91d2-5747e8476560" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_3d3f516e-2aef-46d5-91d2-5747e8476560" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_e7c7cce2-6901-4512-afa6-1e5a94ceb110" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_e7c7cce2-6901-4512-afa6-1e5a94ceb110" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AILongTermIncentivePlanSharesMember_06bec1be-d8c1-4aca-8e52-6b348e7144bf" xlink:href="rdnt-20231231.xsd#rdnt_AILongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_AILongTermIncentivePlanSharesMember_06bec1be-d8c1-4aca-8e52-6b348e7144bf" xlink:type="arc" order="10"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>rdnt-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:97227b0c-cc0e-485b-bbeb-be4e8b957c79,g:17ec1eaf-cfc2-4d82-aff2-f13ccefcfa9a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_3ccc7504-66e5-49e3-b1ab-362ff34ee290_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 7 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_5c52fd07-726b-4284-8e64-1c4b65c0b5e2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_bf94cbc9-9439-4055-9b34-f782bebd7214_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_38e03e61-8343-4e73-83db-5b5f22669ac7_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability, period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_40c51736-7fd7-43b9-9cbd-290e7ada77b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInterestMember_f96f74cc-58fe-4de9-9af3-b4c3d9ee21c6_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest</link:label>
    <link:label id="lab_rdnt_JointVentureInterestMember_label_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest [Member]</link:label>
    <link:label id="lab_rdnt_JointVentureInterestMember_documentation_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInterestMember" xlink:to="lab_rdnt_JointVentureInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MadisonRadiologyMedicalGroupIncMember_7c101e99-766f-432c-a66d-2cfcb97ba852_terseLabel_en-US" xlink:label="lab_rdnt_MadisonRadiologyMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madison Radiology Medical Group, Inc.</link:label>
    <link:label id="lab_rdnt_MadisonRadiologyMedicalGroupIncMember_label_en-US" xlink:label="lab_rdnt_MadisonRadiologyMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madison Radiology Medical Group, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_MadisonRadiologyMedicalGroupIncMember_documentation_en-US" xlink:label="lab_rdnt_MadisonRadiologyMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madison Radiology Medical Group, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MadisonRadiologyMedicalGroupIncMember" xlink:href="rdnt-20231231.xsd#rdnt_MadisonRadiologyMedicalGroupIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MadisonRadiologyMedicalGroupIncMember" xlink:to="lab_rdnt_MadisonRadiologyMedicalGroupIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_efc69524-b0c7-4df8-8b86-b19238ed81b6_terseLabel_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical malpractice deductible per incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_label_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Malpractice Deductible Per Incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_documentation_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Malpractice Deductible Per Incidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:href="rdnt-20231231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:to="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_StockHoldbackMember_66e2b43a-1313-48a1-9179-6b333b67623c_terseLabel_en-US" xlink:label="lab_rdnt_StockHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Holdback</link:label>
    <link:label id="lab_rdnt_StockHoldbackMember_label_en-US" xlink:label="lab_rdnt_StockHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Holdback [Member]</link:label>
    <link:label id="lab_rdnt_StockHoldbackMember_documentation_en-US" xlink:label="lab_rdnt_StockHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockHoldbackMember" xlink:href="rdnt-20231231.xsd#rdnt_StockHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_StockHoldbackMember" xlink:to="lab_rdnt_StockHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ca0829b0-3352-4e16-a663-4a3cb8bbcff8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_ebda3ba8-48b5-464b-9015-55e2b6ce71c5_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7ab9f46f-a9c6-4394-a30a-b54c3220191b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a900903-84bb-4de1-9786-9b80de416760_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_74da20de-82bd-4323-9b7a-9d95063283f9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_2f2a96ee-37d3-4a94-aa28-9fe0a1d43dad_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_a074e8cf-3f7f-4070-811d-aab7eaddb583_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0234ddfb-825d-4a1f-b444-3e50bb80e2d7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_0a325db0-1198-44a1-8084-9ab2d824497f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f4c3b193-6462-4870-b6a7-771b4eb3365e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_563bf1fe-0bce-4fae-a39d-442f7f685b90_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2b970320-6073-4797-b7c1-3c1ae1679b8e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e8fbe5e1-2bc6-4451-9314-cc222baa7497_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_0a2b5c81-149d-43ef-9edf-1ba0bc9f6dfc_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:to="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_3f0f14b9-4637-4543-8d81-1d719e3dc72d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_bbf137bf-b849-4332-a7fa-3dac07724ba4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_0e136394-60d4-4edb-aa34-d8d1307ae701_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_c1102a54-b0c7-46f3-a802-d33e0c0fb76e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_a2a83163-189a-47e0-970a-412ced4b690d_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8c669899-8773-41a3-a3ef-e2b8773f2d48_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_55c4ce82-5c57-467d-addf-6d38ee3a12ca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_5d80ebb4-aac0-4dfa-ae09-8c78920b0aa0_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_dc9832ee-7577-40b7-8926-34c98d47c629_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_12b73ec6-3be6-4ab8-b8fb-a3705df0e6ab_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5807e5f8-8241-439d-bc76-d15bfab91518_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax rate adjustment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c0c56650-ab79-47f1-8b26-25a8b053f0a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled, forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_54ee73d0-fa9b-4751-9db1-64f155790866_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_bd0eddb8-ad77-4f27-8a52-63d24301edf2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived asset</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b245dc17-4878-40e0-9b8f-282e37086475_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ad7c1d08-b392-4735-b962-01a47123a36d_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to RadNet, Inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3d180f0d-679e-4c95-ae01-33e56ff0e908_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_23afe1bd-3b98-450f-9dbc-6fd810bdeda8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b4884000-d128-4001-8ada-e5e66a268c28_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TruistMember_8b20aa8d-6cd0-4cf6-943e-4e3c74bbedec_terseLabel_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist</link:label>
    <link:label id="lab_rdnt_TruistMember_label_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist [Member]</link:label>
    <link:label id="lab_rdnt_TruistMember_documentation_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TruistMember" xlink:to="lab_rdnt_TruistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GeneralHoldbackMember_63aea830-5a30-4007-8bde-bbc5942d2520_terseLabel_en-US" xlink:label="lab_rdnt_GeneralHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Holdback</link:label>
    <link:label id="lab_rdnt_GeneralHoldbackMember_label_en-US" xlink:label="lab_rdnt_GeneralHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Holdback [Member]</link:label>
    <link:label id="lab_rdnt_GeneralHoldbackMember_documentation_en-US" xlink:label="lab_rdnt_GeneralHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GeneralHoldbackMember" xlink:href="rdnt-20231231.xsd#rdnt_GeneralHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GeneralHoldbackMember" xlink:to="lab_rdnt_GeneralHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_bbf637d2-55f6-4a5e-8f7a-cd238d9e73a5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalEquipmentMember_c479f32d-90ec-4b22-822a-ff01839e288a_terseLabel_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_label_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember" xlink:href="rdnt-20231231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalEquipmentMember" xlink:to="lab_rdnt_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_99e23809-80ff-48c1-a570-7251d1e70839_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_d716fccf-cdc2-40d5-917d-d8600c8f03a5_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_b237f352-2716-4306-be00-c5ec1a9c9698_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20231231.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_d3680414-629d-4766-9ff7-09bbf7d3938f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment at cost</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20a105b2-7e05-447e-a8c4-740f4c33db1f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryOneMember_26b295cd-a133-4251-a542-b2be3969e327_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary One</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryOneMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary One [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryOneMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryOneMember" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCSubsidiaryOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCSubsidiaryOneMember" xlink:to="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e7c7a190-d642-479f-bfc3-1890dd46aba6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_e648ea2b-c32d-44ca-b2cc-58c045bef5cd_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_892855db-cbd0-4c09-8fd1-066bd2f82c7d_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20231231.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cf362c49-2dcf-41da-8b5e-6016b9d33ca3_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_eb2ab480-8fef-4749-bba3-c76299709b75_terseLabel_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant not to compete and other contracts</link:label>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_label_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember" xlink:href="rdnt-20231231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CovenantNotToCompeteMember" xlink:to="lab_rdnt_CovenantNotToCompeteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DRTLLCMember_ba2e1e16-e9d3-44e3-8540-c503ae62f18c_terseLabel_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC</link:label>
    <link:label id="lab_rdnt_DRTLLCMember_label_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC [Member]</link:label>
    <link:label id="lab_rdnt_DRTLLCMember_documentation_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_DRTLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DRTLLCMember" xlink:to="lab_rdnt_DRTLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c450c126-9499-4dd3-96fd-1350909ff442_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ca4cf555-95b4-415f-8407-a06a7ad5ba79_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8998ac3e-8f71-413a-bb16-ee1ef8a04cd4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_24041610-99df-41bd-8768-85a0d2f320da_terseLabel_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart &amp; Lung Imaging Limited</link:label>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_label_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited [Member]</link:label>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_documentation_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HeartAndLungImagingLimitedMember" xlink:to="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_b12481c4-0f25-44eb-a24a-2a29708d0e68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f4bce764-f6f1-4774-b161-c9ebbf87e76d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_9dd9292b-4269-42b1-b4c2-74f42df4ec26_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20231231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_5ab89a66-29ca-4d1a-adc2-56b2a0c29b15_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_ec0cb53f-7580-4434-8a74-1bf53fbc0d76_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9106208a-6996-4929-b92f-ead885608b85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0dc1fc4e-6228-4a5f-b9ed-b2ddb94cf032_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_50fefbac-3192-4a6c-b627-99023606d067_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a2c53096-3ced-4df7-8c4c-959405aeb017_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c7b31365-ba8a-4754-8299-f12286cdcfcb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available in grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_13c4f93d-eee8-4a2f-bac9-05348c883bc6_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a588d96f-2afe-4bfb-b96c-33a40d9ea6e4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_193d649c-8a2a-43b2-85c1-7980416917d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_3a7c3f90-d3cd-4cfd-bafb-f886732b080f_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, percent of ownership sold</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Percent Of Ownership Sold</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Percent Of Ownership Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:href="rdnt-20231231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:to="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_86b92e7e-60fe-47a5-bf96-bb60336b7afc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1e154591-35ee-42f4-8bc8-ba63cb8c1301_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_df3f08bb-8caf-4e8e-9322-0984a3fe784d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_b7b2330f-a792-4210-b0a5-bb7b6841053b_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbitaiIncMember_35234e19-6c3f-4b5e-891e-66bb609b7465_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbitaiIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbitaiIncMember_label_en-US" xlink:label="lab_rdnt_WhiteRabbitaiIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">White Rabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbitaiIncMember_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbitaiIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember" xlink:href="rdnt-20231231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbitaiIncMember" xlink:to="lab_rdnt_WhiteRabbitaiIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_11099cd8-ad8f-48f3-9631-5f797dc68a5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_cf0ff2e9-27c7-4997-848b-18d971fee802_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Canceled (in dollars per share)</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_99c13280-4ae8-4015-9d0a-01f1125b1d2d_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_d6688d68-84e4-4fb6-a271-969525e67c58_terseLabel_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases</link:label>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_label_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases [Member]</link:label>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_documentation_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:href="rdnt-20231231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:to="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_f4f1de38-5470-47ae-be0f-9319fb20997c_terseLabel_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_label_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Depreciation And Amortization</link:label>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_documentation_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:href="rdnt-20231231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:to="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_d02f7d47-199c-49cf-ad87-7e05e5c15dda_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_ee23591f-a02a-4260-9a14-1cac8a5e1484_terseLabel_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC</link:label>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_label_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC [Member]</link:label>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_documentation_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FrederickCountyRadiologyLLCMember" xlink:to="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_05ffdcf8-4707-436f-b23c-ef67d425fd78_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseCost_d313ddcd-8835-4fdc-b244-03d6e5c74826_totalLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_label_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost" xlink:href="rdnt-20231231.xsd#rdnt_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseCost" xlink:to="lab_rdnt_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_fdac5255-ae51-470a-940d-529c9fa984d2_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20231231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_d06607cc-ba9e-4d1b-bd04-f10d231496dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7250a518-86e3-4f2d-9e4c-19946c6bf78f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_c56fbb1b-e701-4b95-82f0-e0065f8ebdaf_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_7b9ff9e2-2e86-41ec-9cde-f365dd053344_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_6b30fbd4-6f8b-4b3f-a37f-c5d344af49fa_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20231231.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_6049b88b-102c-4c6c-be10-54f260a673a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_0c98c2e6-d379-4582-9d57-4923209ce760_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCentersContributed_302ba759-7539-4e3f-a5f7-0ab0dfc40116_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCentersContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers contributed</link:label>
    <link:label id="lab_rdnt_NumberOfCentersContributed_label_en-US" xlink:label="lab_rdnt_NumberOfCentersContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers Contributed</link:label>
    <link:label id="lab_rdnt_NumberOfCentersContributed_documentation_en-US" xlink:label="lab_rdnt_NumberOfCentersContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCentersContributed" xlink:to="lab_rdnt_NumberOfCentersContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_75559e57-61b0-4756-bf3e-15e83c5c568e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d6f7f21b-c184-45a5-9771-399a464c72a5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_142d1e42-4b8f-482d-b6d0-70de376fdd9f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_07f56a25-b7e2-4d58-82ce-1ebdd0a2c26d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_cf3c172b-8e31-4826-85d6-61426731dc97_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_label_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Contract [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceContractAxis" xlink:to="lab_us-gaap_ReinsuranceContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_28d87454-c5bf-4095-ae68-35cce149b802_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20231231.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d606ee2b-5191-438e-b6d2-d04425e3ae90_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_6988d6af-73d8-406d-a30a-ae576e39ad82_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_900158f1-785b-4996-974f-59f757852354_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_82e451cd-2b88-436a-8873-7671f062724c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_402c4a02-aa63-4c8e-a9ff-71217c9118db_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_9ed01dae-1464-4736-bfe1-2afde45e8706_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of subsidiaries acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_label_en-US" xlink:label="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Subsidiaries Acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Subsidiaries Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationNumberOfSubsidiariesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:to="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ebee9bfd-17ed-4502-9cd6-82d976c6f82c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_6f79404a-3b55-48d8-8d23-11f4d5fd44d8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred charges</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c1bf3369-6524-4b72-98fa-82082e4b4fda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_e28e08ee-7941-4a7b-a1ad-d85b7da03e3d_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_44b899ff-4eb5-4c4d-9dfa-e0f3bd24144d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_79febdb0-a313-4555-a63e-8cf70f1f390d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7be40dbe-eaeb-4e06-a86a-7c34f41b6341_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4d1806a0-5aaa-4313-abad-85fd4843d571_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_8a978428-f476-4422-b14d-2360425ac86f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_74d313cd-f50c-4237-9331-96c27fd1fb01_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0d6aaada-d41d-43be-b3fb-34784f2b23d0_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a8a2e7c1-7bb3-44dc-b7da-d5f6837f2573_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0177d6a6-0454-4c58-baf3-51cd6bc1b0f0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_74bfe239-1abd-4c87-acc2-0be1c717c5b0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_a5bb0788-c659-4e5d-9e08-bea161fcd2d3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_ac936533-2015-4db2-85e3-24310ced2c9d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, lease not yet commenced, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_f55258d0-ec3a-4ded-ab2a-1066f1d5f4b6_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_e9b41916-2a54-42d5-b4ff-82434ddccd9f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_13c49b62-8fba-4e53-80d4-1aaabe973bae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_b2adb545-d417-4530-96bc-1f49c7717318_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_b9461025-cdde-4703-95e2-d48eae1419a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Term Loans and Truist Term Loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_7ff16ac5-34b6-4d2e-8c9a-6ada555c5608_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_b1f98b63-d5ec-4a0a-b241-199726f6d31c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d6173990-2254-41f5-a0a9-7fe59418c338_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_54139a88-b1cf-45f0-a1c6-1999ef1256ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_2767d069-f752-44c7-b052-f7972d53fada_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4f08b02f-e90a-4ab2-8f76-b547b3528c33_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_c463f6b5-0437-4a75-b908-5a2afb6efe48_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f4e45329-9cb3-48bd-85b3-b897a847d537_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_cc148ee0-7feb-48d2-a2b2-1289980de9f9_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_014ad4fa-b095-4d81-a549-91b05975ae49_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_3f56a7e1-aa29-4648-8891-12082e715717_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7720e62d-badd-4dd2-8759-0555e8e3bb3c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_bf208d48-0e61-401f-af44-d4b10256b5fa_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_6c83f705-d28a-41d4-ab4f-70c0c45b8289_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENT IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_fe892039-4d1c-4693-a3dc-e58f8fae7bae_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:href="rdnt-20231231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_51ee2a7e-b8ff-4edc-a874-8b4490748779_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9c75041b-a8e4-414e-b65a-9db81e8572ed_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_4179f170-b885-44b1-9c83-d68550209f64_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNotesPayable_8915b942-abc0-4954-bf84-607a947e6dc9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</link:label>
    <link:label id="lab_us-gaap_OtherNotesPayable_label_en-US" xlink:label="lab_us-gaap_OtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNotesPayable" xlink:to="lab_us-gaap_OtherNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_1e624e38-9956-4252-bde3-4dd0f06dfd26_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_3304ed31-1f0f-4ad2-bec1-59f27f7b2342_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_fa5ca661-30f7-403e-acd3-4473e545e06a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_872e784f-394c-42ed-afa1-cb7dd2e72e93_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_bcf348f9-6709-41fa-a575-fb52fe9df725_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal current tax</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4e51e518-eaa8-41ce-aa62-36f2bd01321d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_c3138f7f-a8be-45f7-a930-fef2ddad39e1_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life(in years)</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20231231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_66aa4acf-928c-4fb7-a7c6-154a1be4b589_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_8bedab2e-ddcc-452a-9572-1fc1dd91d56f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_03b12653-7a5a-4f76-ab77-5f2cc4588bf5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d8d57bfc-2800-4cd4-92dc-f946770f9f49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled, forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2f68e8c9-cb01-4c4c-a9ac-97892ef315bd_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_c6a73a4c-dcde-4f33-b305-5044f53309ef_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_cd67cf0e-3863-4efb-b927-346de61c7840_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_338846d0-fe43-4d60-80e7-363b113869c8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_5ee52592-e51f-4b31-838c-197161d73231_terseLabel_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract" xlink:href="rdnt-20231231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashFlowLesseeAbstract" xlink:to="lab_rdnt_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4abd1c8-fbaa-4273-9aa0-988945a3eac2_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_label_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charge</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:to="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_113bbaff-e191-4593-88d8-a8b012992e8d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7422346b-f9a2-49e9-a4b3-46b4f987e510_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40966225-ab5f-4ca1-ad81-e8864cdfe072_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_426c8364-4968-4d3e-8c92-da8180e32780_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of interest in minority shareholders</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_label_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Interest In Minority Shareholders</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Interest In Minority Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:href="rdnt-20231231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:to="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_fe72fe06-ffc5-404f-9047-866cea1f745d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_f59f6fc7-cee1-4e94-a7a0-f558e1963c56_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging centers and other operations</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_170e079d-636b-48a3-8f93-1c4eab566a07_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Translation Amounts</link:label>
    <link:label id="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Translation Amounts [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Translation Amounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:href="rdnt-20231231.xsd#rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:to="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_41d27112-d25e-4530-b94d-faae008138e7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd70738c-20db-442b-ac56-d080e15a66bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cd9ddfe6-684d-4c0b-82f0-4ab95c89fd6b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cec24153-34ed-4c48-b105-5f616bb25a61_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6e568b9d-1ae0-41d6-8b85-8aa39eb2960c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_727e24a7-a170-49e7-86d2-0c74bc5294c3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_87baecb5-4a9c-4bc6-a9ad-63eeafded67f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_02f8471a-0791-4537-8a6e-1bd432d02c62_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ef5ed896-e22d-4009-9d1a-f0d279431940_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_64c4f1da-9740-4f45-95c7-9440514422ac_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_0e1273ff-e01e-499c-b9ff-022a26652b6d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d6245677-4b65-4b4b-b75a-f31036c86583_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_2de77850-a6d2-4382-a0a6-67f8323290df_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1e0f1f10-e04f-49a6-a9a7-ea48ce5d42c6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_a62fc2bf-96cd-483d-887a-e05f90edeb7c_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture With Calvert Medical Imaging Centers LLC</link:label>
    <link:label id="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_label_en-US" xlink:label="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture With Calvert Medical Imaging Centers LLC [Member]</link:label>
    <link:label id="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_documentation_en-US" xlink:label="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture With Calvert Medical Imaging Centers LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:to="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_222dbf5a-f198-479c-bd62-ce30aae11681_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_a7abc4c3-45cd-4881-b588-f3318a0e023e_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_ffef6e31-f9d0-44a5-8f24-77dcbc23ead7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_253e0a22-da7d-4f7b-bf9f-df84d167a27a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ef9f5ab0-2dc8-42b7-8652-3f5edafec2e8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_5997d3ff-6ef1-4e29-9dbc-75332367a6ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0346b045-f502-4bf5-9bbf-797d45610b99_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6275944c-ffa8-41af-abc5-ef2a912bbca2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cb509852-6c59-4184-b76c-19eea4fc9ae9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_06508b09-bd38-4ca2-a29b-0aa26fd173ad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_baa69930-948a-4574-8f19-f7acb9ad0724_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCENTRATION OF CREDIT RISKS</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_ba7d5f8e-5d08-4357-8d47-2f3c6376a01e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_f132f80b-3cf4-488a-8a58-2e015352dad4_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_6b0f2814-712a-49a4-9f6b-4fe5a99f05bc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6c01e118-a216-4522-b1bb-d1e73ea57969_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State franchise tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c00f707b-eddd-4af3-b2ab-3f978b6aebab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_178e4242-0533-4d86-b8e2-a8d9574c8dca_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_83787fc3-cde4-4ceb-9c5d-dfadb4b01cbf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_abedee92-ae7a-41cc-99e6-11bd7120767a_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_df578d29-fdb7-4556-918e-e696c6e9743a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MontclairMember_711b1774-5d90-4845-9680-00d017324320_terseLabel_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair</link:label>
    <link:label id="lab_rdnt_MontclairMember_label_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair [Member]</link:label>
    <link:label id="lab_rdnt_MontclairMember_documentation_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MontclairMember" xlink:to="lab_rdnt_MontclairMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_dd3ec220-d547-4701-9f45-8e8043a430c9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_6bffec7c-d7d6-4549-8724-45f59de755c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3d1ddb66-ef0c-42da-bfc6-2c2df1a7f12b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_3bea8127-7d9c-4f05-88c8-0a9bdc0876cb_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_d78f43ce-9a41-47d5-806a-f3d317fedac9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_b553e5fd-c9ee-4dec-8d27-9c4a9cfaa232_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_ec2c4297-90c6-42d1-8609-416d7820115e_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_df1ec03c-f3e6-4a32-8b61-c3aad51e4303_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_069e205f-6d34-484e-a666-f54a03daeac1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_44b9aa2a-c5ea-41cd-97a1-353bc0e2f9c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Principal Maturities of Notes Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_96901941-86e3-4db4-a412-a67259b254b6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_515b6831-6cff-4796-9ef2-03cbd0ab0bde_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_d86c0b63-4de8-4663-9075-08f92f9c6e9f_negatedLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_6b835656-e9e2-4579-9ab7-1c9716d205d3_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20231231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_2d226723-025e-4a87-9e2f-790c1ca7c22c_terseLabel_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:to="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_8d2ecbf0-f3a8-4d1c-bac1-797981bf39c8_verboseLabel_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging center segment revenue</link:label>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_label_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember" xlink:to="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_678ac99f-b406-4a76-bcbd-472957e581a2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_b3864c7b-4f73-430c-9557-aaefe100882a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_7806e343-85c1-45f2-a08b-b7904e00e67f_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationMember_477a0fdd-0e62-40f3-acfe-de979b0e276c_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acsuition Contingent Consideration</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce51fdbb-1446-4012-b11f-7225acf53c26_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_62daf9d4-3831-497a-aa5e-a6834afb6687_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Acquired and Leasehold Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20231231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_ddb6445f-fb9c-4bdc-8a0e-1ca15014128b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_0e19b860-4927-479f-8751-771c1b28ad48_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE DEVELOPMENT COSTS</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2913511d-5792-4c8c-a2a1-13ca95e36b9d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency&#160;translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_73f0c188-9f6a-47e3-b8a4-4cad19bfcab3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_2e5524dc-1f28-44bb-8ad3-1461f618d1ca_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliates</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_e3577995-a542-4dbd-b993-4adf62d2f227_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_5ecfd5e6-2f13-4a50-a415-dd64f9b02677_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_b0aede6e-fe7c-4063-9459-7a820992a028_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0a668adb-782c-4766-93e8-337bf09b4dc0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_245f047e-e2fa-4b00-8c35-89efb4dfef57_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ef76cc08-f42a-4305-912b-f8bfc91d6af9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ecbc2e29-e021-461e-8047-450f93279e01_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_2e08e823-b58f-4ae7-84af-12c35b86d5fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_8e0ec126-39df-4c91-8a3c-18e4db3d9d6c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration to guarantee share value issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_515b9497-686a-4981-9ff8-63905277a042_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_c0fb4b3a-5eb4-4f81-a12e-f9ed1819bf80_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6fc4da38-d482-4088-86bc-a9d449279152_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DelawareDiagnosticImagingPAMember_d6fa4f2c-4690-4d9e-b358-fc7d81a1977e_terseLabel_en-US" xlink:label="lab_rdnt_DelawareDiagnosticImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware Diagnostic Imaging, P.A.</link:label>
    <link:label id="lab_rdnt_DelawareDiagnosticImagingPAMember_label_en-US" xlink:label="lab_rdnt_DelawareDiagnosticImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware Diagnostic Imaging, P.A. [Member]</link:label>
    <link:label id="lab_rdnt_DelawareDiagnosticImagingPAMember_documentation_en-US" xlink:label="lab_rdnt_DelawareDiagnosticImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware Diagnostic Imaging, P.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DelawareDiagnosticImagingPAMember" xlink:href="rdnt-20231231.xsd#rdnt_DelawareDiagnosticImagingPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DelawareDiagnosticImagingPAMember" xlink:to="lab_rdnt_DelawareDiagnosticImagingPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_05943239-c0cd-4bbf-9df8-bc62ebe59aac_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_6086f4ac-1b76-4a12-9ad6-298e94c7b923_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_f4785927-b4ad-43e0-b0f1-de588dc1fda5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_d25bc130-2d7e-4b1a-b0b2-8a6f8887b12d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_7e6497dc-e9a9-4593-9430-2906d7dd9394_terseLabel_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:href="rdnt-20231231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_237048ec-dcd3-4df4-a966-f9bef16a0678_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ec09bd3d-5d20-4515-9cbb-82e5b6c8d728_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_01a946bf-189f-4d57-9551-a678af64d6b9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer Compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5f769dde-4127-4e7e-beff-f5bf2f7766e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_22a5ef2d-02db-4c13-a64c-aa4ac8faab9e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CurrentOtherTaxExpenseBenefit_97fabe82-2253-438a-9b08-ee410d105249_terseLabel_en-US" xlink:label="lab_rdnt_CurrentOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current tax</link:label>
    <link:label id="lab_rdnt_CurrentOtherTaxExpenseBenefit_label_en-US" xlink:label="lab_rdnt_CurrentOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Other Tax Expense (Benefit)</link:label>
    <link:label id="lab_rdnt_CurrentOtherTaxExpenseBenefit_documentation_en-US" xlink:label="lab_rdnt_CurrentOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CurrentOtherTaxExpenseBenefit" xlink:href="rdnt-20231231.xsd#rdnt_CurrentOtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CurrentOtherTaxExpenseBenefit" xlink:to="lab_rdnt_CurrentOtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_bdb4aa2d-9ff5-47df-af18-47e0d6a1b59f_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeApproachValuationTechniqueMember_f58f0b4a-4ec4-4abd-bbcf-9ff68e96c9cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Income Approach</link:label>
    <link:label id="lab_us-gaap_IncomeApproachValuationTechniqueMember_label_en-US" xlink:label="lab_us-gaap_IncomeApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Income Approach [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeApproachValuationTechniqueMember" xlink:to="lab_us-gaap_IncomeApproachValuationTechniqueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ba3a47-f118-4c48-a855-866623b4aa5e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_31c500d0-a3d8-4504-9e32-4f03d46e720d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_41d3cb7e-110b-4ba1-9dd3-18b6862eb6cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_46b20f4b-6df8-431f-b7a6-7b9efbbd67f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d6038d59-d3e2-4619-8b37-78702316064c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c426d8d5-a3a6-4c24-bc11-252b19ea1bda_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_1a6bf27b-556a-4a2b-a480-425e20389fbc_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_30754b4f-530f-45da-8ffc-8fa50ad1f236_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment, furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_a3596896-3d67-413e-b1ae-4496899333a6_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_21676155-2e74-421e-bc1f-03ebb3e7ffad_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_47b82d7e-6702-4c7c-a5fa-92003e62334c_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory note</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_422b4556-b718-422d-9ddb-4784d3348692_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_a2790f75-306e-41ba-b96f-8f6a0ef76c1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c372f697-4af9-4051-8860-83f782034c83_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd8ea0db-4c00-4f50-ae11-97244aa766e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_421c1038-1e5d-4bfe-b1ae-b38852f06cd3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_cb72c8d4-7f66-4b92-9505-8a1a7a0740df_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6667e584-cdb2-471e-a792-521ba1b79202_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_4678531f-276b-4d10-9453-309d5c930f73_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_31cd1336-9fca-4c9f-8c1e-4f1689cd2878_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d8571551-77a2-4dfc-bcb7-21f1c4b9a9a6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_f4dace1a-4fa0-47e7-bb6c-b3fa9d2f3765_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_debeb852-083c-445e-895e-07c55eb2690f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ad5e66b1-44fc-4815-8376-29efa225339b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_ddabc8da-332c-4eb1-b518-705420708191_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock (in shares )</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b8e4dc22-6011-4f16-8719-9acd8402383b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bcd8921c-b678-46e8-9200-797b8c66f490_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_48ed7d4b-e8d9-4f3a-8a1f-23676694690e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_2d0701b6-8929-49d0-a56c-591cf56ae3e5_terseLabel_en-US" xlink:label="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Southern California Diagnostic Imaging, Inc.</link:label>
    <link:label id="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_label_en-US" xlink:label="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Southern California Diagnostic Imaging, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_documentation_en-US" xlink:label="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Southern California Diagnostic Imaging, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:href="rdnt-20231231.xsd#rdnt_SouthernCaliforniaDiagnosticImagingIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:to="lab_rdnt_SouthernCaliforniaDiagnosticImagingIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_00fd501a-27e1-4bc1-9d6f-ac901e629285_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a3383c93-c5f2-43eb-8818-54e78c1f098e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_db14ff2c-187d-4209-bb3d-1d2ac83ee366_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_6d38ae87-1c1d-4b82-849d-1e78f1870a38_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_736ccef7-818e-4d49-9a9f-1b2f0c93d9fc_terseLabel_en-US" xlink:label="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value associated with contingently issuable shares</link:label>
    <link:label id="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_label_en-US" xlink:label="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Net Income Attributable To Assumed Share Settlements</link:label>
    <link:label id="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_documentation_en-US" xlink:label="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Net Income Attributable To Assumed Share Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:href="rdnt-20231231.xsd#rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:to="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_62b909e8-d073-4069-ae0a-6fdb8335948a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c459b649-419d-4e25-921f-11d59031ba76_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3084a914-8546-4796-bf7d-576048235e6d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVentures_d3f38ea0-ebaf-4dc9-a2b2-e62ad7296f0c_terseLabel_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Data:</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVentures_label_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key Financial Data For Joint Ventures</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVentures_documentation_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key Financial Data For Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVentures" xlink:href="rdnt-20231231.xsd#rdnt_KeyFinancialDataForJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures" xlink:to="lab_rdnt_KeyFinancialDataForJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_af08242c-286b-4bb3-9594-eace2a65459b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ValueOfEstimatedSharesIssuable_59030846-e2c4-47f7-90a0-d56a4674ac6a_terseLabel_en-US" xlink:label="lab_rdnt_ValueOfEstimatedSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of estimated shares issuable</link:label>
    <link:label id="lab_rdnt_ValueOfEstimatedSharesIssuable_label_en-US" xlink:label="lab_rdnt_ValueOfEstimatedSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Estimated Shares Issuable</link:label>
    <link:label id="lab_rdnt_ValueOfEstimatedSharesIssuable_documentation_en-US" xlink:label="lab_rdnt_ValueOfEstimatedSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Estimated Shares Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ValueOfEstimatedSharesIssuable" xlink:href="rdnt-20231231.xsd#rdnt_ValueOfEstimatedSharesIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ValueOfEstimatedSharesIssuable" xlink:to="lab_rdnt_ValueOfEstimatedSharesIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_2db9c696-3535-4e29-94dd-2de94f9010f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of RadNet stock issued in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BlueShieldMember_d12dc2e3-e17b-4589-993a-b9051a4364ce_terseLabel_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_label_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_documentation_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember" xlink:href="rdnt-20231231.xsd#rdnt_BlueShieldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BlueShieldMember" xlink:to="lab_rdnt_BlueShieldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_70895bf5-ee34-4726-a274-5757d0e0ff26_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_c34c369b-4463-4153-9daa-dd5b341e8a92_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight average shares for which the exercise price exceeds the average market price of common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cfa2968b-f9fc-4fdd-aca0-6754a81df076_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6bcfad85-9bf1-4b62-8cdb-11a41705e0f9_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations for the assessment of taxes</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ab18816e-c668-443d-b68e-335953dd911a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_0c71a409-8064-4a6c-bede-798b8549766d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_ded5d321-f3d8-415a-a474-d7cad7744428_terseLabel_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_label_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:href="rdnt-20231231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:to="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_b561ae1a-3e57-4146-b46a-feb189fb9f9f_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20231231.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_25e1cb52-2710-4ed5-873d-ada596acc586_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d84249c1-84fc-4236-a959-518c7fc3349c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cae8dd14-1827-4a7a-b435-0c347aeb26e7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d2fc2003-bc6c-46d1-b530-9718c1997d31_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling&#160;interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_07089004-a78b-488a-a687-22b34d87ab04_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f092d2c1-fead-48e7-97bb-515b4a2bc9ad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_0c6b47f8-5879-4b7e-82cf-0f081db9df2a_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution of earnings</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6f8f605e-11f0-4298-9910-16137ecf4ac3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase agreements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d334d7a6-2b18-4b2c-aefb-0f4381fddb28_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fece01de-8e31-4697-89fb-d6bb6c7f6a50_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_d3242521-d9e2-487a-9ee2-ec1baec92fba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_7f3d648b-6fff-40ba-8d69-54f6d3baab30_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_359b72ec-8a91-4f38-8850-c41c40ba38db_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use-assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_label_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:href="rdnt-20231231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:to="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_67582acc-3e0e-475f-8837-43eacda64aaa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate swaps</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c448d400-c812-4eb9-abc4-8731cb19e3c8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_98268989-8eb8-4fd7-8054-5e81b6ac61cb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1f8bb8fb-b72d-46b1-a493-fa80189f3433_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_b4be475b-5be8-4381-a7c6-fbb83a2b7634_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_37f82941-ac05-497f-a697-2b8c8abc354b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_c8e93e9a-5a62-47ce-bc8d-b32aa259191f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_efefbc41-6c5b-4797-8542-9cdd61ba4096_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purpose</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_104e9ec7-36c4-4eb0-aeed-26c07bfe2901_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_e0cad011-0bdf-4a64-9bb3-625e9833e346_terseLabel_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC</link:label>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_label_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TarzanaMedicalCenterLLCMember" xlink:to="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_50290994-181b-4931-b660-d2bfd5e23ed4_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_593b1566-11f7-4405-9c5b-880887c05964_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_73932d9c-8d5c-49ab-b7bb-ba47aaaea4ff_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to RadNet, Inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CertainSellerMember_0d5f91b3-b999-4616-9e42-a48cfaf9a9a6_terseLabel_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller</link:label>
    <link:label id="lab_rdnt_CertainSellerMember_label_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller [Member]</link:label>
    <link:label id="lab_rdnt_CertainSellerMember_documentation_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember" xlink:href="rdnt-20231231.xsd#rdnt_CertainSellerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CertainSellerMember" xlink:to="lab_rdnt_CertainSellerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_98784594-dca5-43e4-8b21-62b34892155a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_70225eba-20e9-489a-a2c6-3c46146b95ec_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_613c065f-a88a-41bb-9b62-d4c7b6397f53_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_5ce4a240-1a29-4bca-b276-f8f0703ce035_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20231231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_26799d45-e97f-4717-b4a0-355b7e01215b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_f91ba82b-5419-47b6-b203-2727c3f74cb6_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_d1d1c81d-54a3-481e-a06d-610a00cb0555_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SecuredOvernightFinancingRateSOFRMember_b9a03419-f717-4dd8-90bd-ef8e8813c4fc_terseLabel_en-US" xlink:label="lab_rdnt_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_rdnt_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_73d1f6f9-1044-4770-8845-d7608ef4cf09_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_efba7658-bbcd-45da-a2f6-635899e93119_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRINCIPLES OF CONSOLIDATION</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_b0c704b2-6dec-4c2a-bbbf-3c07b46d3c19_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_6e7b7d5c-db85-4fbd-8a58-ce24573a9c4b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ebf3772c-e13c-41a0-980f-c9979816149b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_9846d173-86c9-40b0-b93f-fd377415d5e4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_a510d95f-2eee-4256-94f1-06eb5f1ca346_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_62eac0fc-f28b-43c4-9b05-47d0cc87ecaf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1ca9ee37-736c-4e20-8413-a21ea5f0fa85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LosAngelesImagingGroupLLCMember_f9bee7e1-98eb-4a7d-9661-435936a2a856_terseLabel_en-US" xlink:label="lab_rdnt_LosAngelesImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_LosAngelesImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_LosAngelesImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_LosAngelesImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_LosAngelesImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LosAngelesImagingGroupLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_LosAngelesImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LosAngelesImagingGroupLLCMember" xlink:to="lab_rdnt_LosAngelesImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_54deea47-d0b3-42a6-ae75-8e9b2212cfdd_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_fb66cf08-ef43-4cfb-8c05-e7a190fb5941_negatedLabel_en-US" xlink:label="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt and related expenses</link:label>
    <link:label id="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_label_en-US" xlink:label="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment Of Debt And Related Expenses</link:label>
    <link:label id="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_documentation_en-US" xlink:label="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment Of Debt And Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" xlink:to="lab_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_cdb65c05-e4b6-4fac-8311-0a00640b4710_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling partner</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:href="rdnt-20231231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:to="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_5c19a475-fa52-4544-b143-83eec55dedab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_29211e61-c81a-450f-a84b-77da81aa06bb_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_ffbdaba6-438e-4baa-adc2-643c07293f6c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4fda81b1-71bb-4d76-9b8d-0234de819e83_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_2dce3b6c-00e1-4bed-b435-8251e936b61c_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_f370d341-19e6-4371-b5c0-e84c317cd37d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total notes payable obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_24034f88-bc3a-42fd-b9ec-7456240f6fdc_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_552c6206-936d-40ca-8adc-e2c01e43c5df_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:to="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0919b674-c4e7-4b6f-81c2-9563f02a0cd4_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_d41a5792-00a5-43aa-8ed9-1da7333b0f33_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20231231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_1ade765e-024d-4683-90c1-2c353d1250df_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20231231.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_7575178d-8a99-4bb3-823a-1d4580bfe6ba_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6ff671f3-8886-4169-ab84-a4ae9818c276_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_f5d06be7-8e84-492f-b379-531c665a00e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_49169707-37ea-4146-b0db-83fdda645d85_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets and Deposits and Other</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f376bd9a-e4e3-4a68-a226-a57c69771dac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_4dadb967-3535-4674-a6c2-36b7740609f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1eda266b-fb74-4231-8ad0-4a88177f0910_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_cbeaa009-dc86-44f9-9b26-c585faf1140b_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts</link:label>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_label_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceContractsMember" xlink:to="lab_rdnt_ManagementServiceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_5c146d5a-0ee7-4d39-8535-3e40bd8d4acb_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5dac8cb7-65ea-42c8-b8ae-87c570f32199_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_69617bf6-af18-4fc8-a380-9ef5692d2f55_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_c2450625-0d76-4aed-92b5-2f5cb2b10a5a_terseLabel_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center</link:label>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_label_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center [Member]</link:label>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_documentation_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember" xlink:href="rdnt-20231231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CedarsSinaiMedicalCenterMember" xlink:to="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_8d230e73-2c9e-408e-bbeb-5af1a5417ac4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY INVESTMENTS AT FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ChelseaDignosticRadiologyPCMember_fd2512fd-aeee-4e6c-aecc-c5acd0e22a20_terseLabel_en-US" xlink:label="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chelsea Dignostic Radiology, P.C.</link:label>
    <link:label id="lab_rdnt_ChelseaDignosticRadiologyPCMember_label_en-US" xlink:label="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chelsea Dignostic Radiology, P.C. [Member]</link:label>
    <link:label id="lab_rdnt_ChelseaDignosticRadiologyPCMember_documentation_en-US" xlink:label="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chelsea Dignostic Radiology, P.C.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ChelseaDignosticRadiologyPCMember" xlink:href="rdnt-20231231.xsd#rdnt_ChelseaDignosticRadiologyPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ChelseaDignosticRadiologyPCMember" xlink:to="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_277cf6cf-5489-4da3-9b10-757e8b7d3636_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AILongTermIncentivePlanSharesMember_c489d093-9807-4245-8ccc-26cb22c0f2cf_terseLabel_en-US" xlink:label="lab_rdnt_AILongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI Long Term Incentive Plan shares</link:label>
    <link:label id="lab_rdnt_AILongTermIncentivePlanSharesMember_label_en-US" xlink:label="lab_rdnt_AILongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI Long Term Incentive Plan shares [Member]</link:label>
    <link:label id="lab_rdnt_AILongTermIncentivePlanSharesMember_documentation_en-US" xlink:label="lab_rdnt_AILongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI Long Term Incentive Plan shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AILongTermIncentivePlanSharesMember" xlink:href="rdnt-20231231.xsd#rdnt_AILongTermIncentivePlanSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AILongTermIncentivePlanSharesMember" xlink:to="lab_rdnt_AILongTermIncentivePlanSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_65f076e0-61f6-4690-9952-896331f343b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ad558018-2c74-4728-8469-1acc37be01e3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8658ef6e-f253-405f-aff4-7d08c8e9a6e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_cfe388d9-4a85-4960-a622-448f98419cde_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation liability, current</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesAcquired_254c5e4a-87e1-46ac-84e6-f25972c3dfd6_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares acquired (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesAcquired_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Acquired</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesAcquired_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesAcquired" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesAcquired" xlink:to="lab_rdnt_EquityMethodInvestmentSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2f7ffbfc-1708-42fe-aaf3-722c54c1b283_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a0611ffa-05ae-47ff-b389-71dce4201c15_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_bf2ea332-dbc9-4987-b4fd-e914a410cc43_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_e0241c6f-d757-4962-b628-43e322ebf0c4_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable other than term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentAdditionalContribution_95a55727-769f-46fe-9c6d-c78d370c762a_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contribution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentAdditionalContribution_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Contribution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentAdditionalContribution_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:to="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_38f8366d-307f-4f48-8fe4-918effeb56b8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceMember_c1efd567-ae0d-4aaa-8a7f-1a9aefdb2e03_terseLabel_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:label id="lab_rdnt_AidenceMember_label_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence [Member]</link:label>
    <link:label id="lab_rdnt_AidenceMember_documentation_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceMember" xlink:to="lab_rdnt_AidenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_a1192a7e-1e97-4971-a5ff-199075d410c8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_bbed9b04-97ef-43e6-b1cb-665b03d2dc7c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3682a2e3-445f-4f11-af4f-732db7df3930_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposition of property plant equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ba5f6266-a63e-4ca4-9fec-b60b4691b68e_negatedNetLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Disposal of Equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bd59ae08-7c78-4623-8910-db5d69ec2992_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_01741d6d-1e90-4b07-9eae-9c573cdce8b2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1a7bad4a-5baf-4068-84e2-5f08e7196ee3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FixedAssetsMember_bdf8ab17-9b1f-4b9c-86a1-471788d4134c_terseLabel_en-US" xlink:label="lab_rdnt_FixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets</link:label>
    <link:label id="lab_rdnt_FixedAssetsMember_label_en-US" xlink:label="lab_rdnt_FixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets [Member]</link:label>
    <link:label id="lab_rdnt_FixedAssetsMember_documentation_en-US" xlink:label="lab_rdnt_FixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FixedAssetsMember" xlink:href="rdnt-20231231.xsd#rdnt_FixedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FixedAssetsMember" xlink:to="lab_rdnt_FixedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_f7fe6cc6-5adb-4ab5-ae36-749739d65526_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_2ae6a117-6ae3-455f-aefe-87c9eb7778f8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_77be0af8-c418-4933-a7fa-b3672901a67e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_690a7e45-5f5c-4510-9638-5abf208c182b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Operations</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_312b5c17-79de-4f2a-ab31-3aeb5e883d20_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7430cecc-3c5c-42fb-b084-0597e4717dc5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases - years</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d525ce90-8169-4073-a942-a20c544c8445_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_e31d8754-b0ff-4974-b085-8a1b64d6083b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_186037ba-dd69-4f2b-8d0f-d1ae4dc2f847_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate swap</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InglewoodImagingCenterLLCMember_421ce98c-45bd-446d-89aa-d04e76f18b5f_terseLabel_en-US" xlink:label="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inglewood Imaging Center, LLC</link:label>
    <link:label id="lab_rdnt_InglewoodImagingCenterLLCMember_label_en-US" xlink:label="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inglewood Imaging Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_InglewoodImagingCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inglewood Imaging Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InglewoodImagingCenterLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_InglewoodImagingCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InglewoodImagingCenterLLCMember" xlink:to="lab_rdnt_InglewoodImagingCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2b86e5dd-fcd4-4fd7-af12-739be95e9add_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_62f99f69-d960-4278-b27d-832a5dfabd36_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4ba97e02-7dd2-4f92-a151-bfed6b9b0cf0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1a1470f2-b6e0-4637-b56a-fe379aab9284_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0a2f1b6c-41ff-47d3-a6e0-09edac4d3084_terseLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20231231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2d9c5e96-164f-454e-a39e-c889d41aaa8c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2f3ca166-f6f8-497d-82b8-28e233588c88_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PP&amp;E useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BeverlyHillsImagingCenterMember_e7445f4c-877b-46df-9b9d-a580a73fb3a1_terseLabel_en-US" xlink:label="lab_rdnt_BeverlyHillsImagingCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Hills Imaging Center</link:label>
    <link:label id="lab_rdnt_BeverlyHillsImagingCenterMember_label_en-US" xlink:label="lab_rdnt_BeverlyHillsImagingCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Hills Imaging Center [Member]</link:label>
    <link:label id="lab_rdnt_BeverlyHillsImagingCenterMember_documentation_en-US" xlink:label="lab_rdnt_BeverlyHillsImagingCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Hills Imaging Center</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyHillsImagingCenterMember" xlink:href="rdnt-20231231.xsd#rdnt_BeverlyHillsImagingCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BeverlyHillsImagingCenterMember" xlink:to="lab_rdnt_BeverlyHillsImagingCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_2c16a2b3-2697-461f-8864-1ee37f97ed38_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software costs</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_b2f1afaa-547c-4a01-9dd5-5c1826a2b11a_terseLabel_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_label_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_documentation_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:href="rdnt-20231231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:to="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e3a4d5af-5aca-418c-9684-a3e282f8657f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_0376a40d-176a-4749-902e-c3546363f821_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_c6fbc167-c033-4c2f-9336-a85bb49c5205_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_deb17631-d18d-4bb8-b6b5-41e4bacad952_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4b0670e6-fbeb-42ec-9fc0-9b50bccfe476_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_6e6b17f7-be89-480d-b3cb-27bbb51ea7a1_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_68f1a561-41fb-4f22-a29d-183ec9088b5f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_8c7d03d0-9637-4026-b09b-da6225d11636_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Joint Venture Investment and Financial Information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment and Financial Information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment and Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_79ba4eed-b414-4134-b271-95006ad819d5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_8f4eeba6-69c7-4f0a-a09e-4130026cf4b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_135ef138-876f-4223-b752-24a09c3a4729_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_7c877b9f-96bc-40d0-a793-4a9922ae9ae5_terseLabel_en-US" xlink:label="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Months Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Months Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Months Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20231231.xsd#rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_7c1e9d66-91ba-4d7a-8191-6d6488e0761d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_0a911e54-8941-4584-bb76-02adb1792ae8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and write off of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ForeignCurrencyTranslationAdjustments_5b7aee4e-7c6b-4f5e-9652-8d9b66ef5550_terseLabel_en-US" xlink:label="lab_rdnt_ForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_rdnt_ForeignCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_rdnt_ForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_rdnt_ForeignCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_rdnt_ForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignCurrencyTranslationAdjustments" xlink:href="rdnt-20231231.xsd#rdnt_ForeignCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ForeignCurrencyTranslationAdjustments" xlink:to="lab_rdnt_ForeignCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_e3c92c3a-b128-4a83-94bb-ba7736b35013_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, tax benefit may not be realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:to="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_910e513b-e803-4500-9e1d-3e6a8b0cb0b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6487ad9e-c0b2-486d-a0f3-bc6c29e4d9c3_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_1bc168b7-78bb-40a0-96b2-221e54ac0231_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_9c122918-4349-4049-ade0-a97341d62955_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_55bd440f-3ed4-4743-8c2f-817f249731a8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_bd2e8097-5306-4466-b8e0-c87a2f5112ca_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of leased equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f4ece954-7b93-48bb-846a-8eafeae0dd07_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_c4771b96-5313-453a-a96e-4fe438b2b15f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration settlement</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RamapoRadiologyAssociatesPCMember_4872e13d-def1-4e27-a1ec-970ea4bf88ee_terseLabel_en-US" xlink:label="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramapo Radiology Associates, P.C.</link:label>
    <link:label id="lab_rdnt_RamapoRadiologyAssociatesPCMember_label_en-US" xlink:label="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramapo Radiology Associates, P.C. [Member]</link:label>
    <link:label id="lab_rdnt_RamapoRadiologyAssociatesPCMember_documentation_en-US" xlink:label="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramapo Radiology Associates, P.C.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamapoRadiologyAssociatesPCMember" xlink:href="rdnt-20231231.xsd#rdnt_RamapoRadiologyAssociatesPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RamapoRadiologyAssociatesPCMember" xlink:to="lab_rdnt_RamapoRadiologyAssociatesPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0cd683e7-3497-4590-a007-ea2fe93face5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_26b06103-4e37-4f33-a29b-370d52deac8c_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_07ccfd59-4c71-4cca-9d05-48f838034479_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e7839d9b-9846-401d-8b8e-a077155c5a20_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_23a898c7-fbbd-464d-952d-a42bd9056818_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_89bd3fc5-1339-4630-aab4-d0fb633e5178_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A6.0NotesDue2028Member_1a14867a-cc4c-41c5-a55a-679cef0a50b2_terseLabel_en-US" xlink:label="lab_rdnt_A6.0NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.0% Notes due 2028</link:label>
    <link:label id="lab_rdnt_A6.0NotesDue2028Member_label_en-US" xlink:label="lab_rdnt_A6.0NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.0% Notes due 2028 [Member]</link:label>
    <link:label id="lab_rdnt_A6.0NotesDue2028Member_documentation_en-US" xlink:label="lab_rdnt_A6.0NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.0% Notes due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A6.0NotesDue2028Member" xlink:href="rdnt-20231231.xsd#rdnt_A6.0NotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A6.0NotesDue2028Member" xlink:to="lab_rdnt_A6.0NotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_180f50da-5bda-457d-80cc-5c1adad74a8a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's Reporting Status Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_d9ea7aa1-680e-43d8-a737-ffb2a42834a2_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_616e443b-d72b-4fb8-bdc4-7fdc4bce1de1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_7bb9b26e-2f63-4254-992e-657ab5d29236_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20231231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_8ed54602-ee9b-4258-bd7c-50d72c5be12a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6173e687-0260-41f5-b5bb-b284fb74259f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_1cc6e49d-e857-43e2-8deb-9cebab94d577_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_69c85b12-0976-4cc3-889a-11da81d6ea4a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d337b588-b9a4-4805-a80b-a22d69d38914_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_245ca2a0-1c4e-4860-9851-52391d4de2be_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_40e838d7-4d60-495e-b44c-6790dd7c0748_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e64debcd-c6fc-482b-bed8-a0df4efdd4b5_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_ca602990-7a5d-4384-9a91-c97bbdc0e74a_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_f0b0a7fd-d10f-4149-8e10-76b93e379a27_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of location</link:label>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_label_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Location Offering Multi-Modality Services</link:label>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_documentation_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Location Offering Multi-Modality Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:to="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_069c35d5-dfb3-4167-9744-1b3b7c6284a8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_7e358505-d543-4cda-9e52-805426d8ac5d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_4d51be6c-1c5d-4011-a3c0-b20abf308022_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance accrual</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_e9141928-5a00-4c15-a808-a2ae4bb316d8_terseLabel_en-US" xlink:label="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contribution of imaging centers into joint venture</link:label>
    <link:label id="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_label_en-US" xlink:label="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain On Contribution Of Imaging Centers Into Joint Venture</link:label>
    <link:label id="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_documentation_en-US" xlink:label="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain On Contribution Of Imaging Centers Into Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainOnContributionOfImagingCentersIntoJointVenture" xlink:href="rdnt-20231231.xsd#rdnt_GainOnContributionOfImagingCentersIntoJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GainOnContributionOfImagingCentersIntoJointVenture" xlink:to="lab_rdnt_GainOnContributionOfImagingCentersIntoJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_f855aeb0-577c-4cab-8b07-ca34a9b4e11d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_541cc7e9-e191-4ff9-8d0a-ee745e75f464_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a8440f3e-3bce-4b1b-9512-e62e565c8af6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_256b79ff-3591-4325-87cc-bbf4f7cee9bf_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_bb103842-8b32-4d50-b3ae-c0495fbb6ba7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges_6f5ee75d-1a59-4dba-bb1d-46a967821a9d_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges_label_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charges</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharges" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseLeaseAbandonmentCharges" xlink:to="lab_rdnt_OperatingLeaseLeaseAbandonmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_fab5ea3b-8486-4f4a-b058-890b2349dfd1_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable, fair value of additional shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2ec62595-7f5d-46e7-9837-005c280879d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_f5141dc9-2538-4e81-9d3b-100368ec464a_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20231231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_f068dcff-3421-49e4-b493-5b5c354ad2d3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITIES AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2cd0a6e3-a528-4cc2-8095-4f3a0ce651d4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_57952e1f-4626-4ab8-88df-41be8343ca3c_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_584e4180-b059-4c90-be7a-098ac6a0b35a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9c1fa085-0605-44bd-90ff-bfe3376b5c21_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_ba5d1143-25a9-4003-bfc7-29962635e97d_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Roll Forward]</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Roll Forward]</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_734a309e-cc2f-4114-bc8e-627933b3b1ed_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d1540731-b73f-4330-a5a2-65489b94464b_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_06002806-0847-4826-8e3d-15f8a1251f72_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_f9a8a5f2-15d5-45f7-a18a-56d449b81d51_terseLabel_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:href="rdnt-20231231.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:to="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b8d4e339-9dd2-495a-b2da-443277eecc4f_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_0b8d1f0a-ec79-42a5-be69-334b61aac3f5_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_0a7e3dbe-8313-4705-a07f-5f3cca5e7de2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_93d2a075-6b90-4057-8d3c-f2d5658a2060_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_513a688b-f484-4d84-b57f-b54a3bb33b2e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_fea82e05-b0fb-4eb2-b8c7-1ad84ed9e891_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of loan</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_f4459dc9-e11a-464d-b74e-b25d245088dd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_9529777c-40ba-4c79-bb5f-7f78c5010e62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_09991ed3-a61b-414e-8c03-7c6a620f36b4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d2f5bfe4-4902-4fb2-b6ec-09867243c8db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_1e570e34-8639-4209-a49e-fd042b7b4633_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_0d41a97b-ba50-4646-9273-3d67e7946fe9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e8fd51c8-4829-4f3b-8ae7-f82822007747_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_dda5b36a-0cf9-4307-9f94-6c535bbcee93_terseLabel_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC</link:label>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_label_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC [Member]</link:label>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_documentation_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TangentAssociatesLLCMember" xlink:to="lab_rdnt_TangentAssociatesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_a84a605f-6721-437c-92ee-400363040c26_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_documentation_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember" xlink:href="rdnt-20231231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingSystemsMember" xlink:to="lab_rdnt_TurnerImagingSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_f9a69174-1014-47f1-86d7-ae8744af9f0e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PreferredStockExchangeRatePerShare_5dd15a28-ce99-43e9-a195-450f52fa544b_terseLabel_en-US" xlink:label="lab_rdnt_PreferredStockExchangeRatePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange rate In dollars per share)</link:label>
    <link:label id="lab_rdnt_PreferredStockExchangeRatePerShare_label_en-US" xlink:label="lab_rdnt_PreferredStockExchangeRatePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Exchange Rate per Share</link:label>
    <link:label id="lab_rdnt_PreferredStockExchangeRatePerShare_documentation_en-US" xlink:label="lab_rdnt_PreferredStockExchangeRatePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Exchange Rate per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PreferredStockExchangeRatePerShare" xlink:href="rdnt-20231231.xsd#rdnt_PreferredStockExchangeRatePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PreferredStockExchangeRatePerShare" xlink:to="lab_rdnt_PreferredStockExchangeRatePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_cb2cbf9c-1f29-4e52-a4ae-da217e84b58b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_4eaa3803-b550-439f-a9a0-f571533ad466_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c980904f-df63-4bb6-86c0-1fc5eed39363_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_119acbb7-fde3-4239-b97f-1b3e5354f413_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d0c57d76-bbc7-41e2-854b-92fbdf34aa7a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b830325-4a3c-47e0-a4fa-81b73146dac8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_ec0bfa70-16e4-421e-9e41-89de1beeb0ad_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_69c3ce18-6ce5-49fd-b138-706e9f0a6a6c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_1c06c6dc-d4e8-4bb0-9365-9d57b9d60755_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20231231.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_46bdbe88-4cb8-4c6e-ada5-b6cfaa5a825a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dfc6f221-bcc0-401c-8f4f-f4479178fd61_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5b99bd7c-e91a-404a-bed5-e540842142b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_68f0a334-d42e-4623-a259-143e8715a238_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SoftwareAndTeleradiologyMember_35329af3-b170-4421-a5ba-7fde5220934b_verboseLabel_en-US" xlink:label="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and teleradiology</link:label>
    <link:label id="lab_rdnt_SoftwareAndTeleradiologyMember_label_en-US" xlink:label="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Teleradiology [Member]</link:label>
    <link:label id="lab_rdnt_SoftwareAndTeleradiologyMember_documentation_en-US" xlink:label="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareAndTeleradiologyMember" xlink:href="rdnt-20231231.xsd#rdnt_SoftwareAndTeleradiologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SoftwareAndTeleradiologyMember" xlink:to="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_03d23411-e0b7-44b5-a100-2b52df70cf00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_daa73e75-31fd-4a28-bbc9-8f8a3610f55c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3d4bfe55-e730-47e6-924e-9261e3d6a4cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to RadNet, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f4e8fee1-9037-4ee2-985e-24c119f45823_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7f07c1a9-a538-4a24-9668-08cd76b1bb6b_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c68179fa-2e60-45ff-8e83-72766fa20ffc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4f096905-9cd7-4ec2-b7c3-e4b36a3aae4c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FOREIGN CURRENCY TRANSLATION</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2e4a5d55-141a-4fb2-82a8-6142c89e163c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_893186aa-0b9d-4fcc-bfed-23fa7284d19d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_91ec41c1-b727-484e-8e3b-8680d17b4fde_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f26be56-8c6f-4440-a921-98455e9e26ed_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_3afd546a-f61a-4655-81db-93f1416361c6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4cfa7adb-06c2-4cc7-841f-bb1c4b56a5c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_667612f5-c797-4135-9bae-176c74015b99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c8e6170b-da68-48e6-a2a6-f4360ba31309_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_58239f83-4d3c-42fb-8912-17e34ab6609b_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5b6a7315-ffe2-4ffd-8f8c-4ab978373e25_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_64bdf876-8dc8-4682-a121-27299a47229c_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.00x but &#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6d5a68e6-9212-4c17-9cfc-001e1ef38d04_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ef681577-2377-4ba8-873c-ca7052788c0c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_b4f0d908-1302-4a28-abe7-405c5f811533_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_c35aace2-de71-48ac-918a-98242819d5ba_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_918c5b1b-2925-4df5-a848-c95a810324ca_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20231231.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3708ef1e-62b4-4972-81a7-ef072669892e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_dfe0b06e-5309-4c97-b736-0ce4310e871d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_1793db2b-d6db-42ee-833e-a283bdadc919_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0cab5240-9127-46e9-9454-3781fb8381b9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_6be62843-6bb2-4fad-8a2c-f125df1b4fa4_terseLabel_en-US" xlink:label="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock to settle DeepHealth contingent consideration (in shares)</link:label>
    <link:label id="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_label_en-US" xlink:label="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Settlement Of Contingent Consideration</link:label>
    <link:label id="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_documentation_en-US" xlink:label="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Settlement Of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:href="rdnt-20231231.xsd#rdnt_SharesIssuedSharesSettlementOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:to="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_1cead410-9ff2-4ee4-bd38-32c0b4a297aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_6a8fe38d-15a4-4669-ab99-a7e58c3265ec_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_348613d3-43fe-4dc3-801b-1cdba8c6e4d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ERADMember_2eba35c1-1564-423c-b2fc-bb16f7a25924_terseLabel_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD</link:label>
    <link:label id="lab_rdnt_ERADMember_label_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember" xlink:href="rdnt-20231231.xsd#rdnt_ERADMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ERADMember" xlink:to="lab_rdnt_ERADMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SantaMonicaImagingGroupLLCMember_818227a1-05e5-4a05-9c7b-4cf3436e14df_terseLabel_en-US" xlink:label="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SantaMonicaImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SantaMonicaImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SantaMonicaImagingGroupLLCMember" xlink:to="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_3454c2da-b566-4f55-ae29-823f634baab7_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_5c2e380f-8ea3-4797-8472-dabd2a3053ea_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_f9fa8a8a-c201-485b-ab77-a45d5a4acef2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_667554c4-9a5a-4a06-a9dc-683036c6a58e_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Arrangements Change In Currency Translation</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Arrangements Change In Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_c9c493c4-542a-4dee-8d3b-808951d78e74_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_451609d1-81ad-4a0f-9b2f-9d6e01ccc728_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AIMember_76517d2f-b1a2-4236-b9bd-306295c2b5e1_verboseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI segment revenue</link:label>
    <link:label id="lab_rdnt_AIMember_895ce970-d189-4650-af70-1672884775a7_terseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:label id="lab_rdnt_AIMember_label_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI [Member]</link:label>
    <link:label id="lab_rdnt_AIMember_documentation_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AIMember" xlink:to="lab_rdnt_AIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ecabb094-88e3-4cf1-bff2-4019c4e2446c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_36aa5abf-00c4-43a8-97f2-2708519f5cd8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_50b91933-9513-402b-969f-ec42b896f6d7_terseLabel_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks</link:label>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_label_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks [Member]</link:label>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_documentation_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember" xlink:href="rdnt-20231231.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatentAndTrademarksMember" xlink:to="lab_rdnt_PatentAndTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_40269c6c-d05b-456f-b8a7-f4123916b55a_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_14b2041d-3fa2-470f-bd5e-84fc8069e4a0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment loan to company outstanding</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_25642e19-0b37-4884-b648-012148bc2b12_terseLabel_en-US" xlink:label="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antelope Valley Outpatient Imaging Center, LLC</link:label>
    <link:label id="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_label_en-US" xlink:label="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antelope Valley Outpatient Imaging Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antelope Valley Outpatient Imaging Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_AntelopeValleyOutpatientImagingCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" xlink:to="lab_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f686a7cd-a353-46d4-8b57-a03a72b501cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_55e9311d-7fb0-4474-b561-3bb98619fcbd_terseLabel_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_label_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid Year Six Thereafter</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_documentation_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid Year Six Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" xlink:href="rdnt-20231231.xsd#rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" xlink:to="lab_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiAdventistMember_d1a7abbf-a9e4-477e-a67e-ac9a4ad7ac89_terseLabel_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_label_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist [Member]</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_documentation_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember" xlink:href="rdnt-20231231.xsd#rdnt_SimiAdventistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiAdventistMember" xlink:to="lab_rdnt_SimiAdventistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_53e1ff4e-981a-4bed-b1fc-e0d51caaa416_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional deferred finance costs on revolving loan amendment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ad3f5285-6942-4c95-9761-d76218349645_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_aa5b8589-7b8b-42fc-b0e5-d8c6f5b7b8ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_92028dd4-ca0f-4339-afe4-3cfd1fde44cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_83adc497-e48c-47c5-9437-8774cf640395_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e8d62894-1067-4c29-a881-1b501bb6081a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_0169ced7-7e59-444b-812d-74b14ceac389_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_d0e786c1-15a3-4448-9041-af6701f31314_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_ef52597d-7c55-4b3e-b5ff-279b3abf50e6_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_a273225b-dbe5-45bc-b7db-39d1fa5868e8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_ab1e71dd-2c50-46d2-a952-b7279c0ff80d_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_dd52c654-c945-4fa9-851f-5141f407be9e_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Notes Payables [Abstract]</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-Term Debt and Capital Lease Obligations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7801b2cb-9523-4249-b22b-5d38f604504c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_c74774f8-2781-44eb-b39d-f31edf67735a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale to noncontrolling interests, net of taxes</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_c3814374-5c6e-4e67-af1d-d2755dce3426_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7ddf8681-2a5d-4521-beec-813801de037d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_94405268-012d-4e87-96cd-1d9c4855b230_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6cc26f4f-b898-4177-b054-539dfbb92849_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_81b4aee1-0e97-4bfa-a21b-869e1485e698_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e53099e6-c43c-49e7-8cc8-27230a0392a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a464249f-10b9-4438-82b0-f06ec1b56135_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_04b2d772-cb4a-4382-af9e-63f6dd07249a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_193e5863-3ac2-490b-8b20-8bd224cd9e0f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_d33878a1-783b-466c-87fd-bb8bbc29ea3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet, Inc. stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_a4bd35ca-2a73-4ee1-8c02-69b33ae0a27e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d3e32d9a-3cdd-48ef-a565-e154b35f9b53_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_54a173ed-dd04-4e6b-a81d-b20c2a9ec4f9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USE OF ESTIMATES</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c1b51642-be41-47be-880d-dc951c3f38ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_569be3c6-3d22-4f96-9fd1-ddd349552b33_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_QuantibMember_66f443dc-7918-44c3-8ff6-d91ff562ff1f_terseLabel_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:label id="lab_rdnt_QuantibMember_63f5a379-cb98-43c5-89f4-77a8c8f1da42_verboseLabel_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib B.V.</link:label>
    <link:label id="lab_rdnt_QuantibMember_label_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib [Member]</link:label>
    <link:label id="lab_rdnt_QuantibMember_documentation_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_QuantibMember" xlink:to="lab_rdnt_QuantibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_157c65e4-b66e-46ec-804b-a0cb8b522367_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_63b4bd82-5ab6-48f5-92c9-2f025a43ba45_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a051a61d-a047-4066-a5b4-4b73f03578c5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_3458ad01-6c90-4805-8bd8-db49bb55cca4_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_117e2d82-dbcf-4161-bc71-5553bea0f88a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_ad831881-77e2-462e-a637-a724c7b44df8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_329034f4-f9be-4430-9608-844822d5f905_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_9cc46272-12ce-4825-b6bf-e4bfcda0dac0_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20231231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_b510b942-2c83-453a-a357-26c4c591cb1e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider relief funding</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_60ff0d71-f737-495e-a7b5-f20823f38239_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_4e7f4ffb-2835-4408-b416-ca87624fc829_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd69b819-44bb-42c3-93c0-a787b492d7ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_deac3759-4054-4389-a3a1-5a1fecf0c28d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_405a3ce8-b415-45ff-bd48-5f3ac87bcc19_terseLabel_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investments</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_label_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Number Of Investments</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_documentation_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Number Of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:href="rdnt-20231231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:to="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_4d347508-5955-462e-8b00-639e8494871d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1f6ee6c7-f4b5-4208-9a59-03ec4b190751_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-LIVED ASSETS</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OtherSellersMember_0a15c0c9-22cd-4e42-bb5c-3cf52c6dea15_terseLabel_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers</link:label>
    <link:label id="lab_rdnt_OtherSellersMember_label_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers [Member]</link:label>
    <link:label id="lab_rdnt_OtherSellersMember_documentation_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember" xlink:href="rdnt-20231231.xsd#rdnt_OtherSellersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OtherSellersMember" xlink:to="lab_rdnt_OtherSellersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bc03e115-ca1d-40e7-8364-f478aa8f42fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_d972cf5f-e934-4e77-9476-7635fc1823f9_terseLabel_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="rdnt-20231231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_ffa8a3f0-53bd-4d12-8098-468504b62b56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_094eb51c-10eb-42cd-9de1-3e64dcbbe31d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_d092ca86-d42f-4234-802b-b0f5c737bf2a_terseLabel_en-US" xlink:label="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited liability company (LLC) or limited partnership (LP), managing member or general partner, ownership lnterest disposed</link:label>
    <link:label id="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_label_en-US" xlink:label="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest Disposed</link:label>
    <link:label id="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_documentation_en-US" xlink:label="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest Disposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" xlink:href="rdnt-20231231.xsd#rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" xlink:to="lab_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_6c95a7d5-9b96-40ad-8578-0766d923b6d8_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_0c5ddd39-01ae-40f3-a9ab-6e98e0a23055_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_9825c4db-251c-4fc0-a5c7-5d80e9535d54_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_91148b02-0038-4bec-90cc-16a9773d1289_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a379583d-b7ac-482b-8d18-0a82f0ea464d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_cc31caea-1b63-4002-9285-32f109ae58b6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_98e791d3-705f-458b-90d1-504600fd530a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bc16356c-6c6e-46d9-9226-c502083bee0b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SunTrustMember_4c664fc3-cf56-4dde-879c-dfed93ac3246_terseLabel_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust</link:label>
    <link:label id="lab_rdnt_SunTrustMember_label_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:label id="lab_rdnt_SunTrustMember_documentation_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember" xlink:href="rdnt-20231231.xsd#rdnt_SunTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SunTrustMember" xlink:to="lab_rdnt_SunTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_685d6c43-eb09-4f5c-a2f4-e547bd84c4b0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_659ca140-4a22-4460-9958-969ebbc75722_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_f4d864ba-cda9-4824-ad05-b30244bd16c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax provisions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_d4b7b30b-4379-456e-b2ad-83862f12ad14_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_d3a930d7-d8fb-40d9-80b5-2d4697e7d7be_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a6a1cc56-7a10-4752-9663-9c175948fd05_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_84d9c5ec-a2b3-4f41-bbf1-bf871823f0d7_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionsMember" xlink:to="lab_rdnt_BusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_fe65bb0f-8e7d-4817-aff3-5022d6813c26_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_11e334b0-89c6-434b-a8cd-e5ddea10fc4d_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Ownership Percentage, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_55c021f7-86f4-4edb-9931-7b5ddcb3aff2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise price Per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_166315c2-9ebd-466a-aff6-2ef326fb656c_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20231231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7c9d1a67-29f3-448f-80d7-35bdba70969d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_33578fa5-e454-4ee9-80e3-a8cf184d9319_terseLabel_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Lessee</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities Lessee [Table Text Block]</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Assets And Liabilities Lessee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="rdnt-20231231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CCDGLRSServicesIncMember_c2b4f00b-d058-46e3-a769-527d75807aaf_terseLabel_en-US" xlink:label="lab_rdnt_CCDGLRSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.C.D.G.L.R. &amp; S Services Inc.</link:label>
    <link:label id="lab_rdnt_CCDGLRSServicesIncMember_label_en-US" xlink:label="lab_rdnt_CCDGLRSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.C.D.G.L.R. &amp; S Services Inc. [Member]</link:label>
    <link:label id="lab_rdnt_CCDGLRSServicesIncMember_documentation_en-US" xlink:label="lab_rdnt_CCDGLRSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.C.D.G.L.R. &amp; S Services Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CCDGLRSServicesIncMember" xlink:href="rdnt-20231231.xsd#rdnt_CCDGLRSServicesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CCDGLRSServicesIncMember" xlink:to="lab_rdnt_CCDGLRSServicesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_d40e6ed9-cd52-4ba6-a5a7-bac9f630f4b7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_a5b1496f-6361-4a48-88d1-c4a4a06abfdf_terseLabel_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology &amp; Software</link:label>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_label_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology &amp; Software [Member]</link:label>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_documentation_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember" xlink:href="rdnt-20231231.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DevelopedTechnologySoftwareMember" xlink:to="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_969b3298-90ec-4371-8eaf-e285382314fa_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_dd68a226-0949-496f-ac81-5dc06f0351d2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_5bf84eea-0e9a-4a07-91b8-7cb26bf96111_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f8cf8a47-e343-47fb-ad58-9263cbf89ec3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_04ff0046-0bcf-4243-974c-343dd4ea6c29_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_afff280f-2e59-4c72-b940-4e372fbf4911_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INDEFINITE LIVED INTANGIBLES</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_385551e6-f6b9-4b14-a96d-e7548e163357_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_c142a4dd-2a64-479a-afd6-d178b9a0ba3d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_d69c322b-d294-4ad1-9f29-57adaf369a43_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets and Deposits and Other</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AuditorInformationAbstract_label_en-US" xlink:label="lab_rdnt_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_rdnt_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_rdnt_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AuditorInformationAbstract" xlink:href="rdnt-20231231.xsd#rdnt_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AuditorInformationAbstract" xlink:to="lab_rdnt_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b406bfab-3328-44ae-98cc-d2cc5782233f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_0c7693da-8e21-46c1-bf56-27ad6e39e86b_terseLabel_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Operations</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_label_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_documentation_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:href="rdnt-20231231.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:to="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_92b88e8b-1eb6-4a69-bd08-1b89a839039c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_33727077-fc9a-4a65-9c00-710b5e688434_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0109429a-1299-472e-9d6c-d9cf2c3b77df_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_9df3f598-fdb3-4292-93db-4bf67c31c6b3_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryTwoMember_8d3ae829-f8d3-4d83-b8d6-98aeb152107f_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary Two</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryTwoMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary Two [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryTwoMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCSubsidiaryTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:to="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ec8990a8-df55-494c-8fca-bca7507efffa_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_13b8e2b6-0bf1-410a-a97d-430ae96eddb9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_bec5d56e-fe06-4a4f-a1c0-79074d5d7325_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_52e78c8b-9b78-40ba-8969-fc5f68d1ddcb_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radnet, Inc. Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_5b4acf9b-b6cf-4db4-aeec-fff8ddc90021_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fff10fa-966a-4d05-9501-6860537b8be2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0c3b5a85-c86c-49e1-a5fc-3963782ef9af_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_cd5484fc-a350-4b8d-a1c4-53e87f9f953e_terseLabel_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:to="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e4ee9822-7954-4a2c-b4c6-cd66178cd390_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3dcc7f61-4be4-4917-af3f-abb2e57e1d29_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashHoldbackMember_0a4f2a28-8030-490c-803a-0f7cd06c96f0_terseLabel_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_label_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback [Member]</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_documentation_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashHoldbackMember" xlink:to="lab_rdnt_CashHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_77a8d247-5d6c-4335-8ae6-d662a914e9f8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_85b1f50e-66a0-45fe-94b6-4c30056e3ae4_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_22f9f176-cf3c-4aa9-afb6-cfebe6875502_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_839e8a71-3e6a-4303-9703-9c559741dc55_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_79a2102a-9bd2-45ed-9e25-d62ae9b5ece3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_29c03bfe-133a-4a9c-9fc9-073e127b00b9_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20231231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_2dc796c4-0c5b-46bd-84b6-b8c50f3e299a_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_eb3b316f-4ac7-4023-b51c-7f36397b2843_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7dd9f82a-69f7-4d4c-9fd5-fa0f21ce4752_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCentersMember_c8b635b1-1697-4879-bc37-272bf023c459_terseLabel_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_label_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCentersMember" xlink:to="lab_rdnt_ImagingCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_7ac64075-05ab-42f5-82d9-e0b616c79f8e_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ArizonaDiagnosticsGroupMember_ff48d3c7-eff6-40dc-9863-234f517356c8_terseLabel_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostics Group</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticsGroupMember_label_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostics Group [Member]</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticsGroupMember_documentation_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostics Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember" xlink:href="rdnt-20231231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ArizonaDiagnosticsGroupMember" xlink:to="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_2d9d67c2-24ae-455c-9d05-402703514373_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_21d4ac5d-4e37-41bf-bc19-df11dc0d80a5_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting traches</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_a29f1304-bdfa-4ed0-8755-b1b9fa516e4f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Received a dividend from the partnership</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_c5a539c4-a228-45cd-93e2-7296af94a6dc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9eddd5c6-ecbb-4856-8a4b-b7450a373bc1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_32d2ae32-340d-432e-be5a-662bfcd2a32c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7f0ae06f-41ed-4b08-9c8f-0ebcb18fe26f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_4d93df7c-052a-423f-8af3-a3c939913ecf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_0b6a83bb-877a-4395-a342-6bab040f641c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e2296756-c5d0-4c97-be2a-ff5a15f3ba2f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4f888d7f-d840-476c-8e71-20d4bf2a1d60_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_c1989bf0-1515-45ee-a8d1-104b106f1c65_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_2367dc8f-b467-4390-9cc1-c5a1413f52ec_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_d669d40c-73d6-4cfd-85fa-b2d1bf83accd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-ups and other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_d097ad60-130d-4c31-bf0f-065475c1bba6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_eafb30af-e45d-4e95-bbb6-f98af1c09848_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_1fa54651-7325-446c-85f4-8b941a17f494_negatedTerseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Canceled (in shares)</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_9e568ce5-552d-44f0-aa3f-311130bed8f5_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of identified milestones</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Identified Milestones</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Identified Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_ac4e8b01-2866-4121-868a-498600966608_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_55cf7b00-bfd9-46eb-93a2-a40363d53e4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_1ba8c804-d6d6-4bbf-8f69-36bd14e226d4_terseLabel_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTIPs</link:label>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_label_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares [Member]</link:label>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_documentation_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:to="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_da9d13fc-f94c-409f-80e8-777846829b70_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $.0001 par value, 200,000,000 shares authorized; 67,956,318 and 57,723,125 shares issued and outstanding at December 31, 2023 and 2022 respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cce89f25-c6a4-499f-acf0-1ea66d9c9578_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_177e7b84-4121-4bf0-9143-8fddb40e928d_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_139d0f8c-a2e5-4639-ab27-3ae9e58bb247_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_13851165-062e-4aa6-8747-4618753b4dd9_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority partner ownership percent</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_9710f970-64c5-4f4a-b525-4dd4bc889409_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_68c39191-7772-4511-9651-839f7194ade8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d041f5ea-d30a-48d9-83ba-78c2614cc384_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4228c214-99a2-4ca5-ab9a-96489982ca74_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1d41a121-b586-465a-935d-a03b4fee41d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_eb917dca-60d0-4be9-9498-320c754496c9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_4991d2e4-2097-4a6e-9066-ed64e4a1beae_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52e31c52-6cfe-4d17-8630-78dfaf9ca0d0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ea770f13-9979-4179-b068-9c9186203fe2_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4fc0b831-4158-4e97-b436-4f7fd8ee7efc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_82c53077-7e60-43b2-84c7-0dfdcd424874_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_a4ce0679-fd42-4c77-abf6-4eb4ec523c40_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_12176762-1f32-4cf0-bf42-9811db211a91_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_abb4f121-af08-4a98-9d64-c80590fd3683_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_5320fd42-e476-4d12-9042-71ce31b92fa6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_8dbfafd1-4b4b-4a95-a196-1c314641dfeb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_17f9b1ed-e433-4489-98f5-298d0adde178_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_e316cd8a-9dcb-4a5d-8667-02a47cc8e803_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Base Rate Spread</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthIncMember_a0f0dd02-b1a2-4b6c-bb66-a723a98877ee_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_label_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_documentation_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthIncMember" xlink:to="lab_rdnt_DeepHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_cb0c8257-198a-4010-9928-aa4da537239a_terseLabel_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration</link:label>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_label_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration [Member]</link:label>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_documentation_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContingentMilestoneConsiderationMember" xlink:to="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_8fe769dc-2783-432a-81bb-5dd4eeac9aa8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedPartnersContributedCapital_19fb2a75-ee78-447f-875d-d8461cbea111_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedPartnersContributedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partners' contributed capital</link:label>
    <link:label id="lab_us-gaap_LimitedPartnersContributedCapital_label_en-US" xlink:label="lab_us-gaap_LimitedPartnersContributedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Partners' Contributed Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersContributedCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersContributedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedPartnersContributedCapital" xlink:to="lab_us-gaap_LimitedPartnersContributedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_666c961c-b7a2-4b9a-bec3-e09e1983a303_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatientServicesNetMember_448e8c69-68ad-46f7-9ce6-8457ede6aeeb_terseLabel_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_label_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_documentation_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember" xlink:href="rdnt-20231231.xsd#rdnt_PatientServicesNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatientServicesNetMember" xlink:to="lab_rdnt_PatientServicesNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_736c5019-3d16-4d42-a394-531ffca7c833_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20231231.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_21e140cf-0735-4800-b4a5-51c5b4fd140b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d524c075-4139-4f32-9d85-7b0385c10940_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_0c450b42-008e-499b-8c3d-b9574fbc8462_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_ed1698e6-b589-4438-bde6-19b0598e1748_terseLabel_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="rdnt-20231231.xsd#rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_52055e27-7ad6-439c-906b-09ff226c7707_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4453caaa-c9d1-43ee-bf59-f88c977bcb11_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_cd62adf3-7678-4529-8e3c-0f999a67292d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_14a0cb58-b9c4-43ac-82a0-101dc72d0bf8_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State current tax</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_51c5d057-8488-4159-927d-fbb653e1e5e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NorthJerseyImagingCenterLLCMember_0a383aff-ca28-4ee1-aa74-5e802e6d5da7_terseLabel_en-US" xlink:label="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Jersey Imaging Center, LLC</link:label>
    <link:label id="lab_rdnt_NorthJerseyImagingCenterLLCMember_label_en-US" xlink:label="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Jersey Imaging Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_NorthJerseyImagingCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Jersey Imaging Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NorthJerseyImagingCenterLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_NorthJerseyImagingCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NorthJerseyImagingCenterLLCMember" xlink:to="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_8fea5cdc-12d3-46b4-9940-eefb7128fa94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9b1ed9bd-0ca2-446f-9b14-85f002fa8266_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject to service vesting</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_9fdb4868-46e9-4290-a8c0-f47b579db1ae_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_f0f844e8-a50e-4e9b-9ece-f081ca4a5887_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of economic interest in majority owned subsidiary</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_label_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" xlink:href="rdnt-20231231.xsd#rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" xlink:to="lab_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_322157c0-cae9-4981-90c8-897629c2a5cf_negatedTerseLabel_en-US" xlink:label="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contribution of assets to majority owned subsidiary</link:label>
    <link:label id="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_label_en-US" xlink:label="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary</link:label>
    <link:label id="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_documentation_en-US" xlink:label="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:href="rdnt-20231231.xsd#rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:to="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_44526ea5-5bb8-4460-9b49-1beea252d812_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f60215a-2046-40c4-a7c3-990ae66bc062_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_5e18d0dd-08b5-4dd3-a9a1-80b30d000714_terseLabel_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNINSURED RISKS</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:href="rdnt-20231231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:to="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_f7477f0b-628b-4542-b1b8-2e780d42d99a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e0a856f8-9630-4fa6-b80a-f2cc79b7e209_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f06cc60-ec1e-4428-bef4-06c0e2620d89_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_06221401-3fcb-4e5f-9818-4c8b9f282197_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_9808e074-9eaf-4c6b-ae67-a4a4dd0232ee_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_a1b2d8d5-1f88-47c8-8b52-6dc51982bca0_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_b7a62bd4-dbfb-4dc4-9e4f-d3f099903a7b_terseLabel_en-US" xlink:label="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_label_en-US" xlink:label="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contributions in Existing and Purchase of Interest in Joint Ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_documentation_en-US" xlink:label="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:href="rdnt-20231231.xsd#rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:to="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9a6f9d71-12e8-4901-bc17-f922e6a978ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HoustonMedicalImagingLLCMember_5ac0ef35-6b90-4a5c-af0f-18696716d2e6_terseLabel_en-US" xlink:label="lab_rdnt_HoustonMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston Medical Imaging, LLC</link:label>
    <link:label id="lab_rdnt_HoustonMedicalImagingLLCMember_label_en-US" xlink:label="lab_rdnt_HoustonMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston Medical Imaging, LLC [Member]</link:label>
    <link:label id="lab_rdnt_HoustonMedicalImagingLLCMember_documentation_en-US" xlink:label="lab_rdnt_HoustonMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston Medical Imaging, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HoustonMedicalImagingLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_HoustonMedicalImagingLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HoustonMedicalImagingLLCMember" xlink:to="lab_rdnt_HoustonMedicalImagingLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_82f3fff0-dd84-485f-ba29-f24dd65836d9_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, percent of total amount</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1b2e1149-4b7a-4ffc-81e4-352bc41073d8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_57d2ccac-fe10-4b0b-8f28-8715c8b02bc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_d775d02f-65f9-4c17-96a1-fc71833742ca_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Different between the sales price and carrying value</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_bd7b0557-1fab-4c93-8c76-9c8468865a58_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0578c298-1b0f-4d2d-99c0-f62dd07b5ff9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_2b29c0ff-3af4-44dd-948e-60bcc8396f0c_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_2af2c1cc-133a-4e3a-9b5d-14bd01a91b9a_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_40502026-da24-474f-ba47-bc4076c6c1c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_eb38a968-f5d8-4e5f-8d50-2cd95030cac8_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:to="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_75a3e873-d70b-4572-8f62-d1fe1a026957_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_83954447-f1f2-4a3d-8429-51ff691caca4_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20231231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_02fac884-65a6-4d42-9ce0-0b5df4f7e17f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_162a9f1c-1379-4812-b602-76a05ebee234_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable, additional number of shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_735c11fb-a3e8-4545-9d84-008aa2abe635_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility, borrowings available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5c7d2244-07a7-4ef9-a1c0-acffdf03d0f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_732558ce-c7c7-4f61-a5ea-2bc48862bc28_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cf337c72-6882-4d2f-8179-ac7c19ce3673_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4dd130f7-82cb-4b34-9799-da4ac2bf9b48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_d927f302-970b-4961-b81b-fdb75ccb5a5c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment at cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a18450b1-5115-4ce7-8d99-6688b9c4833d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_059aa537-3b75-4161-b39f-833151770061_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HeartLungImagingLimitedMember_1c10bab8-3882-4a3a-93c4-af3efce2541d_terseLabel_en-US" xlink:label="lab_rdnt_HeartLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart &amp; Lung Imaging Limited</link:label>
    <link:label id="lab_rdnt_HeartLungImagingLimitedMember_label_en-US" xlink:label="lab_rdnt_HeartLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart &amp; Lung Imaging Limited [Member]</link:label>
    <link:label id="lab_rdnt_HeartLungImagingLimitedMember_documentation_en-US" xlink:label="lab_rdnt_HeartLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart &amp; Lung Imaging Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartLungImagingLimitedMember" xlink:href="rdnt-20231231.xsd#rdnt_HeartLungImagingLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HeartLungImagingLimitedMember" xlink:to="lab_rdnt_HeartLungImagingLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_ade0163a-d34b-4f42-b34f-4f3c1cabb156_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of LTIPs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_2e157889-5fa4-4962-8e71-9bc7391c721f_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_58209ae0-1d05-4c7b-afa5-821c65102fe1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fdfaa6ac-cc29-4a98-af62-1c2658ad7304_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_bda03bdb-66d6-4b03-b990-991d66f8fce9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_53745550-101e-4239-ad19-964fd88442b2_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_779dd8d6-a75b-44b9-8457-9b4205342004_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock_78a7d0f5-0f8d-421c-805e-decd091c4515_terseLabel_en-US" xlink:label="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheulde The Estimated Fair Values</link:label>
    <link:label id="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheulde Of Estimated Fair Values [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheulde Of Estimated Fair Values</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" xlink:href="rdnt-20231231.xsd#rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" xlink:to="lab_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2da4dced-d504-4d01-ba8a-676f3614af6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_28a5c628-390a-4f49-bcf0-9044eab450b1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_31e71a4e-4235-4534-9369-2240308e6213_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f49c7ea-5c1a-4e05-9e75-dace5f8d890b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_d9e832d4-bce6-4ef8-a601-37af87049ee7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_8e017680-a396-4d88-a082-89fe750c7386_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20231231.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_79e6022a-fd2c-4372-b7ab-0f787adf4bd6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_0509dadb-4540-411b-86da-de9e9def1b05_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_650acc8d-ad44-4d0c-a583-3872d8c6d447_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d42c2821-eb7b-4051-b9df-1fefeb93c899_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d8b5bd96-1593-44be-a8f2-32b808c64b92_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_09e92aed-dbe3-463b-9fa6-ccb0087a8c9e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_690c964f-9c9c-491d-a418-c34c3da80aa8_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software developed for internal use</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_10ebcae2-b356-4bc0-84e3-1fcea99908da_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_3212c566-219d-4a03-9860-a5fd8fcb7bca_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_410e1ec1-f89a-400b-afde-0d65a0e40c9b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_feefa8b0-2760-4834-a8ce-b39964c40c3e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_40b1af62-0ea3-4ecf-8ead-4d08e717af8c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5bf76050-614e-438a-b7a4-a402430b01ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_a87a93b1-c13a-4add-a63f-ba275e84de80_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign current tax</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_74dcb5eb-3c80-4c92-a461-76e85743eb8e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_757139b3-4e61-4ea0-9b91-cfa67bf34aeb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to RadNet, Inc's common stockholders for diluted share calculation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_52b0a1a7-1ef0-4b5c-a0dc-1388a1144fac_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_b9553031-7969-4487-984b-889a7d6628b1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_f71704d0-45cd-473b-af25-7c10cab12c30_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d0491ad5-6c88-410c-9504-1378c108a504_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8ef9d71c-8fb1-4769-9a43-e50bfbf9de2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9a35bc5e-02c0-4deb-be7a-b501bebb3f84_terseLabel_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stop loss policy claim amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_label_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_documentation_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:href="rdnt-20231231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:to="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e6c6d0a1-84ce-4ffe-bbaf-7d0b547a721f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_ad144ef1-2f9e-44bd-b1bd-882d560c75a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_4380190e-84de-45b6-9ec9-2bb515df08b6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_ad24f474-9b75-45b6-b01b-5d12c0fbecb3_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_93f55188-6b71-4ac0-a74f-985baf55d080_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4ceb889f-bf1a-4802-ba50-386771ac0064_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_97ba9fd3-781e-4c00-8013-3d3a18beabf3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MontclairRadiologicalAssociatesPAMember_f1bdf966-1049-4a87-b286-ff3202907bcb_terseLabel_en-US" xlink:label="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair Radiological Associates, P.A.</link:label>
    <link:label id="lab_rdnt_MontclairRadiologicalAssociatesPAMember_label_en-US" xlink:label="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair Radiological Associates, P.A. [Member]</link:label>
    <link:label id="lab_rdnt_MontclairRadiologicalAssociatesPAMember_documentation_en-US" xlink:label="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair Radiological Associates, P.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:href="rdnt-20231231.xsd#rdnt_MontclairRadiologicalAssociatesPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:to="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_65ac64eb-af90-489e-a451-7c3276fb097c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_ef355c68-0ffc-4925-a0b3-eab00fa4cc5c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RavenHoldingsMember_1fd0d9d7-5505-488f-b76c-4edf37a42fc3_terseLabel_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_label_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_documentation_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember" xlink:href="rdnt-20231231.xsd#rdnt_RavenHoldingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RavenHoldingsMember" xlink:to="lab_rdnt_RavenHoldingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c801308-e2bc-4e72-be20-a4e389fcb452_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_e0d5b8bf-fedb-469d-8e3f-a0c6703e910c_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add additional shares issuable upon exercise of stock options, warrants and holdback shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7a129def-4192-46d5-a65a-244e3ba5bce4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IntersegmentMember_5cc6ef9d-b184-43f0-b567-1cd8a28a1c33_terseLabel_en-US" xlink:label="lab_rdnt_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_rdnt_IntersegmentMember_label_en-US" xlink:label="lab_rdnt_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment [Member]</link:label>
    <link:label id="lab_rdnt_IntersegmentMember_documentation_en-US" xlink:label="lab_rdnt_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IntersegmentMember" xlink:href="rdnt-20231231.xsd#rdnt_IntersegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IntersegmentMember" xlink:to="lab_rdnt_IntersegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_3e72408a-d899-44cd-b6da-1027ae61b17a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_08af48ed-08ca-4c85-b7ce-c6d5136a5caf_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_e2a8f91e-5352-4f71-a091-ecd94bf4e73e_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_bb86d211-65ac-4409-9c72-227f3108ce44_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_8181fcc4-20e7-44a5-b94e-d0decd24b9b9_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, leverage ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_label_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentLeverageRatio" xlink:to="lab_rdnt_DebtInstrumentLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_559b6566-2a98-4ad0-a563-2a94b1a4f4ba_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_e8c60039-6931-4741-9cbd-107783e87e83_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_6c908a7f-4c9b-474d-aee2-82b9aa40b513_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Contingent Consideration</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Settlements</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_072d060e-3a45-4163-9f5c-46a62d972c7f_terseLabel_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc.</link:label>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_label_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_documentation_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember" xlink:href="rdnt-20231231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FrederickHealthHospitalIncMember" xlink:to="lab_rdnt_FrederickHealthHospitalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_1dd24dc3-70c9-4272-af20-1b53a01b446b_terseLabel_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued in acquisition</link:label>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_label_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</link:label>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_documentation_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:href="rdnt-20231231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:to="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_93016fce-9f99-4304-9ddc-a5c9c2332e5c_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_4d592779-be91-4c55-a6b8-cbd473062464_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_6af13e0e-a542-4b48-819f-900351aadadb_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_9cee242c-4563-42eb-9718-b8b22834001d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_d517261f-b849-425a-ac8d-89bdbf25e429_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4f58a67c-4c39-449b-a030-be56a018dba7_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d3b07959-1c8d-419b-bfe0-5e87131366bb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_2edffef4-ff2b-462d-a9a6-f5f9dd68c086_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20231231.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9aafb088-7ea2-4834-83e0-cdfb4da837f3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_011c8ea0-97ab-4eb2-943a-330e688960ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7e468491-2f03-4cc7-b586-ff83c24dbc88_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_01557c85-6859-4b66-b694-06d1f4e49c7c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9aa2b84d-207d-4734-a85a-cc138e636fcf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_c83f04cf-2c97-4e5a-aa1d-4146cd04f780_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued during period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a96edd27-ca24-43c4-ad7b-a35a671055c0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_86e3aa91-a152-4f26-b32f-d5ce41561384_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Valuation of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_6c6afc5b-67ab-4195-905a-613b5890d2a2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_c70684fe-31cc-4a08-b4da-94f46bc9c959_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_bf202018-9574-45a8-b77d-78a2bf71312a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PublicOfferingMember_17d914db-9ec5-44fe-a75a-3205aa975efd_terseLabel_en-US" xlink:label="lab_rdnt_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering</link:label>
    <link:label id="lab_rdnt_PublicOfferingMember_label_en-US" xlink:label="lab_rdnt_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering [Member]</link:label>
    <link:label id="lab_rdnt_PublicOfferingMember_documentation_en-US" xlink:label="lab_rdnt_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PublicOfferingMember" xlink:href="rdnt-20231231.xsd#rdnt_PublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PublicOfferingMember" xlink:to="lab_rdnt_PublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_47e2f74b-64bb-4cba-a818-8f4b13f680bd_negatedLabel_en-US" xlink:label="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_label_en-US" xlink:label="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture</link:label>
    <link:label id="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_documentation_en-US" xlink:label="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" xlink:href="rdnt-20231231.xsd#rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" xlink:to="lab_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ThirdPartyMember_39812e0a-228d-487d-9515-962ef9a1573f_terseLabel_en-US" xlink:label="lab_rdnt_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:label id="lab_rdnt_ThirdPartyMember_label_en-US" xlink:label="lab_rdnt_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:label id="lab_rdnt_ThirdPartyMember_documentation_en-US" xlink:label="lab_rdnt_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThirdPartyMember" xlink:href="rdnt-20231231.xsd#rdnt_ThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ThirdPartyMember" xlink:to="lab_rdnt_ThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3b6b9ef2-7f3d-4e5d-8188-55fb8d9f35f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_eca81ef8-a3ac-4144-9a28-564c227ca249_terseLabel_en-US" xlink:label="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20231231.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_534404d6-0f61-46d9-8804-18618e52552e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_679441cf-3bb6-455e-92ac-8620f79024a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_55ad0d17-0fab-4943-8a31-724f724de162_terseLabel_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term of contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_label_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_documentation_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract" xlink:href="rdnt-20231231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeLeaseTermofContract" xlink:to="lab_rdnt_LesseeLeaseTermofContract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member_50b89c37-fdbb-4ce2-84f8-e86f92b167e9_terseLabel_en-US" xlink:label="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member_label_en-US" xlink:label="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR1) [Member]</link:label>
    <link:label id="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member_documentation_en-US" xlink:label="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR1)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LondonInterbankOfferedRateLIBOR1Member" xlink:href="rdnt-20231231.xsd#rdnt_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LondonInterbankOfferedRateLIBOR1Member" xlink:to="lab_rdnt_LondonInterbankOfferedRateLIBOR1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d5bfee37-a0ba-454f-b206-a17ae01ac76d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_967fdd10-85ec-4f16-85c0-912c529f0422_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment Summary [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_a6aabf27-6400-47e4-a08f-cb0f5475ec19_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salary and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_ecfbc872-a2b6-4766-9fe2-8caf5d936470_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_8db90044-46df-44e1-8617-1c39ded047d5_terseLabel_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net</link:label>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_label_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and Equipment, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember" xlink:href="rdnt-20231231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProperyAndEquipmentNetMember" xlink:to="lab_rdnt_ProperyAndEquipmentNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_b22e2d6f-ba3e-4660-957b-712b190cad1d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_70b57dff-1965-4a98-b2db-12c19bf9f3ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_42166332-d7b5-4d4f-a494-4ab753269103_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_143ef240-9de8-4ed4-955c-94d85412c0d2_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_577b612b-25f4-4847-b1c4-d1c60c7d7e40_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bdeb341c-9462-40cb-8836-a5323db05058_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_44466c7d-2bda-4538-8be7-953f499a5d27_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_faae4b04-26b6-4746-b63d-1b294b421d04_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, tax impact if recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c52de70a-6a75-4589-9e39-2181ed4e4333_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_441b6c13-984a-46f3-ad6b-6d62aa7b10f7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_01acf4db-cfbe-4b46-8201-0218d357e387_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_ecc6ed04-d8ef-49db-95ef-278025f746f0_terseLabel_en-US" xlink:label="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Months Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Months Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Months Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:href="rdnt-20231231.xsd#rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_9060fde4-807f-4c19-bddc-65bf1cdee104_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests in partnerships</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_41523b08-c3f4-40ef-9581-d9df0d8babc6_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20231231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_1dfbd795-c3e9-489e-8a8b-94c51d16a5f9_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20231231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_7d802ca9-0e9f-4396-91d5-9fd9fdeb5c38_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_beb91f17-783f-4669-a256-9b68c3a6e902_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_1263ce18-d385-4a6e-ac52-1caa44b06721_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_7d5c28b3-c70d-41ff-a31b-6470ef063690_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_f0651e5e-d578-4685-be8a-61d993c9c9c4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfAssetsSold_442bc347-4a96-4619-9539-9f3eb1b403cd_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfAssetsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets sold</link:label>
    <link:label id="lab_rdnt_NumberOfAssetsSold_label_en-US" xlink:label="lab_rdnt_NumberOfAssetsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Assets Sold</link:label>
    <link:label id="lab_rdnt_NumberOfAssetsSold_documentation_en-US" xlink:label="lab_rdnt_NumberOfAssetsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Assets Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfAssetsSold" xlink:to="lab_rdnt_NumberOfAssetsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12699326-0643-42d0-8dde-e2821eb662f7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_227fd9b1-505b-4bf9-b2fa-cdd42ac65d2e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_feaa132a-b934-42ec-9a4f-ac0f4ba7d8c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount, current</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_454c906b-c630-4d4d-9db8-6eda38036b58_negatedLabel_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside basis difference</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_label_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Outside Basis Difference</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Outside Basis Difference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxLiabilitiesOutsideBasisDifference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:to="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_14c9c3ee-5ac7-452d-a239-5dacc4f29866_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 6 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b6c5e3b7-02da-4017-8ba2-2040c745fe4c_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_30ab2d58-c7c9-4bf3-a853-89f3a3ecfce2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_d40dbb99-1965-4003-89ee-acf46dd216f6_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to change in rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_537ef7b7-400f-45ca-8e25-8b6c70f7200c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_5345fa9a-7a73-4c21-bfe0-485ac170a1f8_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_c48f5430-3a00-484f-b5d6-592cc758c0da_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1d4213ad-e807-4660-857a-3ed4c1d7a8c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_05a2a0d0-062f-4707-833f-bfada10665fa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_631a69a3-4e9a-4f03-9e12-1345293d3420_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d9831a14-16be-47b7-b7e4-b04a2ee3a301_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_f4c8c2c0-f4a5-4042-840f-ce6f467602a0_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_da54b061-f689-4dc1-9765-a781ca557768_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92aeda32-81ee-41b9-8189-a5d3dde3167a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCMember_2fd3c0ea-0746-48bf-8909-8d90f4619bc7_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C</link:label>
    <link:label id="lab_rdnt_IFRCLLCMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCMember" xlink:to="lab_rdnt_IFRCLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_a704b225-b799-4742-9a75-15a183d9ed26_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2035af79-1d50-4a6a-8f10-53b07c2f111f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued as consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7660e913-7c27-4839-bf4d-4838fbda6f0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_19b4c659-d04e-434e-85b4-74db63ca72e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_9e17b34c-e245-48a0-912a-f16506cd4a68_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ba332e0-62bb-4932-8c5a-94c28d899830_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ac339deb-ab5f-4746-91fa-8a772b46af7e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_aaae258b-71af-453f-ab92-f1006181e116_terseLabel_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. milestone consideration</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_label_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. [Member]</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_documentation_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember" xlink:href="rdnt-20231231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceHoldingBVMember" xlink:to="lab_rdnt_AidenceHoldingBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1aed1aba-64df-4c65-8120-0931c4f83020_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GainLossOnContributionIntoJointVenture_216a9d9a-8357-4614-b6ae-f785eded2072_negatedTerseLabel_en-US" xlink:label="lab_rdnt_GainLossOnContributionIntoJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contribution of imaging centers into joint venture</link:label>
    <link:label id="lab_rdnt_GainLossOnContributionIntoJointVenture_label_en-US" xlink:label="lab_rdnt_GainLossOnContributionIntoJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Contribution Into Joint Venture</link:label>
    <link:label id="lab_rdnt_GainLossOnContributionIntoJointVenture_documentation_en-US" xlink:label="lab_rdnt_GainLossOnContributionIntoJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Contribution Into Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnContributionIntoJointVenture" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnContributionIntoJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GainLossOnContributionIntoJointVenture" xlink:to="lab_rdnt_GainLossOnContributionIntoJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d4c7749-56af-4072-a835-69bc3f14dead_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_8a3d800d-9566-44b7-accd-94d3051c9b50_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SaleOfStockCost_6a9eb857-a406-45cf-b59d-697f9e15a7be_terseLabel_en-US" xlink:label="lab_rdnt_SaleOfStockCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering expenses</link:label>
    <link:label id="lab_rdnt_SaleOfStockCost_label_en-US" xlink:label="lab_rdnt_SaleOfStockCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Cost</link:label>
    <link:label id="lab_rdnt_SaleOfStockCost_documentation_en-US" xlink:label="lab_rdnt_SaleOfStockCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SaleOfStockCost" xlink:href="rdnt-20231231.xsd#rdnt_SaleOfStockCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SaleOfStockCost" xlink:to="lab_rdnt_SaleOfStockCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_7ee929cf-8e7d-4427-8791-fc4a8475c385_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20231231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_67cb7e96-33c4-45e1-a8c2-347209f52a52_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d6ddeae3-7077-4048-9370-bbb6d827276a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_760e97bd-650c-4e5e-a58f-a26996f7af77_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_33a94228-b41f-46da-b4b4-b29ac9a28f75_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_b99bab0e-22a3-40ba-9283-44ff58a5a86c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_84b1425c-c405-419f-ba84-412c0483e66f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_e8614fb9-950f-4514-a33d-0c7c9e210d87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_2182aa41-ab80-4ed7-8e50-fa0818e797ed_negatedTerseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_label_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:to="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_918f7a42-7f08-4d0f-b883-c5a7b435e3d7_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_c946887c-1ebd-4858-a06c-313bba81e7fa_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_87c01000-3480-4f47-a578-651f03d3943f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>rdnt-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:97227b0c-cc0e-485b-bbeb-be4e8b957c79,g:17ec1eaf-cfc2-4d82-aff2-f13ccefcfa9a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/COVERPAGE" xlink:type="simple" xlink:href="rdnt-20231231.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8918ba01-8f3b-49f3-b73f-937dff8b6c3d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentType_8918ba01-8f3b-49f3-b73f-937dff8b6c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0aa027fa-3a79-4a58-bf9b-34ff3e1ae97b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentAnnualReport_0aa027fa-3a79-4a58-bf9b-34ff3e1ae97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0641770f-f6d9-4d42-97d7-f02b545032cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentPeriodEndDate_0641770f-f6d9-4d42-97d7-f02b545032cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_29e852ac-4ef9-4637-94ed-c097326396d5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_CurrentFiscalYearEndDate_29e852ac-4ef9-4637-94ed-c097326396d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_afb63a47-8aaf-45c7-8383-57901f4190bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentTransitionReport_afb63a47-8aaf-45c7-8383-57901f4190bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_340127d1-0b4c-481a-8920-2a2d4da67a33" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityFileNumber_340127d1-0b4c-481a-8920-2a2d4da67a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a8b96dbf-b38c-47cf-8156-6a9ee4809915" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityRegistrantName_a8b96dbf-b38c-47cf-8156-6a9ee4809915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5939717a-1bf4-4c5b-9c53-7f582a29d7bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5939717a-1bf4-4c5b-9c53-7f582a29d7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8589f0e4-1ab0-48a6-996c-17c947103571" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityTaxIdentificationNumber_8589f0e4-1ab0-48a6-996c-17c947103571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dc15aa76-a24e-4c54-840e-04c7031e6d6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityAddressAddressLine1_dc15aa76-a24e-4c54-840e-04c7031e6d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3c1d0423-6fda-480b-a4af-1b25432fed96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityAddressCityOrTown_3c1d0423-6fda-480b-a4af-1b25432fed96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3b2dc70e-5894-41d2-8faf-694d55574e29" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityAddressStateOrProvince_3b2dc70e-5894-41d2-8faf-694d55574e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4f4376e9-6518-4678-ae1b-7a65e70edb6c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityAddressPostalZipCode_4f4376e9-6518-4678-ae1b-7a65e70edb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_88fbf6fe-3435-403e-be58-31d6ad5e731f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_CityAreaCode_88fbf6fe-3435-403e-be58-31d6ad5e731f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bf8dce9b-cef8-455b-8ec7-3f1aa79c17f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_LocalPhoneNumber_bf8dce9b-cef8-455b-8ec7-3f1aa79c17f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_bd2e4f71-3f5c-4310-be05-0f0815bb3580" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_Security12bTitle_bd2e4f71-3f5c-4310-be05-0f0815bb3580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8d0547f1-eb7e-4003-919e-6e7a6d674661" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_TradingSymbol_8d0547f1-eb7e-4003-919e-6e7a6d674661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_961d875d-7141-427a-81c1-d9ea09967177" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_SecurityExchangeName_961d875d-7141-427a-81c1-d9ea09967177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_51c28b84-f716-4507-83d5-c911f677ec20" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_51c28b84-f716-4507-83d5-c911f677ec20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_0a2128c5-a570-4682-901d-1da91ac2662d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityVoluntaryFilers_0a2128c5-a570-4682-901d-1da91ac2662d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ccf4d673-493e-4fbd-9428-34c764501f7f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityCurrentReportingStatus_ccf4d673-493e-4fbd-9428-34c764501f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ad40d2ab-5519-4f8e-baf9-6e5832ca0186" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityInteractiveDataCurrent_ad40d2ab-5519-4f8e-baf9-6e5832ca0186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_1482e0e1-3653-45f6-bf31-391fe68e3438" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityFilerCategory_1482e0e1-3653-45f6-bf31-391fe68e3438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_182d724d-fb89-4650-90c0-4345f37b2b67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntitySmallBusiness_182d724d-fb89-4650-90c0-4345f37b2b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_16dd04b3-f929-41d6-8109-ae23da55cce6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityEmergingGrowthCompany_16dd04b3-f929-41d6-8109-ae23da55cce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_c7e3b7ee-f5a6-40b7-b19d-31197370d78a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_IcfrAuditorAttestationFlag_c7e3b7ee-f5a6-40b7-b19d-31197370d78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_6cb368e0-02d1-4aa8-b32b-ce1dc078ce3a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_6cb368e0-02d1-4aa8-b32b-ce1dc078ce3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6b1883ba-fb54-4092-9fd5-eef2f9ac01ce" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityShellCompany_6b1883ba-fb54-4092-9fd5-eef2f9ac01ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_bb20d746-ea25-4705-a9e1-81067c559555" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityPublicFloat_bb20d746-ea25-4705-a9e1-81067c559555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6c68cc33-91e9-49f5-9a10-29090e64e8e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6c68cc33-91e9-49f5-9a10-29090e64e8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_eb127a05-d702-4f38-bfbc-bce1e22b6d40" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_eb127a05-d702-4f38-bfbc-bce1e22b6d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_517ea55f-541b-49eb-9561-a365b62d90ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_EntityCentralIndexKey_517ea55f-541b-49eb-9561-a365b62d90ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1f65ea7f-fa6f-4d83-8f88-d5303896f39c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_AmendmentFlag_1f65ea7f-fa6f-4d83-8f88-d5303896f39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4638094b-1779-4fd9-92f2-58a7e8874aeb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4638094b-1779-4fd9-92f2-58a7e8874aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4b175e98-86df-4861-b7ce-512a463291c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf238ca4-1928-42c8-b40e-91a7df732d56" xlink:to="loc_dei_DocumentFiscalYearFocus_4b175e98-86df-4861-b7ce-512a463291c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/AUDITINFORMATION" xlink:type="simple" xlink:href="rdnt-20231231.xsd#AUDITINFORMATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/AUDITINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AuditorInformationAbstract_8329e2c5-768f-4de4-8b2b-185d4e61f9a8" xlink:href="rdnt-20231231.xsd#rdnt_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_a0f8d0f5-bdf5-4d31-98f7-028890e49773" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_8329e2c5-768f-4de4-8b2b-185d4e61f9a8" xlink:to="loc_dei_AuditorName_a0f8d0f5-bdf5-4d31-98f7-028890e49773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_092f1fb8-dbc7-4cea-a362-3959acbe1103" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_8329e2c5-768f-4de4-8b2b-185d4e61f9a8" xlink:to="loc_dei_AuditorLocation_092f1fb8-dbc7-4cea-a362-3959acbe1103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_d44386e9-3540-497d-aa1c-33afa3fabbdf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_8329e2c5-768f-4de4-8b2b-185d4e61f9a8" xlink:to="loc_dei_AuditorFirmId_d44386e9-3540-497d-aa1c-33afa3fabbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e1ba24e7-7fb3-4997-8634-760b4235ccab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e1ba24e7-7fb3-4997-8634-760b4235ccab" xlink:to="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e5fb999c-6a85-4765-9098-ef273da93c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78055445-051c-4eb3-bb2c-4dc4d942bdf2" xlink:to="loc_us-gaap_RelatedPartyDomain_e5fb999c-6a85-4765-9098-ef273da93c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_72b9c449-6fda-46b5-a741-c288d4ef5c89" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e5fb999c-6a85-4765-9098-ef273da93c5d" xlink:to="loc_srt_AffiliatedEntityMember_72b9c449-6fda-46b5-a741-c288d4ef5c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d03efd2-4cfa-4f46-ad5a-70f70819bdd0" xlink:to="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:to="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8087958b-ce33-44de-af14-22ae2ed78be8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8087958b-ce33-44de-af14-22ae2ed78be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_59b7b9e5-514d-4baf-9055-7abb500e5e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_59b7b9e5-514d-4baf-9055-7abb500e5e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_eb130988-2718-4d25-9f6d-7296f72d7324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_eb130988-2718-4d25-9f6d-7296f72d7324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cfada7cb-8546-4e6e-a941-42b6c74dc506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cfada7cb-8546-4e6e-a941-42b6c74dc506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cecb99b0-adcf-4b74-8d50-3c8a3415f58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_216a1f89-e9d8-4dfb-8a4b-5b3a56792bcf" xlink:to="loc_us-gaap_AssetsCurrent_cecb99b0-adcf-4b74-8d50-3c8a3415f58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3f72eaa5-4670-4590-9665-add1494a5d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3f72eaa5-4670-4590-9665-add1494a5d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_66181a50-9353-421b-b237-71cf8fd28e31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_66181a50-9353-421b-b237-71cf8fd28e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_59c3f550-871e-4a6b-b735-2e75b6688b2b" xlink:href="rdnt-20231231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_946bfe8e-5be7-49cb-8cb8-8c95a09b8802" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_59c3f550-871e-4a6b-b735-2e75b6688b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6114dcd2-a1ab-4185-8546-72d399f1269b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_Goodwill_6114dcd2-a1ab-4185-8546-72d399f1269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_560f723d-285a-487a-a63c-6b1c48f3b541" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_560f723d-285a-487a-a63c-6b1c48f3b541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_e70b660e-d69b-4c41-90c7-2c9fa636db9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_e70b660e-d69b-4c41-90c7-2c9fa636db9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_75455453-0d0d-4c20-ba45-1aeac334555b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_75455453-0d0d-4c20-ba45-1aeac334555b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_930d4415-a3b8-407f-8616-842c4ffd55e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_ed6b34f0-c292-43a9-b18b-646ca8e5f261" xlink:to="loc_us-gaap_DepositsAssets_930d4415-a3b8-407f-8616-842c4ffd55e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_14f07c98-a7ef-4f68-a21b-9eb2ee19475a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29e907f5-9e88-4831-9641-6da9ab9f22b2" xlink:to="loc_us-gaap_Assets_14f07c98-a7ef-4f68-a21b-9eb2ee19475a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5da98d6c-a6d7-4e67-a8eb-e43b610714f7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_85925fef-8a7c-4a20-b79c-8e89e040ea5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_85925fef-8a7c-4a20-b79c-8e89e040ea5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_814fc18a-dfad-4dc7-9bf0-795ac085a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_814fc18a-dfad-4dc7-9bf0-795ac085a0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_336f1b35-d8a0-4f6a-90a1-c6a51bded0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_336f1b35-d8a0-4f6a-90a1-c6a51bded0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9ccc27ce-f7da-42ef-8aa5-dfc493f9219f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9ccc27ce-f7da-42ef-8aa5-dfc493f9219f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_0851f818-3300-441a-bc64-d345a34a4937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_NotesPayableCurrent_0851f818-3300-441a-bc64-d345a34a4937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_16cf638d-8537-4950-8144-88efc96542eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e22b43b2-0984-4b1d-9020-51df4d135054" xlink:to="loc_us-gaap_LiabilitiesCurrent_16cf638d-8537-4950-8144-88efc96542eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5cd5c2a-83f4-4e68-9f79-eea5f8cf5826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5cd5c2a-83f4-4e68-9f79-eea5f8cf5826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_b9158572-d27a-4059-8d63-96e03abe3579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_LongTermNotesPayable_b9158572-d27a-4059-8d63-96e03abe3579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef865b41-a196-4470-9aae-123e452d17e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef865b41-a196-4470-9aae-123e452d17e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e4cf89ac-11e4-44a1-b272-03724f3b593a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e4cf89ac-11e4-44a1-b272-03724f3b593a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_65a7b7fb-c4ee-4d34-9f20-771a7be66979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9f756fa5-bbb9-48ee-9a0b-e3f189855834" xlink:to="loc_us-gaap_Liabilities_65a7b7fb-c4ee-4d34-9f20-771a7be66979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:to="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ff50b741-ea0e-44af-b35c-f431b20e7c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_CommonStockValue_ff50b741-ea0e-44af-b35c-f431b20e7c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_648cdfe4-b5ef-41d9-9a5c-6be3498b2f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_648cdfe4-b5ef-41d9-9a5c-6be3498b2f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_05143439-6253-496c-b486-25fb815eb205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_05143439-6253-496c-b486-25fb815eb205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c1ef82a-9782-45a6-a42d-1e5f1de60965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c1ef82a-9782-45a6-a42d-1e5f1de60965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4c037fa8-37a2-44a5-aabd-d2cd06995e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_61dde928-256a-46f3-9ae3-4f76f7327a1d" xlink:to="loc_us-gaap_StockholdersEquity_4c037fa8-37a2-44a5-aabd-d2cd06995e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_50137e31-023f-468a-a83b-021078836a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:to="loc_us-gaap_MinorityInterest_50137e31-023f-468a-a83b-021078836a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_06bb1eed-fc89-44d1-af72-1ebe98862d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6985587b-adc2-45ea-91af-ebe5acba3c49" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_06bb1eed-fc89-44d1-af72-1ebe98862d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_025e7621-96a5-4ebd-907d-0a4f70faeff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c59da78-e91d-4d3a-b42d-295bb41d28b7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_025e7621-96a5-4ebd-907d-0a4f70faeff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cf59ac0c-169d-480a-94ba-c535f3ede358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_31bbfe4e-de43-4d03-9c62-c3e154ad8bba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf59ac0c-169d-480a-94ba-c535f3ede358" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_31bbfe4e-de43-4d03-9c62-c3e154ad8bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_83061ab4-e114-4085-929f-e3a7155e6300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf59ac0c-169d-480a-94ba-c535f3ede358" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_83061ab4-e114-4085-929f-e3a7155e6300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_cadb371c-276d-4526-afa3-abaaa11dfe07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf59ac0c-169d-480a-94ba-c535f3ede358" xlink:to="loc_us-gaap_CommonStockSharesIssued_cadb371c-276d-4526-afa3-abaaa11dfe07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f8af093f-43ac-444e-866f-65ee5c3d2014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf59ac0c-169d-480a-94ba-c535f3ede358" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f8af093f-43ac-444e-866f-65ee5c3d2014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_08ca3154-e3d8-43b6-98ae-0457b2d0fab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_08ca3154-e3d8-43b6-98ae-0457b2d0fab2" xlink:to="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:to="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a08fa854-09fc-4cb4-9c7d-4354a80e1789" xlink:to="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_a5a15eab-0d22-437d-81cf-dcbe8e04d44b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_a5a15eab-0d22-437d-81cf-dcbe8e04d44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_7e25736d-0fd8-4a94-b322-1881e2bb57e9" xlink:href="rdnt-20231231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882067b4-a84d-40aa-b38d-bea174c08015" xlink:to="loc_rdnt_CapitationArrangementsMember_7e25736d-0fd8-4a94-b322-1881e2bb57e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c47ce2a6-fc65-4f20-83cb-7199db001e06" xlink:to="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_549a5cf7-0664-454f-81d0-46ecb073ba5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_549a5cf7-0664-454f-81d0-46ecb073ba5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_572033a2-caf6-46ff-a743-e111491376ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2eeb4052-0dc2-4440-9265-d502032e3682" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_572033a2-caf6-46ff-a743-e111491376ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_13006b5a-3b7f-46d1-a013-03ebce5e443f" xlink:href="rdnt-20231231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_13006b5a-3b7f-46d1-a013-03ebce5e443f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnContributionIntoJointVenture_da99b688-fd43-4f40-afa6-e88e7b1cd2e7" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnContributionIntoJointVenture"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_rdnt_GainLossOnContributionIntoJointVenture_da99b688-fd43-4f40-afa6-e88e7b1cd2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_452f6fbe-dfab-4714-9f6b-7b913e2d39ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_452f6fbe-dfab-4714-9f6b-7b913e2d39ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dd4806f5-3bc3-4a43-91a0-64a3a0f3e0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dd4806f5-3bc3-4a43-91a0-64a3a0f3e0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_7a04dc2b-b680-4e38-a785-bc9b0512a16a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_7a04dc2b-b680-4e38-a785-bc9b0512a16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0a1755d0-268e-4d67-8edd-996c0e73a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_SeveranceCosts1_0a1755d0-268e-4d67-8edd-996c0e73a49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_eab19547-550c-4332-91dc-cc8c2d3a13bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_90f41643-c105-4505-b354-2af479af6a82" xlink:to="loc_us-gaap_OperatingExpenses_eab19547-550c-4332-91dc-cc8c2d3a13bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9c813d8e-7d5c-40b0-b2d5-961aa9aac61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_OperatingIncomeLoss_9c813d8e-7d5c-40b0-b2d5-961aa9aac61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_847aa363-212e-433c-9a20-197ec8ae0bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_InterestExpenseDebt_847aa363-212e-433c-9a20-197ec8ae0bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dfbcab87-f0e1-40e5-8f71-3bdc0af64082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dfbcab87-f0e1-40e5-8f71-3bdc0af64082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fc991012-17cf-4ef5-86db-dba0a7ad6971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fc991012-17cf-4ef5-86db-dba0a7ad6971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_4b26e906-321b-4db0-8d16-3431ac7a7620" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses_4b26e906-321b-4db0-8d16-3431ac7a7620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_94bc18e5-19c3-49f2-b4a1-4778334cb7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_94bc18e5-19c3-49f2-b4a1-4778334cb7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_fd1ff07c-4e77-451d-b782-03b4309b386e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_805d08fb-e798-474f-84d4-67988a0f55fb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_fd1ff07c-4e77-451d-b782-03b4309b386e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50c14343-b449-4110-a376-d6283922c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50c14343-b449-4110-a376-d6283922c4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ae8a35b-29ac-4de8-a825-cb7e0be3d603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ae8a35b-29ac-4de8-a825-cb7e0be3d603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f86d067d-4bce-4842-a8aa-057e984f155b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_ProfitLoss_f86d067d-4bce-4842-a8aa-057e984f155b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aeddd0ed-f8d3-45b4-9d8a-121671d49efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aeddd0ed-f8d3-45b4-9d8a-121671d49efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f2409315-2eab-4823-b56e-3a91e565d5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_NetIncomeLoss_f2409315-2eab-4823-b56e-3a91e565d5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_39a3f561-6cdb-4294-8eb2-ac8a715ec689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_EarningsPerShareBasic_39a3f561-6cdb-4294-8eb2-ac8a715ec689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_99370854-eca4-41f9-bec8-fda0e490fe28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_99370854-eca4-41f9-bec8-fda0e490fe28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:href="rdnt-20231231.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc3c0e90-3935-459e-ac5c-ab860508ec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc3c0e90-3935-459e-ac5c-ab860508ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c2cfa01-468c-48d1-832d-837f8bc1aaff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_0897417c-bcec-4476-9008-e7792da57f3b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c2cfa01-468c-48d1-832d-837f8bc1aaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b667795a-376b-4461-bacd-474af50092a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ba530d8-567a-42c4-ac24-825297e66b8d" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b667795a-376b-4461-bacd-474af50092a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ba3522c9-f525-4542-99ff-57669cfd925e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:to="loc_us-gaap_ProfitLoss_ba3522c9-f525-4542-99ff-57669cfd925e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20af6494-ec94-497b-9fbf-296a0c7b6dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20af6494-ec94-497b-9fbf-296a0c7b6dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_bb8cbf9e-9cdc-4cd6-ab91-576c73a7c049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_bb8cbf9e-9cdc-4cd6-ab91-576c73a7c049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_37f3903c-e491-4ac3-b279-40a776ff4b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_37f3903c-e491-4ac3-b279-40a776ff4b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ea7ca286-a104-4f3c-a29a-14d44e8cc1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ea7ca286-a104-4f3c-a29a-14d44e8cc1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c42d9d3-932d-414c-822b-e4bc955a48bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb22da70-2e85-4dad-ad8d-86696be904fa" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c42d9d3-932d-414c-822b-e4bc955a48bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4980b127-dc59-49cc-adcb-7564c157caf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4980b127-dc59-49cc-adcb-7564c157caf3" xlink:to="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67196be5-434f-4d30-b7b8-b679508043cd" xlink:to="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:to="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fe6b8851-b9cf-409b-8fda-66aec3d44dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_CommonStockMember_fe6b8851-b9cf-409b-8fda-66aec3d44dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e2763d76-2365-4826-bf2c-4987d0366af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e2763d76-2365-4826-bf2c-4987d0366af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f32d05b4-a288-4a48-b636-797c1c217bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f32d05b4-a288-4a48-b636-797c1c217bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a906cd4f-33a0-4c4b-9234-cc9f3736a823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f9a0fb6c-cbbb-4332-8124-fdd4601bc8d4" xlink:to="loc_us-gaap_RetainedEarningsMember_a906cd4f-33a0-4c4b-9234-cc9f3736a823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_a8c5f6bb-df8c-4dac-82ff-9ddd8092f648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5808641e-8c6c-4f00-b07e-70014ef69036" xlink:to="loc_us-gaap_NoncontrollingInterestMember_a8c5f6bb-df8c-4dac-82ff-9ddd8092f648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_47ab8477-5150-4f12-ac90-e4ce3afbb9cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8f617d59-291a-4090-a02d-a3fa4c555a70" xlink:href="rdnt-20231231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:to="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8f617d59-291a-4090-a02d-a3fa4c555a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_d23f91c7-2018-4097-ac8c-45ea89a5f08e" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6faf9275-25e6-4831-88c7-1d7d4b4e9365" xlink:to="loc_rdnt_DeepHealthIncMember_d23f91c7-2018-4097-ac8c-45ea89a5f08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3b77a0aa-e863-484b-a415-7e3315795317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d816afd-1771-4ac7-9d48-07dfeb80a767" xlink:to="loc_us-gaap_StatementLineItems_3b77a0aa-e863-484b-a415-7e3315795317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b77a0aa-e863-484b-a415-7e3315795317" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_89410622-9b52-4e2f-b54b-e81b0ab4e14c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_89410622-9b52-4e2f-b54b-e81b0ab4e14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc7ea99f-41b4-4550-9e85-24bf62708401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc7ea99f-41b4-4550-9e85-24bf62708401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6a4276b6-bcbb-49df-8112-437e6dd43ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6a4276b6-bcbb-49df-8112-437e6dd43ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d54e138a-d35e-4b3d-8dc8-6d6828a548b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d54e138a-d35e-4b3d-8dc8-6d6828a548b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b3f87633-c4b8-46c8-b934-278047a2f978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b3f87633-c4b8-46c8-b934-278047a2f978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_d659e68d-eda9-4189-bd0f-2922e1bf0dd3" xlink:href="rdnt-20231231.xsd#rdnt_SharesIssuedSharesSettlementOfContingentConsideration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_d659e68d-eda9-4189-bd0f-2922e1bf0dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8162605-8814-40f4-95c6-e4deb7dc0d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8162605-8814-40f4-95c6-e4deb7dc0d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9d2ae39e-7120-4ab0-b0ac-6c6ea437f16d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9d2ae39e-7120-4ab0-b0ac-6c6ea437f16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_a4adbaf2-071c-4381-ad2a-2ecb0c3cbb27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_a4adbaf2-071c-4381-ad2a-2ecb0c3cbb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_3f36623c-a854-4eda-a7e7-d4e1b32e8b7e" xlink:href="rdnt-20231231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_3f36623c-a854-4eda-a7e7-d4e1b32e8b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fcb00b64-3c8d-44b5-80f7-8163a9dfce67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fcb00b64-3c8d-44b5-80f7-8163a9dfce67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_182c3262-301c-44a5-ba7e-c56c5cdd8775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_182c3262-301c-44a5-ba7e-c56c5cdd8775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7d565673-6e24-4219-9ed8-6e3748625374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7d565673-6e24-4219-9ed8-6e3748625374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cfd0013d-2274-4d17-ac59-012de21d8602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_ProfitLoss_cfd0013d-2274-4d17-ac59-012de21d8602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_bada90b5-4e38-4716-b866-1606908a47ff" xlink:href="rdnt-20231231.xsd#rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_bada90b5-4e38-4716-b866-1606908a47ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fb254b56-56a2-4387-9c19-fc0361eaf72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fb254b56-56a2-4387-9c19-fc0361eaf72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f19abfb6-904d-4cc2-ae6d-165bc211d8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f19abfb6-904d-4cc2-ae6d-165bc211d8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_148d55ea-fd99-4f0e-b292-148f89d2a739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_148d55ea-fd99-4f0e-b292-148f89d2a739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_483f5885-58ce-4a30-9483-5e01788516ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_483f5885-58ce-4a30-9483-5e01788516ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_701bc86f-e63f-4c1e-8313-ba8b82adbd52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_701bc86f-e63f-4c1e-8313-ba8b82adbd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_f3bb2d80-de43-440e-9037-3f02bb5677aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_f3bb2d80-de43-440e-9037-3f02bb5677aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_be1e9a26-7322-42a5-9cc2-174653bab889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_be1e9a26-7322-42a5-9cc2-174653bab889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a4b8ec25-ef7d-4604-9cb4-0298e2990c67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockholdersEquityOther_a4b8ec25-ef7d-4604-9cb4-0298e2990c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6af77aec-e0dc-4c0d-8ddc-89fde9fa272e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6af77aec-e0dc-4c0d-8ddc-89fde9fa272e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd2d0392-3cfe-4df7-a72a-66c5c8b41f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_002dbb72-2537-40dd-9f9a-cba9da69b5e8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd2d0392-3cfe-4df7-a72a-66c5c8b41f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69315c8f-1b64-4f3f-8a52-23e7eeba935a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69315c8f-1b64-4f3f-8a52-23e7eeba935a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_15ddb0cd-1aef-4dc6-83c7-0e0ee599608d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69315c8f-1b64-4f3f-8a52-23e7eeba935a" xlink:to="loc_us-gaap_ProfitLoss_15ddb0cd-1aef-4dc6-83c7-0e0ee599608d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69315c8f-1b64-4f3f-8a52-23e7eeba935a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d5fb9a1e-9a68-4ccd-b71c-e7f349ea1b40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d5fb9a1e-9a68-4ccd-b71c-e7f349ea1b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d8f45732-6fd6-459f-825f-6a61ce37a743" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d8f45732-6fd6-459f-825f-6a61ce37a743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_d125e117-6059-49f9-b151-8563ed0fc011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_d125e117-6059-49f9-b151-8563ed0fc011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ed329140-6ab3-413a-8e3a-3c0a7f5811b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ed329140-6ab3-413a-8e3a-3c0a7f5811b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_7ed3f819-c789-4792-b6c3-58c71a5e13df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_7ed3f819-c789-4792-b6c3-58c71a5e13df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnContributionIntoJointVenture_64e3011d-fb54-46db-b45e-5d74935cadb5" xlink:href="rdnt-20231231.xsd#rdnt_GainLossOnContributionIntoJointVenture"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_rdnt_GainLossOnContributionIntoJointVenture_64e3011d-fb54-46db-b45e-5d74935cadb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_627466b1-0644-4701-9d36-ef0511ec800d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_627466b1-0644-4701-9d36-ef0511ec800d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a019c56-e62b-45b1-b1da-57bf95b21631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a019c56-e62b-45b1-b1da-57bf95b21631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2c9adb37-3649-432c-b464-874be8b7b4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2c9adb37-3649-432c-b464-874be8b7b4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_09f89ad2-a654-439b-8a1a-e40252c6d98f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_09f89ad2-a654-439b-8a1a-e40252c6d98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_4ecd145e-7e63-44af-b62a-07d5a97417b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_4ecd145e-7e63-44af-b62a-07d5a97417b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4eae0bae-2cc0-45de-ba1a-7935f0a3d74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_ShareBasedCompensation_4eae0bae-2cc0-45de-ba1a-7935f0a3d74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6dde4496-f9ef-453b-9378-13b94285abb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6dde4496-f9ef-453b-9378-13b94285abb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6aa1521-20b9-4764-8769-09393462ad9d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_64437028-d0b3-47eb-95e6-1868eb5ccf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_64437028-d0b3-47eb-95e6-1868eb5ccf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_bfd681a3-3145-442b-991b-fd2f0581d69c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_bfd681a3-3145-442b-991b-fd2f0581d69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_feb8d844-3d59-4a2c-8978-1628c7c1b4db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_feb8d844-3d59-4a2c-8978-1628c7c1b4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_0bb5c76d-43ef-4e7d-b7dd-914faa0dc0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_0bb5c76d-43ef-4e7d-b7dd-914faa0dc0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_dfb2657a-2f8c-4b25-8191-4ee81bc35ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_dfb2657a-2f8c-4b25-8191-4ee81bc35ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_fab84931-4dca-4b78-819f-22c3cbc3b8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_fab84931-4dca-4b78-819f-22c3cbc3b8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f197518-3d9d-4c98-9636-d280a84c8ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6717db71-2cbb-4f1f-95be-0fb9d02f4541" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f197518-3d9d-4c98-9636-d280a84c8ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b55a9b2d-1b48-4d9a-bd1a-58c40ed55e67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69315c8f-1b64-4f3f-8a52-23e7eeba935a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b55a9b2d-1b48-4d9a-bd1a-58c40ed55e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_a8670bb6-4669-415d-9a30-87e33ad503b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_a8670bb6-4669-415d-9a30-87e33ad503b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_ef634678-5920-4130-a105-fc143bdd8bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_ef634678-5920-4130-a105-fc143bdd8bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_ed7e97a7-dc28-4e5d-9024-aad4f557aeef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_ed7e97a7-dc28-4e5d-9024-aad4f557aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e4c78998-9ef7-46c8-9a93-961cf794f80d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e4c78998-9ef7-46c8-9a93-961cf794f80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_8079a94e-8375-4ebc-9f42-461f2f8edf13" xlink:href="rdnt-20231231.xsd#rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:to="loc_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture_8079a94e-8375-4ebc-9f42-461f2f8edf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d791d47e-0d2a-4686-8d5e-c92582a68443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cdee57c1-3430-48fe-9697-977ac5b82469" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d791d47e-0d2a-4686-8d5e-c92582a68443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f30589cb-80e5-434d-9b88-4900b4988b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_RepaymentsOfDebt_f30589cb-80e5-434d-9b88-4900b4988b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_eb48eed8-de5b-43f3-a9b8-d0856b89c75e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_eb48eed8-de5b-43f3-a9b8-d0856b89c75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0b64147d-0628-4c1b-b2ec-116ec5a210d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0b64147d-0628-4c1b-b2ec-116ec5a210d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_db429bf8-7a8a-4232-85bc-8ea0c2d4cdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_db429bf8-7a8a-4232-85bc-8ea0c2d4cdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_e70cef9d-7ab7-42e0-9503-64f0f951278d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_e70cef9d-7ab7-42e0-9503-64f0f951278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_e066650c-cd3f-4df8-89dc-375e940ae0d2" xlink:href="rdnt-20231231.xsd#rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary_e066650c-cd3f-4df8-89dc-375e940ae0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_8fbee0f7-f20a-4609-89cb-91e75813b5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_8fbee0f7-f20a-4609-89cb-91e75813b5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_80098df5-a66d-4d71-b798-4c99e8e64ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_80098df5-a66d-4d71-b798-4c99e8e64ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_b9104374-d1c7-4600-896d-e60915dfb1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_b9104374-d1c7-4600-896d-e60915dfb1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f4ea7225-15a8-483c-a750-f3e2e917371c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f4ea7225-15a8-483c-a750-f3e2e917371c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_2b375676-1783-4b43-8a93-9c78955b69d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_2b375676-1783-4b43-8a93-9c78955b69d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2f24574d-ea28-4f57-9758-38eefa921edc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2f24574d-ea28-4f57-9758-38eefa921edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daab58f8-8b31-48e7-8700-bdeab413a135" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b031be31-16bd-4178-84c5-2dae5d0358a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daab58f8-8b31-48e7-8700-bdeab413a135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd59b1f0-d47a-42ec-8ce2-1561df03bbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd59b1f0-d47a-42ec-8ce2-1561df03bbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_679212d9-2a50-4ce0-8bcb-0e528df0f45e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_679212d9-2a50-4ce0-8bcb-0e528df0f45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de133db8-cc0b-42b1-bb0d-2f8a85e6f261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de133db8-cc0b-42b1-bb0d-2f8a85e6f261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a229f7b6-13d9-4534-9279-af7afb816927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a229f7b6-13d9-4534-9279-af7afb816927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f719c41-ff52-43b7-809c-c4e1cbc00fce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7810a54e-4e50-4f8c-a4ca-42acf10f6811" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f719c41-ff52-43b7-809c-c4e1cbc00fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_7abb2830-71fd-4632-9c91-1f66824c728b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f719c41-ff52-43b7-809c-c4e1cbc00fce" xlink:to="loc_us-gaap_InterestPaidNet_7abb2830-71fd-4632-9c91-1f66824c728b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_1656206c-ac61-4757-9bbf-701d91e8ef96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5f719c41-ff52-43b7-809c-c4e1cbc00fce" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_1656206c-ac61-4757-9bbf-701d91e8ef96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4f5eb4b4-b8de-47db-8eed-c41cc1f9efd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4f5eb4b4-b8de-47db-8eed-c41cc1f9efd3" xlink:to="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_86bc7c9b-b719-4d4c-a99c-7f7e3c4cb578" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_164e989f-9f2d-4f9e-98ac-3c382d5de38d" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_AidenceMember_164e989f-9f2d-4f9e-98ac-3c382d5de38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_1ebf1526-f073-488b-a679-75e84abe6270" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_QuantibMember_1ebf1526-f073-488b-a679-75e84abe6270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember_0a4d6600-9b20-4484-9ba3-581802a046be" xlink:href="rdnt-20231231.xsd#rdnt_DRTLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_DRTLLCMember_0a4d6600-9b20-4484-9ba3-581802a046be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_da74f072-0f87-494e-ae6d-12c5379705c4" xlink:href="rdnt-20231231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_TangentAssociatesLLCMember_da74f072-0f87-494e-ae6d-12c5379705c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartLungImagingLimitedMember_0ee9f8c5-a4f6-46e9-9b76-66b940a63d97" xlink:href="rdnt-20231231.xsd#rdnt_HeartLungImagingLimitedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_HeartLungImagingLimitedMember_0ee9f8c5-a4f6-46e9-9b76-66b940a63d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_18d1a09a-37b3-4cfd-b6cc-faad4c8e22dc" xlink:href="rdnt-20231231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b1596385-319d-4fb5-a56c-7bc832c69bfb" xlink:to="loc_rdnt_AidenceHoldingBVMember_18d1a09a-37b3-4cfd-b6cc-faad4c8e22dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_65830023-f29c-41b9-a1bb-e7b34ec15f19" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockHoldbackMember_56592527-409d-4885-90fb-0a556dece80e" xlink:href="rdnt-20231231.xsd#rdnt_StockHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:to="loc_rdnt_StockHoldbackMember_56592527-409d-4885-90fb-0a556dece80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GeneralHoldbackMember_210c2dfc-c7b3-41ec-b738-f110b8d00711" xlink:href="rdnt-20231231.xsd#rdnt_GeneralHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_36e44fd2-70cc-45fd-8ac8-c0917ed0d989" xlink:to="loc_rdnt_GeneralHoldbackMember_210c2dfc-c7b3-41ec-b738-f110b8d00711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1e94fd76-c884-49c9-a3c8-7f6035d6a20a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember_6020179a-e2e5-42e2-9923-82b5d37d67e3" xlink:href="rdnt-20231231.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:to="loc_rdnt_SantaMonicaImagingGroupLLCMember_6020179a-e2e5-42e2-9923-82b5d37d67e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_2ca1f127-abac-44ab-8cf9-1c02f0944e15" xlink:href="rdnt-20231231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5fa6219a-e315-4cbd-80fd-ec77d7a382b0" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_2ca1f127-abac-44ab-8cf9-1c02f0944e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d6a46c3-ef89-492b-a415-b1f0d462b42f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c72bfd6-0b2b-4c2d-b7aa-9f9d4c226837" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d6a46c3-ef89-492b-a415-b1f0d462b42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_097de270-7b85-46c2-9d03-663b26a0c928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d6a46c3-ef89-492b-a415-b1f0d462b42f" xlink:to="loc_us-gaap_UnsecuredDebtMember_097de270-7b85-46c2-9d03-663b26a0c928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c3003f58-6eaa-4cf8-a56e-635bcbfac2be" xlink:to="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_6080c308-24a0-4e8e-96e7-c55fa438138f" xlink:href="rdnt-20231231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_6080c308-24a0-4e8e-96e7-c55fa438138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_ed3422f5-c007-450c-ae15-bbdf583c4e0d" xlink:href="rdnt-20231231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_ed3422f5-c007-450c-ae15-bbdf583c4e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_4b502053-dc69-406b-8704-6d42587520ef" xlink:href="rdnt-20231231.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a85e3444-cb20-4840-98fa-4d530529191f" xlink:to="loc_rdnt_SimiAdventistMember_4b502053-dc69-406b-8704-6d42587520ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c6e4d20f-a154-4a04-8db5-6727b0dbed8a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_b4a1b280-d01a-4eea-a481-676205e2ee64" xlink:to="loc_srt_OwnershipDomain_c6e4d20f-a154-4a04-8db5-6727b0dbed8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_36462316-e669-4bda-b8f6-9cd951a7bcb1" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_c6e4d20f-a154-4a04-8db5-6727b0dbed8a" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_36462316-e669-4bda-b8f6-9cd951a7bcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22c14112-7908-499d-aa24-21428f6a32b6" xlink:to="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_fced9035-21a8-47c3-b7d9-83b05a6410a0" xlink:href="rdnt-20231231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_fced9035-21a8-47c3-b7d9-83b05a6410a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c011095c-492f-4dba-97d9-47ba86962572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c011095c-492f-4dba-97d9-47ba86962572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_5574cece-04f1-496b-833a-2fdc73b8a948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_5574cece-04f1-496b-833a-2fdc73b8a948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_959dc4b9-99f3-449d-808b-285b371c93fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_959dc4b9-99f3-449d-808b-285b371c93fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94413670-c488-4f73-8acd-136aa2bd3c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94413670-c488-4f73-8acd-136aa2bd3c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_05ce1777-916f-45aa-b965-19314e003d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_05ce1777-916f-45aa-b965-19314e003d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_dc198238-b9a1-491d-aee7-ede920a18f40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_dc198238-b9a1-491d-aee7-ede920a18f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_03532a9a-18fa-4efa-b1ec-9ffc4efb7cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_03532a9a-18fa-4efa-b1ec-9ffc4efb7cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_35b67d83-fdd1-48b1-a8d7-6e3bb7ca30c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_EquityMethodInvestments_35b67d83-fdd1-48b1-a8d7-6e3bb7ca30c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9353fae-47e3-43a5-a8e7-f177de7d30c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9353fae-47e3-43a5-a8e7-f177de7d30c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_f5474ff1-1a64-4148-9bf9-a21c363bd23b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_f5474ff1-1a64-4148-9bf9-a21c363bd23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_83f1efb4-3fe6-4b28-9b28-83219c911707" xlink:href="rdnt-20231231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d85c7fdb-4e94-4bdf-a753-3ad559e9f20d" xlink:to="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_83f1efb4-3fe6-4b28-9b28-83219c911707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#NATUREOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06b549b3-8f93-430f-9221-02722b12a327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_4e014ddb-6bd3-418e-92b4-0004d9611429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06b549b3-8f93-430f-9221-02722b12a327" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_4e014ddb-6bd3-418e-92b4-0004d9611429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aa298a07-936b-4b19-9199-be40e0a89b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e5e7037e-fe0e-4d91-8c71-470fa779df17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aa298a07-936b-4b19-9199-be40e0a89b37" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e5e7037e-fe0e-4d91-8c71-470fa779df17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#RECENTACCOUNTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a22df481-f9e8-4972-9b2b-30452c7b3e00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d1f53408-98ec-443f-a4c1-54b51a2546a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a22df481-f9e8-4972-9b2b-30452c7b3e00" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d1f53408-98ec-443f-a4c1-54b51a2546a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_70e17906-85ce-473c-a9df-1bf40d9fa794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_89f9462e-abf9-4a87-a407-f35dceaaa74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_70e17906-85ce-473c-a9df-1bf40d9fa794" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_89f9462e-abf9-4a87-a407-f35dceaaa74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SEGMENTREPORTING"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_75223d1c-194d-425b-9ffa-c66995c8b15b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_6f1f4c3c-aeef-4f2d-ac53-4b1ced06bbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75223d1c-194d-425b-9ffa-c66995c8b15b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_6f1f4c3c-aeef-4f2d-ac53-4b1ced06bbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_736cadb0-d14a-4fce-8ec0-f2ff3f367509" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_74aeb355-d793-4d6f-9302-e1b873755c84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_736cadb0-d14a-4fce-8ec0-f2ff3f367509" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_74aeb355-d793-4d6f-9302-e1b873755c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d6ca91e2-12af-4036-a924-eeafa64e3ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_95a97f56-baff-4c3b-ac63-599978961eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d6ca91e2-12af-4036-a924-eeafa64e3ca1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_95a97f56-baff-4c3b-ac63-599978961eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0f987c3f-69db-4735-af30-3fae01c8ebbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_40aba06b-ff29-45f9-b7a4-9d39cae5552a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0f987c3f-69db-4735-af30-3fae01c8ebbb" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_40aba06b-ff29-45f9-b7a4-9d39cae5552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASES" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_acf4e27d-f878-427f-bf89-d045cb16ae8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_a0df782b-c530-4604-8bc4-80039646c7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acf4e27d-f878-427f-bf89-d045cb16ae8f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_a0df782b-c530-4604-8bc4-80039646c7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_872829a3-fbe3-4d50-8267-10a682b97a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9a130fa8-1e5c-4a62-b25c-f8c63c008ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_872829a3-fbe3-4d50-8267-10a682b97a39" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9a130fa8-1e5c-4a62-b25c-f8c63c008ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_112fd6bb-6b6e-42cf-b750-5581dbdf6fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_38ec7024-cca8-4e5e-9b29-c88a6f9c27b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_112fd6bb-6b6e-42cf-b750-5581dbdf6fc4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_38ec7024-cca8-4e5e-9b29-c88a6f9c27b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_5efccd69-dd04-4dad-9e45-75dfc1532720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_a9edecde-5e95-4c3e-a337-1c7281d2fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_5efccd69-dd04-4dad-9e45-75dfc1532720" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_a9edecde-5e95-4c3e-a337-1c7281d2fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_187968bf-3660-48bc-8837-ea4ff7ae8bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_187968bf-3660-48bc-8837-ea4ff7ae8bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_616ad2cf-b1d7-483b-9367-6ab3b6a15179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_UseOfEstimates_616ad2cf-b1d7-483b-9367-6ab3b6a15179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_05199dc2-f29c-4215-bf0c-85e8a47824e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_05199dc2-f29c-4215-bf0c-85e8a47824e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_d0c1c263-64ad-4352-8f1d-4dd6c0897dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_d0c1c263-64ad-4352-8f1d-4dd6c0897dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7d72359b-5c17-42b9-8045-07d976c402ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7d72359b-5c17-42b9-8045-07d976c402ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_4a0cd7df-1c72-4610-af4f-ac28406c5209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_4a0cd7df-1c72-4610-af4f-ac28406c5209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_a68df2f4-f3ac-4483-8f9f-46abaac624d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_a68df2f4-f3ac-4483-8f9f-46abaac624d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_fa71db34-dc00-492e-9931-9fecad4aa8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_fa71db34-dc00-492e-9931-9fecad4aa8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_603541b8-5cc0-4041-83bc-9f3c1f8a05c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_603541b8-5cc0-4041-83bc-9f3c1f8a05c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_632b5849-d75d-4019-9dd1-81422a211b77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_632b5849-d75d-4019-9dd1-81422a211b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_c302fe60-3722-4a6b-aa54-d8de8aac1891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_c302fe60-3722-4a6b-aa54-d8de8aac1891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_7cc12c45-c52e-4431-a9dc-9a5bd51e97a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_7cc12c45-c52e-4431-a9dc-9a5bd51e97a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_c6a46700-4693-421f-8295-17907198fad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_c6a46700-4693-421f-8295-17907198fad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_a10344e3-afb2-4fd9-9d4b-6ae5212f766a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_a10344e3-afb2-4fd9-9d4b-6ae5212f766a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_ac177248-d96d-4ad8-bd59-5943eb79f05c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_ac177248-d96d-4ad8-bd59-5943eb79f05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock_ede11718-9788-421a-b8c0-1212b1f9c9e1" xlink:href="rdnt-20231231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_rdnt_UninsuredRisksPolicyTextBlock_ede11718-9788-421a-b8c0-1212b1f9c9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_17b18f04-20f2-463e-a2ec-fc7a29b74a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_17b18f04-20f2-463e-a2ec-fc7a29b74a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_3d90266a-da3d-48e9-9820-ab2148c0c83c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_3d90266a-da3d-48e9-9820-ab2148c0c83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_be182935-143b-4703-afb2-2f8c064be8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_be182935-143b-4703-afb2-2f8c064be8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_df0aba33-4922-4aff-a157-d9267634b2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_df0aba33-4922-4aff-a157-d9267634b2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_31f785d7-486d-4c7f-9948-b6b1f2f2181f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_31f785d7-486d-4c7f-9948-b6b1f2f2181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_fb96beb5-1e24-436c-b098-63c75e7c4cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_fb96beb5-1e24-436c-b098-63c75e7c4cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ab5d2ef0-bdd4-460e-8c73-cd7a00d13c02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ab5d2ef0-bdd4-460e-8c73-cd7a00d13c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_27b971d1-ae55-40ab-abc3-ec319279cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_27b971d1-ae55-40ab-abc3-ec319279cca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_ea54f84b-5817-45e3-925f-2179a0a3631b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_ea54f84b-5817-45e3-925f-2179a0a3631b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_dbfa119d-7037-4e10-80ba-6e5b207d8d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_dbfa119d-7037-4e10-80ba-6e5b207d8d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a4e300fa-ab5c-4959-b191-2a410ea90386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9748ff3a-8a1c-4589-aeb4-8d518dd64082" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a4e300fa-ab5c-4959-b191-2a410ea90386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_8512aa8a-5b16-4f65-885d-4a90bc8a85f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_8512aa8a-5b16-4f65-885d-4a90bc8a85f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_e473b21d-d320-4ead-9bb4-37f0c08e20e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_e473b21d-d320-4ead-9bb4-37f0c08e20e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_6303725b-ab51-437c-9414-9e2dae56c275" xlink:href="rdnt-20231231.xsd#rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_6303725b-ab51-437c-9414-9e2dae56c275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3332a94a-f04b-454f-afbb-da58724464c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3332a94a-f04b-454f-afbb-da58724464c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_1083013d-b8de-4616-b382-87d2da8204c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_1083013d-b8de-4616-b382-87d2da8204c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_7ff398f4-0d28-4907-a8d0-3e4795a84215" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_7ff398f4-0d28-4907-a8d0-3e4795a84215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock_5be60a03-66fe-4200-8561-e5ca2b5cb587" xlink:href="rdnt-20231231.xsd#rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock_5be60a03-66fe-4200-8561-e5ca2b5cb587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c352e46c-337d-4f01-b202-4b7b0b3c35a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c352e46c-337d-4f01-b202-4b7b0b3c35a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_8213df02-7c2d-446a-a67e-a8c7f7955795" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_8213df02-7c2d-446a-a67e-a8c7f7955795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_0f06870c-49fe-43e3-8bcb-17e0ef69cb3e" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64f13ff0-4495-4069-92c5-496cbbeee384" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_0f06870c-49fe-43e3-8bcb-17e0ef69cb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c41481e5-98da-423d-bb24-d1790c4abbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c4813dc6-51fe-427f-8ae1-9dc1ae3d2886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c41481e5-98da-423d-bb24-d1790c4abbcc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c4813dc6-51fe-427f-8ae1-9dc1ae3d2886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SEGMENTREPORTINGTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1e04850c-b800-41cb-9ede-24d027cb8db2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_84a71d34-fdbb-418c-a640-ba06afaf4b84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1e04850c-b800-41cb-9ede-24d027cb8db2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_84a71d34-fdbb-418c-a640-ba06afaf4b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0fe720b-918f-42d6-ad22-b2af34879c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_dcd3c82e-dabd-4ebb-82d7-caad12f24cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0fe720b-918f-42d6-ad22-b2af34879c6f" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_dcd3c82e-dabd-4ebb-82d7-caad12f24cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2e1e7e4e-3242-4a6e-8a1b-0a9f672c7034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0fe720b-918f-42d6-ad22-b2af34879c6f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2e1e7e4e-3242-4a6e-8a1b-0a9f672c7034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f1299ffd-cd2c-47d9-8620-007c24a94006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_73faef72-d162-467b-aed5-0a0e4e3ff364" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f1299ffd-cd2c-47d9-8620-007c24a94006" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_73faef72-d162-467b-aed5-0a0e4e3ff364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1cddec1f-f43f-4273-b9a7-6e352bfde783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_15666dd0-4f9d-45fa-9307-f35b3e77b557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1cddec1f-f43f-4273-b9a7-6e352bfde783" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_15666dd0-4f9d-45fa-9307-f35b3e77b557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3947b59a-787f-4f1b-b31a-7de877ff8a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1cddec1f-f43f-4273-b9a7-6e352bfde783" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3947b59a-787f-4f1b-b31a-7de877ff8a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_d472dd3a-ddc7-4b02-90f0-63f9077ba03c" xlink:href="rdnt-20231231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1cddec1f-f43f-4273-b9a7-6e352bfde783" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_d472dd3a-ddc7-4b02-90f0-63f9077ba03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7eacc0e4-43e1-488e-96b4-9689a8a15af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7bdf7baf-8a8b-4e0d-8890-986e0fe563c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7eacc0e4-43e1-488e-96b4-9689a8a15af2" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7bdf7baf-8a8b-4e0d-8890-986e0fe563c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_20ed7bd3-9f7a-4e3d-afde-943cb390d08f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7eacc0e4-43e1-488e-96b4-9689a8a15af2" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_20ed7bd3-9f7a-4e3d-afde-943cb390d08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_93db2370-2a7e-4edc-b80e-759e19b271af" xlink:href="rdnt-20231231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7eacc0e4-43e1-488e-96b4-9689a8a15af2" xlink:to="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_93db2370-2a7e-4edc-b80e-759e19b271af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_52c60590-ace7-44da-a712-603a75e03eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7eacc0e4-43e1-488e-96b4-9689a8a15af2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_52c60590-ace7-44da-a712-603a75e03eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e56e8f90-ce15-4b9e-86c4-d23e7df2ba39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_474803d2-4496-4ddb-9a92-dbd0f286930a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e56e8f90-ce15-4b9e-86c4-d23e7df2ba39" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_474803d2-4496-4ddb-9a92-dbd0f286930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c9c4e755-cb84-4da8-a19a-4c2d1f8edcac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e56e8f90-ce15-4b9e-86c4-d23e7df2ba39" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c9c4e755-cb84-4da8-a19a-4c2d1f8edcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f47b76bc-ae86-4b0c-b343-c720bfc057e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e56e8f90-ce15-4b9e-86c4-d23e7df2ba39" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f47b76bc-ae86-4b0c-b343-c720bfc057e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_57b64295-25a8-422d-9d2c-9d95f41f447d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e56e8f90-ce15-4b9e-86c4-d23e7df2ba39" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_57b64295-25a8-422d-9d2c-9d95f41f447d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_d9bc97af-6c4b-49de-a97b-88c2a7191e69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e56e8f90-ce15-4b9e-86c4-d23e7df2ba39" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_d9bc97af-6c4b-49de-a97b-88c2a7191e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b43fd7e-7fba-46a3-ba60-43d115a09b86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8a5f5a52-b90c-42b4-8645-7db61e75ee17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b43fd7e-7fba-46a3-ba60-43d115a09b86" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8a5f5a52-b90c-42b4-8645-7db61e75ee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_aa54a364-0968-479d-98cb-4c6eac5276e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b43fd7e-7fba-46a3-ba60-43d115a09b86" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_aa54a364-0968-479d-98cb-4c6eac5276e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_519763d3-a3b3-4ba7-8ca9-40be25dc7192" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b43fd7e-7fba-46a3-ba60-43d115a09b86" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_519763d3-a3b3-4ba7-8ca9-40be25dc7192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#NATUREOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bd3df636-c7c5-4ee3-aa81-ba741a589f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bd3df636-c7c5-4ee3-aa81-ba741a589f6f" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2218642f-d96f-4c2c-93b4-0605f611f28b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_daef39da-bee9-4cde-a482-67775a708e31" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2218642f-d96f-4c2c-93b4-0605f611f28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_29f5485e-6575-4166-9e44-26de2770a43d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2218642f-d96f-4c2c-93b4-0605f611f28b" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_29f5485e-6575-4166-9e44-26de2770a43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2401209a-8719-4289-8e16-533734598cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8f67255-4b9e-49d8-9299-702340edb5af" xlink:to="loc_us-gaap_EquityComponentDomain_2401209a-8719-4289-8e16-533734598cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f89af121-6ebe-42af-9ed9-5d7403abb3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2401209a-8719-4289-8e16-533734598cfb" xlink:to="loc_us-gaap_CommonStockMember_f89af121-6ebe-42af-9ed9-5d7403abb3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d0559de0-86dc-47e6-bf2d-43e83b5ec8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fa54d35d-50e6-4eec-931f-e12ffb6e05f0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d0559de0-86dc-47e6-bf2d-43e83b5ec8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PublicOfferingMember_4f15caa4-0623-4aab-8333-020d761f228f" xlink:href="rdnt-20231231.xsd#rdnt_PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d0559de0-86dc-47e6-bf2d-43e83b5ec8c4" xlink:to="loc_rdnt_PublicOfferingMember_4f15caa4-0623-4aab-8333-020d761f228f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_10211485-2bc4-4d14-a8f2-5a830d93c9aa" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_d3c961c9-15c2-4c8f-a108-bb83cce4e0ef" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_rdnt_NumberOfCenters_d3c961c9-15c2-4c8f-a108-bb83cce4e0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_23d921ba-5bdc-42ac-bd8a-653033cdccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_NumberOfReportableSegments_23d921ba-5bdc-42ac-bd8a-653033cdccd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fbe03a29-64a3-4c5d-9f82-85d95ca256aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fbe03a29-64a3-4c5d-9f82-85d95ca256aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_ce2aca93-c1f2-4acf-9b2d-88081f97661c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_ce2aca93-c1f2-4acf-9b2d-88081f97661c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_2353fd15-a770-4a51-9980-f41851dc4e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_2353fd15-a770-4a51-9980-f41851dc4e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SaleOfStockCost_2db72bf1-ff30-4a78-9fcb-4e47c230dc5c" xlink:href="rdnt-20231231.xsd#rdnt_SaleOfStockCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_rdnt_SaleOfStockCost_2db72bf1-ff30-4a78-9fcb-4e47c230dc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_314b4eea-5d23-4769-9579-e135862c39b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_314b4eea-5d23-4769-9579-e135862c39b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_224becb8-48ff-4122-81e1-ee15985aa399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_224becb8-48ff-4122-81e1-ee15985aa399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_ec3fa892-0546-4c07-adf5-bb6816ab4c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_ec3fa892-0546-4c07-adf5-bb6816ab4c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dd222540-d343-403e-8ceb-884f254f828a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_Assets_dd222540-d343-403e-8ceb-884f254f828a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4c43d4f3-ed84-4d59-b738-c7ed8b0c3b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_Liabilities_4c43d4f3-ed84-4d59-b738-c7ed8b0c3b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_df2b8eeb-4f97-4014-9752-0e08de6bfc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_df2b8eeb-4f97-4014-9752-0e08de6bfc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_969629b8-eff6-4bda-9365-791c49da7463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_EquityMethodInvestments_969629b8-eff6-4bda-9365-791c49da7463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ba7ed6cc-35a6-48d1-badc-661561882c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_1a3fbe28-1cdc-487b-8d41-1fec763e3596" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ba7ed6cc-35a6-48d1-badc-661561882c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5c51c02a-2ef9-4fb2-a011-18cf70cc23af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5c51c02a-2ef9-4fb2-a011-18cf70cc23af" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:to="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9eca6045-11c4-4eb7-aaa4-7c2f0ed2f88a" xlink:to="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:to="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_0a225ef2-f989-4eb2-98b8-1d296c317fea" xlink:href="rdnt-20231231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_CommercialInsurance1Member_0a225ef2-f989-4eb2-98b8-1d296c317fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_49a4f328-f86b-4ced-bc47-eec61a247912" xlink:href="rdnt-20231231.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_Medicare1Member_49a4f328-f86b-4ced-bc47-eec61a247912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_872fa65b-d1d0-4fec-9473-af8baf8f1273" xlink:href="rdnt-20231231.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_Medicaid1Member_872fa65b-d1d0-4fec-9473-af8baf8f1273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_e4ec6c1c-4297-4257-bd25-ad5f97330922" xlink:href="rdnt-20231231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_e4ec6c1c-4297-4257-bd25-ad5f97330922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_a1305a59-7148-4122-8b52-360cd5a6f128" xlink:href="rdnt-20231231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_a1305a59-7148-4122-8b52-360cd5a6f128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_35b19ef4-71a5-4d49-b528-d6d42001ddc0" xlink:href="rdnt-20231231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_HealthCareManagementServiceMember_35b19ef4-71a5-4d49-b528-d6d42001ddc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareAndTeleradiologyMember_d6db942e-2f59-4010-a572-8ad4c63e7e74" xlink:href="rdnt-20231231.xsd#rdnt_SoftwareAndTeleradiologyMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_SoftwareAndTeleradiologyMember_d6db942e-2f59-4010-a572-8ad4c63e7e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_57b57894-ed16-453d-984a-f0b2244a74a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_us-gaap_HealthCareOtherMember_57b57894-ed16-453d-984a-f0b2244a74a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_238f4327-6760-4c70-9d06-39e2943caf72" xlink:href="rdnt-20231231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_77ac32c6-5acc-4a64-a41d-9c31ec1e959e" xlink:to="loc_rdnt_CapitationArrangementsMember_238f4327-6760-4c70-9d06-39e2943caf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_4ed4496b-2ac1-4ec5-8a9e-4144f8070f9e" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_521d2a0d-e95e-4d2e-b296-01cf353b6272" xlink:to="loc_rdnt_AIMember_4ed4496b-2ac1-4ec5-8a9e-4144f8070f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f8651f1d-db69-4084-98de-a821427b3e31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_216be937-904e-4afd-9c76-aab038e39e0f" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f8651f1d-db69-4084-98de-a821427b3e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5186ac8-6d3d-48d9-b68a-08f523ea3856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f8651f1d-db69-4084-98de-a821427b3e31" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5186ac8-6d3d-48d9-b68a-08f523ea3856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6fa405d4-95ac-48fe-b9fc-7e34992b6b63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6fa405d4-95ac-48fe-b9fc-7e34992b6b63" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_3002c31c-40f6-41aa-8cc6-091c9d74fe02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_bb254f03-7c58-43ed-aa63-a7a11c386469" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_3002c31c-40f6-41aa-8cc6-091c9d74fe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_3055c9d5-e87f-432b-9ea9-4544307d75b5" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_3002c31c-40f6-41aa-8cc6-091c9d74fe02" xlink:to="loc_rdnt_COVID19PandemicMember_3055c9d5-e87f-432b-9ea9-4544307d75b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ccd0adee-e8c7-4bf7-b6b3-17f8d2efbc64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_d2c7ec3e-205c-4bdb-a745-47ab0f8fd2e1" xlink:href="rdnt-20231231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:to="loc_rdnt_AdvanceMedicarePayments_d2c7ec3e-205c-4bdb-a745-47ab0f8fd2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_84f5b5bd-3f32-4cbe-a113-5b240ffbecab" xlink:href="rdnt-20231231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a12c0155-677f-42b8-8430-179083a63ab0" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_84f5b5bd-3f32-4cbe-a113-5b240ffbecab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1d0a4248-ad1e-46a8-a827-d747e6867b22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e17eac95-c213-4038-a122-86b0438ce723" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d0a4248-ad1e-46a8-a827-d747e6867b22" xlink:to="loc_us-gaap_AccountsPayableCurrent_e17eac95-c213-4038-a122-86b0438ce723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4e98f8f4-8440-4e7e-8c6f-0b760c928673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d0a4248-ad1e-46a8-a827-d747e6867b22" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4e98f8f4-8440-4e7e-8c6f-0b760c928673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9caf8cf1-dd61-4681-bac3-a3e06684d239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d0a4248-ad1e-46a8-a827-d747e6867b22" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9caf8cf1-dd61-4681-bac3-a3e06684d239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1b81d89b-ddaa-43b5-ae80-63207cd9f93e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d0a4248-ad1e-46a8-a827-d747e6867b22" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1b81d89b-ddaa-43b5-ae80-63207cd9f93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5f1ecf36-9491-449b-8469-04aefd207eba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d0a4248-ad1e-46a8-a827-d747e6867b22" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5f1ecf36-9491-449b-8469-04aefd207eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_91bdd39b-a8a1-46ee-b9fa-171ca2e550d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91bdd39b-a8a1-46ee-b9fa-171ca2e550d1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_686b2f5d-5efb-43e9-854e-7aea8e29bf96" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_41230135-f939-42ab-a25b-f5d35a467289" xlink:to="loc_srt_ProductsAndServicesDomain_686b2f5d-5efb-43e9-854e-7aea8e29bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_78bacd7b-204f-4c95-8649-f7b955881310" xlink:href="rdnt-20231231.xsd#rdnt_PatientServicesNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_686b2f5d-5efb-43e9-854e-7aea8e29bf96" xlink:to="loc_rdnt_PatientServicesNetMember_78bacd7b-204f-4c95-8649-f7b955881310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2f38c123-626b-488b-b6ff-89010e614718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_621ef76b-2d00-497d-94d2-8aa010e703b2" xlink:to="loc_us-gaap_SegmentDomain_2f38c123-626b-488b-b6ff-89010e614718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_a12a3f45-0532-4c30-add3-827a4f6cf4dc" xlink:href="rdnt-20231231.xsd#rdnt_ERADMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2f38c123-626b-488b-b6ff-89010e614718" xlink:to="loc_rdnt_ERADMember_a12a3f45-0532-4c30-add3-827a4f6cf4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_644af85d-3baf-4f1e-bcbf-fc3497ff746a" xlink:to="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2939edef-b036-451e-a863-f9857adcc6b4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:to="loc_srt_MinimumMember_2939edef-b036-451e-a863-f9857adcc6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_664fd4c5-f692-48ae-a067-accd932a17ae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fad14807-0d2f-4cf5-9ebd-f454472c9387" xlink:to="loc_srt_MaximumMember_664fd4c5-f692-48ae-a067-accd932a17ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fb1439e-2242-4ca2-900b-75e8fd041223" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_e6913b57-3d93-4dfa-8a9e-7fe5970dec27" xlink:href="rdnt-20231231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_e6913b57-3d93-4dfa-8a9e-7fe5970dec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f662ee28-9355-44da-9358-957969a6d856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b78588b9-4a3c-4c0d-8ad2-95d7fd0195e4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f662ee28-9355-44da-9358-957969a6d856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0a8827f-f283-4c54-ac35-33eea2c1e72f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_502aa3a0-6fb0-42f8-b336-4c038725f9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_502aa3a0-6fb0-42f8-b336-4c038725f9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_c14e9e90-b7b5-485a-b45e-60667b463b64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_c14e9e90-b7b5-485a-b45e-60667b463b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d639195a-b84b-4572-bab4-e319fa4b8d30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d1dee391-bae9-45ce-9526-976bd596fd48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d639195a-b84b-4572-bab4-e319fa4b8d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_396a8bc3-0676-4487-a4e8-a8d8c9b18e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_396a8bc3-0676-4487-a4e8-a8d8c9b18e78" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1912abc2-b7be-4ebf-928c-430926eb59ce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_66aa87c6-d428-4936-8824-0140dcb39bb5" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c419a498-756d-4891-a3d0-1d05a7a201fb" xlink:to="loc_rdnt_AidenceMember_66aa87c6-d428-4936-8824-0140dcb39bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d3e1ce8f-bab1-480e-b0c6-c45b10dbfb8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5cb58bf2-ae6f-4672-820f-5a6003c15c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c53dd7f-bb00-4761-9034-7fb93213367e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5cb58bf2-ae6f-4672-820f-5a6003c15c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_014087a6-0ae7-4c14-bdb4-6f249376dabd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_ReinsuranceContractAxis_014087a6-0ae7-4c14-bdb4-6f249376dabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_18f223d7-7280-41ef-9954-d7938bacd8d6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_b05e90cb-d67a-445a-8a18-81b4eddfca24" xlink:href="rdnt-20231231.xsd#rdnt_BlueShieldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09c58f8f-3c67-4ffe-be9d-9eded45b3d8e" xlink:to="loc_rdnt_BlueShieldMember_b05e90cb-d67a-445a-8a18-81b4eddfca24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_af9c7fd5-bd0f-48af-87fe-8ad26647bbf4" xlink:to="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_90dbbe68-0530-4034-b14b-28b5dc930219" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:to="loc_srt_MinimumMember_90dbbe68-0530-4034-b14b-28b5dc930219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4856e65e-5b89-458d-9cea-d137caf0c73a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_817ce5fd-3dc7-4fe8-95c5-67281cd12ac9" xlink:to="loc_srt_MaximumMember_4856e65e-5b89-458d-9cea-d137caf0c73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fb51e9-b3f3-4507-aa20-8b9c9f56704f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a12df55e-b125-4479-8b24-26b8114b4de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_Goodwill_a12df55e-b125-4479-8b24-26b8114b4de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae0685f5-4fd3-4401-8f2d-3ac2b064bd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae0685f5-4fd3-4401-8f2d-3ac2b064bd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dc733947-bcf4-404c-9378-8bf268765f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dc733947-bcf4-404c-9378-8bf268765f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6b56fbb5-2a1e-4699-8133-de658ebebc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6b56fbb5-2a1e-4699-8133-de658ebebc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_a4a1e62e-c092-4cde-9091-a83e841254b3" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_a4a1e62e-c092-4cde-9091-a83e841254b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_47fd4546-0f0b-40a6-91dd-3fe2988f721e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_47fd4546-0f0b-40a6-91dd-3fe2988f721e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_0ecac555-1e93-440a-abcd-2de98b7525d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_0ecac555-1e93-440a-abcd-2de98b7525d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_310a48b6-daba-4447-99c6-67bdd9688bce" xlink:href="rdnt-20231231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_310a48b6-daba-4447-99c6-67bdd9688bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_3cb92020-38d2-4688-9f40-79adedc482a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_us-gaap_SelfInsuranceReserve_3cb92020-38d2-4688-9f40-79adedc482a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9d1064c4-f47b-4066-9bb9-e27d5b8c8144" xlink:href="rdnt-20231231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d15596b0-9f83-421a-859a-b46fa43c033b" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_9d1064c4-f47b-4066-9bb9-e27d5b8c8144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6932c196-1394-4a56-84ea-8d9dd3a6ac97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6932c196-1394-4a56-84ea-8d9dd3a6ac97" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:to="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cead0a4b-3aec-4cdb-b408-415b53a1cb01" xlink:to="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_454eb6f5-21cb-4310-b937-9d270612176f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:to="loc_srt_MinimumMember_454eb6f5-21cb-4310-b937-9d270612176f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_411ccc6c-1056-45e4-8b97-4bda61751e87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f5be1d14-a1e3-4c8b-8e57-d559a7a79eb3" xlink:to="loc_srt_MaximumMember_411ccc6c-1056-45e4-8b97-4bda61751e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:to="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d221b969-b14e-41b2-afa9-c3b0521698b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_47e4d74c-8659-4a4a-b690-c3a074dfef93" xlink:to="loc_us-gaap_PlanNameDomain_d221b969-b14e-41b2-afa9-c3b0521698b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_0290aa07-63c7-478d-87b2-cd7f1f70db61" xlink:href="rdnt-20231231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d221b969-b14e-41b2-afa9-c3b0521698b2" xlink:to="loc_rdnt_RestatedPlanMember_0290aa07-63c7-478d-87b2-cd7f1f70db61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bb6cc48f-07cd-4461-bd1c-5a31475cf9fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_fb001c1e-a052-42d6-a3a1-4748fddf074f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_fb001c1e-a052-42d6-a3a1-4748fddf074f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c454192e-0538-4e1e-9472-ab4870a74a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c454192e-0538-4e1e-9472-ab4870a74a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_06cbf8f4-de32-4bfa-a40f-35dcd3336027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_06cbf8f4-de32-4bfa-a40f-35dcd3336027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_21934f20-5322-4ea1-862a-c507208aaa82" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_21934f20-5322-4ea1-862a-c507208aaa82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0728d3fc-6365-477e-97d8-15152827829f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0728d3fc-6365-477e-97d8-15152827829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e0670a69-c8e6-40f9-83e1-53e4a9cc5406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e0670a69-c8e6-40f9-83e1-53e4a9cc5406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2dcf2463-2c3b-4141-afc3-4924267e277f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f3513e0-a37d-411a-bbea-4fde11ef7494" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2dcf2463-2c3b-4141-afc3-4924267e277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b7afc46a-e24d-4aeb-a309-4ee655c72d78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_66370c08-00e2-4a6c-b114-a767231bd7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7afc46a-e24d-4aeb-a309-4ee655c72d78" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_66370c08-00e2-4a6c-b114-a767231bd7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_17458b1c-3bf0-4dbd-a82e-51c930fc2411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_66370c08-00e2-4a6c-b114-a767231bd7f6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_17458b1c-3bf0-4dbd-a82e-51c930fc2411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_242989ef-2ac3-49ca-8289-5ba939b14c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_66370c08-00e2-4a6c-b114-a767231bd7f6" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_242989ef-2ac3-49ca-8289-5ba939b14c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5961c032-275a-40e9-9355-91ba1cbb6d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_66370c08-00e2-4a6c-b114-a767231bd7f6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5961c032-275a-40e9-9355-91ba1cbb6d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b31fcd5a-2689-49d1-a811-568bb43dc775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b31fcd5a-2689-49d1-a811-568bb43dc775" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_22d747e9-2a31-4abe-b136-f4338c7768e9" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_17d6c532-e108-49ab-bf32-296338b322da" xlink:href="rdnt-20231231.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:to="loc_rdnt_A2019SWAPSMember_17d6c532-e108-49ab-bf32-296338b322da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_54239f54-7075-4771-b2b6-854d6de7f926" xlink:href="rdnt-20231231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_11afb9da-b46a-4f83-a149-a2e5e1520212" xlink:to="loc_rdnt_A2019SWAPS1Member_54239f54-7075-4771-b2b6-854d6de7f926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_edad3053-4907-4934-84ce-02b586d60adf" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_68da5503-9ae6-44e4-853d-896584f7b145" xlink:href="rdnt-20231231.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:to="loc_rdnt_October2023Member_68da5503-9ae6-44e4-853d-896584f7b145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_2c1d68e8-7a50-4534-8b26-946c27103201" xlink:href="rdnt-20231231.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_fd1d641f-e786-4155-a0b3-f547152cf9e8" xlink:to="loc_rdnt_October2025Member_2c1d68e8-7a50-4534-8b26-946c27103201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d2d1681-be81-438d-bdae-bb690bf150c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cccfcc87-f377-466a-b0bf-dd0acc7f5ecc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d2d1681-be81-438d-bdae-bb690bf150c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7f4ac293-ec37-4609-8103-e262e12ae653" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d2d1681-be81-438d-bdae-bb690bf150c7" xlink:to="loc_us-gaap_InterestRateSwapMember_7f4ac293-ec37-4609-8103-e262e12ae653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21ca32bd-c448-47a4-b9ae-629a1f1da3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f4c243ac-e3de-4526-adc5-a00ca880a5f3" xlink:to="loc_us-gaap_VariableRateDomain_21ca32bd-c448-47a4-b9ae-629a1f1da3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LondonInterbankOfferedRateLIBOR1Member_11615878-3f25-49f6-9ec1-6ef6932d99ab" xlink:href="rdnt-20231231.xsd#rdnt_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21ca32bd-c448-47a4-b9ae-629a1f1da3fc" xlink:to="loc_rdnt_LondonInterbankOfferedRateLIBOR1Member_11615878-3f25-49f6-9ec1-6ef6932d99ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_383ad4f7-67e4-4c1c-86ad-c874dd6d7650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0369063-13d1-43e0-8ee6-f01d91678f51" xlink:to="loc_us-gaap_EquityComponentDomain_383ad4f7-67e4-4c1c-86ad-c874dd6d7650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1cf1b439-91a2-4268-82c8-12d0f41dfc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_383ad4f7-67e4-4c1c-86ad-c874dd6d7650" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_1cf1b439-91a2-4268-82c8-12d0f41dfc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f1076cf6-20b7-4a74-af38-f27992f5454a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_98f9e775-2a45-49bc-a1b7-9ca49f0246c8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f1076cf6-20b7-4a74-af38-f27992f5454a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c8eb9b55-4236-47cc-85d1-0365fc022663" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f1076cf6-20b7-4a74-af38-f27992f5454a" xlink:to="loc_srt_ScenarioForecastMember_c8eb9b55-4236-47cc-85d1-0365fc022663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df01bb83-7b2f-4b1f-ac2c-bd23cb733e16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_1b4dd2cc-b637-4900-a0c9-88c6fc5de8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_1b4dd2cc-b637-4900-a0c9-88c6fc5de8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d2432e96-c5e1-4481-97a5-84c78834ddba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d2432e96-c5e1-4481-97a5-84c78834ddba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_603b512d-68ab-4bf5-bcbf-fcb9b58075a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_603b512d-68ab-4bf5-bcbf-fcb9b58075a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2028228b-0415-48ac-84ea-3c5f41650dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_us-gaap_StockholdersEquity_2028228b-0415-48ac-84ea-3c5f41650dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_21895e85-4ea0-4de5-8550-2a863e78a6cd" xlink:href="rdnt-20231231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7fce43c-2158-4072-b49c-fdd268f41c1f" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_21895e85-4ea0-4de5-8550-2a863e78a6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3c08c6cd-d992-4857-8aab-4b245a48307f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3c08c6cd-d992-4857-8aab-4b245a48307f" xlink:to="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6a6f387d-9f00-4f71-a781-1159846f51d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_23e3e188-5d7f-445a-b3cb-e1e634c2a170" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6a6f387d-9f00-4f71-a781-1159846f51d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6a35ceea-b7d4-48d1-bf04-9b076f4d0b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6a6f387d-9f00-4f71-a781-1159846f51d3" xlink:to="loc_us-gaap_InterestRateSwapMember_6a35ceea-b7d4-48d1-bf04-9b076f4d0b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f80f8287-3b3b-4625-bd5a-0c7eed5ddc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b3a83a6-eb29-4f9f-9d22-9ec01e041e88" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f80f8287-3b3b-4625-bd5a-0c7eed5ddc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_ec439680-1bfe-4277-bf0d-fd1240dc4fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f80f8287-3b3b-4625-bd5a-0c7eed5ddc6d" xlink:to="loc_us-gaap_InterestExpenseMember_ec439680-1bfe-4277-bf0d-fd1240dc4fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_ef91d8f3-eaa7-4823-9812-886f130a2e4a" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5cc68106-3b6e-449b-9352-0adaa53c7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5cc68106-3b6e-449b-9352-0adaa53c7efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_40f7873e-1bfa-4c90-80e9-b44652c67d55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_40f7873e-1bfa-4c90-80e9-b44652c67d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_261e41db-59b7-4342-a81a-6c7d8c8f9d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_255a8e1b-9b09-4ab2-8fc5-07a2747b1ca8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_261e41db-59b7-4342-a81a-6c7d8c8f9d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee191993-d238-4bca-988a-1ab43d9ef4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee191993-d238-4bca-988a-1ab43d9ef4dd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46ab2f94-e215-4213-bc9e-8688579a7ff6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_7bfbe2c7-70e2-4a02-bfe2-b6814dbd0157" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_AidenceMember_7bfbe2c7-70e2-4a02-bfe2-b6814dbd0157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_e4f62bf1-ebe5-4204-b381-5d88a36a861a" xlink:href="rdnt-20231231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_AidenceHoldingBVMember_e4f62bf1-ebe5-4204-b381-5d88a36a861a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_3e58507f-74fb-47f5-bea2-31da1045f0c5" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_QuantibMember_3e58507f-74fb-47f5-bea2-31da1045f0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_6f31de6b-8d98-4aa3-b45e-b2c4db65da6d" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_MontclairMember_6f31de6b-8d98-4aa3-b45e-b2c4db65da6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_98a72e1b-68ca-4a0d-86b9-0c52bc606f0a" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a95e97f-133c-4213-9bc1-c7c2da245409" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_98a72e1b-68ca-4a0d-86b9-0c52bc606f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_2301dc2c-c8d6-4efa-a610-cb73d0972255" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_a62f02b8-f92e-4f8e-9c1a-17ba61da7605" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_a62f02b8-f92e-4f8e-9c1a-17ba61da7605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_01182365-bfc5-4136-98bc-d31bf6829acc" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_CashHoldbackMember_01182365-bfc5-4136-98bc-d31bf6829acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GeneralHoldbackMember_da005e5d-b82e-4281-aae6-51affd448d57" xlink:href="rdnt-20231231.xsd#rdnt_GeneralHoldbackMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_GeneralHoldbackMember_da005e5d-b82e-4281-aae6-51affd448d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockHoldbackMember_311ef255-2033-4bad-a360-ce1f27362f50" xlink:href="rdnt-20231231.xsd#rdnt_StockHoldbackMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9ca1e6de-78ec-4660-9786-6c323cd81ad5" xlink:to="loc_rdnt_StockHoldbackMember_311ef255-2033-4bad-a360-ce1f27362f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aa4a593f-12d8-4393-969a-c9a2a7675a00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7ee99a27-015a-4c79-82b7-b36afec86475" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7ee99a27-015a-4c79-82b7-b36afec86475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_69b08684-eb7b-4f4c-9aac-bd1b132dbf2b" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_69b08684-eb7b-4f4c-9aac-bd1b132dbf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbfdcd20-f108-47de-b3ad-f22b72ed9774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbfdcd20-f108-47de-b3ad-f22b72ed9774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_127c9d95-c6cd-4d2f-8fba-fc3a155abcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_127c9d95-c6cd-4d2f-8fba-fc3a155abcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5fefbed5-0c43-4d0c-92d5-b629911cce4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5fefbed5-0c43-4d0c-92d5-b629911cce4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6bff1f86-7c81-444e-bec2-a2a69ef50ef2" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_6bff1f86-7c81-444e-bec2-a2a69ef50ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d7165ca4-8459-438c-a4d6-144ce04c1c1f" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_d7165ca4-8459-438c-a4d6-144ce04c1c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_5dab09f6-df3a-4220-a3cc-6f294ac5b43c" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_5dab09f6-df3a-4220-a3cc-6f294ac5b43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ed44a32e-4728-4159-8d48-1a0ee79909c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ed44a32e-4728-4159-8d48-1a0ee79909c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_5da7250e-0bbd-4ac0-972a-3f313647831f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_5da7250e-0bbd-4ac0-972a-3f313647831f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_cecfc67e-2fcd-419c-ba0b-65150af95dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_cecfc67e-2fcd-419c-ba0b-65150af95dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b25c6fbe-e967-47f6-92dc-4beaec188935" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b25c6fbe-e967-47f6-92dc-4beaec188935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_5c79ccb5-e1b1-4d62-8c07-aeb1de7f6393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b160149d-4eef-4291-8e51-788a7e680c83" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_5c79ccb5-e1b1-4d62-8c07-aeb1de7f6393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4d90713f-d5c7-47d5-a855-e6956b7f2417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d90713f-d5c7-47d5-a855-e6956b7f2417" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c53a82e-a0f4-45a5-9090-8c379c423f5f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_85075a32-3a0f-4bf4-9e24-0451e92f966a" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_AidenceMember_85075a32-3a0f-4bf4-9e24-0451e92f966a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_b7a0c4eb-c675-4327-a75e-67f298b5a9c5" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_QuantibMember_b7a0c4eb-c675-4327-a75e-67f298b5a9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_31bb8117-f617-4b2d-9b6c-0e5b9fea82a2" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_MontclairMember_31bb8117-f617-4b2d-9b6c-0e5b9fea82a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_1d005c5e-40e8-427c-8668-90f995c59327" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c1bb1d-2560-4be7-bbd0-e5c4499a0377" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_1d005c5e-40e8-427c-8668-90f995c59327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_96e42a63-e667-48dc-9af6-fb8ccf82e2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_ad94c9f4-6942-429d-a27f-bbaffc3e57a9" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_96e42a63-e667-48dc-9af6-fb8ccf82e2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_96e42a63-e667-48dc-9af6-fb8ccf82e2bf" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a5aa47b-f29a-4153-8fbb-b4abe36a28c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a5aa47b-f29a-4153-8fbb-b4abe36a28c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_64368b9d-0300-4507-a131-80166d81df85" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements_64368b9d-0300-4507-a131-80166d81df85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc67f370-048d-4c1a-b7b6-e16991ac4f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc67f370-048d-4c1a-b7b6-e16991ac4f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_49ae6bf6-30ef-443c-84a1-9bd87a3a1c76" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_49ae6bf6-30ef-443c-84a1-9bd87a3a1c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_041f5a34-5004-46ae-a24a-6703b03e4400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_319ccc19-38de-4c98-8dfc-e76b1bafc395" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_041f5a34-5004-46ae-a24a-6703b03e4400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ca48c83e-e61c-4593-b18d-8a0b106a27ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ca48c83e-e61c-4593-b18d-8a0b106a27ae" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d7b38f7f-5488-4c55-a158-249ccf30c6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8959a45d-9c95-454c-a25b-a0d513259a4c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d7b38f7f-5488-4c55-a158-249ccf30c6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf8491d4-945b-480b-b6c4-bb39949f1d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d7b38f7f-5488-4c55-a158-249ccf30c6e0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf8491d4-945b-480b-b6c4-bb39949f1d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8140d348-515d-4329-b0fa-b6a04a47d2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf8491d4-945b-480b-b6c4-bb39949f1d32" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8140d348-515d-4329-b0fa-b6a04a47d2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77bdf4c2-747a-48ed-bbc6-ea6f03f50622" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b2c440d9-3158-4446-b80b-3ba0b58ddc44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b2c440d9-3158-4446-b80b-3ba0b58ddc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_26107671-f9d6-40d9-9015-eb01cbb7315e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_26107671-f9d6-40d9-9015-eb01cbb7315e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cd1a8397-e6e4-45b8-91be-31ececfdb318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fbbfe830-c795-4259-ba8a-026c03318c6e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cd1a8397-e6e4-45b8-91be-31ececfdb318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1fa4ee3-a888-4bda-859d-c94275aa25c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1279b212-4623-4f23-b21b-f52883ad2ffa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1fa4ee3-a888-4bda-859d-c94275aa25c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cf3e09a4-b636-4ce6-a330-4e3780641a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1fa4ee3-a888-4bda-859d-c94275aa25c2" xlink:to="loc_us-gaap_InterestRateSwapMember_cf3e09a4-b636-4ce6-a330-4e3780641a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4c32875e-89ad-4778-a193-4bf251ce5576" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_58ed104d-dff8-4ed4-8c49-7a770bf397c5" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_AidenceMember_58ed104d-dff8-4ed4-8c49-7a770bf397c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_bcdb834c-e144-4356-977e-14168ad8ef18" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_QuantibMember_bcdb834c-e144-4356-977e-14168ad8ef18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_51eeee52-3dbc-4db4-a0a0-be34fde1719d" xlink:href="rdnt-20231231.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_MontclairMember_51eeee52-3dbc-4db4-a0a0-be34fde1719d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_034e6958-b27f-429b-88e2-110af200ed2a" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65184153-f49e-415e-9d65-3b3a89459bb5" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_034e6958-b27f-429b-88e2-110af200ed2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e613e542-d7bc-4a57-ba88-87bc16e629b4" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_62091312-2a3f-402d-9eba-cc16749f1097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_DerivativeAssets_62091312-2a3f-402d-9eba-cc16749f1097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7c049d2d-3d5e-4a9b-8380-a608a1291fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_DerivativeLiabilities_7c049d2d-3d5e-4a9b-8380-a608a1291fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_7b4f2927-4203-474f-be06-f6ff3ea7ba6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_7b4f2927-4203-474f-be06-f6ff3ea7ba6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_b3f56280-52f4-4683-92df-2b38f9f35b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_7b4f2927-4203-474f-be06-f6ff3ea7ba6b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_b3f56280-52f4-4683-92df-2b38f9f35b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_2e82d54e-4ce2-4a8d-b0b7-61882621e5f2" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_2e82d54e-4ce2-4a8d-b0b7-61882621e5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ValueOfEstimatedSharesIssuable_8a776c90-a763-480c-971a-8cfd54b4799d" xlink:href="rdnt-20231231.xsd#rdnt_ValueOfEstimatedSharesIssuable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a11e1971-6950-4501-ac2f-8d075253c882" xlink:to="loc_rdnt_ValueOfEstimatedSharesIssuable_8a776c90-a763-480c-971a-8cfd54b4799d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9fdcf9fd-82c7-487e-ad3e-9a502efbb4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9fdcf9fd-82c7-487e-ad3e-9a502efbb4a2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b34c2d57-c447-47fb-8968-c610d51d8f9f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0a63d162-e319-4744-b52a-dbcccdbe8ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0a63d162-e319-4744-b52a-dbcccdbe8ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b37b727f-707e-4d81-92d8-8a49a1c19d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b37b727f-707e-4d81-92d8-8a49a1c19d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_55b078d1-93a6-4af9-995e-a9e2e7e7fbce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_762cfd42-fdb8-46dc-9588-184ebe95f5b5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_55b078d1-93a6-4af9-995e-a9e2e7e7fbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8eb6f34a-52bc-400c-9e56-fc0b667026df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_c275d2e7-4f57-480a-84a6-90f1fe354e2e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8eb6f34a-52bc-400c-9e56-fc0b667026df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cb8b93fd-9061-40f2-bfe0-22d16354b4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8eb6f34a-52bc-400c-9e56-fc0b667026df" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cb8b93fd-9061-40f2-bfe0-22d16354b4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a36137d-6153-4007-a301-5067fbaa37ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cb8b93fd-9061-40f2-bfe0-22d16354b4b1" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a36137d-6153-4007-a301-5067fbaa37ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9b9af29-54ef-4115-880d-d2a7274a039d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_e5f6fccd-0e35-42a1-ae12-c9120b2870dc" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:to="loc_rdnt_BarclaysMember_e5f6fccd-0e35-42a1-ae12-c9120b2870dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_5812881f-2328-42ca-913c-0e39f425df7a" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e90f8143-c90b-4198-90ff-f6a4d9a6466f" xlink:to="loc_rdnt_TruistMember_5812881f-2328-42ca-913c-0e39f425df7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c013c60a-41b7-4e4e-b7d0-83257662c7de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e34d4ec6-c55b-4391-ab70-781b9c56858a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e34d4ec6-c55b-4391-ab70-781b9c56858a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e164795e-7abb-4a68-87d8-89aa69a60370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cee0c4cb-05ed-4feb-883a-e3337380fb9f" xlink:to="loc_us-gaap_LineOfCredit_e164795e-7abb-4a68-87d8-89aa69a60370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3420d520-8963-4c0e-82c9-7f6c05632baa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b14debed-a345-45c2-88da-e9ec52a77eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3420d520-8963-4c0e-82c9-7f6c05632baa" xlink:to="loc_us-gaap_NetIncomeLoss_b14debed-a345-45c2-88da-e9ec52a77eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_f03a7e7a-209f-455a-8bde-8c15cc30f717" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3420d520-8963-4c0e-82c9-7f6c05632baa" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_f03a7e7a-209f-455a-8bde-8c15cc30f717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_077bcb88-90f4-4f78-af71-08c0d75bb03d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_f03a7e7a-209f-455a-8bde-8c15cc30f717" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_077bcb88-90f4-4f78-af71-08c0d75bb03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_17d9f03c-ebbe-4133-8d71-2e9b79152a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_f03a7e7a-209f-455a-8bde-8c15cc30f717" xlink:to="loc_us-gaap_EarningsPerShareBasic_17d9f03c-ebbe-4133-8d71-2e9b79152a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3420d520-8963-4c0e-82c9-7f6c05632baa" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a1e2825c-d500-4438-9267-9932b9a26119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a1e2825c-d500-4438-9267-9932b9a26119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_97cba27c-87c5-4d41-865a-37eab2636c86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_97cba27c-87c5-4d41-865a-37eab2636c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_44ccda59-5fde-4af9-98ea-4c7b43dfb1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_44ccda59-5fde-4af9-98ea-4c7b43dfb1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2dd6bd52-7daf-40ad-8b01-9ed9a887df01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2dd6bd52-7daf-40ad-8b01-9ed9a887df01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_a2fb6adc-be14-4a9e-b569-00f62b2f9d97" xlink:href="rdnt-20231231.xsd#rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_a2fb6adc-be14-4a9e-b569-00f62b2f9d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_070d65db-e881-4798-a505-03491708078e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_070d65db-e881-4798-a505-03491708078e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5bbd4085-c447-40b8-b2c9-8600888cb01f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_39c86348-d6b5-4ad6-8313-7eb95031f060" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5bbd4085-c447-40b8-b2c9-8600888cb01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3420d520-8963-4c0e-82c9-7f6c05632baa" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_187d0813-1bc3-4ae9-8aee-586d30b430a2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c60a5aff-393a-45f3-80e2-258c8ec39c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c60a5aff-393a-45f3-80e2-258c8ec39c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fb408488-2b7b-4514-a641-d807272749f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c705a4e2-ddf1-40b2-8a26-ea96a8ee18cc" xlink:to="loc_us-gaap_CommonStockMember_fb408488-2b7b-4514-a641-d807272749f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_72c0f3d5-a60e-41e0-9c11-79ab916221ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a1cc945c-8915-4b1a-b2b4-82f2ef104bff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_72c0f3d5-a60e-41e0-9c11-79ab916221ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_5142c4f6-fc61-4e6d-8ff3-0ee1c4c3e4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_72c0f3d5-a60e-41e0-9c11-79ab916221ad" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_5142c4f6-fc61-4e6d-8ff3-0ee1c4c3e4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a961082-ae7f-41f0-927a-6c0cd924371f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_5142c4f6-fc61-4e6d-8ff3-0ee1c4c3e4ce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a961082-ae7f-41f0-927a-6c0cd924371f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e4cf6eb-4e4a-4549-8988-cc9f049a0fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e4cf6eb-4e4a-4549-8988-cc9f049a0fee" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d2bc705-7584-43ed-b331-1ce050cd0286" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_9181ec45-1026-49ab-ac04-4fee5c5d5e97" xlink:href="rdnt-20231231.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:to="loc_rdnt_MedicVisionMember_9181ec45-1026-49ab-ac04-4fee5c5d5e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_f927f525-21be-4898-8370-bd233f915ab5" xlink:href="rdnt-20231231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:to="loc_rdnt_TurnerImagingSystemsMember_f927f525-21be-4898-8370-bd233f915ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember_55d58a58-27b1-4dbf-89a3-67e8acc68e40" xlink:href="rdnt-20231231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3a50a237-e4fc-4d63-bef7-5ecf8afe7d88" xlink:to="loc_rdnt_WhiteRabbitaiIncMember_55d58a58-27b1-4dbf-89a3-67e8acc68e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a551f9e6-fc92-42ca-a7f6-b23317f69b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6c1ddb92-9eb8-4021-859d-25ef32c6964c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a551f9e6-fc92-42ca-a7f6-b23317f69b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_16fafa62-a6c0-439a-b12c-52756510ed4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a551f9e6-fc92-42ca-a7f6-b23317f69b93" xlink:to="loc_us-gaap_CommercialPaperMember_16fafa62-a6c0-439a-b12c-52756510ed4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d76fa8ed-b134-44fa-9959-d510f4c2ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2a0a9d59-110e-4f43-a0c0-6b6073d9b497" xlink:to="loc_us-gaap_ClassOfStockDomain_d76fa8ed-b134-44fa-9959-d510f4c2ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_975b982d-b176-47c6-ad13-efadf528d3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d76fa8ed-b134-44fa-9959-d510f4c2ca89" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_975b982d-b176-47c6-ad13-efadf528d3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d454cd8-914d-4790-90cd-1d36d4087525" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ced21281-92dc-4265-8ea5-113f1b15d078" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d454cd8-914d-4790-90cd-1d36d4087525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_08b408a2-085c-4c66-ab38-1af1aeef5d53" xlink:href="rdnt-20231231.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d454cd8-914d-4790-90cd-1d36d4087525" xlink:to="loc_rdnt_DignityHealthMember_08b408a2-085c-4c66-ab38-1af1aeef5d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9125dd51-2fc1-4d5c-84fa-c47257436d10" xlink:to="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d6edc945-dce6-4a52-a8dc-4d3326bbe209" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:to="loc_srt_MinimumMember_d6edc945-dce6-4a52-a8dc-4d3326bbe209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba046d6b-5dfd-4742-b177-64a6b225aadb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29407c60-7760-4b4b-b0b5-a83231ea3fe0" xlink:to="loc_srt_MaximumMember_ba046d6b-5dfd-4742-b177-64a6b225aadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2d05ce66-6373-4d5b-8c7f-78ae536cd339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_172c5d02-a4ad-4a49-b793-1adde84c244a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2d05ce66-6373-4d5b-8c7f-78ae536cd339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_f62c5106-923d-49d6-9254-89e5890cfe2d" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2d05ce66-6373-4d5b-8c7f-78ae536cd339" xlink:to="loc_rdnt_JointVentureMember_f62c5106-923d-49d6-9254-89e5890cfe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_60b40247-a354-4888-b2da-773090ec5e88" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3a16856d-9e9f-4615-897e-8644d2cb86ab" xlink:to="loc_dei_EntityDomain_60b40247-a354-4888-b2da-773090ec5e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_b8058f46-ed41-4870-9ea1-7d957b75eeb6" xlink:href="rdnt-20231231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_60b40247-a354-4888-b2da-773090ec5e88" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_b8058f46-ed41-4870-9ea1-7d957b75eeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1aaa5237-2e29-4995-a19b-ea0ea32148d1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9f52dc4e-1cf9-45c4-a80c-16151f63e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9f52dc4e-1cf9-45c4-a80c-16151f63e3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_f1205a4c-98c6-4c0a-89a8-b3a776d06ae9" xlink:href="rdnt-20231231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_f1205a4c-98c6-4c0a-89a8-b3a776d06ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_963e8bb3-313a-422e-a31b-1ebde51327ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_963e8bb3-313a-422e-a31b-1ebde51327ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4212057e-cf6b-4410-9f13-b775ac0afc29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4212057e-cf6b-4410-9f13-b775ac0afc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_2d44eb91-ab27-43d6-9046-b79a0c95a315" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_2d44eb91-ab27-43d6-9046-b79a0c95a315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_4525b63b-0148-485c-aad1-914b72f3e5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_4525b63b-0148-485c-aad1-914b72f3e5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_8f166383-04f4-4f08-b7d1-f08a4a0b287d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_ShortTermBorrowings_8f166383-04f4-4f08-b7d1-f08a4a0b287d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1ca0f10a-a7d2-476d-b1db-e2ce066fb5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1ca0f10a-a7d2-476d-b1db-e2ce066fb5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesAcquired_6a75f28c-7139-4294-92c1-feaeca18f47b" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_EquityMethodInvestmentSharesAcquired_6a75f28c-7139-4294-92c1-feaeca18f47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_88a087f0-375f-495e-a44a-bfd06a359099" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_88a087f0-375f-495e-a44a-bfd06a359099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6a7c667c-b2b2-45fb-8597-41cb86edda8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6a7c667c-b2b2-45fb-8597-41cb86edda8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PreferredStockExchangeRatePerShare_2af9a8a2-2388-43ac-9e68-2079d9836859" xlink:href="rdnt-20231231.xsd#rdnt_PreferredStockExchangeRatePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_PreferredStockExchangeRatePerShare_2af9a8a2-2388-43ac-9e68-2079d9836859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_06f86770-0cbe-48ec-8248-cfece0795c0d" xlink:href="rdnt-20231231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_06f86770-0cbe-48ec-8248-cfece0795c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_6a144f02-fc22-4a4f-babe-426ccd6c5e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_431307c9-703c-4201-8706-8aec86b47980" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_6a144f02-fc22-4a4f-babe-426ccd6c5e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b3cae73a-3cf4-4bd2-80dd-41ac148856f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:href="rdnt-20231231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b3cae73a-3cf4-4bd2-80dd-41ac148856f0" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1bc9e072-4fef-41cb-a252-0dc2c86b2a08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1bc9e072-4fef-41cb-a252-0dc2c86b2a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_5b80214e-c521-4d41-9018-dc5a4c2baad1" xlink:href="rdnt-20231231.xsd#rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:to="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_5b80214e-c521-4d41-9018-dc5a4c2baad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7548c833-5102-4a1a-b4ce-aff3ce030327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7548c833-5102-4a1a-b4ce-aff3ce030327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_b7435671-2220-4ee1-bf27-920d288f14ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_b7435671-2220-4ee1-bf27-920d288f14ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_15ebe488-3049-4052-abf8-a76b7dcf8a11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_58ac3b11-2784-4817-87fa-c88bca9c046b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_15ebe488-3049-4052-abf8-a76b7dcf8a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4ec7a745-11f3-4a5f-b28e-573112a56b65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4ec7a745-11f3-4a5f-b28e-573112a56b65" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1748c5cc-8a93-41ac-9332-acf4941fa0a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e7047c91-6e3f-423c-859c-b6f063f5b52e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1748c5cc-8a93-41ac-9332-acf4941fa0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_e3aec82c-68cc-42e8-bc06-07d6fd4dc64b" xlink:href="rdnt-20231231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1748c5cc-8a93-41ac-9332-acf4941fa0a3" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_e3aec82c-68cc-42e8-bc06-07d6fd4dc64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daabf9-c7bb-4844-aad8-1e5f76e79d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_b2f5a9d2-0e2b-437f-879a-0486ea4955c4" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_rdnt_ManagementServiceFees_b2f5a9d2-0e2b-437f-879a-0486ea4955c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution_56112a4f-1eb4-43c1-8bea-84b0e7270bc7" xlink:href="rdnt-20231231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_rdnt_EquityMethodInvestmentAdditionalContribution_56112a4f-1eb4-43c1-8bea-84b0e7270bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold_c094796a-be60-4197-a86b-144c4867b3ea" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_rdnt_NumberOfAssetsSold_c094796a-be60-4197-a86b-144c4867b3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_832313b9-5630-48cf-930e-fbc7f31cf53c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_832313b9-5630-48cf-930e-fbc7f31cf53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_76db6160-ff09-48c6-879a-b197351f12c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_76db6160-ff09-48c6-879a-b197351f12c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_67ae1a6b-b054-4157-987f-2d77a8202ead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_67ae1a6b-b054-4157-987f-2d77a8202ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_caa27697-badf-43a6-9636-89f73505e66c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_EquityMethodInvestments_caa27697-badf-43a6-9636-89f73505e66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5935e3b4-ecf1-40e3-a12d-ec6f109d7e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_468b9708-d4ad-4f8d-908f-5e1205e5afa0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5935e3b4-ecf1-40e3-a12d-ec6f109d7e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_54e85fa6-4621-4ad9-8575-bd0fbccf7c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_54e85fa6-4621-4ad9-8575-bd0fbccf7c22" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3e678080-71dc-4149-9759-e35ae6122d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_4ad40992-0e83-463c-8e0c-ea0fdaa5813a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3e678080-71dc-4149-9759-e35ae6122d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fa9faf99-1be4-4ec7-acda-373fc68b0066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3e678080-71dc-4149-9759-e35ae6122d3b" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fa9faf99-1be4-4ec7-acda-373fc68b0066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ce12727e-98f5-4ee6-9d2b-0d2095b50ee3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e82915a-e170-4fb0-8252-c6eba495b848" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ce12727e-98f5-4ee6-9d2b-0d2095b50ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember_edeb3f8b-ce9b-47dd-8845-7b581e224ec6" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ce12727e-98f5-4ee6-9d2b-0d2095b50ee3" xlink:to="loc_rdnt_JointVentureInterestMember_edeb3f8b-ce9b-47dd-8845-7b581e224ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c76c1ba5-abd1-42df-9c61-302cfb693ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5cf54905-a018-4038-bb4b-8f7ef3aa4e61" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c76c1ba5-abd1-42df-9c61-302cfb693ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:href="rdnt-20231231.xsd#rdnt_KeyFinancialDataForJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c76c1ba5-abd1-42df-9c61-302cfb693ec5" xlink:to="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_69c73a22-43b0-4f69-9cf4-8dcef81bbc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_AssetsCurrent_69c73a22-43b0-4f69-9cf4-8dcef81bbc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_37dca1de-9c77-4453-a403-5aa54779c443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_AssetsNoncurrent_37dca1de-9c77-4453-a403-5aa54779c443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6140a1de-b299-4436-843e-ad08356c8f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_LiabilitiesCurrent_6140a1de-b299-4436-843e-ad08356c8f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_e36d1a01-3e16-4d51-abb7-c4fc28271f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_e36d1a01-3e16-4d51-abb7-c4fc28271f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_b7c6b785-9ac4-4722-aec8-90513a840f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_b7c6b785-9ac4-4722-aec8-90513a840f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e2378ee7-268c-44df-aef2-6511b78654de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_Revenues_e2378ee7-268c-44df-aef2-6511b78654de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0525d12-a50d-4da0-b7a8-fca3d4082459" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_bfc6efad-f59d-44d9-8850-afc450c6d8bd" xlink:to="loc_us-gaap_ProfitLoss_a0525d12-a50d-4da0-b7a8-fca3d4082459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e777d19-cf53-40f6-8014-187888b6c957" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e777d19-cf53-40f6-8014-187888b6c957" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5ba1e3b5-9d96-4e4d-8d26-b07f2ff93dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5ba1e3b5-9d96-4e4d-8d26-b07f2ff93dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f6efc0df-6746-4716-9d1d-74422816f2fe" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7d2fd43a-a584-45ac-a962-0eca83e9c20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7d2fd43a-a584-45ac-a962-0eca83e9c20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1cc324a4-01b2-477c-a608-e5df9d05ea11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_10f0f71b-6cd6-4a62-bae7-112cdb3ed526" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1cc324a4-01b2-477c-a608-e5df9d05ea11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_66a62818-eef7-40ed-89cd-fbda38b7bdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_66a62818-eef7-40ed-89cd-fbda38b7bdfd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:to="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_a384b39f-e326-4dfd-879b-6dcec3cb0288" xlink:to="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LosAngelesImagingGroupLLCMember_23453fb5-b2c8-4dfb-84da-847497d5e1c4" xlink:href="rdnt-20231231.xsd#rdnt_LosAngelesImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:to="loc_rdnt_LosAngelesImagingGroupLLCMember_23453fb5-b2c8-4dfb-84da-847497d5e1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember_72281f2f-fe21-41fa-986e-885efc49e7da" xlink:href="rdnt-20231231.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:to="loc_rdnt_SantaMonicaImagingGroupLLCMember_72281f2f-fe21-41fa-986e-885efc49e7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyHillsImagingCenterMember_3f7033e5-4c81-4aa9-b70f-083cd634743c" xlink:href="rdnt-20231231.xsd#rdnt_BeverlyHillsImagingCenterMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b3c55b74-77b8-4bfa-8817-6caacd786f20" xlink:to="loc_rdnt_BeverlyHillsImagingCenterMember_3f7033e5-4c81-4aa9-b70f-083cd634743c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:to="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_95a8ddb1-b95e-404c-9776-943c42790a67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e8e83d93-b71f-44db-a42b-5eb135324a38" xlink:to="loc_dei_EntityDomain_95a8ddb1-b95e-404c-9776-943c42790a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_a980b77c-dcd0-4cd4-a8e3-7fdc6663ccbc" xlink:href="rdnt-20231231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_95a8ddb1-b95e-404c-9776-943c42790a67" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_a980b77c-dcd0-4cd4-a8e3-7fdc6663ccbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7183d22d-feb6-4a49-974a-88fc77c8ded6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_70c1c844-9f7c-41c2-8a37-c181f73e3edc" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_70c1c844-9f7c-41c2-8a37-c181f73e3edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed_bc481ae4-6740-467f-89c5-93f83e55aaa5" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_rdnt_NumberOfCentersContributed_bc481ae4-6740-467f-89c5-93f83e55aaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8594ada2-343d-4d7c-9ee2-d147a96d984b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8594ada2-343d-4d7c-9ee2-d147a96d984b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersContributedCapital_ed9fe4ec-a3a5-4aa2-a6ad-8f35ec351195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersContributedCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_LimitedPartnersContributedCapital_ed9fe4ec-a3a5-4aa2-a6ad-8f35ec351195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_e0a40103-9a76-4c67-b8cd-4cd96f6d911d" xlink:href="rdnt-20231231.xsd#rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed_e0a40103-9a76-4c67-b8cd-4cd96f6d911d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_39c0b2af-f575-4de1-a713-18e1f5a66d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_39c0b2af-f575-4de1-a713-18e1f5a66d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6b1960e9-7c98-430d-b7a9-8945e16b8807" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_20a50a14-49a5-4e00-a4ad-24e8f4192a2b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6b1960e9-7c98-430d-b7a9-8945e16b8807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5b72906d-e1dc-470d-a221-ab848b387fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5b72906d-e1dc-470d-a221-ab848b387fcc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_99985f85-d6b3-40f1-b422-b4012c30ed46" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CCDGLRSServicesIncMember_51b50cf7-a55e-4ec7-aa40-641a8d7a24a7" xlink:href="rdnt-20231231.xsd#rdnt_CCDGLRSServicesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_CCDGLRSServicesIncMember_51b50cf7-a55e-4ec7-aa40-641a8d7a24a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_dcd17b68-7d8f-4e39-a53d-ee64f1454ae4" xlink:href="rdnt-20231231.xsd#rdnt_SouthernCaliforniaDiagnosticImagingIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_SouthernCaliforniaDiagnosticImagingIncMember_dcd17b68-7d8f-4e39-a53d-ee64f1454ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InglewoodImagingCenterLLCMember_d3d8644a-9724-4f04-b06d-e26a5cf16e40" xlink:href="rdnt-20231231.xsd#rdnt_InglewoodImagingCenterLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_InglewoodImagingCenterLLCMember_d3d8644a-9724-4f04-b06d-e26a5cf16e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamapoRadiologyAssociatesPCMember_86790728-95af-4f44-ba78-e19512105d00" xlink:href="rdnt-20231231.xsd#rdnt_RamapoRadiologyAssociatesPCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_RamapoRadiologyAssociatesPCMember_86790728-95af-4f44-ba78-e19512105d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MadisonRadiologyMedicalGroupIncMember_8d4ec440-1b88-40d2-bbeb-cc86d823909d" xlink:href="rdnt-20231231.xsd#rdnt_MadisonRadiologyMedicalGroupIncMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_MadisonRadiologyMedicalGroupIncMember_8d4ec440-1b88-40d2-bbeb-cc86d823909d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DelawareDiagnosticImagingPAMember_8dd44242-bbd9-43d9-9a97-97a7b6044a14" xlink:href="rdnt-20231231.xsd#rdnt_DelawareDiagnosticImagingPAMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_DelawareDiagnosticImagingPAMember_8dd44242-bbd9-43d9-9a97-97a7b6044a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryOneMember_f60dc3ef-6517-43bc-8521-d700d7bcecf0" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCSubsidiaryOneMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_IFRCLLCSubsidiaryOneMember_f60dc3ef-6517-43bc-8521-d700d7bcecf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryTwoMember_5ce655e5-7a4e-4c04-adeb-d90c52bfc82d" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCSubsidiaryTwoMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_IFRCLLCSubsidiaryTwoMember_5ce655e5-7a4e-4c04-adeb-d90c52bfc82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairRadiologicalAssociatesPAMember_3840e238-b05d-4e12-a728-e1117aae9ba4" xlink:href="rdnt-20231231.xsd#rdnt_MontclairRadiologicalAssociatesPAMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_MontclairRadiologicalAssociatesPAMember_3840e238-b05d-4e12-a728-e1117aae9ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_4f23fdce-efbf-4748-ab6c-fc98adb691fe" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_4f23fdce-efbf-4748-ab6c-fc98adb691fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ChelseaDignosticRadiologyPCMember_2947f360-b492-4b43-9b0f-4497b45e7ab9" xlink:href="rdnt-20231231.xsd#rdnt_ChelseaDignosticRadiologyPCMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_ChelseaDignosticRadiologyPCMember_2947f360-b492-4b43-9b0f-4497b45e7ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NorthJerseyImagingCenterLLCMember_e31b1429-c179-4da9-9aed-074aefb2791f" xlink:href="rdnt-20231231.xsd#rdnt_NorthJerseyImagingCenterLLCMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_NorthJerseyImagingCenterLLCMember_e31b1429-c179-4da9-9aed-074aefb2791f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember_7e2edf47-45e7-46a1-b8e9-a7ca8e386025" xlink:href="rdnt-20231231.xsd#rdnt_IFRCLLCMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_IFRCLLCMember_7e2edf47-45e7-46a1-b8e9-a7ca8e386025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_066cac35-9beb-403f-8137-59e9c2d359ca" xlink:href="rdnt-20231231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_TangentAssociatesLLCMember_066cac35-9beb-403f-8137-59e9c2d359ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_60a585cb-b1d5-4b9d-aa59-d72343c1041e" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e2ce785-793a-4f6f-9840-d6d016f98049" xlink:to="loc_rdnt_BusinessAcquisitionsMember_60a585cb-b1d5-4b9d-aa59-d72343c1041e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:to="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e9478ddc-fc59-4268-832a-b8dfe89a7a7b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_50186a3d-7dbe-407e-b5fa-de9bf7875518" xlink:to="loc_dei_EntityDomain_e9478ddc-fc59-4268-832a-b8dfe89a7a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d14fb047-234e-4aed-81a8-5832e1af80ff" xlink:href="rdnt-20231231.xsd#rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e9478ddc-fc59-4268-832a-b8dfe89a7a7b" xlink:to="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d14fb047-234e-4aed-81a8-5832e1af80ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46576e40-523f-46bd-983a-7611a1f2075e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5682bcc-fa91-4e72-a7e6-3efc336d9595" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5682bcc-fa91-4e72-a7e6-3efc336d9595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_388d039b-6ab6-4982-a656-afb288380812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_388d039b-6ab6-4982-a656-afb288380812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_d5ecc61f-6736-4f69-aadc-1fa7df429618" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_d5ecc61f-6736-4f69-aadc-1fa7df429618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebe86fbe-85f7-48cb-a6c2-5a3c5084f1da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_Goodwill_ebe86fbe-85f7-48cb-a6c2-5a3c5084f1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d2c7d423-f8a0-4268-80cb-516fa175090c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d2c7d423-f8a0-4268-80cb-516fa175090c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_fe7e2346-ee20-49b0-a92a-a800a2be2b65" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_fe7e2346-ee20-49b0-a92a-a800a2be2b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_d32f0a73-b71e-473d-a9be-add3575be28c" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_d32f0a73-b71e-473d-a9be-add3575be28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_83f58c3a-2f91-4548-8495-8d94b7866a16" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationNumberOfSubsidiariesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_83f58c3a-2f91-4548-8495-8d94b7866a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23520433-aa91-4402-b71d-ba992c076e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b1d086cc-1a56-4ac9-a77b-16d3fe267ca6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23520433-aa91-4402-b71d-ba992c076e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5e9e2e1-138c-4b93-a4fd-53fbce6d838d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5e9e2e1-138c-4b93-a4fd-53fbce6d838d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9909994-e708-453b-b19b-5cd823fd97a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b27a8f7-277c-445f-94fb-6d6f6f26268a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9909994-e708-453b-b19b-5cd823fd97a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_549d83cd-76b0-4f98-95b9-6b46f47e65d8" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9909994-e708-453b-b19b-5cd823fd97a2" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_549d83cd-76b0-4f98-95b9-6b46f47e65d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f0417080-7c79-48e7-b3cf-1e5d667673e3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_c4044948-17ab-49d5-9b31-3c65d087dc43" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_c4044948-17ab-49d5-9b31-3c65d087dc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_1f1e20bf-f283-4ef8-88bd-96c216e42cc6" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_634b094a-cee8-4bb9-9606-32eb1211bb22" xlink:to="loc_rdnt_CashHoldbackMember_1f1e20bf-f283-4ef8-88bd-96c216e42cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_69912a4e-700a-4207-a7e7-bdd1d915b969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7b23d1c4-0d1a-4d51-b4ec-51f8ae5bcfc5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_69912a4e-700a-4207-a7e7-bdd1d915b969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_904f917c-1a4f-437d-8725-e2633a5fac55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_69912a4e-700a-4207-a7e7-bdd1d915b969" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_904f917c-1a4f-437d-8725-e2633a5fac55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_83a71a0b-7d47-4e57-9ddc-fdb60beaa879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_846c4823-669c-4262-b5dc-b6d43629a1bf" xlink:to="loc_us-gaap_ValuationTechniqueDomain_83a71a0b-7d47-4e57-9ddc-fdb60beaa879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_c9a621a1-7250-4bbd-b30c-a58c36b1073e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_83a71a0b-7d47-4e57-9ddc-fdb60beaa879" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_c9a621a1-7250-4bbd-b30c-a58c36b1073e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83196e9d-6991-46ad-8f97-defd85990abe" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9200232b-5ab0-47c8-9fff-2004b3eacb42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9200232b-5ab0-47c8-9fff-2004b3eacb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9c61424-c5a6-485c-94fc-e604615dca14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9c61424-c5a6-485c-94fc-e604615dca14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5d566dcc-de3e-4b07-9699-0412829a727a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5d566dcc-de3e-4b07-9699-0412829a727a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a707532d-679c-431a-bc08-16d4ed91a441" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a707532d-679c-431a-bc08-16d4ed91a441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1bf4a110-577a-4061-9a23-71ed9d631c67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1bf4a110-577a-4061-9a23-71ed9d631c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_55b9b603-5a09-44e8-ac4a-847f7a73042e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_55b9b603-5a09-44e8-ac4a-847f7a73042e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1afb242b-0496-4e33-92d4-bd54058fb4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1afb242b-0496-4e33-92d4-bd54058fb4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_079a1fd0-396b-4fd3-bd7e-f84ad9b90087" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_079a1fd0-396b-4fd3-bd7e-f84ad9b90087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_3a8c8d82-afec-4e99-b846-8ea5a4d255dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_3a8c8d82-afec-4e99-b846-8ea5a4d255dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_19bd9cb7-ff76-4122-9d49-1642590c8273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_19bd9cb7-ff76-4122-9d49-1642590c8273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c8f19ee3-3843-4ba8-b232-a823600aff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c8f19ee3-3843-4ba8-b232-a823600aff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2fef69e8-0b5e-4e03-8dfd-98dcab4084b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2fef69e8-0b5e-4e03-8dfd-98dcab4084b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9d8b08ea-b896-4d85-a8b2-33c6a0b25512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_Goodwill_9d8b08ea-b896-4d85-a8b2-33c6a0b25512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_250910c8-8381-44a8-a61c-d8590da984a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c80248ff-fb7a-4064-ae00-2b1a6dd615ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_250910c8-8381-44a8-a61c-d8590da984a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fbec09e6-5ff2-4f2d-9082-4cb9a9fb7779" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fbec09e6-5ff2-4f2d-9082-4cb9a9fb7779" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b4787e3-8f3a-4d5b-8183-5aea715069e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33e38f20-2d56-4a79-8ab8-b7873dfbd437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b4787e3-8f3a-4d5b-8183-5aea715069e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_3e20f849-43af-4873-a56e-c43f33936b3a" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b4787e3-8f3a-4d5b-8183-5aea715069e3" xlink:to="loc_rdnt_AidenceMember_3e20f849-43af-4873-a56e-c43f33936b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9a0c443-5f0b-473d-8ded-59039675aa0e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_45882933-4467-45fd-a45d-0edac065031a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_45882933-4467-45fd-a45d-0edac065031a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_7ab216de-823b-489f-a0b7-a777012a19e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_7ab216de-823b-489f-a0b7-a777012a19e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4fc1843d-f43b-4576-8406-2dfdcf3d03f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4fc1843d-f43b-4576-8406-2dfdcf3d03f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_163d387e-c30d-43f0-9aba-0badd91ff613" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf613c2c-63f8-4e8b-98a9-fe4ef75da627" xlink:to="loc_us-gaap_TradeNamesMember_163d387e-c30d-43f0-9aba-0badd91ff613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e50053c0-08e6-478a-a1d7-451b152c16de" xlink:to="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_589e687b-3f9d-41c6-86cb-1084da41b98b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:to="loc_srt_MinimumMember_589e687b-3f9d-41c6-86cb-1084da41b98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1a7f4daf-015b-4200-acf1-130b07f3dcf8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_730cffdd-3a01-4fac-bfb8-87bb889b7bcb" xlink:to="loc_srt_MaximumMember_1a7f4daf-015b-4200-acf1-130b07f3dcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_99861889-af9d-4e7a-b177-480b189787d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_17810235-7e88-4c99-a6f5-37e2e3d779a2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_99861889-af9d-4e7a-b177-480b189787d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_02510946-14a9-4817-bd7c-8ea95e9e9c73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_99861889-af9d-4e7a-b177-480b189787d4" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_02510946-14a9-4817-bd7c-8ea95e9e9c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_24e7bb56-3de3-4c31-92da-5d7c1f2927c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_e3a130c3-dbc0-438e-9015-7ccd4c936158" xlink:to="loc_us-gaap_ValuationTechniqueDomain_24e7bb56-3de3-4c31-92da-5d7c1f2927c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_ee410f36-d6b9-49ea-bbf2-ffa386144362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_24e7bb56-3de3-4c31-92da-5d7c1f2927c8" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_ee410f36-d6b9-49ea-bbf2-ffa386144362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e01f16b-e1aa-4ed1-aade-800b38d56b0c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8e472bfc-4feb-4858-9f85-7af15333b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8e472bfc-4feb-4858-9f85-7af15333b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_730c8627-702a-4d1d-b796-485b21b6cdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_730c8627-702a-4d1d-b796-485b21b6cdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f9ee72e-33f6-4b71-a834-780350634042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f9ee72e-33f6-4b71-a834-780350634042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8769604e-5b43-4fcb-9daa-4f37647e42da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_Goodwill_8769604e-5b43-4fcb-9daa-4f37647e42da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d97b5686-3cb8-4f92-b07c-2ed88de94c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d97b5686-3cb8-4f92-b07c-2ed88de94c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_53498495-ce4a-4853-804d-8f446c82e3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_53498495-ce4a-4853-804d-8f446c82e3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6e3e05ba-b380-46a3-95bb-506893ff0745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d6026fec-688c-4a52-937f-8c488f590fde" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6e3e05ba-b380-46a3-95bb-506893ff0745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eba13132-fd9d-4ca4-b92c-4bb35451a6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eba13132-fd9d-4ca4-b92c-4bb35451a6a9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_409a3215-89c6-4476-8913-85eea2ec139b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_811e37f5-6345-4769-9e67-ae77e5899d26" xlink:href="rdnt-20231231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:to="loc_rdnt_QuantibMember_811e37f5-6345-4769-9e67-ae77e5899d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_dd8d04fe-9310-4b58-a258-e14e8842a7da" xlink:href="rdnt-20231231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_dd8d04fe-9310-4b58-a258-e14e8842a7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_cba29583-b777-484f-b106-37f26c035d04" xlink:href="rdnt-20231231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4daccca7-3e86-49e4-a2fd-3737161cf1e7" xlink:to="loc_rdnt_AidenceMember_cba29583-b777-484f-b106-37f26c035d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c6fe91f8-e644-4421-9199-655bb9b0b7a2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember_ec190688-aafe-42ca-9404-3ed53aaefb4f" xlink:href="rdnt-20231231.xsd#rdnt_OtherSellersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:to="loc_rdnt_OtherSellersMember_ec190688-aafe-42ca-9404-3ed53aaefb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember_37491f6d-4331-4584-b7da-09ced4b8968f" xlink:href="rdnt-20231231.xsd#rdnt_CertainSellerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e519ee2-af91-4fa3-a579-c460586083cc" xlink:to="loc_rdnt_CertainSellerMember_37491f6d-4331-4584-b7da-09ced4b8968f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_cf8df255-04f8-44ce-a566-cc9db941d5a0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_7a8d7d89-0d7d-4da5-bf7d-2e12c367de2a" xlink:href="rdnt-20231231.xsd#rdnt_BusinessAcquisitionContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_7a8d7d89-0d7d-4da5-bf7d-2e12c367de2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_1711d5e7-6172-415d-b1b9-88be6f39a17f" xlink:href="rdnt-20231231.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:to="loc_rdnt_CashHoldbackMember_1711d5e7-6172-415d-b1b9-88be6f39a17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_a4935519-c832-4e99-bb1f-95c8a85e633f" xlink:href="rdnt-20231231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06c2c3b0-4344-430d-b099-4e094612db68" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_a4935519-c832-4e99-bb1f-95c8a85e633f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_372d740b-56af-460a-9b15-51c39988b796" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_77d18dfd-c2fa-413b-b04b-0e5f9b83510c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_77d18dfd-c2fa-413b-b04b-0e5f9b83510c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a6895803-ced6-4347-9353-517e6095eaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a6895803-ced6-4347-9353-517e6095eaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_90f06a99-9734-4381-97dd-12b2a88f8fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_90f06a99-9734-4381-97dd-12b2a88f8fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1a200092-c79d-4135-abb4-f0623cba01a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e6261702-bd79-4dd0-8049-915bbbbac6e3" xlink:to="loc_us-gaap_TradeNamesMember_1a200092-c79d-4135-abb4-f0623cba01a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2ad386a4-7d24-4246-800e-2adec6ccdda0" xlink:to="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db60e217-f07b-4f89-bfee-56366e5460de" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:to="loc_srt_MinimumMember_db60e217-f07b-4f89-bfee-56366e5460de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ef185e60-6853-495e-a8da-43dabcd385a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0444db16-9e19-48c4-abf2-67290a57bc9f" xlink:to="loc_srt_MaximumMember_ef185e60-6853-495e-a8da-43dabcd385a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_749c16fb-e1fe-40c0-8f37-c0f9078ec227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0b4c4906-d96d-4024-8fed-5ee5f5d5d399" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_749c16fb-e1fe-40c0-8f37-c0f9078ec227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_6c5f3d32-531b-4f75-acc0-d8a14d343c84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_749c16fb-e1fe-40c0-8f37-c0f9078ec227" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_6c5f3d32-531b-4f75-acc0-d8a14d343c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_3a5d8c95-10e8-485d-a4da-4a9bb1b9647f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_98286e6d-ee8c-4fda-be51-89598bac649e" xlink:to="loc_us-gaap_ValuationTechniqueDomain_3a5d8c95-10e8-485d-a4da-4a9bb1b9647f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_8d0607de-3819-4550-b4de-869598aaa082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_3a5d8c95-10e8-485d-a4da-4a9bb1b9647f" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_8d0607de-3819-4550-b4de-869598aaa082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_571db5b7-3701-4251-a3a8-e75b2c9c5502" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_efbda5b8-4951-4fb4-9767-2fb13a0a1239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_efbda5b8-4951-4fb4-9767-2fb13a0a1239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3af50f58-8c27-44fe-8b3a-df9449a556ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3af50f58-8c27-44fe-8b3a-df9449a556ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02cf9052-5bbc-46ad-aafe-38b16d56a875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02cf9052-5bbc-46ad-aafe-38b16d56a875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_03081184-e90c-413f-bb62-9c974700f5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_03081184-e90c-413f-bb62-9c974700f5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_bcda18f7-57c7-4291-904e-315bbe6ff72d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_bcda18f7-57c7-4291-904e-315bbe6ff72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_931cddb1-6a1e-4d55-8d51-fb56e7a627fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_931cddb1-6a1e-4d55-8d51-fb56e7a627fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbc80fc0-56fe-424b-9cf2-6a93cbb73bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbc80fc0-56fe-424b-9cf2-6a93cbb73bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_2aa4e88b-9fa3-42e9-881f-a604f5f6f37e" xlink:href="rdnt-20231231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_2aa4e88b-9fa3-42e9-881f-a604f5f6f37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d4f38e2a-3ce4-4b6c-ade8-1b45d3f0f765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_d4f38e2a-3ce4-4b6c-ade8-1b45d3f0f765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2b572b60-0d3b-4a76-a9f1-346fd414b580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2b572b60-0d3b-4a76-a9f1-346fd414b580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_26cc3f82-342b-4bda-bc6c-86b44b72c5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_26cc3f82-342b-4bda-bc6c-86b44b72c5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9334b3e2-5c65-4f53-9142-bb16b40aa829" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9334b3e2-5c65-4f53-9142-bb16b40aa829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c755374-d095-4cec-93df-5eb924be812d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_Goodwill_9c755374-d095-4cec-93df-5eb924be812d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_26d6912b-3b76-40e9-8b68-862de12b4292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_26d6912b-3b76-40e9-8b68-862de12b4292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_aef0a9d3-4f1b-4a33-b470-175dbaa5f2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_aef0a9d3-4f1b-4a33-b470-175dbaa5f2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06191695-bf52-4cfa-b36d-a4ed2f07f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06191695-bf52-4cfa-b36d-a4ed2f07f7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2612cf61-536f-45a5-b742-1f21d2c1a6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2612cf61-536f-45a5-b742-1f21d2c1a6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbdd1060-ee9b-4e00-8612-897ed84c030e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbdd1060-ee9b-4e00-8612-897ed84c030e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_54b345b0-6a4c-4ba8-8be7-a4527fe60234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_54b345b0-6a4c-4ba8-8be7-a4527fe60234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_d425e4b3-34d2-416b-98d9-b88bbf803bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba64450f-21db-4453-94ce-63d35bc68675" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_d425e4b3-34d2-416b-98d9-b88bbf803bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details" xlink:type="simple" xlink:href="rdnt-20231231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a21b2ca6-103a-4861-a956-cf154bfec5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a21b2ca6-103a-4861-a956-cf154bfec5ec" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c1f1d7fa-06ac-49a9-9319-a286e53cf42e" xlink:to="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_46b5b767-3f2b-4ca1-942c-dd8c59ae0de6" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_46b5b767-3f2b-4ca1-942c-dd8c59ae0de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_97ab895d-9989-4b9f-aaa7-69f72c79494b" xlink:href="rdnt-20231231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_97ab895d-9989-4b9f-aaa7-69f72c79494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_83c1d7e0-01d4-4ac1-a127-6584cf35f296" xlink:href="rdnt-20231231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d515372f-083b-4a5a-b2e8-0e1059e985e7" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_83c1d7e0-01d4-4ac1-a127-6584cf35f296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6fe8fb51-ed4b-4cce-896f-e3f503693e35" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3f6838e7-391c-429a-9a7e-530f05c9ccfa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6fe8fb51-ed4b-4cce-896f-e3f503693e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_c1005954-de75-4a01-b61d-f21acd3a2caf" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fe8fb51-ed4b-4cce-896f-e3f503693e35" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_c1005954-de75-4a01-b61d-f21acd3a2caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_98f030af-2a14-4bbc-9938-ea5e3562b36a" xlink:to="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_8d0cb4af-e765-4164-9370-fe1d46ab2d5c" xlink:href="rdnt-20231231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_8d0cb4af-e765-4164-9370-fe1d46ab2d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LosAngelesImagingGroupLLCMember_d12d41a8-722f-4c0e-b39a-8902655376f8" xlink:href="rdnt-20231231.xsd#rdnt_LosAngelesImagingGroupLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:to="loc_rdnt_LosAngelesImagingGroupLLCMember_d12d41a8-722f-4c0e-b39a-8902655376f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_46439d91-2edd-43f8-8474-168b5e2f3f24" xlink:href="rdnt-20231231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1d24d587-758c-40a7-81c1-0cca5dcee86f" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_46439d91-2edd-43f8-8474-168b5e2f3f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f74dae32-69b8-416e-9f14-933aad2df72a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FixedAssetsMember_887062b1-3fe2-42dd-99c7-adc5fcdbe45f" xlink:href="rdnt-20231231.xsd#rdnt_FixedAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:to="loc_rdnt_FixedAssetsMember_887062b1-3fe2-42dd-99c7-adc5fcdbe45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_9d10da78-5828-46d7-b399-585b44ba535f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be68ba57-f43b-4cd7-944d-f9bb246c061b" xlink:to="loc_us-gaap_EquipmentMember_9d10da78-5828-46d7-b399-585b44ba535f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6a0704f1-4117-4fc7-a2b9-b5f244ed9d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd0e9dd5-cd43-4fd6-856d-b0ba336b1c9d" xlink:to="loc_us-gaap_EquityComponentDomain_6a0704f1-4117-4fc7-a2b9-b5f244ed9d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_425470a7-1c18-46dd-a9f8-65b07a7325ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6a0704f1-4117-4fc7-a2b9-b5f244ed9d4d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_425470a7-1c18-46dd-a9f8-65b07a7325ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_68988eb5-07d7-4126-b008-7134d16f549a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4ac8857b-661c-4faf-9f91-b2c29b48472f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_68988eb5-07d7-4126-b008-7134d16f549a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_08940456-4076-4397-9cfd-a9437149f2dc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_68988eb5-07d7-4126-b008-7134d16f549a" xlink:to="loc_srt_SubsidiariesMember_08940456-4076-4397-9cfd-a9437149f2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_920db4a1-ed25-4b2a-8a30-a547828c0c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1f4311fb-2c70-4ff0-936c-eb1b0cc707fd" xlink:to="loc_us-gaap_AssetAcquisitionDomain_920db4a1-ed25-4b2a-8a30-a547828c0c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember_af2c6350-bac9-4604-a4b2-d3617828a64f" xlink:href="rdnt-20231231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_920db4a1-ed25-4b2a-8a30-a547828c0c3c" xlink:to="loc_rdnt_TarzanaMedicalCenterLLCMember_af2c6350-bac9-4604-a4b2-d3617828a64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_94c60831-8e26-47cf-bf86-6fa8d8fbc1b2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_e2ac22cc-3123-4f0e-89fa-e421a1799044" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_e2ac22cc-3123-4f0e-89fa-e421a1799044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed_0f37621a-7f72-4633-8ec0-1c87f948104c" xlink:href="rdnt-20231231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_NumberOfCentersContributed_0f37621a-7f72-4633-8ec0-1c87f948104c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_507547a1-85d0-49df-bb72-0e4c230e5390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_507547a1-85d0-49df-bb72-0e4c230e5390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_519eef36-9705-4154-8930-36393ec18f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_Goodwill_519eef36-9705-4154-8930-36393ec18f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5cb327d8-7510-4636-985a-3c91d9e70871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5cb327d8-7510-4636-985a-3c91d9e70871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_08fc163b-3925-4d82-a245-3df530350412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_08fc163b-3925-4d82-a245-3df530350412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fbfa9ff3-faaa-4992-9c67-d1a2000f6966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_EquityMethodInvestments_fbfa9ff3-faaa-4992-9c67-d1a2000f6966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_2e289f6a-771e-46d4-a409-b222fe8047c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_2e289f6a-771e-46d4-a409-b222fe8047c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersContributedCapital_8cd4a39c-a1ae-467c-8329-a5250927832c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersContributedCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_LimitedPartnersContributedCapital_8cd4a39c-a1ae-467c-8329-a5250927832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_c6c19c53-0c06-41c7-b5dd-5505ea14b35b" xlink:href="rdnt-20231231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_c6c19c53-0c06-41c7-b5dd-5505ea14b35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_f08c1d8b-6163-4319-a310-336cc56bec70" xlink:href="rdnt-20231231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_f08c1d8b-6163-4319-a310-336cc56bec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_6478e1e6-6bab-4eeb-a778-b7f8ea3e4e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_6478e1e6-6bab-4eeb-a778-b7f8ea3e4e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_b614fa63-916e-4d1f-93a9-2d98abcf96c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_b614fa63-916e-4d1f-93a9-2d98abcf96c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_41346a02-3fc2-40a4-b3db-ae4d16f321b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ec74dbcb-e0f8-4055-9433-fc6d5b3a26c7" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_41346a02-3fc2-40a4-b3db-ae4d16f321b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SEGMENTREPORTINGDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a24775a3-3ae8-44a3-b412-0a6aeac53c65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a24775a3-3ae8-44a3-b412-0a6aeac53c65" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_52a6aa96-bcb6-4822-a3e8-68f74c99f326" xlink:to="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dd6d1f2a-78d0-4d9a-9830-9eb5a21f8dce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:to="loc_us-gaap_OperatingSegmentsMember_dd6d1f2a-78d0-4d9a-9830-9eb5a21f8dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_c3be91eb-dc83-4957-8411-5150b16e17a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_45a33cdf-ed3c-4d31-95af-14d9ed59c4d2" xlink:to="loc_us-gaap_IntersegmentEliminationMember_c3be91eb-dc83-4957-8411-5150b16e17a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13f491ca-88cd-4b56-92d6-86e07e681277" xlink:to="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_9ef2e964-0f17-46b8-a46c-cd7d958b34d0" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:to="loc_rdnt_ImagingCentersMember_9ef2e964-0f17-46b8-a46c-cd7d958b34d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_9ec820c8-532b-42ab-bdf6-0a2c11fd3d7d" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_65b20f62-e080-4ce6-a61f-6ff5deaf37d6" xlink:to="loc_rdnt_AIMember_9ec820c8-532b-42ab-bdf6-0a2c11fd3d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_62fc2897-0d19-4cac-84d5-94917b59b964" xlink:to="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThirdPartyMember_2c1b4d6f-ac8e-4575-99d2-7382a237b680" xlink:href="rdnt-20231231.xsd#rdnt_ThirdPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:to="loc_rdnt_ThirdPartyMember_2c1b4d6f-ac8e-4575-99d2-7382a237b680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IntersegmentMember_ca24ef10-c684-4d9f-bfd3-6752bc120a33" xlink:href="rdnt-20231231.xsd#rdnt_IntersegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e4d1c58a-a44e-4eb2-877c-fbeb0a4ec3b7" xlink:to="loc_rdnt_IntersegmentMember_ca24ef10-c684-4d9f-bfd3-6752bc120a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_a8e4b927-c24e-462d-a63e-89402f331b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_26f2003b-3558-451e-a6ea-f51331ec0b55" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_a8e4b927-c24e-462d-a63e-89402f331b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_037ce62e-77d9-4682-b1ca-5e521214bda5" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_a8e4b927-c24e-462d-a63e-89402f331b0e" xlink:to="loc_rdnt_COVID19PandemicMember_037ce62e-77d9-4682-b1ca-5e521214bda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7c5ad7a2-fb21-42f5-9d69-82aa621a60a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7e2a3b03-b7de-405a-9667-bf391e08da45" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7c5ad7a2-fb21-42f5-9d69-82aa621a60a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_03517311-12b5-439e-8230-d91360a71df7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_7c5ad7a2-fb21-42f5-9d69-82aa621a60a0" xlink:to="loc_srt_ScenarioForecastMember_03517311-12b5-439e-8230-d91360a71df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9dcbc8ce-b16e-4219-9654-16afec444cc9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a5ea0dcd-0e73-4d9e-8ba0-6f7ac4777415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_Revenues_a5ea0dcd-0e73-4d9e-8ba0-6f7ac4777415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_3102e986-d716-4ca1-b7f1-f502cdad96ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_3102e986-d716-4ca1-b7f1-f502cdad96ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_b6211886-c53b-4361-844e-aa621d477de4" xlink:href="rdnt-20231231.xsd#rdnt_GainOnContributionOfImagingCentersIntoJointVenture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_rdnt_GainOnContributionOfImagingCentersIntoJointVenture_b6211886-c53b-4361-844e-aa621d477de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_557b964a-9e2e-43a5-86ac-0ed1708841dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_557b964a-9e2e-43a5-86ac-0ed1708841dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_027e8e0d-06c3-4a20-892c-f0907a97d9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_027e8e0d-06c3-4a20-892c-f0907a97d9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1a85b19d-9d6a-468f-8a8f-4d4c88066c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1a85b19d-9d6a-468f-8a8f-4d4c88066c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_6d58a67a-0165-430a-aa09-ac0a72ecd410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_SeveranceCosts1_6d58a67a-0165-430a-aa09-ac0a72ecd410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_2c039481-ca30-4d84-8015-8104255431d9" xlink:href="rdnt-20231231.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_2c039481-ca30-4d84-8015-8104255431d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_de2be495-8bac-4229-8875-8a01ff9e74dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be2fd9c2-93ae-463b-9abd-5a2bc0e85726" xlink:to="loc_us-gaap_NumberOfReportableSegments_de2be495-8bac-4229-8875-8a01ff9e74dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0508fec-25d8-469e-9feb-0fd8dadad131" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0508fec-25d8-469e-9feb-0fd8dadad131" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7977b23d-e213-4e34-b0d1-27f90c11c229" xlink:to="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_6a09ed5c-031d-4f49-bd9b-a1ef8df578d1" xlink:href="rdnt-20231231.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:to="loc_rdnt_ImagingCentersMember_6a09ed5c-031d-4f49-bd9b-a1ef8df578d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_28d793e4-f116-44ae-bf02-71d1987ce8fd" xlink:href="rdnt-20231231.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e8c80ea1-a6ea-4f07-822c-bb1fe8880f4e" xlink:to="loc_rdnt_AIMember_28d793e4-f116-44ae-bf02-71d1987ce8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_82f500c0-0b76-4f7b-b0ad-142fe15bfb07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1710e964-84cc-44e9-8df8-6668b4795ee5" xlink:to="loc_us-gaap_GoodwillLineItems_82f500c0-0b76-4f7b-b0ad-142fe15bfb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_82f500c0-0b76-4f7b-b0ad-142fe15bfb07" xlink:to="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0178bf15-a177-4d39-92f7-0eb8461bdab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_Goodwill_0178bf15-a177-4d39-92f7-0eb8461bdab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e48fb9a0-ee39-409f-a809-b9ca9f677988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e48fb9a0-ee39-409f-a809-b9ca9f677988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_42f23ff6-4b8d-4e14-9972-5b926982250b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_42f23ff6-4b8d-4e14-9972-5b926982250b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1669a128-e2c8-493b-8178-8f5ec3fefcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1669a128-e2c8-493b-8178-8f5ec3fefcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_082e584d-e7a6-42da-9e52-5f5a9a3f3c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_082e584d-e7a6-42da-9e52-5f5a9a3f3c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c625792e-0995-46c1-a4ad-f4ac5b27df63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4445aca7-b9a6-4237-b77b-5b1385b644e0" xlink:to="loc_us-gaap_Goodwill_c625792e-0995-46c1-a4ad-f4ac5b27df63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_835eb947-a2bf-44e6-b3b1-1f1395222942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_835eb947-a2bf-44e6-b3b1-1f1395222942" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_936286d6-aab7-4b25-9d44-c501cff7e994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e1047f6-5935-45ea-a03f-68f669bac9a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_936286d6-aab7-4b25-9d44-c501cff7e994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_aac1732c-ad8c-48d3-9011-97ca71e09ca2" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_936286d6-aab7-4b25-9d44-c501cff7e994" xlink:to="loc_rdnt_ManagementServiceContractsMember_aac1732c-ad8c-48d3-9011-97ca71e09ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4d896ec3-c6d8-4618-aa4a-9a9ab08f70cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3ef97539-799e-41ce-bce0-8eca0e10d339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3ef97539-799e-41ce-bce0-8eca0e10d339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_88ba231f-5b15-4b60-91e6-fe316ab2ef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_AdjustmentForAmortization_88ba231f-5b15-4b60-91e6-fe316ab2ef2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f523c26b-ccc6-4cd1-9c86-ff0fc53dc52f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7789f08-d69c-4d65-b3a1-01e856ab0d5d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f523c26b-ccc6-4cd1-9c86-ff0fc53dc52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bf11e54a-a2dc-4217-b2fe-1d00cdcda942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bf11e54a-a2dc-4217-b2fe-1d00cdcda942" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52f1ec4f-ab20-479a-9d95-725996442aa2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_8c359512-2881-4ee5-b57e-fa5f516830bc" xlink:href="rdnt-20231231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_ManagementServiceContractsMember_8c359512-2881-4ee5-b57e-fa5f516830bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_64eaa4cb-c5a2-4c9f-b890-ddf9cc1d369d" xlink:href="rdnt-20231231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_CovenantNotToCompeteMember_64eaa4cb-c5a2-4c9f-b890-ddf9cc1d369d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3789e845-e7d0-46a4-8681-bb04ac2a2f97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3789e845-e7d0-46a4-8681-bb04ac2a2f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember_b01ea4ab-b418-4ae4-929e-07cdc4022585" xlink:href="rdnt-20231231.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_PatentAndTrademarksMember_b01ea4ab-b418-4ae4-929e-07cdc4022585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember_cb47b8ed-2590-4976-a4c1-666d5ca0214f" xlink:href="rdnt-20231231.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_rdnt_DevelopedTechnologySoftwareMember_cb47b8ed-2590-4976-a4c1-666d5ca0214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_05d201fa-2e56-4e91-9a8a-8fd87b6ec0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8cd85988-7069-42c2-adf9-59e53d67612b" xlink:to="loc_us-gaap_TradeNamesMember_05d201fa-2e56-4e91-9a8a-8fd87b6ec0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6c94119-43de-43c1-9467-f4cbb41290ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f026f911-d039-4b0c-80b4-e0155927550c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f026f911-d039-4b0c-80b4-e0155927550c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5f9cb198-51f9-4ee0-89f1-4d46d707dd22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5f9cb198-51f9-4ee0-89f1-4d46d707dd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0df427b1-f56b-4cdf-ad7d-171f189fe15c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0df427b1-f56b-4cdf-ad7d-171f189fe15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_077a1a8d-705b-4ba1-97bc-6a426a228652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_077a1a8d-705b-4ba1-97bc-6a426a228652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_68b210bf-7a85-4bbe-923b-ea00a081e71e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_68b210bf-7a85-4bbe-923b-ea00a081e71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_33b2f0dd-dfa5-4a87-9226-c2eb92d3e72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_33b2f0dd-dfa5-4a87-9226-c2eb92d3e72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c49c2fd-d2fc-4512-95e1-ded3ea53ae22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c49c2fd-d2fc-4512-95e1-ded3ea53ae22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cd18cbbe-f9d9-4247-a1c8-d8f30521567d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d330cf5-91d9-4033-9ac6-b7cb201584e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cd18cbbe-f9d9-4247-a1c8-d8f30521567d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bf11e54a-a2dc-4217-b2fe-1d00cdcda942" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5ba98479-cbed-41b9-a00c-9924c9bdf100" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_58d43317-629a-4f12-9dac-991acb56bf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:to="loc_us-gaap_TradeNamesMember_58d43317-629a-4f12-9dac-991acb56bf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e7da53cf-ff18-42d9-8692-3b16ef26bc19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_906bfbb8-3132-46f0-a68d-4f1e8ed9a78a" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e7da53cf-ff18-42d9-8692-3b16ef26bc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_fb2203c8-71fa-4f80-bc21-e50b71dc8cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_66e55e73-ab26-4855-b328-470593d985bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_fb2203c8-71fa-4f80-bc21-e50b71dc8cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_76455f7f-6fe5-41ba-9806-e36bda881336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_fb2203c8-71fa-4f80-bc21-e50b71dc8cc5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_76455f7f-6fe5-41ba-9806-e36bda881336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc75cbe5-620d-4f8a-bc78-0de85ca83867" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bf11e54a-a2dc-4217-b2fe-1d00cdcda942" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc75cbe5-620d-4f8a-bc78-0de85ca83867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_75f163ae-3f96-405b-a23a-f8aa4dcd42bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_75f163ae-3f96-405b-a23a-f8aa4dcd42bb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_388f5e2b-5dfd-4635-8af7-11127d451e0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_edd4783c-3090-491a-8891-288b0b035972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_LandMember_edd4783c-3090-491a-8891-288b0b035972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d0630e1c-4a52-4e68-b245-04ff7dea322e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_EquipmentMember_d0630e1c-4a52-4e68-b245-04ff7dea322e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f82fb4bc-1db6-4941-9ac3-1423596b8020" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f82fb4bc-1db6-4941-9ac3-1423596b8020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e9fe31a0-078e-4458-b674-073e5689218a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e9fe31a0-078e-4458-b674-073e5689218a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_503cf5ef-7819-49a1-8a44-312686f2796f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f2123b26-8591-45ed-bcef-4aacc5c45fbd" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_503cf5ef-7819-49a1-8a44-312686f2796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d79f1470-26a5-4ff4-a7a2-166d939892c5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_29006341-df40-47bd-9052-71036494a802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_29006341-df40-47bd-9052-71036494a802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2f7d0a6a-dae0-43af-a510-a6937749d336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2f7d0a6a-dae0-43af-a510-a6937749d336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_56f46ca0-1b69-4ebd-a7ee-488cfff48b89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_56f46ca0-1b69-4ebd-a7ee-488cfff48b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_b2450b0d-1c01-428c-a8ac-183f0361491a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_b2450b0d-1c01-428c-a8ac-183f0361491a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4e630598-d3c9-4a2f-963d-6aaeb613a7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f9b8b50-ddd1-4aa6-ae76-679abee2aa1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4e630598-d3c9-4a2f-963d-6aaeb613a7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#PROPERTYANDEQUIPMENTAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0242ee4d-38f5-46ae-ac2f-c55032a241c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0242ee4d-38f5-46ae-ac2f-c55032a241c8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd6b9b39-b306-4bf7-960f-945eb20455cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8c1f253a-3c42-4e18-83ff-26c4c7b21e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_us-gaap_ConstructionInProgressMember_8c1f253a-3c42-4e18-83ff-26c4c7b21e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_ba2627f7-d81a-449d-81b0-6a9f95a0136f" xlink:href="rdnt-20231231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_rdnt_MedicalEquipmentMember_ba2627f7-d81a-449d-81b0-6a9f95a0136f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_a7232879-7414-4777-b4f0-c99dc293ff7d" xlink:href="rdnt-20231231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_a7232879-7414-4777-b4f0-c99dc293ff7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_a9dc604a-8f0b-4fc7-b1c0-98c5b6de9c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_a9dc604a-8f0b-4fc7-b1c0-98c5b6de9c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_442d3965-d480-4adc-863a-52fcb4b23f73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_db38c4c9-330a-497d-8804-e13a07d91add" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_442d3965-d480-4adc-863a-52fcb4b23f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e240805-4f50-468e-9319-9fb685596618" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c56511a9-308f-496d-a668-ad0fcb8a335b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c56511a9-308f-496d-a668-ad0fcb8a335b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_4b490a14-b7b5-40dd-a9ce-7673bfbc2f55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_ConstructionInProgressGross_4b490a14-b7b5-40dd-a9ce-7673bfbc2f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ed91fdc1-1132-4a9f-ba62-2af45bef7d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d7a209af-dd6c-49aa-8f3c-0a0a2da074db" xlink:to="loc_us-gaap_DepreciationAndAmortization_ed91fdc1-1132-4a9f-ba62-2af45bef7d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b800db7a-bbf2-4114-af5c-46920f39f7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b800db7a-bbf2-4114-af5c-46920f39f7dd" xlink:to="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c76dc255-2758-4d7e-bc9a-f2318a03500f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_7060989d-e735-470a-b81d-991e309a3dd7" xlink:href="rdnt-20231231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:to="loc_rdnt_TermLoanMember_7060989d-e735-470a-b81d-991e309a3dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f108d174-aa1d-4d94-9297-fea86610677d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a02e21e-1191-469a-ba7e-538a113f3e13" xlink:to="loc_us-gaap_SecuredDebtMember_f108d174-aa1d-4d94-9297-fea86610677d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:to="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a18d960a-8728-4995-9fe1-cc18fce1268e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_ad3f5a9d-1e12-488c-b319-e0a9000f60e2" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:to="loc_rdnt_FirstLienTermLoanMember_ad3f5a9d-1e12-488c-b319-e0a9000f60e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_a62ad858-f2ea-4527-9339-1f7a91916c3d" xlink:href="rdnt-20231231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:to="loc_rdnt_RestatedAgreementMember_a62ad858-f2ea-4527-9339-1f7a91916c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A6.0NotesDue2028Member_f1908311-ac32-460b-874a-e22b9e94925f" xlink:href="rdnt-20231231.xsd#rdnt_A6.0NotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e03ac1e9-6969-4c7b-b4af-1696a81eedcb" xlink:to="loc_rdnt_A6.0NotesDue2028Member_f1908311-ac32-460b-874a-e22b9e94925f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59720453-1698-4666-ab96-b34d16639935" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88bd121d-5b50-4ca4-92e4-f5f050f3d832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88bd121d-5b50-4ca4-92e4-f5f050f3d832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_76809db8-1f28-4f48-8eab-17dfe93c9b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebt_76809db8-1f28-4f48-8eab-17dfe93c9b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_52c7fd7d-56d9-4587-98d0-ff3f64584301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_52c7fd7d-56d9-4587-98d0-ff3f64584301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNotesPayable_7ad6d171-e77e-4153-bb54-a901c3303147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_OtherNotesPayable_7ad6d171-e77e-4153-bb54-a901c3303147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8f6cf781-7fb9-4eb2-bc57-632c01d00a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebt_8f6cf781-7fb9-4eb2-bc57-632c01d00a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f61256f5-3b44-40b0-b75c-89b496ef475e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebtCurrent_f61256f5-3b44-40b0-b75c-89b496ef475e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_aaeed584-903a-4130-b844-aea5697e1a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc2108e8-1fea-4db1-a3a3-c892ec73213c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_aaeed584-903a-4130-b844-aea5697e1a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b59743b2-3f76-4ec9-ada7-dd0345dd2889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b59743b2-3f76-4ec9-ada7-dd0345dd2889" xlink:to="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a7e877ef-efa5-408d-b6da-c49c0e21c67b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a7e877ef-efa5-408d-b6da-c49c0e21c67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4497aafa-d136-420a-933d-ddd8b03ffd63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4497aafa-d136-420a-933d-ddd8b03ffd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_19210d6c-5f31-4ab0-b9e8-c2ea949f40d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_19210d6c-5f31-4ab0-b9e8-c2ea949f40d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_873f56d0-d480-4775-9a2f-e80a1f38d863" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_873f56d0-d480-4775-9a2f-e80a1f38d863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9c903fb6-4413-47d5-88f5-bd06153f814e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9c903fb6-4413-47d5-88f5-bd06153f814e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e3146ece-1828-4c13-918b-a39d56059168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_2bc70844-f1ba-443c-bb43-87a5064556dc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e3146ece-1828-4c13-918b-a39d56059168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_349df987-9684-42ca-922a-2bd8a79d2f40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_349df987-9684-42ca-922a-2bd8a79d2f40" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1b4bbc9e-2b00-492e-affd-3e9acbe729b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_eee9e727-7f9f-4531-9932-a74efaa1ed3e" xlink:to="loc_us-gaap_CreditFacilityDomain_1b4bbc9e-2b00-492e-affd-3e9acbe729b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a3d4a323-1074-49e2-a630-f2bf847eaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1b4bbc9e-2b00-492e-affd-3e9acbe729b2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a3d4a323-1074-49e2-a630-f2bf847eaa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_035c98a4-afe7-4ea6-b6b0-cf3a6f58f5e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_096f57ba-514c-48e9-bc03-41d141667110" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_096f57ba-514c-48e9-bc03-41d141667110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_fa9e981d-f193-47e8-b677-de9e66c0b566" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dcb2e0c6-33f4-472d-80c3-eceab0e3705b" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_fa9e981d-f193-47e8-b677-de9e66c0b566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_48e2916b-9561-4b6f-8c6a-85ed32458eb8" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_8fd34656-f4eb-4402-b6bb-c0be3e9aa5a3" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:to="loc_rdnt_BarclaysMember_8fd34656-f4eb-4402-b6bb-c0be3e9aa5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_6d2388ad-2f4e-4b9d-b7f9-d0c194544ed6" xlink:href="rdnt-20231231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ff7d76e9-b8dc-471a-b4bb-4e78c539976a" xlink:to="loc_rdnt_SunTrustMember_6d2388ad-2f4e-4b9d-b7f9-d0c194544ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_24fb3e88-5d5f-4cda-a472-488b87e96bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e9703852-28d6-43b2-8400-ec5ec5c4e314" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_24fb3e88-5d5f-4cda-a472-488b87e96bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_5d72c4ba-41ff-4708-a5bc-64caed93344e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_24fb3e88-5d5f-4cda-a472-488b87e96bbb" xlink:to="loc_us-gaap_LineOfCreditMember_5d72c4ba-41ff-4708-a5bc-64caed93344e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_3e99d598-44b8-42a3-958a-a5bb1d1fb0bf" xlink:to="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a807a10e-b752-4a22-97bd-3370093d8f3d" xlink:href="rdnt-20231231.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:to="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a807a10e-b752-4a22-97bd-3370093d8f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_c118f2ab-cfd5-4b51-ab6a-06887e61d08e" xlink:href="rdnt-20231231.xsd#rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:to="loc_rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember_c118f2ab-cfd5-4b51-ab6a-06887e61d08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_0181d982-4788-4075-b03b-3ea776519593" xlink:href="rdnt-20231231.xsd#rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ea42f0bc-5d9c-43db-ad9c-e0029cca892f" xlink:to="loc_rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember_0181d982-4788-4075-b03b-3ea776519593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f4211458-52c0-4367-a7ee-257337162959" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f844fdd1-b14c-4c23-b18f-7e70488cc732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCredit_f844fdd1-b14c-4c23-b18f-7e70488cc732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d8d972a7-bf5e-45bb-8ff7-4ccc17c5f84a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d8d972a7-bf5e-45bb-8ff7-4ccc17c5f84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4939f350-81a6-4037-b7f2-64df0580d6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4939f350-81a6-4037-b7f2-64df0580d6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c6faa8bf-f6ee-4fc4-aea7-32233d4f0341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c6faa8bf-f6ee-4fc4-aea7-32233d4f0341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34017b75-d284-4465-8e35-ef16c69fb9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_30ca302a-e7a7-4835-ab55-f63e5054a651" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34017b75-d284-4465-8e35-ef16c69fb9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_71492806-e46a-49e1-a21f-fd90d9569a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_71492806-e46a-49e1-a21f-fd90d9569a4c" xlink:to="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8e58a50b-d247-4121-bbb9-954475f2583d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_249702d2-b72b-49cf-b297-a6d7651fc3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:to="loc_us-gaap_MediumTermNotesMember_249702d2-b72b-49cf-b297-a6d7651fc3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9f092a27-7891-47d0-ba1f-18723271a0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:to="loc_us-gaap_LineOfCreditMember_9f092a27-7891-47d0-ba1f-18723271a0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_16695ea2-745d-4ade-b574-102addd81dae" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39db57f7-1bd9-4aa3-9551-9e87563ce652" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_16695ea2-745d-4ade-b574-102addd81dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7f950ec0-8870-423c-9f77-3d659bb00006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d9d437b2-c023-43cf-846a-11081da51736" xlink:to="loc_us-gaap_CreditFacilityDomain_7f950ec0-8870-423c-9f77-3d659bb00006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1ea12cf0-29e1-4a50-9376-21ba9d39ca4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7f950ec0-8870-423c-9f77-3d659bb00006" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1ea12cf0-29e1-4a50-9376-21ba9d39ca4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b89debc1-bc80-4c50-9116-64bea959d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_34f0abe9-244a-4bba-8d6a-f9216b19733b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b89debc1-bc80-4c50-9116-64bea959d9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_dc5451d3-317d-4c91-b432-85d2b1302b4f" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b89debc1-bc80-4c50-9116-64bea959d9e1" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_dc5451d3-317d-4c91-b432-85d2b1302b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c078bf29-7aa7-48a5-a396-a7429d226b3a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_aebba7cf-241e-4a89-b3e8-375ff22ced80" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:to="loc_rdnt_BarclaysMember_aebba7cf-241e-4a89-b3e8-375ff22ced80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_6e6a8528-61cc-4765-a38d-7dfadf40121c" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a057733c-e9fd-41c8-b95d-5df95f824fec" xlink:to="loc_rdnt_TruistMember_6e6a8528-61cc-4765-a38d-7dfadf40121c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_588da7b7-975e-4c7a-a927-0498359c2f29" xlink:to="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_45cdaa03-b52d-4e2b-9c93-33e6417d6c31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_LineOfCredit_45cdaa03-b52d-4e2b-9c93-33e6417d6c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c57cb353-d7b4-488f-a9b9-e554d541b294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c57cb353-d7b4-488f-a9b9-e554d541b294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_cbe11fa6-f34c-46ea-a62f-13da76b28dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_cbe11fa6-f34c-46ea-a62f-13da76b28dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_8cfe9839-b7bc-42d4-8cfd-b594a9de21d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_8cfe9839-b7bc-42d4-8cfd-b594a9de21d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b005f3f8-86da-4ba8-a9c3-e4e7b3b85d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b005f3f8-86da-4ba8-a9c3-e4e7b3b85d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f62387a-0016-475d-b065-692732cf9c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f62387a-0016-475d-b065-692732cf9c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_b4a5e102-e6b5-4541-9023-759a971e447e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66d8ce93-1ba1-49cb-a9d4-24f2f1c2fd54" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_b4a5e102-e6b5-4541-9023-759a971e447e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_39992c9d-e0c2-442f-8d2c-9c7a3c72f5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_39992c9d-e0c2-442f-8d2c-9c7a3c72f5fc" xlink:to="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_27e7fb5d-3cf3-4983-869e-6665eab3814a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4f8afa41-1251-4990-b0bc-6a909b71ecea" xlink:to="loc_us-gaap_CreditFacilityDomain_27e7fb5d-3cf3-4983-869e-6665eab3814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_dfd65103-10a4-4c97-ad0e-931822129e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_27e7fb5d-3cf3-4983-869e-6665eab3814a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_dfd65103-10a4-4c97-ad0e-931822129e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_176a22de-9486-4288-9be8-2767f8cefdbb" xlink:to="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_301fb674-acd0-46da-9791-dd7dea6e5e92" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIMember_301fb674-acd0-46da-9791-dd7dea6e5e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_86a82aca-af8e-45bd-b4fc-e44d5bbe7995" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIIMember_86a82aca-af8e-45bd-b4fc-e44d5bbe7995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_e1920ae8-19e1-41a1-aea5-c03e709fe584" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIIIMember_e1920ae8-19e1-41a1-aea5-c03e709fe584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_a5d4478e-7dd0-4ec0-b329-e96d721b9249" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelIVMember_a5d4478e-7dd0-4ec0-b329-e96d721b9249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_c7c163b5-074c-41fa-a96c-7d4508184a8b" xlink:href="rdnt-20231231.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_446b494c-4c2a-4ce7-beee-767762fefae5" xlink:to="loc_rdnt_PricingLevelVMember_c7c163b5-074c-41fa-a96c-7d4508184a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b1d8bffb-1199-4b42-8aaf-4a69abad73de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef578917-1b4b-494a-bf43-a9db3c17ccad" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b1d8bffb-1199-4b42-8aaf-4a69abad73de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_2de76d6e-c891-477c-8522-6ddcafb82fc2" xlink:href="rdnt-20231231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1d8bffb-1199-4b42-8aaf-4a69abad73de" xlink:to="loc_rdnt_RestatedAgreementMember_2de76d6e-c891-477c-8522-6ddcafb82fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_353bfdc0-1309-44f2-99db-fe849f8c84ae" xlink:to="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_3ef9c03b-a8cb-4b8c-a570-7b6ed8141ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:to="loc_us-gaap_EurodollarMember_3ef9c03b-a8cb-4b8c-a570-7b6ed8141ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_8744f201-4359-4da8-9199-278a285072da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f6add55f-3128-4aad-b4bf-376e6caf6cac" xlink:to="loc_us-gaap_BaseRateMember_8744f201-4359-4da8-9199-278a285072da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_17d81ba6-f3c4-4658-bcb6-858de0eca0c3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_4e19d701-b55b-4f19-a27a-110961e6421b" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_4e19d701-b55b-4f19-a27a-110961e6421b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_3c105937-8026-4c9d-9e7f-05faafc46113" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_3c105937-8026-4c9d-9e7f-05faafc46113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1bdfb852-43f7-4a73-b5ac-b78bee74f0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1bdfb852-43f7-4a73-b5ac-b78bee74f0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_eba47662-6e26-4242-9a71-9f18a0510347" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_eba47662-6e26-4242-9a71-9f18a0510347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a8cf1367-2a90-4931-b34c-33ec6e73bc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adfb14b2-d0cc-4b15-8257-a5779eb4df14" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a8cf1367-2a90-4931-b34c-33ec6e73bc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_43971a76-f0c0-41a4-bd09-9a261f8a23a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_43971a76-f0c0-41a4-bd09-9a261f8a23a0" xlink:to="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3dab0968-f0f8-4523-a138-d14c054ebda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d6530471-ddc2-43e7-af4f-29478498bb9f" xlink:to="loc_us-gaap_CreditFacilityDomain_3dab0968-f0f8-4523-a138-d14c054ebda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_bde7d04c-5e5d-46d2-ac12-afd2a7b8965e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3dab0968-f0f8-4523-a138-d14c054ebda4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_bde7d04c-5e5d-46d2-ac12-afd2a7b8965e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4650056e-a798-4a8b-92c9-1cb70dd3b7c4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_a66dd23c-017e-4116-8f94-a7f09ac3c6ca" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_a66dd23c-017e-4116-8f94-a7f09ac3c6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_52cb7487-2b40-4399-a2ec-422f1a59c261" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f73368a-a01f-4f78-b533-05cef84e34f8" xlink:to="loc_rdnt_FirstLienTermLoanMember_52cb7487-2b40-4399-a2ec-422f1a59c261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f8b11d8e-8e16-447e-91fb-57aec4c80294" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e3ab51a1-da94-40d9-bd95-eb04f9f504c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:to="loc_us-gaap_LineOfCreditMember_e3ab51a1-da94-40d9-bd95-eb04f9f504c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_bd75d2fc-7156-4e50-865b-7dc1c738256a" xlink:href="rdnt-20231231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:to="loc_rdnt_TermLoanMember_bd75d2fc-7156-4e50-865b-7dc1c738256a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_d7007d81-7a82-4dfe-ae24-f1e35da695f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb3834c4-ae62-4d0b-b799-e282079651c7" xlink:to="loc_us-gaap_MediumTermNotesMember_d7007d81-7a82-4dfe-ae24-f1e35da695f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f320f67f-890e-41c5-82c6-62230ad1231d" xlink:to="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_7d78d213-4b95-45ea-80d9-156059763360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_us-gaap_EurodollarMember_7d78d213-4b95-45ea-80d9-156059763360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_7c90fbd3-8a4c-4c13-a1c9-26d58a4be414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_us-gaap_BaseRateMember_7c90fbd3-8a4c-4c13-a1c9-26d58a4be414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_505fa60a-69a4-41cd-a8f4-5134ebd5446a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_505fa60a-69a4-41cd-a8f4-5134ebd5446a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_07b6c5c1-6dd3-4864-9d7c-31b2d5deeed0" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_07b6c5c1-6dd3-4864-9d7c-31b2d5deeed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a4f53956-541f-4e04-aae4-9023f293ab54" xlink:href="rdnt-20231231.xsd#rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c3f20774-6e71-4e6e-8ff7-5ff1896d3217" xlink:to="loc_rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember_a4f53956-541f-4e04-aae4-9023f293ab54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_275f0485-4e4a-4085-ac59-6a7f07c6dca1" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_e4369a86-e47b-4cee-99de-2639407ceba2" xlink:to="loc_rdnt_LeverageRatioDomain_275f0485-4e4a-4085-ac59-6a7f07c6dca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_7547dfa9-9263-46ac-b346-24dc031ead20" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_275f0485-4e4a-4085-ac59-6a7f07c6dca1" xlink:to="loc_rdnt_LeverageRatioThreeMember_7547dfa9-9263-46ac-b346-24dc031ead20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2a67a982-70d2-452c-940f-bb086bf3e7de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_5db4a32b-9590-4ebc-b3f2-fa0a0664b62f" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:to="loc_rdnt_BarclaysMember_5db4a32b-9590-4ebc-b3f2-fa0a0664b62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_d7cbf86f-00d3-4a5a-b82f-576e99def4ea" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_44470326-c97e-458d-a4e5-68e64ee5e74c" xlink:to="loc_rdnt_TruistMember_d7cbf86f-00d3-4a5a-b82f-576e99def4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_47598967-3c8a-4e28-aaf3-e580691e6cf2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c24aa074-a70f-438f-a7f1-53ce489afafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c24aa074-a70f-438f-a7f1-53ce489afafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_2d6bee12-953b-4d3e-9e17-7bb202e93f2b" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_2d6bee12-953b-4d3e-9e17-7bb202e93f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b009cbe-3337-45f2-97ee-70457773cc61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b009cbe-3337-45f2-97ee-70457773cc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6ca204f6-92a4-48dc-9f42-fa00617e99a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6ca204f6-92a4-48dc-9f42-fa00617e99a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_e2172496-d667-493c-899d-d6dae0188932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_e2172496-d667-493c-899d-d6dae0188932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_dbfa7f26-b158-4ade-a6de-caac7eff4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_dbfa7f26-b158-4ade-a6de-caac7eff4ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_4ef532ba-0d78-4cbb-a30c-a3aeb0f23048" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_4ef532ba-0d78-4cbb-a30c-a3aeb0f23048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_1d886c2f-701a-448b-b72f-37993abbc4d7" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e3ce66ab-5f81-4717-9a9e-9ea3d2f992e8" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_1d886c2f-701a-448b-b72f-37993abbc4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_924b0b25-b081-490d-ba1d-a9a347bdd56c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_924b0b25-b081-490d-ba1d-a9a347bdd56c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a5119b49-b4ea-472f-bf75-a19540e85f91" xlink:to="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_87f98a23-f26f-4aee-91c2-cbd99ffaa546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_87f98a23-f26f-4aee-91c2-cbd99ffaa546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_75c34e7e-091f-416b-8e74-90fbdff19a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c0c0adcc-4b1c-4b78-ab72-9b0f9fad2538" xlink:to="loc_us-gaap_LetterOfCreditMember_75c34e7e-091f-416b-8e74-90fbdff19a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6e3a80e-9136-43d2-8f52-954640a151ec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0729eea4-09c2-48a6-a9a7-0e81879b6341" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_0729eea4-09c2-48a6-a9a7-0e81879b6341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_6852491a-74cc-4ac5-90fa-d39c97097a36" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75be83d8-30c3-414e-bcac-cdbe958dff29" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_6852491a-74cc-4ac5-90fa-d39c97097a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_b1a5f784-b4e3-4200-8125-723bab1fa9cb" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_9cae78b2-b716-4a9f-83af-be95b4f0f30b" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:to="loc_rdnt_BarclaysMember_9cae78b2-b716-4a9f-83af-be95b4f0f30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_bbc0cd5a-c692-4aaa-8303-def833605bcd" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b565c19e-ddd6-46df-af2f-a177be679141" xlink:to="loc_rdnt_TruistMember_bbc0cd5a-c692-4aaa-8303-def833605bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b8a5f87-f1f4-4fa3-b4fb-fee19360fcb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_abf2f5b7-5fc9-46b2-9153-55cfb7ac5dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:to="loc_us-gaap_LineOfCreditMember_abf2f5b7-5fc9-46b2-9153-55cfb7ac5dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_0bb14f65-d8b9-49e6-87dc-63d68d4548e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95cad53c-40f9-4330-888d-3e2dd1ec72be" xlink:to="loc_us-gaap_LetterOfCreditMember_0bb14f65-d8b9-49e6-87dc-63d68d4548e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_00017082-64c3-4287-b4af-6f7795ab47bb" xlink:to="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_897f9c72-1d68-4735-94e5-89e946d333a7" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:to="loc_rdnt_LeverageRatioThreeMember_897f9c72-1d68-4735-94e5-89e946d333a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_6ac16e07-89c6-4d3c-b86d-c4c001dbca4b" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:to="loc_rdnt_LeverageRatioOneMember_6ac16e07-89c6-4d3c-b86d-c4c001dbca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_6abc564c-4286-4704-98a1-76738b418bba" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_a615346a-0136-412c-b40c-c3f25f427e82" xlink:to="loc_rdnt_LeverageRatioTwoMember_6abc564c-4286-4704-98a1-76738b418bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e602c6cb-d780-4231-94bc-6159a8b733f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_419d742a-864a-4936-8006-c61a3835c8b8" xlink:to="loc_us-gaap_VariableRateDomain_e602c6cb-d780-4231-94bc-6159a8b733f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_cc97b8bd-3e1a-4144-856f-a2badb5d6fba" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e602c6cb-d780-4231-94bc-6159a8b733f4" xlink:to="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_cc97b8bd-3e1a-4144-856f-a2badb5d6fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_71b3733a-3863-4211-8b46-e122d8f47bf3" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28ba6d0d-c1f4-43ac-a814-01f01413217a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28ba6d0d-c1f4-43ac-a814-01f01413217a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_175830a4-14c9-449f-9f44-a2d1c59aa29e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_175830a4-14c9-449f-9f44-a2d1c59aa29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b274726f-315c-4452-acb2-ce767813eb47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b274726f-315c-4452-acb2-ce767813eb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_62cc8cbf-baed-4f28-9b36-84d21acd57b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_62cc8cbf-baed-4f28-9b36-84d21acd57b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9aa64a06-c8c8-434c-b4bc-0be66b412109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9aa64a06-c8c8-434c-b4bc-0be66b412109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_476dc12a-7f04-4f97-a65d-c9f4aef9d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e0fbc757-dd38-4386-a6e1-c340d928456d" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_476dc12a-7f04-4f97-a65d-c9f4aef9d98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_90473b1a-60d2-4d69-b6a6-76e236784554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_90473b1a-60d2-4d69-b6a6-76e236784554" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99d2cab4-d168-402f-91ad-14894a31a5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29cf389c-391b-40d6-998c-0df4b773c11d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99d2cab4-d168-402f-91ad-14894a31a5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d114a1d3-0e0f-4a06-a328-d71c197aaeed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d2cab4-d168-402f-91ad-14894a31a5c3" xlink:to="loc_us-gaap_LineOfCreditMember_d114a1d3-0e0f-4a06-a328-d71c197aaeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7fbe69ba-740e-40ed-a716-fb5eefa08168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_28492070-838c-4c2a-9d63-983f8d9d0843" xlink:to="loc_us-gaap_CreditFacilityDomain_7fbe69ba-740e-40ed-a716-fb5eefa08168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d1552170-9450-4e8d-ba79-d58cee2aa491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7fbe69ba-740e-40ed-a716-fb5eefa08168" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d1552170-9450-4e8d-ba79-d58cee2aa491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_fbc7bcfe-f49a-44d9-b0ed-b26dfccca30f" xlink:to="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_f50a16ca-8497-4a81-acdc-6427c34b7384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:to="loc_us-gaap_EurodollarMember_f50a16ca-8497-4a81-acdc-6427c34b7384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_fac82e28-c021-4966-aa71-a8bc74227f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:to="loc_us-gaap_BaseRateMember_fac82e28-c021-4966-aa71-a8bc74227f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_5beff012-5db2-4141-8893-c338c3033518" xlink:href="rdnt-20231231.xsd#rdnt_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_de2d5fe8-6893-43d1-9265-2ff25dd0ae88" xlink:to="loc_rdnt_SecuredOvernightFinancingRateSOFRMember_5beff012-5db2-4141-8893-c338c3033518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f245012e-fa74-4a5b-9c15-8ff47031ac7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0406e3c-c933-423e-b897-1f20a5777cf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f245012e-fa74-4a5b-9c15-8ff47031ac7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_646c8b39-a935-42cc-ba2f-475e462e63e5" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f245012e-fa74-4a5b-9c15-8ff47031ac7d" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_646c8b39-a935-42cc-ba2f-475e462e63e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_fd86a6e9-48ee-458f-8b56-3efef84027c6" xlink:to="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_e64759f3-3ce4-4e31-bc6a-35871245faca" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:to="loc_rdnt_LeverageRatioOneMember_e64759f3-3ce4-4e31-bc6a-35871245faca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_b601179d-9cfc-4f22-866c-82d26e8a5496" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:to="loc_rdnt_LeverageRatioTwoMember_b601179d-9cfc-4f22-866c-82d26e8a5496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_1952dc0c-219a-4b68-95eb-de1d7b46fe6e" xlink:href="rdnt-20231231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_eae0b848-3e4d-4810-8622-d4fece3ed3f2" xlink:to="loc_rdnt_LeverageRatioThreeMember_1952dc0c-219a-4b68-95eb-de1d7b46fe6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c13dd28a-f833-4947-831f-a403f75bb449" xlink:to="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7b2b2bf3-38cb-4160-8b92-980cafcd374c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:to="loc_srt_MinimumMember_7b2b2bf3-38cb-4160-8b92-980cafcd374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b38b290-6e0a-4cc5-88e2-08265fa7f622" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3433a191-6f23-476e-b165-599bccb5679b" xlink:to="loc_srt_MaximumMember_8b38b290-6e0a-4cc5-88e2-08265fa7f622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c95dcb18-324c-47b1-b728-752f9a0a48aa" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_6dd61845-7dd6-4f19-9609-316215b3acf1" xlink:href="rdnt-20231231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_6dd61845-7dd6-4f19-9609-316215b3acf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f4c2cb77-c763-47bd-852d-59d6cb73b5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_697ea37d-d68e-45bb-a5a9-0d49c36cd9bd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f4c2cb77-c763-47bd-852d-59d6cb73b5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_870665c3-f979-4a7c-8773-9a262398df8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_870665c3-f979-4a7c-8773-9a262398df8a" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fdb21b5b-63ac-4d38-9b4e-4c87246e0547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1f7ba788-6a38-4a13-9073-dee94b2bd8d1" xlink:to="loc_us-gaap_CreditFacilityDomain_fdb21b5b-63ac-4d38-9b4e-4c87246e0547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6cf692eb-7204-4f40-bbc7-a95565d7b812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fdb21b5b-63ac-4d38-9b4e-4c87246e0547" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6cf692eb-7204-4f40-bbc7-a95565d7b812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_44e91c98-4bf5-471e-bb2e-d4d1fcccd6d8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_4c10456e-a473-4736-87d8-3ffc9f9eba2d" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_4c10456e-a473-4736-87d8-3ffc9f9eba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_62cad816-be68-40c9-a533-0a2d3764395e" xlink:href="rdnt-20231231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83c00a86-0a17-4360-aba4-1181459e9ae9" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_62cad816-be68-40c9-a533-0a2d3764395e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2226af5c-dee4-428d-86ec-8b03bb3965b9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_037538aa-a0cb-4aee-b5da-119373b2158a" xlink:href="rdnt-20231231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:to="loc_rdnt_BarclaysMember_037538aa-a0cb-4aee-b5da-119373b2158a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_b940ba53-ad8e-4b49-80f4-6d785bae4a4e" xlink:href="rdnt-20231231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0bf0a68c-5cb6-42a3-8160-63c3a4883aac" xlink:to="loc_rdnt_TruistMember_b940ba53-ad8e-4b49-80f4-6d785bae4a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_50cf44fd-c1e8-48d0-9706-daf8c5f980af" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_aef10bba-7172-4056-8d7e-8e75a433dd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:to="loc_us-gaap_LineOfCreditMember_aef10bba-7172-4056-8d7e-8e75a433dd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_6a3a045d-bd97-484f-a385-054ea81dbbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b326d2ef-eb27-4735-ad91-6a8878028bbc" xlink:to="loc_us-gaap_MediumTermNotesMember_6a3a045d-bd97-484f-a385-054ea81dbbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_243e6742-af23-4c51-b088-98f1405ce252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_1b2e6dc8-ab9b-4842-b727-995a98b0052f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_243e6742-af23-4c51-b088-98f1405ce252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_4615261b-bb79-4c1b-b6ce-2598e74e30c7" xlink:href="rdnt-20231231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_243e6742-af23-4c51-b088-98f1405ce252" xlink:to="loc_rdnt_COVID19PandemicMember_4615261b-bb79-4c1b-b6ce-2598e74e30c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e4edb024-53db-44f5-a6ae-bf53810a8e01" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_40c5e951-27d2-4ce4-847f-fcc815073dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_40c5e951-27d2-4ce4-847f-fcc815073dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_85048973-5632-4caa-853a-95e2ce968d58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_LineOfCredit_85048973-5632-4caa-853a-95e2ce968d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d88cf045-cd84-4f89-bf05-fee9c2726ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d88cf045-cd84-4f89-bf05-fee9c2726ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4868328c-3b17-4378-8537-852677d99a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_3bfb2293-cb24-47c9-af34-81735f73f4d7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4868328c-3b17-4378-8537-852677d99a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fc332dcb-a58a-4f51-91e3-05647a55c1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fc332dcb-a58a-4f51-91e3-05647a55c1c6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:to="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7c245d62-1bab-40b2-8b74-25c0b9dacc6c" xlink:to="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ce227269-d360-4750-9075-83daace51c46" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:to="loc_srt_MinimumMember_ce227269-d360-4750-9075-83daace51c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cbda833-2bc1-4b46-94cd-03e70803b158" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ca29ad45-789e-4ad8-b9b6-808d6c46b432" xlink:to="loc_srt_MaximumMember_5cbda833-2bc1-4b46-94cd-03e70803b158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f92e4089-9374-45e3-aa93-aa256c476397" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed6b2140-ea81-444c-bd4c-f9af256c230d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ed6b2140-ea81-444c-bd4c-f9af256c230d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_17d18b85-c1e6-45d1-8cc4-e8c892e49657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_17d18b85-c1e6-45d1-8cc4-e8c892e49657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_ba67e2ff-3d63-42a9-8db0-99b0ba910500" xlink:href="rdnt-20231231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_rdnt_LesseeLeaseTermofContract_ba67e2ff-3d63-42a9-8db0-99b0ba910500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_a4ce6b08-9384-4217-b38c-6ab9c22a6453" xlink:href="rdnt-20231231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_a4ce6b08-9384-4217-b38c-6ab9c22a6453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_58d0fc42-b830-403d-a4da-b8d9685dd09d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1aeb3edf-2ec4-4e49-a38b-1405ef785d12" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_58d0fc42-b830-403d-a4da-b8d9685dd09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESLeaseCostDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b6b2a967-c924-4586-b239-749e2753f600" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a8c2c81d-4532-40a4-abfd-ddf11fe3fe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6b2a967-c924-4586-b239-749e2753f600" xlink:to="loc_us-gaap_OperatingLeaseCost_a8c2c81d-4532-40a4-abfd-ddf11fe3fe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_babb6259-a3fa-42c1-b9a1-43feb3ddc648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6b2a967-c924-4586-b239-749e2753f600" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_babb6259-a3fa-42c1-b9a1-43feb3ddc648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_756dabcf-5cf1-412b-8e9c-914a0460c922" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_babb6259-a3fa-42c1-b9a1-43feb3ddc648" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_756dabcf-5cf1-412b-8e9c-914a0460c922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_fa733f3b-6889-4fd6-8ad2-31d3a08d1f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_babb6259-a3fa-42c1-b9a1-43feb3ddc648" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_fa733f3b-6889-4fd6-8ad2-31d3a08d1f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_c3c92bd3-6ec2-41dc-b43a-b0fa3992bd2c" xlink:href="rdnt-20231231.xsd#rdnt_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_babb6259-a3fa-42c1-b9a1-43feb3ddc648" xlink:to="loc_rdnt_FinanceLeaseCost_c3c92bd3-6ec2-41dc-b43a-b0fa3992bd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharges_d87c7531-7d6b-48fc-9f19-6bc52420bf08" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6b2a967-c924-4586-b239-749e2753f600" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharges_d87c7531-7d6b-48fc-9f19-6bc52420bf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESSupplementalCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_41725e5c-fdba-4dee-b115-1bc8182a76d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract_a43851de-3f85-4f07-9be1-8809f2339dd3" xlink:href="rdnt-20231231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41725e5c-fdba-4dee-b115-1bc8182a76d2" xlink:to="loc_rdnt_CashFlowLesseeAbstract_a43851de-3f85-4f07-9be1-8809f2339dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9dee5a8c-b836-4bdd-bb1c-411383c82089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_a43851de-3f85-4f07-9be1-8809f2339dd3" xlink:to="loc_us-gaap_OperatingLeasePayments_9dee5a8c-b836-4bdd-bb1c-411383c82089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9964d458-7bd8-43b3-bf1b-efdf5e7a2614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_a43851de-3f85-4f07-9be1-8809f2339dd3" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9964d458-7bd8-43b3-bf1b-efdf5e7a2614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_fe5e749c-22a0-4a8f-966a-be80cf76415b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_a43851de-3f85-4f07-9be1-8809f2339dd3" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_fe5e749c-22a0-4a8f-966a-be80cf76415b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_514724b5-cc56-4764-a960-b0f2d479f72c" xlink:href="rdnt-20231231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41725e5c-fdba-4dee-b115-1bc8182a76d2" xlink:to="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_514724b5-cc56-4764-a960-b0f2d479f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cfae9942-4a97-4769-9c3e-eab0699a8c61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_514724b5-cc56-4764-a960-b0f2d479f72c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cfae9942-4a97-4769-9c3e-eab0699a8c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESSupplementalBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bcdf4952-25b7-4ae8-a0d4-84c2c6bff9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bb9a9b03-0aef-4e17-b2f6-614be0a38d58" xlink:href="rdnt-20231231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bcdf4952-25b7-4ae8-a0d4-84c2c6bff9d2" xlink:to="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bb9a9b03-0aef-4e17-b2f6-614be0a38d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_43ed3214-e9de-44a8-a12c-7e93fc061302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bb9a9b03-0aef-4e17-b2f6-614be0a38d58" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_43ed3214-e9de-44a8-a12c-7e93fc061302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e9ce3120-66ad-4f63-a1da-5a523df71b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bb9a9b03-0aef-4e17-b2f6-614be0a38d58" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e9ce3120-66ad-4f63-a1da-5a523df71b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_14a9164a-8215-4234-9de5-30b442dfc495" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bb9a9b03-0aef-4e17-b2f6-614be0a38d58" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_14a9164a-8215-4234-9de5-30b442dfc495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0ecd012d-6d6e-4e37-82f3-a7439fab98be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bb9a9b03-0aef-4e17-b2f6-614be0a38d58" xlink:to="loc_us-gaap_OperatingLeaseLiability_0ecd012d-6d6e-4e37-82f3-a7439fab98be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_26de9095-d1d2-4911-81ba-e84867b97394" xlink:href="rdnt-20231231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bcdf4952-25b7-4ae8-a0d4-84c2c6bff9d2" xlink:to="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_26de9095-d1d2-4911-81ba-e84867b97394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_bb3e61c8-64d2-495a-9cd7-84a5086b8666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_26de9095-d1d2-4911-81ba-e84867b97394" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_bb3e61c8-64d2-495a-9cd7-84a5086b8666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_27f750b7-e308-4c3a-9e81-9dadbc61baad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_26de9095-d1d2-4911-81ba-e84867b97394" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_27f750b7-e308-4c3a-9e81-9dadbc61baad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_20ae3d30-8957-464d-b99b-d89459488a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_26de9095-d1d2-4911-81ba-e84867b97394" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_20ae3d30-8957-464d-b99b-d89459488a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4aa868b9-d6b3-4522-ad94-78abf7c69d24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_26de9095-d1d2-4911-81ba-e84867b97394" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4aa868b9-d6b3-4522-ad94-78abf7c69d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_002a6490-cb20-469b-bf7d-be53d6392bfd" xlink:href="rdnt-20231231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bcdf4952-25b7-4ae8-a0d4-84c2c6bff9d2" xlink:to="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_002a6490-cb20-469b-bf7d-be53d6392bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7760494b-673b-45d9-8407-224e5997f2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_002a6490-cb20-469b-bf7d-be53d6392bfd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7760494b-673b-45d9-8407-224e5997f2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_77cd5846-6c57-4cd8-84e5-d72171d44d07" xlink:href="rdnt-20231231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bcdf4952-25b7-4ae8-a0d4-84c2c6bff9d2" xlink:to="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_77cd5846-6c57-4cd8-84e5-d72171d44d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_25c51c02-bb77-41b6-b3ff-f7d00a468be7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_77cd5846-6c57-4cd8-84e5-d72171d44d07" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_25c51c02-bb77-41b6-b3ff-f7d00a468be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESMaturitiesofOperatingandFinanceLeaseDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_799c418a-7e52-4818-bdba-b880d0958e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_799c418a-7e52-4818-bdba-b880d0958e2f" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4d2cc960-ac5e-407f-b364-54def01e107f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4d2cc960-ac5e-407f-b364-54def01e107f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_642a1a4b-2ed9-4463-bd5c-0f67878f7c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_642a1a4b-2ed9-4463-bd5c-0f67878f7c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8a04d3a2-ca5c-4d62-9711-1090c3c45343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8a04d3a2-ca5c-4d62-9711-1090c3c45343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_93793b1f-061e-44ef-9551-a2ad6c30c238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_93793b1f-061e-44ef-9551-a2ad6c30c238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d54d744b-3426-4aae-96ad-d23c44c447ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d54d744b-3426-4aae-96ad-d23c44c447ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_e5b64cc2-17bf-45fa-a0ac-cbbbd5b9c2a6" xlink:href="rdnt-20231231.xsd#rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter_e5b64cc2-17bf-45fa-a0ac-cbbbd5b9c2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6847ce30-8295-4f3b-aa6b-2cb21f402456" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6847ce30-8295-4f3b-aa6b-2cb21f402456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_682ddb43-ef5c-4620-af03-bc99a53c4a02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_682ddb43-ef5c-4620-af03-bc99a53c4a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c7752af4-1e73-4c21-8267-01af1f27e341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35646bcd-d4a1-4ec2-b450-3b2936d165da" xlink:to="loc_us-gaap_OperatingLeaseLiability_c7752af4-1e73-4c21-8267-01af1f27e341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1" xlink:type="simple" xlink:href="rdnt-20231231.xsd#LEASESMaturitiesofOperatingandFinanceLeaseDetails_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESIncomeLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_61c614a4-490e-4e8e-abe4-a91cd5d27f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_515886fa-5057-4d3c-8c80-072c44b9d69a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_61c614a4-490e-4e8e-abe4-a91cd5d27f29" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_515886fa-5057-4d3c-8c80-072c44b9d69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6d3443df-0999-4321-aab0-726bd16ea264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_61c614a4-490e-4e8e-abe4-a91cd5d27f29" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6d3443df-0999-4321-aab0-726bd16ea264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aecc6745-75ff-4381-a8c8-d0c98ca8684c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_61c614a4-490e-4e8e-abe4-a91cd5d27f29" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aecc6745-75ff-4381-a8c8-d0c98ca8684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_458eb1ca-c3ca-4c95-8731-7de1a5db6729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_458eb1ca-c3ca-4c95-8731-7de1a5db6729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_e6d32b0c-0f14-4d71-aada-0ff86bd0d4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_e6d32b0c-0f14-4d71-aada-0ff86bd0d4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ca98325b-97d2-49a5-a0c0-ff99e5b9e6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ca98325b-97d2-49a5-a0c0-ff99e5b9e6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CurrentOtherTaxExpenseBenefit_78a29df5-fe69-45ef-b382-796ad79967f7" xlink:href="rdnt-20231231.xsd#rdnt_CurrentOtherTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_rdnt_CurrentOtherTaxExpenseBenefit_78a29df5-fe69-45ef-b382-796ad79967f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fc00640-7eca-401d-980a-d3ab0fef2bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fc00640-7eca-401d-980a-d3ab0fef2bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_bc6bd2e0-8a4a-4b11-ab2a-0dbfa8389ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_bc6bd2e0-8a4a-4b11-ab2a-0dbfa8389ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b8847d84-b19d-4585-b496-022ff9297cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b8847d84-b19d-4585-b496-022ff9297cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignCurrencyTranslationAdjustments_6a41354c-0cb0-4131-a7d6-2595419a99f3" xlink:href="rdnt-20231231.xsd#rdnt_ForeignCurrencyTranslationAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_rdnt_ForeignCurrencyTranslationAdjustments_6a41354c-0cb0-4131-a7d6-2595419a99f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f0b1fe68-02fd-4499-b3c9-7c724c1f386a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_515f34ae-eeb5-4681-a566-a886ab4c7bd8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f0b1fe68-02fd-4499-b3c9-7c724c1f386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9eef36e8-eb16-477d-92fd-d4c03d033ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9eef36e8-eb16-477d-92fd-d4c03d033ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_aa26e6d8-ab11-494b-929a-a4e232c3e3af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_aa26e6d8-ab11-494b-929a-a4e232c3e3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_84f757c1-9a06-4575-8f00-d2a97f9ae00d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_84f757c1-9a06-4575-8f00-d2a97f9ae00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_f7ef9a5b-a89b-4ba4-8456-94d5e78a1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_f7ef9a5b-a89b-4ba4-8456-94d5e78a1e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_f6b2dd21-2da7-490d-a858-d9eeabf01ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_f6b2dd21-2da7-490d-a858-d9eeabf01ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bab1f37f-e7cd-4812-adbe-c5810becd676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bab1f37f-e7cd-4812-adbe-c5810becd676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_0e9de622-367f-4c2f-8352-5c47af015de3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_0e9de622-367f-4c2f-8352-5c47af015de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c2a86ee3-ebe0-42c2-84b2-7d93d78f11cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c2a86ee3-ebe0-42c2-84b2-7d93d78f11cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2b1bf448-1d10-491e-a2de-4d2e862dbdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2b1bf448-1d10-491e-a2de-4d2e862dbdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_24c389b0-7bde-4637-b96e-5508d4884de8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_24c389b0-7bde-4637-b96e-5508d4884de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_959b901e-52d9-44d1-8261-7822ff89f5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_959b901e-52d9-44d1-8261-7822ff89f5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2f12a6ea-179d-4ff0-be4a-0cd8becf55b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2f12a6ea-179d-4ff0-be4a-0cd8becf55b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_eafb666d-40f8-4cc6-a2e9-de62d333f9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89d7f756-b8b8-4dd0-8cd2-cd2a924fa526" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_eafb666d-40f8-4cc6-a2e9-de62d333f9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_95f8ea2f-a921-4bc2-8eee-d556d30323b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_95f8ea2f-a921-4bc2-8eee-d556d30323b7" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3b64265d-5f05-458c-9564-164210e6c1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3b64265d-5f05-458c-9564-164210e6c1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b445f7d3-f2d9-4c41-9bdb-0df9c4c00736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b445f7d3-f2d9-4c41-9bdb-0df9c4c00736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_bc1f67ef-c7cf-4e9e-aea6-0da483be4b8c" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_bc1f67ef-c7cf-4e9e-aea6-0da483be4b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_42fecf66-2778-4b89-a4a1-c3997105dd32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_42fecf66-2778-4b89-a4a1-c3997105dd32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_53a83566-04e7-4de4-848a-a882d98e6e46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_53a83566-04e7-4de4-848a-a882d98e6e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7c5895ba-64aa-4636-94d8-83d224d5c340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7c5895ba-64aa-4636-94d8-83d224d5c340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_28aea171-4ef2-4130-b53f-1fc43e427223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_28aea171-4ef2-4130-b53f-1fc43e427223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_69d4499b-3ffc-4cdb-abe0-d22be069f5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_22d05f78-6a73-4429-8c19-3d1f3b626d61" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_69d4499b-3ffc-4cdb-abe0-d22be069f5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_95f8ea2f-a921-4bc2-8eee-d556d30323b7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0f294709-11eb-4912-9361-64b0aad5a0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0f294709-11eb-4912-9361-64b0aad5a0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e66f1c4e-173e-4f28-ab34-583cc7ce031b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e66f1c4e-173e-4f28-ab34-583cc7ce031b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_e9054f2f-8e47-48df-b0c3-6a9da461a45a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_e9054f2f-8e47-48df-b0c3-6a9da461a45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_7ca77c55-bfde-4d32-b107-0d3a9c32e8b0" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_7ca77c55-bfde-4d32-b107-0d3a9c32e8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_4a24ce76-e96c-488f-9289-004d95a7c074" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxLiabilitiesOutsideBasisDifference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_4a24ce76-e96c-488f-9289-004d95a7c074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_d09dafed-b799-46be-9ad5-b39e5cda4218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_d09dafed-b799-46be-9ad5-b39e5cda4218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_2d08eb09-92ec-44ff-b6f0-f40fa18d2877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_2d08eb09-92ec-44ff-b6f0-f40fa18d2877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_c96e1229-f61d-425c-a282-b2b1a1fd79a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_088f7917-1038-4f71-953e-807f520ffd8a" xlink:to="loc_us-gaap_DeferredTaxLiabilities_c96e1229-f61d-425c-a282-b2b1a1fd79a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7ae59042-bd2d-4e9e-a78c-0f3c43400d55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7ae59042-bd2d-4e9e-a78c-0f3c43400d55" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_627558cf-837f-48f8-9952-9bc2aa86eb70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_65e19ea0-def6-4b4d-adf0-a137f3f8e460" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_627558cf-837f-48f8-9952-9bc2aa86eb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_e3321ba0-3d5d-4d97-8bd6-695500beac32" xlink:href="rdnt-20231231.xsd#rdnt_RavenHoldingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_627558cf-837f-48f8-9952-9bc2aa86eb70" xlink:to="loc_rdnt_RavenHoldingsMember_e3321ba0-3d5d-4d97-8bd6-695500beac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c773ffde-dceb-4523-a1b4-17633c1334ff" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9cd69733-bfb3-47ce-ad03-9d4d4fa65f77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:to="loc_us-gaap_DomesticCountryMember_9cd69733-bfb3-47ce-ad03-9d4d4fa65f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d660e612-cd92-4db1-a644-f63e47e21472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83b64b1f-538b-4316-836f-cbb7425808bd" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d660e612-cd92-4db1-a644-f63e47e21472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b42d776-16fb-47eb-a42e-74f963a15e55" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_974ff3db-50cf-4b0a-8fcb-b945e0077082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_974ff3db-50cf-4b0a-8fcb-b945e0077082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a9d60bb8-e789-43d7-8fa6-3ab4e2bc4dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a9d60bb8-e789-43d7-8fa6-3ab4e2bc4dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f01e2cf2-0056-412a-8afb-dcc83c308919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f01e2cf2-0056-412a-8afb-dcc83c308919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_6088f258-86ee-4a7d-9669-ba27670a87dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_OperatingLossCarryforwards_6088f258-86ee-4a7d-9669-ba27670a87dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_b65db217-ac62-4b65-af13-d8f609fdaf04" xlink:href="rdnt-20231231.xsd#rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_b65db217-ac62-4b65-af13-d8f609fdaf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_d45ff4f5-3ac0-4f56-9d22-549138ec4929" xlink:href="rdnt-20231231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_d45ff4f5-3ac0-4f56-9d22-549138ec4929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_d0934ad2-2a2a-4451-a445-8c8fcbcb5c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_d0934ad2-2a2a-4451-a445-8c8fcbcb5c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_310a23ea-793e-4dc8-94a6-4a61efdbf465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_310a23ea-793e-4dc8-94a6-4a61efdbf465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_033167ad-cccd-4c1b-8e51-45ed9f1bec2e" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_033167ad-cccd-4c1b-8e51-45ed9f1bec2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_61fec4e5-acdc-4f46-8378-76e8742c6209" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_61fec4e5-acdc-4f46-8378-76e8742c6209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a526536b-003e-48bc-b990-a70ca4a64109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_161fb08e-0f4a-4f8e-9555-a27f5747d402" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a526536b-003e-48bc-b990-a70ca4a64109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#INCOMETAXESUnrecognizedTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_228699fc-6cfc-463c-86ab-d5ef90540200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_228699fc-6cfc-463c-86ab-d5ef90540200" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4b37b177-3ca9-4875-9d05-3530373c5a00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4b37b177-3ca9-4875-9d05-3530373c5a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_169787ff-e974-4d1f-9d48-af85ce295837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_169787ff-e974-4d1f-9d48-af85ce295837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_57828326-5a7e-4a0e-94f4-00226014e57d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_57828326-5a7e-4a0e-94f4-00226014e57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c6e5d980-90b9-4ebf-ad96-3a81234da2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c6e5d980-90b9-4ebf-ad96-3a81234da2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_2aa4ef94-0bbf-4a7e-b319-20b71d04d337" xlink:href="rdnt-20231231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_2aa4ef94-0bbf-4a7e-b319-20b71d04d337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4862557e-9e4a-4a0c-8d7d-d8cf711f0f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_022813b3-879d-45fb-9cc2-459628f7fa5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4862557e-9e4a-4a0c-8d7d-d8cf711f0f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fde22e75-b467-4496-b94a-3b05c0e71c44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fde22e75-b467-4496-b94a-3b05c0e71c44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d1786b1d-744e-4024-baec-4b90721d7d5c" xlink:to="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c4010a2-cd5d-4354-9e17-bbf8a21c5a7d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:to="loc_srt_MinimumMember_0c4010a2-cd5d-4354-9e17-bbf8a21c5a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01be6c57-bb70-45d5-a77a-dc63d6fa754f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d0c42edd-654c-40c5-ab44-804bc95bf6f7" xlink:to="loc_srt_MaximumMember_01be6c57-bb70-45d5-a77a-dc63d6fa754f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4587acd2-adc7-4030-969e-6adb47b97b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_be7f08c4-df8e-4567-af7c-1b3d08d80483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_us-gaap_RestrictedStockMember_be7f08c4-df8e-4567-af7c-1b3d08d80483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_3238726a-d17c-47ea-9f63-b8f5c57e6502" xlink:href="rdnt-20231231.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_FutureServiceMember_3238726a-d17c-47ea-9f63-b8f5c57e6502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a7febb45-f419-4a8e-81f8-f06b148e76c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a7febb45-f419-4a8e-81f8-f06b148e76c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_15e201ae-9ffb-4f07-b9aa-e79dc784703b" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_15e201ae-9ffb-4f07-b9aa-e79dc784703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_d665099e-2bb4-4a92-b5d9-884b135385de" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_d665099e-2bb4-4a92-b5d9-884b135385de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_87f3d6b4-e2e5-4ae1-8a85-3d3d125d5520" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7eb768c-d073-4331-a38d-6a3268d49278" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_87f3d6b4-e2e5-4ae1-8a85-3d3d125d5520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45212cc0-f57a-4aba-aef5-ff0dbda76825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_51f9bccd-85c2-4f7c-80b4-5a09f9fdaaa7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45212cc0-f57a-4aba-aef5-ff0dbda76825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_c698d657-68bf-482b-aabf-5b5f09eaf860" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45212cc0-f57a-4aba-aef5-ff0dbda76825" xlink:to="loc_rdnt_DeepHealthIncMember_c698d657-68bf-482b-aabf-5b5f09eaf860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_07e6f216-87be-4557-b491-9fdccb4cf492" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1e013b14-36a8-42b6-9d82-8bf1cca2eb8d" xlink:to="loc_us-gaap_PlanNameDomain_07e6f216-87be-4557-b491-9fdccb4cf492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_3f574937-1792-4a8d-a100-acdd38cba7bd" xlink:href="rdnt-20231231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_07e6f216-87be-4557-b491-9fdccb4cf492" xlink:to="loc_rdnt_RestatedPlanMember_3f574937-1792-4a8d-a100-acdd38cba7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46740adc-e7b9-4cea-a13b-f17bf3e4d493" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_0b0624db-ff63-4b30-b96c-bd0ea2de5d24" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46740adc-e7b9-4cea-a13b-f17bf3e4d493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f1494be9-3d0d-45b4-8493-a12518bd2d01" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46740adc-e7b9-4cea-a13b-f17bf3e4d493" xlink:to="loc_srt_DirectorMember_f1494be9-3d0d-45b4-8493-a12518bd2d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da444f8e-8fa2-4f74-b408-e9e64d478529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_cbf2afe3-b311-4893-89e0-22231847001b" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_cbf2afe3-b311-4893-89e0-22231847001b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8a564619-285e-479d-ada1-12a4e84326ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8a564619-285e-479d-ada1-12a4e84326ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c5c312aa-5f1b-4889-8f8a-38759bb02067" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c5c312aa-5f1b-4889-8f8a-38759bb02067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_99149eae-bbb9-4464-b55f-a4b03f60f929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_99149eae-bbb9-4464-b55f-a4b03f60f929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d4c7b659-03dd-4ae7-815c-74d6b1758e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d4c7b659-03dd-4ae7-815c-74d6b1758e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c862ce4f-2fb3-401c-922a-8974a9575aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c862ce4f-2fb3-401c-922a-8974a9575aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8e405aa9-62de-49d1-812b-dc5eced74b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8e405aa9-62de-49d1-812b-dc5eced74b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15500f60-70c4-46cf-bf5d-948d5e607022" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15500f60-70c4-46cf-bf5d-948d5e607022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e475fb4b-2113-4c12-a365-2e12a81c5869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e475fb4b-2113-4c12-a365-2e12a81c5869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db1f0786-0470-4975-8a78-d82a1265e534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db1f0786-0470-4975-8a78-d82a1265e534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_8fcb13b6-ee06-48ce-96de-435d20cc7c7c" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_8fcb13b6-ee06-48ce-96de-435d20cc7c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19247710-8ca0-4ae1-8afb-8947aba22341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19247710-8ca0-4ae1-8afb-8947aba22341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_bc429454-6e14-4de8-bfbb-7132740a8145" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_bc429454-6e14-4de8-bfbb-7132740a8145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9ecda032-22ac-42dd-b48e-c2833b7c19c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9ecda032-22ac-42dd-b48e-c2833b7c19c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_b1e2549f-11cf-42af-8206-6aa246676f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharesIssued_b1e2549f-11cf-42af-8206-6aa246676f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_41852d46-34ee-48c8-9f34-8f0739d41483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_41852d46-34ee-48c8-9f34-8f0739d41483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_46fa6877-6931-49ef-bc36-47213467e392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_46fa6877-6931-49ef-bc36-47213467e392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_83d76477-93bb-4256-8f25-be5fac456cef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_83d76477-93bb-4256-8f25-be5fac456cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_9b2167d2-4c20-4526-83e2-0864f5bae8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e6e204c-1adb-4b66-a620-598fbd482e6d" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_9b2167d2-4c20-4526-83e2-0864f5bae8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_980d155b-094c-4fca-b440-f9850c6ec5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_980d155b-094c-4fca-b440-f9850c6ec5bf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dea95c8e-8fd2-4432-8134-17ef03d06872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0eb22b0-e307-419b-8927-5cbd60c8a546" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dea95c8e-8fd2-4432-8134-17ef03d06872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_aff81830-9cd5-4e3a-8272-e1abba1e00fa" xlink:href="rdnt-20231231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dea95c8e-8fd2-4432-8134-17ef03d06872" xlink:to="loc_rdnt_DeepHealthIncMember_aff81830-9cd5-4e3a-8272-e1abba1e00fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:to="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_888c4467-0eed-434e-be2f-4f90cf81d8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_06535a53-6eb9-42d8-9598-ce228f47a804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_888c4467-0eed-434e-be2f-4f90cf81d8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_2537e0ca-0762-49b8-89a0-7d2bfadd860a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_888c4467-0eed-434e-be2f-4f90cf81d8cd" xlink:to="loc_us-gaap_StockOptionMember_2537e0ca-0762-49b8-89a0-7d2bfadd860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_092cffa4-ad8b-428e-8743-d8eca59eadfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3172a448-33ed-4e68-b454-5a703dedb108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3172a448-33ed-4e68-b454-5a703dedb108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_13dc2467-e9d6-46f2-bda0-e117a5a674f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_13dc2467-e9d6-46f2-bda0-e117a5a674f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_51d19ea2-85a2-40ac-8930-417871d64599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_51d19ea2-85a2-40ac-8930-417871d64599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8812c6e9-4c03-4b43-aa43-b5c3d54ed889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8812c6e9-4c03-4b43-aa43-b5c3d54ed889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7b7547f-284a-4e1b-a7d3-dfcc1d15db78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_19e97d1e-4f06-4f5d-87f1-84c0cad12ca4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7b7547f-284a-4e1b-a7d3-dfcc1d15db78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2787e90e-bdb2-4239-943a-d44a225cc04a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2787e90e-bdb2-4239-943a-d44a225cc04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16f1d66f-6237-447e-b2fd-b6c90b770057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16f1d66f-6237-447e-b2fd-b6c90b770057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b623262c-118e-4f2b-b85d-4ec95737aebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b623262c-118e-4f2b-b85d-4ec95737aebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_868994d8-7dc5-48ed-aea1-887653162dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_868994d8-7dc5-48ed-aea1-887653162dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_91c8684a-33af-4fbf-b085-33dc69a90738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_91c8684a-33af-4fbf-b085-33dc69a90738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_48b55853-cd38-49ea-b986-35a5d19fac61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35eba5aa-c162-4778-8b54-30c10fe35628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_48b55853-cd38-49ea-b986-35a5d19fac61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e4711bdd-3785-47a1-bbcf-283ca51a90c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e4711bdd-3785-47a1-bbcf-283ca51a90c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:href="rdnt-20231231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6d6dd4f0-2a14-4e7c-a606-899417e0bf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6d6dd4f0-2a14-4e7c-a606-899417e0bf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_fe1779a4-2443-4269-86ef-d7a683b5cf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_10c73747-82fb-4444-be1e-be2879102a1c" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_fe1779a4-2443-4269-86ef-d7a683b5cf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:href="rdnt-20231231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4e35fd6-510d-4efe-8fad-584757392d05" xlink:to="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_29b89ceb-97de-4b56-91ca-fcb7535e6785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_29b89ceb-97de-4b56-91ca-fcb7535e6785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1768cf3-9e85-47a4-845b-1ae85007fa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_49a73a5b-c459-470c-b2b7-7123f0192bb2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1768cf3-9e85-47a4-845b-1ae85007fa7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca7e5b56-f6f2-4811-aeeb-72dbcf9db66e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca7e5b56-f6f2-4811-aeeb-72dbcf9db66e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:to="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4656c0ff-80ec-439a-bf56-f57094f68a22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d9c11cf1-a53e-458e-bb2f-f13e8f0c0748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_us-gaap_RestrictedStockMember_d9c11cf1-a53e-458e-bb2f-f13e8f0c0748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_976b9056-cad4-469b-a0d5-99feb85de380" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_976b9056-cad4-469b-a0d5-99feb85de380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_ea2ec59b-77fd-48a9-b38f-7ed5077fa622" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_ea2ec59b-77fd-48a9-b38f-7ed5077fa622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_1f9c5938-5ed1-4076-ad7f-4198e5de88c6" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_1f9c5938-5ed1-4076-ad7f-4198e5de88c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AILongTermIncentivePlanSharesMember_43fd4710-83dc-4310-a841-52c8e50c237c" xlink:href="rdnt-20231231.xsd#rdnt_AILongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0cbba4c-58ed-43f3-9059-6aa79e0f162c" xlink:to="loc_rdnt_AILongTermIncentivePlanSharesMember_43fd4710-83dc-4310-a841-52c8e50c237c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:to="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c31a8169-8fd9-4efa-b989-06871a805edd" xlink:to="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8e979df1-e05a-46c5-9a8f-32786bfe4a3d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:to="loc_srt_MinimumMember_8e979df1-e05a-46c5-9a8f-32786bfe4a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2f1da66b-448d-44f4-a45f-8df877cf7a34" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a08c95e3-46c2-48a1-bc01-9cb4e7cbc9b8" xlink:to="loc_srt_MaximumMember_2f1da66b-448d-44f4-a45f-8df877cf7a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9f4f95c-5351-4438-af5b-052b5199ce52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3662490d-f590-4011-8873-ec70d3b4608e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3662490d-f590-4011-8873-ec70d3b4608e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1906a821-bbef-4716-ad0d-81b73d6914d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1906a821-bbef-4716-ad0d-81b73d6914d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_acd13342-3a84-4021-bb36-bb4277d1a370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_acd13342-3a84-4021-bb36-bb4277d1a370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f0a7be73-1973-4672-b219-d2af795af2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f0a7be73-1973-4672-b219-d2af795af2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_534c3c16-d18f-40d0-bacf-6423f23901ff" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_534c3c16-d18f-40d0-bacf-6423f23901ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_00ffbe86-eb9c-49da-9e52-348aee72bc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_52997cdc-f8a4-4126-b4aa-a14a9296554e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_00ffbe86-eb9c-49da-9e52-348aee72bc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_82e731cb-5cd5-4ddd-9779-b10da2ab7410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_82e731cb-5cd5-4ddd-9779-b10da2ab7410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fe313e91-50e2-419f-a02a-6709bfa6f6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fe313e91-50e2-419f-a02a-6709bfa6f6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5fd317db-6060-40f4-867e-5d348489b325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5fd317db-6060-40f4-867e-5d348489b325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_711b38ee-663a-4769-9288-ade0bbc7044e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_711b38ee-663a-4769-9288-ade0bbc7044e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a48242e3-0640-4e36-b7f0-51e1536c5a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a48242e3-0640-4e36-b7f0-51e1536c5a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_4781fb7a-e287-42af-bbd3-7b7d7411a53c" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_4781fb7a-e287-42af-bbd3-7b7d7411a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1b4a4b7d-fcdc-4a23-a179-074a0f42c620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02dc3ed0-3d40-4338-8ab6-11edc8db3391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1b4a4b7d-fcdc-4a23-a179-074a0f42c620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_87881ff0-9ea9-4c8f-b647-3612cee0b1c0" xlink:href="rdnt-20231231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_87881ff0-9ea9-4c8f-b647-3612cee0b1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c64caa06-d9da-468e-9708-64341d9a3675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c64caa06-d9da-468e-9708-64341d9a3675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8cd223ad-afc4-4f6d-9fd8-0e51c8e176f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8cd223ad-afc4-4f6d-9fd8-0e51c8e176f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_984c2a1d-2b9e-4853-b484-ed37642e5eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_984c2a1d-2b9e-4853-b484-ed37642e5eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8cdcdecf-c700-4ae2-afc6-7d808cf4232f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_750abcb9-8470-460e-b060-50443d0e09b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8cdcdecf-c700-4ae2-afc6-7d808cf4232f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20231231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_83829aa3-3e47-48b2-8b69-80b2b4f2a3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_83829aa3-3e47-48b2-8b69-80b2b4f2a3fb" xlink:to="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0794c7d8-b0e1-4be7-94f2-10df05fc8907" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HoustonMedicalImagingLLCMember_3d0893f3-0ae4-4b78-b342-e7cce066bfcd" xlink:href="rdnt-20231231.xsd#rdnt_HoustonMedicalImagingLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:to="loc_rdnt_HoustonMedicalImagingLLCMember_3d0893f3-0ae4-4b78-b342-e7cce066bfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_617e69ad-1495-4345-a865-8ed3047eeb50" xlink:href="rdnt-20231231.xsd#rdnt_AntelopeValleyOutpatientImagingCenterLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f2a4ddf-9b2c-4812-b40b-42b81948607a" xlink:to="loc_rdnt_AntelopeValleyOutpatientImagingCenterLLCMember_617e69ad-1495-4345-a865-8ed3047eeb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15aa6332-188d-45f3-8f1a-2b894fc4a990" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7e61dd6d-641b-4e8a-970d-d29cf1090449" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15aa6332-188d-45f3-8f1a-2b894fc4a990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2031e2bc-3f04-4f4f-b41c-95d3101cfcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15aa6332-188d-45f3-8f1a-2b894fc4a990" xlink:to="loc_us-gaap_SubsequentEventMember_2031e2bc-3f04-4f4f-b41c-95d3101cfcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_32e38438-b830-467f-878f-bbdf5c5c4152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_fde3485b-43f6-4f3a-b1d9-86eeeb06a8a5" xlink:to="loc_us-gaap_SubsequentEventLineItems_32e38438-b830-467f-878f-bbdf5c5c4152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a04c3da9-ee52-4399-bf9c-57de5dc3bf89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_32e38438-b830-467f-878f-bbdf5c5c4152" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a04c3da9-ee52-4399-bf9c-57de5dc3bf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20231231.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_FutureServiceMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:href="rdnt-20231231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:href="rdnt-20231231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AILongTermIncentivePlanSharesMember" xlink:href="rdnt-20231231.xsd#rdnt_AILongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rdnt_AILongTermIncentivePlanSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex1011-amendmenttoemploy001.jpg
<TEXT>
begin 644 ex1011-amendmenttoemploy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\S\>?$6;PKXW\.V84C26F,>HSX^4%U 5<]BH8.1Z
M$5Z%J5_#I>G3WMP',<*%BL:%V;V '))]*\K\6>$[GQ-\+[RXFU%&GESJ:P_9
MOF%QC/EAOO9 _=CC. * /0_%OG+X5U&:UNIK:XB@:2*:%L%6 X/H?H:X7X4^
M+M6GU/Q#X7\4WIGU72YF=9I,+OB!VGIC@'!SZ/2^'?$MQJ/P:FBU:WNX=4M;
M8VDD4MNXDE(&$91C+9&,X[@U%XH\#W.J?%70_$&D.RV&HP/!JDD8X,:I@AO]
M]?D]BHH SM,\3^(-2^.%MI5SJ=RFDW=NUVEFN$"H8RT8) W X"D\]2:L7&MZ
MH/CM<^')==O+?1$M//*><!L/E!B=Q&<9R>34$JN/VE8=2$$W]GK:>2;H1-Y0
M;RB,;\8Z\?6J.IV5E??M!W5WJNFO=:)):>2\LEHTD);R@,9VD9SQGL: /3O#
MUA=W-O=7)UK4+K2]2M8)[)I742VY8,6 ( [%#SGN.:\U\&_$#Q!X;\36VB^.
M;QI['6((Y[#4'  7>H(!( XYP?0CT.:]%\/Z_90!-&LTN3IVD:?&DEY-;21J
M[#"JJ;A\QPI)QGJ,5D7G@_3OB#\*M+TZ<&*[@LXA!,Z%7MYEC ((/..Q'I^!
MH L:JU[8^#/&%[%JE\;FR-Q):R--DQ;(PRJ.Q&2>N<URF@:GXJO_ (,'Q?;^
M(KLZO;+/.Z3+&\,R1NV5*E>/E7J"#FK>D6NKV'P.\0Z?KBS-JWEW=KM8%WE;
M9M0+CEL@#![CFLKPK>W=C\!I/#\&EZC-K=S%<VR6BVD@93(S#<Q(PJ@-G).*
M .DB\47_ ([^%=MK&D7<FEZQ)/':EH6^5)3*J'(.05.X'GD ]:;\*_'MQJW@
MS4SX@F=]4T61UNRRC>R\E3@=\AEQ_L^])X<\.MX"^&^DZ7J#DWTNI6]S.L2E
MPI\Y&;[H/"JHR>G!J"/P)=6OQKGU>T8IH&H6HO+K;]QY5=2%^N\+)]-PH I^
M =<\1ZI\6=?T;7-5N)8+.W:46R,%2.0LG *X)"[B!S571_$U^WQ"\:66K^(;
M^/1]'BDFB5954J%8<;B,G@X&?:I?!(>#X\>+-0FAFBLKJ)U@N)(F6.0[X_NL
M1@]#^58FF:+INJ?$_P <?V]82_V=?QRK:W4MF[J'+##HVWJ.H(]* /4[S3M7
MTKP?XC$VN7LTL7G7-C=LRB6-!$"%.!@X<-U'(KD/ GC?6=/\47G@3QU<,=29
MC]BO2=GG ]%##'7JIZ]1UP*ZG4_%$6L^&_%(@MKI;2"T>W@>2VD1[B5HWR$4
MC)'*@<=<]JJ_$7P/:_$+PY#>Z;((]7M5\VQN1E23UV,>H!/XJ?QR 7],TK5-
M2T[3S_;^H1QQW-R;F02+YDP5V1$SC  QDX';WKB_!%_KOB7QOXTT6[\1ZFEO
MIMP\5HT;J&C D=03E?FX4=:[[X?F\B\ :8VJAX[T1NUUYPVL'WL6W>G.:X#X
M5QS6_P 4O',\]O/##?7;O:R2PLBS+YKG*DC!X(- 'K%D;G3] MSJ,CW%U;VJ
M_:'C0LTCJOS$ #))(/ %>6:K\0YYK?Q2]H-<B:>X@L-.QI\P$+817(^7Y7W.
MWR]3M7CD5Z[<JSVLR),T#LC!95 )0X^\ <@XZ\UXQI7AS7KVV\+(_B'48SJM
M[/JTRFT@_<L TBORGWBS1\'CDX' P ;'QB\3Z_X?\)Z=J.B:A]CAN[B.!E:V
MQ. R,WWF/RGY<8V@C/6O5*\@^.]M<W/@O2=.MUN-0O8[Z.23RH2SLJQN"[!1
M@9)'H.>*];@GBN8$FA</&XRK#O0!YI\1_P"W?#?@C7M?A\07R7@N5:VC1E\N
M&-I54*!MY^4YY[GVK2\*)J<OASP[XFNM>O)(FLO/U&&=E,;@Q$[@ N00V.,X
MQFH_C2DES\,=2LK>*2:ZG:$10Q(7=\2H3@#G@"M/P-;1WOPOTG3IU=#_ &<E
MM/&RE70[-K @\@T <Y\/->U3XE2ZMK=Y>7-GI,-Q]FLK&UD\K& &+.X^9FPR
M]\=>*D\,^,=1L?BCJ?@/6+DWJHOG:?=NH$A78'V/@ -A2><9^4^O&=\+()OA
MS'K/AGQ&K6JB[-S:7KH1#<H5"G:_3/R@[2<\T_PQX>O?$'QEU/QW-:S6VE0I
MY%@9XRCW!\L1EPIYVXW')'.1[T =3\4[Z]TGX>:IJFG7<UK>VJHT4L38QF10
M<CH>">M<[X=EU/Q#X-THP>*-13Q%=:>U]@2H4.UE7#*5X#%L=NA]*V_B^KS?
M#'6+2&.26YG6-8H8D+NY$B$X YZ<UR_@BXT'PIX1TS6GTZZ368=->VN+:WT^
M3S9V+A@&PO4%<9/][K0!?^,%UXDTRUCO_#>JW-J\%K-=7,2$,KHCQ+D @XP)
M"3CL#6RGC"37OAM9:KI<HBO]3B\I"O/DR!292,_W DA&>I ]:NW%Q!>^)-,L
M]1C!>?2;B*YC\MO+#2&#Y">@R V 3G KB_ '@^_\':=XICU260V5I+/#IJL,
M[E=%)<#N6 C QW##N: '?"G6M7\2_#76=5U75KR>^CGFBBE\S;Y86)&& ,#.
M2>H-<I8^-/$\?P=D\7MXENO[4@U+[.L<JQM',GR_*5*]<$G(YXK?^#BR:3\*
MM=M-0@GM;G[1/((9HF5V4Q( 0",G)!''>IO@;X<T\^$&_M?1(1JD%Z[H;RT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH R_$&EW>L:2]G9:K<:7.S*1=6X!=0#R.?6N0_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*[C2[2:PTNVM+B\EO9HHPKW,H :4C^(X[U;HH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBL?4?$^EZ7>R6ER]R9XX1/(L%G-,$C
M)8!F*(0/NMU/:@#8HKG;+QQH.H"T:UGNW2\S]FD.GW"I+A2V%8H 3A3QGG'%
M:&A:[8^(]*34M.>1[9W=%,D90DHQ4\'D<@]: -*BJ1U2$:VND^7<>>UN;@/Y
M3>7M#;<;^F[)Z=<5=H ***J7NJ66GSV<-W<)%)>3>1;JW\;[2V/R4_Y- %NB
MBB@ HHHH ***BN;B.UMI+B7?Y<:EFV(7; ]%4$G\!0!+15#1=8L]?T>VU6P9
MGM+E=\3,NTD9(Z'ITJ_0 4444 %%%(&##(((SCB@!:*CN)X[6VEN)FV11(7=
MCV4#)-01ZC;2W,%NK-YLT!N$4J1\@*C)]/O#CZ^E %NBLVQU_2]2U2]TVSNT
MFN[$(;A$!Q'OSMYZ$_*>E:5 !15=KV!;];(,6N&3S"BC.Q><,WH"00/7!QT.
M*6N>(=/\.Z>+W4'E$#2K$&BB9_F9@H!P,#DXYQ0!JT452TO5(=6MI)X([B-4
MF>$B>)HSE&P2 >HXX- %VBBH+B[AM6A65\-,XCC4 DLV"< #V!)] ": )Z*A
MANX;B:>*)]S0,%DP#@,1G&>A.,<=LBHGU2RCU:+2FN$%]-"TZ0]RBD G\V'Z
M^AH MT444 %%%% !116=KFMV7AW1[C5-0:5;6!=TC1Q-(0/HH/Y]* -&BF12
MK-"DJ9VNH89]#3Z "BBB@ HHK)U+Q-I&D:EIFGWUV(KC5',=H-C$2,,<;@,#
M[PQGKF@#6HK!L_&>A7ZWS6U[O6PN3:W;&-E$#Y(RV0,+D$;NGO6]0 4444 %
M%%% !13)I5@A>5PY5 6(1"Y_  $G\*HZ'K=EXBT:WU73G=[2XW&-G0J2 Q7H
M>1R#0!HT444 %%%% !1110 45@ZGXOTK29I%N#.\<$R07$T,)=+=WQM#D=,[
ME]<9&<9%;Q( ))P!WH **R[SQ#I]CKFFZ/,THO-1W_9P(F*-L4LWSXV]!TSG
MD5J4 %%%'09- !16;I>O:9K4UY%IUVEPUE((IR@.%?&<9Z'CTK2H **0,"2
M02.H]*6@ HK+N/$%A;>(+/0Y6E%]>1O)"OE-L*H,M\V,<9' .>:U* "BBB@
MHHILDB0Q/+*ZI&BEF9C@*!U)- #J*Q-/\5:;J6J1Z?$MRDTUM]KMVE@94GBR
M!N1OQ'!P>1Q5O6=;T_P_ILFH:G,\-I%S)*L3R!!TR=H.!SUH T**@LKR'4+.
M*ZMRYAE4,A>-D)!Z'# ']*GH **** "BBB@ HHHH **QM>\4Z1X:2,ZG<.C2
M@E(XH7E<@=3M0$X&1D].:FLO$6D:CH(URUU""33/+,AN=V%51USGIC!R#TH
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M;;/(E2.)7"$%C@')YY.3U&,'TZN.C\$W2:5XGL3JT1&ORRRN_P!D(\DR($8
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M5_%LEWJ<MR(M9DAVNBC.(HL'@<8'&!Q^-;OC#Q WAOP^UY#&DEU+-';6ZO\
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MA]0AU R*6%W#C9*,G##' XQQ6E0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D^([CR-$G7_2
M!YZF'=;V<ERR[@1G8G/X]*X?19[G0/#EOHEAJ&M+!;QF.*5O"]RTBC).>F">
M?2O3J* /-KV2UN-0\/74)UZ/^Q-QB5] NI#,S)L8N=HSD$].YS4[7T!\;IXE
M UL,ME]A^S_\(]=;3&7#DYVYW9'7I[5Z%10!Y1!90V&JWK:9J?BNST>^F:>Y
MTU-!G8%V^_LD,>Z,-WQSSP1QB6ZAAC\2W6LZ%?>)](^W*BWT$?A^:5)2HP&7
M?'A&QQG!^E>I5'<3"WMY)F1W"*6*QJ68_0#K0!Y[=2:<^N:1JEE_PDMH^GV[
MVC*-$N)/.B8J2"6CX;*@[N3UJ;1=0M=(UW6M3:/79SJLJ2O'_8%TOEE5"#!V
MGC '7O77>']<M?$FA6NL62RK;72EHQ*H#8!(Y )]*TJ .!T:YT31-;UG5+:P
M\0>9JDPF>,Z-=;8SM ;;\G\1&X^IQZ5C1VD5CK%]-I6I^*[#2M0F:XNM.CT&
M=@7;[YCD,>8]W?'/H1QCT#_A(K/_ (2M?#GEW O&M&NPYCQ&4#*IPW<Y8=!6
MJ[K&C.[!4499F. !ZF@#GD\7Z?&BHFF:ZJJ, #1;K@?]^ZQO%FI6?BGPY=Z+
MY.O6L5TNR60:#=.VW(/'R #I[UV5IJ$%Y:)=H2D$A B>3Y?,!QM(]CGC/7\J
MI6GB*SO/$E]H4<=PMW9PI-(SQ[4*L2!M.<GH>V* .+NY5U324TC4KSQ(VG;!
M'+%:>'[B!IT QM9]C'![[=N:=J/]FRZAH=YI*>(-*?2(W@BCBT"X=#"X4%=K
M1\'Y1@_SKTFB@#R7^RM./AW5=(-UXH9;W4/[0BE;09\P2>8).@C^;YASG\ *
ML:M$EYJEGK6G:CXGT[6H8/LTUVOA^>1;B/.[:T9C"\$G'I[UZ4;V$7_V($M,
M(Q*X X1"2 6/;)!QZX/H:+*\BO[2.Z@W&&4;HV(QO7LP]CU% &=X9EBDTK"-
MJ,DBN?.FU"U>"25SR6VLJ\<X&!@8P.E7=4OC86$DL<337!!$$"_>EDQPH_J>
M@&2< 5'8ZU8:CJ.HV%K.LESITB1W*#^ LH8?H?S!]*T* .#LO"VK^'_#GAK2
M]*U66*>TN!)>K' 'CNMS[I=S'[JC<Y'<\ <].\HHH P_%'AW_A([.SC6\>SN
M+*\BO8)E0/B1,XRIZC!-56\*36WB)M=TS4_(OI[=+>]\^ 2I<A/NN54KAQR,
M@XQQBNFHH S=#T6WT'3C:6[/(SRO/-,^-TLKL6=SCC))_#@5I444 <+)\.6;
MPCJ/AI=<F%A=SM(@:W4F%6D\TJ#D9.[N>W;O6Q<>&I[KQ3INNS7\9>RMY+?R
M5M\+(KXW$DL<?=&/ZUT5% '$Z+X N-#F^QVWB2]/AY93)'I31(=F3NV>;][9
MG^'C(X)Y.>VIID02+&74.P+!<\D#&3C\1^=<F?B3H"Z(^KL+Y;6.\^QRAK1P
M\3XW;F7&0NWG/H?7B@"YXP\+OXLTN*P^W_8XDGCN"RP[V+(<KU(&,^U2RZ1J
M]W+;B[UI#;1RK+)%!:>69=IR%+%C@9 SCKC'0UI6VHP7-W<6@+)<V^"\3C#;
M3G:X]5.#@CT(X((%N@#DHO!DT=EXEMO[44C7GD>5OLW^J+H$.WYO[H&,]_RH
ME\&326OAJ'^U% T%D>)OLW^M*H4&[YN/E/;OS[5T%UJ/V74K&R^QW<OVLN//
MBBW10[5S^\;^'/0>IJ[0!YAX2AGU;5?'-M8ZS##%<:M(KA(A(X4QH"Z-N&#U
M&2&&5Z=<]/<>#(OM?AM["Y6TM]!#"W@\K>'!3RR&.X?P_KSS6SK&J6VA:/=Z
MI<QRM!:Q-+((8]S;0,DX^@J>PO(]1TZUOH0RQ7,*3('&" P!&??F@#G8_!\U
MC>ZN^D:J;.TU>1IKFW: 2%)6&'DB;<-I;J<AAD9QVK.\2GP]9>'?^%?Q1L]U
M=6'DV-DL3MD?=5BX&!M8;B2>,$UW='>@#F]5\(1:AX%;PK#=M!;O L#SE-[E
M1C)Y(^8D9).>IHNO#-S=Z]H6K2:B@DTA)45%M^)?,4*Q/S<< 8QT/K7244 <
M;+\/K>^MO$=MJ-\TT.N3+.XBC\MH)%"A60Y/3:IY[C\*L:9X6U>VLYH]3\3W
M&J3>2T-N\ULB+"&&"Q5>7?'&XGU]3GJJR+/Q%9WOB._T...X6ZL8HY96DCVH
M5<D#:<Y/W3VQ0!A#P'*OAWP]HZZL!'HEU%<PR&VYD,>=H;YNG)SCK[5JV7AE
MK#Q;J6N0ZC*(]1$1GM/+7:71-@(;J!CMZCKVJQJ_B*ST6^TRSN8[AI-2N!;0
MM''E0Y!/S'/' /OQ6O0 5D1Z1<CQ/)J\M\LD9M_L\=OY./*7.XD-NZDXSQSM
M7IBM>FK(CE@CJVT[6P<X/H: .;UGPI-J?BS2O$-MJ0L[C3D>-5$&\3(_WE<[
MAD>F,8)S7#WE[!=^+=7G;QC'HEXMWY<=EJ.G12R ( H:(N VUB"P"D_>SU)K
MUZC SG'- '&VN@ZMK-SX=US4=02.\TLS[5%F4$ZOE S*6RA,84[>Q)SZ5)K/
M@NYNO$G]OZ)KUQHU]+$L-UL@2:.X1?NY5N PS@&NNHH X_5_ AO'TR]TS6[O
M3M8T]71+\(LIF5SEQ(AP&RW/8 G@4^_\&7&H:?IT,VM2R7-KJ$>HRW,L"DSR
MQXVC:" J\ 8 Z <YR3UM-D<I&S!&<@9VKC)^F: ,%/#EQ'XQN/$0U",RRV2V
M?DFW^4*K%@<[LYW,?PX]ZQ1\-HF\))HDFJSB6WO6O[.^AC$<EO,69LCD@C+,
M,>A_&KD7Q'T"739=3(U!-/AE,,MTUE)LC8'!W$ X /!/2NJ@GBN8(YX)$EAE
M4.CH<JRD9!![C% '*7'@R_U'PUJ&F:MXBFOKJ^A^SO=M;(@CC[A(UP 3W)SG
MCT&+,WA6XGU?P]J+ZDF_14D1$%OQ+O0(Q/S<< 8QW]>E=-61J'B*STW7M*T>
M:.X-QJ;2+ ZQ_NP40N=S?0=LT 8R^$[K2++Q#_9^O7ENNI7$MW&(K99&MY9&
M!<J,9;D<=, GZCHM%2_CT2Q35)!)?K @N'  W/@9/''7TXJ]10!0UO1[3Q!H
MEYI-^A:UNXS'(%.",]P?4'!'TKET\":E(VA_;O%$]P-&G\VW9;1%=QL*@.3G
M)P<9Q^&>:[5Y$C +NJY(49.,D]!1(Y2-G",Y SM7J?I0!P<_PUDETN]TQ/$5
MU'92W_\ :$$?V=&,4GF"0@L>7&0<=.O.:VU\*%/%4FMKJ<Q%Q:1VMW;M&A$X
M0G!)QQ]XY '/M5GPYXITKQ5;W,VES._V6<V\Z2(4=''4$'G_ ":36?%>EZ'J
MFFZ9=R2-?:DQ2U@B0LSD8SGL!SU./TH Q="\!76@R+9P^);V3P_%)YD.F/$G
MR<[@AE^\4!_AX]#D9S'+\/)HX=>L=-UV6TTG6?->:T-NLGE22*0Y1B>%/=<?
M0CK7<@Y .,>U% %+1]/.DZ-9Z<;B2X^S0K$)9  S!1@9  ':JOB?0(?%'AN]
MT:>>2!+I /-C^\A#!@??D#CO6O10!QX\$WDFN+K%UXBN9;LZ<^GRE;>-%96;
M<" /NX//J?4#BKMMX7D;6]-U?4[Z.\N].@DA@E2W\IGW@ F0[CN.!T&!DDX]
M.CHH *YZ_P###2>)X_$6F7HLM0^S_99Q)#YL4\6<@,H93N!Z,#[<BNAHH Y2
M\\$17/A/5-#CO6C?59));V[,09I'<_,0,@#@ #K@ =>M=%86\MK8PV\TRS/$
M@3S%39NP,9QDU9HH KW]J+_3KJS+[!/"\18#.W<",_K7-WGA+4-2T/\ L&_U
MXW&ELBQS%K4"YE08^5I VWG&"0@/OGFNJ=TBC:21E1%!9F8X  ZDFG4 <CK/
M@F:YUZ'6]"UN?1+]8!:S&.%9HYH@<J&1N,CL:P?$L"Z=XX\!64.JJMTDEZ[7
M%SM=G9HN2Z@K]XDC QUP,8%>C7=P+2UDN&CDD6-2Q6,9; ZX'>J'A_7K'Q/I
M,6JZ<LK6<V?*DECV;\$@D \]0>M &;/X,M[ZPU^*^NFEN]<B\FYN(TV;$"E4
M5%R<!<D\DY)//I2U'P'<7UCI$B>(+JWUO2LBVU*.%/NE0K(T?0J0!P>_Y5VE
M% '(ZCX+N=4T*.QN]<EFNC=174]Y);KF1HV#(JJ"%100.![\Y)-7F\.7#>,D
M\1_;X_-6Q-CY'V<[2I8.6SNSG</RX]ZZ"J][?6^GVQN+E]J;@H &2S$X50!R
M220 !0!R*_#T'P_>:7+JLA:?4SJD<Z0!3%-YGF8P20R[ATXX[UL1>&Q<:BVH
MZU/'?W7V9K1 D/E11QOC?A2S'+8&23T  QSG9$Z[5W@I(R%_*."^!C/ SG&0
M.,]:SO#_ (AM/$EE/=6<<\:07,ELZSIM;>APW&3WH PO#_@:]T%HK/\ X2:]
MNM$MG#VNGRQ)F/!RJM*/F95."!QT';BM7PUX=E\/2:JS7PN5U"]DOF'D[-CO
MC('S'Y>!CO[UO44 %87BWPZWBG0VTK[9]EB>2.1W$6]OD=77'( Y49ZU>;6+
M-(;F8NQB@E$+.%R&DSMV+_>.XA>.YQU!PS5-=L='6V%V[BXNFV6]M&ADEE;&
M2%5<DX[GH.Y% &?XKM=;N="BCTC4Y+34EE5E>"W#K*0#\C!L[$)P2<]!WS@]
M%6*OB:U74+*PN[6]LKJ]=DMTGAX<A&<_.I*CA3P3GVK:H R/$FD7FN:2UC9Z
MK)IID8>9+'"LC,O=<-Q@]_4<=ZIZ+X>UC3[U9M2\47.IVZ1E([8VD,"*3@9/
ME@9P,@ \<UT=% ')Q>!H([&WTAKLOH5M=?:H;+R^00^]8V?/,:L<@8!X )('
M*:GX6UV\UZ75+3Q=/8Y3RXH4L(9!$G< N"<D\D]\#T&.MHH Y/4?"FL7VCV5
MB/%5RDD,AEGN&M8Y&N6SD;E/RA1V4#' ]*T-"T;5=.GGFU7Q%<ZNSJ%C$D$<
M*QC.3P@ )/')Z8]S6Y10 5Q&H_#UKYO$<4>NW,%CKOSSVZPHQ638%R&/.W '
MR\=.HKMZQ;GQ1IUIXD30IA<K>/;FX0B!BC@9)4,!@MA2<>U %"V\)7-OX@T[
M5VU<S2V5BUEMDMQ^\5B&).",'*C&!T'?K6?)\-XKC1;^PGU23SI]4;5[>ZAB
M"/:W);=E>2" >Q[$\^FSI'C'2M9L;6\MS/%!<RF!6GB,>V4'_5L#]UCVSP<@
M9R0*Z"@#E;+PE?Q^*K7Q#J&O275U#9M9LD=JD2.I8-TY(Y [_D.*ZJBB@#EK
M[P?)<^);S5[;6+BT2_M%M;N!(D?>J[MI5FSM/S'L>O8\TS1_".H:'IFEV5IK
MQE2QMFMF2YM \<J';C*JRD%=O')^\<UUE5M0O8]-TZXO9DD>*",R,L2%F(')
MP!UH I^'-!MO#6A0:5:$M%$7;) &6=B[8 X RQP.PK5JCHVJ0:YHMEJMJLBV
M]Y"L\8D #!6&1D GFKU !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %8?BJ[N[/3('M;^"Q#742332#
M<_E%OF6)=K;I#T48/6MRL/Q/X;7Q';62K>S65S8W:7EO/$JMMD4$<JW!&&/%
M ''-XEUQ-)\?QQWTZ2Z)&)[*:Y@C\T*8/-VL ,'D<9&<'GFI)=1\26VH>#Y!
MKQD37$,-Q"]K'LC/D;PZ8 ;=D'J2"3T XK6D^'XD/B(MKEZ_]O0+#=;TC.,1
M^66& .=O0=!Z=,6YO![S/X=8ZFP;0^8<0C]Z=A3Y^?[I[8YY]J .<;Q9JOAR
M+QK;WEZVIG1FM3:3W$:*W[]1@/L"J0K'/;CO6U:Q^+4\1P*);HZ3- ZW#WWV
M<O#*!E'C$?4'H0>.]32>!K2[O?$<NH7+7,&O1QQW,&P*$$:[4*'J"!SSGD \
M4N@^$K[1P@NO$M_J8MT*62W2)B#C&X[0#(V"1ECT)]: .,L/$?B@^!?#?BFX
MUPRR3ZA';W%J+:-8YHWG,9R<;@V,8(( QT/4]9;:E?>)==\16EKJ,MA;Z4ZV
ML?DHC,\I3<SMN4\#(  QT.>HQ$GP\6/P=8>&EU:;[-97*W,<IA7S"5D\P ]L
M;CZ=,5<;P:\/B2[UK3-8N+!]01%OX8XD=)F48#J&!V-CC//TH X[P5K=U:^"
M?!&B6:S>9?VUQ*[P>7Y@6)NB^8=N27'// ./4:UQKOBG0;$66ID>=J.L0V&F
M7<WEM(L4N26D5/E+*%;'8G&>]6E^&-M%X8TC2X-9OX;W1W:2QU% @DB+?>7
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MR0%  &>G'2N1+:/XY\7:9=VD,\G]@S3&:>2!XE$G"K%\P&[Y@'XSCRQZUW5
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MUX& #&M3XM?5=*N(I;F33IXV%_\ :3; )E<K)#LR1@]FR",=3S7/>'8?$/\
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M5)(Y?)7S/ED\P GIC=[=* (6UO5?#WC74++4-2DU*Q&B2:J$:%$,3QOM*IM
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M3?+IC%FN ,9*D8V[3M"]@!U[@#SXEUQ-/\?11WTZ/HL*7%E-=01^:H: R;6
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M?^@"NFK+\.Z*OAWP_9:1'=37,=I$L223!0VT# 'R@#^ON:U* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *RO$.OVOAG1YM5OHIWM( #*T*AB@) SC()Y(Z9K5K!\8JK^&)T=0RM-
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M^IQQ+]H#M]\L2<$-W&,< # XKJO"2M':SQS1ZP]SD-+=:I&JO,>@ V\ #'0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-R[0VX8.,'/6EH **** "BBB@ HK"N_%^DV5[';2R3%7NELC.D+-$D[8Q&S
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M=Z@9^7;G=^%6X)EN+>.9 P610X#*5.",\@\@^U $E%%% !12$A1DD =.:6@
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M[>W9@@D$+N QZ [0<9]ZT8I%FB610P5AD!T*G\0<$4 /HHHH **** "BBB@
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M@4C5?,^11M7N<D9/4YG\9^&?^$N\,SZ/]J6U,K(PG\K>T95@P*C<,'(ZY]:
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M9:41@X+*CGCIQGUJ];^([J_\+:CJFAZYIVHPB2,6]U<%8A AV^9YHX 9068
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MN[AAO6)5QE >&D)"@#!Y;H:YV'Q_>V>A>()+@"YN;'5$T^R::$PF4R!-AD7
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M P_AP#S5GQ3XKN=*\076FW>I2Z)'+;I_9=Z\"M;33$'<)793M(..,KQSGD4
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MA2< ]3CZ5RMGXFUMM0\6Z?9^=J,MA8Q76G"ZMQ%*[NK_ ",H5<C<@QP#S^-
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M]?\ @1+[POK&DF_*W&LS&:]O/)R6)QPJY^4 *J@9. .Y.:ZW8N[=M&?7%.H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4+>1[8!IE#@&-3R&(/0>_2O)OM+?\(7XON+ M<1VOBU[JYCM2&=H%FC9B!]
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M9.3@#'/O5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>[OXH7,BQ$MG8KM]U6;&U6.1@$@G(J&\\8>'=/FNH;K6+2.6T"^>GF9:/.<
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MV:=&D6[@,2Q^6I .XC!&.IW&K-Q<6FD_$CPK))!_9]I)HTUM;PLN-K;HRL0
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M Q.Y"K*5)SSUS@>@K0TC27L9;B[NI8)KZY"+,\$'E)M7.T!<D\;FY))Y],
M'(>.;VUTC6?#&N3&5= 1ITN[FS) B:1$$4A*<[<*RY]#63K::2/#=UK_ (8@
MOKRQ_M6UO=1GBED8W21M\YCW')V_*<CC(Z_*<>LD @@@$'J#0      .@% '
MG-O>^$-535M?T:YFO)AI,EO/?RS2E$0\K&=_&XG)QU&.<9&>?>?3Q\-OADCR
MVV$U.P+J67Y<*V\D=L$\_7FO9E55&%4 >@%+B@#RG7?,U#QKXUL=*G1K^Y\.
M)'"D;C<\@\SY1_M8(^F15CPYJOA#Q-/HDT+7LVLZ?\WV:668&P;;B0N"=H4
M8YX/ KTZD"J"2% )ZD#K0!X9<7-C_P */\4B.:#S'U>9@%898FZ!4^_RC(]A
M7;2:A:6_QI@EDG41WN@)%;..1,_VAB0I'4@$'V'/2N^P*,4 8_BK0T\2>%M1
MTACM:YA(C?\ N2#E&_!@#^%>:MJ>O2QZ!X_%A-]J3;I-Q8[0IE#_ ",Q]/\
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M?RK';V\9=B3RV!G ]2>@%7=J[MVT;L8SCFEH \SU;PE=:S\.;P3:Y$)+I6U
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M,>=JKU)]@,UY]:>*;K5-'.A:]&MOXDTS4]/6ZC'"SK]KAVS)ZJW'T)[9%6-
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M4E5E:3')V@CG%/M?$6DWMP]O;7J2SI$9C$H.[8" 6 QDC) _&N0\?2R0^/O
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MA75E!Y .",<XSD53D^'GV>PTF73KY4UG3+V6^6ZDC^2>24DS*R@Y"L#C@Y
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MRMNR1R+)$9 &3>3Q@CAJ--\77VI:9X1MU\B/4M=M#=2RE"4B1$5G*KGDDLH
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MU_#OA>?24UV*^NH+N#5KV6[9$B*;/, 5DY8Y&%Z\5G^'/"'B#01!I;^)%N-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-%5/[5TXZ?\ VA]OM?L6,_:?.7R\?[V<4L.I6-S>36<%[;RW4'^NA256>/\
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MD4L$7JQ Z#W-<+?:YXP\.ZQH\VKC2KK3-3O8[)X+2-UDM7D^X0Y/S@8Y.![
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<E\4"!\,?$63C_0WKK:@NK.UOHO*N[:&XCSG9*@<9^AH J#4
M;+2_#T-]?W4-M:1PQEYI7"HN0 ,D^Y _&M$$, 000>015=]-L9+ V#V5NUF1
M@V[1*8\9S]W&.O-6>@P* "BBB@ HHHH *\SCM+2^^-VO1W-Q/'MTJWQY%Y)
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M^"+@V\/FMJ=ENEVC<<S%3\W7ID?2NMDL;&'XM:A9Q6MNEO-X95I(5C 5R)V
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M^5&= .U/]T>?@?A3KSPUKFHM$U[?^';EHO\ 5F;06?9],W'% 'GEAIX;PSX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !45Q;P74)AN(8YHFZI(H93^!J6B@" V5HWF;K6$^8 KYC'S = ?7':
MFP:?96MN]O;VEO#"^=T<<856SP<@#!JS10 R**.&)(HD6.- %5$& H'0 =A3
MZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M110 45E'Q/H"RM$=<TP2*=K(;N/(/H1FM165U#*05(R"#D$4 +1110 4444
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M5IG.T[0"<< G%<_::7?S27U[K%GIUQ>N^VUC$K/''$/NKEDR#G)) .2?0
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MA&?=VR/]P^E21:#JNE^(O$.I::;.4ZOY+J]P[ P.D>S!4*=R_P 0&1U(XZT
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M2L+P=X3U;PS =/>#2'BBFD:+4UW&Y>-W+89"@&[G&=Y'3@T =Q&S/$C,A1B
M2I.=I]*QKSQ!M\01Z#I\ N=0,/VB8LVV.WBS@,QP3DGHHZX)X'-;=<LFA:GI
MOBK7=8TX6DYU6* #[1(R&!XE*C@*=RG.>H.<^N0 96L>.KU/ _B#4;&V@CU+
M2[J33W5I"R>;D*K)\OS9+IP<=2,\<]-X;TC^R?#^FV=Q%$;JUAV-(K;R6/WV
MW$ Y8_,?<UR#^&(X(_#WARVN#>^?J3:OJEV<?OC&=[,P' W2F, >B]\&O1Z
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MQPJ*/4G^I/ IVB6$FE:#I^G37+7,MK;QPO.W60JH!8_7%8_BS0]3U/4-!O\
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M@,Q$D009R%*C.<H!DKC>,XP:9;>%=4T[QCK&I0VND7MKJ4R7"3W983VKA I
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M<#\:EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *"0!D\"BN \>7,VJ^
M)_#?@Q)'CM=3>6>_9#@O!$N[R\CLYX..WUH Z9O%>@HC2-JEN($.&N,_N5/3
M!D^X#GCK6M#+'<01S1,&CD4.K#N",@U6NM,M+O1YM*>%5LY8&MS$@  0KMP!
MT'%8L'B"XU.[U2VT2.W2UTIC!)=7 )1YE&6C501PHP"V>#P : .FHK@A\0I[
MK3_"-W9:>C/KS'-N[$N@52S[3P#R ,G ^8$X%4KCXB:U%H.O7D>F6,MQIFHF
MS7;*_ER?,B!0<99R[%>P^7)QP" >E55O-.LM1$0O+6*<1/OC\Q<[6P5R/P)'
MT)%8&I>(=3A\;V?AZPM+>836;W4TCLP\A00JDX[%L^YQVZBEIOCJ:33;T7EG
M')J<&KR:1!#;L0EU*N"""<E5 )+9S@*W7I0!VJJJ*%4 *!@ #@"EKE[37M4?
MQA=:%/'9M':Z>MW-<Q[E"N[$)&02>RN2>XQP*P+'XA:O?Z)H.I1:;:>7J>I)
M9X\QN49V&4XY(12Y)X'3D@X /1Z*YNW\07K>*-9T:Y@M8OLMG%>6TOF'#JQ=
M3OR.,%.WK6KHMU=WNB65U?P)!=S0J\L2$E58C) SSCZ\T 7ZHZMJ]CH6G2:A
MJ4_D6D7WY=C,%^NT&LOQ+XC.B:AHUH3% FI7#0?:YU+1Q,%RJD CECP.1T-<
M]XTO[JZTCP]HVIVZ1W6JZD@N+:$[MT43&0JI/7=MC7G'WNU 'H2L'16&<$9&
M1BEKC;#QK,EKXCNM9MH8H-)NQ;(;1FD,SE4/EC(&7W.%[ D]JG;Q!K,'B?0]
M(N+2TW:E'-/.J,Q-I'&HX)Z.2SJ,X Z\&@#<&M6!UE](\YOMZ0?:##Y;?ZO(
M&X'&",G'!_E2Z7K%CK,,TMA.94@F:WD)1EVR+]Y<,!R*Y#3M2BCU?QMXON.;
M:Q'V&$G^Y;H6DQ]9'8?\!K:\!Z;+IG@K3(KG_C[FC-U<D]3+*3(^?Q8C\* .
MCHKG?&OB"[\-Z"+VQMX[F[DN(K>&W?.97D<* ,=^2?PJH?%5WI_BXZ3J\5I%
M:MILFH>=$[$P+&P#!\\$8.<C'0C'>@#K:*XJ]\6ZM'8Z-?6]A J:Q?16UK;S
M;A*L;Y;S7P?[BD[,<9&3U%:%OXAOF\2:YH]S!:1&RM(KNVE\QMKJ^\?.2.,%
M.<=C0!TM5[Z_M=,LY+N]G2"WC&7ED.%4>I/85#HUS=WNBV-U?0+!=S0(\T2$
MD(Q&2!GG\ZY;XJW,O_"&_P!D6H9KO6KF+3HE4C)WM\_7C[@;KQ0!N+XP\.NU
MNHUFSS<LJ0_O!^\9ONA?4GMBMNN?TEGU,7-C=:,;*ST^2!+>.9U9BZ!9 PVD
MC _=XYZ@URMQ\1]431[W4(K"R:*WU@:?&YD8+,OF"/Y>.6^^?0 #KG@ ]*HK
ME=.\37]YXFUG3I[2WM[:QLXK@2LY+1E]^%D[ [5W8'3/4UAP^/==/@[2/$MQ
MI=I';WEU%$UON;S'CDDV*R>AP0<'KST[@';W&LV%IJMGID\Q2\O-WV>/RV/F
M;1EL'&.![^GK5^N(FO;>7XC:GJ=Y*$L/#>E['=NB23?O'/X1QI_WU3[GQE?V
MNA:=XAGL8H=/O;F&)+5\^>(Y6"HY.<!N0VS!X_BS0!VE! (P1D&N:MO$-\WB
M37=(N8+2)K*TBNK:7S&VNK[Q\Y(XP4YQV-58?&$KI;6MPMK:7R64=WJ4LSGR
M;/>/E7G!9F(.%R. 23T! .EL--LM+@$%C:Q6\0  6-0!@< ?0#@>E6JXZT\9
M74EAID5U91P:K?B641RDQI%;HQ'GR \H"-A"GG+ 9')&KX9U>[UF&]FN(H_L
M\5R8K6YC0HMU&%'SJI).-Q8 Y(.,C@T ;E%9VMZS;Z%I<E]<*[@%4CBC&7ED
M8A411W)) K'77M8C\7Z9H=Q;69-U:RWEP8BQ-NBX4+D_>RS*-V!T/% '4T5Y
MM/\ $/5_^$?U74[33K*;['J9LHLR-MF'F+& O'+LQ/H  #SFO2: "BL;4M:>
M+6+71;"-)=0GC:=B^=D$(."[8Y.2<!>,G/( )KG)?'.H6_ACQ1K,MK:;-'NG
MM8/F8"X9,*3WQESM YQZF@#K]3TC3]9M?LNI6L=U!D-Y4@RI(Y!([\U;C18H
MU1<[5&!DYKD['Q/JMQXKTW29;&V6&ZTY[N1E=MZ;2BAL= K,Q ')P,G'2L27
MXAZNWA[4=3M-.LIOLVJ&QAS(P68>:L2A>,ER2Q[ #!YS0!Z345S;07MK+:W4
M*36\R%)(Y%RKJ1@@CN*P?^$AN_\ A/FT$VT"V<>G&\DG+G>OSA5SV .'_P"^
M<^U4=/\ '!OO#]KJ26:O/J=[);:7;JY!G168*[''RC:I<G!P/4X! .LMK6"T
MA$5O$L:9SA1C)]3ZGWJK8:S8:G=7EK:3%Y[)Q'<(8V4QL1D Y [<\>H]:Q].
MU_4)?%NI:/=I:&WTZSCGGNH@RX>0DJN"3C"JQ//ITJ#X<HT_AR76I5(EUJ[E
MU @]0CMB,?\ ?M4H ZZBLGQ-K$F@>&M0U:.V:Y>TA,@B7/..I..PZGV!K-'B
MAK/2+C5KQK>ZT\I";&:R!S=M)P$523@EBH SWR<=@#J*H1ZS82ZS+I"3'[?%
M")WB,;#$9. V2,$9XZ]CZ&L1=>UB/Q=I6B7%M9DW=M+=W!B+$VR)@!<G[Q+,
MHW8'0\5DZ5K%M:7?B[Q?>;VA-XNG6JH-S2+#^["IZEIG<#WQ0!Z!17*_V_K,
M/BK1M&N+6SW7\,US.(V8FUCC &,_QDLZC=@#KQ5+3_%7B'6'U!-+TRQG^QZH
M;-I6F9$\I6"NV<'+9W<#H%SSD @';T5QT'BG5KC0O$4J65G_ &II5\UI'"9&
M\N; 1EYQG+!\ 8ZXKL1TYZT %%8$FORWGB6XT+2DC:6SB62]N9062 ORB!00
M68@$]0 .YSBN4UWQAJ>I_#NZFTUH;74Y=0;1L@%@TIE\K=$<C'!+#.<>^* .
MOTBZ\/07AT[2?L\<S(\H2&,J'17VL5;&" S8X/!)K5NKJWLK=KBZGCAA3&Z2
M1@H&>!R?>H=*L5TW2;.Q58P+:%85\L8 "@ 8S]*Y_P"(5E?S^'H=0TUXOM6D
M72:DL,V=DXC#90X]03CW H WM-UC3M7$QL+N.<P2&.55/S(PXP0>1TJM'XIT
M"76CHT>L63ZF&*&T68&3<!DC;UR ":Q_ 5W8:MHAU&VA>#5 HL]06=,2)/&6
M9@P_WI&;W#5F^$8=2T/Q?<>&]8^Q7[BT-_::G%;"*5P7VNLF,_-ELYSSDYZ\
M '2ZGXR\-:->M9ZGKNGVERH#-%-.JL >F033=6D\,ZEHD&L:I-9RZ7$5GBNI
M9/W2G(VN#G&<D8/OQ5/Q%I]G<R1Z-:VD(O=5=FN)Q&"\< QYDF[KG!"+Z%EQ
MPM+XM\/ZG?:+:0>'[FTM)+!O,BMKBV$D,VU"JQL,_*O/7!P<'M0!M:3J^F:U
M9?:=)OH+RV5O+\V"0.NX <9]>14]Y?VNGQ+)=3+&'8(@/)=CT50.2?8<UE>#
M=3CUKPCIFJ1V<=G]JA$CP1KA5?HV/;(-8NGRR:Y\6=6DER;70+6*VMU/3SIA
MO=Q[A0J_0GUH ZII-.U?2)2[07.GS1NDN_!0KR'#9].00>F#FH='O=(EMUM-
M)>!888U*0Q+L C.=K*,#*G!P1P<&O)K.^GUW3K/28V;['XF\3WDQQ_'91-O=
M?HVW!^I]:W_$_B!]'\>ZI?VX#1Z-X8ED<?P^:\H,:'_OC/T- '?-K6FK??8C
M>1^?O$97/ <C(0GH&(Y"DY/I5^O*M6M)M&^&/AK2M[/JNIZE9&20_?:X>43R
M.3[%3SZ5ZK0 UW6-&=V"HHRS,< #U-0I?6TGD;91F<$Q @@N!U('7'3GIR/4
M5R]W>2>(/'Y\/IG^S-*@2[OQ_P ]IG/[J(_[( +D=R%'3-;TFBV\GB*+6S+<
M"YCM6M0@DQ&49@Q)7UR!S0!9>_M([66Z:=/(A)$D@Y5<=>?;OZ8/I5*Q\3Z%
MJ<L,5EJ]G/),"T2I,"9 .I7^]CVKF_%$*^"_A5=:9I<MQ-*8OL5F9Y-\C23/
MM7GO@OQ["L.2T-YKOA#P9<6K:/%I!BO[=Y65Y+SR%QLC*94=RV3G';O0!ZM1
M7'ZGXQFATC6]8L(8'T[2!(K22DYNI$^^J8Z 'Y=QSELC'&2^\\47MC=>&["[
MCMK.[U:%B\LRLT23A5/DCD<L6;!)_AZ$F@#K:*YB7Q1/;MI^GW,5M!JT]I]K
MNQ)+B&RC& 69N_S':!QD@\@"KOAG5;S6--ENKNW$2BXD2WD5"@GB!PLH5LE0
MW. 3TYZ&@#:K-N/$&E6MR]M)>(T\?,D<0,C1CU8*#M_'%87Q+U^\\/>"[B;3
MFV:A=2QV=L_]QY&QN_ 9(]\5N:!H=IX=T:WTVT4[8UR\C<M*Y^\['NS'DF@"
MS8:E9:K:BZT^[ANK<L5$L+AT)'7!'!JU7+I?Q:=K:>%M#MT-QMDOKF1_]7;)
M)(S9(&-S,[-A<C@$YXYR;[Q_<V?A;7;\6UL]]I.H_P!G%2S+'.Y9 I7J1GS!
MD9.,'F@#OJ*X?_A,]4'B6_TEK"U58-.2\5VD8&+<6_UO'RC:N[ R1D#/.1$W
MC?5O^$5\*:E'IL#7^N3Q1&TRW"N"Q9?8(">?44 =[17&GQK)I6N:W9:\EM';
MZ=8QW_GVQ8X5F9?+(/5LKQC&<]!4]MXCU2YUW3[%;2V/VB.22[@0EGL%"Y3S
M'!V[F.!MQW."0N2 =717F\'Q#U:[T"TU2VTZRD2YU5;&/]XP$JM+Y8V<<MM!
M<DX &.ISC;U3Q1?1>)KS0K"&V%[#8+=VL5SN'VTDL&5&! &W:,]2=W8#- '6
MT5@S:Y-<ZQ=Z;IH@'V"-7O;J<$QQLPW+& ",MCYB<_*".N<5RM_XMUW5?A[H
MU_9)!I^HZ]=I:P+AG,<<C'# Y'(C!?.,>U 'HDD\,3QI)+&CRMMC5F +G&<#
MU. 34E<C+>^=XYL](O+.PF33]/.H-=LI+6[D^6-N<XS\YSGHM5;OQS=+X/NO
M%]M:1#1X#NBCFR);J(.%+@YPF>2H(.1C.,\ '<45R=YXJO4\;+H%G:V\P;3_
M +9N9V5E);:H;CY5X8D\] .I%7/!^M7?B;PC:ZI=1I;37/F;3 <KM#LJNN[U
M #<YZT 6X?$VB7%M87,.IVSP:A*8;1U?B9QG*KZGY3^5:,<\<KRHC@M$VQQ_
M=. <?D0?QK.A\.Z;!%I\,< $%A(98(OX1(<_.>Y;YF_%B>N,9>GZ@TOQ,URQ
MC.88=.M&D']V4O-^I4K^0H ZFBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KF/$FOZEIGB#0=+TR"WN)-2ED$B2@@I&B[F?<#P.5'0]>_2NG
MKA+<WVK_ !-UF_L&M3'I-I'IJ&;<0)'_ 'LC#'7'[L$<9QU% $D/C>XL+OQ+
M::Q%#,^D2V\<#6:%?M+SKE(@K,?GR0.N.0>*M-KFNQ>+=*T22+3V:[M9KNX\
MM7S;(F !G=\V7=1NP.AX]*U_X$E;2K1;#4$&J0ZJFK3W5S%N6YF&00R@C"X(
M  / 4?6I(-&;0?%UWXFUG7K41W<$-HOFJ(@&&X[%+-A5).0HR?E&2><@"6WB
M?6KKP_KTD<%@=6TW4GL8XSO$4Q!0KW)#,K@#MDCM5B^\53&#7+VP6W%AHJR"
M>><$^?*B[GC3!& . 6.>21CBE\.Z T.MZQK$DA-M?7GVJT@9=NP^4D9=O<[3
MCT!]3@8<_P .]7G\(W_ALZU;_8YKQIXB+=@SJ\WFLLIW?-U8<8[?2@!OB"^U
M37]'\&Z7/;0#4-7N(KVZMP2L:Q1 2LISDX#>6#ZUH+XSOM/7Q?%K"6C2:! D
MZSVRLB3!XV=5*L20P*XZ\Y%:LGA^]7Q/;ZY'=0SRQ6!LA',A14)<,TBXSUPH
MV\<*.:I:MX(DO?#]U8V][&+N^OHKR^N)XBPGVNK%-H((7"*H&> ,9Y)H IZ1
M?#PAX=\/^'F:'^U;BV:XN'N'VQP_QS2R'TWO@#C).,CDCH/#6JW^K17TUW#&
M+=+DQV=PD;1BXB"CY]K$D#=N .>0,C@UG:GX5U&3Q98>(M/O[4W<-F;*=+VW
M+JZ;MX==I&U@<_4'M73VL<T4 6XG\^4G+.$"C/H!V'U)/N: )JX+0->AOK36
M/'6J2[--A:6'3QU"6T9VLX'=Y'4_@%%=XPW*1ZC%<#:^$9K_ .$EKX9AN5M;
MFW"(9'3<GFPS;CN&1E2R'\\T 7KGQ'KUOJ/AVW>TLXY-9N"#;.&,EM"JEW+,
M&PS;1CH "1][OG6D^H7?Q#\1ZG<W]J++0K46L)-LQ5"Z^:Y^_P D 1ACW P-
MM6YM'GM?&MCXAUC7[,21:?+']G\O8!AE9VB!8X&T ,3D\GID;8;#PKJ&H?#C
M5[.27[#J?B!Y[J=I%)\KSCPA'7B,*I]* (?#_B;4K#PEI=]K$T-SJ_B"8S6L
M!!A6-6&[+$EL(D8!.![<DY-B]\9:G9:)XCU0"RGL].A1K.[6%UCNI2#N0#><
MC=L&\'&6(YQ5K5_!][=W'A[4+*]M%OM&\Q5CN+<M!)'( "NT'*X"KM.2>.<U
M>UCPW=Z]865I?W\;QI?175S&L&U)4C.X1@9) +!222>A_  FT:\U^\O%DOK2
MSATYK1&1T9O-:8GYOE/W5QR!R>1GG(&[1377>C+DC<",CJ* .)U?QG=_\(QK
M6OZ6+==/L!)'!),I8WDBG:=F" J[_E!^;)SQC&6:5J$/A+3-'\*1S6T=Y;V"
MW%[<W+XC@!/S,>1N9W+87(Z$YXYIQ?#G51X3TK0)M9M'@TR\BEB M6"R1I)O
M_>#?\S=.F!UZYR-F7PKJ=MXSE\0:9?VA-U:QV]RE[;&0@QYPZ%67!()R.!_0
M CL_%NHRVME;36"?VKJ-S,EG&4:)3;(?^/AU)+(-N#MSDDJ.,\9(O[W_ (2_
MQ/KER]I,OAW3Q:12*K)'N8>=*Q&2054(" ><=1GC=O/#&IOXLL==L]6C62.Q
M>QN//M]Y*,X?<F" K9&.<C&,YK+'P^O4\&>(-"358_,U6ZEG$IB. 'D!(<YR
MQ*@*3D?U(!<M_%VH/:>#H)K6W75=<VR3PC=MAB$9DD8<Y!'R@9[FK8\0ZEJ\
M&JW'A^UAEAL&D@B,HR;R=!\RI\RA5#?+N)Y.>,#)C@\)WJ>,++79M1A?R+)K
M=T6#'S,RD^7DD(N% QR<9YR<T>&O#6K>'+-])BU*V;2UN))87$!\\*[ERA).
MW.6/S8Z=A0!6EOM:U#XCV&F1W,$%G8V(O[R$1%CYCDQK&7##/'F$<8& 2#QB
MBOBF:T\*^*?%AM--6>UN);>&=("OVM(3L3<=V3ERRCGBM^P\.WUEXDU_5?[0
MC/\ :13RE$7S1A(PBAB3R =QP,9+=:RK7P#.O@S1O#MYJ$4T%I=13W06'"SJ
MC%RG)S\SX8DY[\"@"Q8>)M9G\6:1I4]K9B"[TZ2[GV;O,3;L4/R<!69B IR<
M#).<@95QX_U1_!8\5V=K:?9I[Q;>RL95<RSJ9?*!+ _*Q.6V[3@#'TUM4MW\
M-Z[K7C2]N?-M!90PI;QQ?.BJ6R-Q. I9]Q.!C ). <X-O::QX5NK6\O=/T'5
MK>ZO@T<EJS1W"/,^"T:$%&P&Y*[20"3W- 'I%J;DVL9O%B6XV_O%A8L@/L2
M2/PK&\::Y/X;\*7NK6WD&: +Y:3@E79F"JO!&,DCFM^L3Q#H!U]]*CDF5+6T
MODNYHBF?.V E5Z\#<5;O]V@#,N_$^JZ/'+>ZI96PLY5@AT^*-R)KBY<D;6#<
M(.A[X&<DX($7_"9365S?W-^]I-HUC9>=<7EHC;4GW "%6+$2''H!@X!ZX%_Q
MCX9F\26FGFTN8H+S3[U+R SQ>9$[*""KKD<$,>G(J#Q#X8U/Q'X6GTZYU*WB
MNV>*6(Q0$0(T;AP"I)9@2,'GTP!W (;CQ'KMMJ'AVUEM+..?69R#:D,7MHE7
M>Y+9PS!1CH &8=>\2>-[BWMO&%_J$-LECH;B.%HR<R2",,R$G@G<RKP!R:K:
M':W&H_%/4+V^N8[F;2-/CM6,2E8TFF)=@BDDC"*G4DG<?8"*7X=:C<>'KS3)
MM6MG\_4VOL_9VPX:;S&\SYLL2OR\8 &>N<@ T+[5+V[N_"6E7^GZ?-+JB^?>
M6\T)<0>4@=F7)ZABJC(ZG-,/B;Q'?:OXCTW1+33KJ73GBC@DF+QIN*AG#D$Y
M(W* !C.&Y&,5I_\ ".7K>-X->?44:&'3Q9^68?G+;]SL#G W87/';C'6K/AC
M0#X?TZ>*69;B[NKN:[N9U3;O>1R>F3T&U?\ @- &)J/C:1X]4.D&V=[)WMH$
M=&EDO;E1RD<:L#M#84MSSG@!<G2B\07=_J,VFVL=O!-8P))J-Q-F2."1EW")
M0"NXXY)R !CKGBEX;\)ZKX<-W96^I6G]F2W,EQ&_V4_:5#L6*%MVTX).&(/T
M]*MQX&U1[?Q59P:Q#'9ZW)+<+^X/FI(\83:S;L%!M' &3TSC((!9^&JS77AR
M?7KI56YUN[EOF SPA.R, GML1<?6NOE$AB80E%DQ\I<$@'W Q5/1-.;2=$LM
M/:59/LT*Q HFQ0%&  .<  =R35^@#@XO']PGAC2[ZYM(C?7.I"RN8XL[(5%U
MY#OR<XZ8]V'8&KOB7Q)J6C:9XCO5BLY;>Q2(6@9&8RRN,&)QD<[F3!'9^Y!J
M&3X?HWAO4],COF2XO]1^V_:-F?*'VGSE51[<_B2>]:'B+PO+JNEZ98V5U'!'
M:7\5W+YZ&3S@A+8;!&27PQ]2* ,C6#J=MJOA3PSI$ECIZ3!KBZB@M3LC2$!B
M  XPC.57'?)YZ@Y.I^()X/%7C'7[);>1M#L$LXWGSY:;5,L@(')9F** "/NG
MGC!Z]?#MX/' UXWZM"+!+,1F+]YPY9CGH-QVYP/X<#%9,O@&=O!D^BI?PFZO
M-1^W7UP\)*SDS"1E*ALXP%7KT% %7Q7J,^H2>"])N;<"[OKA+^XM4/7R4#[.
M>WF%.3T"D]C5FT\>7-OH>KW^JVL,LMMJS:991661]JD^554;N^\L">GRDXK;
MA\.N/%[Z_<W0GD2P2RMU:/!C^8L[G'&6.WH!PM8=EX!N;;PMHVGS:C%-?:7J
M"ZBDOE$1R2;G+!AG/S;VYSP<''&* --M?U'3O%.B:/J2VDAU:*=E^SJP,#Q*
MK$$DG>I!(SA>0..>,32-;M['_A)_%UPCS?;=2%A8Q1\M.(CY,:)_O2>8?QS7
M11^')I-<N->O+E&U(VQM;157,5HAY. >68G!+<9   '?"3P#J,'A'P]ID&JV
M_P!MT:\BNT=X"89&4,""N[<<[V;.>OIV #5?[3U;QQX9T:_:T:.'?J]Q%;JP
M,1C&R-22?F&^0$'"_</'HU/$TMOH/BWQ0]KIJRZ?-+;0W"0$&Z6'@!CNR07+
M*.>.M:NF>%;ZQ\7:EKTVJ1S/>6T4('D8*E=V1U.$RV=HY^49/7.?:^ +D>"-
M.\-7NI130Q7<<]WMAPLZ+(9&7KG+/@DG\J )[#Q1K5QXDT#3I[2S6*_L9+FX
MV;O,CV!/G'. K.^ #DXYR.@SKOQ_J?\ PA=SXKLK6T^R"\^SV=E*K&:Y F\K
M.X'Y6+9(7:< >_&MJUJ_A_7]5\:W=SYEG!IR0K;119D"J69AN)P 2P)Z?=&2
M #GGX[;6/#$\6IW>GZ#J]K=7PE1K=FCN$>5\9C4@HY ;JNTL 2>230!OZCXF
MU2QU[3]$F2QMKR\LY)HG<.\4\ZG_ %*-E<''.2._2E\5:C<V<7A/S0JW]QJU
MM&RIT!*-YF/;;N'XU)JWAB\UN)+;4KNW>"'4EOX)U4B6!4?<J+VS@;=V1P3Q
MWI4TYO$/C"UUV88TW2XW33U/_+:5QAYO]T+\J^N6(XP2 =57,^-]2FT_1K>&
M"WM+J34+N*P%M=QETE\UMI! (X"[B>O KIJY[7_#]WK&N:#>PWL<$.FRRRO&
MT6\NS)L5EYP"H+8R".>AQB@"C<^(;VT\;#PSIMO9-!'IHN0"I3R?FV*"0<!0
M%8]/0=\UH>"M;O/$7A*RU:^BACFN-[ 0@A&0.P5@"21E0#U[U4E\)7#?\)7<
MQWR+J.MIY4,_EG%O&(MB+UYP2S=N36SH6F'1M"L=-,JR?984A!1-JX4   <\
M8'<F@"]--';P23S.L<4:EW=C@*H&237$ZCXPUA="L-7L+6U6/5+R&VL+>X5O
M,=9&PLK$,,97+;<<#J>H'3^(=).N^'-2TD3F WMM)!YH&=FY2,X[]>E<R?!N
MLW5]X:N[[5[4MH^_=%#;$1G,>Q64%C\PY.3D#C X.0#8&NW.I:S?Z?I$<133
ML)<W,JE@92NX1(H*Y(!!)) &0.><5[7Q%J5W>66C?8X8-9-FMUJ 9M\5F#P!
M\I^9F(. #T!.>!EFE>&]6T75-7-CJ-K_ &?J5X]Z?,@+30R. '"G=M(^48R.
M/0T[_A'-3L?%U]K6EW]KY>HP0Q7,5W"SE6B!"LI5AV8Y4XY[T ,E\3ZG:RV.
ME7&GQ#6[^YF2WC#?(L$9YG?!.!MP=N<DD#(YPQO%=S::AXDTZ\>U\S2+)+T7
M*1,$*,K$JR%B01L/\7(/;%7+KP[<_P#"26&OVURDMY;VDEG(MP,+(CLK;@5^
MZ05]#D'''6L^[\!?:]$U>TDU M?:U/')J-V8\;XU8?ND7/RKL!4<G&23F@"*
MR\7:PF@V7B'5[2RMM'^P&XNW0L93*=NQ(T/4$L5&2<D=@1FIXEEU;6;GPUH=
M]';0QZM>+<7%HH)>*&#$I5FSALD*IP!R<#/6NC\7>')/$/AO^S;.XCM)8Y89
MH6:/=&#&X8*R@C*_+BJ=OX5U'_A-H/$=WJ<,KI8FV>-(",$ON.S+':N HYR>
MO(SP 0ZIXQN8]%UO6]/CMSINDB10\P)-W(G#*A!&U0WR!N<G/&!DI>^*=7L=
M6\+Z8]M:27NIV[RW4"JP,;(@)VG/ WL!R#@ GG%9:_#K5SX/L_#DNMVKVMG>
M)-&!;,/.C$OF$2_/\Q/H,#N<G!'40>'9$\67&OW%VL\_V".RM@8\&( EG8]B
M68KTQPM &-I_CBZ71-1O=3MH)9XM7?3+&*SR!=."%4#<3_%N!/3"DXK7GU?4
M]'>>ZUJ.U328+%[F>ZAR!$X(_=@%B7XW'.%Z#UP,&#X?W]MX4T.PCU6$ZEI%
MZ+Z.5H#Y4C_-N#+G/S;V.<YR>/2MO7?#=WXG\*:EI&IWZ1O>Q! UO%A(B#N!
MP3EN0,\C('04 4[/Q1JE_J>E16]O;.MTQ>[MD!9[*'82K22 [0Y.T;-O<X)V
MYKL*Q]$L]8MH(EU2[LF,:[1'96YC1CZG<3^0QCWK8H YW4-?N=+\86.GW0MA
MIEY:7$PEP0\;Q;"=QSC;M8GIVJE8>*]0U?2);FTLX8;J/6#8?9[C.XQK( QX
M/#[,MZ#!]*T]8\.1:SKNC:A-*0FFM*_E#_EJ6"@ ^PQG'? [9IFA^&5T?4M5
MO6N&F-[>27,<9&%AWA0P'J3M&3^ [Y ,NUUEI]7\6:A-#I\::*GV:'4!;DO@
M1^;(K'=DJI*\ C)!KF-2O=5?X36,6MW8>_\ $US#&WEQE61)FWL@&3G$0*@#
M'8<GD[__  @NI'P1K>AOJT)N=4GEE><0D+^\E+-NYR25.WJ  !QUSLS>&'N]
M=T/4+NZCDBTF.8I"L6T-*X"AASP%7< .3SU)YH A\.:WJ-]XDUO2;JTM8;;3
M4MQ%Y!)*,ZEC&QZ$A0IX 'S=^M=17/\ AOP_<Z+=:S/<WB7#:C?R78"1[=JM
M@*"23DA54=AQ704 <='>ZKJ/Q/N;..]A72=)M(Y)8A"03-+G +;^2$4D'&!O
MZ'@URFA^)M0@L&U[3K>WF_X2#Q"(]T^[<\;/Y2(F/[L4>XL>!R,'G'6P^$]2
MAC\5;-5B6;6I)7BE$)S%NC5$W'/.P+P!CJ<]L.D\%F.7PK%8W4=O8Z$K_NC%
MN,C&/8K#G 8 N<D'ELT +J/C&--0U&TLYK>-=/ 2::5#*9)RNX0Q1J07;!!.
M#QD#!.<;VBW%]=Z)8W&IVJVM]+ CSP*<B-R.5_ USVE>%-4T37=8GL-0LQ8Z
MG=M>-YMJ6GB=@ RJVX CC(R./0UUR@JH!8L0,9/4T <U\0O$,WA;P'JVL6P'
MVB"(+"2,X=V"*?P+ _A5KPCH47A[PW:68)>X91+=3L<O/,PR[L>I)/KVP*M>
M(-#L_$F@WFCWZL;:[CV/M."O<$>X(!'TK-TK3_%-E91:?<ZII\\<2B,7OV=A
M,RC@$INV[L=\XSSCM0 V\U*+1];MM"TBV234]4DDO)-_W(4&-\KXY/.% XR>
MXZUG7?C6YT^#Q?'<BU:X\/PQS"98V$<H>,NJE=Q(;(Q][N#[5J3>')X?%,.O
M6$\;SC3_ .SY$NBQRH?>K[ASG.<COGJ,5G7'P_CGT6:PDOC++J&HQ7NJ7$D?
M-T%8,8P,_*ORJH'. ._6@"K:^,M=DU_1M,DT^S,E_IK73Q*65T<;0&).0J$E
MN,$X7/7Y:A;QUK/_  KE=?CMK*34)KXVEI"D;E+G,YB0J-P(R!NZ]O>M^7PO
M,^O:[K*WBB\OK%+*S;R_^/5 &)[\Y=MW;H*Y9=(N[/6?!WA*WGM[EM%MFU&<
M,I2,[%$,?3)&6=VR<\@GV !OR>*+_3/&":7JPLELI=-EOVDB#!K81D!MY)(9
M<'J O(Z57O\ Q9K2:9I&H6MI:HNL7T-M:6TZMYBQOD^8Y##G8I;8!QGJ<8J?
M5/!#:SINO?;+X?VIJUK]E^T)'\EO$,E8T7.=N22W.6)/3@!C>$M8O-=\/:K?
M:M:F32TE5HH;<K'EE"@H"QP<;N3GKP* &W?B[44\4ZYI-LEDT.F627#S2!AY
M3,"QWX/("J#@8)+#H 33(?%VLC0_"&J75I9HFLS00740#;HS*K%60YX&0O!S
MUJ2[\#W$WAWQ191:A&M_KUP\DET8CA(SA5CQG) C&WKW)HUJRBU_3M/T72]3
MMWO=/OX)I)(0&6V\EP2&4'Y>FT*3GUS@F@#H-/O+ZXU?5H)TM_L=N\:VTD1.
MXDH"ZOGC()'3C!'<&L?7=4A\&0Z9%"L5O;:A?F.YOKA"Z1.X9M[X(Y9@%SD
M9] !736MK'9VR01 [5SRQR6).22>Y)))/J:PM?T&_P!<MM6L)9[633M0MA;K
M%-&28#@YD'/S')! ^7&T<T :^EO?O8@ZFD*70>0,(<["H<A2,DGE0I_&KE06
M-JMC86UHCNZP1+$'<Y9@H R3Z\5/0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4SI")V6.X5BL9Y#G!^Z?7I7#2)X7UBXU+6;'6VUB\?1I8IF5XFB2'[R^8$4
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MWPPN+*1_%T5G- R_\)!<R*L3 C:RIAACL>>:?=W5O9_&VV:YGCA$OA]HXR[
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M( P:FAM+:VA,,%O%%$<Y1$"J<]>!4U% %>ST^RTZ)HK*TM[:-FW%8(P@)]<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIC31+*D32()'!*H6
MY8#J0/;(H ?13(IHYE+12)(H)4E6R,@X(_ T/+'&\:/(JM(VU QP6."<#U.
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M6D02R2,M<V\QDC\QMVZ+)4?,H )Q_>&<5O51TN"XM[0)/#:V^/N6]J/W<0]
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M1_LN2?0#CG PK/XBZA?:-HFI0Z/!Y6I:DEEC[2> SL 4^7YB%4N<X '')S@
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MR'";L#.![\#$@^(6JOX1TKQ+/HL$5E>74<+1&X;S"DDFQ70;>>H/.,\]!@D
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M++M.5!W97C'7-30>)M0FUS3;#^SH@UW&\LT E)ELT"Y1I2!@%CA=OJ3@M@T
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MHMB^F:+9V,ACS;PK$!$,*H48 &>3@ #/?KQTI=6UFPT*R-YJ4_D6X8*9-C,
M2< < ]20/J:O4 9VI1ZD]S:FS6UDM0'%S#.Q7S 1A0"%/OG-<>W@/4;+PQI5
MAID]H)=/UG^TX[:9W\A4WNPA# $X7>,''5<X';T&J,.L6$^KS:5'/F^@C$LD
M11@50G .2,8)S^1]* .>T[PYK4'C74M?N[RTE^T6<=O  &_=;=Q* =E+%3G)
M)V]!GC*C\#ZY!X'T/3$NK!]1TS4(KYU8N(9V5F9@S8W9+,6SMX( QQFNVU36
M;#1HHI=0G\E)9%B1MC-EV.%7@'DDX%6Q-$TS0K*AE0!F0,-R@]"1[X/Y4 <E
M9>'-<B\;7OB&ZN[.7S;!+:%!N_=D%F9 ,<*6*'=DD[>@SQH^%M&B\)^%K/3[
MFXB,X^:XG)P)9W;+')ZY8G'?I6_5:^TZRU.!8+^T@NHE<2!)XPZAAT.#W% '
M-:!H<C>(];U=YE?3+R\2YM(@/OL(40R'U&5.WL?O?W3774=*C::-)HXF<!Y,
M[ >^.O\ G_"@#EX?#^JZ5JOB&ZTR:S_XF\J3+/.S;K=A&$/R@8<#&0-R]<>]
M9%OX;M8;[PEX?TV0W.G::SZM=7!8,99,$1L2.I9W=O\ @!]*]"(# @@$'@@U
M5MK/3]'LV6V@M[.VC7)"*$50!W[  #\ * +=<WKMCKD^J1FR^S7&G3B))H)9
M#&8BCM(6R V0XPA&,].V:Z-65U#*P92,@@Y!%+0!@Z9HMUI-AJTL#V[:KJ$\
MEVQ((B64J%4>NT!5!/4\GC.*T-)TR+2=*AL8V:38"9)'^]*[$EW;W9B2?K5Z
MB@#B8/ \I\.:9X8N9(3HME,'D"DE[I$<O&C#&%&=I;DYVX[\:<NA7UIKNLZI
MI4EN)M4MX8V><G]R\890P !W###C(Y7KSQT=% '+:=IMUX8;0- T6&.734$I
MOYI@QD^Z2'##C<TAY!]>!@'"R^'+^WO/$$NEW$,+:T49IW)WV[",1DJH&&X4
M$9(Y/I7444 <L/!UOIS>&VTE(U70EDCBBE8@.DB;6)8 _-G!SCGGUJ"?P,FH
M:+XCAOKA3J.OJ1<3H,K$ NV)%!ZJ@QZ9.3QG ["J6K:O8Z'I\E_J4_D6L?WY
M2I8+]< T 91T"?4=?T[5-4\A4TR-OLMM"Q=?-88:1B0.@X48XR3GICHJ16#*
M&&<$9&1BEH YK0M.-EXQ\57+C]Y>RVTRGUC$(0?^/))72TWRT\SS-J[\;=V.
M<>E.H Y3Q9H>KZWJ.B/:+8M9:=>+>R13S.C3.H(0<(V "<]\X'2FVWA>_O?&
M=OXFUNYM_-LH'@L;2U#%(M_WG9VP68CCH *ZVB@#S(> O$C>![3PU->Z<8+:
M]61]K./M<0F\QO,.WY2?0 @GG/:MOQ%X8U;Q+IEYI=])9-%)<136EVK,LMJ5
M"995V_>W!R/F_CP??LJ* .,U/PMJ!\=GQ#9PZ7>PSVB6TL%_N#1%&+*\9"M_
M>.1Q]:ZZW29(%6XE627^)E3:,^PR<#\33O.B\_R/-3SMN_R]PW;<XSCKC/>H
M;^_MM,L9KV\D\JVA4O))M)"J.23CL* ,OQ?X9A\6^'9]+DG:WD+++!<(,F*5
M3E6QWY[>A--LCXKDMTM]0CTJ%P-KWEM.[EO=8F0 $^[$#WZ5LVEU#?6<%W;/
MO@GC62-L$;E89!P>>AJ:@#ETT#4=-\4:QK&G-:SG4[>",_:I&4PO$&4'A3N4
MALD9'(Z\\9Z?#\16>CV/VI9X8=4.JZG+*,/=SX8@X'&-Y4X]% YKN*HV>LV%
M_J%Y86T^^ZLMHN(]C Q[@2N<CN 30!RE_P"#-2N+'QG+#=6RZKKW[F&5BP6*
M ($52<9!QO)P.IJJMO>R^/M*T^TAM;A/#FF;W5I&B1)9LH@!"L>(XV R.C9K
MT.J-MHVFV5]/?6UC!#=W&/.F1 'DQTW'O^- '):QX GU?P[KD<M[%_;6K213
M23E"8E\I@T<0'7RQMP>Y+$]\5KPZ=KG]@7ENL6DZ;=R6[I%'9;C&)2N!(6*J
M<9[!?Q-=)6?=ZYIEC<_9I[R,7&W<84R\@7U*KD@>^,4 <R?!$]K;^#[#3I;:
M/3]$<R3*X.9)/+*JZ@#!.YG;DCD]^E3W/AK4]6U'1+S4FLTNM+OGN5N[=V+M
M&=W[H J, @J#R?N].>.DT_5+#5H7FT^\@NHXW\MWA<.%; )4D=\$<>]6Z //
MKGP?XE_L[Q=I]GJ%C%'K%Q-<07&7$H,B*NQN,*!MQD9..PZB]+X4U/[5X3\F
M:S2VT:.17C^;"L8Q&A08^;:NX<XY.?:NSHH Y&/PK?S:_P"*+N\NH%M=7@2V
MA,63*D:Q%<'(P,,SMQG.1TQS67P;?7WAG1_#6IR6L>E6"PK<+;LS->"+&U2"
MHV*2H9A\Q[9[UV]% '(2>%;_ .T>+=2BN+<:IJT/V>RD.<6\:Q;4!.,CYRS'
M&>W6MOPYI;Z+X<T_3',9-K D/[H': H XSR>G4]>O'2M2B@""\NX;"TDN9V(
MC09.!DD]@ .22> !R2:XZRT[6=%T/7]?CMXY/$NK/YZ6T@+JFT;88#M/.U>"
M<@9).<<UVKQ1R,C.BLR'*$C)4XQD>G!-06.I66IQS/8W45PD,S02&-L[9%.&
M4^XH GA,AA0S!1+M&\+T![X]J?110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF:@]DL!E;RYB"F,'&<LKC QU(JU>^*9!'K5S81PM9:*CFZGE)Q)(B[FB3'3
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M]I<^H63FYU1KUOD<+*&F#MYAZD[!L ' ]3P0 :FHZI/J$WA/2]1TBRF?5O\
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M;9VVJ6L=KK4LMQ%(4;S5=XPFQCT"#:.F3CB@"W\-A+>Z#=^(+E MQK=[)>$
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MS\3N,-)_NJORJ>Y+$< $@'65S7CC4FT_0XH5LK:].H7,5@+:XSMD\UMI&!U
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M0#/;Q 0Y&0'9@BDCT!8'\*F\(:"F@>'K>!V,M[,HFO;ESEYYF&69CU// ]
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MH **** "BBB@ HHHH **** "BBB@ K"UUO$LLRVWA_\ L^#;'ODN;Y'=222
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MM%'<KY91+O;'@,75E4[-P&<'DCN:[_P7IFDZ9;ZFNC:C-?6\]Z\\CLR-&LK
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MTS3K7PCHMW:V=O'//IMN))XXP'D&P'YFZGDD\^M;,.CZ7;V;6<.FV<=JQW-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUB\82RNLK+=(RJQDC.0,#<1@ \KR1F@#L*CGN(;:(RSRI%&" 7=L $G Y^I
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MZ8Z]\U0_X2CPW'HLFM_VC9KIT3M&UUT7<#@@'N<^E;8D0QB3<-F-VX\#'K0
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ML[7'53[BI: /.)O ^NS>!?$F@E].6XU:^FN8Y!.Y6-9'#D'Y,Y&,>_M5Z_\
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M'8LR*!\IP2<,3QUP>E2P^&-?T;7=>?2)-/FTO6I#<.EU(Z26T[+M9E"J0ZG
M."5^M=S10!@>"M&O?#W@_3=(OY()+BTA$1:#.T@?7G]!6_110 4444 %%%%
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M%9'W?>X8'< .G2J,'C36;I=%U&TTN2ZT_498Q+;QV$ZR6T4@RLIE/R.!QN
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M<AA\N4Y'4^HYSH>'K/Q:KH?$NH:;*L"[8Q81NIF;&-\A8XZ?P@8R<]A2^,-
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M6'G&YN@766X_YX(BN&SP3GGJ,"LL>.]4NM-\&WEGI]IMU]@DBRRMF-O+9L#
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M]Y@GEI#IR.L78EF+G)8X&.@'/7-.U73]1O\ 6]*D06ITVTE,TL<CL'=]I52
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%]VT$ @D_)DCC@CUH U:*YCP+XDF\1>$=,U+4GMH[Z[\W,<7R@[9&7Y023T
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MH H:A>7\?QAT[38KZY%C+I<MT]KYAV-*KX!]0.>G3BN7ME@U;X$:CJ5X,:[
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MP,EV\TE3\RCU/09ZV?P]XB,\U[;1^%X-3:$PI>+8OYBC' W%CP/3I[5QMO\
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M-QI3ZS M^3]W9SLW_P"QOVYSQP*26T:'XR0-8H!#<Z0YU)%'RMAP(F8=-W+
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M!;B73PV^TO Q P%_A8YP,?08K?D:U_X7+8W%Y%# TOAXMB7 (D\].,GJPZ4
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M.>XN;>.:[>*3S(PX&U<<D*VT9..<$$]16GK-O>S:AIE[X3O--EO[2RD#:;<
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M6RZ/IZP3MNEB%L@60^K#&"?K2RZ!HT\=O'-I%A)';_ZA7MD(B_W01Q^%:-%
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MDEI8H%5B3U.0,\]_6K]% !6?-H6D7.J1ZG/I=E+?Q8\NZ>!3*N.F&(R*T**
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MU:QCO=/N8KFUDSLFB;<K8)!P>_(-6: "BJ<NK:?!J<&F27L"WUP"T5L7'F.
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ME\>3Z]?Q6$-M<Z4EFT4,[.\3"1VX)4!^O)^7KT.,GLZ* /-+?P/XC7X?Z5I
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MV@J-JDG<<\\8YZUDWWA+Q(MCXSTBRCT][/7))KF&YEG8.C21A3&4"^J_>W<
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M4[/*RQ1L[ X!VDD*J@=!D\\9KM].U2PU>!Y].O(;N%)#&9(7#+N'49''%6Z
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MJG:2Q.TY) Z]..;[:)JDGQ$M/$++9K:1Z:]DZ"9C)N9U<L!LP0-N.HZYXZ4
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MDGTQX=:MA'#/.[F6W'E[?* "XV;LG(/&2=I- %G6YUNOB-X N44@2PWSC/4
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M==@2R^P6UA)9E&F82'>RMD#81QM QF@#H[6SMK"U6VLK>&W@3.R*) JKDY.
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M3*?,M;A2KQL"01R <<9!QR"*UZJZ=#=06,:7TZSW1RTKHNU=Q.<*.RC.!GG
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M4 %(RAE*L 01@@]Z6B@#$L_!WAK3[[[=9Z#IT%R&W"2.W4%3ZCC@_2MNBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#+U;PWHFO-&VK:59WCQ?<>:(,R^P/45<LK"TTVT2UL;6&VMT^[%"@11^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex1011-amendmenttoemploy002.jpg
<TEXT>
begin 644 ex1011-amendmenttoemploy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M")&QD>09RFS&X,,'((X ).!S0!MT5S;>.]!CT^YO99YHX[2Y%I=*T#[X)20
MKJ!D9+#!Z'/6M"7Q!80ZVVCNTWVX6S78B6%SOC4@$J0,$Y(&!S0!J45ROACQ
MM:Z[X;EUFYAFLH4EE7][$P&T2LB 'HS' !"YY.*T;+Q/IMYJ5SII>6VO;>$7
M#P749B;RB<>8,\%<\$CH>N* -FBO./%7B2.\U/P<^FW&HQ176L1*'"O'#<PE
M6)]F&0I&>HY&1S7?:CJ%II.G7&H7TZP6MNADED;HJB@"S16+:^*=.NKV>R(N
MH;N&V%V8);=P[0DX#J #N&>,#D'J*SK7XB^'+Q-.E@N+AK?4)1!!<&UD$7F%
MBJHSE<*Q(X!YZ9QF@#JZ*Q=6URP@:ZL&:[DFC@\R?['&S- ASAB5Z$X. /F.
M"0*R_A?=W-]\-=#NKNXEN+B6$M)+*Y9F.]N23R: .NHKE_%/B"SATG6;6*6\
M,]K:LTTMFCDVQ*DJ2R]#T.!R!R1@U#X3UM(/ 7AI[R2XNKVZT^)U109992$4
MLWZC)/&2.<D4 ==17G?C?Q%!JOP^DU71-0N8F@OX('\MGA='\]$>.1>"#@D$
M'UKH[F]TS_A.+&T>\OEU-;25H[5=X@DCRN6/&UF' '.1F@#H:*Q=.\5:7JEK
MJ5Q:O.4TV1HKK? Z%'499<, 20/2GR^([*.""1([N:2:'[0D$5NQE\O^\5QE
M?QP3T'- &O17,OX_\-K::9=+>O)#J99;5H[>1M[#.5X7AN"-OWL\8JQ#XOTV
MYL(+JVCO9C-&TJVZ6K^<J*Q4ED(RO((&>N.,T ;U%8L7BS1KG2;'4K6Z^TP7
M[;+184+/,W.5"XSD8.<XQ@YQBN>\$ZE+?^-O&<?VB]>W@FM5BANV;,),1+J%
M;H-V>G![<8H [NBLW4=<L],N[:SD\V6\N@[0V\*%W=5 +''8#(Y/J!5>W\5:
M3>:59:C:3//%>R&&W1(SYDDB[MR[3@@C8V<XQM- &U5?[%$=0^VMN>8(8TW'
MB-3@D >Y R>O J/3=3M]4MWFMQ*H21HG66,HRLIP1@\_X]JK7_B&RL+F6V*W
M%Q/!$)IHK:%I6B0YP6QTS@X'4X. : -6BN(\:^,8[7P!_:^B7#S+>&)+>ZMX
MV=55Y$1CD#Y6PQQGG(QU%;>AZ9#937>HVUWJAM[L*?LEX\C")ER"55_G!;N.
M^,]Z -RBO--6\82>(OA_XON+5-0TZ;3_ +2D,BJ\3 Q #EQQNW9^7.<5T>@>
M+M,NI-,T@RW'VV>S62)Y8'5+C:HW[)",.1G)P30!9\3>'9O$+Z48[Y+4:??1
MWR@P>9O=,X!^88'S'WK>&<#/)[XK"O?&.CZ?(OVF69;8W'V4W?DL8%ESMVE\
M8'S<9Z \$YK:FB6>%HF9U5A@E'*,/H1R* )**\J\!ZE::G\.K75->\2WHOF\
MX2O_ &BR/Q(RKA <9P!@8YK;\7:U=:#9^&M*:6\FEN[VWMKNYAB?=(@5B^&4
M?>8IT!S@F@#NJ*\PO+I=&\4Z/H*7.O3Z9J+7-Y+%*)FD0")-L2,!OV@L21DX
M. ?2NBAUK2O!VE26MWJ.I7MM92;)[V=&G^S[CE5D<#L&4=R!C- '6T5D:AXE
MT[3RZEI;AXX/M,BVL9E*1<X<XZ X..YP< X-8]WX^LEUCP]:6,4]W;:O').M
MS# [J8U0G"@#);)7/' SF@#KZ*YBUU?2(_$/B*6*[U*:ZLXH#>VS)*R0C#;3
M&F.20"3MSGBKMOXJTNZT"VURW>:6PN71(76!RSEFVK\N,\L0.E &U16'JOBW
M2M'6XDNFG,%J56ZFB@9TMR0"-Y XX()ZX!!. :V5:.X@#(X>*1<JZ-U!'4$?
MS% #Z*\X\%6UWKDWBD7FM:MFRUNXL[8I=L/+B4*5&#P<9/)S5CP_XJO-+\1Z
M]X:\37R3_P!EVXOX=19 ADM3U,@48W*2!D#GT]0#OZ*P[/Q9IE[>"S07,=PU
MK]MBBDMV5I8>FY!CGJ..O(XJAX9\;VNN>'IM7N89[.&.>1 )(6&0)6C0 X.Y
MS@#:N3DXH ZNBLC3O$>GZEJEQI:&:#4+>-97MKB(QN8R<!QG[RYXR.AX.*UZ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .4LO"NL:7)+#8^*;A-/DFDF\F:TCDE0NQ9MLA]R
M?O!JZ2RLXK"TCMH =B \L<EB3DDGN222?<U/10 4444 %%%% !1110 4444
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M'/<^7*C.VPC=]U<#/)P>,8S)!J/]J?%?2]3MK'4?L#:/-"MQ)9R(NXRHPSN
M*_=/+  ]LUZ%10!XY:6&K/\ "IM-MM*O7U'2-5-W-:20O'YZK=-)L1B!NRO(
MVY[=\5I7EO9^,?#NL-X=T"]M=1DTR6W^U7\#PN"W_+!2_7/.<?*/7FO4:* /
M)]0UHZQI7@A(=)U6.YL-7M6O8#I\H-OLC=6_AP0/;/%=QXVN+RU\%ZI/I^FI
MJ-RL/R6KQ>:'R0#E/XL#)QWQBN@HH \QTJXV?$ZWU18-:GLI]":+[9=6D@W2
M"8,?E*C8,#IA0>P.1G%MH+J/X,^&[)M/OQ=P:G"\L'V.3S$5;DN25VY V\YK
MVBB@#SO2+Z;P[XX\30:I9WSQ:M-'=V%U#:R2K*OEA?+)4':RXZ'%:/PHCF@^
M&>BV]Q;7%O/#$4>.>)HV!W$]& R,$<UV=% 'EMC=7&@/XVT75+&_:XO[NYO;
M*:*UDE2XCD0!5#*" 5V@$'&*R[076C6'@O6+_1=3N--AT;^S;V**"036LGR$
M.4&&*DKC/_UJ]FHH \M\46UM-\.;UM&T"[M5O=1MYTB6U?SI\2QL\KH 6'"G
M[W. #WK:U%FE^+/A^YCM[EK==.N$>86[[%9RA4%L8!(!ZUW%% 'G^I:'J%O\
M09HK.!FT?Q% IU!A]V)X2 V?^ND9V?7GM5?Q)(=!^(;ZIJ>EW][HU_8Q6ZSV
M<;R&VEC9SM94YVL'Z^M>D44 >8ZE;06UYX+:PT*YL;./5)+EH([5R8HVC=0\
M@4'822#@\C//0U-XBE.@_$.;4]4TN_O='U&RAA2XLXWD-O+&SG:RISA@^<^O
MXUZ110!Y;=P'P_KWA;7[;0;FTT&%;J*6V@@9I+7S<%97C7)&[;SW&>>>*U_"
M$[7'Q!\8W0M+V*VNS9O!+-:R1K(%A ;!8#G..#SS7=T4 <9XGOY[?QAI%O+9
M7:Z=+;R[KVRM6EE\S*XAWJ"T:L!DD8R0.1@UR&B:;;W'@:QTK5[/6].F@U:Y
M:*]ACD26SD+RLK[@#E<':6Y7YNOI[%10!R_@6367T:Y36I1<R17<D=O>&#RF
MNX0!MD9>Q/(SW !YZG*TV2;PW\0?$SZI%<?8]5,%S9W20O(IV1[&B.T'## P
M.XZ5WM% 'CU_HM]I7P?EL7LKMKF\U5;R*SA@:1XHS=+)M(4'&$&3Z$D5Z]%*
MLT2R)G:PR,J0?R-/HH \C9+J'P+\0='?3=0^V37M_)$JVDA$JRG]WL(&&W9[
M9QCG'%:UT9)/$OPZF2UNS';0SB=_LTF(=UN$ <[?ERW'->C44 >0:%%;6VGS
M>$?$'A:_O=4BGD6(M [VMVID+)(7^XHY&2>F/7BO6YYDMH'FDW;$&3M4L?P
MR34E% 'D_P .UTNS^&EIINO:/>I=+YWG1R:5.S@&5V4@B,\X((Q6MXMO)]1'
M@JZ_LZ]1AK$5W)$ML[M!#LD ,F =I^9<@]"3Z5Z%10!PVOREOB?X3N$M[I[>
M"WO!-,EM(R1ET39N8# SM-8%N;?2M9U[0_$?AS4[\WNH37-G)! \L-U%*VX(
M2#M4KG!W8 %>L44 >9V][/X+\;ZH=1T>\?3-6MK7[*]A;/<)"\4?EM"0H)'J
M.*M:SY]KXJ\$:F='N8;2!;R-X;6W,GD&1%$:L$!"DXP>P.><<UZ%10!Q/A\2
M#XI>+97M[E(9X+-8I7@=4D**X<*Q&#C<.AJKX6T/4-,\27VAR0,NA:==-J%A
M(>A\X';&/9&,Q^I2O0** /*(FM](U[Q!HWB/P[J=^M_?2W-G+;P/-%<QR8/E
MG!V@KR#NP,=>*]-LHUL]+MXO(2W6&%5\F/E8P%'RCU Q@5:HH \T\!ZFFD3>
M+3>V6J1?:=>N;J ?V;<,98F"A67"'.<&J[:9KDEWXM\<2Z)ON;C3_L>FZ5<(
M'=X5Y)D09Y8C.SKCBO4Z* /+=)E>7XA^'M2CMM9G@ETJ:![FYM)(U$A:,XVD
M 1@ 'H #C@L:S;>QU8_#5K"WTF^DO]'UEKR>T>%X_M"+<L^U&(&\E3D;<]/4
MC/LE% '$>']0T6]N9]<T[P[J$#V]FZS7-U:NDV 0WDH&Y?H2<<9 [FNMTR_3
M5-,MK^.&>%+B-9%CGCV2*",X9>QJU10 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME#AB#CU[5RVNZ7%X:L?#>@7&OZG96=G'(R:H]JDL.0H18G785!VEB"WH>I/
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MQ2^2N]BC[U![8S[<C'XZK>&/-\7'Q!/>>8[6'V![;R1Y;1EMQ[YSG\,<8[T
M<]IU_P"+]3M_#VLV/G/#=F*6^@G-N+?R)%R3%M/F;ER,9//>LJ?6/%,GASQK
MJ*>(GBDT+4+A;<):Q8D2.-'"/E3\O)Z8.2>3P*Z/0O +:#,EO#XAU&;1(9/-
MM]+DV%(R#N +XWE0>0N0.!G/>0>!C_8_B+33JDABUV>6>X;R1F,R*%8)STP!
MC.: ,BY>[U+XE^%IQJ5W;I<Z1-<>3'L*(?W>0 RGKGDGGC@BO1JY>3P=OOM#
MO4U6YAN=*MVM=\2(//B8*"&!!P?E'(]^G:SH%EJEKJ^M27>HW-W8SSA[5;E
MIA.6W*F.=@&P#/7!/0Y(!@?$K_D(^"/^QBM__07I[SZ_J7Q UO0XM>DL[.&Q
M@GA,5M&7C9RX(!8$'[HSD'VQUK9\2^%CXCNM*F;4'MAIEVEY"J1!MTBYQN)[
M8)X&/K3K?PW-;^*+[7EU'-Q>6R6[1F ;%"9*D<YSECU- '+:!XRU36=%\%VD
M]PL-_K0N?M%U&BYVV^=VU2"H9CM[8 W8'3'9:':ZS9R7\6JZA'>P^?NLY-H$
MJQ$?=DP "0<X('3K7.#X9VR>&-+TF+5KN&ZTF=I[#4(U42Q,Q)8$=&!W$$8&
M1BMD>&[T:#=VA\0WQU.Z"[]4V()%P> J@!57J, ?Q$YR<T =#1344JBJ6+$#
M!8]3[TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBFNZQHSNP55&22< "@!U%,BECGB66)U>-QE64Y!'K3Z
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 0FL3PMJL^LZ;-=S[?^/J6- !C"JV!6EJ,K0:;=3)]Y(6
M8?4 USOPW@\KP/8.2=TV^4_5F- '65@:AXB-MXITW0[>$2RW(>29B<>5&HZ_
MB>*VYI4@B>61@J("S$]@*X/PBLFK>-M7UJ;D+&D<6?X _P P'UV!#^- 'H%%
M%% !1110 4444 %8'C:8P^#=4(."T)3_ +ZX_K6_7)_$>39X(ON<%BB@_P#
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M^'=,EUFYB.V9XW"01'T,AXS[#-)'XHUNPN(5U_PZUM:RN$^U6DXG6,DX&\
M@9[]*U?"\6DP^&[%=$,9L/*'ELG\7');_:SUSSFMB@ HK \1^(7TF?3+"RC2
M?4M0N5CBB8G 0',CG'8+G\2*WZ "BBB@ HK&\2^(K?PWIHN9(GN+B5Q%;6T7
MWYI#T4?XUSR^(/'L"">Y\'6\L1Y,<%\OF(/H>"?I0!W5%<A8_$?1)K@6NIBY
MT:\Z>3J,1CS]&Z8_&NLBECGC62&1)(V&0R'(/XT /HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_%'B
M"/POH%SK$]K-<V]LNZ582NX+D#(#$ ]?6MBN-^*__)+?$/\ U[?^S"@"S>>-
MXM)LK74-7TJ^LM.N"B_:R8Y(XB^-OF;6+*#D#."*ZFO)/B!::W_PK:VN+^[L
M[S1+=+>6_LK>!K>6>(%2%$C.XZX)&!G'45N:WJ+Z=K/AGQ7%=WBZ#>;+>[MV
MF81Q>:H\F4IG P2%;M\P/6@#OZ*Y2QTZ7Q%H>J3G5-2M(]5F+VTMO<L'@A4@
M(8\Y"[]I?@='QV%=2B[$5=Q;  RW4_6@#'\77@L/"6JW)S\EL^,>N,"IO#EK
M]C\-Z;;X ,=L@./7:*ROB$3_ ,(?<QYXDDBC/XR+6MJ>J0:+I/GRY) "11KU
MD<\*H]R: (-7O#-(-,M\>8^&N&/W8H<_-GW(! _/M6#X+US13!>2'4;1+J]O
MII?*:50P7.U1C/\ = JIJ=G,T3:?=W#+<7%K+J%^4;!< 86('^Z,X^@]ZU/#
MGA71[CP3IEO=Z7;,7M$W[HQNR1D_-USSUH ZPS1AU3>NYN0,\FGUX]!;:[HG
MC"UGU"TO;G2=(>2&.Z52S&)N5)QRP ./PKNSX\T A1#<R7,C?=B@A=W/X 4
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MO]O:W_T)^H_^!5K_ /':7^WM;_Z$_4?_  *M?_CM=#10!SW]O:W_ -"?J/\
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M_B-[WQ?JN@/8F'[!##,)S*&\T2%L?*!Q]WUK>H YT:[K0&!X/U  ?]/5K_\
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M%+8&<9/2J_AW5O[>\.:;J_D^1]MMDG\K=NV;E!QG SU]* ,]M;UEP _@V_8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex1011-amendmenttoemploy003.jpg
<TEXT>
begin 644 ex1011-amendmenttoemploy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKGO'9=/ FNSQ33PS06$TT4D$K1LCJC$$%2#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex1013-amendmenttoemploy001.jpg
<TEXT>
begin 644 ex1013-amendmenttoemploy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM=M-0@GM;G[1/((9HF5V4Q( 0",G)!''>IO@;X<T\^$&_M?1(1JD%Z[H;RT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH R_$&EW>L:2]G9:K<:7.S*1=6X!=0#R.?6N0_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
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MD5J4 %%%'09- !16;I>O:9K4UY%IUVEPUE((IR@.%?&<9Z'CTK2H **0,"2
M02.H]*6@ HK+N/$%A;>(+/0Y6E%]>1O)"OE-L*H,M\V,<9' .>:U* "BBB@
MHHILDB0Q/+*ZI&BEF9C@*!U)- #J*Q-/\5:;J6J1Z?$MRDTUM]KMVE@94GBR
M!N1OQ'!P>1Q5O6=;T_P_ILFH:G,\-I%S)*L3R!!TR=H.!SUH T**@LKR'4+.
M*ZMRYAE4,A>-D)!Z'# ']*GH **** "BBB@ HHHH **QM>\4Z1X:2,ZG<.C2
M@E(XH7E<@=3M0$X&1D].:FLO$6D:CH(URUU""33/+,AN=V%51USGIC!R#TH
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M;;/(E2.)7"$%C@')YY.3U&,'TZN.C\$W2:5XGL3JT1&ORRRN_P!D(\DR($8
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M5_%LEWJ<MR(M9DAVNBC.(HL'@<8'&!Q^-;OC#Q WAOP^UY#&DEU+-';6ZO\
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MA]0AU R*6%W#C9*,G##' XQQ6E0 4444 %%%% !1110 4444 %%%% !1110
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M7<WEM(L4N26D5/E+*%;'8G&>]6E^&-M%X8TC2X-9OX;W1W:2QU% @DB+?>7
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MR0%  &>G'2N1+:/XY\7:9=VD,\G]@S3&:>2!XE$G"K%\P&[Y@'XSCRQZUW5
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MUX& #&M3XM?5=*N(I;F33IXV%_\ :3; )E<K)#LR1@]FR",=3S7/>'8?$/\
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M5)(Y?)7S/ED\P GIC=[=* (6UO5?#WC74++4-2DU*Q&B2:J$:%$,3QOM*IM
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M3?+IC%FN ,9*D8V[3M"]@!U[@#SXEUQ-/\?11WTZ/HL*7%E-=01^:H: R;6
M&",CC(S@\\U8M=5U^SUKP9)<ZPUU;ZY"R7%L8(U1&$'F*R$#=G(YR2#G@#I5
M"3389)/$+L_BISKMNL%UOTK/1"A8848.TD =!Z'C%MT227PY(8=?W:$/W.-(
M?][\GE_/_P !],<\^U %BU\0ZII%]XITC5]0FNKZW5;C2V,<2&6&3Y(PH50"
MPE.PD@C)'%=A9:8Z)93:A<O>7UO#L,S *"Y'S,%4  GITX''<YX*?7=%\5>+
M-(UBVT?6ITTCSU>9=/D'[P[0L9&.<'+>Q4>M>C6-V+ZSCN5AGA#Y_=W$9C<8
M)'*GD=* .>\7Z5!%\.]?MXMRD6<]P)"V6\T N')]=P!]L#&,5I^%M2EUCPEH
M^I3_ .NN[*&:3_>9 3^IJMXPAN-2\/W>B66?M>I1&V#8XBC?Y7D;T 4G'J<#
MO59=%OK'Q%H:Z9?W4>DV5I]GGLB@\DQA&"MNZE]VSIT"GIGD T/%-S>6?AN\
MGL;VTLKA57;<W9Q'&"P#'H><9P,')Q7+6&NZL_B/Q#I27UV8(=,CO+26\MT6
M6-B7!^7:/E.T'##(Y[5U'BCP]%XGT.339;F:V)D26.>'&Z-T8,IP>#R!P:RT
M\%3+K5SJ[Z]>2W=U8BSF+Q1[6P6PV !C&XX [X)SSD YBPU_Q)'H/@?7KG6F
MG_M:[M[2ZM/L\:QLLJM\^0-P8$ \$#V]=634K[Q5IWB^6WU&6RM]-FGT^"*)
M$.YHXP7=]RDG)8C (X'J<B\/ 6W0- TA=5D$.B7,5S;OY*[G:/.T/SC')SC&
M:63P*8M4U:YTW6KFPM]7!:]M4B1T:0K@NA894GOUS^6 "U\._P#DF_AO_L'0
M?^@"NFK+\.Z*OAWP_9:1'=37,=I$L223!0VT# 'R@#^ON:U* "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI)& P9'QN/N< #]*X/PU<:QK'B;Q797/B&_2#3;U(K<1I ,(4W8),9S7?D@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHH **** "BBB@ HHJCJ>JVVDV2W=PLSQ-(D8\B)I#EF"CA<\9/6@"]1110
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MBBL*X\7Z3;:A#:/),1-=?8EG6%FB$_\ SS+@8!SQZ9XSD&@#=HJ.>9+>!YI
MY1!D[$+G\ H)/X5SUOX_\-W6G#48;V=K#G_2_L4XA&#@Y<IM&"#WH Z6BJ$^
MLV,6AR:Q'-]ILDA,PDM1YN]0,_+MSN_"K<$RW%O',@8+(H<!E*G!&>0>0?:@
M"2BBB@ HI"0HR2 .G-+0 4444 %%%% !116%<^+])M+^*UDDF(DNQ9>>D+-$
MLYZ1E@, Y./3/&<T ;M%,FE6"%I7#E5&2$0N?P !)_"N;@^(7A>XLHKU=29;
M*5_+2[EM98X2V<8\QE"]>.M '3T4 @@$'(/0BB@ HK*N_$6G6.N6FCSM,+VZ
MCDEB18'(94&6PP&"1QP,GD<4[1_$.E:]]J&FW8F>TE\FXC9&1XG]&5@"/R['
MTH TZ*H0ZS93ZM-I<;3&[@17D0V\@"J<@'<5VX.UL<\X-7Z "BD!!) (..#[
M4M !167KGB+2_#=HMWJUP]O;LP02"%W 8] =H.,^]:,4BS1+(H8*PR Z%3^(
M."* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7#?%2SF7
MPU!X@LT+7N@74>H1@=613B1?H5))^E=S45S;Q7=K+;3H'AF0QNAZ,I&"/RH
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M(A9DK.D3 ;3ELJ",],G/>NNN_#%[=^(- U9M3@5](CE3RQ:'$OF*%8Y\SY>
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M=)*\GWY&Y7+'UZ>U+)X2O9-7\-7YU6 -HD,D03[(<3;T",2?,^7A1CKSZ]*
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M>2&-'BA+JA"ELN1]T<=35VN.UG4M7T;Q!X3L(]0$UM?W4D-R985\QP(V<<@
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MF.UB\N(L-[L ,D<*,GN:YD>(M4\/^+M7L=8OUO[&#16U=66W6)HMCE608ZC
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MVO:&^KKY>L7<MU+*+7!C,ARP4;^G QGI[UV]% $-M%+#9Q122*\J(%+A-H)
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M.\MM=.;F#R"FT>7Y>%.X\;<5U-% '(>'/!NI:&8+6Z\47>HZ5:8^R6<L"(4
M^Z'D'+A>PXY ]!4&E^ ;C1[J>VLO$-S%X>FF:8Z5Y"':6.6193\P0GL!G&>>
M2:[:B@#GK?PS+9^+=3UVUU-T744B\ZU:$,I>-"BMNSG&#R!C)'7M3_"GAO\
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M)W;L@DD_A^=8H^'%_P#V%9:&WBB9M.L+J*>S!M$,J+&VY49\X8#@ X'X]*]
MHH 1054 L6(&"3U-+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<7XTU
MG5= UOP[<Q7ICT>\OEL[U?*0E"X^1@Q' R,'/MTKM*Y_QOH'_"3>#-4TI1^^
MEA+0'TE7YD.?]X"@#'DU[4;'XNV_A^[U)6TZ^L'N;6+RT#B56Y0G&2NT,1WX
MZG%:\,FHWVMZRL6IRQV5LJ0QJL49*S%=[G)7D!6CX]2WX><7Z:GJ7P]LOB'-
M;,NM65Q!?B+'S>1&!&Z?[K#S)/\ @5>G:-$=+\,K+J#)#/(KW-VSL %DD)=A
MD]@6P/8"@#(^'.K:GXG^']CJ^HWS&\O0Y+11HHCVR,HVC'HHZYK#T;Q-KU]\
M']1\3SZE_P 3*"*ZECVP1A!Y1< ;<=#MYY^F*@^$>F:/=?"S2KF>5MZ++YQ%
MY(@3]Z_4!@%XQ63X9O;-?V<-83[5""+>_3!D&<LTFT?4Y&/7- '=:>==O?"F
MFZHOB!DN[NUAF$<EO%Y;.Z@[.%R 2<=>/>J^K:GK(^)FGZ!:ZHUO97=A+=-B
M"-F5D8# )'3GOFLO0Y/!-IX.\/ZG<ZA8Q7-E:6\^4N@9/,$8!79GDG)&W&<G
MUJ'Q$+/5?C#HUE<WDEJ\NBSHWD71BEC=F&!N4CGKQT..] &_X/\ $FI:IK_B
M7P_J30S2Z/-&B7UNFP2K(I(!7) =<<XX]JK>%[_7->U7Q);3ZW+%'IFI-:P^
M7;Q99 H(+97D\]L57\ 7]OX;FNO!>KBVM-5M7,D4^!&-2B8_+-G^)^S=3D?6
ML?PDWAB\\0^-SJMW8Y?6'">;=!-R;0./F&1G/- 'IFB_:_[+C-[=QWDC,[+<
M(H421EB4.!QG:5SBN9T'QI/J7C[4]%N8A'9O#Y^E2?\ /=(V,<ISW^<9'^SS
MT-)/XCTJQ\'0V.C:E"H9TTC3[EI%*NX"H9%.?F"<DGN4(]*Y_P =:7=^$](T
M/Q*E_;R#PY-&L<*0>4SV[8C= =QSE<?E0!T_B_Q,VD:]H.DO?KI=MJ;2B2_9
M5.TH%VQJ7!4%BW5@>F,9/&KI$6M6^KWT&H7HO; 0PM:3&%4?<2^\.5PK'A.0
M!P>GKE:]JOA/7HM.TK6#9W6F:M!)-!-*X$99"@ #?PL0_!R#P16#X+C;PMXH
MUK2+369-0\*6=BMRLLTGF?89,G,(<=1L!;'88]<D ].KGW\7:8WBU_#2W*+>
MK;^:S$XVLS!549ZGJ?; ]:TM(UC3]>TN#4]+NDN;.<$QRH" <$@\'D<@C!KD
M)+VUL/C;*+N=(3<Z%$D <X\QA.^0OJ0#D^@YZ4 +X.\9P'3&B\1:Y;?VA)J=
MS:P><R1M($E** HP.V/K71R743>+H+9-=C61;5R^E#86?E<2G^(8Z>AS7D=S
M/8?\*1\62I+;^8VL3-N5ER3]J!4_7'(]J[B\N[1OC3HNRXA+/HMP!AQSF1"/
MS )% '6Q:[I4U\EE'?P-<.S(B!N79<[@OKC!SCICFM"O*?#MU<Z5JGA^#3M0
MM]<\.7UQ)]DCD ^UZ<Q1R<D'YE4%E.>1D#TSZ3JVJV>B:5<ZE?S+#;6\9D=F
M.. ,X'J3V% '+:YXTGTKQ[I&F>4/[(F?['=W)Z)=2+NA3V.%Y_ZZ"NJU#5=/
MTF%)=0O;>UC=@B&:0+N8] ,]3["O/]5\*:CKOP\O?-U>T66\!U+<L0^2?.]0
M)=_12%0-C[HK,\0^+K#Q;\$[74Y)[?SY)[-;B,L,I*)TWC';HQ^G- 'HR^+O
M#K->*-;L";( W \]?W8SCGGUX^O%6K76M+O=)&JVVH6TNGD%OM*R#R\ X//0
M8/%<==R:?_PNS2,/;;ET.8)RN1^]3;C\-V/;-<>+X6_AG5[VV=Y+"P\:2W%Z
M+0AF2V#YW@#/ 8JWX9H ];C\3:');75P-6M%BM"!<,\H3R2>F[.-N>V>M%KX
MGT.^U%-.M=6LYKQXA*L"2@N4(SG'T(/TK@-4F\*ZAH/BS6](U&34+B70IX+B
M[:7,8&PE$/ &_K@=1WQD98T]A"WPI,4MLF.A5E'#6I!_-L9]Z .J\=>)H='\
M,:PUIJ\5IJ=M:O+'PK%7VDHI!! +8P >O:KUAXFTR'2]/74M6M(KV2Q2XD26
M55;&P%G([#GKTKS:/6K.'X;>.M&UBYAAUY9+]I[>=@))BP)C=0>6&W;@CH%%
M:MG=Z?<^-OA\RSVTA_L6;:=RGYML6/QX;\C0!VK>-?#"6$%\VOZ>MK.Y2.4S
MJ S X(_#(SZ9%:=]JECIL2RWEU'"KYV[CRV!DX'4\<\5Y3#+IO\ PB/Q7*O:
MY:\O>05R<P+M_P#'LX]\U(NN6NDZYX:OM7U*:STB\\/0P6]]&_[M9P=SJS8(
M&X;?^^?:@#TD^)=#$%G-_:]CY5Z<6S>>N)O]WGG\.E0+XO\ #\NDWVJ0:M:S
MV=CG[1)"X?80,XP.Y[>O:O.]7MO#EGIWA*/3&SIL_B=)T:Y?(F#(^YU#?P%C
MZ8/4<$9T)I89?&OQ%MX)(VEET:#]VA!9F$4H/ ZD94?B* .[\.Z[:^(]#M-3
MM67;/$DC(&#&-F4-M/N,U%+=1-XMM[9-=C21;9R^E#86DY7$A_B&.GH<U0^'
M=_:7_P /]"^R7$<WDV$$4AC.0CB-05)]1W':LS4KBW7XUZ(AEC$ITBY7:6&<
MET('Z'\C0!U<>NZ5-?)91W\#7$C,B1AN7902P7U(P<XZ8YJY-/%;023SRI%#
M&I9Y'8*JJ.I)/05Y;X?NKG2=5T"'3M0M]<\.7UU(+6*0#[7ISE')Y!^95!=3
MGD9Q]>Q^(-Y:6'@/5[F^T_[?;+"!);;BH<%@.2.0!G)([ T :UAK>F:I-)#9
M7L,TT:AWC5OF"GHV#S@]CT-/U'5M.TB!)M2O;>TB=@BO/($!8]!D]Z\\T;5;
M2?XPP2C6(+_[3H&R.6!0(G83@E(\9R ,GDL1SD\<=MXKT-?$GA;4=)8[7N(2
M(G_N2#E&_!@#^% %M=:TQ]4_LM;^W-_L\S[,)!YFW^]MZX]ZKOXHT&/8'UFQ
M4O*85#3J"7'WEZ]1W].]>9-K.LR+H'Q!^P3>9$%TBZLPF&EW_*S?07&U0/;/
M>MCQK:VFEVG@:RO9H&==>@>9I"!YC%9"[D'L7;)^M '3KKVEZOJNBR:9XIM?
M*E:8BSA:-S>@*1_O (5)R/3FHK;X@:!<2:UF]C2'2G*2N3R^%#,5'4@$XXZG
MI63XF-C9_$KP%$AMX/WU\VU<+]Z \X]V/XFJ&F7,(O/B3I9D7[?+<2RI;#_6
M,AMEPVWKC/&>F<#O0!V>C^*=,U;PW:ZT+F&&":*-W#2 ^6S $(?]KD#'K4A\
M5: NF2:BVL626<3F*25Y@H1QU0YZ-[=:\P77;6V\&_#S5#>2'1["-(-1GM3N
M^S2-;[%+8!QM)(/<;O<4[QC_ ,(V_P //&6J:->/=_;UMA<7CR[HYI5< *G0
M%@,9QZCN#@ ]3L]?TC4-2N-.L]3M9[VV&9H(Y0SH,X.0/0\'T-7+FY@L[:2Y
MNIHX8(E+222,%50.Y)Z"N%U">PC^+GA9+:6V56TRZ11&R@%<QE0,=N#@?6M;
MXBWUIIW@F]GOK%;RVWQ*T<A8(I,BX=RO.U3ACCTQ0!MV&L:=J<DT5E=Q32P8
M\V,'#IGD$J>0#V/>JS^*M B=5EUBRBW;@C23*BOM.&VL>&P>#@G%<'IE_9WG
MQ.U>-M:6[%[H$86YMU 5L/)N,6W.0H[Y;!XR365X;U'1=9TOP7IDWB'18O['
MG25,70$\^U&1$,9 VE@PW#)Y&!G.: /3Y?%OAV"Y-O)K=@LPF6W*?:%R)&SM
M3KUXZ5/)X@TB'4$L)-2MDNI)/*2-I "7Z[/3=_L]:X_PRNG7?Q0\=*1:S2B2
MQ*@[6(VPCD?1@/Q KF?#UUX?U3PU!X;\1WM]_;MI=$2Z7O*R/<"0LKI@9().
M[=G'))..: /5M0U_2-)D":AJ-O;-P3YC@;03@%C_  @G@$XIMUXDT2QN);>Z
MU:RAFBB\Z2-YE#(F0-Q&>!E@!ZYKSEM2T6#7?%V@>+]2N+%KV[:6.-FVI=VS
MQJJA#@DD!=N <\<<YJ_8)IUI\6-$M5 B%OX8,<4=PX,L>)4VAB>=VW/ZT =>
MWC/PRMO9W#:[IXBO#BW<W"XDYQQSZ\?7BK^HZOI^DQA[^[B@!!8;SR0.IQUP
M,C)[5X[))IW_  J+XA>6]K\VJWH&TKS^\!3_ .M^E;EUKUCI/CP3ZYJLUCIV
MHZ3;BQO5<"%F0N70M@@$[P?R]J /0)/$FAQ"U,FKV*B[0R6^;A?WJ %BR\\J
M "<].*IS^-/#\7AV\UV+4X+FPM-PE>W</\P&=N!WZ<>^>E<'<6GA_3K_ .'M
MGIPV::-1N9+=;ILEE,;D. W.TL01]13=0DAFE^+]O;.CNUG&PCC())^R$,<#
MW'/O0!Z=HVJV^M:3;W]NZ,LL:LP1MP5B 2N?;-)>Z[I6G2M%>7\$+J 6#MC;
MGIN/;/;/7M57PE?VFH^%=,FLKB.>);:-"\9RNX(,C/MT/H<CJ*X;Q7/<:5JO
MB+5=$U*UNA&8EU?0;T#$_P"Z0*T1'S*Q0J ,$$CU&* .Z6ZBD\7M;IKL;,EF
M=^DKL+*=X_?$_>'!"XZ<U)<>)=$M)6CN=5M(2LAB+2RA5#@9*;CQN _ASFN7
M6Z@;XXP@NB3-X<(,98;@?M .TCUQFN-L;W1+KPY%X5N/$FD6\-KK3SBXN;GR
M[G:MPTG,;#AR<C);H<]>* /5KCQ;X=M?-\_6]/3R8UED_P!(4[5;[I//?MZU
M<75].;3(]26^MVL9%#).) 4<'I@]\GBN,MY; _&Z_8R6V]-!AP25RO[U\_3Y
M2,^U<5H^IQ:;X'\&ZE+<2IHUEJEZE[+:G<;?>\RQ.0 <*-WIT;W% 'LUGK6F
M:A9S7=K?V\MO 66:0.,1%>H;^Z1WSBN6D\4-=?$S1=-T_5EFT^YL[B6:V5%X
M*A=C9QNP=QQS@XKE?$PTAO#NKZYX=EN=2M9KZREUBY1S(D\4;_,JXX)"A=V!
MT//>MF\U[1=2^+'A*YL-1L[A)+&[0212*P)/EE5)'?KQUYH Z'XBZCJ&D> M
M6U+3+LVMW;0^8D@17[],,".]7].\3Z)?W3Z?;ZO9SW\$>Z>!)E+K@<Y ]._I
M65\4(WE^&/B%(T9V-HV HR>HK&U*WT[5O$/@>30#:RW%G,9I)K0J1%:>40P)
M7H&8J .YSCO0!VUIK^D7]E/>VFIVL]K;DB6:*4,B8ZY(X&*N6]S!=VT=S;RI
M+!(H9)$.58'H0?2O.+RPO-)\97_ANU@?^RO%)^U"1/NV[# NA[;TP0?[S5Z6
MJJBA5 "@8 '0"@#B;SQO:ZMX?\4MH=^L-YI*3B*0!6+F.(.6"L.5W';G'..*
MT?"_BG3M1T[2+*?5K676IM/AGE@\Q?,8F-68[1WYSBN,MM1L[;0OBA83W,4=
MV;N^F\EFPVQK= K8]"> >YI/M%A!:_"=HI;="&7E64?>MB&_-N#[T >D77B#
M1[&\6TNM2MH9V=8PKR 8<_=4GH">P/)K0=TBC:21E1%!+,QP /4FO';*\T"Z
ML-;\*^+KZ\BU#^T9S)8;B&NP\QDB:( 9;.5 P<\#M7L$*[;>-"&&% PQR>G<
M]Z ,?_A,_#!FM81K^FF2[8K;@7*GS"&*\<\_,"/<C%6M0U_2=*D,=_J%O;NJ
M"1@[XV(3C<W]U<\9.!7D%G;Z1?\ P,U6P6.WEU&2[N4BA0#S6N#<-Y0 ZY^[
M^'M6IKVIVT;^+M(GGAL=331(X[AS\\^I-Y#D; V1L7)!VJ3R>5Q0!Z3?>(]$
MTV18[W5K*W=HS,%DG4$H!DMC/3'>LVS\=Z#J'B)=(L[^"9C:K<"97&QMQPJJ
M>YQDGT_EQ%G>Z7>ZY\*MUQ;2@:9<*=S _-Y$0 Y[Y!'U![BMZ*>RTOXSSV\C
MQ6RSZ'!%:Q8"AR)I,J@[X'8=!STH Z30[ZW>TU*Z/B&#4[9+N5O.!0);+@'R
MMR\$*.YYYYJU9Z]I.H/<):ZA;R/; -,H< QJ>0Q!Z#WZ5Y-]I;_A"_%]Q8%K
MB.U\6O=7,=J0SM LT;,0/H"?3@UN23>"/$$>J:Q!JEWJ/_$FF@O+J*0GR+8@
MDJPP &ZD C/!]* ._LM:TW49V@M+R*694$AC4_-L)P&Q_=/8]#5B\O;73[9K
MB\N(X(5(!>1@!DG 'U)( '>N&\(WFK6WBH:/J%[9ZY;C3C/::O;@+((]Z@)*
M 2I)Z@CKM/OC1^(6IV>EZ;I,M[! ROJL"QW%R2(K23)*S/@C(7'0D#)&2* .
M@MM<TN[M+BZAOX&@MB5N'+@>20,D/G[IQSS3K'5K#4I)HK2ZCEEA"F6,<,F[
M.W<#R,X./I7E,%SHUWJGQ"M=0UN3[/<M8/\ ;8]JL 8T42C  V*Q7YNA ZG.
M3U?@V^U@>(]3TK6);+4I8+6"2/5[1=OG1EGVI(HR X^8X'9LT =5?ZSIFER0
MQW^H6UJ\[;8EFE"ES[ ]:KIXHT.738M1BU6UDM)2PCECD#!ROWL8ZXQSZ5S'
MQ,DLUN?!Z7;PA3X@@8K*1]W9)SSVR1^=4O$&HV/AOXD6LNJ74FEZ/=Z;Y5M=
M0X2)9Q*SR*QP0"P*G/?;0!W@UG3&TM-374+9K"0 I<"4%&R<#!Z')X^M5HO%
M&A3174J:M:%+10UR3(!Y .<;P?N_=/7'2O.9IM$\,ZCX1O[1IH_"?VZ\=[J<
MDQB>1 (Y.>BDF0 \#DD<$&IQ<0:SKOQ+ETQUNDN-%MUB>+D2DPS ;3_%Z9%
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M+OKK0[JT1/+-V]@S7$B]RP9BN\]2QR,\D&M]/%6@M=O:-JMK#=("6M[A_*E
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M8(_*N%U__DL_@_\ Z\KW_P!!6@#HG\9>'8[**\?5[9;::0PQS$G:T@."@/\
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M&2%XF\L]' <#<ON,BM6J6FV\T=M%)=M;RW.P+YL,!C^7J!@LQ_6KM !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !116=?Z[IVF:C86%W.8[F_D,=LGEL=[ $XR!@< ]30!HT5
M'/,EM;R3RDB.-"[$ D@ 9/ Y-1:=?V^JZ;;7]HS-;W$8EC9D*DJ1D<'!'XT
M6:*SM:UW3O#UD+S4YS# 76,,(V?YF. /E!ZD@5HT %8^HZ??7.NZ9>P-;B"S
M,A='+;GWKMXP,#'7OGVK8HH Y?Q-X*L_$.K:/JX;R-0TRZBE651_K8U<,T;>
MHXR/0_C3[_PS*GBE?$VCS10Z@T'V:ZAF!,5U&#E<D<JP/1L'CC!KI:* .:;P
MY<ZMX@L=7UR2 C3BS6=E;Y9$D88,CN0"[ < 8 '/4]'>-/"5OXQT>"PGD,1A
MNXKA9%ZC:WS 8[E"P_$5I2Z[IT&NV^B23D:A<1M+%%Y;?,J]3NQCC([]ZT:
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M*T413&]V<@Y)SRWM3O&'A@>*-+M[>.Z>TNK:ZCN8+E/O1E3AL?5"P_$5T-%
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M:[;1K*?3M%LK*XFCFEMX4B:2.,HK;1C."3CIZU>HH XO5?!][KL]NNI/9/\
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M[);>2JAQ@NPR=S_D!SQS4-EX/O6TK1=)U:]MI[#1VA:,00LC7!B&(R^6( &
M2!G) Y X( RR\3W]EXA\1Z9K\]LBV%L+ZT>& KYML0<L<L<E6&T@8[>M=)HK
M:B^C6CZMY0OWC5IUB0JJ,1DJ 2>G3.><5R&K1:'XT\8:.-/O4N+G29Y3?&W?
M(6(?\LI,>L@3 /4*_O7?4 >>:IXPUK2KNV>X:S#R:S'9/81H9-EN[[$=I%.%
M<@A@#C@XQWK5DUG6M:E\0)X?>UB?293;1)/&6^TSA%<ACD;4^8+QSG)SVK';
MX=:Q_8W]EIK]MY$&JC4K9WLBTA;S?,Q*V_YN2>F#TY[5H-X.US3_ !)>ZGH&
MOPVL.I[&OH+BT\T>8J[3+'AAAB!T.1GUZ  Q]>U^/0_B/H>HZPBV\SZ%(C0H
MX(\YY8@$#' QN.-QP.YQ6OXFUGQ/X:\')J4DVFS7_P!H@CE18'$8$DBIA3NS
MD;OO$=NE2ZEX%&J:_;W5W<0W.G1Z:^G26T\99Y58J2Y?/WLJ#T]ZJ3>"-=N_
M!$7AN[U^WN/(FB>.[DM6+[(W#JK#?\Q^4#=QQVSS0!8C\2:KI/C&^TO7)K.>
MS727U1)+:!HS"$?:R'+'=P0<\?052O?&.M:?X(L?&THMGT^413W-BL9W1V\A
M !5\\NH92<C!YX%;5SX6N+[QB-:NKFW>U?2WTV6T\ILNKL&8[MWJ,8QTK.M_
M EX/#$7A.\U**XT**1=I,1$[PJX=8F.=O8 L!R!C /- %F77M5M_&M]HUS=6
M4-I+IQO=.G: \%6Q('._YMN5/&.#[53\,^+=5\0^&-*F$EM%J\]\]M=QFW8+
M#Y98R#:6R/E P2>KKD<UM^)O"D'B2ZTB>29H6L+@NQ4?ZV)E*R1'_9;C/L*-
M+\*6^E^+=7UV.5C_ &@$(@_AB? $C#W?9'G_ ': .8AUF+P]XJ^)>KS(9$M(
M[.78#@N1;\#/;)P*U8M;\16VN6/VFV-SI,T4C7LWV1H/L;*NX,"6.Y3R,8R.
MN>U//@AKO4O%<FHW44MEX@BCB>&.,J\(2/8"&).3CGIUI= \->(;2**RUWQ#
M%J6G6Z&.)$M?*DF&"H\UMQS@'H!R<$DT <GXRU35?$?PE?7?-MX;&\GMY%M/
M*)98?M"!#OS]_P"Z3QC!(QWKL;K7-0N_&5[X>LI8K,VNGK=B:6/>969F4<9'
MR+MY[DGJ,<X#_#G6QX-G\(PZ_:_V2LJ-:22VC-/&BRK($8AP"!C@XY]JJ>(9
M6U/QM=PC7M M[BPM(K=[?6+0%6+@N[Q N#M(*@\G[N.W(!HZ/XZU34?#GAZY
MN88([_7))/+6"W=A#'&I+';N)<G;QR!A@>V"^3QAKNC6.IC5-.#R"\@M=*N7
MB,*W33' WIDD;#G/3('&*:=$U3Q=H-I.-1LK+5=(O"VFZEIT1-O*FP X1C]P
MY9" 2/EXXXJ]J7@O4?$/ANXL]<UH/J;R1RP7-K!Y<=L\9RA5"3GDG))YSVP*
M *-U#J,/Q?\ #0OKN&Y4Z=>%&2'RR&_=[AU/'3'?KDFO0JXZ'PQX@N/%&C:[
MJ>KV#2Z?!-"\=O9LHE#[<G)?@_+G/3VK2\)-K;6%T-;O(KUUNF%O<Q0>2)(L
M*0=OLQ8 ]P ><Y(!BB;5I/C+-:?VA']CBT=)DA:#(4-,0P!W?>.P?-S]*Y33
M=9USPYX(US7+"2R^R66N7336\L+.\ZFXVL P8!, \<-TKT"Z\.7A\<Q^([/4
M(HE:Q%E/!) 7+*LA<%6W#:<D@Y!X]^F'+\/M0E\#ZQX;;5;8'4KR2Y-P+9OW
M>^3S"NW?SR,9S0!I:EXAO[G6]3TG26,4EA#&S2_9&GW22 LJD C"@ 9[G=QC
M'.SX<OM2U+P[9W>KZ>=/U&1#Y]L3D(P)'')X.,CGH:P-2\):VOB3_A(- UJW
ML;RY@2"_AGMC+#/LSM<#<"&&2.O3\<]7I]K)9V,4$UR]S*N3),XP78DDG X
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M>V\(7<VLZ'JNK7-I-?:2C*+NWA*2W6Y"GSY)P.2<9.3Z=#>\6^'KKQ!::?\
M8;Y+2YL+Z.]C,L1DCD*9^5U!!(YSUZ@4 8-MXYO(+'QE)/$+[^P%66!UA:%I
MT:+S &4],'/S 8(Y J7_ (2'7X_$'A>Q2YL+B#6[9[B1_LS?NMBJYVX?[I#8
M!.<''7-4]7TJ^\*VGB[Q#=ZXN-4@B4M%9X,$H00J_P!XX09!YR0!DDXYJ>'S
M?Z/?6":=JOA#4HY&C@,6GVQ2=H2P#,I5VX4$L<C'!Z9H TM%\0^)M0GU>ZN;
MC2X].T;5+BVN0MN^^6&- <K\QVGG/.<Y[8Y=:>)O$MZNA:E:6#7-GJ#QFZMA
M:E/L\,@R)%E+88KD9X^;L!6OX=\+SZ2FNQ7UU!=P:M>RW;(D139Y@"LG+'(P
MO7BL_P .>$/$&@B#2W\2+<:!:N#;PFVQ<; <K&TF<;1P.F2..!0!5N_%GB"_
ML+W4?#UH;@VUY)!#9FU8BY6.38^9=P"DX8CCCC.:[B2:?^SFGAMRUQY1=('8
M*2V,A2>@YXS7'VW@S7=)UB__ +$\1):Z+J%PUS+;26OF20.YR_E/G R?4$#T
M-=5J>FC4=!O-+6>2W%Q;/;B5#EH]RE=P/J,YH X_3/%NJ?\ "3^'],O)[2Y_
MM2VG:Y6WB(6VGC56*)("5<#)4C)((!R,XJ3PWXPN-=UE+0WUK!>PW$J7^DSP
MF.:&,!]A0D_-R$R0""&_AZ4EEX(UJ&]\+W5QK=F6T**2W5(;$JLD3(J=W.'P
MHYZ?[/K;_P"$/N[W4-#N]7NK2>YTB;S8[V&$I/,-K*$8DG ^8$\G<1T&: -#
MQS]I_P"$&UQK6=(76PG8LR%LJ(VR!R,'W[>E<[I&L7FFZ'X)T=9;:2_U>W5;
M>4P$+!#' KOD;CN;  '(&2#CC![#Q#IT^L>'M0TRWFC@>\MWMS+(A<('4J3@
M$9//K7/7'@JYFT?PZJ:A%'J_A_9]DNEA.QU"!&5TW9PZCG!XXH DLM?OD\6:
MIX5U3RII4L1?VES$FSS(22C!UR0&#=QP1V%<1'_R0?PC_P!?EC_Z4"O1(/#U
MR=6OM<NI[=M5N+1;.+8A\N"($MCKEB6;)/'0#MDX@\ 7Z^ =)\,+JMMNT^XB
ME%P;9L.(WWJ-N_@D\$YH U?[:OM8\4ZOH>EW$-H-*AA,TTD/F%I90650,@;0
MH!/<[L#&.><?Q]K#>%8]9\JTMVTW5O[.UM#&SJBB0(\D9W# &Y3@YX)].>C?
MPS>V?BRX\0Z3=V\<U];I#?VT\;&.5DX212#D$#(QR"/3K4UEX/LK?POJ&BW#
M^>-2:>2]EV[?,DF)+L!SCKP.P Y/6@#,C\6W%MX]UC1M1NK5;&VL?MEO(D#!
MN #(K,6P2H9&P!T:J^I>+K_0SHD'B"[@TQ;ZW9Y;XVI,,<^5VPM\Q"\%LDGG
M;P14_P#PKN"33O#4,][))<Z1-YL]P1\UT&4B16_V6.WCT7%;FK:9?WMV?+DL
MI]/EMS#/8WD19'.<ALYX]",'/J,4 -A;7[FST2:.YTTYVOJ)"LRR*5_Y8D$X
MYP1DGC]=RN9TCPU?^']'T'2=,U1%M+!C]K$L&XW"')VKS\F&/'7  Y..>FH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BAMH+<R&&&.,R,7<
MHH&YCW..I]ZEHHH **** "BBB@ HHHH **** "BBB@ JM=:=8WK(UW9V]PR?
M=,L2N5^F1Q5FB@     & .U%%% !1110 4444 %! (((R#U!HHH K6NG65DS
MM:6=O;L_WC%$J;OK@<U9HHH **** "BBB@ HHHH 0@,I5@"",$'O5>UT^RL2
MYM+.WMR_WO)B5-WUP.:LT4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSC/3.>G-%YJVFZ='')?:A:VJ2?<:>94#?0D\]10!<HI%8,H92"I&00>"*6@
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MDU Z>FH6K7HR3;B93(,=?ESFF3:YI%OGSM4LH\2^0=]P@Q)@'9R?O8(XZ\T
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M-:((8 @@@\@BJ[Z;8R6!L'LK=K,C!MVB4QXSG[N,=>:L]!@4 %%%% !1110
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MP_%K4+.*UMTMYO#*M)"L8"N1.P!*]#@<5J'PKJY@2 W?AHPHQ98SX?.U2>I
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M8 24Q+N7'3!QD5D:%I^NO>_VEXEDTXWD<;06\>GA_+1&8%F)?DLVU![;?<T
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M-1$BC6.-51% "JHP /0"G4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *BN+>"ZA,-Q#'-$W5)%#*?P-2T4
M 0&RM&\S=:PGS %?,8^8#H#ZX[4V#3[*UMWM[>TMX87SNCCC"JV>#D 8-6:*
M &111PQ)%$BQQH JH@P% Z #L*?110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*RNH92"I&00<@B@!:*** "BBB@ HHJE#J^GSWYL8KN)[D*S>6#R0I ;'KM)
M..A(S0!=HHHH ***J:EJEAH]D]YJ5W#:VR?>EF<*H_$T 6Z*16#J&4Y!&12T
M %%%% !1110 44$@#)X%4[+5K#4998K.[BF>)5=E0_PMG:P]5.#@C@X- %RB
MBB@ HHHH **** "BBB@ HHHH ***I+J^GOJ L%NXC='=B,'DE<;@.Q(R,CJ,
MB@"[145S=6]E;O<74\4$*#+22N%5?J3P*S5\5>'79%77]+9G("@7D9+$] .>
M: ->BBB@ HHJG<ZMI]G?6UE<7<,=U=$K!"S?-(0"3@=^ ?RH N4444 %%%%
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MV>$2@9VEAC..XK#N/#EWJJ:%9ZPUG:Z?ITD<OV:WE+_:IHU^09*KA!@MCDG
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M,W!VY;]Z0^,+Z9XR=Y="U,_$$ZY+-;-9)IRVD?7S =Y9_EQ@;CLYST7&.<@
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MRP52<C/.U0,9)QR.F&<#/7O0!RWQ#U?4M&\(7,^D^5]MF9+6%G8@J\K!%*@
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M.K>/]"TR[M(=FG02:Q)%!-OR^#%$F6"\AF8@\ X[8J>+Q_(?!DFNR:;&9GU
MV-G;1W!(N6\[RE*L5'!()Z= :DT[PQKEIX@\2ZI+>VCS:E!'';2C=N0K&0!C
M&$4.S' +$C&>0<Y5GX$UJ+3O"%M++IX319 \L2N[("L; .ORC>Q=MY!VC@ =
MR0#;NM7U>X^)%OHEFMN+"TL_MMTWFL&;>2B*?E('\;8[[0<CI532?$6G16FO
M>*+G3([65[XV&^WD,KWQB;RH]N0O)8LH'YFKVG:%K%EXB\2ZH9;/.HE/LK98
ML%2,+&K#'R@-O)QG.[MCG!?P#JY\ :#I(ET]]0TF\BO/*E+-!.R[MZNVW)W%
MV;.W@X&.,T =!'XINUUFZL9].1Q;6#7<YM)3*87!&V%OE +L,D >GH0:E\,^
M(KKQ#;65ZMK;?V?=VGVA;B"<OL?('E$%1R,G)]0>!3XK778+*#[);:59LLRE
M[.%V\L1\[L/L!+'C'R#'/6F^%O#C:!/K$H$<,.H7GVE+2%BT<&54-@D#EF!8
MX&!G':@#HJ\HM?%4UA/XE\46E@E\;G5HK% TVP>5&RP(J'!W,7:1L<#!R3R
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MLG8':N[ Z9ZFL.'Q[KI\':1XEN-+M([>\NHHFM]S>8\<DFQ63T."#@]>>G<
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M;-<O:0F01+GG'4G'8=3[ UFCQ0UGI%QJUXUO=:>4A-C-9 YNVDX"*I)P2Q4
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MC^.RB;>Z_1MN#]3ZUO\ B?Q ^C^/=4O[<!H]&\,2R./X?->4&-#_ -\9^AH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<SXG\+S:OJ.E:SIEVEIK&E.Y@DE0O'(CC#QN 0<$=QR
M*Z:B@#*M(]:N)(VU)K.WC0Y,=H[.9#[LP7 ]@.?7&0<"#P=J%KHFIZ#;7T4-
MC?W4TSW:Y,ZQRL6= ,8W<E0^>!@[<BNTHH YFV\(QV?B.QU"W,2V>FZ9]AL+
M;!/E,2-SD^ZJB^O7UK(3P!=V_AC0M)@OX/-L]274;Z:2,G[1)EG)QG^^5(S_
M '17>TUT61&1U#(P(96&01Z&@#@?#XU75?$7BG6M/:T"S7"Z;;W$Y+&-8!AF
M"@8<&1G.,KTJS+X&N+";PY-H5W LFE2SO,;U6?[0TRX>1MI'SY)/8<D<"MV[
MGT#P7I$UX]M!IUBK RFUM#C). 2(U/<XSCO6P6 0N0< 9Q@D_E0!Q$/@O6(8
M_%K?VO"UUK@*QSF,[HQY809]-OS8 _O58O/"R6-SX9GM[RVLM(\/PR[Q,,=4
M"!\G@87?R?[V>:Z+2=9L=<M9+G3Y6EBCF>!F:)DPZ'### '@\?A5NXMX;NWD
MM[F&.:&12KQR*&5@>H(/!% '*G1AK/CF36HKE&TP6"V<RJ,BX=96? /=1G!]
M?N_WA774V...&)(HD5(T 5448"@= !VJ.XNH;15:9]N]@B#!)9CV ')/7IZ&
M@#G/$OAW4/$6GZQI5P]G)I]\JK 9-V^U(49<#&&(;Y@,CD=>:L?\(T9/&%EK
M5Q.)HK"P-M;1N,LLC,-\A/J551^==#5:\U"VL!%Y\F'E;9$BJ69SC. HY/ )
M/H!DT <,/ >L+X9@M!J5H^I0ZR-6+-$WE2N)6DP_?G</IM''<ZUAX9U2'QS/
MXBO-1@F\VQ2U"+&1LPS,RJ">%)*GJ2=M='I]_;:II]O?V<OFVUP@DB?!&Y3T
M.#R*LT >?IX%U;_A6S>&I-1M'NI9A)/)Y;!) 9O,DSW);)!^N/>N\A21($66
M3S) /F<+M!/L.PJ2B@#B/$K7&J?$#P]I5HD,O]G1RZM/',Y52?\ 51<@'!R[
MD<?PT_5_ \VM:5K[75Z@U?5K86RS*I\NWB4Y6)1U*YR6/4DG@< =/_9>F07L
MFIKIULMX5.ZX2W'FL/3<!N/TIND:S8Z[8_;=.E:6W\QXP[1LGS*2K## '@@C
M\* .7N_#VJOKNA^(-7U;3X(=)AF,R(A2*,LH7<NX]=N\;FZ9'''-D:-_;'CF
M;6XKA6TS[#'9RJHR+ATD=\9[J-W/J>.S"NJN+>"[MY+>YACF@D7:\<BAE8>A
M!X(JB^KZ;8ZK9:(6,5U<HQMH5@;:509;# ;0 ,=^X]: -*N3U[P_JVJ>+=%U
M:&6R%KI7FO';RE\R2.FW<2!QM&<=>IKK** .?CLO$<VI2W-W>V,<*6[I:V\"
M/@2MT>1C][ X  '4^U9-IX!6WT[PGISW"26FBRFZN%*G-S<;3A_;YW9N?:NV
MJ%+JWDNI;9+B)KB$*TD2N"Z!NA(ZC.#CZ4 ><>)M+U+1-&\4.;V&2\\37Z6=
MH$0AE$H2)0Q/]U QX]SSQCIX_#4MW/I']HBWCL=(VM:V5NQ=3*J[5=F('W1G
M"@<'G)XQM7NDZ=J3Q/?:?:W31'=&T\*N4/J,CBK@  P!@4 <0/ UU=Z+XKTZ
M_P!0CQKES-*LD,9W(&P$W9/.U548&!P>N>+E[H<EZ^F7?B&YM+?3]'(N1!$Y
M$;RJ,+([,!A5Y(7UY).*ZNHKBW@N[>2WN88YH)%VO'(H96'H0>"* .6&C?VO
MXYFUN*X5M,^PQV<JJ,BX=)'?&>ZC=SZGCLPIG_"*ZG9>.-2U[3YM.DBU)8O-
M%Y"S26[QKL!C((R".H)'/>NOCC2*-8XT5$0!551@ #H *=0!QVJ^$]1E\76'
MB&RN+&XFBLC93Q7\1*E=^\.A7[K Y[=*ZNUCGC@ N9Q-*>694V+] .<#ZDGW
MJ:B@#G?%V@WVN0Z6^G7$$5SI^H1WJK<*3')M##:<<C[V0?4"J5EX7UBV\5ZO
MKLNIV\LUW9QP0YB(\HJ&X R<)N8' R3CD]<]3<W5O9Q"6ZN(H(RP0/*X4;B<
M 9/<DX%34 <,/ 4]MX<\+Z/9WD*1Z5=)=73O&3Y\BJQ+ >OF-NY]!Z5W(Z44
M4 <K+X=U9/&M]K%G?VT=M?6D5O*)(RTL1C+$>6<XYWGKT/.#638?#Z\C\&:1
MX>O[ZWFAM[Y+J]"HQ%PJNTA4D\DLY!)/88QWKL+'6[#4M0O["UE=KFP9%N4:
M)TV%AE1E@ <CGC/!'K6A0!S'_"/:DOBW6=;CO8!]JLH[6T4QDM%M#GD_W=[[
MN.3@>G.</ <UMH'A;2+*[ACATBY2YN&>,DS2*K?.!Z^8V_GOCTKN*0D $D@
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M,50NOFN?O\D 1ACW P-M6YM'GM?&MCXAUC7[,21:?+']G\O8!AE9VB!8X&T
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MH$L#\K$Y;;M. ,?36U2W?PWKNM>-+VY\VT%E#"EO'%\Z*I;(W$X"EGW$X&,
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M>?/EIM4RR @<EF8HH (^Z>>,'KU\.W@\<#7C?JT(L$LQ&8OWG#EF.>@W';G
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M&HRL!:Z)8I9*QZ"23][*?P41"@#H=.URQU6]O[2T>5IK"18K@/"R;69=P'S
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M4^]244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@7/A^
M=?%4GB#3[F&.XFLA9RI/$77"L65AA@<@L<COQTQSOT4 <?)X!MFT:/3?MCN)
MM234=2EE0,UZRL'*G! 4$JOJ %QCO6AXL\.S^(;73_LEZEI=:??Q7T+R1>8A
M9,C:R@@D$,>A%=!10!RVF^$[JR\7WOB";5//DNK6.!E\C!!7<3@Y.$RP.T#/
MRCD\YS[7X?3+X*M/#=[JRSPI=I/=,+? N%$OFLF-V06;J<GZ5W-% '.3>&);
MCQ?=ZT]_B&;3UL4A2/#(,L20V>A+ ],Y4<X&#@Q_#S4SH&@:5<:]"Z:+=0RP
M[+,JKI&#M#KOY?.TYSCCIS7H-% &)8: ++Q+JFN3W7GRW<,,$>Y,&&*,'(SG
MG+,S'@=O2LF]M;7QEK6B:EI>HK)96'G-+<6[;EE61-GEJP[]R1R/8D5V--CB
MCAC6.)%1%& JC 'X4 07=U;:3IDUU,5BM;6$NV. J*,_R%<'X3\.ZCJ_@.*.
M_O(H;;6F>_O1#&1+(LYWF,ONP 00I(&<<#!YKT&>WAN8S'/#'+&>=LBAA^1H
MA@AMXA%!$D48Z*BA0/P% ',GPG<P>*Y=5T[4H[2SN+**SEMA;Y9%C+;?*;<
MG#$=#_AF:7I%MX=\(3^"Y-5AOM3FM90L"*$=A*7^<KDG!);+$XX[5WM,\J,2
MF78OF%=I?'./3/I0!R[>#9'\ R>'/[29;F>T2UGO?+R64*%("Y&!M! YXSGD
MYSHZ_P"&K37?"=UX>)-O;30B%#&/]7MP5P.X! XK:HH Y]_#LNI:QI^HZS<Q
MSG3LO;6\$92,2D8,K9))(&=HZ+D]3S6;'X+ODT#Q-I_]L+YVM37$BS+;X\KS
M>.?FRQ"X7.1P!Q7944 4M*LCI>D6UF\RR"WB";@FQ0 ,  9. !P.3QU)ZUQ'
MA*VU+7[+7-;M-0AMH=<OI3'.D1:9((SY*;3NV@[4R"0<$YP:]"DBCFC:.5%=
M&&&5AD'ZBF6]K;VB%+:"*%2<E8T"@G\* ,"+P=9V^IZ!+;,L5AHD$J6UH$SF
M1P%\PMGJ%W=LDL3FEUGPY>WWBC2]<T_4H[66TAEMY$EM_-#)(5)*_,-K J.>
M1[=CT=% '!?\*W:3P[XCTBXUAW&KWC7:S"'YXVW*R;B2=^-BC^$8SQS736]E
MK+V<BZAJ=N;@Q,B-:VQC56(QO(9F)([#('UX(UZ* .'_ .$#NAX&TOPXNJQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML;V6*6ZL[>>2$YB>6)6*'U4D<?A2WEA9ZA$L5[:07,:MN"S1AP#ZX(ZU8HH
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MC;4#'!8X)P/4X!/X&@!]%%% !1110 453O-5L-/D2.[NXH6<J ';'WFVJ3Z
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M0^."?;.*X6'P+J$W@30?#-X]F+>WN()-0C5V82QI\[*"0-Q>0 G(& 2.<9(
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MM:7)49(.[Y0/X>O(S;.@7]WXC;Q%>-;_ &NUM7M],M0Q:.$O]YW;&2S8 X&
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M1-/L4(TKPUIS;#G.9I0$4$]V"*S'_?'K0!V=O;0PJK);PQ2>6L9\L#A5Z+G
MR!DXJEXDU=- \-:EJTF,6EL\H![L!P/Q.!^-:E<IX]T+5O$NC1:5IZV7V=[F
M*2[^TS.GF1HX8H-J-U('/Z4 8W@6T,/A;3/"5_HMRBS:?)<7DURJ;)&<@LHP
M3DEI#U X%7K_ ,:2Z5J>LZ3:Z5#(FCV"W._[450+M+8;Y/EPJ]MWWE]R-:5/
M$]WJ-FI@TRRL5D#W,D5U)+,ZCD(H,:@ D $D],U@WG@;4;S0_$ELUS;+?:_J
M >XG#-\EH&50@.W)81*1CIECS0!;TWQQ<:AJ7AJV_LCRHM9MGF9VG^:%DC#L
M NWYE!8)N)'/;'6)O'&IRV_B:>TT2W>+0I'1Y'O2J3>6F]PI\O[PZ8QC/4U)
MJ&FSZ'XFF\3.;6/1-+T4P11@G>@4EW &,#(6,9S_  XQSD9GA_PUJ^I?#ZST
M>_6"T@U'-UJ4R2LTLPE8R.@&T;2V[:22<#(&>H +>K:A'XJU#P3:0HRP7K+K
M,R-U6*) R!O^VCQ_E6C-XQ>;3M8U/2[*.YT_2O-$D\LQC$[1@F01X4Y P1N.
M 2,=.:?:>'[Z#QY<:M_HB::-/BLK5$)WQJI9F7;C !)4YR>$ QW&19^"=4B\
M"P^#'N+>&P!>*XO8G)EF@+EB I4!68'!))QDXSV -F+Q:9M;T&U2R7[#K=H]
MQ;7/F_."J*^UDV\95NH8]*!XKE1OLTVG@:A/?S6EE;QS!A.L?)E+8^50/O<'
M!&.3@&IK>D/?ZYX971)H81I;2&1E^80P-"T8QVW9Q@'T)Y -1:_X1NY/$>C:
MKIEIIU[;V5M):26-^[*I5RIWJVU_FRO.0<T 68?&\:PZE+=6H*6UW'96KVLG
MF+>S.!\D>0,D,2I[#!.1@XO:7K]U>^([O29;.$"VMTEEGMYS(D<C$CRF)4?-
M@;OH>@XSE>)_"^J:O9Z+-;IIKW.F7HN18R[EMG385,>0"<@'AMO7L.E=)I%O
M<VUKMGM[.T7^"VL^4C]?FPN[/^Z/ZT 8^N7%CX,L]4\2- ))[N:!+B1B$4#<
M(T+$ X10Q).">OL*V-+O+V[^U?:[2.%8I0D,D4I=9T**V\' P,L1WY4\U!J]
MM?W<ZP+:V=WI4MO+%=6\[E3(S%=N/E(P &!''WO:F>$=$E\.>%=/TB>X\][9
M"N_)( W$A03R0H(4'T H VJXW6O&LEOX>UK6-,M8Y[+3@\?VB27:)I5.TB,8
M.X!N,DC)! ]:Z^9&D@DC5RC,I <=5)'6O,XO WB5O!>A^'YY-,$6FWD+RHDT
MFRZC1RY9CLSDG'R].ISTP :OARZN/"\OACP;]A\QI;&2:YN3-\R.H5G;;@Y#
M228R2.<\4[4_'DZ>$/$&MZ=8PM_9]V]G;&64E;EE*IN  _YZ-M SSCJ*L7'A
M[6I?&UUJRSVGV>738[..7<RRIAF9P% P-Q*_-NR .A/(R;;P1K=OX*\-Z+G3
MC)87\=U=IYC"-PI9SSM^8F0AL8'IGC) -"]EF:X\*^&]=TVWU"YNB9Y9OM3?
MNW@ ;S<;!GYMO' RV.15C5?&PM;'4[S3[2.ZAL)#;[I)2AN;@?\ +&(!26;/
MRY]>.<'$XT/5&^(2ZW++:M91Z<MI'R?,#%RTA"XP-V$YST7&.<C+\'^%-6\-
MQ&PDM=(=(IY7BU4%FN7C=RV&0H/FY(SOQTX- &A>^+;J/6;S2;+34EO[;3TO
M1;33^6\X8L"L>%.=NW!/J0/>NK[<UQUUX;U35]4T2_U!;2&\TR]><7EO*2S0
M'=^YQM'!!4')_ASSFNQH Q_%6L#0/"FJ:K_';6SO&/[SXP@_%B!^-<QX-U.7
M1Y-!\)+8*8#I;7!O/.^9F4J'<IC[K.YP=V3Z>N]XO\/S>)K"RT[=$+'[=%-?
M)(3^]A0[M@ '.6"]<<9JE)X8U"Z\5Z[?SSP1VE[IT=A:O&298D ?=Q@ ?.^<
MY/W1TH ;<>."UI;WVG6*W5K=7:VMH#-MEN_GVN\:A3\BC<V21D*3P,$MG\9:
MH^J:]INF: M_=:88UC6.["B4LH8[BR@)@,O'.2?8D'@KP_JV@Z99Z?=V.C6[
M6D2P->6A9Y+E%X&047:3QGYF[\=QI>$M FT.RO7O6ADU&_O9KNYDB)*DLQVJ
M"0#A4"C\#0!4U7QFMK:ZK<65O%/%IA,4LDLQ02W&,^1& I+-D@=.I &3D":R
M\47-SXN70Y=+-NO]F"_DE>8%HR6"A"H&!_%SG^$\5D^%_"FK>'Y[JV:UTB6-
MKN:>'5&+&Y"R,6(9-G+<D9WXZ<'I1?>%M?N-7\6W4$]DB:K;QQ6LAD;> D15
M8V&W"KO9B2"<@XQWH ?-\0B/"=IX@ATV-H+S4/L=LDER5,B&4HLGW#U"E\=@
M.IJ_9>+VDUS6K/4+)+&TTRUCNGN7FW%4?<<2+@;&PF< G@_A5&U\%W13P?:W
M9M/L&A(9'@C+'=.J!(B,CG;EV).,G'%4=4\#ZWJ6C>,;=KBR6ZUB\6:!RS$-
M$AC")(<?*-J$$#/WC0 >+]4OM?\ #VF::EA]GM?$5Y%:IOE(G6 GS'=DQ@9C
M1N,Y&1GDD#;U/QA'96^JO86\,L&E#RI9)92B-/MR((P%)9^5'L6 &3D"LWA_
M7[[QKHVNWSV"0V=M*AMXY'<0NY4'9E1O)4,-QVXW=#CFOX;\*:MH-[?PFUTB
M:*6]FNH-3<L;E5D8L59-G)&2,[P/;M0!>F\87L>O6FDIHI>YN-.^V^5]HQ(C
M$@"-@5P.=WS9Z(>,X%=#I5Q=W>DVMQ?V?V*[EB5I;;S _E,1RNX=<5EZ5H$U
MMXLUO7;QHGEO/*@MMA),4"+T.0,$N68@<=*M:9>ZE=:OJ\=S;PII\$J)9S)N
MW2_+F3=GT;C(XZCJ#0!K5R?B76-7B\5:!H>EQVY%XSW%P[RLK"*+!(X4X#$J
M,\YR1@=:ZRN971-2_P"%ASZZ[6QLC81VD/S,9% 9F<;<8^8E/FST7&.X .5U
M'Q(UCXL\7>(H+5+PZ)9)9QJ\OEHH4&64EL'!+,B@8Y*]@"1V4WB0+/8V,=L#
MJ5S;?:Y(9)-JVT0QN:1L' R=HXR3GH 2.9?P)J8\$'2@]E)J%_JBWVJNSL$F
M!F\QU!VYZ!5' X!JY>^%=47QQ-KD=II.JV]W9Q6\L=\QC:!XR2&3Y'&#D\<'
M/>@#H/#6MR:_I3WKVHA03R11,K%DG16($B$@':V,CC\QS6Q45NLJ6Z+.Z/*!
M\S(NU?P&3@?C4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117!^.[V
MXU'Q'X=\&V\TD$.K/)-?21L58V\2[C&".1O/!([?6@#IW\3:%&[*^L6*[&VL
M3.NU6]"<X!]NM:44L<\*2Q.'C=0RLIR&!Y!%4[K1K&ZT*;13;I'82V[6_E1J
M %0C& .@XK*A\02WUWJ5EH=O T&E?N9KB=BL9F"Y,2@#L,;F[9'!YP =)17#
M'XA^?IWA6\LM.\P:\V!"TN)(PJEFP,8;D!<D@98=JI7'Q'U.#0]=O5T:VDN-
M*OS:%%NF\M_F10 VS)<LQ7&,?*22.,@'HU5$TNQ34)+];2(7<A!>7;\Q(&T'
MZ[>,]<<5AZEXEO[?QG9>'K+3H;AI[1[IY6F*^4JD*"PVG +'&>>G2JFG>.C+
MIEZ]Y9 :C;:J^DQV]O)N%S.,$;"0,#!R2>@5CVH [*BN9M/$.I2>+KC09K.U
MS;V O);B.9MJL[%4CY'^RY)] ..<#"L_B+J%]HVB:E#H\'E:EJ266/M)X#.P
M!3Y?F(52YS@ <<G. #T.BN=MO$-W)XFUC19[.WB>SM([NWD$Y*RHY<?-E1MP
M4]^M:>BWEQJ.B65[=VXMKB>%9)(5;<$)&< T 7ZIZGJMAHUB][J5U';6R?>E
MD. *S/$/B/\ L74='L=L2-J<[0I<3DB-&"Y"G'\3'@#CO]#SGC749[W0M"TG
M4;46]QJVHHEQ:QOO)AB8R,H) R6V(O0??H ]!5@Z*R]&&12UR%AXU;[/XBN=
M8M([6#1[D0;K>4R^:Q16V#@9?+JN!W./>IF\2:K#XCT32;C38$?4TFF<+,6:
MUCC4$[N,,260<<9)ZXR0#;.K:<^J/I)NHVO5A,SP=Q'G!8^V3BJWAQM"&FM;
M^'EMDLK:5H62V3:J2#&X?4=ZYO3M0A77O&GBRY.;73E%A$3V2!"\N/J[D?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1E3M['[W]TUUU'2HVFC2:.)G >3.P'OCK_G_  H Y>'P_JNE:KXANM,FL_\
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M:.[$)-T%=BQ1OX202<,2?]VJT_@K7/(\6V=MJEK':ZU++<12%&\U7>,)L8]
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MRQHS:O<1P,28O*&U%8G[P\QU.<#[IXI(_$@M])\7>*CIE@D^G2RVJS*2#=+
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MO<@DDL>,YZ# %,?PMKM[KWAS4[Z_L5&EK*'MX(V\M69 @9 >K8W\GID8'!R
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MMOJ-E$-0N;Y[:P02!%GC5=QF;EMB !B>IP!QDXJHWBW5(=+\1ZA'9PZC::;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K"UUO$LLRVWA_P#L^#;'ODN;Y'=222 BJI'/&22>,C .>-VL/Q#XDLM%
M$5J][9PW]T#Y"W,RHJ@=7;)'RC\R>!UH K^"?$-YXCT6>74;2.UU"SNY;*Z2
M(DQF2,X)0GG::Z2N;T._\-Z/X>E^RZS9RV=HY:[O3.I0RR-N9G<?+N9FSC/&
MX>U=("" 0<@]"* "BBB@ HHHH *Y"U\0:CKOB36]+TR]L+-M)D6(Q7$#2R2D
MJ&WD!UVIS@8SG!.>U=?7G^M^%="\;:I>7MA>RZ5XDTN4P-?6<FV5" "N]?XE
M((Z_3- '6:+>WLNAK=:TD%K=(TJSA"1&NUV7()[8 .35VTOK2_A\ZSNH+B+)
M&^&0.N1VR*\C'BG4KCPQX4U#Q,\;V,.N/;7]V@Q#.J;UBE/;9O .>F5!]*T?
M'3Z7!X:\3ZGX=?SY[IK5]6EM)2ZF$,%8#!P&\O.['.TY/44 >D6FI6-^TBV=
M[;W#1G#B&57*GWP>*:^K:=')'&^H6JO(YC13,H+..J@9Y/M7&^([>*;QIX)N
M]'$1>5I8Y#$!MDLO+RV['!0'9CMEACK7'VWA_0+KX5^,II[*V^T6U]J @E"#
M?"Z.QB5#U7YBN%&,[O>@#V6\U"RTZ,27UY;VT;' :>4("?3)-6%974,K!E(R
M"#D$5Y38WQB\6G3O%>K-I]S-H=F(3.(MDWRMYZYD4C.\\@=0!G.!78>$QH?A
M_P .Z5I%EJS36TC21V#WDRF2X 8D[, ;E Z8'W<=L4 =/1110!GZYJ?]CZ+=
M7PC,LD:8BA'660G:B#W9BH_&J/@SQ$OBKPG8:L5$<TJ;;B,#'ERJ=KKCJ/F!
M_#%5=8-WJ_B:TT[3YK91I@%[<^>A==[!EB4@$>CO[%4-<]X6:X\*?$K5O#M]
M+!Y.M*=5L_)4H@ESB9 "2<G ;'M0!KZ;KVLW6I>,K.2:TWZ3)&MHP@.T!HA)
M\PW9/7'45J>"]5NM=\%Z1JEZ4-S=6RRR%%P-Q]!7.Z(P_P"$I^)'(XE@S_X"
MK6I\,CGX9>'<?\^4?\J .JDD2*-I)'5$499F. !ZDU535M.ELI;V._M7M(@3
M).LRE$QURP.!BN3^(MT]K/X7:?C23K$0OF/W0,'R]_\ L[]IYXR!4%[9LOQ:
MF:R0>1<:&QU%%'RLP?$3,/[WW@#UP#Z4 /UOQPTWA;3=;\/75LT-Q?P02"1-
M[>7)*$SU&TD<\@]:[6WOK2[DFCMKJ"9X6V2K'(&,;>C8Z'ZUXS$]G-\"_"\,
M;Q,_VRP$RHPW#,^.<<CH?RK?U*V;2_B+KD.@6\=M<OX2:6**W0+NF65PAP._
M04 >B1:E837DEG%>VTEU&,O DJEU^JYR*!J5@TZP"]MC,[LBQB5=Q91E@!GJ
M <D=J\U\.Q^&/$.F^$[U/$$\EY9,GD6<30"59"N)(W4)O*XW;LGD G/>KWPX
MT/2'F\079T^U:XM/$=Z()/+!:$ @ )_=&">!ZT >C53&JZ<9H81J%J99R1$@
MF7,F#@[1GG!!''I5F6*.:)HI462-QAD<9##T(KPFVT'2KC]G]+Z"TA&L13/]
MDN(U'GK.+IA&JMU'4#:/6@#V^XU*PM&9;F]MH60 L))57 )P,Y/<\"B?4K"V
MN8[:XO;:*>7_ %<4DJJS_0$Y->?6N@Z7J7Q8UFWU33K.Y+:/:R2QR1*RM)O?
M+8Z$\#GK^=0:+]EU/P=XZMM="?;$O;O[:)?O(H7,3#/10@7:?]GB@#TI[^SC
MNEM7NX%N&QB(R .<^W6JFIW?F:;?QZ?J=G;7L49Q+*0ZP-V+KD<?6O/+V'4=
M,\%>#O&=_&[:IHL<1ORPS(UM(H24-W+ $-SW!K1\76<5S\)_$NI75NAFO[>2
M\Q(@R@V@1#GH0@3\<^M '<OJ%K96D#W]_:QEU $CN(UD;'.W)_'O5>]FGDN]
M*DL]3LX;:20F1)%#&Y0H2!&<]>AXSQ7(:G;:NUUI=_X<NK*;4;?256;2[T?)
M<P.1RK?PME<9Z=,UF-<V&I3_  NU*TL!9H\KQQ1N 7CC%NX";NX&./7@T >F
M7.I6-G-'#=7MM!++Q&DLJJS_ $!/-2RW5O Z)-/%&\F=BNX!; R<9ZX )KSW
MP[]EU./Q_8^(%C,XU&<7 FQD6FP>2>>B[02/?)KG]'L9+RX^%7]O6Z2WDMM>
M++YZY:2,0YC#YY/R[>#0!Z]#J%E<V9O(+NWEM@"3,D@9!CK\P..*6UO[._0O
M9W<%PJ]3#(' _*O+[;3K>6/QYI4%\FDQ?VW;&WD5 4BF(A*Y7IAG"@COFNF\
M&ZAJ,VN:WI^N:;:VVLVRP-/<V;$PW2,&". >5;@@@^U '955M]2L;N>2"VO;
M:::+_61QRJS)]0#Q6!\29=1A^'.NR:5YGVL6QVF/[P7(WD>^W=6%XB2UN!X
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M3@-CT!H ] EU&Q@N5MIKRWCG?&V)Y5#-GI@$Y[&EGU"RM?\ CXNX(OD+_O)
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M1@L/=3WH ZAW6-&=V"HHRS,< #U-06NHV-]$\MI>V]Q&AP[PRJX7ZD'BN?\
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MB@.CZ>8H6W1Q_9DVH?4#'!IUUH.CWUY'=W>E6-Q<QKM2:6W1G4>@8C(%:%%
M$5M:V]G;I;VL$4$"#"1Q(%51[ <"I:** "BBB@ HHHH **** "BBB@ HHHH
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MQC3+,1N0640+AB.A(QS0!Y]-K,%G\0%CUO67TVWO-&@^PW#^4(I,%C*NZ16
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M6ME"S;5>YE6,$^@)/6KM96MPV\5I/?OHS:I/'"46!$1G93R5 <@<]_7 ZX%
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M4KSB\N9;3X]&2&QN+QCX9 *0&,,!]IZG>RC'XYYH [NPU;3=5$AT[4+2\$9
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MA\H9_+(/R[<XZ-R#TH [>BN0U+QAY7B"'1X)[*TN)[%+NV^WY"W3,6'EH00
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M4$<#Y@,YYQT% '645QVC>+I]=U*2&SDL2;>]DMKNP?*W-NBLRB0\\YPIQMP
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M%)&B:2%PR[AU&1P:N5Y!I7B#5O#'ACQ-J]G96DUA9Z_>/<K+(PD=3, 1& ,
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MLY8);IT8CS?,WDB,@>F.?K72Z7K&G:U!+/IMW'=0Q2M"[QG*AUZC/?&>U7J
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M';CK67'X%UV+X::7X8#Z<;FSNHYFF\YPC*DWF\?)G)Z?K[5Z110!R-[X9O\
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M_%?B/6/]#>/5(H$BC\U@4,2LHW';WW9XZ8[U@6_P_P!=T_PYX;73M2LX-=T
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MII<EM,@D=G +"1G'R\XVXQWZ^U<3HZ:W:Z/!KD#>$KZU,C7T?F331N7<ELA
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M).<8!YZYH T:*CCGBF9UCE1S&=KA6!VGT/H:1;FW>=X$GC:9!EHPX++]1U%
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M09:,."P'N.M$MU;PAS+/%&$P6WN!MSTSZ9H EHHZU#)=6\,R0RSQ)+)]Q&<
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M:/8RV$/^JMV@79'_ +HQQ^%.E\.:)/:VMK-I%A);VA!MXGMU*PD="HQA?PH
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M?+^%$6@Z1#)=R1:79(]XI6Y98%!G!X(?CYA]: (_#D=K%X?L4M$A1/(C+"(
M#<4!YQWY!_&M2JUAI]GI=G'9Z?:PVMM']R*% BK] *LT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVU"RO6D6TN[>=HCB012!BA]#@\5X_KUF_A^?Q\WAZ!H-*6VLVN8;5<(DA?\
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M'JORYP!_6NATF'PQJ^H>'=:L/$+S7$$+I:V]MY*GRV3YDD5%!VJ!T.,''<T
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M<#3VUW!-"N=TD<@91CKD@XKC_B1=/:KX;,W&E/K,"WY/W=G.S?\ [&_;G/'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ JM>Z?9:E"L-_:0742L'5)XPX##H0#WY/-6:AN;JWLXO-
MNIXH(\A=\KA1D]!DT 5)- T>6S6SETFQDME<N(7MT9 QZM@C&?>GC1M+6\6\
M&FV8ND38LX@7>J],!L9Q[4#6M*)N@-3LB;3_ (^<3K^Y_P!_GY?QJ1-2L)-/
M&H)>VS617<+@2J8\>N[.,4 5H/#>A6RQK;Z-IT0BE\^,1VJ+LD_OC X;WZT]
M="T=#<E-*L5-T,7!%N@\T?[7'S?C5BSO[/48C+97<%S&&*EX) X!'49!ZURF
ML>*W3QCX;T[2]3L)[:\N98;R&,K)(NV-V'(;Y1E?3/'6@#K+.QM-/MUM[*U@
MMH%Z10QA%'X#BF7^FV.J0"#4+.WNX0P8)/&' (Z'![TV;5M-M[Z.RFU"UCNY
M,;('F42-GT4G)JY0!!;65K9VPMK6VAA@&?W4:!5YZ\#BJ^FZ'I.C&4Z7I=G9
M&8YD-M L>\^^ ,T^TU?3;^9X;/4+2YEC&72&9791TR0#Q3#KFDAXD.J60::0
MQ1*;A,NXX*KSR1Z"@!VL6]Y=Z->VVGW*VMY+"Z0SLNX1N1@'%<):^!3>0I:W
MW@[PSISH IU"S<O*"/XHQY2D-Z$MP>?FZ5WNH:C9Z=!NN[ZUM-^0CW$@52<>
MY&?IFL+P!K=]K_A@WVHRQ2W N[B+?$FU2J2LHP,GL!W- &S>:'I.H7*7-[IE
MG<3HNU99H%=@.N,D=,]JNR1I+$T4B*\;J596&00>H(K'A\5:1/XFN- CO8#?
M6\:O(GF#AF)P@]6P,D=@1ZU>_M;3OM_V#^T+7[9_S[^<OF=,_=SF@"R(8Q"(
M1&GE!=FS'R[<8QCTK/L_#NB:?;W%O9:/86\-Q_KHXK9%63_> &#^-6M1>>/3
M;E[5XTG6-F1I$+J"!W (S^=<]X*\4Q:SX9T634=0M/[7O;43M )%5VSGD)G.
M* -H:#HXTXZ>-)L18EMQMA;IY9/KMQC-']A:1YUO-_95CYML,0/]G3=$/13C
MY?PJ2\U;3=/ECBO=0M;:24XC2:94+_0$\U<H SWT'1WU9=5?2K)M148%V8%,
MH[??QFB\T'1]1O8KV]TJRN;J$8CFF@5W0>S$9%+_ &YI/G01?VI9>;<,5A3[
M0F9"#@A1GD@@CCO4E]JFGZ8BOJ%];6B.<*UQ,L8)]LD4 26=E:Z?:I:V5M#;
M6Z#"Q0H$5?H!Q4=WI6G:A-%->V%K<RPG,3S0JY0_[)(X_"EGU*QMO+^T7MM%
MYBET\R55W*!N)&3R  3]*YC7/&=E'K>CZ/9ZQ9PKJ*2RR7BRQMY2(@*XSE<L
M67!.1@''J #H?[!T??<O_9-CON1B=OLZ9E'^UQ\WXU9M+*UT^V6WLK:&V@7[
ML4,811] .*R]/U%]+L;>T\2ZQIAU-B0&5Q#YJ[B%(5CU(QG'&<XK3N+ZSLV1
M;FZ@@9]Q02R!2V 2<9ZX )/L* ([O2=.O[FWN+RPM;B>V.Z"2:%7:(^JDC(_
M"H6\.Z(]L+9M'T]K<2&41&V0J'/5L8QD^M/&N:08A*-4LC&8?/#_ &A,>7D#
M?G/W<D#/3F@ZYI"QVLAU2R"79Q;,;A,3'_8Y^;\* '?V/IGVY+[^SK3[6BA4
MG\A?,4#H V,@5<=%D1D=0RL,%2,@CTJM?:E8:9$)=0O;:TC8X#W$JQ@GZDT^
M6]M8+3[7-<PQVV WG/( F#T.X\4 1V.EZ?I<;QZ?86MHCG<RV\*QACZD #-0
MV.@:/I=Q/<6&E65K-/\ ZZ2"W5&D_P!X@<UA>%O$5UK/BWQ/9/>6MU8V)MOL
MCVRC;B1&9LD$[CD8SGMT%=+)J-E%=K:27ENERXRL+2J'(]ESGM0!7M=%TO2\
MS:=I-G!*JD+Y$*1G!Y(! XR:YSP)X0&B:+'%JVEV/]HQ7,TRW"!9"=\C.I#$
M Y ;%=/%J^F3132Q:C:21P_ZUTG4B/\ WCGC\:YL>*)H/B'/876HV2Z&-&6_
M27A I,NS+2$D$8'7@<T =#J6A:1K)B.J:797IA.8S<P+)L/MN!Q3]1T?3-7M
M5M=2T^UO+=2&6*XA6101T(!%3+>VC60O5NH3:%-XG$@V;?7=TQ[U';W]MJ=K
M))IE]:SXRHEC82HK>^T_ID4 )/I.G76GKI]QI]K+9* %MY(5:, =,*1CBHI=
M!T>>Y^TS:5923X4&1H%+$+T&<=L#'IBN!/C+Q ?@U;^)UN+8:D9]DK&#*E3=
M&+Y1G P,=<]/QKT8:C8F]-D+VW-V.L'FKYG3/W<YZ4 6:H7VAZ3J<Z3W^F6=
MU,@VK)- KL!Z D=/:K,%Y;7,DL<%Q#*\+;9%C<,4/H0.AJ$ZMIHEFB.H6HD@
M!:5#,N8P.I89X_&@"AKJ^(MUI!X?73DA<,EQ+=%MT(P-K(JC#8YX..U:6GV,
M.F:=;6-N"(;>)8DSUP!CGWI@U?3#:BZ&HVAMR^P3>>NPMZ9SC/M5'^T%L+_6
M;K4-;LCI]ND3B#"JUF,'<9&SD[B,C('3 S0!LLJNI5@&4C!!&0168/#>A""&
M :+IWDP,7AC^RIMC8\DJ,<'Z5R^K>-I+K1?#6K:#=V_V?4-4M+:X1E#N(Y6&
M1U^1L>H)Y[5V5KJ=A?B8V=];7'DMLE\F57\MO1L'@_6@!L.DZ;;WLE[#I]I'
M=R#$DZ0J)'^K 9-1Z?H.D:3/-/IVEV5G-/\ ZV2W@6-G^I YJOI%[]GT.U?4
M]:LKV5W,?VR+;%'*Y<@*HR1GHN >HJ_::E8W[3+9WMO<M VR40RJYC;T;!X/
ML: +#*KHR.H96&"",@BLW_A'-#^P26']C:=]CD8,]O\ 94\MF'0E<8)J+7?$
M^E^'7LH]0NHHI;V=8(49PI.3RW/10.2?P[BL6'Q1+#X\U2RU#4;*/1H--ANX
M93B-5WNRY9R<'H.>!STH Z>VTO3[.X:XM;&V@F=%C:2*%58HO"J2!T'8=J>U
MC:/!<0-;0F*XW><A0;9-PP=P[Y''-))J-E#9+>2WENEJP!6=I5"$'IALXYK,
MUGQ;HVB^')M=FOK>2S13Y;12JPF;LBD<$D\?_JH T[W3[+4H!!?6D%U$K!PD
MT8=0PZ$ ]^>M.M+*UL(?)M+>*"+);9$@49/4X'>G6]S!=P+/;3QS0MG;)$X9
M3@X."/>N/TCQ!JWB>XUIM+U#3[:33KV6T6RF@+L=AQND(8$!B#C X'][D4 =
MA<6T%W;R6]S#'-!(-KQR*&5AZ$'@U!9:5IVG0/!96-M;1/\ ?2&)5#<8Y '/
M'%8C>+[72=+T'^WYH+74]36)6@+A=KE<N>3PJ\\GV'>MFXUG2[22*.YU*SA>
M4 QK).JEP>A )YS0 MCI&F:8SM8:=:6C2'+F"!8]Q]\#FK<D:31/%*BO&X*L
MK#(8'J".XK'O?%>D6'B*UT.>]@2]N(VEV-(!L48QG/<D\#O@^E7I=6TV&^2Q
MEU"TCO)/N6[S*)&^BYR: (!X<T-8[>,:-IP2V_U"_94Q%SGY>/EYYXJ>#2=-
MM;J:ZM]/M(KB<8EECA57D_WB!D_C5RB@#/TW0M(T=IFTS2[*R:8YE-M L9<^
M^ ,U>DC2:)XI$5XW!5E89!!Z@TZB@#+3PWH<=VEVFC6"W"-O61;9 P;U!QU]
MZMSZ=8W5W;W5Q9V\US;DF":2)6>(GKM)&1^%6:* ,L^&]"/GYT73CY\@EF_T
M5/WC@Y#-QR0><FK?]G6/]H_VA]CM_MNSR_M/E+YFS^[NQG'M5FB@#/M=!T>R
MU&;4+32K*"]FSYMQ% JR/GKE@,FM"BB@"@=#TDZB=0.F69O20QN/(7S"1T.[
M&<CUI;C1M+N[Q+RYTVSFNDX6:2!6=?HQ&15ZB@ JCJ6BZ5K"QKJ>FVEX(SE/
MM$*OL/MD<5>HH JP:986UBUE!96\5HP(:!(E"$'KE0,'-5[?P_HMI]G^S:18
M0_9MWD>7;(OE;OO;<#C/?'6M*B@#-7P]HB6TULNCZ>L$[;I8A;(%D/JPQ@GZ
MTLN@:-/';QS:1821V_\ J%>V0B+_ '01Q^%:-% %&\T72M1$(O=-M+GR.(O.
MA5O+'3Y<CBBZT;2[Z&&&[TVSN(H,>2DL"N(\?W01Q^%7J* *<VD:9<74-U-I
MUI)<0#$4SP*7C'^R2,C\*A'A[1 DZ#1]/"7!S,OV9,2_[W'/XUI44 9TN@:-
M/%:Q2Z38O':'=;(UNA$)]4&/E_"K-I86=@)19VD%OYTAED\J,)O<]6..I/K5
MBB@"IJ&EZ?JT"P:C8VUY$K!U2XB610PZ$ @\USGC;PL=5\(:QINB6%G%?:FJ
MK))@1!B".7(&3@# ZUUU% &;INEV>GP>?;:5;6MRT8#K"B@G'\.X <9KG/!7
MA#^RK2Y.L:78F]:_FNHYE"R'#N77YB 05S_A7:T4 4Y-*TZ:_2_ET^U>\C&$
MN&A4R+]&QD4EKI&F6+3-::=:6YG_ -<8H%3S/][ Y_&KM% &?I^A:1I,4T6G
M:796<<QS*MO L8?Z@#FF6_AW1+00"VT?3X1;R&6'R[9%\MSP67 X)]16G10!
MG_V%I']H'4/[+LOMI8,;CR%\PD=#NQG/O4DNE:=/?QWTVGVLEY%_J[AX5,B?
M1B,BKE% &>V@Z.^K+JK:59-J*C NS OFCM]_&>E:%%% %9=.L4U!]06SMQ>N
M@C:Y$2^8RC^$MC)'M4-MH>DV5V]W:Z99P7+DEI8H%5B3U.0,\]_6K]% !6?-
MH6D7.J1ZG/I=E+?Q8\NZ>!3*N.F&(R*T** *5_HVF:H\;ZAIUI=/%GRVGA5R
MN>N,CC-%UH^F7J0)=Z=9SK!CR1+ K"/'3;D<?A5VB@"G'I&F0WKWL6G6B7<@
MP\ZP*)&'H6QDU7_X1G0?LT=M_8FF^1&YD2+[*FU6/5@,8!]ZU** *5WI&F7\
MEN]YI]I</;'= TT*N8CZKD<=!T]*3^Q-*^Q7%E_9EG]EN6+SP>0NR5CR2RXP
M2?4U>HH I6VD:99Z:=-MM/M8;$J5-M'"JQD'J"H&.>]0MX=T1XH(FTBP,=NI
M2%?LZ8B4]0O' ]A6G10 R**."%(88TCB10J(@P% Z  =!3Z** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC9B<N?J!G'2L6XL-/B^"OBB[CMK=9X=6G\N8(-R;;L;=I[8[ >OO7L\6BZ5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[U?6-#31M.&J6"Q2JYO6\AHY 2O.S=NRI&-N.^1WGT[QE=:UX<T'5+#2RO\
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M<1W=LK&*Y5C@(-P&'W$#&3U!H ZZ;4K&VO;>RGO(([NYSY,#2 /)@$G:O4\
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M "BBB@ HHHH **** "BBB@ HHJG=:MI]E>VUG<WL$5U=-M@A=P'D/^RO4]*
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MGE>']9T_7/#<6MZ5"UM):/J :">%E4,I? (;*!AQ@9QSC)])_LC3/^@=:?\
M?A?\*/[(TS_H'6G_ 'X7_"@#SWQ#<W7B'PS'!/K/AQ;]KV"X,*ZB!#"D;J^T
M-@EF.#DX Y]N5\8>(;)_&/@BYM+_ $V:2&XN6E7[8H108"#EAT[XR.3CI7H/
M]D:9_P! ZT_[\+_A6)KFC>#[::UU'6;>PMWB<);R2/Y>&/&% (R3[=: .3UB
MVCU2'Q)J5MXCT>RU?4H(+:V07Z[8X8VW%6<<Y?+ XZ CDU)8RM;^,8];%[X6
MM[8Z0+'['!J0Q$1(7 !V@$'/7 QZ''/H?]D:9_T#K3_OPO\ A1_9&F?] ZT_
M[\+_ (4 >=Z5:6L7PAF\(WFO:''?&RFM5EBOU>,EMVTDD CJ,\58FO+?4-%T
MW3M:;PO?V2VS17=I_:*-M<!!&Z,P&3P^?NXW#!.,GO/[(TS_ *!UI_WX7_"C
M^R-,_P"@=:?]^%_PH Y;PG::GI7AO1M/TN]T[4K:&Y=+R4W+2^3"2S*D;#[Q
M4%5YQP.@[=K6=I][I#W=WIVFSVAGM2IN(+<KF(MG&X#H3M/7GBM&@!#D X&3
MV%<CX1T'5]'U_P 27E_':"#5+P7,7DSL[( NW# J/0=#77T4 <E9Z+K%IXV\
M0ZSY%H]MJ%M!# OVA@X,08?,-F #N[$XQ6#;^"O$%OX'\*:+LT]KG1]1ANIF
M^TL$=(W+84[,Y.>XXQ7I=% ' ^+?"-]XI:\CFL+);A9$;2M5CF*3V8"KG.%R
M<,'( )!R,XZUW9WI#\O[R0+QN.-Q]_2GT4 <UH?A]FANKGQ!ING2ZC<W+S.Z
M_OAM)PB@LH(VH$7\">]8OA_PQK^@Q^)M/BM]/_LJ_FEGL(EN6S SC!4CR\!<
MX/'3GK7?U574K)]4DTQ;J(WT<0F> -\ZH3@-CTR* .%/A'7AX/\ !^DK'8&X
MT6]MKB=C<L%=8<\*=F<G/<#%7-0\(7^L>*==N+M;>/3-4T@:;N28F5""YW;=
MH'\?KVKN*JC4K)M4;2Q=1&^6$3M;[OG$9.T-CTSQ0!R_AJU\;VT5MI^MMI9M
MK-0OVNVD<RW0484%2,)GC<>>X YR,2;P3XAF^'&N^'MFGK>:A?2W$;_:6\M5
M>7S.3LSD8QTKTVB@#B3H?B#2O'%WXATJ"RN8=6MXH[ZTGN6C,4D8(5T<(<C!
M((P#6-%X)\2IX2MM*9--:>+7!J187#A3&)C+M^X>><?UKT.;5M/M]3M]-EO8
M$OKD,8;<N/,< $DA>N  >:N$@ DG % '*?V-JW_"R&\0^3:_8CI(L=OGGS-_
MF>9G&W&.W6N<C\"^(H_#:+!/8VVM6.L2ZI9-YC21.)&8F-_E! *N0<"O0M/U
M73]6CFDTZ\@NXX93#(\+AU5P 2N1QD9%7* .(U;2O%OB/P9J]CJ$>F6UY>VQ
MMH;>&=S&F>KNY7)/H ./4YXDN= UFX\0^$-0$-FL6D13+<K]H;),D83Y/DYQ
MC/.*[.B@#EO"6B:KH5]KD5T+1K&[U&>^@ECD8R'S2#M92H Q@\Y.<]L<KXNT
M74]7O_#TU@ELT>G:BMY-YTQ0LH5EVKA3S\V><=*ZBJ=]JVGZ9);1WU[!;R74
MJPP)(X#2N3@*HZDY(Z4 8%AH^KV?CK7=;,%HUK?6T$4*BX._,6[[PV8 .[L3
MC%<WIG@SQ/I?A[PI9;--NAI$TQN[)[EQ#<!R2C[O+/*$DX*GGGJ!7H<>K:?+
MJLFEQWL#W\<?FR6ZN"Z)D#)';DCK5R@#CO"VBWN@KKT>NR:=]FU+4I;F,HYP
M_F@94A@ .A&,G.>V.6?#?0_[)T:>7[4]U#),\-C(_5;-'?R5SW'S,P/<,*Z3
M5]#TO7[1+35K""]MTD$JQS+N 89P<?B?S-27FH:?HUHKW4T5M"HVH.G &< #
MT SQT H S/&V@S^)_!VI:-:RQQ3W**$>7.T$,&YQSCC%59-&U#7M;TC4-7MH
M+2'3/,D2"*8RF29EV9)VC"J"V.Y)[8YZ*RO;74;.*\LKB*XMIEW1RQ,&5AZ@
MBIZ . \,Z%XR\.P)X=6;39=$@<BWU NWVA(,Y";,;2X!P#G Z\XQ79ZOIT6L
M:-?:9.2L-Y;R6[E>H5U*DC\ZLRRQP1/+-(L<:#<SN<!1ZDGI4.GZC9ZM8QWN
MGW,5S:R9V31-N5L$@X/?D&@#E/#%EXWL8+72M7DTMK.R"H+V!W,URB_=!0C"
MDX&XY/? YR*NK^%M?OI+7Q!:FTA\46UWNCS</Y'V7)!A)V9*E>3QG<200,"N
MT&I61U5M+%U$;]81<&WW?.(R=N['IGBK5 '#:CHWBFP\5MXB\/II\QO[:.#4
M+"[F95#)G8Z.%[!B.1_/A-9\.>)AJ>C^)-,N+&XUJTCE@N[>8M'#/%(0VQ6
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MVVDE\M@\?W)%."",$@@X]>>E9>I>!M2E\!>(-*M3:-JFNW4MU.SRLL4;.P.
M=I)"JH'09//&:[?3M4L-7@>?3KR&[A20QF2%PR[AU&1QQ5N@""S\_P"QQ"YC
M2.8* RH^X ^QP,_E4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %<[XTUZ]\,Z"=6M;>&>&"1!=
M"0D%(F8*7&.NW.2/3/-=%5;4+&#4]-NK"Z3?;W,30R+ZJPP?T- '/KXIF3XA
M#PW.+002V!O8)E8[GPV"F.@(^]GN*YOQ%?W]_/X%U![:!IYM6=[>-&*JT9AD
MV%B<D9&&/!QG')',_P#PK:[D\,Z+:SZGNU>RN%:>]7@O"4\EXQQQF$ ?5<]Z
MWO$N@ZAJ>K>'+BP6S6#2[O[1(LLK(6&QDVJ I'\6?PH JV'BK595\46-]I]D
MVHZ(JOMBF80S(\>]>2I(. 0>*-,\6O=Z-X6BM;2WBO\ 6[7SHXN1%;QJ@9S@
M<D#<H XSGJ*2/PWK,>N>+[\"P*:U!%';KY[Y0I&4^?Y.ASGC/3'O68W@C7[3
M0O"<VFW-A'KOAV(P*LC.UO<QL@5U8[0PR%!''!_.@"#Q[>ZM=?#G64U?35MY
MK74K:.*2)@4N4^T1%9%!.5SG&">#WKI-/\1:I_PF\GA[5;.TB$MB;ZVDMI6?
M"APC(^0.?F!R.*H^(O#WB7Q'X0GL;F;31J%S/!(461U@@2.17VJ=I+$[3DD#
MKTXYOMHFJ2?$2T\0LMFMI'IKV3H)F,FYG5RP&S! VXZCKGCI0!T=S-]GM9I]
MC2>6C/L099L#.![US/A3Q1/XF2TO+>73[BPGMVDE^SL?,M9?EQ$X)Y."W.%^
M[TYKI;M)Y+*=+9PEPT;")VZ*V."?QKCK'PE>1^++7Q(;+3K"^CMI8[P64[;+
MYV V[AL& ""<X)Z=<4 <MX,\1:KX<^''AVY6QM'TE[UK69FE83?O+EU#J ,8
M!(X)R?:NL\4^+]2\/Q:Q=_9+6&TTZ-'A%T^&OSMW.(R#\NT<=&R>PK)B\#:_
M'\-]-\-;M--U:7RW+2^?)L95G,N!^[SGG'Z^U3:QX.\2:C-XKB2?3'AUJV$<
M,\[N9;<>7M\H +C9NR<@\9)VDT 6=;G6Z^(W@"Y12!+#?.,]0#"AJ7PB /'_
M ([P/^7NU_\ 2=:<?#>N2:YX1U"4Z<1H\$T=R%E<;S(@3Y/D.<8ZDC/H*N^'
M]#U+3?%7B34[O[)]GU2:*2(12LSILC"88%0.<9X- $GC\ _#OQ)D9_XEEQ_Z
M+:N=T_Q3K>A1>%X]4TNT71=26"RAG@G9IHI60;/,4@##8[$X]3W[/Q%I;:YX
M:U32DE$37MK+;B0C(4NI7./QKGX?#>J:E:^'[/64LX+;1Y8IS]FF:4W$D2[4
MZHNU<G<>IR /<@%34/'M\MC<:GI.FM?VMO=-!]ECMYFFG5)/+=T91M&"&(4Y
MR!U!.!W:.)(U< @, 0",'\JX/3/#?B_P_?7NG:3?:6V@W5S)<127 ?[19^8Q
M9U50-K8))&3WY]*[U5VJ%R3@8R3DT <Q+KM]JM_K-CHT5JR:6!%,]QN(FF*[
MC&N/N@ C+'/)QCBN8\#>(1I7P[\(:="H-W>VLCJS1O(L:(?F8J@R>648XZ]>
M*V;?PYK^A^*=9N]':PN-,UEQ/+'=2.CVTVW:67:I#@X!P2OU%8]GX#\2Z5X<
M\,/I][IR:]H2R1!7+FWN(I,;D8XW \#! ZB@#5MO'EU'I\RZCI4D%\-16PMS
MY4JQ7.X%A*H*[MNU6) !/RXSS3)O&^L6=KXB,NCB<Z79F]@NO+EMX+A I++\
MZDAQCIDY]14NL^&?$?B#089;G4+.TUZUNX[VS\@,UO"Z @*<_,P8,V3@=1QQ
MS+=:5XMUOPKJ]GJSZ3%>7EE+9PPVLDGDKO4J9&8J23SP ..>3G@ JMXRU^"[
M\.^;I-B]MKD>V%4N&#QR^5Y@+DKC:<'IDCWZ5/:^-[BRC\4)K]K D^@".1S9
ML629)$W(%W8(;MSWIMQX8UJ7_A#BHT_.AL&N,W#_ #XB,?R?N_?/./3WJ.Z\
M$7FJZCXR%^]M'8Z_!!%$T,C-)"8D*AB"H!Y(/7MB@"S!XNU&'Q!9V=[8;["Z
MAD=[N"WF5;-D7=MD+J 5(SAN.1TKFO&VLZCX@^&T.KQV]M'I=W>6KQ1MN\Y8
MOM";)">F6P/EQP&ZG%=/HVF>,+FV_L_Q1=:8]HD31/+9%_-NP5*Y?< $X.3C
M.2!T'7GI/!7BX^!!X0\[29;>UFA-K?/+(KO%'*KJKQA, @#&0QZ 8[T >HUP
M]IJ^K?\ "S==M;FXMETRQL8)0F&&Q&,A+>[<<]L ?CVT>_RU\S;OP-VWIGOB
MN4D\,WY\<:CJ:M:/I>IV,=K<I(6$J;-_W0!@@A^I(QZ&@"C<^.;ZV\)P>,&L
M86T.1E>2$$_:(X&;:)<]">0Q3' /WN*[E'61%="&5AD$=Q7G]OX*UG_A"#X)
MNIK232P1"M^LC"8VP?=M,>W ?'RYW8[^U>@(BQQJB *J@  =A0!YNLNMQ?$[
MQ?\ V#:64UR;2Q8F\F9$&%DX^4$DG\ ,=>QT-/\ B(FIZ1I3I:&VU.^EG@D@
MD5I1;M#Q(2$&6 .W &,[AR.:O?V+K.G>--5UO3X[*ZAU*W@B:.>=HFA:(, >
M$;<#N]B*R+GP!J>GZ=I%WH&H6XU[3;F>Y:2Z0B&Z,YS,K 9*@\8ZXP._- '0
M^%=?OM9;4;?4=.DMIK*?RUG$3I%<H1E73> ?4$<X/?FK^NW]]I]E$^GV7VJ>
M6>.$Y.%A5FPTC_[*C)./TZTW1(]:\AY]<DM!=28 @L]QBB4>A;EB<G)P.PQQ
MDT/&NBZGKFEV<6ERVPDM[V*YEM[IF6*YC4G,;E03@G!Z'H.* ,=?'EW_ &=X
MM>*"QO9_#Z"42PS%8KA#$9,C[V",$8R1D=14UGXOUC^U_#<6H:=9QV.NQ-Y3
M13,TD4@B\SY@1C!&1@$X]35*?P?XCGE\9.TNE8\06<<**KR#RG$)BP?E.0,Y
MSWQT7/%V7PQK4D_@R0"P']A@_:!]H?Y\Q&+Y/W?OGG'I[T =M7$R^,M0N/#F
MH>)=*L[:XTNRDE A=B);B.)BLCJW1?NMA2#D <C/';5P5CX0UK2-!UCPS8R6
M3Z5>O-]EN)9&$EJDV=RE I#[2Q(.X9[XH DNO&NJW>MZ?8:!IUE<1ZEI3:A:
M3W$[(#]W <!>!\W;.21TYJ]IFOWLWC:ZT?4--M+>:'2X;IIH)#(S;F(*Y*C@
M$-@<^O>H+;PG>:;XNT2\L5M?[*TS2SIH629O-*DJ0V F.-@[\Y[5,^F7FG>.
MM2\57<EG'I7]EK;L?-8R((V9RY&W&.3QGM0!DM\0-2D\.Z+X@M=/M);/5[Y;
M.&WDE:-XM[E$=G ;/*\@+QGJ<5LQ:[>/X^N]#;3;-98]*2[CG$Q+29D*A"=O
MR@$-V/K[5Q.CVNOZ;H5KK?\ 9?AV^L(V;4(RNH31_,^6W)$5:)'^8@8Z$GGF
MNTCT;53\09?$@CM!:2:4EDL3S,)0P=I 2-A ^]CJ<8SSTH P;7XAZY+X7TSQ
M)-I%C'IT]Z+6Y07#&4!IS$&3C& <=>O/ K6\4^+=2T&+6+H6EK#::="LD)NW
M(-^=I9UC(/R[1QT;)[ 5D)X&U]?AI:^&=VFFZAO1<&7SY-A47'G8_P!7G/\
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MZ&?!\L 8! .<D_A7;:KXHF35[O2M,6+[3:0)-(\T,LBEGW;$Q&,CA<ECTR,
M\XP)O ^O3^ O$F@%M-6XU:^FN8Y!.Y1%DD#X/[O.1C'O[5?O_#_BFQ\4'Q!X
M>ETPR7MM'!J-E>N_EEDSM='5<Y )'(''Z '1>&-8FU_P[9ZE<Z=<:=<3*?,M
M;A2KQL"01R <<9!QR"*UZJZ=#=06,:7TZSW1RTKHNU=Q.<*.RC.!GG &:M4
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M)!]L 8'%=E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4C*&4JP!!&"#WI:* ,2S\'>&M/OOMUGH.G07(;<)([=05/J..#]*VZ** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,O5O#>B:\T;:MI5G>/%]QYH@S+[ ]15RRL+33;1+6QM8;:W3[L4*!%'X"K%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9FM6^H
M7$%NNGBTD FS<079(2:(JP*9 ..2IZ'I6G10!YN_PZO[;2IHM)EL;3?K,>IK
MII9VM BJ 8B< X)&_P"[@$ 8XS5B;P;X@FE\8N]YIC?\)#:)" %=?*80F(^O
M !S[_P"S7H%% '%7'A?5Y5\(;38@Z&RM-F9_WI$1C^7Y..#GGZ>]0WO@6ZU?
M4/%_VZ:".SUZ&".-H78R0-"I"L05 /.#UXQCGK7=T4 <OX=LO&$;PKXCU'39
MHK881K%'#W)Q@-+NX'!SA1R<'(Q@R>.-!OO$GATZ;8O;QR-/#*7G9@ (Y%?'
M .<[<?C7244 <O\ V'JG_"P?^$CQ9^1_9?V'R?.;=N\SS-V=F,9X_7VK.T7P
MQKVCZ&+ C2KE7U">XN(97?RYH92[%#E#@AF'8@X]Z[FB@#SMOAU<P>%+K3=.
MFM;69M735+:VRS6\&UD/E X!VG:3P!RW2ME-!U@^/;3Q!.]BT4>G-92HC.&)
M9PY91@\#;C!//7CI75T4 <7<^&-<B\4:_?:;<V L];@B28SA_,A>.,H-H PP
M((ZD8/8]#2LO!6MVEAX,MVN-/E.@,6D(9U\P>68\#@]CG)Q]!7H-% ')V?A_
M5K3Q+XGU7_0F35HX5A3SG!0QH4^;Y.^<\=,=^M84/@+7].T#PTVF:A8PZ[H*
M/ C2!VM[F)\;E?@,.@/&<8_+TFB@#B=<\-^)-?\ #(M+R[T\ZA)=03N(]Z01
M+$X<*F0222.6..O3@"KXT/4F^(<7B)OL@M1IAL6B$K%\F02%A\N,9&,?C[5T
M]% '$^'_  [XH\->"AHMC>:2]S;2;;226.0H8S*68OCG=M8@ <9'7GCMJ**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex1013-amendmenttoemploy002.jpg
<TEXT>
begin 644 ex1013-amendmenttoemploy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &U<G)Q0!U=%9&G>(]/U+5+C2T,T&H6\:RO;7$1C<QDX#C/WESQD=#P<5KT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7&_%?_ ));XA_Z]O\ V85V58WBK0!XH\/7
M6C27;6T%TNR5XT#-MR#@9X'3T- ' 3_:/%'B_P ,^']9CBTR'34AU6T*.93J
M#(OW58A=NW^)<$GZ<UUGB*\U!-=6UAU1K>!K%WBM[)%>Y>;=C>P92JQ@8Y)
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MXI?)7>Q1]Z@]L9]N1C\=5O#'F^+CX@GO/,=K#[ ]MY(\MHRVX]\YS^&.,=Z
M.>TZ_P#%^IV_A[6;'SGANS%+?03FW%OY$BY)BVGS-RY&,GGO65/K'BF3PYXU
MU%/$3Q2:%J%PMN$M8L2)'&CA'RI^7D],')/)X%='H7@%M!F2WA\0ZC-HD,GF
MV^ER;"D9!W %\;RH/(7(' SGO(/ Q_L?Q%IIU20Q:[/+/<-Y(S&9%"L$YZ8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5K_\=KH:* .>_M[6_P#H3]1_\"K7_P".T?V]K?\ T)^H_P#@5:__ !VNAHH
MY[^WM;_Z$_4?_ JU_P#CM']O:W_T)^H_^!5K_P#':Z&B@#GO[>UO_H3]1_\
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M7TT6PT2[M8W<?:%-Q"7:/NJD/CGH3GIFJ6NKK6N:(VEP^']1TY-R$2+-:O\
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MYX&/7.O\+\?\*R\/$#_ES2K=WX*TFZUN?5U-W;75U&([K[+<O$MP ,#>%/)
MXSUK1T+0[+PYH]OI6G+*MK ,(LDK2$?BQ/Y#B@#S7P9HUIK.N^---UE,ZE;:
M_P#;4))#B,X,1'?:57'T(KJ7U>^MOB98>&H7@%BVFO>,7C+2C#A=H8MT/T[5
MM:CX9T[4=3BU3;+;:E$GEK>6LACD*?W6QPZ^S BDL_#5C::T=9D>XN]3,/V<
M7-Q)DK'G.T*,*!GG@4 ;->=>)X[J3XQ^%5M)XX)?L%W\\D7F#'R]LC^==KI&
MCVVB6LMO:M.R23O.QFE:0[G.3@GM[51U'PCI^IZ[!K,\UZM];HT<,D5PR>6K
M=0 ..?>@#C;8W>D?&VV379%U*[U/3WCT^YA3REMHTR[(8\GK@G?N/I3-(&N>
M+/"NG>);34XK&\\XW,MPU[*455<[X7AP$"@#;CMC.<Y-=U8>%M*T_5I-62*6
M?4I(_*-U<SO*X3KM4L3M'L,5G6_P\\/VNMRZG;Q7,1EF^T26B7+BV>7.=YBS
MM)SSZ9[4 8>DZ7-J_C[Q5!<ZSJZV^G7MG+;Q1WC*H)B#E3ZJ23\O3D^V,JZD
MUW4= U"*.?4E\5IK)BC\B218_*\T# (^41"(G/H1S\U>B6'AVSTO5M1U6V:X
M:[U JUQYDI*N5&%XZ# XXKSC3-#:172XTWQKINK2RR2S0V-ZR6HD=RQ*-OV;
M<GO^6: .@N)+K5?&6H^&P[/!8:?;M$DE_+ [[]X:3<@)<C"#)Z'W-95_::W9
M#P1IM_XCN;BZ?4);2[N+2=D$R!)" WJP  SUR,]:ZB_\"V&N1:7=:O+<C6;.
MW6)M0LKAH)7X^8;EQ\I.3CW.,9JY<>#]*N/[* %Q$NEOYEH(IB-C\Y8]V)R<
MELYR<]30!I:1IB:/I<-A'<W5RD.0);J4RR-DD\L>3C.![ 50\8?\BU/_ -=8
M/_1R4R[\/_:/&EAKL<EQ$]M T4G[\^7*A#83R^F<L&+'^ZHY[:&KZ3!K5B;.
MZDG6$LK,(9"A)!!'(YZ@&@#QW5O"MG:>,_[!2\-M.[+-IT03(E@:7<4'IL;<
M?]T$]JZ_PE;Q6?Q4\76<"XC@L[!!ZGY'Y/J:[-]'LIM1LM1GA$M[9(\<$[_>
M4/@-^>!^OK5.Q\+V&G^(+S7(9+HWUZJK<,\Q*R!1A1MZ# Z8Q0!SOQI_Y))K
MGT@_]'QUT?BVXM+7P;K,U^RBU6RE$F[H04(Q^.<?C5.X\":/=^%AX;N&O9=,
MWEWC>Y8LY+[_ )FZD!N@S4\W@[2KPP_VC]KU%(6#I%>73R1AAT)0G:Q^H- &
M=\++:[M/AAH$-\&6<6V[#=0I8E!_WR5KL*S[W1[6_P!2TZ_F:<36#.T(CE95
M)9=IW*.&X]:T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "D;&T[NF.:6D(W*0>AXH \DNM(USP!I<VM^$;N/5?";1FZFT:[/^KA(W,8
M7],$G!_)C6K>-:ZW\0_"5W&;E;74=*GN3&)G3( C*9 /8,>.ASSFNAC\"Z5%
MI2Z3'<:B-)"!&L3=L8V7^Z2?FVGNH(';&*NZCX7TO4[[3KR:*6.;3PRP&"5H
ML(P 9"%(RIP./:@#B+:+6?&.D:I=6%\EA?6^I30PW"WLJ?9!%)A5,*C804 R
M#UW9] )8-.N/$'C[Q!IEWKFIK9BPM)@EG=M&H=]^2A'('&<#KQG.*Z.?X?Z#
M-K\VLB.ZAGN2&NH8+EXX;DCO(@.&]^Q[YK(M=*GNOBIKMV1JEG!+96\,-S%&
MR)(5W[UR5*]UP?R/6@#E%NM3U+PMX5MM2O9IKFS\7"Q6]XWRK&95#Y.<GMGV
MK5N]5OO"%WX^BL+J[GBL=/M[RU2ZG><PR.'#$%R3C(#8SCBNVN/!ND3V>EVB
MQS0P:9,+BU2*4KME&<.3U8\GKG.3G-2KX6TT:MJ&I2++--J,(@NEE?=')& 0
M%*], $_F: ,&TT74_P"V=*U2VU5(-/EB:.YC_M"6X^VAURC+N "N#SE>H]A7
M%QOJ$/PKB\2G6M5DU*SU4K$[WCE2GVWRRK+G#@J3][)[# XKT70O 6B^')2^
MGF] 4,L$<UV\J6P;KY:L2%/OC/YFD_X0'1?^$<;0,WG]FM-YYB^T-G?OWYW=
M?O?-UZT =17CT4B>#=6T#Q:6$>FZCYFF:JQX5#YCF&4_0@J3V%>NF(FW\KS9
M =NWS,C=]>G6LA?"FE'P^VA7$4EUIS,&,5PY?G?OZGG[W- ' :E%)+XP\#ZQ
M<(RW.J:G/<;6&#'%Y.(D]L( 2/[S-7K58NK>%[#6=3L-1NWN1<:>YDM3'*5$
M;$8)P.#D>N:M6VC6UKK5YJJ/.;F[CCCD#2DH F<87H#SSB@#C_BZ';PYI"QN
M$<ZW9A6(S@[S@X[UN2#6M$@US5;V^34(XK$26\*0^4 \8D9AC)SNRG/M5OQ!
MX9L/$T-O#J+7!B@F6>-8I3'B1?NMQSD9K62/;$(V8O@8)?DGZT >5:C>W]I\
M)]-\;6>HW<NL)';7<I,[&.X,CJ'B,>=NWYR  .,#%:,>ES:Y\2/$VG7&LZO#
M:0064\45O>,FQSO)QCH..G0Y]ACI;/P5H]BB6\*S_8(I_M$5@TI,$<F[<"J^
M@;D+G:#R!5NU\.V5GXAN]<B>X^VWB*DQ:4E&5<[1MZ#&3C% 'G6E:=!;>#OB
M=)&T^4N]2B >XD9=OD*>06(+?[1Y]ZL6$,VD7?PZN;?4+YCJ, M[J)[AC$Z?
M9MR@1YVKM(&" #ZYKLI/!.CNVKD"Z1=7W?:XTN7",6 5R%SA2P !(YIS>#]-
M8:.#)=_\2?'V+]\?W>%V\_WOEXYSQ0!Q7VR]'@7XCM_:%]YFGW]X+23[5)OA
M"1(RA6SD $GC.*FN;,ZSXZ\*PSW=W&)O#TK2R03%)'YBR-X^89/<$'WKI[WP
M!H=_<:K)*+M8]44_:K>.Y=87<KMW[,XW8 Y]0#U&:LR>#],9M.E@:[MKC3HC
M!;7$5RQD6,XRA+$[AP/O9Z"@#SY=;U;PZFK^'SJ,]S:6^NVEC!>W4YWI#,@=
MD,N"1CA=W4;NV!CHI]&UC2VUV<ZJ;>QN-,D>*SBO999(ID&?-1WP5&" 0.^#
MWKI)_"6BW6@W6BW-D)K*Z8O<"1B6E<G)<MG.[('.>,#'2JNF^"-*TS3+JRBF
MOY1<Q>1)-<7;RR"/^XK,3M7V&* */P\TQ_\ A&](URXU/4;J[O-+MQ*MQ<L\
M>=H.X*> W.,]^IY)-=E5'1])MM#TJWTRS,OV6W01Q+(Y8JHX R><"KU !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %8WBG7'\->';S61:"ZCM$,DD?F;&*CKC@Y/Y5LUR7Q/\
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ML%9B!_P%6/X5/7D,:#7+CX4WVHO+-=7-O*)I?-96;_12<Y!&"3R2.M>N@8
MZ"@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN'>.$MUV(Q(4G)Y S@D=*LV'A/2]/-D(EN'CL<FTCGN'D6 E2N5#$\X) SG
M) Q6Y10!@P^#M#ALM4LC:-+;:I(TMY%-,\@E=L9;YB<'@=,=!Z57L_ 6AV=U
MIUTHOI9].W"T>:^F<Q!@ 5&6Z8&,=,5TU% ',1_#[PW%KTFL16+I<2RB>2-)
MW$+RYSO,>=I;//3KSUJXOA32DNM5N52X$VJJ%O&%U)^\ &T?Q?+@<<8XK;HH
M YYO!&A-INF6'V>=8-,?=9E+J57AXVX#AMV,'&,XQ70*JHH50 H& !T I:*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex1013-amendmenttoemploy003.jpg
<TEXT>
begin 644 ex1013-amendmenttoemploy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***\_^,FHWVC?#ZYU/3+VXM+R"6())#(5X9P"".AX/>@#
MT"BO,]!677=#T3[%XCU+^VEL+/4+L?;"Z-NVED=3G&[#\#&*I_%\>)_#Z6OB
MC0M3O?L$$BC4+!9F"%<C##'(!^Z<=,@^M 'K%%<5H-\GCFYL?$&GWM_;Z-%#
MM\E9V7[3*<9##/ CY&1]YB>PYY*]UJ_MOV@[?0Y-8NXM&>V\Y[=KIE3=Y;'K
MG(&0#C- 'L5%>.W6MWTO[06GZ%;:S=OHT]N9I+>.Z8H7$;MU!R!E0<9I]_JN
MJ)^T-8>'EU2^729[8S26HN&"EO+=NN<@94'&: /7Z*\<US6+RW^/%IH4VNWM
MIHD]F9I8_M;(JML<Y#$\<J.,XJ_\,M<UW6?$'B73[F\N=3\.V\K)8ZE)\K-A
MB-JR*!OXYR/0=,T >J45XO\ ##4-?\3+XWM9]<O7N;9S;6,LLS$0%O- ;'<C
M"G)STH\9W.JZ!\1_!VA6>O:L;/4'1+KS+IBTOSA2<]N/3% 'M%%9.BZ5=:5/
M?K+J-S>6TTJR6XN9"[0C: 5R>HR,CZUPOQOUW7_#GA2WO='U3[&LUTMM((XA
MYA#*[9#D\?='0 \]: /4**:G**3Z"G4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKGO'9=/ FNSQ33PS06$TT4D$K1LCJC$$%2#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex1015-amendmenttoemploy001.jpg
<TEXT>
begin 644 ex1015-amendmenttoemploy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM=M-0@GM;G[1/((9HF5V4Q( 0",G)!''>IO@;X<T\^$&_M?1(1JD%Z[H;RT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH R_$&EW>L:2]G9:K<:7.S*1=6X!=0#R.?6N0_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
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MD5J4 %%%'09- !16;I>O:9K4UY%IUVEPUE((IR@.%?&<9Z'CTK2H **0,"2
M02.H]*6@ HK+N/$%A;>(+/0Y6E%]>1O)"OE-L*H,M\V,<9' .>:U* "BBB@
MHHILDB0Q/+*ZI&BEF9C@*!U)- #J*Q-/\5:;J6J1Z?$MRDTUM]KMVE@94GBR
M!N1OQ'!P>1Q5O6=;T_P_ILFH:G,\-I%S)*L3R!!TR=H.!SUH T**@LKR'4+.
M*ZMRYAE4,A>-D)!Z'# ']*GH **** "BBB@ HHHH **QM>\4Z1X:2,ZG<.C2
M@E(XH7E<@=3M0$X&1D].:FLO$6D:CH(URUU""33/+,AN=V%51USGIC!R#TH
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M;;/(E2.)7"$%C@')YY.3U&,'TZN.C\$W2:5XGL3JT1&ORRRN_P!D(\DR($8
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M5_%LEWJ<MR(M9DAVNBC.(HL'@<8'&!Q^-;OC#Q WAOP^UY#&DEU+-';6ZO\
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MA]0AU R*6%W#C9*,G##' XQQ6E0 4444 %%%% !1110 4444 %%%% !1110
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M/) ET@'FQ_>0A@P/OR!QWK7HH X\>";R37%UBZ\17,MV=.?3Y2MO&BLK-N!
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M6>,2 !@K#(R 3S5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4[>.]97B^:U\7Z ^DS6'B"UC>1)/-BTMRZE6# J2.#D=?3-<WXO\1*EWI?\
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M %CQS_R3_P 1_P#8+N?_ $4U<9%>>(O#6F^#M3_M@7>FWSV=C/I[6R*L:RH
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M"_1%$D3,Q9@1]UE)8@C'3%:ND^%)=/\ $UUKUQK-S=W5U;QV\J&*-(R$R0<
M9'4]_KF@#)^(Z327?@]+>58IFUV,)(R;@I\J7G&1FLZ;Q-KG@[6M?T_5K\ZS
M!;Z,^KVDTD*12+M;88FV  @G!!QTKL?$?AU/$$=B?M<MK<V%TMW;2QJK 2*"
M/F4CD88\<?6HT\+6L\FHSZJ_V^YU"V^R3NR;%$'/[M%!^5<LQ/)))Z\# !C6
MI\6OJNE7$4MS)IT\;"_^TFV 3*Y62'9DC![-D$8ZGFN>\.P^(?\ A6^O7FD:
MY>G5(KZ]>$2QQ2!V25N#E,DL!CKUQC XKJ_#O@J?07@AF\1ZCJ&G6G_'G9W
M3;%C@;F W/M'0$X'IP,7_#GAE?#C7RP7]Q-;7-S)<1V\@4+"9&W, 0,GGU/%
M '+?\)G/)XF\)W,&ISMHFK6RB>,QQ;8II%)A#-MSEBD@(!X([=*N3^(-3ABT
MB-+BXF?7KZ7[,52$-#;*CNNS("EF55/S9QN/4@5:/PWT7_A%+SP\IE6VN;LW
M>]3AHF\S>H0]@H 4>V?6M+Q/X3L_$NE6]FTTUE+:2K/9W-J=KV\BC *^V.,4
M <W=:WXH\.6>IMJ"/+;37=M;Z7-<&$S*97".'"$(=I)*DXST)JV6\76E]J+>
M=<#2C8/)'+>_9VF@N%R?E$?#(1V/0^U79/ \6I>'KW3-?U6\U66\55>Z<)$T
M84Y3RU4 +@\YY)/7(XI=.\)7UM93PZAXEO=3F:!K>"6XC0"%&&"0% W/C^)B
M3^9R <M8Z]XDBT;P+KMSK37 U>YM[2ZM#;QK&PE1COR!N# KG@X]A7J=<=_P
M@F-"\/Z4NJR"+0[B*XMW\D;G,8(4/SC&"<XQFNND$AB81NJOCABN0#],T >$
M66JWUI\.M0TTP00:7JNL7EC<:I(Y<68D<KN:/ X.< [L GFO3KZTE\+^#M)T
MW3-2BM8+5[>V>YG&Z1HA@,(UVMNE;HHP>33M#\#VFD^']0T.ZN&U&POI)994
MGC .9#EAD=L\CC(]:J/X E?0=-TMO$-ZS:5<QW-A=/&C21% 0%;C#C:Q'(S[
MT 8K^.M1T33O&LMP9;G^R)K=;'[9&J/^_5=H?8!P&;/8XZ\U9URPO;3XA>!&
MN-6GO-TUT&$L<8 ?[.WS+M48'L<]O?.F_P .;*[?7QJ.I7MY!K<<:W,<FQ<.
MB@*X(48(P"!T'H:6+P->->Z)=7WB>^NI='=VMV,$2E@R;,,=IR<<$]_8\T <
MQ<:UXJ;PMXQU5?$+1RZ%J5RENJVL6)$C5"$?*GC!/3!R2<G@#HY]?U#5]>.D
MV8O(1%IL-W(UD8?,+RE@!^]XVJ%[#DGGIS+_ ,()G0O$&DMJLABURXEN+A_)
M&Y&D #!.<8P!C.<4FI> WNKO3M2L-<N],U>RMA:&\MXU(GA'(5T;(///U_#
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M@4Q:IJUSINM7-A;ZN"U[:I$CHTA7!="PRI/?KG\L %KX=_\ )-_#?_8.@_\
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M3Z-#JUA'.MG/DQ/,H4N 2"0,DCD'KBN-\"OK@^%6D""WTXP?V<-K/.X;&#U
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M!P2001TP>!5/3+KQ;JMGX>UVQF8I=&*:^BGEC^SM ZY81@#<K+D;><G'S9H
MU9?B)I,.DW^H/8ZL$L+K[-/%]B;S%_Z:;?[F 3GVKH+75;:ZO9+-2R3J@E5'
M&/,C/1U]1GCU'<#(R/I%G)!=0O&S)=OON,N<R=!@G^[@ 8Z8XZ5ROCNX?3/$
M/@K4(.)&U86# =XYD8,#[953]0* .XHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %9/B6#4[CP[?+HUX]KJ2PLU
MM(BJV9 "54A@1@GBM:B@#R36/%VJM\&M*\6Z?K5Q%=1>5]L7RXB9SOV2K@I@
M$'<1@# %=QJ=U-?2:!!I6ISQ"\?SGEB5&,ENJ;F8[E/4F-<C'WZY+0O"]PGC
M3Q!X?N[?=X=CE?48 >C-<H8R@_V1^^X]2*N_"W3=4M+&>+5U._26?2+1F_CB
M1RQ<>S QK_VS% '?SQ-- \:S20LPP)(\;E]QD$?I7'_"O5-2UWP!8:MJU_)>
M7ERTN]F1% VR,H "J.RBNPGN(;6!YYY4BB099W. !]:X/X+NH^%^EVS';/"T
MPEB;ADS,Y&1U&00: +7C5-<TO0/$6N6WB"[MS;P--9VT44)C0+&/O;HRQ)8,
M>O0BKWARTU>6UT?5)M>N[N*>T5[FVGCA"EF0$,I2-2,'L3T/M3/B7(B?#C7H
MV8!Y;.2.->[L1@ #N:TO"<T<WA#1VB=6"V4*M@]"$&0?0CTH R/B#-XALM,M
M;SPW>,M^+J.-;1U0Q7 .<HV5R"<8R"/ZU _BY?$7PTU/7-(N9K"^M+69I(]J
MF2VGC0DQNK C@CTY%:GBV\MK7^QQ/.D9.I0G#-C@$Y/T'K7'?$;PWJ&EQZIX
ME\,Q[UU"T>VU>R7[LZ,I43J!_&F<GU&??(!ZA%$T4"QM-)(P&#(^-Q]S@ ?I
M7!^&KC6-8\3>*[*Y\0WZ0:;>I%;B-(!A"F[!)C.:[\D $DX ZDUY-X=;PQ/X
MS\:S:W'ILJ2WZ&WDO(D8.OEX.PL.1D=J /2-"68:8K2ZDVHI(S20W+*H9XVY
M7.U5' .,@<XKE-1\1J_Q&F\.ZGK$VCP"UBDL/+*H+MV+;SO8'E<* O&>>O;H
M_#%UI\^DBWTE&&G61%K Y! <(H&5R/NC[N>^#VZX?B27PMK]UJ&@>++>WCAM
MRC07%SF-3N0$[)3@!P>H!SC% '0Z#;ZI:V]U#JMXUY(MRWDSLBH6BP-N0H R
M.0>!R#7-^+;_ %6V\>>$]-L]6N;2TU1[E+E(TB/^KB#*060D<T?"^"_M-&U&
MTFN[F\TN"^>/2KBYSODMP!CD]5SD ]\<<8K-^($FFR_$/P2FH"WEM()+MKI9
ME#I&&B 4N#P,G&,T =C86US!KCH==N+V)+?]];3K%E&9AL8%$4]%D!!/I4VJ
M:?J%_=6OV75KC3[:-7,PMTC+R,=NT9=&  ^;ISTK*T6Y\,VVNO:^'H;8RWD8
MDN19(%B18\@,VT8W$N%QU(^E=.[K&C.[!4499F. !ZF@#S?PFWB/Q#8:^Y\4
M7R7-AK%S9VV8;?8R1E=H<>5DYS@D$>U=]JWF_P!D7;03R02K"S))&%)4@$@_
M,"/S%<3\*9XG@\4('&^3Q!=SHIX+1L5VN!W4^O2NSUJ>*VT2^EFD6-! _P S
M''\)H Y[P!>:EKOPYT[4-0U.XEOKR$N\X2-2IW$?* NWMW!K/\!>*W_X55:>
M*?%.K.^\.T\\D:A4 E9%PJ*/;L:I?#?2/#A^&&EW.H:=IIFA@(N7G@3>C;C]
M[(R#TZTGPSUC3]"^"EC<:H66*R607,8B+NFZ9L90#/.0>G3F@#TU6#J&4Y4C
M(/J*6D5@ZAAT(R.,4M !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%9-_XETK3-7L]*N[B2.]O21;
M1B"1O-QR<$*1P.O/% &M161#XFTF?Q#+H,=Q(=3B3S'@-O(,)TW9*XQR.<XJ
M237]/CO[FQ9K@W-M$)I42UE;:A) .0N#DJV,9Z'TH TZ*RM)\1Z7KFD_VIID
MTMS9<[94MY/GP2#M!7+<@C@&JMOXUT"ZT&;7(+R5],AW>9<BUEVKMSN/W<X&
M#D]J -^BL$>,M&:TCN]]Z+61599SIUP(RK8P=Q3&#D<YQ3[[Q9H^GZNFDW$U
MS]O>,RI!'9S2,R#@L-J'(]Q0!MT5G:5KNF:W;2W&FWB7*0N8Y0@.Z-AU5E(W
M ^Q&:HV_C/1+N:YAMI+V>2UE,,ZQ:=</Y;CJK83@T ;]%5=.U*UU:R6\LW9X
M69DRT;(0RL58%6 ((((Y':D@U.SNM0N["&X1[JSV?:(AUCWC*Y^HH MT50U/
M6;'2!"+N5Q).Y2&**-I))"!DA44$G Y/''>H],\0:;K%S<VUG,YN+4(9X987
MB>/=G;N5P",[30!IT44A(4$D@ <DF@!:*S'U_3X_$<6@L\HU"6!KA4,3!2BD
M G=C!ZC@&M.@ HHHH **R)?$VEI>S6<<D]S/ =LRVEM).(CZ,44@'V//M5G2
M]8L-9BFET^X$Z0RF&0@$;' !*D$9!&X9'8\=: +U%%% !1110 4444 %%%%
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M%N]6N'M[=F""00NX#'H#M!QGWK1BD6:)9%#!6&0'0J?Q!P10 ^BBB@ HHHH
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MM9:QH&O2Z9J4%L+2:6:$7"W40.?G4D?-DD[O>NGTRRDL+%89[J2[N"2TMQ(
M#(QZG X [ #H * ,KQ5K\NCG2;.UV"\U6^2TB=QE8P069\=\ ' ]2*H1ZSJ=
MAXX'AB\NA<0WUB]S97AB421NAPR.!A6'(8' ]#GK6GXI\-1>);&VC^TO:7EG
M<I=V=TB[C%*G0D?Q#D@COFDM= N#KG]MZC=03ZC':FU@\J I'$I.YCM+$DD@
M=QP,>I(!S_PNANA8:U)->&5/[9O5*&,#+^:<MGW]*[#63.-%O3:W!MYQ Y24
M*&*$#.0#Q^=9GA/PY<^&K6]@FU".\6YO)KO*VYB*M(VXC[[9&<UNW$*W%M+
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M"B7FKW1A25UR(D5"[MCN<  #IDYYQ@W/#.@P>&?#MIH]O(9(K96PQ&,EF+'
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M; *2 /[Z]0?Y]#TZ>$M;N->T+6-3\0P7%QI23Q@0V'EB82!02<N<'Y><<=,
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M"TU*\CL+J)HD7RI) =KQ%0"%##!#%N".<\T =?>WL.GV<MW<>9Y,2EW*1LY
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MQ0EU0A2V7(^Z..IJ[7':SJ6KZ-X@\)V$>H":VO[J2&Y,L*^8X$;..0  .!T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3K%B&2*ZCC$@:-L;D=#PPXS[5KZ/ITVFV92ZOI;ZZD;S)KF10N]L <*O"@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG->/$)5@24%RA&<X^A!^E<!JDWA74-!\6:WI&HR:A<2Z%/!<7;2YC V$HAX
MW]<#J.^,C+&GL(6^%)BEMDQT*LHX:U(/YMC/O0!U7CKQ-#H_AC6&M-7BM-3M
MK5Y8^%8J^TE%(((!;& #U[5>L/$VF0Z7IZZEJUI%>R6*7$B2RJK8V LY'8<]
M>E>;1ZU9P_#;QUHVL7,,.O+)?M/;SL!),6!,;J#RPV[<$= HK5L[O3[GQM\/
MF6>VD/\ 8LVT[E/S;8L?CPWY&@#M6\:^&$L(+YM?T];6=RD<IG4!F!P1^&1G
MTR*T[[5+'38EEO+J.%7SMW'EL#)P.IXYXKRF&73?^$1^*Y5[7+7E[R"N3F!=
MO_CV<>^:D77+72=<\-7VKZE-9Z1>>'H8+>^C?]VLX.YU9L$#<-O_ 'S[4 >D
MGQ+H8@LYO[7L?*O3BV;SUQ-_N\\_ATJ!?%_A^72;[5(-6M9[.QS]HDA</L(&
M<8'<]O7M7G>KVWARST[PE'IC9TV?Q.DZ-<OD3!D?<ZAOX"Q],'J.",Z$TL,O
MC7XBV\$D;2RZ-!^[0@LS"*4'@=2,J/Q% '=^'==M?$>AVFIVK+MGB21D#!C&
MS*&VGW&:BENHF\6V]LFNQI(MLY?2AL+2<KB0_P 0QT]#FJ'P[O[2_P#A_H7V
M2XCF\FP@BD,9R$<1J"I/J.X[5F:E<6Z_&O1$,L8E.D7*[2PSDNA _0_D: .K
MCUW2IKY+*._@:XD9D2,-R[*"6"^I&#G'3'-7)IXK:"2>>5(H8U+/([!551U)
M)Z"O+?#]U<Z3JN@0Z=J%OKGAR^NI!:Q2 ?:].<HY/(/S*H+J<\C./KV/Q!O+
M2P\!ZO<WVG_;[980)+;<5#@L!R1R ,Y)'8&@#6L-;TS5)I(;*]AFFC4.\:M\
MP4]&P><'L>AI^HZMIVD0)-J5[;VD3L$5YY @+'H,GO7GFC:K:3_&&"4:Q!?_
M &G0-D<L"@1.PG!*1XSD 9/)8CG)XX[;Q7H:^)/"VHZ2QVO<0D1/_<D'*-^#
M '\* +:ZUICZI_9:W]N;_9YGV82#S-O][;UQ[U7?Q1H,>P/K-BI>4PJ&G4$N
M/O+UZCOZ=Z\R;6=9D70/B#]@F\R(+I%U9A,-+O\ E9OH+C:H'MGO6QXUM;32
M[3P-97LT#.NO0/,TA \QBLA=R#V+MD_6@#IUU[2]7U719-,\4VOE2M,19PM&
MYO0%(_W@$*DY'IS45M\0- N)-:S>QI#I3E)7)Y?"AF*CJ0"<<=3TK)\3&QL_
MB5X"B0V\'[Z^;:N%^] ><>['\35#3+F$7GQ)TLR+]OEN)94MA_K&0VRX;;UQ
MGC/3.!WH [/1_%.F:MX;M=:%S##!-%&[AI ?+9@"$/\ M<@8]:D/BK0%TR34
M6UBR2SB<Q22O,%"..J'/1O;K7F"Z[:VW@WX>:H;R0Z/81I!J,]J=WV:1K?8I
M; .-I)![C=[BG>,?^$;?X>>,M4T:\>[^WK;"XO'EW1S2JX 5.@+ 8SCU'<'
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M%Y87FD^,K_PW:P/_ &5XI/VH2)]VW88%T/;>F"#_ 'FKTM55%"J % P .@%
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ME '?V6M:;J,[06EY%+,J"0QJ?FV$X#8_NGL>AJQ>7MKI]LUQ>7$<$*D O(P
MR3@#ZDD #O7#>$;S5K;Q4-'U"]L]<MQIQGM-7MP%D$>]0$E )4D]01UVGWQH
M_$+4[/2]-TF6]@@97U6!8[BY)$5I)DE9GP1D+CH2!DC)% '06VN:7=VEQ=0W
M\#06Q*W#EP/)(&2'S]TXYYIUCJUAJ4DT5I=1RRPA3+&.&3=G;N!Y&<''TKRF
M"YT:[U3XA6NH:W)]GN6L'^VQ[58 QHHE& !L5BOS="!U.<GJ_!M]K \1ZGI6
ML2V6I2P6L$D>KVB[?.C+/M211D!Q\QP.S9H ZJ_UG3-+DACO]0MK5YVVQ+-*
M%+GV!ZU73Q1H<NFQ:C%JMK):2EA'+'(&#E?O8QUQCGTKF/B9)9K<^#TNWA"G
MQ! Q64C[NR3GGMDC\ZI>(-1L?#?Q(M9=4NI-+T>[TWRK:ZAPD2SB5GD5C@@%
M@5.>^V@#O!K.F-I::FNH6S6$@!2X$H*-DX&#T.3Q]:K1>*-"FBNI4U:T*6BA
MKDF0#R <XW@_=^Z>N.E><S3:)X9U'PC?VC31^$_MUX[W4Y)C$\B 1R<]%),@
M!X')(X(-3BX@UG7?B7+ICK=)<:+;K$\7(E)AF VG^+TR* /2#K6EB2RC.H6P
M>^4-:CS1^_!&<I_>XYXK.M-5L8M2UNYF\2VT]K 8M\#-&J6'RD$,X_O$$_-T
MKSQ?$&D7-A\+Q!J%O)]GFA2<HX(B;[,R[7/16SQ@\UHQW=F/$?Q3!N( /LMO
MNRX[6I!_7B@#N[7Q1H-\\JVVL64K0P+<R!9E^2)AD.?0$$'/N/6I]/UK3-5D
MGCL;V&>2 @2QJWS1YZ9'4 ]CWKS"816WP5\+ZG8P>9%:)82W[6B@R>2A5I.G
M4JWS$>H)-2:VVD:]HOB#5_"%_=:KK+Z,]NUQ%(6"Q;@WED #YR-V!C=P?:@#
M?\1>+0/$/A>VT?68FCO-1$%Q#&%82Q[7)(8C) *@94]ZZO7)+B'0;^6UG,%Q
M';N\<@4-M8*2.#P>E>:ZMXE\.ZE%\/)]/OK3RXM2A!17&ZW7R77:P_AYP,''
M2O2];5GT'4512S-:R@ #))VF@#GO!OC+3M2T/0K2_P!:M)-=NK&*:2 RJ)'9
MD#'Y1W/7'I70V>MZ7J%Q<V]GJ%M<36IQ/'%(&:(^C =#]:\H2UT_5_A3X-T_
M2OLTFM)+9M (-ID@D1E,SMCE< -N)[XSSBNB\3)J/AGQFFIZ/ SKXBB&GS!1
MD17:@^3,WMMW ^RB@#O+*^M-1MEN;*YBN(&) DB8,I(.#R/>K%5M/L8=,TZV
ML;<$0V\2Q)DY. ,<^]6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YCQ[X@G\,^%VU" ^6#<0P
MRW!CWBVC=PK2[>^T'@>N* .GHKF-/74GOM+O-/\ $#:MHMQO\YG2)C]PE65X
MU4;<CD8ZXYZBM*[\2:/8W:VUU?Q12&00Y;.T2'HA;&T,<C )!Y% &K16;J7B
M#2M(+"^O$A*)YDG!;RTSC<^ =J\'DX'!K.NO&>EVWBBQT+S=\MU;M<>8H)0+
ME0N"!@[MV>.@'N* .CHK$T>]M+C4]9>#7AJ"1RJ'@!4I9D+RH('?!)R>*GM/
M$>D7UY':6]]&\\J&2)3E?.0=6C)&''NN10!J45S\_CGPM;1R22Z[8A(IC ["
M4$*XQD$CTW#)Z#/-;ZL&4,I!!&01WH 38GE^7M79C&W'&/3%*RAAA@"/0UYM
M>^*+C7/'%SH>E^,X=#FMI/(2SETX2M<D#+.KO@=25 &?NY[UZ2!@ 9R?4T -
M$48! 10#U&.M'DQ8QY:8_P!T5Q6H'Q7I?B31)4UA+V&_N_)NM-%LBI#%M+-(
MCXWX3 Y8\DCID"NXH 9Y,0_Y9)_WR*#%&6W&-2?7%9J>)=&DO8K1=0B\V9S'
M$3D+(XZJK_=9A@Y )/!KG=:\2I<^.(?"ZZC-90FPDGEF@&)/-WHB*"0< 98^
M_';((!VK1HY!9%)'J*;Y$7_/)/\ OD5SNK:VW@CP.^H:W>-J%Q:0X:98=AN)
M/X?E7(7/&3T'6LO6_$KVWC+PG)%JQBT>\6\-U&ZJL9\N+())&X8)]<<"@#MS
M%&0 8TP.@QTIS(KC#*&'H1FL[3_$&D:KIDNI66H02V<)999MV%C*_>#9^[CW
MI;#7M,U.[FM+2[5[F%0TD+*4=5/1MK ':?7I0!>:&)D*-$A4@@J5&"#VIJV\
M<5L8;>..)<$*JH-H_ 5*3@9/2N'\(^,KK6?%>L:7?1"*-D2^THX_UMH?DW?]
M]+N_X'[4 =;ING0:79+:VX.W<SL3C+,S%F/&!R2>!P.U62BLP8J"0" 2.F:K
M7NIV>GM$ES-MDF)$4:J7=\#)VJH).!UP.*S?^$T\,&R>\&OZ<T",JLRW"DJS
M?=4@'()P>.O!H VO)BQCRTQ_NB@11@@B-<CH<5EV_BG0[N">>VU.WFC@G^SR
M&([CYN,[ !RQQV&<U-::]I5]ITNH6]_ ]K"S)+(6VB)EZJP/*D>AP: +J6\$
M<K2I#&LC##.J@$CW-/95<8901Z$5E0^)]$F2\<:C#&+(!KD3$Q&$'H6#8(![
M'H:@B\9^&YKFUMTUFT,EU'YL(+X#KMW=3Q]WG!YQS0!N;%V[=HV^F.*;Y,7_
M #R3_OD5GZ3XBTC7&N5TS4(;IK9@LP0\IGD9'H>QZ&F0>)M%N;T6D6HPF=HS
M*@8E1(@ZLA/#@=RI(H T_*CSGRUSZXI5C100J*,]<#K6"/''A<F #7;)A<2^
M3$5DR&;.W&>G7C/0FD?Q?IR^,QX:W-]I%MY[L5. 2X55!QSG+9/08H W8[>&
M*+RHX8TCZ[%4 ?E2^3%Q^[3CI\HJIJFL:=HL"3ZE=QVT3N(U>3."QZ#ZFFIK
MFFOK!TE;I3J C\TV^#O"?WL8Z=L^O% %M[:"20N\,;.5V%F0$[?3Z4\QH6W%
M%)]<5SNJZWIEU!9>5XB&GEM12%2N-T\BOAH,,.<G@XY'YTH\6Z?<^+;KPU'+
M(EU# KM*$/#L2 %R,$C&<].WK0!T'DQ8QY:<_P"R*22WAEB\J2&-X_[C*"/R
MK@_!'C6U.@6D7B#7(GU.XO;B",S%59\3.B#"@ 9VX'3..*[R:>*V@>>>5(HD
M&YW=@JJ/4D]* '&.-L;D4XZ9'2@1H&W!%#>H'-8UEXQ\.:C<""TUFSFD,#7.
M%D'^J4X+9Z8_ISTJQ9>(=)U"[EM+>]C:XBC$K1."C>7_ 'P& RO^T./>@#25
M%1=J*%7T Q2&-"VXHN[UQS69%XET:9V5;^-<0FXW2@QJ8@0#("P *Y8?,..:
MJ0^.?"]Q?6EE%KMD]Q> &W02#]YGICW/8=^U &XEO!'*TJ0QK(PPSJH!(]S3
MR P((!!X(/>LW4O$.DZ.S"_O8X-H#.2"1&I. 7(&$!/=L#BI+W6=/T](VN+E
M1YJEXU0&1G4=6"J"2!D9/09% %Q8HTV[8U7:-JX&,#T%/KF-2\=Z-83Z(D=R
MMPFK2$0RPY= @5F+Y&1_#C'7GV-;M]J-MIVF3:A<N5MH8S([!2QV^P')^E %
MC8FW;M7&<XQWSG/YT-&C_>16^HS6%HGBW3=7\,6VN-*MO!+&C,)#C8S8PON>
M0..IZ5HZ?K&GZJTZ6=RLDENP6:(@J\1(R RD KD=,CF@"X8T8@E%)'0D4H10
MY8*-Q&"<<FJ.H:YI>E36\-_J%O;2W#;84ED +GO@>GOT%9P\<^&#9W%T-:M3
M%;2>7*=QRK8SC;U/ )X'0$]J -WRH_+,?EKY9R"N.#GKQ2+!"D2Q+$BQK]U0
MH 'T%53K.FC3(=2^VPFSG"F*96R)-WW0N/O$]@.32Z?J^GZJDS65TDI@?9,O
M*M$W7#*<%3[$"@"UY48(/EKD=#BG,JNI5E#*1@@C(-<%XB\5J_B+PK#I&KMY
M5YJ(BFB1!LN(MC$LK%?F ( RIQSS706>HV1UW6W77Q=+;)%YUDNUELN&_NC.
M6P20?2@#0U33VOM)N[.VN&LIIH&ACN85&^'(P"/IUKF8/"VL7ED--UHZ"]D(
MQ$\EK8L)9$ Q@;F(0X[C..V.",;3?%J:M9CQ!<^)VTJ&VU*5)8'B#0-;+(45
M&R.&8 '?G()^@KT"75K& V8EG"&\;9;AE(\PXS@<=< GZ GM0!;$:*VY44'U
M IOD1>?Y_E)YN-OF;1NQZ9KG;#7]'LK#5]2N/%$-W8QWKAII'0);'"_N5(ZX
M_$\UH6?B?1-0U5],M-3MYKU$\PPHV3MZ$CUP>N.G>@#2>"*1T>2)'=#E&902
MI]O2G&-"VXHI;UQS67=^)]$L'D6[U*"!8Y/*DED.(XY,9V,_W5;'8G/-7TO+
M:6R%[%/'):E/,66-MRLN,Y!'48H D\F+&/+3'^Z*22WAFC$<L,;H#D*R@@'Z
M5YOXD\=MJWPNUC7?#]]/97%J[!&$8W%1-Y>2'7C(R>,$<5W%EXCT;4=4GTRS
MU&WGO8%WR0HV6"YQGW /!QT- &DT:,<LBDCN10(T4DA%!/<"LQO$FCKJ$5BU
M_$MQ+(8HP<A7D'5%;&TL/[H.?:M6@!%544*BA5'0 8 IC6\#RK*\,;2+RKE0
M2/H:XK7/&=UI7C_2;#RQ_8DLGV&[N#_#=2*'B7VP /\ OY[5V=W=VUA:R75W
M/'!!&,O)(V /QH 66$2(X4^7(RD"15&Y3CJ,UQNG^%O$$-C'I=]=:'=6B)Y9
MNWL&:XD7N6#,5WGJ6.1GD@UOIXJT%KM[1M5M8;I 2UO</Y4H &[.Q\-C'.<8
MQ4=EXQ\.:C<)!9ZS9S2/"UPH60<QJ<,V>F!C\N>E &I:V-M9VD-M#$HCAC6-
M,C)V@8'/TJ7RH]C)Y:;&&&7;P:S['Q!I6HWKV5K>H]TD8E\D@JQ0\!P"!N7_
M &AD4V/Q+HTNH1V*:A%]HEW>4IR!+M^]L8\-CO@G% &E'%'%&(XT5(P,!5&
M!]*;%;00 "*&./:"!L4#&>M8DOCKPM!"TTFNV0B68P,XDRH<8R"1Q@;ASTYZ
MU;@\2Z+<ZRVD0:G;R:@JEO(5\D@=<=B1W Z4 :M1Q00P!A#%''N.3L4#)]3B
MLZ\\2:/I]T+>[OXH7,BQ$MG8KM]U6;&U6.1@$@G(J&\\8>'=/FNH;K6+2.6T
M"^>GF9:/.< @<YX/'7 H BT'2-8ANFO_ !#J-M>WRQM##]F@,21QE@3P226;
M"Y_W1[D]!7-:QXWTC2H-'E$XN$U6>..WDB!9"K<E\@=, X]3^..CCD66))$.
M4<!E/J#0 &.,EB44EL9..N*3R8N/W:<=/E%/HH C:")IEF:)#*HPKE1N ]C3
MI"XC8QJK/CY0S8!/N<''Y4ZB@#F/!/AJ?PWHB65\+26XCFF=)X02<22,Y'(!
M&-V.O-=*8XR^\HI?&W<1SCTIU% #!#$,8C3Y1@?*.*<44L&*@L!@''(I:* &
MK&B9VHJY]!BFQV\,*%(H8T0DDJJ@ FI** (XH(8 PABCC#'+;% R?4XISQI*
MA21%=3U5AD&G44 -\M"2=BY;&>.N.E-A@BMTV0Q)&F<[44 9_"I** &M&C_>
M16^HS22PQ3Q^7-$DB?W74$?D:?10 R2*.6(Q21J\9&"K#(/X5SNE:#?6/C;6
MM:D:U^RZC%!$D:,V^,1!@">,'.[IVQWKI:* (TMX(\;(8UP2PVJ!@GJ?K2^5
M'S^[3GK\HYI]% "*JJ,*H ] *;%#% FR&)(USG:B@#/X4^B@")+:"-BR01JQ
M8N2$ .X\9^M2T44 1I!#'(\D<4:N_P!]E4 M]3WK#L](UB77GO=8U&VN+2WF
MD?3[>" H8]P*@NQ)W,%+*,8^\3Z8Z"B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\2:M9
MZ1I\3ZC"LME<3K;SADW@*X(R1@Y'K[9K8HP#^% 'DUAI&G>'_B'I#>!=2$EC
MJ#R'4],MYQ+;QQA21+P3LYP!ZG@<9%4].N_#TVGZIX1\7&_.J_;IRUAYDP^V
M[YFDC>,*<'.1Z=,G KV-8T3.Q%7<<G QDTNU2P;:-PX!QS0!YA::[I?A_P 6
M>*]&\6'R5U.1);9IT:1;N Q+'Y:D [B,$8ZG<:LW%Q::3\2/"LDD']GVDFC3
M6UO"RXVMNC*Q #^+:.@]*]&*JQ!*@D="1TI: /'=1CN=6A^*UEHLJRWTS0F.
M.)@6D40H' QUSAE^O%;&LWMEXL@\%/H$T;WD.IP7)2(C?;0*C>:' Y48^0@X
MY(%>E4@55)(4 GDD#K0!Y MSI[>&_BN1-;%Y;BYP=RY<?9U"X]?FR![YKTCP
MI,D_A#1I(Y%D4V4/S*<\[!G]:V,44 >>^+;WP]XZ\.W.FZ7=P7>LQR[;18\B
M>VN%; <@C<B@CEC@8S78OK>GP:U'HTMR!J#VS7*Q;&YC4X+9QCKVSFM *H)(
M !/4XZT8&<X&>F: /-/$B^'_ !?/I.K^&+^"X\00WL/D36DN76,./-$BCH@3
M=G</0=\'O=<AN[C0-2@L'V7LEK*ENV<8D*D*<_7%7E55SM4#/)P.M+0!XY<S
M0:[\&-)T'3V6/Q# ;2VCM.D]O<Q2('8KU7 #,2>QSWKIIKZT3XY6\;7,(?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWF"("V!D9.,#(]:OUY_<+J;?&V!$O+4(-#D=5:V9L(;A 1_K!\QP/FZ<?=H
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M,C0PQ,&B<Q2$*&+'<,$@G Y /&<  ],HJO?S7%OIUU-9VWVFZCB9H8-X7S7
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MPPV%B&V_*<<9ZX$(\::KJNM>'H-&CL5L]:TV2\1[E7+Q%0O4 @'&[H,9QU%
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M10!QT7A?6-)\6:GJFBW]FEGJQ22[MKJ)F,4JC;OC*D9R.H./K6/:_#G6-/\
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MZMP5()D,BM@]U;'?G%6=+T#Q)=6<ECXKU>SO;3R'@"V<#1-.&4J6E))&<$\
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MLA )'R\<<5>U+P7J/B'PW<6>N:T'U-Y(Y8+FU@\N.V>,Y0JA)SR3DD\Y[8%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $4-M!;F0PPQQF1B[E% W,>YQU/O4
MM%% !1110 4444 %%%% !1110 4444 %5KK3K&]9&N[.WN&3[IEB5ROTR.*L
MT4      P!VHHHH **** "BBB@ H(!!!&0>H-%% %:UTZRLF=K2SM[=G^\8H
ME3=]<#FK-%% !1110 4444 %%%% "$!E*L 01@@]ZKVNGV5B7-I9V]N7^]Y,
M2IN^N!S5FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!*.3.9-B1;6X[$D=3D8Q6MJ&NKX7\)?VIXDN;99K> &=H<JDDN/NQ@\\GH*
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M:WFUK1)(67:T;Z*Y4CT(-QC%06_AO7;2T>TMM0\.PVS_ 'H8]!94;ZJ+C!H
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M#;^;IEXCB)0N\ QD9QUYR:T9/#6MRK*LE_X<=9G\R0-H+$.W3<?](Y/N:/\
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M' )5!C)W$_W:[=X(9(# \2-"R[#&R@J5Z8QTQ5*/P_HL,J2Q:18)(A#*ZVR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%91\3Z LK1'7-,$BG:R&[CR#Z$9K45E=0RD%2,@@Y!% "T444 %%%%
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M 7**** "BBB@ HJF-6T]M6.E+>0F_$7G&W#9<)D#<1V&2*N4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!Q$?@C6H?#]GIT7BZ<7-C>^?:
MW9LHR4AV%/*9>C'#-\YYR<UT>MZNFF011I)"+RZ;R[=96PN<9+-_LJ.3^ ')
M%:9SM.T G' )Q7/VFEW\TE]>ZQ9Z=<7KOMM8Q*SQQQ#[JY9,@YR20#DGT
M.:^']ZVF^#/$VLR//?XU.^NMV09)UC^48[9(C &.*ZCP[KEUKD4-U]GMC83V
MJ7$5U;SEU9F)RF"HY7')]^@K'\)^'O$7AGPMI^F#^S7F@O)9;DK,X2:-S(Q
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M"6I*+J,&XSSQ[B0&0H-IYY.YOI0!MOX@DN=3OK#2[87#6"C[7,S$*CD;A&H
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M81GW=LC_ '#Z5)%H.JZ7XB\0ZEIILY3J_DNKW#L# Z1[,%0IW+_$!D=2..M
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M\<.?E*S.P\R3'0#:H Y/4T <WXMU7Q)J&DV.C2:7!I\VL:F;$QF[+NUN,LS
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M;@VSNY8 8Z#.16E:>+)Y?%<NDW-C';VB:;_:'VIIOF5=^T;U*C:#AB.<X7D
M\#)L? E]_P (UX5T2_DLS:Z9<+<WL:,S><R*2H!(^;,IWG('ISU-F[\':CJ-
M[XQ:XN[>*+6[9;6V>/<SQH(MH# @ #<SD@$YW=L<@&C;>);Z_M+'4;'2))=/
MO+B..([L2&)C_KV7&%3'S $DD8Z$XJKJOC;[/8ZE>:=:QW,-E*;9"\I4W=P.
M##"H!+'/RY]<\'!(TO#UOKMMI]E::G%I\"VL2Q$VDS2^=M7:#AD78.^/F]*P
MO!WA/5O#,!T]X-(>**:1HM37<;EXW<MAD* ;N<9WD=.#0!W$;,\2,R%&(!*D
MYVGTK&O/$&WQ!'H.GP"YU P_:)BS;8[>+. S'!.2>BCK@G@<UMURR:%J>F^*
MM=UC3A:3G58H /M$C(8'B4J. IW*<YZ@YSZY !E:QXZO4\#^(-1L;:"/4M+N
MI-/=6D+)YN0JLGR_-DNG!QU(SQSTWAO2/[)\/Z;9W$41NK6'8TBMO)8_?;<0
M#EC\Q]S7(/X8C@C\/>'+:X-[Y^I-J^J79Q^^,9WLS <#=*8P!Z+WP:]'H X[
MXH7\MGX!O[>U!:\U';I]N@ZN\QV8'OM+'\*L:-#;W]K_ &!/HD]M8Z2EJL8N
MPA+NF&4KM9A@;%[]_P XO%&A:UK'B+0;JVCL'T[2[AKIX9[AT::3850\1L!M
M))[Y]JT(8_$L^LK-=)IUK811.5AM[AY'FF(PN]BB@(!G@ \X/:@#FK_XDWEK
MIVN7D.C02KI5^+,G[80LAW*G!V?>W-C;C^$DD<9W;'Q1<WWBV[T8:<J0Q6"W
MD4[3'<=SE5#KM^3.TD<DXZ@'@8UM\/[A?#_AW2+F>WDCMM0_M'56&<W,OS/@
M<<CS&'7'"CZ56\16NK>'K7QGK;RV[3:OY5KIZQ%B^6588@<@8PS,V!G.<\8Y
M )4^(VH-X,3Q4VAPKIPN1$X^U$N\9E$0>,;/FZ@\[<_K6A>31W_Q/A:5U6T\
M/Z:]S*Y.%26<[1GZ1QN?^!4ZW\)W-S8Z'I5^EM!I.D")Q;P2M(;B2, )N)5<
M*"-V.<G&<8YB7P?J-W#XRAO[JWC&NM(D4L.YG6,Q+'&&R!C: >!G.X\T 27'
MCEX?#<?B<:>!HKS1JADD*S21.X02A,8 RP(4G)7G@\5IV_B"Y?Q=J&@SV,4;
M06:7EO*LY82HS,OS J-I!4>O6LR;PS>:GI^BV&L-:6VEZ7Y4TT,$A<7#Q ;
M257;&"-Q'.< <8Y==:-+JWC[^T8)T_LY---E=[>3(3('" ].F=WLV.IR ">T
M\6RW%OIL#64<>JW=J;N6 S_NK>$'!D:3'W2<;>,GV )$=CXU-SIUM(UCNO+V
M\EMK"*-_ENE0G]\"1E8]H+$X/'3.1FMJ'A74%\=2Z[:VFE:A:W5I';R0W[%&
MMVC)(:,A&!!W<CCGO2^(?"VJ7VO:+K,":9J$EE%-!<6EZ#'$ZR8.Y"%?:1M
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M-8ACL];DEN%_<'S4D>,)M9MV"@VC@#)Z9QD$ L_#59KKPY/KUTJK<ZW=RWS
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M4%<D @DD@#('/.*]KXBU*[O++1OL<,&LFS6ZU ,V^*S!X ^4_,S$' !Z G/
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M04!8X.-W)SUX% #;OQ=J*>*=<TFV2R:'3+)+AYI P\IF!8[\'D!5!P,$EAT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1LLA+F(F0)N4_=<'=Q[^F* )]=UR^TOQYX=LC=P1:5>PW;W"N@!'E1A@2Y/
M^;/;I71V>IV&H6/VVROK:YM.?W\,JNG'7Y@<<5QWBN*WN/BCX'AN$CD79?ML
M< @D1H0<'W'Z5R%[.VGZ+XV:U#BRM?$\,]W';J"5@'DM(0N"#T)((QP<\9H
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M8]!D]S5==<TA[26[75+)K:*0Q23"X0HCCJI.< ^W6N3^+<5N_@M#<+&0-0M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%,::)94B:1!(X)5"W+ =2![9% #Z*9%-'
M,I:*1)%!*DJV1D'!'X&AY8XWC1Y%5I&VH&."QP3@>IP"?P- #Z*** "BBB@
MHJG>:K8:?(D=W=Q0LY4 .V/O-M4GT!8@ GN<5<H **KWE_9Z=#YU]=P6L6<;
MYY BY],DU);W$%W D]M-'-"XRLD;!E;Z$4 24444 %%%% !1110 4444 %%5
MIM0LK:ZAM9[RWBN)SB*)Y 'D/^R"<G\*LT %%%5K_4;'2K4W6HWEO:6X.#+<
M2B-0?3).* +-%1P7$-U;I<6\T<T,B[DDC8,K#U!'!%0VFI6%^SBSO;>X*8WB
M&57VYSUP?8_E0!:HJC_;.E_VI_9?]I6?]H8W?9?/7S<8SG9G/3VJ]0 44R*:
M.=-\4B2+N*[D8$9!P1]001^%/H ***IVVJV%Y=/;6UW%+,B[RBMD[<D9'J,@
MC([C% %RBBB@ HHILDB11M)(ZHBC+,QP /4T .HJKI^I66K6:WFGW45U;.2%
MEB8,K$'!P1UY!%6J "BBB@ HHHH ***J7^J6.EQ>;?744";6;+G'RJ,LWT Y
M)Z#O0!;HI%8,H92"I&00>"*6@ HHHH **** "BBB@ HHHH **** "BJ=IJMA
M?S20VEW%-)&JNRHV?E;(#>X)4@$<<'TJT[I%&TDC*B*,LS'  ]2: '45D?\
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M &HJ@7:6PWR?+A5[;OO+[D:TJ>)[O4;-3!IEE8K('N9(KJ269U'(108U !(
M))Z9K!O/ VHWFA^)+9KFV6^U_4 ]Q.&;Y+0,JA =N2PB4C'3+'F@"WIOCBXU
M#4O#5M_9'E1:S;/,SM/\T+)&'8!=OS*"P3<2.>V.L3>.-3EM_$T]IHEN\6A2
M.CR/>E4F\M-[A3Y?WATQC&>IJ34--GT/Q--XF<VL>B:7HI@BC!.] I+N ,8&
M0L8SG^'&.<C,\/\ AK5]2^'UGH]^L%I!J.;K4IDE9I9A*QD= -HVEMVTDDX&
M0,]0 6]6U"/Q5J'@FTA1E@O6769D;JL42!D#?]M'C_*M&;QB\VG:QJ>EV4=S
MI^E>:))Y9C&)VC!,@CPIR!@C<< D8Z<T^T\/WT'CRXU;_1$TT:?%96J(3OC5
M2S,NW& "2ISD\(!CN,BS\$ZI%X%A\&/<6\-@"\5Q>Q.3+- 7+$!2H"LP."23
MC)QGL ;,7BTS:WH-JEDOV'6[1[BVN?-^<%45]K)MXRK=0QZ4#Q7*C?9IM/ U
M">_FM+*WCF#"=8^3*6Q\J@?>X.",<G -36](>_USPRNB30PC2VD,C+\PA@:%
MHQCMNSC /H3R :BU_P (W<GB/1M5TRTTZ]M[*VDM)+&_=E4JY4[U;:_S97G(
M.: +,/C>-8=2ENK4%+:[CLK5[63S%O9G ^2/(&2&)4]A@G(P<7M+U^ZO?$=W
MI,MG"!;6Z2RSV\YD2.1B1Y3$J/FP-WT/0<9RO$_A?5-7L]%FMTTU[G3+T7(L
M9=RVSIL*F/(!.0#PVWKV'2NDTBWN;:UVSV]G:+_!;6?*1^OS87=G_=']: ,?
M7+BQ\&6>J>)&@$D]W- EQ(Q"*!N$:%B <(H8DG!/7V%;&EWE[=_:OM=I'"L4
MH2&2*4NLZ%%;>#@8&6([\J>:@U>VO[N=8%M;.[TJ6WEBNK>=RID9BNW'RD8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[;CZT =-HUKH]AI2+HT5I#8'+K]F "$]SQ]/TJ:RU2PU+=]BO(+C: Q\IPV
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MCIK"^M=3L(+ZRF6:UG0212+T93T-6* //%\$ZX?AG)X<ENK![ZXF#W+@N(Y
MTWF2Y;;G+ D=..GO7?P+(D"+*ZO(!\S*NT$^P["I** .(\4-<ZGX\\.:3:11
M3?85DU:XCED*+\H\J+D*W.YV(X_AHUKP1>:YIGB":XNX4UG5;3['$RY,5M"#
MD1@XR03DLV!G/3@"NH_LG3(-1DU9;&%;XIA[E8\R,OID<D>U.TO5K'6K/[7I
MTXGM][1[PI W*<,.0.A!'X4 <I<^']<N/$&@:WJ5WIEO;:5%,98(V;RXF90N
MY<@;CMWC+;=N1@'!S9;17U7Q]<:K'.ATO^SX[*X4<^=(DKOLSTVC=AO7[O\
M>QU-W:6U_:2VEW!'/;RJ4DBE4,K@]B#UJG_:6EZ=J%EHBND%Q,C?9K=(B%*H
M,G;@;0 ,?F/44 :5<CX@T+6M3\7:'JD"V#V.E&618)IW1I9'3:&.$(&WG'7K
M7744 <_'!XFGU*6XN7TZWMX[=Q;6\$CONF/1I&*KE0!T [D\X%8MIX >#2_"
M6F23PR6FD3F\O1SFXN-I(8<=-[LW/H*[JF+-$\SPK*C2H 70,"R@],CMG!H
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M':1ADC+%GVYSC@8YZGMK+6;#4+Z]LK6??<V15;B,HRF,L,KG([@9X[8]:O4
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M%VC.[]T 5& 05!Y/W>G/'2:?JEAJT+S:?>074<;^6[PN'"M@$J2.^"./>K=
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M(IPRGW% $\)D,*&8*)=HWA>@/?'M3Z** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*IV6D:;ILDLECIUI:R3'=*T$*H7/J2!S^-7*P=4\0/!K]EX?T^)9M2N8VN'9
M\[+>!3@R,!R<DA0HQD]QB@#>J"[L;2_C2.\M8;A$<2*LT8<*PZ, >A'K7'77
MC:YL=/\ %_G+;-=^'@I$BHPCGWQ!T7;NRK9.T\GG!]JG;Q3JVGV2ZIJUA;II
MIM(_+$#$SW%V[!1&B'@*Q/&23R"2.0 #H=7UJPT.V2XU&5XHGD6)66)W^=B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYI8\' 4Y^4YQS_\ J.A110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(XWU"U5Y',:*9E!9QU4#/)]JXWQ';Q3>-/!-WHXB+RM+'(8@-LEEY>6W8X*
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M:1M=F,3! 92A.P-CG&>V<]:XKP]#;_\ "V?&.(XMR6]@1A1D$I)DUW) 8$$
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M$-<!1YC!BP(+=2,<8] /2M^.YM+3Q/\ $V.YFAB\R*W8+(P&X&VQP.^3Q]:
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M!#\(O %R5C2.._TN263  4!@"Q/]:Z6PO+.;XVZB(;B%V.APK\C@Y83/D>Y
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M=E3<W=G%-*5&!N903@=JVJY?X<2QR_#?PZ8W5]NGPJ=IS@A!D?6NHH ****
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M1M+5B-P6>=4)'KR>E $:Z%I"Z=)IRZ59+8RG=);"W01N>.2N,$\#\A6@  ,
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M+-+%!%'),P:5T0 R$# +'N<<<T 2T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA7&R3!P22#CMD_6MKQ[KD_ASP=?:K!96]YY 4M%<,0I!8+G !SC(XX^M '2
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M.1P.A/3&3XB:C<>%O#.L6VD6\CZO?BPDB-P1L?<ZY7Y>0?+/)/&1P: /0B0
M23@#J:K:=J5EJ^GQ7^GW,=S:3 F.6,Y5L'!Q^(-<KI7BG7#XHO\ PUK.G6,>
MI)9_;K.2VG?R9X]VT@DKD$'';\/7!OO%>KZA\-/#FL:<EII[:AJ%O#+$BDA5
M:?;M7!& <<^Q.,9H ]2JE>:OIVGW5K:W=[!#<7;^7!$[@-*WHHZFL#7-?UG2
MC.#%8V\5O9>?]KN<^7<3?-^Y0;@0<+G//4<5AZ]JRZ_I_P .=7$/E?;-6MI_
M+)SLW0R'&>] '>IJ=E+JDVF)=1M>PQK+) #\RHQ(!(].*MURL6OWTGC/7-(3
M3;7S;33X[B"19"7G+%PJL2!M&1TYQGK5:3Q+KJ>+['P[%#IUW<.GGWS1!PMI
M#ZDD\LQX5<<]3@4 =G45S<P6=O)<7,T<,$8W/)(P55'J2>E<+<^/=0;3TUC2
M]+DO['[28C:PVDS3R1!RAE5P-G;=MQT[@\5HW>NWVL?\)!;:-':F#2PUO*]P
M&/GS;-S(N"-H 91N.>2>..0#IK&^M=2L8;VRG2>VF7?'*ARK#U%6*Y/X8_\
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MA?1%\4^%3/H][;W$DAU90LBPMN 'RYR?T]ZU+G5[!_&>HZ[:^*O#$(GT?[!
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MB+09VD#Z\_H*WZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L+ 76B7TT"QAGV.J(C;B>I/S>U7K?Q-K</BK0K#4K:P%GK5O*\/D%_,A>-
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MB$?F-GGO@9SP,X'L!3-#TV_MKS5+O5%M6GO)PZ-"[-LC"A53E1TP3GN6)P*
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M[U*0I^Y3Y [!0SD[44D],L0,^]5= MO$@)G\1W>GO,$\M(=.1UB[$LQ<Y+'
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MP1*PY<[LLS'\ ,8'<D KS>*?$EMK>@6LEGICPZY$X@56=6@D6/S,NW(92,\
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M8O=2JSXPJ1I]Z1R<*B^Y) H MT5SW@?7[KQ/X0L]7O((H+B=YE:.(DJNR5T
MYZ\*.?7TKH: "BBB@ HHHH ***YA_$=WJGB:\T+0DM\Z>JF^O;A2\<3L,K&J
M*07;')^8 >YXH Z>BL2WN==@UZ&SOHK2>QE@D?[7;HT9612N$*%FP""QSNYQ
MT'?6-S MP+<SQB=AD1EQN(]<=: ):*C\^(R^6)4\S^[N&?RI1-$5=A*A"?>(
M8?+]?2@!]%11W5O+ 9XYXGA )\Q7!7CKSTH%U;G=B>+Y6"M\XX)Z ^YR/SH
MEHJ..>*8N(I4<HVUPK [3Z'T-4M)EO4TF)M7NK*6[W,LDMJ"L1.\A0,DG.,
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M/A.H?VW="6XM&L/*C,$2*?.5N=Q8YQ@\8P.QH OT5$MS \[0+/&TR#+1AP6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<CK?_"3KXFBN;'0K34;*VB_T?S=0\C;*
MV0[E=C9./E![ MZUUU% 'G'PDU&>V^'$4NJPVUA8P2S&.Y>Z!#YGDW;L@!,,
M<#DY]NE>C]1D5GR:%I$ND-I#Z9:'36Y-IY*^4?FW?=QC[W/UYJ^ %    '
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M (NZ]I^K+&YM]/M_[-BF (,3;C,R@]26V@GT4"N':VLO^%%W0CCB*VNMD0$
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M+K'[Q1]L9<!NH7!/'3DUVQAM[?XS:HZX@$GAM))9(QAL^>X+<=3@#\A74?\
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M_ &_GNL_VU TTDSGB=+]925YZA]VT#O@@=*W]3M_-^(7@$:C!"UY)97GVD%
M=SB*/.?7!S0!VNBIJT>F(FMRVDM\K,&DM594=<G:<'H2,9'3.<5B6_B.^\0>
M(=2TW0S;0VFER""ZO;B,R;YL9,<:!E^[W8GJ<8/6NKKS;X:D:%KOBOPU?L(]
M0;59=0A#G!N()0-KK_>QMYQT)H Z^RN-;CUUK+44M9;,VQEBNH$9"SA@"K*2
M=N 1W.<]L5H6^H6=\9$L[VVG>/AA'('V'W -8_B[5M,M?#.MI?&>2"*QD:Y2
MV.'5",8!_A8Y./H37':7<PP_$[PYFYT^-7T*2)(;9\A$W1^6A<GYSZ' SV%
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MF+?P[H-U\(_%5S-96_VNUO+[[/,%'F0NDK&)$/5>=ORC&=WO0!Z3=ZUJ-O\
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M&LD;JZ,,JRG((^M.K \$W]MJ?@W3+JTL6L8&B*K:L<^5M8J5![@$'!],5OT
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M2*&,(H_ <4R_TVQU2 0:A9V]W"&#!)XPX!'0X/>FS:MIMO?1V4VH6L=W)C9
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M#6PMCI5B;</Y@B-NFT-_>QC&?>IO[.L=MPOV.WQ<_P"O'E+^]XQ\W'S<<<T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG!(!T<>I6,VH2V$5Y ]Y$H>2!9 713T)'4?C5JO.9I-1C^+VI-I-E!)=2:%
M<7,OEHI\Z3[Q4,2>W _$5U?A'Q!_PE'A>RU@V_V=YPP>'=NV.CE& /<94T ;
M=(2 "2< =2:P9]>N+GQ%=:'I,4#W-G;I/<RW#D(F\G8F ,DD*23V&.N:X[Q9
MXLN==^$7B*ZM+=;2[M?.L=0A>4[H74A7"D#YL@C!XX- 'H-CK>EZG/-!8:C:
MW,L(!D2&4,5!Z$@=CZU?K+TNP4>7?W5C9Q:CY @\Z#YCY0.0NXJ#C/..E:E
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MR=F<C&.E>FT4 <2=#\0:5XXN_$.E065S#JUO%'?6D]RT9BDC!"NCA#D8)!&
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M55 Z#)YXS7;Z=JEAJ\#SZ=>0W<*2&,R0N&7<.HR..*MT 06?G_8XA<QI',%
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M/;^:H4@Q[<,5QD?,,]\4EQX/O])U3PW=^'!:2QZ39/I[PWLK)NC8)APRJWS
MIDC'.>U &1XC\8ZU<?#[Q'>6@MK2YT[5&TQY%+'<@D1"R_W6._WQ]:]*MOM'
MV=/M7E>=_%Y6=O7MGFO/)/ 6N7'@_P 4Z/-=V'VC5-3:_MY%#A03(C@.,<9\
MOMG&>^*] LC=FSC-\(%N2,R+ 244^@)P3]<#/H.E &-KFL:C8ZA]GMXK6WM5
MM6F:_O3^Z,F["P@ @[CR<]AV-<CKNNCQ1X,\#:WY'D&[UVPD,6[=L/F$$ ]^
M0:Z/4]#UR3QS#K-E+82V7V$VOEW9?=;.6),D:@88D8!&5/ YK M/ WB&W\$>
M&=$:33'GT?4H;MF$LBJZ1N6 !V'YCGT 'O0!JJ!_PO&0XY_X1M?_ $I-=E//
M':V\MQ,X2*)"[L>@4#)-<XNAZG_PL@^(6%H+(Z6+'8)6\P,)#)NQLQCG&,^_
MM70W=K%>V<]I.-T,\;1N/56&#^AH XJZ\<WUGX4M?%\MC"=#F*/)"I/GQ0.P
M59<]&/*DI@8SU.*BU*;4Y/C!I$<+VK0C2KB2(/NQM,D08G'\7 Q[4D'@O69/
M!*^"KZ:SDTQ&6'[<LC"5[97#!?+VX#X&W.['?VK7N="U1OB%8Z[ EE]@MK"2
MS*-,PD.]E;(&PCC:!C- '1VMG;6%JMM96\-O F=D42!57)R< <=237#W'CG5
MK;0?%%S)8V0U'0;C8]J9& FB*AD<'L6#<#'48[UW]<M=^$?M/CN+71,JV;VP
M2\M<<3RQMF%CZ[=S'ZJM %NRUN;4KK219FWFMKNR^V32@$;5.W9MY_B).,_W
M37GO@SQ%JOASX<^';E;&T?27O3:S,TK";]Y<NH=0!C )'!.3[5V_@WPK-X2T
MJ[M1.MTYF<6N]B!';AF,41.,X&YNQ^\:YZ+P+KT?PWTWPUNTTW5I?+<M+Y\F
MQE6<RX'[O.><?K[4 ="?$30>/[W2;JSMHH+?21??;%8L[)YA7!X& -K''-,L
MO$.NW]OHNJVVDQ3:7J;KNC1\36T+@E)6).#QC*@9&>"<4DOAJ_O/'EUJ]TMI
M_9MSH_\ 9KQK,QD^^SEL;,8^8CK[^U4_"F@^+]#M;70KN^TV31[%@L-W'O\
MM,D2G*QLI&U>, G)XXQGF@#G[#6-7T&'Q_J>F65G/#9:Q-<SBXE92ZK%&65
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M31I$Z]8WWC'(Z-D9]!71ZC?V^EZ;=:A=/LM[6%YI6]%4$G]!6'X>A\8,\?\
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M%V-W#8SP+:R*,[7,G# C@,,<]N:L>.==NO#OA\:A:VMM< 7,,3K.QP \BJ"
M!R02#U% '2T5R%]XAUW_ (3N3PWI]IIX4Z9]MCN)W<X/F;/F4 >_ ]>HZ5FQ
M?$25?"&G:KJ,=M8RS:B^GW=P59[>V9"X+D9!VDH ,D8+C)XY /0:*\[\7:SK
MZ>%[.XM[VP7S]7MX!<6R%TGA:1-K*=_&><\GC(![U>U+Q#XHA\6IX<T^TTJ6
MXDTM[Q)YGD5-ZNJ\J,D+SC )/(.>,4 =M17':?XEU>XO?%&GW,=BEUHT4#H\
M:N4=GB\P@@G.!TSD>N.U48_'.KW%CX,N(-/LB=?7]X'E8>6WE%\#CIQUY/M0
M!W]%<';>)/%EU>^(=(2VT<:AI!C?[03)Y,B2(70;,[MW!!.<#T-36GCLZEI'
MAV2W@\F\UBU:Y(\F2X6!4"[SM3YF^9E Y'4G/&" =M17G5YX[\0V'AVZO)]#
M1+FUU*.TWS1RPQW,;NJK)&K#/\7()XQU-:]GKVNGQA=^'+Z+3HYGT[[?9S0;
MW5!OV%9 2"V"0<C;D>E '745QOPOO]4U7P-9:AJES%/)<F60,L95LF5\Y.2#
M[8 P.*[*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&
M4,I5@"",$'O2T4 8EGX.\-:???;K/0=.@N0VX21VZ@J?4<<'Z5MT44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9
M>K>&]$UYHVU;2K.\>+[CS1!F7V!ZBKEE86FFVB6MC:PVUNGW8H4"*/P%6**
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MA4R"221RQQUZ< 5?&AZDWQ#B\1-]D%J-,-BT0E8ODR"0L/EQC(QC\?:NGHH
MXGP_X=\4>&O!0T6QO-)>YMI-MI)+'(4,9E+,7QSNVL0 .,CKSQVU%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ex1015-amendmenttoemploy002.jpg
<TEXT>
begin 644 ex1015-amendmenttoemploy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &U<G)Q0!U=%9&G>(]/U+5+C2T,T&H6\:RO;7$1C<QDX#C/WESQD=#P<5KT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7&_%?_ ));XA_Z]O\ V85V58WBK0!XH\/7
M6C27;6T%TNR5XT#-MR#@9X'3T- ' 3_:/%'B_P ,^']9CBTR'34AU6T*.93J
M#(OW58A=NW^)<$GZ<UUGB*\U!-=6UAU1K>!K%WBM[)%>Y>;=C>P92JQ@8Y)
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MXI?)7>Q1]Z@]L9]N1C\=5O#'F^+CX@GO/,=K#[ ]MY(\MHRVX]\YS^&.,=Z
M.>TZ_P#%^IV_A[6;'SGANS%+?03FW%OY$BY)BVGS-RY&,GGO65/K'BF3PYXU
MU%/$3Q2:%J%PMN$M8L2)'&CA'RI^7D],')/)X%='H7@%M!F2WA\0ZC-HD,GF
MV^ER;"D9!W %\;RH/(7(' SGO(/ Q_L?Q%IIU20Q:[/+/<-Y(S&9%"L$YZ8
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ML\O[J,^A(Y/X $_A0!!X?\1MKVIZO%% HL[&801S _ZQL9;\N/SKH*Y7X>6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBN4L=.E\1:'JDYU34K2/59B]M+;W+!X(5("&/.0N_:7X'1\=A74HNQ%7<6P
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MHM+U71],6'[%?QS7+1*6<Q _,2>2<=:VIO'\%R3'H.EZAJTHZF*(I&/JS8%
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M&\+WPU;P[8:BT#132P*'\Q<-D<'\,ULT %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M [^WM;_Z$_4?_ JU_P#CM']O:W_T)^H_^!5K_P#':Z&B@#GO[>UO_H3]1_\
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M3["+3=-@L(&D,,$8BC+MN8*!@#/? K/TGPO8:+J=_J-H]S]HU!Q)=&28L)&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ex1015-amendmenttoemploy003.jpg
<TEXT>
begin 644 ex1015-amendmenttoemploy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKGO'9=/ FNSQ33PS06$TT4D$K1LCJC$$%2#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ex1017-amendmenttoemploy001.jpg
<TEXT>
begin 644 ex1017-amendmenttoemploy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM=M-0@GM;G[1/((9HF5V4Q( 0",G)!''>IO@;X<T\^$&_M?1(1JD%Z[H;RT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH R_$&EW>L:2]G9:K<:7.S*1=6X!=0#R.?6N0_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
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MD5J4 %%%'09- !16;I>O:9K4UY%IUVEPUE((IR@.%?&<9Z'CTK2H **0,"2
M02.H]*6@ HK+N/$%A;>(+/0Y6E%]>1O)"OE-L*H,M\V,<9' .>:U* "BBB@
MHHILDB0Q/+*ZI&BEF9C@*!U)- #J*Q-/\5:;J6J1Z?$MRDTUM]KMVE@94GBR
M!N1OQ'!P>1Q5O6=;T_P_ILFH:G,\-I%S)*L3R!!TR=H.!SUH T**@LKR'4+.
M*ZMRYAE4,A>-D)!Z'# ']*GH **** "BBB@ HHHH **QM>\4Z1X:2,ZG<.C2
M@E(XH7E<@=3M0$X&1D].:FLO$6D:CH(URUU""33/+,AN=V%51USGIC!R#TH
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M;;/(E2.)7"$%C@')YY.3U&,'TZN.C\$W2:5XGL3JT1&ORRRN_P!D(\DR($8
M;^?E Q[_ )4 45\0Z]!J_A*[N+NV>QU[Y)+)(,>03"9%*OG)/&#G@^@JOKOB
MK6M(>6Y:\A>2+6([8V4$0DB6V=U0>9)C*2D-NQN[CY<5M2^#KJ5/#"_VK$#H
M+*RG[(?WQ$9CY^?CY3[\_E67/\-KR72;[2X_$;I9S:C_ &A IM%9HW\T2$.V
M[YQD<?=/J3TH UH-6O\ Q!XCUS3M/O?L,&D>7#O6)7:69EWG=N!^0 J,#!)S
MR*Y'P-KEU8^ ?!ND6B2&YU$73,\*H61(W8MM#D+G++USQG@UU:^#[ZQ\3W6M
M:1KGV8ZA'&NH0S6HE$SH-HD7#+L?'L1[5F1?#&2V\+:/IUMX@GAU31IGELM1
M2W7*;R2RE,X93G!!/84 ;_A6X\12/J5OKUJRQ0S#[%=/Y8>>(C^-48@,IXSP
M#D<58\3WE[8Z;#+9W%M;*US&EQ<3L!Y<)/S% >&?H%!SDGH>E2Z'IE]I\#OJ
M>J-J5]+CS)_*$2@#.%5!P!R3U))/7H!5\5>')?$,.G&VU V-UI]XEY#*8O-0
MLH(PR9&1ACW% '-6WBW6_L'B^.WBGU"XT>:(6I:VV3O&Z*QS'A<LH+$# S@<
M5N>#]>@\0?:[FQUQ=3LE6,(KQK'/!)\V]9% 7'\..!W^M58/!>I6NH:W?0>(
MY%N-4>WF+&U7$<D6WG (RI"XV\<'DGK6II/AL6'B'4-=GE@>^O88X9/L\'E(
M0A8[B"S$L=W4GH /J -\8>()/#^EVK6ZH;N^O8;"W,@RBO(V-S =0!DX[XQ6
M=/K&IZ)XWTK0[N[-[9:S#,()GC59()HEW$': "I4\<9!'4UL>*/#EMXIT5].
MN)9(&$B307$7WX94.5<9]#^F:@M_#]S-K%EJVL7L%W=V,,D5KY-L840O@.Y!
M=B6(4#J  3ZT 8'PZM[M=6\7/+?O*JZY,CH8U&]O+C^;(''T'%:'Q1ENH/AK
MKDUG=R6TJ6S$O&!DKT*Y/3(/4<U>\->'+G0+O5YI-0CNEU*]>]91;F,QNP48
M!WG(PHJ[XDT2+Q)X;U#1II6A2\A:(R*,E,]#COS0!Q?B""^3Q7\/HH[Q7NC)
M=[9IHAA<VQ_A7&<#Z9IT/C+5=)T_Q+;ZA+%?WNF:C!9VTPB$?F>?Y>S<H('R
ME^>1D#MUK:D\):C<:GX=U"YUN.6?1S(W-G@3%T\L]'^4;>G7GOVJO<?#Z/4$
M\30ZC?\ FP:[)'*PAA\MK=T"A&5MQSC:IZ=1^% %G2KCQ1'XI\BZMKB?1);<
ML;BY$"20S _= C;YE(]L@]ZZNN<\/:!K6GNCZWXDDUAH5V0#[,L 7MN;!)=L
M<9SW/'.:Z.@#BO!G_(X^.?\ L(P_^B$JKI?BV>^\3-I-UJ1T_58KV17TRZ@5
M5FM@S!&A<C+$J%8G<?XN!Q6_H/ARXT?6M9U"6_CN!JDRSO&MN4\ME4(,'><C
M ':J<_@^XU"73AJFI0W46G7PO;=Q:[9U(8LJ;]Y&T9 . ,@ >] %#X?_ &^7
M5_%LEWJ<MR(M9DAVNBC.(HL'@<8'&!Q^-;OC#Q WAOP^UY#&DEU+-';6ZO\
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MA]0AU R*6%W#C9*,G##' XQQ6E0 4444 %%%% !1110 4444 %%%% !1110
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M7<WEM(L4N26D5/E+*%;'8G&>]6E^&-M%X8TC2X-9OX;W1W:2QU% @DB+?>7
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MR0%  &>G'2N1+:/XY\7:9=VD,\G]@S3&:>2!XE$G"K%\P&[Y@'XSCRQZUW5
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MUX& #&M3XM?5=*N(I;F33IXV%_\ :3; )E<K)#LR1@]FR",=3S7/>'8?$/\
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M5)(Y?)7S/ED\P GIC=[=* (6UO5?#WC74++4-2DU*Q&B2:J$:%$,3QOM*IM
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M3?+IC%FN ,9*D8V[3M"]@!U[@#SXEUQ-/\?11WTZ/HL*7%E-=01^:H: R;6
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M?^@"NFK+\.Z*OAWP_9:1'=37,=I$L223!0VT# 'R@#^ON:U* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *RO$.OVOAG1YM5OHIWM( #*T*AB@) SC()Y(Z9K5K!\8JK^&)T=0RM-
M"",@CSDH U=.U"VU73;;4+.026US$LL3CNK#(K*T[Q=IFK>)-1T.Q\Z:YTTJ
M+J0*!'&2.!DGDY!' Z@UQ7AW5)?!+Z_X,QOGM)!/H:.?];%.V$3Z)(V">PSZ
M5/X&TQ=*^)/C+3XI6)CM+ -,0-SN8V+.>V2Q+'W- '>6&JB[L)KNXM+C3TBD
MD1EO%"':A(W]3\I R#Z5H5XWK&H:IJOP<U*YO=4N7N8=7,!D3:GF(+M8P& &
M,8[#%=KJS7T.MVNG#6;J2(V4C+;VH7[7)+O&)&.T(L:CCG:"3@YH U]?\16W
MA[^S_M-O<2B^O(K.-H5!"/(V 6R1@?3/2M:1RD;,L;2$#(1<9/TR0*\FN=8O
M/$'PT\"ZIJ#B2[N-:L3*X4+N(F(S@<#..U>MT <;#\3-#ETPZI)!J,&FK,8)
M+R6V/EQN&VD-M)(&>,D8]Z[".1)8UDC=71P&5E.00>A!KQOPMI&L^(_A?JFA
MV*V$-O>ZA=1274\K%HT,IW$1A,$^GS"NIU*.ZT<Q:-9ZM/\ 9[+1E6VM;, W
M'F)E?.D+#:$PH R0"=W!H [IY8XR@=U4NVU<G&3Z#WI]>2R7NH>(5^&&HW.H
MW,,]ZS--Y&U5+_9W)?:5(SUZ\ $X K9N-0U_Q#+XB@T>>Y@GTVX-G:-')$JB
M18U;=(&!+ LV".FT<<Y- '4W7B*VM/%%AH$EO<?:+Z*26*4*/+Q& 6&<YSR.
MW>M=F"J68@*!DD]!7G]T][)\0_ ;:DL2WQT^]^T+"V4$FR+=M/IG-7/BO>36
MO@"ZBA=D-Y-#9LZG!5))%5OS4D?C0!T5OKMI="U:%96%VQ^S$ ?O4 !,@Y^Y
MR.3C.1C.1F.]\0VECI=_J1BGFM+#?YTD2@_<SO(!(SMP0<=P1S@TFK>%](UI
M]->]M2S:;,LUJ4=D\MAC ^4C(X''3@5A>)/#6EZ+X2\;:A80-%<:E87$MR?,
M8JS"-SD G Y8DX]: -&/QC!+I$6K+I.JFPEA6=9A"I'EL 0V V<8.>E=)7">
M%!XB;P/X5$(L#9FTLQ* &\PP[%SUXSC&?;.*=<3:O??$R[T./7+FWTYM'2[4
M0QQ;XV,I4[6*GLHZ@]3C% '<T5X^^N^)8_AC+XF?7YVO-*NV@$:PQB.Y5+CR
MSYHVDDE?[I7''&>:Z._?7-1^)-[H%OX@N;*P.DQW:^3#&7C8RLI"DJ?[HY.>
M^,=0 =+XE\16WA?2QJ%W;W$T)E2(^0H)4NP4$Y(XR16Q7C>J:OJFI_"G6;76
M9EN+[2M=BT][E4"^>$N(B'P. 2&'Y5VW]IW.N>.]5T!+R>SMM,M(78P$!Y9)
M=QSD@_*H X'4DYSTH ZZBO*WUWQ3>>"]9N+>_E_M3PWJ<MO.T,48^WP1E6;@
MJ0K%#_#CD>]=#<^)C,MWKNG7<DVDZ;I#7CQ*%VW$C)YB G&051<D C_6+Z4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S=
M<TG^VM.-D;N:U1G1R\(4M\K!A]X$=0.U:5% &/<>&M/O/$&FZ[<Q^9J.GQ21
M0RX X< $D>W./3<:JZ?X473O%&J:_'J5T]SJ21I/&ZIL 1=J;0%R,9]>:Z*B
M@#D!\/K+_A$=0\.2:A>R6UY<-<F4[!)'(9!)E<*!]X X(J=_!@;7;?6%US4T
MO%M/LERZF/\ TF/<7^;Y/E.2>4VX'3%=110!Q4'PXM+?PWI>AIJ^H?9]-O$O
M(&/EE@R,613\N-H)/;)]:[)T=H2BR%7(QO !(/KCI3Z* ,'PIX6B\):=+8VU
M]<W4,DSS_P"D!,AG.6Y51QFH+[P=#>>([C6(M3OK1KNV6UNX(&39.BYV\E25
M/S$94@UTM% ''0_#VVM]&T.PAU?44ET:;S+6Z!C+@;2A7!0KC:<=,]Z=>^ 8
MI/$$VL:9KFJ:5-=*BWJ6LB[;C:,!CN!PV.-PY_'FNOHH Y^;PG;2:]H^JQ7=
MQ"=)A>"W@7:4*. &W$@L3A1SGM4WBWP^OBCPO?:09/*>9 8I<?ZN12&1OP8"
MMJB@"GI=Y+>V,<EQ UO=* L\+?P/CD ]QZ$<$5F^+XQ=>'[C3VBU%XKU&MY3
M81*\@1E(/WN!P>M;U% 'F]O'>6N@P:-;R>,8K6&W6V0I96P<1JNT -MR#@8S
MUJQ%LM_%#:[!I7B2.4V*V"P"SC\M(E)9<#.<@GUKT"B@#RQM%MW\'WGAEK+Q
M6;.[G:>23[)#Y@+2>80#TQN]JI-KMQ+\69+FW@UB*5=&CM2/LB,SN)78@KG'
M0@\$'VQ7L%% 'FE]IUG>>&&T(:3XHABEN1=W$Z6L9EFE\P2%F))&2P!X Z8&
M!5J[/FZ]%KMGIGB.SU-;?[--*EE&R7$><@.I;&0>01@CIR.*]!HH X*W\2:9
MX2L%MWT'Q$3=W#N\CV/F/<3N26+;3C)^@&!@<"H?"OV;0O"G]D-X4UE8YS(]
MQ"+8,O[PG*9W<@*0@]E%>AT4 >8>'],7P_+%%'%XRNM,MVW6NGW$*&*$]1SG
M<P7L"<#@]0#4=GHL&GZE</9VWC"#2;F8SRZ2D*>0SDY8#G<%)ZJ",].G%>IT
M4 -1M\:OM9=P!VL,$?6N;\4:6WB2XT[20I^QPW<=W>R$?*5C^98QZEFVD^B@
MYZC/344 9]MILMOK-]?MJ-U-'=+&$M)&!B@V@@E!C(W=36A110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF[!)C.:[\D $DX ZDUY-X=;PQ/XS\:S:W'ILJ2WZ&WDO(D8.OEX.PL.1D=J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/$_HRL 1^78^E &G15"'6;*?5IM+C:8W<"*\B&WD 53D [BNW!VMCGG!J_0
M44@()(!!QP?:EH **R]<\1:7X;M%N]6N'M[=F""00NX#'H#M!QGWK1BD6:)9
M%#!6&0'0J?Q!P10 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *X;XJ6<R^&H/$%FA:]T"ZCU",#JR*<2+]"I)/TKN:BN;>*[M9;:= \,R&
M-T/1E(P1^5 'E>M:R(_B'H?C*S9#HV8M'N)0.7$Z^:K$_P!U2\?XYKN_#_\
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MFROE1N#O"C!?YN^!R,$U<O? !GT6&QMM26&?^U!JUS</;;S/.'W_ '0PVC(
MQSP />MS4=,U&ZNTE@OK80&W:&XM;BU,D<N3][&\8QR,<Y!_&@"SHLTUQHMG
M-<7,%U*\09I[?'ER?[2XSP>M9GB;7IM-O]$TFT*)>:O=&%)77(B14+NV.YP
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MLD"H]O.H7#@CK@H,#C@D'/6@"'4K6_MOBQX-^V:A]L1K:_VEHE0JVQ-V-O\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK%\47E[9:9%+9W5M:
MW,23SSGE(BV&V @AI#T4$')/0]* -JBO,9_%^N0:-XZ\B[+3:&J2VL]W:!9&
M1H1)AD&T9ST) X/(JQ<:WXIT35/#-]?:C;7FF:U/'9RVJVH0V\DB91E8'+<@
MYSCV SP >C45Y8NK^-]1T'Q+J-GK5E%+HNHW44</V($7"0X.UB3\H(SC'.3U
M]+2^)?$/B#6M!M]+U"#3K?6-#:^&ZU$K02?)SR?FY;'88]: /2:*XK2]1UCQ
M#>ZU80:O]E?2&CL_/BMT/GW'EAG=E8'"9( 52#P>>F,1O&^LW/@K1O%7FBT@
MAOA:ZU!'&K*J"0QO(A8$@!L'Z'VS0!ZA17(:[XCN='M=?UF.7S;*PCC@A@8+
MM:X;&3NQG:-\8Z]=WIQ =1\3Z3JZW=Y#=7&@+:2RWLET+97MW12P,8C;+*<$
M8.2..: .AUWQ!8^';6&XO_.V33I GE1%_G=@HR1P!D]216K7DOBBXU76?AYH
MFO7-_M2^OK&X:R6-/+1'E4HJMC=N&5R22#SP.,>JW+2I:3- $,P1C&)#A2V.
M,GL,T 2T5YUIGB;5AXE\,V$NI"^35;:X^U,( ($FC0/F!PJEUR2.K<8YS67<
M>)O%J>#_ !)KHU>V5]$U.XA6);-=LZ1N!M8DY (STYSW/0 'K-4M-U./4TN6
MB@N8A;W#V["XA,98J<%ESU4]CWJTCF6!77Y2Z@C/.,BO+[SQ=XC@^''BO5DO
MK?\ M#2M4GMHI/LPV^6DBH %SP><Y.: /4Z*XHZOK6D>/K+3]1U"*[L-0L;B
M?REMPGV=XBI^4CE@0W?/3MTI-'O_ !)XAT31O$6G7UNB7DZRS6,R+Y2VI)!
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M4=$L_'5[J+Q72Z)/&EK&D?ECYT4J#R3]YQDYH ]&HKB=7U;6?"U_X>GNK_\
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MK@&\&V.(2$\L8^?GY1W[\^U=510!Y3J>GMH'B?X;Z)%J]N)[%+J&.:6(<J(
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M-VUU] -W"^W)-=C10!@6/AMHO$I\07UQ#/J'V/[&&@M_)4IN#$L"S%CD#'.
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M2!HVQN1T/##C/M6OH^G3:;9E+J^EOKJ1O,FN9%"[VP!PJ\*    /3N<DZ%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N+\::SJN@:WX=N8KTQZ/>7R
MV=ZOE(2A<?(P8C@9&#GVZ5VE<_XWT#_A)O!FJ:4H_?2PEH#Z2K\R'/\ O 4
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M+)+.)S%)*\P4(XZH<]&]NM>8+KMK;>#?AYJAO)#H]A&D&HSVIW?9I&M]BEL
MXVDD'N-WN*=XQ_X1M_AYXRU31KQ[O[>ML+B\>7='-*K@!4Z L!C./4=P< 'J
M=GK^D:AJ5QIUGJ=K/>VPS-!'*&=!G!R!Z'@^AJY<W,%G;27-U-'#!$I:221@
MJJ!W)/05PNH3V$?Q<\+);2VRJVF72*(V4 KF,J!CMP<#ZUK?$6^M-.\$WL]]
M8K>6V^)6CD+!%)D7#N5YVJ<,<>F* -NPUC3M3DFBLKN*:6#'FQ@X=,\@E3R
M>Q[U6?Q5H$3JLNL646[<$:2945]IPVUCPV#P<$XK@],O[.\^)VKQMK2W8O=
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MI0!W]EK6FZC.T%I>12S*@D,:GYMA. V/[I['H:L7E[:Z?;-<7EQ'!"I +R,
M,DX ^I)  [UPWA&\U:V\5#1]0O;/7+<:<9[35[<!9!'O4!)0"5)/4$==I]\:
M/Q"U.STO3=)EO8(&5]5@6.XN21%:29)69\$9"XZ$@9(R10!T%MKFEW=I<74-
M_ T%L2MPY<#R2!DA\_=..>:=8ZM8:E)-%:74<LL(4RQCADW9V[@>1G!Q]*\I
M@N=&N]4^(5KJ&MR?9[EK!_ML>U6 ,:*)1@ ;%8K\W0@=3G)ZOP;?:P/$>IZ5
MK$MEJ4L%K!)'J]HNWSHRS[4D49 <?,<#LV: .JO]9TS2Y(8[_4+:U>=ML2S2
MA2Y]@>M5T\4:'+IL6HQ:K:R6DI81RQR!@Y7[V,=<8Y]*YCXF26:W/@]+MX0I
M\00,5E(^[LDYY[9(_.J7B#4;'PW\2+675+J32]'N]-\JVNH<)$LXE9Y%8X(!
M8%3GOMH [P:SIC:6FIKJ%LUA( 4N!*"C9.!@]#D\?6JT7BC0IHKJ5-6M"EHH
M:Y)D \@'.-X/W?NGKCI7G,TVB>&=1\(W]HTT?A/[=>.]U.28Q/(@$<G/123(
M >!R2."#4XN(-9UWXERZ8ZW27&BVZQ/%R)289@-I_B],B@#T@ZUI8DLHSJ%L
M'OE#6H\T?OP1G*?WN.>*SK35;&+4M;N9O$MM/:P&+? S1JEA\I!#./[Q!/S=
M*\\7Q!I%S8?"\0:A;R?9YH4G*."(F^S,NUST5L\8/-:,=W9CQ'\4P;B #[+;
M[LN.UJ0?UXH [NU\4:#?/*MMK%E*T,"W,@69?DB89#GT!!!S[CUJ?3]:TS59
M)X[&]AGD@($L:M\T>>F1U /8]Z\PF$5M\%?"^IV,'F16B6$M^UHH,GDH5:3I
MU*M\Q'J"34FMMI&O:+X@U?PA?W6JZR^C/;M<12%@L6X-Y9  ^<C=@8W<'VH
MW_$7BT#Q#X7MM'UF)H[S41!<0QA6$L>UR2&(R0"H&5/>NKUR2XAT&_EM9S!<
M1V[O'(%#;6"DC@\'I7FNK>)?#NI1?#R?3[ZT\N+4H045QNMU\EUVL/X><#!Q
MTKTO6U9]!U%44LS6LH  R2=IH Y[P;XRT[4M#T*TO]:M)-=NK&*:2 RJ)'9D
M#'Y1W/7'I70V>MZ7J%Q<V]GJ%M<36IQ/'%(&:(^C =#]:\H2UT_5_A3X-T_2
MOLTFM)+9M (-ID@D1E,SMCE< -N)[XSSBNB\3)J/AGQFFIZ/ SKXBB&GS!1D
M17:@^3,WMMW ^RB@#O+*^M-1MEN;*YBN(&) DB8,I(.#R/>K%5M/L8=,TZVL
M;<$0V\2Q)DY. ,<^]6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ***YCQ[X@G\,^%VU" ^6#<0PR
MW!CWBVC=PK2[>^T'@>N* .GHKF-/74GOM+O-/\0-JVBW&_SF=(F/W"597C51
MMR.1CKCGJ*TKOQ)H]C=K;75_%%(9!#EL[1(>B%L;0QR, D'D4 :M%9NI>(-*
MT@L+Z\2$HGF2<%O+3.-SX!VKP>3@<&LZZ\9Z7;>*+'0O-WRW5NUQYB@E N5"
MX(&#NW9XZ >XH Z.BL31[VTN-3UEX->&H)'*H> %2EF0O*@@=\$G)XJ>T\1Z
M1?7D=I;WT;SRH9(E.5\Y!U:,D8<>ZY% &I17/S^.?"UM'))+KMB$BF,#L)00
MKC&02/3<,GH,\UOJP90RD$$9!'>@!-B>7Y>U=F,;<<8],4K*&&& (]#7FU[X
MHN-<\<7.AZ7XSAT.:VD\A+.73A*UR0,LZN^!U)4 9^[GO7I(& !G)]30 T11
M@$!% /48ZT>3%C'EIC_=%<5J!\5Z7XDT25-82]AO[OR;K31;(J0Q;2S2(^-^
M$P.6/)(Z9 KN* &>3$/^62?]\B@Q1EMQC4GUQ6:GB71I+V*T74(O-F<QQ$Y"
MR..JJ_W688.0"3P:YW6O$J7/CB'PNNHS64)L))Y9H!B3S=Z(B@D' &6/OQVR
M" =JT:.06121ZBF^1%_SR3_OD5SNK:VW@CP.^H:W>-J%Q:0X:98=AN)/X?E7
M(7/&3T'6LO6_$KVWC+PG)%JQBT>\6\-U&ZJL9\N+())&X8)]<<"@#MS%&0 8
MTP.@QTIS(KC#*&'H1FL[3_$&D:KIDNI66H02V<)999MV%C*_>#9^[CWI;#7M
M,U.[FM+2[5[F%0TD+*4=5/1MK ':?7I0!>:&)D*-$A4@@J5&"#VIJV\<5L8;
M>..)<$*JH-H_ 5*3@9/2N'\(^,KK6?%>L:7?1"*-D2^THX_UMH?DW?\ ?2[O
M^!^U '6Z;IT&EV2VMN#MW,[$XRS,Q9CQ@<DG@<#M5DHK,&*@D @$CIFJU[J=
MGI[1)<S;9)B1%&JEW? R=JJ"3@=<#BLW_A-/#!LGO!K^G- C*K,MPI*LWW5(
M!R"<'CKP: -KR8L8\M,?[HH$48((C7(Z'%9=OXIT.[@GGMM3MYHX)_L\AB.X
M^;C.P <L<=AG-36FO:5?:=+J%O?P/:PLR2R%MHB9>JL#RI'H<&@"ZEO!'*TJ
M0QK(PPSJH!(]S3V57&&4$>A%94/B?1)DO'&HPQBR :Y$Q,1A!Z%@V" >QZ&H
M(O&?AN:YM;=-9M#)=1^;""^ Z[=W4\?=YP><<T ;FQ=NW:-OICBF^3%_SR3_
M +Y%9^D^(M(UQKE=,U"&Z:V8+,$/*9Y&1Z'L>AID'B;1;F]%I%J,)G:,RH&)
M42(.K(3PX'<J2* -/RH\Y\M<^N*58T4$*BC/7 ZU@CQQX7)@ UVR87$ODQ%9
M,AFSMQGIUXST)I'\7Z<OC,>&MS?:1;>>[%3@$N%50<<YRV3T&* -V.WABB\J
M.&-(^NQ5 'Y4ODQ<?NTXZ?**J:IK&G:+ D^I7<=M$[B-7DS@L>@^IIJ:YIKZ
MP=)6Z4Z@(_--O@[PG][&.G;/KQ0!;>V@DD+O#&SE=A9D!.WT^E/,:%MQ12?7
M%<[JNMZ9=067E>(AIY;44A4KC=/(KX:###G)X..1^=*/%NGW/BVZ\-1RR)=0
MP*[2A#P[$@!<C!(QG/3MZT =!Y,6,>6G/^R*22WAEB\J2&-X_P"XR@C\JX/P
M1XUM3H%I%X@UR)]3N+VX@C,Q56?$SH@PH &=N!TSCBN\FGBMH'GGE2*)!N=W
M8*JCU)/2@!QCC;&Y%..F1TH$:!MP10WJ!S6-9>,?#FHW @M-9LYI# USA9!_
MJE."V>F/Z<]*L67B'2=0NY;2WO8VN(HQ*T3@HWE_WP& RO\ M#CWH TE147:
MBA5] ,4AC0MN*+N]<<UF1>)=&F=E6_C7$)N-TH,:F($ R L "N6'S#CFJD/C
MGPO<7UI91:[9/<7@!MT$@_>9Z8]SV'?M0!N);P1RM*D,:R,,,ZJ 2/<T\@,"
M" 0>"#WK-U+Q#I.CLPO[V.#: SD@D1J3@%R!A 3W; XJ2]UG3]/2-KBY4>:I
M>-4!D9U'5@J@D@9&3T&10!<6*--NV-5VC:N!C ]!3ZYC4O'>C6$^B)'<K<)J
MTA$,L.70(%9B^1D?PXQUY]C6[?:C;:=IDVH7+E;:&,R.P4L=OL!R?I0!8V)M
MV[5QG.,=\YS^=#1H_P!Y%;ZC-86B>+=-U?PQ;:XTJV\$L:,PD.-C-C"^YY X
MZGI6CI^L:?JK3I9W*R26[!9HB"KQ$C(#*0"N1TR.: +AC1B"44D="12A%#E@
MHW$8)QR:HZAKFEZ5-;PW^H6]M+<-MA260 N>^!Z>_05G#QSX8-G<70UJU,5M
M)Y<IW'*MC.-O4\ G@= 3VH W?*C\LQ^6OEG(*XX.>O%(L$*1+$L2+&OW5"@
M?055.LZ:-,AU+[;";.<*8IE;(DW?="X^\3V Y-+I^KZ?JJ3-9722F!]DR\JT
M3=<,IP5/L0* +7E1@@^6N1T.*<RJZE64,I&"",@UP7B+Q6K^(O"L.D:NWE7F
MHB*:)$&RXBV,2RL5^8 @#*G'/-=!9ZC9'7=;==?%TMLD7G62[66RX;^Z,Y;!
M)!]* -#5-/:^TF[L[:X:RFF@:&.YA4;X<C (^G6N9@\+:Q>60TW6CH+V0C$3
MR6MBPED0#&!N8A#CN,X[8X(QM-\6IJUF/$%SXG;2H;;4I4E@>(- ULLA14;(
MX9@ =^<@GZ"O0)=6L8#9B6<(;QMEN&4CS#C.!QUP"?H">U %L1HK;E10?4"F
M^1%Y_G^4GFXV^9M&['IFN=L-?T>RL-7U*X\40W=C'>N&FD= EL<+^Y4CKC\3
MS6A9^)]$U#57TRTU.WFO43S#"C9.WH2/7!ZXZ=Z -)X(I'1Y(D=T.49E!*GV
M]*<8T+;BBEO7'-9=WXGT2P>1;O4H(%CD\J260XCCDQG8S_=5L=B<\U?2\MI;
M(7L4\<EJ4\Q98VW*RXSD$=1B@"3R8L8\M,?[HI)+>&:,1RPQN@.0K*" ?I7F
M_B3QVVK?"[6-=\/WT]E<6KL$81C<5$WEY(=>,C)XP1Q7<67B/1M1U2?3+/4;
M>>]@7?)"C98+G&?< \''0T :31HQRR*2.Y% C122$4$]P*S&\2:.NH16+7\2
MW$LABC!R%>0=45L;2P_N@Y]JU: $5510J*%4= !@"F-;P/*LKPQM(O*N5!(^
MAKBM<\9W6E>/])L/+']B2R?8;NX/\-U(H>)?;  _[^>U=G=W=M86LEU=SQP0
M1C+R2-@#\: %EA$B.%/ER,I D51N4XZC-<;I_A;Q!#8QZ7?76AW5HB>6;M[!
MFN)%[E@S%=YZECD9Y(-;Z>*M!:[>T;5;6&Z0$M;W#^5* !NSL?#8QSG&,5'9
M>,?#FHW"06>LV<TCPM<*%D',:G#-GI@8_+GI0!J6MC;6=I#;0Q*(X8UC3(R=
MH&!S]*E\J/8R>6FQAAEV\&L^Q\0:5J-Z]E:WJ/=)&)?)(*L4/ < @;E_VAD4
MV/Q+HTNH1V*:A%]HEW>4IR!+M^]L8\-CO@G% &E'%'%&(XT5(P,!5& !]*;%
M;00 "*&./:"!L4#&>M8DOCKPM!"TTFNV0B68P,XDRH<8R"1Q@;ASTYZU;@\2
MZ+<ZRVD0:G;R:@JEO(5\D@=<=B1W Z4 :M1Q00P!A#%''N.3L4#)]3BLZ\\2
M:/I]T+>[OXH7,BQ$MG8KM]U6;&U6.1@$@G(J&\\8>'=/FNH;K6+2.6T"^>GF
M9:/.< @<YX/'7 H BT'2-8ANFO\ Q#J-M>WRQM##]F@,21QE@3P226;"Y_W1
M[D]!7-:QXWTC2H-'E$XN$U6>..WDB!9"K<E\@=, X]3^..CCD66))$.4<!E/
MJ#0 &.,EB44EL9..N*3R8N/W:<=/E%/HH C:")IEF:)#*HPKE1N ]C3I"XC8
MQJK/CY0S8!/N<''Y4ZB@#F/!/AJ?PWHB65\+26XCFF=)X02<22,Y'(!&-V.O
M-=*8XR^\HI?&W<1SCTIU% #!#$,8C3Y1@?*.*<44L&*@L!@''(I:* &K&B9V
MHJY]!BFQV\,*%(H8T0DDJJ@ FI** (XH(8 PABCC#'+;% R?4XISQI*A21%=
M3U5AD&G44 -\M"2=BY;&>.N.E-A@BMTV0Q)&F<[44 9_"I** &M&C_>16^HS
M22PQ3Q^7-$DB?W74$?D:?10 R2*.6(Q21J\9&"K#(/X5SNE:#?6/C;6M:D:U
M^RZC%!$D:,V^,1!@">,'.[IVQWKI:* (TMX(\;(8UP2PVJ!@GJ?K2^5'S^[3
MGK\HYI]% "*JJ,*H ] *;%#% FR&)(USG:B@#/X4^B@")+:"-BR01JQ8N2$
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MXW$\XZ\$UW-(JJHPJ@#.>!0!S7C/4H([&#1!?1VMYJ\@M49G 9(R"9''T0,
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MK_AB"^O+'^U;6]U&>*61C=)&WSF/<<G;\IR.,CK\IQZR0""" 0>H-
MZ 4 ><V][X0U5-6U_1KF:\F&DR6\]_+-*41#RL9W\;B<G'48YQD9Y]Y]/'PV
M^&2/+;834[ NI9?EPK;R1VP3S]>:]F554850!Z 4N* /*==\S4/&OC6QTJ=&
MO[GPXD<*1N-SR#S/E'^U@CZ9%6/#FJ^$/$T^B30M>S:SI_S?9I99@;!MN)"X
M)VA0!CG@\"O3J0*H)(4 GJ0.M 'AEQ<V/_"C_%(CF@\Q]7F8!6&6)N@5/O\
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M=*UI? #[19QC9\DI7@AOE )P25]JYFSAL-:^ >BZ/ISP/K4DD(M8HR/-2<3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(B3X7D^W'X5V$1?QE\6+.]A@;3?^$862.ZCN"!<3F5?E 521Y?4AL\Y.!WH
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ME=Q/\)&0<'(-2V?BGQ!'J?A1M033FL=>BVF.!'$D,GD^8#N+88'!XP,>IZD
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M'=PSC*-NV@#'4CK^E=510!R/B'PWJ^L^(?#^K03V,#:0\DGEN'<2ETVD9&,
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M/38M;LM3\&WD<LCWJ?:8Y%G,CDG!".567!V_*N>W->R,P12S'  R?I6#H/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/D]!MSGN*+C5M-L[J*UN=0M8+B4@1Q2S*KOGI@$Y- %RBJ=SJVFV1E%UJ%I
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MA2:"1)8G&5=&#*P]01UI] !1110 4444 %%%% !1110 4444 %%%% !1110
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M'_C6QUA4,S^0T*3 8>S\O VYZJ&W9[98YJ\?"^LM!# ;SPV88<^5&= .U/\
M='GX'X4Z\\-:YJ+1->W_ (=N6B_U9FT%GV?3-QQ0!YY8:>&\,^ (]0B6:(Z^
M\5J9AEFM,3>6I)Y*D;<#H1BNV\+0P6OQ0\:V]M''%%Y5@_EQ@*-QC?)P._ K
M0N?#^OWC1M=:EX?G:/[AET)FV_3-QQ1%X?\ $$%T]U#J?A^.X?[\J:$P=OJ1
M<9- &'\1XGTWQ3X/\52JS:;I=U+'>,!D0I,H42'_ &01R?I7=2ZK8QV:78N8
MY(I,>48F#>:3T"8^\3VQ62VG^+'4JVO:,RL,$'1Y""/_  (JA9>$]6TV=I["
MZ\,VLS?>D@\/E&/XB>@"C;65E?\ QAU];NWAG"Z5:X650P&6D!X/L?U]ZYCP
MKJ=C!X0^'D,_E"]>6[^QW-S*1!;[/,4E@"-YVG:JY'U&*[H^&]<:XDN#J'AT
MS2 AY#H+;F!ZY/VC)J,^%=7:V6W-WX:,"OYBQ'P^=H?^\!Y^,^] 'FU_+97'
MPG^(41N+:Y>+6YI49=O ,D6'4=@23@CU-=W>6=GIWQ=\-K900V_FZ9>(XB4+
MO ,9&<=><FM&3PUK<JRK)?\ AQUF?S) V@L0[=-Q_P!(Y/N:/^$:UT2QS+J'
MAY9H@!'*-!.Y,=-I\_C% '!V\-EK'A63PO)JNER2)KKS_;YKN/<RK<%V8QD[
M_,/S)@C!'.<&MNXO-.MOB#X@T?6M6&D6\]E;K8JXA2*6V"$.BF1"!ABW (Z^
MU58/ ?B]YEM=0M? UW:\B2_N-->6YESU=E) +$DD_-C)KI3X1UF6PLK.ZU'0
M+R*S14A-WH;2LNT  Y,_7@<T 7_#$NB:+H>BZ+::D[QRQNNGB[E!EN(T).5Z
M;E"X(P/NXKI*S[/3Y=EO+JALKR_MRWE7$5KY6P-P0H+,5XX.#S6A0!S/BVW\
M.ZS)9>&_$4$,B:BLKV_F-M/F1[>$/4-AR1CL#7':9!XA\,:QK_A/3]5N-6LH
M]%DN[%YCNFLYCE8XBW?/4?3@#G/I]U86=\FR\M(+A<%=LT8<8.,CGZ#\A3;'
M3;'3(3#865O:1,=Q2")8P3ZX H \S\-OX8\0Z9X2N!X@N)-0L'C,%A&T*S12
MA=LB,H0/M^]NR>0,YIOA;4?#NJ>#)-*\321MK%OJ<CW=HTI2XDNA,60J 0S$
M_*!CC''05Z9!I.FVM[+>V^GVL5W-_K9XX561_JP&3^-+_96G'4O[1^P6OV[&
MW[3Y*^;CTW8S0!QNA26B_%3QK:W#0A[A+$1Q2$9D'DOG /4=<UQEE<&R^&'A
MZ0 #28O$S?VAM^XL N9,;O\ 8#;,_A7M#V%G)<M<O:0-.T?E&5HP6*?W<]<>
MU-ATRPMK>2W@L;:*"3.^-(E57^H P: ..U&S$WQ=TN6T1'BFTJ<:HN 5>+<O
MD[AT)W%L9[ ]JX;3[.Q@^"OA:^B@@2Y75[=A.%&\$79'WNO3CZ5[1:Z3IME;
M/;6FGVEO!)]^**%55OJ ,&F'0](,"P'2K'R5;<(_LZ;0?7&.M %UW6-&=V"H
MHRS,< #U-<-_PE7A?6]7MK^XU[3#:V,A-E;BY1I)IB"GF; =QP"508R=Q/\
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M*BUW9$6UBI /=<C@^F*WZ:B)%&L<:JB* %51@ >@%.H **** "BBB@ HHHH
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MM_( ">7CY=H'08JY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<6\%
MU"8;B&.:)NJ2*&4_@:EHH @-E:-YFZUA/F *^8Q\P'0'UQVIL&GV5K;O;V]I
M;PPOG=''&%5L\'( P:LT4 ,BBCAB2*)%CC0!51!@*!T '84^BB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %HHHH ***IP:MI]SJ,^G07D,EY;J&FA1LM&#P-P[4 7**** "BBB@ HHHH
M**0D*"20 .23533]5L-6CEDT^[BN8X96AD:)MP5QC*Y]1D4 7**** "BBB@
MHJF-6T]M6.E+>0F_$7G&W#9<)D#<1V&2*N4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!Q$?@C6H?#]GIT7BZ<7-C>^?:W9LHR4AV%/*9>
MC'#-\YYR<UT>MZNFF011I)"+RZ;R[=96PN<9+-_LJ.3^ ')%:9SM.T G' )Q
M7/VFEW\TE]>ZQ9Z=<7KOMM8Q*SQQQ#[JY9,@YR20#DGT   .:^']ZVF^#/$V
MLR//?XU.^NMV09)UC^48[9(C &.*ZCP[KEUKD4-U]GMC83VJ7$5U;SEU9F)R
MF"HY7')]^@K'\)^'O$7AGPMI^F#^S7F@O)9;DK,X2:-S(Q RF5(9D_[YZUJ>
M$?#A\-V^HQCRXXKN^DNHK6)BT=NK!1M4D#J06Z #=@=,D WIYXK6WEN)Y%CA
MB0O([' 50,DGVQ7)3^.)(?#]MXC;3MFCSSQ1IYDA$[1R.$64)C !+ [<YV\\
M'BMWQ)I']O\ AG4]($Q@-Y;/")0,[2PQG'<5AW'AR[U5-"L]8:SM=/TZ2.7[
M-;RE_M4T:_(,E5P@P6QR3@=,<@%:XN-1U;XL6^GF.W.G:/:_:V E;/FR[D0L
M-N-P4/@?[6<]J[:.*.%-D4:HN2=JC R3DG\SFN6\&6LDUWKWB&8<ZK>GR#ZV
M\0\N,_0X9A[,*ZPYQQUH X;3O%&HO=^+=7OUMUT;1R]O$L<K$EHEW2'E>22V
MW/&-F .IK-\$ZS>:3;^%M%>P60:NEQ=7%V9</YN#+(VS'*[G"9)&3T&,$V+?
MP/K,GP['AJ]N;,2W-T'OI(G<^8C3>9,0VT$LP)&,  =ZW!X=O!X[CU9&MH],
M@TP64$:YWQDN2V!C ! CYST7&.<@ JZEXX:+3KJ_TRSCNX(;C[+ &E*O>S!M
MK)"H!S@Y&[U4\8&:[$=.F*X;P3X5U;PQI\.F36^C[+9F5-2AW&>:,L6PR%!M
M;GD[F'M7<T <%\4)#>VNA^'(X)+EM6U&/S8(]NYX(?WLF-Q _A7J>];]A,/$
M"F_GTAK>;3[N06B76T/N"%&8E=P )9QQG@ ^U9E[H>O3?$&#Q L&FS6=I9/;
M6T$EVZ.KNP+2'$1 RH"X_6K:1^+_ +5/=-'I"C*1P6BW$A14))D=V\L%G^[@
M;0.#SS0!!H_BG5=9EFMH-'A2ZL;]K74 ]R1'&H/#1MLRY*D,!A?<C(J/4?'#
M1Z=<7^F64=W!'<?9;<-*5>^E#;66%0#D Y&X_P!T\8&ZI=(\,ZEI/B?5KI+R
M)]/U-(I9V)/G>>JLK%1C ##8<YXVX [BGX(\+:MX8TZWTN>WT8):DHNHP;C/
M/'N) 9"@VGGD[F^E &V_B"2YU.^L-+MA<-8*/M<S,0J.1N$:@#+OC!(X R.<
M\52MO%=]-XAT/2IM&:V?4+%[N<23 O;;0G!4#D;G"Y)!R#QZQ:'H>O:#J&M0
MP?V?-9:CJ$M]'<R2N)8C)C*F/;AL8X.\<4EUX<UF;QI?ZM'<6HMI].CLXG+-
MYJ;69F7 & &)7+ Y ' S@@ JZGX\N1X,UW7--LH6-E>/969EE)6Y8,L88 #O
M(2 ,\XSFI+R68WWA7PUK6G6VHSSYN)9S<,3$]N ?-QL&<L5[CEL8(%4;;P1K
M5OX.\,:,'TXOIM]'=72;W\M]H9N#MRW[TA\87TSQD[RZ%J9^()UR6:V:R33E
MM(^OF [RS_+C W'9SGHN,<Y !'+XNEN;+6;[2;..XL=*\Q9)YI2@G>,9=8\
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MF@>.,IM"[<8));.>,G@T 02_$"ZB\%ZEXA.DPXM;YK.&%KH@3XD$6X-L[N6
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MR#^&(X(_#WARVN#>^?J3:OJEV<?OC&=[,P' W2F, >B]\&O1Z ..^*%_+9^
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M$K/&K$+*N0#M;J/ZCFMFHK=94@19Y%DE ^9D7:,^PR<#\:EH **** "BBB@
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MQ9L$G^'H2: .MHKF)?%$]NVGZ?<Q6T&K3VGVN[$DN(;*,8!9F[_,=H'&2#R
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MK^0H ZFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?$_A>;5]1T
MK6=,NTM-8TIW,$DJ%XY$<8>-P"#@CN.17344 95I'K5Q)&VI-9V\:')CM'9S
M(?=F"X'L!SZXR#@0>#M0M=$U/0;:^BAL;^ZFF>[7)G6.5BSH!C&[DJ'SP,';
MD5VE% ',VWA&.S\1V.H6YB6STW3/L-A;8)\IB1N<GW547UZ^M9"> +NW\,:%
MI,%_!YMGJ2ZC?321D_:),LY.,_WRI&?[HKO::Z+(C(ZAD8$,K#((]#0!P/A\
M:KJOB+Q3K6GM:!9KA=-M[B<EC&L PS!0,.#(SG&5Z59E\#7%A-X<FT*[@632
MI9WF-ZK/]H:9</(VTCY\DGL.2.!6[=SZ!X+TB:\>V@TZQ5@93:VAQDG )$:G
MN<9QWK8+ (7(. ,XP2?RH XB'P7K$,?BUO[7A:ZUP%8YS&=T8\L(,^FWYL ?
MWJL7GA9+&Y\,SV]Y;66D>'X9=XF&.J! ^3P,+OY/][/-=%I.LV.N6LESI\K2
MQ1S/ S-$R8=#AAA@#P>/PJW<6\-W;R6]S#'-#(I5XY%#*P/4$'@B@#E3HPUG
MQS)K45RC:8+!;.95&1<.LK/@'NHS@^OW?[PKKJ;'''#$D42*D: *J*,!0.@
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MGA5RA]1D<5<  & ,"@#B!X&NKO1?%>G7^H1XURYFE62&,[D#8";LGG:JJ,#
MX/7/%R]T.2]?3+OQ#<VEOI^CD7(@B<B-Y5&%D=F PJ\D+Z\DG%=745Q;P7=O
M);W,,<T$B[7CD4,K#T(/!% '+#1O[7\<S:W%<*VF?88[.55&1<.DCOC/=1NY
M]3QV84S_ (174[+QQJ6O:?-ITD6I+%YHO(6:2W>-=@,9!&01U!(Y[UU\<:11
MK'&BHB *JJ,  = !3J ..U7PGJ,OBZP\0V5Q8W$T5D;*>*_B)4KOWAT*_=8'
M/;I75VL<\< %S.)I3RS*FQ?H!S@?4D^]344 <[XNT&^UR'2WTZX@BN=/U".]
M5;A28Y-H8;3CD?>R#Z@52LO"^L6WBO5]=EU.WEFN[.."',1'E%0W &3A-S X
M&2<<GKGJ;FZM[.(2W5Q%!&6"!Y7"C<3@#)[DG J:@#AAX"GMO#GA?1[.\A2/
M2KI+JZ=XR?/D56)8#U\QMW/H/2NY'2BB@#E9?#NK)XUOM8L[^VCMKZTBMY1)
M&6EB,98CRSG'.\]>AYP:R;#X?7D?@S2/#U_?6\T-O?)=7H5&(N%5VD*DGDEG
M())[#&.]=A8ZW8:EJ%_86LKM<V#(MRC1.FPL,J,L #D<\9X(]:T* .8_X1[4
ME\6ZSK<=[ /M5E':VBF,EHMH<\G^[O?=QR<#TYSAX#FMM \+:197<,<.D7*7
M-PSQDF:15;YP/7S&W\]\>E=Q2$@ DD #J30!Q=[X0U6YUGQ->1ZC;I%JMM'%
M"-C;T*1E55CG&S>Q8@#)SCIUBA\%ZM8GPG+8WUB)=$MI+9TEA8QE71%W* 0=
MPV=SSD].E=K;7-O>6T=Q:SQ3P2#*2Q.&5AZ@C@U4?6["/7(=%>5Q?S1-,D?D
MOAD7&3NQMXR!U[T <I%X)UB'2_%T U:%[O7'D,5PR'<H9 B[CVP <!1@9^@'
M6Z/8OIFCVEB[HQMXEC'EKM4 #  'H  .:;K.MV&@6!OM2E>*V#*I=87DP6(
M&%!ZD@?4UH4 9VHPZD]U:263VY@3>+B"8D>:" %P0#C')Z'T]QR3^ +NU\.:
M98Z7=VT4UAK!U2.&56,"@LY\D8Y"KOX/JN<#/'?5GPZW87&M3Z/'*YOK>(32
M1F)U 0G .XC!R0>A[&@#"T[PQJMKXQU+7[G4H)GNK2.WC B(\O;N)4 GA-S
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M=2>QCC.\13$%"O<D,RN .V2.U6+[Q5,8-<O;!;<6&BK()YYP3Y\J+N>-,$8
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M<+.BR&1EZYRSX))_*@">P\4:U<>)- TZ>TLUBO[&2YN-F[S(]@3YQS@*SO@
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M).X>8XYP.4SCL!?$]S#HGC#Q))%IJMIDLMM;7"VQ!G6$='._)'F%E&"!W[T
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MD^^T,2H6^I YJU110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF>T2UGO?+R64*%("Y&!M! YXSGDYSHZ_X:M-=\)W7AXDV]M-"(4,8_U>W!7
M[@$#BMJB@#GW\.RZEK&GZCK-S'.=.R]M;P1E(Q*1@RMDDD@9VCHN3U/-9L?@
MN^30/$VG_P!L+YVM37$BS+;X\KS>.?FRQ"X7.1P!Q7944 4M*LCI>D6UF\RR
M"WB";@FQ0 ,  9. !P.3QU)ZUQ'A*VU+7[+7-;M-0AMH=<OI3'.D1:9((SY*
M;3NV@[4R"0<$YP:]"DBCFC:.5%=&&&5AD'ZBF6]K;VB%+:"*%2<E8T"@G\*
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MGP)\/I-(@MAK/G6+PRVZCS.%4SEB.2H ;=GOC/- 'JEKJ^FWIF%IJ-I.8/\
M6B*97\O_ 'L'C\:FM;NVOK=;BTN(KB!L[9(7#J?H1Q7GNN"]\*>-9I-+A8P^
M*8Q I1<B"^4860_[)0ECZ^6:] L+*#3=.MK&V7;!;Q+%&/15&!0!#-K.EV]_
M'8SZE9Q7DA"I;O.HD8GH I.2:9=:_HUCY_VO5K&W^S[?.\VX1?+W9V[LGC.#
MC/7!KRO3KC0M9\-ZGH'B?7;FVU*+49C<Z>&B2:27SB\;193>Q/R8P3Z=*WM*
ML-.F^)OC83VUNY%E9[A(BDC=')N)]SQF@#J=9\8:+H<NFQ7=_;J^HR!8,RJ
M5(R7)Z;<#KTR0.]3QW1D\1N5UNU>U^QAAIZA"ZG=GSMV<[2"!C&.^:\LTF[B
MA\$_"NZN9T2&.^"O+(X"K^[E !)X'I76VXM)?C7=>6L+)/X<C=@ ,/FX;D^O
M&/TH ZZVUS2;RXCM[75+*>:56>..*X1F=5)5B #D@$$$]B*+;6=,O[B6UL=3
MLI[J-=S1Q3*[(.F2H.<9KRGP_ID;? B]O-(LX7U98;Y8YHD!E ,KAE5NH)0
M8'M70Z)<^%/$FK^'M5L->FOK^VC<6UM$T*M!&R8<2HB*0HP!SQG&.M &EX2\
M4O+I.IW'B+4[.(V^KW-DDLA6!"L;84#)Z\$]2:ZE]1LHWMT>\MU:Y_U"M*H,
MO?Y>?F_"O/?"VBVGBCP;XOTBY*F*ZUO4$W#G8WF95A[@X(^E7_ ]_J'B26&Z
MU>!H[K1(WL)MPX>[SB1QZC8J$$?\]6% ':W=[:6$0EO+F&WC9@@::0("QZ#)
M[FJZZYI#VDMVNJ636T4ABDF%PA1''52<X!]NM<G\6XK=_!:&X6,@:A: ,W8&
M9,X/;C-4_%4FG^%_&7AV:21-'T:=;E7N;>*-(TNF$>UGW*5!**RAB,]><9H
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M ]Z+U'_UGVHNS1$#J228]OK@ 5Z;H45V/#.FPZK\]Y]CB6ZW\[I-@#Y]><T
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MTU#R=08G?:3R8CVNN[URG!Y!'K0!WU% QCCI10 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@X.".O((JU0 4444 %%%% !1152_U2QTN+S;ZZB@3:S9<X^51EF^@')/0=Z
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MAMK>,9:69PJC\34T,L<\,<T3!XY%#*PZ$$9!H ?1110 4444 %%4_P"U=/\
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M>HN+V2;SUF</=1R3[W$AV?(=I(XW9XZ#J ;<OCBYM[+PO--I*K+KF"8!<$O
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M&T;3G !...G6NAKA]<DN=2^)>C6=I!'<)I%K)J$R22E!ODS%'SM/('F''XT
M7D\8-:>([_2M:M8+)+;3O[3%PEP9%$.XJP?*C:P(SQD'UI8O%EU-J>D6RZ6
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M',&$ZQ\F4MCY5 ^]P<$8Y. :FMZ0]_KGAE=$FAA&EM(9&7YA# T+1C';=G&
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MS'-;%16ZRI;HL[H\H'S,B[5_ 9.!^-2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%<'X[O;C4?$?AWP;;S200ZL\DU])&Q5C;Q+N,8(Y&\\$CM]:
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M R.>N,D #J2>P!(YZ3QW=P>'/$VKR:= 4T6Y>U0>>0+ET #$':<99MH'/UH
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MAJSABXBG82L^UFQGH5[<;!]:U[#P[K*>/)_$-]=VDD;V"6R1INS%\Q9E4$<
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M@5BVG@!X-+\):9)/#)::1.;R]'.;BXVDAAQTWNS<^@KNJ8LT3S/"LJ-*@!=
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M&Y>N/>LBW\-VL-]X2\/Z;(;G3M-9]6NK@L&,LF"(V)'4L[NW_ #Z5Z$0&!!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI*&6*8,P8#G!9"./6@#3N/$^L07WA^%M.@1M9N"BV[L?,MXE4NS.>A;:.@&
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MG<?>LO4_$$MOXO\ %NNVD4,[:%IRVB&9RL:8!FER0"<DF-0!U*GTKJQX?O\
M_A.QKK7D+6RZ>EFJE/W@(<L_^R-QV9/^SC'<8\O@*\?P7=:0MW:F]U#4OMVH
M3LC;)@9@[+QS]T*OT';- $7BW4Y-17P;IEQ;E;C4;F.^N+13DD0H)/+Y_P"F
MAC&3Q@$G@&K=IX\DAT36-0U:SC#V>IMIUM%9N7-U)\H"KN R=[%<\#Y2:UHO
M#LI\9MX@NYXYFAT];.U79@H2Q:1SV!;Y1QV%85EX"OX/"NBV5Q>VTVH:9J2Z
MED*1'-)N<L&/7GS&.<<''''(!L'Q!?6/B71M(U."VW:M%,T8MRQ,#Q*&*DG[
MXP?O87D=.>,32-:MK*7Q5XONP\B7&H+I]G'&,M,L/[I%3U+2F3\\UO)X=N9_
M$$WB"]GB.H):M;6,29:*U4\ELG!9F(&3@< #'<X">!-7@\'^'-.AO[-K_1KV
M*\^=&\F4J&W G[V279L^O:@"35VU+5_&GAC1;Y+98T9M7N(X&),7E#:BL3]X
M>8ZG.!]T\4D?B06^D^+O%1TRP2?3I9;59E)!NE@'0MC/WR5'N*T],\,:G:>,
MM2U^YU"WF:ZM8H$Q&05*[B5 SA4W,#@9/RC)ZDYMMX"OF\!V'AJ_OK>1!=QS
M7VQ#MF02&5UR>27;J3@8XQZ@%RP\6:K<^(=!TZ;3[9(M1LI+F5ED8O'L5,L!
MC&PL^T<Y/7CI5"[^(-ZO@ZZ\66=C;OI\=UY%M;2LPENAYOE;@P^X2V<+M;@>
M_&CJEL^@>)-3\9W]PATZWTU($ABCS(JJS,PYX +,O/\ LC. *Y]+35_"\J7V
MJZ'I6I6,NH"9&M+EE>"25\*R0,/++#<.4()Y/))) .COO%&HVFN6.BR6UG;:
MA=64ES&KRL\<\BG'DQOA><<DD< _=-)XIU.XLXO"CR*J7MSJUO$R*<[2R.)
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M4U71/$.L7-I-ICVFI7;7@GFA8W,#. &08X9>..1CT-=FH*J 6+$#!8]3[\4
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MNP49R2.>.E,U;QM>Q>%]2\1Z7;V\EA;.8K59@Q:\?>(]RD$;5WG X);';(H
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MYECE6$@1^:-HW<Y)"A5&,8QWKM** *.CV+:9H]I8O(CFWB6,%$VJ !@ #G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,R(>%._@'@G/7-%M<V&E^,-.TR\UNZM=-;0HH]+NKSROWP#L) 6D0C<5\L]
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MX8[QM7L0UP%'F,&+ @MU(QQCT ]*WX[FTM/$_P 38[F:&+S(K=@LC ;@;;'
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MA,^1[D#% &<WC37_ /A3:^*%EM!J(G*29@)0K]I,7RC=Q@8ZYZ5Z=7B99?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?V>HQ-+97<%S&K;&:"0. V <$@]<$<>]-O=2L=-C$E_>VUK&QP&GE5 ?Q)H
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M:'(J_9YY#&C))R'4NN$*\<=^H[4 :MOH>DVE]-?6VEV4-W.")9XX%5Y,]=S
M9-266EZ?IID-C86MJ9#ES!"J;C[X'-.34;&2P%^EY;M9%=XN!*ICV^N[.,5E
MZMXPT/2?#EUKDFI6LUG;@C=#,K[W XC!!Y8^E &U*SK$S1IO<#A<XR?K7(>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %4M3UG3-%MUN-5U"ULH6;:K
MW,JQ@GT!)ZU=K*UN&WBM)[]]&;5)XX2BP(B,[*>2H#D#GOZX'7 H T8)X;J"
M.>WE26&10R21L&5@>A!'45)7&?"N33S\/K"'3VFVP/+'-%,FQX9=Y9XRO;:6
MP/;%=G0 4444 %%%% !63/XI\/6UR]M/KVEQ3IPT4EY&K+]03FM:N TM1_PO
M'Q <#/\ 9-M_Z$: .XM+RUOX!/9W,-Q">DD,@=3^(J>O,M:BC\+?&+PW/I:B
M"+7TN(-0MX^$D,:AED(Z;ANZ^@]S5\^/=0GM+#5M.TN2]TZYN%0V\5I.9EA)
M($P?&P]F*XZ'[U '7ZGK6FZ-%YNHWD=NFTO\W7:,9; YP,C)Z#(I=*UK3-<@
MEGTN^@O(8I3$\D#AE#@ D9'L1^=<9%_:<_QDU*&1K.2 :/"#&ZL1Y332<=?O
M'OVZ<5#'XQN]+\#>)M1L]$TVW;0K^6T6UA<K$4C"#=PHR>>F%X':@#T>BN1@
M\3:O#XOTO2M3L;..UU6VEEMF@E9I(VC"DA\C'(;MT/'/6LY_'NH36=GJ^FZ7
M)?:=<7 0V\-I.TPA+%1*' V'^]MQT_BH [F[N[:PM9+J[GBM[>(;GEE<*JCU
M)/ I+.\M]0LH+RTE6:VG0212+T=2,@BN0U37;[6]*\4)I$=K]ETU9K20SAB9
MY5CS(JX(V ;@,D-DYX '.E\/?^2<^&_^P;!_Z * +]YXFT#3[I[6]US3;:XC
MQOBFNXT=<C(R"<C@@T^Q\0Z)JEQ]GT_6-/NY]N_R[>Y21MOK@$G'-<]\1[*W
MMOAQXJFBB59+BU>25@.68*%!/X*!^%7[5]/TWPAI^N7D8']G:8)3*H^94$0+
M ?4#IZ@4 =)17%0>+=9;5=)1M):XL]1!#F&UG4V3%<KO=EVLIZ%@%QUP:KZ/
MXL\5:S#=W<&D:4MK97=U:SA[MPQ,60I0A#QD8)('7H,9(!WM%><0^/M>.@^&
MM=DTJQ:RU>>&V:%)F$JO*2%8$C:%SV.3CGCH-:W\5ZK::YK.E:O86SSV6G#4
MH/L+LWF1Y8;#N&=V5P".N>@H [&BN8\+>(Y_$2V]W!<Z=>:?-;F1Y+0D-!+E
M<1."3V+<\'Y>@KIZ "LNX\2Z#:7+6USK>FPW"?>BEND5E^H)S6I7G%Y<RVGQ
MZ,D-C<7C'PR 4@,88#[3U.]E&/QSS0!W=AJVFZJ)#IVH6EX(R YMYEDV$] =
MI.*N5SEK=WU]:ZMJ%AI2VFJJ_D+#>D R",94,48@9WG!!/!%4?"/BS4/%0A=
M;2*W6!&CU-)$8-!<AB/)7GD@#)/H5_O8 !V-%<<OB?6M2THZUH6FP7MB+MH$
MMBVV:>-9#&\BL2%7!#$*0<@=1G 9JWC"^#ZPNBVBW#Z4_E-$UM-(;F0('9%9
M!A.& !.<GL!R0#M**X4^,=>O?$%GI.G:+;PRWFD?V@GV^5T:%MRJ5D4+D8R1
M@9)..@S6%J_CC7+_ ,$7Y6&#3=7L-5BT[4$!+J=TB#,9XP&#=3SC/L: /5Z*
MBM_/$"?:3&9L?,8P0N?;/-<;XJ\8:GX>@UB]-K:0VNGA&@2Z<A]0^4,_ED'Y
M=N<=&Y!Z4 =O17(:EXP\KQ!#H\$]E:7$]BEW;?;\A;IF+#RT(( (VC/4_,,#
MBNIM'FELX)+B,1S-&K2(/X6(Y'YT 345RX\0:EJUYK4.@Q6C#29?L[&YW?Z1
M,%#,@((V ;E&X[N2>..>;N?&6H^(&\#WVBR16UIJEU*LT,ZDL)$CDRC$$?*&
M4_4@'VH [^UU?3KZ_N[&TO8)[JTV_:(HW#&+=G ;'0\'BKM>:PS:Q!\1O&K:
M1!9R70M+%V:Y=EC!$<G&%Y)/Z?H=6T\>#4='\/36\'E7FLVS7&TQO,L"H!O.
MU!EOF90.G7.1C% ':T5YU>>/M<L/#EY?3Z"!<6>H1VA:020QW$;NJK)$'4$Y
MW<@D8QU-:%WXC\2Z-J.E+K-EI<5E?ZE]C\VWED<Q!ES&3D#EB"OH#@\YQ0!V
MM5)M3LK;4;73YKJ-+R[#M!"Q^:0( 6P/8$5RUIXRN6U3Q5I]V+1)=$C62/R@
MS><K*6!QGKD;2H[]ZL3:[J-KXN\-:3?6%EOU&WN)'GC<EHGC12RJ".!\P&<\
MXZ"@#K**X[1O%T^NZE)#9R6)-O>R6UW8/E;FW1691(>><X4XVX ;J<53OO'>
MHFPFU72-,>_M8;IH?LD=K,TTZ+(8W='4; <@D+SD#D@\  [VJFI:I8:/8O>Z
ME>0VELGWI9G"J/;GO[5:1@Z*P! (S@C!KR_QIKM]XD^%GB+4]/CM1I)2:&,2
M!C),B/L:0-G"_,&PN#D#J,\ 'IZ.LD:NARK $'U%-GGBMH'GGE2*&-2SN[ *
MH'<D]*Y2;Q+-'<)H^G!!<V]C#/+++;2S*"X(1,1\C.QB23QQ@')QSGBW7-7U
MOX;Z9?26#:7+/J%M'=6ETCAPPN% QG&4)&>1R"* .XM/%N@7VIIIMOJML]^[
M,HMMV),J-Q^4\C@YK:KC[C49]-\=Z'8S:7IIN-6BG,U]$"),PID+R,XPP')/
M?@5DS^.?$G]C^)M1@TG30F@WDL4RO<.?-CC16(4A1\V&)R<#H,'F@#T:BN4O
M/%K2WT%AIJA)Y+%+YY);>2945R0B[8^<G:V3D8QWS52P\;WU]::-:2:2]CKF
MIS31?9[I75(UB&7EY 9EQMP.,E@,C!- '4VFKZ=?7UW96E[!/<V>T7$<;AC$
M6S@-CH>#Q[4_4M2LM'T^6_U&YCMK2$ R2R'"KD@#/XD"N+\(?;!\3O&XOA 9
MA'8#?""%<;),'!)(..V3]:VO'NN3^'/!U]JL%E;WGD!2T5PQ"D%@N< '.,CC
MCZT =("",CI17)ZIXCUB#QK:^'K"PLW%S8R7,<\TS#:590=P"\#YN@SGCIUJ
MWX.\07/B#2[I[ZWB@O;*]FL;A86)C+QM@E<\X/'6@#H:I6NKZ=?7UW96E[!/
M<V>W[1'&X8Q%LX#8Z'@\>U<QXQU'6;7Q3X3L].N+>.WO+N19%D5B7*Q.P!(/
MW>^/4#TK(AFUBW^(OC=](@LI+H6M@[-=.RIQ')QA1DD_AC]* /0+[4[+3?LW
MVVZC@^TSK;P[SCS)&^ZH]S@U;KA)?&\USX>\'ZO%IENT6M7MO!()9"3;L^<E
M1CG&&P<CMQ5N?Q=/+XCU/1;&2Q2^L7C"65UE9;I&56,D9R!@;B, 'E>2,T =
MA4<]Q#;1&6>5(HP0"[M@ DX'/U(%25P7Q%AM_$43>%GU**RW6SW<KO,(_F&1
M O)Z&0%O^V7O0!WM%<KX%\23>)_ MGJ2K&^H+&8;B-WVCST^5LD X!(ST/!%
M<]!\0]>D\(Z-XH?2;'[#=W*03P+,WFC?*8P4R-O!QUZ^U 'I=%<A;>*M1L_%
M=YH^NV]E%''IK:G%-:R,P6-7VLK;@,D<'( ^E5(/&NJS3:+<Q:3)<6&IR(CQ
MQ6LPDM%<921W(V,O3=C&,\%A0!W5(2 "20 .I-><S^._$8T3Q'JD.DZ:(]"O
MIH)D>X<F6.-5)VG:/FPQ.3@=!@\FNC?Q)+?ZY;Z-I(A6X>Q%_--<*66*-CA%
MV@C+,<]Q@#/.10!L:=JVGZO%++IUY#=Q12F%WA<,H<8R,CC(R*N5Y#HWB+4O
M"_@SQ7JZV-M-<Q^)9TFB\TA07DC0E>/FY;OBNKE\2>([?Q>N@2:?II>\M'N;
M219WQ'L8!A)\N3PP(V@<\>X .SHKAK'QY/\ V!<S:A9Q+J=OJ[:/Y<!9HY)@
MPPR\%MNT[L8)X-(_C'6[5M<BET@7"V-@U];WGD36T$H7[T;;U.''4 $Y'I0!
MW5%<)9>,M:-SX5EO]/LH]/U^-57RI6,L4AB\P$@C&TX(QU''/:IO!>HZUJ'B
M#Q0NH7%M)#:ZD8$5$8; (D("Y/3GGU))]J .UI&8*I9B H&22> *6N*?4=:;
MXO+IBW%L-/CTC[0(BC9PTP5B3GEOEX[ 'ZT =3INJV&L0//IUY#=0I(T320N
M&7<.HR.#5RO(-*\0:MX8\,>)M7L[*TFL+/7[Q[E99&$CJ9@"(P!@$ YR?R]>
MVU3Q/.-7N]*TM8_M%K;QS222VTLREGW;$Q&,CA<EB>,C /. #J:*R/#&KW&N
M^';/4;O3;C3;F53YMI<*5>-@2#U ..,@XZ$52NM=U"\U?5=+T2.V,^F0H\S7
M()#R.I9(U (QP 2Q/&X<'G !TE%<K)K^M&#36FTZ#2?/M6GNY[YP\=M("H$7
MRLN222<Y' Z$],9/B)J-QX6\,ZQ;:1;R/J]^+"2(W!&Q]SKE?EY!\L\D\9'!
MH ]") !). .IJMIVI66KZ?%?Z?<QW-I,"8Y8SE6P<''X@URNE>*=</BB_P##
M6LZ=8QZDEG]NLY+:=_)GCW;2"2N00<=OP]<&^\5ZOJ'PT\.:QIR6FGMJ&H6\
M,L2*2%5I]NU<$8!QS[$XQF@#U*J5YJ^G:?=6MK=WL$-Q=OY<$3N TK>BCJ:P
M-<U_6=*,ZF*PMXK>R\_[7<Y\NXFRW[E!N!!PN<\]1Q6'KVK+K^G_  YU<0^5
M]LU:VG\LG.S=#(<9[T =ZFIV4NJ3:8EU&U[#&LLD /S*C$@$CTXJW7*Q:_?2
M>,]<TA--M?-M-/CN()%D)><L7"JQ(&T9'3G&>M5I/$NNIXOL?#L4.G7=PZ>?
M?-$'"VD/J23RS'A5QSU.!0!V=17-S!9V\EQ<S1PP1C<\DC!54>I)Z5PMSX]U
M!M/36-+TN2_L?M)B-K#:3-/)$'*&57 V=MVW'3N#Q6C=Z[?:Q_PD%MHT=J8-
M+#6\KW 8^?-LW,BX(V@!E&XYY)XXY .FL;ZUU*QAO;*=)[:9=\<J'*L/458K
MD_AC_P DR\._]>25UE !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !63J$
MGB&/4XO[.M=,GL#'B07%Q)%*KYZC","N,<<&K5CJMCJ<EVEE<I,UG.;><+G]
MW( "5/OR*N4 <U!HFJ:)X<OTT62Q?6KNY>\9[I6$!ED<%N%^8 +P/H,]ZZ1<
M[1NQNQSBEJC+K.FP:O;Z3)>1#4+A6>*WSEV51DG'8?6@"]15>_O[72]/N+^]
MF6&UMT,DLC=%4<D\5)!-'<P1SPN'BD4.C#HP(R#0!)1145S=065L]Q<S)#"@
MRTCM@+]30!+7ER:O:V7Q"U3Q#%K_ (3DBNK6.U$$FLA'382<GY#Z]/UKU&H_
M(A_YY)_WR* /.K&[\.7'BP>)M?\ &&@7%Y#"T%E;6][&(;5&^\02V7<]"V!Q
MQBLWP[J+^'8QH,'CCPH_AV*0_9[AKT?;(HB<^6!G;D9P&SQUQVKU?R(?^>4?
M_?(H\B'_ )Y1_P#?(H \]M];TF+XB7FOMXE\,FRGL8[-4&JKY@V.S;B,8YW'
MC/;K6%-]@F\)>+M(/BGPJLVN7\UU$_\ :JE8EDV\-\O)&WMUSVKU_P B'_GE
M'_WR*/(A'_+*/_OD4 ><7>KZ5=^*O#.K'Q+X86'2X9XYT_M92S&557Y>.VW/
M.,Y[5G>'M0;PZG]@VWCCPF_AU)&-O<->C[7#$23Y8&=I(R0&)XZX[5Z5IFHZ
M1K*7#Z;-;W26TQMY6B (60 $KGOPPZ>M7O(A_P">4?\ WR* /*([NTTB\\1V
MVD^+/"LVE:W++<_Z5J2I);32+A\!<AU)P<97'\^D\(^(O#^A^$]+TJ^\5^'Y
M)[.W2 M!?Q[3M  ZG/:NS\B'_GE'_P!\BCR(?^>4?_?(H X?QIK^@^(/".HZ
M/8>*/#RS7D)AWSZDBJ@/?C)/TI\>M^%KSP7_ &#JGB;0E\RQ^QS&#4HV&"FP
MD$X^O2NU\B'_ )Y1_P#?(H\B'_GE'_WR* /,_#7B*YL(;;3M7\;>$9K"R 6.
MXM[X"XN54?('R=J=LD9SC'?-2>&=6TO1M$UJTN/$WAAYKR\N;J'R]57:/-8G
M:Q(!&,]0#GVKTCR(?^>4?_?(JC>ZEH^G7MI9W<]M%<WC^7;Q,!ND;V']: /,
M%;3T\$^%]$7Q3X5,^CWMO<22'5E"R+"VX ?+G)_3WK4N=7L'\9ZCKMKXJ\,0
MB?1_L$!.J*624,SJY&,8RV,9[9]J])\B'_GE'_WR*1XK=$9WCB55&22  !0!
MYUH*:+<>.8M9LM3\.6VHS6DD$UMIFH++]MD)#!F4!?N[6/0DYY/'/>:-_:O]
MDV_]MFT.I8/G_8]WE9R<;=W/3'7OFJ'_  E'AN/19-;_ +1LUTZ)VC:ZZ+N!
MP0#W.?2ML2(8Q)N&S&[<>!CUH =7&7&@:\GQ)?Q1;1:;);_V9_9RP2W3HQ'F
M^9O)$9 ],<_6NETO6-.UJ"6?3;N.ZABE:%WC.5#KU&>^,]JO4 <\Z>*Y5OIE
M&EP3&$1V<(G=T5R3N>1O+!./EP /7GFLRS\)ZAH?BZ+4]%:W6QNK<1ZK#/.V
MZ>4'B884_/R<DXW9Z#K7:44 <#HOA?Q5X=ENM'T^_P!._P"$>FN))H99 _VJ
MV5V+,B@?*>2<,3QG)!Z5*_AWQ5HOBC4KWPW=Z6^G:K(L]Q;Z@),P3;0I=-GW
ML@ D$CIU%=S10!YW.FH6OQ@TZ.V,5Y.GAUUE:XD,?F?OURV0K8.<<8QUJ;4?
M =[>>&-8ACN+5=8U+48]1=FW>2K(Z%8\XSM"H!G&223CM70Q#PW=^+9O*%I+
MKUM"#(R\RQQD\ GL,]OTK=H AM/M/V6/[9Y7V@C+B'.P'T&>3CUXSZ#I7 :U
MX*\1:@WBVWBN]->WUN,"&XN-YFA 0 18 P$R"00>,D[237HM% '$:MX7U76M
M*.F:K8Z-J-JUDD:AY'0V\XW NAV,<8*<Y!^4\<X'4Z+82:5H5AI\UR]U+:V\
M<+SOUD*J 6/UQFKU% '(67A[5_#_ (AUJ[T?[%<6.K2"Y:&YE:-H)\88C"MN
M5L XX(Q5 ^ KO3-+\*P:-<6TD^B73SR&ZW(LYD5Q(?E!(.7) _#-=]10!R-E
MH&LVGBOQ%J[BPDCU.W@BB43.I#1*PRPV' .[/!.,=ZPK;P'XBTSP_P"&7TR]
MT^/7=!22$>87:WN8GQN5OE##H", X(_+TNB@#A]?\.^)_$/A5K2ZGTS^T);J
M"9E1Y%@A6)U<*IVEF)(.20.O3BMSQ5H3^)O"=[I99(;J6(-#(&)$4RD,C XS
M@,!SCI6Y10!Q<G@3=KF@ZDMW\UI&Z:B<8-YEQ*"?3]\-^/<BKVKZ'J-]XX\/
MZS!]E%IIB7"2*\C"1_-51P I'&WUYSVKIJ* .%N?!U_JFLZ3J5]!IT&H:?>B
M;^T[61O.FA!.(F78,Y!"G+$=2.N*9I?AGQ=X?O+S3=*U#3#X?N;B2>)YU<W-
MH)&+,J ?*W))!)[\YZ5WM4]-U6QUBU:YT^Y2XA61XBZYP&4[6'/H10!;4;5
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MQ.PRL:HI!=L<GY@![GB@#IZ*Q+>YUV#7H;.^BM)[&6"1_M=NC1E9%*X0H6;
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M-;M<E-P^5 RKSZ9+<>N#5Y;B%U9EFC*K]XAA@?6@"2BD5E=0R,&4]"#D&EH
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M8ICC*=2&7!/.0<CI5I=<L[O5K_1[.ZA.H6D4;R!OF5"^[:" 02?DR1QP1ZT
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MO;:/PO!J;0F%+Q;%_,48X&XL>!Z=/:N-M_AWK]UFTN/"?@ZPVQ[%U&'S#*&
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M<_Z.O[__ '^/F_&F'PQH12!1I-F@@0QP[(0OEH>JKCHI]!Q0!YU')HVJZO\
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MOR#^-:E5K#3[/2[..ST^UAM;:/[D4*!%7Z 59H **** "BBB@ HHHH ****
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MWUK44^)T.A,\!TZ72I+Q0(R) ZR(G+9P1@GH!UKJ*XFX(_X7;8C//_"/S?\
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MGC@4DMHT/QD@:Q0"&YTASJ2*/E;#@1,PZ;N6 /7 /I0 ^P\0ZKXEO+U]#O\
M3HTL-3:U:UG&[SX4VB1]RG(.2=N!C@9ZUU6JZI9:)I=QJ.H7"06MNA>1V.,
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M[F0B"*/RT#G;D;WQT&1@;CGUL_"2>)_!\T$<\4GDZA= ",C"J9GVX&> ><4
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M'TQ6_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFZ,7RC.!@8ZYZ?C7HPU&Q-Z;(7MN;L=8/-7S.F?NYSTH LU0OM#TG4YTGO\
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M+LK..8YE6W@6,/\ 4 <TRW\.Z):" 6VCZ?"+>0RP^7;(OEN>"RX'!/J*TZ*
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M!CMU*0K]G3$2GJ%XX'L*TZ* &111P0I##&D<2*%1$& H'0 #H*?110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7"_%N&"3P.7F1"R7UIL9ARN9T!P>W&:[JJ]W8V=_&([RT@N44Y
M"S1AP#ZX- '"W.E:8OQGTZ%;&V5#H4K&,1J%)69-I(Z'&3BN=L;S3-.\.7\%
MS C0CQK)!9H93%#!()=R%R.B+@G'0\#C.1ZQ_9.F_:%N/[/M//4!5D\E=P &
M  <9QBF?V'I'V:6W_LJQ\B8@R1?9TVN1TR,8/XT >.ZOJ=U#'\4O[-U"&YOG
MALW#6F%W+Y>)F0 D\+G)R<8ZYKH]<U#0)_$GPZNM.N;+[,)Y1 R.HV1&!@![
M#.T8]>*]&BL+."5I8;2".1D6-G2, E1T4D=AV%5K;0-&LW5[72;"!E<R!HK9
M%(?INX'7WH \LL)-#USP]K.B>)O$%Q9ZA%J<S75F&A29I/.+1M%E"[$C8%P3
MV XP*],\27-K8^#]4N+^.>6UBLI#.D9Q(R;#N (Z''?M5R32=-EU%-0DT^T>
M^082Y:%3(H]FQD5;95="K*&5A@@C((H \EL+VR;QUX)S>:=]GDTFXA2W@<,L
M:%8MD;,3ES]0,XZ5BW%AI\7P5\47<=M;K/#JT_ES!!N3;=C;M/;'8#U]Z]GB
MT72H%A6'3+.-8=QB"0*!'N^]MP.,]\=:0:%I @: :58^2S;FC^SIM)]2,=:
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M]"1Q0!P<6B:1:_&>WM+?3;.*!/#K,L*0JJ@BX7!V@8]:Y.?3M/3X.>-I$M8
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M>M>C"*-96E$:B1P%9P.2!G )]!D_F:ABTZQM[F2YALK>.XD^_*D2AF^I R:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$EU)H4!Q<R^6BGSI/O%0Q)[<#\175^$?$'_"4>%[+6#;_9WG#!X=V[8Z.48
M]QE30!MTA( ))P!U)K!GUZXN?$5UH>DQ0/<V=ND]S+<.0B;R=B8 R20I)/88
MZYKCO%GBRYUWX1>(KJTMUM+NU\ZQU"%Y3NA=2%<*0/FR",'C@T >@V.MZ7J<
M\T%AJ-K<RP@&1(90Q4'H2!V/K5^LO2[!1Y=_=6-G%J/D"#SH/F/E Y"[BH.,
M\XZ5J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>(;?P1X9T1I-,>?1]2ANV82R*KI&Y8 '8?F.?0 >] &JH'_"\9#CG_A&U_\
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MMRTOGR;&59S+@?N\YYQ^OM0!T)\1-!X_O=)NK.VB@M])%]]L5BSLGF%<'@8
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MI_!+SVCZ4Q:&*_\ ,;SEMV;<5,>W!< E0=V.A[8.M;>'M1L_'LVM0QV0T_\
MLN.PBB\Y@XV.6!(V8QSCJ>F>>E &=!\15D\*Z'JMXEOIS:E=26<TTY+06SH7
M!)/&06CP,D?>Y/%,\5ZUXB@T?1'B:R@>ZUNWMG>,LRRQ&4%"ISP& &>O!(]Z
M?H?A;7-)\+6FC75MH]_ +BX:[MY96,<T<CLXQF/[RENXP<=L\5?^%>W]IX4A
MT_3I;9)K;6TU6UM997,,**X(A#XW8ZG..I/UH WI-;O(?'FGZ)/869:?3I;@
M72N2P92@*@$?*N2.YS@5S.F>*_$-CX/\5:_=FSNWT_4+I?+PZAA$P3:O)VC
MXZ^_7-=)+H>L3^.]*UV3[#Y%K8R6TRK(X8LY5B5&TC VXY//M67'X(U5O#OB
MS09KFR6TU6>ZGM9DW%P9CN <8  4^F<Y[8Y -F[\2W5MXE\.Z:+>%H=8AF?>
M6(:)HXP_T(.<>U<_H'BO4[+1O%&KZV\-Q'9ZM/:HD(8$NK)$B+G.%)QZG))Y
MJU%X>\4W>O>%=4O_ .R8?[(2>.:*&61]X>-4W*2HY.,XP,8ZG/$1\!:E<Z/X
MIT6XO+:*SU2_EO[2XAW&6.1G61=P(  5E[$Y]NX!JZ;XFU.7Q3%I-UI[2VMQ
M TJ7L%M-&D3KUC?>,<CHV1GT%='J-_;Z7IMUJ%T^RWM87FE;T502?T%8?AZ'
MQ@SQ_P#"2SZ6J0+@?V?O)N&QC<^X *.^T=^XQ@[.K:;!K.CWNF7.[R+N!X)-
MO4*RD''OS0!RMUXSU#3-'TGQ!J%E;KI&H/$LJ1L?-M%EQL=CT<<@, !C/&:9
M-XK\13:QXFTW3]+T[S-&6)UDFN'VR*\9?'"YR0 ,=!SR:9'X1UJ^\*Z=X6UA
M[)["SDA$EW%(Q>XBA8,B["N%)VJ&.X]\9SQ<MO#VL6_B'Q;J.VQ:/6(H4MU\
M]P4,<93Y_D[YSQG'O0 V'QTE_IV@O:PB*ZU>R-YAXWE6! %W9"#+?,X Z=SD
M8P=+PGKU[KEI=_VCILME<VERT!)C=8YU'22/> =I';M7*P^"/$FEZ1X8N=*N
M].36]$MFLY(Y6=K>ZA;&03M#*<J"..M=QHT6JK:M+K,MNUY(V3':[O*B&,!5
M+<MW))QUZ8 H 9KNH7VGP6OV"T$[SW"Q22N<1VT>"6E?D9 QTR.2.17)2_$.
M\C\*^)M2AM+*[N-#G,1:.8K#.FU6#KPQZ-]W/;[U;GC'1=5U==*DTM[5_L5Z
MMQ-:7;LL5PH!&&*@G()##@C(![5S=YX(\276F>,K,SZ4?[>=7C;=(OEG8JG/
MRG@;>.N<Y^7I0!MV_B?5HO%FE:7J=A:16NK6\LML\,S-)&T85B),@#D-VZ'C
M)ZUS'CO7;[Q)\)-<U:QBM?[(D#1Q!]WFR1K*%\T'H.02%P>.<@G%=/=^']7N
M_$_A?5"EBL.E0SQW">>Y9C(BK\OR<XVYYQG/:N<;P'XHM_ >I^";272Y=,?>
M+&[FED66.-GW['0(02"3\P;\* /3X?\ 4Q_[H_E7&OJ6M-\71I:S6W]GQZ1]
MI6(ALX:8*Q/JWR<=@#[FNOM5F6TB6X\OS@H#^7G;GVS7.7FA:JOQ"@\0V+V;
M6S:=]AGCG9@Z@2^8&7 (.<D<D8Z\]* .)TGQ#JOA?POXEU>UL+6?3[+7[Q[D
M2RE9'0SX/E@# (!SDG\*[;5?%$R:O=Z5IBQ?:;2!)I'FAED4L^[8F(QD<+DL
M>F1@'G&!-X'UZ?P%XDT MIJW&K7TUS'()W*(LD@?!_=YR,8]_:K]_P"'_%-C
MXH/B#P]+IADO;:.#4;*]=_++)G:Z.JYR 2.0./T .B\,:Q-K_AVSU*YTZXTZ
MXF4^9:W"E7C8$@CD XXR#CD$5KU5TZ&Z@L8TOIUGNCEI71=J[B<X4=E&<#/.
M ,U:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHK \7>(U\,:5!>2%(XI;J."2XD0M';JV?G< @X
MX ZCEAS0!OT5R[:UK(T4W5M%87QDO$BAN[=\0"V8+NG8%CD+EL@-SCKWK)3Q
MU?'3/%[Q1V%Y/H$8F2:)F2*XC,7F9QECD8(ZX/J* .^HK@6\7^(X+KPTTMAI
MKVVNQ[(T61U>*4Q>8"S<C:<'( R/4U+!XXO-.3Q3%KMO;-<:%Y+!K+<$G69<
MQ@!LD'/!Z]: .YJGJ>J6.CV9O-1N4M[<.J>8_3<Q"J/Q)%<]8^(=:/BBTTZY
MT]KBPNX78W<-C/ MK(HSM<R<,". PQSVYJQXYUVZ\.^'QJ%K:VUP!<PQ.L['
M #R*H( ')!(/44 =+17(7WB'7?\ A.Y/#>GVFGA3IGVV.XG=S@^9L^90![\#
MUZCI6;%\1)5\(:=JNHQVUC+-J+Z?=W!5GM[9D+@N1D':2@ R1@N,GCD ]!HK
MSOQ=K.OIX7L[BWO;!?/U>W@%Q;(72>%I$VLIW\9YSR>,@'O5[4O$/BB'Q:GA
MS3[32I;B32WO$GF>14WJZKRHR0O., D\@YXQ0!VU%<=I_B75[B]\4:?<QV*7
M6C10.CQJY1V>+S"""<X'3.1ZX[51C\<ZO<6/@RX@T^R)U]?W@>5AY;>47P..
MG'7D^U '?T5P=MXD\675[XATA+;1QJ&D&-_M!,GDR)(A=!LSNW<$$YP/0U-:
M>.SJ6D>'9+>#R;S6+5KDCR9+A8%0+O.U/F;YF4#D=2<\8(!VU%>=7GCOQ#8>
M';J\GT-$N;74H[3?-'+#'<QNZJLD:L,_Q<@GC'4UKV>O:Z?&%WX<OHM.CF?3
MOM]G-!O=4&_85D!(+8)!R-N1Z4 ==17&_"^_U35? UEJ&J7,4\ER99 RQE6R
M97SDY(/M@# XKLJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "D90RE6 ((P0>]+10!B6?@[PUI]]]NL]!TZ"Y#;A)';J"I]1QP?I6W11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!EZMX;T37FC;5M*L[QXON/-$&9?8'J*N65A::;:):V-K#;6Z?=BA0(H
M_ 58HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ex1017-amendmenttoemploy002.jpg
<TEXT>
begin 644 ex1017-amendmenttoemploy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &U<G)Q0!U=%9&G>(]/U+5+C2T,T&H6\:RO;7$1C<QDX#C/WESQD=#P<5KT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7&_%?_ ));XA_Z]O\ V85V58WBK0!XH\/7
M6C27;6T%TNR5XT#-MR#@9X'3T- ' 3_:/%'B_P ,^']9CBTR'34AU6T*.93J
M#(OW58A=NW^)<$GZ<UUGB*\U!-=6UAU1K>!K%WBM[)%>Y>;=C>P92JQ@8Y)
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MXI?)7>Q1]Z@]L9]N1C\=5O#'F^+CX@GO/,=K#[ ]MY(\MHRVX]\YS^&.,=Z
M.>TZ_P#%^IV_A[6;'SGANS%+?03FW%OY$BY)BVGS-RY&,GGO65/K'BF3PYXU
MU%/$3Q2:%J%PMN$M8L2)'&CA'RI^7D],')/)X%='H7@%M!F2WA\0ZC-HD,GF
MV^ER;"D9!W %\;RH/(7(' SGO(/ Q_L?Q%IIU20Q:[/+/<-Y(S&9%"L$YZ8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)CU+5K:&9<?Z.K;Y3GIB-<L?RK,/BK7-3=DT'PM=-'T6[U1OLD>?7809"/\
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MTC24GL["Y6YO(R#>323"6X=R/O2GKDXZ' XX%>#^.];\56UI%HOB&:\TZXG
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MW;I^"*__ 'T* .L\-7%]>>'+"ZU(J;N:%9)-HP!GD#'T(K5ID2+'$J(,*H
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M0_%&D>(FG73+KSF@(#@HRGGH<$#(]ZV* "BBB@ HHHH **** "BBB@ HHHH
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M0'&*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^G:-X,T:^O88/+CCC>YNIV.^6;:"2S,>6/'<UIZ;>KJ6EVE\L,L*W,*RB.4
M.H8 X8#//->9_%_Q?&OA[4_#VF02WMR(U;46@&1:0%AG<>S,. /?/:N3\2_%
MWQ7=W\'A7PQHC:?J(Q$P5UN9/N@A5P-HP.IYQ[8H ^@J\X\13:CK'QA\.:38
ML/L6EQ-J%Z5.=I8,JAN>IQP/]K-;OA:36]"\'^?XYU2T:[B+/)/PJQIV#$8!
M/7D#OWZUR'PQOY-7^(OC+5VCD2WOU@FLR_62 -(BN.X!V4 >LT444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %9?B#0;7Q+H\VE7TDZVDXVRK"P4N,@XS@D<CMBM2L3
MQ5X@?PQH<^KG3Y+RWMQNF6*0*ZKD#(!X/7UH J7/@?3=0LX;'4KK4+^QB*D6
ML]P?+;;]W<% W 8'!R.*K^*G.LB?P<NAWTL-[ JO>^2!:Q1EL-\^?OJ!D#'7
M;VYK<L=:MM8T"+5](9+R">/S(OGV[O4$\X(Y&#W&*?HFI-K&BV>I&W-NMW"D
MZ1E]Q"LH(S[X- #=3T6VU/0I-',D]K;/&L8:TD,3HHQ@*PZ=,?2KC[H+5O+C
M>9D0[4W#<Y X&2>I]2:EHH YW^W=:_Z$_4?_  +M?_CM<Q/H^IS#5$70->BA
MU*837$<=Y9@$]"!\^<''->DT4 <;?OK.H:%-HUKX8NM.26$P+,\MNZ1+C'W5
MER>/2N?^'T_B'3+&]6[TBZO[F)X[4JCQQE!&@ SO<9Z]J]2KF[3Q.T_C:[\-
M#32DUM;K=27'FC8R,<# QDGV]NM #_[>UO\ Z%#4?_ JU_\ CM)_;NM_]"?J
M/_@7:_\ QVD7Q2[>.7\+?V<PF6T%Z;CSAL\HOLZ8SNSV_6NCH YW^WM;_P"A
M/U'_ ,"[7_X[2_V]K?\ T)^H_P#@7:__ !VNAHH Y[^WM;_Z$_4?_ JU_P#C
MM']O:W_T)^H_^!5K_P#':Z&B@#G?[>UO_H3]1_\  NU_^.T?V]K?_0GZC_X%
MVO\ \=K;O;A[6QGN(X3,\:%A&&"[L#ID]*S_  QK@\2>&=.UD0?9Q>0B41;]
MVW/;.!G\J .,TR]UVP\=ZL[Z;+*U[#'.+)3$L@ RH^<R;>/8\^U=3_;VM_\
M0GZC_P"!5K_\=KGO%VL16?BNWO=,CEO+W1X2^HQ1#Y4@<<!C_>XR!UQD]*WM
M!\6IK=U:0+I\T2W-F;M)]ZO'@%!LR#D-\_0@=.] #O[>UO\ Z$_4?_ JU_\
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M]O:W_P!"?J/_ (%6O_QVC^WM;_Z$_4?_  *M?_CM=#10!SW]O:W_ -"?J/\
MX%6O_P =H_M[6_\ H3]1_P# JU_^.UT-% '/?V]K?_0GZC_X%6O_ ,=H_M[6
M_P#H3]1_\"K7_P".UT-% '/?V]K?_0GZC_X%6O\ \=H_M[6_^A/U'_P*M?\
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M/V<OYQV^5NW;-O3&>?6H!X)T=6NT19TL[R;S[FQ64B"60G))7MD@9 (![@T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex1017-amendmenttoemploy003.jpg
<TEXT>
begin 644 ex1017-amendmenttoemploy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***\_^,FHWVC?#ZYU/3+VXM+R"6())#(5X9P"".AX/>@#
MT"BO,]!677=#T3[%XCU+^VEL+/4+L?;"Z-NVED=3G&[#\#&*I_%\>)_#Z6OB
MC0M3O?L$$BC4+!9F"%<C##'(!^Z<=,@^M 'K%%<5H-\GCFYL?$&GWM_;Z-%#
MM\E9V7[3*<9##/ CY&1]YB>PYY*]UJ_MOV@[?0Y-8NXM&>V\Y[=KIE3=Y;'K
MG(&0#C- 'L5%>.W6MWTO[06GZ%;:S=OHT]N9I+>.Z8H7$;MU!R!E0<9I]_JN
MJ)^T-8>'EU2^729[8S26HN&"EO+=NN<@94'&: /7Z*\<US6+RW^/%IH4VNWM
MIHD]F9I8_M;(JML<Y#$\<J.,XJ_\,M<UW6?$'B73[F\N=3\.V\K)8ZE)\K-A
MB-JR*!OXYR/0=,T >J45XO\ ##4-?\3+XWM9]<O7N;9S;6,LLS$0%O- ;'<C
M"G)STH\9W.JZ!\1_!VA6>O:L;/4'1+KS+IBTOSA2<]N/3% 'M%%9.BZ5=:5/
M?K+J-S>6TTJR6XN9"[0C: 5R>HR,CZUPOQOUW7_#GA2WO='U3[&LUTMM((XA
MYA#*[9#D\?='0 \]: /4**:G**3Z"G4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKGO'9=/ FNSQ33PS06$TT4D$K1LCJC$$%2#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex1019-amendmenttoemploy001.jpg
<TEXT>
begin 644 ex1019-amendmenttoemploy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;:?=M;:A;32H\;Y@W#!QD$,\??UK@_CNK:Q8>'5T^":]"732R+;PM)M3 Y(
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M]\2_]%(UO_OTE>AT4 >>?\*]\2_]%(UO_OTE'_"O?$O_ $4C6_\ OTE>AT4
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M].GYU5M?!]P^H:'>ZMJ,-[<:.K"&=+7RI924*?.V]LC!)( &3@^U '5UY/\
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MF:SM\LD"3;&=(^<D*"<'/J<XKHW\.7;^,X?$9U&'?%8-9>1]F."&8.6SO_O
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MCCBW8+OMW$EC@9Y' P,<FL6#P?XK@:<KXY8?:)#),RZ7%O;/HQ)(P.!Z #%
M&=XU\5^'[MM7TF^UFR@2PMY!]FEF"O<7)C)4;>ZKD$>K$?W.>@^&^H6>H?#S
M0C9W,4XM[&""7RVSLD6-=RGT(STK;U+2H-1TR[LV55-Q"\/F% Q&Y2,\]3S3
M=!TE-"T#3]*C?S%L[>.#S-NW?M4+N(]\4 <WXFNWN/B+X0T0G_1F:XOI5[.T
M28C_ "9MWU ]*AN?[0D^--M NIRI;+HCS+"$4J/W\88=.^!SUXXK2\4:5(=<
MT'Q);QM(^E2R+/&@RS02IM<@#DE3M;'H#CGBIKOP\]_XKL?$UAJOD%+-K61%
MB$BS1,X<;6S\IR.O/'IUH \_M[_7-&\->.-:TJ^MX%T_7[R<PR0>9Y^&7*DD
M_*,>G/O7:7_B"^OM?.C::MU%Y=A'>2RVR1.X,C,$7]X0,#82>"3D=.]=O -R
M_AKQ%HS:Q'MUN[EN9)1:$&(R8W #S.>@Q_6I-5\$W]QJ.GZQI.OG3-8MK46<
MTZVHDBN(@<A6C+=CD@Y[T ;/A2YURZT"%O$=FEKJ:LR2*C*5< _*X"D@9&.,
M\'-;54]+L9+"R6*>[DN[@DO-<2  R,>IP. .P Z "KE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M075Y#:>4)6.Z:01QHHR7;!. /H"?8 GM4]8_B'PW8^);:VAO9+F(VTZSQ26T
MQB=6 (^\.Q!(/UH LW&KVEO'>.QE=;(9G,<3/MXW8X')Q@X'J/6LJW\<Z-=:
M2NJ6Z:E+8M&9%GCTZ=E*CJ>$Z<47/ANRTZ;7]9MY+D3W]JPFB:8F($)]Y4Z
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M+O#5M=ZHES:ZY;3[X!;J@@>.-7#(PY.<D')(]AT !W896+!6!*G# 'H<9Y_
MBEKA/AJEXP\1RW6IW5WLUR[@Q,$YV,%#9"@YP ,#CT KNZ "LK4O$-CI6JZ9
MIUR)_/U&4Q0%(B4W!2QRW0< \=?:HO%NOKX6\*:EK;1>;]DA++'G 9B0%!]L
MD5R'B&TU*#Q/X#EOM4>[+Z@WFQF)%19/(<Y3: 0O488MVYZY /2:3<N_9N&[
M&<9YQ7FVN^)];TDRW0U))9(M9CMC:6\*O;I;O(J!9'*Y$N&R0&X)'&*LVTES
M;_%7Q)//JEVUM::;;S>3A"NS,A*#Y<@<9X.3GDF@#T&J.L:M;:'I%UJ=YYOV
M:VC,DGE1EV"@9)P*XRPU?Q?JEGH&MZ?!/+#>M%+=VLOV98%MW&28V#>9N4$=
M>O/ Z53UC5-0\5?#[Q?JD&H-:VD,=Y;P6Z1(RR1Q*RL7)!;+8;&",#'7G(!Z
M-8W<>H:?;7L(817$2RIN&#M8 C/YU/63X7_Y%+1O^O&#_P!%K4GB"XO;7P_?
MW&G26D=Y'"S127C[84('5SV ZT :5%<%I7B+5&\9W&D174^HVSZ-]N@:Z@6%
MFE$FS"D*N4;(Y(^AQ2^"_%+Z[J45O/JTZ:A#:M_:&D7MND,L4V4PR84$H/G'
M5N"N>: .\HHKE9-7NM6\;WOAVTO)+&*PLXYYIHD1I'DD)V@;U8!0!D\9)(Z8
MY .ENKF"RM)KJYE6*"%#))(QP%4#))^@K*TWQ+:ZEJK:<+6]MY_LXNHS/#M2
M6(D#<K D=2/E.&&>E<!KNM:EK?PL\96E_<&.^T:6>SGE@10MTJ@%6((.W(89
M QR/0XKTG0X);?1[5)KN6Y8QJ0\BJ"!M''R@#% %]F"J68@*!DD]!7.-XYT9
M+1;UOM@L)"%BO/LDGE2$G PV.A/0G .1@G-;E_!#=:==6]RVV"6)TD;=C"D$
M$Y[<5Y4=0U_X<Z8FC>*K,:QX115MXM4MAB6VC^ZHE3T' R/;DGB@#UVBN-O=
M<U#5?$6HZ1I4EW&EE:PR&>S6!F9Y=Q7/G'&T!1T&3D\C'.0^L^-EO_!VFWTE
MGIU_J8NH[U!$LH#1QDJX(8CD8;:,<\'CB@#TDG R>E(K*ZAE(92,@@Y!%>1:
MUK/B.'0/'?A[4]6>6ZTNR6ZMM0MXDB>6*16^1@!@$$$9&#[BNE&JW]G)H/A^
MVGO)YKJP>[DGC6 2JB"-0J[PJ=7ZD$X'OD '<!54DJH!8Y.!U-+7F>JZUXVT
M;PPTUZ\4%PFL0V\$\L<;/<6TDBJ"X0E5;D@X'TQ5_P"T^)4\?S>'#KRM!<Z9
M]N2?[&@>W(DV%4'0@Y!^?=C'>@#J-=\0V/AV&VEOA.5N;A+:/RHBWSNP49/0
M#)[FM6O']6U?4]8^'<7V^>.:_LO$T5D;CR]HE,=R%5RHX&>,@5O7&OZ]X1\6
M"SUK4$U;3;RPN;R%EMEA>!X%#.GR]5*GC.3GOZ@'H5%<%8ZCXPO3H&J6D4TU
MK>;'OH9A;K#'$ZYWQ%6\SY<CAB<CT-'A2[\3ZYJ>IRW&N0I:Z9K4]HT"62_O
MXE5<+G.5P2#D9/7.>, '>UF:YXATSPY9K=:I<>3$[B-<(6+,2 !@ ]R.>G-:
M=<5\6/\ DGEY_P!?-I_Z4Q4 =K1110!3U35+/1K![V^E,<*$#Y5+LQ)P%50"
M6)/0 9K.\/\ B_1_$TEU#I\TJW5J0)[:XA:&6//0E& .#ZUM20QRM&\B*S1-
MO0D?=.",C\"1^-<1+:27&M>(?&%DNT)I+6-DRC_7E-SM)[C=M53WVD]"* -^
M+Q1H[W@BCE8++<&U6Y\HB&2<<% ^,$\$>F1C.>*K:]XZT/PY<M!J$MSF-0T[
M06LDJ0*>AD900OX\UY[J0%O^S#:2P,1+':VTT;KU$OGHV1[[B:],UJ6.ST.Z
M5+5);N^4QI; ?Z^9EP ?; Y/95)Z"@!^H>)]*TW2K?4I+AIH+H#[,+6-IGGR
M,C8J EN.?I1X>\3:5XHLI+K2K@R+%(8IHW1DDB<=596 (-1>'=#MO#'AG3+*
M61&.FVGE-<OP , N<GH"5S^ JEX4THIJVO>(6B,/]LSQO%$1@B*- BL1V+?,
MV.N",\YH ZFBBO._&?B+6M'A\175OJ:(]A%'-9VMM"LHVA06-P2IV9.X##+P
M.,F@#T2BN&O-6UZZ\=Z=I-IJ,5I9WNDO=$"W5WC<,@R">I^8XSQZ@UFV?C75
MH?#JVMS<13ZL_B%]!BNVB"@X<CS608&0@/ X)Q0!VP\0V)\4?\([B?[=]E-W
MS$0GEA@O#'@G+#IGO6K7GUO:W5K\;;=;B_EO%;P_*4:9$5E_?ID?(J@COTSU
MKT&@ HKC_$^I:I;:G<PP:G]EA73VFMX;2)9;B28$Y9U9& B "C/')/-8\WCB
M]B\,^%M9U(W5IIE_9^;J%]8VXD\B4JFS<"K;8SE^<'D+^(!Z116;X?N6O-"M
M+A]0AU R*6%W#C9*,G##' XQQ6E0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D^([CR-$G7_
M $@>>IAW6]G)<LNX$9V)S^/2N'T6>YT#PY;Z)8:AK2P6\9CBE;PO<M(HR3GI
M@GGTKTZB@#S:]DM;C4/#UU"=>C_L3<8E?0+J0S,R;&+G:,Y!/3N<U.U] ?&Z
M>)0-;#+9?8?L_P#PCUUM,9<.3G;G=D=>GM7H5% 'E$%E#8:K>MIFI^*[/1[Z
M9I[G34T&=@7;[^R0Q[HPW?'//!'&);J&&/Q+=:SH5]XGTC[<J+?01^'YI4E*
MC 9=\>$;'&<'Z5ZE4=Q,+>WDF9'<(I8K&I9C] .M 'GMU)ISZYI&J67_  DM
MH^GV[VC*-$N)/.B8J2"6CX;*@[N3UJ;1=0M=(UW6M3:/79SJLJ2O'_8%TOEE
M5"#!VGC '7O77>']<M?$FA6NL62RK;72EHQ*H#8!(Y )]*TJ .!T:YT31-;U
MG5+:P\0>9JDPF>,Z-=;8SM ;;\G\1&X^IQZ5C1VD5CK%]-I6I^*[#2M0F:XN
MM.CT&=@7;[YCD,>8]W?'/H1QCT#_ (2*S_X2M?#GEW O&M&NPYCQ&4#*IPW<
MY8=!6J[K&C.[!4499F. !ZF@#GD\7Z?&BHFF:ZJJ, #1;K@?]^ZQO%FI6?BG
MPY=Z+Y.O6L5TNR60:#=.VW(/'R #I[UV5IJ$%Y:)=H2D$A B>3Y?,!QM(]CG
MC/7\JI6GB*SO/$E]H4<=PMW9PI-(SQ[4*L2!M.<GH>V* .+NY5U324TC4KSQ
M(VG;!'+%:>'[B!IT QM9]C'![[=N:=J/]FRZAH=YI*>(-*?2(W@BCBT"X=#"
MX4%=K1\'Y1@_SKTFB@#R7^RM./AW5=(-UXH9;W4/[0BE;09\P2>8).@C^;YA
MSG\ *L:M$EYJEGK6G:CXGT[6H8/LTUVOA^>1;B/.[:T9C"\$G'I[UZ4;V$7_
M -B!+3",2N .$0D@%CVR0<>N#Z&BRO(K^TCNH-QAE&Z-B,;U[,/8]10!G>&9
M8I-*PC:C)(KGSIM0M7@DE<\EMK*O'.!@8&,#I5W5+XV%A)+'$TUP01! OWI9
M,<*/ZGH!DG %1V.M6&HZCJ-A:SK)<Z=(D=R@_@+*&'Z'\P?2M"@#@[+PMJ_A
M_P .>&M+TK598I[2X$EZL< >.ZW/NEW,?NJ-SD=SP!ST[RBB@##\4>'?^$CL
M[.-;Q[.XLKR*]@F5 ^)$SC*GJ,$U5;PI-;>(FUW3-3\B^GMTM[WSX!*ER$^Z
MY52N''(R#C'&*Z:B@#-T/1;?0=.-I;L\C/*\\TSXW2RNQ9W..,DG\.!6E110
M!PLGPY9O".H^&EUR86%W.TB!K=285:3S2H.1D[NY[=N];%QX:GNO%.FZ[-?Q
ME[*WDM_)6WPLBOC<22QQ]T8_K7144 <3HO@"XT.;[';>)+T^'EE,D>E-$AV9
M.[9YOWMF?X>,C@GDY[:FF1!(L9=0[ L%SR0,9./Q'YUR9^).@+HCZNPOEM8[
MS['*&M'#Q/C=N9<9"[><^A]>* +GC#PN_BS2XK#[?]CB2>.X++#O8LARO4@8
MS[5++I&KW<MN+O6D-M'*LLD4%IY9EVG(4L6.!D#..N,=#6E;:C!<W=Q: LES
M;X+Q.,-M.=KCU4X."/0C@@@6Z .2B\&31V7B6V_M12->>1Y6^S?ZHN@0[?F_
MN@8SW_*B7P9-):^&H?[44#061XF^S?ZTJA0;OFX^4]N_/M7076H_9=2L;+['
M=R_:RX\^*+=%#M7/[QOX<]!ZFKM 'F'A*&?5M5\<VUCK,,,5QJTBN$B$CA3&
M@+HVX8/49(897IUST]QX,B^U^&WL+E;2WT$,+>#RMX<%/+(8[A_#^O/-;.L:
MI;:%H]WJES'*T%K$TL@ACW-M R3CZ"I["\CU'3K6^A#+%<PI,@<8(# $9]^:
M .=C\'S6-[J[Z1JIL[35Y&FN;=H!(4E88>2)MPVENIR&&1G':L[Q*?#UEX=_
MX5_%&SW5U8>38V2Q.V1]U6+@8&UAN))XP37=T=Z .;U7PA%J'@5O"L-VT%N\
M"P/.4WN5&,GDCYB1DDYZFBZ\,W-WKVA:M)J*"32$E146WXE\Q0K$_-QP!C'0
M^M=)10!QLOP^M[ZV\1VVHWS30ZY,L[B*/RV@D4*%9#D]-JGGN/PJQIGA;5[:
MSFCU/Q/<:I-Y+0V[S6R(L(88+%5Y=\<;B?7U.>JK(L_$5G>^([_0XX[A;JQB
MCEE:2/:A5R0-ISD_=/;% &$/ <J^'?#VCKJP$>B745S#(;;F0QYVAOFZ<G..
MOM6K9>&6L/%NI:Y#J,HCU$1&>T\M=I=$V ANH&.WJ.O:K&K^(K/1;[3+.YCN
M&DU*X%M"T<>5#D$_,<\< ^_%:] !61'I%R/$\FKRWRR1FW^SQV_DX\I<[B0V
M[J3C/'.U>F*UZ:LB.6".K;3M;!S@^AH YO6?"DVI^+-*\0VVI"SN-.1XU40;
MQ,C_ 'E<[AD>F,8)S7#WE[!=^+=7G;QC'HEXMWY<=EJ.G12R ( H:(N VUB"
MP"D_>SU)KUZC SG'- '&VN@ZMK-SX=US4=02.\TLS[5%F4$ZOE S*6RA,84[
M>Q)SZ5)K/@NYNO$G]OZ)KUQHU]+$L-UL@2:.X1?NY5N PS@&NNHH X_5_ AO
M'TR]TS6[O3M8T]71+\(LIF5SEQ(AP&RW/8 G@4^_\&7&H:?IT,VM2R7-KJ$>
MHRW,L"DSRQXVC:" J\ 8 Z <YR3UM-D<I&S!&<@9VKC)^F: ,%/#EQ'XQN/$
M0U",RRV2V?DFW^4*K%@<[LYW,?PX]ZQ1\-HF\))HDFJSB6WO6O[.^AC$<EO,
M69LCD@C+,,>A_&KD7Q'T"739=3(U!-/AE,,MTUE)LC8'!W$ X /!/2NJ@GBN
M8(YX)$EAE4.CH<JRD9!![C% '*7'@R_U'PUJ&F:MXBFOKJ^A^SO=M;(@CC[A
M(UP 3W)SGCT&+,WA6XGU?P]J+ZDF_14D1$%OQ+O0(Q/S<< 8QW]>E=-61J'B
M*STW7M*T>:.X-QJ;2+ ZQ_NP40N=S?0=LT 8R^$[K2++Q#_9^O7ENNI7$MW&
M(K99&MY9&!<J,9;D<=, GZCHM%2_CT2Q35)!)?K @N'  W/@9/''7TXJ]10!
M0UO1[3Q!HEYI-^A:UNXS'(%.",]P?4'!'TKET\":E(VA_;O%$]P-&G\VW9;1
M%=QL*@.3G)P<9Q^&>:[5Y$C +NJY(49.,D]!1(Y2-G",Y SM7J?I0!P<_P -
M9)=+O=,3Q%=1V4M__:$$?V=&,4GF"0@L>7&0<=.O.:VU\*%/%4FMKJ<Q%Q:1
MVMW;M&A$X0G!)QQ]XY '/M5GPYXITKQ5;W,VES._V6<V\Z2(4=''4$'G_)I-
M9\5Z7H>J:;IEW)(U]J3%+6")"S.1C.>P'/4X_2@#%T+P%=:#(MG#XEO9/#\4
MGF0Z8\2?)SN"&7[Q0'^'CT.1G,<OP\FCAUZQTW79;32=9\UYK0VZR>5)(I#E
M&)X4]UQ]".M=R#D XQ[44 4M'T\Z3HUGIQN)+C[-"L0ED #,%&!D  =JJ^)]
M A\4>&[W1IYY($ND \V/[R$,&!]^0..]:]% ''CP3>2:XNL77B*YENSISZ?*
M5MXT5E9MP( ^[@\^I]0.*NVWA>1M;TW5]3OH[R[TZ"2&"5+?RF?> "9#N.XX
M'08&23CTZ.B@ KGK_P ,-)XGC\1:9>BRU#[/]EG$D/FQ3Q9R RAE.X'HP/MR
M*Z&B@#E+SP1%<^$]4T..]:-]5DDEO;LQ!FD=S\Q R .  .N !UZUT5A;RVMC
M#;S3+,\2!/,5-F[ QG&35FB@"O?VHO\ 3KJS+[!/"\18#.W<",_K7-WGA+4-
M2T/^P;_7C<:6R+',6M0+F5!CY6D#;><8)" ^^>:ZIW2*-I)&5$4%F9C@ #J2
M:=0!R.L^"9KG7H=;T+6Y]$OU@%K,8X5FCFB!RH9&XR.QK!\2P+IWCCP%90ZJ
MJW227KM<7.UV=FBY+J"OWB2,#'7 Q@5Z-=W M+62X:.218U+%8QEL#K@=ZH>
M']>L?$^DQ:KIRRM9S9\J26/9OP2"0#SU!ZT 9L_@RWOK#7XKZZ:6[UR+R;FX
MC39L0*5147)P%R3R3DD\^E+4? =Q?6.D2)X@NK?6]*R+;4HX4^Z5"LC1]"I
M'![_ )5VE% '(ZCX+N=4T*.QN]<EFNC=174]Y);KF1HV#(JJ"%100.![\Y)-
M7F\.7#>,D\1_;X_-6Q-CY'V<[2I8.6SNSG</RX]ZZ"J][?6^GVQN+E]J;@H
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MV6JVJR+;WD*SQB0 ,%89&0">:O4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A^*KN[L],@>UOX+$
M-=1)--(-S^46^98EVMND/11@]:W*P_$_AM?$=M9*M[-97-C=I>6\\2JVV101
MRK<$88\4 <<WB77$TGQ_''?3I+HD8GLIKF"/S0I@\W:P P>1QD9P>>:DEU'Q
M);:AX/D&O&1-<0PW$+VL>R,^1O#I@!MV0>I()/0#BM:3X?B0^(BVN7K_ -O0
M+#=;TC.,1^66& .=O0=!Z=,6YO![S/X=8ZFP;0^8<0C]Z=A3Y^?[I[8YY]J
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M"J NT\]#DGG/2G:?]HM["YAU"[\5:G<20-;0S7&DD>2C<$A5 W,?[S$GCZY
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M101\RD<C#'CCZU&GA:UGDU&?57^WW.H6WV2=V38H@Y_=HH/RKEF)Y))/7@8
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MI=8\):/J4_\ KKNRAFD_WF0$_J:K>,(;C4O#]WHEEG[7J41M@V.(HW^5Y&]
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MZU@Z3XRT[6=#O-9MH;I+*T,@D>953E/O@9;MZG KH:\#\)ZS)I-I9MK]N?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<#USSGIJ* .'_P"%:6I\,6WAU]:U-]-MYED6%C$0R*2RQL-GS*"<G/)P,G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&/5;EI4M)F@"&8(QC$API;'&3V&: ):*\ZTSQ-JP\2^&;"74A?)JMM<?:F$
M$"31H'S X52ZY)'5N,<YK+N/$WBU/!_B371J]LKZ)J=Q"L2V:[9TC<#:Q)R
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M:X'P!<^(4^&/AQ;/3;&2W*PH\ANF,GE&4!SY?EXSM)XW?X4 >E(ZR1JZ'*L
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M68L<@8YP!GCFE\0^&5UJ]TS4K>Z-GJFF2,]M<!-ZX88='7(W*PZ\@^AK>HH
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M%QB0'/)SS5FX\.7][I.L6MWK EGU.(VYE%MM6&(J5VHF[K\S'))Y/H!71T4
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M/ASJVI^)_A_8ZOJ-\QO+T.2T4:*(]LC*-HQZ*.N:P]&\3:]??!_4?$\^I?\
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M+LTC#VVY=#F"<KD?O4VX_#=CVS7'B^%OX9U>]MG>2PL/&DMQ>BT(9DM@^=X
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M;22#W&[W%.\8_P#"-O\ #SQEJFC7CW?V];87%X\NZ.:57 "IT!8#&<>H[@X
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M:]\47&N>.+G0]+\9PZ'-;2>0EG+IPE:Y(&6=7? ZDJ ,_=SWKTD#  SD^IH
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M^T,BFQ^)=&EU".Q34(OM$N[RE.0)=OWMC'AL=\$XH THXHXHQ'&BI&!@*HP
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M%EQM;=&5B '\6T=!Z5Z,55B"5!(Z$CI2T >.ZC'<ZM#\5K+195EOIFA,<<3
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M(& /]XJ.]<CX[MYO"%YX>\7/J*R_V9<+:R0B%8R]K)\KA0OWMO! [<FO5**
M/-_%6OZ5I'C?P_X@_M6T6.6PN(0;AV6"2,LARLBJV'W8XQR >1@9Y[6GT6+X
M+ZTMIK5CJ'VK4EN9?L\@*(\ERCF-0><!?4<X)P*]$U71-<;Q!_:VD:K:(&MU
MMWM+ZU,L8 8G<A5E*DYYZYP/05H:1I+V,MQ=W4L$U]<A%F>"#RDVKG: N2>-
MS<DD\^F  #D/'-[:Z1K/AC7)C*N@(TZ7=S9D@1-(B"*0E.=N%9<^AK)UM-)'
MANZU_P ,07UY8_VK:WNHSQ2R,;I(V^<Q[CD[?E.1QD=?E./62 000"#U!H
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M]2*BTBZT]/BYXMD>>V4_8+0%F=1T#[QGV^7/X5Z#1B@#P[PU=FR\,_#;5I9
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M&&PL0VWY3CC/7 A'C35=5UKP]!HT=BMGK6FR7B/<JY>(J%Z@$ XW=!C..HH
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MQW/AW_D6-)_Z\X?_ $ 4 :5%<1:>,+G4/$EWI$-W86U]:W_DMIMS$RS26X8
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M W+[C(K5JEIMO-';127;6\MSL"^;# 8_EZ@8+,?UJ[0 4444 %%%% !1110
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M72M/GOKV0QVT"%Y'VEMJCJ< $TMA>P:EIUM?VKE[:YB2:)B"-R, 0<'D<$4
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M5(V\M)3SYDF3R!@8''5JT-:UW3O#UA]MU.<PV^]4W"-G^8G 'R@]20/QK1H
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MW(6!#?-UZ''3FNI\5>'KW6Y-)N=/OXK6ZTV[%RBSPF6*3Y2I#*&!SAL@YXK
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M=CE8_P!H!"(/X8GP!(P]WV1Y_P!V@#F(=9B\/>*OB7J\R&1+2.SEV X+D6_
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MO';V;*)0^W)R7X/RYST]JTO"3:VUA=#6[R*]=;IA;W,4'DB2+"D';[,6 /<
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MS<A,D @AOX>E)9>"-:AO?"]U<:W9EM"BDMU2&Q*K)$R*G=SA\*.>G^SZV_\
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M=(\-7_A_1]!TG3-41;2P8_:Q+!N-PAR=J\_)ACQUP .3CGIJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** (H;:"W,AAACC,C%W**!N8]SCJ?>
MI:** "BBB@ HHHH **** "BBB@ HHHH *K76G6-ZR-=V=O<,GW3+$KE?ID<5
M9HH     !@#M1110 4444 %%%% !00""",@]0:** *UKIUE9,[6EG;V[/]XQ
M1*F[ZX'-6:** "BBB@ HHHH **** $(#*58 @C!![U7M=/LK$N;2SM[<O][R
M8E3=]<#FK-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/>< AT8BWS]#SBN?U%I+#1_B7'IT;+%#J=O))#;J,B(K$9L#IR@?/'K7J_\
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M0 JJ, #T IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 45 ;RU$;2&XBV*_ELV\8#9QMSZYXQZU/0 44Q
M)HI7D2.16:)ML@4Y*' .#Z'!!^A%/H **** "BHKBY@M(3-<2K'&"!N8XY)P
M![DG@#O3+*^MM1M5N;299H6+*&7U4E6!]"""".Q% %BBD9@JEF("@9)/:JNG
M:I8:M#)-I]W%<Q1R-$SQ-N <=1GU% %NBBB@ HJM>ZC8Z9!Y]_>6]K%G'F3R
MK&N?J356#Q)H5U<QVUOK6G33R'"11W2,S'V .30!IT444 %%%% !112,RJ 6
M(&3@9/>@!:*** "BBB@ HK*/B?0%E:(ZYI@D4[60W<>0?0C-:BLKJ&4@J1D$
M'((H 6BBB@ HHHH ***I0ZOI\]^;&*[B>Y"LWE@\D*0&QZ[20#CH2,T 7:**
M* "BBJFI:I8:/9/>:E=PVMLGWI9G"J/Q- %NBD5@ZAE.01D4M !1110 4444
M %%!( R>!5.RU:PU&66*SNXIGB5794/\+9VL/53@X(X.#0!<HHHH **** "B
MBB@ HHHH **** "BBJ2ZOI[Z@+!;N(W1W8C!Y)7&X#L2,C(ZC(H NT5%<W5O
M96[W%U/%!"@RTDKA57ZD\"LU?%7AUV15U_2V9R H%Y&2Q/0#GF@#7HHHH **
M*IW.K:?9WUM97%W#'=71*P0LWS2$ DX'?@'\J +E%%% !1110 445!;7MI>-
M.MM<PS-!(8IA&X;RW&"5;'0\C@^M $]%%% !15.^U;3]-DMX[V\A@>YE6&!7
M;!D<G 51W-7* "BBD#*6*@@D=1GI0 M%%% !115.#5M/N=1GTZ"\ADO+=0TT
M*-EHP>!N':@"Y1110 4444 %%%% !12$A022 !R2:J:?JMAJT<LFGW<5S'#*
MT,C1-N"N,97/J,B@"Y1110 4444 %%4QJVGMJQTI;R$WXB\XVX;+A,@;B.PR
M15R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .(C\$:U#X
M?L].B\73BYL;WS[6[-E&2D.PIY3+T8X9OG/.3FNCUO5TTR"*-)(1>73>7;K*
MV%SC)9O]E1R?P Y(K3.=IV@$XX!.*Y^TTN_FDOKW6+/3KB]=]MK&)6>..(?=
M7+)D'.22 <D^@  !S7P_O6TWP9XFUF1Y[_&IWUUNR#).L?RC';)$8 QQ74>'
M=<NM<BANOL]L;">U2XBNK><NK,Q.4P5'*XY/OT%8_A/P]XB\,^%M/TP?V:\T
M%Y++<E9G"31N9&(&4RI#,G_?/6M3PCX</ANWU&,>7'%=WTEU%:Q,6CMU8*-J
MD@=2"W0 ;L#ID@&]//%:V\MQ/(L<,2%Y'8X"J!DD^V*Y*?QQ)#X?MO$;:=LT
M>>>*-/,D(G:.1PBRA,8 )8';G.WG@\5N^)-(_M_PSJ>D"8P&\MGA$H&=I88S
MCN*P[CPY=ZJFA6>L-9VNGZ=)'+]FMY2_VJ:-?D&2JX08+8Y)P.F.0"M<7&HZ
MM\6+?3S';G3M'M?M; 2MGS9=R(6&W&X*'P/]K.>U=M'%'"FR*-47).U1@9)R
M3^9S7+>#+62:[U[Q#,.=5O3Y!];>(>7&?H<,P]F%=8<XXZT <-IWBC47N_%N
MKWZVZZ-HY>WB6.5B2T2[I#RO));;GC&S '4UF^"=9O-)M_"VBO8+(-72XNKB
M[,N'\W!ED;9CE=SA,DC)Z#&";%OX'UF3X=CPU>W-F);FZ#WTD3N?,1IO,F(;
M:"68$C&  .];@\.W@\=QZLC6T>F0:8+*"-<[XR7); Q@ @1\YZ+C'.0 5=2\
M<-%IUU?Z99QW<$-Q]E@#2E7O9@VUDA4 YP<C=ZJ>,#-=B.G3%<-X)\*ZMX8T
M^'3)K?1]ELS*FI0[C/-&6+89"@VMSR=S#VKN: ."^*$AO;70_#D<$ERVK:C'
MYL$>W<\$/[V3&X@?PKU/>M^PF'B!3?SZ0UO-I]W(+1+K:'W!"C,2NX $LXXS
MP ?:LR]T/7IOB#!X@6#39K.TLGMK:"2[='5W8%I#B(@94!<?K5M(_%_VJ>Z:
M/2%&4C@M%N)"BH23([MY8+/]W V@<'GF@"#1_%.JZS+-;0:/"EU8W[6NH![D
MB.-0>&C;9ER5(8#"^Y&14>H^.&CTZXO],LH[N".X^RVX:4J]]*&VLL*@'(!R
M-Q_NGC W5+I'AG4M)\3ZM=)>1/I^II%+.Q)\[SU5E8J,8 8;#G/&W '<4_!'
MA;5O#&G6^ESV^C!+4E%U&#<9YX]Q(#(4&T\\G<WTH VW\027.IWUAI=L+AK!
M1]KF9B%1R-PC4 9=\8)' &1SGBJ5MXKOIO$.AZ5-HS6SZA8O=SB28%[;:$X*
M@<C<X7)(.0>/6+0]#U[0=0UJ&#^SYK+4=0EOH[F25Q+$9,94Q[<-C'!WCBDN
MO#FLS>-+_5H[BU%M/IT=G$Y9O-3:S,RX P Q*Y8'( X&<$ %74_'ER/!FNZY
MIME"QLKQ[*S,LI*W+!EC#  =Y"0!GG&<U)>2S&^\*^&M:TZVU&>?-Q+.;AB8
MGMP#YN-@SEBO<<MC! JC;>"-:M_!WAC1@^G%]-OH[JZ3>_EOM#-P=N6_>D/C
M"^F>,G>70M3/Q!.N2S6S62:<MI'U\P'>6?Y<8&X[.<]%QCG( (Y?%TMS9:S?
M:39QW%CI7F+)/-*4$[QC+K'@'@8QN/&> #UJ*?QR/MOAN*SL/M$6N6S72?O=
MLJ*$5@-F,')=1G< ,DG@$U1M/!6J0^"!X.^TV\-@SR)/>QNQFE@>1F*A"N%9
M@VTG) Y(SGC6M?"S6WBZ76 +<0VVFQV&F0C/[E027)XXS\@XSP* +'A37[GQ
M!:ZC)=645J]G?RV?[J8RI)Y> 6#%5[DCIU4UNNZQHSNP55&23T KG_!&AWOA
MWPI::=J$D$ETFYY6A)*L[,68Y(!)+$GH.N.V3/XML=5U3PQ?Z=H[VT=U=PM
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M5<#/)P">M6K3Q'>S^);;29=/B4R6SW$_E3;VL\%=BR<8RV3@ _PG&1S7-R^
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M#;R<9SN[8YP7\ ZN? &@Z2)=/?4-)O(KSRI2S03LN[>KMMR=Q=FSMX.!CC-
M'01^*;M=9NK&?3D<6U@UW.;24RF%P1MA;Y0"[#) 'IZ$&I?#/B*Z\0VUE>K:
MVW]GW=I]H6X@G+['R!Y1!4<C)R?4'@4^*UUV"R@^R6VE6;+,I>SA=O+$?.[#
M[ 2QXQ\@QSUIOA;PXV@3ZQ*!'##J%Y]I2TA8M'!E5#8) Y9@6.!@9QVH Z*O
M*+7Q5-83^)?%%I8)?&YU:*Q0--L'E1LL"*AP=S%VD;' P<D\@'U"^6Y:PN5L
MV1;HQ,(6D)VA\':3C/&<5Q*>!+NRT+PEI-C+:"'2KE;J]:0MF64(WS@8^;]X
MV[!QT'- &_J'B6&WU*ZL+?R=UE")[VXGDV16RMG:&.#EC@G'H,DC(SD+XYO
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M]EF4;L#H>* .IHKS:?XAZO\ \(_JNIVFG64WV/4S919D;;,/,6,!>.79B?0
M 'G->DT %%8VI:T\6L6NBV$:2ZA/&T[%\[((0<%VQR<DX"\9.>0 37.2^.=0
MM_#'BC69;6TV:/=/:P?,P%PR84GOC+G:!SCU- '7ZGI&GZS:_9=2M8[J#(;R
MI!E21R"1WYJW&BQ1JBYVJ,#)S7)V/B?5;CQ7INDRV-LL-UISW<C*[;TVE%#8
MZ!69B .3@9..E8DOQ#U=O#VHZG::=93?9M4-C#F1@LP\U8E"\9+DECV &#SF
M@#TFHKFV@O;66UNH4FMYD*21R+E74C!!'<5@_P#"0W?_  GS:";:!;./3C>2
M3ESO7YPJY[ '#_\ ?.?:J.G^.#?>'[74DLU>?4[V2VTNW5R#.BLP5V./E&U2
MY.#@>IP" =9;6L%I"(K>)8TSG"C&3ZGU/O56PUFPU.ZO+6TF+SV3B.X0QLIC
M8C(!R!VYX]1ZUCZ=K^H2^+=2T>[2T-OIUG'//=1!EP\A)5<$G&%5B>?3I4'P
MY1I_#DNM2J1+K5W+J!!ZA';$8_[]JE '745D^)M8DT#PUJ&K1VS7+VD)D$2Y
MYQU)QV'4^P-9H\4-9Z1<:M>-;W6GE(38S60.;MI. BJ2<$L5 &>^3CL =15"
M/6;"769=(28_;XH1.\1C88C)P&R1@C/'7L?0UB+KVL1^+M*T2XMK,F[MI;NX
M,18FV1, +D_>)9E&[ Z'BLG2M8MK2[\7>+[S>T)O%TZU5!N:18?W85/4M,[@
M>^* /0**Y7^W]9A\5:-HUQ:V>Z_AFN9Q&S$VL<8 QG^,EG4;L =>*I:?XJ\0
MZP^H)I>F6,_V/5#9M*TS(GE*P5VS@Y;.[@= N><@$ [>BN.@\4ZM<:%XBE2R
ML_[4TJ^:TCA,C>7-@(R\XSE@^ ,=<5V(Z<]: "BL"37Y;SQ+<:%I21M+9Q+)
M>W,H+) 7Y1 H(+,0">H '<YQ7*:[XPU/4_AW=3::T-KJ<NH-HV0"P:4R^5NB
M.1C@EAG./?% '7Z1=>'H+PZ=I/V>.9D>4)#&5#HK[6*MC! 9L<'@DUJW5U;V
M5NUQ=3QPPIC=)(P4#/ Y/O4.E6*Z;I-G8JL8%M"L*^6, !0 ,9^E<_\ $*RO
MY_#T.H::\7VK2+I-26&;.R<1ALH<>H)Q[@4 ;VFZQIVKB8V%W'.8)#'*JGYD
M8<8(/(Z56C\4Z!+K1T:/6+)]3#%#:+,#)N R1MZY !-8_@*[L-6T0ZC;0O!J
M@46>H+.F)$GC+,P8?[TC-[AJS?",.I:'XON/#>L?8K]Q:&_M-3BMA%*X+[76
M3&?FRV<YYR<]> #I=3\9>&M&O6L]3UW3[2Y4!FBFG56 /3()INK2>&=2T2#6
M-4FLY=+B*SQ74LG[I3D;7!SC.2,'WXJGXBT^SN9(]&M;2$7NJNS7$XC!>. 8
M\R3=US@A%]"RXX6E\6^']3OM%M(/#]S:6DE@WF16UQ;"2&;:A58V&?E7GK@X
M.#VH VM)U?3-:LOM.DWT%Y;*WE^;!('7< .,^O(J>\O[73XEDNIEC#L$0'DN
MQZ*H')/L.:RO!NIQZUX1TS5([..S^U0B1X(UPJOT;'MD&L73Y9-<^+.K22Y-
MKH%K%;6ZGIYTPWNX]PH5?H3ZT =4TFG:OI$I=H+G3YHW27?@H5Y#AL^G((/3
M!S4.CWND2VZVFDO L,,:E(8EV 1G.UE&!E3@X(X.#7DUG?3Z[IUGI,;-]C\3
M>)[R8X_CLHFWNOT;;@_4^M;_ (G\0/H_CW5+^W :/1O#$LCC^'S7E!C0_P#?
M&?H: .^;6M-6^^Q&\C\_>(RN> Y&0A/0,1R%)R?2K]>5:M:3:-\,?#6E;V?5
M=3U*R,DA^^UP\HGD<GV*GGTKU6@!KNL:,[L%11EF8X 'J:A2^MI/(VRC,X)B
M!!!<#J0.N.G/3D>HKE[N\D\0>/SX?3/]F:5 EW?C_GM,Y_=1'_9 !<CN0HZ9
MK>DT6WD\11:V9;@7,=JUJ$$F(RC,&)*^N0.: ++W]I':RW33IY$)(DD'*KCK
MS[=_3!]*I6/B?0M3EABLM7LYY)@6B5)@3(!U*_WL>U<WXHA7P7\*KK3-+EN)
MI3%]BLS/)OD:29]J\]\%^/85AR6AO-=\(>#+BU;1XM(,5_;O*RO)>>0N-D93
M*CN6R<X[=Z /5J*X_4_&,T.D:WK%A# ^G:0)%:24G-U(GWU3'0 _+N.<MD8X
MR7WGBB]L;KPW87<=M9W>K0L7EF5FB2<*I\D<CEBS8)/\/0DT =;17,2^*)[=
MM/T^YBMH-6GM/M=V))<0V48P"S-W^8[0.,D'D 5=\,ZK>:QILMU=VXB47$B6
M\BH4$\0.%E"MDJ&YP">G/0T ;59MQX@TJUN7MI+Q&GCYDCB!D:,>K!0=OXXK
M"^)>OWGA[P7<3:<VS4+J6.SMG_N/(V-WX#)'OBMS0-#M/#NC6^FVBG;&N7D;
MEI7/WG8]V8\DT 6;#4K+5;476GW<-U;EBHEA<.A(ZX(X-6JY=+^+3M;3PMH=
MNAN-LE]<R/\ ZNV221FR0,;F9V;"Y' )SQSDWWC^YL_"VNWXMK9[[2=1_LXJ
M698YW+(%*]2,^8,C)Q@\T =]17#_ /"9ZH/$M_I+6%JJP:<EXKM(P,6XM_K>
M/E&U=V!DC(&><B)O&^K?\(KX4U*/38&O]<GBB-IEN%<%BR^P0$\^HH [VBN-
M/C632M<UNRUY+:.WTZQCO_/MBQPK,R^60>K97C&,YZ"I[;Q'JESKNGV*VEL?
MM$<DEW A+/8*%RGF.#MW,<#;CN<$A<D ZNBO-X/B'JUWH%IJEMIUE(ESJJV,
M?[Q@)5:7RQLXY;:"Y)P ,=3G&WJGBB^B\37FA6$-L+V&P6[M8KG</MI)8,J,
M" -NT9ZD[NP&: .MHK!FUR:YUB[TW31 /L$:O>W4X)CC9AN6, $9;'S$Y^4$
M=<XKE;_Q;KNJ_#W1K^R2#3]1UZ[2U@7#.8XY&.&!R.1&"^<8]J /1))X8GC2
M26-'E;;&K, 7.,X'J< FI*Y&6]\[QS9Z1>6=A,FGZ>=0:[926MW)\L;<YQGY
MSG/1:JW?CFZ7P?=>+[:TB&CP'=%'-D2W40<*7!SA,\E00<C&<9X .XHKD[SQ
M5>IXV70+.UMY@VG_ &S<SLK*2VU0W'RKPQ)YZ =2*N>#]:N_$WA&UU2ZC2VF
MN?,VF Y7:'95==WJ &YSUH MP^)M$N+:PN8=3MG@U"4PVCJ_$SC.57U/RG\J
MT8YXY7E1'!:)MCC^Z< X_(@_C6=#X=TV"+3X8X (+"0RP1?PB0Y^<]RWS-^+
M$]<8R]/U!I?B9KEC&<PPZ=:-(/[LI>;]2I7\A0!U-%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+H!JT+W>N/(8KAD.Y0R!%W'M@ X"C S] .MT>Q?3-'M+%W1C;Q+&/+7:H &
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M@XSSGTV]?\+ZEXCTR^TJ_N;:2VN)XI8+@ K+:[ F2H P6RK$'(QO(Y'7KZ*
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MK8ZM'/)87*3K!.]O*5_AD0X93[B@"S%YGDIYVWS=HW[.F[OCVI]%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGWJ2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI-M>-*I?[5$PC9.<_P"KP<^E6]'TXZ9IRP22^=.S-+/-MV^9(Y+,<=AD\#L
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M>'E+LZY^[C'7FK-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDCJB*,LS'  ]30 ZBJNGZE9:M9K>:?=175LY(66)@RL0<'!'7D$5:H ****
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MDR.S!OD$H>(QMCK@Y((^F/>JMOH.J6!UO6;;[%-XAU(J$\]V$$*(-L:9"EB
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M*C>=N\9.W&>AP=U2[\$:I)X2\36L4MH=8UZ\:2:4R,$\DN%$>[;GB$$=.I-
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ME ^9D7:OX#)P/QJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK@_'
M=[<:CXC\.^#;>:2"'5GDFOI(V*L;>)=QC!'(WG@D=OK0!T[^)M"C=E?6+%=C
M;6)G7:K>A.< ^W6M**6.>%)8G#QNH964Y# \@BJ=UHUC=:%-HIMTCL);=K?R
MHU "H1C '0<5E0^();Z[U*RT.W@:#2OW,UQ.Q6,S!<F)0!V&-S=LC@\X .DH
MKAC\0_/T[PK>66G>8->; A:7$D852S8&,-R N20,L.U4KCXCZG!H>NWJZ-;2
M7&E7YM"BW3>6_P R* &V9+EF*XQCY221QD ]&JHFEV*:A)?K:1"[D(+R[?F)
M V@_7;QGKCBL/4O$M_;^,[+P]9:=#<-/:/=/*TQ7RE4A06&TX!8XSSTZ54T[
MQT9=,O7O+(#4;;57TF.WMY-PN9Q@C82!@8.23T"L>U '945S-IXAU*3Q=<:#
M-9VN;>P%Y+<1S-M5G8JD?(_V7)/H!QS@85G\1=0OM&T34H='@\K4M22RQ]I/
M 9V *?+\Q"J7.< #CDYP >AT5SMMXANY/$VL:+/9V\3V=I'=V\@G)65'+CYL
MJ-N"GOUK3T6\N-1T2RO;NW%M<3PK))"K;@A(S@&@"_5/4]5L-&L7O=2NH[:V
M3[TLAP!69XA\1_V+J.CV.V)&U.=H4N)R1&C!<A3C^)CP!QW^AYSQKJ,][H6A
M:3J-J+>XU;442XM8WWDPQ,9&4$@9+;$7H/OT >@JP=%9>C#(I:Y"P\:M]G\1
M7.L6D=K!H]R(-UO*9?-8HK;!P,OEU7 [G'O4S>)-5A\1Z)I-QIL"/J:33.%F
M+-:QQJ"=W&&)+(..,D]<9(!MG5M.?5'TDW4;7JPF9X.XCS@L?;)Q5;PXVA#3
M6M_#RVR65M*T+);)M5)!C</J.]<WIVH0KKWC3Q9<G-KIRBPB)[) A>7'U=R/
M^ UK> =/FT[P5IPNA_IERAO+DGJ996,C9^A;'X4 =+17/>,_$4_AC0?M]K:)
M>3M/%!% SE3([N% 7 .3SG'M58>*[FT\6_V/JMI;VT#Z?)?I.DY8Q*C ,),@
M <'.02.".>M '545QEYXRU"*QTF_M]+C:#5[V*ULXY9"LFQ\GS6&.!L5FV]<
M8R1R!H6WB*\E\1:WH\]G;PR6-K%<V[_:"5E5]X^8E1MP4YZ]: .CJ"\O;33[
M9[F]N8;:W3[TLSA%7ZD\5!HUY<:AHMC>7=N+:XG@222$-N",1DC-<O\ %6ZE
M7P5)I=JK-=ZQ<1:="J8R3(WS=2!]P-U(% &\GBWPY))%&FOZ6SS,%B5;N,ER
M>@'/)-;%<YI9CU9)M.N-$EL[32Y+=($N2A;S$ =2-C,, >7@YSUKG+CXE7T>
ME7U_'I-LT=KJPTX,;H[9!YBQY4[.6R6.,  +G/(H ]&HKE].\47E[XDU?3)-
M/B@ALK2*Y65YCD;R^%D&WY#A-V!G ]^!B0?$+57\(Z5XEGT6"*RO+J.%HC<-
MYA2238KH-O/4'G&>>@P2 =M/J]A;:G:Z;-=1I>76[R(3]Z3:,G'T S5J6*.>
M%X9D62*12KHPR&!X((]*XR:[@N/B5?7]U*J6'AO2_G=^B2S'>Y_".-?^^JDG
M\:W-OHEAK\NG+%I=[<PQ1QNY\_RY6"I(1C Z@[.N.^>* .JLK"UTZW$%G D,
M8Q\JCT  SZ\ #Z 58KG+;Q%>2^(M;T>>SMX9;&UBN;=_M!*S*^\?,2HVX*<]
M>M5X/%[SQ6L#V\%M??84O;\S38ALD8<;F[DD' XX!)(XR =717)6/C*:ZT_2
MP^G[-4U$RM%;LY11#&Q!G<D95"NT@$9RX'O6CX:UN?7(KZ62!!!!=-#;W,1/
MEW2  EUSVW$KGD';D&@#<HJAK.KVNAZ7+?W>\QIA51!EY'8A511W8D@#ZUC+
MXBU1/%>F:'<:?;A[RVENY6CF+?9T3 P>/F)9E&>!U].0#J**\ZN/B/J*Z#JN
MI6VCVTOV'439*/M3;90)%C&T[.69B<+C  R3R,^BT %4+?1-.M=3GU*"V"7M
MP )I@QW2 = >>0,\>G:J^I:T;?5;72+*)9]1N4:7:S82&)2 9'/7&2 !U)/8
M D<])X[NX/#GB;5Y-.@*:+<O:H//(%RZ !B#M.,LVT#GZT =Q17)6/BO4+GQ
M1INDR:;"L5W8/=M(LY+)M*#)7;C86;"G.3C.!TK'F^(^H_V#J.IVVCVTHM-2
M-DH%T=LH\U8AM.SEV8GC   R3R,@'=2:78S:@M_):1/=*H02E<G )*C\"21Z
M9..M6ZYX>(K@^/#X>^QQBW73S>/<&7YA\X505Q@ _-WS\IJE8>.([[P_!JB6
M99[^]DM=,MTDRUR%=E5R<?*"%9R><*._2@#KJI66KV&HW-U;V=TDTMHP2=5_
MY9L1D ^^.:R-.\0WL_BR_P!%NK6W6.PM([B>ZCD.T-(3M3!''"L2?8=,U4^'
M2M<Z!<ZY(")-:O9K[GJ(R=L0_P"_:I^= '7T5E>)=9_X1[PW?ZO]G:X^R1&3
MRUXSCUX. .I.#P#5#_A)S9Z9=:GJ"P/IZ1PO:7%FQ?[69. J*>Y)4 9.<YR.
MP!TE4H]7L)=6DTJ.Z1KZ*+SG@'WE3.,GVSQ6(OB+5(_%6E:)<Z?;J][;RW4I
MCF+&VC3 P>/F)9E&>!U].<G2M6M;;4O%_B^]9OLR7*:=;[1N9EA^7:@[EIG<
M =SB@#OJ*Y;_ (2/58O$^CZ-<:= KZC%-<2;)BQM8XP.&XPQ+,@R,#D]<<T[
M+Q?K>JR7\>F:';W#V>I_8G;[7M01JP5Y-Q7D@[OE _A)[@$ [6BN0A\6ZE/H
M7B"Y33+?^TM)O'M1:_:3LF(",,-M!RP<8&.3@5UXZ<T 17-M!>6LMK<Q)-!,
MACDC<95U(P01W!%):VEO90^3;1+&F<X4=3ZGU/O61+K[W'B.;0M+A26YMHEE
MO)Y"1';AON*0.6=L$XXP.<] >5U[QIJ5]\/;NZTF.&VU-[YM(Y<MMF,OE;HR
M!SUW#.,>^* .Y@UG3KJ_-C!=QR7(5G"#^)58*Q!Z'#$ XZ$X-6I[B&U@>>XF
MCAA09:21@JJ/<GI532-.CTS2K*T$,2-;0+ NSG"@ 8!(!["L+XAVFH2^'X-0
MTT1R3Z3=QZB;>5L+<+&&)0GL<'(]U% '0V&J6&J1R26%Y#<I$YC<Q.&VL.H-
M9\7C'PQ/<I;P^(])DGD<(D:7L99F)P  #DG/:LCP.VD:[H$FH0Q2+=W$0L]3
M213'(LR%RZL.H;=*Y^A%+;:'I%YXL5[/2[&WL]%/WX;=$WW)7ID#HB-_WTX[
MK0!M:\VA7%J=/UR:U\B8;F@GDVAU'<C/*Y(Z\=*NM)9Z38*99DM[6(!0TLG
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MBTZTDD _AE+2_J5V?]\B@#J**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N7\4^&+K5-5TG7=)N8;?5]*=_*\]28IHW&'C?'(R.A&<>E=110!E6G]
MMW,D9U"*SLHT.YDM;AIS(?3<R)M'X'/M7/6WA'5;+0]5T*UN[>&VU"[GF-\&
M8S+',Q9ALQC> 2H;=Z'':NVHH Y6U\'I8^(].O;<0BPTG2S9:?;DDE)&(W.3
MCNJJ,]>6K(C\ ZC;^%M#TN&ZM&N(-474M2ED#;9Y,LY( 'S?.4.#C(4<BO0:
M:Z+(C(XRK#!'J* .!T(ZKJ?B?Q3K6GI9NK3+I=M/<R-^[$ PS!57YAYCN<;E
MSMQQUJ:3P/>:;/X<GT2>VFDTR>XFNOMQ8?:9)UP\I*@_/DDXZ8.,BN@E;0/!
M>DRW)B@TVP#;I##"0H8GJ0H[D]?4UL%@$+G. ,]#G\J .%A\(:_"OB^7^T;1
M[S6EV07!# H/+"+D8^4+ER -WWASQS9N/"36-UX5^QSVEOH^@12F039!W; B
MN!TR 9,DD8+9YZ5TVEZO8ZS;/<:?/YT4<K0LVUEPZG##D#H>*GNK6WOK26UN
MX(Y[>52DD4BAE=3U!!ZB@#EI-%?5O'LVJ13H=,&GK97('/G.LK/L!Z8&<-]=
MOKCKZC@@AM8(X+>)(H8U"I'&H55 Z  =!23W,-J@>:0(&8*OJS'H .Y]A0!S
M'BGP]J7B73M7TF=;%[&["?99'=A):L%'SX"\D-\PY'IGFK+>&I)_&>GZS=3)
M/;Z=8-!;*^2XF<C?(>W*J!^)KHZKW=];6*HUQ+M\QMB* 69VP3A5'). 3QV!
M/:@#@O\ A!M=7PO#;?:]/?4X]:&K.&+B*=A*S[6;&>A7MQL'UK7L/#NLIX\G
M\0WUW:21O8);)&F[,7S%F501P"=AW9R=IX&1CIK"^M=3L(+ZRF6:UG0212+T
M93T-6* //%\$ZX?AG)X<ENK![ZXF#W+@N(Y TWF2Y;;G+ D=..GO7?P+(D"+
M*ZO(!\S*NT$^P["I** .(\4-<ZGX\\.:3:113?85DU:XCED*+\H\J+D*W.YV
M(X_AHUKP1>:YIGB":XNX4UG5;3['$RY,5M"#D1@XR03DLV!G/3@"NH_LG3(-
M1DU9;&%;XIA[E8\R,OID<D>U.TO5K'6K/[7ITXGM][1[PI W*<,.0.A!'X4
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M]G@D++),@PK,S*NU%Y(&.3C)XP>LJ&[M+:_M);2[@CGMY5*212J&5P>Q!ZT
M<LVBOJOCZYU6.=#I?V".RN% SYTB2N^S/3:-V&]?N_WL0MX5U.T\=:GKEI%I
M5W;ZDL);[:&$MJ\:[ 4PIW CG&5Y[UV4,,5M D$$2111J%1$4*J@=  .@I]
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M4Y91A[N?#$' XQO*G'HH'-=Q5&SUFPO]0O+"VGWW5EM%Q'L8&/<"5SD=P":
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MX)J"QU*RU..9[&ZBN$AF:"0QMG;(IPRGW% $\)D,*&8*)=HWA>@/?'M3Z**
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M[ZXM%.21"@D\OG_IH8QD\8!)X!JW:>/)(=$UC4-6LXP]GJ;:=;16;ES=2?*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?JE[(P%MH=@EHI;H)93YLA_!%C'XT ='8:U8:G>7UI:2N\]BZQW"-$Z;&89
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M0=MFB@#EM(\,WWA_1/L6D7=M \NHM=R*\1:*.-WW-%&,C  X!]<G SQU-%%
M&?J$.J2WFGO87<$-M',3>))%N:6/!P%.?E.<<_\ ZCH444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH;D! < 3'J.N.1^8KI+BQL]-^(W@1K*WA@:XLKU)FC4 R@1QL-QZMSD\]R:
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MW_:=G]FC;8\WGKL5O0MG /M7EUYH&A6$/@BSTZ9[^Q777CBGN"C[D9)"R*5
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M'_#:..W/BRV@54@A\0W*QQH,*@VQG '89)XKJ-=5'\/ZB)%5E%M(3N&1]TT
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MDA2=ERA#.&7;N,@!Z @GMFNL\(:;H]C?ZU/I&J37XNYTFN6WQM"DI4YV>6H
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M29M/UZQA@DG.],I)]K&T_NT.>"#@\9/%:$&J:?=3316]_:S20_ZU(YE8I_O
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MK&Z>ZM--L[>X<DM+% JLV>N2!GFFC0='!N"-*L?](&)_]'3][W^;CG\:T**
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M@CKZFO<KJRM+Z(1WEM#<1JP8+-&' (Z'![U')I6G3>9YMA:OYK!Y-T*G>P&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !63J$GB&/4XO[.M=,GL#'B07%Q)%*KYZC","N,<<&K5CJMCJ<E
MVEE<I,UG.;><+G]W( "5/OR*N4 <U!HFJ:)X<OTT62Q?6KNY>\9[I6$!ED<%
MN%^8 +P/H,]ZZ1<[1NQNQSBEJC+K.FP:O;Z3)>1#4+A6>*WSEV51DG'8?6@"
M]15>_O[72]/N+^]F6&UMT,DLC=%4<D\5)!-'<P1SPN'BD4.C#HP(R#0!)114
M5S=065L]Q<S)#"@RTCM@+]30!+7ER:O:V7Q"U3Q#%K_A.2*ZM8[402:R$=-A
M)R?D/KT_6O4:C\B'_GDG_?(H \ZL;OPY<>+!XFU_QAH%Q>0PM!96UO>QB&U1
MOO$$MEW/0M@<<8K-\.ZB_AV,:#!XX\*/X=BD/V>X:]'VR*(G/E@9VY&<!L\=
M<=J]7\B'_GE'_P!\BCR(?^>4?_?(H \]M];TF+XB7FOMXE\,FRGL8[-4&JKY
M@V.S;B,8YW'C/;K6%-]@F\)>+M(/BGPJLVN7\UU$_P#:JE8EDV\-\O)&WMUS
MVKU_R(?^>4?_ 'R*/(A'_+*/_OD4 ><7>KZ5=^*O#.K'Q+X86'2X9XYT_M92
MS&557Y>.VW/.,Y[5G>'M0;PZG]@VWCCPF_AU)&-O<->C[7#$23Y8&=I(R0&)
MXZX[5Z5IFHZ1K*7#Z;-;W26TQMY6B (60 $KGOPPZ>M7O(A_YY1_]\B@#RB.
M[M-(O/$=MI/BSPK-I6MRRW/^E:DJ26TTBX? 7(=2<'&5Q_/I/"/B+P_H?A/2
M]*OO%?A^2>SMT@+07\>T[0 .ISVKL_(A_P">4?\ WR*/(A_YY1_]\B@#A_&F
MOZ#X@\(ZCH]AXH\/+->0F'?/J2*J ]^,D_2GQZWX6O/!?]@ZIXFT)?,L?L<Q
M@U*-A@IL)!./KTKM?(A_YY1_]\BCR(?^>4?_ 'R* /,_#7B*YL(;;3M7\;>$
M9K"R 6.XM[X"XN54?('R=J=LD9SC'?-2>&=6TO1M$UJTN/$WAAYKR\N;J'R]
M57:/-8G:Q(!&,]0#GVKTCR(?^>4?_?(JC>ZEH^G7MI9W<]M%<WC^7;Q,!ND;
MV']: /,%;3T\$^%]$7Q3X5,^CWMO<22'5E"R+"VX ?+G)_3WK4N=7L'\9ZCK
MMKXJ\,0B?1_L$!.J*624,SJY&,8RV,9[9]J])\B'_GE'_P!\BD>*W1&=XXE5
M1DD@  4 >=:"FBW'CF+6;+4_#EMJ,UI)!-;:9J"R_;9"0P9E 7[NUCT).>3Q
MSWFC?VK_ &3;_P!MFT.I8/G_ &/=Y6<G&W=STQU[YJA_PE'AN/19-;_M&S73
MHG:-KKHNX'! /<Y]*VQ(AC$FX;,;MQX&/6@!U<9<:!KR?$E_%%M%ILEO_9G]
MG+!+=.C$>;YF\D1D#TQS]:Z72]8T[6H)9]-NX[J&*5H7>,Y4.O49[XSVJ]0!
MSSIXKE6^F4:7!,81'9PB=W17).YY&\L$X^7  ]>>:S+/PGJ&A^+HM3T5K=;&
MZMQ'JL,\[;IY0>)AA3\_)R3C=GH.M=I10!P.B^%_%7AV6ZT?3[_3O^$>FN))
MH99 _P!JME=BS(H'RGDG#$\9R0>E2OX=\5:+XHU*]\-W>EOIVJR+/<6^H"3,
M$VT*739][( )!(Z=17<T4 >=SIJ%K\8-.CMC%>3IX==96N)#'YG[]<MD*V#G
M'&,=:FU'P'>WGAC6(8[BU76-2U&/479MWDJR.A6/.,[0J 9QDDDX[5T,0\-W
M?BV;RA:2Z];0@R,O,L<9/ )[#/;]*W: (;3[3]EC^V>5]H(RXASL!]!GDX]>
M,^@Z5P&M>"O$6H-XMMXKO37M];C AN+C>9H0$ $6 ,!,@D$'C).TDUZ+10!Q
M&K>%]5UK2CIFJV.C:C:M9)&H>1T-O.-P+H=C'&"G.0?E/'.!U.BV$FE:%8:?
M-<O=2VMO'"\[]9"J@%C]<9J]10!R%EX>U?P_XAUJ[T?[%<6.K2"Y:&YE:-H)
M\88C"MN5L XX(Q5 ^ KO3-+\*P:-<6TD^B73SR&ZW(LYD5Q(?E!(.7) _#-=
M]10!R-EH&LVGBOQ%J[BPDCU.W@BB43.I#1*PRPV' .[/!.,=ZPK;P'XBTSP_
MX9?3+W3X]=T%)(1YA=K>YB?&Y6^4,.@(P#@C\O2Z* .'U_P[XG\0^%6M+J?3
M/[0ENH)F5'D6"%8G5PJG:68D@Y) Z].*W/%6A/XF\)WNEEDANI8@T,@8D13*
M0R,#C. P'..E;E% '%R>!-VN:#J2W?S6D;IJ)Q@WF7$H)]/WPWX]R*O:OH>H
MWWCCP_K,'V46FF)<)(KR,)'\U5' "D<;?7G/:NFHH X6Y\'7^J:SI.I7T&G0
M:AI]Z)O[3M9&\Z:$$XB9=@SD$*<L1U(ZXIFE^&?%WA^\O--TK4-,/A^YN))X
MGG5S<V@D8LRH!\K<DD$GOSGI7>U3TW5;'6+5KG3[E+B%9'B+KG 93M8<^A%
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M;I%_)!)<6D(B+09VD#Z\_H*WZ** "BBB@ HHHH **** "BBB@ HHHH ****
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MMYV?R9XE.0RL!E6!YZ'KCZ@'.Z;K^K>%_"'CO6([>SGO;;Q%-YBL6$9RL*Y
MZ]\X)_&NKNO$/B6S\86NAO;:6RZE;2RVCAI/W#1E=PD/\8PPQ@+SQQUK*NO
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MSZ=J<J7&S8WFJZQA"N>F.,YZ]O>@ \5>*4\.WNE6\]Q;V4%\\B&^NHRT,3*
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M\:R#[T#,I /'<$_I7(:?X.\0PZCX4NY[O2(QHD,ML\5O"^&1T5=PR1\QV^@
MSWH N>&O&%QXDO(A;SZ?\D\L=]I[(R75F%#;2<M\WS!03M ^;CI6OXM\0?\
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MM*B,ZEC(RL2O!X&T#D\]>.E8S?#[5+C1=4MVO[>UOY-;?6K"YAW.(92<A6!
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M//'3O6QHJ:JFDPKK<MI+J(W>:]HK+&?F.,!N>F/QS0!?HHHH **** "BBB@
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MG(_.@"6BHXYXIBXBE1RC;7"L#M/H?0U2TF6]328FU>ZLI;O<RR2VH*Q$[R%
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ML[5 ]"!TKL[+0->TV=[BTA\-17#C:\PM9?,8>A8ODCVS3#X;UDZ@U^;3PO\
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M+RJ=:DT1P@LI 4\I3E9-J\;AD[3U."!T-4-9M[4>%_ ^J^'DC2]^VV:6TD(
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M;I%W>7]W=CC.,]?6N:T;4OL7@KP'%>W8M])?4+N"::90\:,KRB!7SQM!'&>
M5![5Z\-"TD7TM\-,M!=RILDG$*[W7T+8R1[5&OAK0UTJ32ET>P73Y#E[5;=1
M&QZYVXQG- 'F'C30=(L? WC2:TOUO6N#;W,D2(@AMY=P7<@7[K,!D\YZ'O70
MSZ;9Z/\ %G03IMK%;O=:9>"?RQ@SE3&07/5CDDY.376)X7T"/2!I"Z-8?V<&
MW?93;J8RWJ5Q@GWJ;^PM(^V07G]F6?VJW7;#-Y*[XQZ*V,@?2@#QR[DL]9_9
MZU74;Y89=6,KR7KR >:ER)\8/<$+@ ?W<#I77S:5IM]\:%6XL[>>.7P[OD1T
M#+(1<  L.C8]\]!Z"NJN/!_AN[N[B[N-"TZ6XN?]=(]NI,G^]QS5E- T:.\6
M\32K)+I8_*698%#A/[H.,X]NE 'C=QH^FI\'O%EPMG%Y^GZE=I92E<M;*EQE
M1&>J >@QUKK;J\@O/B/?Z7K%[;P+)ID!L4NHD=)4)?SMN[C).W..2%'I79#P
MOH LIK(:)IWV29_,E@^S)L=O[S+C!/N:-1\,:#JUM;VVH:/8W4-O_J4E@5A'
M[+QP/:@#S=_#VD6NJ_#O3X;AM3M([B]MUN9\%I8A$YV9'WD!X Z$>H-0:E86
MEIHOQ8T^VM88[.W"30P(@"1NUJI+*O0'//%>JS:%I%Q+:RS:99R26@VVS- I
M,(]$X^7\*(M!TB&2[DBTNR1[Q2MRRP*#.#P0_'S#ZT 1^'([6+P_8I:)"B>1
M&6$0 &XH#SCOR#^-:E5K#3[/2[..ST^UAM;:/[D4*!%7Z 59H **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J.:>*VA::>5(HD&6=V"J![DU)7->-;*>_T_3XK+4H;'45ODDLVG3?%+
M*JNPC<>A ;W! (YH K^-?$ESI7A;^UM$NK.7;=01.2OF@J\BH<$, #AL\YKI
MX;RUN)98H+F&62$[941PQ0^C =/QKR'Q!J$M_P##WQ!;ZAI4>FZG!K5HE\EO
M)NBDD,D!WHW497:<=1WYK=N(=.T'XK2O!;):VO\ PC,TLZ6J!"P29><#&6 S
M@]: .^AU&QN+F2V@O+>6XC^_$DJLR_4 Y%<II_B'6;F?QE!)+9^;I$H6U80-
MLQY0D^9=^3UQU%<=I]Y91ZO\-)[>>SMK$K<>1")0TL<36['][)GDD@9&  V1
MDXS70Z,1_:_Q*Y'$Z_\ I*M '4^#]4N=;\&Z/JEX4-S=VD<TFP8&YADX%4M?
MUS4-,\9>&;"*2W&GZC)<+<!XSO'EQ,X(;. ,@=NW6CX;_P#)-?#G_8/B_P#0
M167XXM;6]\<>![:]BCEMY+JZ#QR#*M^X. 1W&<<=Z .VMKNVO81-:7$4\1.
M\3AE)^HIMMJ%E>M(MI=V\[1'$@BD#%#Z'!XKQ_7K-_#\_CYO#T#0:4MM9M<P
MVJX1)"_[X(HX!\GE@/49KKM'M?#U]XITO7-.\0->W9M'ACBMC"%:#&?WBHH(
M"G&,XP2!0!W55X]0LI;A[>.[@>>/[\:R LOU&<BDU%2^EW:K<?9BT+@3_P#/
M+Y3\WX=?PKRC1-,M?$^C>!K*1--8:4PEGE>:*47"!",*F2Q,A*L0RJ1@YY%
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M%%% !1110 4444 %%%% !1110 4444 %5KW3[+4H5AO[2"ZB5@ZI/&' 8="
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M7-)#Q(=4L@TTABB4W"9=QP57GDCT% #M8M[R[T:]MM/N5M;R6%TAG9=PC<C
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M(1>Z;:7/D<1>="K>6.GRY'%%UHVEWT,,-WIMG<108\E)8%<1X_N@CC\*O44
M4YM(TRXNH;J;3K22X@&(IG@4O&/]DD9'X5"/#VB!)T&CZ>$N#F9?LR8E_P![
MCG\:TJ* ,Z70-&GBM8I=)L7CM#NMD:W0B$^J#'R_A5FTL+.P$HL[2"W\Z0RR
M>5&$WN>K''4GUJQ10!4U#2]/U:!8-1L;:\B5@ZI<1+(H8=" 0>:YSQMX6.J^
M$-8TW1+"SBOM355DDP(@Q!'+D#)P!@=:ZZB@#-TW2[/3X//MM*MK6Y:,!UA1
M03C^'< .,USG@KPA_95I<G6-+L3>M?S74<RA9#AW+K\Q (*Y_P *[6B@"G)I
M6G37Z7\NGVKWD8PEPT*F1?HV,BDM=(TRQ:9K33K2W,_^N,4"IYG^]@<_C5VB
M@#/T_0M(TF*:+3M+LK..8YE6W@6,/]0!S3+?P[HEH(!;:/I\(MY#+#Y=LB^6
MYX++@<$^HK3HH S_ .PM(_M ZA_9=E]M+!C<>0OF$CH=V,Y]ZDETK3I[^.^F
MT^UDO(O]7</"ID3Z,1D5<HH SVT'1WU9=5;2K)M148%V8%\T=OOXSTK0HHH
MK+IUBFH/J"V=N+UT$;7(B7S&4?PEL9(]JAMM#TFRNWN[73+."Y<DM+% JL2>
MIR!GGOZU?HH *SYM"TBYU2/4Y]+LI;^+'EW3P*95QTPQ&16A10!2O]&TS5'C
M?4-.M+IXL^6T\*N5SUQD<9HNM'TR]2!+O3K.=8,>2)8%81XZ;<CC\*NT4 4X
M](TR&]>]BTZT2[D&'G6!1(P]"V,FJ_\ PC.@_9H[;^Q--\B-S(D7V5-JL>K
M8P#[UJ44 4KO2-,OY+=[S3[2X>V.Z!IH5<Q'U7(XZ#IZ4G]B:5]BN++^S+/[
M+<L7G@\A=DK'DEEQ@D^IJ]10!2MM(TRSTTZ;;:?:PV)4J;:.%5C(/4%0,<]Z
MA;P[HCQ01-I%@8[=2D*_9TQ$IZA>.!["M.B@!D44<$*0PQI'$BA41!@*!T
MZ"GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZYAN;S3[2XG@.8I9H5=H_P#=)&1^%6I"XC8QJ&<#Y5)P"?KVH \,MM#T>Z^
MU[.MI =2CN)UMY8U'G+.+EA$BD<@G*@ ?WO>ND.H0P>.]6TSQ/K)TU[G3;86
M[2^2(IXPA$JAI%(^^6R 1G/M70>!/")T#1(8=5L--;489II%N81YC8>1G'S%
M01@-BNFOM*T[5!&-0L+6[$9W(+B%9-I]1D'!H \O_L+0K?Q%\.+"U#7E@%OX
MXI+S:[31B/*9. &3NO&,8K=U:SL;'XG^";.UMX((8[._5(8T"JHVQX  ^AKM
M)M,T^XGCGGL;:6:/ 21XE9EQTP2,BDFTO3KBY%S/86LMP.DKPJS#\2,T <%X
M=>UO;;Q_8>(?+$XU"X-TLV,_92@\IN?X-@X^AK!T^PDG3X4+K\"27CK<++YZ
MY9D$#%%;/)XV\'O7K5SI&FWMS'<W>G6D]Q&,)++"K,O.>"1D<TZXTVPNYTGN
M;*VFEC^Y))$K,OT)'% '!Q:)I%K\9[>TM]-LXH$\.LRPI"JJ"+A<':!CUKDY
M].T]/@YXVD2U@#V^IWB0N$&8PL^4"GL!G@#U]Z]H?3+"2[-V]C;-<D8,QB4O
MCI][&:B&AZ0('@&EV(A=@S1BW3:Q'0D8Y- '!W>K6UO\2+NVUO6&TV&[TJ#[
M#+)Y0BE4%_-7=(I&22I(&,@#.<"L^'^R_#NL^ [&"\GE\,*]X+:YNW!1I_\
MEF=V ,<OL/OD=C7IMUHNE7MM%;7>F6<\$)S'%+ K*A]@1@?A4MWI]E?VAM+R
MSM[BV.,PS1!TXZ?*1B@#B?"$]B?BAXZ2UEMR9&LGVQL/F/E'<>/?K[U9^(2?
MV6='\71IE]%N@;@@9)M9?W<O'?&0W_ :ZVUTZQL69K2RM[<L%5C#$J9 & #@
M=@ !4TL4<\3Q31K)&XVLCC(8>A!ZT >56$=_9^)]0T&:V:.V\6@:BBA," $X
MN$;T8Q;.?[S5M2V=G=?&XQ7%O#*L?AQ"B.H8*?M##(!]C^M=V8HVE64QJ9$!
M57(Y .,@'T.!^0JNVEZ>]TUT]A:M<,"&E,*ER,8P3C/2@#QO2[IK+PEX2,A"
MZ)!XEN([K^Y&/.D\K=V"!R#SP"%]J[A;:2/XT-/8\02:,#J(7[I?S,1%O]K&
M_'L#75QZ3IT-K+:Q:?:I;R_ZR)85"/\ 48P:6VTS3[*U:UM;&V@MWSNABA54
M.>.0!B@#QX.G_#-43;AC[2.<_P#3_78^.5'AS6-+\<0Q$K9G['J8C7+/:2$?
M-ZG8^UL>YKK/[$TG[-]F_LNR\C=N\K[.FW/KC&,UE7VEZW?ZLMBQTR'PROE/
MLC5_M#E#GRR/N!"0/PR,<Y !=\-V<MKI(FNH]E[>NUW<KW5WYV_\!7:GT45R
MWBIW\,^.=/UZWM3/'JUNVE7$2KP\X!>WS]2&3)Z BO0*8\4<NWS(U?8VY=PS
MM/J/>@#S/P59W=G>OX&O%,D.A7?VP3;,))"WSP+]1(S'V\FIK&"%/&7Q,BAC
M1=UI:,410,L8).<>M>C"*-96E$:B1P%9P.2!G )]!D_F:ABTZQM[F2YALK>.
MXD^_*D2AF^I R: /(WFLKSX5?#Z!9890-2TN.958'!S@AL=#UKI].L[.#XO:
MW9Q6\"6\VBVS2PJ@".1)(N2O0\8%=>=#T@PI"=*L3$C%U3[.FU6/4@8X)I_]
MD:;Y[S_V?:>:ZE6D\E=S \$$XY% 'C-I;VD_P8\$^;'$P77($4D#@&Z<$ ]N
M*[?3K:VL?C/?V]G#%;QR:#"[QQ*%!83. <#N!@5U?]A:085A_LJQ\I6W*GV=
M-H/J!CK4R:981W?VN.QMDN<8\Y8E#XZ?>QF@#D/B.\44_@^:9D2-/$,&YW(
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MNO>-/%EQ\,[KQ!;:99V%M/IT4T5Q]J+RHTA"MA0O!^;*G/H3SP #U2BN6O\
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MV.MZ7J<\T%AJ-K<RP@&1(90Q4'H2!V/K5^LO2[!1Y=_=6-G%J/D"#SH/F/E
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MNWO(YKEW$MFTARX" 8<9Y R/<UWU4]3U73]&LGO-3O8+2V3K+,X5<^G/?VH
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ML< /(J@@ <D$@]10!TM%<A?>(==_X3N3PWI]IIX4Z9]MCN)W<X/F;/F4 >_
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M#$LX<LHP>!MQ@GGKQTKJZ* .+N?#&N1>*-?OM-N; 6>MP1),9P_F0O'&4&T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex1019-amendmenttoemploy002.jpg
<TEXT>
begin 644 ex1019-amendmenttoemploy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &U<G)Q0!U=%9&G>(]/U+5+C2T,T&H6\:RO;7$1C<QDX#C/WESQD=#P<5KT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7&_%?_ ));XA_Z]O\ V85V58WBK0!XH\/7
M6C27;6T%TNR5XT#-MR#@9X'3T- ' 3_:/%'B_P ,^']9CBTR'34AU6T*.93J
M#(OW58A=NW^)<$GZ<UUGB*\U!-=6UAU1K>!K%WBM[)%>Y>;=C>P92JQ@8Y)
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MXI?)7>Q1]Z@]L9]N1C\=5O#'F^+CX@GO/,=K#[ ]MY(\MHRVX]\YS^&.,=Z
M.>TZ_P#%^IV_A[6;'SGANS%+?03FW%OY$BY)BVGS-RY&,GGO65/K'BF3PYXU
MU%/$3Q2:%J%PMN$M8L2)'&CA'RI^7D],')/)X%='H7@%M!F2WA\0ZC-HD,GF
MV^ER;"D9!W %\;RH/(7(' SGO(/ Q_L?Q%IIU20Q:[/+/<-Y(S&9%"L$YZ8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBHYYX[:"2>9PD<:EF8]@* 'Y^;
M'M5>_6Y>U9;.01SG[KD9 (YY'H<8_&J&D137D[:O=[E:5=MO"?\ EG%U&?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6(]]O3ZF@#M;"]CU"PM[R'/E3QK(N>N",U9JKIUJMAIMK:*,+#$J ?08JU0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\'VT;QL7L7>W65DP'4'AESV((H ZO3XYXM-MH[IP]PL2K*PZ%@!D_G5FBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "LOQ!H-KXET>;2KZ2=;2<;95A8*7
M&0<9P2.1VQ6I6)XJ\0/X8T.?5SI\EY;VXW3+%(%=5R!D \'KZT 5+GP/INH6
M<-CJ5UJ%_8Q%2+6>X/EMM^[N"@;@,#@Y'%5_%3G61/X.70[Z6&]@57O?) M8
MHRV&^?/WU R!CKM[<UN6.M6VL:!%J^D,EY!/'YD7S[=WJ"><$<C![C%/T34F
MUC1;/4C;FW6[A2=(R^XA64$9]\&@!NIZ+;:GH4FCF2>UMGC6,-:2&)T48P%8
M=.F/I5QPT-LQC1Y61/E3<-SD#@9/<^I-2T4 <'X@_P"$@UIM.D@\-7UM-8W2
MW"L\]LX; ((XE'7-&G+KMOK=UJ]]X9OKN\D'EPE9[95@B_NJ/-/?DGO7>44
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M G<&ZMIY74Y_UBESD_4$_J*Z+1_&=OKGBS5M"LK1R-+VB>Y9P%8MGA1U."K
M].E $IUW6F&#X.U C_KZM?\ X[0-=UI1@>#M0 _Z^K7_ ..T_P 8^)E\(>'9
M];FLWNK:W*^:L;A7&Y@H(!X/+#O575/&$V@6BWNMZ%>6U@"!+<P.DZP9[N%.
MX#W - %C^WM;_P"A/U'_ ,"K7_X[1_;VM_\ 0GZC_P"!5K_\=K=@GBNK>.X@
MD66&50Z.AR&4C((/<8J2@#GO[>UO_H3]1_\  JU_^.T?V]K?_0GZC_X%6O\
M\=KH:* .>_M[6_\ H3]1_P# JU_^.T?V]K?_ $)^H_\ @5:__':Z&B@#GO[>
MUO\ Z$_4?_ JU_\ CM']O:W_ -"?J/\ X%6O_P =KH:* .>_M[6_^A/U'_P*
MM?\ X[1_;VM_]"?J/_@5:_\ QVNAHH Y[^WM;_Z$_4?_  *M?_CM']O:W_T)
M^H_^!5K_ /':Z&B@#GO[>UO_ *$_4?\ P*M?_CM']O:W_P!"?J/_ (%6O_QV
MNAHH ;&S-&K,A1B 2I()4^G%.HHH **** "BBB@ J&[FE@M9)8+9[F51E849
M59SZ L0!^)J:FN6",44,^. 3@$_6@# _M[6_^A/U'_P*M?\ X[4%YJNMWEG+
M;?\ "*:I$)5*EX[NU# 'KC]Y5?1O&M[KMO?SV7ARYD2QNY+251<Q!FDC.&"@
MD ]>Y%:_ASQ/IWB>UGDLO-CFMI3#<VMPFR6"0?PNO;ZC(]Z ,W3[[4M,LH[2
MT\%ZA'$@X'VNUY]S^]ZU*VKZL\RRMX,U#S%!"M]JM<@'M_K:Z:BFVV[L#G?[
M>UO_ *$_4?\ P+M?_CM9=YJ^LZO.UL/#EXUG$=MU!'<P"0MU"LWF@;2"#@9]
M#BNAO=3N[*\NC+8 :;!9F?[;YPYD!.8]G7H =W3G%8-UK$O@WP9:ZD]DUY+<
M3Q&X/F!,/,X&2<'."P'3M5)67,)[V+\6LZO#$L47@R_2-1A56ZM0 /\ O[45
MYXGUBV@R_A>\@9R$1Y;B!EW'H,+(6/X"NCN[N"QMGN+F01Q(,DG^0]37'Z)K
MCZ[XZU"TN+&5)=,BC=1(P"Q"525('4N0.<XP.*275@^R'Z9>>([.>ZGOO"]S
M=74S_P"N@N(%78!PH#2YP.?2M+^WM;_Z$_4?_ JU_P#CM=#7.)XI=_',GA?^
MSF$R6@O3<><-AB+[!QC.[/;]:3=W<$K%;4M4\4WEC+#I_AN>UF92/,N+B \?
M[.V3[WIG I-/U+7+72X;.7P=>'9'L8)<VVTC\9:TM*UZ?5M3O8(=.86-K*8A
M?>:#',PZA!C)P>">@((R<5MT7=K#.3AO+^" PIX(O_+*[=K7=LWR^G,O3VIU
MG?ZAI\1BM/ ]["A.2$N;49/_ ']KI$NX)+R6T253<0HDDD8ZJK%@I/UV-^53
M478'/?V]K?\ T)^H_P#@5:__ !VJS7^H/<2SOX(OFEE01NS7-J=RC/'^MZ<F
MM^>[9;^"SB&7<&1R1PJ#^I)P/QJ/5+]K*!4@7S+N8[((_5O4^PZDT).^@F<S
MH6L:_;63V[>'+FZ6&5HT,-Q"OE@'[C;I.2O3(XK4_M[6_P#H3]1_\"K7_P".
MUKZ=9BPL8[<,789+N>KL>23]35JG)W>@)61SW]O:W_T)^H_^!5K_ /':/[>U
MO_H3]1_\"K7_ ..UT-%2,Y[^WM;_ .A/U'_P*M?_ ([1_;VM_P#0GZC_ .!5
MK_\ ':Z&B@#GO[>UO_H3]1_\"K7_ ..T?V]K?_0GZC_X%6O_ ,=KH:* .>_M
M[6_^A/U'_P "K7_X[1_;VM_]"?J/_@5:_P#QVNAHH Y[^WM;_P"A/U'_ ,"K
M7_X[1_;VM_\ 0GZC_P"!5K_\=KH:* .>_M[6_P#H3]1_\"K7_P".T?V]K?\
MT)^H_P#@5:__ !VNAHH Y[^WM;_Z$_4?_ JU_P#CM']O:W_T)^H_^!5K_P#'
M:Z&B@#GO[>UO_H3]1_\  JU_^.T?V]K?_0GZC_X%6O\ \=KH:* .>_M[6_\
MH3]1_P# JU_^.T?V]K?_ $)^H_\ @5:__':Z&B@#GO[>UO\ Z$_4?_ JU_\
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M.>!CUSM?#F=[GX>:'/(07DM@S$>I)J:[\%:3=:W/JZF[MKJZC$=U]EN7B6X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZUHMCX@TR73
M=1222TF&)(TE:/>/0E2#BM"B@#"N?"&CWEGIUK-%<%--<-:N+J59(_EVX#AM
MV-O!!/-*_A'29&G#I.8+B83S6QG<PNX(()3. /E' P#CD&MRB@#/AT6R@UVY
MUE$D%[<PI#(QD8J54DC"YP.OI47B#PYIGB?3_L&K12S6I8,8DF>,,0<C.TC.
M" :U:* (XX5BMQ"&D*@8W,Y9OS/-9ND>&],T.VNK:RAD$%U*\LT<TSRAW?[Q
M^<GKWK6HH YK0_ 7A[PY?&[TVTEC8%C%&]P[QPENNQ&)"DY/(&<$CI5FP\)Z
M7IYLA$MP\=CDVD<]P\BP$J5RH8GG!(&<X!(&*W** ,&'P=H<-EJED;1I;;5)
M&EO(IIGD$KMC+?,3@\#ICH/2J]GX"T.SNM.NE%]+/IVX6CS7TSF(, "HRW3
MQCIBNFHH YB/X?>&XM>DUB*Q=+B643R1I.XA>7.=YCSM+9YZ=>>M7%\*:4EU
MJMRJ7 FU50MXPNI/W@ VC^+Y<#CC'%;=% '/-X(T)M-TRP^SSK!IC[K,I=2J
M\/&W <-NQ@XQG&*Z!55%"J % P .@%+10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
B%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ex1019-amendmenttoemploy003.jpg
<TEXT>
begin 644 ex1019-amendmenttoemploy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKGO'9=/ FNSQ33PS06$TT4D$K1LCJC$$%2#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ex109-amendmenttoemploym001.jpg
<TEXT>
begin 644 ex109-amendmenttoemploym001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM=M-0@GM;G[1/((9HF5V4Q( 0",G)!''>IO@;X<T\^$&_M?1(1JD%Z[H;RT
ME1=J8*[AG&<\B@"#X@>*_$%JO@*[M;RZTN76]OVZWC;@$^5P P.W&]OZU[3'
M&(HU12Q"C&68L?Q)Y->-?&Z*:Z\1>#3:VUQ<BSNWEN/(A:3REW1$%MH.. ?R
MKT"]\86QO=.L-,CN;FXN[E(V86LFR*/.79F*@#Y00.>I% '*>'O%6H?$#XAZ
MU8V]Y-9^']&_=[+8[)+J0L5#,_4+\K$!2.V:=<^+-0\'?%BP\,WUW)>Z-K$:
MFV>?!EMI&8J%W=64L!UR1N'/'.=X0TB?X;?$CQ#'J,4B:+K!$UK?A"8E(9F$
M;L/N'#L.<9V^].U'1;CQ[\9=)UBUAE70=#C1FO'0JL\JL7"QY^\,E<D<<'GI
MD 9J^OZUX'^+^GVVL:M=7'A?5,BV\U^('.!@D $A6QU/W6!.2*]!ACFU;Q/<
MW,5[=)IMHAMFB24A)Y_XCZ@(,+P>6+9Y6N/^/%BNH^ 1!#:O=7Z7,;P1Q1EY
M!U#$ <XQGVKL/!4D,?@71_X#%91>>'!5EDV ON!Y#9R3GO0!YGIWB[Q!X;^+
M%II^LZK/=:!JTMQ;VOG8_=,LSQJ,XR2"BCZ.*E^,_B_7]&DM7T/4I;*WBN1:
MRF(+F21DWL#D'A5*8QW9O2I?&WAQO&7PUEGTJ.5]5TS4KFZMU$;)(5:X<D $
M \J0P]=HK+^,>CWL?@_PYIL4<^H:C'=-<7C00LY9V!+N0HX!8G'MP.E &W\9
M=9U?PK:: ^C:K>6K7%R89CYF_>N >=V>>O2NNL[2>?Q%%-IGB"_N+;3[MK;4
M+::5'C?,&X8.,@AGC[^M<'\=U;6+#PZNGP37H2Z:61;>%I-J8') !Q^-=AI^
MI:'X?O?L'AVRE9]7U%)3##92)# "J+(Q. J_*A./4].M ''>,?$WBWP-XRFU
MN*ZN+_PK#=K;7-HY#&(M$CGG&1]_Y23U&#U&>\BO5UW5;/4-&U6>2SO=+FGA
M19/W9D#(JL1U!&X@CID<C-2V(TS7;OQ1I=U$)[>XN%#QR1D+*GD1*2I(Y *D
M9'0BN0^'/@S5/ _CW5-+DFFGT0VK3:=(W( 9TW*?1AM7/K@'O0!G?$2]\0^#
M[KP=96OB74I9-0N##>R.R?O,&,' V_+]YJ]2TG2K[3=4OWFU6ZO;*9(C!'<L
M&:%QOWX( X(*=?0UYC\;89[SQ%X-^RVUQ<?8[MI+CR86?RE+1$%L XX!_*O9
M(Y$EC62-@R,,AAT(H @U&^BTW3KB]GR8X(RY"C);'8#N3T ]37"_"?QO=^+=
M.U2VU9?+U?3[R19HCP51F)4?\!.Y/^ CUK8\0W1U+7]/T""X:W*'[9+,T!="
MR%?+CR?ER6._&<_NQZUYO=6E_P" _CC#JT(GOK#5H]NI-;6K8B9C@E@N<<A7
M]>6H Z/6O%^IZ[\5(/ FBW;V%M;IYVI7D0!E("AMB$@A>J@GKD^W/3:GX?U>
MV^QRZ%K5\NR[@-U;W,OG+-#YB^9AGRRG;GH<'D8Y&.*O]"O/"7QH'C1;>:YT
M'4XC'<RV\9D:U8J!EE&3M)53GMD^G,GC+6M9U'QSX9@\(ZA?SZ?<3*-4^Q9>
M../>@RQP0GREO3IZT +XQUC5[/XS^'-"M-6O+?3=1A#W$,;CD[G&02"1]T=*
MGTKQ-K5A\;)_"']H2ZKI+6WG$S*IDM&V;L%E R,X'/\ >'XXOCZQCU#XV^%V
MEM)KG3(+<0W4OE.\:9:3AFQ@'D=^.M'A&TO_ (6_$6]T2>SN+KP]JQ$UMJ*0
MES$>PD<#IV.?9N 30!:;7-3_ .%Z:EX=N->O+?0X+3[1L\X+Y9\I&)WD9QDD
M\FN\\.V-W+!=7$FKWUYINH003V9G<"6#<"64%0/]D\^N.:\NO;&QO_V@=3N]
M7TU[K0YK,0F:2T>2%F\E!P0I&<@C([UZ7X?U^S7.DVJW!T_2;&))+V>W>(2/
M]U0FX#/"DG&>HQ0!YY\+O$6H^)?#=W<Z_P")=26Y;44LK8PRHC$N%Q@%<$C)
M/3H#7;Z]8>(;?P%!:PZU<)KJ3)!'>J0/,+2[5++TY!';BO,OA#I6F6.B7,WB
M'3Y[/4;74H[NUFDL)#*%4#(4A<D'##'OG'2O4;KQ(FJ>'K+4);:XMHYM5B$$
M4D#B3RHYU!=EQE1\I;) P"* ,7X6>/KC5_!.HOKTKR:IHKNMWN4"1UY*\#OP
M5QZK[UE?#_6_$>J_%7Q!HVN:K<30V4+2"W1@J)(63(!7!(&X@<U<@\"75G\:
M[K5K5C'X?O[87MR!]QYE=2%^N\"3Z9'>L[P*'M_CGXNOYX9HK.ZC<07$D3+'
M(=Z?=8C!Z'\J (M$\2W[^/O&MGK'B'4(](T9))(5655*@/@#)&2<<#/6N\OM
M.U?2O!OB,2ZY>S30B:YL+MF42H@B!56P,$!@PY'(KRW2-&TW4_B7XY_MZPE&
MGWPE%I=2V3LH;?P\;;>HZ@CK7INJ>*(M9\,^*?(MKI;2&U>V@>2VD1[B5HVR
M$4C)'*@<=<]J .6\!^-]8LO$UYX#\=7#?VGO/V.\)V><#T4,,=1RI^HZ@"NN
MTS2M4U+3=-8Z_J"1)-<-<R+(OF38<JBYVX &,\ =/>J'Q'\#6WQ \/0WVF2"
M/6+4>;8W(RA;'.QCU'/3^Z?QK:\ F[B\ :6^J!X[P0LUSYHVL'W,6W#MSF@#
M@/ M]KOB?QCXUT:[\1ZG'#IMPT-F\;INC'F2*"<K\W"CK7KFF174&DV<5]*)
MKM($6>0?QN% 8_B<UY%\)XYK;XE^.9KBWGABOKMY+626%D69?-D.5)'/!!KV
M>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH R_$&EW>L:2]G9:K<:7.S*1=6X!=0#R.?6N0_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
MA7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^
M%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z*
M ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]
M^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_W
MZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*1K?_ 'Z2O0Z* ///^%>^)?\
MHI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\ A7OB7_HI&M_]^DH_X5[XE_Z*
M1K?_ 'Z2O0Z* ///^%>^)?\ HI&M_P#?I*/^%>^)?^BD:W_WZ2O0Z* ///\
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MD5J4 %%%'09- !16;I>O:9K4UY%IUVEPUE((IR@.%?&<9Z'CTK2H **0,"2
M02.H]*6@ HK+N/$%A;>(+/0Y6E%]>1O)"OE-L*H,M\V,<9' .>:U* "BBB@
MHHILDB0Q/+*ZI&BEF9C@*!U)- #J*Q-/\5:;J6J1Z?$MRDTUM]KMVE@94GBR
M!N1OQ'!P>1Q5O6=;T_P_ILFH:G,\-I%S)*L3R!!TR=H.!SUH T**@LKR'4+.
M*ZMRYAE4,A>-D)!Z'# ']*GH **** "BBB@ HHHH **QM>\4Z1X:2,ZG<.C2
M@E(XH7E<@=3M0$X&1D].:FLO$6D:CH(URUU""33/+,AN=V%51USGIC!R#TH
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M;;/(E2.)7"$%C@')YY.3U&,'TZN.C\$W2:5XGL3JT1&ORRRN_P!D(\DR($8
M;^?E Q[_ )4 45\0Z]!J_A*[N+NV>QU[Y)+)(,>03"9%*OG)/&#G@^@JOKOB
MK6M(>6Y:\A>2+6([8V4$0DB6V=U0>9)C*2D-NQN[CY<5M2^#KJ5/#"_VK$#H
M+*RG[(?WQ$9CY^?CY3[\_E67/\-KR72;[2X_$;I9S:C_ &A IM%9HW\T2$.V
M[YQD<?=/J3TH UH-6O\ Q!XCUS3M/O?L,&D>7#O6)7:69EWG=N!^0 J,#!)S
MR*Y'P-KEU8^ ?!ND6B2&YU$73,\*H61(W8MM#D+G++USQG@UU:^#[ZQ\3W6M
M:1KGV8ZA'&NH0S6HE$SH-HD7#+L?'L1[5F1?#&2V\+:/IUMX@GAU31IGELM1
M2W7*;R2RE,X93G!!/84 ;_A6X\12/J5OKUJRQ0S#[%=/Y8>>(C^-48@,IXSP
M#D<58\3WE[8Z;#+9W%M;*US&EQ<3L!Y<)/S% >&?H%!SDGH>E2Z'IE]I\#OJ
M>J-J5]+CS)_*$2@#.%5!P!R3U))/7H!5\5>')?$,.G&VU V-UI]XEY#*8O-0
MLH(PR9&1ACW% '-6WBW6_L'B^.WBGU"XT>:(6I:VV3O&Z*QS'A<LH+$# S@<
M5N>#]>@\0?:[FQUQ=3LE6,(KQK'/!)\V]9% 7'\..!W^M58/!>I6NH:W?0>(
MY%N-4>WF+&U7$<D6WG (RI"XV\<'DGK6II/AL6'B'4-=GE@>^O88X9/L\'E(
M0A8[B"S$L=W4GH /J -\8>()/#^EVK6ZH;N^O8;"W,@RBO(V-S =0!DX[XQ6
M=/K&IZ)XWTK0[N[-[9:S#,()GC59()HEW$': "I4\<9!'4UL>*/#EMXIT5].
MN)9(&$B307$7WX94.5<9]#^F:@M_#]S-K%EJVL7L%W=V,,D5KY-L840O@.Y!
M=B6(4#J  3ZT 8'PZM[M=6\7/+?O*JZY,CH8U&]O+C^;(''T'%:'Q1ENH/AK
MKDUG=R6TJ6S$O&!DKT*Y/3(/4<U>\->'+G0+O5YI-0CNEU*]>]91;F,QNP48
M!WG(PHJ[XDT2+Q)X;U#1II6A2\A:(R*,E,]#COS0!Q?B""^3Q7\/HH[Q7NC)
M=[9IHAA<VQ_A7&<#Z9IT/C+5=)T_Q+;ZA+%?WNF:C!9VTPB$?F>?Y>S<H('R
ME^>1D#MUK:D\):C<:GX=U"YUN.6?1S(W-G@3%T\L]'^4;>G7GOVJO<?#Z/4$
M\30ZC?\ FP:[)'*PAA\MK=T"A&5MQSC:IZ=1^% %G2KCQ1'XI\BZMKB?1);<
ML;BY$"20S _= C;YE(]L@]ZZNN<\/:!K6GNCZWXDDUAH5V0#[,L 7MN;!)=L
M<9SW/'.:Z.@#BO!G_(X^.?\ L(P_^B$JKI?BV>^\3-I-UJ1T_58KV17TRZ@5
M5FM@S!&A<C+$J%8G<?XN!Q6_H/ARXT?6M9U"6_CN!JDRSO&MN4\ME4(,'><C
M ':J<_@^XU"73AJFI0W46G7PO;=Q:[9U(8LJ;]Y&T9 . ,@ >] %#X?_ &^7
M5_%LEWJ<MR(M9DAVNBC.(HL'@<8'&!Q^-;OC#Q WAOP^UY#&DEU+-';6ZO\
M=,DC!5+8[#.3["F:)X:ET77-7O(M29[/4;DW9M3" 4E*JK'?G)'RC P,>]6/
M%/ARV\5^'[C2;J22$2%7CFB^_%(I!5A]"* .5U"UOK;XL^$?M>HM>(UI?;=\
M2H5;:F[&T#Y3Q@')'/)J.Z\5:UI][I+3WD,LUUK8T^YM((@]O#$[,J@2@9\T
M *2"W<_**UXO".L3>(-$UC5/$4=S/I<<T>(;$1"82!02<NV#\O...F .^;%\
M-;V'1]/TM/$K_9M-U);^SS9J64AV?:YW?.<L>>.O(- %^'Q#>Z3XTUC3-=OE
M%D++[?I\@B5<Q+GS0Q[LIQ^!SBNAT Z@^B6LNJ/NO94$DB[ NS/.S [@<'W!
MKD]8&A>-O$>EZ;:W#75YHM\SWKHI7RD52'C<X (=MH*CJ >P-=]0!S%WK-S>
M^-SX9L[@V@AL/MMQ<(BLYW/L1%W @="22#V Q7,:GKFIZMX$\=:7>SK'J&BQ
MW$,L\,8"W,1A+(<'.TE3SCH1QUKK-4\,27'B>U\1Z9>K9ZE% ;67S(?-CGA)
MW;64,IR&Y!!_.J\_@WS?#NN:>E\JWFMF0WMV8,YWKLPJ;A@!0  2<8YSF@"_
MX1AFA\)Z6)KDSDVL14E NU=BX7C^=9/Q6_Y);XA_Z]?_ &85T>CV,NF:/:6,
MTZ3M;1)$)%CV;@J@ D9//'K6)XE\*7OB2XF@DUIXM&NK46]S8>0&W8?=O1\@
MJQ'R\@C':@"*ZOKZUMO#\,=XEG8S6Q\Z2-1)<NX1=B11E6W?Q$\'A>U<X/&O
MB&;P+H^J12VJWDNM+IUP7@(\Q?/,><9^0D#G@]3C%=9JOA:XN_$>F:SINJ?8
M);*W>U:,P"57B8J2 "1M8;1SS]#6-'\.+F+0X=*37RT4.JC4XVDM 2")#(%.
M&&?F/)^F * +6GZEKD7C75/#M_J4=PO]G1W]O<16RQF$EV0IC)!&5R,\^]9,
M'C'6IOA]X2UXSQ"ZU"_M[>Z41#8Z22E#@=0<#CFNIB\.3KXVE\1R7\;"2P6Q
M:V%N1\H<ONW;SSECVZ?G7.Q?#6^CT&PT3_A)#]ATV]CNK,"S7<H1RX5SN^8@
MG (P/4'L 'C+Q-K6AP:_>0WT,;Z?''+9VD,0F\Q, LUQQE 3N Y7IWJQJNK^
M)+KQK:Z)I>H6EG!>:1)=H[VOF-$X9!GEOF^]TX'/?%&H_#RZO4\26R>()(K'
M7?WDL9M59TDV!<[R>5^4?+@>Q%:5MX3O8?$^G:U+JZ3/9V)LFC-KCS%9@Q.0
MW!RHQP<#KGK0!2LM<U/1_&5UI/B/4HI+5]/%Y9SK"(E;9_KP>O*\,!_=/.:Z
M+PZ]_-H=M<:FY:ZG7S2I0*8U;E4('<# /OFN6\0_V#XWUZPT:WF:XO=*O_,O
M/*#+Y$84AT<XP5?(3&><GT-=[0!5NGL[!9]2N-L>V(+)+C)VJ20/?EC@#J37
MD_B'1Y]$^'202Q&W76O$<=S=6PZ01RS!A&<<<!4![9S7>>(_#VM:SJ%K<6'B
M)=.AMOF6 V*S!I/[YW-R1VXXZ]>C6\)7.I>';_2O$6M3:H]TP*SK L!@VX*%
M%7(R&&[/?OP* ,OQ4[1?%3P+Y.0TZW\,H7C='Y2M@^P(!JYXNTB#6X=)\-6L
M2+Y=U!<N4&!:P1-G(]"V-B_4]E-:,'AVX;6H]9U&^BNK^WMFM[4I;F..+=@N
M^W<26.!GD<# QR:Q8/!_BN!IROCEA]HD,DS+I<6]L^C$DC X'H ,4 9WC7Q7
MX?NVU?2;[6;*!+"WD'V:68*]Q<F,E1M[JN01ZL1_<YZ#X;ZA9ZA\/-"-G<Q3
MBWL8()?+;.R18UW*?0C/2MO4M*@U'3+NS954W$+P^84#$;E(SSU/--T'24T+
M0-/TJ-_,6SMXX/,V[=^U0NXCWQ0!S?B:[>X^(OA#1"?]&9KB^E7L[1)B/\F;
M=]0/2H;G^T)/C3;0+J<J6RZ(\RPA%*C]_&&'3O@<]>.*TO%&E2'7-!\26\;2
M/I4LBSQH,LT$J;7( Y)4[6QZ XYXJ:[\//?^*['Q-8:KY!2S:UD18A(LT3.'
M&UL_*<CKSQZ=: //[>_US1O#7CC6M*OK>!=/U^\G,,D'F>?AERI)/RC'IS[U
MVE_X@OK[7SHVFK=1>781WDLMLD3N#(S!%_>$# V$G@DY'3O7;P#<OX:\1:,V
ML1[=;NY;F246A!B,F-P \SGH,?UJ35?!-_<:CI^L:3KYTS6+:U%G-.MJ)(KB
M('(5HRW8Y(.>] &SX4N=<NM A;Q'9I:ZFK,DBHRE7 /RN I(&1CC/!S6U5/2
M[&2PLEBGNY+NX)+S7$@ ,C'J<#@#L .@ JY0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%U>0VGE
M"5CNFD$<:*,EVP3@#Z GV )[5/6/XA\-V/B6VMH;V2YB-M.L\4EM,8G5@"/O
M#L02#]: +-QJ]I;QWCL976R&9S'$S[>-V.!R<8.!ZCUK*M_'.C76DKJENFI2
MV+1F19X].G92HZGA.G%%SX;LM.FU_6;>2Y$]_:L)HFF)B!"?>5.@)P,FN6^'
MUQXA3X8>'%LM/L7MRL*M(;EC)Y1E <^7Y>,[2W\5 '?7VL6MC!;2.6D>[<1V
MT48&^9BI;"Y('0$\D  '-9,'C;3[JWS;V>H27@\W=8"#;.HB(#DJ2!@%E'!.
M<C&:P_&=G._CSP0D%_/;(US<*B1)'B(BW?E<J>HXYR/3%(]E='XVPK_:MT,:
M"TF=D7W?M"@I]SH>N>OO0!VVEZE;ZQI=MJ-H7-O<('3S$*-CW!Y!JY7G1UWQ
M7KNCRZQX<AG:5;R1+>U<6XMI8XY3&0[,WF!B%)R,8.!@CDZ2:EK/B6Y\10:3
M?C3I=+D%K;J41Q)/Y8<F4LK?)E@ORX. 3DY& #LBRA@I8!FZ GDU3L]22\OK
MZT6WNHVLW5&DEA*I)E0V48_>'.#[UQ$\>KR_%+P_%>:I+#*=&EEFAM@AA60-
M$'";ES@GN>< 8Q5W3=0\0:KJ/C/2TU)([BPFCCL)5@4+&6B#@,#G(R<'/..F
M* .WHKA_#GB&^\0^'_#P2\EBU*5W&H_NTW)Y.5F!7;@?.448YPP/-4Y-=\5:
M[I5UJGAR*X,T5[)%;6S"W^SRI'*4(D+-Y@)"L<C&,@8/4@'HE<_+XSTB'7)M
M&(OGU"&,2R0Q6$TF$/ ;*J1BMZ-F:)&=-CE067.=I],UP=C_ ,EUU;_L!0_^
MC30!U.D^)-)UN:X@L+L/<VQ GMY(VBEBSTW1N P_$5JUYKXR7['\7O MU8C;
M>W7VFWN0G62 *#\WL,DC_P"M1J'B?6].NM/E;4DGEFUY+&XMK>%7M8X7D**O
MF;0?- VDC<<'.1B@#TG<I<H&&X $C/(!Z?R/Y4M><6-W<Z=X]\>:A<ZE=SVV
MFVMM-Y!$>&3RI7V#Y<@ YQC'7G-6[#4/%]Y)H&I6T,\]I>;&OX9OLRPQQ.N=
M\15O,^7(X8G(]#0!?;XD^&5T635FNIULXKS[%(QMI-T<F,_,N,A<<YZ?CQ71
MVVH6]S=3VJ,5N(,%XF&#M.=K#U4X."/0CJ"! ^B6DMK=V\GF.EY)ON<MS-P%
MVM_L[0%P,<#ZUS/B^Z?2O''@V]AX-S<RZ?,!_''(FX _1D!_/UH [>D9E12S
ML%4<DDX I:X?XI_:1X7MFMKZ>VSJ-JCB+;\X:91@Y!X'7^>1Q0!W%%<B-4O;
MWQC+X8@U*>%;&P2YN+M8XS-*[L0H&5*   DX7DD=,',O@K7K[51K&GZIL>^T
MB^>T>>-=JSK@,CX[$@\@<9H ZAF5!EF"C(&2<<DX%9<?B&QE\3R^'E$XOHK7
M[4VZ(JGE[MHPQZ\^G'!KF_B6+KR/#8M[^XM5EUVTBD6+;AP7R"<@YP5! Z>H
M-4[NTOYOC ;:TU)K>;_A&D#W9A1Y/^/AN0N-N2?;'7CT /1:*\VTCQIJMWX;
MT&"8F;5=0O[BQDG@1%)6$R%G56(0,0@&#QDDX.,'I?#3^)%U+5+?68I'T]61
MK"YG,(F8$?.KK$=O!Z' R#0!K:OJUIH>F3ZC?&1;6!2\KI&S[% R20H)P*S5
M\9:4UC%?"/4?LDBJZS_V?/LVMC#9V<#D'-1_$'_DG/B3_L&7'_HMJS/#DWB!
MO"7AF$:=8&PDMK9)W6Y:1_),8_@,8'/&?F. 3UH [>BN(FOM?O?B'J6@0:NE
MI9IIL5U$\=JC/&S.R\;L@GY>^1[=QS@\5>*1\.+?Q9)JL/FV=V()[9+50ETH
MN?)8L3RI(Y^7 % 'K596O^(;'PY9Q75^)S'+,D"^5$7^9V"C)Z 9(ZFN9O+W
MQ+J'C_5/#]EK4-A;1Z?%=12K9K(\99V7&&.#]WJ>/;G(YK5-=U'7/AE*NL",
MZEIWB"'3[F2)=JRO'<1_.!VR"* /8**Y-=6O-<\9:SH5I?26$6DP0&22%$:2
M268,P^^K#:JJ.V23UXKFI?%GB2X\%7VJ13B.^\/ZG)::HD$*D74,3#S'0,#M
M;8=WIP>.F #U&BN8?4KO5-3N)-(U("QM]/63=Y2NDDL@W(>F>$PQ&1]]/?/'
MP>)?%7_"'^$O$;:O"[ZC=6]M/:M:H(W$K%=Q(^;<#@\$#MCN0#U>BN /B/5?
M#GB77K+5+[^T[2TT7^UXR84B9-K.&C&T<@[<C.2/4U+97GC"XNM$OK>.:>SN
M@#?QW MUBC5ER'BV-OX)Z,3D>] '=4A90X0L-Q!(&>2!U_F*\FN?$OBQ/!OB
M/7AK4(DT74[B%(5LTVSQQR!=K$\@$9Z<Y[GMN3"\N/C-9JNJ74=O_8;SK H0
MJN9HPRC*GAL#)Z\<$"@#OJI:GJ]CH\,,U_<+"DT\=O&6_BD=L*/S_K5VO-O'
MEM:^+)M3T>87FRQM<6SP6DTJB]8!E8LBD HH3OTE:@#TFBN1\*^*Y];^'":V
MMNTVHP6TBSVV,,;B,$,F.Q+#I_M"L*W\1Z]=Q>"KBSU=)VUU2;R(VR,L.(][
M% ,$!6^0[B>H[]0#TNBO/].O_$VI^)_$%NVNPV]EH]_#E%LE8RPF,.T?)RO!
M^]DG/Y&.QUOQ=K.F:-KVDV\\D=W*DL]I+]F%O]G;KM;=YF]1CDGDYX'0 'HE
M%>>SZYXHURRU2\\.)<">TOI;:VAVV_V>7RGV,)"[>9EL,<KMP".O),_]H>(]
M0\>7>AC4DT^#^R8;P".W21X79V4@$Y#'Y>IR/;N #NZ*\E_X2KQ4OPXB\5R:
MM#YMC=^1-;I:J$NE6Y\EBQ/*DCGY<8_ETVH:SJVIZ]K>DZ2UY VF1Q*)+5;=
MMTLB;P7\T_=P5&% /WN>F #M*0D $DX ZDUYY)K'C'^V?"&FWLUKIUUJ=O="
M^B2)90CQ*"&4Y/7.0,\<9SR*RM7U?6KGX<^.[2[U65[K2)Y;=+R*-(WFBV*P
M# # .'()4#\* /6 0RAE(((R".]+5#189(-'M4EN9;EO*4[Y H/0<?* /TJ_
M0!F>(-=L_#6BW&K7XF-M;KN?R8B[?D.GU.!6C&XEB21<[64,,^]>2^)M4U#Q
M9\&]<\11Z@T%I.DWD6:Q(4,*2%/F)&[<=I;(8 9 QP<]+K>I:I:RF*#4_LL*
M:5YUO#:1++</,,Y9U9&"Q@!1GCDGGI0!VS,JXW,!N.!D]32UY5<:EJ?B"?X9
MW[ZC/:/J(>2:.W5-GF?9G.X!E//)&#D 'UYK7N]9\0ZT=>30#=)/IEPUI;>6
MMN8Y9416/F^8=V"6Q\N,#GD\  [UF"J6.< 9X&3^59F@Z_9>([.:ZL1,(X;B
M2V;SHRC;T.&X/(Y]:P++6]6USQ&=#DD.E3V6G0W-_P"0$D?SY<X12P9=J[2<
MX).1R,','PK26/0=72>02S+K=Z)) NT,WF')QVR>U '=45@^)[R\LUT_[/?0
MV<$MT$N92-TQ7:Q"PIM;<Y8 8P>,\>G*V?BS7G\+:_.L5U>3Z7K)M-T=NOVG
M[,#&S-Y8&TR!'/&,<#CJ* /2**YOP=K<&O6EU>6>MC5+0R@1%XU26'Y1N210
MJX.<GD="/K2^+]?FT6#2K>U*K=:IJ$5A'(PR(M^2SX[D*IP/4CM0!T=8%YXO
MT^SNO*,-W-"ETME-<P1;XX9FQA6P<_Q+D@$ G!(-9AU75-*\>6OAVZOI+NSU
M6SEEM;AXXQ+!+'C<#M4*5P01E>OK5+X96UQ&?$LDFH3S*NO7L9C=8P&8./G)
M"@Y]@<>U '?U2.KV*ZVNC&X7[>UN;D0]_+#!=WYFKC,J(7=@JJ,DDX %>+:]
MJ<=K=:=\0HH;\7<%^6N UE,J_P!G.!&%W%=O"A7ZXW.U 'M5%<?XWUK5=.A\
M/2Z+=VZ+?ZI!:.9(MX=),G.<]..W//!%9<>K^)]'\6:CX>O]5AOA-I;ZA8WA
MM%0PLC;61E4@$<Y!_G0!WE_>+I^GW%X\4TRP1M(8X$+NP SA5'4^U9MUXHL+
M*YT>WN([I)=68);JT##:2I;#D\*< \=?:N,L]5\6O\,Y?%LNO0-(VBM<I;?8
M5PLJKNW[LC.0,8Q@9]JLZ]<RWDGPWNIVW337T<DC8 RQMG).![F@#T2N6U+X
MA>'-)U(V=Y=31A91#)<_9I#;QR?W&E V@^O/'?%=37*^--/CU+PU-X8M(D\_
M5 8E7;Q&I8&24^RYSGNQ4=30!MZCK%GIC6T<S.\]TQ6"")"[RD#)P!V Y)/
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MP2V %*\#.<G@ [#2-4M]:T>SU2TW_9[N%9H]XPVUAD9'K5VN9^'?_)-_#?\
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M.XN+9;4Q-X:NF18U.1V!SGO^E>F44 >?:9-I-GKLNNWL'B74=6>/R5N)]%N
M(8\YV1HL8"CUZD^M<^NC6R:3!I<>I>*%M+/45O[-/^$>F)B82&3#$QY?DG!.
M.O(->PT4 ><H^G)XEU+5"/$;V^IV\<-Y:/H4Y$VQ60$MY>0,,<@8R?RJGX:M
M1HT]M8?VMXINM%@D!M+"?0IE\O!RH>;R]Q53@@<#@9X&*]2HH *Y;4=-.O\
MC32+@#-CHAEF=^TEPR[%4>NT;B3V)4>N.G+H)%C+J'8$A<\D#K_,?G7)O\2-
M CT6XU5Q?+;VUW]DG!M'WQMC.YEQD)CG/]>* +_AFVU>VDU0:EJ,U] ]T7M'
MG@$3JAZJ /X0> 3R<$]"*E\4^'D\3Z&^G-=/:OYL<T<Z*&*.CAE.#P1D=*OP
M:E;SWTUD"R7,2A_+<8+(>CKZKV]N^*MT <Q/X3F_MVTUZSU0Q:M';&UN)98
M\=S&3NPR K@@\@@C'0YK3T/1(=$@N0DC2W%W</=7,S  R2-C)P.@   '8 =>
MM3ZGJ/\ 9L4$GV.[NO.G2#;:Q;RFXXWMZ*.I/:KM &)XH\.CQ)86T"WCVD]I
M=Q7D$RH'VR1G(RIZCKQ5>+PQ<Q>+?^$@.J>9-_9XL-DEN.5#%]Q(8?-N/8 8
MXP.M=$3M4DYX&>!FLK0/$-IXCM[N:SCGC6UNY+219TVMYB8W<9Z9/>@#FO\
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MPK+)XDT[7$U22&YMK,V<ZQPKMGC+!L<YV'(ZC/X5TE% #7#F-A&RJY!VEAD
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M?K@?BG_Q[>$_^QFLOYM6_P"$;+5+#3+B'5-1N;_-RS6\UT@64Q$+PP'3YMQ
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M1110 4444 %%%% !1110 53U72K'6]+N--U*W2XL[A=DD;]"/Z'/(/8U<HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MST62,[GN(C/-(3EGD=B6)/<Y./PJWXEU-/#"6XL(HUOM<U2&V#N,JLCJ%,A
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M=6S)8"5[=Y'#,,9/F=P.!C=SGC'4:3]M_L:Q_M/:;_R$^T[0 /,VC=C''7-
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M'&.U=!J^KZSX6O/#US=7_P#:%IJ5Y'87431(OE22 [7B*@$*&&"&+<$<YYH
MZ^]O8=/LY;NX\SR8E+N4C9R .2<*"36'#XYT2YTI=4@.HRV+1F03IIERRE1U
M.1'TK6UG_D!:A_U[2?\ H)K@? %SXA3X8^'%L]-L9+<K"CR&Z8R>490'/E^7
MC.TGC=_A0!Z4CK)&KH<JP!!]0:=7%ZGJ&MCXAV>@6-_!:V%QI<LX M@S1LKH
MN02<'@\=AW!KG6\0^+?^$+\1:G_;4 N?#UY<P;A9K_I@B(/SCHN5./EQZYH
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MR[@3AF)&%*X'O0!VU%>:6GC76=?F\#3Z?-!9V^NQ7/VB)H-Y1XXR202>FX'
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MVTN>=RA5XQQW&0>3VN:]KD\7BC1/#MI+Y$NHB::6X"AFCCC4'"@@C<21R00
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MTVUGEAO7CEN;23[.L"V[C)*-N\S>H(Z]3G@=*[*RMM2BU+4);R_CN+25T-I
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M#^=;^CZ*VJZ?X>O]1U*&\M=/B2XMDBAV R>7M#NVXABH+8P%&3GTQUQ4,,,
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MBF?X>,CC.,YU](M]8B\2ZQ)=:C+=:9(4-M%);B/R&YW(IZL,8.3QSQWK?HH
MYW6_#,^I^(-+UJRU62QNK%)8B/)659(Y,;A@]#\HP?T-8G_"MY5T2?2EUZ5H
M9-4_M)6DME)5O,\S;P1G+=3^0%=[10!S-SX2-]XIFUB\NXY8I],;3)K00$*\
M3-N)W;L@DD_A^=8H^'%__85EH;>*)FTZPNHI[,&T0RHL;;E1GSA@. #@?CTK
MT"B@!%!50"Q8@8)/4TM%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK/9V.?M$D+A]A SC [GMZ]J\[U>V\.6>G>$H],;.FS^)TG1KE\B8,C[G4-_
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MU&>U.[[-(UOL4M@'&TD@]QN]Q3O&/_"-O\//&6J:->/=_;UMA<7CR[HYI5<
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MZ3;BQO5<"%F0N70M@@$[P?R]J /0)/$FAQ"U,FKV*B[0R6^;A?WJ %BR\\J
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MC#IFG6UC;@B&WB6),G)P!CGWJS0 4444 %%%% !1110 4444 %%%% !1110
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M/R;O^^EW?\#]J .MTW3H-+LEM;<';N9V)QEF9BS'C Y)/ X':K)168,5!(!
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MDPN)?)B*R9#-G;C/3KQGH32/XOTY?&8\-;F^TBV\]V*G )<*J@XYSELGH,4
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M7[JA0 /H*JG6=-&F0ZE]MA-G.%,4RMD2;ONA<?>)[ <FET_5]/U5)FLKI)3
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M C&['7FNE,<9?>44OC;N(YQZ4ZB@!@AB&,1I\HP/E'%.**6#%06 P#CD4M%
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MUPK8#D$;D4$<L<#&:[%];T^#6H]&EN0-0>V:Y6+8W,:G!;.,=>V<UH!5!)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9&AAB8-$YBD(4,6.X8)!.!R >,X !Z915>_FN+?3KJ:SMOM-U'$S0P;POFN
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M\=SX=_Y%C2?^O.'_ - % &E17$6GC"YU#Q)=Z1#=V%M?6M_Y+:;<Q,LTEN&
M,J,6 ;*Y88!XX]RL?BK5GM?&>19>?H3MY#"%]L@$(D^8;\YYQD$4 =?>7EO8
M6QN+J41Q@A<GDEB<  #DDD@ #DDUE0>+]#NH)9(;QW:*9K=X!;R><) -Q7RM
MN_. 3]WH,UQOBF_U/5]"\ :BD]K ;[4K"5X_(9@)6C9\_?&5!_AZ]/FJSKMO
MJB?%+PJL=Y8)));7C[A9-@L$B#%AYGS9[<C XYH ZO0?%NA>)WN%T;4$NS;A
M&EVHR[-V<9R!S\IXZC'.*VJXB/Q=)I6J^,XK^VMDL-!MX;J,6R$/()%D=MV3
MC)( Z#DGUK2M+OQ2U]I,LMO83Z?>1,UV(@4:S;:&3!+'S 3\IPH]>.E &QIV
MK6.JF[%E/YOV2X>UG^4KLE7&Y>0,XR.1Q5VN"L_'-Y'H6MWFH06YN;/6VTFW
M2W1]KDLB*2.2>7)..PP!FIU\0^)(M2O[<V27-HMBUS!?-8S6R)*O6)U<DD$<
M@@^WO0!VU%><6/C/Q&=.\(:Q>QZ9]AUR>&UE@BC?S$>1&(<,6QC*_=P>.Y[:
MSZ_K^KVVLW/AR&R<Z;=O:16]PIW73QX\SY]P"#)('!Z9/7% '8T5R9\0:M:>
M/;'1]12TBT[4;1Y;5E1O,\],%XBV[;PI+ XYP?2M;P]?WFIV,M[<F P23R?9
M/*C*[H0Q"L<L<[@-P(QP10!K4R66."%YII%CBC4L[N<!0.22>PKG9-<O-1\5
M7^@Z5);P/I]M'+<SSQ&7YY,[$"AE[*23GN![UQOBCQ+?^(?A#XH9Q!9WVG23
M6&H1JC.K,A /EG<, A@><]2/>@#T+3O$FDZKJ$UA:7+&[AC69H9(7B;RST<!
MP-R^XR*U:I:;;S1VT4EVUO+<[ OFPP&/Y>H&"S']:NT %%%% !1110 4444
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M41#.]0A9@V>ASN/'ZUR/@?0KWQ+\(M!TF\DMETJ14DF9-WFR1K)O\O;C R5
M+9/&>!GCU&:"*YA>&>))8G&&1U#*P]P>M1V5A9Z=!Y%C:06L.<^7!&$7/K@#
M% &';>';ZS\=:CKD%[!]CU&"!+B!HB9 T08+M;. #NYR#T_&G^,- O/$&FV<
M5A=Q6]Q:7L-XHG0O%+Y9)V. 02O0_4"NAHH X.7P5K<MQXKFDU2Q<^(+-+=P
M+=E\IA&T>1\Q^4!LXZD]QWLR>$]3?_A$3]HM =!P7^]^_P#W1CX_N\'/?GBN
MSHH \[;P'K=GI'B'0-,U.Q&C:J)WB6XA<RVS2@[D!!P5R>">1GH:[;1K*?3M
M%LK*XFCFEMX4B:2.,HK;1C."3CIZU>HH XO5?!][KL]NNI/9/]EU$7EK?HK"
MYAC$N\1#C'3Y<YQC^'(S45YX.UDZAXG%AJ-G'8:]'F02PLTL4GE>60I!QM.
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MRQW#Y@=W'3H*CUKPCK&O>%IM-O=9@:^N9H999Q;$1((W5U1$W9 RO))).3[
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M[I/&,$C'>NQNM<U"[\97OAZREBLS:Z>MV)I8]YE9F91QD?(NWGN2>HQS@/\
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MR%P5;<-IR2#D'CWZ8<OP^U"7P/K'AMM5M@=2O)+DW MF_=[Y/,*[=_/(QG-
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MD*9^5U!!(YSUZ@4 8-MXYO(+'QE)/$+[^P%66!UA:%IT:+S &4],'/S 8(Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH BAMH+<R&&&.,R,7<HH&YCW..I]ZEHHH **** "BBB
M@ HHHH **** "BBB@ JM=:=8WK(UW9V]PR?=,L2N5^F1Q5FB@     & .U%%
M% !1110 4444 %! (((R#U!HHH K6NG65DSM:6=O;L_WC%$J;OK@<U9HHH *
M*** "BBB@ HHHH 0@,I5@"",$'O5>UT^RL2YM+.WMR_WO)B5-WUP.:LT4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%<]XYUG4/#W@[4M6TV.V>XM(3(!<9*X'L.OYB@#H:*AM)&FLX)7QN>-6./4B
MIJ "BBB@ HHHH ***XF'7/$%W\0]5\.Q76G16UI9Q7,<C6;NYWDC!_>@<8H
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MPNY(PB@[0,@%V) &3CKUZ5=TQ]=BUNYM-2DMKBS6!)+>XAA,;,Q9@RN-Q&0
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M6M^+=Y+=;E@=Q ./EW GGCBJ_AWQ!'/X+T35=8O;:":\LXI7>5UC5G9 QQG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 453&K:>VK'2EO(3?B+SC;ALN$R!N([#)%7* "BBB@ HHHH **** "BBB@
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M#<9YX]Q(#(4&T\\G<WTH VW\027.IWUAI=L+AK!1]KF9B%1R-PC4 9=\8)'
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MSY(XG5B5GC5B%E7(!VMU']1S6S45NLJ0(L\BR2@?,R+M&?89.!^-2T %%%%
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M5U#PQJ%W?^&I8KVWC@TEY7D3RCRQ38A09P-H+ 9SU!.>_4NRHC.[!549))X
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M'KD.BO*XOYHFF2/R7PR+C)W8V\9 Z]Z #0]/?2=#LM/D='-M"L0\M=J@*
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MV<-II\B/#:PN<74Z*=I);'"@%@@STR20*Z^JEY%8W$D%O>P0S,S%H5FC##<
M<XR, X)]\9]Z ,#P99R/-K>OS@A]7O3)#GK]GC CB_-5+?\  ZW-8M+J^TBZ
MM;*Z%I<RH5CF*;@A]QD9].M7JCGGBMH))YY4BAC4L\DC!551U))X H YBS\/
M7]_<65WK0MHFMKQ[_P J!BY>8JR(2Q P%0@8&<D YXP9GT/4;CQ];Z]/):M9
M6MG);00 MO1G92TF<8R0H7'IWKHXY$EC62-U=' 964Y!!Z$&G4 9,<VK/XJG
MBV1#1H[1<,8V#FX+'(!/#+MQT'7OUK/@T?7=2MDM/$MUITUO'.LI%G$Z^>%8
M,@;<3M (!(&<XQG&0>FHH P;K1+B/Q)-KFGM!]IGL5LW6?.U=KLRN,=>6;(X
MSQR*HCP/;6_A_3["VE+W%E?IJ1GF'-Q<!]SL^.F[+#VR.N,5UE% ',2Z/=6E
MUJ_B0E)M:EM/LUFBQM(D"#)5 !@MESN8\=AP!FI;K1;W5K'P_=WQ@75].ECN
MI%7(B:3RRDB@\D#YVP>>@KHJ* .:C\)17)UVXU*02WFLPFVF:/I#!M*K&F?3
M<23W))P. &0^%I;B30EU.6%[;155H(8LXEF5=BRMGIM&<*,X+9R<"NHJAK.L
MV&@:9+J.I2M#:18WR+$[[<\<A030!AS>%+@0:]8V=TD%KK5R9YYAGS8@Z*DB
MJ,8)(3AB>-W0XYZ2QLK?3;"WL;2)8K:WC6**->BJHP!^53*VY0PS@C/(Q2T
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M8JA=?-<_?Y( C#'N!@;:MS://:^-;'Q#K&OV8DBT^6/[/Y>P##*SM$"QP-H
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MHK+(^U2?*JJ-W?>6!/3Y2<5MP^'7'B]]?N;H3R)8)96ZM'@Q_,6=SCC+';T
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MQ[T^9 6FAD< .%.[:1\HQD<>AIW_  CFIV/BZ^UK2[^U\O48(8KF*[A9RK1
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MT^K^+-0FAT^--%3[-#J MR7P(_-D5CNR54E> 1D@US&I7NJO\)K&+6[L/?\
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M@VL=Q?O*D<DJ0H8X6?+L0JCY0<9) YJTM]:/?26*W,+7<:"1X X+JIR Q7J
M<'FN'U8:GJOC7POHM_+:.L9?5[J&W1AY7E#;&,DG</,<<X'*9QV OB>YAT3Q
MAXDDBTU6TR66VMKA;8@SK".CG?DCS"RC! []Z ._HKA]/\3Z]/XA\-6-Q#9"
M+4+*6XND1&\Q B+\X);"J7<  @G').> S5O&FHKX3U'Q+I45J;*)_)L(YD9F
MO&WB,/D,-JECP.20,Y&> #NZ*Y#4/$.L6OB_2M!MULKB6>QDN;E?+92K JJD
M-N.%+%CR"<+@9)%-LM:\1V?B30]*UU=,8ZE:W#O]CC<>7+&5. S,<@JWH.10
M!V-(%5<X &3DX'4UF:#=W][8RS7_ -G)^TRK ]N&"O$&(1N>^._0]1P:RM=U
MW5K7QCHFB:5':RB]CFFN?-C8F&-  'R&'!9E&,<^HZ@ Z26VMYWC>:".1XSN
MC9T!*'U&>E2UPEIXXO+7^W;?488+NZL=1CT^S-HAB6[ED565,,S;2"WS')P
M3VJ\FL:Z/&EOH#/I[@Z>][<RI"X\L[MB*!OY!;)R>H4]* .MHKB]/\2ZW?\
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M<V<<3B2)C&7+ABY& 1RN.,]>]+I_B+Q-K5SK,.E1:7(MCJ8M%FE1T4QJ5$G
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ME;?%)Y3N"K;L;24/4=* .YHKBX?%NH:G8^)/[/@@BO+"Y2&Q6X5B)@\<;)N
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M=NA^U+"WS2F,R/E=_15V\9[]>P .RJKJ&H6VE6$U]>R&.VA4O)($9MB@9).
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M![BZA\X7,KA@[2 %>3N.,$8P ..BVNE0>%?$^I:_JWB"';JIAA19U"$NB'Y
MQ/0G<0H [<G'/4WVH6NFVXGNYA&C.(UX+,[$X"JHY8GT S5/3-:TO7S,+9O,
MELY2KQS1%'C8%E#;6&0#AL'V/O0!F^&/#S:?=ZGJ4[N1?7TMW;P.NWR X4'(
M_O';GGH#CC)S>\,:"/#NDO:M<"YN)KB6ZN+C9L\V21RQ.,G'4#KT J"U\;>'
MKWQ VA6U^9=15WC,2P28#(#N&_;MXP>]7+_Q%IFG3S0W$[;X(A-/Y<3.(8SG
M#.5!"C@]>P)Z T 8$/@62+PU)X8_M';HLDTC.(XRL[Q.Y<Q%\X RQ!8#)7C@
M\UH+X8>+QE!K4-VD5I!IRV,=HD/*@/N.&S@ X4$8_A'-:]]JMEIT,,MQ-@3N
M(X512[2L>0%5<EC@$\=@3T%.L-1M=2@::UD+*DC1.K*59'4X*L#R#0!E>%_#
MUQH"ZC]HOQ=->7LUV2L6S!=L\\G) P,\#"CCN<GXB.VH1:+X9@EC6?5[] RR
M#(\F+,KY&02/D4=1]ZNIO]4M--:!+B0^;<.4AB1"[R$#)PH!)P.2>@[U5^U:
M'>6+:U)]E,$(8O<31A3%L)#!MPRI4@@@\@B@"&+099M<36M1N(Y[R")HK.-(
MR([<-]Y@"269L $\<#  YR[PWX>3P]X:ATC[09W =IK@+L:61V+.^,G!))[F
MK5CK5EJ,[00/*LRQK+Y<T+Q,4;(# , 2,@_3O47_  D>E?:_LPN"2)_LID$;
M&,3?\\]^-N[/&,]>.O% '(Q_#G4AX:T;19M>A>#2;R*:$"S*K(D;%@)!O^9N
MG.0..AZUMKX9U*Q\57VLZ9JD"KJ,,,=W%=6QD.Z(%5=2K+C(/(QCO[5U%% '
M.7OAJYN_$VCZL-3.S3X)8BCQ!G=I"N7!R I(4KT/!.,=JH\%--)XJ%[J)DAU
M[<I$<6UHT,0C +$G.T XX'4YSD8Z.^U"WT]8O.8[YI!%#&HRTCD$[5'T!/H
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M\MMNA8,A1E"!@0,'CYB?<T_0_"LVC^)M8UB34C<_VCY64:(!LHFWYFSR,EB
M ,9QT QTU% &5XDTB37_  W?Z3%=FT-Y$86F";RJMPW&1U7(Z]ZH3^%=_B/0
M]0MKI;>STFVD@BM5BS][8,JV<#Y4V]#P3C&<CI** ./C\$S0Z+?Z#%J?E:5>
MW,LTA2+$^R5BSQA\XYR1NQG!QC/-:&K^$K'5+/1;$?N++3+E)EAC'#(L;H(_
M9?F&?4 CO7044 85CX9BM/%.J:XUP\C7K1LD&,+$R1B/=[L0,9[ GU-9^C^%
M-3T._P!46RUB%=,O[R2\,;6F9XGD.6"R;MN,\C*G%=;10!@:UX7BUO6M(OYK
MF2--/$P,:]9A(H4J3V&!SZU6U3PO>R>+K3Q'I&H6]K<QV9L98KFV,L;Q;MXP
M RE6!SWYKJ** ,"]\-R:CJ6B75Y?F9--GDN6B:(8EE*%4(P?E";FP,$].<\G
M?JM8:A9ZK9I>6%U%<VSDA987#*V"0<$>A!'X59H Y_5O#MQJ7BG1]72_$,>G
MQS)Y7E;B3)M!93G .%(Y!X8U1N?!4DNE>*X8]2"WWB!WW77D\Q1E!&B8W<A5
M!YR/O$\5UU% '(R>$+Z+6M(U*PU:*![*Q>PD5[7>K1L5;]V-PV$;0!G=QC.>
M]%?A[=)X3\1:*-9RVL74LYF: DJ'8$A_FRQ*@+G(X[5WE% $%G ]M:1PR2"1
ME&"P4*/H .@'0#G@#D]:Y[7/#6I:KXGTK6(-4M(8],\TPV\UFT@+NNTLQ$B\
M@9QQQDUU%% ',:=X3FMM?N_$5]J*WNM36XMHI#!LAMX@=VU(PQ/)Y)+$_2J6
MG^ GB\&ZWX?U/48[PZM+/-+<I;&,B27DL07.2#C'(Z"NTHH YN/0M:-MHL-U
MK%K.-/D5YF-DP-R50J,_O.#DAN_('TJ.W\'C3]1U[5-.NUBU'59-ZS31&1;<
M%%4A5##DE0Q.1G !Z"NHHH Y;1?!5O8^ %\(ZC*E[:>2\+ND1B+AB23C<V&R
M2<YZU WAGQ ?#$GAS^W+5K1K<VHO'M6^T"(KMYPX4OMXW<>N*["B@"II>GP:
M3I-GIUL,06L*0QY_NJ !_*LS6M$OM5_M& WEN;"^M!:FVG@+B,_/F0?,,D[A
MQC^$<UO4$X!/I0!S</A"*+5?#]R;II+;0[)[:VAD7+%RJIYC-GJ%4C&/XB<U
MDW/P_NKC0-;L#K"BXU'4_P"T8Y?L_P J,)%=59=V6P$5>HX X]>HT;7;/78[
MN2R\[;:W+VLGFQE/WB8W  ^A.,_6M*@#E(/"E^?&=MXCO-72:6.R-J\26^U0
M2X8F/+'8#@ YR>O/I3'@6^_X0O7-".M*9]5EFD:X%O@#S9"S9&[+$@[<Y P!
MQP<]C=7,=G:2W,N[RXE+ML4L<#V%0:1JEMK>D6NIV>_[-=1B6(R+M)4]#CW'
M- $UE;M:644#2"1D7&X+M'T [ = .> .3UKG]6\,WT_B^T\2:3J,%M=1VALI
MH[FV,T<D1;>",,I5@??FNGHH Y?5O#&HWVJZ)JEMK")>Z:TVXSVWF)(LJA6
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ML'@^?"[FSW57.W QCJ:IW_C+5K?P*?&7DPPVK/%);V#H2\L#R*J[FSP[!MP
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MQ:+S%D$;A]C+D<$J.]">'%_X2F#7)[MYY+>Q-G"CH/E);<\F?[S84< 8 ]Z
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M(VY(&TD9/H<XK:TG4-9N_$$2"9;G35MF-U<"#RXO.RNQ8">6&-V22PZ<@\4
M=));PS$&6&-R.A90:DKEO&6NWVD3Z%;::Z&XU#4%@,)CW,\84L^TYP#A<9/
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M'85 ).0<DX6JMIK/BC7=0\1VND75BD=C?):P7$\!VKM"F5< \MEF'MM''S9
M!WE9NO:W:^'=&N-5O5E:VMQF3REW,!TZ9]:K^+]4?1/"&K:G'-Y,MM;/)&^T
M-\X'RC!XR3@?C7#:S!>6'AKPCX7OIGOK_4[Z.:Z0C!D\O]_*I]C)MR>P)]*
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MVG,9$<[*"6"-T/"L?0@$C.*X#4O$&O3_  ANX+J8-K4M^VB?:HUVB1O/\DR
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M4=!G SCK@>@H L4BJJC"@ =< 4M% !1110 4444 %%%% !1110 4BJJ+M4
M=@*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;?O39G<>0V"WS<GYB>O-)'X3NK/Q-J6K:;K,EK#J91[NV-NLGSJNW>C'[I(
MZAA73T4 9=]K%AHRQVL\SM<&!Y(8CEI)@F 0/5B648ZDFN?T[P1YWP_CT74Y
M2E]/+]NN)H\$K=&7SB?1@&X]P*[2B@#$C\/"77H-:U.X%W>VT316JK'Y<4 ;
M[S*I).YNA))X&!CG,OAO0HO#NBQZ?',T[>9)++.ZX:61W+LQ_$UK44 8WBC0
M/^$DT;^SOM1MU\^&8MY>\-Y;A]I&1D$J.](GAV/_ (2:VUN:ZEGEMK)K2))
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MOB:&\N8;5@7:!?*:0J!_ND_\!- 'JT/B;1)UNF75+51:*&N/,D">4IZ,V[&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'X4 6J*** "BBJ+ZS81ZS%I#SXOY8VE2'8WS*,9.<8P,COWH O4444 %%%%
M!1110 45!=WEO91+)<2!%9@BC!)9CT4 <D^PINGZA::I8QWME,LUO)G:ZY&<
M$@]?0@C\* +-%%% !1110 4444 %%%% !1110 44R66."%Y9I%CB12SNYP%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH+,3_O.<\=@*P[?P'JECX>\+PVU[:-J.A3><%D5A#-N0JX)'S DLS;L'D]*
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M)=.M'O8QA+EH%,B_1L9%7*\TN/B#K7_"/:SJ5G9V$QLM3-E QWA9_P!XL8
M.2S,3WP  ><UT[>(+T?$!-!$%N+-=/:\EE+'>OSA5]@"=_'^SG/:@#I*@N;&
MTO?+^U6L,_EG<GFQAMIQC(ST."17)Z?XY:]\/PZDEHDDNHW\MKI4",09T5F"
MNQYVC",Y..%'0G&;FGZ[J<GC*]T2Z%F]M8V*7$]S$K)AY&.U,%CCA').?3I0
M!KV.M6&I7U]96LKM<6+*ERC1.FPL,@?,!G(YXSP1ZUH5R'PZ5KK0+G79 1)K
M5[-?#/41D[8A_P!^T3\ZO>+O$9\-VNGS-Y<4%S>);374REH[96#8=@"."0%Z
M@#=DGL0#H:*YN;7M0LHK*RN;>WDUF_N98K6&(D1F-"?WK'DA0@#$>K!>IS4&
MG^)KPZYXBM=0%K]@T2&-I+J)64N[(9&&"QP%7'&3US[4 ;FF:U8:P;L6,KR&
MTF-O.&B=-D@ )7Y@.<$?G5^O/_"^H2Z-X0TC= )M<\17$EXL+-@;Y2969SV5
M$*Y^@'4UIVGB/46UWQ!87)LEM='M8Y)+M8V ,CJ7(*[C@*H&1GN#D=* .MHK
MB=!U_P 6:_H^DZC!IVFPPW5L\L[RNXPY&4"KUQS@DGJ#P!C-G1O$^HZUX?\
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M9F@O=8OX=,BG7K%YA.6'O@$>V:ZC2=*L]$TJWTVPA$5M;H$11^I/J2>2>Y-
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M&2=KL,ASG).P;>, 5W]9T&N6%QKEQHT<DAOK>)9I4,+J%1B0#N(P<D'H3T-
M&)>^&-4;Q!HVK6.HVJ265M+:RI-;$IM<J<QJ&&"-H !)XZD]\Z+P#J">'O$N
MEMK"EM:NY)6G,9+B-RH(8YY/EKM&, 9Z>G6:OKEAH4,,M_)(B3S)!&4A=\NQ
M 5?E!QDD#FK27MK)>2V:7,+742J\D(<%T4YP2O4 X/Y4 5IK[2]%AM[22>"V
M'E[;>WW ,ZK@81>K8RHP!W%9'@CPW+X>T.""\D$MPOF!!CB&-I&<(/?D9/?
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M$5_&NH^(&V"X,9Q%"$"+'C/.%W<^K512WO+CXAV5G9M;3KX;TP;P^8T66?(
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M9ECM7A1CD\'GF@"MJGC&Z30M<UW3UMAINEB1$:92QO)$X8*01M7=\@/.3GC
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MB/.6$=&^?)S(648('YT >@45PVG^)/$$WB+PU8W*60CO[&6YO(UB8.@15_>
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M+(FBW44T&VSVJR1@[0R[SE^0=W3Y?N\G/5W>O6]EX@T[1I(+@W%^LC0NBJ4
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MD:Y%OC;YDA9LKN^8D':3D< <#OVU% $%E;FULXH&D\PHN"VW:/P'8=@/3UK
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MA(P/N@J !QDUNT4 <+<_#R6YT+5[!M9(GOM3.I1S"W&(W$@=0R[OGP%5>HX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5POQ3DEN_#]EX>ML&YUR^BLP"V/W8.^0D@' VJ0>#UKNJYK5_"UQJG
MBC3=<753#)IJR+;0_9PR R+M9CDY)QQVH MZ3_:DT]['JUM:00121QVD4+%U
M(50^_+*,G) Z<;*X"7QOXB?P\^J6]U!Y<VO"QL";8$W,?F[-H&?[JNV>220!
MC'/<Q^'[]M0GO;S79YY&MG@MT6%8TMRV,N .K<#DGU]34%KX)L+6'PU;I+(;
M?003#$0,2R%-@=O<98_5J *6GZ]JC^)?$L.H74":?IEG#*WEQ#_1Y&5G9=W\
M>$"DD]ST%8D?B3Q9;^"O#NNWES!]MO[RWC^Q" ?OHYGX!/56"$$8Z8YSV3QE
MI<.A:/J]D-7<W?BO4DAQ(540I*41SZD+&I&3TX'&3GM+?PZ'O[*]U"Y6Z:P3
M;9Q1Q>7%$2-N_;DDOCC). "< 9- '/3:K;0>-?$OB.]8_8/#VG): KSEV'G2
MX]\>4M+J'B+7-,T#1M<NV2.XU"^MX?[,5 5"3-C9NQN,@4YSG&0?EQ6A'X$M
M&TG7]-O;VXN;?69YII!PGE^8<\8ZD84 G/W1QUS+?:5:VGV;7/$>H?:(M'C,
MD6(2D<;8P92@W%GQD#L,G !H @AUK48?%/B+2KZ]A6&WL8;NTE$',0<R*V1G
MY\%!]>E4X/%=ZUY'HEU<!+^RLH9=3E@@\R5IG7(CBC&>>"Q." "!WR-.VT6'
M5O%Q\3[Y1;_9([:&)EVK-M=G$A!YP"WRY],_W32GPG-!XIO]:TW6)[,:BL8O
M(!"D@=D7:K*6'RG;QT(]J ,F+Q5JMJ-)T75'A@UJ[BENKAV4,8+<.0GR+PTK
M JN%XR&."!@]!X9GU:XM[V74UD$+7+?8O/C"3&# P9%  !+;B!@'&,C-5;_P
ME)+XAM-<T[5I[*]AM39RED$PGAW;@&#=PW.:Z"U@-M (VFEF;JTDIRS'\, ?
M0 "@!+VVBO+&>UGSY4\;1/@X.&&#_.O-_ <UUI&O_P#",ZU&;LHK#2-3*@"6
M&W)B*$?PLNYN>X8_CWFN:9-JEBD=M=O:W$,JSPNN"I=3D!P0<J>XZ^E5=(\.
M?89[6[O+G[5=VML;:$A-B1J<%R!DG<Q4$DGMQCG(!E:Q_P 3;XFZ#IO6'2[:
M75)AVWM^ZB_'F0_A75WMRME8W%TPRL,32$#N ,_TK'TKPY+IWB35=:FU#[3+
MJ*1(Z&$*(Q&"%"')('S$G.<DU/866HOJ&M/J-PTNGW4BK:VKJO[I FU^5[,<
MG!YQZ9Q0!YJSW%E^S]<W4H,NJ^(5+MCK--=/@ ?\ 8#Z+71>&HI+KXCZ[<7+
M[HM#LK;3+<GH"R"25O8D[!GT%;UIX1MX$T>"XN&N+31E L8&3 5E7:CN<_,R
MKP#P.2<9QA]WX7CN)=6\F[DMHM7V_;1&OSMA0AV-GY<H #P>F1@\T >8:5)<
M:[!H%FX86?B3Q)>:JZGHUO"=ZJ1Z$JI_*NWAE?4/C5<F+)@TO11#,1VEFE#@
M?]\H#6_<>';4OI,MDJ6LFE!EM $W(J,FPH5R.,8Z$<J/<'/N_#MY9:#?P:'>
M20ZQJ%PLTVHLJ%MY898@\;0HVA0#@8^M &?XL\S4_'WA'0SDVBR3:G<+_>,(
M C'TWN#^ KE_%^M7EOKGCK5M/+ Z=I5KI43K_P ]YI,Y!]5\T?3BO3+[1ENM
M5L]5AE$5]:Q20H[)O5D?:6!&1W12.>WO5+_A#]./AN[T9FE9;N4W$]PQ!DDG
M+!_,/&,[@"!C P!C H YGQ%IZZ9%\/\ PG8#YTU*"3CO%;+O=C]3C\ZJZ#JA
MM? 7C#QI=G]]?3W4L9;KY<68H8_S7'_ J[NVT-%UM]9O)1<W_D_9XF";4ACS
MDA5R<%C@DDG. . *H+X-M/L4.F23%](ANVNUL]F-S&0R!7;/S('.0,#HN2<'
M(!/X)L)M+\#:%8W(*SPV,*R*>JMM&1^'2H=3UVYD\66GAG3-JW#VYO+NY8;O
M(AW;1M'0NS9 SP "<'I725AW/A]CXB?7+&[%M=RVHM)M\7F*R!BRD#(PP)//
M(YY% '*ZCXMO[;1/'*?;6WZ$0MM>K&FZ1FB#!",;=P<[<@=QQFNJ\'Z-)X?\
M)Z;IDTK2RPPCS&8 '>>6Z=?F).>O-<S)H>F7]A9^'-&>2>W.JFYU>>4'>YB?
M<_F$@99Y%0>A ..%KT*@#C_B-/>G1;+3-.O9;2ZU6^BL0\0&[8V3(>1D817.
M1@]*R]3EEN/B3I>EVTB,=$TR2Y::1/DB>7]V'8# X17P!C.\=!DCJ-9\.#6-
M:T?43>S0'33*0D:CY_,4*>?X2!D9'/S'H>:@E\)1/%XF*WLJW.O*4DG"C,*^
M5Y:JOLHR?J30!S">)]>G^&FBW_VF+^U]6O([:W9K==KI),0I*]!^Z!;\*U_$
M6O7^G^*[/1TG%C!>V;"PN#$K1RW@)Q$Y(X&W:0!@G)YJS+X)CDC\.QKJ=RD>
MBEB@"K^\S'Y8_P!W )QCIGUYJ:Y\*-?I';W^H&XM(M1_M"-&B D5Q(9%0/G[
MH)QTSCC- '00+(MO&LSAY0H#L!C)QR:XGXEF74;71O#-L$>;6+]%D1R0#!%^
M]DR0#@?*HZ=Z[JN:U'PO=7WBJWUY-7,,MK;O;P1?9PR('(+-R?O' &?0=* .
M:MKHZA\49G\3/%;7?AVR>ZLXK8EH/)E&UY6<X)8 8V[0!U&:L:KXFUV3PO9:
MS8S):7&KW<-OIMG)$K?NY6PKOGDOLR^!@ #!!P36Q#X$L1!K;7=W=WE_K5NU
MM=WLI4.(RI4*@4!54 \ #ZYJJO@!W;0)+O7;JXET8D1MY2(&7R]@  ^Z<<[N
M3GZ#  FOZ]J=MXN71(KD6/VNQ+:7.\2M%<70+;HY"1Q@;" ,9R>>@J6Z\5^=
MK]_I-K/(JZ:B"X>WA\VXFF8;@D:8(&!@LQ!'S <<FKDGA1KLV::AJ!NH+34#
MJ,0:("02;V=1NS]T%N!C. !G&<LA\)3V7B'4M2T[6;BT@U)UENK40H_[P*%W
M(S#Y<@#/!H U/#QU5M LFUQ8UU,QYG6/& ?3CC.,9QQG..*Y'XDR/J&L>$_"
MS,5LM7OF:\P<>9%"H<QGV8D?E7?QH(XUC4L0H !9BQX]2>36-XE\,VOB6UME
MEFFMKJTF%Q:7<! D@D'0C((([$'@T ;!BC,/E; (]NW:!@8Z8KE].U2?6=8U
M+3-+D%CI.CE;1[A%5GDG"@E%W @*@(!R"23VQSIVNEZD3'_:FK"[2,@A(;80
MAR.A?YF)Y[# ]0:HGP>$CU>UMM1EM['5KA[FYCC0>8&< .$DS\H;'H2,G!'&
M #F(O'6L:AX7\)7=IY7]H:MJ#6[1K'Q-%&S[W7.=H*H#GG&[VJ"\\9>(X=+\
M:3QWMLRZ3.(+>X6UX$NQ1Y2KGG,C!<G. .G(QV\/A6PM]9TN^@'EPZ79O:6E
MJH&R,/MRP[YVJ%_$UF2> K8>&8-(74IHQ'J(U*>YV*6GD$IE.X'C&<?]\CK0
M W4M5U\>+O#VBV4\"R36DMSJ0:(,L:J%4,._+MP/;M69#XYO-*MO$"W\L=\U
MGJR:;I\S 0B>1U4['(X&PDY8#H#QFE\.^;K_ (N\2ZKIVK1)'"8]*A<H)I!'
M&NYG4EN[NW)# XZ&MK4? EA=>'K+2[.YGLI;&[6^M[M</(+@$DR/GARQ9LYZ
MYH K#6-7@N+V]ENV?1K33I)KBZDMA&AG&"/)!^8H%#9)+#E<$\UD:5XF\474
M/@@SSVZS:NY>XA^SX+PB-I'?.?E RBC'7J2<XKJ=2\,2ZSX>N]+U+5KB8W:J
MDTJ(J#8&!*JHX&X @DY//6GW?AE;GQ-9ZTE[)";2S>UBMT0;1N96W9ZC[JC
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MF:)=YE*&1\D  [5 &,#[W/-8NG^+/%4DG@M+A[=KG5XI99K7R-I9!'N#$_P
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MATF6**77?$"Q0-+%O,Z>8(D0<\*L498GGDGICGO8O")AN?$,Z:I<!]9+'(4
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M29YY#"KJHD$.X^7Y@7@/MQG%<[\6=1N[/P='9V<S02ZK>PZ<9E.#&LA.XC\
M1^-=M!#Y$"Q>9))M'+R-EF/J?\X]*S_$/A^Q\3Z+/I6HJY@EP0T;;7C8'*LI
M[$'F@"WI]A;:7I]O86<2Q6UO&(XHUZ*H&!7/_P!IR2^*W\,:,JV\5I#]JO[D
M+N,9D8E8T!XW,=S$D$ =B3Q;M-&U=8%MM0U][NW4;25MEBED'H[@D?4J%/O2
M/X;:'6M0U/3;XV<NHPQ17(\H/_JP0KIDX5@&(Y##@<>H!R5]XWU6'PCKTMO.
MC7]CK/\ 95G,80WVABR 94<;AO(..NWIVJRWB;78_%6M6$EW;):V&EQW4[&
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M1A5 P /2@#G/&VIZAHF@#5+":-!;W$'GQO'N\R-I45@#VX8\U67Q5++XQO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHKFM3URZF\76GAG3"(I6MC>WET5#&&'=M4*#P79L]<@ $X-
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M!ED5!\D:(@!R[;222" !TYXW?#+:P^E/)K61.\\C0JX42+"6_=B39\N_'7%
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M#^ZBCV!1CY\-@#HFX_>R?2:* .:TG3WO/&&I^(Y0?*,$=A8Y&,Q*2[N/9G;
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M/)9KA2V]B[1EQSY98GCKSC..*ZFB@#)A\/VD/B0ZVI;SELEL8H@ $BC#%CM
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW>2>-$.G6HRS  E5DW#ZC(SZ9H Z6U\;^&KVZLK:WU:&26^'^CX#8<XR!G&
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M -6BFLZHA=B H&23V%<YH6L:1#H4U[!K5UJ-JU[(@FG#._F,^/*0!02 3@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N*^)27<>DZ5J-O;75U!IVI1W-W#:LPE:':ZL5VD$D;@
M>#VKM:* .&T2\\-7IU'7M(@NBIM/*GU&[,X+XZ1CS>6Q[=,@<YXYN&11^S<U
MF0WVH:8T'D;3YGF$D!=O7/\ ^NO7:* /,?$=]'I^H^%?$%PE[/H264MI=2V3
MR!K9W$95V$9#8^3!]/KBJVM16L6AVGB+PUI%[)86^MPZC>964RWB*K*\H23Y
MC@L",]=I/0 GU>B@#@=6U'3O%?A#Q-=:!I\D[SZ3-$;S[(T3SML;;&NY0SXR
M?8$@#))QT7@^]AOO"6ER0B3:EK%&?,C9/F" 'A@.AXSZ@UN44 >*>,+\ZAX>
M\96?V.YM+J#45*V-K9L!,BR1_P"DR.%^8L 3U P!P2,UL>*G!U+4]:T#59K#
M5TMD\S3[N M!JL>S*IY; '><E?E^8<9 S7J=% $%K-(^GPSW48MY6B5Y8R>(
MSC)&?:O*='ATV\\"W=KJ4UW:(_B">2.ZM\I):L96>*;IPO Y/&#[5Z[10!R'
M@.YU>1=6M=3N8-1CMKE5M]5AB$8O%*+DD#@LO"DCCC':J+7#:!\5]0O=6;RM
M-U/3X8[6[DXBC>,MNB+=%)W%AGK]:[VB@#Q?4=.EL_"FI3O%(EOJ7BR.^M8"
MASY'FIE]O4 [6;IT(/>NOCFB?XUF5'#1MX?$0D7E2_GEMN>F=ISCKCFNYHH
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M@N)PQLC%&J-;%B,B0N&W@<^F>,4 =Y?7L&FV$][=,ZP0(7D9(V<A1U.%!)_
M4S3-1MM7TNUU*S8M;742S1,5P2K#(.#TX-<==ZOJ/B72O%CZ?=QVMKIC3V,:
M&(/YTD<>9"Y/1<G: N#P3DYQ6Q\/?^2<^&_^P;!_Z * )M0\9:%I4UY%>74J
M&RQ]I9;65TBRH8;F52HX(/7O4VG^*=(U2\BM+6>8S31&:)9;66+>@QEE+J 1
MR.GK61\2XHX_AIXF9$"F2T=G(_B. ,G\ /RJY'?6^C^ ;;6+B+S%T_2Q<8'7
MY8LD#ZCB@#HZ*XBUU7Q;)J6CS1VCW%C>+B]#PHBVV5RKQD/N90>"#DD>E4]
MU?QCK5K?W_\ :.EQ16%]>6KQ&R9O-$>0K??!7D#C)[\]J /0Z*\MA\6^*O\
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M:TN[));2]E@WP27#%LQR,>%  4]LY/(XKM+)I7L;=IV1IC$ID*'Y2V.<>V:
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M;'VLF-QR,'().:AL]=\67AT'4K6Q>XM+]HS>0-%&J01.N1)&^_<VW(SG.[G
M7I0!WM(3@$GM7E\_BCQ<WASQ9JL=]IT9T'4)XU06A(G2)4;:<O\ +P3SDG)[
M8YZ5?$-SK/B6#1+"46@73DU"YF"!W&\X2-<\=B22#Q@#KD &UHVO6&OPW4NG
MR2.EM<O:R[XFC*R+C<,, >,^E:5>.6&L:UX;\"^+=2M)[1KZ#Q-,DK/"=LF^
M6-"5&[Y?O9YW5U4^I^*+;QU%H)U&P>+4+&2YBE^R$&U9&4$ ;OGR&[D<\^Q
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MBBB@ HHHH **** "BBB@ HHHH ***1F"J68@*!DDG@4 +1110 4444 %%%%
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MH& !@"O/9/AQJ$.@:QX;L->BAT*_,C10RV>^6VWG+*K[P"N<GE<\]>]>AT4
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M58KF34HX$DABM?+53&I *DLQQ\QX.?K5GQCX>E\5>%[O18[Q;,76T-,T/F8
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MGFPW*KG:=A;*L,G!R?3USV=% %73K1[&QC@DN9+F49:2:3 ,C$Y)P.!R> .
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M\X'F#!(8 @Y'RBMG1M*@T/1+'2K9G:"S@2!&D.6(48!/OQ0!P4WBOQ#'X/\
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M[G='Y9Q\_/RCOW_*@#H-&OFU70=/U!E$;W=K'.5'12RAL?K7G6B:W?Z!X?\
M&>LW-]-?R6VMSVT<<RH S[HHD8D <#*C (&!VKT71-/?2-#L=-><3FT@2 2A
M-FX* H.,GG ]:YT?#^"6U\1:?=ZA+-I>M3R7+6PC56AD?:2P?DG!4$<#'?-
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MAO$N%16:5_,V8&X$848)&,_,.0.LOC#PK)XHCTSR-1%A/I]XMY%.L'F.'4'
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MMG?6&DPVVI:DVI7:;M]TT*Q&3+$CY5X& 0/PH OT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4T(@<N%4,>IQR:=10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !361'QO56P<C(SBG44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4451U;4?[-L
M]Z1^=<RL(K> '!ED/1?8<$D]@">U %ZBN8^'NLW_ (@\$V.IZFZ/>2R3B1HU
MVK\LSJ !Z84"NGH **** "BBB@ HHKD(=>OO$GBK4M(TBX%G8:25CN[P('DD
MF89\N,-E0%'WB0>> .] '7T5B6\&N6FO0QR7PO=)>"3<TL2K,DN5VY*@*5(W
M_P (P?7M:EU_2(;U;.74K5+AI!$(VE .\\A/][VZT :-%4EUG3'U5M+74+4Z
M@J[S:B5?-"^NW.<>] UC33#<3"_MC';/Y<[>:,1M_=;T/(X]Z +M%90\3:$=
M/GO_ .U[);6!_+FE:956-O[K9/!]CS4:^+?#K3M -<T\S+,L!C^T+N\QONIC
M/4^E &S16;8^(M%U1;IK#5;.Y6T.+@Q3*PB_WB#P.#S[&J.D:S86>@64M_XF
MM-0\^5HHKYFCC%PQD("J%."0?EX]* .@HK/TW7=)UB6XBTW4K2\DMF"S+!*K
MF,GIG'T/Y5$_B;0HI-DNKV49)909)U4,5.& )."0>"!T[T :M%-<&2(A)"A8
M<.N"1[C.17'_  \UC5==L=4N=4O!,UMJ4]G&J1*B[8R &.!G)Y[X]J .RHJM
M>ZA9Z=&DEY<QP*[;$WM@NW7 '<\'@>E5&\2Z$EA#?OK%BEI,_EQS-.H1GSC:
M"3USVZT :E%44UG3)-3.F)J%JU^%WFV$JF0+Z[<YQ[U-9W]IJ$3RV5U#<1HY
MC9HG#!6'53CN/2@"Q116;JT&J7/V6/3+U+,>:3<2M$)#LVGA0>,EMO/H#0!I
M45YUHE_XJUN_\4646NQ1RZ5=?9K9FLT(<[ P+_B>U6K3Q6^F>,_$EOXAUBW@
MTZTM[-X!-LC6-I!(6&>K'Y?4]* .[HJI)JEA%81WSWD M9 ICFWC:X;IM/?/
M;'6ET_4K'5;476GW<-U 6*[XG# $=0<="/2@"U15)]9TR/5$TM]0M5U!UW+:
MF51(P]0N<XI'UG3(UNV?4+519D"Y)E4>23T#<_+^- %ZBLO^UK74]/OO[*U&
M)IX%*LR89H6QD;E/0]^:YC1-=N=2^&6AZCJ/B.+3+^\6)VO)$C_>-OY0*<#+
M#CCIF@#NZ*HZCJECIR!;N^AMGD5O+WD9..I [@<9[#O7$^'_ !%=:K\/VO=0
M\4P6-R^H2PQ:@R1894G("JIPIW*,<<\YH ]$HKG[CQCI%MXM3P[+=1)=FV:=
MR[A0IW*JISU9MQ./;WK0M->TB_LY[RTU2SN+:#(FFBF5DCQUW$' H T**BM[
MF"[MH[BVF2:"10R21L&5@>A!'44Z66.")Y9I%CC12SNYP% ZDD]!0 ^BJ-AK
M.F:G++%8WT$\D(!D2-P64'H2.N#V/0TRVU_2+R\6SMM2M9;A@62-)02X'4K_
M 'L=\=* -&BL6Y\7^&[-96N==TZ)8I!#(6N4 5^NT\]?:KUWJVGV*QM=7D,0
ME!9-S#YE&,D>PR,GH,T 7**YS4/'&A:?J6CV;W]NQU0-)%*)!L6((6#ENF"0
M /7/M5N?Q9X=MIFAFUS3TD658"IN%R)#T7KUXZ4 ;%%9A\1Z(NF_VB=7L18[
M_+^TFX7R]V<;=V<9SQBIM0U?3M*4-?WL-N&!8>8X!('4X]!W/:@"[17.ZGXV
MT33-3TBREOK<MJ>YXY!*-BQA&;>6Z8)  YYS[5:L;I)_$FHI'KL-TL<48.G(
M$)M3\V6)'S?-Z'TH V**SHM?TB>^6RBU*U>Y<L$C$HRY7[P7U([@=*@N_%GA
MZQ^T?:M;T^+[,RI-ON%'ELV<*>>"=IX]J -BBF12QSPI-#(LD4BAD=#D,#R"
M#W%4+SQ!H^GW!@O-2M8)5V[EDD V;N%W?W<]L]: -*BLV\\0Z-I]Q+;WFJV4
M$T41FDCDG561,@;B">!E@/QJ6WUC3+K21JL%_;2:>5+_ &I91Y>T=3NZ<8-
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MCW]* -^BJ6DZG;:QID%[:RQR)(@)\MPX4X!*Y'<9J[0 4444 %%%% !1110
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M>UDPDHQWQPP_W:K^)I[?1_!,5YK%DDDM]J,$TQG9ECMI7D4H\A4@[8@$'OL
M[UWS*KJ590RD8((R"*22-)8VCD171A@JPR#^% 'F/A[4[/\ X6#XQ+:M#=&?
M3[619AM59 J2;BN."HR!G)[ DFL22XMA^SSX>9IHOEFLP"6'!%PN?Q SFO9_
M(AY_=)RH4_*.0.@^E)]EM]NWR(MN<XV#&: .!M]:MM*^+NMC7+J*VCN]/MCI
M<UPX2-HUW&558\9WL"1[5QC7>GGX':E''/ /*UP@*& V#[:K#CM\O/TKW&2V
MMYA&)((G$9RFY =I]1Z4?9H"@3R8]@)(78, T </=WUK9_&JSDN+B.)+G0&B
M@+-CS7^T*=J_WCCG JA>V-YH_C'4/#=I#)_9?BD_:5D086W<8%T,]MR8(/\
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MAEN;6Q:%';!D"K)N*CN!W/;O7=I&D:[4157T48%(T,;L6:-&8KMR5!./3Z4
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M??N.#_>/KRL5[I?@CQ9H%Q/%/8>&9=(DL[*:YW$02&;S/G+<IO0+C// '8X
M.QU7QWHFG66EW4=W'<Q:E=);0/$=R\MAB2.FT9X/<8K3N_$>D6*;[F^CC01K
M*S$$A$;[K,0/E!YQG&:X+Q1-HUOH?AS4=-MTL](7Q-!<O/LV1LIW;ICGHI8]
M3P>"."*C\579M]1UO6O#^LVS3K;Q_P!HZ+?KF.^C\L%2G1E8JVT8ZD8^H!ZK
M7!+XNCT3QWXEM]>UQ(=+MX+1K9;C8H1I/,+*N "WW>^3@5W%M*\]K#,\31.Z
M*S1MU0D9P?<5P5O<Z;I_Q9\32:K-;6ZSZ=:^2UT542(-^_:6Z@?+G'M0!ULG
MB;1(EL6?5+7;?X^R,) 1/G^YC[WX5<_M"T_M'^S_ #T^V>7YOD_Q;,XW?3/%
M>::5X/O+KX636]K&UK>0W\VIZ*CKM:#$I>$8/3<.,>CUU?@J[EUZR?Q/<VSV
MTNHI&L4+_>BB0$ 'ZN9&^C+Z4 ;FK:K::)I5SJ5\Y2VMHS)(54L<#T ZFN*U
M?Q?-=:?X.U?3M0-M;7^HV\-Y#A2NQXS(RLQ&1C Y!'>NJ\61O+X-UR.-2[OI
M]PJJHR23&V *\VO=6TJ]\'?#15N[:5(]1L5D#,, K P8'/H2 ?0\=: /3]*\
M0:1K<=P^F:A;W2V[;)C&^=AZ\_AW[TEGXBTC4+[[%:W\,ER8_-6,'!=/[RY^
M\ON,BO--=\V_\0_$FRTF1)+Z?2;4)%$P+2%5D#* .IVG'XBMCP]J?A#Q7K&C
M:A87%[>:K9J[)%)+)NL@R8<2#H!P%P>IQCUH ]$=2T;*KE"00&&,CWYXKC?
M_B&67P4VI:]J0=TO;B$W$H5-V)F1!A0!G@  #FNS9E12S,%51DDG  KQ?2=;
MTZQ^&]A-,EK,G_"2.HN)B6BLF,\C+.X!'  XR0#N'.* /4O^$HT06%S>MJ4"
M6]J_EW#R$IY+>C@\J>1UQUJ0^(=)%W9VAOX1<7B;[:(GYIEQG*CN,5PGA4:?
MJ_C'QYID]XU]%?Q6N7= #-&8"K,,*!MYP"!@\<GK6&6UR/PS8ZK-%+]J\#7!
M@DPO-XBMLE(/7'D;#GN2?2@#UI]<TR,W(:\C#6LBQ3+R2KMC:N.I8Y& .3D>
MM36&I6>IQR26<ZRK%(8I, @HX )4@\@X(X/K7&ZY86[>%K ZGJ<NC:A>Z@MU
M'>KM_P!'N6#,@;/!4*/+P>N!5[P)J.IWD>KP:LEI+=6MYY37]F,17G[M/GQ_
M> PK8X!&.U '475W;V-L]S=3QPPI]Z21@ .W7ZU5L]<TR_%S]FNT=K7F>,Y5
MXN,C<IP1D=,CFN7^)#SVD?AW4BK-IMCJ\,]_M&=D>"!(P_NJQ!/X'M3 (M1^
M+-IJVEW$4MI;Z1)'?7$+AHSEP8T+#C/WF]A]10!%HVM7GC&^U"33]?:QEL-5
M>**!(E>.6WC*AMP(R2V6YR,9&.G/7:]K=GX<T2[U:^9A;VT9=@HRS8'0#U-<
MK\,;VUN8O$ZP7$4C'Q!>2 (X)*EAAOH?6MGX@1O+\._$<<:,[G3I\*HR3\AH
M P]7\53-?>#KZTU,6^GWUPR7L7R^7@0LYRQ&1@CU KK=,U_2=9M)KK3M0M[B
M"!BDKH_$9 R0WIQSS7G>IZOI.H2?#9X[RVEA%V"26&W(MR,\^C$#/8\=15'6
MGEO+_P"*-OI)%Q<XL)1!"X+2JJ+YH '4E05/Y4 >I6/B#2=2O'L[2^BDN402
MF+D,4/ < ]5_VAD5;O9WM;"YN(X6F>*)G6)>KD D*/KTKAO#NH>$?$_B#3M6
MTF[O-0U*WA<;GED_T5&7YA(#QDG  .3GD< FNWU&Z-CIEW=A-Y@A>4+GKM!.
M/TH X/0=8U?Q1X-CUS1O$PN-1*![BQ%O$8X6ZM$%V[U8#(!9CDC/(-=+/XOT
MV#QC%X;:3%T]LT[,0<*=R*J].2=Q/MCWKSKQ98^'9K'_ (3'P=J2Z=XF8HT4
M%HX#W<C$?NI(.I8YY&/<YKI;B]2Q^,.ERZBR6[W6@- @[/-YZ$HOJ>^/2@#J
MQXDT8WR6?]H0^>\Q@09^5I1UC#?=+C^[G/M533_%^FZEXIU+0H)/W]B(PQ((
MWNP<E1QS@*.??VKRR[U_3;S1M#N(IHM/CMO%$+S:7&O_ !Z 7#;GF8@D,>3U
M5?FP <9KI1<,WC7X@V%M,8M3U'3[9M/0Y5Y"+=QN ] V,GL>M '=0^(]'N-1
MCL(M0@:ZD#&),X\W;][8>C8[XSBM2O*/"VH>%/$5IX=M7DOY=<TQXB-.>217
MM)4 5RR\ (!GKP1@=3BO59 QC8(0'(.TGL: ,V7Q'H\%X+674($E,OD<GY?,
M_N;ON[_]G.?:L'Q1XIBLO%&C: +XVB7GGO=3)]^-40%5!(.,EAS[>]<7:3PW
M'P/U#PU?8_X2&$36TEBY_?O=&4LC!>K;B58,/<YXK?U.YCLOB)X!MK^]A-Y#
M97:7#-(,[S%&,GZD''K0!V^B6=_8:8EMJ.I'49T9O]):(1LRY.T,!QD# )&,
MXZ5SFFZW?^+O$&KV^G7C6&D:3/\ 9&GAC1I;B<#+@%PRJBY Z$G/45V=>9>#
M;FW\#:_XA\/ZY,EDE[J4FH:?=3MLBN$D RH<\;UVC(Z\T =A;)J^GZS+]NU%
M;G1Q:EUFEC1'CD##=O90%(VG(P!T.?6K5CK^E:I<&ULKZ-YS$)E0 AFC/ =0
M1\RY_B&163XEU_3Y/"6MS0V@UBSALI#,D+9CEXP8]P]LYQG 'N*X[2M8L9OB
M/X8N4U:&[BFTB>%&MX]L*-NC/EI@$\ <@L2,<XH VM"UNYG\)^)GUGQ%]C:V
MU2[LXM1E$:&%4.U#C 4D?3FKOBKQ4FAZ?H5M%J ,NHW=O UT5&X1,"6E QC)
M"GMQNZ5QT-]9O\+/B-BY@;=J.I;<.#G<?EQ]>WK6MXGU*Q71OAXQO( #JMG(
M#Y@^Z(G!;Z D#- '4V%]%H,,W]J>(C?PSL;BT\R(>;%!@9W;!EE!_B(&,@&M
M*?Q'HEK;V=Q-JMFD-ZRK:N9EQ,6Z;>>>O:N3T_48])^*GB(ZO<1P0:C:6LFF
MW$SA8WCC5A(BL>,AF+8]#FN-FMXM-\):2EZT46GW'C1;FQBF(4+:&4X.#T7&
M6],-[T >I0>./"URL9AU_3W\S>5Q.N<)G<?8#'6BY\0Z/J?A:\O[/Q#;VMKM
M>+^T%=<0/C&?FXW#C@USWB5].C^*7@9"ULO%])C*CYFC7:WU)'![FN?DOK+_
M (1OXLHMS!AIK@JH<<EK=1D?5ACZT >F#5[&PTVP:ZU 3&>-?*DVY>XPN2P1
M1D\<G XJW8:A9ZI91WMA<QW-M*"4EB;*G!P?R((KSN37=-MI_!$<LMM:--IC
M>5JTF&V?)&&BCS\N]L#[V?NXP2:T/A+<Q2>%[RW21WD@U.[$@="K+F9B-PP,
M''..,9Z"@#L[[4;3384EO)TB5W$: \EV/15 Y8^PYJDWBG0DTF35)-6M([*-
MS%)-)(%"..J'/(;_ &>OM6'X[U:STO4/#GVQ+> 2WK!-2N?]79,(VYZ@;F!*
MC/ SDYQBO/;VZ@?X=_$ZV6XDGE_M-YLRIM9D80X<@* ,D'' SCB@#UVT\5:!
M?ZG<Z;:ZO9RWML"TT*RC<@'4_AW].]5G\=^%(WMT;Q#IV;AS'$?/4AR#@X/3
M&>,],USFJV]AJWC+P3-H36\DMDTDLLEL01%:^41AL= 6*@ ^^.AKF;+^Q[KX
M4>+].D%O+?37]\D=NH!EDG,C>3A>I.[;CZ>U '>WNHZA!\4M)TY;U_[/N=/N
M)GMBJ[0Z,@!SC=_$>]:.B7]I.=7N(_$$>I01W3;B&39:8528]R]0.N3ZUR4;
M?8?B5X.L;ZZC-[#H<L,V9!DR?NOU)5OKBN?NI)+SPQ\1DTK;=S)K@N'MX6#-
M+"ODEP .H(5Q[X(H ]7LO$&DZA<R6UK?1/.D8F,9.UC&> X!ZK_M#CWIEIXB
MTC4[A;2SU&)YY8C)$%_Y:(."Z9&' R.1D5S#^)_"GB"UNM:TNT76+FWTR;S?
M*C(=(MNXPL<<,Q& O7J>U<OIFM:?<^*?AU=0ZC#)!]FN85@MD_<VI,*!85."
MQ88 (8D\ X&<4 =%X3\=6-O97%OXE\0VXOCJMU;0FX9(V9$D*KP  !QC. ,U
MJZEJ.H6_Q.T+3X[U_P"S[NSN9)+;:NW>FS!SC=_$>^*XJS.E/\/O&ND7202:
MC<:C?JED0//DE=SY.$^\23M(/X]!6LF=.\?^ ]/O[J,WL&C3PS9D&3)LB'ZE
M6QZXH [B?Q'H]K?)9SZA#'.\@A4,<#S#T3=T#'^[G/M6I7B^CW7A^]T*X\)^
M*9;\ZW#>2"33/-D5KF0RM(CQXZAB0=V>.2>.:]H[4 <_I/B_3=8\0:GI%K)F
M6P98V)!&]BI9L<= ,<]^:N0>(]'N;V.TAU"!IY=WE#/$NW[VP]'QWVDXKSZ5
MYY-:^)ND6,NS6+R-'LXAP[C[*!N7VR,;N@)'?%1ZA<VGB/X>>%+'1Y$&KPW5
MD(K=3B6U>(@2EEZJ$4/G/]10!ZS69>^(M'TV<PWFH0PNK*KEC\L9;[H=NBYR
M,9(S6G7E&BZWHEM'XD\*^+(MU_-JD\OV.6(LU]&[[HFC 'S<!0 .FT=* /2-
M0UO3=+;;>7:1-L,A7!9@@ZL0,D*/4\5'<>(M%M8K.2?5;-$O2!:L9EQ-GIMY
MY'N*Y'2-031OB5XFCUR2*S6^@M9;!YW"HT4<95T5CQ\K$DCWS7(BUCTWPIX7
M@OC'%:3>,!<6<,^!LM2\FTX/1<'/T84 >J1>,/#]QIM_?V^J07%O8#-RT)WE
M.,C@<G/;'7M5;2_'&AW^AZ9J5Q?VUH;\1B.*:0!M[@$(,]2,CI7,23P3?$/Q
MO;V\L;S2Z)"HC1@6=PLH(P.I (_,5@SZKI-U\,OAW$UW;.L&I:;'.&884H,.
M#GCY>_IGGK0!Z?#XMT"YLXKJWU2">*9W2(PDR%V3[P"J"3COQQ5M-:TR724U
M2._MVL' *7"N"C9.  >YSQCKGCK7)^(]5TW3O&^C6K_9M.>>UG>/5'49.67,
M46?E+L<-D@], $M7":-JR:7X4\,ZE+YTNF:3KUV=2 C),&]YE1W7'&TL"1C(
MR..10!ZCJ_CG1-+\.:CK(NEG2QRLD* ^8),9"%<94GCJ.G/2M$>(=,^RP3M=
M+B<$HJ*S,0N-QP!G R,G&!D5POC"YT76_A]XQU'P_ EP;FT4W%[ AVW#)V!_
MBVJ.2.!G'KBQK=U:ZO>Z1J'A_P 40:;JT=DYM99L-:W<1*[T;/7!5>5Y'/7'
M !Z!:7=O?VD5W:3)-;S*'CD0Y5E/0@^E35@^"]0FU7P?IM[<6*6,LL1+01YV
M##$97/\ "<;A[$5O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4C*K*0P!![$4M4-5UK3=$MTGU.]
MBM8W<1H9&QN8G  '4F@"\J*BA54*HX  P!2X%8*^-?#;374*ZO;F2U4/(G.=
MI. 5X^<$\?+GFK$'B?1;G14UB'487L';8LHSR^[:% Z[MW&W&<]J -4(HQA0
M,'/3O2X'I6?8:WIVI+=&VN03:MLN$D4QO"<9^=6 *\<\CI7(ZQXI%QXU\(6^
MEZI.+:\GE$T'E%8[B,1,RNK,H+#..5)'2@#OJ1D5U*NH93U!&0:RKSQ/HUA=
M"WNKY8F,HA+LC>6LAZ(TF-JL<C@D'D5J22)%&\DCJD: LS,<!0.I)H 4 *H5
M0 !P .U(D:1YV(J[CDX&,GUK*LO$^C7]PMO;WJ^8T'VA!(C1B2+^^A8 ,O(Y
M&1S53_A//"Q$)&MVI6:;R4922N_=MP3C &> 3P>QH U=7L9-3T>\L(KN6SDN
M(6B6XB^_&2,;A[BN=A\-ZW=V8T[6[K19K ((W-KI[)+(@XQEG*ID>@/MC@C?
MU+5[&P(@N+ETGE1F1(8VED"CJX50QP,CDC'2N?\ AIJMUK/@\7EY?/?2&\N4
M6X;&7196"G@ = .@H ZYHT=E9D5F4Y4D9(^E.(R,'I7.V_B^QN?&-WX=19?.
MM84=W,3[2S%OE!QC "]>G..QJVWB?1ENX[9KY TDQ@1RK")I1QY8DQL+9!&W
M.<C% &OTIJ1I&"$15!.3@8R:KZD)3IEUY,[P2B)BLJ!2RG'4;@1^8KB_ WCS
M2KOP[X?LM4UR%];O+=2RR-\SN><$XP&.1\O7D<4 =]@48'I65J?B32-'9Q?W
M@B$8!E;8S+$#T+L 0@/JV*T3/$L!G,J"$+O\PL-NW&<Y]* '>6AD$FQ=X& V
M.<?6AHT9@S(I9>A(Y%<X/B#X2,EI&->LR;MBD!#':Y#%>O0<J0,XSCBM34]=
MT[2 ?MMP4(0R,J1M(50=78*"0O\ M'B@#0      '0"EQ6)=>,/#MF+8SZS:
M*+J(SP8DW>9&%W%ACMC\^@YKG-8\;V-YKGA_3K&_F_L[4HIYY;FVC?<R*BE
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M=1;0JM'(P+*69<XQW4XZUV6G^*-$U7[;]BU*"3[%C[1DE?+!&03G'! .#T-
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M <<C/:C:NTKM&#U&.M+10 BHJ($50J@8  P!37BCD7:\:LOH1D4^B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KAOBU)"O@9HY63+WMKA6_B G0MQ[ $GVKN:* .!NKJR;X
MU:9)YT! T.90^X<,94*C/J5W$>V:Y:UUJST_P]JTSPVTT1\8R'[1*GF)9JTF
MY;@J.H&.#TR17L]% 'AVJ_:M03XF6>D37E[>7=M92PLT15[B)4_>8PH&"NX#
M YR,9K>U3Q5H>O>(_ 5YI=PLL<=Y+O2-"6@S PV, /E.<#!]/2O4Z* /&]-N
MO#[66I^#_%L.HR:M]NG;["))\7P>9I$>,*=N#D<\8QDXKTWQ',++PCJ<K6!O
MEBLI";/);S@$.4]3GI6O10!Y!IFL64_C7P1?)?F>!]/N8OW5N4@A8K'B),#@
M+@YR21CDBLRYGM6^"7BM(Y(C+)JT[*JD;F)N0RD#J?E&1["O<J* /.(-=M-$
M^*NL3ZS<I#9ZK96O]EW<A_=.J!M\:OTR6;=CO^57?A--')X0G2,,NS4;OAHR
MN 9G(ZCT(KNJ* //6F:W^*OB&V$C07>H:1;K9,4)WLID!(P/X203Z5S8EBU/
MX(KX4"A/$<2):?V>QQ.MPLHP^WKCC?OZ8R<U[-10!5FCD&DR1,QDE\@J2!RS
M;?ZUY!;0VNM_!C1/#5B8GUY7MU6W7_6VDJR@N[KU3:N[)..N.XS[310!Y-)J
M.B:9XE\4:'XQ:^A_M*Z::UVO/Y=Y \:IL41GEAMVXQGH.U>F:/;16>B6-M!;
M/:PQ6Z)' [EFB4* %)).2!QU/2KM-DW^6WE[=^/EW=,^] 'B6GG3=2^!M_H<
M7D3ZK<W-RD-HN/->8W#;&"]>.#NZ  \X!K9NM1LO"_CB_A\6W-Y!::A9VJVE
M['),L4C1H5DC8H>NXE@#_>/KSVO@SP]<>%_#R:5<745UY<LLBRQQE,[W9R""
M3T+5T- 'E<D.C:9XJ^'5I96WV*Q@-^T,%PS%HU=/D+;SN7<3D!N1G'48K7\0
M7=I!\6/"$9FBC$5K>JPW !-RQ[0?3.TX]<5WM% 'FF@:A::._C/1_$DB17-Q
MJ-Q=1I,<&[MY5 3RP?O\#;M&<8 K(L+271?^%5:?K4B+=VWGF9)2,Q9A;8&S
MTP2JCW%>Q44 <%)-:1?&^$-)"FSP\\8R0 K>>#M]CMR<>E<=--:-\'/',<;P
MEY=4O"BJ1E]TV4P.^0,CV%>W44 >67^N:;H?CN6]U^YNH=)U33K9;&_@EE$0
M:/?NC8QGJ=^X9_K4-P=-\*:MX+U&WLY[#PG ;Q TN\BW>7[DC[LLH;YL9Z!C
MG&<5ZS10!Y_X.U"SO?B5XUEM)!+%.+%XY$4[) (2"0V,'J.>^15[XB02VNGZ
M?XEM(GDNM"NUN2D8RTD#?),@^J'/_ :[*B@#RVUTO5[+QC+ID\+M9^*(A?W>
M,;;9XV'G1\=0R-''GOUK5-S:+\<97DFA&SP\$W,P^5O/9B,]CMYQZ<UWM% '
MA^E3R6_A7PWJ29ETS2_$=S+?)&-WE1O)($E('\*[]WT.:[6 P:C\5!KVG7,,
MFFV^C&"[NXG!B=C)N1=PX) #,?0$>M=W10!X>+F#_AG&.+S4\T70!CS\V?MN
M_&.OW?F^G-=QX[633_[+\:Z9&;F;2WVSQPD$W%I)@.H]2#M8?0UW%8%YH>IZ
MAKXFN=8!T13'(NG+;*"9$.03)G)7< <8[ =,Y +GA^QEL-'B2ZQ]LE+3W1'(
M,KG<^/8$X'L!7+^+H[_1O&&C^(-*MC/+>1OI-P@&1ELO"[?[*N#D^C&N[HH
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M>1<H8W959>AD4X!&,]<#!KU"C ]* /);F\U2+PS\.M3\3>9'<PZBIO)9$(*
MQR*C/Z$@KG/<U7\7ZQ;7L'CRQ1'L+G[&&$$=L?.OQY.1(Y*D[%'RX&,8.3SB
MO8J* /,4U*VB\:>"M1D:06L^C3012&)OGD_=X4#&<G!QZ]JQ]*N?#\NEWO@[
MQ7!J,NM+>39T_P VX O2TS2(Z;3MP20<\8P2>.:]FHH SK76;"YUB\T>&8M?
M64<;SQE&PH<$K\Q&#G'8UHT44 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
=%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ex109-amendmenttoemploym002.jpg
<TEXT>
begin 644 ex109-amendmenttoemploym002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XOXB^()-%T^T
MA$NIV<%S(3<:C86AF-K&HSD\$#)VCGMNKM*Q]3\3:;I&I06%]]I22XC+QNMM
M)(C8.-NY01N]J (O" C;P]#<0Z_/KD-P3+'>S%<E3QM&T #&#QC.<YK=KB]$
M2W\$^&=8U*>TN8K&:_DO(K2&$M)%&Y50 @Y&3\V/X0W.,&NS4AE##.",\C%
M"T444 %%%% !7#Z=JMWXQ\6ZW9Q7<UIHNC2BU86[;)+F?&7RXY55Z84@D\D]
MJ[BO-M%#> ?&7B*+4XIETC6;LZA:WZ1L\:2-_K(Y" =AST)X([T =;;:9J%A
MKZ2KJ=Q-I'V613!<.&,4NY"I#GYF!7?]XG'XT1>+M%FN+.);IU6];9:S/"ZQ
M3MZ)(1M)/;GGMFJVM3R>)O#.KV&B[F-Q8S11W1!1#(RD*%)'S=>2.!]:XZ\W
M>)_ASH/A^VMYH-;AFLXY8'B97LVA9=[MD?*H"M@]\@#.: ._3Q/I,C:HJSRE
M]*V_;$^S2[HLKN'R[<MD<\9XJM+XV\/0QZ6[ZAA-5C\VS/E/^]7:6X^7@X'0
M\G@8R:Y.6[&D^,O'D%S;W9EU2W@DLA';NXF"V^QL,!@88<Y(K-TIF6U^%:R6
M]S&;1'%P);=U\K_1R@+9' +8 /0]J .TNO'VD1^&-5UNU%U<KINY9[?[-(DJ
M.!G#(R@J,$')&,5H6GB2TET>RO9Q.LETH"PBUD#N^W<=J%=Q ]<8QWK@;^":
M]_X6M#:P2R/=VZ&V58S^^Q;;3LX^;YACCO3M4U'R'\)>(Y++5)]$@LI+*[,$
M<L<D#.L1$FT88KE"I/MWXH [-_'?AR/2QJ,FH>7;_:?LC[X75HYL@%'4C*')
M'W@*B7XB>%S(D;:B\;R320HLEM*A9XUW, "OIC'KD 9)KCO$T>ES>#9+K1]*
MNHH;S5K2<M)#*9;K;(I>4HP+;0!U/7'I@G;\:WEM;^-O =W,X^S_ &FY.\#<
M # <-QVY!SV'- &[8>./#NI:5?ZE!J*K;:>2+OSHWB> _P"TC ,,]N.>U6;?
MQ1I5S<W5L)9HKFVA6XDAFMY(W\HY <*1DC((XSSQUK@-:CGCOO&OBC3=*34;
M.:TM;9(G@\V.Z=6^>0)_RT5%(Z<':0#Q5C2[V)/B>=1W:G<6EQH 07MS:R*K
MN)BQXV@(,8XP!Z9)Y -J\^*7AN+2+B^LIKB^,=F]VB0VLN'13@_,5P.2,Y/
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MUK3\-,E\LX2Q8##MO<[><8 ')R. ,XY^Z5Y/@SXKM4@G-S-JEP\4 A;S'#7
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M;F)4M9=C!^%)8J !D@'G(Z=>*PK:=(_%?BR8+J<L%[HD7DW-S;2#SB!*">5
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MYQM.<U>\77%[JD7C;3FTO44D:T'V&.SM'"WB^5_K))5'SD'*[">@ P37K5%
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MY<M\'K;PU)H^J1ZSITMK#/;+92-GRYT.]6"[6! R,'G->V44 -C<21JX# ,
M0&4J?Q!Y%<%)!=1_$S7XO(NXQJFE016MU' S1AE\P,2X&U2NX'DCVZBN_HH
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M)!YKVCA5D:96"LV, [03R>.AP>* -RS\6Z=?#4Q#'=B73$CDN87A*NJNF]<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#:HJMJ%]'INGSWLL<KQ0(7<1+N;:.20._'I6!/X^T6W\)1>*)/M?]D28(G6
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MDGL :OT %%%% !161IWB*SU37=5TB&.X2YTSRO/,L>U3Y@8KMYR>%].XK7H
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MXA$"I\Q0K[N<G@=L8H P_BVBIX/LU10JC5;3@# _UHKI/%Z+_P (=KK[1O\
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MRM:>0[/F7Y]V2RC'&WIZFJ>L^$+K7)='FN=;D6;2IQ<121VZ R2 8RP/'3L
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MO?6PM[B![<.G0@NF3\K$'ON' XK7T^P@TO3+73[4%;>UA2&(,<D*H &3WX%
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MJMFUW!&C">$=%=&RI(ZY]?PQU&FV"Z;8I;":6=AEGFF.7D8G)9B,#)/H !T
M % &%XPO(7^P:-+'/)%>R[[I8+=YC]GCP6!5 3AF*(>.CFL#X87J:=>:WX/(
MG2/3YS<Z>)X7B8VDI) VN WRMD9QW%=C:Z/-!XBO-6DOFF^TQ)"L+1 ")$+$
M!3UY+$G/7CIBJ%_X3:\\:6?B:'4I+:YM8#;>4D2E98R<E7SR>>1C&* .6UCQ
M3K(TSQA=1:@UCJ.D7GDV-EY:,)8\)L)4@LWF$L!@^F.AS<U*Z\3_ /"5>']%
MCUQK4:AI]Q)._P!EC9HY$"8(XQD;L8Z<=*PH[M;C7=2N%\77^B:C+>R$:=<Z
M6D\J8^1=A:,LP95! 4D ''/4]E9>'M1U#4M#\0:G?E-0L8)(C$MN%617QDL,
MDJQ"J< \'CF@#*_M'Q%J4FLZ58WMZ]YI"QVJW5O';()I_*5S)(LG0$L!M48P
M#R>TT>N:_?:I;Z%=13VVH0Z7'=7O]G-"3YKNR?*93C:-A/ )RP&>.;VI^!Y)
M_$LVNZ/KU]HUU=(L=ZMNB.EP%&%)5P0& XW?_7RFK^ X[N\T_4=)U:]TG5+*
M$VZW<6V0RQ$Y*R!\A_FRV3W)/- &)=ZIXTT^R\+0ZE>0VU]=:M]BN"L2.)HR
MKLKD#A3A1D*1SFK-@?$5WXK\0^&V\3W(AM8K>X@N_LT/GKY@;*?<V;<KG[N>
MV16Q>>#/M<>D ZK<&73KP7QFE17>XF (R_08P2, # P!C JS;^&Y;7Q/JFNQ
M:@?.OX8X6C:$%4$>=A'.<_,<YZ^U '*:-XUU75?#O@^-_,;4-82=IY;98U<B
M#(.T/\H+':3Z#=@="(]?U/QKH/@S7KN>[,)MKJ Z?<3)"\TD4DBHRR!?E!&X
MX('/%:H^&=LOA;2]'BU:[AN=)F::PU"(*LT18DD'LP.2",#(Q5N_\#RZKX9N
M=)U#7;NYGNWC:XO7C0.PC8,JJH 55!'H>I]: ((KK6K+XB)HESK,MU:ZAIDM
MRO[B-#;2HZKF/"_=PW1MW3J:C^$R7!\$QW%QJ%S<F6ZNLK-L."+B3+9"AB3U
M.2?;%;<GAR2;Q99>()+\^=:VK6HA6$!&5B"Q/.<Y48]/>E\,>&5\,6L]I!?W
M%Q:--)+##*% A#N78 @ MRQY.?\ $ P/%T-U+\2/!<46J7EM'*;SY(O+*JRP
MGY@&4@G#$<YXZ8YJ>PU'5?%C>)&T_5)-/.FWTFGVB1QQL#)&JDO)N4D@LV,#
M' ]>:V=>\-+K6I:3J,=_<65WIDDC120JK961=KJ0P(Y'?M59?"+66K:E>Z1J
MDMBNIX:[A$8D'F 8\R,G[KD=2<@X!Q0!-X'\0R>*_!FF:U-"(9KF,^8B] ZL
M5;'ME21[5T%4])TNTT32;73+"+RK6UC$<:YS@#U/<]R:N4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5C^(O$5MX;M;:XNK>XECN+F.V!A4':SL%4MDC R:V*XCXJ!SX5M!&P5SJM
MEM9AD ^<N"1QF@#MZ*\YN]5UKP9XOCM[W5I]8TR_T^ZNE2>-%D@D@4.=I10-
MI!Q@CC^<VFS^+=0C\.ZS:3,T-SY4FH1SRQ^0\,B@DQJHW*RY&WGGN2: /0*Q
M[KQ%;6GBBPT"2WN/M%]%)+%*%'EXC +#.<YY';O53QQK\WA[P[]HM=HNKFXA
MM('<96-Y'"[R.^ 2<=\5SVHZ=-:?%CPHKZE=W*R65\!YQ4E&"QY8$ =<CCH,
M< 4 >B5CR>(K:/Q;#X=:WN!<S6KW22E1Y952 1G.<Y8=JX&?Q-KR?"+5=975
M9AJ-GJ$L,<_EQY*+<B, C;@_*?2M_41N^,>CJ&*DZ+=#(ZC]Y'0!V]%><V6N
MZQ8Q>)= U#4IKC7(+A%TZ9TC4R13X6%@ H!VMD-P?NFN[>0Z;I+RS2R7!MH2
MSR, &DVC)/  R<=A0!;HKSK3;SQ;K&G>']>L)6Q<M%/>Q331_9VMW&65 !N5
MER,'.>.<U%J>J:[I'CG_ (1Z?79/LFL^6UA=LL0:R()+QD;,,7"D(6]^N#0!
MZ517'ZKJE]/XN7PW:O=;8=-6[D>"2-)9"SE!RPZ#82<#DL.W!S;35?$MK<^'
MO#6MW4<=_?SW6^[A*EW@A4,HZ;5=MR@X'0'')R #T*BO._%4WB3PQX2U2[&O
M&5XK^ V3^6AD6"25$*297#=6P>OO6M=7^H#XH0:.E_,EA<Z/-.8E5/DD61%#
M*2N<X8\$D>U '5QRQRJ6C=7 8J2IS@@X(^H(Q3Z\D\+:M>:%\++6\CO+B>YO
MM4:T0S,C"-I+MU+Y(Y;!)^8D9QVK:O\ 4_$GA/\ MC6;K?<:)#IS3)#=S(TJ
MW*G@*4'W&&,YZ'IQ0!U.M>(K;0KO2[>XM[ASJ5VMI$\:@JKL"1N)(QP#TSTK
M8KR_Q':WN/ -]=ZK/=23ZS;-,C!1&7:-VRH ^4#D 9Z'G)YKO/$EQ<VGAO49
M[.]M;*Y2!C'<W?\ JHC_ 'F^GXT :E%<#I&JZC)X]ET1;W4/L$^C"[CDNXT$
M@E$H0NH(R 0?NL.HZ 5SVGZ[XD_X0/PSXIGU^>:>;4(K>>W\F,12QO.8VW87
M.['0@@# X[D ];N)OL]O)-Y<DFQ2VR,99O8>]9_AW7;;Q-H%GK-G'+';W2EX
MUE # 9(YP2.WK6#9ZA>>*->\1VL.H3V-OI4JVD(@"Y,NS<TC9!R,D +TP#G.
M>&_"7_DE?A__ *]S_P"AM0!U6I7R:9IMS?212RI;QF1DB +$ 9. 2*CT75(=
M<T2QU6W1TAO($G19,;@K $ XXSS7%OJ%YXKTOQC.FH3V<.G37&GV\4(7&8HQ
MN=\@[MS$C'0 #'/-4?#6L7CZ+X.\/6@F42Z EY*T#HDC!1&@4,W0?,2<<\#M
MF@#N/$OB*V\,:6-0N[>XFA,J1'R%!*EV"@G)'&2*MRZ@\>L6]@+&Z=)HGD-T
MJ Q1E2/E8YR"<\<=J\W\5)K\/PQU&#Q#(DLT>JVPMI0REW@^TQ%/,V@#>.0<
M=<5T]_J&HP?%'2=-6^D_L^ZT^XE>WVK@.A0!@<9_B/4T ==17GMGK>JZ;J7B
MK0]1U&:ZOXC'-I3NJ*7BF^2,#:H!VR?*20>U6[B_U.X\1S>&HKF]D^PZ?#-+
M<0O%%+-)(SC<<C  V#@#&6YXH [>BO,KJ\\96:^$+'4M66VO[N^DM+QK=(W6
M1 CLK\KP^ .!\N>Q'%7HKC6&UJX\+_VE?WCZ?91RR7<;0PS2O*\F"<C&%"J.
M!R3S0!W]8^E>(K;5M:U?2XK>XBGTMXTF,R@!MZEE*X)XQCKCK7*V>L>)!?>'
M/"^M7,<.J727$U[=6I7+QQ?="\85FW#=@<8.,9&)?!=O):_$+QU#+<RW)66R
MQ)+C=@P9 . ,X'&?;GF@#O:*YGQ%<W*:UIELFH/%;RI,7M+49N;AQMV[3C"H
MN2225&2N3S7+6'BCQ#/\/=+U62&]OO*OYH=2-FB?:3 CR(&51P3D)NV\XSCU
MH ]/HKG_  =JEMK.AF]L]7;5+=YW\N:10KH/^>;C PR].1D\'O6;:ZA=^)O%
M'B/38]0N+"#23%!%]GVAFD=-YD;<#D#( '3@YSG@ Z;5=4M=&TR?4+V39;PC
M+$#)))P !W)) 'N:JZ7K;ZAJ%[8S:7?V,UJ$8FX1=DBMG!1U)4]#D9R*\RU[
M5]0\2_!Z2ZU"X>*]M-2CL[GR%4).Z74:[\$''0' P,Y[<5Z[;P/!:K"US-,X
M!_?2;=YS] !Q].U %#7=?M=!T2^U29);B&Q4M.EN SK@!CP2.Q!Z]ZOVEPMY
M9P7* A)HUD4'J 1FO(K>"9/A?\1));^ZN-MUJ46V9E;.W@,3C.<#'7'M6_97
M6K:1XF\&V[:M-<VFKVDL<UJ\:".(QPAU,>!N'<').<T >B5'-(T4+2+$\I49
M")C<?ID@?K7G%OJGBOQ)H$.O:%(\=PURS1Q2RQBV,*RE3&PP6SM7ENN[T' ]
M+H YC2O&]KKFD1ZKINE:K<V4F[9(D*?-M)!P"V>H(Z5I7'B&RMM)L=0;S&2^
M:)+6(* \KR#*J 2 #CDY/&#7G?PS_P"$C_X5%9?V3]@_Y>/+\S?YG^N?..V>
MN.W3-;7Q%M6EU'P<8KV>%#KD,82+9M4^7+\PRI^8=/3VH VH?&,4KBU?2M1@
MU)KB2WCLID17E*+O9E8ML*;2/FW=P.M:NBZJNM:7'>BSN[,LS*T%W%LD1E)!
M!'3J.H)!KC/$6GSM\4?!\8U6]4M:WH#CR\KM2,$CY,9;J<CZ8ILNH^)?$MMK
M4VA33075EJ$MI:8DB$(,3!3YBD%FW8)/H",8ZD ]%ICRQQM&KNJM(VU 3@L<
M$X'KP"?PKC+74-3\2ZYK>D_;VTV72[:V7%J5.9Y8RY<D@Y5> !T.#G/&,K4K
M35CXX\"0:AK,IO&M[Q;A[3:L9D2-<LJLI&3N(.1],4 =];Z@\^JWEB;&ZB6V
M6-A<R(!%-N!.$.<DC'/ ZU=KB]-NM5O_ !OXPT>35IU@MX+1K1ECCS;F17)Q
M\N#R!][/2J/AK6]5U?P]9Z7<ZA,GB"'47M-0E54RHB;<[8VXVLFP XZR+0!Z
M%2,2J$A2Q R%&,GVYKSR;4?$?B2+76T.:>WN;"^DL[0K)$(@T6 ?,5@2VXYS
MZ C'/)[VQ>XDT^V>[6-+EHE,RQME0^!N /<9S0!SUCXYL]2:^%GI>K3?8+A[
M:Y*6X.R1?O+@-EB,CIFM71/$&E^(K-KK2[H3I&YCD4J4>)QU5U8 J?8BN4^&
M/_'QXU_[&:[_ ))6*LL]E\7O&SZ3<VUJO]B)-/-.<0170 V-)Z?+DG\: /6*
M9'+'*"8W5PK%25.<$'!'UKS_ $C5]2;QK8:5]OOY;*^T>2=I;B-5+2JR#S8P
M0&4'<>& '3 K&\,:K>Z'\-K:YCO;F>YO]9>R0S,C>67NG4N"1RQ&3EB1G';B
M@#URBN5T6#Q);>)[@7<COH<ML&1;J9'FCG#<[2HY0KSST(XXKJJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%=8!MCQ)N38=_P O]WTQ7244 <9;?#NVLM3NI;/6=3M]+NYC//I22+Y#NW+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )9"1SP0<=<'.,50D^)'AF.WEN#=7)@@N#;3RBSEVP."%/F';\@R<9;'?TH
MZRBL?4_$VFZ5<R6TSS23Q6YNI8X(6D:.$'&]L#@<'W.#@<4]_$>EK9Z?=)<^
M<FI8^Q+$I9I\KN&T=?N\DG  ZXH U:*P[+Q?HE^M\8[IT^P;A=^="\?DE>H8
ML ,]. >^11%XMTJ2_FL':Y@NXX/M/DSVLB.\6<;D!&6YZ@<CN* -RBN4C^(W
MAF6"PN1>2BTOG\N&Z:VD6'<20%:0KM4G!X)SZXK2TKQ3I>L:E<Z=;/<)=VZ"
M5HKBVDA9HR<!U#@;ER",B@#9HK"'C#1OMMG;M-*BWSF.TG>%Q#._]U7Q@DX.
M/[W;-49OB/X:@@NYS<W3165P;>Z9+*8^0PQDO\ORK\P&3@'!QG!H ZNBN8O_
M !C#9^+]-T)+:YE%W;O<&>.!W7 V@!=HY^]DGH./7CIZ "BN%^(5S>6>H^%/
ML=]=6PO=8AM+A892HDB8,2,=NG4<UL77C31+"_N],:2[EO;*-7DMXK2663:<
MX( 4EAQR1D>IH Z*BLB/Q/I$^CV6JP77G6M]@6OEHS/,2"=JKC.>#D8XP<XP
M:ETC7M/UP70LI6,MI,8+B&1"CQ..S*?Y]#0!I4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<=\4UDF^&^M6L$,T]Q/!LBBAC9V=MPX 4$UV-% 'EQTUO
M"=[IOC#0-.DDLKFWBM=8L+>W(DVX 69$ SN4\,,<C\36EJNKF[\91P&RODL;
MC3<P75I9OYMU)O.86D"[HU7@X)7DY) Z]_10!XEH#7^CZ/\ #W6+G3=0^P:5
M'<VE^GV5]\#2 !9-F-Q48() _G6I<W)N[_XF3PV5^8K_ $J%+5S92@3,+>1<
M+E>N67CJ<^E>LT4 >82E]GPRQ;W/^BE3<8MW_<C[,4^?CY?FXYJAI?V2R&I>
M%?$?AS4[Z]:]G>WVQ2R6]\DDK2*VX'8O+<[L 8SUS7KU% '"Z:LNF_%?5EEL
M[D1WNG6BV\D<#M$?+WAP7QM7&1U([>HK9\93K%HT *2NQO[-]L43.=JW,3,<
M*#P%!/X5T-% 'FTOAG48_B%=0V4>?#6O(E]?'!PDL1&Y1_UTRF<]1N]*BTBX
MN(/%_P 1[N#39[DW$4#V44L#JEVT=NP* D8(W<?C7IU% 'D.GW4EQXC\!ZG]
MDU9Q%#<Q76;&2**VD:%0(DCV@(H((SC&!RQQQ#<1S2?"_P >VJV=V;BZU6\>
MWB^S/OE5W!1E&,D$#J/2O9** /-=4U":ZUVZL7L+Z.";1T^RRV=F^^]<ALQO
M*%R@0X^4E?O$DX.*Q(+D:=X2^'>HR6NI6][IH:')L9) H\DK(&C WD'  8=,
M$\CK[+6!K?ARXU'5+75-/UFYTV^MHGA!2-98WC8J6#(PZY5>00>* .!FCM==
M\)^*D\/W,U[KMW<Q:E/;26TEJ6".A"(K@'&V/&03DGMD"M_0=2T+6;R/4[30
M-2@NK6!_.N+^"56M@1@QJ6SN8GLN1@'/8'J],TJ6TD-S>W\M_>E-GG2(J!5S
MG:JJ  "<$]2<#G@8TZ /&((IX_@SX4LVL[P74&HVS2P?9I-\82?<Q*XR %YS
M72ZC#+?_ !2NQ;K,B7'AI[6.Y\IQ&LK2E@-V,9P<XKT*B@#RGPE-I]Y8:/H>
MI^%]2&NZ8T2R1W,4I@B:/ \]7)V 8!(QR2<#UJ(+(W@OXF0"UNO-O+Z\>V3[
M,^Z8/"BJ4&/F!(/2O6Z* /-@\MKXL\%:BUG>O;?V1+:EH[9V*2D1X5@!\OW3
MRV!P?2NRT?Q'9ZUJ&IV,$5U%/ITOE2K<0F/=DL Z9^\I*L ?:M>J\%G%;SSS
MKN::<@R2,<D@=%]@,G 'J3U)) .(^))=]3\'B*"XF^SZW#<S&&!Y!'& P+,5
M!P.14NG3JGQ7UV[>.=;9],MD28POL9E9RP#8P2 1P*[JB@#Q/0_[1T/POX%U
MMM,OI;?2)KR+4+5+=O.B69F"R;",D*.>!T:O1H?$EE%HVH>((M)O4LAM?*6;
M+<7)X!81D!B!E0"<=#V )Z:B@!J,'17 (##.",'\J=110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1144]Q#;('GD6-"
MP7<QP,G@4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$\XZ0 _S;T%:SO*R7J1'0;?2-JMX=+MS^X3F\D!Z#_GF#ZGOZ#ZUL*JHBHH
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M.34;B;7KE2K7 V6R'_EG".GXD\G\*WF=4&78*,XR3BL-$\172!%^Q:9"!@
MS.!^BBK-GHB07*W5U=7%[=*.'F;A?]U1P/YTIV;O<:;[&K1116104444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !0>E%% '&^)[C?XT\+62+EA-),WL N*[(=*Y"\A%S\4M/.>;;3Y'/_
M  )@O^-=?VH Y[QIK0T3PS=7"OMF<>7%CKN(Y/X $_A3_!>F?V1X2TZU9<2>
M4'D]V;YC^IK \8HNKWD%HC[U-W%9;.P9B'D/X(N/^!&N[0!5"CH.!B@!U%%%
M !1110 4444 (:XG3/WOQ8UAR/\ 56:+^>T_TKMB,UP_AI_,^)'BDGDJ(@/R
M_P#K"@#N:**0G SVH PM<\56FA3QPRV]S<.5\R06\>_RH\XW-Z"MBUNH;RVB
MN;>19(95#HZG(8'O6+H%N+G[;JLR O?2-LSS^Y7Y4'T(Y_&J/A+=IFL:QX>)
M_<6LBSVH/:*3G:/8$$4 =<3@5YG"]QJ?Q"TK4EFD_?/.$CW85;>/Y0<=RS9/
MY5Z%J%PMII]S<,<+%&SG\!7(>'T2;QK>38"0Z7816:\\!GP[G^0_.@#N:*IV
M6IV.HF065Y#<&,X?RG#;3[XJY0 4444 %%%% !1110 45FZ[JZ:+I<EVR&63
M(2*(=9)#PJCZFN;TW6?$5AXLM-,U\VTD6I1.\'D+CR77DH?48QS0!VU%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<=\4VD@^&^LW4$\\%Q;P[XI8)6C9#N'0J0:[&N2^)EM<W_P /M7T^QM9[
MJ[NH?+BBAC+%CN'X#\: ..\2:S8V7AO2Y?"FO2S^)Y'@%M:0:@]Q]H)(WK)&
M68;<;B20,8ZBO0YO$MO;^*+3P_-:W2W=U"TT4NU?*=5QNPV[.1D<8SWZ<UQW
MC&UNO%'@&+0K'P_?2ZFR0K%+<0^2MJZE<N7;&, '[N2>E:GC32;R#P=8:E#.
M)M;T Q7,,S'!G=0%D0_]= 2,=R10!MW7B>&UM=7N%TW4;A=+D$<B6\2R-*Q"
MG$8#9; =2<XQSZ&MM&WHKX(W '##!'UK!B^T^&/"!G-E<:C?(IGG@M "\TSM
MN?:#VW,3]!6\C%D5BI4D9VMU'L: '4455U&]73]/FNF5GV+E449+'L /<TTK
MNP&=JOB"SM99M.&^2]9,1Q*I^=CP #TSR"?05%X.LEM=!AD;<;F08F9CDY4E
M=OT&,8JIIGAV2^M!>:L9([QR9(O+;#0,3DL#_>/\@!4UKHVKV=S- -6E-I*3
M)YB0H'#GJ#]>O ]:W:BHN"9GK?F:-34]7BL (D'G7C_ZN!3R?<^@]S3;&V33
M8);R_N(S<R_-/.QPH]%&>BBJUUX4TV[T^2TD$VZ1P[S[\R,P[DGK].E5KS3K
M+3DB\T7.J7I.+:&>3?EL>G"@#N<<5*Y&K)C?-N4KZ[N+S6XKRS>2UTZ:/[++
M>LG7DD%<]!G(W'CFNEM(K#3+5887C2,<DLXRQ[DGN?>L]/#YOD\S6KB2YD;K
M CE(4]@HZ_4U8C\.:+ /ETVV ']Y ?YU4Y0:4;[$Q4D[EB;5K&&TEN/M,4B1
M#YO+8,<]A@=S4.DV<RF2_O!_IES@E?\ GDG9!]._N361'HFEZUJC3)8P)86I
M**8E">=)W.1V7M[_ $K:BTA(F&V\O2HXV-<,1_C^M1)1BK)E*[=V:%<%XBTB
MUCU@WVGV\<,NG#[9/*!DN[-D*?R)_&NTO+N'3;"2YF8B.)<G)R3[>YK(72[B
M?PS>H^#?WR-))_O$<+] ,#\*=*7*^8)JZL;-U=Q6=I)<S-MCC7<?\![UQNKV
M<5Q)%>>(;R6-KC(M;&%-Q7CIT/S<]:Z"]2\U&QA,=HT;0R),8IF WE3G;QG\
MSZ"H?['_ +:NOMFK6?E!%VP0^9ED.<EBR]#P,8-.E)0U_P"'"2;T,B'3;71M
M%@BD@C?53"7>27]X8$ZECGI@<#U-7_ T5G_8;7%L<O/(6DS]Y?0'\.?QJ[=^
M&[:73FLH&,232*;AV)=Y4!R5+$YYZ5 ]MJMKKEW<:?;P"T\F,>6_!F89^Z1T
MP,#D=J;GSQ:ON2HV:9T-%5K"]BU"RBNH<['&<'JI[@^XJS7/L:A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1QJ@)(48R: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:*%1=011T5-4N5 ^@$F!6!XKA4_%CP1%EQ%="^^T1AR%EV1 IN&<'!]:]!H
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M:Z&UG-S:0SM!+ 9$#F*4 .F1G#8)&1]:3=W<$K*QB?\ "%:-ZZG_ .#:Z_\
MCE'_  A6C>NI_P#@VNO_ (Y70T4AG/?\(5HWKJ?_ (-KK_XY1_PA6C>NI_\
M@VNO_CE=#10!SW_"%:-ZZG_X-KK_ ..4?\(5HWKJ?_@VNO\ XY70T4 <]_PA
M6C>NI_\ @VNO_CE'_"%:-ZZG_P"#:Z_^.5T-% '/?\(5HWKJ?_@VNO\ XY1_
MPA6C>NI_^#:Z_P#CE=#10!SW_"%:-ZZG_P"#:Z_^.4?\(5HWKJ?_ (-KK_XY
M70T4 <]_PA6C>NI_^#:Z_P#CE'_"%:-ZZG_X-KK_ ..5T-% '/?\(5HWKJ?_
M (-KK_XY1_PA6C>NI_\ @VNO_CE=#10!SW_"%:-ZZG_X-KK_ ..4?\(5HWKJ
M?_@VNO\ XY70T4 <]_PA6C>NI_\ @VNO_CE'_"%:-ZZG_P"#:Z_^.5T-% '/
M?\(5HWKJ?_@VNO\ XY1_PA6C>NI_^#:Z_P#CE=#10!SW_"%:-ZZG_P"#:Z_^
M.4?\(5HWKJ?_ (-KK_XY70T4 -C01QJBYVJ !DDG ]SR:=110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ.#?37D$YM89H\0(DB/M9V*AFPIZ=SCH,UW,;L\(=HG1B,[&(R/;@D?K3Z*
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M=/D2=XXXS,LOF1@_+)D=-PYQU% &A1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^U&QTR#S]0O;>TASCS+
MB58US]2:LUQOQ7 /PM\09'_+M_[,* .AM/$&BW\ZP6>KV%Q*PRL<-RCL1[ &
MM&O'_B'J)O/ 6DV<NEW>G.\EL8]8N47RK$@J?,+(S,I.,#@?>ZBNYU/Q,\6K
M?V1IS(UPEHMU).]O).@#$A!MC_O;6.<C  ZYX .GHKS]_'6LQ:'HNK7>C"PA
MN;Y;&_2Z1U:V+-M$HR!E"<=<8W"MS5O$SZ.=9NYHTDT[38$)V ^8\[=(^N.A
M0Y_Z:#TH Z2H;J[M[&UDNKN>*"WB&YY97"JH]23P*Y2V\3ZT?$=OILFE_:(+
MN!W2ZCMIX8[>51G9(SJ>#V88Y'W:SM(\2>(/%7A"75+C3=/M],N+&[#[9V:4
M.I91@8QM(![YXSQTH [NSO+?4+*&\M)EFMIT$D4B'AU(R"*GKS32/$%]X<^'
M?@BY2&W;39X+6VNYY-V;8.H"OQP5S@'IC(KMK?4+FY\27MDBPFRM(H]\F#N\
MULG9UQPNUC_OB@">_P!:TK2F1=1U.RLR_P!T7$ZQ[OIN(S3['5-/U1&?3[^U
MNU0X8V\RR!3[X)KB?BHXB_X0Z0HS[/$MH<*NYCP_ '>JNA#_ (2CXK3^)]+B
M:SL-/MGTZ\\S"2W,X.<-'U 7(Y;!...* /2Z1F5%+,P55&22< "N'\4^-=2\
M.6VJW\EI:0VMA(BPP7#XEODPI=HR#\H&['1ONG.*V)M>N;SQ)+H6DB 36ULE
MS=3W"EECWDA$"@@DG:23G@ =<\ %O_A)]#_L>;5_[5M3IT,GER70D!C#;@N-
MW3J0*UJ\AT77;SP[\+-:U4Z=:7$L6M7(F@DD.Q2UP%X^7YL%O;I7?7.NW%QX
MGE\/Z7Y"W-O:K=7$\ZEE0,Q"(%!!)."2<C  ZYX -/5-7T[1;)KS4[V"TMU.
M#),X49]!GJ?:KM>5>,/$A\1?"3Q2ES;"VU#3K@6=W"K;E$BRI\RG RI!!'_U
MJ[6ZUV>;Q.?#VF" 745H+N>>=2R1J6VHH4$$DD$]1@#OF@#H**X0_$0P^'=3
MN;JP5-5T[4%TV:W$A\LRLZJCAL9V$,&Z9ZBKJ^(=;7QK+X8-MI\CBP^W)=[W
MC&TL4VF/#9.X?WAP<]L4 ==3)9HH(FEFD2.-!EG=@ ![DUQNE^,=0O\ PC<7
MLEK;1:U#?&P>QRQ5)_,"!2>IR"&W=@<XXKLTW;%WD%\?,5&!GVH @L=0LM3M
MA<V%Y;W<!)42P2B1<CJ,@XIMYJNG:?+#%>W]K;23DB))IE0R$8SM!//4=/6O
M+?AVS>$_$=OI3DC3/$=J+VTST2Z08E0?[RX;\ *74F;4OBYX-UMB3#<7-[;V
MBYX\F*$C?_P)R[9[KLH ]<I&940N[!549))P *XK5O&=^HU=]%LA='2Y3"8#
M;32-=.JAG5&0$(1G SG)!X P3=M_$]UK.J)INEVZVUPEC%>W9OHVS!YGW(B@
M(._AL\C&.^> #3_X2?0_['EU<:K:G3HI/+>Z$@,8;<%QNZ=2!6M7D.BZ[>>'
MOA9K.J'3K2XEBUJX$T$LAV*6N0O'R_-@M[=*[ZZUJ[N?$%SH>D+;BYM+9+BX
MFN 612Y8(@4$$D[6).>!C@YX .@JEJ>KZ=HMK]JU.]@M(,A0\SA02>@'J?85
M@CQ!KK:=I$EUI,6E2W*2M?37<@>*RV< '##=O.,<C Z^E<IXI\1-XH^">J7\
ML,<4J7:6\@C8LA:.Z1=RD\X.,_C0!ZM5&^UG3--D2*^U"VMY)!E$EE"LP]0#
MR:M7$WV>VEF*EA&A? ZG S7!_")CJOA$^)[MA+JFL7$LMQ*>2 LC(D8/95"\
M#W- ';6>I6.HJS65Y;W(4 DPR!P,YQT^A_*K5<1%KUA#KOBMM*TJ9=8LK:)[
MY)]L<3%5=HR64L264GD \  XJM:^.=:3PU9^(-1TRQ2SU"WMQ9117#>;)<RL
M%"MD85.<YY( [GB@#T"BN5E\1:CI?BG3]#U1+4C58I#97<",%65!N:-T)/8Y
M!!&<8P*R7\?:@OPZF\3_ &*U\ZWO&MI(-S;6 G\G(/4>O>@#T"BN,O\ Q+XA
M?QC?>'-*TW3FEALDNXI[FX<)AF9?F 7.?EZ#/KGM6AX+\32>*=$EN+FT^QW]
MI<R6=Y;AMPCFC.& /<<@_C0!J2:WI,-^MA+JEDEXWW;=KA!(?HN<TD>O:/->
M26D6JV+W,8)>%;A"Z@=<KG(KD-5 _P"%X^'C@9_LFYY_X$*70 /^%T>,#@9^
MQ67/_ 6H ["QUG2]3DDCL-2L[MX_OK!.LA7Z@'BKU<#\,@!>>-L #_BI+K^2
M5WU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG\3>)M0&-(\+RP@#F749!%SZ!1DF@#3\8:C/8:,D=K)Y=S>3I:POC[K.>OY
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M)4_NN.H_K^-;E '.GQGH+'):]./^H;<__&Z7_A-M#_YZ7W_@MN?_ (W70T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ex109-amendmenttoemploym003.jpg
<TEXT>
begin 644 ex109-amendmenttoemploym003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKGO'9=/ FNSQ33PS06$TT4D$K1LCJC$$%2#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>rdnt-20231231_g1.jpg
<TEXT>
begin 644 rdnt-20231231_g1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@#
MP 3* P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ ^/?V'_V'_P!N3_@KK^W)\=_A1\*/V[O$'@C_ (0CQ!J%^[ZM
MX@U.6*6)]3FA6*-891MVX^F.*^P/^(3;_@J9_P!)=O\ RH:Y_P#'J/\ @TV_
MY2F?M=_]O'_I\GK]_J /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_T
MEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O
M_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH
M:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?
M_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZ
MOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_
MJ* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@
M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
MB$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-
MO^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@
MJ9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?
M])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27
M;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\
MJ&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AK
MG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\
M>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_
M?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^H
MH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /
MP!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?
M^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$
MV_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^
M"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9
M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_LV?M=3:%X*^)NB:3>W>C:]X4TW4+2PEN9[^WE*8@2X=%6U658S.,R<%PAP
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MB0,0-WE@DCX3_P"#H/\ X)AI^WQ^P+>?%OX=Z +CXC_!N*YU[0?)CS-J&F;
M=1L!CEB8HUG10"3);*BX\QJ\:_X(2?ML?$W_ (+*_LH?#[]EKXLZ?=RZ3\#;
MFTD^,^MWD@(\6QVKAO#MAR2TBRM"T]X6^^=+5&W+>,  ?J3^R;\8/BK\??@3
MH7QA^+WP'G^&NH^(;2.]M?"-_K8O;VSM9(U>/[45AC6&<Y.Z$;R@P&8-N1/2
M*^ O^#B'_@JE\1/^"77['>D:W\"4L(_B'\1/$JZ!X7U35;836^CH(FDN+]HF
M!65HU"*B,"N^968.J%&\P^$_[>GQL^"7_!6GX6?LK_#_ .//C;XZ_!?XG>!Q
M;^*O$WB'03+)X;\41"YQ=)<PVL(AAN/*@#6S9CC\XLFT +0!^IE%?C5^U]^V
M7_P4@T?X=_M<?$K]K/XI^+?V<;CP!=3_ /#+>G:%JVE6]KXM2U%S(52*2"6Y
MU1VB@@DFD#F%$N&PD/EN:]'_ &:O^"DG[6G[5G_!M=XN_;PUCXHR^'/BWX/\
M&>([D>+/#VEV:_;+S2FF,4SV\\,D $J1H)45 I)<H(P0% /U.J.]N19V<MXR
MEA%$SE0>N!FOQ#_X)O?$W_@X)_X*V_L ^"_CG\)?V^O"O@BZ\/?$VXL]=U+7
M_#$"WGBJUBECDDE9[6T:**&!'6&.U6)?M#B8RS*HC%?M_)&DL;12H&5@0RL,
M@@]J /S=^('_  7E^.?PG_X)_P!K_P %*OB?_P $Q=>T'X;:A%83Z8-0^)EB
M-2N[:]E2*VN%M5MRRQN71@7*DHP8 @@F[X._X+F?'?Q]^PAHO_!2#P=_P3-U
MW5?A=JS3/<W>F_$JRDO]-MH;^6QFNIK0VZOY22PN6*%RJ?.P"ABN3_P=4Z)H
MWAG_ ((:>-_#?AW2K>PT_3]9\-6UA8VD*QQ6\,>IVRI&B* %55   X   KJ/
M^#:#0-#\5_\ !!'X,>%O$^CVVHZ9J6F^)K74=/O8%EAN8)/$.JI)%(C AT92
M5*D8()!H _02BORQ^-O_  4:^._[5W_!??2_^"0GP;^+&L_#_P"'7@KP]<:A
M\1]<\)K!'J^NWPTP7B6T5U-%(;6",SVR-Y2K(S"8%\%-K?\ @E/_ ,%'?VD/
MV@?VU?VH/^"/OQX^.&J7WB'X7WVL'X<?%FUTRQ36O[(M]0%D3<(;<VDUU"+B
MT=9&@(<M(75\"@#]'/!?[07PG^(?QD\:? ;P9XJAU#Q)\/;;3)?%UI;_ #+I
MS:@D\EM"[#@2F. R%.JI)$3]\5VE?@'_ ,&A_@_XS_&[XE_M _&;5_VM_']A
M<:?X^T6]\5Z;"--NX_&,LG]HLQU&:\M)KG)*M\UO+"Q\QLDG:1ZE^UY^VY_P
M4L\/?L__ +4WQD_:W^+/B[]G'Q7X(\1'_AFCPUHNJ:5%:>)[.!Y#(L=N\$MS
MJA$4:23W!<P8N 46(12"@#]-?^"D/[9][_P3X_9$\3_M>GX4'QEI?@X6\VNZ
M/!K@L;C[-+/'!YD+-#(LC+)+&2C%/DWD,2 C2_\ !.#]MG0?^"B_[%W@K]LO
MPQX#O/#%CXTCOW@T._O4N);7[+J%S9'=(BJ&W-;%Q@# 8#M7YO\ QL_;3^*_
M_!0+_@T3\9_M/?'0V<GB_5O"LEEKUW86RP17DUGXCCM!<>6N%C:1(4=E4!0[
M-M"KA1]-?\&PO_*#'X%?]>WB#_U(]3H [O\ X*[?\%2]5_X)+_!?3?VB_%?[
M.I\;^#[[7K?19I=*\6K:7UM>31SR(6@DMF1H=L!&]92VY@-@'S5YKK/_  6Y
M^,'A']A;1?\ @I)XH_X)P>)+KX2:KHUOJ]WJ/A?X@:??:EIMA,X1;B:SEC@)
M4,PW;';;G<VU06'D_P#P>0_\HC=/_P"RO:-_Z2W]?&'QT_X+'Z5\ /\ @@I\
M)_\ @FU>_LS^--(\4?%OX)6FDZ-X[\6'3X?#3Z7<2-;W%]#/;W4\KE%W Q21
M121[T=U *AP#]S_V&_VX?V>_^"A_[.>C_M/_ +,_B:?4/#FKO)!)#?6_D7FG
M7<9 EM+F+)\N9"1D LI#*RLR,K'UVOSD_P""7/[+-O\ \$ ?^",7C3QE\7O&
MNG>,[_2[/5_B3XF/AF[+V,\QT^!8K.SF91YB-%9VZB4J SRLV-N*^,-'_P""
MPW[;WBK_ ()N^&_^"F7@']IG6?$OQKU+XIRSWOP%T7PT)M 'AA+V>S;3!;1V
MK2Y"Q)/]K\XW #X+GH #]MOCG^T%\)_V</#6E>*_B[XJATNUUSQ5I7AO1E?F
M2]U/4;N.UM;>).KLTD@)Q]U$=SA48CM*_GW_ .#@7Q+\3/C#_P %7?V&[W2O
MCSXZT?P]\1-4\+ZWX<\/31VB+X/N;C5;.,7-M ]N4:Z&X.S72SX==F/+'EU[
MC_P<C_M>?\% O^"4'[//P1U/]FO]O/QK=:SK.KZQIGB77/$?A[P]/-JZH1<P
MRR)'IJ11R1B;R1Y2(ICC3<K/N=@#]EZ*_(;_ (*M_P#!0+]M_P#9=_X+G?LK
M_LT?!S]I35M/^'7Q9U3PP/%_@^;1=,F@D6?6_L5PD<SVIN(UEA49Q+D,6*E<
M@#,_X+N?\%%_^"@G[$G_  5;_9S^$7[*7QOU!_#?Q*N](_MCX<W>GZ:;/4YC
MK$=JUJMS)9R7%NMPA$;LKDH6+)@\4 ?L917YQWWP=_X+*?LP_!/]K?X^?M1_
M\%%-&\3V47PSO]?^$4G@KPQ!:2^']0L;.YNV'V6ZMI(HH 4CA\LR7+2H"[.D
MG)_//P1_P4+_ ."P7QN_X(!?$7_@IMKW_!1W5]+USX:?$VVT[3M/T/P9I5O-
MJT4MYI5LXNYU@ \M#?[HXXHT!VR>:TH=!$ ?T445\\_\$GOVG_'O[9W_  3D
M^$/[3?Q3%L?$OBOPA%/KTMI (HY[N-W@EF5%X3S'B+[1PN_ P *^AJ "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_RAL_:$_[)_-_Z.BK^,*O[
M/?\ @OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^#3;_E*9^UW_ -O'_I\GK]_J_ '_
M (--O^4IG[7?_;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M!ES;6]Y;R6EW DL4J%)8I%#*ZD8((/!!'&*_&7X#_P#!)[]M_P#X(7_\%'O$
M_P"U#^P5\%F^-/P!^(-K+9^(_A[H^NVMEX@T"V:83Q>2EY)'%=FV?*Q%9"TD
M4CHZHV):_9VB@#YFA_:>_;'_ &BH+?PA\ OV,O&/PM^V,@U;Q]\:DTR"'1X"
M1YAM=.LKZYGO[L+D(DGD6X;#-*P7RW^6O^"EO_!,KX\6G_!8#X%_\%B/V:_A
MW=>.;7P>\&E_$_P5I-Y;Q:G]C1;B%=0LUN9(X[AA!=,K0[U?,$6T-O<I^GU%
M 'Y<?L7_ /!,_P"/OQ._X+J?%?\ X+1?M _#2_\  GAZXLDTSX6>$-:NK9]7
MO2NDVVE/?W$=O+(EM&8()ML3N)"UP"P0)\_!_P#!*3]@_P#X*"?LO_\ !:O]
MIK]M_P"-7[%_B'2_ 'Q73Q+<>%;N'QAX;N;DM/K$=_;1301:HQC>6*(H#DHL
MC*'95W.O[!T4 ?B'_P $5_\ @FU_P4I_8@^!/[97A#X]?L2:[::I\8O"Z_\
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MV<$L\T>EZ1;Q^:R6]SNMU2.5K.&'RT,A8Q^6/WPHH _%WX*?\$_/^"DN@?\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110
M4444 %%%% !1110 5X7X!_Y2">/_ /L1-*_]&-7NE>%^ ?\ E()X_P#^Q$TK
M_P!&-0![I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\@?\%^/^4-G[0G_9/YO_1T5?QA5_9[_P %^/\
ME#9^T)_V3^;_ -'15_&%0!^_W_!IM_RE,_:[_P"WC_T^3U^_U?@#_P &FW_*
M4S]KO_MX_P#3Y/7[_4 %%%% !1110 4444 %%%% !7A?@'_E()X__P"Q$TK_
M -&-7NE>%^ ?^4@GC_\ [$32O_1C4 >Z4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?('_!?C_E#9^T)_
MV3^;_P!'15_&%7]GO_!?C_E#9^T)_P!D_F_]'15_&%0!^_W_  :;?\I3/VN_
M^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%%% !1110 4444 %%%
M% !7A?@'_E()X_\ ^Q$TK_T8U>Z5X7X!_P"4@GC_ /[$32O_ $8U 'NE%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'R!_P7X_Y0V?M"?]D_F_]'15_&%7]GO_  7X_P"4-G[0G_9/YO\
MT=%7\85 '[_?\&FW_*4S]KO_ +>/_3Y/7[_5^ /_  :;?\I3/VN_^WC_ -/D
M]?O]0 4444 %%%% !1110 4444 %>%^ ?^4@GC__ +$32O\ T8U>Z5X7X!_Y
M2">/_P#L1-*_]&-0![I1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!\@?\%^/^4-G[0G_9/YO_ $=%7\85
M?V>_\%^/^4-G[0G_ &3^;_T=%7\85 '[_?\ !IM_RE,_:[_[>/\ T^3U^_U?
M@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%% !1110 4444 %>%^ ?^4@GC
M_P#[$32O_1C5[I7A?@'_ )2">/\ _L1-*_\ 1C4 >Z4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?('_!
M?C_E#9^T)_V3^;_T=%7\85?V>_\ !?C_ )0V?M"?]D_F_P#1T5?QA4 ?O]_P
M:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U !1110 44
M44 %%%% !1110 5X7X!_Y2">/_\ L1-*_P#1C5[I7A?@'_E()X__ .Q$TK_T
M8U 'NE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M
M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[
M_P"WC_T^3U^_U !1110 4444 %%%% !1110 5X7X!_Y2">/_ /L1-*_]&-7N
ME>%^ ?\ E()X_P#^Q$TK_P!&-0![I1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\%^/^4-G[0G_9/Y
MO_1T5?QA5_9[_P %^/\ E#9^T)_V3^;_ -'15_&%0!^_W_!IM_RE,_:[_P"W
MC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %%%% !1110 4444 %%%%
M!7A?@'_E()X__P"Q$TK_ -&-7NE>%^ ?^4@GC_\ [$32O_1C4 >Z4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?('_!?C_E#9^T)_V3^;_P!'15_&%7]GO_!?C_E#9^T)_P!D_F_]'15_
M&%0!^_W_  :;?\I3/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4
M ?!G[8/[=OQ0N_V\+S]@GP'\8K7X8W.CZ?X#UG3+LZ=#/JOBX:KXH@L+M;3[
M3F(6UK",2J(WDD:8C<B1/O\ JGX+^*OB]X0^$&L:U^U[XA\-V]_X:U+5/MWB
M;3;-M.L+G2+>1W@OY(YII?()M0CR_O"BN)-N%  ^9/\ @JO^SM^R+^WYX9N?
MAOK]Y+I7Q6^%GQ(\%VFC>-?#UV+/Q'X1_M?6-,C2]LIT.\1O%<2!=X,9FMV.
MW=$K#R_]GG7/^"J'[8_[(-AX$AU/X4?$A_AG\=M?\,^*/$_CG6+_ $2Q^)VD
M:+,D>GWRG3[*\#QO=AOM$:A8Y7L-A9XY)D< ]E_80_;_ /C5^TA^VK^TIX%^
M+_AZU\*^ ?AUX;\&ZQX#TR\M##?P:=J=MJ=P]Y?E@&26:*V@F\A@#;J1&P\Q
M9"?.H?\ @IS^T9=?\$\)/^"S$,]G_P *VC\2->Q_"<:*GGOX*75SIS7ANB?-
M_M3R@;X ,+?9BW,1;]_7G'[(WAW]OCXL_P#!5[]LWX:?%[P7\(M';Q1\-?!V
MF?$2Z\,^,M5N_P"S5FT/68M,DTWSM.B^U%G<_:!-Y'EJ,QF4\5R"W6NQ?\&I
M+?LQ)X;F7XDBP/PF/@G ^WGQ3_PD']GG3_+Z^;G,V/\ GE^\^Y\U 'V]K?[7
M/CO]H[]O*_\ V(?V:OB);^'-)\&_#&R\8>./'-KI<-]<R3ZC*5TO3K:.X!AC
M5H4DN9I'1V9#$D?EEFD7K/\ @G%^V)K?[87P=\2S?$'2;"P\=_#+XCZW\/\
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M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH
M V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH
M V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**R[/P
MEIMC=)=PW%T6C;*A[EB/Q%:E 'R!_P %^/\ E#9^T)_V3^;_ -'15_&%7]GO
M_!?C_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T^3U^_P!7X _\
M&FW_ "E,_:[_ .WC_P!/D]?O]0!YC\=/V,/V4OVE[VVU?XY_L]^#O$VHVEQ9
MR0:MK'ANUN+M4MKJ*Y2#SI(V?R6>)0\6=KH61@0Q%>@^'?#GA[P?H-GX6\):
M#9:7I>GVZ6]AING6J006T2C"QQQH J*   H  %7:* ,O3/ W@G1/%.J>.=&\
M'Z5::WKD=O'K>L6NGQQW6H) K+ L\JJ'E$:NX0,3M#L!C)K(3X#_  .C^)S?
M&R/X,^%%\9NNU_%P\.VPU-AY8BP;K9YI'E@)][[HQTXKJZ* .9^)WP6^#GQM
MTJWT+XS?";PSXNLK2<SVEGXGT&WOXH92I0R(DZ,%;:S+D#."1T-=!I^GV&DV
M$&EZ790VUK;0K%;6UO&$CBC4 *BJ.%4   #@ 5-10 4444 %>%^ ?^4@GC__
M +$32O\ T8U>Z5X7X!_Y2">/_P#L1-*_]&-0![I1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\%^/^
M4-G[0G_9/YO_ $=%7\85?V>_\%^/^4-G[0G_ &3^;_T=%7\85 '[_?\ !IM_
MRE,_:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%% !1
M110 4444 %>%^ ?^4@GC_P#[$32O_1C5[I7A?@'_ )2">/\ _L1-*_\ 1C4
M>Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?('_!?C_E#9^T)_V3^;_T=%7\85?V>_\ !?C_ )0V?M"?
M]D_F_P#1T5?QA4 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[
M>/\ T^3U^_U !1110 4444 %%%% !1110 5X7X!_Y2">/_\ L1-*_P#1C5[I
M7A?@'_E()X__ .Q$TK_T8U 'NE%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\
M1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3
MY/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 5X7X
M!_Y2">/_ /L1-*_]&-7NE>%^ ?\ E()X_P#^Q$TK_P!&-0![I1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!\@?\%^/^4-G[0G_9/YO_1T5?QA5_9[_P %^/\ E#9^T)_V3^;_ -'15_&%
M0!^_W_!IM_RE,_:[_P"WC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %
M%%% !1110 4444 %%%% !7A?@'_E()X__P"Q$TK_ -&-7NE>%^ ?^4@GC_\
M[$32O_1C4 >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>/\ _L1-*_\ 1C4 >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@'_!2+_@F[
M^SC_ ,%0/V<;_P#9Z_:%T#^]<>&?$UG$OV_P_?[<)=6[G\ \9^61<JW8CW^O
MB#_@JY^W%\8]#\4^'/\ @FA^P!<Q7?[1'Q<M7\C4P2T'@#P_DI=>(+PC/EE5
MW+ IY:09 9E2.0 _DT_;3_96\3_L4_M1>-_V8/%?C#1O$5WX*\0SZ5-KWAVY
M\ZRNWC"L=K#[LBAU$D1^:*3<C<J:Z[_@FY_P3<_:._X*@_M'6'[/7[/6@_W;
MCQ-XFO(F^P>'[#=AKJX8?B$C'S2-A5[D?U+^*_\ @WZ_8.\:?\$V;+_@G+K_
M (8EFMM/$NI6WQ$,2'7!XCE4>?K;2G)>:5P \;$HT06+[J)M]F_X)N_\$W?V
M<?\ @E_^SC8?L]?L]:!_=N/$WB:\B7[?X@O]N'NKAQ^(2,?+&N%7N2 '_!-W
M_@F[^SC_ ,$O_P!G&P_9Z_9ZT#^[<>)O$UY$OV_Q!?[</=7#C\0D8^6-<*O<
MGW^BB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\ HZ*O
MXPJ_L]_X+\?\H;/VA/\ LG\W_HZ*OXPJ /W^_P"#3;_E*9^UW_V\?^GR>OW^
MK\ ?^#3;_E*9^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ KPOP#_P I
M!/'_ /V(FE?^C&KW2O"_ /\ RD$\?_\ 8B:5_P"C&H ]THHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***XK]HO\ :%^$?[*/P1\2_M$?'?Q?;Z%X3\)Z8]]K&I7!^ZBX
M"HB]9)7<K&D:Y9W=5 )(% 'E7_!3+_@H1X-_X)W_ +/H\?R>'9O%/COQ/J,>
MA?"OX>:=E[WQ1KLY"P6L:+EO+#,K2.!\J\#+NBMQW_!*+_@GOXR_94\+>(_V
MD?VK?$4/BO\ :,^,5TFK_%?Q9PZVAP#!HUF1D1V=JNV,*GRLR9'R+$J>5?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^#?@^ST#PMX7TN+3M#T>Q3;';6\:X5>>68\EF8EF8EF)))(!TBJJJ%50 !@
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M$)Y?^"STWBN]7X^&1_B-%KIU&8PQV*ZT0OA\1;MHTLZ:/LQM<;"Y,^/._>4
M?KI17P!\,?C/I/\ P4H_X*B^-?@]XUM9[WX5?"7X*^&=5M?!UQ<NMK?ZYXBB
M^W)?7*(5$[P62QQ0A\B)Y)9%PY5E[[_@CA^T'X^^*GPU^+WP%^)OBF^U[4_@
M+\>O$GP\L/$&K7+3WNJ:39S)+I\]S*Q+2S"WG2%I&)9S!O8LS,Q /L&BBB@
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M%^ ;^XUG5KFYDU7QSXSU++7_ (HUN?#76H7+L2S,[<*I9MB*JY8@L?=ZS?\
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M_P#1T5?QA4 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\
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M_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ*
M(?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_
M +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L
M[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA
M_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?
M[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[
M]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3
M_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?
M^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.
MT_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"
MIJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^
M?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_
M0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* /.?VJM
M.^/W_#./C3_AD.Q\,_\ "S?^$?N/^$*_X2F(_8/M^W]WYNW\=N?EW;=WR[J_
MB(_:H3]HR/\ :,\9I^URFOK\3!X@N/\ A-!XG#"^%]N^?S<_AMV_)MV[?EVU
M_<%^TI^TS\"OV0/@UK/Q_P#VC_B1IWA7PGH4'F7^J:C)@%C]V*-!EYI7/RI$
M@9W8@*":_%3]MK_@E;^UK_P<<W6N_P#!07P]\']!^!>DZ;X6-I\%-&\4Z44\
M1_$&%7#QW>L2*X6RA>,,MME7*B09W18E< _GIKO_ -E=/VC)/VC/!B?LC)K[
M?$P^(+?_ (0L>& QOC?;OD\O'X[MWR;=V[Y=U+_PRI^T=_PT=_PR%_PI?Q!_
MPLW_ (2#^Q/^$*^P-]O^W[MOD^7_ ./;L[=OSYV_-7] 7['7_!M+^U5_P3B^
M!_A3]L?]D_X[6+?M8>&_.O\ 5O"^KK%+X8UNPFC43>'2Q ='*J0+P.H,C$?N
MUV2Q@'ZZ?LJZ=\?O^&<?!?\ PUY8^&?^%F_\(_;_ /":_P#"+1'[!]OV_O/*
MW?ANQ\N[=M^7;7H']G:?_P ^,/\ WZ%?.'_!.3_@II\)_P#@H)X3U;1%\.:A
MX$^*O@F?[#\3_A%XG'E:MX:O0=K95@IFMF;_ %=PJA6! (1LH/I6@"'^SM/_
M .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B
M@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA
M_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/
M[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\
M8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"
M'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?
M^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.
MT_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&
M'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*YGXS?%/X1_L]?
M"GQ!\;_C+XBT[0/"WA?2Y=0US5[Y0([:"-<L>!EF/"JB@LS%54$D ]6S*BEW
M8  9))X K\P/$5Q=_P#!P)^V'+X"TJ>63]C/X&>*%_X2*\A8B#XM>*[=@RVB
M,.)=+M&P7(RLK$$;@\;P@&[_ ,$[_@A\0O\ @IG^TS;?\%EOVPO L^D^%M/@
MEM?V5OA;JT( T32)#AO$5U%RIOKL -&>=D>UE+ 0.GZ._P!G:?\ \^,/_?H4
MZUM;6QM8[*RMHX888PD,,2!510,!0!P !P *DH A_L[3_P#GQA_[]"C^SM/_
M .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[
M]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3
M_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*F
MHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\
M8?\ OT*FHH B2QLHV#QV<2L.A6, BI:** /D#_@OQ_RAL_:$_P"R?S?^CHJ_
MC"K^SW_@OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^#3;_ )2F?M=_]O'_ *?)Z_?Z
MOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "BBB@ HHHH **** "O"_ /_*03
MQ_\ ]B)I7_HQJ]TKPOP#_P I!/'_ /V(FE?^C&H ]THHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ!('25&&5=6'#*0001P0: ):*** "BBB@ HHHH **** "BBB@ HHHH ****
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M5&RKQ. Z,"K $8H [>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGK]_J "BBB@ HHHH **** "BBB@ KPOP#_RD$\?_ /8B:5_Z,:O=*\+\ _\
M*03Q_P#]B)I7_HQJ /=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7BO][JVOW)(9D5F+&VM58#9;H< (FXNRAJ^FZ "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZQ06=M$@2.&-% "(J*%"C@  5H4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_
M -'15_&%7]GO_!?C_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T
M^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444
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MSXD_';Q:OC/X\_%;4!KOQD\?2X9KR_8$I8VYP-EG;*QBB0!5X9@J!E1/JN@
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M^CZM9R6FJ:7J=JD]O=V\BE9(I8W!5T92058$$$@U^9?BGX9_M"_\&^?BV_\
MBS^SGH&O_$K]C34KZ2]\9_#"WD>\UGX5-(Y:;4-*+DM<::"2\MNQS&,N2/GE
M(!^H=%<G\#/CK\(/VE_A/HGQR^ WQ T[Q1X3\16:W6CZWI4V^*>,\$'H4=6!
M5XV =&5E8!@0.LH **** "BBB@ HHHH ***K:QK&D^'M(NM?U_5+>QL+&V>X
MO;V\G6**WA12SR.[$!%5026)  !)H X3]J_]J;X+_L5_L^^)_P!IK]H'Q4FD
M>%O"NG-=7\YP99WR%CMX4)'F32R%8T0'YF<#CJ/D+_@EU^RS\:/VCOC9??\
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M^;_T=%7\85?V>_\ !?C_ )0V?M"?]D_F_P#1T5?QA4 ?O]_P:;?\I3/VN_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBOP!_X.1?^#D7']O?\$]/^">GCW_GKI_Q+^)FCW/U672]/E4_59KA
M3ZQH?O-0!^WWP'_:J_9Q_:@_X27_ (9Z^-'A_P 8?\(?X@ET3Q-_86H+/_9]
M_']^%\?CAAE6P=I.#CT"OX@_^";G_!2/]H[_ ()??M'6'[0O[/6O?W;?Q-X9
MO)6^P>(+#=EK6X4?B4D'S1MAE[@_U^_\$W?^"D7[./\ P5 _9QL/VA?V>M?_
M +MOXF\,WDJ_;_#]_MR]K<(/Q*2#Y9%PR]P #W^BBB@ HHHH **** "BBB@
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M//G*G*V9 5 VUU4&5)?TFL+"PTJP@TO2[*&VM;:%8K:VMXPD<4:@!451PJ@
M  < "@#G?@M\%/A-^SI\+M&^"OP-^'^F>%_"OAZS6UT?0](MA%!;QCG@=69B
M2S.Q+.S,S$L23U%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X!_P
M5'_;G_X=K_L)^.?VUO\ A5W_  FG_"%_V9_Q3/\ ;?\ 9WVS[9JEI8?\?'D3
M^7L^U>9_JVW;-O&[</R _P"(YS_K%U_YFS_[RU]__P#!T=_R@H^.?_<L_P#J
M3Z37\@5 '[_?\1SG_6+K_P S9_\ >6C_ (CG/^L77_F;/_O+7X T4 ?V^_\
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M110!Z;\-_ASX$^$'@#1OA7\,/"MEH?AWP[ID.GZ)H^G0B."SM8D"1Q(HZ *
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MM7Z+T4 ?G/\ \1%/[->E_P#(_? O]H7PIC[Q\1? 34H]OU\LOZJ?^!"GP?\
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M5S1_PZH_X*AZ#_R(/_!P#\4+;'W?^$B^%FB:M^?F%<]6_-?[M 'W/]B\;_\
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M&MM6TZ4KY]I(<;D#A5(D7#(RJPS@@_VD?LJ_'C_AJ#]G'P7^T+_PK;Q!X/\
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MKP_HMA'YE]J^MZC%:6MLG]Z265E1![DB@!GV+QO_ -!NR_\  8_XT?8O&_\
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M7'PL_:#\ *9OAQ\6M$CQ-"1D_8+] ,7EC)N96B<-M$C[05>2.0 ^E_L7C?\
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M10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\
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M/_X3#Q!+K?B;^PM/6#^T+^3[\SX_'"C"KD[0,G/H%%% !1110 4444 %%%%
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M[_9,_:8^"%@/A!I4"Z;HGQ9\,ZA<7TFD2RR!'AGM'_>Q0.1"591Y:O N2",
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MP]^S_P#!+]L:XTGPEX4T\6.@:7<^"="OVM+922L0GN[&69U7.%#.=JA57"J
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MD\2ZHT2BQM5DF3S R[&D5$.0=V.: /V-J.[N[6PM9;Z^N8X8(8VDFFE<*D:
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MA3AT;#(K##*I'U?0 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?\
M9/YO_1T5?QA5_9[_ ,%^/^4-G[0G_9/YO_1T5?QA4 ?O]_P:;?\ *4S]KO\
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M?%?4)O#/_!.O]E'XT_M)ZDDAB74O G@>XLM!BE!P5N-2OUC6%<\;Q&RGL>E
M'Z!5#J&H6&DV,VJ:K?0VUM;QF2XN+B4)'$@&2S,>% '))K\_#)_P<<_M;?ZN
MW^"7[)GAVY/61F\;^*;8'Z;=.? _W3GVZ3:?_P &]WP3^+E]#XC_ ."C/[7/
MQJ_:2U!9!*^E>-?&T^G^'XY <AH-,L&C6$9YV^8RGCCKD ]#_:&_X+R_\$K?
MV=-:_P"$,U3]JG2?&/BAY#%:>$OAC;R^)-0N)A_RQ"V"R1QR<'Y9'2O-O^'F
M'_!6/]J3_1_V#?\ @D!K?A72;@_Z-X\_::\01^'H8@?NNVD0%KR5#][*/T'N
M*^P/V>?V.?V4?V3-%_L#]F;]G/P7X%MS$(YCX8\.V]I+<#UEE1!),>!\SLQ.
M.M>DT ?GM_P[-_X*O_M2?Z1^WI_P6 UWPQI-Q_Q\^ _V9M C\.P1 _>1=7G#
M7DJ'[N'3IWY->E?L\?\ !!S_ ()6_LY:S_PF>D?LJ:3XP\4/();OQ;\3;B7Q
M'J%Q/_SV+7[21QR<#YHD2OK^B@"&PL+#2K&'3-+LH;:VMXQ'!;V\81(T P%5
M1P !P *FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#^0+_B%Q_X+K_]&,_^9-\,?_+.C_B%Q_X+
MK_\ 1C/_ )DWPQ_\LZ_K]HH _D"_XA<?^"Z__1C/_F3?#'_RSK]?_P#@U*_X
M)<?MV?\ !-?_ (7U_P -K? S_A"_^$T_X1;_ (1G_BIM+U'[9]C_ +7^T?\
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MQP^$7[-_PNUCXU_';XAZ7X5\*:!:&YU?7-8N1%# @X SU9V)"JB@L[,%4%B
M0#J)IH;>%[BXE6.-%+.[M@*!R22>@K\YOCA_P45_:4_X*0?%/6?V*O\ @C#J
M5M;Z1I-T;#XI_M2WUKY^B>&1_P M+31Q]W4M0*GAU)C3*D'#">/F#)^U[_P<
M%7FR ^*/@=^Q>TOS2?-9>*_B["#V_BT_27'_  *9#_'O_<?HM\#_ (%_!_\
M9J^%FC_!+X#?#O2_"OA30+46^DZ)I%L(X8$ZD^KNQ)9I&)=V8LQ+$D@'F/[
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MLO\ [0_Q\D=MMM>?#/X07IL6.<;I)[WR/+3_ &RIQGI0!^@5%?GW_P -O?\
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M7IFB:?%I.C:=!:6MN@2"VM85CCC4=E50 !["IZ /S\_X9_\ ^#C;X\<_$_\
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M  M/_A=__"::A_PEW_"0?VY_PD7V@_:O[2\_[1]JW]?-\[]YN_O<T ?N]_Q
MQ_\ 647_ ,PG_P#?JOU__P""7'[#'_#M?]A/P-^Q3_PM'_A-/^$+_M/_ (J;
M^Q/[.^V?;-4N[_\ X]_/G\O9]J\O_6-NV;N-VT?&W[*__!RKH7[3O[/'@^Z^
M G["GQK^,/Q6N-!MX_&FB^ ?!QCT72=76,"=)]3G80P1,_SHP#X21 V&R*[_
M /M'_@XX_:W_ ./'0_@G^R9X=N1_K+Z=O&_BFV!Z$*FW3GP.H;!SCWP ?H)>
MWMGIMG+J&HW<5O;P1F2>>>0(D: 9+,QX  Y)-?)'[1/_  7=_P""5O[-NL?\
M(=X@_:PT7Q5XG>0PVOA+X;12^(]0GG_YX!+!94CD_P!F5TKS>R_X-\OA'\8[
MR+Q!_P %'_VR?C9^TA>B199=%\7>,YM+\.I(#D-#IFGM&(1GDKYK*< 8ZY^M
M_P!G;]B_]DG]D?1_[#_9D_9N\%>!83'LFD\->';>UGN!_P!-9D7S)CP.79CP
M.: /D/\ X>=_\%4_VH_]'_8'_P""/GB/P]I5P/\ 1O'G[2VNQ>&[>('[KG2H
MB]W,AZAHWZ=N10?^":__  5N_:E/VC]NW_@KWJO@_2+@_P"D^!/V8_#R:!%$
M#]Y4UBY#7CJ>F'0\?4U^A-% 'QY^S[_P05_X)7?L]:Y_PF]I^RWIOC;Q5)()
M;OQ=\4KN7Q)?W,P_Y;,;]I(DDX'S1QI@\]:^O--TS3=&T^'2='T^"TM;:(1V
M]M;1"..) ,!550 H Z 5/10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_H_["/\ P17^(XL)^(/%_P ?M=M?!]M$O:;[$YDN+B,]0(V#$'..U'_#(O\
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M?\#_ !L^.5RC%%M_A)\&]4O3(X.-JFZ2W4\\9!Q[TS_AZ3_P53^+AV?LQ?\
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M_''_  <B_P#!&;P7J']AV?[8UMXEU-B5@TWP;X4U;5I)V]$:VM6C/XN*P_\
MA_YX<\<_N?V;/^"77[7/Q%\S_4:GIWP>>QTQO3==74R[,]LIZU]R^!_AC\-?
MACI_]D_#;X>:'X>M=H'V;0])AM(\#H-L2J*W* /S^_X>%?\ !;;XF_)\&/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_
M -'15_&%7]GO_!?C_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T
M^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444
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MI5OJ-R=.N3#-/=6ME#+%!;2!+N7;+'NCM74NH8D?M_\ L#_\$HKKX0?%*?\
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M?\#_ !L^.5RC%%M_A)\&]4O3(X.-JFZ2W4\\9!Q[TS_AZ3_P53^+AV?LQ?\
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MOQ-\KPOXW\Z7;#;>;(/L=^V>!Y%P5W.?NPRS^M?U^T4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U
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M16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M^0/^"_'_ "AL_:$_[)_-_P"CHJ_C"K^SW_@OQ_RAL_:$_P"R?S?^CHJ_C"H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y _X+\?\ *&S]H3_L
MG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_-_Z.BK^,*@#]_O\ @TV_Y2F?M=_]
MO'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH
M*\+\ _\ *03Q_P#]B)I7_HQJ]TKPOP#_ ,I!/'__ &(FE?\ HQJ /=**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /D#_@OQ_RAL_:$_[)_-_Z.BK^,*O[/?\ @OQ_RAL_:$_[)_-_Z.BK
M^,*@#]_O^#3;_E*9^UW_ -O'_I\GK]_J_ '_ (--O^4IG[7?_;Q_Z?)Z_?Z@
M HHHH **** "BBB@ HHHH *\+\ _\I!/'_\ V(FE?^C&KW2O"_ /_*03Q_\
M]B)I7_HQJ /=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\ HZ*OXPJ_L]_X
M+\?\H;/VA/\ LG\W_HZ*OXPJ /W^_P"#3;_E*9^UW_V\?^GR>OW^K\ ?^#3;
M_E*9^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ KPOP#_P I!/'_ /V(
MFE?^C&KW2O"_ /\ RD$\?_\ 8B:5_P"C&H ]THHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0/^"_'_*&
MS]H3_LG\W_HZ*OXPJ_L]_P""_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O^4IG[
M7?\ V\?^GR>OW^K\ ?\ @TV_Y2F?M=_]O'_I\GK]_J "BBB@ HHHH **** "
MBBB@ KPOP#_RD$\?_P#8B:5_Z,:O=*\+\ _\I!/'_P#V(FE?^C&H ]THHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1?\ P O/_C- 'T917SB__!7#_@G-&A=OVH]'P/[NGWI/Y""E'_!6_P#X)SD
MC]J/1N?6PO/_ (S0!]&T5\Y_\/;O^"='_1TFB_\ @!>?_&:/^'MW_!.C_HZ3
M1?\ P O/_C- 'T917SG_ ,/;O^"='_1TFB_^ %Y_\9H_X>W?\$Z/^CI-%_\
M "\_^,T ?1E%?.?_  ]N_P""='_1TFB_^ %Y_P#&:/\ A[=_P3H_Z.DT7_P
MO/\ XS0!]&45\Y_\/;O^"='_ $=)HO\ X 7G_P 9H_X>W?\ !.C_ *.DT7_P
M O/_ (S0!]&45\Y_\/;O^"='_1TFB_\ @!>?_&:/^'MW_!.C_HZ31?\ P O/
M_C- 'T917SG_ ,/;O^"='_1TFB_^ %Y_\9H_X>W?\$Z/^CI-%_\  "\_^,T
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M_P#C-'_#V[_@G1_T=)HO_@!>?_&: /HRBOG/_A[=_P $Z/\ HZ31?_ "\_\
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M ,9H ^C**^<_^'MW_!.C_HZ31?\ P O/_C-'_#V[_@G1_P!'2:+_ . %Y_\
M&: /HRBOG/\ X>W?\$Z/^CI-%_\  "\_^,T?\/;O^"='_1TFB_\ @!>?_&:
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M*N3W. * ./\ ^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\
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M>(?@EX1OYT\:ZO$DU[X;M976-;@A4!:,D*!P!T%>U?\ #+_[-/\ T;QX%_\
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M_P"S3_T;QX%_\)*S_P#C5=S10!PW_#+_ .S3_P!&\>!?_"2L_P#XU1_PR_\
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M_P#C5=S10!PW_#+_ .S3_P!&\>!?_"2L_P#XU1_PR_\ LT_]&\>!?_"2L_\
MXU7<T4 <-_PR_P#LT_\ 1O'@7_PDK/\ ^-4?\,O_ +-/_1O'@7_PDK/_ .-5
MW-% '#?\,O\ [-/_ $;QX%_\)*S_ /C5'_#+_P"S3_T;QX%_\)*S_P#C5=S1
M0!\N?M/_ +/_ ,!M'^,/P:L=)^"7A&U@O_&LL5]#;>&[5$N(_L['9(%C =<\
MX.17M7_#+_[-/_1O'@7_ ,)*S_\ C5:OC?X4^$?B#XB\.>*/$<,[7?A;4FOM
M),,Y15F*%"6'\0P>E=)0!PW_  R_^S3_ -&\>!?_  DK/_XU1_PR_P#LT_\
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M /C5=S10!PW_  R_^S3_ -&\>!?_  DK/_XU1_PR_P#LT_\ 1O'@7_PDK/\
M^-5W-% '#?\ #+_[-/\ T;QX%_\ "2L__C5>7_MH?L[_ +/^@?LL>-]9T+X&
M>#K*\M]$=[>ZM/#%I')$VY>598P5/N*^B:Q/B1\/O#GQ5\"ZG\._%T4KZ;JU
ML8+Q8)2CE"0>&'0\4 <-\-OV9_V<+OX=Z!=77[/W@B6671;5Y))/"EFS.QA4
MDDF/))/>MO\ X9?_ &:?^C>/ O\ X25G_P#&J[#1M*M-!T>TT/3U8065M'!
M';)"(H5<GN< 59H X;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_
M (25G_\ &J[FB@#AO^&7_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\
MA)6?_P :KN:* .&_X9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$
ME9__ !JNYHH X;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25
MG_\ &J[FB@#AO^&7_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\ A)6?
M_P :KN:* .&_X9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__
M !JNYHH X;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\
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M_P )*S_^-5W-% '#?\,O_LT_]&\>!?\ PDK/_P"-4?\ #+_[-/\ T;QX%_\
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M!^H?$OQW?K9V-C"BS31V[2SSLSA(;>*- 7GFDE=8XX4#/))(J(I9@" >0?\
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M10 4444 %%%% !1110 4444 %%%% %37=3DT71[G5H=)N[][>%G2RL45IIV
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MEN]5U.\G>XN[VX< !I9979CM"HHPB*B*J+V=% !1110 4444 %%%% !1110
M4444 %%%% !7FG[7G[+O@[]L[]GWQ'^S3\1_%WB#2/#?BVP:QU]O#<UM%<W-
MJ_WX?,G@F"*W<J WHPYKTNB@#QCXO?L6Z%\9_P!DE?V._$7QU^(>GZ%)ID&F
MW^OZ!JEG9ZO?6,:[?LTDT=IY8C= J2;(T+J"K$JSAO/_ (3_ /!*SPU\*_B%
MH_Q$N_VW/VB_&#^'HYCHVA>.OB>=1TBWN&MY(8[EK(P+%+)#YA>+>&5)%1@,
MJ,?4]% 'F>H_LO\ AK_AE2V_9*\$_$3QAX/TJP\+6NA:7XF\(ZV+36["*WCC
M2.>&Z*,!/B,%G*,&+-N!#$5G_"3]D;2?A_XJT7XA_$KXT^-OBGXG\-:9/I_A
MOQ%\09=.,^F03[1.8HM-LK.W\Z1416N'B:<H"GF;6<-ZY10!XK^TC^Q!X+_:
M:^,'PV^-7BKXK>,]&U3X4ZW+J_A"V\/S:>EM%>RP/;R2RK<6<S2[H7>/:6V@
M,2 &YKT#3?A+H.G_ !HU7XY2:C>7&JZIX:L=#2"=D,%G;6T]U.3" H97E>Z_
M>DDAA;P# V<]510!XS^UU^Q-X'_;*N? <_C_ .)GB_1$^''CS3O&7AN#PQ/8
MQ*-9L3(;6XE-Q:3-($\UQY61&V?F4X%=Y\1_ASXB\?>%XO#&E_&;Q1X8/E&.
M[U/PXM@MY<@@*<O<6LJQ$C=\T2HP+95EP,=510!Q_P "O@'\)/V:?AQ:?"?X
M*>#8-$T2TFEG,*2R32W-Q*YDFN;B>5FEN;B5V9Y)I6:21F+,Q)S78444 %%%
M% !1110 4444 %%%% !1110 4444 0:I9W&H:;/8VFJW%C+-"R1WMJL9E@8C
M =1(CH6'4;E8>H/2O&OV2/V'/!?[&'PF\0_![X4?%GQK=Z=X@UO4M9-WKMQI
M\US8:A?RO-<W$#1V<:Y::1I LBR(K8 7;E3[910!\4:3_P $1/A_HNBW/AC3
MO^"A?[6,&E7]]<7>IZ;:_&AK>*]EN)6EN&E,-LC,97=R[;@S%R<Y.:^I_A3\
M%/"/P@U#Q1J?AAYVE\6:\FJ7_G! L)CLK6Q@MX515"0Q6]G BKZAF))8D]A1
M0!\]>%O^">FE6=G=>$OBS^UA\8/B?X/N=?&KCP/\1-<TV\L4F2X%Q%"T\-A#
M>W%M'($*VUQ<RQ$1JKHZY![?]L/]E;P7^VM^SWXB_9F^)?B[Q!I/AKQ79FSU
M_P#X1J>VBN+JV)!:'S)X)MBG R4"MZ,*].HH \ZB_9PT&70?ASX>\0>.->UB
M'X;:LFHZ=+J36H?4IH[*YM(/M8A@C1Q&MSYJ[%3][#"YR5YX;]L#_@G[X=_;
M(\;>%?''B+]IOXP>")O!JS/H=I\-O%T.E0QW,JO&]VW^C2.\YB=H@Q?"QLZJ
M%\R0O[]10!X)^S[_ ,$]/AA\#] \;>'O&/Q<^)?Q;C^(&F+I?B"7XS>,7U]O
M[."3(UC"'15AMW%Q*7C5<.6&[.T8?\)?^">_PD^%OBKP+XGU+QUXP\8)\*M*
MGT[X6:9XOU"VGM_"D$L(MF^SF&WBEN)1;*MNL]V]Q,L6\"0&64O[Q10 4444
M %%%% !1110 4444 %%%% !1110 5!JEG<:AIL]C::K<6,LT+)'>VJQF6!B,
M!U$B.A8=1N5AZ@]*GHH \3_9(_8<\%_L8?";Q#\'OA1\6?&MWIWB#6]2UDW>
MNW&GS7-AJ%_*\US<0-'9QKEII&D"R+(BM@!=N5/BFD_\$1/A_HNBW/AC3O\
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MOB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X@?\
MA16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X45C_A
M0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\ A0!^
MWU%?B#_Q&\_LL_\ 1CWQ _\ "BL?\*/^(WG]EG_HQ[X@?^%%8_X4 ?M]17X@
M_P#$;S^RS_T8]\0/_"BL?\*/^(WG]EG_ *,>^('_ (45C_A0!^WU%?B#_P 1
MO/[+/_1CWQ _\**Q_P */^(WG]EG_HQ[X@?^%%8_X4 ?M]17X@_\1O/[+/\
MT8]\0/\ PHK'_"C_ (C>?V6?^C'OB!_X45C_ (4 ?M]17X@_\1O/[+/_ $8]
M\0/_  HK'_"C_B-Y_99_Z,>^('_A16/^% '[?45^(/\ Q&\_LL_]&/?$#_PH
MK'_"C_B-Y_99_P"C'OB!_P"%%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\
M"C_B-Y_99_Z,>^('_A16/^% '[?45^(/_$;S^RS_ -&/?$#_ ,**Q_PH_P"(
MWG]EG_HQ[X@?^%%8_P"% '[?45^(/_$;S^RS_P!&/?$#_P **Q_PH_XC>?V6
M?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X
M@?\ A16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X4
M5C_A0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\
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M>?V6?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y
M_P""_'_*&S]H3_LG\W_HZ*OXPJ_L]_X+\?\ *&S]H3_LG\W_ *.BK^,*@#]_
MO^#3;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H ****
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M_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]%
M' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!
MP'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\
M,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#
M)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_L
ML_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+
M/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\
M1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M
M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P
M_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__
M /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_
M  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-
ML?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;
M'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\
MXU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU
M1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_
MPR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR
M?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^
MRS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS
M_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T
M;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&
MU?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/
M_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_
M /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#P
MC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\
M"-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_
M .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?
M_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5
MW]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=
M_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]%
M' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!
MP'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\
M,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#
M)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_L
ML_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+
M/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\
M1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M
M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P
M_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__
M /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_
M  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-
ML?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;
M'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\
MXU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU
M1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_
MPR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR
M?^RS_P!&U?#_ /\ "-L?_C5=_10!^#O_  >A?!SX1?#+]F/X+7_PW^%?AOP]
M/=>/-0CN9M#T.WM'E060(5C$BE@#S@U^T?[)_P#R:S\-/^R?Z-_Z0PU^0'_!
M[S_R:S\#_P#LH&H_^D(K]?\ ]D__ )-9^&G_ &3_ $;_ -(8: ._HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_RA
ML_:$_P"R?S?^CHJ_C"K^SW_@OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^#3;_ )2F
M?M=_]O'_ *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\0?^#WG_ )-9^!__
M &4#4?\ TA%?K_\ LG_\FL_#3_LG^C?^D,-?D!_P>\_\FL_ _P#[*!J/_I"*
M_7_]D_\ Y-9^&G_9/]&_](8: ._HKC_C]\-_%GQ?^#?B'X9^!?BYK'@/5]9T
M\V]AXPT".-[W2I"0?.A$@*EA@CGCFOC'_AS]^W7_ -)Z?V@/_!3I?_Q% 'W]
M17P#_P .?OVZ_P#I/3^T!_X*=+_^(H_X<_?MU_\ 2>G]H#_P4Z7_ /$4 ?>V
MK:MI6@:5<Z[KNIV]E8V5N\]Y>7<RQQ01(I9Y'=B JJH)+$@  DU_,U_P<,_\
M'(OBK]KCQ5>?LA?L$>/=0T7X7:+J"_V[XVTFY>VNO%EU"X9?)D4AXK%'4,N"
M&F90YPH53]O_ /!5G_@B9_P5:\<_L8>*-&^"/_!6+XL?%RX6W\W5_AAXH2WL
MX_$=FGS/;Q2VQ3=+QN$,@*2D;<@[<_S,ZMI.JZ!JMSH6NZ9<65]97#P7EG=P
MM'+!*C%7C=& *LK @J0"""#0!_3=_P &Z'_!Q?I7[:^E:5^Q-^VSXJM[+XOV
M5N(/"WBF[=8XO&<2+Q&YX"Z@JCE>!. 67Y]RG]AJ_A3_ &-?V8OVCOVP/VCO
M#'P+_91\+ZAJ7C;4M0232Y-/F:'^SO+8,;V2=?\ CWBAP':4D;<#&6(!_J6^
M'W_!'/\ X*-Z?X'TFQ^('_!?'XX2ZW%I\2ZJ^E:59&V\\*-PC:<-*Z@\!W.Y
ML;C@G  /T6HKX!_X<_?MU_\ 2>G]H#_P4Z7_ /$4?\.?OVZ_^D]/[0'_ (*=
M+_\ B* /OZJ?B'P]H?BS1+GPWXETJ"^L+R(QW5I<QADD4]B#^>>Q (KX\^ /
M_!,;]K_X0?&3P]\3/'7_  6-^-'CS2-&U!;B_P#!_B#3=/2RU6, CR9C&@8*
M<@\<\5]B:]K=EX;T>XUW4(;R2"UCWR)8:?-=S,/]B&!'DD/LJD^U 'X2?LZ^
M+O@/IO\ P1:^)/Q)US]J7QEI?[0=EXO\7V?PJE\/?%;57\47NK6U_,FD6,%E
M%=-)=QNR11O$8G0PEV8 +O'ZE_#[]KWQU^S7_P $]?A#\7_V_M&U%/B9XETS
MPUH.K^'='T^+[?J?BG4O)@BLDB+QP13R3O\ /N>.&,A\LJK7P;^Q-_P37^+7
MQR_X)C'0K+P#XJ^$'[2'PL^,7B/QO\'O$_BOPE=:9+:74]\]Q!#))-$%GLKN
M!A!/$"X (+HWEA3]!_'C]N?]MGXJ_L)> O'_ (7_ &+/BUX0\;K\1_#]C\=_
M"FF_#RYNM9T+0_-D&IWV@^9$\5^^^.(120^;+'%.9-J.@90#Z:^$/[?7P;^)
MOB?XM^!?%FA:]\/M=^!\5I=?$?3/'(LX_P"S;"ZLY+RVOQ<6=S<6SV[P0S/N
M67<GE.'5",5\8?\ !3#]H_1_V@O''[$GQ \/_ WXEZ#I7B#]JSPA=>%_%NOB
M"VTW5M-D6YE"FVBO7FA>8?9[B-+NVAD*1'A61D'GOB7]CO\ : ^.GCW]O?X-
M?!_]FKXG^$K'X]?!KP>OPW\3>.DD$6HSV%CJ*SQ7E]=W,D@GN)9HHC'*[W"+
M/F9(@K!>F^//QR^.O[4?P#_8]T6P_8%^.FD^+_AA^T;X)U/XG:!??#*\MH=)
MCTZSO8KJ:"YF5(;NV+9=)X6>,)L$C1.Z(P!%^V!XF_:2_P"":/\ P4@\=?MK
M?LQ:=K/B+X(^%O!'A>X^/GPALK^XN/*T^_N-6237M,MY)#'!):"P1WBB5%9'
MD)VJ9)%^K/&VI? +]IO]J']F7]H/X9ZQ9>(_#OBO2=?U#3]4TZ[D^R:O;KIT
M4EL\\0(6<Q,25692T3[N%8''3_"369-?_P""@?Q@&L_#'Q;;:1K/P^\)Z99Z
MGK/@N^BTV_GM)M=>\@2YDA\B0(MY;@G?M?S<(7PV/FO]FW_@FQ\=/V"/^"I7
MAO1?@=-<:A^RSK$/B3Q#X>\/F-I/^%>Z_=6Z)<6$39_=V%SS+$OW5=&3Y6^:
M< ^C/C__ ,%1O@G^SOX.\0_&#Q+\,?'FL?#;P;XE.A>-/B;X<TZQN-)T.[2Y
M6TN/,C>[2]N([>X80S26UM.L<BR+DF*4)S>C_P#!0[XH^*?^"JDW[$WAW]G;
M7[OP=8?"6T\4)XHL-4T:2/48[_4DMX=4^:^5UL8E@G4*@:Y=G=OLY58F;Y/_
M &=/!-Y^RIXN^(7[#?[4_P#P1BUWXR:Q>?$G7]5^&?Q1TKX6Z=JVA>)],U74
MI[^W&K:K<KLT^2*2Y9)#.6V(@VABJ*_O]EX'^+?P4_X+:Z1\2+C]GKQ!J/A'
MQ5^R[HO@RS\0^"/#Q.AZ5JEGKMU//!,Y8+8PI;S+*@<_,B[(]\F$(!]U5^=_
M_!6?PMI=S_P4K_8BT^.:^M;7Q?\ $C6['Q;96&I3V\&N6UOIBSPPWD<3JERB
M2("%D##!*_=)!^JOV-_VS-'_ &PM,\8RP_ WXA?#S4_!/BZ;0M4\/_$CP]_9
MU[*%1)8;R)-[!K>:-U=&SDC)Q@JS?-?_  5(T/X@>)/^"BG[&OC'P7\'/'?B
M#1?AU\0M9U+QOK7A[P1J-]::1:W6G);0R22PPLK[I&Y5"Q4*Q8*!R >N>+_^
M"HWPE\)?M!>._P!DOP3^SM\7/%_CGX=Z#8ZI=^'_  EX-B/]H6MPTJHUI)<W
M$$951"WSRM%&V56-Y'94.[X _P""EG[-?Q3_ &7/AU^U5\/I-<U33OBQ?IIG
M@'PO#IR)K.JZH6G633UA>18TFA-K=><SRK#$MM*[2A%WUY%\&H/%OA[_ (+3
M_'?XS:Y\)_'-MX1UCX.^%],T?Q,_@34S9WUW82WTMU##(+<B1E6XCP!]\Y5-
MQ!%?'?P"^"O[9_[/7[!G[(_[37A#]E'X@:WXF_9L^,'CB^^(/PE;PS<6NMWF
MAZ_?ZO&]U8V\ZI]LGCM+V*1(XR23*02I5\ 'Z@?LT?MK?#C]IGXD?$CX*:;X
M,\3^%/&_PGU.QL_&WA+Q;:6RW-HM[;FYLKA);.XN+>:&>)696CE8C80ZH>#[
M%7SIX)_;?^('C/X(^./VHH?V)OBWI?ASPUH'VG0?!NL^#_LWC+Q/=1+(\T=O
MI;2^9&@'E1Q++MDE=I2$")&TONW@3Q0_CCP/HWC67PUJFBMK&E6]ZVCZY;"&
M]L#+$LGD7$8+".9-VQU!.&4C)QF@#5HHHH **** "BO$/VWOV5_C/^U1X5T/
M0/@Q^VMXX^"MUI6H27%[JG@>UMI9=2C9-HAE$X("J?F&.<U\X?\ #G[]NO\
MZ3T_M ?^"G2__B* /OZBO@'_ (<_?MU_])Z?V@/_  4Z7_\ $4?\.?OVZ_\
MI/3^T!_X*=+_ /B* /P _P"#H[_E.O\ '/\ [EG_ -1C2:^ *^O_ /@O7\'_
M !W\!/\ @K%\5OA-\2_CUX@^)VMZ3_87VWQQXIBBCO\ 4O-T+3YD\U8@$'EI
M(D*X'W8ESSFOD"@ K^_ROX Z_K^_X<_?MU_])Z?V@/\ P4Z7_P#$4 ??U%?
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M=-@EACF@5SL:565U7R3]@"Q^(7@'XX?MV>+?''P)^).DZ?X^^(<VM^![B_\
MAQJT?]NV2Z<UMOMP;?+,9$P(R Y#*0N#D>2V7PD^.FE_\$5OV-O@G<_LY_$H
M^,/ 'QD\$7_C'PU%\/=3>\TJUTO53<7L\J"#B-(B&##(DSA-Q!  /T(^,W[5
M_P /+KQAXS_9Q\,?!_QU\2M3\,^'H;KX@Z=X -K&VC6]W&[P02RW%[:LUQ-"
MCR+;V[23>7M8JHEB\SY?_P""&'[0WA?X3?\ !%K]G9M8L]:\1>(/&5SK=CX6
M\.Z5Y<NIZW=_VMJMS(%-Q+'&NR"&6:26:2-%"'<^YE#3?LV^(_C1^PI_P46_
M:,T/XL_LW?$[Q5X0^.GB[3_&GPT\>^"?!-WJUL\C6$5K-I.H-"A_LN2)HHUC
M:Z,46P,S/&,9^5/@=^SO^U9\+_\ @F[^QQ\=O%'_  3X\6^.A\ _$OBRW^)_
MP2UWPK%+J^IZ/K5Q<XO[+3[C)N)K<&"5(BJNQ<@84.Z@'Z,Z7_P55^$6J^"_
MB_J\7P-^)J^*O@/=Q)\4?ABNDZ?+X@TFVEMFNH;U(HKY[>[MY;=6EC:WGD9U
M4X3(Q73_ +.W_!0CX2?M4:KX)M?@GX)\4:O8>-?AW;>,UUV%;!K+1-/N))(H
M(K]DNV:&YD>*55A19&)BE'_+&;R_*_@C\;/!7@+X1>.OVIO@)_P2J\3?#N'4
M;6QL-#\./\(UT?Q3XKU%3* UY9V$4LUMI\.^)1-<+O ^TLL>T1>?YI^P9\%O
MBW_P2L_;2UO]E?3/AIX@\6_!SXS6X\9Q>+_"OP[N8['P5XMF.R^T^3R(2L.F
MS[%DMU+L;0 1R?*S3$ _1>BBB@ HHHH ***^$/%G_!);]MWQ#XJU/7]+_P""
MY7QXTJUOM0FN+;2[32]-,5G&[EEA0E,E4!"C/. * /N^BO@'_AS]^W7_ -)Z
M?V@/_!3I?_Q%'_#G[]NO_I/3^T!_X*=+_P#B* /OZOG#_@K/^WQX;_X)K?L&
M>.OVI]4EMY-7T[3_ +#X-TZX((O];N 8[2+;_$JOF60#GRH9#VKQ#_AS]^W7
M_P!)Z?V@/_!3I?\ \17X$?\ !PO\9_C!I'[6E_\ L->(/V__ (B?'+P_\,[B
M-M2O?&4END%OKSQ'SXX8K=0K&&-UA+MEED,Z# !W '[#?\&FG_!4WQ)^V=^S
M!XC_ &6/COXXN-8^(WPSU"2^MM1U.X,EUJVB7DS2+*S'EV@N'DB8]%22V'>O
MUOK^%O\ 8G_:=^)'[)7[16@_%;X<?&OQ9X #W":?XA\1>"ID74(M*FD070C6
M0%)2$7>(W&TO&G0@,/ZEO"?_  2I_;(\=^%=,\<>#O\ @X"^/&I:1K.GPWVE
M:C::;I;Q75M,@DBE1@GS*R,K ]P10!^AU%? /_#G[]NO_I/3^T!_X*=+_P#B
M*/\ AS]^W7_TGI_: _\ !3I?_P 10!]_45\ _P##G[]NO_I/3^T!_P""G2__
M (BON[PGH]_X>\*Z9X?U37[C5;JQT^&WN=4NP!+>2(@5IG X#.06..,DT ?E
MKXD_:C_9E^'W_!3GXO\ [//_  65M=6\-WOBOQ+!+^SQX\\2:I=V?AI/#0M+
M=([;3[N&1$TR]2X$\DUR&C=I) K2J8XE/Z!_L=?"34_V;_V;-.^'/B_XLZAX
MMCTK4M:O(/%_B+77O[J]T^XU2[N[6:YNY23-(+6:$/(3@E20<8KPCXL?$SX0
M?M$^$/B1^S/_ ,%*/V(_'&O^&++QGJ=KX8O$^#VK>(+'7],65A;7=J^E6T\E
MG<1AC"KMY,K&-98F8/N'Q7KG[)W_  4$_9J_X)"_"?X56GP4\?>._ &A?M*)
MKOC'X/0?Z?XGD^%RZA+/:Z+<6\;'[2Q587FM$+8\U8F 1)54 N?\$KOCKXI_
M:6\%Z5\<(I-:U'XH?!3XM>)]8_:9^*=EKGVO^VM)']J&UT:RA2<_;[>X@DLC
M!$B"T@CL3)&WFB)7^M?^"@GQ_P# 7[7'_!$KXN_M1_"W1?%.D6'_  JC5?$/
M@/6]7T^;2-05X[)IK;4+;YEFA5N"K_*74G@HP+?)_P"V+\+_ -H+7_VE]3_X
M*1?\$YOV1OC+)X \=>%+/PY^U#\.;SPJ_AO5/&>DI)$@?2=/OE2[:]CM%D@D
ME6&/,4BBVE+O,Z?4G[8GQP\6?M@?\$C?C=H?PH_8Q^+?AE?$7PTOO#?@/PGX
M@^'US::UJ-Y/9R1"-=+A1Y+2VC+1(LTNQ6(DP B(\@!\F_%#QUJ'[-_P3_8/
M^)/[ _QT\27GQN^(^M^$+'QC\/;3Q]?:O;>+]'NM+675[G4-/FN)8T$,@0M=
M[$:'SG.X;04_8KQOX-\,_$+PG?\ @SQCI$=]INH6YBNK:7(##J""""K @,K
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M_P %%_B)X/\ A]KOB\^&=*^'NKVWA>RUJ/[3=N= O+B5(YK^=(XE+O)(<N
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M)>6ZM,C2P1; TC[1E9%,8EP^WYG^)GP[^-G[=_\ P1[\!?\ !,/Q#^SAX_\
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M_1_PWS_P>2_]&6?^8XL__C] '[_45^ /_#?/_!Y+_P!&6?\ F.+/_P"/T?\
M#?/_  >2_P#1EG_F.+/_ ./T ?O]17X _P##?/\ P>2_]&6?^8XL_P#X_1_P
MWS_P>2_]&6?^8XL__C] '[_45^ /_#?/_!Y+_P!&6?\ F.+/_P"/T?\ #?/_
M  >2_P#1EG_F.+/_ ./T ?O#X#^&_A'X;6E_;^%K"5)=5U%]0U>]NKJ2XN;^
MZ9$C,TTLC,[L(XXHUR<)'%'&@5$11NU^ /\ PWS_ ,'DO_1EG_F.+/\ ^/T?
M\-\_\'DO_1EG_F.+/_X_0!^_U%?@#_PWS_P>2_\ 1EG_ )CBS_\ C]'_  WS
M_P 'DO\ T99_YCBS_P#C] '[_45^ /\ PWS_ ,'DO_1EG_F.+/\ ^/T?\-\_
M\'DO_1EG_F.+/_X_0!^_U%?@#_PWS_P>2_\ 1EG_ )CBS_\ C]'_  WS_P '
MDO\ T99_YCBS_P#C] '[_45^ /\ PWS_ ,'DO_1EG_F.+/\ ^/T?\-\_\'DO
M_1EG_F.+/_X_0!^_U%?@#_PWS_P>2_\ 1EG_ )CBS_\ C]'_  WS_P 'DO\
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M#]_J*_ '_AOG_@\E_P"C+/\ S'%G_P#'Z/\ AOG_ (/)?^C+/_,<6?\ \?H
M_?ZBOP!_X;Y_X/)?^C+/_,<6?_Q^C_AOG_@\E_Z,L_\ ,<6?_P ?H _?ZBOP
M!_X;Y_X/)?\ HRS_ ,QQ9_\ Q^C_ (;Y_P"#R7_HRS_S'%G_ /'Z /W^HK\
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MYF9V9B>Y)K[O_P"&^?\ @\E_Z,L_\QQ9_P#Q^C_AOG_@\E_Z,L_\QQ9__'Z
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M:SX3_9X\!>%O$>G26FH:9X+TNUO[28?/#-':1(Z-[A@0?I0!VE%%% !1110
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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2&U=G1M[J@W$?+T'K7X6T ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627170032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER PAGE - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 27, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity a Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity a Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,475,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive proxy statement for the 2024 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629665648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUDIT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628968096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 342,570<span></span>
</td>
<td class="nump">$ 127,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">163,707<span></span>
</td>
<td class="nump">166,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">47,657<span></span>
</td>
<td class="nump">54,022<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">579,276<span></span>
</td>
<td class="nump">367,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">604,401<span></span>
</td>
<td class="nump">565,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use-assets</a></td>
<td class="nump">596,032<span></span>
</td>
<td class="nump">603,524<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets', window );">Total property, equipment and right-of-use-assets</a></td>
<td class="nump">1,200,433<span></span>
</td>
<td class="nump">1,169,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">679,463<span></span>
</td>
<td class="nump">677,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">90,615<span></span>
</td>
<td class="nump">106,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">1,643<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">92,710<span></span>
</td>
<td class="nump">57,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">46,333<span></span>
</td>
<td class="nump">53,172<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,690,473<span></span>
</td>
<td class="nump">2,433,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">342,940<span></span>
</td>
<td class="nump">369,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">4,647<span></span>
</td>
<td class="nump">4,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">55,981<span></span>
</td>
<td class="nump">57,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">17,974<span></span>
</td>
<td class="nump">12,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">437,452<span></span>
</td>
<td class="nump">466,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">605,097<span></span>
</td>
<td class="nump">604,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">812,068<span></span>
</td>
<td class="nump">839,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability, net</a></td>
<td class="nump">15,776<span></span>
</td>
<td class="nump">9,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">6,721<span></span>
</td>
<td class="nump">23,015<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,877,114<span></span>
</td>
<td class="nump">1,942,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>RadNet, Inc. stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $.0001 par value, 200,000,000 shares authorized; 67,956,318 and 57,723,125 shares issued and outstanding at December 31, 2023 and 2022 respectively</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">722,750<span></span>
</td>
<td class="nump">436,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(12,484)<span></span>
</td>
<td class="num">(20,677)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(79,578)<span></span>
</td>
<td class="num">(82,622)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">630,695<span></span>
</td>
<td class="nump">332,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">182,664<span></span>
</td>
<td class="nump">158,457<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">813,359<span></span>
</td>
<td class="nump">491,452<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">2,690,473<span></span>
</td>
<td class="nump">2,433,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Due from affiliates</a></td>
<td class="nump">25,342<span></span>
</td>
<td class="nump">18,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to affiliates</a></td>
<td class="nump">$ 15,910<span></span>
</td>
<td class="nump">$ 23,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property Plant and Equipment Net Including Right of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913635150912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - issued (in shares)</a></td>
<td class="nump">67,956,318<span></span>
</td>
<td class="nump">67,956,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - outstanding (in shares)</a></td>
<td class="nump">57,723,125<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627381104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,616,630<span></span>
</td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingExpensesExcludingDepreciationAndAmortization', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">1,395,239<span></span>
</td>
<td class="nump">1,264,346<span></span>
</td>
<td class="nump">1,123,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainLossOnContributionIntoJointVenture', window );">Gain on contribution of imaging centers into joint venture</a></td>
<td class="num">(16,808)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="nump">5,146<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">128,391<span></span>
</td>
<td class="nump">115,877<span></span>
</td>
<td class="nump">96,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">2,187<span></span>
</td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">3,778<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,517,933<span></span>
</td>
<td class="nump">1,383,698<span></span>
</td>
<td class="nump">1,241,633<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">98,697<span></span>
</td>
<td class="nump">46,363<span></span>
</td>
<td class="nump">82,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">64,483<span></span>
</td>
<td class="nump">50,841<span></span>
</td>
<td class="nump">48,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(6,427)<span></span>
</td>
<td class="num">(10,390)<span></span>
</td>
<td class="num">(10,967)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate swaps</a></td>
<td class="nump">8,185<span></span>
</td>
<td class="num">(39,621)<span></span>
</td>
<td class="num">(21,670)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses', window );">Loss on extinguishment of debt and related expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="nump">6,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expenses</a></td>
<td class="num">(6,354)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="nump">59,887<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">23,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME BEFORE INCOME TAXES</a></td>
<td class="nump">38,810<span></span>
</td>
<td class="nump">42,969<span></span>
</td>
<td class="nump">58,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(8,473)<span></span>
</td>
<td class="num">(9,361)<span></span>
</td>
<td class="num">(14,560)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="nump">30,337<span></span>
</td>
<td class="nump">33,608<span></span>
</td>
<td class="nump">44,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">27,293<span></span>
</td>
<td class="nump">22,958<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 3,044<span></span>
</td>
<td class="nump">$ 10,650<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EarningPerShareBasicAndDilutedAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">63,580,059<span></span>
</td>
<td class="nump">56,293,336<span></span>
</td>
<td class="nump">52,496,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">64,658,299<span></span>
</td>
<td class="nump">57,320,870<span></span>
</td>
<td class="nump">53,421,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other (income) expenses<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other (income) expenses<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,463,197<span></span>
</td>
<td class="nump">$ 1,278,016<span></span>
</td>
<td class="nump">$ 1,166,743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 153,433<span></span>
</td>
<td class="nump">$ 152,045<span></span>
</td>
<td class="nump">$ 148,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EarningPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earning Per Share, Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EarningPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossOnContributionIntoJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Contribution Into Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossOnContributionIntoJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Extinguishment Of Debt And Related Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingExpensesExcludingDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingExpensesExcludingDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623774000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="nump">$ 30,337<span></span>
</td>
<td class="nump">$ 33,608<span></span>
</td>
<td class="nump">$ 44,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
<td class="nump">4,617<span></span>
</td>
<td class="num">(3,943)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,576<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE INCOME</a></td>
<td class="nump">38,530<span></span>
</td>
<td class="nump">33,352<span></span>
</td>
<td class="nump">47,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">27,293<span></span>
</td>
<td class="nump">22,958<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 11,237<span></span>
</td>
<td class="nump">$ 10,394<span></span>
</td>
<td class="nump">$ 28,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624244064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Acquisitions And Asset Purchases</div></th>
<th class="th"><div>DeepHealth, Inc.</div></th>
<th class="th"><div>Radnet, Inc. Stockholders' Equity</div></th>
<th class="th">
<div>Radnet, Inc. Stockholders' Equity </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Radnet, Inc. Stockholders' Equity </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 258,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,051)<span></span>
</td>
<td class="num">$ (117,999)<span></span>
</td>
<td class="nump">$ 92,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,658<span></span>
</td>
<td class="nump">91,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(2,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">44,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,727<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary', window );">Gain on contribution of assets to majority owned subsidiary</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">11,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,404<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">346,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,421)<span></span>
</td>
<td class="num">(93,272)<span></span>
</td>
<td class="nump">117,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">725,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_SharesIssuedSharesSettlementOfContingentConsideration', window );">Issuance of common stock to settle DeepHealth contingent consideration (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">23,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,465,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">19,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(3,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">33,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,650<span></span>
</td>
<td class="nump">22,958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,710)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">$ 6,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">57,723,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 491,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,677)<span></span>
</td>
<td class="num">(82,622)<span></span>
</td>
<td class="nump">158,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="nump">12,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,128,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">26,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">2,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(5,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,972)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="nump">4,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">30,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,044<span></span>
</td>
<td class="nump">27,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,711,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">245,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock in connection with acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock in connection with acquisitions</a></td>
<td class="nump">11,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">2,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">57,723,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,956,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 813,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 722,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,484)<span></span>
</td>
<td class="num">$ (79,578)<span></span>
</td>
<td class="nump">$ 182,664<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SharesIssuedSharesSettlementOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Issued, Shares, Settlement Of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SharesIssuedSharesSettlementOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627251152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 30,337<span></span>
</td>
<td class="nump">$ 33,608<span></span>
</td>
<td class="nump">$ 44,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">128,391<span></span>
</td>
<td class="nump">115,877<span></span>
</td>
<td class="nump">96,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">61,102<span></span>
</td>
<td class="nump">68,847<span></span>
</td>
<td class="nump">73,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="nump">5,146<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures, net of dividends</a></td>
<td class="nump">9,176<span></span>
</td>
<td class="num">(5,952)<span></span>
</td>
<td class="num">(6,260)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization and write off of deferred financing costs and loan discount</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">2,693<span></span>
</td>
<td class="nump">3,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainLossOnContributionIntoJointVenture', window );">Gain on contribution of imaging centers into joint venture</a></td>
<td class="num">(16,808)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">2,187<span></span>
</td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Loss on impairment</a></td>
<td class="nump">3,949<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge</a></td>
<td class="nump">3,576<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate swap</a></td>
<td class="nump">8,185<span></span>
</td>
<td class="num">(39,621)<span></span>
</td>
<td class="num">(21,670)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">26,785<span></span>
</td>
<td class="nump">23,770<span></span>
</td>
<td class="nump">25,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="num">(3,880)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="num">(30,078)<span></span>
</td>
<td class="num">(5,890)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(8,441)<span></span>
</td>
<td class="num">(3,327)<span></span>
</td>
<td class="num">(15,777)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(1,484)<span></span>
</td>
<td class="num">(12,166)<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">6,056<span></span>
</td>
<td class="nump">13,356<span></span>
</td>
<td class="nump">19,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(54,763)<span></span>
</td>
<td class="num">(68,943)<span></span>
</td>
<td class="num">(72,553)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">626<span></span>
</td>
<td class="num">(7,316)<span></span>
</td>
<td class="num">(28,319)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">15,086<span></span>
</td>
<td class="nump">49,778<span></span>
</td>
<td class="nump">9,915<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">220,863<span></span>
</td>
<td class="nump">146,417<span></span>
</td>
<td class="nump">149,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging centers and other operations</a></td>
<td class="num">(10,918)<span></span>
</td>
<td class="num">(129,961)<span></span>
</td>
<td class="num">(77,691)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(176,600)<span></span>
</td>
<td class="num">(119,451)<span></span>
</td>
<td class="num">(137,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">3,904<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="num">(14,035)<span></span>
</td>
<td class="num">(1,441)<span></span>
</td>
<td class="num">(1,441)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(201,470)<span></span>
</td>
<td class="num">(246,949)<span></span>
</td>
<td class="num">(221,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(41,063)<span></span>
</td>
<td class="num">(53,750)<span></span>
</td>
<td class="num">(619,529)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable other than term loan debt</a></td>
<td class="num">(2,930)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,302)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Additional deferred finance costs on revolving loan amendment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(938)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">147,996<span></span>
</td>
<td class="nump">717,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(5,972)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary', window );">Proceeds from sale of economic interest in majority owned subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">128,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(128,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Sale of noncontrolling interests</a></td>
<td class="nump">5,121<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payments on contingent consideration</a></td>
<td class="num">(5,495)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">245,832<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of options</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">195,635<span></span>
</td>
<td class="nump">93,647<span></span>
</td>
<td class="nump">104,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="num">(292)<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">214,736<span></span>
</td>
<td class="num">(6,772)<span></span>
</td>
<td class="nump">32,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">127,834<span></span>
</td>
<td class="nump">134,606<span></span>
</td>
<td class="nump">102,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">342,570<span></span>
</td>
<td class="nump">127,834<span></span>
</td>
<td class="nump">134,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">64,695<span></span>
</td>
<td class="nump">39,151<span></span>
</td>
<td class="nump">29,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 1,587<span></span>
</td>
<td class="nump">$ 587<span></span>
</td>
<td class="nump">$ 1,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossOnContributionIntoJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Contribution Into Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossOnContributionIntoJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624014336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 12, 2023</div></th>
<th class="th"><div>Sep. 20, 2023</div></th>
<th class="th"><div>Jul. 07, 2023</div></th>
<th class="th"><div>Apr. 13, 2023</div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
<th class="th"><div>Oct. 22, 2021</div></th>
<th class="th"><div>Aug. 24, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 01, 2023</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,700<span></span>
</td>
<td class="nump">$ 111,800<span></span>
</td>
<td class="nump">$ 63,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,710<span></span>
</td>
<td class="nump">57,893<span></span>
</td>
<td class="nump">42,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">3,904<span></span>
</td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 604,401<span></span>
</td>
<td class="nump">$ 565,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember', window );">Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingGroupLLCMember', window );">Santa Monica Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember', window );">Arizona Diagnostics Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Received a dividend from the partnership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,002<span></span>
</td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="nump">$ 30,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Stock Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember', window );">DRT LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued', window );">Value of shares issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember', window );">Tangent Associates LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,658,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Stock Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">64,569<span></span>
</td>
<td class="nump">56,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember', window );">Aidence Holding B.V. milestone consideration | General Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiAdventistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_StockHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_StockHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_GeneralHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_GeneralHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634355008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS</a></td>
<td class="text">NATURE OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2023, we operated directly or indirectly through joint ventures with hospitals, 366 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting. In June 2023, we completed a public offering of 8,711,250 shares of our common stock at a price to the public of $29.75 per share. The gross proceeds as a result of this public offering was $259.2&#160;million before underwriting discounts, commissions, and expenses totaling $13.4&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc. as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group (the "Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $205.6 million, $189.1 million, and $179.6 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2023, 2022, and 2021, respectively and $205.6 million, $189.1 million, and $179.6 million of operating expenses for the years ended December 31, 2023, 2022, and 2021, respectively. RadNet, Inc. recognized $849.4 million, $786.5 million, and $749.2 million of total billed net service fee revenue for the years ended December 31, 2023, 2022, and 2021, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31, 2023 and December 31, 2022, we have included approximately $94.1 million and $110.3 million, respectively, of accounts receivable and approximately $16.7 million and $16.2 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634215568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the fees for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by the Group as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and co-payment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service fee revenues for the years ended December 31, 2023, 2022, and 2021 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,175&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,279&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,249&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,849&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,082&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,238&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,433&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,045&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020. As part of the CARES act, we received $39.6 million total of accelerated Medicare payments which were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed. Through December 31, 2023, all of the accelerated Medicare payments have been applied to revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.   Amounts remaining to be collected on these agreements were $14.3 million and $15.4 million at December 31, 2023 and December 31, 2022, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS PAYABLE AND ACCRUED EXPENSES - Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"><tr><td style="width:1.0%"></td><td style="width:67.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,888&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,678&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,059&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,574&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,940&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,595&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; We have developed and sell Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we recorded approximately $20.2 million, $13.2 million, and $10.5 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statements of operations. At December 31, 2023 we had deferred revenue of approximately $1.3 million associated with these sales which we expect to recognize into revenue over the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. The cash in the financial institution is in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Deferred financing costs, net of accumulated amortization, were $1.6 million and $2.3 million for the twelve months ended at December 31, 2023 and 2022, respectively.  See Note 8, Credit Facilities and Notes Payable for more information on our revolving lines of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATIONS &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $679.5 million and $677.7 million at December 31, 2023 and December 31, 2022, respectively. Indefinite lived intangible assets were $9.0 million at December 31, 2023 and $24.1 million at December 31, 2022 and are associated with the value of certain trade name intangibles and in process research and development ("IPR&amp;D"). Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested goodwill, trade name and IPR&amp;D for impairment&#160;on October 1, 2023.  In September 2023, we determined that an IPR&amp;D indefinite-lived intangible asset related to Aidence's Ai Veye Lung Nodule and Veye Clinic would not receive FDA approval for sale in the US without a new submission and additional expenditures for rework in the original projected timeline. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the related IPR&amp;D intangible asset and resulted in impairment charges of $3.9 million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The estimated fair value of the IPR&amp;D intangible asset was determined using the multi-period excess earnings method under the income approach, which estimates the present value of the free cash flows associated with the asset and tax amortization benefit to arrive at the fair value of the asset. Our annual impairment test as of October 1, 2023 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2023.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2023 and December 31, 2021 we recorded lease abandonment of $2.5 million and $7.1 million, respectively in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2023. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers to maximize utilization rates. We may abandon low utilization leases and divert the patients to nearby centers. During 2023, we experienced lower utilization at two imaging centers. To complete the closure of these locations, we took a lease abandonment charge of approximately $5.1&#160;million and $19.7 million at December 31, 2023 and December 31, 2021, respectively. Of these amounts, $2.7 million and $12.6 million were related to right-of-use assets impairment and $2.5 million and $7.1 million were related to the write-off of leasehold improvements for the years ending December 31, 2023 and December 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNINSURED RISKS &#8211; We maintain a high-deductible workers&#8217; compensation insurance policy. We have recorded liabilities of $3.4 million and $3.9 million at December 31, 2023 and December 31, 2022, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for all years covered by this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2023, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2023 and 2022 of $7.2 million and $7.4 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contributions.  We contributed $0.0 million and $3.0 million in matching for each of the twelve months ended December 31, 2023 and December 31, 2022.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, third on April 15, 2021 and currently as of April 27, 2023 (the &#8220;Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023. We have reserved 20,100,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric. We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options generally vest over <span style="-sec-ix-hidden:f-664">three</span> years to five years and expire <span style="-sec-ix-hidden:f-666">five</span> years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.  The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2023, 2022 and 2021 is provided below (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"><tr><td style="width:1.0%"></td><td style="width:58.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,943)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER COMPREHENSIVE INCOME (LOSS) &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2023, December 31, 2022, and December 31, 2021 are included in the consolidated statements of comprehensive income.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 swaps</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They matured in October 2023 for the two smaller notional and will mature in October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month Term SOFR rates at 1.89% for the $100,000,000 notional and at 1.98% for the $400,000,000 notional. In October of 2023, the two agreements of $50,000,000 each matured and the remaining 2019 swaps have a total notional amount of $400,000,000 as of December 31, 2023. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of other accumulated comprehensive income (loss) in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 1.98% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.89% did not match the cash flows for our Barclays term loans and so we determined that they were not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional was recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million per month through October 2025.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(8,185)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-703">Other Income (Expense)</span></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,576)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39,621</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-706">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,687)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,670</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-709">Other Income (Expense)</span></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,695)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we agreed to pay up to $10.0 million consideration upon the completion of two identified milestones in RadNet common shares or cash at our election.  The contingency had a fair value of approximately $7.2 million on December 31, 2022. The fair value is based on the yield rate of S&amp;P B-rated corporate bonds and the probability of meeting the milestones which were tied to FDA approval of artificial intelligence screening solutions. In September 2023, we determined that the milestones could not be achieved under the contractual terms of the stock purchase agreement because the original submissions of artificial intelligence screening solutions did not receive regulatory clearance. A new submission would be required; and therefore, the probability of the milestones being achieved became zero. Accordingly, management recognized a gain of $7.2 million in 2023 representing the change in fair value of contingent consideration within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, there was a general holdback of $4.0 million for any indemnification claims, which was settled on April 30, 2023 by the issuance of 144,227 shares of our common stock.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we agreed to issue 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. In addition, there is a general holdback of $1.6 million to be issued in cash subject to adjustment for any indemnification claims. On July 7, 2023, we settled the stock holdback contingent liabilities by issuing 113,303 shares of our common stock at an ascribed value of $3.5 million and also settled the general holdback for $1.6 million in cash.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Montclair. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $1.2 million in contingent consideration which was based on the anticipated achievement of specific EBITDA targets within a defined time frame. In June 2023, we determined that the contingent consideration thresholds were not achieved and, as such, we recognized a gain of $1.2 million representing the change in fair value of the contingent consideration within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart &amp; Lung Imaging Limited. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed our acquisition of 75% of the equity interests of Heart &amp; Lung Imaging Limited. The purchase included $10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in subsequent periods.  The milestone contingencies had a value of approximately $6.2 million and $11.1 million as of December 31, 2023 and 2022, respectively.   The contingent consideration is determined by the achievement of a specific number of physician reads. On September 20, 2023, we settled a milestone contingent liability by issuing 56,600 shares of our common stock at an ascribed value of $1.6 million and cash of $1.8 million. On December 12, 2023, we settled a milestone contingent liability by issuing 64,569 shares of our common stock at an ascribed value of $2.3 million and cash of $2.1 million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular roll-forward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,000)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,158)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,854)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,453&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at December 31, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward SOFR curve in 2023 and forward LIBOR curve in 2022. respectively. The forward SOFR curve and forward LIBOR curve are readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs. For Heart &amp; Lung Imaging Limited, the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Heart &amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. Holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs. For Aidence Holding B.V., the milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval. For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares. For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame. For Heart &amp; Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads. As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart &amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data, they are classified as Level 3.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our Barclays Term Loans and Trust Term Loan long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,759&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,759&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823,063&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2023 and December 31, 2022, respectively.  Our Truist revolving credit facility had no aggregate principal amount outstanding as of December 31, 2023 and December 31, 2022, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily relate to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations and other notes payable to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,580,059&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,580,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,995&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,539&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options, warrants and holdback shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,658,299&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,320,870&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,421,033&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value associated with contingently issuable shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc's common stockholders for diluted share calculation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,044</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,926</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,727</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight average shares for which the exercise price exceeds the average market price of common stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES- Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million, represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was identified as of December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired 2,315,350 shares of Series A Preferred Stock interest at a cost of $1.0 million and also loaned the company $2.5 million in support of its operations. On October 6, 2023, WhiteRabbit.ai Inc. commenced another offering of preferred shares and the Company converted its note receivable outstanding principal and accrued interest in exchange for 20,325,203 shares of Series C-1 Preferred Stock at an exchange rate of $0.123 per share. No observable price changes or impairment in our investment was identified as of December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2023 and December 31, 2022 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,712&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,438)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,993&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,603)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,710&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the imaging centers underlying these joint ventures of approximately $17.9 million , $22.2 million, and $19.6 million for the years ended December 31, 2023, 2022 and 2021, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures. As we have the ability to exercise significant influence over our joint venture entities, we consider them related parties. Amounts transacted between ourselves and the entities in the ordinary course of business are disclosed on our balance sheet in the due from/to affiliate accounts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key financial data for these joint ventures as of December 31, 2023 and 2022, respectively, and for the years ended December 31, 2023, 2022 and 2021, respectively, (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,819&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,587)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,834)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,334&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,194&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,256&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,023&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2023 and 2022, we made additional equity contributions of $2.4 million and $1.4 million, respectively, to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we contributed eight of our imaging centers to ADRG of $12.7 million and recorded a loss of $0.5 million which was calculated as the difference between the sale price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $4.5 million of the sale price as an offset to due to affiliates while the remaining $8.3 million was recorded as investment in joint venture on our balance sheet.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our 49% economic interest in ADRG, we received a distribution from the partnership of $4.5 million to reduce our overall investment to $8.3 million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary and sale of economic interest</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Los Angeles Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of three locations in Los Angeles, California. We contributed the operations of 3 centers to the subsidiary. Cedars-Sinai Medical Center ("CSMC") purchased from us a 35% noncontrolling interest in LAIG for a cash payment of $5.9 million. As a result of the transaction, we retain a 65% controlling economic interest in LAIG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Santa Monica Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed, in conjunction with Cedars-Sinai Medical Center ("CSMC") the Santa Monica Imaging Group, LLC ("SMIG"), consisting of two multi-modality imaging centers located in Santa Monica, California with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest. RadNet accounted for its share of the venture under the equity method. On January 1, 2019, CSMC purchased an additional 5% economic interest in SMIG from us and, as a result, of our economic interest in SMIG was reduced to 35%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, RadNet contributed an additional multi-modality imaging center and a newly constructed imaging center located in Beverly Hills, California valued at $27.2 million and purchased an additional economic interest in SMIG for cash payment of $11.3 million. Simultaneously, CSMC contributed five additional multi-modality imaging centers located in Santa Monica, California. As a result of the transaction, our economic interest in SMIG has been increased to 49%. We recorded a gain of $16.8 million, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Gain) on contribution of imaging centers into joint venture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, representing the difference between the fair value and carrying value of the business contributed. The related gain on disposal of business was calculated as the difference between the fair value and carrying value of such imaging centers which included equipment, other assets, accrued liabilities, and an allocation of goodwill to such imaging centers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of the imaging centers contributed to SMIG, we used an income approach which is considered a level 3 valuation technique. See Fair Value Measurements above for further detail on the valuation hierarchy. Key assumptions used in measuring the fair value are financial forecasts and a discount rate. We also utilized the cash paid for an additional interest in the joint venture to substantiate the fair value of the contributed assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913732858544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-07 ("ASU 2023-07"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance requires entities to provide enhanced disclosures about significant segment expenses. For entities that have adopted the amendments in ASU 2023-07, the updated guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2023-07 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-09 ("ASU 2023-09"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax (Topic 740) Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to the rate reconciliation and income taxes paid information. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is currently evaluating the impact of the adoption of ASU 2023-09 on its consolidated financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org//250/tableOfContent<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -SubTopic 20<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -SubTopic 20<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628853136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">BUSINESS COMBINATIONS AND RELATED ACTIVITY</a></td>
<td class="text">BUSINESS COMBINATIONS AND RELATED ACTIVITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended 2023, 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California, Delaware, Maryland, New Jersey and New York markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,689)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison Radiology Medical Group, Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Diagnostic Imaging, P.A.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10,765</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$3,942</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$8,173</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$6,473</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$300</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$50</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(8,173)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,877</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,665</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,690</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,200</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Diagnostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$142,781</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$22,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$7,225</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$106,045</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,325</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(2,145)</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(6,684)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+See detailed description of the Heart &amp; Lung Imaging Limited acquisition below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart &amp; Lung Imaging Limited.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we acquired a 75% controlling interest in Heart &amp; Lung Imaging Limited (&#8220;HLI&#8221;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#8217;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $31.9 million, including: i) shares with a fair value of $6.8 million (359,002 shares issued at $19.06 per share), ii) cash of $6.3 million, iii) contingent consideration of $10.8 million ($10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $8.0 million. We recorded $0.6 million in current assets, $15.8 million in intangible assets, $0.6 million current liabilities and $16.2 million in goodwill in connection with this transaction.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 19.0%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2&#160;million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0&#160;million, ii) cash of $1.8&#160;million, iii) contingent consideration of $11.9&#160;million ($7.4&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $4.5&#160;million), and iv) a settlement of a loan from RadNet of $1.5&#160;million.  In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6&#160;million.  As a result of this transaction, we recorded $1.0&#160;million in current assets, $0.2&#160;million in property and equipment, $27.7&#160;million in intangible assets (including developed technology of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$21.1&#160;million and IPR&amp;D of $5.5&#160;million), $3.2&#160;million in current liabilities, a deferred tax liability of $3.5&#160;million, and $22.9&#160;million in goodwill. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15% to 17%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company originally expected to complete the project following twelve months of acquisition. Subsequently, in September 2023, we determined that the In-process Research and Development ("IPR&amp;D") related to Aidence's Ai Veye Lung and Veye Clinic would not achieve FDA approval for sale in the US without a new submission and additional expenditures for rework.  The additional expenditures, delay, and reduction of US sales affected the estimated fair value of the associated IPR&amp;D intangible asset and resulted in impairment charges of $3.9&#160;million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The useful lives for the developed technology asset was set at 7 years, for customer relationships 5.4 years, and trade names was 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3&#160;million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9&#160;million, ii) cash of $11.8&#160;million, and iii)  contingent consideration consisting of 113,303 shares with a fair value at the date of close of $3.0&#160;million and cash of $1.6&#160;million both to be released 18 months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $2.4&#160;million in current assets, $0.1&#160;million in property and equipment, $21.3&#160;million in intangible assets (including developed technology of $19.6&#160;million and IPR&amp;D of $0.7&#160;million), $0.7&#160;million in current liabilities, $6.7&#160;million in long-term debt and deferred tax liabilities, and $26.4&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 50% to 55%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The useful lives for the developed technology asset was set at seven years, customer relationships three years, and trade names seven years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed above, for the acquisitions of Aidence and Quantib, the Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiaries</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frederick County Radiology, LLC.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc.  The operation offers multi-modality services out of six locations in Frederick, Maryland.  We contributed the operations of four centers to the enterprise and Frederick Health Hospital, Inc.  contributed $5.4 million in fixed assets, $3.0 million in equipment, and  $11.0 million in goodwill.  As a result of the transaction, we recognized a gain of $6.6 million to additional paid in capital and retained a 65% controlling economic interest in FCR and Frederick Health Hospital, Inc. retains an $11.1 million or 35% noncontrolling economic interest in FCR.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary and sale of ownership interest</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Los Angeles Imaging Group, LLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023 we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of three locations in Los Angeles, California. We contributed the operations of 3 centers to the subsidiary. Cedars-Sinai Medical Center purchased from us a 35% noncontrolling economic interest in LAIG for a cash payment of $5.9 million. As a result of the transaction, we retain a 65% controlling economic interest in LAIG.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tarzana Medical Center, LLC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634273168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text">SEGMENT REPORTING<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  We also provide teleradiology services in the United Kingdom though our majority-owned Heart &amp; Lung Imaging Limited subsidiary.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Centers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,610,707&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,923&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,616,630&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,610,707&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,469&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,546)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,616,630&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Centers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,604,161&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313,662&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,616,630&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,371,036&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,240,593&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,117,941&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,395,239&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,264,346&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,123,274&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,808)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,808)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Lease abandonment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,146&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,675&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,146&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,675&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">120,776&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">109,524&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,174&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">128,391&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">115,877&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,694&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,191&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,506&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,246&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,187&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,529&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,246&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,973&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">926&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,778&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">946&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">119,847&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72,116&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">77,882&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(25,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">98,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In the first quarter of 2024, we revised our reportable segments to combine our eRad business, which was included in the Imaging Center segment, with our AI segment to form a new Digital Health reportable segment. As a result of the change, beginning with our Quarterly Report on Form 10-Q for the quarter ending March 31, 2024, we will report our results in these two reportable segments. The change in reportable segments will be reflected retrospectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913719740096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2022 and December 31, 2023 is provided below (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"></td><td style="width:33.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,551&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,697&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,248&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,483&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,182&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,665&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,235)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,235)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,906&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2023 is $142.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $12.2 million, $10.1 million, and $4.4 million for the years ended December 31, 2023, 2022 and 2021, respectively. Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,671&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,106&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.8</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,745&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,210&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,046&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,117&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,688&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,645&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,283&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,833&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,818&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,505&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,531&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,615&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627039264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,540&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,467&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,853&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501,963&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment originally acquired under finance/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441,300&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320,700&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(836,899)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754,739)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,401&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,961&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2023  is approximately $42.7 million total of construction in process amounts consisting of $12.2 million in medical equipment, $1.9 million in computer and office equipment, $6.0 million in software costs and $22.6 million in leasehold improvements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2022 is approximately $73.4 million total of construction in process amounts consisting of $26.6 million in medical equipment, $5.3 million in computer and office equipment, $0.4 million in software costs and $41.1 million in leasehold improvements.</span></div>Depreciation and amortization expense of property and equipment, including amortization of equipment under finance leases, for the years ended December 31, 2023, 2022 and 2021 was $116.2 million, $105.6 million, and $92.3 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634144000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CREDIT FACILITIES AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022 our term loan debt and other obligations consisted of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,687&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on Barclays Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Term Loan collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on Truist Term Loan </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,011&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,974)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,400)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812,068&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,324&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,676&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,454&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,073&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2023 and had reserved an additional $7.6 million for certain letters of credit.  The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2023.  We also had no balance under our $50.0 million Truist Revolving Credit Facility, related to our consolidated subsidiary NJIN, at December 31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2023 we were in compliance with all covenants under our credit facilities. On February 1, 2023, we issued a promissory note in the amount of $19.8 million to acquire radiology equipment previously leased under operating leases.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2023, we entered into the First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement related to our Barclays credit facility (the "Barclays Amendment"), which replaces the interest rate benchmark, from the London Interbank Offered Rate ("LIBOR") to the Secured Overnight Financing Rate ("SOFR") and includes applicable credit spread adjustments of 0.11448%, 0.26161%, and 0.42826% for interest periods of one month, three months, and six months, respectively. The replacement of LIBOR with SOFR and the credit spread adjustments were effective as of March 31, 2023, which was the last day of the last-ending existing interest period of currently outstanding loan bearing interest at LIBOR. Other than the foregoing, the material terms of the Barclays credit facility remained unchanged.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Barclays Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "Barclays Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the Barclays Term Loans were used to refinance loans outstanding under our prior Barclays credit agreement and provide funding for current and future operations. Total costs of the Barclays Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs, $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the  Barclays Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Truist Restated Credit Agreement") which provides for a $150.0 million of a secured term loan (the "Truist Term Loan") and a $50.0 million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior Truist term loan agreement and provide funding for current and future operations. Total costs of the Truist Restated Credit Agreement amounted to approximately $2.7 million segregated as follows: $2.0 million capitalized to discount and deferred finance cost and $0.7 million expensed to loss on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Truist Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Truist Restated Credit Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Truist Restated Credit Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:8.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Barclays Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March 31, 2023, the Barclays Term Loans bore interest at either a Eurodollar Rate or an Alternative Base Rate (in each such case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin. The applicable margin for Eurodollar Rate and Alternative Base Rate was 3% and 2%, respectively, with an effective Eurodollar Rate and the Alternative Base Rate of 4.63% and 8.00%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Barclays Amendment, effective March 31, 2023, the Barclays Term Loans bear interest either at a SOFR or Alternative Base Rate (in each such case, as defined in the Restated Barclays Credit Agreement) plus an applicable margin. The applicable margin for Eurodollar Rate and Alternative Base Rate was 3% and 2%, respectively. At December 31, 2023, we have an effective SOFR of 8.38%, with an applicable credit spread adjustment of 0.26161%, and an Alternative Base Rate of 10.5%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Restated Credit Agreement provides for quarterly payments of principal for the Barclays Term Loans in the amount of approximately $1.8 million. The  Barclays Term Loans will mature on April 23, 2028 unless otherwise accelerated under the terms of the Barclays Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Term Loan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Term Loan currently bears interest at a three month SOFR election of 5.33% plus an applicable margin and fees based on Pricing Level V described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the Truist Term Loan began March 31, 2023 with quarterly payments of $1.9 million, representing 1.00% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $0.9 million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the Truist Restated Credit Agreement.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $1.1 million at December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin which adjusts depending on our  net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternative Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the effective interest rate for borrowings on revolving loans under the Barclays Revolving Credit Facility was 10.3%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for SOFR revolving loans which is currently 3.00% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Barclays Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Barclays Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated with the Truist Revolving Credit Facility of $50.0 million are deferred financing costs, net of accumulated amortization, of  $0.5 million at December 31, 2023.  As of December 31, 2023, NJIN had no borrowings under the Truist Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level V as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to prior Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Truist Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2018, under an Amended and Restated Revolving Credit and Term Loan Agreement, our NJIN subsidiary secured a term loan commitment of $60.0 million and established revolving credit facility of $30.0 million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Truist Restated Credit Agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634087904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material lease contracts are for facilities and advanced radiology equipment.  In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from 5 to 8 years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our incremental borrowing rate used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our incremental borrowing rate is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:60.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2023 and 2021 included $2.7 million and $12.6 million, respectively in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:61.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,516&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,004&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,288&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,852&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,080&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,695&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,981&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,078&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,724&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1511"><span style="-sec-ix-hidden:f-1512">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,374)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,171)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:59.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.896%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,603&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,400&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,633&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938,299&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,078&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $4.6 million.  These operating leases will commence in 2024 with lease terms of 1 to 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627039264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we have the following income (loss) before income taxes (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Domestic</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,374&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,529&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,806&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,560)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,810&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,969&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,879&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,724)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,843)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,430)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,150&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,023&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,752)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,821)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,114)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,987&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,083)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax rate adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets and liabilities comprise the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,247&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,124&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,097&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,347&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,095)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,419)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,820)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,840)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,802)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,761)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,081)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211,996)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225,572)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,776)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,256)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we had federal net operating loss carryforwards of approximately $128.9 million, which is comprised of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $63.9 million, which expire at various intervals from the years 2026 to 2037, and had carryforwards of $65.0 million of net operating losses which do not expire. Federal net operating losses generated in tax years following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  We also had state net operating loss carryforwards of approximately $145.3 million, which expire at various intervals from the years 2024 through 2042. As of December 31, 2023, $24.9 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code. We also had foreign net operating loss carryforwards of approximately $45.8 million, which do not expire and are carried over indefinitely.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2023, we have determined that deferred tax assets of $196.2 million are more likely-than-not to be realized. We have also determined deferred tax liabilities of $42.4 million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018. We do not anticipate the results of any open examinations would result in a material change to our financial position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,144&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(999)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,144&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, we had unrecognized tax benefits of $3.1 million of which $2.5 million will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2023 the Company accrued approximately $47 thousand of interest and penalties. As of December 31, 2023, accrued interest and penalties amounted to approximately $0.4 million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2021, the Organization for Economic Co-operation and Development ("OECD") announced an inclusive framework on base erosion and profit shifting including Pillar Two Model Rules defining the global minimum tax, which calls for taxation of large multinational corporations at a minimum rate of 15%. Subsequently multiple sets of administrative guidance have been issued. Many non-US tax jurisdictions have either recently enacted legislation to adopt certain components of Pillar Two Model Rules beginning in 2024 (including the European Union Member States) with the adoption of additional components in later years or announced their plans to enact legislation in future years. We are continuing to evaluate the impacts of enacted legislation and pending legislation to enact Pillar Two Model Rules in the jurisdictions that we operate in outside of the US.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 was signed into law on August 9, 2022 to boost domestic semiconductor manufacturing and encourage US research activities.  The act provided a 25% investment credit intended to promote domestic production of semiconductors. This act is not expected to have a material impact for us.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634111616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, second on March 9, 2017, third on April 15, 2021, and currently as of April 27, 2023 (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023.  We have reserved for issuance under the Restated Plan 20,100,000 shares of common stock.  We can issue options (incentive and nonstatutory), performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:f-1680">one</span> to five years and expire <span style="-sec-ix-hidden:f-1682">five</span> to ten years from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the twelve months ended December 31, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Restated Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,914&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,723)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.11&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled, forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.60&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.22</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,561,659&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668,809&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,387,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2023 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2023. As of December 31, 2023, total unrecognized stock-based compensation expense related to non-vested employee awards was $1.4 million which is expected to be recognized over a weighted average period of approximately 1.23 years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2023, total unrecognized stock based compensation expense related to non-vested DeepHealth options was insignificant.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:46.197%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,073&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,749,368&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,612&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2023, we have issued a total of 8,718,185 RSA&#8217;s of which 537,358 were unvested at December 31, 2023. The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2023:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,767&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,255&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.31&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,008)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.31&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,358&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.99&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based on the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2023 we issued 50,765 shares relating to these awards, amounting to approximately $1.3 million of compensation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022. In January of 2023, based on the performance condition achieved, the board of directors issued 12,843 units with a fair value of $29.44 per unit.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we granted certain employees PSUs with a target award of 60,685 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2023 through December 31, 2023. As of December 31, 2023, 121,370 shares are expected to vest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSOs to purchase a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022. In January of 2023, based on the performance condition achieved, the board of directors issued 27,981 options with a strike price of $29.44 per share.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we granted certain employees PSOs with a potential to purchase a maximum of 235,227 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 235,227 shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period January 1, 2023 through December 31, 2023. As of December 31, 2023, all 235,227 shares are expected to vest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AI Long Term Incentive Plan shares ("AI LTIPs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a <span style="-sec-ix-hidden:f-1757">two</span> to four year period, conditioned on continued employment through the vesting periods. We determine the fair value of all AI LTIPs based on the closing price of our common stock on the award date.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all unvested AI LTIPs activities during the twelve months ended December 31, 2023:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:61.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.824%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,471&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,460&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.24&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,309)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,897)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.82&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the 20,100,000 shares of common stock reserved for issuance under the Restated Plan at December 31, 2023, there remain 4,069,349 shares available for future issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634079728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposed acquisitions of imaging centers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2023, we acquired Houston Medical Imaging, LLC for a purchase consideration of approximately $29.0 million. Houston Medical Imaging consists of seven multi modality imaging centers located in Houston, Texas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2024, we acquired Antelope Valley Outpatient Imaging Center, LLC for a purchase consideration of approximately $3.5 million. Antelope Valley Outpatient Imaging consists of four multi modality imaging centers located in Palmdale, California.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629143440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to RadNet, Inc. common stockholders</a></td>
<td class="nump">$ 3,044<span></span>
</td>
<td class="nump">$ 10,650<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627137680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627345232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the fees for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by the Group as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and co-payment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div>We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">SOFTWARE REVENUE RECOGNITION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; We have developed and sell Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">SOFTWARE DEVELOPMENT COSTS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">CONCENTRATION OF CREDIT RISKS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. The cash in the financial institution is in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Notes Payable for more information on our revolving lines of credit.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATIONS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATIONS &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">GOODWILL AND INDEFINITE LIVED INTANGIBLES</a></td>
<td class="text">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2023 and December 31, 2021 we recorded lease abandonment of $2.5 million and $7.1 million, respectively in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2023. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers to maximize utilization rates. We may abandon low utilization leases and divert the patients to nearby centers. During 2023, we experienced lower utilization at two imaging centers. To complete the closure of these locations, we took a lease abandonment charge of approximately $5.1&#160;million and $19.7 million at December 31, 2023 and December 31, 2021, respectively. Of these amounts, $2.7 million and $12.6 million were related to right-of-use assets impairment and $2.5 million and $7.1 million were related to the write-off of leasehold improvements for the years ending December 31, 2023 and December 31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UninsuredRisksPolicyTextBlock', window );">UNINSURED RISKS</a></td>
<td class="text">UNINSURED RISKS &#8211; We maintain a high-deductible workers&#8217; compensation insurance policy. We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2023, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, third on April 15, 2021 and currently as of April 27, 2023 (the &#8220;Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023. We have reserved 20,100,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric. We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options generally vest over <span style="-sec-ix-hidden:f-664">three</span> years to five years and expire <span style="-sec-ix-hidden:f-666">five</span> years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">FOREIGN CURRENCY TRANSLATION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a </span></div>component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER COMPREHENSIVE INCOME (LOSS) &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2023, December 31, 2022, and December 31, 2021 are included in the consolidated statements of comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div> The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They matured in October 2023 for the two smaller notional and will mature in October 2025 for the two larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of other accumulated comprehensive income (loss) in the consolidated statement of equity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward SOFR curve in 2023 and forward LIBOR curve in 2022. respectively. The forward SOFR curve and forward LIBOR curve are readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs. For Heart &amp; Lung Imaging Limited, the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Heart &amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. Holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs. For Aidence Holding B.V., the milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval. For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares. For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame. For Heart &amp; Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads. As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart &amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data, they are classified as Level 3.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily relate to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations and other notes payable to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">EQUITY INVESTMENTS AT FAIR VALUE</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES- Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost as follows:</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENT IN JOINT VENTURES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2023.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED</a></td>
<td class="text">RECENT ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-07 ("ASU 2023-07"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance requires entities to provide enhanced disclosures about significant segment expenses. For entities that have adopted the amendments in ASU 2023-07, the updated guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2023-07 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-09 ("ASU 2023-09"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax (Topic 740) Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to the rate reconciliation and income taxes paid information. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is currently evaluating the impact of the adoption of ASU 2023-09 on its consolidated financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UninsuredRisksPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uninsured Risks [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UninsuredRisksPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//712/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -SubTopic 50<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482610/350-50-25-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482633/350-40-30-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628910160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Schedule of Service Fee Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service fee revenues for the years ended December 31, 2023, 2022, and 2021 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,175&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,279&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,249&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,849&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,082&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,238&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,433&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,045&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text">Accounts payable and accrued expenses were comprised of the following (in thousands):<div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"><tr><td style="width:1.0%"></td><td style="width:67.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,888&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,678&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,059&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,574&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,940&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,595&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock', window );">Schedule Of Foreign Currency Translation Amounts</a></td>
<td class="text">The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2023, 2022 and 2021 is provided below (in thousands):<div style="padding-left:72pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"><tr><td style="width:1.0%"></td><td style="width:58.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,943)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(8,185)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-703">Other Income (Expense)</span></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,576)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39,621</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-706">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,687)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,670</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-709">Other Income (Expense)</span></span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,695)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular roll-forward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,000)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,158)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,854)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Valuation of Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,453&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our Barclays Term Loans and Trust Term Loan long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,759&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,759&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823,063&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans and Truist Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock', window );">Scheulde The Estimated Fair Values</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. Holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,580,059&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,580,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,995&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,539&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options, warrants and holdback shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,658,299&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,320,870&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,421,033&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value associated with contingently issuable shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc's common stockholders for diluted share calculation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,044</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,926</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,727</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight average shares for which the exercise price exceeds the average market price of common stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investment in Joint Ventures</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2023 and December 31, 2022 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,712&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,438)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,993&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,603)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,710&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Schedule of Joint Venture Investment and Financial Information</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key financial data for these joint ventures as of December 31, 2023 and 2022, respectively, and for the years ended December 31, 2023, 2022 and 2021, respectively, (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,819&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,587)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,834)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,334&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,194&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,256&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,023&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture Investment and Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Foreign Currency Translation Amounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Scheulde Of Estimated Fair Values</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628853136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.C.D.G.L.R. &amp; S Services Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,689)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Diagnostic Imaging, Inc.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inglewood Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramapo Radiology Associates, P.C.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,775)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison Radiology Medical Group, Inc.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2023</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Diagnostic Imaging, P.A.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10,765</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$3,942</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$8,173</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$6,473</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$300</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$50</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(8,173)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,877</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,665</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,690</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart &amp; Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,200</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Diagnostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$142,781</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$22,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$7,225</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$106,045</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,325</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(2,145)</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(6,684)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.</span></div>+See detailed description of the Heart &amp; Lung Imaging Limited acquisition below.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634087904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Centers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,610,707&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,923&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,616,630&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,610,707&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,469&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,546)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,616,630&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Centers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Party</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,604,161&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313,662&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,616,630&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,371,036&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,240,593&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,117,941&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,395,239&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,264,346&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,123,274&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on contribution of imaging centers into joint venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,808)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,808)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Lease abandonment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,146&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,675&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,146&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,675&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">120,776&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">109,524&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,174&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">128,391&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">115,877&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,694&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,191&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,506&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,246&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,187&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,529&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,246&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,973&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">926&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,778&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">946&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">119,847&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72,116&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">77,882&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(25,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">98,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634016944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Intangible Assets</a></td>
<td class="text">The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2022 and December 31, 2023 is provided below (in thousands):<div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"></td><td style="width:33.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,551&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,697&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,248&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,483&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,182&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,665&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,235)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,235)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,906&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Annual Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,671&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,106&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.8</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,745&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,210&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,046&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,117&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,688&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,645&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,283&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,833&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,818&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,505&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,531&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,615&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634147440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,540&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,467&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,853&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501,963&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment originally acquired under finance/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441,300&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320,700&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(836,899)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754,739)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,401&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,961&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913635202560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022 our term loan debt and other obligations consisted of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,687&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on Barclays Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Term Loan collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on Truist Term Loan </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,011&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,974)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,400)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812,068&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Annual Principal Maturities of Notes Payable</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,324&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,676&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,454&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,073&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of Leverage Ratio</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Truist Restated Credit Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Truist Restated Credit Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:8.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin which adjusts depending on our  net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternative Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913635066944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:60.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2023 and 2021 included $2.7 million and $12.6 million, respectively in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Cash Flow, Supplemental Disclosures</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:61.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,516&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,004&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,288&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,852&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,080&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,695&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Assets and Liabilities Lessee</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,981&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,078&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,724&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1511"><span style="-sec-ix-hidden:f-1512">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,374)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,171)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:59.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.896%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,603&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,400&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,633&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938,299&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,078&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Assets And Liabilities Lessee [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624137904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we have the following income (loss) before income taxes (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Domestic</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,374&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,529&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,806&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,560)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,810&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,969&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,879&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,724)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,843)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,430)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,150&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,023&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,752)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,821)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,114)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,987&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,083)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax rate adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets and liabilities comprise the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,247&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,124&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,097&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,347&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,095)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,419)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,820)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,840)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,802)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,761)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,081)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211,996)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225,572)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,776)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,256)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,144&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(999)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,144&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913634036432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the twelve months ended December 31, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Restated Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,914&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,723)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.11&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled, forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.60&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.22</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,561,659&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668,809&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,387,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:46.197%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,073&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,749,368&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,612&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA Activity</a></td>
<td class="text">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2023:<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,767&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,255&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.31&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,008)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.31&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,358&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.99&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of LTIPs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all unvested AI LTIPs activities during the twelve months ended December 31, 2023:</span><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:61.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.824%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,471&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,460&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.24&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,309)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,897)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.82&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628166832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS (Details )<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>loan </div>
<div>center </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205,600<span></span>
</td>
<td class="nump">$ 189,100<span></span>
</td>
<td class="nump">$ 179,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,600<span></span>
</td>
<td class="nump">189,100<span></span>
</td>
<td class="nump">179,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849,400<span></span>
</td>
<td class="nump">786,500<span></span>
</td>
<td class="nump">749,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,690,473<span></span>
</td>
<td class="nump">2,433,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,877,114<span></span>
</td>
<td class="nump">1,942,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,395,239<span></span>
</td>
<td class="nump">1,264,346<span></span>
</td>
<td class="nump">$ 1,123,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">8,711,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_SaleOfStockCost', window );">Public offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,100<span></span>
</td>
<td class="nump">110,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,700<span></span>
</td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SaleOfStockCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SaleOfStockCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rdnt_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rdnt_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624455216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Net Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,616,630<span></span>
</td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember', window );">Imaging center segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">1,604,161<span></span>
</td>
<td class="nump">1,425,665<span></span>
</td>
<td class="nump">1,313,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">897,948<span></span>
</td>
<td class="nump">785,128<span></span>
</td>
<td class="nump">743,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">363,863<span></span>
</td>
<td class="nump">311,124<span></span>
</td>
<td class="nump">280,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">43,175<span></span>
</td>
<td class="nump">38,279<span></span>
</td>
<td class="nump">34,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">47,364<span></span>
</td>
<td class="nump">51,339<span></span>
</td>
<td class="nump">44,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">42,249<span></span>
</td>
<td class="nump">31,849<span></span>
</td>
<td class="nump">19,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">17,936<span></span>
</td>
<td class="nump">22,235<span></span>
</td>
<td class="nump">19,630<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_SoftwareAndTeleradiologyMember', window );">Software and teleradiology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">18,082<span></span>
</td>
<td class="nump">14,238<span></span>
</td>
<td class="nump">10,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">20,111<span></span>
</td>
<td class="nump">19,428<span></span>
</td>
<td class="nump">12,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">153,433<span></span>
</td>
<td class="nump">152,045<span></span>
</td>
<td class="nump">148,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_AIMember', window );">AI segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 12,469<span></span>
</td>
<td class="nump">$ 4,396<span></span>
</td>
<td class="nump">$ 1,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_SoftwareAndTeleradiologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_SoftwareAndTeleradiologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631267824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information1 (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 15.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="nump">$ 39.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624130416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Payable and Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 122,888<span></span>
</td>
<td class="nump">$ 102,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">124,059<span></span>
</td>
<td class="nump">181,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salary and benefits</a></td>
<td class="nump">71,297<span></span>
</td>
<td class="nump">62,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">24,696<span></span>
</td>
<td class="nump">23,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 342,940<span></span>
</td>
<td class="nump">$ 369,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627142128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information2 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,616,630<span></span>
</td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember', window );">Patient Services, Net [Member] | eRAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 20,200<span></span>
</td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="nump">$ 10,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624045712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 679,463,000<span></span>
</td>
<td class="nump">$ 513,820,000<span></span>
</td>
<td class="nump">$ 677,665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseLeaseAbandonmentCharge', window );">Lease abandonment charges</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="nump">19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Workers' compensation liability, current</a></td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MedicalMalpracticeDeductiblePerIncidence', window );">Medical malpractice deductible per incidence</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_BlueShieldMember', window );">Blue Shield | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_BlueShieldMember', window );">Blue Shield | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceContractAxis=Health Insurance Member', window );">Reinsurance Policy, Type [Axis]: Health Insurance Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-insurance accrual</a></td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived asset</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment loss</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Insurance, Stop Loss Policy Claim Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalInsuranceStopLossPolicyClaimAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalMalpracticeDeductiblePerIncidence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Malpractice Deductible Per Incidence</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalMalpracticeDeductiblePerIncidence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLeaseAbandonmentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Abandonment Charge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLeaseAbandonmentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_BlueShieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_BlueShieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceContractAxis=Health Insurance Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceContractAxis=Health Insurance Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624437344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information4 (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>incentivePlan</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution, percent</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Expected employee contribution | $</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629225104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Foreign Currency Translation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward', window );"><strong>Currency Translation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (4,385)<span></span>
</td>
<td class="num">$ (442)<span></span>
</td>
<td class="num">$ (377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease', window );">Currency Translation Adjustments</a></td>
<td class="nump">4,617<span></span>
</td>
<td class="num">(3,943)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Ending Balance</a></td>
<td class="nump">$ 232<span></span>
</td>
<td class="num">$ (4,385)<span></span>
</td>
<td class="num">$ (442)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentSummaryRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913618285888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information5 (Details)<br></strong></div></th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630,695,000<span></span>
</td>
<td class="nump">$ 332,995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 swaps | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 swaps | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.98%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_LondonInterbankOfferedRateLIBOR1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_LondonInterbankOfferedRateLIBOR1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623741200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Interest expense<span></span>
</td>
<td class="text">Interest expense<span></span>
</td>
<td class="text">Interest expense<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="num">$ (3,576)<span></span>
</td>
<td class="num">$ (3,687)<span></span>
</td>
<td class="num">$ (3,695)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</a></td>
<td class="num">(8,185)<span></span>
</td>
<td class="nump">39,621<span></span>
</td>
<td class="nump">21,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps | Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="num">$ (3,576)<span></span>
</td>
<td class="num">$ (3,687)<span></span>
</td>
<td class="num">$ (3,695)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623478368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information6 (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 12, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 07, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 13, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>loan </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 20, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,880)<span></span>
</td>
<td class="num">$ (325)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,495<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Purchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones', window );">Number of identified milestones | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,158)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,002<span></span>
</td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember', window );">Aidence Holding B.V. milestone consideration | General Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,401<span></span>
</td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Business acquisition, equity interest issued or issuable, additional number of shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution', window );">Business acquisition, equity interest issued or issuable, fair value of additional shares issued after execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Contingent consideration</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | General Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Stock Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Business acquisition, equity interest issued or issuable, additional number of shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember', window );">Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Business acquisition, equity interest issued or issuable, additional number of shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Contingent consideration settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for acquisitions (in shares) | shares</a></td>
<td class="nump">64,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for acquisitions</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number Of Identified Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-7<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_GeneralHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_GeneralHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_StockHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_StockHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628124976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contingent Consideration (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in Valuation of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,880)<span></span>
</td>
<td class="num">$ (325)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements', window );">Settlement of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="nump">11,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in Valuation of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,158)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements', window );">Settlement of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,110)<span></span>
</td>
<td class="nump">4,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in Valuation of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,401<span></span>
</td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember', window );">Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements', window );">Settlement of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in Valuation of Contingent Consideration</a></td>
<td class="num">$ (1,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements', window );">Settlement of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,854)<span></span>
</td>
<td class="nump">10,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in Valuation of Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="nump">$ 11,656<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Arrangements Change In Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Settlements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624404480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurements (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ValueOfEstimatedSharesIssuable', window );">Value of estimated shares issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Business acquisition, equity interest issued or issuable, additional number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | 2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">15,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Other Current Assets and Deposits and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | 2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Other Current Assets and Deposits and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | 2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">15,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Other Current Assets and Deposits and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | 2019 swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Other Current Assets and Deposits and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ValueOfEstimatedSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of Estimated Shares Issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ValueOfEstimatedSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624104688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Barclays Term Loans and Truist Term Loan</a></td>
<td class="nump">$ 823,063,000<span></span>
</td>
<td class="nump">$ 864,125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_TruistMember', window );">Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Barclays Term Loans and Truist Term Loan</a></td>
<td class="nump">824,759,000<span></span>
</td>
<td class="nump">843,594,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Barclays Term Loans and Truist Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Barclays Term Loans and Truist Term Loan</a></td>
<td class="nump">824,759,000<span></span>
</td>
<td class="nump">843,594,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Barclays Term Loans and Truist Term Loan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624285984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to RadNet, Inc. common stockholders</a></td>
<td class="nump">$ 3,044<span></span>
</td>
<td class="nump">$ 10,650<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">63,580,059<span></span>
</td>
<td class="nump">56,293,336<span></span>
</td>
<td class="nump">52,496,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to RadNet, Inc. common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">63,580,059<span></span>
</td>
<td class="nump">56,293,336<span></span>
</td>
<td class="nump">52,496,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Add nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">202,995<span></span>
</td>
<td class="nump">172,139<span></span>
</td>
<td class="nump">259,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Add additional shares issuable upon exercise of stock options, warrants and holdback shares (in shares)</a></td>
<td class="nump">875,245<span></span>
</td>
<td class="nump">855,395<span></span>
</td>
<td class="nump">664,815<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">64,658,299<span></span>
</td>
<td class="nump">57,320,870<span></span>
</td>
<td class="nump">53,421,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements', window );">Changes in fair value associated with contingently issuable shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (724)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to RadNet, Inc's common stockholders for diluted share calculation</a></td>
<td class="nump">$ 3,044<span></span>
</td>
<td class="nump">$ 9,926<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to RadNet, Inc. common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">754,131<span></span>
</td>
<td class="nump">152,723<span></span>
</td>
<td class="nump">47,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_CommonStockMember', window );">Weight average shares for which the exercise price exceeds the average market price of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">70,760<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Net Income Attributable To Assumed Share Settlements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913621725680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information7 (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>investment </div>
<div>jointVenture</div>
</th>
<th class="th">
<div>Oct. 06, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 11, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments', window );">Number of investments | investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | jointVenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember', window );">Dignity Health | Minimum | Joint Venture | Glendale Advanced Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember', window );">Dignity Health | Maximum | Joint Venture | Glendale Advanced Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock (in shares ) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,325,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_PreferredStockExchangeRatePerShare', window );">Exchange rate In dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesPurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock issued upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems | Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbitaiIncMember', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesAcquired', window );">Shares acquired (in shares) | shares</a></td>
<td class="nump">2,315,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Equity investment loan to company outstanding</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Number Of Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PreferredStockExchangeRatePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Exchange Rate per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PreferredStockExchangeRatePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbitaiIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbitaiIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913635160800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment in Joint Ventures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="nump">$ 57,893<span></span>
</td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="nump">43,993<span></span>
</td>
<td class="nump">9,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">6,427<span></span>
</td>
<td class="nump">10,390<span></span>
</td>
<td class="nump">$ 10,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distribution of earnings</a></td>
<td class="num">(15,603)<span></span>
</td>
<td class="num">(4,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 92,710<span></span>
</td>
<td class="nump">$ 57,893<span></span>
</td>
<td class="nump">$ 42,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity contributions in existing joint ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623379376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information8 (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
<td class="nump">$ 22.2<span></span>
</td>
<td class="nump">$ 19.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember', window );">Arizona Diagnostics Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentAdditionalContribution', window );">Additional contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfAssetsSold', window );">Number of assets sold | center</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Different between the sales price and carrying value</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Received a dividend from the partnership</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentAdditionalContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Additional Contribution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentAdditionalContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfAssetsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Assets Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfAssetsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627082912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Key Financial Data on Joint Ventures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVentures', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 579,276<span></span>
</td>
<td class="nump">$ 367,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(437,452)<span></span>
</td>
<td class="num">(466,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,616,630<span></span>
</td>
<td class="nump">1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">30,337<span></span>
</td>
<td class="nump">33,608<span></span>
</td>
<td class="nump">44,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember', window );">Joint Venture Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVentures', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">147,334<span></span>
</td>
<td class="nump">106,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVentures', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">39,819<span></span>
</td>
<td class="nump">39,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">224,936<span></span>
</td>
<td class="nump">134,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(46,587)<span></span>
</td>
<td class="num">(29,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(70,834)<span></span>
</td>
<td class="num">(37,952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">184,194<span></span>
</td>
<td class="nump">145,256<span></span>
</td>
<td class="nump">129,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 12,968<span></span>
</td>
<td class="nump">$ 21,169<span></span>
</td>
<td class="nump">$ 21,893<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_KeyFinancialDataForJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key Financial Data For Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_KeyFinancialDataForJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623787104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623882528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information9 (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 01, 2023 </div>
<div>USD ($) </div>
<div>location </div>
<div>center</div>
</th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Apr. 01, 2017</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on disposal of equipment and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,187)<span></span>
</td>
<td class="num">$ (2,529)<span></span>
</td>
<td class="num">$ (1,246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,710<span></span>
</td>
<td class="nump">$ 57,893<span></span>
</td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember', window );">Los Angeles Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember', window );">Los Angeles Imaging Group, LLC | Cedars Sinai Medical Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfLocationOfferingMultiModalityServices', window );">Number of location | location</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCentersContributed', window );">Number of centers contributed | center</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersContributedCapital', window );">Limited partners' contributed capital</a></td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SantaMonicaImagingGroupLLCMember', window );">Santa Monica Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersContributedCapital', window );">Limited partners' contributed capital</a></td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on disposal of equipment and other</a></td>
<td class="nump">16,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SantaMonicaImagingGroupLLCMember', window );">Santa Monica Imaging Group, LLC | Cedars Sinai Medical Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed', window );">Limited liability company (LLC) or limited partnership (LP), managing member or general partner, ownership lnterest disposed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_BeverlyHillsImagingCenterMember', window );">Beverly Hills Imaging Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersContributedCapital', window );">Limited partners' contributed capital</a></td>
<td class="nump">$ 27,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest Disposed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCentersContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCentersContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfLocationOfferingMultiModalityServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Location Offering Multi-Modality Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfLocationOfferingMultiModalityServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital contributed by the limited partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_SantaMonicaImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_SantaMonicaImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_BeverlyHillsImagingCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_BeverlyHillsImagingCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913617762800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Assets and Liabilities Assumed (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 679,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_CCDGLRSServicesIncMember', window );">C.C.D.G.L.R. &amp; S Services Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_SouthernCaliforniaDiagnosticImagingIncMember', window );">Southern California Diagnostic Imaging, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_InglewoodImagingCenterLLCMember', window );">Inglewood Imaging Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RamapoRadiologyAssociatesPCMember', window );">Ramapo Radiology Associates, P.C.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MadisonRadiologyMedicalGroupIncMember', window );">Madison Radiology Medical Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DelawareDiagnosticImagingPAMember', window );">Delaware Diagnostic Imaging, P.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryOneMember', window );">I F R C L L C Subsidiary One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryTwoMember', window );">I F R C L L C Subsidiary Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (857)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairRadiologicalAssociatesPAMember', window );">Montclair Radiological Associates, P.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">6,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ChelseaDignosticRadiologyPCMember', window );">Chelsea Dignostic Radiology, P.C.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NorthJerseyImagingCenterLLCMember', window );">North Jersey Imaging Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember', window );">I F R C L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired', window );">Number of subsidiaries acquired | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember', window );">I F R C L L C | Joint Venture With Calvert Medical Imaging Centers LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired', window );">Number of subsidiaries acquired | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember', window );">Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total</a></td>
<td class="nump">10,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">3,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">8,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="num">$ (8,173)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,684)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number Of Subsidiaries Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationNumberOfSubsidiariesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_CCDGLRSServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_CCDGLRSServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_SouthernCaliforniaDiagnosticImagingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_SouthernCaliforniaDiagnosticImagingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_InglewoodImagingCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_InglewoodImagingCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RamapoRadiologyAssociatesPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RamapoRadiologyAssociatesPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MadisonRadiologyMedicalGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MadisonRadiologyMedicalGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DelawareDiagnosticImagingPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DelawareDiagnosticImagingPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairRadiologicalAssociatesPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairRadiologicalAssociatesPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ChelseaDignosticRadiologyPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ChelseaDignosticRadiologyPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NorthJerseyImagingCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NorthJerseyImagingCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629607616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information1 (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 20, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 679,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,665<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 31,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share)</a></td>
<td class="nump">$ 19.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Business combination, noncontrolling interest</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913617686640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information2 (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 679,463<span></span>
</td>
<td class="nump">$ 677,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913622927456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information3 (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 20, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 679,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,665<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Long-term liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Minimum | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Maximum | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Business Acsuition Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Other Sellers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 31,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Business combination, noncontrolling interest</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart &amp; Lung Imaging Limited | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,158<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities', window );">Settlement of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Other Sellers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,117,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Certain Seller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_BusinessAcquisitionContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_BusinessAcquisitionContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_OtherSellersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_OtherSellersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_CertainSellerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_CertainSellerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913622715072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information4 (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 01, 2023 </div>
<div>USD ($) </div>
<div>location </div>
<div>center</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($) </div>
<div>center </div>
<div>location</div>
</th>
<th class="th">
<div>Sep. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 604,401<span></span>
</td>
<td class="nump">$ 565,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,463<span></span>
</td>
<td class="nump">677,665<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (loss) on disposition of property plant equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,187)<span></span>
</td>
<td class="num">(2,529)<span></span>
</td>
<td class="num">(1,246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
<td class="nump">6,623<span></span>
</td>
<td class="nump">11,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember', window );">Tarzana Medical Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">$ 2,236<span></span>
</td>
<td class="nump">$ 6,623<span></span>
</td>
<td class="nump">$ 4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC | Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (loss) on disposition of property plant equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember', window );">Los Angeles Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember', window );">West Valley Imaging Group, LLC | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestPercentOfOwnershipSold', window );">Noncontrolling interest, percent of ownership sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders', window );">Proceeds from sale of interest in minority shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling interest, ownership percentage by parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCentersContributed', window );">Number of centers contributed | center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfLocationOfferingMultiModalityServices', window );">Number of location | location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember', window );">Frederick Health Hospital, Inc. | Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest', window );">Minority partner ownership percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember', window );">Frederick Health Hospital, Inc. | Frederick County Radiology, LLC | Fixed Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember', window );">Frederick Health Hospital, Inc. | Frederick County Radiology, LLC | Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember', window );">Frederick Health Hospital, Inc. | Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember', window );">Cedars Sinai Medical Center | Los Angeles Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfLocationOfferingMultiModalityServices', window );">Number of location | location</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCentersContributed', window );">Number of centers contributed | center</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersContributedCapital', window );">Limited partners' contributed capital</a></td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestPercentOfOwnershipSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Percent Of Ownership Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestPercentOfOwnershipSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCentersContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCentersContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfLocationOfferingMultiModalityServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Location Offering Multi-Modality Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfLocationOfferingMultiModalityServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Interest In Minority Shareholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromSaleOfInterestInMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital contributed by the limited partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_LosAngelesImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_FixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_FixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623842032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,616,630<span></span>
</td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,395,239<span></span>
</td>
<td class="nump">1,264,346<span></span>
</td>
<td class="nump">1,123,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainOnContributionOfImagingCentersIntoJointVenture', window );">Gain on contribution of imaging centers into joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,808)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,146<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,391<span></span>
</td>
<td class="nump">115,877<span></span>
</td>
<td class="nump">96,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,187<span></span>
</td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,778<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income from Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,697<span></span>
</td>
<td class="nump">46,363<span></span>
</td>
<td class="nump">73,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | loan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=rdnt_ThirdPartyMember', window );">Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,616,630<span></span>
</td>
<td class="nump">1,430,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=rdnt_IntersegmentMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,604,161<span></span>
</td>
<td class="nump">1,425,665<span></span>
</td>
<td class="nump">1,313,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,371,036<span></span>
</td>
<td class="nump">1,240,593<span></span>
</td>
<td class="nump">1,117,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainOnContributionOfImagingCentersIntoJointVenture', window );">Gain on contribution of imaging centers into joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,808)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,146<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,776<span></span>
</td>
<td class="nump">109,524<span></span>
</td>
<td class="nump">96,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
<td class="nump">2,506<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income from Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,847<span></span>
</td>
<td class="nump">72,116<span></span>
</td>
<td class="nump">77,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember', window );">AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,469<span></span>
</td>
<td class="nump">4,396<span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,203<span></span>
</td>
<td class="nump">23,753<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainOnContributionOfImagingCentersIntoJointVenture', window );">Gain on contribution of imaging centers into joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,615<span></span>
</td>
<td class="nump">6,353<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income from Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,150)<span></span>
</td>
<td class="num">(25,753)<span></span>
</td>
<td class="num">$ (4,438)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,610,707<span></span>
</td>
<td class="nump">1,425,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Imaging Centers | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,610,707<span></span>
</td>
<td class="nump">1,425,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Imaging Centers | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,469<span></span>
</td>
<td class="nump">4,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | AI | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,923<span></span>
</td>
<td class="nump">4,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | AI | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,546<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,546)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,546)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainOnContributionOfImagingCentersIntoJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain On Contribution Of Imaging Centers Into Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainOnContributionOfImagingCentersIntoJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingIncomeLossExcludingReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Excluding Relief Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingIncomeLossExcludingReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=rdnt_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=rdnt_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=rdnt_IntersegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=rdnt_IntersegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623915632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 677,665<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">6,473<span></span>
</td>
<td class="nump">169,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="num">(9,235)<span></span>
</td>
<td class="num">(4,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period and other adjustments</a></td>
<td class="nump">1,603<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="num">(1,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">679,463<span></span>
</td>
<td class="nump">677,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">606,483<span></span>
</td>
<td class="nump">489,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">6,473<span></span>
</td>
<td class="nump">120,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="num">(9,235)<span></span>
</td>
<td class="num">(4,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period and other adjustments</a></td>
<td class="nump">1,603<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">606,557<span></span>
</td>
<td class="nump">606,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember', window );">AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">71,182<span></span>
</td>
<td class="nump">24,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">48,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="num">(2,272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 72,906<span></span>
</td>
<td class="nump">$ 71,182<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631352720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purpose</a></td>
<td class="nump">$ 142.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629324512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Annual Amortization Schedule (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 12,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">12,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">11,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">10,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">10,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">32,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">$ 24,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">90,615<span></span>
</td>
<td class="nump">$ 106,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember', window );">Covenant not to compete and other contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 2,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 1,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">1,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">10,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 15,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">17 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember', window );">Patent and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember', window );">Developed Technology &amp; Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 7,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">7,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">7,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">7,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">7,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 43,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627258896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Equipment at cost</a></td>
<td class="nump">$ 13,971<span></span>
</td>
<td class="nump">$ 13,971<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">1,441,300<span></span>
</td>
<td class="nump">1,320,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="num">(836,899)<span></span>
</td>
<td class="num">(754,739)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">604,401<span></span>
</td>
<td class="nump">565,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">714,400<span></span>
</td>
<td class="nump">649,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Computer and office equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">127,540<span></span>
</td>
<td class="nump">119,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">47,286<span></span>
</td>
<td class="nump">36,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 537,853<span></span>
</td>
<td class="nump">$ 501,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631179232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Additional Information (Details ) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 116,200<span></span>
</td>
<td class="nump">$ 105,600<span></span>
</td>
<td class="nump">$ 92,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">42,700<span></span>
</td>
<td class="nump">73,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">12,200<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember', window );">Computer and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">47,286<span></span>
</td>
<td class="nump">36,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">537,853<span></span>
</td>
<td class="nump">501,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">$ 22,600<span></span>
</td>
<td class="nump">$ 41,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631181184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">$ 830,042<span></span>
</td>
<td class="nump">$ 851,744<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">830,042<span></span>
</td>
<td class="nump">851,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(17,974)<span></span>
</td>
<td class="num">(12,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term portion of debt obligations</a></td>
<td class="nump">812,068<span></span>
</td>
<td class="nump">839,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">678,687<span></span>
</td>
<td class="nump">714,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(9,041)<span></span>
</td>
<td class="num">(11,127)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">678,687<span></span>
</td>
<td class="nump">714,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | Restated Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">144,375<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(990)<span></span>
</td>
<td class="num">(1,254)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 144,375<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | 6.0% Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNotesPayable', window );">Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment</a></td>
<td class="nump">$ 17,011<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term notes payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_A6.0NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_A6.0NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628289040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Annual Note Payable Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Maturities of Notes Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 20,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">22,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">22,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">124,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2028</a></td>
<td class="nump">650,454<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable obligations</a></td>
<td class="nump">$ 840,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627417440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 27, 2023</div></th>
<th class="th"><div>Apr. 23, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | One Month Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11448%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Three Months Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.26161%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Six Months Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.42826%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Credit facility, borrowings available</a></td>
<td class="nump">187,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913617751680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE- Second Amended and Restated First Lien Credit and Guaranty Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 07, 2022</div></th>
<th class="th"><div>Apr. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">Amendment No. 7 First Lien Credit Agreement | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">Amendment No. 7 First Lien Credit Agreement | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624495760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details) - Restated Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913621635888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Senior Credit Facilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 27, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember', window );">One Month Secured Overnight Financing Rate (SOFR) | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11448%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt periodic payment</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Debt periodic payment, percent of total amount</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Debt periodic payment, amortization increase</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">Term Loans | Term Loan | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.63%<span></span>
</td>
<td class="nump">4.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Alternative Base Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Term Loans | Alternative Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Term Loans | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.38%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.26161%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629146368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Line of Credit | &gt; 3.50x | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Line of Credit | &gt; 3.00x but &#8804; 3.50x | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Barclays | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Amendment No. 6 First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913621628160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio (Details) - Line of Credit - Revolving Credit Facility - First Lien Credit Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.00x but &#8804; 3.50x | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.00x but &#8804; 3.50x | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Alternative Base Rate Spread | &gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Alternative Base Rate Spread | &gt; 3.00x but &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Alternative Base Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Secured Overnight Financing Rate (SOFR) | &gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Secured Overnight Financing Rate (SOFR) | &gt; 3.00x but &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Secured Overnight Financing Rate (SOFR) | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=rdnt_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=rdnt_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623888144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE - Recent Amendments to Prior Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 07, 2022</div></th>
<th class="th"><div>Apr. 23, 2021</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember', window );">Truist | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631274560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount', window );">Operating lease not yet commenced</a></td>
<td class="nump">$ 4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">35 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeLeaseTermofContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Term of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeLeaseTermofContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629197152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 106,954<span></span>
</td>
<td class="nump">$ 107,475<span></span>
</td>
<td class="nump">$ 121,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Depreciation of leased equipment</a></td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">2,896<span></span>
</td>
<td class="nump">3,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">$ 2,896<span></span>
</td>
<td class="nump">3,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseLeaseAbandonmentCharges', window );">Lease abandonment charges</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLeaseAbandonmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Abandonment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLeaseAbandonmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631476304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Supplemental Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 101,516<span></span>
</td>
<td class="nump">$ 108,004<span></span>
</td>
<td class="nump">$ 110,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from financing leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from financing leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 55,852<span></span>
</td>
<td class="nump">$ 88,080<span></span>
</td>
<td class="nump">$ 186,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913621630784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Supplemental Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 596,032<span></span>
</td>
<td class="nump">$ 603,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">55,981<span></span>
</td>
<td class="nump">57,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">605,097<span></span>
</td>
<td class="nump">604,117<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">661,078<span></span>
</td>
<td class="nump">661,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Equipment at cost</a></td>
<td class="nump">$ 13,971<span></span>
</td>
<td class="nump">$ 13,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property Plant and Equipment Net Including Right of Use Assets<span></span>
</td>
<td class="text">Property Plant and Equipment Net Including Right of Use Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated depreciation</a></td>
<td class="num">$ (13,374)<span></span>
</td>
<td class="num">$ (12,171)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Equipment, net</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 1,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted Average Remaining Lease Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases - years</a></td>
<td class="text">10 years 7 months 6 days<span></span>
</td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted Average Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leases Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631250704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Maturities of Operating and Finance Lease (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 97,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">92,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">91,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">88,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">85,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter', window );">Thereafter</a></td>
<td class="nump">482,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Lease Payments</a></td>
<td class="nump">938,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(277,221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 661,078<span></span>
</td>
<td class="nump">$ 661,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid Year Six Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913624116624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Income (Loss) Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">US Domestic</a></td>
<td class="nump">$ 60,374<span></span>
</td>
<td class="nump">$ 59,529<span></span>
</td>
<td class="nump">$ 58,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(21,564)<span></span>
</td>
<td class="num">(16,560)<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 38,810<span></span>
</td>
<td class="nump">$ 42,969<span></span>
</td>
<td class="nump">$ 58,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623774960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal current tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State current tax</a></td>
<td class="nump">3,442<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="num">(2,191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign current tax</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_CurrentOtherTaxExpenseBenefit', window );">Other current tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred tax</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">6,470<span></span>
</td>
<td class="nump">9,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred tax</a></td>
<td class="num">(2,724)<span></span>
</td>
<td class="nump">5,863<span></span>
</td>
<td class="nump">6,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign deferred tax</a></td>
<td class="num">(1,843)<span></span>
</td>
<td class="num">(3,430)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ForeignCurrencyTranslationAdjustments', window );">Currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 8,473<span></span>
</td>
<td class="nump">$ 9,361<span></span>
</td>
<td class="nump">$ 14,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CurrentOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Other Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CurrentOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ForeignCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ForeignCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627355424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal tax</a></td>
<td class="nump">$ 8,150<span></span>
</td>
<td class="nump">$ 9,023<span></span>
</td>
<td class="nump">$ 12,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State franchise tax, net of federal benefit</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="nump">4,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other Non deductible expenses</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Officer Compensation</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">759<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interests in partnerships</a></td>
<td class="num">(5,752)<span></span>
</td>
<td class="num">(4,821)<span></span>
</td>
<td class="num">(4,114)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="num">(2,569)<span></span>
</td>
<td class="nump">6,124<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="nump">5,987<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="num">(2,530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Deferred true-ups and other</a></td>
<td class="nump">483<span></span>
</td>
<td class="num">(1,451)<span></span>
</td>
<td class="nump">5,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(1,083)<span></span>
</td>
<td class="num">(737)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax provisions</a></td>
<td class="num">(884)<span></span>
</td>
<td class="num">(749)<span></span>
</td>
<td class="num">(321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Tax rate adjustment</a></td>
<td class="num">(984)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 8,473<span></span>
</td>
<td class="nump">$ 9,361<span></span>
</td>
<td class="nump">$ 14,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913628965216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 43,247<span></span>
</td>
<td class="nump">$ 68,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses</a></td>
<td class="nump">4,432<span></span>
</td>
<td class="nump">3,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="nump">136,097<span></span>
</td>
<td class="nump">142,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Equity compensation</a></td>
<td class="nump">4,179<span></span>
</td>
<td class="nump">4,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="nump">3,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">15,755<span></span>
</td>
<td class="nump">6,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(9,688)<span></span>
</td>
<td class="num">(12,095)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total Deferred Tax Assets</a></td>
<td class="nump">196,220<span></span>
</td>
<td class="nump">216,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(7,851)<span></span>
</td>
<td class="num">(9,214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="num">(42,419)<span></span>
</td>
<td class="num">(38,820)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(15,578)<span></span>
</td>
<td class="num">(18,640)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets', window );">Operating lease right-of-use asset</a></td>
<td class="num">(122,840)<span></span>
</td>
<td class="num">(129,802)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference', window );">Outside basis difference</a></td>
<td class="num">(18,547)<span></span>
</td>
<td class="num">(20,015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(4,761)<span></span>
</td>
<td class="num">(9,081)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total Deferred Tax Liabilities</a></td>
<td class="num">(211,996)<span></span>
</td>
<td class="num">(225,572)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net Deferred Tax Liability</a></td>
<td class="num">$ (15,776)<span></span>
</td>
<td class="num">$ (9,256)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Outside Basis Difference</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxLiabilitiesOutsideBasisDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913629651712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 43,247<span></span>
</td>
<td class="nump">$ 68,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration', window );">Foreign operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">45,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized', window );">Deferred tax assets, tax benefit may not be realized</a></td>
<td class="nump">196,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Deferred tax liabilities goodwill</a></td>
<td class="nump">42,419<span></span>
</td>
<td class="nump">38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">3,082<span></span>
</td>
<td class="nump">$ 4,144<span></span>
</td>
<td class="nump">$ 5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized', window );">Unrecognized tax benefits, tax impact if recognized</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod', window );">Unrecognized tax benefits, income tax penalties and interest accrued during period</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, income tax penalties and interest accrued</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">128,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">63,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">145,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember', window );">Raven Holdings | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 24,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Benefit May Not Be Realized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Tax Impact If Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631237968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Unrecognized Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at beginning of year</a></td>
<td class="nump">$ 4,144<span></span>
</td>
<td class="nump">$ 5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations for the assessment of taxes</a></td>
<td class="num">(1,180)<span></span>
</td>
<td class="num">(999)<span></span>
</td>
<td class="num">(713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate', window );">Increase related to change in rate</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at end of year</a></td>
<td class="nump">$ 3,082<span></span>
</td>
<td class="nump">$ 4,144<span></span>
</td>
<td class="nump">$ 5,088<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913616152960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>tranche </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>tranche </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>incentivePlan </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,069,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Nonvested restricted stock subject to service vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,718,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Future Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of stock upon exercise of options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options | DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">235,227<span></span>
</td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">27,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,725<span></span>
</td>
<td class="nump">169,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">60,685<span></span>
</td>
<td class="nump">25,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares expected to vest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">12,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">235,227<span></span>
</td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913623766304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Outstanding Options and Warrants (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares) | shares</a></td>
<td class="nump">678,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(12,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares) | shares</a></td>
<td class="nump">911,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares) | shares</a></td>
<td class="nump">668,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">11.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">16.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life(in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 2 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">5 years 2 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 16,561,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 13,387,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">261,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled, forfeited or expired (in shares) | shares</a></td>
<td class="num">(16,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled, forfeited or expired (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 17.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares) | shares</a></td>
<td class="nump">116,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(37,909)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares) | shares</a></td>
<td class="nump">79,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares) | shares</a></td>
<td class="nump">76,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life(in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">5 years 9 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">5 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 2,749,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 2,663,803<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913627184624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - RSU's and LTIPs (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>tranche </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>tranche </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">536,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(785,656)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,008)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">60,685<span></span>
</td>
<td class="nump">25,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">235,227<span></span>
</td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod', window );">Forfeited or Canceled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94,897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue', window );">Forfeited or Canceled (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,725<span></span>
</td>
<td class="nump">169,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_AILongTermIncentivePlanSharesMember', window );">AI Long Term Incentive Plan shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,309)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_AILongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_AILongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139913631390608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Feb. 01, 2024</div></th>
<th class="th"><div>Feb. 16, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HoustonMedicalImagingLLCMember', window );">Houston Medical Imaging, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AntelopeValleyOutpatientImagingCenterLLCMember', window );">Antelope Valley Outpatient Imaging Center, LLC | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HoustonMedicalImagingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HoustonMedicalImagingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AntelopeValleyOutpatientImagingCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AntelopeValleyOutpatientImagingCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>129
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%Y9/Z-3.@9OC6M,ZAR'P2D/@F7/Y/:W[A/"-&MA^!06Y!0N5[##5-[O_<^G
M'-<:VSF<@5<Z \^<S\\F#PLT3L-(,H[&4A+PZ-G4Y$.,-UIJ9KVZ15!S6&MH
MYW !?ND"?',27ZQ0/404TR ")YK-"67G[CG/9L7AU9#OTOE+H=3O5S#?IK8%
MFN-:[TTXAUGP2[/@-UI>6&XA]S5UUQ,R];"L.@5;:E58I5/P&SF%>;J*HP#Z
M*,/:[,.LTGHGC%7'L%?K9VIJA]WSR+MR;[K/.C!'NX,:&8'J],1RBZ% Z',J
M852CRKAK8=G=-I2K71]5[WK8&_1[/;^HXQ[$.<R 7YH!WYRX'P8Q<;2R![G5
M2JV/K@GDM?IY[1.J<^4K&!5JLDEN">+%6NN//PP]=_"+4!L,(QIE6?2.L]<W
M)(JQ<PTCIXI26\X.VW$^$9(Y%1#,'NN6Q2'A L&C1=%QR;=0Z(BJ"O!#!=26
MO#GF$LUFL[Q$$03FNCSS0$B]ZAA/D-KFA"3+;D]>I2I-5JZ#[A5:IL'V;R5^
MB6#46A&TAI0TA"-(.93"?@8D(NIV83D/HMIG)++]G[N4BU2M0<--%V23QOE[
MU^V-$642P2%1,#"<\AP4XC>06N?G" IB)HB!\3K?;?)&,-<N4)N?8NLN?0Y[
MYI?VS&]DSR;P/#A4>D9#\HI^(_JWB%G*@7^#]T[?N]92LVK/;*E5J97VS#?;
MJC&TWS#/8FI2O1,"]6]<JR[,EEH54^G"?+-[.LKULBZUW_OV *>U9NR$W,-7
M+3&K3LR66I58Z<3\AONWCK>\U?,RB]7M#S2'M29FU81UCW:6*SN:[= 7*% ;
M9?)-YL79XE< XVSO>[>\//\)P2>LW*Q ,5E#J',U@#&#Y[OR\P/)=MD^]163
MDB79QRW!\()4%\#W:\;DX4#=H/AMQ.A_4$L#!!0    ( !N'75B,>P3?30(
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MO_?97)6L&D9E:%&X(CT(;4K>37/38T%:![-_%$*?#7M T[6COU!+ P04
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MA>\<<HO^0A'GY?_@96?K=$"XSJ5(=HV5@B1*MW^#'[N!V&L 24L#M&N 3FV
M=PW*D>MOE95N#0,9#"XS\0*RPEKU5GPHQZ9LK;R)TF(:IS)3OT:JG1S<W-]-
M[V_'P^O9: @^7=]>W]V,P/3+:#2;@AYXG [!KQ]^ Q] E(+94JSS()WGEWVI
M[ERT[X>[NWS:W@6UW&7(PPN 81<@!V%#\YO3FZ/#YGWE;^4TJIQ&97^XS>G'
MR61T-P/7TZGRT^3.MCTQMR]"ZV.^"D)^U5&QD_-LPSN#GW^"U/G=Y-R9.CMP
M%5>N8EOO@YL@7P(U:2 L/O#OZV@3Q#R5QDG<=L7*KHKXWPPP02YS+ON;?7]T
M,XB8ATEE=J"45$J)5>EU&(JU$J:20\B5RJ>8FS1N.Z'[-Z>8.:RAT61&L<O,
M&MU*HVO5^)#Q51#- ?^ATFC.\W)DA5SR3,5JEJEQ!4&><_/HNIHDPJC;%*Y;
MN:1<]2;=M-)-K;IG0@;Q"1*I?G/F(T8;&G4S3!GT6A8 JT0R:U0^3.X?1I/9
M/UTP^O-Q_/"UC-"[(9B,/W^9]>[_Z#U.1Y:09><,V3-U=C .7C4.WI%%IB"=
MR==R<141NU+8E%V0<FGRV],F@SJ$.+ Q9[J92UV?0O.<^956WZKU7BD-9)0^
M@Y@KF(*LH&9/+'KKG/?:UYFOB_&I@U%#LVZFC%S4LLZ@4S//.2$<5KMQ[M:#
M7 [YB3[L[G&08E3Q1#!N>&$RA-0GGMOBQQZ[H35B[F=?1A-+2.R:GRDFSM7;
MH;,ULZ&5DX//0LQ?HC@V.HKTE<)\0K6I,-DQ2MMFHJ8LM&/VOF1 E,H@?8X4
MN2PY=M?3O@;?H=!M2M7-H$,1\EJDUIB%=LX.^8(K#LS!(DJ#-"QB-Q1YBU83
M1HDVJKJ5TNFT"*U9"^VP':<;GLLR+%7U^:]0HPLVZFJM5I=1K(Y.Q2[8K%X,
M9B[S?-PBMT8LM#-VR%<BC^1>36 4J;-3+5,]9QA(C"%K*0-@C5AH)=<N\UD6
M)].GDOH.89I @Z%*?;[34F'!FG[0.ZDXOQU??QK?CF?CD3FW62'Z[MQVIMX.
M?:XI"NT8K6K?5?!:%+Y=M;T-LS4W59K&P=!)J2IWGVAKWV!'?==OR7^H)BJR
M$[5**AE7(;HV5NY(YR"AI%G_FJP<U%*FH!J5R$JGP<VN]EV)K#P^$ L@&K5+
M' 5/41S)5Z-XJ >DZWO-*LMDQFA;4*"]#:L=?@;YJ9"\6C!&R3KL(/,9:4HV
MF"'BM*1O5",1V9%XN.=X&]S(G+N13CN"&7&;%:')CE*&6K(WJJF(B#7KW-[?
M?>[-1I.OQ_(.LM+UW4<#9^KMT.L:L<B.V%N1/O<DSY)W!H..4.JXCJ_%LLF.
M0-@6#C5KD9VU=_MKO]P9%1$1'@:)4;G.54]5[=1K*C?881^3EJT'J@&,[ "N
M$J4,?M2#W+JY0SIFH<NT#;G!S$<N;1%;HQC9=Z+;JC85:>_4,#9L1AG2DJ1N
MA; #VR!44Q39*;K-.,<DZ@B$'F,0:GG18.@31-P6G;B&)7:LN682S.^XVM"/
MT_ "Y%*$WY8BGO,L_Z7<B<K7C\;#.2N!WYMXSM7;X1#4.,9'<"R21&&L=![T
MP(<+QW&@"N@,;()XS8N37J?K;/^!?!ED106TEDN11?_Q^>^ LJ[OTBZ&7ED8
MN:RK&-"%R'TSCO*\*)_*JFDM<[4OFQ?)+9!@R$.>/*EU_78>71H5)\NJ>,E7
MO'RN$!OS'M;IWDQY!I.6,,0U_+$=_M?S>50DM.+,(HCFO4C%8["*U&(WBM1Y
MSA!BKG:*J]L13)'7LL'$>R?.=O"K8G:=K.- \NIL5"1J%2V+AS\;A1:1FT^?
M=;;W5"7B-0/39*=2.&NA"JYK 'ST!+H2/N>+*(R,.1GKV]T>\]4>LJG38.<A
MVG:6BVMJ8SNUMWEN/XO\DAOSB%&]@<G8H7[S_,%@AS'RV[8*N&8W/L;N-!2I
MS$0<%Q&I=O5<Q5W+ PD=PU -(=66A,'.]4C;<3^N<8U/V2];1E,'KP<Q=OVF
M0-V.^'"_OCT46",:VQ&M,:\Z-6X1;&"O<8-O,K1M\'&-:7QDL[M8**TJRLQ3
M;FW\;LR=J;?#)UHUZ8F=],<?-)*S4OU<O1VZ6U.=V*D^7'.PR$0" NL4$YV1
MR,6DN=<SF$'/9RU' :3&*3GMZ>^1C1XYZS/@<_5VZ'/-9&)G<C$S4AR;%\.#
M7=?7#E -9@A#[<"@O_=20O%&R-<@>X[27.TO%ZJ=<\$48++M2Q;;"RE6Y7L*
M3T)*D90?ESQ0/"L,U.\+H79]NXOBU8?J59?!_U!+ P04    "  ;AUU8"*BG
MP:L"  !9!P  &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;*U576_:,!3]
M*U8V39VTD2\2NBY$HH&JE;H6E6Y[F/9@D@NQZMB9;:#;KY_MI!&T=*72>""V
M<\^YYUP[U\F&BSM9 BAT7U$FATZI5'WBNC(OH<*RQVM@^LV"BPHK/15+5]8"
M<&%!%74#SXO="A/FI(E=FXHTX2M%"8.I0')555C\/@7*-T/'=QX6;LBR5&;!
M39,:+V$&ZFL]%7KF=BP%J8!)PAD2L!@Z(_\DBTV\#?A&8".WQL@XF7-^9R87
MQ=#QC""@D"O#@/5C#1E0:HBTC%\MI].E-,#M\0/[F?6NO<RQA(S3[Z10Y= Y
M=E !"[RBZH9OSJ'U$QF^G%-I_]&FB8T&#LI74O&J!6L%%6'-$]^W==@"^/UG
M $$+" X%A"T@M$8;9=;6&"N<)H)OD##1FLT,;&TL6KLAS.SB3 G]EFB<2K/K
MJ]GUY<5X=#L9H]/1Y>@JFZ#9^61R.T-'4RR J1(4R3%]CSZBM\A%LM2K,G&5
MSFXXW+S-=-ID"I[)-(:\AT+_ PJ\(-P#SPZ'![MP5WONC >=\<#RA<_PS116
MH(^C0GR!S@C#+">8HBF7Q)ZO'Z.Y5$*?LI_[K#;<_?W<YLL[D37.8>CH3TN"
M6(.3OGOCQ][G?<;_$]E.&<*N#.&_V-.,5Y5VJ\]9?J<WN,8"K3%= 3HB#!6<
M4BPDJD$TV_Y^7RV:!,<V@6D:Z]3K>9[G)^YZV^6+83OZ^YW^_FOTXY4JN2!_
MH+ &FK.Z5W5#&V_)T8VO^3T2?DCDCO:HTQZ]1CN1<O6R[NB)FGCP*8I#__B1
M[ ,"=U3'G>KX-:KUS2 59@5ARY>DQT\418-!$/I!]$CZ 8&-='>K\9E+YPL6
M2\(DHK#04*\WT$4032-O)HK7MA?.N=*=U0Y+??>!, 'Z_8)S]3 Q[;6[3=._
M4$L#!!0    ( !N'75C(M4/RD @  &TG   8    >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&ULQ5IM;^HX%OXK%CM:S97:$MMYO=LB49+;HFFA GIGI-%\2,%
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M3_=$U%=Q,]NT?:.JVVG-CV4[6'=O_]'4O>0,LVU.."H@E9360U>6%5;W9_5
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MC$I&#&8R!)!)$6-FS@;!*"6F=X=@V _#@6R&:+E$W'*II>.@8<N7$681,VE
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M:BTYE;5^EVI11MRUI=M7U004&?02V<\D*:C [@5J0=B+L5EF '$DC@,S:8"
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M=69R]>8U6J;98$6$V<K*(G84D@ 0==C"&U"=3$LTYI9HAT'F?;R.;]P=AR0
M9.0D=G <RJVZYONI^:X5:,LC'YO[/!, 9=%Z\TX>TPJ+N2M6AR/UGLT2!E2>
M?!:;(AF 6:Q<D#XK+7+8$9'36UE=*&@VA#8;M6.N-K_>$2N8K5L(\R-JN5$;
M9_%U0?I\M?AAQ\3/6_BBW;;91>=EEK>9D=@.UB085(.RZ *%K]C, @$0BP8T
M -.*A[D5#UBPTZ=:W#D0@XX9^8&5XP&XF ;6Z2O(G,>"P0BAA0X[<G#I\G(Z
MN5=GB:?_F_P^GOTV17?C^REJ/\_1S:PY9 Q2!$I )+8&$! XV(KZT%&E@33>
MU]+&=TN;V?0>7<TF=]/Q?(I^3J;MIU_DO?;@]'B6M!^F__UV]7U\K4Y5@^<N
M@:TT*=*H65\&<*,@-(50 L H\8?FJZ\ECN^6.(.</J '_I@7ZEA:4U7C92X6
M(%% AI#P<"]F3Q22*RSP3-$*X3SBX2&J6M?X;EWCH,I51=1)$B@L,>);Q0D
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M^@YEQ"'@T*G=[-!'N>/15];*^#5_2Z;#$62H?'#M[_:?JZ_D*^VP7+YU8QP
M#((JS0JOGLPNSR<R_Z:+UC7\S7;IVM95_+,P&D,J+<#SE</8%B]H@_XC_LO_
M E!+ P04    "  ;AUU8M:*VMV$L  "CA0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6S=75ESVTB2_BL56L^,% '1O'1UNQU!4Y2;,[:D%25[.S;V
M 22+)-H@P,$AFO/K-Z\Z (*RIG=V'_:AVY((5&5EY?'E4<5WVS3[EJ^T+M3W
M=9SDOQRMBF+ST]NW^6REUV'>2C<Z@4\6:;8."_@U6[[--YD.Y_32.G[;;;?/
MWZ[#*#EZ_X[^=I^]?Y>611PE^CY3>;E>A]GN@X[3[2]'G2/SAX=HN2KP#V_?
MO]N$2SW1Q=/F/H/?WMI1YM%:)WF4)BK3BU^.!IV?/O3Q>7K@2Z2WN?>SPI5,
MT_0;_C*>_W+41H)TK&<%CA#"/\]ZJ.,8!P(R_BYC'MDI\47_9S/Z#:T=UC(-
M<SU,XZ_1O%C]<G1YI.9Z$99Q\9!N?]6RGC,<;Y;&.?U?;?G9?N](S<J\2-?R
M,E"PCA+^-_PN?/!>N&P?>*$K+W2);IZ(J+P.B_#]NRS=J@R?AM'P!UHJO0W$
M10ENRJ3(X-,(WBO>3YX^?QX\_*;N;M1D_/%V?#,>#FX?U6 XO'NZ?1S??E3W
M=Y_&P_%H\NYM ?/A6V]G,O8''KM[8.Q.5WU.DV*5JU$RU_/J &^!4$MMUU#[
MH?OBB-=ZUE*]3J"Z[6[OA?%Z=O4]&J]W8+S!;):621$E2W6?QM$LTKGZS\$T
M+S*0EO]J6C&/UV\>#S7HIWP3SO0O1Z BN<Z>]='[/_];Y[S]\PO4]BVU_9=&
M_Q_NU8MC-U/^^@G5_</X=CB^_P0_PM/#N]L)?'(]>!S?W:H__]MEM]/Y63VN
MM )KDH7$<-+'J$"6IPLP"M,\FD=AAK^'F591,HM+D!KX017P8@A;M=Z$R0[?
MG:5)#OLU#PMX8!$E83*+PECE!?P!+$:1JV.<M-O^N>E#^JCS\XE:9.F:!L>!
MD(IP]O<RRB.T%RTU3IYU7O!P0 1/C^3!+]M5-%NIK5:K\%DS?=,HCHJ=*E*E
MO^ML%N5:Y=$RB1;1+$P*>&D1ESJ9Z4!-RT(E:8&K*+(T#FB](8LBKB<%0[.C
M0360 V.N=;%*YRTUB&,8IX#1F14*Y#3)0[)OP+5D#@8JAN7J/  S4JQ46F95
M7L%BF.7X,,Y0)KDNBA@^"M<X/W+A\!1VT IA\ )R2N.TQ(^IUHG2<03VBF8E
M[ADJB+>#G/>#/KM-@?L=X&#Z#-Q!JCYF:;FA=Z*\(/GX,AXQT<!S;T7T=*-,
M>=Q09!YI&!W.5BWU-!FAE(XFC^//@T<0V5.2S49!<@L"O=C 3A')N%O9G 8G
MGCRU)BVUU D0$L<[_%AO<'6A,S";#$0ZVL1 V_''P>#^)! IRI"9H'-@UA/P
M@S@M2M$Z_ 8"D!<1N!Y93YB#[]SP5A2KL%#A8@'>C>6/MB^'T39I5CB]:5P4
M#>8K%(BCSEO(A?RE266^9U#3M$2""Y 4V'565AP(A<.28&A"S<IS+1/'$>N*
MJ-*>C-9V+2RLBM)(AQ;U,XTTC_)9G.9E1OJ,&@94(4</$/#ZT?'-0ZO+]+-.
M2F&8_@Z(*3^P.&\3X#V17&3MO,R0?S@_ST RHX'1\X:- 8U+8Q#,W\OYDD<C
M,00IVI! I"HIUSK#35J 4J29$1C@RSQ:@$T"U(*/@5#/(WB#=CI#2=^E\*,3
M13+>%S_GQEJ1[H8X$XP0H,:5P"C#"Y#V&-\&L8A($W RG5E+ZR^BI1Y&7T:W
M3Z!_QD/<$7^%ETZ=,AV3KL.J *9N@&.XHPLP./#13 .LF_,,1C WX0Z7C(N2
MIW']>@UH$"P5&+VYSGA!0+]GT'&[@.>$=5$$TVD<+66#D#O$L/0YFB,7PV62
MPEIF"KUE!$87/\;],U/" JU<9+BM:#. 5&^K>8-A=LVRXD_X@\EPR!P>S1>1
M!M]P]P+IZ%$.#>&X; =38(<SV&,A#N04C!8)$!"9H++L2"(M!U$":(]PME6T
M$6DT?$#[H-8PMYH!?H9?PSA/K0B','"4S4_!MH)'H9U3QY]1*H&\0/%/T3P0
MF9PK_+M:Z3#&*<!4\#Z#,5NCVPW118+^$Q.LS_9-%+^3HEQJ=(*@)<L5[88,
MZM[7WV>PZ*7.3ZS#)*E#AN(OEI.R4:Q#<PT&8(XB6FY2ML*@#VOO*7#O9H4T
ML%LD#)SH95I$9"V(C?^3=?,^ 5/)JX19AJOQ#,8>ZQO6!A[7R*$(..NCKUN[
M#=!/0@3V)UKLS)1D8(UQ\*0(A!4L83(/,UC!*LR68CN=-)HID1P[&,9?<^8J
M&BZ-; 4@.U<96440V$8Y3]DO&'RE]2F,>BH?\[LM]=EY7W8;I=B>9XP$:=V^
MO(L9BXB4=$9+2QFRH''!Q8#(I1F8<K1=Y89=##P3AUM>;*:791PZ\$;BA6B
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MG5^3;!R 4>6#T< &"@V9! [/T1LDN*;3?(/LQFU@Q\@+SM)E%J[S@$-N(*T
MJBM N 5RUYA^LNYA4V9Y&7(2/$WT*?K0NE.NSHGO(9;^JDWH#EX"A@0 $P%0
M\T!:[ER4ER.DL"+$M'[B8#?'MB'BUVDU]2#8>2;)*@\"1GF.'I%2K:8X%&$F
MB*&V<7,>?G2@D<BG-\AJDMX!!SA]2V)KT7@5F,!F0?!1NB@?M  P, 1!H50J
MZG+"\I&DR2GJ%;!;^X-'B<U[$0^H-N"]GKNZV;3<$>,Y/5VM1NW5M$+.&U,P
M@+QJIDV0BT</#8M)9$W5!PRM)!<MB4I,;$3Y-Q]T<T3C*)8_&7KO,6.C 44
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M,[N<@_K=!A=@5Z647FG1]=I-A>\D/YQ7,GJ ;193;%.3K#MI@4OT[A-IHT3
M(K^7UHNF!WG>Q (3-&$(CU8X3;B)?+& ]W$P(Z\M]63Z6+ Y(RYM:U3CJI2
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M$'</*S0I5?;\E8^H.D_Y,&RYX+&IW\)9,[ ^LV\(2BG 84,@F*;RT5KS#5Q
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M6'$3=XYW9))"F9J; 1U8<F[KFE+!^?.T^5J3VV<[LH0>P@%2BKR7.Z,4T@,
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M(KIR3K!%<IUU_)QMX3-KHE^M^1T<J(P&0+H90#5D'N)''-BX?;-8VW''G9;
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M!?;<=(TGJVSY 'Y?:FVW"Q:P>P2?_A]02P,$%     @ &X==6-6=FDJ\ P
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M;Q^>_H#%^QNX_?CI;GE_^_YIZAO$MA9^OL.YZG'("9R0P+VLS4;#;5VPXC6
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MX]@1T:-XXPH%.)J5&+-/G29-:(:18S78(XV//.5$\L6NL)\F99<'GS7/:-7
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M(?T1@-F)B.1/R\/;X;^&&W_$WB_W?U1\PTXJ,0)68@G1<)PE(]\U=@]6M>[
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MCA#$5U4->B"*0GQ!D?&4Y4R#28*WCZUJJ.!^I9>O&MRP(TFG"*ECQ-HA#XU
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M@/=+#3/X&]J@^U^*=_\'4$L#!!0    ( !N'75@W<;=TM H  .8@   9
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MEX+#>IJ \;E"YG /M$'W7QO._@E02P,$%     @ &X==6'-=TW[0 @  IP8
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M!R4N2<OTC=A\Q[Z?D>4K!%/N"9LN=AQX4+1*B[H'FPIJRKLW>>CGL ,(QP<
M40^(G@.2 X"X!\2O!20]P(W:[UIQ<\B))EDJQ0:DC39L=N&&Z="F?<KML=]J
M:7:IP>EL3AYAK6".TGU"O$#(J2J84*U$^ 1WMSE\./D()T Y_*Q$JP@O5>IK
MD]LR^$6?9];EB0[D"2.X%EQ7"K[R$LNG!+XI>J@\VE8^BXXRYEB<01R>0A1$
M\9Z"+E\/C_; \]?#PR/=Q,,YQ(XO_I]SV#?NCB[93V?%XEPUI,"I9]1 H5RC
ME[U_%XZ#+_M&]99D^1N1/1EC,HPQ.<:>_3!"27DA:@2BM:2+5I,%0] ";DAI
M=D_ABIN3,Q&U41USO8K[2K 2Y=YONDLV<<FL@*ZS.$B2U%_O#N]E4!B,1\'3
MJ/QE5)1,HLD0U;7K[]SD&N7**:(RY;9<=U=C\ ZB>^&TYIE_9L2XT\Y_-)V2
M7Q.YHEP!PZ6A#,XF(P]DIXZ=H47C]&(AM%$?MZS,#P6E#3#[2R'TUK )AE]4
M]A=02P,$%     @ &X==6&0ZHFM# @  B@8  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&ULG95;;YLP%(#_BL6D/;7AELN6 5+2;EH>.D5IMST[< "K
MQF:V">V_KVT(RZ:$2GD!VYSS^3M&'**6BV=9 BCT4E$F8Z=4JEZZKDQ+J+"<
M\!J8?I)S46&EIZ)P92T 9S:IHF[@>7.WPH0Y2637MB*)>*,H8; 52#95A<7K
M&BAO8\=WC@L[4I3*++A)5.,"'D']K+="S]R!DI$*F"2<(0%Y[*S\Y7IAXFW
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MMY_=^J?::)7Q6OU_R)WN.##'5,*(V&P0FXUR?G!V>X7<./0]N?D@-[_JU)Y
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M=F0>(!(J -HNRTO'NZV;(F ^4P-+Z**/6"BZ)I7Y'D%49!4NN 1J!<IC@8&
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M0MT,5O^4^4+>QIWD99G/Y>.,ARC\U #?IWE>-O^0@O9^]O%_ %!+ P04
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M0:BL 9V74IJ#8@.,?[7%_U!+ P04    "  ;AUU8/YE@B_<%  #(#P  &0
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MQ9>?:ZXQ8*Y) .>7"@^]JD,&ZL?[Z']02P,$%     @ &X==6 5GHIRF!0
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MDF S5NUEI_TPLG87C*DT>%UQPR7>#[FR"_#_7.*QH_NP&_0WSM&_4$L#!!0
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M6/)R^C%S&<Z4)P#492S 2PG@2%-%;5-%KVZJV\G@:$,=1?H/#;6N[H6V%<'
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M7.+JQR5NS4)9 _P^E]+L7FR =@_O_PU02P,$%     @ &X==6!C.+ /E!0
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MJB'%K*@J<EH6Z5PH$CK@CF1\PT"8+?&R+F")^A\;X1P:,7&TBG]ML[? M:^
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M+:,KMF&KH4,O\%K8VLD&P[[?PJ9(Y@7.)6S!$5O0=8"A*");.=U1'.%X)Z=
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M=7E6#[+6!X5<5:.=7V2A.JUZN11</4++ /7^7,KBY:#\@.TX\>A_4$L#!!0
M   ( !N'75COKTI'" ,  '\*   9    >&PO=V]R:W-H965T<R]S:&5E=#,V
M+GAM;+5676_3,!3]*U<!(9"@:=*TA=%&ZI(-(M&M6AD((1Z\Y+:U<.S,=EOV
M[[&3++2059M47A+;N>?XGA-_W-%6R)]JA:CA5\ZX&CLKK8L3UU7I"G.B.J)
M;KXLA,R)-EVY=%4AD60E*&>NW^T.W)Q0[H2C<FPFPY%8:T8YSB2H=9X3>7>*
M3&S'CN?<#US1Y4K; 3<<%62)<]37Q4R:GMNP9#1'KJC@('$Q=B;>23RT\67
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M&V"^+X30]QT[05-SAK\!4$L#!!0    ( !N'75A!)YJFX (  ,<'   9
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;*V576_:,!2&_XJ555,G;4WBA 0Z
MB$2A[9!6B@ILFJ9=F'  JTZ<V0;:?S\[23,^THZ+W1#;.>_+<T[LX_:6BT>Y
M E#H*6&I[%@KI;)+VY;Q"A(B+W@&J7ZSX"(A2D_%TI:9 #+/10FSL>,$=D)H
M:D7M?&TDHC9?*T93& DDUTE"Q/,5,+[M6*[ULO! ERME%NRHG9$EC$%-LY'0
M,[MRF=,$4DEYB@0L.E;7O>R%)CX/^$9A*W?&R&0RX_S13 ;SCN48(& 0*^-
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MI>Z]Y1Y5>R K]D!=LH5#F#N8-K*)7(R;S6;;WNRF41/FX"#\&[8'Z%> _K\
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M8'?:V=E<<RK6)("AI283 7P#UNC];[CG?&[3S23,-P1K:-JI-.WHZ*.%XM$
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MR0IOF;SFNT^DZ%#>P("S-/^+=D59JX6";2IY5 2K%D0TWO_']X40!P%V_YD
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M"F.@GT><J\W$O*#JN\?_ E!+ P04    "  ;AUU841>;/YT/  !>[@  &0
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M5$O<]D6;W&%'JH_1*!HVC:*A_EI&>W>'15:6DVPUN^V*IE[M&TU4\U#-1[4
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MGZ(2]].0W:[MJ'D2*\>M36E?5V \M95 L]0";=^N3 W3F#]1?;F"1),8H;9
MWUN(-*L2:99:I.WNS-0 C8E#@K9P.^WZWH+$2E)-?8E9O3LS-L[21B2=%H>8
M,S!.%C%='14M[Y8'I4^+X\&U^P-XXJ^..U<PJ]/7ESAEKYL,A.2109I';=8S
MIJL#S:L+FLR+$[NCA-(D*C[."&:+/3=@WS\F"7VYR <HCY7W_P=02P,$%
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MA9[E)X3Y0-!-=LCV0(6@<7:[!KP E@;(]TM*Q=,@/;<KSVF'_P%02P,$%
M  @ &X==6##KN =C!@  /1P  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&ULU5EM<^(V$/XK&GK3WLWD@M\-:<(,8.Z.:0(9(+WI=/I!V"*H9UM4DN'N
MWW=E$P.V<9*.;]I^2?SR[&/MH]W5"EWO&/\BUH1(]#4*8W'36DNYN6JWA;\F
M$1:7;$-B>+-B/,(2;OEC6VPXP4%J%(5M0].<=H1IW.I=I\_N>>^:)3*D,;GG
M2"11A/FW 0G9[J:EMYX>S.CC6JH'[=[U!C^2.9$/FWL.=^V<): 1B05E,>)D
M==/JZU>>D1JDB%\IV8FC:Z1<63+V1=V,@YN6ID9$0N)+18'AWY8,21@J)AC'
M7WO25OY-97A\_<3^(74>G%EB088L_$P#N;YI=5HH("N<A'+&=I_(WB%;\?DL
M%.E?M-MCM1;R$R%9M#>&$40TSO[CKWLAC@QTYXR!L3<PB@;6&0-S;V"^U,#:
M&UBI,IDKJ0X>EKAWS=D.<84&-G61BIE:@_LT5O,^EQS>4K"3O?G#W5U_]AN:
M?D#S\<?)^,-XV)\L4'\XG#Y,%N/)1W0_O1T/QZ,Y>H]&F,<T?A3HGG T7V-.
MT%N/2$Q#\0Y>/\P]]/;-._0&M9%0;P6B,7J(J107\!"N%VN6"!P'XKHM8?!J
M"&U_/]!!-E#CS$!U ]VQ6*X%&L4!"4X)VN!U[KKQY/K J&7TB'^)3/T"&9IA
M5@QH^')SH\+<>[FY7N.-F4^DF?*99_CZOL^26,+TH'L64I^"^K_WET)R2*T_
MJO3.^*QJ/E5OKL0&^^2F!05%$+XEK=Z//^B.]G.55DV2>0V1G>AHY3I:=>R]
M"=1:&OLL(@A+R>DRD7@9$B09FN$ WEZ@<0Q3!X@(ZA8DJ/]ES<* \,J@SC[F
MIA]3-7C;,S7+NFYOC\4K@W3-L;53E%=&&99KN#GJQ%T[=]>N#9M!?SX>HLEH
M@<:3X?1NA.Y',S3_U)^-4'^QF(T'#XO^X':$%E,TZWN NU# 2P38N^D$S1?3
MX2^?IK?>:#:O<M]N,L::)/,:(CL1W<E%=VIC['.Z&I$ X2WAL+JB.(F64%+9
M*@^KK'S"0BTDU$N5U4'"U3^Y)FA#.&4!>DN?@.^JM,_&X!S%BV/:'4VSNX7P
M*P-MQ^B:IND4(K ":%A=QW&[U4'HYGJXM7H,L* ^B@^9!PYFGKTZ!U-1 A:&
M&*YSFDI]LC%UC[S1+C6[H$T52"\(Z%6!K#.)V<DUZ=0FIC>^?5B,O.^7FITF
M4[-),J\ALA/9N[GLW?] :G9?FIIEX)G4K #6IJ:N'1I$K5:1?A"@F,5;(I0L
MX!$DI*\NT[2##</R3^CA$8O#;RI!U810GR"%5Z(\H\3^X\<#AX:HVRWF805.
M=PW=+*9B%9_=M<US,ASUR?JS,N @H&JW@L.\OQ4B24M3LH'0(%\)]ZD@*EHR
M==A&X:']W6'.<2P%@I!!JE8ML1(O8WE.([WD4\>%Z2UI5(&SP76[J%$9YSA6
M1[?/:&0<-#*:29Y$  B<]G'H)R%. R6@8:)L*Y>!YQ0RRAY9CMV!0"IJ5$;:
MKFEH';?8;E4A3<O0-=,\H].A5==K.]C><(WCQVQWM,*4HRT.$UCJA& ^Q4J#
M'95KD"QMYTDL(;/R0,M4J!3!+#6(6M'[,N2]:UA%S^N(3ET^=-5Z$VWU3Z)R
M35\QGH='%@]YX+"X4HH7M=T5J&[7*%;6"E1-WZT?&F^]ML7L>77Q_AW;GOVP
MGNE[*E&Z6]2F"F4Y9Z0YM,=Z?7\\KRJN:G4]6V K':W]R&L[G$;9O*;83@4^
M]-NZ6]M<SH^U2Y<D6.'?EY=X#,M6($!V/TP"N%]Q%J43 2&X@>A,?[J#N7A*
MSJ, CM2O$< M%!YJ'%FM5)NP8TD8H"4 H+BE9G1+KBJGKW;/\.KI:Y+-:XKM
M=/H.6P.]M@4NK[/[9575R=V:^NO39-EPU9#!)!("D_ED$V'^!4I/]O)HA4Y#
MX[GUME-:&UW;TDV]6$7*.-TV7,,LUI$RSG+=KG&FD!R:>?TEW?P_DDF]>HE4
ME?+4CNK5H=LDF]<4V^E/KH?=A*'][RN/4;LA>NWT-<KF-<5V.GV'79!1OPOZ
MURN/4=Z[N)KK%!O="EBQOZ^%9/*TC\Y5(L(?T_,IU:)"@&7G#/G3_ RLGY[\
M%)X/]"LO.\DZT&0':W>8/U+(A)"L@%*[=*&CXME9578CV28]O5DR*5F47JX)
MAIY/ >#]BC'Y=*,^D)\8]OX&4$L#!!0    ( !N'75@8D;Q@M@<  .!&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;+6<;T_C.A;&OXK5O5K-2'-I
MD]("LU )FC^W5Q<&36&N5JM]81K39B>Q>VT7!FD__#II2.HV]5#M R\@27-^
M=N('GY,G:<Z?A?RN%HQI\B//N+KH++1>?NYVU6S!<JJ.Q))Q\\FCD#G59E7.
MNVHI&4W*H#SK^KW>L)O3E'=&Y^6V6SDZ%RN=I9S=2J)6>4[ERQ7+Q/-%Q^N\
M;OB:SA>ZV- =G2_IG$V9OE_>2K/6K2E)FC.N4L&)9(\7G4OO<]SWBX!RCV\I
M>U8;RZ0XE <AOA<KD^2BTRMZQ#(VTP6"FC]/;,RRK""9?OQ503MUFT7@YO(K
M/2H/WAS, U5L++(_TT0O+CJG'9*P1[K*]%?Q_!NK#FA0\&8B4^5O\ESMV^N0
MV4IID5?!I@=YRM=_Z8_J1&P$^&=[ OPJP']K0+\*Z&\%' _W!!Q7 <=; >;<
MMP<,JH#!=I>\/0'#*F"X';"OA9,JX*0<K/79+8<FH)J.SJ5X)K+8V]"*A7)\
MRV@S(BDOI#C5TGR:FC@]FMY?7U]^_2?Y$I'I)+Z91)/QY<T=N1R/O]S?W$UN
M8G+[Y8_)>!).R:_D,DG20D T(Q.^_C<P:R?D0\ T33/UD?Q"ND0MJ&2*I)S<
M\U2K3V:C6;Y;B)6B/%'G76WZ7;3>G55]#-9]]/?TT?/)M>!ZH4C($Y;8@*XY
MX/JH_=>COO*=Q!OQ=$1Z@T_$[WEGY'X:D ^_?*PZWM*_L9L6L0=#\TK:Z<]I
M@9L6L-D1Z9<TOU_34O[$E#9S@";_$2G7W\S22K(6?.C&?YEIT]EAA=\8K[W]
MC=X ]+SJ7.ZEQ&[*[Y37Y[ >$<=(]VM]]TMN?P_W5II96^J73^0VH^;D&062
M\*]5NBQ/Y;_^,+N3B6:Y^G=+GZ_6[.-V=I$E/JLEG;&+CDD#BLDGUAG]_6_>
ML/>/-A$A80$2%B)A$1(6@V"6=(YKZ1R[Z*.;5?[ )!&/&_]\BOQW8ZU-,D[F
MH9)!PH(U;%C"B@KE:=0_[SYMZ@#97(2$Q2"8I8-!K8/!&W6PXC/!E<C2A&J6
MK"=B\K2>B0ME_&1FOG*V<Z@VD+!@L*,-;UL<R/8B)"P&P2QQ#&MQ#)WB"-*Y
M*7)>R&^,9GIA-'"=\C1?Y6;I]U(>E1S,>IPQGM",F3+JB?*9$= DI_.4S]ND
MXFSU4*D@80$2%B)A$1(6@V"6J$YJ49V\8]%R@I0.$A8@82$2%B%A,0AF2>>T
MELZI<SX*3882>3HS58IF!M]:HS@1ARH$"0O6,*^WD8AZ1_W!5BI"-ADA83$(
M9@W]63WT9P>F(OH#D8J<K1ZJ%B0L0,)")"Q"PF(0S!*5UVL,HMX[)J,*#E(/
ME!9 :2&4%D%I,8IF2VC#8_3^_Z3D9ARL%"0MJ&A;>6FPG9>@C4906HRBV1+P
M&PGX3@E,F4S--?*8W$KVR*0T*6>JQ>Q[JQ*<J(.5@*0%4%H(I4506HRBV8)I
M?%OO/8U;#^K<0FD!E!9":1&4%J-HMH0:_]9S&[C-5*.*J89\2/GKS8Z/I@C>
M>ZOBRLT]6#U0%Q=*"[U=4]CO]?V!^67GM@C:;HRBV<IH'%W/;>F&/V8+RN>,
M2*K--,))(K*,2D7,E+/612&0YN98JTB@;BZ4%D!I847S?*OZ\?P=B4!=713-
MEDCCZWIN8_>:):9@_986SURT#C_4H872 B@MA-(B*"U&T6R1-#ZM]YY&K0=U
M:J&T $H+H;0(2HM1-%M"C5_KN0W;.Z%I1C@SXE&*Z?94 S5LH;2@HIULWCKT
M>[WM*V.H90NEQ2B:+8#&M?7<MFTQ7^B7VAHI2I"9F3WHO/46LAMVL!2@=FQ%
M\SR[3CCVO6TU0+U6*"U&T>SGTAJWU7=:<:.[E>2F!JWL>#)]447Z:%."&W2H
M$J"T $H+H;0(2HM1-%LNC;/J>^]8@/A0RQ5*"Z"T$$J+H+081;,EU#BS_D^<
MV;4CLEQ)<TVL6+)AD[A=$C?W8/7XNTZ$URM^[.010)L-H;0(2HM1-%L8C0/K
M.^VYT:1YY)AJ,A/MMVW<D(-5T-^I)OT6"4 =5"@M@M)B%,V60..@^H<YJ*E2
M*[.R6@IN!&'T(<NOI+QYQH#ZJE!: *6%4%KD[[JTI[LS8XQJU!9+8ZKZ;E.U
MO70U@C!%2FZ4(^0+X4*W7M:XT0<K VJF0FDAE!9!:3&*9@NHL5S]X7L6LU!#
M%DH+H+002HN@M!A%LR74&+*^TZTSQ:R0^E?-9$X2]M!>L$!=5R@M@-)"*"V"
MTN**9MF&&PG-'O[&3/7=9NJ?BU2SK_3A(=5'-"43/CMJE0#43X72 B@MA-(B
M*"U&T6RM-+ZK?_:>V0;JPT)I 9060FD1E!:C:/972QNSMN\V:]]VA5Q!MJ:Z
MK>)][&[J4 E :2&4%D%I,8IF2Z Q8/ON1ULK]XS.S,PA#S#/*JQE=_6]07^P
MHPNHJPJEA5!:!*7%*)JMB\95[;M=U?JN7CU#9()RHH69)O(EY2]$K+32)NGL
M^=9%Q;><L,'NK %]N!5*"Z&T"$J+4;2U.KH;[]_(F9R7KU919J177*]?Q5%O
MK5_?<EF^M*3;[+Y^]\LUE?.4*Y*Q1Q/:.SHQE^1R_3J5]8H6R_)M'@]":Y&7
MBPM&$R:+'<SGCT+HUY6B@?JE-J/_ 5!+ P04    "  ;AUU8!BV5#8T#  #F
M"@  &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6RM5FMOVS84_2N$5@PM
MT$9/2W9F"["MI/6P/! G'89A'VB)MKA*I$M2=OKO1U*R8DN*9@3]8O%Q[^$]
MYY+7=[RG[!M/$1+@.<\(GQBI$-M+T^1QBG+(+^@6$;FSIBR'0D[9QN1;AF"B
MG?+,="S+-W.(B1&.]=H]"\>T$!DFZ)X!7N0Y9#]F**/[B6$;AX4'O$F%6C##
M\19NT!*)I^T]DS.S1DEPC@C'E "&UA-C:E]&0V6O#;YBM.='8Z"8K"C]IB:+
M9&)8*B"4H5@H!"@_.S1'6:: 9!C?*TRC/E(Y'H\/Z->:N^2R@AS-:?8G3D0Z
M,88&2- :%IEXH/LOJ.(S4'@QS;C^!?O*UC) 7'!!\\I91I!C4G[A<Z7#D8/M
MO^+@5 Y.T\%[Q<&M'-QS';S*P=/*E%2T#A$4,!PSN@=,64LT-=!B:F])'Q.5
M]J5@<A=+/Q$NGVYNI@]_@;MKL%Q\OEU<+^;3VT<PG<_OGFX?%[>?P?W='XOY
MXFH)/H$%V2$N9-(%P 3\3K$<?)6S@B$.WD=(0)SQ#]+P:1F!]^\^@'?*[C&E
M!8<DX6-3R(C5N69<13<KHW->B<YVP TE(N7@BB0H.04P)=6:KW/@.W-Z$2,4
M7P#7_@@<RW$[ IJ?[^YTN$?GN]L];-PZ>Z[&<U_!>TD(5TI+D<$TV4$2(R H
MF*[7.,-0(/X1+(L5QPF&#*O9E',:5SO*J9'*OQ]HE@'YKO:0)?]TI:T,R^L.
M2Y6J2[Z%,9H8LA9QQ';("'_]Q?:MW[HD_YE@T4\".TF'5Z?#ZT,/9VB#"<%D
M(TM1IK+0)5T)$6@(591WX2 8CN1=W!UKTK;R',<9G5I%O>&\D>R@)COH)7OU
MO<#B!XCE^V1X5:@JKB\A>L9<* W4Q=H6+$YE609T+?<$DF'HVO&OOG"[ZL)U
MR50>[A\+X(Y:,K6M1H'M-%3JY?%&E?Q:)?\<E90ND*FKH342J3SH#!'\%CW?
M<X*&!FTCVW)'5D,$OW6A;&ODOV"=L MJ=D$ONTBF^I!\E>(#QRXN02O,3_;
MMYH9[3#S/'?88-,;UAM3.JQ)#_M32I+_>>+#EM8C)[ ;&9FWK3H*0=2V.BT$
M)07SJ /($=OH3HK+QUD04?XYUJMULS;5/4IC?2:;N++G>H$I.\ ;R&1UXR!#
M:PEI703R6;&RJRHG@FYUG[&B0G8M>IC*1A0Q92#WUY2*PT0=4+>VX7]02P,$
M%     @ &X==6(F4!2"$!   *A4  !D   !X;"]W;W)K<VAE971S+W-H965T
M-3$N>&ULM9AM;^(X$,>_RBBW.NU*NWGBN0=(%-(>TD)1V=[I=+H7)AG UR1F
M;0/;TWWXLY,T)32-BI3KBQ([GI_'_[$GMOM'QA_%%E'"CRB,Q<#82KF[LBSA
M;S$BPF0[C-6;->,1D:K(-Y;8<21!8A2%EFO;;2LB-#:&_:1NP8=]MI<AC7'!
M0>RCB/"G:PS9<6 XQG/%/=ULI:ZPAOT=V> 2Y<-NP57)RBD!C3 6E,7 <3TP
M1LZ5YS2T0=+B-XI'<?(,>B@KQAYU81H,#%M[A"'Z4B.(^CG@&,-0DY0?WS.H
MD?>I#4^?G^DWR>#58%9$X)B%O]- ;@=&UX  UV0?RGMV_!6S ;4TSV>A2/[#
M,6MK&^#OA6119JP\B&B<_I(?F1 G!F[O#0,W,W#/#=PW#!J90>.]!LW,H/E>
M@U9FD S=2L>>"#<AD@S[G!V!Z]:*IA\2]1-KI1>-]4192J[>4F4GA\N'V6QT
M_P?<W<!R>CN?WDS'H_DW&(W'=P_S;]/Y+2SNOD['4V\)7V 4!%2'EX0PC=-)
MJDI=^#A!26@H/L$'H#',:!BJ>M&WI/)0]V/YF3?CU!OW#6\<%V8LEEL!7AQ@
M4 18:FCY^-SG\5V[E<0Y.YA@.Y_!M5T7'I83^/CA$_@82^1E_E73)NB;T$AI
MC6=:"6;R?HQ;@?'>CW'*,07-&OF<:"3<QAO<!5=YB,NGS[ (22R!Q %XW_=T
MIQ*$A#^_JN8PE1B)OTI\OD[9S7*VSGM78D=\'!@JL0GD!S2&/__DM.U?RL)1
M)VQ2)\RK"58(4#,/4+.*/IR16"7Q)!H:37V$-6+9>KNN!%T:C1362F#Z"W08
M.AVSU[<.IRJ_;N2ZIEMLY)60>F8[;U10I96KTJI49<3I/RHWP8223<R$I+Z
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MFOD\O9A+"Y+MDING%9.21<GC%DF 7#=0[]>,R>>"[B"_'AW^!U!+ P04
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M&E^-';)L*.5$B\(]XH70IB6X<&UZ,$J;8/8S(?1A8OM"W=6C?U!+ P04
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MG"]5[>QZ7]"< )2F0VD&E&9":1:*5A59F1E0Y:F!GWBE)B=O1R74_G!79M
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M)(_*8%6"B,7%+_E15D0C  ]?";#+ 'O7@$$9,-@U8%@&#'<-&)4!HUT#G#+
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MR?P \_U<"/V\D3>P60\^_!=02P,$%     @ &X==6-L:5'0K$P  ;00! !D
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M(HSV!>S/] 7PP;P%/#C?3P^'2##$5$U; H9H"6"6MR@')_OIX1 )AIBB:"_
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M-.6JWXC\KFR:<MG_^J2R>U5U >W_/Y1E\_JA.\!NM_R+WP%02P,$%     @
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M'19^"$$LUTRHL<^$8 BB&8(\A2&(Y5Z+*#9C",$11',$\>0(8JE/Q(08]D.
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M_:8LY>-"\W:#W=LLYO\#4$L#!!0    ( !N'75BZ9$3/*00  *\4   9
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ML'O8D^>P[[#R[U!OX$]9D9KN7+F!QHK4XO2;"](Y+#RL/#S4F_A/E BZ9%$
MPE@5OJ'IG6^OV:B5-TK#IFAU$2LW#\]IYZ%1/V^4ADW1ZF\[*T>/]([^Z(4)
M-8UZU^WUN^Y!:[;%.7#@'<1A_?A.K;]R].AGCO[HI:D@[K]Z0ZCQ4V72$M:!
ML+$ZZ<=W;/WVW@O]F/)%MC$BE!=:)S)_"5Y>+3=?KK,MAX/K-_ *YULH%2;?
MT;DC?!$F D1TKI#.94\]67F^29*?2+;*M@V>F90LS@Z7E 24IP'J\SEC<G>2
M?D&Y537^'U!+ P04    "  ;AUU8@/IP_$($  !^$@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V-BYX;6RM6&%OXC@0_2M6;N^T*[7$3D("/4"BT-4AL;VJ
ML'<ZG>Z#(0:B36+6-F5[VA^_XQ " 9.VJWQI$S+S\MYDQL])9\O%%[EB3*%O
M29S*KK52:GUCVW*^8@F5#;YF*5Q9<)%0!:=B:<NU8#3,DI+8=C#V[81&J=7K
M9+\]B%Z';U0<I>Q!(+E)$BJ>;UG,MUV+6/L?'J/E2ND?[%YG39=LPM3G]8.
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M*HZ--"MQWCJ)-8&5)+<*R:U:EZ!6G<)K BL);Q?"VS^U!+7/.LL/6GXK.&G
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MVS+#K?I/ -<!:G_-E,MVHGM7]^=)_P)02P,$%     @ &X==6%N^588T!0
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M>OM""+5?,>\V'5Y^Z_T+4$L#!!0    ( !N'75C!]S1-J <  &9/   9
M>&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;+V<_4_C-AS&_Q6KFZ:;=$>;I"_
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MK4B.C")Y+W-/$;\3/(O)12IX_D+Z,=*ZZ@ )<Y$P#PFC2!@#P12Q6(/6(1E
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MRXDX:N R30-<-L"Y[J*C7.7,E_YX*)(#$MG3*EIVD \U;ZW$!7&6E7LIU-U
MM9/CZ>)Z-G] -Y/I_';^,+^^1Y,O,_3E]P=U=#?Y<W)U>XU^19]]L0YB=)\G
M'EVI65@A-:6W?,^%RAU:^&J*/Z(9?Y)H'J=2[%3BY ?TRXQ+/PC3#RK&@J?2
MEZKA9"TXS^X/^U*-(-/17Y9JKPJU6*/6Q>AS$LM-BJ[C%5^]#M!70Z_&CU_&
M?X6-$6=\>8:(^Q%A!Q-#/%+-)\GC>9IX=R)8!O$ZGYH0S>N&: R0?0HOTZV_
MY*.>FNV4BSWOC7_^R67.;P9Y7B7/RZ,3[7!?90C]=:L>0'/)H_3O.JU>!UII
MI94:I[)RERC<I6RC_".0W/AQG=8B&LNC9<5H/U8)W=<(8)4 UB27M<DT1F@Y
M08-*W\!J,@<=:#VOM)Y;36813153R"8^H_7YO*@T7#32$/(TU0JX.-5-K@.E
MUFGDIUI#F6.TS))[A /7JJ?*<);E8I"+K=JJ#'><5JQ)*U1\UUSR&]FJC'6:
ML5THZZZQ$K^UUF-MUUT4<Q>JN4OM.LM(A[9RH?:[YN+?V%GL_XEUM8F%$N\:
MJW)#<PU.=C?4;==<N%\[J]Y8Q@AM,P55W;VP:RPC)5K*Q4 !;*9 HXR6L4YS
M%88JCXUE>;S@^R3<9VF="KX*)+KQET$8R!_H7W3"-UAS]+8S"$4?8ZL)QT:&
MM)4+?,!F/DR3* IDKO29<[3E8JF.E0-JM99\<(\2[IPY6)=R( 0V$^)KO,O>
MVI:^&JE*]$>T;"3+JY7E>#I=@ 5L_I;?P(KJRO5.)*LD#'U1J[(+9&! !F9V
M?=G%RP,&M& S6M1K?)"B8C$G>YO?^R+PG\*\,-6;8-#,F\ 8;&9,,P],0L7A
MV,]6<_*EB&SU@9=K$[6RN\ 3!CQANWC"7>") )Z(&4^-75'&>^L*5^,* I B
MUB!5O\[2!:4(4(K8I13I@E+D:-W*(J6(AE*Z4D  4Z1+3!$=IC2R@%+$&J7>
MQY2YK[:9!DP1NY@B76"* *:(94P1#::TY@1.$6N<:@,J<^]M)QI 1>R"BG0!
M*@] Y5D&E:<!E<X7'I#*LT>J6E29X[>=2D"59Q=57A>H\@!5GD54E;&R9=57
MU4"3\Z,?4KH$E:<!%=%Y$4CEV2/5^Z@R=]8VTX JSRZJO"Y0Y0&J/,NH*N.=
M:DX E6</5&U(9>Z^[3P#J3R[I/*Z(!4%4E'+I"KCO;6%6V\+"IRBUCA5N]!K
M#M]V'@%3U"ZF:!>8HH I:A%3M/Z-RAUH@$ !5+1+4%$=J#2RCG[<M\:IQW<Q
M9>ZK;:8!4]0NIF@7F** *6H94[3^C4IO3@ 5M0:JQQ:<,O?>=J*!4]0NIV@7
MG&+ *6:94ZS^C<K1^8(!J9@M4M6"RAR][40"J)A=4+$N0,4 5,PBJ)@&5+J4
M Z=8EYQBS3C%@%/,%J?>QY2YJ[9Y/MK.9A=3K M,,< 4LXPIIL&4SII *6:+
M4FT@9>Z\[30#I)A=2+$N(#4 2 TL0VJ@@=1;5_2/-E%'7*SSK>*IJD*[6!;[
MJ:NKU7;T2;$)&QXO]K(7VZ53%/)GU=0Y&ZC/O2BVAQ<G,MGF6[*?$BF3*#_<
MJ/%PD3V@[C\GB7PYR3JH-NF/_P-02P,$%     @ &X==6/K\K<4+!P  2SX
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M?#;S+/N!.GLHFAWRVMECM[-_P^PWCLS$E+!\DC+*\N*AP"Q7MU%,T*H!*(V
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M?[J&B&W[#G:>+TSI<B7U!7?06Y,E/(#\O)YP57,+E3F-(1&4)8C#HN\,\56
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MAUT9IBN]?J$7[]'#,1H*KF<*W? QC/\5" U<21BO"?NQ5W$ :1TU< W%4=Q
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M+.CJY>%!3WCZ\G#_B)JPVY30\H4'^*S]-28YTO<:X8HW3$GM>48;;9<Q7Y6
M*L"R$7;+$"\0U4U E. %H401D..^C6DG'O1/;'+,6-8X@ZFCDX@$\0!.\NZ-
M'WD7?::>DBP]$=F6X8/.\,$Q]N1[#0(KPI8H,]87]N07@E>(=R/6W][#WG*/
M++=)LP^)[_E#/YJX#YMN]<%BSQMLP](>F.\%<=S!MA0..X7#5RHL",,L.ZZP
MY8XVUN3MB'L6D>XC!E&_IJC3%!W5=-.M_#6:HF<U/8M(]Q%AN+&A6ZI&G:K1
MT<MO7]XS7IPU^CJ_PU5]@:[_-*2V]QQ+"3H5\(7.R:Q-!?"8E9@MP>:*-@GP
M!25+;-[5_B0P.F42."59>B*R+>/CSOCXA5?D\*&)]R[G<!@/@YV#LX^*8WW5
M=P[//LJ/H^C3<.?XN!N/>P5B:8LDB3+S*+0/9-?;U6&7MOS8Z9_I^JPMI_[3
MM,7=-RR6A$FMN]"4WOE(WU71%DQM0_':EA +KG1!8C]+76.",  ]7G"NGAIF
M@JYJ3?X!4$L#!!0    ( !N'75C9LRG6$ 0  "(/   9    >&PO=V]R:W-H
M965T<R]S:&5E=#<X+GAM;+U746_B.!#^*U9N==J5VB9.(($>(%'H:E?J[:+2
MWCZ<[L$-!JQ-XJSM0/OO;^RD@8#)M1*Z%XB3F<_?-YZQQX,M%S_EFE*%GM,D
MDT-GK51^[;HR7M.4R"N>TPR^++E(B8*A6+DR%Y0LC%.:N+[GA6Y*6.:,!N;=
M3(P&O% )R^A,(%FD*1$O-S3AVZ&#G=<7]VRU5OJ%.QKD9$7G5#WF,P$CMT99
ML)1FDO$,";H<.F-\/<%=[6 L_F)T*_>>D9;RQ/E//?BZ&#J>9D03&BL-0>!O
M0R<T2302\/A5@3KUG-IQ__D5_;,1#V*>B*03GOQ@"[4>.CT'+>B2%(FZY]LO
MM!)D",8\D>87;2M;ST%Q(15/*V=@D+*L_"?/52#V',+@A(-?.?AO=0@JA\ (
M+9D965.BR&@@^!8);0UH^L'$QGB#&I;I99PK 5\9^*G1W>UX?CM'EVA>Y'E"
M88$42= -24@64S0WF?1Q2A5AB?P$9H_S*?KXX1/Z@%B&'M:\D"1;R(&K@(M&
M=.-JWIMR7O_$O%,:7Z$ 7R#?\P.+^^3M[G[3W84(U&'PZS#X!B\X@?<]IX(H
MEJW0'86DL HJ$3IV!%UNUS(G,1TZ4$^2B@UU1K__AD/O#YN\,X$UQ :UV* -
M?4]LHL4BH5/]DB\O"Q@0*:FRZB]!(P.J=X?-J-L/O0#"O]E7=FP&1EV_4YLU
M.'=JSIU6SI-"",A-E'-ARI\O$3^0D3#RQ!*F7FSD2_1PGWRWW\,'W"U64>A%
M=NK=FGJWE?H=SU:7BHKT?8R[1UQ"K^OUHP/*-K,.QB<XAS7GL)7S ]?;P"F^
MS%X@X3&5$'M1[X"QU2PZE2!1S3AJK>#/+#-;UNGZC<Y9OV<":TCMU5)[K8MS
M^ZM@N=ZI$5$HYE+9U/:.RA '_>@PX?_+JL&O7_/KM_)K+,4%NG_=7AXAA<9Z
M>[E <T64.6QT(9?V#!)NQB4SY?WW[;/2O<)3 C!,JG]L$MM9S(1.7_6"9G"6
M0:BR!=H%[AL<:U^S."D6.KL-0\VD9FA+H,G_-U\C[-C;G>5>*X5Q'!=ID4!H
M%]#*0.9!4'4XK<>S=[3TES@(HLY!AECM?'PJ1_!>XX'?EL47**/6%*X FB?.
MX?YG,<(][Q2[73^ VQN"'Z;_@SB.-[ 'KBBZI[HIKCL$]  ;NI7T6=N$<Z$U
MH[!K%/"[.@4)#> +)<+>[[5#8:]T11%*>:;6$H5H05ZLA?96*'BHL/R.!:PI
M>M=IX,[[EG[*9,P+J.)[J"RK]-;>Y=UK?B:TIOQ=MX+;VY7#-;<*+B$PWJLZ
M[\H+CXKSA-WA6>_N76#T[?%/(E8LD\!@"7[>500XHKR0E0/%<W.G>>(*;DCF
M<0V76"JT 7Q?<JY>!_J:5%^+1_\"4$L#!!0    ( !N'75A>.Q)O_@(   D+
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;*V6_T^C,!C&_Y6&,Q=-
M3H'"^.)M)+II[A+-+4[O?J[LW6@$RK7=IO_]M8 X-V2&W"];"WV>?IX6Z#O<
M,/XD$@")GK,T%R,CD;(X-TT1)Y 1<<8*R-6=!>,9D:K+EZ8H.)!Y*<I2$UN6
M9V:$YD8T+*]->31D*YG2'*8<B566$?YR"2G;C S;>+UP1Y>)U!?,:%B0)<Q
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MKVS_&1I#,\V7L$)4OVA?8[W00,E.2%8VP4I!F=/ZGQR:1!P%V-Z9 -P$X&Z
M>R; :0*<2P/<)L"M,E-;J?(0$TFB.6=[Q#5:L>F'*IE5M+*?4SWO*\G5VUS%
MR>C^C^67ASOT=//WW0I]1/<T826@)W) =P>UM@2@]S%(DA?B@WK];16C]^\^
MH'<HI^@I8SM!:"KFIE1*-)^9-*/>UJ/B,Z/:&#TP*C.![F@*Z2F!J2RT/O"K
MCUL\RAA#<H4<^S>$+>P,"%I>'HX'PN/+P^T1-TX[*T[%YYR;E;=IB'.1%$SL
M.*!_;IZ%Y&JG_#N4\9K1'6;4Q\>UV)($%H8Z'P3P%S"B7W^Q/>OWH6S]3++X
M)Y&=9-)M,^F.L4>?( 5."K65. <JD22'H>35)'Y%HH_*E\B:FR_'&9E$Q&.(
M$^VS5OML5/M*$@E3RFL*[VA4QW5Q1_P R+<[\ON8C]@.[6$+7FO!&T\_X^KD
MI5,FO-[8GA-T//0Q@=^QT(?8P;!^O]7OC^K_(C/@4^K]WK#=Q3.)B,<0)\J#
M5GEPT<)7=R H]>DY\4$_K:'7U=\'>:[?M= 'A8%S9OV$K8OP@BTPY2$<6+H^
M=CLF^JA9X#D=$WV0%UIXV(1MO5VRUD7;8,I(0W/BQ [<CLCE$,QQG>Z$#,#.
M+"K[J%RP1YTLJZV0_$#J(J*B(+IX&W1B3VZ*:4@\"CEU@-\<X%$'S=VJ9@!!
M7>(,ZL>]TSQP_=Y$]%&AXW5/U@&4[<Z\KA/SJ(HK@6^J:EB@A.VHK NAMK>M
MN&^J.K/3?ZLK\:HZ?*.IR_@'PC<Y%:B M:*TKGQUZ/.Z,JX;DFVK6O&9255Y
M5H^9^IH K@'J_9HQ^=K0 [3?)]'_4$L#!!0    ( !N'75A/$+F8L@0  &,0
M   9    >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;*V86V_;-A3'OPJA%4,+
M-)&HJ]79!I(XQ?J0-HB3;<"P!UHZLK5*HD=2=OKM1TJR;(NTD(>^V+K\S_'Y
M\7+.H:=[RK[S#8! KV51\9FU$6+[R;9YLH&2\&NZA4J^R2@KB9"W;&WS+0.2
M-D9E8;N.$]HER2MK/FV>/;+YE-:BR"MX9(C794G8CULHZ'YF8>OPX"E?;X1Z
M8,^G6[*&)8B7[2.3=W;O)<U+J'A.*\0@FUDW^-,"A\J@4?R1PYZ?7".%LJ+T
MN[KYDLXL1T4$!21"N2#R:P=W4!3*DXSCO\ZIU?^F,CR]/GC_W,!+F!7A<$>+
M/_-4;&;6Q$(I9*0NQ!/=_PX=4*#\);3@S2?:=UK'0DG-!2T[8QE!F5?M-WGM
M!N+$0(*:#=S.P!T:^!<,O,[ >ZN!WQGXS<BT*,TX+(@@\RFC>\246GI3%\U@
M-M82/Z_4O"\%DV]S:2?F7[[>?7NX1\\W?]TOT15Z@H1625[DI)D5FB&Q ;04
M1-2"LA_HY7IYC3Y#"HP4Z(D(0*1*T7V603-_S2..WB] D+S@'Z3'E^4"O7_W
M ;U#>86>-[3FTH)/;2&#5R'821?H;1NH>R%0[*('6HD-1_=5"NFY UM2]^CN
M ?W6'?6X@.0:>?@C<AW7,P1T]W9SUV"^>+LY'J'Q^HGT&G_>I8FL$EH">B:O
M:)'SI*"\9H#^OEEQP>3F^L<TXJU'W^Q199Q/?$L2F%DRI7!@.[#FO_Z"0^<W
MTVC]3&>+G^3L;"3]?B3],>_SP_(6Y-4T:*UQU!BKK+J;3W#@3.W=Z6#HHKA9
M9*>BA2["KA<&O>HL^J"//AB-7NU50!DC5;+).2B*CZB2!43NY:PC6T$%62Y,
M=*WS\"0F+_*&=+HHB(,!G*[Q<3PQLX4]6SC*]DTF(X:^RL0D,T M,\ZJ  2O
ML@9R,*:44 L"Q^$ 1M=XSA!&UUS%GIDEZEFB<98LRQ-)<T=+%7^3;TT(D8Z
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M@^>WZ@3=G.J.;MKC]P-AZ[SBJ(!,NG2N(SF^K#W1MC>";ILSWHH*>6)L+C=
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M*9,?M/W7AVOP_MT'\ [0$CSN>"6UM9R[2J.9%[A9@_'QB(%&,*Y)=@%\^!M
M'O(M[JO7NZ-S=U<7I*T*:JN"ZGC^:+RF#$J7 ==EN+0E=8P2V*.8%7@I]S@C
M"T<O,4G$$W&6O_X"(^]W6XIO%.PL8;]-V)^*OORL&X9N#0(K6FX!XSIEZRP>
MH\1U%-,AGI:!CX)X[CZ=9C*TBA*(@M;J##%H$8-)Q*LL$Y6>$O*L6]@(WC%"
M=(JG^7IT0R,_#: =+FSAPDFXNZYV1#<5P)KU\M-&&0X H!]Y:;^*%K, ^2?%
M/B.-6M)HDO3F1Z6Q0,8+4T9L>JF-,1I6$L9IC]!BY"<C?''+%T]/,]/*@LN,
M *U1(.?56FTJIMM]QJM266<]'F @F"8]UJ&1[\4CLYZTK,GTK*L=$3:B9#AU
M81R&/:2A512.?8AIBY1.(GW#K,)'@7PII TP';QZED9)OV86*XB\-+0C0J_3
M'&\2\I$KS&Q:8Q4.;UC,-$+(Z\%:[!",?!B-T)XH)'R]&+!."*V*T,1Z(TEX
MJVCGF7<J""<U9WDOC";H;F&V $0WCKW>P"EKVFCXJ<1)"/MS9#%+$1Q1!MBI
M%YR6KS\YSP^4,2N:/WQG@ +8;V8V.S])3KZS<[A.M^"T<-V6"I=;NF9VS8)#
M/9K!,(S[B]%JET3!&%\G7?#_:9<P.]\9W\PJ/:@W/U;LH3SIYH"28+ NK89I
MXJ$1\$[)X+24W55*TIR8;3R5(*<;O4[)2,.#0ZW2U0L'6Q>;G3X2P;&>U\D:
MG-:U4:V 0V6:!7$T6#H6L]1+1N0"=A(&IS7,THM/-OM6X*%NS1"$:1KUD6V&
M2'_:8S/?B1R<5CFS7;4B6_=;3;#X?(7%\8#78I>BL"\@[LEIRQQU/V&QI:74
MJV>C_;R+6'_PXGAZ/ X4W]<'L#57^CA77^[TB9L(8Z"?;SA7+P-SIFO/\,O_
M %!+ P04    "  ;AUU86S2:&U<%   0(P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970X-"YX;6RUFFUOVS84A?\*X15#"[212,N.TCD&4DM%,R1-T:3;@&$?
M:(FVN4JB1])Q,NS'CWJ)9%D*81<W7Q)+YGU$GB.1/(DF6R&_JQ5C&CVD2:;.
M!RNMU^\=1T4KEE)U(M8L,]\LA$RI-H=RZ:BU9#0NBM+$(:X[=E+*L\%T4IS[
M(J<3L=$)S]@7B=0F3:E\_, 2L3T?X,'3B:]\N=+Y"6<Z6=,ENV7ZV_J+-$=.
M38EYRC+%188D6YP/+O#[D)"\H&CQ&V=;M?,9Y4.9"_$]/[B,SP=NWB.6L$CG
M"&I^W;,92Y*<9/KQ3P4=U-?,"W<_/]$_%H,W@YE3Q68B^9W'>G4^\ <H9@NZ
M2?17L?W$J@&-<EXD$E7\1-NJK3M T49ID5;%I@<IS\K?]*$28J< CY\I(%4!
MV2_PGBD85@7#0PN\JL [M&!4%11#=\JQ%\(%5-/I1(HMDGEK0\L_%.H7U48O
MGN4WRJV6YEMNZO3T\O/LYCI$=Q=_A+?H';J(8YX;2!-TF96W86[GZX!IRA/U
MQC3Y=AN@UZ_>H%>(9^AN)3:*9K&:.-KT)F<Z477E#^65R3-7Q@1=BTRO% JS
MF,5M@&.&48^%/(WE [$2 Q:=H"%^BXA+ACT=FAU>3GK*@\/+<4]Y>'BY:Q%C
M6!L[+'C#9W@W:R:->=D270FET(Q*^6@,W5(9*_3GE6F-+C5+U5]]SI5HKQ^=
MSUWOU9I&['Q@)B?%Y#T;3'_^"8_=7_I4AX0%D+ 0"-;RQZO]\6STZ6>S"(C:
MH\1XQ'H?HI)R6E#R6?]^Z@V)=SIQ[G<U[K8:^YAX[5:!M4?'B@<$:XDWJL4;
M6<4S:X19 ;(] 5&T>Y._19G09@&<_VW6)*0%8@]K+HOYK$_G\H+C79U'ONON
MZ6SMUK'W,B0L!(*U[!C7=HRM=@1LP:1D,=+T 5%S)VNC?OYYSC*VX-HL6(^%
M&W-F-A<TX?_NS_>E!^..!_AL3#HF6#MSK F0L! (UC+AM#;A]' 3$D[G/#%+
M.5-H*42\Y4G2I_AI]ZXG'C[;$[S;:NC[9,^6P-J]8Y4$@K64]&LE?:N2WS+)
M(K',\MMT]S;NG9_]KC:N3_8$]+N3./;V9^=NHY'K^^U&84\CSV](K?&>U>,]
M^['QE@\Q3XW2&O$%:IKU*7'648*,.L^NM2?'/KN0L! (UG( N\TVW/U1#W@6
MB905)TT\I$GQ4)L]M_E",],7;=)6)#>F+M[(?"TTBR(7O195G=CUZ%UG+V'O
MZ;$>@=)"*%K;I9VPA%_<I5Y?<'<>[CPZ]KX=[0LD+82BM7TAC2_$OO89Z97F
M$;HS\E]L]$I(KA][E;:"CHTVH+0 E!9"T=J6-/$3OV#^Q* !%)06@-)"*%K;
MI2:$8I@46F%:6W/BGW7G*,B(&8#20BA:6^HFLF)[9KVQ9M6#<RKN!M7QL,<(
MT*0*2@NA:&TCFK"*[6G5;L11?S3 W<0Z-GO>CAF@B164%D+1VF8TH17;4^NM
MIIH5^Z0K$=$$_6JVL"KFT;.*0Z;,&2@M *6%4+2V,4T&QOX+KM_6@'VT2Y"T
M )060M':+C7)'=NC>W?];LUGO=YT<SKV1L/NI 4:U4%I(12M_6^F)JP3>UC_
M2N]9ACZ))#:J*_0?.CQ_V,G'/AF@M "4%D+1VAXU49W@EYN_"&0XGH'2 E!:
M"$5KN]0$=V(/[D";XNHJNW\6)5YW4VSOS-%&@,9U*%IIA+/S1D#*Y+)X%</H
M*S:9+E\.J,_6KWM<%"\Y.$WS\EV1:RJ7/%,H80M3ZIZ<FMV[+%^_* ^T6!?O
M%\R%UB(M/JX8C9G,&YCO%T+HIX/\ O5+,-/_ 5!+ P04    "  ;AUU8/B^<
M=I<#  !E"P  &0   'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6RMEFUOVS80
MQ[\*H15#"Z31HY\RVT#\4#0OL@9.V@T8]H*1SA91BM1(*G;[Z4=2BFH]V/"P
MOK%%\N[/^]W9IYONN?@J4P"%#AEE<N:D2N4WKBOC%#(LKWD.3)]LN<BPTDNQ
M<V4N "?6*:-NX'E#-\.$.?.IW7L0\RDO%"4,'@22199A\6T!E.]GCN^\;FS(
M+E5FPYU/<[R#1U"?\P>A5VZMDI ,F"2<(0';F7/KWZPFQMX:?"&PET?/R) \
M<_[5+.Z2F>.9@(!"K(P"UE\OL 1*C9 .XY]*TZFO-(['SZ_J'RR[9GG&$I:<
M_D$2E<Z<L8,2V.*"J@W??X2*9V#T8DZE_43[RM9S4%Q(Q;/*64>0$59^XT.5
MAR,'?WC"(:@<@K9#=,(AK!S"2QVBRB&RF2E1;!Y66.'Y5/ ]$L9:JYD'FTSK
MK?$),V5_5$*?$NVGYG>_+S_=K]'3[9_K1_0>?68"8KYCY#LDZ D?T (8;(E"
M;U>@,*'RG3%Z7*&W;]ZA-X@P])3R0F*6R*FK=#Q&U8VKNQ?EW<&)N_T W7.F
M4HG6+(&D*>!JD)HF>*59!&<55Q!?H]"_0H$7A#T!+2]W#WK<5Y>[^V=HPKHV
MH=4+3^AM="E83"C!]B_"MR?+(Z_0^A#3(B%LAVXS7C ET0,(73)FMA37YUC_
M?"JW#:A",(G^VG!*D?X#[;%(_NZK8!EAU!^AZ4DW,L<QS!S=="2(%W#FO_[B
M#[W?^K+_,\56/TFL49FHKDQT3GW>J(/2"7TNZW"%%IAB%@/"2N_M"+/IUY7[
M!ECTY;>\9V3O,2WZ91[Y431U7X[SUC4:>.-QTVC58Q2-?R@U. <UY^ LYQV+
M];M$@M0=GF)E8#G*!>'" EGTG$MB?I^]#:"4'S:":L'UF Q::%V3T!_UDPUK
MLN%_)XL+(8"I"]F&G:B&08NM:^*UT,Y9-,!&-=CH+-CZD!-1-PR5 I(*JT*!
M65*2$64/)=(C@SW&4F=!9H;;.. #]-*..H&^]_UQ"V?98S693%K,/48C/^S'
M'M?8XXOJV2AGBMD.S$M*)P3ZH,:=2-H5[%JT*WC.HH$RJ5$F_[^Y $O.M95)
MIQF$WKC-UC7J]IY5UZC1>TI"]V@ R4#L[" G46Q>1.7;N]ZM9\5;.R*U]A=Z
MABQ'OA\RY0!ZCX5NIQ)1V&I)[WJDFX(HA[IRH7ANQYQGKO309!]3/0>#, ;Z
M?,NY>EV8"^K)>OXO4$L#!!0    ( !N'75@7Z6B;;@X  *J]   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@V+GAM;,6=[W/:R!V'_Q4-O6DO,SF#?N/48<9F
M?US:2^*)+^V+3E_(>&W4 .(D82>=_O&5A,RR(+Y"SB?#O3ACPCZ[UGZ05H]6
MJXNG)/V2397*K:_SV2)[VYOF^?)-OY]-IFH>96?)4BV*?[E/TGF4%[^F#_UL
MF:KHKBHTG_6=P2#HSZ-XT1M=5.]=IZ.+9)7/XH6Z3JUL-9]'Z;<K-4N>WO;L
MWO,;G^*':5Z^T1]=+*,'=:/RS\OKM/BMOZ'<Q7.UR.)D8:7J_FWOTGXCAWY9
MH/K$/V+UE&V]MLH_Y39)OI2_O+M[VQN4+5(S-<E+1%3\>%1C-9N5I*(=?]30
MWJ;.LN#VZV>ZJ/[XXH^YC3(U3F;_C._RZ=O>L&?=J?MH-<L_)4^_JOH/JAHX
M2699]7_KJ?[LH&=-5EF>S.O"10OF\6+],_I:;XBM MZA DY=P-DIX)P?*.#6
M!=R= JYSH(!7%_!VF^0>*.#7!?S=)MD'"@1U@>#8 F%=(*PZ:[UUJZYA41Z-
M+M+DR4K+3Q>T\D75OU7IHD?B11G%FSPM_C4NRN6CF]\_CO_^R]7E#6?6^./[
M:_[AYO+W=Q\_6#\SE4?Q+'ME_63UK6P:I2JSXH7U>1'GV>OBS>+U^W@V*_*4
M7?3SHBDEL#^IJ[U:5^L<J-:VWB>+?)I9?'&G[AK*,[J\VU:>M]3O$(!^L0TW
M&])YWI!7#DG\6[0XLUS[M>4,'-?*TVA1[#6VM]WZ1T-3Q\>#G0WX((VUT%8E
M;5#1!D<UC]- IB9;?_?G&V;]_-.K(AP3M2AW,M>S:'&8+8YG.X<IDJ9<+M,S
MR_8KBMU(,3K<W7QSW KK'OKFE*!?RMW@G35.YL6Q(8NJO>ME6O31@RKVU[EU
M^\W:_MQU]*UZ^_(I2N^L?_U6(*UWN9IG_V[Z"JWK]YKK+X]1;[)E-%%O>\5!
M*%/IH^J-_OPG.QC\M2ED2!A#PC@2)I P"8(9\?(V\?(H^NC#:GZK4BNYMY;%
M5RBS_F=^IYKR0@*[Y@4)8T@87\.""E:.M!Y']D7_<3L$R.HD"&:$P-^$P"=#
M<+/>-T>K?)JD\7^+/<C/\?/N]%53!$A<UP@@80P)XTB80,*DOQ=.9V /RO\V
M&362$&R2$)!)^*2R/,K+0\B!+S]9O&O/(V$,">-(F$#") AFI"/<I",\\5@D
M1,8+"6-(&$?"!!(F03 C7L--O(9''88>BQ/"Z':FK/LDM>Y7^2I55IQEJ^*4
M1+VVDF49N>+<L A4D;KR++$^MR@&,<6//(TGY1ZL.*>=?+&BQ9V5Y--BB'.;
M+%8%O(QAUG9\(]O9-89(&$/"^'#O*.(-@G/7.]\9Z" KE2"8D;#S3<+.R80Q
MI9:_JFB63U];[Q:3LZ:^)PE=^QX)8T@81\($$B9!,",@]D"+JL&)CW%U T )
M@](8E,:A- &E213-C-F6#[7)/='']5',>B@/8?4)UUTRFT5I9BV+HU5U<'I5
MG(YK=]:8);*6SEE"TEA-.]\^@P[.SEWSX,*AE0HH3:)H9D@<'1*'EC/)XK$8
MT!3QV!O79*O;_ZA);N6)5=8;3Y15?C1>/#3&A*RG<TR0- :E<2A-0&D213/3
MI$6R?6J3;$-5,I3&H#0.I0DH3:)H9LRT4+9IHWQ3[I_J^$RV8]9RSD5C.X<'
M*I:A-&[OJ^5A: _MH;]SW@6M5J)H9BZT8[9IR?SIYO(OF;5Z/J*UI0&JF*$T
M!J5Q>]_E^F[H^L/=,$ %,HIFAD%K9IOVS')KV$NE *J;H30&I?&:9NP3'-_Q
M]W8)4)F,HIDIT#K9)G7B2*S=WLUZ -L8 *@0AM(8E,:A- &E213-C(G6PO;P
MU -7J/"%TAB4QJ$T :5)%,V,F7;#-BV'CSTF004QE,:@-%[3C)')( SV#DE0
M^XNBF;/KM/YU2.\W>E=?9RHO)JU-RVI9[&G45Y5.XJQZN[X 5;JYIGS0%73-
M!Y3&H#1>T_QMP7>VH_<$M$J)HIGIT-;6H:UM?86RNAA97J"LLI%/E9&/=6SJ
ME#0F!"IMH30&I7$H34!I$D4SHZ3=KN.<>%#C0*4OE,:@- ZE"2A-HFAFS+3T
M=4C;-_J\2-4D>5A4L_JR0VI.?2U?JX.'-*C7A=(8E,9KFGE(\W8/:5!=BZ*9
M =&ZUJ%UK1&0YQP\5;?6%&]$CRJ-'E1Y23).FFZ N*+QG;,!U;90&F_9D+;U
M346IY5CS]1T?CFO=1=^:;T> >ET4S0R0]KK.49.'.XR)BMW,,1-QZ'H[)PNJ
M@*$T#J4)*$VB:&:ZM"AV@E,/DZ".&4IC4!J'T@24)E$T,V;:1#NTB3[2_="4
MSEF!ZNB:9LSFM!W/W1F]<&BM DJ3*)J9 BV:'7H"\K5*J[NN2_]S5>U*JHO9
MUD?B7!YJCJ$T!J5Q*$U :1)%,W.CS;%S?NJ#%%0Z0VD,2N-0FH#2)(IFW@BL
MW;1+N^GM^"SK^%3W,[Q>_WB> 4B<K;74X%;G,(UWC[^X)*-+=LT'E":@-(FB
MF?G0=MJE[?21@YB:8MP\Z/J.$YH#A7'#YVS;/G=VKO\PNE6=^Q>JC*$TB:*9
M_:N5L=LR'7ASK_;S%SU/H\E4E2?4]8(-C?WM[/6CN]O5K1]A=-LZ]S+4V$)I
M$D4S>WEKO0?:V+8,0DMY$J=JDB=I8V=C5W/ +N> 7<\!NZ #=D6''^%T7>UT
M7>_$XU$7:GVA- :E<2A-0&D213-CILVO>[3Y/6+4T;!D07@^M'>/1%!-"Z5Q
M*$U :1)%,Z.@-:U+S^<UH["Y@>VEM[75M6W?.N:<GWG>;EB@LA5*XU":@-(D
MBF:&1<M6EY:MO_W^[KJYVZ%Z%4IC4!J'T@24)E$T,QU:PKJGGNWK0ITME,:@
M- ZE"2A-HFAFS+2S=>G9OMUN1Z)AG2,#]:]0&G?W)_TZCA?N6A_1\#D[./?"
MG0&=1+7.7-U..U./]I)'.C&:TK5_H30&I?&:9O2O'7C!8'=Q.Z@91=',%&@S
MZM%F])!3J5:9;<P#=(HNE,:@- ZE"2A-HFAF:K1O]4X]1=>#3M&%TAB4QJ$T
M :5)%,V,F1:^'BU\ 9?UZ!HZYXAN+W&I#]H.#J4)*$VB:&9FME;M)=7>T<,:
M;^]@'PR"W74&Q@T?<_Q@N'L)B&Y3Y]Z%BE4H3:)H9N]JL>K18O6%%_IH:N>]
M0(.PW0T$5*]":0)*DRB:&0BM5SU:K^I U$M=EA/UJ]6@\J3*2.N. #K)%4IC
M4!KW]A=2L!W;#??.;Z!&%44S\Z&-JD<;5?+\IN6*,8WN' VH=(72.)0FH#2)
MHID!TM+5.[5T]:#2%4IC4!J'T@24)E$T,V9:NGJT=.UTQ=AK,(S.T-N=NT17
MV3D*4)D*I0DH3:)HYA,GM)CUCYC,BKMB7-?6=L68;E37L$!I'$H34)I$T<RP
M:'_KT_[V?;R(YZMY8\=#32V4QJ T#J4)*$VB:&8^M*GU3VUJ?:BIA=(8E,:A
M- &E213-C)DVM?X/-[5T#9US!)V?"Z7QEFVYOEV^,3)048NBF9'1HM:G12T1
M&?5U&:?KW121%Z37'$-I#$KC+1O2/WC504#;(5$T,S!;CV*CW6\]U"D&O)_:
MGL5%DSIG _L<-NR#V+!/8L,^BNU'J&%?JV'_U LD^%!W#*4Q*(U#:0)*DRB:
M&3-MF'W:,".&/E#1#*4Q*(VW;,O#%] %M!T213,SHZ6R?\3SW+YG[ -5QE :
M@])XRX:DQCY0/8RBF8'1>MBG]; >^[Q@)0Z:W3DM4*L,I7$H34!I$D4SGUZK
MK7)PZJ>W!="9PE :@](XE":@-(FBF3'3/CJ@??2E,>1)R\42L]?ED:Q\='KT
MT#@[AT9V#LZ:5C[%;G/!8V>* X/6R*$T :5)%,V,@];/P;$+,V2[C["-%^M'
M_+5=[ SV5V#8Z<XQW8C.^PJH-(;2!)0F430S'%H:![3HU(.:@_<]TH3.NP:H
M%(;2.)0FH#2)HIDYT:8X\$X]=(&Z9"B-06D<2A-0FD31S)AIOQP<L6C#]XD<
MNH;..8)Z9RB-MVQ+Y_!Y.;0=$D4S,Z,=<T!//VX_+S]X(QU-[IP5J#R&TCB4
M)J TB:*9^='R. A/?6B#NF4HC4%I'$H34)I$T<R8:=\<T)KT16?EP];SZ/$1
MGV%TTSIW,G0*,90F432SD[4C#EH<<?3UT%1 NF3GG0#4 $-I'$H34)I$T8Q\
MA-H AZ<VP"'4 $-I#$KC4)J TB2*9L9,&^#PB"?!?=]I%%U#YQQ!9RY#:;QE
M6Q*7-Z'MD"B:F1FMB4-:$W_O]7 :WSDP4)T,I?&6#6D/B,1 W3&*9B9&N^.P
MQ1VO!SO'3 :D29W# 77(4!J'T@24)E$T,R_:(8>G=L@AU"%#:0Q*XU":@-(D
MBF;&3#OD\(<[9+J&SCF".F0HC;=L2VKP W7(*)J9&>V0PR-6"/Z>P0]4)$-I
M#$KC+1N2'/Q K3&*9B9&6^.0GB:K!S\OF U(LSO'!2J$H30.I0DH3:)H9H*T
M$ Y/O:I%")VB#*4Q*(U#:0)*DRB:&3.MI$-:20.F?X4-J^XV/9.IX7.-SV2B
M6]RY[Z&Z&4J3*)K1]T.MFX?T,A;Z('5P=A=-Z+J/@-(8E,:A- &E213-S(GV
MQ4/[Q(>B(50G0VD,2N-0FH#2)(IFQDPKYN&+%?.Q9^9T#9US!+7,4!IOV9;>
MX?,L:#LDBF9F1DOFX;&2N?/L+IK<.2M0Z0RE<2A-0&D213/SHZ7S\-32>0B5
MSE :@](XE":@-(FBF3'3TGE(B]*7S.ZJD<;,K9U%C,='?(;13>O<R=#5+* T
MB:*M.[F?397*691'HXNY2A_46,UFF35)5HL"7XYJ-N]:J;HO0F"_N71Z_;WW
MK^PW8[M\OZ\QHXMET>WOH_0A7F363-T7R,%9J;FK<#S_DB?+HG=[UFV2Y\F\
M>CE5T9U*RP\4_WZ?)/GS+V4%3TGZI6KVZ/]02P,$%     @ &X==6(90/>FA
M!0  Q1P  !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULM9EO;]HX'("_
MBL5-IU9J26R').PH4J'=;;KK6JWM]MHE!J(E,;--NTKWX<].TC@=B8&LO&@A
M$/_\^._C'QD],?Y=+"F5X&>:9.*LMY1R]=YQQ&Q)4R+Z;$4S]<V<\91(=<D7
MCEAQ2J*\4)HXR'5])R5QUAN/\L]N^'C$UC*),WK#@5BG*>'/$YJPI[,>[+U\
M\"5>+*7^P!F/5F1!;ZF\7]UP=>544:(XI9F(608XG9_USN'[B8=T@?R.KS%]
M$K7W0#?E@;'O^N)3=-9S-1%-Z$SJ$$2]/-(I31(=27'\*(/VJCIUP?K[E^@?
M\L:KQCP00:<L^19'<GG6"WL@HG.R3N07]O21E@T:Z'@SEHC\/W@J[W5[8+86
MDJ5E8460QEGQ2GZ6'5$KX+450&6!O".<HJ*<\H)(,AYQ]@2XOEM%TV_RIN:E
M%5R<Z5&YE5Q]&ZMR<GQ[=SW]YW1R?GMY :;75S>7GV_/[SY=?P:GX'HMA219
M%&<+<+W2?2B N@3?".<DDP(<75!)XD0<@W?  6)).!4@SL!]%DMQHCY4[^^6
M;"U4*3%RI,+5E3JS$FU2H*$6-(C %<OD4H#++*+1ZP".:F?56/32V FR1KR@
MLS[ \ 0@%V%P?WL!CMZ]@B]>+#7AJEMQ7A-NZ]:&0 5A4<YK+J?7X'NQ(C-Z
MUE.+3%#^2'OC/_^ OON7A<JKJ#Q;]/&$+N(LT^,Y(0G)9A0<J2$J&GT,_FML
M?D%=Q/7SN'JA/X[](!Q";^0\-O ,*IZ!E>?R)^6S6-!H9X[!!L<I1 '"S1Q^
MQ>';.8I)OF^G^!LP0P@]")MA@@HFV*53R$-" 9% +BF@V>X]%&R.E!^&[K 9
M*JR@0NM\_I;O;FJ@SA\I5[LU>!DZL.*QZK(;RL&4I:G:9_.IWT06'F#F#RO^
M88>9'[$D(5R E:+/>U1WK=D.FAI15#.L=2\<] /4W+O0-;NPN\=*Z,!5QE?V
MJ9'!?MMDA#4_P'W71A<\V(#G]_T6.F3H4-?%TH42;8ZNUP\&+91&!M!N@XW5
M\X7J Y/NUZDR'%='DS5)P+_QG&KR9ZJXCQL!#V$/:/0!M_BCG 2JIW4OL[GN
MW)A%C:CV4'[12H! 6C@>#D%$GFWNA48K<">O_#(K&BGM@0:_4B)_*Z61#O2M
ML^)\L>!T020%G]0<B-5!=P:^DF3=N'E"J\&ZCKQQ$K1+R; ^:D+ :F=#M:H:
MB8N(P:L5/_#57XN+H)$1M+IB@X;6QKN-)MRDP3@,AJAMAS1J@7:W7/Y8Q_*Y
M/"(WUFTMWW'LD'$+<CN>19%52EW!C%J072U_ZS1BC\-?&:Y^MD$^1,AM'D%D
M+(+L%IGJ72VAT0E0:>Z<QAJ*<36M5C'?AP\UG$Y]UVWC,_Y >_JCP^D+'4(=
MR*@#V??[^EAW,',9_969P[[?DG\@8PIDW^!W&/DNM(--VJ#OMIQVD#$&LN<I
M%Y2N/E*2R.6)<L:LWUCW(42!C"A0T'6SL1JF*YAQ!K([HWON6P:N+VL(_6'8
M<NA'1AQHBSCV3G_+@*]V&!P,V[([;!R!M^0?W3+@,FJ=1]$$+>DX-F; 6Y*.
MW\N!\:8H E^9H@7+> *C@^_#V*JBCLL UWZ7LN[S;Y<(V^MI;@>P-<&H!-M5
M\MNY,M[\-:M%T=B(!&]).=XD3<:;OV^UD1EIX"T_;KUIBEQ6%NQ :)R![<YX
ML_08'T(QV"@&;U','NGQEE OB>>P3#QM?,8W>"??[) 6;PFT!YUG%.39TY2]
MTF'O$)F+9_SDV?W4(1TN(]87#@J\(?;#YN7C&2MY]NRE0S9<1GP%X_LX='\U
MMU-[LI12OLB?GPDP8^M,%@^9JD^K9W3GQ9,I<WOQ@.^*<*4> 1(Z5T7=?J#V
M.EX\,RLN)%OESZD>F)0LS=\N*8DHUS>H[^>,R9<+74'UY'+\/U!+ P04
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M@*K53("V5T[;JWDZ>DP.D&(ZA=)$13-R8(VV=P)4K68.M.9R6G/E]IGI,8F
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M)Q]+"/16U%L)]%;46PGT5M1;"?16U%L)]%;46PGT5M1;"?2.J'<DT#NBWI%
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M'G]=?I]$G%=7G.O[BN'I+U!+ P04    "  ;AUU8IY'J63<"  #?,@  $P
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M?@%02P$"% ,4    "  ;AUU8!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !N'75@GEH+9[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( !N'75B97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ &X==6(FR(SXM"   )S$  !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( !N'75B,>P3?30(  ,$%   8              " @7$0  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  ;AUU87" WU-<'  #V(@
M&               @('T$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ &X==6 BHI\&K @  60<  !@              ("! 1L  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !N'75C(M4/RD @
M &TG   8              " @>(=  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    "  ;AUU8^4M,]LD#   P"P  &               @(&H
M)@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ &X==6# I
M%<=O$P  ^Q0! !@              ("!IRH  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( !N'75BZDJ#^C L   HV   8
M  " @4P^  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  ;
MAUU8@VM]1$$,  !@KP  &               @($.2@  >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ &X==6+V+OJYI#   T!\  !D
M         ("!A58  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    "  ;AUU8M:*VMV$L  "CA0  &0              @($E8P  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !N'75@2@PP;_ ,  #P*
M   9              " @;V/  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ &X==6.LL8=6_$@  1CP  !D              ("!\),
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  ;AUU8B;)7
M:C$)  #O%0  &0              @('FI@  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( !N'75B-_ &XCP8  ! /   9
M  " @4ZP  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
M&X==6-6=FDJ\ P  +PD  !D              ("!%+<  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    "  ;AUU8(3EKK D.  #:+@  &0
M            @($'NP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( !N'75C )(3N<0<  (T1   9              " @4?)  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ &X==6/"(<=Y&#0
M5R$  !D              ("![]   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    "  ;AUU8-W&W=+0*  #F(   &0              @(%L
MW@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( !N'75AS
M7=-^T (  *<&   9              " @5?I  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ &X==6$&==,Q] @  K@8  !D
M     ("!7NP  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !N'75B( K:)" 4  ,H,   9              "
M@><L 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ &X==
M6*&L5AE!!0  ]0L  !D              ("!)C(! 'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    "  ;AUU8H:2M^#L#  #A!@  &0
M        @(&>-P$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( !N'75@_F6"+]P4  ,@/   9              " @1 [ 0!X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ &X==6 5GHIRF!0  ?0X
M !D              ("!/D$! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    "  ;AUU8XQ*K_B8'  !Y$@  &0              @($;1P$
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( !N'75BMNYF*
M4 0  ),+   9              " @7A. 0!X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ &X==6!C.+ /E!0   R$  !D
M ("!_U(! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  ;
MAUU82D5N_#@&  !:+   &0              @($;60$ >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( !N'75COKTI'" ,  '\*   9
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M 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ &X==6'N
M*QCY!   ,R   !D              ("!O' ! 'AL+W=O<FMS:&5E=',O<VAE
M970T,"YX;6Q02P$"% ,4    "  ;AUU8&4,41>8"  !4"   &0
M    @('L=0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M !N'75ADD LA3 <  +Y-   9              " @0EY 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ &X==6,$I1W?T P  @P\  !D
M             ("!C( ! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    "  ;AUU841>;/YT/  !>[@  &0              @(&WA $ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( !N'75B\IDKH,08
M &(N   9              " @8N4 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ &X==6/6?O"?="   TUX  !D              ("!
M\YH! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  ;AUU8
M_+'IDN0#  "S%0  &0              @($'I $ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( !N'75@PZ[@'8P8  #T<   9
M      " @2*H 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ &X==6!B1O&"V!P  X$8  !D              ("!O*X! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  ;AUU8!BV5#8T#  #F"@
M&0              @(&IM@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( !N'75B)E 4@A 0  "H5   9              " @6VZ 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ &X==6)V8"[2.
M!   WQ0  !D              ("!*+\! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    "  ;AUU8992IJ9,"  #A!0  &0
M@('MPP$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( !N'
M75C'O@WP#0<  ))    9              " @;?& 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ &X==6*K8L&I#&P  "/H! !D
M         ("!^\T! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
M    "  ;AUU8^W0E!*L&  "1,P  &0              @(%UZ0$ >&PO=V]R
M:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( !N'75BIK![6\P8  !L^
M   9              " @5?P 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL
M4$L! A0#%     @ &X==6-L:5'0K$P  ;00! !D              ("!@?<!
M 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  ;AUU87A*7
MUUL+   )A0  &0              @('C"@( >&PO=V]R:W-H965T<R]S:&5E
M=#4Y+GAM;%!+ 0(4 Q0    ( !N'75B-=-W\"0H  #E?   9
M  " @746 @!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @
M&X==6.:S!CJ5!   E10  !D              ("!M2 " 'AL+W=O<FMS:&5E
M=',O<VAE970V,2YX;6Q02P$"% ,4    "  ;AUU8/UA#Q38#  "F"P  &0
M            @(&!)0( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4
M Q0    ( !N'75@W<&Q/+P@  -E"   9              " @>XH @!X;"]W
M;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ &X==6+ID1,\I!
MKQ0  !D              ("!5#$" 'AL+W=O<FMS:&5E=',O<VAE970V-"YX
M;6Q02P$"% ,4    "  ;AUU8 -JDW(4$  "V&@  &0              @(&T
M-0( >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( !N'75B
M^G#\0@0  'X2   9              " @7 Z @!X;"]W;W)K<VAE971S+W-H
M965T-C8N>&UL4$L! A0#%     @ &X==6'S@5)N5 @  A08  !D
M     ("!Z3X" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !N'75CH<S.U8@4  '0E   9              "
M@7=< @!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ &X==
M6 /?6S5E!   OA<  !D              ("!$&(" 'AL+W=O<FMS:&5E=',O
M<VAE970W,RYX;6Q02P$"% ,4    "  ;AUU8U<^KZ0L$  "-&   &0
M        @(&L9@( >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0
M   ( !N'75A978?W"P,  & ,   9              " @>YJ @!X;"]W;W)K
M<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ &X==6"@'!/@^ P  $PL
M !D              ("!,&X" 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q0
M2P$"% ,4    "  ;AUU8NLB<.$D#  #!"@  &0              @(&E<0(
M>&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( !N'75C9LRG6
M$ 0  "(/   9              " @25U @!X;"]W;W)K<VAE971S+W-H965T
M-S@N>&UL4$L! A0#%     @ &X==6%X[$F_^ @  "0L  !D
M ("!;'D" 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    "  ;
MAUU8=/=IY-\"   P"   &0              @(&A? ( >&PO=V]R:W-H965T
M<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( !N'75@F'#7.@P,  *L,   9
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M970X-2YX;6Q02P$"% ,4    "  ;AUU8%^EHFVX.  "JO0  &0
M    @($WE@( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    (
M !N'75B&4#WIH04  ,4<   9              " @=RD @!X;"]W;W)K<VAE
M971S+W-H965T.#<N>&UL4$L! A0#%     @ &X==6$9W@I@Q"@  76D  !D
M             ("!M*H" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"
M% ,4    "  ;AUU8"CA#:JH"   $"0  &0              @($<M0( >&PO
M=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( !N'75B/*I03=0,
M 'T8   -              "  ?VW @!X;"]S='EL97,N>&UL4$L! A0#%
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K @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !A &$ GAH  $;( @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>498</ContextCount>
  <ElementCount>532</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>179</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - AUDIT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/AUDITINFORMATION</Role>
      <ShortName>AUDIT INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - NATURE OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESS</Role>
      <ShortName>NATURE OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - RECENT ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS</Role>
      <ShortName>RECENT ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTING</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - SEGMENT REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGTables</Role>
      <ShortName>SEGMENT REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTING</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - NATURE OF BUSINESS (Details )</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSDetails</Role>
      <ShortName>NATURE OF BUSINESS (Details )</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Net Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Net Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information1 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information1 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information2 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information2 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information4 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information4 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Foreign Currency Translation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Foreign Currency Translation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information5 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information5 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information6 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information6 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information7 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information7 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment in Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment in Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information8 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information8 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Key Financial Data on Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Key Financial Data on Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information9 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information9 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Assets and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Assets and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information1 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information1 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information2 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information2 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information4 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information4 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - SEGMENT REPORTING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGDetails</Role>
      <ShortName>SEGMENT REPORTING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTINGTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Annual Amortization Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Annual Amortization Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - PROPERTY AND EQUIPMENT - Additional Information (Details )</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Additional Information (Details )</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Debt (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Annual Note Payable Maturities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Annual Note Payable Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE- Second Amended and Restated First Lien Credit and Guaranty Agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE- Second Amended and Restated First Lien Credit and Guaranty Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Senior Credit Facilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Senior Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Recent Amendments to Prior Credit Facilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE - Recent Amendments to Prior Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - LEASES - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESLeaseCostDetails</Role>
      <ShortName>LEASES - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - LEASES - Supplemental Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails</Role>
      <ShortName>LEASES - Supplemental Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - LEASES - Supplemental Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails</Role>
      <ShortName>LEASES - Supplemental Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - LEASES - Maturities of Operating and Finance Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails</Role>
      <ShortName>LEASES - Maturities of Operating and Finance Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954527 - Disclosure - INCOME TAXES - Income (Loss) Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Income (Loss) Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954528 - Disclosure - INCOME TAXES - Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails</Role>
      <ShortName>INCOME TAXES - Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954529 - Disclosure - INCOME TAXES - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails</Role>
      <ShortName>INCOME TAXES - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954530 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954531 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954532 - Disclosure - INCOME TAXES - Unrecognized Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails</Role>
      <ShortName>INCOME TAXES - Unrecognized Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954533 - Disclosure - STOCK-BASED COMPENSATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9954534 - Disclosure - STOCK-BASED COMPENSATION - Outstanding Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Outstanding Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9954535 - Disclosure - STOCK-BASED COMPENSATION - RSU's and LTIPs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - RSU's and LTIPs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="rdnt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9954536 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>89</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="rdnt-20231231.htm">rdnt-20231231.htm</File>
    <File>rdnt-20231231.xsd</File>
    <File>rdnt-20231231_cal.xml</File>
    <File>rdnt-20231231_def.xml</File>
    <File>rdnt-20231231_lab.xml</File>
    <File>rdnt-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rdnt-20231231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1522">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>136
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rdnt-20231231.htm": {
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "rdnt-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rdnt-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 454,
   "keyCustom": 78,
   "axisStandard": 46,
   "axisCustom": 1,
   "memberStandard": 55,
   "memberCustom": 112,
   "hidden": {
    "total": 16,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 12
   },
   "contextCount": 498,
   "entityCount": 1,
   "segmentCount": 179,
   "elementCount": 984,
   "unitCount": 12,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1522,
    "http://xbrl.sec.gov/dei/2023": 38,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://www.radnet.com/role/COVERPAGE",
     "longName": "0000001 - Document - COVER PAGE",
     "shortName": "COVER PAGE",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.radnet.com/role/AUDITINFORMATION",
     "longName": "0000002 - Document - AUDIT INFORMATION",
     "shortName": "AUDIT INFORMATION",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENT OF EQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-16",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-16",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.radnet.com/role/NATUREOFBUSINESS",
     "longName": "0000010 - Disclosure - NATURE OF BUSINESS",
     "shortName": "NATURE OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "0000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS",
     "longName": "0000012 - Disclosure - RECENT ACCOUNTING STANDARDS",
     "shortName": "RECENT ACCOUNTING STANDARDS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY",
     "longName": "0000013 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.radnet.com/role/SEGMENTREPORTING",
     "longName": "0000014 - Disclosure - SEGMENT REPORTING",
     "shortName": "SEGMENT REPORTING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "longName": "0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENT",
     "longName": "0000016 - Disclosure - PROPERTY AND EQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE",
     "longName": "0000017 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.radnet.com/role/LEASES",
     "longName": "0000018 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.radnet.com/role/INCOMETAXES",
     "longName": "0000019 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "longName": "0000020 - Disclosure - STOCK-BASED COMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTS",
     "longName": "0000021 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-498",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-498",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "longName": "9954472 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables",
     "longName": "9954473 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGTables",
     "longName": "9954474 - Disclosure - SEGMENT REPORTING (Tables)",
     "shortName": "SEGMENT REPORTING (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "longName": "9954475 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables",
     "longName": "9954476 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables",
     "longName": "9954477 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.radnet.com/role/LEASESTables",
     "longName": "9954478 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.radnet.com/role/INCOMETAXESTables",
     "longName": "9954479 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "longName": "9954480 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
     "longName": "9954481 - Disclosure - NATURE OF BUSINESS (Details )",
     "shortName": "NATURE OF BUSINESS (Details )",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:NumberOfCenters",
      "unitRef": "center",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:NumberOfCenters",
      "unitRef": "center",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails",
     "longName": "9954482 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Net Revenue (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Net Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details",
     "longName": "9954483 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information1 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information1 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails",
     "longName": "9954484 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Payable and Accrued Expenses (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Payable and Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
     "longName": "9954485 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information2 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information2 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
     "longName": "9954486 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information3 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:OperatingLeaseLeaseAbandonmentCharge",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
     "longName": "9954487 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information4 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information4 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails",
     "longName": "9954488 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Foreign Currency Translation (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Foreign Currency Translation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-22",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details",
     "longName": "9954489 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information5 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information5 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-161",
      "name": "rdnt:MonthlyAmortizationOfDeferredHedgeGains",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails",
     "longName": "9954490 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-163",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
     "longName": "9954491 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information6 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information6 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
     "longName": "9954492 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contingent Consideration (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contingent Consideration (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-143",
      "name": "rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
     "longName": "9954493 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurements (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "rdnt:ValueOfEstimatedSharesIssuable",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "rdnt:ValueOfEstimatedSharesIssuable",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails",
     "longName": "9954494 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Debt (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails",
     "longName": "9954495 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
     "longName": "9954496 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information7 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information7 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments",
      "unitRef": "investment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:EquityMethodInvestmentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments",
      "unitRef": "investment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:EquityMethodInvestmentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails",
     "longName": "9954497 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment in Joint Ventures (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment in Joint Ventures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details",
     "longName": "9954498 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information8 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information8 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:ManagementServiceFees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:ManagementServiceFees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails",
     "longName": "9954499 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Key Financial Data on Joint Ventures (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Key Financial Data on Joint Ventures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-260",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails",
     "longName": "9954500 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details",
     "longName": "9954501 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information9 (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information9 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossOnDispositionOfAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-276",
      "name": "us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
     "longName": "9954502 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Assets and Liabilities Assumed (Details)",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY - Assets and Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-277",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
     "longName": "9954503 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information1 (Details)",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information1 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R57": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
     "longName": "9954504 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information2 (Details)",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information2 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
     "longName": "9954505 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information3 (Details)",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information3 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
     "longName": "9954506 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information4 (Details)",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY - Additional Information4 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-327",
      "name": "us-gaap:PaymentsToAcquireIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
     "longName": "9954507 - Disclosure - SEGMENT REPORTING (Details)",
     "shortName": "SEGMENT REPORTING (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rdnt:GainOnContributionOfImagingCentersIntoJointVenture",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
     "longName": "9954508 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
     "longName": "9954509 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails",
     "longName": "9954510 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Annual Amortization Schedule (Details)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Annual Amortization Schedule (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
     "longName": "9954511 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)",
     "shortName": "PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
     "longName": "9954512 - Disclosure - PROPERTY AND EQUIPMENT - Additional Information (Details )",
     "shortName": "PROPERTY AND EQUIPMENT - Additional Information (Details )",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
     "longName": "9954513 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Debt (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Schedule of Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails",
     "longName": "9954514 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Annual Note Payable Maturities (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Annual Note Payable Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
     "longName": "9954515 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Additional Information (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-400",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-401",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
     "longName": "9954516 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE- Second Amended and Restated First Lien Credit and Guaranty Agreement (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE- Second Amended and Restated First Lien Credit and Guaranty Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-452",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
     "longName": "9954517 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-410",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-410",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
     "longName": "9954518 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Senior Credit Facilities (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Senior Credit Facilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-400",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-438",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
     "longName": "9954519 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Revolving Credit Facilities (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Revolving Credit Facilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-451",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
     "longName": "9954520 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Margin Spread Based on Leverage Ratio (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-440",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-440",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
     "longName": "9954521 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE - Recent Amendments to Prior Credit Facilities (Details)",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE - Recent Amendments to Prior Credit Facilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-403",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-453",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.radnet.com/role/LEASESDetails",
     "longName": "9954522 - Disclosure - LEASES (Details)",
     "shortName": "LEASES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.radnet.com/role/LEASESLeaseCostDetails",
     "longName": "9954523 - Disclosure - LEASES - Lease Cost (Details)",
     "shortName": "LEASES - Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails",
     "longName": "9954524 - Disclosure - LEASES - Supplemental Cash Flows (Details)",
     "shortName": "LEASES - Supplemental Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails",
     "longName": "9954525 - Disclosure - LEASES - Supplemental Balance Sheet (Details)",
     "shortName": "LEASES - Supplemental Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails",
     "longName": "9954526 - Disclosure - LEASES - Maturities of Operating and Finance Lease (Details)",
     "shortName": "LEASES - Maturities of Operating and Finance Lease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails",
     "longName": "9954527 - Disclosure - INCOME TAXES - Income (Loss) Before Income Taxes (Details)",
     "shortName": "INCOME TAXES - Income (Loss) Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails",
     "longName": "9954528 - Disclosure - INCOME TAXES - Income Tax Expense (Details)",
     "shortName": "INCOME TAXES - Income Tax Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails",
     "longName": "9954529 - Disclosure - INCOME TAXES - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates (Details)",
     "shortName": "INCOME TAXES - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9954530 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)",
     "shortName": "INCOME TAXES - Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails",
     "longName": "9954531 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails",
     "longName": "9954532 - Disclosure - INCOME TAXES - Unrecognized Tax Benefit (Details)",
     "shortName": "INCOME TAXES - Unrecognized Tax Benefit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
     "longName": "9954533 - Disclosure - STOCK-BASED COMPENSATION (Details)",
     "shortName": "STOCK-BASED COMPENSATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
      "unitRef": "incentiveplan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CompensationRelatedCostsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-495",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
     "longName": "9954534 - Disclosure - STOCK-BASED COMPENSATION - Outstanding Options and Warrants (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Outstanding Options and Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
     "longName": "9954535 - Disclosure - STOCK-BASED COMPENSATION - RSU's and LTIPs (Details)",
     "shortName": "STOCK-BASED COMPENSATION - RSU's and LTIPs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-458",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-470",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
     "longName": "9954536 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-496",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-496",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rdnt-20231231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "rdnt_A2019SWAPS1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "A2019SWAPS1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 SWAPS1",
        "label": "2019 SWAPS1 [Member]",
        "documentation": "2019 SWAPS1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_A2019SWAPSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "A2019SWAPSMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 SWAPS",
        "label": "2019 SWAPS [Member]",
        "documentation": "2019 SWAPS [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_A6.0NotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "A6.0NotesDue2028Member",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "6.0% Notes due 2028",
        "label": "6.0% Notes due 2028 [Member]",
        "documentation": "6.0% Notes due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_AILongTermIncentivePlanSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AILongTermIncentivePlanSharesMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AI Long Term Incentive Plan shares",
        "label": "AI Long Term Incentive Plan shares [Member]",
        "documentation": "AI Long Term Incentive Plan shares"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_AIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AIMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "AI segment revenue",
        "terseLabel": "AI",
        "label": "AI [Member]",
        "documentation": "AI"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable, accrued expenses and other",
        "verboseLabel": "Total",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r874"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r286",
      "r287",
      "r581",
      "r846",
      "r989"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r278",
      "r602"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r181",
      "r271",
      "r681",
      "r720",
      "r723"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r23",
      "r55",
      "r585",
      "r588",
      "r639",
      "r716",
      "r717",
      "r989",
      "r990",
      "r991",
      "r1002",
      "r1003",
      "r1004"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "rdnt_AcquisitionsAndAssetPurchasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AcquisitionsAndAssetPurchasesMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions And Asset Purchases",
        "label": "Acquisitions And Asset Purchases [Member]",
        "documentation": "Acquisitions And Asset Purchases"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in-capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r874",
      "r1108"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r537",
      "r737",
      "r1002",
      "r1003",
      "r1004",
      "r1080",
      "r1109"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r87"
     ]
    },
    "rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AdjustmentToNetIncomeAttributableToAssumedShareSettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in fair value associated with contingently issuable shares",
        "label": "Adjustment To Net Income Attributable To Assumed Share Settlements",
        "documentation": "Adjustment To Net Income Attributable To Assumed Share Settlements"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on contribution of assets to majority owned subsidiary",
        "label": "Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary",
        "documentation": "Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r502"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_AdvanceMedicarePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AdvanceMedicarePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance medicare payments",
        "label": "Advance Medicare Payments",
        "documentation": "Advance Medicare Payments"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliates",
        "label": "Affiliated Entity [Member]"
       }
      }
     },
     "auth_ref": [
      "r785",
      "r835",
      "r880",
      "r1038",
      "r1089",
      "r1090",
      "r1092"
     ]
    },
    "rdnt_AggregateIntrinsicValue": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AggregateIntrinsicValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "documentation": "Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r912",
      "r922",
      "r948"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r903",
      "r915",
      "r925",
      "r951"
     ]
    },
    "rdnt_AidenceHoldingBVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AidenceHoldingBVMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aidence Holding B.V. milestone consideration",
        "label": "Aidence Holding B.V. [Member]",
        "documentation": "Aidence Holding B.V."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_AidenceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AidenceMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aidence",
        "label": "Aidence [Member]",
        "documentation": "Aidence"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r907",
      "r916",
      "r926",
      "r943",
      "r952",
      "r956",
      "r964"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDeferredCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred charges",
        "label": "Amortization of Deferred Charges",
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDeferredHedgeGains",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of cash flow hedge",
        "label": "Amortization of Deferred Hedge Gains",
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization and write off of deferred financing costs and loan discount",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r458",
      "r617",
      "r997"
     ]
    },
    "rdnt_AntelopeValleyOutpatientImagingCenterLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AntelopeValleyOutpatientImagingCenterLLCMember",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antelope Valley Outpatient Imaging Center, LLC",
        "label": "Antelope Valley Outpatient Imaging Center, LLC [Member]",
        "documentation": "Antelope Valley Outpatient Imaging Center, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "rdnt_ArizonaDiagnosticsGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ArizonaDiagnosticsGroupMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arizona Diagnostics Group",
        "label": "Arizona Diagnostics Group [Member]",
        "documentation": "Arizona Diagnostics Group"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r265",
      "r302",
      "r353",
      "r368",
      "r374",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r577",
      "r582",
      "r604",
      "r678",
      "r778",
      "r874",
      "r889",
      "r1029",
      "r1030",
      "r1093"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Lessee",
        "label": "Assets And Liabilities Lessee [Table Text Block]",
        "documentation": "[Table Text Block] for Assets And Liabilities Lessee [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails": {
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "terseLabel": "Current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r272",
      "r302",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r577",
      "r582",
      "r604",
      "r874",
      "r1029",
      "r1030",
      "r1093"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails": {
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncurrent assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r577",
      "r582",
      "r604",
      "r1029",
      "r1030",
      "r1093"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.radnet.com/role/AUDITINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r895",
      "r908"
     ]
    },
    "rdnt_AuditorInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "AuditorInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Information [Abstract]",
        "documentation": "Auditor Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.radnet.com/role/AUDITINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r895",
      "r908"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.radnet.com/role/AUDITINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r895",
      "r908"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "rdnt_BarclaysMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BarclaysMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Barclays",
        "label": "Barclays [Member]",
        "documentation": "Barclays [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alternative Base Rate Spread",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BeverlyHillsImagingCenterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BeverlyHillsImagingCenterMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Beverly Hills Imaging Center",
        "label": "Beverly Hills Imaging Center [Member]",
        "documentation": "Beverly Hills Imaging Center"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BlueShieldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BlueShieldMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Blue Shield",
        "label": "Blue Shield [Member]",
        "documentation": "Blue Shield [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r864",
      "r865"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r112",
      "r572",
      "r864",
      "r865"
     ]
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessAcquisitionContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessAcquisitionContingentConsiderationMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acsuition Contingent Consideration",
        "label": "Business Acquisition Contingent Consideration [Member]",
        "documentation": "Business Acquisition Contingent Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, equity interest issued or issuable, additional number of shares",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, equity interest issued or issuable, fair value of additional shares issued after execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of RadNet stock issued in acquisition",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, percentage of voting interests acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill deductible for tax purpose",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (dollars per share)",
        "label": "Business Acquisition, Share Price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessAcquisitionsMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisitions",
        "label": "Business Acquisitions [Member]",
        "documentation": "Business Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, noncontrolling interest",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration transferred",
        "verboseLabel": "Consideration transferred",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r20"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued as consideration",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in value of contingent consideration",
        "verboseLabel": "Change in Valuation of Contingent Consideration",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r996"
     ]
    },
    "rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation",
        "label": "Business Combination Contingent Consideration Arrangements Change In Currency Translation",
        "documentation": "Business Combination Contingent Consideration Arrangements Change In Currency Translation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase agreements",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "rdnt_BusinessCombinationContingentConsiderationArrangementsSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationContingentConsiderationArrangementsSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement of Contingent Consideration",
        "label": "Business Combination, Contingent Consideration Arrangements, Settlements",
        "documentation": "Business Combination, Contingent Consideration Arrangements, Settlements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration settlement",
        "label": "Business Combination, Contingent Consideration, Asset",
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r574"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration to guarantee share value issued",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r118",
      "r574"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityAbstract",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other non-current liabilities",
        "label": "Business Combination, Contingent Consideration, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability, measurement input",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "documentation": "Value of input used to measure contingent consideration liability from business combination."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, contingent consideration",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r118"
     ]
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationContingentConsiderationLiabilityPeriod",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, contingent consideration, liability, period",
        "label": "Business Combination, Contingent Consideration, Liability, Period",
        "documentation": "Business Combination, Contingent Consideration, Liability, Period"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationContingentConsiderationLiabilityRollForward",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Contingent Consideration, Liability [Roll Forward]",
        "label": "Business Combination, Contingent Consideration, Liability [Roll Forward]",
        "documentation": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of identified milestones",
        "label": "Business Combination, Contingent Consideration, Number Of Identified Milestones",
        "documentation": "Business Combination, Contingent Consideration, Number Of Identified Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessCombinationNumberOfSubsidiariesAcquired": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationNumberOfSubsidiariesAcquired",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of subsidiaries acquired",
        "label": "Business Combination, Number Of Subsidiaries Acquired",
        "documentation": "Business Combination, Number Of Subsidiaries Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement of loan",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities",
        "documentation": "The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible Assets",
        "terseLabel": "Intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term liabilities assumed",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Property and equipment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right of Use Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Right of Use Assets",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BUSINESS COMBINATIONS",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NATURE OF BUSINESS",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r196",
      "r197"
     ]
    },
    "rdnt_CCDGLRSServicesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CCDGLRSServicesIncMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "C.C.D.G.L.R. &amp; S Services Inc.",
        "label": "C.C.D.G.L.R. &amp; S Services Inc. [Member]",
        "documentation": "C.C.D.G.L.R. &amp; S Services Inc."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_COVID19PandemicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "COVID19PandemicMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "C O V I D19 Pandemic",
        "label": "C O V I D19 Pandemic [Member]",
        "documentation": "C O V I D19 Pandemic"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_CapitationArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CapitationArrangementsMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue under capitation arrangements",
        "label": "Capitation Arrangements [Member]",
        "documentation": "Capitation Arrangements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r261",
      "r842"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH AND CASH EQUIVALENTS",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r193",
      "r299"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r193"
     ]
    },
    "rdnt_CashFlowLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CashFlowLesseeAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:",
        "label": "Cash Flow Lessee [Abstract]",
        "documentation": "Cash Flow Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_CashHoldbackMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CashHoldbackMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Holdback",
        "label": "Cash Holdback [Member]",
        "documentation": "Cash Holdback"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_CedarsSinaiMedicalCenterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CedarsSinaiMedicalCenterMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cedars Sinai Medical Center",
        "label": "Cedars Sinai Medical Center [Member]",
        "documentation": "Cedars Sinai Medical Center [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_CertainSellerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CertainSellerMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certain Seller",
        "label": "Certain Seller [Member]",
        "documentation": "Certain Seller"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "rdnt_ChelseaDignosticRadiologyPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ChelseaDignosticRadiologyPCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chelsea Dignostic Radiology, P.C.",
        "label": "Chelsea Dignostic Radiology, P.C. [Member]",
        "documentation": "Chelsea Dignostic Radiology, P.C."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r268",
      "r269",
      "r270",
      "r302",
      "r330",
      "r334",
      "r341",
      "r343",
      "r347",
      "r348",
      "r390",
      "r423",
      "r426",
      "r427",
      "r428",
      "r434",
      "r435",
      "r467",
      "r468",
      "r470",
      "r471",
      "r473",
      "r604",
      "r729",
      "r730",
      "r731",
      "r732",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r766",
      "r787",
      "r805",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r971",
      "r998",
      "r1006"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "rdnt_CommercialInsurance1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CommercialInsurance1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial insurance",
        "label": "Commercial Insurance1 [Member]",
        "documentation": "Commercial Insurance1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory note",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r881",
      "r882",
      "r883",
      "r886"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r834"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "verboseLabel": "Weight average shares for which the exercise price exceeds the average market price of common stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r877",
      "r878",
      "r879",
      "r881",
      "r882",
      "r883",
      "r886",
      "r1002",
      "r1003",
      "r1080",
      "r1105",
      "r1109"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock - par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock - authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r766"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock - issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock - outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r173",
      "r766",
      "r784",
      "r1109",
      "r1110"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock - $.0001 par value, 200,000,000 shares authorized; 67,956,318 and 57,723,125 shares issued and outstanding at December 31, 2023 and 2022 respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r680",
      "r874"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY BASED COMPENSATION",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "COMPREHENSIVE INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r281",
      "r283",
      "r291",
      "r674",
      "r694"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r126",
      "r133",
      "r281",
      "r283",
      "r290",
      "r673",
      "r693"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "COMPREHENSIVE INCOME",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r224",
      "r281",
      "r283",
      "r289",
      "r672",
      "r692"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER COMPREHENSIVE INCOME (LOSS)",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ComputerandOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ComputerandOfficeEquipmentMember",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer and Office Equipment",
        "label": "Computer and Office Equipment [Member]",
        "documentation": "Computer and Office Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONCENTRATION OF CREDIT RISKS",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r240"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r577",
      "r578",
      "r582",
      "r583",
      "r644",
      "r835",
      "r1028",
      "r1031",
      "r1032"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r577",
      "r578",
      "r582",
      "r583",
      "r644",
      "r835",
      "r1028",
      "r1031",
      "r1032"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r355",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r376",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r431",
      "r433",
      "r434",
      "r1029",
      "r1030"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r355",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r376",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r431",
      "r433",
      "r434",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r134"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRINCIPLES OF CONSOLIDATION",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r847"
     ]
    },
    "us-gaap_ConstructionInProgressGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressGross",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress, gross",
        "label": "Construction in Progress, Gross",
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in Progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration by Type [Axis]",
        "label": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration Type [Domain]",
        "label": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ContingentMilestoneConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ContingentMilestoneConsiderationMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Milestone Consideration",
        "label": "Contingent Milestone Consideration [Member]",
        "documentation": "Contingent Milestone Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r476",
      "r487"
     ]
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ContractsReceivableFactoringReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Factoring receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "documentation": "Contracts Receivable, Factoring Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock issued upon conversion (in shares)",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r94",
      "r172",
      "r211",
      "r472"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r440",
      "r469",
      "r643",
      "r843",
      "r845"
     ]
    },
    "rdnt_CovenantNotToCompeteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CovenantNotToCompeteMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Covenant not to compete and other contracts",
        "label": "Covenant Not To Compete [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditDerivativesByContractTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Derivatives Contract Type [Axis]",
        "label": "Credit Derivatives Contract Type [Axis]",
        "documentation": "Information by major type of contract of credit derivatives."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditDerivativesContractTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Derivatives Contract Type [Domain]",
        "label": "Credit Derivatives Contract Type [Domain]",
        "documentation": "Represents major types of credit derivative contracts."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation Adjustments",
        "label": "Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)",
        "documentation": "The increase (decrease) in cumulative translation adjustment before transfers included in determining net income."
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CumulativeTranslationAdjustmentSummaryRollForward",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation",
        "label": "Cumulative Translation Adjustment Summary [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal current tax",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1001",
      "r1073"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign current tax",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1001"
     ]
    },
    "rdnt_CurrentOtherTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "CurrentOtherTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current tax",
        "label": "Current Other Tax Expense (Benefit)",
        "documentation": "Current Other Tax Expense (Benefit)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "rdnt_DRTLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DRTLLCMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DRT LLC",
        "label": "DRT LLC [Member]",
        "documentation": "DRT LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CREDIT FACILITIES AND NOTES PAYABLE",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r301",
      "r436",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r452",
      "r459",
      "r460",
      "r462"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r167",
      "r168",
      "r229",
      "r231",
      "r308",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r618",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r999"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total notes payable obligations",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r231",
      "r463"
     ]
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leverage ratio, less than",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leverage ratio, greater than",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r155",
      "r437",
      "r618",
      "r855",
      "r856"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Barclays Term Loans and Truist Term Loan",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r603",
      "r855",
      "r856"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r153",
      "r465",
      "r618"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r438"
     ]
    },
    "rdnt_DebtInstrumentLeverageRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DebtInstrumentLeverageRatio",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, leverage ratio",
        "label": "Debt Instrument, Leverage Ratio",
        "documentation": "Debt Instrument, Leverage Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r461",
      "r618",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r999"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r308",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r618",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r999"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt periodic payment",
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r158"
     ]
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt periodic payment, percent of total amount",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "documentation": "Debt Instrument, Periodic Payment, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Periodic payment, principal",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt periodic payment, amortization increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r94",
      "r95",
      "r152",
      "r153",
      "r155",
      "r157",
      "r210",
      "r212",
      "r308",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r461",
      "r618",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r999"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Discount on debt",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r155",
      "r1034"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, unamortized discount, current",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r155"
     ]
    },
    "rdnt_DeepHealthIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DeepHealthIncMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DeepHealth, Inc.",
        "label": "DeepHealth, Inc. [Member]",
        "documentation": "DeepHealth, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DEFERRED FINANCING COSTS",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal deferred tax",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1071",
      "r1073"
     ]
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs",
        "label": "Debt Issuance Costs, Gross",
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred financing costs, net of accumulated amortization",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r1034"
     ]
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred financing costs",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign deferred tax",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r1001",
      "r1071"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total Deferred Tax Liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r230",
      "r555"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability, net",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544",
      "r679"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State deferred tax",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1071",
      "r1073"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Deferred Tax Assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "rdnt_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability",
        "label": "Deferred Tax Assets, Operating Lease Liabilities",
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating losses",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards, not subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards, subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DeferredTaxAssetsTaxBenefitMayNotBeRealized",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, tax benefit may not be realized",
        "label": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "documentation": "Deferred Tax Assets, Tax Benefit May Not Be Realized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net Deferred Tax Liability",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1069"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangibles",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Goodwill",
        "terseLabel": "Deferred tax liabilities goodwill",
        "label": "Deferred Tax Liabilities, Goodwill",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r122",
      "r123",
      "r1070"
     ]
    },
    "rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DeferredTaxLiabilitiesOperatingRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating lease right-of-use asset",
        "label": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "documentation": "Deferred Tax Liabilities, Operating Right-Of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "rdnt_DeferredTaxLiabilitiesOutsideBasisDifference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DeferredTaxLiabilitiesOutsideBasisDifference",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Outside basis difference",
        "label": "Deferred Tax Liabilities, Outside Basis Difference",
        "documentation": "Deferred Tax Liabilities, Outside Basis Difference"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1070"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected employee contribution",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contribution, percent",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer matching contribution, percent",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_DelawareDiagnosticImagingPAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DelawareDiagnosticImagingPAMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Delaware Diagnostic Imaging, P.A.",
        "label": "Delaware Diagnostic Imaging, P.A. [Member]",
        "documentation": "Delaware Diagnostic Imaging, P.A."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits and other",
        "label": "Deposits Assets",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization expense",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r89"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and Amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r358"
     ]
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetNotionalAmount",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional amounts",
        "label": "Derivative Asset, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset."
       }
      }
     },
     "auth_ref": [
      "r815",
      "r818",
      "r821",
      "r824",
      "r1075",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of forward interest rate cap agreements",
        "label": "Derivative Asset, Number of Instruments Held",
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Assets and Deposits and Other",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r603",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r772",
      "r773",
      "r815",
      "r819",
      "r822",
      "r823",
      "r825",
      "r826",
      "r845",
      "r879",
      "r1106"
     ]
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Derivative, Basis Spread on Variable Rate",
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r758",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r793",
      "r794",
      "r795",
      "r796",
      "r799",
      "r800",
      "r801",
      "r802",
      "r815",
      "r816",
      "r822",
      "r825",
      "r877",
      "r879"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of gain (loss) recognized in income on derivative (current period ineffective portion)",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r145",
      "r756",
      "r758",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r793",
      "r794",
      "r795",
      "r796",
      "r799",
      "r800",
      "r801",
      "r802",
      "r815",
      "r816",
      "r822",
      "r825",
      "r845",
      "r877",
      "r879"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Assets and Deposits and Other",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r603",
      "r749",
      "r750",
      "r751",
      "r752",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r779",
      "r781",
      "r782",
      "r816",
      "r817",
      "r819",
      "r822",
      "r823",
      "r825",
      "r826",
      "r845",
      "r1106"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DERIVATIVE INSTRUMENTS",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r135",
      "r136",
      "r139",
      "r147",
      "r307"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software developed for internal use",
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "rdnt_DevelopedTechnologySoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DevelopedTechnologySoftwareMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed Technology &amp; Software",
        "label": "Developed Technology &amp; Software [Member]",
        "documentation": "Developed technology [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_DignityHealthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "DignityHealthMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dignity Health",
        "label": "Dignity Health [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director",
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1107"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCK-BASED COMPENSATION",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r504",
      "r531",
      "r532",
      "r534",
      "r867"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r894",
      "r895",
      "r908"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r894",
      "r895",
      "r908",
      "r944"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Authority",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ERADMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ERADMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "eRAD",
        "label": "eRAD [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_EarningPerShareBasicAndDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EarningPerShareBasicAndDilutedAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING",
        "label": "Earning Per Share, Basic and Diluted [Abstract]",
        "documentation": "Earning Per Share, Basic and Diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)",
        "netLabel": "Basic net income per share attributable to RadNet, Inc. common stockholders (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r328",
      "r330",
      "r341",
      "r342",
      "r343",
      "r345",
      "r593",
      "r594",
      "r675",
      "r695",
      "r849"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)",
        "netLabel": "Diluted net income per share attributable to RadNet, Inc. common stockholders (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r330",
      "r341",
      "r342",
      "r343",
      "r345",
      "r593",
      "r594",
      "r675",
      "r695",
      "r849"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS",
        "label": "Earnings Per Share, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:",
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER SHARE",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Officer Compensation",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r974",
      "r1067"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued salary and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized expense weighted average period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuable upon the exercise of stock options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity's Reporting Status Current",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity a Voluntary Filer",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity a Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customer [Line Items]",
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment acquired and leasehold improvements",
        "label": "Equipment Acquired and Leasehold Improvements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r254",
      "r285",
      "r286",
      "r287",
      "r309",
      "r310",
      "r311",
      "r315",
      "r323",
      "r325",
      "r346",
      "r391",
      "r394",
      "r474",
      "r535",
      "r536",
      "r537",
      "r561",
      "r562",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r592",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r639",
      "r716",
      "r717",
      "r718",
      "r737",
      "r805"
     ]
    },
    "rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EquityContributionsInExistingAndPurchaseOfInterestInJointVentures",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity contributions in existing and purchase of interest in joint ventures",
        "label": "Equity Contributions in Existing and Purchase of Interest in Joint Ventures",
        "documentation": "Equity contributions in existing joint ventures"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r389"
     ]
    },
    "rdnt_EquityMethodInvestmentAdditionalContribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EquityMethodInvestmentAdditionalContribution",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional contribution",
        "label": "Equity Method Investment, Additional Contribution",
        "documentation": "Equity Method Investment, Additional Contribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentAggregateCost",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total net assets",
        "totalLabel": "Total net assets",
        "label": "Equity Method Investment, Aggregate Cost",
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Different between the sales price and carrying value",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distribution of earnings",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r17",
      "r183",
      "r687"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r302",
      "r390",
      "r604"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r302",
      "r390",
      "r604"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r1000",
      "r1015",
      "r1082"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "rdnt_EquityMethodInvestmentSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EquityMethodInvestmentSharesAcquired",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares acquired (in shares)",
        "label": "Equity Method Investment, Shares Acquired",
        "documentation": "Equity Method Investment, Shares Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_EquityMethodInvestmentSharesPurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EquityMethodInvestmentSharesPurchased",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares purchased (in shares)",
        "label": "Equity Method Investment, Shares Purchased",
        "documentation": "Equity Method Investment, Shares Purchased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of investment",
        "terseLabel": "Book value of RadNet joint venture interests",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r384",
      "r983",
      "r1014"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY INVESTMENTS AT FAIR VALUE",
        "label": "Equity Method Investments [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r151",
      "r387"
     ]
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investment in Joint Ventures",
        "label": "Equity Method Investments [Table Text Block]",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of investments",
        "label": "Equity Securities without Readily Determinable Fair Value, Number Of Investments",
        "documentation": "Equity Securities without Readily Determinable Fair Value, Number Of Investments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r912",
      "r922",
      "r948"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r909",
      "r919",
      "r945"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimate of Fair Value Measurement",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r603",
      "r855",
      "r856"
     ]
    },
    "us-gaap_EurodollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EurodollarMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Eurodollar",
        "label": "Eurodollar [Member]",
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r150"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r598",
      "r648",
      "r649",
      "r650",
      "r855",
      "r856",
      "r861",
      "r862",
      "r863"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r148",
      "r450",
      "r855",
      "r856"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r855",
      "r856"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r490",
      "r495",
      "r598",
      "r648",
      "r861",
      "r862",
      "r863"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r490",
      "r495",
      "r598",
      "r649",
      "r855",
      "r856",
      "r861",
      "r862",
      "r863"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r598",
      "r650",
      "r855",
      "r856",
      "r861",
      "r862",
      "r863"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE MEASUREMENTS",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r648",
      "r649",
      "r650",
      "r855",
      "r856",
      "r861",
      "r862",
      "r863"
     ]
    },
    "rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "documentation": "Finance Lease Assets And Liabilities Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FinanceLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/LEASESLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total finance lease cost",
        "label": "Finance Lease Cost",
        "documentation": "Finance Lease Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/LEASESLeaseCostDetails": {
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r632",
      "r873"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from financing leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r628",
      "r634"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost:",
        "label": "Finance Lease, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows from financing leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r627",
      "r634"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Equipment, net",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails": {
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated depreciation",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r977"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/LEASESLeaseCostDetails": {
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of leased equipment",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r632",
      "r873"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails": {
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment at cost",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r409",
      "r410",
      "r412",
      "r654",
      "r658"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r654"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average amortization period remaining in years",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "documentation": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FirstLienCreditAgreementMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Lien Credit Agreement",
        "label": "First Lien Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment No. 7 First Lien Credit Agreement",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment No. 6 First Lien Credit Agreement",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FirstLienTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FirstLienTermLoanMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loans",
        "label": "First Lien Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FixedAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FixedAssetsMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Assets",
        "label": "Fixed Assets [Member]",
        "documentation": "Fixed Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FOREIGN CURRENCY TRANSLATION",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "rdnt_ForeignCurrencyTranslationAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ForeignCurrencyTranslationAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation",
        "label": "Foreign Currency Translation Adjustments",
        "documentation": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ForeignOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign operating loss carryforwards, not subject to expiration",
        "label": "Foreign Operating Loss Carryforwards, Not Subject To Expiration",
        "documentation": "Foreign Operating Loss Carryforwards, Not Subject To Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r916",
      "r926",
      "r952"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r916",
      "r926",
      "r952"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r916",
      "r926",
      "r952"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r916",
      "r926",
      "r952"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r916",
      "r926",
      "r952"
     ]
    },
    "rdnt_FrederickCountyRadiologyLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FrederickCountyRadiologyLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Frederick County Radiology, LLC",
        "label": "Frederick County Radiology, LLC [Member]",
        "documentation": "Frederick County Radiology, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FrederickHealthHospitalIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FrederickHealthHospitalIncMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Frederick Health Hospital, Inc.",
        "label": "Frederick Health Hospital, Inc. [Member]",
        "documentation": "Frederick Health Hospital, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer and office equipment, furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_FutureServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "FutureServiceMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future Service",
        "label": "Future Service [Member]",
        "documentation": "Future Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_GainLossOnContributionIntoJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "GainLossOnContributionIntoJointVenture",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on contribution of imaging centers into joint venture",
        "label": "Gain (Loss) On Contribution Into Joint Venture",
        "documentation": "Gain (Loss) On Contribution Into Joint Venture"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on sale and disposal of equipment and other",
        "negatedTerseLabel": "Loss on sale and disposal of equipment and other",
        "terseLabel": "Gain on disposal of equipment and other",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1020",
      "r1024"
     ]
    },
    "rdnt_GainLossOnExtinguishmentOfDebtAndRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "GainLossOnExtinguishmentOfDebtAndRelatedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on extinguishment of debt and related expenses",
        "label": "Gain (Loss) On Extinguishment Of Debt And Related Expenses",
        "documentation": "Gain (Loss) On Extinguishment Of Debt And Related Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on disposition of property plant equipment",
        "negatedNetLabel": "Loss on Disposal of Equipment",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnTerminationOfLease",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Lease abandonment charges",
        "label": "Gain (Loss) on Termination of Lease",
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "rdnt_GainOnContributionOfImagingCentersIntoJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "GainOnContributionOfImagingCentersIntoJointVenture",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on contribution of imaging centers into joint venture",
        "label": "Gain On Contribution Of Imaging Centers Into Joint Venture",
        "documentation": "Gain On Contribution Of Imaging Centers Into Joint Venture"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r92",
      "r93"
     ]
    },
    "rdnt_GeneralHoldbackMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "GeneralHoldbackMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General Holdback",
        "label": "General Holdback [Member]",
        "documentation": "General Holdback"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "GlendaleAdvancedImagingMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Glendale Advanced Imaging",
        "label": "Glendale Advanced Imaging [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill, beginning balance",
        "periodEndLabel": "Goodwill, ending balance",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r395",
      "r671",
      "r853",
      "r874",
      "r1016",
      "r1018"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r853"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GOODWILL AND INDEFINITE LIVED INTANGIBLES",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r853"
     ]
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement period and other adjustments",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r1017"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposals",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r853"
     ]
    },
    "rdnt_HealthCareManagementServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "HealthCareManagementServiceMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fee revenue",
        "label": "Health Care, Management Service [Member]",
        "documentation": "Health Care, Management Service [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareOtherMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Health Care, Other [Member]",
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCarePatientServiceMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service fee revenue",
        "label": "Health Care, Patient Service [Member]",
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "HealthCarePatientServiceOtherMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other patient revenue",
        "label": "Health Care, Patient Service Other [Member]",
        "documentation": "Health Care, Patient Service Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_HeartAndLungImagingLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "HeartAndLungImagingLimitedMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Heart &amp; Lung Imaging Limited",
        "label": "Heart and Lung Imaging Limited [Member]",
        "documentation": "Heart and Lung Imaging Limited"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_HeartLungImagingLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "HeartLungImagingLimitedMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Heart &amp; Lung Imaging Limited",
        "label": "Heart &amp; Lung Imaging Limited [Member]",
        "documentation": "Heart &amp; Lung Imaging Limited"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_HoustonMedicalImagingLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "HoustonMedicalImagingLLCMember",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Houston Medical Imaging, LLC",
        "label": "Houston Medical Imaging, LLC [Member]",
        "documentation": "Houston Medical Imaging, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_IFRCLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "IFRCLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "I F R C L L C",
        "label": "I F R C L L C [Member]",
        "documentation": "I F R C L L C"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_IFRCLLCSubsidiaryOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "IFRCLLCSubsidiaryOneMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "I F R C L L C Subsidiary One",
        "label": "I F R C L L C Subsidiary One [Member]",
        "documentation": "I F R C L L C Subsidiary One"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_IFRCLLCSubsidiaryTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "IFRCLLCSubsidiaryTwoMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "I F R C L L C Subsidiary Two",
        "label": "I F R C L L C Subsidiary Two [Member]",
        "documentation": "I F R C L L C Subsidiary Two"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r895",
      "r908"
     ]
    },
    "rdnt_ImagingCenterSegmentRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ImagingCenterSegmentRevenueMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Imaging center segment revenue",
        "label": "Imaging Center Segment Revenue [Member]",
        "documentation": "Imaging Center Segment Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ImagingCentersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ImagingCentersMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Imaging Centers",
        "label": "Imaging Centers [Member]",
        "documentation": "Imaging Centers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of intangible assets",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r34"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on impairment",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1019"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long lived asset",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r88",
      "r206"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LONG-LIVED ASSETS",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r207"
     ]
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In Process Research and Development",
        "label": "In Process Research and Development [Member]",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeApproachValuationTechniqueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeApproachValuationTechniqueMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation, Income Approach",
        "label": "Valuation, Income Approach [Member]",
        "documentation": "Valuation approach converting future amounts to single current discounted amount."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US Domestic",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r568"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME BEFORE INCOME TAXES",
        "totalLabel": "Income (loss) before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r182",
      "r235",
      "r353",
      "r367",
      "r373",
      "r376",
      "r676",
      "r688",
      "r851"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r568"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r183",
      "r234",
      "r360",
      "r384",
      "r687"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity in earnings of joint ventures, net of dividends",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r416",
      "r790"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r790"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Axis]",
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Domain]",
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r538",
      "r547",
      "r553",
      "r559",
      "r566",
      "r569",
      "r570",
      "r571",
      "r734"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails",
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r250",
      "r324",
      "r325",
      "r361",
      "r545",
      "r567",
      "r697"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "INCOME TAXES",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r541",
      "r542",
      "r553",
      "r554",
      "r558",
      "r560",
      "r728"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax rate adjustment",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r546"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign rate differential",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal tax",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationMinorityInterestIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Noncontrolling interests in partnerships",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Non deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred true-ups and other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other differences",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Return to provision",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State franchise tax, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESReconciliationoftheStatutoryUSFederalRateandEffectiveRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax provisions",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the period for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable, accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred taxes",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash change in fair value of interest rate swaps",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r143"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r978",
      "r996"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other current assets",
        "label": "Increase (Decrease) in Other Current Assets",
        "documentation": "Amount of increase (decrease) in current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Add additional shares issuable upon exercise of stock options, warrants and holdback shares (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r343"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r411"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite lived intangible assets",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r203"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r907",
      "r916",
      "r926",
      "r943",
      "r952",
      "r956",
      "r964"
     ]
    },
    "rdnt_InglewoodImagingCenterLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "InglewoodImagingCenterLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inglewood Imaging Center, LLC",
        "label": "Inglewood Imaging Center, LLC [Member]",
        "documentation": "Inglewood Imaging Center, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r968"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r968"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r968"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r85"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r456",
      "r466",
      "r857",
      "r858"
     ]
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Expense",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the period for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r297",
      "r298"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 swaps",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r840",
      "r884",
      "r885"
     ]
    },
    "us-gaap_IntersegmentEliminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntersegmentEliminationMember",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intersegment Elimination",
        "label": "Intersegment Eliminations [Member]",
        "documentation": "Eliminating entries used in operating segment consolidation."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r376"
     ]
    },
    "rdnt_IntersegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "IntersegmentMember",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intersegment",
        "label": "Intersegment [Member]",
        "documentation": "Intersegment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENT IN JOINT VENTURES",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r724",
      "r725",
      "r726",
      "r727",
      "r810",
      "r811"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in joint ventures",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentinJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_JointVentureInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "JointVentureInterestMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint Venture Interest",
        "label": "Joint Venture Interest [Member]",
        "documentation": "Joint Venture Interest"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Joint Venture Investment and Financial Information",
        "label": "Joint Venture Investment and Financial Information [Table Text Block]",
        "documentation": "Joint Venture Investment and Financial Information"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_JointVentureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "JointVentureMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint Venture",
        "label": "Joint Venture [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "JointVentureWithCalvertMedicalImagingCentersLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint Venture With Calvert Medical Imaging Centers LLC",
        "label": "Joint Venture With Calvert Medical Imaging Centers LLC [Member]",
        "documentation": "Joint Venture With Calvert Medical Imaging Centers LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_KeyFinancialDataForJointVentures": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "KeyFinancialDataForJointVentures",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Data:",
        "label": "Key Financial Data For Joint Ventures",
        "documentation": "Key Financial Data For Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease, Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LeasesWeightedAverageDiscountRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Discount Rate",
        "label": "Leases Weighted Average Discount Rate [Abstract]",
        "documentation": "Leases Weighted Average Discount Rate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "rdnt_LesseeLeaseTermofContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LesseeLeaseTermofContract",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term of contract",
        "label": "Lessee Lease Term of Contract",
        "documentation": "Lessee Lease Term of Contract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, lease not yet commenced, term of contract",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease not yet commenced",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "documentation": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Operating Lease Liability",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "rdnt_LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid Year Six Thereafter",
        "documentation": "Lessee, Operating Lease, Liability, to be Paid Year Six Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, term of contract",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.radnet.com/role/LEASES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letters of credit outstanding, amount",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LeverageRatioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LeverageRatioAxis",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "documentation": "Leverage Ratio [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LeverageRatioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LeverageRatioDomain",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leverage Ratio [Domain]",
        "label": "Leverage Ratio [Domain]",
        "documentation": "[Domain] for Leverage Ratio [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LeverageRatioOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LeverageRatioOneMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "> 3.50x",
        "label": "Leverage Ratio One [Member]",
        "documentation": "Leverage Ratio One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LeverageRatioThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LeverageRatioThreeMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u2264 3.00x",
        "label": "Leverage Ratio Three [Member]",
        "documentation": "Leverage Ratio Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LeverageRatioTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LeverageRatioTwoMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "> 3.00x but \u2264 3.50x",
        "label": "Leverage Ratio Two [Member]",
        "documentation": "Leverage Ratio Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r302",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r578",
      "r582",
      "r583",
      "r604",
      "r765",
      "r850",
      "r889",
      "r1029",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r233",
      "r684",
      "r874",
      "r1000",
      "r1015",
      "r1082"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails": {
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "negatedLabel": "Current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r260",
      "r302",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r578",
      "r582",
      "r583",
      "r604",
      "r874",
      "r1029",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails": {
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Noncurrent liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r163",
      "r164",
      "r165",
      "r169",
      "r302",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r578",
      "r582",
      "r583",
      "r604",
      "r1029",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LONG-TERM LIABILITIES",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Economic interest",
        "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest",
        "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP)."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "rdnt_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited liability company (LLC) or limited partnership (LP), managing member or general partner, ownership lnterest disposed",
        "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest Disposed",
        "documentation": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest Disposed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minority partner ownership percent",
        "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest",
        "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP)."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_LimitedPartnersContributedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedPartnersContributedCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited partners' contributed capital",
        "label": "Limited Partners' Contributed Capital",
        "documentation": "The amount of capital contributed by the limited partners."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total credit facilities outstanding",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r231",
      "r1103"
     ]
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lender Name [Axis]",
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r999"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment fee percentage",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility, Lender [Domain]",
        "label": "Line of Credit Facility, Lender [Domain]",
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r999"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facilities available",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility, borrowings available",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r999"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused capacity, commitment fee percentage",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_LondonInterbankOfferedRateLIBOR1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LondonInterbankOfferedRateLIBOR1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "London Interbank Offered Rate (LIBOR)",
        "label": "London Interbank Offered Rate (LIBOR1) [Member]",
        "documentation": "London Interbank Offered Rate (LIBOR1)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "totalLabel": "Total debt obligations",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r231",
      "r449",
      "r464",
      "r855",
      "r856",
      "r1103"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less current portion",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r308",
      "r454"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r308",
      "r454"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r308",
      "r454"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r308",
      "r454"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r308",
      "r454"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term portion of debt obligations",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "rdnt_LongTermIncentivePlanSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LongTermIncentivePlanSharesMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LTIPs",
        "label": "Long Term Incentive Plan Shares [Member]",
        "documentation": "Long Term Incentive Plan Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable, net of current portion",
        "label": "Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r91"
     ]
    },
    "rdnt_LosAngelesImagingGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "LosAngelesImagingGroupLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Los Angeles Imaging Group, LLC",
        "label": "Los Angeles Imaging Group, LLC [Member]",
        "documentation": "Los Angeles Imaging Group, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MadisonRadiologyMedicalGroupIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MadisonRadiologyMedicalGroupIncMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Madison Radiology Medical Group, Inc.",
        "label": "Madison Radiology Medical Group, Inc. [Member]",
        "documentation": "Madison Radiology Medical Group, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ManagementServiceContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ManagementServiceContractsMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management Service Contracts",
        "label": "Management Service Contracts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ManagementServiceFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ManagementServiceFees",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management service fees",
        "label": "Management Service Fees",
        "documentation": "Management service fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAnnualNotePayableMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of Notes Payables [Abstract]",
        "label": "Maturities of Long-Term Debt and Capital Lease Obligations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/LEASESDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r419",
      "r420",
      "r421",
      "r422",
      "r498",
      "r652",
      "r715",
      "r757",
      "r758",
      "r809",
      "r812",
      "r813",
      "r814",
      "r827",
      "r836",
      "r837",
      "r852",
      "r859",
      "r866",
      "r876",
      "r1033",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MedicVisionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MedicVisionMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medic Vision",
        "label": "Medic Vision [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_Medicaid1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "Medicaid1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicaid",
        "label": "Medicaid1 [Member]",
        "documentation": "Medicaid1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MedicalEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MedicalEquipmentMember",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Equipment",
        "label": "Medical Equipment [Member]",
        "documentation": "Medical Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MedicalInsuranceStopLossPolicyClaimAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MedicalInsuranceStopLossPolicyClaimAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stop loss policy claim amount",
        "label": "Medical Insurance, Stop Loss Policy Claim Amount",
        "documentation": "Medical Insurance, Stop Loss Policy Claim Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MedicalMalpracticeDeductiblePerIncidence": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MedicalMalpracticeDeductiblePerIncidence",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical malpractice deductible per incidence",
        "label": "Medical Malpractice Deductible Per Incidence",
        "documentation": "Medical Malpractice Deductible Per Incidence"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_Medicare1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "Medicare1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicare",
        "label": "Medicare1 [Member]",
        "documentation": "Medicare1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MediumTermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MediumTermNotesMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medium-term Notes",
        "label": "Medium-term Notes [Member]",
        "documentation": "Debt instruments with maturities ranging from five to ten years."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BUSINESS COMBINATIONS AND RELATED ACTIVITY",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r220"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/LEASESDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r419",
      "r420",
      "r421",
      "r422",
      "r498",
      "r652",
      "r715",
      "r757",
      "r758",
      "r809",
      "r812",
      "r813",
      "r814",
      "r827",
      "r836",
      "r837",
      "r852",
      "r859",
      "r866",
      "r876",
      "r1033",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interests",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r232",
      "r302",
      "r390",
      "r423",
      "r426",
      "r427",
      "r428",
      "r434",
      "r435",
      "r604",
      "r683",
      "r768"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions paid to noncontrolling\u00a0interests",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest, ownership percentage by parent",
        "label": "Subsidiary, Ownership Percentage, Parent",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "rdnt_MontclairMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MontclairMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Montclair",
        "label": "Montclair [Member]",
        "documentation": "Montclair"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MontclairRadiologicalAssociatesPAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MontclairRadiologicalAssociatesPAMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Montclair Radiological Associates, P.A.",
        "label": "Montclair Radiological Associates, P.A. [Member]",
        "documentation": "Montclair Radiological Associates, P.A."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly amortization of deferred hedge gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "documentation": "Monthly Amortization Of Deferred Hedge Gains"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS",
        "terseLabel": "Net income attributable to RadNet, Inc. common stockholders",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r195",
      "r236",
      "r258",
      "r280",
      "r282",
      "r287",
      "r302",
      "r314",
      "r318",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r339",
      "r353",
      "r367",
      "r373",
      "r376",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r594",
      "r604",
      "r691",
      "r786",
      "r803",
      "r804",
      "r851",
      "r887",
      "r1029"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income attributable to noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r226",
      "r280",
      "r282",
      "r324",
      "r325",
      "r690",
      "r991"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income attributable to RadNet, Inc's common stockholders for diluted share calculation",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r329",
      "r335",
      "r336",
      "r337",
      "r338",
      "r340",
      "r343"
     ]
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]",
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RECENT ACCOUNTING STANDARDS",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r249",
      "r251",
      "r256",
      "r312",
      "r313",
      "r316",
      "r317",
      "r326",
      "r327",
      "r392",
      "r393",
      "r563",
      "r564",
      "r565",
      "r589",
      "r591",
      "r595",
      "r596",
      "r597",
      "r605",
      "r606",
      "r607",
      "r619",
      "r620",
      "r640",
      "r655",
      "r656",
      "r657",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r916",
      "r926",
      "r943",
      "r952"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued",
        "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ]
    },
    "rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of shares issued in acquisition",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued",
        "documentation": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution from noncontrolling partner",
        "label": "Noncontrolling Interest, Increase Contribution From Noncontrolling Interest",
        "documentation": "Noncontrolling Interest, Increase Contribution From Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale to noncontrolling interests, net of taxes",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r96",
      "r225"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interests",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r474",
      "r1002",
      "r1003",
      "r1004",
      "r1109"
     ]
    },
    "rdnt_NoncontrollingInterestPercentOfOwnershipSold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NoncontrollingInterestPercentOfOwnershipSold",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest, percent of ownership sold",
        "label": "Noncontrolling Interest, Percent Of Ownership Sold",
        "documentation": "Noncontrolling Interest, Percent Of Ownership Sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total other expenses",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "rdnt_NorthJerseyImagingCenterLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NorthJerseyImagingCenterLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "North Jersey Imaging Center, LLC",
        "label": "North Jersey Imaging Center, LLC [Member]",
        "documentation": "North Jersey Imaging Center, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of notes payable",
        "label": "Notes Payable, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "rdnt_NumberOfAssetsSold": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NumberOfAssetsSold",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of assets sold",
        "label": "Number Of Assets Sold",
        "documentation": "Number Of Assets Sold"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_NumberOfCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NumberOfCenters",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of centers",
        "label": "Number Of Centers",
        "documentation": "Number Of Centers"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_NumberOfCentersContributed": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NumberOfCentersContributed",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of centers contributed",
        "label": "Number Of Centers Contributed",
        "documentation": "Number Of Centers Contributed"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_NumberOfLocationOfferingMultiModalityServices": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NumberOfLocationOfferingMultiModalityServices",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of location",
        "label": "Number Of Location Offering Multi-Modality Services",
        "documentation": "Number Of Location Offering Multi-Modality Services"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "NumberofUnconsolidatedJointVentures",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of unconsolidated joint ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "documentation": "Number of Unconsolidated Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_October2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "October2023Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October 2023",
        "label": "October 2023 [Member]",
        "documentation": "October 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_October2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "October2025Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October 2025",
        "label": "October 2025 [Member]",
        "documentation": "October 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Line Items]",
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Table]",
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180"
     ]
    },
    "rdnt_OneMonthSecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OneMonthSecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One Month Secured Overnight Financing Rate (SOFR)",
        "label": "One Month Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "One Month Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses from transactions with related party",
        "verboseLabel": "Cost of Operations",
        "label": "Operating Costs and Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING EXPENSES",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_OperatingExpensesExcludingDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OperatingExpensesExcludingDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of operations, excluding depreciation and amortization",
        "label": "Operating Expenses, Excluding Depreciation And Amortization",
        "documentation": "Operating Expenses, Excluding Depreciation And Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "INCOME FROM OPERATIONS",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r367",
      "r373",
      "r376",
      "r851"
     ]
    },
    "rdnt_OperatingIncomeLossExcludingReliefFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OperatingIncomeLossExcludingReliefFunding",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income from Operations",
        "label": "Operating Income (Loss) Excluding Relief Funding",
        "documentation": "Operating Income (Loss) Excluding Relief Funding"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Leases",
        "label": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "documentation": "Operating Lease Assets And Liabilities Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/LEASESLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r633",
      "r873"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment loss",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "rdnt_OperatingLeaseLeaseAbandonmentCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OperatingLeaseLeaseAbandonmentCharge",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease abandonment charges",
        "label": "Operating Lease, Lease Abandonment Charge",
        "documentation": "Operating Lease, Lease Abandonment Charge"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_OperatingLeaseLeaseAbandonmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OperatingLeaseLeaseAbandonmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/LEASESLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease abandonment charges",
        "label": "Operating Lease, Lease Abandonment Charges",
        "documentation": "Operating Lease, Lease Abandonment Charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/LEASESMaturitiesofOperatingandFinanceLeaseDetails",
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease liabilities",
        "terseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of operating lease liability",
        "verboseLabel": "Current portion of operating lease liability",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term operating lease liability",
        "verboseLabel": "Long-term operating lease liability",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r629",
      "r634"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use-assets",
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r873"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases - years",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r873"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r376"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER ASSETS",
        "label": "Other Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings",
        "terseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r279"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in cumulative foreign currency\u00a0translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r181"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_OtherExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherExpensesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER INCOME AND EXPENSES",
        "label": "Other Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to affiliates",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r874"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other (income) expenses",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_OtherNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment",
        "label": "Other Notes Payable",
        "documentation": "Amount of long-term notes payable classified as other."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r231",
      "r1103"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due from affiliates",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_OtherSellersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "OtherSellersMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Sellers",
        "label": "Other Sellers [Member]",
        "documentation": "Other Sellers"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r914",
      "r924",
      "r950"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r905",
      "r917",
      "r927",
      "r953"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r905",
      "r917",
      "r927",
      "r953"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ParentMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Radnet, Inc. Stockholders' Equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PatentAndTrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PatentAndTrademarksMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent and Trademarks",
        "label": "Patent and Trademarks [Member]",
        "documentation": "Patent and Trademarks"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PatientServicesNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PatientServicesNetMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patient Services, Net [Member]",
        "label": "Patient Services, Net [Member]",
        "documentation": "Patient Services, Net [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on contingent consideration",
        "terseLabel": "Contingent consideration",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Additional deferred finance costs on revolving loan amendment",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBuildings",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of imaging centers and other operations",
        "label": "Payments to Acquire Buildings",
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration transferred",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r573"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment at cost",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of intangible assets",
        "terseLabel": "Purchase of intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "rdnt_PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity contributions in existing and purchase of interest in joint ventures",
        "label": "Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture",
        "documentation": "Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity investment loan to company outstanding",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r1089"
     ]
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToMinorityShareholders",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions paid to noncontrolling interests",
        "label": "Payments to Noncontrolling Interests",
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "rdnt_PerformanceBasedStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PerformanceBasedStockOptionsMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Based Stock Options",
        "label": "Performance Based Stock Options [Member]",
        "documentation": "Performance Based Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PerformanceBasedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PerformanceBasedStockUnitsMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Based Stock Units",
        "label": "Performance Based Stock Units [Member]",
        "documentation": "Performance Based Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PostemploymentBenefitPlansPolicy",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMPLOYEE BENEFIT PLAN",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "rdnt_PreferredStockExchangeRatePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PreferredStockExchangeRatePerShare",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange rate In dollars per share)",
        "label": "Preferred Stock, Exchange Rate per Share",
        "documentation": "Preferred Stock, Exchange Rate per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock (in shares )",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r467"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "rdnt_PricingLevelIIIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PricingLevelIIIMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pricing Level III",
        "label": "Pricing Level III [Member]",
        "documentation": "Pricing Level III [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PricingLevelIIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PricingLevelIIMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pricing Level II",
        "label": "Pricing Level II [Member]",
        "documentation": "Pricing Level II [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PricingLevelIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PricingLevelIMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pricing Level I",
        "label": "Pricing Level I [Member]",
        "documentation": "Pricing Level I [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PricingLevelIVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PricingLevelIVMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pricing Level IV",
        "label": "Pricing Level IV [Member]",
        "documentation": "Pricing Level IV [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PricingLevelVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PricingLevelVMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pricing Level V",
        "label": "Pricing Level V [Member]",
        "documentation": "Pricing Level V [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDividendsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDividendsReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Received a dividend from the partnership",
        "label": "Proceeds from Dividends Received",
        "documentation": "Dividends received on equity and other investments during the current period."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from debt issuance, net of issuance costs",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock upon exercise of options",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r33"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from revolving credit facility",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r999"
     ]
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromMinorityShareholders",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of noncontrolling interests",
        "label": "Proceeds from Noncontrolling Interests",
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "rdnt_ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of economic interest in majority owned subsidiary",
        "label": "Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary",
        "documentation": "Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ProceedsFromSaleOfInterestInMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ProceedsFromSaleOfInterestInMinorityShareholders",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of interest in minority shareholders",
        "label": "Proceeds From Sale Of Interest In Minority Shareholders",
        "documentation": "Proceeds From Sale Of Interest In Minority Shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r653",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r841",
      "r860",
      "r875",
      "r979",
      "r1026",
      "r1027",
      "r1036",
      "r1104"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r653",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r841",
      "r860",
      "r875",
      "r979",
      "r1026",
      "r1027",
      "r1036",
      "r1104"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCOME",
        "terseLabel": "NET INCOME",
        "verboseLabel": "Net income (loss)",
        "netLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r280",
      "r282",
      "r295",
      "r302",
      "r314",
      "r324",
      "r325",
      "r353",
      "r367",
      "r373",
      "r376",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r576",
      "r579",
      "r580",
      "r594",
      "r604",
      "r676",
      "r689",
      "r736",
      "r786",
      "r803",
      "r804",
      "r851",
      "r871",
      "r872",
      "r888",
      "r991",
      "r1029"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r977",
      "r1023"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total property and equipment",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r977",
      "r1021"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total property and equipment cost",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r975",
      "r985",
      "r1022"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY AND EQUIPMENT",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r241",
      "r246",
      "r247"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r262",
      "r686"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r677",
      "r686",
      "r874"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS",
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PropertyPlantAndEquipmentNetIncludingRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total property, equipment and right-of-use-assets",
        "label": "Property Plant and Equipment Net Including Right of Use Assets",
        "documentation": "Property Plant and Equipment Net Including Right of Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "PROPERTY AND EQUIPMENT",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r241",
      "r246",
      "r685"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PP&amp;E useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ProperyAndEquipmentNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ProperyAndEquipmentNetMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Propery and equipment, net",
        "label": "Propery and Equipment, Net [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_PublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "PublicOfferingMember",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Offering",
        "label": "Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "rdnt_QuantibMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "QuantibMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quantib",
        "verboseLabel": "Quantib B.V.",
        "label": "Quantib [Member]",
        "documentation": "Quantib"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_RamapoRadiologyAssociatesPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "RamapoRadiologyAssociatesPCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ramapo Radiology Associates, P.C.",
        "label": "Ramapo Radiology Associates, P.C. [Member]",
        "documentation": "Ramapo Radiology Associates, P.C."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/LEASESDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r419",
      "r420",
      "r421",
      "r422",
      "r489",
      "r498",
      "r527",
      "r528",
      "r529",
      "r651",
      "r652",
      "r715",
      "r757",
      "r758",
      "r809",
      "r812",
      "r813",
      "r814",
      "r827",
      "r836",
      "r837",
      "r852",
      "r859",
      "r866",
      "r876",
      "r879",
      "r1025",
      "r1033",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/LEASESDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r419",
      "r420",
      "r421",
      "r422",
      "r489",
      "r498",
      "r527",
      "r528",
      "r529",
      "r651",
      "r652",
      "r715",
      "r757",
      "r758",
      "r809",
      "r812",
      "r813",
      "r814",
      "r827",
      "r836",
      "r837",
      "r852",
      "r859",
      "r866",
      "r876",
      "r879",
      "r1025",
      "r1033",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100"
     ]
    },
    "rdnt_RavenHoldingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "RavenHoldingsMember",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raven Holdings",
        "label": "Raven Holdings [Member]",
        "documentation": "Raven Holdings [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCOUNTS RECEIVABLE",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1011",
      "r1012",
      "r1013"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r909",
      "r919",
      "r945"
     ]
    },
    "us-gaap_ReinsuranceContractAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReinsuranceContractAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reinsurance Policy, Type [Axis]",
        "label": "Reinsurance Contract [Axis]",
        "documentation": "Information by reinsurance contract."
       }
      }
     },
     "auth_ref": [
      "r1101"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r641",
      "r642",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r783",
      "r785",
      "r808"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r641",
      "r642",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r783",
      "r785",
      "r808",
      "r1092"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on term loan debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on revolving credit facility",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r999"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments on notes and leases payable other than term loan debt",
        "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security",
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r440",
      "r469",
      "r643",
      "r844",
      "r845"
     ]
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFTWARE DEVELOPMENT COSTS",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r160"
     ]
    },
    "rdnt_RestatedAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "RestatedAgreementMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restated Agreement",
        "label": "Restated Agreement [Member]",
        "documentation": "Restated Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_RestatedPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "RestatedPlanMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restated Plan",
        "label": "Restated Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r910",
      "r920",
      "r946"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r899",
      "r911",
      "r921",
      "r947"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r906",
      "r918",
      "r928",
      "r954"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonvested restricted stock subject to service vesting",
        "verboseLabel": "Restricted Stock",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r213",
      "r682",
      "r719",
      "r723",
      "r733",
      "r767",
      "r874"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r309",
      "r310",
      "r311",
      "r315",
      "r323",
      "r325",
      "r391",
      "r394",
      "r535",
      "r536",
      "r537",
      "r561",
      "r562",
      "r584",
      "r586",
      "r587",
      "r590",
      "r592",
      "r716",
      "r718",
      "r737",
      "r1109"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service fee revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355",
      "r366",
      "r371",
      "r372",
      "r378",
      "r380",
      "r381",
      "r485",
      "r486",
      "r653"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFTWARE REVENUE RECOGNITION",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r839"
     ]
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueNotFromContractWithCustomer",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provider relief funding",
        "label": "Revenue Not from Contract with Customer",
        "documentation": "Amount of revenue that is not accounted for under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUES",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r839",
      "r848"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, amount",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDeferredRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net revenue",
        "verboseLabel": "Revenue:",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r302",
      "r354",
      "r355",
      "r366",
      "r371",
      "r372",
      "r378",
      "r380",
      "r381",
      "r390",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r430",
      "r432",
      "r434",
      "r435",
      "r604",
      "r676",
      "r1029"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r635",
      "r873"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "rdnt_SaleOfStockCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SaleOfStockCost",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public offering expenses",
        "label": "Sale Of Stock, Cost",
        "documentation": "Sale Of Stock, Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SantaMonicaImagingGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SantaMonicaImagingGroupLLCMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Santa Monica Imaging Group, LLC",
        "label": "Santa Monica Imaging Group, LLC [Member]",
        "documentation": "Santa Monica Imaging Group, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r499",
      "r1005"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r326",
      "r499",
      "r972",
      "r1005"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r112",
      "r572"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r112"
     ]
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax Expense",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Income Tax Expense",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customers by Products and Services [Table]",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r389"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments [Line Items]",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r386",
      "r387",
      "r389",
      "r390",
      "r604"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESKeyFinancialDataonJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments [Table]",
        "label": "Schedule of Equity Method Investments [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r302",
      "r386",
      "r387",
      "r389",
      "r390",
      "r604"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86",
      "r654"
     ]
    },
    "rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Foreign Currency Translation Amounts",
        "label": "Schedule Of Foreign Currency Translation Amounts [Table Text Block]",
        "documentation": "Schedule Of Foreign Currency Translation Amounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill [Table]",
        "label": "Schedule of Goodwill [Table]",
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r853"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r203"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill and Other Intangible Assets",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Leverage Ratio",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Annual Principal Maturities of Notes Payable",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSA Activity",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of LTIPs",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Service Fee Revenue",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation8Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation9Details",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r81"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r81"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r503",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r100"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r870",
      "r1068"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Annual Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "rdnt_ScheuldeOfEstimatedFairValuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ScheuldeOfEstimatedFairValuesTableTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scheulde The Estimated Fair Values",
        "label": "Scheulde Of Estimated Fair Values [Table Text Block]",
        "documentation": "Scheulde Of Estimated Fair Values"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuritiesFinancingTransactionAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Financing Transaction [Axis]",
        "label": "Securities Financing Transaction [Axis]",
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Financing Transaction [Domain]",
        "label": "Securities Financing Transaction [Domain]",
        "documentation": "Measurement of financing transaction securities held."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r381",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r417",
      "r418",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r853",
      "r979",
      "r1104"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTING"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT REPORTING",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r365",
      "r370",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Self-insurance accrual",
        "label": "Self Insurance Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C Preferred Stock",
        "label": "Series C Preferred Stock [Member]",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r986",
      "r987",
      "r1035"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "verboseLabel": "Severance",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited or Canceled (in shares)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited or Canceled (in dollars per share)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSA's unvested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r517"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r517"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r503",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSA's",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of plans",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized",
        "verboseLabel": "Shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available in grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of vesting traches",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable at the end (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable at the end (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canceled, forfeited or expired (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Canceled, forfeited or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate value outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in shares)",
        "periodEndLabel": "Ending Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in dollars per share)",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise price Per Common Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of stock upon exercise of options",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONRSUsandLTIPsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting rights, percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate value exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance at end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at the end",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r215"
     ]
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssued",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Shares, Issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued per share (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SharesIssuedSharesSettlementOfContingentConsideration": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SharesIssuedSharesSettlementOfContingentConsideration",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock to settle DeepHealth contingent consideration (in shares)",
        "label": "Shares Issued, Shares, Settlement Of Contingent Consideration",
        "documentation": "Shares Issued, Shares, Settlement Of Contingent Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term debt",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r229",
      "r874",
      "r1102"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt, Type [Axis]",
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt, Type [Domain]",
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r300"
     ]
    },
    "rdnt_SimiAdventistMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SimiAdventistMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simi Adventist",
        "label": "Simi Adventist [Member]",
        "documentation": "Simi Adventist"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SimiValleyImagingGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SimiValleyImagingGroupLLCMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simi Valley Imaging Group, LLC",
        "label": "Simi Valley Imaging Group, LLC [Member]",
        "documentation": "Simi Valley Imaging Group, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SixMonthsSecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SixMonthsSecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Six Months Secured Overnight Financing Rate (SOFR)",
        "label": "Six Months Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Six Months Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SoftwareAndTeleradiologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SoftwareAndTeleradiologyMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Software and teleradiology",
        "label": "Software and Teleradiology [Member]",
        "documentation": "Imaging On Call [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTAdditionalInformationDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software costs",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SouthernCaliforniaDiagnosticImagingIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SouthernCaliforniaDiagnosticImagingIncMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Southern California Diagnostic Imaging, Inc.",
        "label": "Southern California Diagnostic Imaging, Inc. [Member]",
        "documentation": "Southern California Diagnostic Imaging, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State current tax",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1066",
      "r1072"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation2Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r350",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r381",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r415",
      "r417",
      "r418",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r853",
      "r979",
      "r1104"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r268",
      "r269",
      "r270",
      "r302",
      "r330",
      "r334",
      "r341",
      "r343",
      "r347",
      "r348",
      "r390",
      "r423",
      "r426",
      "r427",
      "r428",
      "r434",
      "r435",
      "r467",
      "r468",
      "r470",
      "r471",
      "r473",
      "r604",
      "r729",
      "r730",
      "r731",
      "r732",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r766",
      "r787",
      "r805",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r971",
      "r998",
      "r1006"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r52",
      "r254",
      "r285",
      "r286",
      "r287",
      "r309",
      "r310",
      "r311",
      "r315",
      "r323",
      "r325",
      "r346",
      "r391",
      "r394",
      "r474",
      "r535",
      "r536",
      "r537",
      "r561",
      "r562",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r592",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r639",
      "r716",
      "r717",
      "r718",
      "r737",
      "r805"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r346",
      "r653",
      "r724",
      "r748",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r766",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r788",
      "r789",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r805",
      "r880"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r326",
      "r499",
      "r972",
      "r973",
      "r1005"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r346",
      "r653",
      "r724",
      "r748",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r766",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r788",
      "r789",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r805",
      "r880"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r901",
      "r913",
      "r923",
      "r949"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_StockHoldbackMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "StockHoldbackMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Holdback",
        "label": "Stock Holdback [Member]",
        "documentation": "Stock Holdback"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for acquisitions (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173",
      "r213"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with acquisitions (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r51",
      "r94",
      "r213",
      "r453"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r172",
      "r173",
      "r213",
      "r729",
      "r805",
      "r829"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued under the equity compensation plan (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r172",
      "r173",
      "r213"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeiture of restricted stock (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of stock upon exercise of options (in shares)",
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r172",
      "r173",
      "r213",
      "r513"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation6Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for acquisitions",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r52",
      "r213"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with acquisitions",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r52",
      "r213"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r172",
      "r173",
      "r213",
      "r737",
      "r805",
      "r829",
      "r888"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeiture of restricted stock",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of stock upon exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r52",
      "r213"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Option",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity",
        "terseLabel": "Accumulated other comprehensive income",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r176",
      "r177",
      "r198",
      "r768",
      "r784",
      "r806",
      "r807",
      "r874",
      "r889",
      "r1000",
      "r1015",
      "r1082",
      "r1109"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r131",
      "r254",
      "r255",
      "r286",
      "r309",
      "r310",
      "r311",
      "r315",
      "r323",
      "r391",
      "r394",
      "r474",
      "r535",
      "r536",
      "r537",
      "r561",
      "r562",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r592",
      "r610",
      "r611",
      "r615",
      "r639",
      "r717",
      "r718",
      "r735",
      "r768",
      "r784",
      "r806",
      "r807",
      "r833",
      "r888",
      "r1000",
      "r1015",
      "r1082",
      "r1109"
     ]
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RadNet, Inc. stockholders' equity:",
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityOther",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Stockholders' Equity, Other",
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsegmentsAxis",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsegments [Axis]",
        "label": "Subsegments [Axis]",
        "documentation": "Information by business subsegments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsegmentsDomain",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsegments [Domain]",
        "label": "Subsegments [Domain]",
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r646"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r646"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r646"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r646"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r646"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r647"
     ]
    },
    "srt_SubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SubsidiariesMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries",
        "label": "Subsidiaries [Member]"
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1089",
      "r1090",
      "r1092"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_SunTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "SunTrustMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SunTrust",
        "label": "SunTrust [Member]",
        "documentation": "SunTrust [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "rdnt_TangentAssociatesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "TangentAssociatesLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAssetsandLiabilitiesAssumedDetails",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tangent Associates LLC",
        "label": "Tangent Associates LLC [Member]",
        "documentation": "Tangent Associates LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_TarzanaMedicalCenterLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "TarzanaMedicalCenterLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tarzana Medical Center, LLC",
        "label": "Tarzana Medical Center, LLC [Member]",
        "documentation": "Tarzana Medical Center, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "TermLoanMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEScheduleofDebtDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan",
        "label": "Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ThirdPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ThirdPartyMember",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Party",
        "label": "Third Party [Member]",
        "documentation": "Third Party"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_ThreeMonthsSecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ThreeMonthsSecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Three Months Secured Overnight Financing Rate (SOFR)",
        "label": "Three Months Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Three Months Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1091"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAnnualAmortizationScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Names",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "rdnt_TruistMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "TruistMember",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESecondAmendedandRestatedFirstLienCreditandGuarantyAgreementDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Truist",
        "label": "Truist [Member]",
        "documentation": "Truist"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_TurnerImagingSystemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "TurnerImagingSystemsMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Turner Imaging Systems",
        "label": "Turner Imaging Systems [Member]",
        "documentation": "Turner Imaging Systems [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "rdnt_UninsuredRisksPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "UninsuredRisksPolicyTextBlock",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UNINSURED RISKS",
        "label": "Uninsured Risks [Policy Text Block]",
        "documentation": "Uninsured Risks [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash change in fair value of interest rate swap",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r799",
      "r800",
      "r801",
      "r802",
      "r820"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits",
        "periodStartLabel": "Unrecognized tax benefit, Balance at beginning of year",
        "periodEndLabel": "Unrecognized tax benefit, Balance at end of year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r549"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued during period",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "documentation": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to change in rate",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expiration of the statute of limitations for the assessment of taxes",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "UnrecognizedTaxBenefitsTaxImpactIfRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, tax impact if recognized",
        "label": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "documentation": "Unrecognized Tax Benefits, Tax Impact If Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnusualOrInfrequentItemAxis",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnusualOrInfrequentItemDomain",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERecentAmendmentstoPriorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation1Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USE OF ESTIMATES",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r238",
      "r239",
      "r242",
      "r243"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation1Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation2Details",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "rdnt_ValueOfEstimatedSharesIssuable": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "ValueOfEstimatedSharesIssuable",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of estimated shares issuable",
        "label": "Value of Estimated Shares Issuable",
        "documentation": "Value of Estimated Shares Issuable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BRMG and NY Groups operating expenses",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management services provided to BRMG and NY Groups",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BRMG and NY Groups revenues",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Economic interest",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r577",
      "r578",
      "r582",
      "r583"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEAdditionalInformationDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEMarginSpreadBasedonLeverageRatioDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLERevolvingCreditFacilitiesDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLESeniorCreditFacilitiesDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r343"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r343"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Add nonvested restricted stock subject only to service vesting (in shares)",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "WeightedAverageRemainingContractualLife",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONOutstandingOptionsandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life(in years)",
        "label": "Weighted Average Remaining Contractual Life",
        "documentation": "Weighted Average Remaining Contractual Life abstract"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_WeightedAverageRemainingLeaseTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "presentation": [
      "http://www.radnet.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "documentation": "Weighted Average Remaining Lease Term [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_WestValleyImagingGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "WestValleyImagingGroupLLCMember",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYAdditionalInformation4Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "West Valley Imaging Group, LLC",
        "label": "West Valley Imaging Group, LLC [Member]",
        "documentation": "West Valley Imaging Group, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rdnt_WhiteRabbitaiIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "WhiteRabbitaiIncMember",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation7Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WhiteRabbit.ai Inc.",
        "label": "White Rabbit.ai Inc. [Member]",
        "documentation": "WhiteRabbit.ai Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WorkersCompensationLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workers' compensation liability, current",
        "label": "Workers' Compensation Liability, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.radnet.com/20231231",
     "localname": "WorkersCompensationPersonalInjury1Member",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSummaryofNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workers' compensation/personal injury",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "documentation": "Workers' Compensation/Personal Injury1 [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "4",
   "SubTopic": "50",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-4"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "b",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "c(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b),(d)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.12)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a),(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-13"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-7"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-8"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-9"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "d",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-5"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-20/tableOfContent"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r220": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r221": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r222": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r223": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "c",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r224": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r225": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23"
  },
  "r226": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r227": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r228": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r229": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r230": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r231": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r232": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r233": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r234": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r235": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r236": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "SubTopic": "20",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "SubTopic": "20",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//250/tableOfContent"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//712/tableOfContent"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479092/842-20-40-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-16"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-3"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>137
<FILENAME>0001628280-24-008035-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-008035-xbrl.zip
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MVJTNGH@ J',/"VW3#L]#>/2R%-N# QE$6RRTARRBEU0Q<(P]L^WC@Y6-6GS
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MZ"_Q-OCUG@PG]L?0Q-'^_P%02P,$%     @ '(==6+\L#SI] P  /0X  !8
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M_TJ C\]]PPP8]BD#]G;[HZEKWNS8:N?9WFY")XLW=/Y:L-/3\Y\ PZD)K"Y
M@>NP(ZHK(DZC^/[>\1%Y]Z"<GMP6;M]H*N,P;&03"TJ$TGCRCK.]W-RHB(P*
ML_9/JWS.M6CS;J]O^\VU\3U02P,$%     @ '(==6)F==$:G!0  ^ X  !P
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MN3A5S,7W4@QU[-_'D^O) D*_>/;_RW<G]XL/_@?J_Y#R/]Z_ %!+ P04
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M,VPCR'",-JB\0_61MDXG44L>/;O6^4Y#&F.FCQ-Y1'?=X,H>].I?Y_I-^__
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MV-/C 0QC@\C?ZF2599-[6F#J<+M" ZTZVV^#4/XW\"S3.>^O1%T:.7JBD$B
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MIDMH^<63_UV^.[E??/"_3_]GE/_M_@502P,$%     @ '(==6%_"U,9D!@
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M$W/WH,K3)D+,3POOK>[<;<;NTCRW! LV" V>C4].$1 8 UJ!6LJ9K*).0$7
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M(QHYDC9&!4T.H1.0^LU1-"50S2$V$RP8ST_#<D/<N+7?%AMM?0\;!1;)#*V
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M [_O '3G*WZ'K_@:-C?KG59S>WQ%L]7^N7Q%L/,5V^@KUJ;9"RYC?8*^MN=
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M+4YCS2FQHHVW%ORP)\Y;9O=B:[$#RUR.%6V_M;ZY#69.P0ZMIM'B4=U=\FJ
MT(J(57>??"TH9$6TL=;M;H*AE?%$W9W\2O#.BFA5>W"@<KRS(L+5'558,]Y9
M$97JCC>L"^\L<7#,4=VAABKPSC(']]0=>Z@:[RR3%G4'(M:*=Y:Y\74'&-:
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M9:]9%Y3=&G[>.O/0*GFRXC"Q-@[>%.$TQ];&B-FAM1D)3:7K=ARU3XGB%Y[
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M0S;363%(Q[M>2/4:^'/PP,&MAI^>&IJ>[GSH[IG.EWHY'YR^\'TZX0/G[VG
M58O,MFR)Z?R +^AC:DY?X2V8H//$OHW#F!0V' _P]N2/<?3CP/ ) T]W'_TS
ME9VQ''E\A-($<?TP1N4_ 4[C)C&H0 EUY:)4]<5OL&=];B6RIVJ&!]L:TZB9
M91DS3!/R77'7X,//O!_!SD[E%G2/:0L.6L26C_*A?.(L*^[G6?'BV^<%R5:T
M$"I=D?-Q+K/%+,><;=,2MKWSX>BD=7!\V#HXV)_CT1?0<&%SLBK*?S]=GOWV
M]?S;[8US\>WL\OKJ\KJ'/>@__LNY/O]\?GW^[>R\^%8OMI/CK#,6]SY.X5+P
M(\ NNX7???2!*F9WX><<MGR"=@_Z4M;9L;1C5^A9JS2!1WA?)Q/<8<I2^##-
M? VC+9#A'=E+V_G*.3G1<$-BTU'H>VACHLTK<IL'^CWB8/& AH_T+J(%= 5*
MRKFXN#"Y4TS>-X,>/@.7.]A)'4U1@T\E<EWZOGO.#29!S:[X'A1OENQ)>-5,
M7B<"&P9FRO7/+"2 94E?G8,>P67P)]E[#!U(F5#IL$&B;$!4LD\=?+G^T#-R
M-VL*+-4A,..I.I0<KV'DQOQ4C=S(C?EY'"\<N3$S;&422HST/?A2#.5F;OQ*
MMDA:73O[">O#2M+D\9_4IB'M8GW3631MYJ53;X[-U)N188D)&X)?'''V?9?$
M[CWS[T$&D7AK'XVS[F/ONO?IV_EM"P^]QT]M6Q9[V_OXY1P;<Y]=?KO%L]KZ
M%6]BFX=.>Z_=/2XE]^L$?G!83G+;T=YAY^G<MM>W0K*L2]=3E?XT:X8,G(O;
M\Z\U+JQ>W$#KJO?+^?-) *\F*@AB7I,O>+O!8&4A[:?(^C.S9BW.*$(GYR]+
M3)C;1X)=WSH7<+2PV1/Q<99<RKZR2TS7T&/Q<7ZMXM4NP"F2K]?96V%B22.*
M)8GBT<X'G8#U(EDL(>UWMD]H5?E"B^BVSGX\X(J_E&2=1VBU@5JDUZB1&JB1
M4_ 81?S=^<S<)(P:55(358(C 0ZW1Y=\;'2)_;H$JX%_"W"8M8^Y)S<)&PP(
M-,=02:-8:J%8D(8X.GWC%8MS<=;H%/MU2F>_#4?=V;3/(Y6X.6TT22TTB:3<
M=NB2;J-*[%<E6/AS%843W&:^4GO$@,Z-"GF;,0(4ZQYO@P+9;Q1(#13(R<Z'
M+WS(? ?4B,NI75.C1^J@1X!PW9-MT",'C1ZQ7X_L=W8^?(6?.#=LP).I\TG$
MF!*81HU54@=M@N1[F39Y8_:")8'N^C<8*'6"9I-MLG(]>:"S35Z8;K*)/%E7
MB^2PL4AJ(&G'8)'($BZLXE@P.$^-R3G_,Q7)M 57^%1>D2OJ<+YB!XA(UDS(
M20C.51JY(Q;+:BKYVUQU10/DUL/> >;HGFZ#]W2T2EU5Q5O]O]<<?GG'O?]O
M/?T@&PE[E80=M'%>Z#9(V'%C#=AO#1SLHS6@6S<9$P!ABE26/^(1W\LU(_EL
M6L^<A8%'Q6O2KL4+00>EOFR <SGA<EW-V5\3S02LL-_= LTDV?6XR5FM@WXZ
MVOGP3ZR^%@E5U)(Z@@]\_7<.4'5Z_3!-='\*S'1M-$\]- \0^6 KO(Z31N?4
M0.><[GS(K)R;K%D;ZIZ;=#+QZ6\636E^4*-DZJ%D@*J'[6U0,J>-DK%?R70Z
MASL?SJC9##;")=T"M@P;1EQI&^I1TY/-:1EU%0WTG]AF!W^0::G,#&K442W4
M$='_=!O<+>=T%9Y6$WXM5QN=@#8*J0NWM',H[<U;=9Y*HU!*5"@G6Z-0FA+!
M.N@4' 5S2=V0+P+9H!)NU6B3>F@3)-[IP59HDZ8XL!;:Y'CG0^;E8-X*BZ@3
M[^<P@F=A-^)(Q)Y0G?:IL?Y5Q.^P^>=%$$]4"_XE]$]W(=';S@+2DTJQ*@W@
M]'AQ.N=B-J9W:B_[1J6W86MR7IN<URU6:=B(6R6]-EFOM;4?.NW&?JB#L.VC
M_8"3>,(H;CGG9AC.I1Z&@[#'F6Y3[OR"0W 07ETIHMH4ZI35@6!_6_R53M.S
ML1;ZYFCG0Z9DSG(CNQI]4@=]<K0U^J3I:%(+?7*Z\T'5TTR=R_L +):1F&"F
M[1EL/1.!\Y$''$P9# ?+[\FBR;)['9FA^V@U3Z.7ZJ"73K=&+S6-4NJ@EPZZ
M.Q^T!B+E@B@K:*:XH&YN<8"X'# &SI=,=I&^F',!3YW@F/'&U:J'"D**;XD*
M:GJLU$(%4;<W$;AB K9/EC+G?.9JKML-C^Z$V_1<J8=^.7RI?FD"4/6"^IL
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MOJQ^%O8@"%^E#R#X2S"$N@ UMAP7MU36I@O?%LC!V% !DS8HNI(4RF6 F\L
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M<LH>JE3.=6Y1,)>_R(I1?Y(7BN-/1BP:,Y>GB30:ABB*=-PR4RN^R\>" D_
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MX,;G)NV@-YLNNB#Y^S:7?E]I/ YN4^3P7.<,F4V9/W\YSIU3T+G.H""G=;$
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M>&GBW.>%O#-+CKVQ/JN+,IT/CF&VJ"=3X&6S IWZ%O%=C^-TP6*"F\P@N2\
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MSB 46PZRT%-GKG9DYT"4U0S[@^R3E1$W*,]F0\_60]WT)/O(JF0#(O=XT]+
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M[ <IV+IPX-Y1Z#@LW]+9)%^Y=G&87T6&C.F<:6'ZP"S$]I(ZV))OJ>!.<7;
MGA?H:&A,OUO"0F<MO!Y-BTP!Y 9GD"-IQCB:9<G9A"[[V[,\>\'8UCDI)G?.
M*,ZUX%)>GY#3O(:<+G$#F<.W"/NW0\@J1-,2IL,&S-E7&>NF ]>!B4+R(B*1
M-MPXCB;(!$G!79,IGH GL14L#\E(9'C81^?<>5?29BY:(\2!G=ID)%0E,\N&
M:-EI7H,9KFIG6P&8 @%%#G5Q6M!MZ!&DH!G]0%JDQN3:IHY2#2-=R5IF1;8"
M^;^\\U&^EVSDRO%*T4P<&T8P>^N<,-<]SJ$<.D%&2QJ[Z9WDZ7GS6'+I#S#;
M*:T$EL\XA2+.EH]1 ;<@R7QQ&=E4U@N@@][)X5$O9O.THRZDPVDOA8Y#:ZEP
MT0D](!MZ.CF*#^.@""TNXB^@GXV*7[Q5@IVAA4_S\V"AQ&/9.,BB%; W3&YY
ML"O.MH>J72)"^1#PYC^??MD[X3U=&]^A>?;L#93&7O=*9%54BG)SW^$V6R=\
MP!2\J0NQYJB*H<28C@45UF<15+:3G-J:)'K/R-D*=[43!]4"+XH.[@(4AAKM
M]($)*7#S@5=^#$T&S0UY;P8*9T_-CTYBJR GM@U2)ALGJ7F;NDAP5"M@MCB8
MVK)?R=JS6#'R:S\[\LJL.E?UI8]G%IFV4^)60635G4BW\ R$QRM?BNOQ[)\$
MQW3CY<=-&;@&^<<>[#CVG19<:7F51A[$M$EB<_*KL"',?%X5E:>N#!L!^I!]
MTO![-6*.]3')R6*D(NLKQBUZ@NZ_'.S?(Z.MJK#-UFRES,N%50;_Y7[TK=Z^
M.#X&77'/A=8<\;@3NNNF#/PW!C6%4+6N;\E@R;D@+84A=F#60,F?B3AL%;7)
M00]ZE9),_L$,6<\8K9MS)2#B%\V98P19L:#/L>Q3H@]&.#;6#.3P:L_C(4-G
MVT:KE^$+S.=N+6!<L,:P?RFPHR19E,OM.20&OU'B-G1XO /&/E8ZAAA2YNWT
M$]3"<Z63W*(9*C!\K!'5DU2BO1"2B<6YS"K7%I&6.D?.DG:ZD$U][94_E\F]
M$ 44QI<0T#7H-"]6O .GY-B\\-0+0/2*7QXV%BUC@[7?CY_'^QN._U\.'][+
MZ4U%J'&&MZGWR*&L&X B%X52Q2&C/?GLSEGNA891:'#B[,2QF\;! VRO4FY1
MUO\:Z"T04W&%(>_*WB/GZTI<6S\JL UR;0_329S!^T;/ _XUWWF?W,^)\0K&
MA[:MT-PD!@#7W)-2 (D-G&\#%S7UJ:LUSVPX>][:92O1A479+<OCH0TTMTI;
M1R-8N_E0,QV.O"/&E4P)?*C1*/>SWWI-1_?"E^C/9=V<Z7X SI3% ?M7%B?@
MU4H2;AHYU7M%QE\S+>2D* $S(.P57Z'BV6&WKCR3!_=N#WCKFKS&-YP'WWFX
MGYTG*3"R!"^3] ?"5.P(\C(8<XD6TIAEI-]"5<;EYW,V4SIZX9+$7<$U!04'
MT,::-[&PI, [,FA,)!LQ7Z459 M'ZH6E,,+Y@JX9HB8_A@UP<16Y*=$NPF'1
MH.AA'!N-H5X!.R P6O%J^&]Z>NT XX'N(1.+U)S>4903._ZG1:6C"4T M%()
M70M(+PAX2H!=L":C16C]QI=T;.#Q 6!K\CJ9%05#"3,,KQ-;"E'A[:JIR[Y)
MZ&YX":*[5H74R:X:AGZ,EDO*7\&"@>(I9L.03$02O-BV*V3O?(6:[S:!+;17
M$FRD?_#VM6W^%#4O2P4:9O\HSKIKQE^<U4)T)C#$OI5>"GG8CSF,;7J"U1Q&
M/8>$IF(C'1>W*.F&V;^4H=/BXTNWX#":0 S88:1IR).CQ@^R0V[\2KAWY6<3
MV:<(U^1[.(Q\Q&7K'*T>7<)53=M'RR?? !D>A@$C58NWQ.IF6<@M2[PL^]\(
MFRRY<0CM2X%^O6*_(G!(B!00^W0N>T#NQV$9$;62>?4#1-81 _2HV1G+&+@6
M2C,"7I%&^"AQ9X@GB G_[/48X7.SSM1=$09/?6>?U^9B GR"5:)KK_?\OZR5
MNF[#6U.S(%>5R\' YS2H<E%(IQ_:>$U=@/ZE*L[U_'&HIH9&ZAD>%'Y:C"CA
M=$Y*^8U<&"6,PY4)RT,I)]*ZKS"VVYKVZ'S&056P.W($7$MGPEUEN!Q:FJ&I
MS*D(Z'-0U"KS(W=70N9?Z>R $F# =[FVH#N^8C.HH7&"@1%WL)!"^CR?47AW
M(@*/J6T1H-*Y-T#823E#\& \J>*0Q[?4.69K00O!/<S4QH.UM?'\:U@<BQAB
MXV3.7#X\C!%$6^X(9@PSJ4A@(> <,3U':=# ]MR1I=7W&W.]=&X< /<<>\-<
M. M'G$,1Y&O"MAS'S0/BXB)]E$N\A8Y,+9NRCR,*[YU;,W? QMM+3Y]P<,-&
M^W.SON7E!$T#NSDQEMOLE*X4*U>[#/%.$74)ZA/:J4OH.EN$G0EXK5(_^QOV
M@ACE+X+IKZC;:S;[?D<DD0DN"^8;(?N(013 I$3 \=8Q;Y"<"84W:8<A-F:.
M_2LBBAY>,E0IFFCP-@D7J?(?Y<(X9\M3;7M7]2?9%,R>+ON>RUSX"G!O)#(
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M;SG/?<UNO@T-@>?W-:A]-*0\.5;O7,@U^('%+W'$D:QFA#<S54@:6:L@O2'
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M\(+7+UXJIH"<;QDUGTD7VM9Q+SDT#)?,.>CSVJ8&=454O)9'?2W"X**+)\;
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M.,5?Y_VZ&;CWK9)!'75Q"H,42/1*=@1"U$'*#N2P&!=BSL,&=@B^?8\Z>,Z
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M<2/\$8"-SZQDV3\M-J_<GJK(8]8EOXWSZ;>7=*1J=$W"E4A8=KU1/%UE+GR
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MKI55V:TR"<8NX:^5'8-!%I)\1/263D5NA1+,($C?B,M&MG/3=A-'YDN$^6Z
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M[&=ND]XR+HC6Y3=L'"]15T8>I0;%C=J2,P T&D2NZ(!KG,RWW%@@H%/.AB0
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M6W79Q'K+9AR^#IR\@^0TMTU 2J*?<S+*\_5N=.WQ=RU[6TEA)MK&C2TD\*%
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M#D@61<0@P&"1S'SZ]RY56$A0(BE*(@EDIA.;) JUW+K[_=T@F>E\UU(S:XG
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MD*Q#@.[*F/ON5BI#8C.R26T?E-[P:T^R;CDR,8H+EW0I+PW]EE/@ ZIP04_
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M#R*?8HNH?->8K4VP3& =N&&^1\5U$(RPX$L#5F$6DL^8 $X4284ESM\1&7C
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MOOX?04F+Y3!Q<"V)7S ;'P[#A)V@G/*K,!4C0S>+GR(L X/=C!(VI95R14D
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M16P4O:VZGCTWAX7:> >Q$P?<O5TU8*>TX25\Z72GMG9([V\Q=&V"[, $R6I
M\-H-8]T!+^($62*^7.204R<H3RM )7K^$[EV,'Z/O7Y&6;A+H0YR),WQYK5+
M])&/$I@-EPODZD TOI:QQ"4I<T !6M-CA73I0ILNPN:7U^Z0\J-5TT;X_ ]J
M8(;I.Y1@$&29R$@,KHI5U%Z$1SYW[GF6AV;)B\K"C1WGW:LAM\+1GM8MM,(:
M47IGJ=SMPTGEWA?MH-"#DC*CS"LS+W9T88)N^T4A@DRY+' \OBP$)$M80P5=
M3+=?*>AGW#TB2V=+_%PZ6/%.+MS!++B1=C-,JR5^ILXL_-=B,:U2\-A7I731
MHED8WZ5Z&JI;!E4#%K.IBS.L1F."?9EXP0#*S!HF63JHY3-6U)$>-0/9H)\_
M47AFCC]/D36S"V'D+\?0<]#YR;E[Z!*[UK#A3-:JY0\F0+G8E#W#E*:,2O46
MMG?TCU0:H+:/<J/J9Y-E0*X\)D6&&^H444/O1 Q5GE,"&UM(A%OVB>1]OT9Y
M\AMA5I8@#57;%85]:@KM?]X!N[M%$_\7!0)PKF Y\$P^.K>I[RG?=A>QP8)A
MDG5;9H@E0@,E7-)";5Q2^ZJ>@QNQV5? AATB=C-A^BF?!?.=Q >]S!U2AV&\
MD-,9"4#GNZ1>4ID<8F:18N N/)H^D$+1*E8WD%3?J5)JTD8\.6>F<3>)Z:++
M532J:)F;31%:F")JT$$G:8K@+"-^;AJ$M0\N&%DCW11Y2KG:Y'T"6SC62/2+
M%([9@N'H-=I1"C%XZGQG<&E"7HRX,%57AR1+0-;91'1*\XJ5U_Z>VE@L2T#,
MPHF# -3!(LER&23COA!^\RU,&MYHZ,)?5C]^N--DR@%3)3$Q41][LDW2BSM'
MY&U#(87";>%KHK&D;YPABM<Z)^1Q3UNU?_R+N90;18FV0<C_SNTL0SF6(=;A
ML-L ^0KW=:-J*YR-C'(E)SGF"[IIC03SR"E6H!L//#>:J%I+.C\_(%SWM'<"
MUPCESD7+DDC%Y@<4[XEU4P,.FJ"Q@*6[N1;K1<&:11)X/(E52AKYGFD'?H=_
M)-@ W5!=F;_+[*5V!3XZ=]>=;BD-;ZS &W[2N L:40_O/]WU4WVMJ=<E.X8)
MS%2?W;M4-+S*MTO,K#=$<\U3'D@,*CNES":5DMM^J<=5 +'>O  ,R7/)A /A
M?F32!6.CV"D\5[L>(+RI$X9S5!JC#$5PZ0N-3Y;FZJ@\D/QO'(\Z5G'/$=<G
MV18[/Y9_RL),]; J_04U KO%@ C&Z_PY3XAZI^HR.="20W>0Q+IXWA%$2XVW
MN$3T(0'!8[.M0>)Z2.HT!/W$>EN0PM+QU<V]4A>OV;/U1I/*[!,VM\;Y'A'?
MM_J]3KY=V;,8M?NB;RYW3=%;:3>:ZYJY)67Q5/6HW UC+I:DHPHUOC5K_!DB
MN^HY>JR U?L[2W?TGR_<CFRVQG9[U!R,[);LC7M#.6X-NGV[/6[W6\W^_[/M
M%X7V='QYTV %=JMYC=T(G5DDW^@_O,5D=3CY-ZY/\Z&'WC+P_&L5X4#?// -
M[+[GJ>.E#>.OE=N^WS=[[29Z[N,0_C?2+U9.?1/6]U/)YY8)=[WTJX9IE3^R
M8JA>Q^PT[#N'^HFFQM.##<!M_L\7S1<+LOV-/?LAK*)D1_FUN >\_*=/@:/X
MR$4LI\+Z.;N+\>CPE\53&\FA8EQO*#,2?_7BG__RT7GJ82WQ5>R,Q\#@IN1"
M*.P G?!/1,2'=\WW:Y:?P;XJ8?7K\2*KV>C7W*ABW.B\.MSH/-^Q]&@XT-/O
M<A<F@]G;XE.N^[R/+)Z2>>8KIGBPNOP9)DAR_[\AX^T$6/@4&L4>N :W8L]:
MMAO4*1!+<-C3P9TB"TUX,SSD-3KUNFE\+(FGB$XY"UUJV,2 1&0?* !)C)GD
MNP$[0IP7^_4B/@U.]VO681[^>!TZ4V5TT%%$Q<9_K\FP1@-^##\DQ!<54\U*
M0%0W1,29S0.T&6J-U#DI[;-+W?HPR0_)*8O$"H6GHQH"NE/R-DELVB<7&@^#
M?3,$>Y1Q[AQ^98082Y*;;),#"?@!A39>ZY (P=Y20Q=O&4#C>>#?]H7:+YW1
M9YG%PM<G&ZR6B0CXC_H_8NFZCE3AN6)\"UTWD8:4+B-Q OI$E!MNL%5X-W<S
MA[<$V"5--UDE#/E<@^9\%$SG%&: 7>-@F*"S$:L7)2W OS8*IC,'_&>!KT%U
M:!)Z[D9ZI=)D^%P#]^SJ<Y:J'S&R=FZE1N%>ZD%&28J KR;@8HGYL)0=Z+[<
M^I*0GXOWK](N%X1B(6@K;/Y-U6N4A84'7,QAG$HGRJH9V)L"Q^3GTI=FBJ9U
MRZ>H4#F0<X&EJ2$IBTSQQD;+G K=D XQ0[XLE%6?DRSYK*S7V.T&<\@6AM%]
M3J[#()EIFD?B?(W3\N!D* ,--/(8:09QJ+A?+S:L!1X*'PXSF7U^<756R+WE
MNY)P*W6N@.0EJJJ[?):N@UA1V35,MX7V*G8C:? YD$@2M![E@G3A:L#)40(=
MG N!Y 4%+IPR(%K]:[S\?'?@WGB!*NXK;(S*)69@= SNI]*7 Q Y%H/7I])W
MY7>TZM @IP0O=6S%[8PE\O2B$I%GKLS51R)]()?EQ FO2I$ *Y"%=*PU)V&W
M?G1_-#MM:ESY&I'A-#O.<JYF&#< :N3\2)R-DO&4F(JWR6<@./I]D" 9$;(E
M,6\D@CI[> ?9PYW#R1Y^IBT"LB=LQ5&JX*A8"JPWH8;Q M_'K!")/*]D@##"
MLFPF;05-'"019A,K-8CB0@N%X*0,3SC@GDFK2G,TTE-?4SB%2ZU#I5^1S)",
M)X^UW^*[G&>=>5'@;ZOQPL&^!_4 CFHZ\X*YI)[I>>A1W?M=RS"=Q*VG=IHO
MJ-.<E5(B)@$5J:-"DHFN5UR!D= 7XP13SM,WZ!6J^DL,O*)R,Y=.2$%/E<U.
MF-JPE]C.<C9QHPD](QG4]D,28@D'YF90@I[N]8:F$D\!]0+.Y4E?K*+]7Y5Q
M^S6G#NO/:/M^QOY D_)CT4#??! \MDO4K>W-:FNVOV.VHC^<8'9VP40BZMC
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MB-=.7/AQVJMSVWG5#3[7 _XIVJX_'GW1B&^P:;<[W) /'/2Z[URESA3@CG9
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M3"UW>+<XL-=)XS>%>$ZZ_^*+S\&-G YD*"Q#H+_6$+>2CS'$\Q3=]DLBZ3
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MM$I57@2Y<OTX*$)Y5<RM?&IUC%ZCMWZ3LMJ*>]I2F]J*>ZP-_DCE%<X 5(7
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MHC1^5-KS(EH(@W23)\TA8E[B14>"Q,PDZ!S^]9_F2&4V-!WIP+M?(QXF+V!
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MHMC"@Y@:=DH-L'54.D-$+H_&?LCU!*4;UK&Q-/'!&CH3Q,ZV09U SE%%\,_
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M7 4LC8F=*XY&<#\^+);7AO0C=GO1F7-GR5XP=U9H=C%^!.XBCUCRCNOLAE1
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M\V*5)7"&_WGAF$331ZHQU/I#52?M47M 1GJ_9:G&R+!TS?I_NGF1N>GJ[[3
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M8QW?8,HY*Q$&H"ZU1DXL &OJV"9MW_4D;S+I/7+EFO'D R_&R*\X946M"_!
MZVN298I_$9 Q'LP^QZ6)AYER'I,NKN1CTIL>F$:L#FQ@AV-IY/HORR6AT3@@
M<8;M/"S,RGS;V&[&W*&)LT)-2E*3&*$$B[D1+X$!2^"A!RN<Q9IRM?EI;4XS
MO4[Y]*$!9HT=_#)3+V^8$AVGQ6!9(!YE.Q1N)<DFB].(0GD!H3RF>2Q@7.57
M%Y@S=4^%*NDH@17*"UTE\*-RA=FA">N8O4[/7PI#YR_[!E5U %:NG12>++N
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MV DB"G6\5TS4GZIL@O;!\9SB#E].9J.YF&>:70=6F!9J=$<$4940,C7I@93
M8E.G/CV2#V8Q"$@6+YO3=X,>2O$CZ9S.8H.WTKYCMO:,YIRE K"YA:?TD1YI
M>Z'TV[BY4(R>1B$!*5YK!GR#OHJF&O9YHJX=^I[-T0,X:!WKUO0RIHG "[[$
M@D*- F9_$Q\$F1E?(B?/0%0]U)H@ &."M:P!#(2I5S)Y7B#&1\N6='] AK0.
MA#I;"5()9M*%*U_[5HN6-4.2LP1;' (#>J'Y&DR#D/YT* WI 9'_,A<GTR&_
M; 0(1A1=FOI'Z][[:%AEB3PSW O4%SM(L+7C'!Z:.YVIA7FC6<\<*7D+AW@
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M\(?;2[]Z<:4:,CC"%5GBRXQ_"3%J'4J,-#"B;=EJ*141H_/T%+\'9&H[F::
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M?<=U(H=L69UKF@SPTM(K&_\5,GP:,KPA.ML>9)A6F%NR81TX7Z9NB1*L2:^
M:BL)JFUWP<>\"$.VBI[=B<2(DY"A37#:=I<A3(?09!A=163H/)WX),F,-_D5
MQVKKT-U]UG;V+R<:7\]"F%,J[*_;B7JK>7&ERZ8NL-@J(P3K ,SW( 0*"D%3
MK1:"0^7S&<[-E^7"(TW](&YU[B^@3KBQH DWMQRLB5TU5[VX,L#;;5<%3E9X
MNT?#FMA5E#2:U6:6=G8DG-X-C:SG8WM['LD63O :^WF+U.(!LRTE7;^X4EJR
MU2J(JB*<WJ-9NA*8;F"/'EDONJ<7B#D;  Z[:<1%(./L8MQV#EVU3-C*:2U9
M-XJBCPG<FPJ*RQJSN+NXM##7VI1;:I5@DNJ0=_+M[O;WR\?N_1]US3RI?'CG
M1#<8WWSOZ3(BP62GX,V9V]7M8C1IB6U1,TLQD@VY:8DX>V5D8+O@RO8R8#&<
M;$41[?/V*0*WV6@*18/'&,M@/NPBPM=;[U!@>7F$U26[(R^H">WFQ54;]N)-
MLR"(BXA:GX0$K=NTE"!!"DB09LF:?L+ R"=@2Y,,C<C^E;J/HL5&$<"?GC?P
M)^31_I79K!=':&FK-*VM5;2IE' @CP[24Y( :!=7EJP:!^9_S9Q'!O@(U+W<
M,K1=TR5_W7YZ(2USZTU4&^%RY5;13"7A.)Z$%*W;D9<F10;-[VT6Q1*MDO=X
M.H>$XG"P_,/!H@)O(EADN]62%:6LCI/B7+"ZEG('24& 7=G255DW3JC1Q5D<
M"6X.&; 37,.Q#@B+#>X\ RKW]A"V?K($>\(&O-L?_!S[+E E_!OM.16]?CR;
MUB<;\V'H/"^,Y1*O_VA2=AXK3=.?3'R/L4BZE-Z]99R_D^!A; ?DS>6\=_ME
MN9(#W_& K_AN!W?!0V1'9/BG[<Y(^DANH)N)@6Z_O5*L&HRQE\%8%U<-8,3R
M=FSI VEJ!](S/DZ65HX_Q->$.PR=CC/LS**Q'P"WAYNM?LE\K.8;Q,T?7 $F
M[SHX!78MS:;<9/^_ <G9B"4[>>.GO9.^%X:SXC-3]T_V[0:F89\5V3),65.6
M#ZN6*8Z@(_LF\=TL"B-X$1C*HM/1]T_G'49GT *$%E;>JLN^YTKQ=BAG&=Y+
M^G+)CJ0;,B"3/@DD39$EM:EJ]"+X197@QBF!YSP3-TV'@95(1/>V*4M-9("N
M%\N["@OVGU4I*Q$ANX,6JZX5#=AP%CS3J%(8[@3V'!T8-1(5.]S:SO#2\2X'
M]M2)[$VZ_9VY^*[#F$I(]QTHU_.N&=T*QE0L<-E;JBJWC,KB2=6/\^N0F<KA
MO(75&*:LMD6[JCW# <XF,Q=WK SS#R8]F09D3+P07#S)]<.ZG=Z^W\D,AC!^
M^"T'KRRF,SV,N\Y2F>4Y? -2WY+H;O1H_RJH+3!P5J/77CZC^"#<Q).6L"5S
M>R0)HS$4V6PM[T8.+F%GZFUF3/&0C)R!<Z:I@GLQL/<DLN%-PZX=>$"/,$/-
M&T;,PA*O@O-IR49KV0-9)?'"[:R (=R#)&@75VU5-M7ERN!]24*9;JBB-M2J
M&S^6\)(]Y/M;F'O,MXLS6N>\AS7[]8<,J;N4T(65!!,,-? 0BN+FGFQ[$B%Z
MI00,2A ]X^)*TU39.@W1.T_W%7-*X:+ =UT\1'*PSPC9K/'UF<O_&M/[A^/Y
M 4A]CU.LL/1CBB*Z)Z9 9:H,S]?8O)UYCLF&1EO6C1,NB3Z=1&SA>A[4]03W
MWYTA1;ZSFO-.% 5.?Q9AO>NC/[_0;*U!;2REUF3-L$[!9Q#N:E5,]Y'$%<_#
M+&4+=+)3<7%/9S7(E.70M*C\U6$^MY\-.Z]W7%V:6)9'A_,Q-9N7+76\X>[[
M9*6Y?0_9TMBWWYV&T#JA=>65@)6C=<KVW66/JG5T$?^-NC%QBB_]P8;:#_"2
M;/YOIAPE\Q+6<?;P8J'2!7M,L+^E/X%WOV)8BB&&VP%\[-$8U5- L_L"BG45
MC4E(I)'CV=[ @<]#+.68P 3"QLJIQN_3&SH,:>J'-/OI8T!<&Y.D/[TXPV@<
M2VGF/L[49GJ+W0?^S:+5MZRBZHDPP] 6\L4S/W&XJ"^.231]I!I#K3]4==(>
MM0=DI/=;EFJ,#$O7K/]G8!D/NVD<I$O!$[GL!\3^>6F/8(8?;??%?@U1BC.$
MF#A>/")=9=[F(JE7$W1CLE:.&TLUDY0;]YV;V^ZC+/5NKQNT[_+#C\\/O9M>
MYSX+IUK5T5_?W3[<?>O==!Z[,/)'^.>/[NWC@W3W1;K[WKWO//;@@LK/XGWO
M5GK\>O?C >C_('7_Y[K[_5%Z^-JY[U*.P$3X7S#/SH?*3V=A+5L<YL0.GD #
M<;%BY8ET:5E8ZV"LKCT-R<?XET\Q^*SCT3?2FS[Q9W$CBIJ\L(Q1FK"ON9);
M5J-M:*CG?&/*7\Q-0 -F\-ORYX;54%4U]ZMF0\G]?-6C%*5A:JU"CUK]N:&=
M^:#T_*_B1Q6+,%3:><]W 9-)*<8FLV**7ZFJ_'\2.PBEKC<DP[F"LKF9UH>/
M&TVJ@FS$\K_R:^M/9NYJC>>N%%'5LT 2N>_^V;W]T=T[E,A)G)IL;-".BWPB
M:"EH6=@VC>A_IUJV]4""9V= I!$AJWI %YGYB0>Y-YIBM46Z2/RZ_7;\^I[)
MPY? G^1U/.[^XJ?5G3 D\'_#+8J!%,14EG53DY6B?3D*:>(^,B067I=W>"14
MYMQ4QCJ^RFBH,FJK+3>5G5$;JJ,R&R45;:H^IRUC2O/X0H;]664%V]+I10_X
M]R5D-2NHYUP&21EB,3T%/Z"B8P>![3VQT\2:5=07TB+E^%J$#6\-#8_L*P*O
M(TKJ2Q4Q]?@BAC4;ABHW]:H J0L1*U7$M..+&):(Z&U9TTZDTU,A#^1T:II7
MA&>*.,YUSL:O@#O01J?:5$S9U K"D.W.T1/8UM5:.M=D<!]"/"T:B].:<M/<
MN;F/$,_S$L\UJ<X'$$\5D<ED33'D9@YT5 7%LV;QBN^!_^Q@J"(@KD-&TFA&
M0:!%A&)'C^36CU:IU;P*C9Q?9'CY;Q+X>=JCX&EG6U743Q5QXL4^\0C^0TG"
MI IA.FMAVFRUWUB8-EC<:6M51=EY6U2M"$-%%NS\##5>WG#[N]3]G^_=VX=,
ML4:1I*)-O.LZWE\S]^_:#VGEFS\E 3VG"F6)Q&X_6)-I ,K/#["\H61/$.+@
MW_0#X2(6=1&#H1=]O&.4]IZZOZ;$@WU5LLNZR5"[XPT[&5H7-LST(%BS#%G5
MRL(W$8M]I41LA>=X0!DS:$:+J<N:7I4^)$+&#N%0'E#&:/M=\#-EM76.QU@G
MX"'\;CN>!()"08P0U@BE!CP&X-@3^@BL<B7$8GI?^I</_TBPS8AFP4Y'7B>H
M687 K-_R$)#B"-5_YUUG:-X#^OX7DO=/1MW"JH3GP:;<;FX.9RX2#T_#3+_E
M"FPC3&]'D=JE19&$-%51FMY:],N7)JMJTE2S , W8H=$LONPN_<]3$Z5!F,[
M>"(B1[7 XKVB$T6J+8\DF#@>=8'O1I3D19=OK7EQ9<B*V&F=IT2M.0?:7)+>
MM+::.$X\;S':M$=.J98)BP$MV6Q5)96Y9AOTF]*#]#5Q=-\VN5FRPN\N*2&<
MI6$1H-J6-:NL3#VQ=ZJ42*U9QO<B4WC4HQARN[3T.B%3E9*I-5D=>Y$IX^+*
M,F73VCGF+C;E6VW*P37#F'L(?*%+.F(@^O 7!MX1;GY*=^KX#6W:+/;J)>[5
M;RBM'>818^9S%!;6'Q,AGY7VSA99[+*J*%*;]J0M5Z9:*%.&*M(YSE*FBN_<
MRY I6MJF5B:HN&:9CY& 8:!DM0B>RE4U"U,\$!B-[0T(3':SMI"U]?C7-*"*
M"8FYFZ%26.>MBRM-;N5T-1>[Q3.0G77-]A:%9TD^]";L_79?$81T5%$ZUO6V
M6R\=RL552S_'L,#I($KX<>:E1'CJI>A,NI>5=BG%M>A:JU.<3$-IR59I6%*5
MJ,TO:5-7:]E;LU+O+GP4<5)K:[)I[>SL">$[+^%;XPCL+GPZBRPHLGD:EJ\.
MI:.]V^N[/[K2E_N[/_*Z9 EDJKTX#SUOX$\(QNP**Q$>P[7!?)\$<(K ]:F>
M[["#[)D75[HI:V99.,)"]LY$]C9U'7:0O=;%55N5#:.L.,,A/(=X$#%A>8O#
MP_9X$??O"N=P@F[=W>/7[KW$G3OL&RJ 000PR*Y+0@^K>DD8Q3%&D6*T[48@
MIB3?2M^0?E1X06Q?7)FZK+<%(/U9"M :=[X,";(NKHRFW-9W3CP7$E1%"5KC
ME)<@0483-H1MN;T[!O9ADH7.+7^F^[\S)WJ5'$\B=N#!!$),!IX#W*A;4DT9
MB!NIAL2[501'9,3^@T1C?]CSGD%S:-^>PCJCP+HMZ^IR_$Y ;IRX-*U=LO<A
M3GB<W)0U:]D$"WDZ<7E:NX#O0YXT*D^660'[5+/M]:WO70[L<(QH&]X3P65]
M9#N!]&R[,T+AM>+]=V!'1 I?[*E Y-B]R@?4*, :]QO"_NUY7X#J?R+1[T9?
MR?")#'L1F?2\V&&^!^HGE] +"B?<&OK%55M6VE4ICQ<[KT-[ H<7.>/B2K-D
M4UW>[6]NV(6X55+<UCL*AQ<W+'=49+.UBU]ZF*C \<M^1 G1SF71,$08_<P)
MQ[0,&KRE(>FS<NB N"#/P]TRHT]WSU$^!&EWCM9W(PP==KSA/:-S?GK@FQA4
M1JMJB']B*WO0ZN@M!6Q9D-H75RU- .F<I1"M*X<NP4IMX-=8&+YMGF6YTPDL
M]W,OA8<,+IU?EV-G."3>1^".V5Q_B7)Q=8< *=)[AP;0/BP[!O/_U".T4N;!
M":7OK>_Y\WE_7.>*JIRIHLII.9E_8N-:.3':"VA*R?)$BZ#:I=6@"*&JE%!M
MBII2LE#IK.5R655U5<J$.*$R:+JPE['1KW4Z_X8:5)[R&!=7AB6W=P='$X4E
MYR6)FWH(Y8FBB5 X6FDHET(2ST02-W4KRI-$!/?3RL!0/X0HEA2'J(B/\6:M
M].?NE[O[;EQ<\]CYGS>J:@3F0'D)F-A>R/%F0(Z[I#/M9P)*1=AUC_8O[#@8
M!390U/'LX!5/-4-02-JGSG==JI+LB+.P-K9A76C+[=+Z6E=B82AI2UEK$2Z4
M]7E<&;8NKG15MLRR\&*%#)^)#!?*-#VJ#+>PYQ78X=9)R'#-DC&^!_ZS$Z*T
M 5,E=KPB12@.-<NY*+\*!92*[R,^$X^,G.**HV#*J=Y:CGJ+.H$3EY^-/)#=
M!4B]N+)DS=PE?U0(4"4%:*/E?W<!PG,W73;,"I0JU2%<<=M]Y$$*$9[82W@"
MW!U0@VW0C%KZQ976E#6MK&XP8B=V)A*W9BW?0>2P_D.3S:; ?14B5V3UWT'D
M$"]0ES5%[-6KMU>_)5&\0[>C*'#ZL\CNN[!=]R5O+E*3E)W6;1-?HJ< Q$YC
M:)T,N1_]DL)B>%C8DE6K+&A.L46KE'BM<0OV+U]MD"]5M@S1(N@LY6N-#[!_
M^;)HPWC#4BLB7U5"<-W([3D6O.H9#:X.P+!I4$CJ/#[>]S[_>.Q\_M:5'N^D
M^\X-?"OCUPT)KOCC[E9Z>+R[_N^O=]]NNO=+22X[V\S*^<3O=IKB&2T'!5:#
MHI:^W<0$R^H4T)7@2 A%.%M%*.)W%]8$A4)MF<;.*65"%80J5&J+4%@55-A>
MZG(K!Q53N/\9)U:#J0S]&<;I*NABG_[HZK #^-QYZ%U+F7W ]^Z]]/"U<R]V
M!,+ZQ];_.PD>QG9 WMP9J(MK0)>C4,=W?[9#9Y"8^V9J[K6+JV:C659AB_![
MA.3O7_+U<D1?1]'?_414B+X0_8.)OE&.Z!LH^KIP\<_<B:[VZ.K@XM_TOOUX
M[-Y0)U]X^<+@[]?+OW'<642&>1;?%'Z^D/T3D_UB?OX;PM^BGGY5W!TA_$+X
MR_;TWQ#^-O7US8H(O_#U:SFZ.OCZ?W5[OW]%9[_S9_>^\WN7.?D/TMV/QX?'
MSNU-[_9WT?.Y>CV?*R)3^4L'C>#4#/]XY7(9XDH7OKE%:BXNE'_1)Y-A!V9H
M/Y';V:1/@KL1733#NUD41K:'!.*ALDT.RS-K*T*0:[+1;LI-HZS2FA,KV*J!
M@.G'DS +059,K":1-6UG'TY(6$4ES#BBA"D@8:JL6Z9LE@;E4Y$*P$HO[7S+
M5@(T,IM&GA^^F9=^QHJUC5YQQBRI5V'-PFX)NFP:;;#?91TSE\CR$RCV$@*^
M%]^D- G78.UHR9K:E-LY[06%A L)/Y)O5)J$ZR#AFJRKBMS<O4U)-22<.E>_
MT:)1^'?H/%_]'7[$H\X\9T"PAO3PT305Q62!M,<?YI(TTV$^CHED#P;^!-[]
MBA@-GA_!TT'L)!@, C8\!;8K3>V ML*,QB0DTLCQ;&_@P.<@EQ&A[>$;*Z?*
MWZ>K#,IBZH<."M]'VDW3>2:?7IQA-(ZU*W,C%[!F>HO=#WU4C)6WK"+KU=_[
MP6]7E><&=J;*#C'[$X>+6NV81--'JC'4^D-5)^U1>T!&>K]EJ<;(L'3-^G_8
MF(S?-$Y.*J9@72[[ ;%_7MHCF.%'VWVQ7T-4J PA)HYWN<"O15*O)F@%R)JO
MBW-Y*9W;&^GAQ^>'WDVO<]_+(*Y7=?37=[</=]]Z-QV,S3\\PC]_=&\?'Z2[
M+YAC\_V^^[5[^]#[,\&1K_R$WO=NI<>O=S\>@!4/'RH_W#66?&('3Z UN-CQ
M4T"*?I/8,+H4PEA=>QJ2C_$OG^)NRXY'WTAO^L2?Q0T?:M_"*DAIPK[FBFE9
MC;:AH6[R> -_,5?;!LS@M^7/#:NAJFKN5\V&DOOYJD<I2L/46H4>M?IS0SOS
M0>GY7\6/6A,X.J7X4+YOF4P*_>+ULV**7ZECTG\2.PBEKC<D0^F&# @Z[)*F
MR',SK0\?-YI4!=FH-E6MP*36G/J>W-S5&L]=*:*JR[O@81__5]%8?5$ WW6S
MW W/LG+&;/,TO<+S/]&HU2'!BBVC++#BHMS99R1UP1YLE.<JM*N^VK4W8&;+
M+ N86:B74*\*3;P:(-16JRP0ZD.H5\U J*]G04"\P:L4!? 4E_82D^SAOV9A
M1(\G!.+TMNX>[6Y_[4^F 1D3+W2>2::)FQ_ 6[V8^(](>_;&CC=\3#G121AQ
M2Z*[T:/]J[#RM4'Y9/.<BJ#.7 1W[#RUHBER1:310NA)2Q<MT,Y.$#?MSKTO
M05R4-;79O+@REPN?J];H*C[/@C&2U7)Y*E>5%!0\&>]I;'M/1'(\:60[@?1L
MNS."Z1X#.QQ+(]=_D<9D"!>, G\B30/'#Z0IO,D?AE) !JX=AL[((4-L^4%X
M9>=6#E<.%4_$R.SD<&UA8JZ!,U^ ,5^1+[_;CH<?WB>\&##[@HD>Q9<WM:G@
M\F:T=B[8>$,K#APJ$.)7KJ^U7_E34?[,=EEA8B%_E9*_,ERL_<J?1N7/VAEN
MIB3Y.Z]RHOPCRKQ4MA)JBY:#:V>O7F^'<W+T*=Y\P%_N#$GSW0^H^I3?GD=M
M8K_2MFQH)9=;K.'S">RLZRNP:P[$CBVQK-VI9I354$I([,E+[)HSIF-++'9+
M;<F67G+1YAXDMF9QEF\D#*5!5CH.TCEUW7GCV>OKUNJZ%_4LK<-J(;Z>P,:W
MO@*ZO0NT%PDMK4>KD-!SD=#M79Z]2&AI75[W+J'BW*P&D:J]0Z$7J;DO:IDJ
MYR87!M,MBSIG9*^W-M=%3;'2!%.LR.KN2?WE,K.BT-9"D84B'VAK4%B361M9
MS2JKH[+09*')0I-+V$(5UF3L@MN6->,,UN1\N*>3@O4I#V1I#1:)@%K:'&K)
M* 5J21=02V</M81(2]U__.@]_K/R$YB#5I*Z_W/=_?[(F[7!I#H?-D>EHU;Y
MX&A&(/N-)I/_(G!&JM(PS+>1=39]5*MAMHH"!*T&#CK?,9D-4V]7;$Q60U?-
MBHVIBKRKXIC:#:M='F!7:71J&V7@=6V(H%/N94?&XVGM!UWJG";?@;&BLVV[
M=27 8#";S&!O0H82S?:N*1UJK07W]M C$6P9O$&CIB2H-?]S)K_+LFJ=)A6N
M_<G$]Z2'R!_\K*D@?+>=X:7CU73V<^'?FM(@XP_4E )4_\>^.R1!^+>:TF ^
M1:RF1'CTHX5M03E[S2*@4]6F$&N.LDE+VDVF7!NR=2;^S(MJJE77]M19U*OZ
MS/X]%DE_D-C9<DUI<$-&SL"IJ_QW_W?F1*\UG7R<;+[)FG&.\\]A?JV2T\55
ME2T,./X Q57G<940-'&5$#1QU?E<)01-7"4$35QU/E<)01-7"4$35YW/54+0
MQ%5"T,15YW.5$#1QE1 T<=7Y7"4$35PE!$U<=3Y7"4$35PE!$U>=SU5"T,15
M0M#$5>=SE1 T<940-''5^5PE!$U<)01-7'4^5PE!$U<)01-7G<]50M#$54+0
MQ%7G<Y40-'%5%01MN44&H?]5HX7=9D 0GSO?.K?77>E2NNE>=__XW+V7-$66
MU*;:W*J_< X%CMT"<S-"K&S?$E)LJ:4.+F:V@TOO]DM."Y>)[U$,-X9.=3>+
MPLCVD"R;]7!IICU<M(LK0Y%-O2D;N_=6RQ?2O;556GC=1FV5-I6BJFG3YJV1
M\F9XFOJ1U][(?+N]41;9D"'1]+R!.T-*?/<#?/QFC6*7FQWIH"A"/X1^5%P_
M6H?1CX*=PHR+*ZW9DEOMG7M]"Q42*K0%)F$A'6HOZE (XX??*J),YL65JLM-
M0UG2I0]"C8XO:T*-N!I9U5:C%G:4;LF690D]$GI468].;5;2HVN#]IB&W-(U
MX=$)%:JX"BF55"'KXLI29<-L"@T2&E1Q#5*KJ$&P-%ZI1EO6FE59A H?Z_#.
MYWGO;;%VS156CEX8SFQO0+"=>(@2(,VF($CD%PD&3D@_]J?(C=58Z&\=^,QW
MA<>F&#DMX<_^.$C5UAP'4=U#5I#AS2Q C8-A^4-V-$2_O&-,Z'*^#(L>$L'Z
M>65HLK7[2E68I?M<QQ9T+Q>$OX;R^1__IZTJZB?!V;/C;*$57]]@Q5^V.G_:
M[HRL,#K+Z[=Z<:7O?B0@1*_ZHB>,BN"LX.QI<;;0<F$<8+G0Q')1$]$31N5<
M.5OH!/$01D4_':-24M+PB4276 !#<BA_04Z L%(T)A*A\44@P&1*O-"F4C1U
M[=4=O452\<Y1)/SYV08-NLY0O7 8R;BX4F2PZW++.*,\L/.6L^U68L$=P1W!
M'<$=P1W!'<$=P1W!G=IPI[XI$ -:EQEG0B3[U1M"IE^)[4;C<K>N.70[#?$L
MNG5=5P][B*VK>7&EMQ19,=62(D4G%H8\/2G;*80LN".X([@CN".X([@CN".X
M([AS_MRIV>DJ;IHN^[@QFM^/DE_X.ZG7::J(9PGN".X</ZN\,_S7+(PFQ(O"
M1[\#E, GVNYWVQGVO&M[ZD2V2R,Z_<6(SCW&UD(G(@\D>'8&A,6 [LG ?_+H
M4VA64.$*LQ96F,EJ6Q?Y"J<AC<)6".X([AP_X;MREKPM+/EI2:.P%57F3IEY
MW)6S%5;%;(4X4Z=GZL!%R1XPCF->OV1[0\D.0Q))TUDP&(-T[(0T<$9:N.(H
MO;7+47HG0_JB!^A:\^*JK<KF[HG?(A9;Y>57<*=ZRZ^ZA&>Z>1E5<9U/EU%-
M@654UBVA\B<B5$+E!7<$=PY@D)>0<0]DD%5AD$]*J(3*5YD[151>VP3%=Q\J
MKU5+Y>N59'%/7&(S($0$Q\3926QG+HT"?T++ ^+(!5Z4E@K4*_WBH!4!.X4Q
M](LK2Y$-Y8Q:99VW:(E3A"ISI] 2N@F*]SZ64(,NH4I5,(:%4 F5%]P1W#F^
M0=X$%'X?!MD4!OFDA$JH?)6Y4TCEM2.I?*M:*E^OA(PO?C B3C0+:) ".W4$
MSB B0Y:64:^,B]4M\ X'O,?Y4;R1@]:^N-)ES5QN9+QYQSL17:[RHBFX<VPS
M4'8OA7468'FMM"ZNVKOTAA4R)#1<<$=PI\K<*69_=\$1+VQ_]::POR<A0T+#
MJ\R=8KW&#ZOA2C4TO%[)%+_;CB>!'-#&H=A*%(7"'[$"D%"*?&EB_\L/$&#1
M?_$P.C'KA\[0L8/7>F53B'"KX([@SA'W]<'0BS8J:D23=N==9PS:W:A#S=FC
M_Y!8K[P5"#LG[K  "7$2RBZX([A39>Z4LL4_@"G6A"D^!7$2REYE[I2RVS^
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MS%.JU3(2YLG1YAUK)8Y FWJ.-I>+-CNZ1AR!-C@GJ*E6VM4<;RX/;W:X 8Y
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M):UAZ[GUD"ED2F"![L:F[4(UC]5<-BHE,$2/1:7,A60NWQ3%PX8MP)_XJVO
MD6D(\,NT1-\@@>W6=KH!#+M1$-X9VHBL^ELJ3CRJBUFSB>*ZUMZ_=71NLYR\
MR"T-U-C., \-).3(<4*!^5[(<6B$(!>:NR.K0=4:&+MC>S:S<3WV^.?A96V7
M3A6'E(MT";)#!&Q2@=DJ83_:NMJJKJ>$YZPQJW(S&19L97^MW,N?000XJ&KL
M0 0XE;?_(\L_Q9_;.-&(.6.##S&RYU1*E4O @R0@>5+<[Q;HAGWX /3%%QS:
M01]_U5RF VW,F>62XH@C"EVXS/01CD0O P[]./+ :$@M%X[9P8^#A.,;(@A6
MN+03CD'-$21KPO,-$:1>N*ZUUKNJG%*X)O($G]5 G[D8C:",%J+;F7'\4!\!
MG$N;49&B6-XPF"(%EVX+IV2UZVHC9A[@8=&.3(Q-22FJ]J%1<H<F\(8XV<1&
M66JCEE:KC1PE+P0E=^@>;XB2+6"3I9K:2*U^ZI1#?,YI5D_O]K;7?5(&MTKO
M?[I_=N[_Z"F/G:>>PG\?*H-[!<?Y[*-XG"WEQ$/F388&]B83-O8&D]ZO\52S
MGMFCYK&!A52%_\?AT2] &I;G/C)L43/V0'6'+T"77_X@<F4<.>$XK':"-BGO
MS\#WY=,7AE1I:@CO@TMM+!TIK[-EB4JG$&K;14*.S)GDD/M."7PGM"X7KAL)
M9K3G,P&/PY7[WI/2O^\^]CK#GO+IIL=_^PR?D7ZA=.YO^"^]__N]_Z-SU[M_
MVCPC\-P3-E.0#=M%PU'4\@#+MT&O'SLX:>>&\9^!PS!*EYQ6DVK[[0JH)^6:
MVJRN-U;*KEC),YG/0\[L.R8YXS12!?FD-H_J=9@C:!8Y]PXG2\;1LE:XKE;4
M>DQ$Z.-Q[@MR VW4P51EQ)X-R\(XE#U1YH1@YY[G<3P5OR41)Z;).I:\-M56
M=3V.GUFBS',(W@XY:]4L82=&0*LUM5$Z(V4_Q\ZWP\Y*)4O8B7W[2A6U5#XC
MA2;W-QVET#!+WZS*O&U\.'-@^H^WV__E<*P=<9CW95@M,,!J8($UU_N;9)9A
MG6WF2,X-<FZ0:=.O?8:F7\X-<FYP,=P@2[9VO50Z0UL[3^$[$EV'WQ\>[GK?
MP+CIW"DW_6'W;C#\_MC#G#XR?F[O!G\I_?O;P>.WSE-_<+_1>UN-RU2I G!U
MVQ^9; WVL7Z,/=T=9_&N#];8KTLE*#@-3_<==/A[4R;,9&1$08>_8^(L61-]
M\9!8$WV'!C#YJ2?C3F>0*+Y=YLGQ&@^ 2O<L:8RQ7L+4+!!B,7V0]F%=:6IT
M.>9>&N;N\.4<B[J5PG6UK9;KZQTW<]3-4?=-$T>.1=TJU@RHI9AN 4OG<IF-
M+W:K/F-[QA1/^[5>A+MOV"YSF]YDX&?25'\'K06/^ E/^% 2JH'YK=9;">LJ
MWR_8G&/JF6#J3BUE'577L;%>N,YQ,<?%-U<[CF:;F"&DMNL)1Q.EX@'\S=-&
M)H.?NO%R_=_TSSN[\"HQ#E*Y&+F,R*:PN0MSWA]OSFF93Z"[:6- 2WCW I4Y
MR_;@Z9H#'UODQ7IV-!/4/8>Z>(*JYS+9;@4^=SW-8]0[NYCYK9[)B21=)B=C
MP]+AKR_E%@B-T]#E8^?FOO>D8N5:D;*)AM^_#OLW_<YCOS<\O^UT!_?#P5W_
MIO/4@ZT\P0^,&@R7(@5#Y1-<]M2__]Z[^7Q^6SQ73-NP[M,L9NC/YR:Q0&"'
MP_&4Z3X?^7-O6U=D*O>M%^9ZU)S*TI6@ X@2M@#9?@29!7@,HOSMPTXGBR5,
MJ3;>8>'QO/0O%&[_\@V'Z0J#GW,\)SJ&,:@ZFF$I)A;]X&0.Q9AA1S$NS,B/
MH<WA@U^@B'G,7"C_<;CY7%\:M=V3Z^B(E74L_4ZNHA]9Q'ZZ82/4#9N%ZT:S
MN&[%* !9$WY1$VZB=I)=8'N;<KFXGF,<;@,/,-E6ZB?92AL.I%IL;]Q)U(&V
M8)KC8KXMH.H-&[/9B#E*M:PJE5*E2O]6:-_P"WSH,'?.D'\ :JIPO^8IKTR9
M:CKJ;]PY1RCL(B=*]KBB@CJA/9FXS.-<:V;[0#6ZSY17>*##QA@9!H*Q%-MW
M:$H*IAL F>C*2#.I"ZX[90S(R,<NBZ1?^DA5<VV!)H2*GS@^TN0O[+2(^B;F
M&0,8G,UJY$QSG@WKBALEG &(CRCKH;1L"F>,$0VL\!3*%7D*<&38-Q@ L1&9
M7>I6N8K/S272[-_?KEJ:7WT7)P.ZA-*N@<]$-/<6TO/M]NG% X<:8\*AW/NX
M.-D>DW^['\*7 H0OER@:66_$H#S?R%I[9,]6$,] 9"(1\,\B(WA,,?K!0!QQ
M S,$\6[N.^.IQGLJ_\GPB__49O/?E3L?<+8_TYX1=^^,F0%XR7%:+.&5H7'C
MCAUC!)#7E!?-].DIB5A*<P-+V?L$5@_@!RZCXV(%]KZ0#UE-N5RXKA37.\](
M3G.Y9#5D<X_35:5T/%TULDE7E<)UO:$V8N9T7AY=-3-%5]@4O+B>(?B1Z*H<
M(:N9IL,9TY'!,?MTFG#"FC(2QZ*\&MX4_IYHAG,H!K2V8P"WIT@CZUN=R03P
M&'0/=^B/7$,W- =P&H[;'M.GH,O]PS8L[P=<[CO[=EN,(  V_6X6UP.]@0X'
ME(9D,]3  E2^V98QU@(R^<.Q_;FJW-UUE;]Q%<H+7\;EHLT_?+"5FL<SXG8V
M&7&=&KRIU5*,J$W B=&RP/2, UCR__4!T8R1\K7XH_@&[+=5RA3[;12NJ\7U
MW+;+9[^=N6.82KEZ-"6URMFD)"PFKM742B7&7[$7)0'1, Q-'$%+'0-.&JS5
M/^$1R*[?BJ8JF:*I5N&Z5HS1)"^>IF[9R/$U9[&DT0BJTG">P S^L.%[C(&A
M>P/13'@_$I]Y=?N9W["1U[=<S_%I]J$V9AUZ4>+3Q*JV]A9O&5*-\($JCJ8;
M .[G1<09.G?8BV'[+HAM\H7JPFECSVGZ(E %?;PEOG?N:'&/_KU0T:T<PVRS
MZ9>IE$",UMMJJ12CQVYFMA@5-AF00G*S\ V8:*;\+17,N]]"=1^'6I1-9J&P
MBY;L'J7C&/^V+4VY,;1GRX:]C97'@"F1M90<,1K;$4,.]WZRA7^?H\4WYDVQ
M_5M@2R9&@0K6$V\)MZ $60XZD8<;2 &T&+>H_,5"7[IF"8\[@@T][<BU ],V
M?9A$)B/=&#BAP-+=1S9FQLL!M%!%A6*SDHY[<9CNCSDC ?P!M<T$Z$C0XP7)
MMK?#1Y36"8/MW_J03E5A?0@*?R5$)=Q(>$X[/#F AJ!E> N<LN5U+#V(Q.V=
M&1<YK#H>UGII?Y0::3RFH#\BR) \:8@CR3D0;6!8X.6W@+4 0A"&753-%B&K
M(I<.2+F+18!_:!9IRL*G?I1.E$U73H4R*<NULEJ):0AQB%849TV^@2+4SI2'
MI@)V?+7T(3WD*=)(.YM.FDJK<-UNU-52/4;3/8!"HK[+-R",3+E9*CA7IKXE
M^6.OA-GL8?U@[-D4;>59#&5$>GG@^MJ)8UJ),0$MWV/CJ<75?"%_,3'E\8EB
M(R!KR44W6A#](/-,2D [W"WWMH5#(P?. [Q'_!'! _')K<QK'C@2,Z2'IFM;
M+O!WAZ:"1FFJG#2%OXJ-1X"FM@=S>6;-!KI"OY3GP#GR^]Y$RFP *&5,I0M-
M(K,D#"HDLBJ8X:48I8\G+%Z\!.KXS[ FI5)311[7&BURW(E2Y)/&7>1AB)1(
M\ C2RY+/*T)F%<R&5!O;15<R,DN?RG84#+VOR*IB67-,9&!/:LHTJ4AEK1Q*
M+<IIISQ&.'0\ZZ$Q,Q2 H,D6,1%\59J&[M28*]JSPR@KE"<\1&_]TW;G!F:#
MHX7Y)]-,_)XY+\:8N45E,.%X9>,5@&HC6*T>D8G)\&>'G^==4R6JM3V8,?$H
M(JH)<YRD#H7V#L?/^^ZWCOO=-(13NAT0"?;%CM"!"H!!+''83#-HGD R,&4I
M@Z;:0#"M-_G8DZL(0JY5>&.$N<W9X!>'F1HF+/_^:NC>5!9K1FX44KT4WJ*-
M7-L$V&Z\95,)V/5_CYS?KC-?.8:B+KK$Z+^X7#P0H\&JM4FEKE='>J7&6I/6
MF$UJHV:[4I_4V[5J^_\U03\5-TV=L(#TF5V-'*;]O-(FL,,OFOFJ+5RL#8WJ
M4Z YK9S7*J@W S0#8'W3PK83K?Y^\-0;*D\#9:F@[;9_W[GO]CMWD=*V PO!
M*LW,U27MB>C5PLFKQQ0\'J6L_.?_:E7*Y=^E[@T*,#J>UZN*XM7#&X:*Z!R9
M''#KKYIKN(/) _!JK$K#3Y_@(5]-T&]#KMPLB(09T!\[GO@,7P'/TN9XZH[/
M 'TZ3Z(_XM?OP_Y];SB4C%RL<86*X3OQ6'IQ^#I\=,P+*X430O^LZ]K0_@!\
M0"AC@38?-.Z@"CD!U=3U0+\ Q4'E00]X.OGCO#G<@%JK'@9@#:'JNE(+$9DO
MWRV,Y2M#+/$&Q;7CQ142@3;',T7@2MUPV-@S%PHU 0K^\J:@0S]/ER/!(E%X
M*K0A5]UL=@KVN:W1?,3JY X*84!VZ58WQK59Q=[PC1BW-7^;JP"UT*8 &")H
MK2I=0 90?BP#?K\!_>,5#D%5;N',#1T^^@8&A@E@5^F8_P%/80M>K(9__]-V
M?H+ZCP:G>(4X,V4^7;@&*%N6 (H\$*##,(T-;)2)-L:_-&&:BB,T>"C+ ^',
MHZF  ;KA4M(.?0-_4"M/E[\]<LPXZ@R#]V L(B+ J=@6E6_)%7SZ]MC_K))%
MS'52>V8_.QHL6/G4?8)O2+=RX+08YD[Q8&]XR4,/K['\L<DT1YDQ'79I <1F
MVDQ>I"J^">: BVW*U"A6AKE*G_[GRM$6\*")Z=N.[8[M^2(23B=%$-8VQYBV
MCJC%#?47S?7@37_#X7B+P-87H+<G8'XH,WBW<36S=3A7N&:5$#B\5BYR/41V
M6!8P"GB2,<'#<1B@M8_9O7 *,U<5\6X7"]QL%Q,?* 9NS$8^( 6=$I\NQT](
M( (F*A)U\D\=AB82+BB"(+;%.&J*P#JNE:.#A0%]W"<M>&ZR)8@H?3!%=-V(
MIF9P8,A,+]MR55Y$" ^4Y;$<Q&[$,.#%ACILV+3G0!H>NG>Q%02Z)$"7?Z88
MV*="IU_XC"L .(C]D/*-K^&/0 8&>R9/!:Z(65..>[BHN<.XY,(-$2H0N@AN
M)8\F7#FAJ -8OYF-F+9F;:W3C7%=23[RR.:V0^U/ANQY/9< V/@8+:%7H#.0
MN7'LIEVX]E[M&%>4>!Z5:X9]-1QZ(9V][P *,7Z!-S7<Z'?4=$T-G!6"W1&T
M-YQ,4;G%%_D.'6SX0L/B^R&3=02"0K3ZD.M3X3>FW&-B9%U5!!241[F4(N+7
M/WQ SD LA(Y(#38Q,N'LB.K$=+RD7L9=4>0A0'PP&:(3+\Y]V+>>0D]>TCA8
M#4RBEMHLE]5*3.>=;>Y$Q'.@ N FBG R!:#8;M(_,(>6OX:QI:7P;V4+&![P
MM>%SUG>%-8-M,-/6=S1'HL?;."M]!J[K<G:"/$:#_Z&P #[#>\( 4JZ>,%8*
M)RO1+FTHFH_+62)W)V!S'QX(V/M +Q^(=R=U4-1PQ'*]'5/CL^S)&3%X+N/I
ML:\@5'";(%MY;3,)22$#72[T@^)F\O4E=N)L! AI.)%S[H+ 3+QGK&NK'AXY
MR:YJO$.G7P[YM#(=X4'26ZJNC^N[%*AQGNCD1)7V0):/&C88 ^%@C8M(LJ\@
M _"G 5\O"700\Z\@6:?B#E  7)G+:9N$MU$QP>,.G"_L7AR@KAVL4"H5+_!>
ME*7!T] 5S[7<8"VOW,(ACND $CL+H#^+D42#WS_!&G4FPR]PU\PF=0*>;\*%
MIOWZ&2P6V#!V[W""E8L^5]&H#I>6HF^!R[6?$6.@T9K&#+:$6_/G0*OA9GG(
ME1X?M,0*DC7U<#.X :[$<0T'\,:471;P)-#HKY1^YV"G/\J_J_+35[;ZB>^N
M?@+B1GRDD'+ Y!==OD_Y)1ET@>9PCE3=X8B-R.BP9]\46A^L<8Y_,*Y2BI(@
MA"X<,IW#0A2D?@8@N/X$\0<5%T91-#*J#&'R(+8&'7GH+M2"I,Z,:.WC2 2!
M$A%L]^<(5:G$ZQA*Q==CM B>I.+1C#[+-V*U$JIHN%Z52])G'F(RL88)SQ L
M ^3& "@TA%Q!$.Q%I)?M(DU5,2B00 %VTKY^2'J344.EQT'S2:#+CWY/H,IG
M2DN.T+6"J;KP_=ZD20\ 0F0.4 ^#6QAIFCOHF6J(X36!LT!3_N5K9.P"N0 \
M-7.!EBX=,P+"XX877]$Z0^%@)E;F<4:U!6+2X0'OEZ;CAN>]3FUZ)HB/J:!]
M$+PFL!M\\IYO0WYCN)M \47Y5/[,O[1?X968#TZ>%,'@ PP5K^=  ZC,0 U0
MT)Q"M5^ST/-B !<0-XHC+C=_!Z,4%FC/0%L#-8_4!D(K6-6G"G^S#>K4<V!B
M8MC$&8'5Z;KT6E4R&VH:R2U;R@X6VT!C!G0T=7EY0+\F6+I@0%BHLIFXZ>AR
MI7Y,AP#&A%@;60N@54L,$*8%QVY"3K#_V0L^8*))2W-L.&-_ABZP,1*@(6>Z
M?^%^$S(ZZ<)8</*%(P('G]*)TN/EGO"LHP%D?A/P!C3VPV<%,%]#*3>H/(-U
M3.U7O&/!TPHL]FQ[7)80\P)P Y;\9-P#$\)0I-#;CE X.3$(OL-_CHTY/6<%
M+ZPH(&STH<C?^<HYZTQ#4.P?.LN8Q"&>)QLK+3'$C:3+\=(EHPBDP821-4!A
M?K#AI:>"GQ(R0_L571^V$S ,+CS0=0K,'M@?%T.BSY+++(,PP=*>65!2$O@0
MH^\C3QN*)NGJ0]^!='WM=FC&^3%7W)C()EW&!0-N94FUB>H\(4L,-46Y/!)\
MRB?\OD!Y%@40/U(+#7QB8)U<B3M4GD9(-Q/YZL ?#/+((?L)MBM8":\GPKUS
MF!N>Y%0H=B. G##8]=QWT*@,&)'T*T8!+I,^R,7(!15>&GM)X$MCOX#]N"3&
M?% JN#OR17"OR.[(V",?ZDS[R34=O@*Q(-MZMO'CH-5&Q/U%Y!^5NR0L+ N0
M"*[7GYG0V#E(D'F!.A1AOF&U9Z0Z(E)%S1D,.HL!X&#F"G4&C@N3!CQ-\G3<
M$N;^*1.0B0'[Y&^EP'%@%4?8\C+RNJ"*._R5SG*J",#!=]<4%'Y6W/\:-;O5
M#5M96I1(G1S#XPUDI,LKUFUJIT:GB*5:Z+R5SE-9?LYOY2[X*26%(0>W9:V7
MXZ";ER-$1 Z27YC!=O!Q4K*BBV&JF9.5%?X)>@"@BRHI8Z:1['28:&R((D%P
M@76ME,P.0C902<-3#GP36*/V:TS8-(E\+P"Z7U??2Q4!(<&@4S1,UAIA@)40
M @CHWTESF':XN:2R+G5UKJJ+7J&+K\Q[!>,4^"Z62]%7C^*H$KN L+--J;ZE
M=".E?I'OOS/LTM)JQ^0<O4$+R???'18N-=M;SHUB)OSI*BB3I(]$1%2H%3 N
M*Z6G:"+T^CU:4:H;FD<> ->4P=KCG"TQ5)M9IX9#-]8Z!V(X='/M?6@A1NRE
M@.K%90]K5L0!GS$Q<.Y J?A*$8LG[5=2N-8QX%5K;RFG/34UI+/-<N&ZV6IL
MJ5W/ FVDL]4*;+46%^2*4@K/2@=-&4U1E!Q"5J"H")3L%&B'RYHXF11X49=L
M.)[L2Y8"6MV&N9#?AP8A1:+Y-L0&Q(+/T=]]MIEI9$UM,@ =)F-!>M!>*3I[
M9,E+$(DB88UI\$P>UUD*YP31&YX(%8GMQ(9SC+5@3G]W*VLMDOZVDKB\DO.8
MIZ\?F+[>WIR^?H),],V9K)6-8!?$>"( 2MY+9+#*D2MA<E= @\=,."CMJ+;N
MD/,EL9BJ%J[;M2W*Z@'RN+2C-OC E>( PW)<_4^H.RR+/(QQR?@\]T-20( <
MF6]X$'>AZROQ'M&0;FQK<93^:1RSW 8M=[N*LSJ,0,2!^#R"J)MPQ?LJ"@&7
M+( $\OG<?6$=CWR[*VFTZ!T5JAN%+D)9'SB_HT66IFT]7Z&'.A)0HPC74D3
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M"<UUO(AG(N)%6$T\E*\L*H\!$W BW;XC=,VI&=/D.6.(OG#'R_"18*(;[L3
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M%8N/Y'H?''O,F.ZB"K"^/8V$WP2QGX^&MN<H9>@,\/V&AXS#YA(0V)C'&],
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M[@Q+RV#;/Z_\>1KYVUD@TU1*J#)2^<1I_SHD$2Q:,;!,EXK->(DIX(M$/70
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M'=-J9)3VNM$ON,VE(7M5>2# 7P*&R V;C7V-8EL9#8&?WH,ZHK14A1L.RFV
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M"5E9@7-66T+68EM"UL]%%'X0WYH4?*!I]BT/E&@#4^&)NZS_K2.K-CQVA]-
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M^^C8CGEJK*AX'/:LH^*"U1%)0(>P0EO"@A]TK[=@[(RJF4.J2>S3O\G@HLT
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M3#1?,]1.HV\DC=F_18TU4D)*^??S%#<@H@97)96+<7R3@;8**VXS1.FV-05
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M[_+CRIS 8C^8]INY\#'0$]L3N#-7:T>_?FK99Q/%=N*WRBE4UXTK16OPSDQ
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M"T80<I'E@!<0.A2A)>'/P9$(W]9$B4(PK45U;&*%JVN3,5%JSZG)0LUB9IC
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MC(;DR=Y )]=_XD\*SO>>"=9=.^8SG5<;HDRE"0E;*R ::AU22O&9]H*#I9*
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M.Y/>-0:?'WYMR"G=XFBSNL_87PXHX#<ZJ?Q]=M.U&&-0"JTO9]P[TIW[RKB
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MMW$+NVT0P)?>.+NNXG<WL&=7%WU;,VZVI(MY*,U:&4*TV\G2L:4\T'"('#R
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M,_$^PP3NYL1S&#XC8R"P%Q>^XR(X!/R^4>!BDI)GBXF##LYD3NNKYC[U!I>
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M^)U;?V.\K=4=1L-UL;DJR&A?FDT7/M82.+P'1Q@T6\?(3LP1_BW$\*SV+0Y
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M@N#NS+$C( [N%WN#$;(L]VA?M^5CR3-G/FU 9%'"-@6P 4*RYM>_F54 "1(
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M&F_P7_"Q[('I@1M:WS:!*:9A[.-G/D1T_/<+^?CJCV9/&4/DOIA23UE\Q7L
M0B6SZJ\4+I)2MA[\UT/TMT7+&MU$C:\U)@VJLDD<--R*HRPO,?_G4[0XH4=R
M\1 1[X\+#VW*!V_RZKW%>%:Y/3W[P<4*Z5>I5DV; H6>O>@1'HC\"D]:3]5]
MT\XNI=V*/!YJ,>4'6;$8JE=\B^C&6#-'^L-(,X@S=H9D;#S8KF:.3=?0W?]!
M:.ACD_/;[?VU9$L7TMI&5'55"W^/PBFHI;?O$R^870:CZS\3?_H,,O79CX>3
M,$XB<@]?_S0)AW_DU*S*E#WH#S*ZG&4_Q,<34,I3%-$H(;W!]Q^WWZ]_W/]+
MNOSV6;K^OS]OOO]^_>V^LC654F]%-^5>>E'Q6JW7,CYNY@C*"*^M4KB@%K'7
M-9A]T*VYV!]:F+(-T?%Z)-L-_9<W'";/"=@1,@+G8!J!)6>'3'^9\\$E+R*2
M%X/]GTS"UUAZYP?2["E,8%VC^/V'2LNPK/>*A0I $FH95PP_D&;B36/R(?O+
MQY$?3R?>VP<_H!ND7_J8/CTU=/B"%9M.W\=^G6IOU^W;BHT*/"VO2%^<ZO8^
M$.QOQ9_;6M]1RG^E]-72GU<]2E7[EFEQ/:KZY[K#]Z2UBW(V/:K$V\F.!<2+
MU/]4-\I;-HN74J)P5BOVW=9OJZ!'TV$90_+\0"))5^7*S0E&J,\(N<:AJN!E
M'9Y#"UE$4S2]QG;KPI.>#E6T8PE,NX%":LK15_ I>'O(NI+6JDF"RKS6[OL_
M4CZKYL;Y"JZU]2FM2D_^MRB,2\%5-1WDUVRJ[?0(22JNGE0A5$*HBD*E-RY4
M1L>%ZM"^;>LDYW<RPJ4LD@<=ZT_>BYQLN$_9)">\-RD(!*L:LB$&]K:)"<S#
M,@%BPAJNK.BMF-HK0I@J)KH*GZ<)!*8TCQJ.Q_Z0+)2G+(V3"+@JP90J_'X,
MIP]_CT\%!G$O@F8=5M"PA%*S9=,0$#2GR4\;1FTWS4]8"JBZLF&U>V#5V7NZ
MV1QHV$<\JZ.13UY0-HSB:EI0W-[ L&7-X1PA*+S<??+ !NSSAGE 5WH#W9(5
MWJ*Q#JG$DW!ROQ(O)D_A9"3YS],H?"%XY,*+72-(S@9@Q:8%"2?4Z;;LF+P=
M><*+[08_;4"<:9J?-. G195=WKDTPHL]+!/-SUD*@8!^X$TF;Y(WA)]&9 0L
M-2*1-(8?!T/RMZ$W]1&@98+:7#B\FUM6D&K4]/W 5]R.?\:L8OX3 7$BEXN*
MNGP/"[^L(9:3+KLV9[^*<(3WQQL;DKV'XPVC3;PA'.3UR%?3\O);3##LXBOO
M=CG?;4'<]NH-_LXCI)]S%='PU=UD%E%J9,-09;TQ6/.VUY<(=F[$KK22G1'K
M1=8U1;:[S,YG'RE<5C2 G&8@\.[X1F9?\FCW!HYNR8[K%J3QO0@5#L\]^]'I
M^^(>IS>P34.V]6-SSUX4\G8/;>NGQ&9W"Q/_-XEG_OBM5:IE7:2XI1O5?0B0
M/9=U=Q@<I#,A-<7LV9?1<GL#2\&*6%Y(G_TS1KL;.H1J$*KA^*[L'E6#H?0&
MIF7*KG7*JF$'CVH]'%'[("RJ\&#RJUSV[EJR\)L (;3(2/(#*4RBJLL ;R;E
M^^TE[*R6)#^6O"E\XQ?P^8Q,WJ3_Y*L.6&Z/-/=1'6#EA$[M#1 IJ2!Q$M!U
M@JN=42\W'.-"XUF4L#T 96"/0Q+'B#B2!+.8_MZ'<PP>\=.<N];7[_HJ]^Z;
M &CP&,&KM]PR#F'2^L5Y._,MP^:>5YNG9-X=&0?<$5X[]XM9@/R&ANN;&_@V
MMU)?NM_-&> Q]HOIZOSFXJ4"8+I%SM-2#K@ALS?0M'ZQ5C:_HTEIF5Z_ 65:
M'Q7N9+2RMK-2-@^KE*W>P-;[Q7:Q RMEZX!"88-06!N$8G>E;!]P1PZXL_UB
MS=W^E+)[P,U!&*^L8]!&E+)ZN V9$'P8:K\8>7 KY;6PH&>@IM=!#VJ(4+4.
ML(XPU&C45>7J789S2/%ME[\)WUC8@*5B279LL8PL(<V>B/1&O"B62("VI.#
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MNPWR;)AI@Q+? S.Y="R]JA6=IY9PDPCD*OLBHL2/9PM%71+%??OOFV_<,9P
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M#3 %=@,[]KHY'K!39/4:O(&#$KP7SY]0AV462J/(>Y62*8YYH!0KL@Y0#]0
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M8*>-8)43895-%[ [1RR.4"SGS2T[1"P4FD?O9K1[%I<;_Q"7&_4$IZI$H8&
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MP7'</2*V%2QQ,'A1Y>L?S<$M\WES32T X ;81L7[9MWBO6\6;--.MJF%&ML
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M*G>G2K4Z0+[;4^W,*^#2:$2@^PKPPP:3S\MA?466Z#(#2;S+(N2EU !_$LG
ME+5J-CPYL!5@B4WHM^8>+E2#4 U;WS <1S>8>"]!?4ZA&[:.P1JZ(A?J0ZB/
MK6^:CJ,^K-Y U63=,H7^.+[^:%>FJ;BI,?U?I^) UF8\CKQ@^.3'M"!'E@(R
MPTNL[,;J@<G65@U2)20YQ>ORK718>0LBB?FUE(U=+'9)%PNGDBIGX+WIH977
M<8<Q=;XOF'-+![V:.TL8T.D-3'=G&]EJ]MO6T@DFW:,;V)P*=7L#0U;=G7%%
MSY:'6^J3=3 WSR!2OX78GSY*@ NQOB>MDH[/K$U]_UX8T'E!YC2:I"=0IB8<
M!>)!USKI!D_1<GQ0/XN/_U3P])6FDA'MY+\=4PIGR*7[&:C2"+]JO8%[8K =
MA^'4EKI3'4QQW8['_A <JJOP&9FU;E?_V49BZZU8G7+^NR<O(I^\F(SR-+_^
M-21Q#%_(<O7/0%S^EA%'1S @U75/.E(3>83].&'-LV\)AQJ]@6V>-G^*;-@Q
MLV$'X6*S-]!*AMP)+A;YL,-*#D0<*!Y1.('?/4H^UBJ3>!;#WZ2I%\T"$L5/
M_O3<4F.[(3C6BO5^]X,P\F=O-RG)V<?2H(_?<[,0+=<VB^BH)Q(/BIQ$8S"0
MQV!/&Z^ '*W^7->.L:=(K!TXL78,)G;H/:9:'YQ>,'';7;8.YMRNGKS@D5 /
M[<6;) P7P4-D R\8UH)Z.J'(;R]0VQ7:A!'^)LCP;>$#EW%,9O$_LF.XS$Z!
M7[>X./C"M(J9C?JZI=7AH$A7'/3F<Y^\ZBHXB4$M&=(B\A?GS-8'O2KE8O 2
M'L9!0\;):EN1?.N")_>#S)(HD&:A-(W"%S_>]O*TNT'@_M-LWR,_C! "9I<*
M5I?.HG(=^Z2+@T1VXJ N6CEGEC"?#J9*W]G9:C7KB?19JYVM9I2H04/<4YL'
M=$;ILWV^6GSJ-#XE6$A\2B3Q-YKOS_/IF%%"+I)I3&&+0ZSU/K,,_OY#0%I!
MOS0MI\0Y,7L#P]D9R:;522&1JVRLA(+/?2XR(*_KC% ILF'N4C[1:M84R?86
M-H#OSK8VILT4191KBUS[L>4E&TM.1T2,_#&X7\#3OC<YLXS[(0LF5@< 8R']
MYQSI^16*@W90*?'33B2%)#*<1W+1-K-J"3>ZO8&M%^^$3H0714Z^A3[9%GQJ
M*0K$MN+ZJ,N9]Y/(>?T,AK :SP_H:-)YR<-VO47=C=P.Z8'!#Z[@>4 A C\L
MO5^V%+4W<)Q=BMI;'9Z)I,&17*I:O*>!"R7*\ 2''J6LH1:'ZKV!OE/?VMER
M:$L]IPXFKX!1T]FF\VRL2%OMO<_G.H!WT<IRAF]?HAR,WL#=R75J=5@E8ONC
M].RL\ET^23KV?Y'1Q;])%);RHXF##QU-U3Z*>%^P[V%34PVPKR785Z2KVB(R
M#"HZNRH<;@D/W=U0[$"%6?,?!8\W,_(<<RD,NS&%T>HH360(#NJ(5?!E"?\Y
MO8$MJEL$@QZC,FLGQ>F>A^(4Z:TN>%J,R^FM8#J*0\S-WM?^3TAWUE2=RU,L
M>6O.+%7!"=B&?8I3;G?- XHAUT*.#^>D[RK(*HZKUJV=89>[*\A[2#P)B182
MO754LZM$:[V!:LBFM?-P5B'21XYP_C;S'B8$_COR7P;9:7Y+GH%9AX/_@A]F
MW\[1&Z_"_?$;.P(_&)%@]D&W8!M,0@;_]1#AXU,6H _>ZD$'%#5MJ3?8G\=%
M\/"(C"=D.),@]*=#I&FT1&<5Q#A0>D:>IV'D16_YC+7T0&:OA 32T(NB-P1X
M]^A, OH-C\*ET;[CB>\]^!-_YL-70 :EL1]XP=#W)O2WBV7 (N E6# C39-H
M&L8D[5N>DLBC/YZ$<<S>!L]Y]:)1W%]_ L<G]XJJH*M<XK]BW+&LSNZ&3V24
M3,CMN !&A^-3%[2]1QZ_AR=]FH3#/W)Z3&<:U \2,KJ<93_$-Q'0>E.D5920
M7ANI=YM$H.NS9G9@D0JV A::1G0*.O#O.$1L/N27=U@-_!0FL(11_/[#\BFL
MJ@'\=THGF@9;HD>Z*D/KVR:L')C3Q\]\B,C$PW$>'U_]T>PILV:Y+S(-_4%9
M?,5[ ,V?S*J_DM,=0X+8TMPJ9^EKASXSQ#%;HG/NSZ<H6\W4>R07#Q'Q_KCP
MQK#8#][DU7N+467G]O3L!Q<KI%^E6C5MYL*6/]5Y?XUN7)0(!O[8Z%5^B\G-
M\A*]Z!%6B5;=I')";<WB^*G-!]I/O&E,/F1_^9C9*3^@%*1?^I@^*^49W.V*
MO:=GS'Z=$L)U^[9B(RW2-%[ZXI1,?2#3WXH_M[6^HY3_2NFKI3^O>I2J]BW3
MXGI4]<]UA^]):Q?E;'K4H=*H7<J6EKNV\TVY=3;%U,^1MF57(*(,R?,#B21=
ME2LW)]B@!$%F;G0_U*!;MYA"4S2=8U,;HIC.[5T[EB"<Q+72-XB2EB.38@V/
M2%^)]-5J^FI#/KH0Y-UF//856.PJ'_OR9[3 LS5T63.:0AIN>T9+R)^0OU7Y
MVY ]WJO\F;V!Y30QV^)X\B<J>JN8\'(XC!+PF-,B$U'0VYP-A+]D/TLO=7X0
M6.8+P10HI3L\B5\<+9RX9NC%J9;=+U(3/,:KY_?$8W9OH,NNT>YIS"+*JVS3
M6$1XQ(O)_-+A[<PZ9!O0[M$HF*USKY"^N>LL?E%#^#;=DA7W% >I"+:J4.A[
M9RL7RT T66\L:NZ0#C\^7+O8K BY*M7']9\)F&)Z^P\.&[VI%5'7'J.NJQRA
MP2M.*^OX=:JFT%G7)]G<)OAL]\BK,3Y3D<_TW2?KB>CK."FU;,@JK1L<A<G#
M;)Q,)&\XI'6&(@8[;(9M?AQ?PNAS>AB7Z5GPRZ:& ]M4UVFU5RV"M19EWYKE
M/X3>DQ6[J8:=3MN&#OK^MV*:5;-U!DA/?BDR>@/5E&W3;+6+)5SY UV6;\=$
M>"\NF^*2I*-N^C^\25HF[V46^LQ<<RX 45[-/"?OW/_AES +NY,MI^AL=QI,
M5# 3MX9N@IELL/F:K+A%F]\2;A)><R76<SCS)M*\NA^AGQE?\-K8LRV=Y-Y_
MNY7-/@W7;U$8;Q&8XSV^:\F:MG/C/>]9'2G@$+(F9&U7N[ZEK+F]@:9:LJY:
MW94U$9C5ZN++]<O7:>5K#I:K,7?_0(L3WF,5/WV/L.-M]D;Q%\B?B3_=>EA(
M=_-G>XKU<S5J&9F_3[Q@=AF,KC-*<^MW7>D-;-DYM='N@K$X_(/],!:%N]/4
MU@[V$TY!%9O]%H:C5W\B1I,WK;8SPH)@W00S+WCT'R8D]<[37_'+F=8;&)IL
MJ+M,,129VS;RV%8:?"\\AI40CNR4Y%M:PF/"(Z\&-\^8X-SZ38^JS_EEC-5)
MF/8N-W#"$V\C;S6MQ_EYRP3><F3+V$5_"V>\%?VEE+P7X?@B@7]0W"WAIN_<
M:9J3NSF]?^ [;\<_XZVESL);<$UV=A([X9JWD:]JMIKNAZ]H=84K.TH1EZ(E
M?"6Z+T7L0<&99[$_(M*#%_MQ#AA<!"*-6BQ&Y4](Y,]S&O.K%8<ZB69)%WM+
MG$01@!S.6C7$4U@]H,B*NDLAH @\.M8^<R8^X%8IH^WZ'PS:#F^7S(YJB<,G
M HE#YH:V9")Z(ZLXK64BX4AS%&7GV$%49I]GM>@^K-5\-MHNB%@&=NZKJNRZ
MQ:)1;K]/U&:WBNF$M#5HUIN1-AVD3<.KPUWR@1VMSLY^G1U5.F&I>S7%K5Z<
MR.>*S9Z;SXWC6TH][@*R;TV=F@YMTT$($:AJ0L[0"ZA)@Q/R!+;*$O'[ "G*
MBMV<PUWOJ-KM= N1.T>1VRJGQB]R)FUP,+LK<8W.RRX,QJT_DO;X4X3+9C!W
M8E;W)1VEG9]=*>',0EEZ)=*3-Y+&!!C+F]")W>NF9-.!W--I%/X"=I^1R9OT
MGUQ&SG279,[<^] D*R>(M,[*Z1<;("2@^ 3^ N1X\H=/DK^8 SW"'8_(V(==
MD73,^/R?16J1N"])_^PL3>^2A_\EP]E]>/UKZD=41OG);/<&EEZ#R@3? 32=
M22]>Y(=)#*2=D>@%MB&-H_"9CN!^(UX4(Z]:TBR$_^JV3$\!"5R@XM'H]BV<
M-4(Z!TAG]HME@!GI<)-E3)=2=!1*03A+"=N7OE0R('SCD03X$X(,3;NZ&:47
M(\]7E(5J,WJ'8#QR,C!A+;S/WIOT0*0$!0;.*1R/@6!2,L5_.,I?<-WC9);
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MG.$7<OJ_JKFW8;$KK>3)["G$=CO^5)6-T""*#"I;5DJ@&W/H($O=D-@Y&[U
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M=UQ=Y10G8BP[N];$M+:"N0XU;Q]J;NPGU-Q(O5%)&M#[\%SN"W;LEHF6NG_
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M50 >WGSO.C_G,@N6PFJ!Y4 YCJJN^YL0ODKQ6"@7D+E6V/<JEI>%':A4NRH
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MI+E1#JCUGMBV.SG5XT@>L-IA<7'JD>8-J?"&0E:C'(84?[E>72/,:BG>\,$
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M?./N=P9_]WUG/,5?\$M:@W2\3DH,/:>.BZ]COCL3=,68/PUG8^S40^U\ ,
M-D,VR.6/-.B"VEG"16,V#;K_X+2,8(X%7>J*#PO?X22?D34)7H>76'9\ 3@?
MK8219$.NP_,%-TMX$;?5X ]XH<&GW)#.8M\A^"W\'(Y<]:0C.O0,R]W#=UB*
M0HY@C]Y'6\$[5<&.MSAK0T[K,%5:CH>K@:.PE3/;#^+(ZCGDS>Y>E-@C.JJQ
M_1CYECT.6N1Z>'I))Q.#+ETH/=,X"L2!Y=!W<*:8G2%OI"=0I4[P;-@\+(#\
M\)[E"P0SK%MX'AJD^'AZ%FX=$(DV1P^=N5/ 3 _3/49TDP?_3!#=9=1_-C9Q
M 0 (B<FE %FQ\F@XQW>JU)"AY4[H([PBPO\%8'@)T,#7X)$J4# Y <IR"4\B
M= F12RXR_ 30G/"YPF+8(ZP5UXVA A4=,!U;8#3@A^7Z@/.X?&>XZO#//N/)
M+<=\+EBT950H"OM@2&B  \Q4Y$=R417Q&3IC^(28*#'6P\"0"@K!TV*1)8M(
M.LYCB ?(;TW*AK%47DQ"A"A?\C27H:/]Q7O:C7*MNOE1!V0_GL^W=WZH4\R+
M_V.M9Y(II^2B.[*<?X_S;AZ?P.@LL4VF:>@78L?WKF4;UI2/5R\]T?Z5?&\J
ME_C^\@B+QM#<;>J CJR00O=KK_OUKO<7ZY99__Z/WLW=Q>_YYT#)$O<K6 Z8
M_(Y;!;-Y[!C?2\D^WEQN6@L5+50.9%,'=&2%%"J=FV^=4++T[WK=VW[W-O\\
M*%FL=,83S@+9TG=<@4,OM&#)]^ZT8#G(31W0D152L%QV_G%]R6Y @?^STWOX
MO_?@/FF4HRD6] -."O?ZQ%W_/PD2);52ER3R.J#NN5E)":E6JDO@?4&GW'P$
MBIKE>F,_G6?;M7*C>;9[H$CK*3G8KM93<K>[0NHI-YT_P>B]Z*+XONG^X_KA
M(?^&4K*6<L.?Y"!EW*GX8?G^+J9O/E&ZT%PHZVBJY631,32?NRNHG/RCUV'W
M9?9;Y^+NO)]_[K-.2,Y<3MODAC/PM',XW[O;09@L>3VJC3=H JF98+Z9X,6O
MO>O^P_5MEWV]ZUW>'6R@[&+D6IZ/#2F_P@DZS\3(GJ><52AL)HFL0TTS&\UL
MWIS9?.OT?J<BLX>[F_MN[Z C*"L%=3*C^LJRN6U8?!RD2:<Z?C"6O]TQ#&<F
MZ]!6$KA7ABX= F_3:J+NLJP7LX?%?!PXYAS^&?F3\9?_!U!+ P04    "  <
MAUU8P5KLG1,?  "1<0$ $0   ')D;G0M,C R,S$R,S$N>'-D[3UID]NXL=_W
M5_#-E[>IBCR'[;7'M=Y7'!UC)1I)D31V]M,61$(28HI00'(\VE__&N A4CP
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M3I2@NFD>XXRQ;M3PMROQOVNCL7'R&X: -#CHKY?; %NH @_; _<W\7E[=D?
M49,*P*WQ48;+3J="L.C+>!PK1M=\;'4GW7YG,'HP)]U!7VV0<U#2L;[)CK5
M8*0PG-"0-P?]\:#7;9F3=NO.[)G]9GO\I=V>C%45O Q<*H2W,/)C&#:<:/P&
ME1'A,D)D9WE,QD/$H%<+[!/@<T_A9'%))?5.75+&SQG<?SE1R8TG\-^'=G\R
M'G0&P_9(6)4=IE0)'JG$WE=);(/4&'2,#=JSK#K-P<-PU/[2[H^[7]O=/ORI
MO-"K(Y1*[Q=UZ67P&R&!4Y?CH-/^QV-W\OL>DDM02&7U04E67%0AQE,7#I\3
MYOA+IS?XMJ<]W*"1"NECC0D%6 V!]BRIS1#OZ7PHX)3*\'87&9ZP.](W)X^C
M]J!S]SCN]MMCQ<F6@Y+)Y?J*[Z6(9SG4"QB&/T(47 XQDA,:]?'CPX,Y^GW0
M&7?O^]U.MVGV)V:S.7CLPP[U?@@*V^RV%66AB$LJH>MM"46(N8A2J(T-;B-&
M?D*2&[6;[?3X@DGIM\Q12U%8Y>!2^=QLRR?$E99'@NV$!!);#W!I[[K]<(L"
MHS!J][C)-YN3[E=E)T\1EU14;[=%%2,VTI@-0&U$N(T8^0E);MR^YVOQJ#T<
MC+CZ*IJ[;2BI--[E#%N(PDAPG-"@WP\&K6_=7@]T;S#YTAYUP1KU[[MWO;8Y
M'BO'\Z18I$)YORV4&*68%0*IL<%JA&A/2$[#$8^X3'Z'T> [PB%76#79%$)*
MY?'+MCQB-$(>":(3DD!SU&YU)QVSV>UU)^#DP#CT!Y/V>&C^;H)**FYO)$BD
M<OFP+9<0H[%!*00DD!H1UA,2$C<XJHYRU%8ZY!^WASP$/*%1#0.$$_.?JD.;
M!I".[^WV^(;0A@ _H5$>3P;-O]^!:K5X>+8-KJ;Z868)K&SL;W+;<(&H(3 9
M:52G)(?'NS$L<+"ZM;_RV)#JMGL+2CKV!1OL&(41XCBI05>)6@RI0RR"O4-&
M0A*<%0*[O7W_[MV'/2(BQL\QF5,*)JH)8(*FSF%%&F&4"C070JDCT)#(*8E3
M+1Q21YRU,$K%N4>8Y13%N1TYJ34/BV&E(I+'7DY1$K+P21W)*.*22FJG@,PI
M"J\HOE)'8!7P4B$I1FE.42R22$L=":FAD@IKE]#-*4HN#*_4$5 &0BJ'DGC.
M*0YU*DY39[SS8-)!KPSRG.+0%T=L:OE@51AD OFH'/DY1>%LY[.TL(^(HRB7
M,F"I2'+QA7Q.C/%SA,TX)7&H[?K'P7*)V)K.^M@?X2?L!KB6W/:F(A7P/O$&
M:!Q2-NC, -I&1#S1B+-";(O*M&U!$#E=EY<X$$Q?'T$GJ@E)U2(7MZBE%AOB
M1IKZ62_*Q659-'!];XC6?&5#K@W?L #;[><5=CWL'4-%5&E*M24?0JFE+1$?
M1L2( 9P8$2M&S,M9=^I-]9N7LBDWREJ2"]\<P*;<G/6BGKC>OI1>O%76BUS$
MZ !Z\?:L%[N)ZX_K%].,/Z[/NO$?H1OO7LIFO%.V&;G Y0'TXMU9+TK%-<(6
M=2WB$,$MG74HPV3N-@/&L&NM)PRY7MB3(^A*?>)2_<D%7&OI3Y8AOON-6#)B
MGHP44V>UJF<%WK^4N7FOK"ZY4/$!S,W[LUZ4BJN%&7D"3I^.LO$MP"[3@-M\
M;+J.!J0HGJ5>;Y+^\E+6X!=E7=@GZ:[,&OQRUHM2<36IZQ-W#MV$3QZQ,3N6
MIR&A)-6,_:+I&^I&AOQ9-4H%UD&$?45.@!\PXD/.K]0?8\FHI"-5B_VBZ9RV
M(8@;:>IGK9!+B\Y:>.H?4Q^R%*2:L%^D/*4)L.?@A,]*4"JB-F(N6%-OB-EX
M@=@Q#E[+2$C58+]0>$S6 +J&('Q6@WJ^WH>7<BH_**O$,2*='\YZ42JNK@N;
M,9^OI,3]&R6N_Q4^PL@?PWN0TI)JQW[QS@U]@[B&X,"(63BK2+T9_?&E3,='
M9>78+YA9;#H^GO6B5%Q_Q^L.<9%K$>2TD(_HT0V((D6IINP7QP0NC(0-@_-A
MT+,YJ1'4G&'&L!UER?%#A'G(PE%BG#)B$F5Y?[5OR#-D($D*3+%P5I+=Y7;8
M WH5<F=%T5%1"GV&VY=R3FZ5K<@Q@N6W)ZD7:C>33<_#OH=<NT?0E#B$/T4!
MWP5+;-=2CH-1DVI(+FA>XXXT:(C@0.2,IG@P(B;.BE(NNOU3T0]!2*H>^URA
M/Z>B'T@OZJ43'X*05"]RH?0#Z,5IIA/O(:YZZ<2'("35BUQL_0!Z<9HIHWN(
MJU[*Z"$(2?4B%V _@%Z<:,KH5J65>IN.$F"I_/(A\'R=EA,4AJRX"G^>V X<
M3&?WE-H_B./4$M?NZ*4"S86ME<JY@-PCDOP,/"9Z%GV!; H-YD&E7TE!J@"Y
M:+2B A3;XK,*% G(=0/DF$O*?/*GX#6>/8?5 RD9F3+D7]]0509!VDC3WEB(
M4U2)HN)-&RL]#-\G72/7;O\[("M^*%Q+%79'+U6!7*BPI'14=@F(28H04$+T
M+/IHM/9?!&ICE0HZ%_$K%;3$U)]4R1%)S:_-)*R=\[@39JF4<X$[E>)BV;E]
MLBF.$HF$BUZ?^CBJF?" _(")R/<A!:] 1JH%N3"=FA9$RSJGG=2%V% _ZT2!
ML/8V]/L0D.I!+BRGJ =G7U_5_O-+J;8)SH^-;?"%1MCCCPS:'<(\OT>PVV08
MQA)^N0\00ZZ_-N<,X]H.X/'9D.I2+I2GH$NPL C.C(@UX2[&S!F".X.S9X3\
MB9]C#HV$Q;/BY27^@-B<N&/H([+O$-  HO@),S3'(\XY7\2[KN>SX-"ZMAME
MJ7KM5!6U883<&"$[AN"'Y\?%'!F"I;^&/LV&J[^<5:K(B+B$LG F=I 5'>H?
MUDQ549"J2"YVJ>C;"JJQB=G0/>M 7D(C_$2=)^+.CZD&4B)23<@%,=4T(2%\
M5H;#K#$ON:JHJ4;^):,#KB-G)2F:S!;T3?AWXH:L3X?LR,M(39)2E<F%0%6M
M"6?#V/!A^-00G)S-2ZJ >RW)9T&DDLO%-.,2[B<[VCT,IJM)O7HN?PFL=/QS
MT<9H_.$#QV5P9"<LC'&P6CEB"XN<)O(6'8?^J&<)%?!(A90+!B9"2N,U.&)#
M8#Y+3(S('7*0:^'Q N-=9I,,E51NN>!=L=PBW(9 ?L*BVP2JZ6RP$E5<W#ER
M[?#R'!8&:0<QUD$K%6DNAI:(-!5FIS,C(20B8A&IR*:>):P@"M4+6[L@/DOY
M2%)./2?3=4%$N$<][P[/*,/AWQ/T7',G40^E5+*Y(&7F]1I^YY_C-'[F5/YB
MA'3B+P6ELURC08]*S.\GS#P>J01S,<1B"0+FN K^J8MLNQ"LO\!CZ%;@4[9^
M''<P+YCFC)#/WS)HSV;8XA47^=\[S]3]*4K5H/H9JJ)BL\"$D7!A/+X9OS$B
M3GAL*'P_(6%&?'7RDSV^9 R3J>C*XJ[JH8A6I@-O<Y'"+1U([DAS8U!RX_'$
M);Q_^H,J,JDT<T&\+6F><QJ*!/CHLO#B_Y]B/MUA%PC5V^TJ8Y.*,!?-VQ)A
M&KV8E!&!DQ1B\:M_]6X%5:*0BBM?8+/TY<"S?**A& 2^Q]-P8-,W6'%*?/'Z
MAAC/>*E9PVAW_%+)Y@MFEDFV8:0H&A%)L4K&1,_"3T9K-'X4OLJD.SR$K(O0
M246;+X)9+EH@\+^1R\-IG*8D'^_&[7\\MON3]E=^Z:)FK9=B8*F4"NI2QIB,
M$-5_NS!^O7SV/J'5BH"OQK\)_W9=&O(NOH)O<!@&%Z)BMNO_$;X%X@]@N\8V
MX8'(4;@PT-3S&;+\SQ<SY'CXPG#1$G^^D$"YQ'%X,O3G"Y\% /0\90[YM,*,
M4)NS_/G"#L*JX?%OTS H#S_@*<?@!4"8P.81VMPS&JP^7X0-B8^7%X8OD(3?
M+"GH$&+K+OS"D5]<EG:V0YZQ'>Y,'O!RBEFZ@R&K8?\*&M;IDQ+WML\:_)-W
M_<FF2T1<A0[T,/"$DSBH"'W&VZOUA-[A(2+V[QBQ,7F>@&PPFOG97F;$N"LZ
M^5@0ER]R?DZ\ECCH/Y9\)PN&\0-U_84WQA98 GOPA)E+Y@L_*@GHSGFD83SH
MC*H58!=,6F@(2.H@ U ?CQ[=MQ8X<&P\F+6!P%+D=,=5T#WQ'O<$/_MW#K6^
ME\Z*6CB.U^M/?DQ%H=]W@4=<F,U-NIR"@#B%?L#E,IB-@2JQ"6*\ZI7U[X"
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M",DTK\-; ^-XS@_N*=J^AL+>4&C'R-RX$@&M=^25UG-.E148^M:1NZ%U:7T
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MYM[*MB ?O8+T2TL/MS!7  ^*4,Q+7L?5URP1)VBOT@9!!L]1&YUU:'TT=P7
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MIXM9F.=.[:);9YVIS)U(4A@!DE6#KX*&2.\@)&V23CD[:UOGT?2TE.-6Y(?
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M:-NZKV,;Y(]6S0Y(X'XZ 5Q=Q?5%+,:X3:?#3R-"K[55"1,"4X73$FI (F4
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M@3P$S=F&CN:7'W-\WR\CNSC%1^.YC-J"I&T35"YA40MH"VIO6<8DKKG\FRY
M;GG* TKLNB\GXSX$VL.UR%L,4_P\/LUOOGR=C+]=J<LMQ@BL3:V]U!J4FK<R
MUVX^/LOX8'+[(LI;X!R/4K26_0.IN=5,A" # U,B R6*@RCE?/ /N>A"%Y];
M5P0]BIK;GC.M^J:J!Z/S$@M.)IA?#T<UU7G>]YXLXB!QA1X]@V@C*;W3 :+2
M"(898Z,R,C8O5]P Y>BTI(7(]^F:_CK%<G;Z=EAPD VMV5=@3D5:MA4D@*@
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MO_"D;YT8?8P-%^Y-<5.QMFZR<8_$IO?CT]/7X\GO89))77U*B7N0+F/ME^S
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M^SA,:QN4^C2I5^.OE_/90@-B=?++I.E(#DQ5!U)K;5FLQ[^JU>3&YTR_[LN
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MWC18VX!R]#18"I4ODLZ$O"!&=(%YB!3B..]4+C%K-<!+[)/*X]\*_JXT6%O
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M W?#2$\:VQ;::][,##-,9Q\I(!Z]P3Q*</$<:]+RBOQ!)=J8D#,NLJ9))\%
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ME?0'TG8Q68<^XQVDIK][8EP0G(4"%EVMD J9 D\9("-CR!S/EK<F=-I-TA]
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MB'!\UMY'QSW*YB^6I-&+9::E_G+Z5_WN.AU9G"A!A0@\!4-@5+5O*<HZR(V
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M!.9,*#+;YHR,VV1YZN=I4UW?QX#I@8$WM?%S>8WZ ?+U*FMY1+8#%;@TL>0
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M>@5A Z\D? ZL%L4C!1X.IPC^9T0R-L;VPTG&QNAY+B1C&TLQA8]%.A]!>AZ
M]G,#GC964D]1H9*)<][\U7@2I>JC+#RD5'V,IJ>K3AXBU7,M51]EL6%ERKNH
M>\)2=9]$Q* @\5I%PD0!SS$!5\XKE!QU;$Y1.?-2]0X8&*/E:4K5$^<*>9+
M<ITV4^,[E+37)<LC]Q8QYY[^T=SJEL?8Y_%2]3'*[9#WWS1?SBDOF&7@)"%9
M18JQ?#(2O)/%)9^84ZU?\Z? +[#/B;^GECOD:#>RJ V1Z3E2BXZRU1!ZR5T4
M/16UJ"TA&Q\J^0FCB(CE!%A;GDO0F21BCK:])VO\\=2BS6T_1K^34XLFKK7@
MM%JO=)T@Z1($M!Z2=C%G@:B:TTH_!6K1438;12TZ1N$=CO][-5$UE1MBR5"4
MKV,:DH=0EQN$227&B)*U;DN<?SWH/D?_7AKN<,FVH3YJB$3/K1YTE)4>KPW<
M1<73U(.F+)(NV8%Q7E;21 Y>& VB%*%38IA=SP+P.=6#-K;Y&,UVL/6KB^4B
M+3Y_QN7545,T0VXB GDTEB)-QP%C[8]5PD:I@I6N=>7O71EF40XZRBZ+ADKM
M<'[7B[2ZM&MI,#J1Z62*3'!0WAA <E0 '4%;"6'+70K(O4U\6X(G;^ ]%'JH
MFFX=<BF,"] IB%I]S*$.8(0H*6*13$K-AXVV>THUW;O8N)M6N]?0K8^GR!0S
M64:(7M:N))DA.-IT>!$,ZVC?V'Q"U%,@@-_'.=]3RQU*F+9RW0Z1Z[D2P(^R
MV5#B[UT4/B4!?!%*T_Y$WBI:19Z'#N CU^!*499)CM&VOI69.P%\%QR,T?-4
M!/#7S<3*1!>D!_12TWICA("BT":HLS(B&YGUH)/_R3!^CS+&&,;O$9KL2I!P
M&8@F9]!D#\KE6I3D"KB@#<A<<G&*46@QC,G]"7 '[7)\-U#;%-Q!0^0Y"NZ@
M48I_C'9F%ZU-P1V4,;/@% $UJT3"<0;." %)E1RSS$F6)\T=U-2(8Y35U7C?
MZ5.RH<W<%PDR9CHZLJ2-)AH$J9WE=*Q0J+\#5\F<"&=&*7T X<P8C74]%+_3
MIP3#.+<^T:E?8NU0$K1$$\&))$QVJ)7?X62<$^%,&R/NIK')6+RXUR)%%D'P
MFFD/QH'7.=#!PY,-RI1L'FU[F#N+5R-#[JBUABFIU?+\Y!V>?;R\)(E<IB0<
M0N5/!^65!2=Y 51,%JM#4&I0XQU]ZHV0DW[Z'F[>>N!Q>*R[Z[ A)= W(:YI
M*P:(,2:E-,2D[5_/Q[W6/91_UWQ[:*[AYGI7'*FD1.XYF")('&LR!&XT:.]#
MC.3$63]H+M2A#;C%86UOOS$*:VRW7TE37RZ^7(^9#8+^K2Z6BZ&.F:5#(G@!
MWK&()29IU:"^TT<L=^NATYV->ZE]T4)G#=W2M2"7["W7K)I!NB \ Y,9G<<Q
M:G N"V!.&'*.;3'#1C _9KR;#WV"QMM99ZW=T=M9Q5MNUHE)R7"G--CUM)G"
M/7C#/$AN!-=!8BS#IF<^\)"Y-6[OTOO85)%=>(P&<ET4%44,UD*TE>/1A@2.
MW&N"<S+TYS+HV'><]M/A'MFG1[:+/;9N#-/U\[_+E8C@VW38U?GB]^7I8GE+
MA:=YU:^M?Z0 O;O[]]'')$W^,I0@1"W@"$(1OJ('+%*!XU;J8F51J35;U8,"
M]6ORSRJGP&B16B;RCU31@ ;IM"Y:.L[093;%D,<9-?F/L?WP)O\Q>IY+D_^&
M!A=>;$#K'!BL]"W()7AFZX2\[!4YVLFEUG!Y"NU^HZS[>+O?&"U/U>DU1*;G
MV.XWRE9#6KYV4?14("@I"!YT %,I1U6E</)!D9L7G16*HC3=G,5QSNU^S6T_
M1K^3M_N96(P7.8 5:Q(MQ2"$: &]UD8G&QP?E,$XLG:_438;U>XW1N'=H^-+
M$G25/8^>L$XG&_E&G(ZX(.CP5(G7II=D4NO^GZ=05;S/\;^GEKM7D]^HIQLB
MUW.M*AYELZ'5I+LH?,JJ8B<C(W0;8,@M*&D88*B$U-QQI7WVV'Q*Y=RKBKO@
M8(R>IZHJ?E7[83Y]R^%<'5DJ<J:TR8#*UL2<7(_5="!+B;[X'% ,FS<_ZK$S
MJCD>9:HA-<?[Z[EUM=4V2=^?_G5?4",B)L<-A+PF0*K9%"TEJ4<D:8V27@\K
MWAGSU&/&P]Y:[DP#=IL/10B#1<<:$:DZQ2R!,SF""TR&(+W180KB[>/S&IMH
M?")6]C<U7[^\)C,:(%\OCLA'9#L06V032PZ Q]YFF&CCN"4G"X6A<1%T#(;D
M1 FNUG 8&24JYR3B%%3K_6'R&)_D05 R1ONM_<Z?Z*,^X]^KZWGMTM*NB C(
M:AT/9MHG=4(Z1[VT,@BNW;""_-N?.Y/;\YV5OFBCL=8NXH?EQ>GJVCD)7K%
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MVB16_7:9KUGPA@C8B2?^4>$.0_K>Q)0#X+&_'0X"&%$$JI0*^" BA09<4&C
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M^(>SOE=_7+_4UJO_^__Z_P%02P,$%     @ '(==6+3NSO-H"P$ A<<! !0
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M=BI]Y#2N:N?=/N/'J6Y,[LV'Y57.#_Q.VNBOB4$% ]P9^!I2J+R#/T!DOH0
M"$'^V (CU89(YU@5.F$RSE7N4^P1^-YI4_V&D EG_9#X:J\+?2I9=J*]&:GK
M5ZW668ZETI^3U;A1G-6!5,@9)0ZV[@B?<9N[5#*T^]5L#FM+KR//;%+EQUG_
M^NPW4\4_' RVNN==>/+UF>3Z,BQ7S24_<'8#XEW*D;1VHMI@Z9()#^,!C53'
MISW45W6%NI],;;%+>B!Z_ @@' VLJB?!9K%[WG"1,DU$!MX^AY?[R)Y,O_<D
MJ%FG>O@B9US1_=S)6QT63QWDDUH2[9R//5F_\4:@\#?99&XY/(5HI@PO<]S
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MKN(\&XF1F#CB& YRP4U<9=^$I3F;%M0U(6KK(D_7F95>X#OO)+EZ=O](Z7)
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MX]3SNMK[_MC9U?P3ZUY\^D@#N+Y0 U_*C;,:KIP#F890  [2*3@U[TB1(/A
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MC*SI$BC1E9Q[%=X<'E9D.E>O^XH__.5:,["M=B(E3 9/&_N3^&)6C==L;2
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M_F;\S?B_B;&O$LK,\;V8]<>TMV):1=YG=U*':R% N/8/>Q;<Q/(_J)P!H@
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M\5^;H2O'EKX_ "_-=\SJ-%XGTAA2O+JKQ8GHI /=?<IS;L\WBB.C_YOUC 1
M@ H*L=Z5-YB&\PR\G,]^*IXERI_>/=).ZM#R?9?V1_$T&<Q/!O3^ ?T0YDNQ
M!(#>65X>9HG\2@ 4Y%/F):F5--BHFYM7R8X3 !6@.3\]F9JZ!>#Q__KV#:4%
M_=?7=/YR&?TV+H+8FT602_&2LMWXJ<$K!__1$^"#_P+O*/WO)_UD7CX"<;@X
ML(+4BI9%/%J-B\/G16+;KOC20I3OM'(>UTDF-9VY,UT2I/SN_LRQ50?DA=[A
M(!<C6,\^%J3?1Q#P(XN;JY;3:6W)LBY0CX<H<^_O9S6Q[!IV28F6!#['&^S0
M/T G%+?TU>N?IT$'C6!=:BK5#RL526+?Y!43;%')OSYP-M7-H9CKQ@I86Y,(
MM!9XW+RI=O\I,W4+H:3GYA>#@[G'$?#NY^4V;R5.XZHTP=8@ZCG2ZA-!GIE%
M13T!G)V$;<,)[R#S!+_71N]LNMEI"VI+/%?SKC]Z5#'YO\NV?VV2F9F9'/?L
MBXH*4]UFH^)@,EAW+ WH\=>-!C9HC;U')X12,'0Z9FHM.JF^J9'"42:L85F"
M;3M\+63$.\D*4^6N3>%6CH639N_V7*@HW_@9I6'[!L$F&^MMW$,(J.42AVI!
MR X<7^E2NN(6;U*7_YQ7;*T7N"P -GKKV-R!WI4T/FEN $IB[]_\[+I&Y",U
MBJ "[X:&V%&PVP."+&Q.Y^P6;IM5&F0,5>U6[S3K#L4C0)CK0=*^=]W_M,=U
MK0RAP2U/'Q\_ JP'UMZN^O_7]3^K_)3QH8U_>I.2MH^MIQGD>]TG:%7,YSD9
M8_#Z_3M[%AR!7::&Q%^?(^+.-YWB;OSUNF)@O3AS+B^8"N4WGFP6K8%QC)SK
M;W%2'Z\TU5ZGUXT.'6M/RG^>V6-C?WY;FXVP@5_$(?NI*Z@E\MP! >#?T!]C
ML=Q-4O2)E/SJU3B"J=)D=7Z8I.W-=MCJ.P16'Z(%IP]N6[@V?\]KB65PE;WC
MC/#,1\IK(UA;"0GU  $0AY/#A.!E^;W4:E6B&2Q.;V":X:4C=UN%;VW8>BTJ
MM AK1C&LG'8T&)CHWSJ<5&G<HUWR3L)V#?]H* L]+]W/79>+@PV^S>HWX4@)
M]G":8GWXAM3MXV55^V"";4/@X.MLZY>AYY\]WS'_FO<.(-8?Q0&$[7#_0\0"
M!S'TQ\VF\.YY+X]EH@)!&]:?N^\ZUCJFM+6F]N>'I'S.!=R)? 6Y1D5'U2.)
M+ZZ_S;1MO^.W3*6GHZO0I.8M!%.X"5)BX)/QU4PLW:B;(DNP>L82*[TP-+N0
M[?1GSU;R[I<ECH[;:N]O"EJ?&2;&-GCY<H]U:WZR'D"1@E#<AW+= H"M$83[
MN;UX1K^%J_DTZ*<;5UZX>RC8/$BR]EI5H6O8\#)13YBF5T*##Q&V"X"]CS'+
M3S%SVZ%NGM@# =#\6/A@,I(LX[K;T=^48_D_"_ARZ#7@FV 49R':Y/%OKM]<
MO[G^S^*BO.Z'C5!<56&(PI>(@GIQ\1B1:C7+#@&@:F5[\O#U@EOOI^ KXB+2
M^V#4:SV4L<RM.)$;J.?@W%-J !H.7(;/8&!O=;0 B$?JG]4(/M&XFW"34FP!
M\.S<U(?+(,RF-=5^Z*)E-ZVBQF'@8*1CYRLCWRM\)?LDS)S_KQ=_>;4"0((R
M-<44 /B9AM=?,:R9NJG:MUVT3.H3$-ZX\A_22<9"O4;Q&)5P-<MVM*J5Y<FU
MM06Q[[S@!!% ;5\'^K6[^/9;-V]OC$8->NJ;_W=;D/[.#L!@?B7X=[;X.SL\
MD-[RF^N_"A<E%:27H&N[.U$QS#G2> ![T[/:,4R04>H4TTKN#!Q),"HB](4Q
M5#ZOMQ>1U-I<M^[+IK87FA>M;R&UU!JDPDGC*B)G O^U,JEK6:DJFUUYWB(H
M5QSRR73$1>9XDO5#3YU[H*@]E7E2Y;2^V?KHHAZ0CO"6UU[G2Z#D^-.8F@_)
M)::T2<=YL[Y^55P!/K%=&90.G5N4RY29FGJ<:CUH\R+6@&%R6HB)A@Z3Q]%S
M(%>NB'WV&:Q$5^&D!;@^?W[K.*L_];M!M0!(-GT.C7G&]Y4;O&2V/?$?3R[.
MW%B^<N7?"V;^Q[GR0ADDU.SAFIKZ$JSFGQJ;WV93_],J7[0R4M796AM'>G7D
MJK*P2TV<@\17LUM&""I7Y\FKS.X_\218#(?/H#NNG*AGW\8;:H?LU#U69^\Q
M_^7,ZL&2&R7[[+7<U)#FDFUMB?C+*7Z'^15\!_4:=?UWLL@"J!(>![O0*:A(
MU^6.[.48[H9P?;/LK-$;&[8ZK^]P/O BW^.4TGF[Q<:=N*;/H89&ONMFO>R-
M#:YO=#BR;6WJ!B_QNI/KU3M661R[+<0BM5$GE-K0RE3Z YH<)I2,(FP;X6K3
MJ>H$5&Q+_;1%=V+1 )[@!1J^O=7_N,\W3#5"9KTAM]@ODV&2L>_SJA_G-:FO
M%SE&Q*'_B[TW@6KBV?:%6Q&1,2*3"!(5%!0011!EBC@!HL:)292HB$P"SD0-
M:4"9A0@*"(A!04&FR"3*%&84%$204<B B B1CFAH2-)YG?^YWWOGGN&>>]Y[
MWWOW^]9AK6)UZ!1=7;5K[]]OUZY=B6#]<BRRY %=SM)!!,BN-^H,C8RE1!1%
M1N(CP9>[1PE(UWK>42S/=9AW>OWK&1%P><QK'=TQ-Q,3:8GE6[F+T^K@F$\?
M&0J?7"$L(%)=8 +7C8F$/F:X$]T:S2H_C5 *X> #A05'C_<W&R#[><OD2Q?I
ME;A5;M_)_<$!F8G8DM8FPL XR[FI,P:K3K):%\N>CL=I6-IRL8[0KY_9B=_N
M^BKEEKY(R#IW5.?:BX83"W>^U2XZ^)F:G_LGKT.U=MV'73B!,J9UTG(#DZBV
M;Y7Y+1%@N*)FI-JH#O?S+AZU1?W13\%O+9F8 *2C6P2,MV#YO_3^Q^4&7[V%
MV"D.#B&=%@'TG93_<?GL2<CJ?U7Y5Y5_5?G_2A6)#M"WT&)T5K"%$H=CW9TB
M;4&UFAFBR*? .^FL]5'"6QP^&/25([@V/C9<$=1>28^B##[&>;\1NPW5<SB7
MTN8%^[56O4)-U0?BPTVU:D.UH!DN8IB^;KB*?+)<6$_^2"WKK*,-2#![2[DH
MO*7 "3E$YX8;REJ>R//<MR$NPOXLFY0T9]R&W:$9_2&9:8)CPI=T9A*]G";0
MO'RU"%68-B0K"+2!U;(G:E6W4B5- I4G]J#Z;K'*!>[PY#+]\)+P4;F7 \X;
M=-2'5==>P(P_0^W6P$F<]UN<=^=BW:D[:7S2?NM5*$:^;4 \M;G6;*@6;X2-
MYS#6#0_5GNRA0VW4LB"!29# 6$VP'EP*-HCM[BV^$K*4]L)L"&%4!=X;$P&C
M0Z45@9T9=%-P!Z&X3Z#AP'<$Z[?52L%'>:W">XB%2P7G-(MN+@*<H-JB8@=6
M7$"#=\\!UL<F*=L-V;)UW^7NV/[H.UL<0JXDMU4&M4[#7EA)$=#H[@)[(:J!
M FT4\$-I*)@W5.1+#?&0F;9A.*"UO>H:(\7_AA3O&E4$6&\2 8S'A&U@_78<
M\QE56@0P,Q\I?2K; WU]S,3'U$I3IW!*B"+QX?7C%1$TF\$!)YES+U%^X'PA
M3R44N'T^<][I_[:T_:O*_TJ5U]0[#&5$$>DDR)!LN/11HZ@RSA_.T;$>T_?N
M<SOB!Y?T&1#5SUEN>!+VKMG11D?B4^F&]4&G '6=1P#M'4;QQ$ET-M517VK6
M+OR8DXSO[V1ZQ:@AR_3?N$19&Q*+AF\9/MG$/KFQZ\6).P4%-AJW6J 0<<9S
M"V0)::?X<&^D>RL#<@T<DJTKG;!6[68F]_&<8+?\G4"72;2"1I/SX4O/YJ>
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MD<+9@HZB,YR511Y@0,X,&2J&*&M;O8+2@!\XVFGL.L&8:3_,E0+<W9.V\RV
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M*=XUS4=Q]1GMGX*L39\=9 #X,H)E<;$(MAV%_ ?X!Q^+@"44@0ZV'X3BO_Q
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MK=_=ED9Y-'AVSE4NXER3RK6. (,C:RLW48\''WX_X+I: $.&Y:_@&DIC1EN
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M.Q*HZS<Q\NT#IX G!08$7L01RW]:5"4,]QJOU7[SA1[5%3>)7A=CB1.'H)L
M(R]/I\?W$\67)(,_!<X^V;/F^F>\)FC_Y*SL:6@T^G:5'?O]2PW. 3<82-P
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MEIORN<R2=1-GT3(87\\=!5MOYA/G?:.>:RTM ,C3BBC#+>_?2YI*+9CC<+B
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MS!Y\\;8/U*;5MRYR6'3K:93F0:3W[+PXK^U2SC,2Y_#@$;TX$<*W-"E/2UA
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M_GC>",(E&\&D_/Z.QR)$ E:8#8P.68K% >^01 BUYS^2_RS[=UZVN!DXB1Z
MV9_Y-0AU-G-H#:C+5)_O;GE3XV VE<#V#4L-7G9T28'.>@V)3VX]86T"0SBB
MH>.&-$D-D$Q"*/E5SW/CAZJ*6>KM67.OW['SXBH0OK]W98?^8*Y[M2E)-/X#
M%7WK3RH?J<?(_NQ;@ FU];)(6Z<Z\@V'P&@?9O&QPOA6._MCU".3<F$SAVS0
MJX'?Z=:[\:+_\&B@#9I"_YW@7J]8+?9WTGS_K\EYM%;Q[:$OD)KP'L:_]"JZ
M/*^6D].LEMK1@E;\\"! 2Y?L&=IMH)?<YYGIGO5]VG$^Q-=E[<8+%QA/E._S
MCQ%ZZK:"R][87R5(0Q_S-H"UP[4$_914XP:ME92R%WM+##^>"BRN'I\_555Q
MS?3E@P0?G31P]XFR+9$8@?(.R G#TX+]5DR-"-$3?:CT.:2+W\6Q;T C?Z(5
M!!&$RO"MFQZTF8:S#:;+M^T-8J5*1/VXY79L.%[2\M;>Q\GN,:NU=L*\6'R2
M]$HLB.;-<H#D1V5@ ,M)(K*;.9?TD#/7Y)189YQ@1OE4L<29Z6CW,=UVK6;G
MQT1Y"<:IYY'%O$8NWB+BNE.#TT YELLK>A!)P\I%>CIPH.(@J?XS5>0KGH-/
M]*HW>WX>]/SB8%;P3N?Z_LJ/CY]-J9FC.-KU;IB7I :G-$H5L:5#AJQE"J87
M?XT<;AK2J+BCD]$RU->RP\MXM^NNPYZW*ZL2S#>\LNIMNB]3V' 9X.%!VV$@
MCE0NG\AYCUX^]FYX)3G)**PV>)(Z61)L-EX47<QOC==->NB \WMU._^F%#VU
ML0010GEAS_[^"!K,UDLEEP0R6J]!ZN XDY2";<S#</22OE\)F!GLV+ N=?A5
MU9GD'U)K;[KK'C8_<2^(UH9C]+,[F:77*95^393/#=U,\Z09*RPS,W$FUT.$
M<.O/^+JZA]FC%B+C\?#PVQ]6+Q0\=JJ?OK-^ZS?02: 0@1460.J$'A*Y:B**
M[SI&4.K#G[P/9CIR&P7.G(1TP^L$ W(?Z]5>N;::6WM/9 R8,L]>TXA56I9/
MR?"]-3<Q+D)L&!$^ B:20-BSV)\E2\R:-V.NHSG/!2<93HL"AC2AGIZ:BZR(
M[M77O.9WM=/T]7,^Y+0V;-Z@YCDAB3 M;XC/) 3&<N;$35@.4'>&&8-ZY8)U
M7+O<DC&*++IEN(F6/5A(NGS*;.7,K.>)6S7/]I<8[4_1LGP6\_YGKQ\5S0T#
M@CI4038EJE!@R/FBM;PKI_"KVR&5A<(GK5R)<V^6NTZTA,V6RN/FC\T#$V\'
M18@C$C9:[.%2&L79B;9KG+<?U.9,TINM3;LLU^!8@ )P%F[40#;A3M&7XP=P
M9TNW-%H20TP&ORBEKMFHHM#EH#4Z-P5]0)-;KP"!QE>3N)Y4#^_[A?-J0X\>
M!%XR>G;-B%Q[Q*DFXSVORU;=8G-:Y&GGT8]IU>X.LOKB!'P;4-2.5)(6A9$_
M@A6KR>(=T^M%"#*Q ?;+&T*&G9;3OQ3QC*KN8X]_2=UA4UT5^<T]6"=/O?K:
MR&K#5]=5ADY?;YS1$ZR@LT8:42F8%^U7*?+6TF<Q\L:6QB4_Z]#<UMBPG-8W
M-9T"AZ H/5ZVTX5O%3UEQZO;NU\:KR%=9*8@)&:5_SV'$85D]_.QH^@7Q DJ
MJY1&; 9D\8ZL6N.&2X%#/RUP\0^J3)[IQ_CZA!CXOWRB_^K*1PD=[1/)LPOS
MCI!,C@BQ/D;X )C(^ DL&,58D5A(-CI?8"',,Z3X:]I2W_QX:DP>7$6FR("7
M>KS.>J1^9:8&/2OY=,?USK<[BA>WV!4835Q[]H%%*E<5*,NX@45\5T?^"J@'
M\Q+VP-9(_+X:SI>Z-9R\3%:0IU.O08UM81-S76#@5VOW-2:M-[PUOKOIZ2UV
M^X26>% )Q$#(#):IM=/5F7Z[\]:VO-WJL5;R4JMFUM4<84XUZJ-HQ;QO72($
MSH'= ]HR^^,J4++X=:^U<X,O[_+''NESGJO8$(@+.O=U'3H@ZZ+2C;T,K4=<
M/1[Q!1C!=2>HZ\65SH:1.69S26'O9FYT'Z?I1"SW'/!H/7?-(VI*)_J^0H+W
MN8<:M_3?UDD"5 >!VS!Q4 ISBDBSYVWEDJA3*N,$Y==<=.R9_K!:\Z/E_3/\
MJ,,[XA7'NO?=.-[Z0]M4]ZY$.N4V?0AZ1^&&6/IP37A9K^:[FPE&Z;:<;ZF]
MH0=6?'^1M'.T\QT@+(Y0EY>->&MWB70/T@Y$5R1.".&(4@(>875<UZ9J[0 !
M;OK./KPB(X>MW>BFHE854UA)SG2[95G[<?Q"9LJ9NM#& (PO44JAN=(9E2]"
M^&,'"QJQY1UL,TX<[W2_M6(DR;D:;&;)E.C9<ZW*!@LS?<QJ[U5=,'C6-=^V
M[FU+[['D>Z1[ROK>1.X@J_T.1YO1FDS8,NX16O4BTF_7ZQZ@G'U7"N>]_H,N
MV;W]])V&EKC%&6$(C?[W:,Z1CGF,TV<_Z,,9F! ]_BJ,)K*M1 A5;59_0^G
M&W2>W)&F5)8(H;BG&]+U4*1>U$(]Z2WLC,6RB.V:$OFR';0BWA2,H$\?\&3
MV 9:*U#F*@M'FCNNO=&[DE_W::0J\T!GA=6>STORHKRW:[KXY,:F*59_D*BI
M'?>*8*/YSJ /#U_'P5W)W/F:B[Q>IQV91'9:%'FP)339:]^8X?<W>6XWVS\'
ME;#O9T05KJE\<-+505,;N >CHDKT1=X^.*Y]X:"F:Y_G0-+V_/50)U;1>BL$
M8X7*Q(DG@0\#K3>#4BSVX4GLDL#LTL]KN/(WGWX6)D KG^^SL+WP$G%JBUR6
MX:U-$H@9^@"=U]H);<'[<CLF&H<IDAV,J2022KO\33_>W#H_,WSN31#K947/
MA)'+$?;6YX?WOO,?OK7=YW1D_T9/FOYT)L^DSWHCU$WA>%.ND\@_2CB\P<9L
MU09ZS!NWAJ^GU#5#PI:=Z=?K:2G[1!Y3LYO;VHG)- W)6FRW^_"W2N1H[[^K
M6G"T/VR[J9?6B&NB0S4E.M*]ZWVS<F%N#'.YR<9)O=C7=^RB5I_N)Q(:*)53
M<4!P:4PFA:R:($"61-H?*..ZOGS@5!CYB.'Y"GWPS2V:V]U=4QI^H>?V)9YX
MQ6^I+:M;"_L]*5NYU@F789GH:W>& 2)]N4MG_YI8[I+/J^-ZG"7Q8@DT$HGI
ME";0>RZX(+Q*6 ^:,*J(E@Z!]T&GX3.E6_/Z;GWQVOK!?7+F_V+OW:.A?-N_
MX2F5D(;L*5,HRBY%VC!3R2Y)DGU,R"XQ*3)EFBFRWX50Q%222LAVQ)C!V%22
M[!EE-DK18 :-*[-[+_>[WO>/^_[>O^=^U_,^Z[>>9WW_N&JM:\UUG,=Y;#_'
MZ3S/X^>/D)[#PWYI6><UX-OLK)[=(SMCK@*M(HADU/$^@]>8(X*J5^B4#JKW
MG>)IC?EW^]]'7DTR;JI'=*,N&X1]6:_5=8E^8=';D'<)LV\ %]8K#^"X>]_<
M,<#L9LRK!$WL L@O[SPH?SSP(^5,5=^YY:;&HB/!VXY]/) \QY/N(#P<^T7F
M1(H@8;>4*+1?QI5WBV2SSS<Z?=B&<MWO[EY=U&_AAWJ5X/3IZVG-%LWMZIZ\
MH[A6YSKR6!GS])U(#H*K#<0&LZ.0G)+2.!^@ESMK-FYQ*_)@?0QCJ<^(:*?T
MX*YGWHF)O>_2*V6SAW$HAW%-"NV--:N)B:?F=9"E^/;,'L.V_&BO&554W"1A
MO]:%N,5M%3O37/9^;$K4HV]I50M66,SC*[G,<ZL!3[:VC:""I-!#1\CSS0$C
MICVBT_L0X,A$;>[EXF4Z @]7=V];^<)RJ?<E.+9?$.LA6 =F7XCC(0"#PID9
M)-L*E;&2?$S/+IS=.75,?KKN\P%*_+;$7LWAV_!R=EZB)B<PSKA7GG+Y\_/2
M4LKU>S47'V>97'FVW!F./(2>%$HJ3(X2=3>106=G76.2D[$Z0W6S830*284]
MW.07O+71Y2&&:UCF14,2%;E7>HQ1W(BOFI]*//:VV/BQL+H8>XYV&VKT$E0.
M+3NIKD-D5^05HTT"O-Y1)QYOKQJ(S9B[5<&4_E&]P7Q]I*(C1DN02@Y,T[;-
M#PXE(NCDS:-!C=A1C^CNCK@M$\-4XZ/>4U.N>Y)48Q;L="2E$-O577DZN-:S
MPK7"?EQ-7CLT0[C_<QTY7@X#&S211C"7XXC7PJJ\ 9>9#[##X8:Y[OX9'_[T
MVRP2KT NG'-?O<)__>8!HC63%J]JW5$9LT*^74M.XY[M99<Z#YLH[PH9<QF?
M#?;#R>,6H,WY(Q$<BT9_'_G$?JU7&JC4U0M::=7D=C#YX]D6>.KRY(:RX@)$
M$D*EKANGBNZUK\KQ5[5,'#0>=3VUJ+G3GW<@+[0Z6&G/0D&"4U6>.EB\K<^3
MG2E:*TBH)<?=M8L*Y_GRS?$4$<3_6\K!6521NQ7B>];X-W)H:3Y$(//TW_0M
M>94_5[HKI?C+S.=ITZAYE-1A=[>GM0-OMFIL\/=J9YON>]&KM2F?8 E!XUFZ
MO## E#L#2$3SCJ%1+3='[D:,&RJ$J&JM!"9[KV^ZL_3KI7[)C;L&G,XHJ_87
MUZ4RB"$4L_\9=Z[XKX.%ZV,L%;^IEC9>TP&'"5+UMMOA)='1G1ZF223#F0L!
MND'&?YB#>A'.YG-SI>E4ZS/7I)\VD2CAH5.0:.LN0Q"GED;H;YGIHI#'54L3
MB5XE/U7A60;\6+,\5YULNR8_?CVW;6JVY>RIZQ4;H":+7;-KP*FX#*\V'TDZ
MO'X$U-LHGBE=VOH5UYE;I) PB1BO70R5_CW(I$HE#)SHY.AY^\J&><FA*1J'
MB58.9T=PS%_"+RN&">3A8*2$F>:NMQ&E]P]/5 14U_B;/XOOI#EO+BUL?&1]
MVPI[ YSWS%?A,%(*NVX:5C?2]I8HSL0GD#>8V98"W5T(23-[QIAP@*G\^H>+
MNQ_9LS!Y^*/+S,%4R(WZGZR%RS(-XGUD0NEL)F-^5)/KQ7&8M6/2XH2[. %Y
M#'OSBM_2IFV<\8=9>X__21_9TEFF'.#5KGA%XD):;?)OA 0Z!J&(=CK%.76@
M1_+238QIL-2!DQ*:KI(.F$"%!3"@G/X-HG1-TRZ!Y?;<G0V W[7MR1'4GVH^
ME,WM@9F_O(LYGDQ4$EP.2SF#+FC)4.98_HB+:%9K+=LW9S7\>\WZ]$=;<==F
MHV10YO>,?NJ(I7.Z^/*Z755H%Y75/[.,_NC R?,=RT*H7\D)F/V,\NN=_8<B
MRO?]82%=FDADM#Z+D1]$8TTW6A>>K/6Y?:_KL[ %P3X#30!KY5Y*ABR0;0%$
M,QW6 :4M).T&-JW=$(*N'W(Z^]G$QMF=@=.K[E;3W6![AM&)7J>PK>,^4@+A
M9S@V:=L?D.^)@@*&E'I5 WR]8M$"Q^<$H:X^34;I[=N<#T^M'A.S/JR-Z>V5
MYFW ?J2N-CDT94([<4F-YPYXFP-]D]T92@#!/L8_)R(NR+>^:F!=XLD/P\/W
MCF?9O'5]]&GF^C[Z6AKK">\J@.)6 DT<'&-#)AO?/J%(!HXP/<WE/)#R4OY9
M"R$ICA'5[??L=-Q2+Z>6%(1OWO<"77FU,@E!+T L9#F,$X0?\'&XWTHUE?4_
M_VT;HLI-@"WO&A#"I,V6<:!<[7K GIDFYPI$,M+V>S8/UPT1TL>=8E;<LQ3K
MW$JB=B>ZY=ZS&OO 4GZ_?!C(IKOR2VF3(H@ !/0QN*6F<X\W-_WCUK9LS&E!
MH4GO%E@LF>T@@B3AE(BF;.$:TW:< N B@MC7Q9Y4/W[>[,"]KY^R9[*[Q,K>
MY?YT-%UG2#Q<6HM1$[P2;L1<%SPP1HU#6[P-7=B*! 82L+DP-*]II*QWU\IV
MTX<;:<62C!' 7?GZZUYJ$Q.1:+:#/8>+PV^(Z+8301*%AVJ;WK!=LK>W.W[\
M51]Z>E[L6W7=HDOP-T3T;LFP?+0CO\!+\) (Y9D(.VCB9/H#V*; _!\G1PPB
M:!N^]EXIOC65%BI'"[EVNG@NI<S.LT$Y(\=_4'-;RW9%DA%8=R*"H GX]1&H
M9!R43"_$FG&^LME>E4F8:\5!^4+\93.339\E>A[D<IZ&'O\M%QX2C7Z05ASN
MI'7\=/Z\4-*)9^HI;(-O \44Z^GP^CQ@T4%U*0AGW-*04A .#\ZCOMGH&[][
M;*!0,<&T3 @30?3V!AAHGIU\(2# E84#"&4PH-#D,<:";*P1$-U",AR.>#FK
M;S(O"UP//7YPV&;L9&E.N"SAVB.)#STU1^Z>.EKYT2$)I\AWYXP()>9%D'5+
MG*AD^.;@(D@5NW*VF.&P"4UI*]IF[65HW]#W>YN=32KE[8,49*U':EB Y*=7
M[HE?CB+LL'+8D5@P@M4J_& 5<O(8 X V<RMV2T;'X=-9)HF_I>R1UL$]Q&S/
M+T]W35\HN'BM[5W)IKY]QB\8TW@5\N4>0X9X*M&580-7"BG2QDD!.)L&3X=-
MLT4BB,M0W9&R1+VE%#?E/<8EH?G!6EEN_<K/TFT/='J<^-/%I0@'&E</4 B[
M8BFGK+F!%%0B :L7<5#B>7/AZRNU"=6WRKH[T5^1EL+VO:U,_-V5O%G]\N,Q
M/YB$I#FB_[K%%QO,][GUC]@>1,R,\S2H76C6K.%R&N3&,NLE&)W-!DE&PL'&
M!)8M[Q3VO?H^ ,8YB=@$VQ*DJI3TVT[Z=*]WOXNC?+8'S<U.:Y^M6B9)[_LQ
M+;FZ& Y^&YE>F\8[[&W!B6*B6+H<>"\W.MLKP2Y[\F?# /6#D1YSXV^QYZ^G
M?D?\R,SS'^]\:AEQT7KB3K,: ]'&,Z0&<FD.@([EUQ=(*<"N900N ]AI5JBY
MVC4]F#/1#XT6%#EH3$P,BB#=-I-%X8U'$MT(0LGU[.Y3@CKB5AS]D?<V@G4_
MWQ;^\!K'10A9=Q,:3V]*_S8><U IZOD73PO8N;12_+,]U9!;IO)5/:H]FY)_
MSJAL.VTA]CEVHM ^7KF<Z;8]S5'V^%.=EC,'(9O;"O]>$_RG-<%7?#L!L8XF
MU<6TUV4@6#U,9)+ZCEI.<U<\48G1*SESH*J;*:&OKU\R:'BQ:/8)88 U&Q88
M?6A7[EFSG_6W/4Y8?.)O9"OTL@+9V9.5LY.<FK99\32XULRR]T&.:8*^O^W.
M*D)=5?J(79_"O?NYW_7+&6D?PJ"1X3K'I]_@78 =#'LYKH,@-\*'D]+>>*MN
M)*%V=QUL*SK=5W%WI.Y#U<5SC>^_253NS/<JULH3RTZ&+")&EX62:>Q);N8;
MX"5#!$G%29D=8P=V(<1B[#B>K=A#N>*W5#_9W3#P):=/?<W7+;".W[WU9,)3
MN;37J:PJ4$:/@E:\'[)KF/@.ASO4KCBL,O_2$*N6#$%/+)Z+=_=Y2TY]_USZ
M;,_14'-#>>AN2D_5LS1M1=;HUD]IO'5(X0!\G:"4I,,_%S_?!M\A>$G4P!CZ
M!YH05ESC^4<VY)G'/]).S13F3DTQ%X*J#ZCT?_G6YDXZ(B LP<:?3W(W"%:K
MY2R<*EP2'3;.A"7"M=!.;3>MD\T.31Y#FQR1EK2I"!PIG[5LR-7QK:M-FU-U
MDDUZOL:9<@&"?8D) +Z7\G>,\%48[R->5,R9>3$E+A=.D14YT\,N7%-30M1"
M_;#@BZ-GZ,\U64%GJN=[,*T@4&SUKR2I\!W8'MC/N#>!'88)- F2%KIH_"@;
MT;D-&VI>7DIL/!*JRG.(O][4SWPDZ'Q[XHHR*FTOS[RI3>88!\<=YN2E5C#L
MTC09&?$[V&&/JG7V1)K;AOXV/R>#CN3M^7FRM&I_97DX6.>+4^R/<%E #@,Q
MYMVI\):=<0<3]0QH8M:_VO SR]Y\>-'A\^?EMT6XFO.GQ(T\NA9G3:\H0D8%
M-;A0AQ1:C65ZR4N^FB"!'\ZY/D+Q<!SD^T<SOKHZO$DX52]Y<3=T?*<KN7%A
MZ-F"?M\[KX*''B=<EN;'RK@QP V>*P;"CIK59A<Q9QPVHVF486IG!O>GV<M^
ME>+-6\Z]E]+(<KZMM<$IQDKB.UB75L8A:W]T]H[E=2"DR!=IJ?"M;.L4DV8-
MYB?ID/8B]7SA]BRK=WU/DIF:EUF;:8C+$VX[[YYJ\5OM<F^."1TB(7"M!TDJ
M0"\2.%3"1Y#[EWB]TDC ^MCQ1FSA@8Q;X26'/>(#--8.^V?:&9VYGGLY;#OL
MU']3 Z)_'I9)JR6S+.B5U 1F*0670M('7D[J*YT!G)D;AOD[0QC3K"T31[AQ
M]. 2SY1#^><[-+MJZ[\8[;"XYDZN5V*),^;'#=M)<AS3)'(P^+4D;GVW?F<*
MBDWKN#?MF/)6MCB$@ B(NG'W-*<LK$VWX0S)+W>Y44=L"A^'9)]R2,!)%Y/A
M6H)GV'U\BX;!W[/0LPU$H'"RYG7WEF#7I\*)3V):)_5G)[YK9%U,W9WW/M5H
M3T.EC: 8%[@M:I(E5!W$[.<Y\$\#?K<8:2?MWJ'@6R_5&QD\:5ZKC-*?9\W-
MSCU5?N>:.!MV3&%Z\(PXE!U"5XHE2=E7A.0'%+\,\=;@V+.BL'LX 63CJS.J
MQ+YVC92/1EKAUEO#7YR+5YZ,V]=Q1NGJ%]1MA"]T/=],\ ;CQ0L))BOP Z.8
M&6H_<V]:D9\C[4L+#]CI.NREMF>6Y+\K<LP]KFS[-F7;]P2%V7-GQ/79&0R#
M6'84924]X<F,4EYE&3KOW(B)VNRQS.=%4RL+GJ7K7KT8@SW8D>KW/5EY0#LL
MI#>#=8Q>PT-!QR>%BF2P\F48J8N#=:]9,.DZ7O!0D,*EU0OR/O!@JQWM8(B"
MJ1MD"AGUC\&RT;^X%FQ<$@F.HYP&-)G0)+[T9 A>6COA=[-?6^7%[M?3?2<7
M/2F1ZW^7?S3PR77W..2LZ+RE$:73H?L<D&/#P.#)FJ7?P$BS5ZC?2N:JHE^'
M',Y]LC=WWGEP7CLZI6D\ ;(AU]WKP:QD\M[$%\DOF@O_O6VYYF-'\-7SL>3+
M\V/+[;@:AW:<$CK6ADU+N:S:A41)]X0J]/24"0#,>_H##<+5QZ;%FT/Z?SZ&
M*@/-/,6?2!70W',$Z7Q+S@A3'?_$]OFQY[1?*QM>!@:6T=PZF[ ]6GW4&[ZF
M1U_N>O>Y,>;UR9KX15!((@C[9*\T1A>(*^:?:!(0$$%D941"\8.?5*5TDG:A
MM0VA(>3&CO3OKU.EY*LMII12T/ZV"LJ;7G0-+IT1?SB#J!9!XLF,''WRQ<IU
M_!.<A-BE,JB4QT\/9!)1LSS%'K1@]*3-C_B?Q6O@FNL?%6_0&[^SR3*0KR7(
MK,4G"/?T87?P3P(#DZADK#9[^"$<SR#+8H[EG=X_?<^A]K1OBGUU#6'QV3G+
MD(2D4AW)&P7NE)O?00\DUZ[JG$P-F12GH-*\]P#ED^9JYP"G\NXRX/@X93%X
M.E2!]<8<K*P(BM>,FYY$902'/C;:OF&J6<P>L'L\+8*HFB#3SUXRS5.M>,DH
MVR:]O?!>:V!HJ/G@M[:U\:XY<^2;MCOBB&)B@>;.\FLF$74C+'LZ;GS/CY9K
M@ C"#$Q9.@&$3_8<Z?16BZ7(C;87NU?M4_-,LN]XUK/=P:0K)U,M<,KICM>/
M=EP"7(.S',=D=^9Q"CK4E>&.Z?-.;.:H_O=WVW=W?_'X4+7%%-.W9Z]^CG]+
ME[,E9+4=*6D-*)Y\[%8/C#:PFSYJ;+^E/SAP[[-J>_V>]HJ+^5/,&^XE;QMR
MQHIL2P*RK'P_MC\:\?DOPA5H >$O@FM&J9<(BOMZI+2BZLM4<C=HKAFT28]+
M<'SK=C.VGQC"M1$DF"GQE#&[.-#6^3B8(B8DJA0=ZSE8EQU5\25X\?SH):4%
MXHBIC/'U\ J/8-6CU7J)Y;>5PL[Q_.77<*RR0?!T L ]_0E6'0-D^A-<7:JJ
ML^!WQT3I<RH_* 1=Z=^04](0?.K NX_^45=G&_8K:1\Z5/E2*,^79V>T25MT
MJ.+CU:_G=>0O7,H37CGZY@&K_/(%0ISC.2TCS[&69-*3!UENV:..1V'F:$^A
MQ'2)^]A7M!VS=]:'$\O$Q<Y%<LHRQ/@G1HS'N^4?&JQO/U/+'K6(#@_=>D=R
M_/SY;EG95XV'OZG3N!1!#E&)%X+MQ6H('I)V DWMJ@[Q1-> RZM=1JQ*ZY.9
M,Z/W/&#[T+M&2\5VKB442R[-Z(A]>BIX9*P2 4N JW/$TTUF?6'QU.I+AR,:
MLST2!I^G?YCJA]8E7DC;:D6 7V*=$[#VOGWOC4:-BPDE> S:N&;GA *G*Y$<
M3$Y5WUC06K;_YW6\--%K<\ZFJ'UEG<NAPC1-XI1V4*Q26^>G5TH?[Y')()"6
MX,%7%P+@RACH9[-0QKPR_SR0QPE#)*KZ3F.WYTV:IB*1*!8]6].M;9N"#R$\
M?#=ZZ,KW>-:L,JX-"6B3VQSB2'O8ADF_#;>A*9T2[+*3^-. ^W,T^4Q]$:WM
MGMW&>E3-@U!F+M/Q<EE8S=?F]FY%MM8&=SM>Q[\/3^=42PH[GSSO]0M^]<6M
MVU@O<X+Z.L!-.57<4>.PXC:K[SXST)-%R1 .8DR3NY6-9/FP"]H1XB1YC#NG
M?**0*8TZ.VP_T11>VG/-YP7RP^+Y+T?[QCK?!C\+7ONN6J,>XO76B9GOP)>5
M8PA3GGX!_$Z#2"%..+PWV'5Y1.EF44$(YTDYLSF7Z9++*-D[KFF4\[6[GO[Q
M_*-O4Z21IZN;I.,0Z\TTV;%G.%:EC(3"$DX ,;]$!'DDH[?KB*ZGLC[CG+/$
M)A?N%8W*%P%:N5I_7./(]*)\Y\+"D;LD/>$P3!FN#<!_(%4;V(AV^VOVQ"K;
M+/IY2RD'Z;NF!,6^=S+E=1T?JV15RXHKCJTH@A@:-@[ENK"1L^4\<R"%&P#D
M,>=E@N&J'*^'-2-@"E(MHNJFE/D>"P*C=8'OHTWW)2=2]WQ$UL3'@LGM!V5B
M.Z>S^;4%>]S%WOITWMF0,ROW^\;.4X]QJS;)%B<._^CQ2L8WQRL=TNU]VG=4
M78QW =>*P!SA742/MY$.<I1F33FQK7)HDX!;FP<8A)0G_4_2IYS1$[/DOF=1
MC]IG97P!M[&AXW^RE(8$62*(+W*3\'U^0F+=+UP&3@&K>6E"RS-HS@2?HGX@
MV_-M38S8;KOHL^]24++!A6/GI#\>.T1MX.;KB'7@ E&CL:VXFJA.$20)"</L
MYR [;WZJX?B=JQO$^(16]I0VUQ)<AG^%KLO4;WYDKSCJ[$<MKXU;?R<LA/KB
MOV@,S4&N$[:K2[%-9S.8&>/7*4QRZAS1B2E8.W!BN+;[?>WB\^:XLG?<S\^"
M ZJU<_O?M=XM& ^?^'BP\M+3V_!S !D,-B7L'QTB2(:ZIN#)./>;H!AC6('.
M50ZM*"<J<#3T]_53^[=-J=EHI@\8M<7;*N_VM7LWUU$XEE&,[<57P2B]8\QE
MRLWGV1SQSB(=,KLSKBQX>*4KW63Q)6V"5!*-BKIQ(_+J3ZV&!K^0T"U-6ZTW
MZ:KNJ;C&JCTCG@K,<ZTX#BG"@Y<0*K70<:=)T[CRR%L&:MNL6ZB;:TK>/ZFV
M*L&\\VT>F-M5\_#.GY+Z?"4ML7LWRF&JV Y<34(ZSG\>\"NW8ZQX EMT=2Y4
M#;#"OJ='[_;)"8R9TTWK=&Y,9RC2SRON4['BZK5GSX!#WL6/*K6HI@I-.<@T
M^!Y@H+W(A#-R&]D:19:)3$E1_FUO>L)GQX'ZX_W]4B$7_'.F#-[,WSBPOR;Q
MJ40?=I!<C8P502YEC,W]X@8,P;<#A%:L*BE9+7J +8*<C6^;"M$908VF9FQJ
M"AT-W9PLWUC1=G)_\<T2^36+2JT(8">8W>'2?-<^K/XE<CUJ5GKR/=&LYD#F
M8_X)H(B:F[UNX9C6VF]C?R34NE5/"CT/[I!XIR*VU0/7JL#7#CGP%@[FA?6J
M@M>U(YQ=E?"7Y?49G*3+I*$;1AML,S*#'O@JG/-;XRBK)/FJ>%951VQ_*QSZ
M&:N.WF_#%H\+W:3JG?#<<WKELO0.OZTRG56=)1G:DH\O+H2<_B]ZI'> D'HT
MH159!^UP $L-)8PGQZG3P^ )NZQ=NAPX.4(9&-U)C)J5:ADXN0H,WB9;@\"@
MP?=X_%0-[K+A*)1"JT<F8;29*#EL_^KG\D*I7,\T11J#G+*COUCIJJ;52!CV
MX]SBQL))EZ]W7:\\P73IST><$>]!2)+I#_";A6K66(PMSX;O#R2$O_Q%52\)
MO\$YTA7HGJO57VDI:'ZTP>:^YWCS!TNM]\I.AMG*OL[A7JZSA3P9=!1WM)]O
M\A2HF9QOGU_O ?BYJ98_0VXVL]W\( SEM$&B]#HA\TM;"_&"S*MO<*FG^U;S
M[N+R/WK__?E,#B"K_$+*/A&\PIH /*\A8^W^UX;"W<#2KY"G;7-9-L-7WF_I
MD&OJ$#NT9YR?V$J7B8;%XZM1%#R$?YXL>&)V['4(?!\0BWLNK8?N[J@YIO\U
M-Q^&KJI-G] )9=$-$\(WV?2_<<EYYG_6_'@RA(F18EO8 I&@!2'9B#B^YVO/
M+T"*VW"D9Z],PIW*ITV#80$-P6=JK<PH4Z^O)%@[IV_,C(W[\7U62K@QCCUY
M]'-!FR*>?09*K?UY;<+AVHN?(9Q"1CTY^'MPV FF6D2@'#%+Y33]TT7?TZ=#
M9F^"2C7SXFU#Q[;#5.I@*>I*@AKL/K23_5!MV2WX<HLZ;-BXYO$S1^OO\83D
M>8>B:!45[%)NS?%V?DMLSTU4&VC ZFL!0_:R#>#,)E/.!*ULB/7-S?<N#'-[
M[6A89J3'.NU>F!08$.#KEA7UXK_IEI;_\@$6A5)2H!_% :&@LJ.!4/I\$FP+
M?/.O(J/8SL/?5D+KZA-PFZ!AG.,[#3J]-VZ?7$M:)X(D3N#\\2M&\XDPP-$-
M3(X0+,T1F8C@J/6R:D00*W..F @BJ0MC%PLU;PAR<3^[2-MQ#$L_H?P:WBU+
M['81I!V%J.X5*"^W0_DZKW%M&4#:#ZZ["%*L#MP!R2ED &?$9W\K &!TD24*
MNQ%+?C09!/MI%4@5P33%CP4*4Z.9XD)Y%P3C*(PPZ,J$\JT6>7HB2%\&YJ@(
MTI;<Q=?YF\N_N?R;R[^Y_)O+O[G\F\O_;;G4Y:8P\M)FX;OX!]C+[2E2*OH7
M.)L3@E]:A.Y?R]%B/WNBG"ZQAFVS]%CZP[^K"/_B@1_]"Y!5R5K^JRO9;B-P
MY'\YPU_&%O^+T_[_\?BK#T(&1U_&_S'!@Z+BGC&!"78HK"3P]+'=R)IM(@BK
MBSVUPN->8V\=Z*&;:]@^!W'MJ85#U8FYOK[OM1YEA2PL"J$W1)!L=P F@OB+
M.8H@_;+(RM5;"OCYO11P5BNFPGN4H^+\?;A_*'.(O?H'R(WCL'^<Y/J7=UX"
M^34M.(KVJI9"D5 1A)U6]7^?*/WG5\ZTOJ-;_R;[-]F_R?Y-]F^R?Y/]F^S?
M9/__( L<$4'$GV"V I;L;JX?H(]CTQC(>+ZY^4B&R<:Y@,]+1Z*M<];?V^'6
MGNPF]DD:VR=\+X(LA""D0;#VD[9B(8T]BFN=1X!O0-C*>GP)L7)<]S>(K1S^
M@9*"19"+X)@@3%(.$B/_NTVH?[7N^[_L#JC_F ..^'^"]9#W8.SH7O!-BPC"
MTU'-$-Y+%N $V2+(MV&L*FX,T4=>BE>%S/^L0$PN4W"*&"1@RH3%8]<#;U^C
MH:[#$8LHGTGIM0<GED_>NX?Y>>+V2Y^80Y/Y0)=PJX 7"0YY$Q<$Y<M/X_B6
MD%L"2PPHY,U80:,(,FV.J!472D:0A1H9P+7EV1$1Q'9:\!C!=BH103CR:Y;K
MR\N"/3;D7*OXU5C8G).6T]1[XT;4OBYY68W<&]M&;[]Z):%G UEKC]N/9%_I
MY6]-8592)SM<\=5*+-G)KQ:6@-?3&2E!TV3HKN^S%43W2*EXY"[+'<PJZS/=
M,:H!9WY(*CB,@T;GC <T OD*(5V(JH1D8U0,@NUBF )3,E"D]0P)E=%/]%F3
MG&WYF%Z4?'V'J5TG8]/M9\]"WQVYQO\X0SU=]O@2X;!BT_/S[DCW\V9*N5%7
M:J^V[C%R3>N[O>=#2\RSM1NW?Q9?^BJ";/B):^U8<9VM+ E&5IG.UC#+H@U3
MN"Y,J!3Z^>SP06+@%D/9MW2#QZ\.>:^C*R+Q5_&CEX3R(H@?<BR%FRYX@PB:
MWX21$MS'&+ZXY'U@L&Y=MEVVP\,GPD\+HT;-6:"8,]!/6J[?SR2(J?BN$9:0
M8+C6K2((O?@F[LY2 2P1QD;"TK?\"@_F&+Q:<<FY&$ID%U])*Y76?6$F?NUM
M50/]$03:=TF7#OL+1> H>'(8><7!8?4X0$RA(5C_/8:27^$3,>9/@)H3;]FT
MI(@7AJ\--8R^>ISO5-%R&HW]\Z,*D@PLTJ%\.34N&3C&R:;0Y,Q +M>G 7V3
M/9I6@XI,$:15N'T@8JEZR ^2L<M/=8/D5>A6#M(WA/HU+WXI.BWJ3/R"C;X?
M3<,M>-'K(T60>,$ZRX+URJ$.@MV"_40R *#/01**)"V^[0CB$E(E&%>[+2^%
MCPQDOT)",2Y#R ZEQKHZ_OMG;JW^"@.V46K5EFKMOA%[\P(@!IR5/#:/V\P9
M88%S7?<;L.#@N,*^.GG@(=-K/\5C<R7C*\PA978%GQQIN&OCZRP-3JO\PFD1
M!/XC7?D=IOK52"NYRI0OAV2.=!D"NXP^OR:*,2OOPFH3VGI3O34YY-9Y.:"R
MS=7C8GV>$\V\7>:]5M_ZH@]S&V0<9 P@VQM-<^4%XIQ)[@]!/7:/L,U[+>CR
M<2*(;V^*MPRGD6_-%F1TX22#R5"#L+I"*8O%BZJ%W-BI$QPD"6#*VD(+],)/
M7Z2FW[DO-EUY%T$ F4DB:0,$.E(QR&.9,AM%Q[CD(667>K>F'!1!:BX;O/Y&
MK"<K*4:9*O:&L2WVS[E':=]G#&WLP/B "MDK*%["4:6Z8%7:[5 H7QK(>SSM
MO5U09K8CDH%3_,64"C5U&;CH^?!X05"E=Y"W#S<ZL7^.JB)Y NUB=>P'::<@
M700)@J87F0N:A=(8F" ?9.5DU^1(:Z5X)04GAY[6DKVT?]1M1M?,-6\D:I^-
M=D-NT%.C#_-74N !-C%OO LF>[L,T\EUL!;$Z++E&\$=[.%@N"'@P[,"M)V
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MOZ5ILC(9%XQ:/XW<JI'M,8C5P<@#=<Q;?MR'0*E_Q:U*7H@MC!H_8E4=IXU
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M.S'%V^VLA@S:0CSNNG1?-=1>/%Y>3?G^LD720N=/=90(0H^A*9*4^4:@=]W
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M,V(P-^C-8JU5OVY^BAE1REVNSZ^K*-@W_Y!@]?F=_(83VF;W=,1^04?GN7V
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MT\OY2"3O5?:Q^C(3>4[9HFGT5]EY_1[7_ /.R]_Q\H7KR._ [7-33P4,-,@
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M-4L*0E&V];@Y<Y>KZX<]/9J^Y#_+,S&VO^HPC^,6)TWT\A8KZO/3\G(&>F9
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MS]]]O 3W-^#V_+V\[DQ=^#.0UWZZN09W]S<7_^NO-Q_?7][>.5EN.C0\\K-
M?>:ED(19("<E801)%@?0\S%*_"#$8<P6*UZ//SCKY'#UV $@+2A5VPSD[;[
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M,,U\#N-8K:9E)$&Q5H:=@3[F]I9OH?P9YW("2'\V6+ _P*/&]L?I[(S\FC<
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MXV6?1#,CR,_\& 98;:<$+(($"0%3Z:PAQBAEF5'4[&!O<Y.8'AW ;9UHTW7
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M9%&"P06USBHUG 1FXH(.+HA[6_?!2:L6.\D?>;=]H5KJ*@.'H8<X"WWH"T]
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M"^(X@&$L L(\/PQ\K3"_(_W,33[6.>VW<!Y;M3#B54\^'+ ULFS8$&6=Z/\
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M^#7+EYI!B5NWS$TO.VB:";)?VS\L5R>8/K+F=*B<+=@>L-0J?&^[G<G"\_:
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MB'G2- ^C!*8,)3 0(8W#),:>SY>9BAX- D;W=Z<U*[:3$CV.<<"M9#.,]CR
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M_U,C@8>YW,2#\DT96'5C\!=E =]YK2:"[&A>Y53]B.7>G]6 _Z"S!9/_5M\
MD#H"VIP/M/N#4@#6J@_>5+"UP@/@US;[*:[5\WD%N!"<SL%?Y6+&Y#9"=CK/
MF]>D56A80]!T\/4,D0&'=.C+R$YR<*=.[%Z:X[I.^C/0VB^;$8$#6#"6V#FR
M;4Q[']7JL81FUQZR;<:.7L\IK1:<W56EX'4M)SF>J?HA7>WDIXA3P2(>PT#X
MBD,C3^7#CB!C,1(9\8(X,6+3_NZF1IZ=M.!M0UR#*D>:&.N1ECODAC:T.M V
M)6WJ'ZVJPKMC(SU0')'/D<Y&Y1H]Q7>I1?,MFU@#^?@,?]3=?H%XF#,><RAX
M0B'R5%)H%&4PP6G@95F O4#KIG-/VU/CB*5T)D[IVV#US_\3(1AXLB\%L_+-
MWX;!Q//>&HZQ_.JU83'TG=^K>+]G_/8K(_J][Y5UVZM]_R/F08WGS>[E0II&
M_+'\7KSERE#:*9"C&=VHT=34**@5&30RJ[N]Q_R5@WD)OM_<76WL!^0"_*A?
MGT(7UG[V&@#1H<T733 '*3-D")=5>*1.^Z/%21HHNQDP:?*:Y;ZH27Z]--$]
M',<I9@0F:2#MF22.81;R%(9A0H27$<2H9U(6:*MU(SH9K3#0,K4';D0UW/!L
M@1>@2'@HX9 ' D-$/ ^F-(Q@FG$AD1-<1&9[2&OPQO"P< :;YK;0%HRA:;21
M:X@MWSZ%7>WPMMH>=T.W3ZU/^[>]#]D1W%6A#H$;+_FK8GU5I!QF<Y;CJDWR
M7]+FM^?%3@IS+I*84B^% @58)8V*8.8'!(J4")KY+,;"J"CD2=),C0/6RB@#
MPB8COZ-!HH0&/,@@]P(?HMCG,)5$#%'DB2P,DHQ[_M,;K_*2/<QQ-9_84.U*
M-N!VC3_GA3IT!03+/U##$FZGC5+ O92G00A)E J(,$]@BK" ?B 729+&+!*\
M&Z7+XD@)K9\T1DNY!KSX*-A/&AZ]97@TP =>MC?T4-RE[@O/V;O"7.V!UHJ=
M@4W5SL!:N=:MW'6A!Z<X.[(63I-E5.O""6R[UHB;1NVLESU%C [D0UBFQOMX
M2KG'J1_$,,R8)%IIIL 4AQ3Z*4>,A"QC>NEM3I!A:I;*1JH/NI5J14[VYP6N
M<#'GO+OG?\>S!0=Y72]TLV:=,EBJI&R&L@3&J7+2S%(?9D*D, XS+PI4HB(4
MF-LN P_9_S$6B\V(4$_NUDF(8<0)@DC($<%^P*'(./-3Y3B;>J9VRBCC,6WK
MQ&8H]&R2@<$=^F9I3\7$LX.YB<Y6Q0\_W!D;)P#HR,2PD6!4P^($B';-B5.:
ML@WO?WN;-8D"\.P"UR_?9N5?5X4HJ]<V'F'I518+BA@.4\A0JO+BI2E,8T(A
MSAA2H;R9'QDE]]?L=VK&PL/O=W?7ERH^]_P:?+UZN+B^??C]_A+<?@,7YP]_
M!]^N;_\!KFZ^W=Y_/W^\NKTQS0>@-QAZW#< Q /SW:;$0(D,E,Q@0^A!_/D,
M@7*63$"OUY%S"QA!\3G5@-GK%EXV7_E,^>GRKSE^+LIZGM.N",K=^=*)(A88
M"75'%6<>1"SCD(11"@5-6.IC/TL2KNUX<[2[J3'44F"PEGA9 ^T,W/WM_&\&
MWBG'L>YG(O<(#DQ 1\&S\?'1^&+UW7Z<HCF2)Y#])VGF&:2-3:^ST/%6QO,?
MTM9HRZ5(_RU+OX!5D.JWLCI_+:MY_J_VT_6B#(5!F$'J4081(0)F3*20T#C@
MA$<9QD;'2P=[FAKK;LH&>!O(9WCQ?1!4S4MP%U -?2&^(9;#V_!CFKNZ&3_8
MS[BWY,?4_71C?O0%.QJXJ#C+YU]YE;\W231JM555YMU&?M;82V.!,(4^251-
M.#^ &68Q#+*49ZKB4A88Q9EK]#DU:FA%!ALR@Z70IV3'U4%?CSD<8SHPAYP.
MIS'!& #DB&IT>AR5= P@V*4?DU<MS[!>)*<]\NKU*R>;G[] 21JI-',$86F-
MA-R#Q!,^9#Q*4T9]P7!D=&:UOY^I$4XC)I0]O0(EZ$DYN ]!JWD"=3I@0Y\X
M-5@]FF)E?L34CX2K(Z4#O8Q[A-2OZJ<CHR./NXF8W\UYR(*(4#_T8, 2+C<J
M/I;40 *8XEBD:9H0/S#*G7:DOZE1Q.7Y_<W5S6\/X.[R'CS\_?S^\K28=+N4
MD@Y!&Y@F]L6<CY$B4A.A@2++?VK:1TW5CT6.NTGEV!RK--FUZW_P_/EESMGY
M.Z_P,U=!%RKWPSV>\W5V+1ZC+&$4\@QG$$69"OU49)-Y,4L8R\(,:9] :W<[
M-9)9B@PZF<%2:*"D-CA U0=>XSAZ$#@'II]69M /J,[5V"G8&AQ2#X+Q2(?5
MSK V.[LVAJSW#%N_M?'.LHTUW#K3-G_;SG#\K2S97_EL=EZP*_FMM>5WVIB3
M/47)GX(P\5#**624A1 Q@2#.XAB*C'#AQ]B+$Z-TYF;=3XWQ?[N]_?J/J^OK
M)KGB,MOBX_G-;U=?KB_!^</#I6E&<\/AT+,[AP-YX'5@*7CC7KX6O:T.56^E
M/1K$'+4#SI%U:MCYJ,:J'3"[MJME*W9$=\/_.J<->ZJ+P:HLY(^TK1BC,J(W
M2;*53_O&,WE!\[<9K]?SC5,O(RQD,&*!)PU=/X(955DE QZ1F*8LT<MQXE*H
MJ9'B_>6%*N=P?G%Q^_O-H]QU@P=)B5_/[[\:<J&3$=-CR+''8>A[QY6<X$'.
M*]9D-_C]C2E+KBD L4H)O_'D2J6!R-0EQHXHUHE(HQ*O2Q!WZ=AIVY;'F$T:
MR54F\4?\0YFZ]URATX0:R:U0<\SQ15K'31D+7M3-;R]_4%[7\H4OO. BGY\W
M&2J?/!]G*"8"^FDFI+T:)3"+(A]B::=B$2,6$Z.89=<"3HV\;X7(:5=?8"FY
MX5&IZR'4/%O]B0,S]&'L4K5EG0<I:[LKWU;OK/E#EU4;_-*I\^M9>X +&\7!
M'?YH"QM6E9K/;=V'5F6'Q[@##8:K<U_7XHU[4#P0N)].EH?JQ_;2>U]7&Y_Q
MEX_U(]U7WJ0,4H4CYQ]713VOFO.TNLFJ^BB7L]LV0_)O*N11+FQW3>38SI%+
M\\>O4O%O.*_^4.&03Y%(XHPQ#I&O2KKQA$/"A8 B(B(021+'W&@3,!G-IK88
M-1)*SOI%&JJLG,UP5:]S4/]J>K$_$9"U70DF(N^$%L+-=6P3E<W%#)"/_>N=
MPN8,M.B #7BZ%-IS"1#H$#H#+49J@]2B=/;Y?+QY!"BH@,(*-&"Y=*"8V/@[
M<]F8BEXC.XE,1>V#;BE3$]#.3/B6%_F<7TNSY=.9XJ8K<&<E_Y/CZIM\]BD(
M<,1%P* 7, (1]4.Y14048HPP307&)-.*H3I-C*DMP'+VIF;+K"7\>FOB\* .
MO("U"L!&@T_W&6?-UJTIS+&IS1E0B@"EB;O5Y30D'2T%ED*,RMNG ;5+LB>V
M9N'#T^4-;#D9_^A:[O9E3UDBY"MI (,@"B$*4PPSXJ60<^1[S/>B &F=CAWO
M:FK,UAI]RWRG\YZ"EZ:8:KCD.$-J8+I:YC5MP=I[N.0,-@-O&V?PC>1A<PJ,
M9DXU6LCT.M+TMS">\XR6)EL.,WIO6 7@D_G:O+THWWDA;=;K7-J]3%J^]^KK
MN>?R7Q5GWR7!ORY>GP@C"&-I3F9"1! E3$ L_%05'O58C'T29<(@)-]8@*G1
M[37O=LU-,I<S\%QQ/.]VW4:1Y>9#H<'' P,\,$LKZ3<.-%2^I%8!E1^I4P$T
M.H"E$F>@4V-@[(WB_ <=@]$B_P<8"].D -9 'DD38-[NF(D#K+7>225@WXYM
M3FYUNW+^]E:5F+ZH(Y#F&WWD]*60W?(N98:(4N')104B3A%$6)6X)%2H!29.
M>1;3C!IE&M#K=FKKR$K.L^5=Z%(#T_3 6J#K'4NXAW+@%>,PB@YK%]FAXRQ-
MKU:G(^?C-0'B<^)=H[=M?23G*HO5756^YXRS+Q^_U^JDXO:M2<)7/)^K^^!\
MGJL\\RG!(48)%+ZR:RE*(4ZC"*9Q' >ALGXC;E(=1;]K(TX:H72*E!Q0E;OM
MK9-=74&52[D!7@ENZOVH/19Z-#4,P@-3E0*W28QWMP'N+TIRD!>_@I7PX/PX
MS!8>BZ:(.?-+U.YX9.]#4T ^^Q@:MW""NP@Y?I]%=N^SNENKRQ^\HGFMRDM=
M%?,J+^J<-O=3_E/HT\CSF =QR%)56 /!C(<!1,(+&8IY$GC,-"GR<.*:3.:Q
M<B>?/S]7_%E=G;<)QOE:>@NOCF%&V<!-XZ>/V_3]+E:>%1L**^NS4WD0[XE!
MA\6E.\0P@H[OWS HX'L=%H;MT7+EH2^<+6:\%#W7?=\6JB+&GDN_G4J;R&<A
M)0F'ON\1B CV8<98"/V4Q*G*,1A38N1KZ%"XJ1T.+'4#I0#G1;' LZV+].6M
MB^$*XW(T-=>4GS1&0Z\B&\/3ZP@A5XE6N[W#-T@-UB&A=[52N!1MW+5A % _
MK09#]&')_W-IV#:GQS-<U[?B82[;//^1UT\H)H$G$(&QRA&+0E] DN 8)D15
M124L3H1938%#/4V-F1OYU+QO) 1_*AE-$[,=1%635%U@-;2_A1%,YN1V# )7
M3'6PGW%IYYBZGSCDZ OF1>HOJTJ9IRIJYIU7'PW1Z%:EW_?NU&:VE+$L>+FH
M9Q_M5F]WB[B47K\ _5[(^B>Y"[0&GMO:0'7VC:/"\GVH6%62W]O@:*7C^]39
MK!7?^YS=LOZ5OU6<MF%O\N<9;[:;!=M*7<YB+TQ9E$$6\D!5W\U@2L($)FFB
M+M1C+T9&M[0ZG4Z-$C9E;K(-8)TLZ/:84Q3$3((.<2AM*40#! GU?1A$ ?$S
MCGW"\)/\"DCYLU#?['Q$W+6RS]OCKF=WN<9R8)K>%/<,K 36Q]/8*C,!R)&!
MIM7EJ+::"0B[9IO1NY9I*195V0:@=HXA/HZ)"!("HTA5*L4!@1BE'D1!Q .Y
M!&2"&/'\;@=3X_2U?(;)(':!TR.-4^ 8VHY;B3: K\PAO5WE/=AM?MR\!0>4
M^Y1WX-!SE@&!BZK(FW.?@GW+?S2%J+N/,?22"!$D8!1Z J*(89@*0>7_X,C#
MS!=!&!L%_1WL:FKS61G'"^6 K=:ULLGY I17XUOKM2J6BC1_%YTJAI& AW'7
M(P$W: Y,!]^VD%J*.0 U'$?#553>X8[&C;P[JO"GZ+KC;Y@?X#1[]<?7Y[^7
M?WTOWO*+HF;RWZL;'<VCG/Y6IL8.C;3@,7]M"M9)F<'WF[NK5?%EW5+P&O =
M/]9QA]S 3' 4-,=I]?3!L3KG.=+T:"<^>BINGOUHOF%G37SG+%^\JO(=-^5\
MM:#A,,KB-(MAR.($(C_DD/B80X34K[,P#+&1(;&WEZFQ1"MD6W>G$=/,/MB/
MI)YI<#(^ W/!)V@&, AZ,7!D"^SO8U0SH%?-70N@_V&[&;^G1+TZ7% 7RN=4
MFLQUWOS*K%2Y6:,3^K*7@H,-R=O#,24[V!!^D,KE=K@YF@V&G8\Z3>R V9T_
MEJV83:RZFC\IJZB<Y:SIXFK.7^OF*C_PXR3VHP@&/$$0!3Y71_D">B$G).2)
M$%BK2M7A+J:VB&Y)"1HQC=PC>L#L9R(W$ W,-A;H:%/*<0#Z:$.^O4$9\E]K
MNNAI>!1*.*[8<MIK/&E9*;=\?57>M7AVA]_X\NP7)21MRL_%B1= 1!,*<20P
MS)1V/ ["T.QR=&\O4YO@=W)<\KHNJP]0E+I5H/IQU#,Q3D9G\+F]E \T @Y@
M(O="X*IR[=X^QJU5VZ?FI^JTO0];I$?YEE?U_#KG15OW]ORYXHT3U7+2!P%!
M411#DJ@XT4#E1&$JQ5Z2(B9G?!IG6CZ/&GU-;>HWT@(E+NB*.*\$-LB[<03?
M?C)PC-K0A^F' 7/(#@:8]";$.-+$>+DO]'392G.A^8IU1HM*52_[RMO_7A5?
MN>"5[.F>O_-BP9]PD&2>2"(8>K%*HTTP)%DL8"IB['&1Q-0W36;1W^/4J&$I
M'JA:^8RS5QP!6,]$< K;P-RPE!7\LI3V5Y6>>07D_1$@;?)6Z('C+F7%D?[&
MSE:AI_Z>1!6:+]KZ8;:M/>(?;53'*A?&^6Q6_H6E=D\T3 (19PE$6&00>9$/
MTS3V8!J*) T\N<](PZ>BB4#6C,_6Z%5KLF3M9-GL>[@YLY(1X*60IGZ Q['6
MHQI7^(WE!=BQBDK6N(Q)6Z-Y?A1-"R] ;7R<.0$>[W%D'T!M"#Z[ .J_>EI0
M[ZTXFBB]/I0IO8UDH"SEV&N2C'L>1"+R(.:^#[,D0 AC53W$MXGH/5FRJ=E(
MF_&B;68!TIN!H%ZG(""?4Q <#:L8>-CU:/*G#.; 9/IY'/LS2=2]J23<A<<,
MAKGC@-_3Y?HIT;[.X#P4ZNNN UM#M,K?L2J0]1O.B^NRKE<!A+>B3==VVT0A
M5?Q%RK8JI'7Y8Z[^*06X+!:O3=ZCLGA"@4]]+TRASR,&$1&="PD)TS0*A!=3
M%II%#CF4;FI+PUJY,Z#4 [\H!56ENZ6.BFRZW(9E6\UPI>?R]W^N504;NAJN
M$&Z_ EUC^B>-[>!F]\\85@M;?0#XG5GU+F4;V?X? -;/.X4A.K'<4RQ(S9_;
M^KKJPIZ2)* I0S 1<2R7@"R 6>1%,,4^3K"7((]I)8T_T/[42'Q#/+N,$#OP
M:5K8]J ,;2?KXV%NX^[7VI6ENM/ZN/;F?M4^68T''K.;NDV5B3TTH0CE6UGQ
M_+EHZU'0CT=IC=8J"6SC2]7\:];:J>R_%O5<273#)?D\XA]/<1PG/$H1I(P$
M$"4^ASB1-! %/L$^D3]Z1@EBAA%S:D2R5 ',UU(#O!+;T"]YH*'58Z>?/V #
MDUQ; V>OX;8T]CH]P6I8-S1M7$TW= 5K9<^ RA4L[</'GF).QL0Y[( XXM^!
MA!R5QH<%>G<U&+@WNT7EG-+%ZV*F+H:6QFF7+OG;K/SK[YP]\SM<;;C6Q$D:
MJ21B01(3B)COP0Q%(0R]C$4T"SV1&!T9&/8_M65@0_SMW>.-JJW8)!%7>H!&
MD3/0JF*V-IB.D![I#XC[P&QN!?D CGZ6"#JB7]/>1^552VAV"=.V&0N'PF6M
ML*;6SFVQK,42^I3Y81C#3% ,$<T$3*DTD)'PXS2C+$B35-N1<'\?4V.T?WN>
M_SL(_Q9Y)M4I#\#73T6.0!F8;E95Y-H*6E+$XURB#9!!K;+3@1JI')D-8&9^
ME/U0]/I/'GAU/+_)?MFW_"6//.HLLE EK'LN\G]Q=L7DYY&+'*\K!-.V[)BT
M0J_EK_-94R9#_DU^26S# V+CCT\LC1(_BGR8)#B0)J*@D%"2P, 7/D4DPYE9
M8/+P(D^-@U>N0'/\ \S6<@+<Z69F08XPYGI&Y[1&<N"%8U_4ZAE8ZPLV%>X<
MOL!2Y>;,84,OT&E]!K;<Q#:>&#3>=:!1&BY&UK7 /SNN=J !T(C%':KG4_T?
MON ZKQ_>*H[9;?$'KAJQY%+)GP1B<D;ZTEX7V%/5CQ-(2"P7H5#@C 4B3.+(
MSJOA8)]36T :04'=2 K* KQWLJI2R,;NN,<1-_4@<(+CB'X!+9P/*SB7(BL3
MUZD_KC9 SF_N#_?XD^[CCT)P^);]^*NG9V/^E(29$T[2*(!>&E*(4,1AFLG_
M\1(:19P$<>89W:/W]#4ULNG-O0RX30&</J1UR<8)?H.3C%[FWS-P4Q9O5<D6
M=+A$P./E_YU,VE^+;+]ND_S>5:IHZ_SC3GX6<]GTY3(?YI>/1]EBXV."6<3C
MF/B25>16&J5^!%-IP\ @XP('012&F5$Y+HT^IT8Q2Y'/0"-T,S\NUZE#E=A6
M[CPZ\.OQC6-0AS[4+(OGKA#6XU89+.=.0 :X."(:G1Y')1P#"':)Q^156P+J
MMFE-X9G&<;V^DALXSIX8PX2F#,,P#"3O<,E )/)3F'@1"KS$2_W,*&CH<%?3
MHYOE(4O=%$7Z)2] W<@+?C4EF(/PZO**"] &II,U7HV49VTD30U:05V2R3$P
MG''(P8Y&IHYC"G]FC*-OV!'%#?_KG-)R4:B*V9*7"ODC;0->)#%=O*CPE_JJ
MV'PF+V@N+=IZE:>0I!PQ&@0P]GR_N42%:>)G,,.4I4@.0AH:63(.9)H:]4B5
MP%I>L*U48_=T:JE$!%L/+C73R8$XV CKD=K(XS8P^VV,PL-<CA"N6 U^?V.J
MU/AZP Z-UR I*QT"[(A174@T*O4ZA'"7HUTV;4;FC.=/E[+)^<?E*Z^>9=._
M5>5?\Q?EE8B+CR<B>3@+? I)G*00Q3QM$N7!)$M(2N-8H,S3(>@C_4R-=%M1
MP5)6T H+.FGU6/08M/W,Z!"P@=G.$BMM"M-$HB>_O&RA923YPYJ(CK4["KEH
M*K<D#-W'3TMJ\RTO5+**B[*>*_^Z)Y1REC!$($]9)JVT$*MH, &#,$[B.$-Q
MYFF5$SW2S]1(8'6Q+AHYU;=-E:AGH&A]_/&&X^DIY07WHZY[K'TREH,?:9-Y
ML_%3\H&+%D$IHONT-0<P<)RJ9K>7GY*>YH"JAU+2''K<PC'VH5RHL(7B L]R
M459%CK_F^+F0+>?TZA4K3KHJ:.?.&# O\7PB=W59()DC8Q[$44QAE/E41#'F
M(=>Z>3?N>6I<LI0=K(4':^E!)_Z9BD+ZFX$7J=%@]!/*H! /3#$FZ-HXZQK!
M;.#".Q3<(SGV.OFHS3Q];1#K]?\U:G \KV ;/;=\A:T:L,VSOI&\_9K7]:/<
ML/[CI9S-/F[_*CA30<\YRW'UT09GJ%]6]4O^=E5(ZN7U_%((3N?UK>AVNG*%
M:M-5>9Y@D>=C&"3<AXA0'V8L%A#3S/-Y'&1!:N2X-9BD4UMNMA0] TI5,)<B
M@U99T&@+UNJNHJ)6&H.ERF>@4UI9O)W:;92K52ZSX3X6/7MY$I_ P,OA)$;?
M(D_^P"/C+-?^4'*.G*]_8+@_Y_P?ND/;1.'SSN.A]6&6S5[^H+,%4Z<K9<G^
MRF>S)QR&:4BS$-)(!!"%G, T]5,8(9ZDU!=>EAH=@>AT.K5%I<V:D*\D![@1
MW31KN ;:C/A(B(!"/TT81(&704)"!GT68)J&G(=Q_#0OYWCVD]!>=?W_![3U
M%D[7& Z\!J[%7:5.5JO6+RN9P5+HPPX<%MG:]3%REK!=H\N1<[;K@_ Y;;O!
MNXXRM_]6E77]%+,PQ3Q-H$]]E?DR#6"*,DDYDM^%I"$/AZD)Y>SO9FHD\ZCZ
M 'L2C9^8H;W%U.P$VQZIP0^P]^1A;X0<,//Z%@A#)5MO._FY^=6W%#V:4GW[
M:8OCZW6^G,=2LDN;<.=\/J]RLI@K:_*Q[,+5&E>I!SZ?S]J;^*<DC"GE(H'2
M\.,0,:3\E#(!?1((3]J&+!-:]6).E&-J9N&&^Y' >07>\6S16"NE<I"7T^:O
M?/X"Y.>A'!>D G(#FJO;(+4TMSZ4!B>Q)PR?QO'W.(,R,%VME0"/96/T=*G-
M-A51?^I4:7TSP88RXXR'P3GY..,RTJGY@.-C=I9^.JJ])^LG-#_>.?OI&&R=
MNCMH[N=G\5@;X=(L#DCF93R%S$M"B+PX@YA[&,:"D30,HPRE^&>E[MB0<VIK
MXM7NMGT"B3HVAU7/,I_ 8 V\5@Z4DN-;7N1SWL53;6@^S90<>X9F@GDX-J7\
M/S;YQAZHA\RXL:\[N_6EJYIWSU^Q_+:+YSM>B;)Z54Y%MV26/S=R7OYXXU1:
M_(_YJWSD5CS(W]:BS5IZ+95J"GL_411E)):;)^1G#"(>1# +?+F-\EF4>:%/
M<&*4#<J=:%-;13K-%"%UNH$-Y<!:NS.PU ^T"C95CC94!'\J)=O:]887M@Y'
M7F_5^3GC.?!",_90&B\H[E%WM(8X%&S49<,]H+LKQ0 ]V"T.ZC*7\]NWIB!)
M\7RM"JXN%Z./KN!5_77!;_B/^>-??/;.OY?%_*5^"KT4X<Q',(U0#%&2Q9"(
MA,$HB3V4!F'$8V:R%-@*,C7BEY, F;&T]1#H<?(8P [,P*T*9V"E!&BT.%M9
M\!]G8%X"PL$=SJ4-_T^.*Y6KU!W%G@JB(T*U%F-4^CP5K%VR/+D]B[N&_^0?
MK>-]CF=?\1Q_*ZO_*/-B_H?L:U&IQ*BA"%4=5L@)%A QFD$<D #R., L";)8
M>/HW"L=ZFQK)?<&SQO9Y>.%\#I3$_[?!P?-1;#6.^UTB-C![25'!2M8&+%6A
M!#3B@J6\+N$S.)UW">-(9_"GP6EVS*X+3^]A^M%&QCLRU]5GZV!<^R4SFN64
M/=V]OS5N@(^2N;](*?];AS'WOC@UAI3+$GBOMS:*7_.:SLI:0G8&&N'UYOQ^
MG/HI\F2(!J;$/>BT/LE 20L:<1ULD'MAZ DZEN]UUAAE:R-L?VNC3-Y>19:3
MM?\ARXI"Q3QG^6RA,G$^<+JHFB/*UJ^+LV]20!6^O&@Y_U9<XDKM9FLYL&W9
MY(_]#;2I\(27!BB@,$A5]2%"0IA%&8)<?C,!CB-UUFA4?6@X6:?&+IN2@K6H
M5FGSAAQBO1WJ1 9N:-\.NS$S+V4T/)JNRAX-*.FX)9*&A_Q3.:41NK38-O^A
M',AD=_4\?U4.9.N<94V<E[HD\E(40QY0!%$B$IAY<@_-HABC.$&8QEHN"1I]
M38VR&VG5A0!?RKO,0KCTJ#/8 AZ!66/_[ Z\@6ESA=M*U,V$A&YQ,]@XN\-O
MI&WS"3B:[9GUD.G=,1]I8KS]LIXN6[MES5?,]\J/%3NOJJN"/>;SF5; VN>W
MID:*C5#ZV^ ="([O@>VU'YC5'BO<!#))Z90'=IOY6LJ9O^=L@6>@'QBC#?!^
M#*QVOSM-C;;UW:_"YK[WP!.G.60V_CEUWES%RI_F'\MHUC8'ZVVUG-7-G#^O
MZ_RYX.PI8"2C<1;#, HCY223P0PQ"27C&1*9YWLBL?&[M!-G:E-^M0[=8Z8<
MJ-NDS'FC@HI#P&LM[?PM+4=-;ZLZWE@,3$ K[\D-3<Y J\LJ@T"7\UE.GI61
M< ;: 5RJY-XM\C1H'7L_6@KS4YP<3P/ND"_CB:U:["&_R'8>7G(^8\NL3'[
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M,I\V!1[PSNNDT,HA1U6#^R<R4F.=V6VH"=9Z@DU%NR%<^5\U09P;RH).VRZ
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M'@=:<ZOF%+ZA#\;,D#/?NVF#X6HS=[S#<7=WV@!\VN[IOVD>S'195>K,Z+S
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MSL]IK&<;&[E>_=>WZZ=_@.O;WZX>G[Y>W3X]@LD3^#*Y?@"_36Z^7;E(4VR
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M2BTOP$9/4"L*=C4%JSG8UQ4TRCHDV7Y6P14=.Y9N6.+N!]IW%-_3-)8?@[U
M[3I-T\<^2CRAVO)R:8?&80))%&,H>)AD&),L2)&1'7IDDM&9G:6,H!'2,O/U
M*)R:_'HF2'V3I"D^YM36 H K?CHVQ; DTZ+D.Z9HN]:JT,\VL;Z.$]N+"[OA
M\A_YA"S+TD)3#P?")S&%R%<A7 D+(59\X&6<88I8Z.FQ@,7<8R.'@R!_LS)!
M1J!K'$;T!V7/%+)7B6,3+7L0&5M)#WYOY#>K0&2$M5%YHKXP'ZQVD5/L3:L<
MV:#740+):,@AZR/9Z'I0/,EJ"#L#4#4^W]:B^X27^?)1VJ>8W16_X4494_R
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M;BP<;?%;)AIT@]^M\.'V7N,..Z(X6I6PGN?M'K^5!NKG-9_&*$TP4WW;/!)
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MNN<<&SL]7OWR587=/US=WST\7=_^8N@ATD!9TQOD%KN^/3^5M& C[HZ?IZ_
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M'N^B]_Q)4ZI<5"$B.QJ5I;MK94%UB<I:/OC'_3LJ%$ #@WQX:B#^JKJ'UEB
M!HRJTD@%ASM3_F.6T=%.8&#A!]U(?,S"'.Y#/D@*6S=Q6?)%);W7=F 0$R_V
M52H%5\7"11BJ;A($AHG'HH!Q3%-JYA0^F&%LFY6F4I&2T-3[>PB>KJ_W#$AZ
M]^QNT>BAA]1)U9WY; _'']A#>T*]]_[84Q>ZRWMXX 7_ \^>^.)EZB64"A9E
M$-'$EW]0##/F11"E(@U3+T0HT2JCJ3G?V-[Q;9S%K#HX752R CGYR_GI#KM(
MZU& 0_QZ)H23R0VUN."I#4(G.0U'@.DQE6%WM@_/8#BBND[BPK';[(BEJN][
M.7]YG1?20/D\5Z%R4YZD8<:D59"E*(;(\QE,2<KEGCA)_"BB$0ZT"J2TSC(V
M$JGK4V^D!+]7<FKZX=H1U:.-LW'JF2S,(3(FB%8('-'"\3D&)8-6-0\IH/UB
MRYW!2NXQY%;E1J[([#_7BWS)Y(8EGQ?-/B'$:9;2! I"&$0Q8C"3^P.(44!8
MYD5QZAO59.N8;VQD4(I;^BM*@<&NQ(:[B Z@-?<4[N#K>X?1@EP?.PX]8%SM
M/SIF&W8WHJ?ZN[V)YFUFO,(IF][.BU_D#%^EB2)W/Y_YDB[RU[*US"9:2H,Q
M]$8:&V%(B>$OD\D]J&4&.T+K$88F@NU\X1Z\GNFB#3?'H69FV+3T$) #U61!
MV98C-(<?A"+,5&T8PO"NLSOD[E2(*"M&3-.,L%#0"/IAF$FC(_0@Q@1!Y@D2
MAR&/_"0UZP?5,IO62S!H%ZA2+.ONM._0U+,LSD7H PIT[95X:0?MG ZOI^!P
MWZKUW4P?U7/UE,HMS5-/WF(1>#6)_^;=SE=<%6*0>*6UB>QC'Z5Q@B&EB$+D
M2X+ 481AG&24"P]''@FTHZV.SS$V<T(*^?^ 4DS UAPH00W"@4[@V$X(CM#I
MF0B. &,3,'4"(8,HJ?.1&B@TRN11,@N&:H>@-0+JQ*W#A3VUR[X7Z]1QJ7D+
MM*MBI?PY546L3<R^VI>MEU,_]43D,0PC(O] 4<)@ZE$*(^ICAEF"<*J55]@U
MT=@8KY+UWY<[22>5H'5!8,W#VTY\VTG0)6I].V-+,1MTWL'FIKV:#A96W=9:
M!QZL^9J.>KN]V+2NMRPD((3*!9'#5<4V;_*"7Z_XRW+*,HX3C'T8IQZ'*&0I
MQ$F80"%(@%&0A@AKF3^=,XV-$K:"UO5AP>]*5E *:W@L<QI>O6V2$]!Z9@1+
MO,Q+#W1AX:H$P<EYABU%T*7NNY($G3><66MDVZ-U&OLQ1R@DD"6!ZF5!4D@8
M13 1\D]"N<^X;U5M9#N'$2T,$%Y\?7MY]_4*?'FX^PKN[J\>)D_7=[>& <3'
MH-0D@O, ZIL"-F$<>QV8>R@[\EY]UX5'=F;XF-(C[U4\67SDR*46_H]+_)I7
MV\')8J$"0<NJE$TO5D(R$L0<!B(.(0HB!+,LX#".$DPB%F1!&&M[0=IF&IL9
M4)=Q NM"P@CH1G* =T0WV/NWHJSA(W&%7<]4L!43[,IIXRUI1<S 9^(*N8$\
M)]8(FKE1=%!I=::T#C"<2T5'CSW'BM8-=J;2_6)..6=E#_NFV]MUD:]R/+M?
MDUE.I8W&%Y*XIREG$8J] '*>$46KRH!**(P\:5'1B' _,*KCI#WSV&CVEX7\
M>H'76GPS<TH?;CTCJQ<0>^;;1F:@7HMMB\%:;%#)#1K!W5EDQE@YLM/TYQW4
M>C.&X]"F,Q_@O(/PRG3</TF3V[HDY'&:0"^(/8A\$4$2J>9702KW>(FDJ4PT
M)^%/^KN[MCDMSL.?!JLN>>K\U^ZT_"CD>LQT-H(??5Y>TKS[\_(V/!P?F!^=
MZD-.S-N4/G5DWGJ/;9;?0@YR>;^HIWA<S>D_F[-S2F..,@9Y&B40A5RU.>4$
M9I033#+$HL2P"-S)N<9FT%2B@DNP$1:4TIIF 9X&5X\R'$'6,V.<0JN7+,%.
M0)SE"YZ>:>#,P4Z5W^<0=M]BQA?+A=QSS8OE?)8S]?DN3[/D''6.2IS1-")^
M +TLB54280C3-,/0]QE.?19SC+1V0NW3C(TE=B4%C:B&N3\=P+;3A#NX^G8H
MV2&E30]Z0+0Q@QQAAQ7DW[:,T#'X(&2@IV## YI7G]NGJ#K2_GO.Y":GK(ZO
M_#&URU5M@:Y^RK>PP+/+]7(E#9?%\M.;W"&Q-5TM)P63)/4CIW7SCRD+PX1$
M:0I)AA%$J1=!G'H$XB!@<<;"-/.171<CAU*.C8 :]W;I-FCT !M% 'D#C2IE
M6DVC3-UOQ_ <O)^%US2$/GHY>R;(WE;RC'9)/2#MO)F22QD_J-52#S"?;L34
MQV1G9)$JKWU3G;,N1+R<_,R7TP!%% ?8@SY%7#7A]&"61CZ,@C#S&6(\(%I5
M,K5F&QNM-[*!WY5TIBS=BJLFV[I"J_>-IQY0=JFA70"X3 P].=?P::%=:A]-
M"NV\R;+&Q'*52XZ2Q/4%YXO?\$RR5//#ME!Y4UG7XVF8L@0BIAS?6<0A08BJ
M7 ^/L81Z"3+*.S>9?&P4TLBN^JHHH4$I=9,I:5XSW&@A]$BF+WA[YIQN9'MP
M>]E@Y:KBA<G4PQ;"L #E77T,FS&LXPI>^6+U=B\?IY4TIJZ:/D?W<IM.W[9I
MVCR6]@VA#-)84&G[! 02KB*W/280%XPA$DU_\ 69&P06:$UM\IKM"M#CR?B#
M"M-\^D=9^%75?+U735F,(PST@-<.,' .9O_Q!:7(%Z 4NMQ!;L26_U@*#GZO
M_]M+DQ93U-Q%&NA-.W2@@1$81^(,S.XW=_8_4E[@13[_5BQ?.<U%SEGMDJ8X
M]H(L\V""(P91F"*8X<R'-$L(8=3CB;ZO_^0L8[.G&D$MO/NGD>QV[CO!I^]-
MF#8T1N[\3M7/\.:?'GLP9WZG>KN^_.Z++2+&;]?*J+D3JIB/\@(UL4E?U[-5
M_G7.\"Q?O34>GZGPB(<3P2#S/0&1CS*8<E^20$RRD(=)A@.M8 #SJ<=&!97P
M9</*6GR#<&@ST-L)HE\H>V:-&L4[ 1K)-_&-H)0=-L)O?-V]P6P0AMX;W /%
MI;N$W2Q4W0JYUMAULQ&'"V:WTG0ONMUN!/.J:U^D?O."/W ZE]NYM\]K_C27
MN][_7LL)1-[,_81_?N(%%_EJ.7E9Z=9ALQE[;%1?ZP :)<HJ&*LY.-1#?0Q4
MM&2C2MEJ=ZWK8[->B?;/PQ"+T/-'HC?\C0J_G0.B52DXJPD'*PYW#AR[Y>+.
M&L><ZR9_X 5;7L[F2SG/U^(U5^Z]*@1!D]%.CS VWJHD!:6H("_ 4_Y2OC=?
M;^^O=_KQ:EI4'>AULY ;X'KF&EW,W$5<Z$%CQ2 MPP[&$]VJ[;*!QM66[>#J
M2(8'/BLI9?D]?VWR3[TXHV'$(L@$">6F-DY@EB $?1*2A,9!BK#1B6'+7&.C
MB$94L">K82NU%FCU?.F. .N9&HYCU<,QGP8<KII]M<PT;&>N;I7?M='2N,6R
M5TY>\#MQN> L7TT3'D9IY$ERB) D!\HPS'@4P-2+4!"S%-.(&37&V1E\;&Q0
M9<K14C8@,*V3B\!\O5JN<,':LDZ[D=3C EM\>G[Y;^;%,U3M4H 24.TT*A$=
M-K8YHKBK+C:[0P_;LN:(4N_ZTQR[QC:/;2:N"VF@J93;![[DBQ]\BECD$QY3
MZ%-U4N7Y/L0A]2 )/$Q$Z*5>8%3][-@D8WN3E8PP;X0$F-*%W%"9YJT= 5/O
M)3X7HK[/JJ1X8",?J 5TF9YV6GUG>6E'IA@X(>VTDN\ST5JNM3BT^@7GQ5UQ
M.2]6BYRL*Q?!]0M^EA^H2UZH%^RZ6,W_<YX7J]_DW^6&;<HS'_E9D,((>Y[\
MCOME9DD*<8 Y(B3TY;=<^^3*?/ZQ$832 ,P+0'=T4%^UO-("T$H-N066F]__
MJQ0!/RI-#,Y?+)9)XZRK7_![IIX2][L"[(JOSF%J!4"M 5 J@%('\-L0N!L<
M?O6+_T G8#VL@]E!F#V*K:=A%L,.=R1FK_/>N=@9P[A)=RYS*$0:19@3#T9)
M0N4'!1.8$B^!%(<(9P1QW]?:&+9-,K:OQHD$7H/\E%9(V\G?%5!]NXEL,#H[
MQ5DW(\4BP7FX!!0=Y;J2FQVDF_R&%[ER.:LFZG6,7H1\2A.>0>YG/D1"9#!E
M'H:<)RCB2210;)27_'Z*L;WJC81 B6C9R?0(D'K[Q_/@Z?D%-T3&>/=X6GE'
M>\<C$PRZ<SRMX.&^L>5*NU?[EJ^VA78GJ\J 4#,\S6^E\,JDF,]F93E>^9+Q
MY6J*4X0\$7(8$LHA(CZ!6>0'D,<!C^*(IEAH%<VUEF!LQ" 5D+O"LC0TWA%?
M'9(6>PJHO6.I@>%YDOD:Z9%*K\CWS#D*]+UZW&!R@/V^"J#1P1TM6</GB+7,
MYQ^4U*SA.>0\^X',HV'N\=MORWN^*&L 2#6W 0XWFMTM-$<9T:LDI04_EF!'
MWIVX#L?]+@S1L0KRT!E_L&@/ V5WPSY,;K/MEO7;?+8N5GCQ]B6?R<_D-(AB
MDF1"P#!2)GT81#!-*(6$""02JHHY"[,V60<SC.W#7;=[PF C)R@%-6V+=0AD
M.T$X@:=G2JB1.<#%:0.L$\J?T?GJ<,2!6UZ=4.A]KZM3%YJ[XAY4A?<ZL(@0
MWPM3%,"4A %$+/(@"3&'U$-9) B)"=9*1#H8=VSOK*JJD2]7.<6S_=H"QOF'
MN^!U^]DL(>G[W-86#2/WVA'=S_"H[8XVF!/MB J[?K-CO[8XA=WTKKF1:\'+
M/R8$%VQ>J%6Y_(X7SZH0N8@X3R(&?1QE\DTE6'YB?091C+,X20,?9UI^<OTI
MQ_82EV("O)43T$I0@R,]/:PU3D^=(]CS.[_M1U7*>E']!^S(#"Y[0M/@3-0Y
MJ@,=@SI U^S8TPBHUI-.O9&&.]PTTFSO/-/L3O-=_K>"+69OSX^<KA?2(/OZ
MS]7](J?\\GOQ?$^U,_G:1QD;YWY3K;YF;V4WVUIB\!4O_LE7H!1;/=;R(ZB?
M^M(!8K>7Q!U^/3.N)G07RH5"VTJ(&;E)]."Q\I!T##V8<T1/Q5V_B.8=%K9;
M4Z5O0O][G2]S]951Y6-6;XU7436NX>QN43:P(;-M/:P[,6&LO '/'B4W\65U
MZ43(&Z]^2E'+SZ7 ).(X)#!%:0R10-+L\Z(4IIE'@A!E3#!?V^SK6]JQL5>C
M+\!;A2\ +U7>'*N O-1$KGGYDU+[ @A5B^Y'68MN+@#>Z Z6I?+-/5BI#WBC
MOX'IU/N#HV'#CNEQZ)F,-T_"9/=)J+3='/* Z\V3<+UY$G:J$MX)L%4;5'HW
M]Y2:@ZLQ/@D&]O>8GHB!3/?1/!EF&X"A5JIU[]"[$,-M.X;"<V_',MBDEFE
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M^1'<W8++R>.O9IN&/M96;V?QP2O6\]>STDX=O33Z5>4NYP500E^4?X(=V2_
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M2^IZD),_\()5A;*ORYIO99'(.U6W^4DRW]UK69'H=EZ5SV9_YRJBD[/)#[[
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M5\%7D[S<<BFQSA&@_K5W:KLYM&U2!=-NG,Q8KV7T>W5I,:@&YZ.LJ=D.(5X
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MD;Q3?WM^)5/?\QZ$^AZFR^.5$[Z2;/X'F:S4CH&GH9^F/DS4G(<H#@0D<9A
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MP2IM:7&'*?B8>SA@)(TA1X%42UV(U.8CH)!Z,F))F% 9&"61[U+HONU12M7
M9'U:P K%P4]*]9^US\"D?.1]H[[ZX\// _!68@#>1.&R/ <O!0S5PP,PJY
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M U!*VXK/NR$RCBS><[UU:L,:JKYOE9J^UI"-_K7*EA_?Q/)UQF^GW\5BJ5?
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M=OA6UW!W1W$&ZNT<S)D\[SXX:<C_L2H*QB[&/(XQ1QZ#2<AU;7K)81I) FG
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M/_!A&J<$(IS&:@<?Q[%G=>1YNJO^+GCSM:Q@40IK6;?Y-+YFIY]N4&MY<=H
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MK8RTL2!)XDD_A!@G&")?_0_UXA1BAOTT#KQ0BL#TJN54)WWCR5).4 @*M*1
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M;D"UB"204*EL>T&18%$0,F1U>GJBG[XM!=MB@J4R#VDIJ!VQGT+5#_PD3N(
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M"X W&H*L4E$%L]9)(@S,G.'&6\/ _)!1')GM-@-XV1W QLNV.>>]W0S@[68
MM\J!N\T ?O^X 30P9#]D(">R=*<=4#-[>'#<>PWFX7J;SJ(>'*$=DWOXUNT.
MJ+Y(*>[%5<%EZS>85O<9-['KG_*BR'_('ZZP_,35W>_(#ZCK"@+5,96J(1S
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M<J/B@*>[G-O4WZL.>P%DIR_*1T0;@<^_.[>'N9[U,2R2(_/#T?MQCPV85Z?
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M_.9&K@,93?'ROJBKO&W]UCL+PI]XN>:W9;GF;.$RYB%&?1@Y-('(BSR(A>=
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MJ2!F^"5,DUEB^RVH0"7<IF@ZK\S$U-^#GBMKAF,\\D)Y5A&$[9=1J][W65R
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M_*%(*5_X)"0)%QZ,A,_494<&8S>.81 ($K-$^('PIDYZJBF[R5R9*@5J1W2
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MCSUHYPCY+'?N;W(1>>._XS3[DI?E?;;]W1U?+<(H0<BE OJ$A! % 8>))VW
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M_3DMJ3KF4V<_#UQ^?U(V&GB,1PZ&(8X":<[%"4RXGT#/C5W.$$>^;W0(8RK
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M&J_8<<5G+K@T<]2MKTXAEH5D@L#E 8<LB&*Y?9&&">$QAJ'+DL2GB?R_;>1
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MJ5)2*D(5*TW94%(A</R4HDQ.<C26O#*0UJ>N$9!M@(')FRBD,:B]GUSXX7@
M*@?G7"3:VW(*J!5Q%&-LR-R(Y)V(ZKD; MM":D%%O]#9E;Z?@=4&PN\1/K,I
M>H(Y#T?#PL B@?\)NGNTA@<7I73+SALZ*.*-9"1B+(=N8%;1/M>QX@8^^(H[
MT,'O;F&S^NWMP&83?4ZJ"K<!ZW)C@M$IA4/\.!LH9-HF'8G7"2,\T(9X"X&
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M.?@9I([U&R$ZJ4,&"R@UP+#6E?41@\4O3GGJ@K6T=J!?D?P6_*LJP5]?*FW
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ML8-O)?5?[F9GJ8S@1.>DB50.[0%7F6BO601AO)&UIS.\EL9^;6QSL-VIBAN
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M@=B8'6&1\DR=E,#46BAY]C7]>$R[A$@]J380K9=FM/-E,]J;8--%PT-.FM#
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MK](0>/:0DT0CBUP+HB4ZCE(H3FQF^ EE%*EU)H58'52KJ.FW!^[.T%1%^$W
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MX5?4S]?'G.3@=(" -ANX)%+H2 )UEF@1C0(390SU.P^MHF8]7/UH9P&5I-\
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M4/^ :?YI-OTWY@DS*197%&2LLUUC"1 4*R!U3EE*:=C#,4)#(?.^8-U7U \
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M80I\9-84E5EDL3&0SJY\>R]+[U:^O8_:NP!/91N[>=E\6_^#:RX+%V5P,AC
M*#QIQY<Z65C4^C_&D3)4=*U;8I\09]QKR_8G6BO-]PNBZ[=/QXH3SH*,E='<
M" VQ\D"Q9!&SSCF9?!H8]7"D-3/[;G ZP 9= &KM6U__6;GTKV=G8U+2&\>
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MYJ9*&3I!BE> HM8I"2XA)H_@C'/:^F!+\[EG6T0Y$RKRO>P^;V^$3K%4?[G
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MX8L2.A>[6S_6W9\Z;L[?WM@':ZR#0V'KB?GVIL@H(;*D4@2F,5-NBK5A3 9
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MAD7%A*H#L G'RKE*(Y8#1:R2>89)XY-EX,_#XN[7QG$A1YMKWD!W8Y\5?[O
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M<EFK8+>]6UNM7')2@N:LQOAU(*!*"*$421FF9%*TYG7;2;!QJO#ZPNUPENP
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MSI8#;H4;_PQQ,X; IP;1WS(NZXOXVXOYYXTAW>3Z;!:CBI EQ0RY!/+?K7*
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M0T">JF'G@6L1ZVF[#63H4V_!A;Z[@<H/ SXSOL%=XLK=!=P#*JXLK62QE)1
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MU5U&8-<N9S!<%32UVZLAIR#Q EZB!Y&\PQ"+-['UF\8^\^VYY^H^\#R8#CO
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M?;ZV)E?OW8B16RDB8'(1E$L2/.,<O"6_FV?FX]TC\8&GXZ=&ZA9+^^MX,9;
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ME7 U?IDOSA:?OW]:E/-_D:RONMP%98/+"<@W)-A[:X .65XK9I..R 1792O
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M2VC];+S%M#H]W7:%PK90VU$O'4#M+7DL5S=**2GK9 3)UD6(',$Y6H-P+K#
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MK.(*E+46@BH,HO<I"B]K!MM6Z'AJI$ZOMEO@I*F0.[!-#R<3(<W7,%7;5K!
M3F.DA?#(P+NH@TG91]LZ/_ 9)W3M8Y7:Z* #,#V62*242-(;#4DY"C\P17"&
MC*T6)085A"RVM9_SK!.Z]@%4*SUT *DM;IF31<$\%DC)Q)JB5K>+C,"0H4@D
M+'6XN_VWSRRA:Y1+@=U4TS/8+G.(HC::<Z0MR5RAU9@$:(P#3(SVCD,I]<&
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MMY[HM/?>SP:W0U7: 6Y_O.][B<OE]]G\\XNOZT?%++DR.6;@KKY61UJ0YRX
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M*B%KQXRG""B6]J7_IU%?-H;O0^K+QI"Z Q/ZT+P HR53MB:DUHH[F4FI%U5
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MFOCP2F:<7=V"P4\>M^Q%[0XP\Y#O?+67-ZMOSMG">Z,2&5VP(3ERQ8*$4'B
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M0)9J=XHHH@FE^)X/#&ZZ!CM!V+Y8I6ND+_/VCA<2@D<?6)T:D NH7'.@1#%
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MW%P)&M>(1DJRZ:[VK=:D9%WA""1G9.JC0N^;IZD\MIB^'.J]6/T\?/:@>W\
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M%.+;IS]02P$"% ,4    "  <AUU84:YU.@\*   <&0$ %@
M@ $     83$P:S(P,C-E>&AI8FET,C$Q+FAT;5!+ 0(4 Q0    ( !R'75B_
M+ \Z?0,  #T.   6              "  4,*  !A,3!K,C R,V5X:&EB:70R
M,S$N:'1M4$L! A0#%     @ '(==6)F==$:G!0  ^ X  !P
M ( !] T  &5X,3 Q,2UA;65N9&UE;G1T;V5M<&QO>2YH=&U02P$"% ,4
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M4$L! A0#%     @ '(==6$OU)4F4)   :00! !X              ( !\S$
M &5X.3<Q+7)A9&YE=&EN8W!O;&EC>6]N<F5C+FAT;5!+ 0(4 Q0    ( !R'
M75BB-+?#<0@  .M    4              "  <-6  !Q-#(P,C-E>&AI8FET
M,S$Q+FAT;5!+ 0(4 Q0    ( !R'75@^(DP'C@@  #)#   4
M  "  69?  !Q-#(P,C-E>&AI8FET,S$R+FAT;5!+ 0(4 Q0    ( !R'75C'
M][C R 0  /89   4              "  29H  !Q-#(P,C-E>&AI8FET,S(Q
M+FAT;5!+ 0(4 Q0    ( !R'75@_RCQ<N 0  !49   4              "
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M,#(S,3(S,5]D968N>&UL4$L! A0#%     @ '(==6+3NSO-H"P$ A<<! !0
M             ( !*^$$ ')D;G0M,C R,S$R,S%?9S$N:G!G4$L! A0#%
M  @ '(==6,PTS)7SSP$ *1$3 !4              ( !Q>P% ')D;G0M,C R
M,S$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( !R'75@JI86%L4(!  3O#@ 5
M          "  >N\!P!R9&YT+3(P,C,Q,C,Q7W!R92YX;6Q02P4&     !0
,% !D!0  S_\(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>rdnt-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20231231"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rdnt-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2024-02-27</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-12</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-12</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-20</startDate>
            <endDate>2023-09-20</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-20</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-07</startDate>
            <endDate>2023-07-07</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:StockHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-07</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:GeneralHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-13</startDate>
            <endDate>2023-04-13</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:GeneralHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-13</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DRTLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-22</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-24</startDate>
            <endDate>2021-08-24</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-24</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rdnt:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rdnt:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rdnt:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:GeneralHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-20</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-12</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-12</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-11</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbitaiIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:LosAngelesImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:LosAngelesImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:LosAngelesImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-01</startDate>
            <endDate>2017-04-01</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-01</startDate>
            <endDate>2017-04-01</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-01</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-01</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:BeverlyHillsImagingCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:CCDGLRSServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SouthernCaliforniaDiagnosticImagingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:InglewoodImagingCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RamapoRadiologyAssociatesPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MadisonRadiologyMedicalGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DelawareDiagnosticImagingPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairRadiologicalAssociatesPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ChelseaDignosticRadiologyPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-01</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NorthJerseyImagingCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-09</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:JointVentureWithCalvertMedicalImagingCentersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:CertainSellerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:BusinessAcquisitionContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:FixedAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-01</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:TarzanaMedicalCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">rdnt:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:A6.0NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:A6.0NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:OneMonthSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-27</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:ThreeMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-27</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SixMonthsSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-27</instant>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-07</startDate>
            <endDate>2022-10-07</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">rdnt:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:AILongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HoustonMedicalImagingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-16</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AntelopeValleyOutpatientImagingCenterLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-01</endDate>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="center">
        <measure>rdnt:center</measure>
    </unit>
    <unit id="loan">
        <measure>rdnt:loan</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="incentiveplan">
        <measure>rdnt:incentivePlan</measure>
    </unit>
    <unit id="agreement">
        <measure>rdnt:agreement</measure>
    </unit>
    <unit id="investment">
        <measure>rdnt:investment</measure>
    </unit>
    <unit id="jointventure">
        <measure>rdnt:jointVenture</measure>
    </unit>
    <unit id="location">
        <measure>rdnt:location</measure>
    </unit>
    <unit id="tranche">
        <measure>rdnt:tranche</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-32">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-33">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-35">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-15" id="f-160">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-161">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-151" id="f-664">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-151" id="f-666">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-703">http://fasb.org/us-gaap/2023#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-14" id="f-706">http://fasb.org/us-gaap/2023#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-15" id="f-709">http://fasb.org/us-gaap/2023#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-1511">http://www.radnet.com/20231231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-5" id="f-1512">http://www.radnet.com/20231231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-457" id="f-1680">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-457" id="f-1682">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-489" id="f-1757">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">478-7808</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-8" id="f-29" unitRef="usd">2100000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">68475443</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s definitive proxy statement for the 2024 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-36">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-37">Los Angeles, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">342570000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-39" unitRef="usd">127834000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">163707000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-3" id="f-41" unitRef="usd">166357000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-6" decimals="-3" id="f-42" unitRef="usd">25342000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-7" decimals="-3" id="f-43" unitRef="usd">18971000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">47657000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-45" unitRef="usd">54022000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">579276000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-47" unitRef="usd">367184000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">604401000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-49" unitRef="usd">565961000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">596032000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-51" unitRef="usd">603524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">1200433000</rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets>
    <rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets contextRef="c-5" decimals="-3" id="f-53" unitRef="usd">1169485000</rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">679463000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-55" unitRef="usd">677665000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">90615000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-57" unitRef="usd">106228000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">1643000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="c-5" decimals="-3" id="f-59" unitRef="usd">2280000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">92710000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-5" decimals="-3" id="f-61" unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DepositsAssets contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">46333000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets contextRef="c-5" decimals="-3" id="f-63" unitRef="usd">53172000</us-gaap:DepositsAssets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">2690473000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-65" unitRef="usd">2433907000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">342940000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">369595000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-68" unitRef="usd">15910000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-69" unitRef="usd">23100000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">4647000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-71" unitRef="usd">4021000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">55981000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">57607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">17974000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">12400000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">437452000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">466723000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">605097000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">604117000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">812068000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">839344000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">15776000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">9256000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">6721000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">23015000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">1877114000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">1942455000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-88"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-90" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-91" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-92" unitRef="shares">67956318</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-93" unitRef="shares">67956318</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-94" unitRef="shares">57723125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-95" unitRef="shares">57723125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-96" unitRef="usd">7000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-97" unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-98" unitRef="usd">722750000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-99" unitRef="usd">436288000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-100" unitRef="usd">-12484000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-101" unitRef="usd">-20677000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-102" unitRef="usd">-79578000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-103" unitRef="usd">-82622000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-104" unitRef="usd">630695000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">332995000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-106" unitRef="usd">182664000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-5" decimals="-3" id="f-107" unitRef="usd">158457000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-108" unitRef="usd">813359000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">491452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-110" unitRef="usd">2690473000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-111" unitRef="usd">2433907000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-112" unitRef="usd">1463197000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-3" id="f-113" unitRef="usd">1278016000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-114" unitRef="usd">1166743000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-115" unitRef="usd">153433000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-116" unitRef="usd">152045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-117" unitRef="usd">148334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-118" unitRef="usd">1616630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-119" unitRef="usd">1430061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-15" decimals="-3" id="f-120" unitRef="usd">1315077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-1" decimals="-3" id="f-121" unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-14" decimals="-3" id="f-122" unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-15" decimals="-3" id="f-123" unitRef="usd">9110000</us-gaap:RevenueNotFromContractWithCustomer>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">1395239000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization contextRef="c-14" decimals="-3" id="f-125" unitRef="usd">1264346000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization contextRef="c-15" decimals="-3" id="f-126" unitRef="usd">1123274000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <rdnt:GainLossOnContributionIntoJointVenture contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">16808000</rdnt:GainLossOnContributionIntoJointVenture>
    <rdnt:GainLossOnContributionIntoJointVenture contextRef="c-14" decimals="-3" id="f-128" unitRef="usd">0</rdnt:GainLossOnContributionIntoJointVenture>
    <rdnt:GainLossOnContributionIntoJointVenture contextRef="c-15" decimals="-3" id="f-129" unitRef="usd">0</rdnt:GainLossOnContributionIntoJointVenture>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">-5146000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-14" decimals="-3" id="f-131" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-15" decimals="-3" id="f-132" unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-133" unitRef="usd">128391000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-14" decimals="-3" id="f-134" unitRef="usd">115877000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-15" decimals="-3" id="f-135" unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">-2187000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-14" decimals="-3" id="f-137" unitRef="usd">-2529000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-15" decimals="-3" id="f-138" unitRef="usd">-1246000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">3778000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-14" decimals="-3" id="f-140" unitRef="usd">946000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-15" decimals="-3" id="f-141" unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">1517933000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-14" decimals="-3" id="f-143" unitRef="usd">1383698000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-15" decimals="-3" id="f-144" unitRef="usd">1241633000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-145" unitRef="usd">98697000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-14" decimals="-3" id="f-146" unitRef="usd">46363000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-15" decimals="-3" id="f-147" unitRef="usd">82554000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-3" id="f-148" unitRef="usd">64483000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-14" decimals="-3" id="f-149" unitRef="usd">50841000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-15" decimals="-3" id="f-150" unitRef="usd">48830000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">6427000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-14" decimals="-3" id="f-152" unitRef="usd">10390000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-15" decimals="-3" id="f-153" unitRef="usd">10967000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1 contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">-8185000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1 contextRef="c-14" decimals="-3" id="f-155" unitRef="usd">39621000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1 contextRef="c-15" decimals="-3" id="f-156" unitRef="usd">21670000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses contextRef="c-1" decimals="-3" id="f-157" unitRef="usd">0</rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses>
    <rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses contextRef="c-14" decimals="-3" id="f-158" unitRef="usd">-731000</rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses>
    <rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses contextRef="c-15" decimals="-3" id="f-159" unitRef="usd">-6044000</rdnt:GainLossOnExtinguishmentOfDebtAndRelatedExpenses>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">6354000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-14" decimals="-3" id="f-163" unitRef="usd">-1833000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-15" decimals="-3" id="f-164" unitRef="usd">-1438000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-165" unitRef="usd">-59887000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-14" decimals="-3" id="f-166" unitRef="usd">-3394000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-15" decimals="-3" id="f-167" unitRef="usd">-23675000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-168" unitRef="usd">38810000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-169" unitRef="usd">42969000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-170" unitRef="usd">58879000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">8473000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-172" unitRef="usd">9361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-173" unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-174" unitRef="usd">30337000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-14" decimals="-3" id="f-175" unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-15" decimals="-3" id="f-176" unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-177" unitRef="usd">27293000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-178" unitRef="usd">22958000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-179" unitRef="usd">19592000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-180" unitRef="usd">3044000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-181" unitRef="usd">10650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-182" unitRef="usd">24727000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-183"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-184"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-15"
      decimals="2"
      id="f-185"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-186"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-187"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-15"
      decimals="2"
      id="f-188"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-189" unitRef="shares">63580059</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-190" unitRef="shares">56293336</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-15" decimals="0" id="f-191" unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-192" unitRef="shares">64658299</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-193" unitRef="shares">57320870</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-15" decimals="0" id="f-194" unitRef="shares">53421033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">30337000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-14" decimals="-3" id="f-196" unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-15" decimals="-3" id="f-197" unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-198" unitRef="usd">4617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-14" decimals="-3" id="f-199" unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-15" decimals="-3" id="f-200" unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-201" unitRef="usd">-3576000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-14" decimals="-3" id="f-202" unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-15" decimals="-3" id="f-203" unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-204" unitRef="usd">38530000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-205" unitRef="usd">33352000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-206" unitRef="usd">47949000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-207" unitRef="usd">27293000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-208" unitRef="usd">22958000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-209" unitRef="usd">19592000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-210" unitRef="usd">11237000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-14" decimals="-3" id="f-211" unitRef="usd">10394000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-15" decimals="-3" id="f-212" unitRef="usd">28357000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-16"
      decimals="INF"
      id="f-213"
      unitRef="shares">51640537</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-3" id="f-214" unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-215" unitRef="usd">307788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="-3" id="f-216" unitRef="usd">-24051000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-19" decimals="-3" id="f-217" unitRef="usd">-117999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-20" decimals="-3" id="f-218" unitRef="usd">165743000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-21" decimals="-3" id="f-219" unitRef="usd">92560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-3" id="f-220" unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-23"
      decimals="INF"
      id="f-221"
      unitRef="shares">53960</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-24" decimals="-3" id="f-222" unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-25" decimals="-3" id="f-223" unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-15" decimals="-3" id="f-224" unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-23"
      decimals="INF"
      id="f-225"
      unitRef="shares">1212758</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-26"
      decimals="INF"
      id="f-226"
      unitRef="shares">471162</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-24" decimals="-3" id="f-227" unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-25" decimals="-3" id="f-228" unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-15" decimals="-3" id="f-229" unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-27"
      decimals="INF"
      id="f-230"
      unitRef="shares">82658</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-28" decimals="-3" id="f-231" unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-29" decimals="-3" id="f-232" unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-30" decimals="-3" id="f-233" unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-26"
      decimals="INF"
      id="f-234"
      unitRef="shares">91517</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-31" decimals="-3" id="f-235" unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-32" decimals="-3" id="f-236" unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-33" decimals="-3" id="f-237" unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c-23"
      decimals="INF"
      id="f-238"
      unitRef="shares">4365</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-24" decimals="-3" id="f-239" unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-25" decimals="-3" id="f-240" unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-15" decimals="-3" id="f-241" unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary contextRef="c-24" decimals="-3" id="f-242" unitRef="usd">4000</rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary>
    <rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary contextRef="c-25" decimals="-3" id="f-243" unitRef="usd">4000</rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary>
    <rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary contextRef="c-15" decimals="-3" id="f-244" unitRef="usd">4000</rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-245" unitRef="usd">123000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-246" unitRef="usd">123000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-24" decimals="-3" id="f-247" unitRef="usd">4206000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-25" decimals="-3" id="f-248" unitRef="usd">4206000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-34" decimals="-3" id="f-249" unitRef="usd">7404000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-15" decimals="-3" id="f-250" unitRef="usd">11610000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-34" decimals="-3" id="f-251" unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-15" decimals="-3" id="f-252" unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-35" decimals="-3" id="f-253" unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-25" decimals="-3" id="f-254" unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-15" decimals="-3" id="f-255" unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-35" decimals="-3" id="f-256" unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-25" decimals="-3" id="f-257" unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-15" decimals="-3" id="f-258" unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss contextRef="c-36" decimals="-3" id="f-259" unitRef="usd">24727000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-25" decimals="-3" id="f-260" unitRef="usd">24727000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-34" decimals="-3" id="f-261" unitRef="usd">19592000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-15" decimals="-3" id="f-262" unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-37"
      decimals="INF"
      id="f-263"
      unitRef="shares">53548227</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-264" unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-265" unitRef="usd">342592000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-3" id="f-266" unitRef="usd">-20421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-267" unitRef="usd">-93272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-268" unitRef="usd">228904000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-269" unitRef="usd">117253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-270" unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-44"
      decimals="INF"
      id="f-271"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-44" decimals="-3" id="f-272" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-45" decimals="-3" id="f-273" unitRef="usd">294000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-46" decimals="-3" id="f-274" unitRef="usd">295000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-14" decimals="-3" id="f-275" unitRef="usd">295000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-44"
      decimals="INF"
      id="f-276"
      unitRef="shares">725577</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <rdnt:SharesIssuedSharesSettlementOfContingentConsideration
      contextRef="c-47"
      decimals="INF"
      id="f-277"
      unitRef="shares">781577</rdnt:SharesIssuedSharesSettlementOfContingentConsideration>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-47"
      decimals="INF"
      id="f-278"
      unitRef="shares">204160</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-45" decimals="-3" id="f-279" unitRef="usd">23543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-46" decimals="-3" id="f-280" unitRef="usd">23543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-281" unitRef="usd">23543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-48"
      decimals="INF"
      id="f-282"
      unitRef="shares">2465294</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-49" decimals="-3" id="f-283" unitRef="usd">63311000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-50" decimals="-3" id="f-284" unitRef="usd">63311000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-51" decimals="-3" id="f-285" unitRef="usd">63311000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c-44"
      decimals="INF"
      id="f-286"
      unitRef="shares">26710</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-45" decimals="-3" id="f-287" unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-46" decimals="-3" id="f-288" unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-14" decimals="-3" id="f-289" unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-290" unitRef="usd">19139000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-291" unitRef="usd">19139000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-45" decimals="-3" id="f-292" unitRef="usd">6623000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-46" decimals="-3" id="f-293" unitRef="usd">6623000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-14" decimals="-3" id="f-294" unitRef="usd">6623000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-52" decimals="-3" id="f-295" unitRef="usd">893000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-14" decimals="-3" id="f-296" unitRef="usd">893000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-53" decimals="-3" id="f-297" unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-46" decimals="-3" id="f-298" unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-14" decimals="-3" id="f-299" unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-53" decimals="-3" id="f-300" unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-46" decimals="-3" id="f-301" unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-14" decimals="-3" id="f-302" unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss contextRef="c-54" decimals="-3" id="f-303" unitRef="usd">10650000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-46" decimals="-3" id="f-304" unitRef="usd">10650000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-52" decimals="-3" id="f-305" unitRef="usd">22958000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-14" decimals="-3" id="f-306" unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-55"
      decimals="INF"
      id="f-307"
      unitRef="shares">57723125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-308" unitRef="usd">6000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-309" unitRef="usd">436288000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-310" unitRef="usd">-20677000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-311" unitRef="usd">-82622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-312" unitRef="usd">332995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-3" id="f-313" unitRef="usd">158457000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-314" unitRef="usd">491452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-61"
      decimals="INF"
      id="f-315"
      unitRef="shares">12424</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-62" decimals="-3" id="f-316" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-63" decimals="-3" id="f-317" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-61"
      decimals="INF"
      id="f-319"
      unitRef="shares">1128453</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-64"
      decimals="INF"
      id="f-320"
      unitRef="shares">37909</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-62" decimals="-3" id="f-321" unitRef="usd">26785000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-63" decimals="-3" id="f-322" unitRef="usd">26785000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">26785000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-61"
      decimals="INF"
      id="f-324"
      unitRef="shares">8711250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-61" decimals="-3" id="f-325" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-62" decimals="-3" id="f-326" unitRef="usd">245831000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-63" decimals="-3" id="f-327" unitRef="usd">245832000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-328" unitRef="usd">245832000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-61"
      decimals="INF"
      id="f-329"
      unitRef="shares">378699</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-62" decimals="-3" id="f-330" unitRef="usd">11470000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-63" decimals="-3" id="f-331" unitRef="usd">11470000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">11470000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="c-61"
      decimals="INF"
      id="f-333"
      unitRef="shares">35542</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-63" decimals="-3" id="f-334" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-62" decimals="-3" id="f-336" unitRef="usd">2236000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-63" decimals="-3" id="f-337" unitRef="usd">2236000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">2236000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest contextRef="c-65" decimals="-3" id="f-339" unitRef="usd">2885000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">2885000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-65" decimals="-3" id="f-341" unitRef="usd">5972000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">5972000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-66" decimals="-3" id="f-343" unitRef="usd">4617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-63" decimals="-3" id="f-344" unitRef="usd">4617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">4617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-66" decimals="-3" id="f-346" unitRef="usd">-3576000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-63" decimals="-3" id="f-347" unitRef="usd">-3576000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">-3576000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityOther contextRef="c-62" decimals="-3" id="f-349" unitRef="usd">-2000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c-67" decimals="-3" id="f-350" unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c-63" decimals="-3" id="f-351" unitRef="usd">2000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c-65" decimals="-3" id="f-352" unitRef="usd">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c-1" decimals="-3" id="f-353" unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:ProfitLoss contextRef="c-67" decimals="-3" id="f-354" unitRef="usd">3044000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-63" decimals="-3" id="f-355" unitRef="usd">3044000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-65" decimals="-3" id="f-356" unitRef="usd">27293000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-357" unitRef="usd">30337000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-68"
      decimals="INF"
      id="f-358"
      unitRef="shares">67956318</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-68" decimals="-3" id="f-359" unitRef="usd">7000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-69" decimals="-3" id="f-360" unitRef="usd">722750000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-70" decimals="-3" id="f-361" unitRef="usd">-12484000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-71" decimals="-3" id="f-362" unitRef="usd">-79578000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-72" decimals="-3" id="f-363" unitRef="usd">630695000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-73" decimals="-3" id="f-364" unitRef="usd">182664000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-365" unitRef="usd">813359000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">30337000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-14" decimals="-3" id="f-367" unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-15" decimals="-3" id="f-368" unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-369" unitRef="usd">128391000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-14" decimals="-3" id="f-370" unitRef="usd">115877000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-15" decimals="-3" id="f-371" unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-372" unitRef="usd">61102000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-14" decimals="-3" id="f-373" unitRef="usd">68847000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-15" decimals="-3" id="f-374" unitRef="usd">73967000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-1" decimals="-3" id="f-375" unitRef="usd">-5146000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-14" decimals="-3" id="f-376" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-15" decimals="-3" id="f-377" unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">-9176000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions contextRef="c-14" decimals="-3" id="f-379" unitRef="usd">5952000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions contextRef="c-15" decimals="-3" id="f-380" unitRef="usd">6260000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-381" unitRef="usd">2987000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-14" decimals="-3" id="f-382" unitRef="usd">2693000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-15" decimals="-3" id="f-383" unitRef="usd">3254000</us-gaap:AmortizationOfFinancingCosts>
    <rdnt:GainLossOnContributionIntoJointVenture contextRef="c-1" decimals="-3" id="f-384" unitRef="usd">16808000</rdnt:GainLossOnContributionIntoJointVenture>
    <rdnt:GainLossOnContributionIntoJointVenture contextRef="c-14" decimals="-3" id="f-385" unitRef="usd">0</rdnt:GainLossOnContributionIntoJointVenture>
    <rdnt:GainLossOnContributionIntoJointVenture contextRef="c-15" decimals="-3" id="f-386" unitRef="usd">0</rdnt:GainLossOnContributionIntoJointVenture>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-1" decimals="-3" id="f-387" unitRef="usd">-2187000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-14" decimals="-3" id="f-388" unitRef="usd">-2529000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-15" decimals="-3" id="f-389" unitRef="usd">-1246000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-1" decimals="-3" id="f-390" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-14" decimals="-3" id="f-391" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-15" decimals="-3" id="f-392" unitRef="usd">-1496000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-1" decimals="-3" id="f-393" unitRef="usd">3949000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-14" decimals="-3" id="f-394" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-15" decimals="-3" id="f-395" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:AmortizationOfDeferredHedgeGains contextRef="c-1" decimals="-3" id="f-396" unitRef="usd">3576000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains contextRef="c-14" decimals="-3" id="f-397" unitRef="usd">3687000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains contextRef="c-15" decimals="-3" id="f-398" unitRef="usd">3695000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-1" decimals="-3" id="f-399" unitRef="usd">-8185000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-14" decimals="-3" id="f-400" unitRef="usd">39621000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-15" decimals="-3" id="f-401" unitRef="usd">21670000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-402" unitRef="usd">26785000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-14" decimals="-3" id="f-403" unitRef="usd">23770000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-15" decimals="-3" id="f-404" unitRef="usd">25203000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-3" id="f-405" unitRef="usd">-3880000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-14" decimals="-3" id="f-406" unitRef="usd">-325000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-15" decimals="-3" id="f-407" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-408" unitRef="usd">-2650000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-14" decimals="-3" id="f-409" unitRef="usd">30078000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-15" decimals="-3" id="f-410" unitRef="usd">5890000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c-1" decimals="-3" id="f-411" unitRef="usd">8441000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c-14" decimals="-3" id="f-412" unitRef="usd">3327000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c-15" decimals="-3" id="f-413" unitRef="usd">15777000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-414" unitRef="usd">1484000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-14" decimals="-3" id="f-415" unitRef="usd">12166000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-15" decimals="-3" id="f-416" unitRef="usd">-662000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-1" decimals="-3" id="f-417" unitRef="usd">-6056000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-14" decimals="-3" id="f-418" unitRef="usd">-13356000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-15" decimals="-3" id="f-419" unitRef="usd">-19834000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-420" unitRef="usd">-54763000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-14" decimals="-3" id="f-421" unitRef="usd">-68943000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-15" decimals="-3" id="f-422" unitRef="usd">-72553000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-1" decimals="-3" id="f-423" unitRef="usd">626000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-14" decimals="-3" id="f-424" unitRef="usd">-7316000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-15" decimals="-3" id="f-425" unitRef="usd">-28319000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-426" unitRef="usd">15086000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-14" decimals="-3" id="f-427" unitRef="usd">49778000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-15" decimals="-3" id="f-428" unitRef="usd">9915000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">220863000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-14" decimals="-3" id="f-430" unitRef="usd">146417000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-15" decimals="-3" id="f-431" unitRef="usd">149491000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings contextRef="c-1" decimals="-3" id="f-432" unitRef="usd">10918000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings contextRef="c-14" decimals="-3" id="f-433" unitRef="usd">129961000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings contextRef="c-15" decimals="-3" id="f-434" unitRef="usd">77691000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-435" unitRef="usd">176600000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment contextRef="c-14" decimals="-3" id="f-436" unitRef="usd">119451000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment contextRef="c-15" decimals="-3" id="f-437" unitRef="usd">137874000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-3" id="f-438" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-14" decimals="-3" id="f-439" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-15" decimals="-3" id="f-440" unitRef="usd">5130000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-441" unitRef="usd">83000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-14" decimals="-3" id="f-442" unitRef="usd">3904000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-15" decimals="-3" id="f-443" unitRef="usd">625000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture contextRef="c-1" decimals="-3" id="f-444" unitRef="usd">14035000</rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture>
    <rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture contextRef="c-14" decimals="-3" id="f-445" unitRef="usd">1441000</rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture>
    <rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture contextRef="c-15" decimals="-3" id="f-446" unitRef="usd">1441000</rdnt:PaymentsToAcquireInterestInJointVentureAndContributionsToExistingJointVenture>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-447" unitRef="usd">-201470000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-14" decimals="-3" id="f-448" unitRef="usd">-246949000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-15" decimals="-3" id="f-449" unitRef="usd">-221511000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt contextRef="c-1" decimals="-3" id="f-450" unitRef="usd">41063000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-14" decimals="-3" id="f-451" unitRef="usd">53750000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-15" decimals="-3" id="f-452" unitRef="usd">619529000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-1" decimals="-3" id="f-453" unitRef="usd">2930000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-14" decimals="-3" id="f-454" unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-15" decimals="-3" id="f-455" unitRef="usd">3302000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-1" decimals="-3" id="f-456" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-14" decimals="-3" id="f-457" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-15" decimals="-3" id="f-458" unitRef="usd">938000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-1" decimals="-3" id="f-459" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-14" decimals="-3" id="f-460" unitRef="usd">147996000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-15" decimals="-3" id="f-461" unitRef="usd">717307000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-462" unitRef="usd">5972000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-14" decimals="-3" id="f-463" unitRef="usd">893000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-15" decimals="-3" id="f-464" unitRef="usd">2426000</us-gaap:PaymentsToMinorityShareholders>
    <rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary contextRef="c-1" decimals="-3" id="f-465" unitRef="usd">0</rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary>
    <rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary contextRef="c-14" decimals="-3" id="f-466" unitRef="usd">0</rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary>
    <rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary contextRef="c-15" decimals="-3" id="f-467" unitRef="usd">13073000</rdnt:ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-1" decimals="-3" id="f-468" unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-14" decimals="-3" id="f-469" unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-15" decimals="-3" id="f-470" unitRef="usd">128300000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-1" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-14" decimals="-3" id="f-472" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-15" decimals="-3" id="f-473" unitRef="usd">128300000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromMinorityShareholders contextRef="c-1" decimals="-3" id="f-474" unitRef="usd">5121000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders contextRef="c-14" decimals="-3" id="f-475" unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders contextRef="c-15" decimals="-3" id="f-476" unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-3" id="f-477" unitRef="usd">5495000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-14" decimals="-3" id="f-478" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-15" decimals="-3" id="f-479" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-480" unitRef="usd">245832000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-14" decimals="-3" id="f-481" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-15" decimals="-3" id="f-482" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-3" id="f-483" unitRef="usd">142000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-14" decimals="-3" id="f-484" unitRef="usd">294000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-15" decimals="-3" id="f-485" unitRef="usd">488000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-486" unitRef="usd">195635000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-14" decimals="-3" id="f-487" unitRef="usd">93647000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-15" decimals="-3" id="f-488" unitRef="usd">104673000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-489" unitRef="usd">-292000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-14" decimals="-3" id="f-490" unitRef="usd">113000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-3" id="f-491" unitRef="usd">-65000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-492" unitRef="usd">214736000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-14" decimals="-3" id="f-493" unitRef="usd">-6772000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-15" decimals="-3" id="f-494" unitRef="usd">32588000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-495" unitRef="usd">127834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-3" id="f-496" unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-22" decimals="-3" id="f-497" unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-498" unitRef="usd">342570000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-499" unitRef="usd">127834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-3" id="f-500" unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-501" unitRef="usd">64695000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-14" decimals="-3" id="f-502" unitRef="usd">39151000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-15" decimals="-3" id="f-503" unitRef="usd">29042000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-504" unitRef="usd">1587000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-14" decimals="-3" id="f-505" unitRef="usd">587000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-15" decimals="-3" id="f-506" unitRef="usd">1950000</us-gaap:IncomeTaxesPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements contextRef="c-1" decimals="-5" id="f-507" unitRef="usd">67700000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements contextRef="c-14" decimals="-5" id="f-508" unitRef="usd">111800000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements contextRef="c-15" decimals="-5" id="f-509" unitRef="usd">63900000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-74"
      decimals="INF"
      id="f-510"
      unitRef="shares">64569</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-75" decimals="-5" id="f-511" unitRef="usd">2300000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-76"
      decimals="INF"
      id="f-512"
      unitRef="shares">56600</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-77" decimals="-5" id="f-513" unitRef="usd">1600000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-78" decimals="-5" id="f-514" unitRef="usd">27200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-79"
      decimals="INF"
      id="f-515"
      unitRef="shares">113303</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-80" decimals="-5" id="f-516" unitRef="usd">3500000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-81"
      decimals="INF"
      id="f-517"
      unitRef="shares">144227</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-82" decimals="-5" id="f-518" unitRef="usd">4000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-83" decimals="-5" id="f-519" unitRef="usd">19800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-84"
      decimals="INF"
      id="f-520"
      unitRef="shares">359002</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-85" decimals="-5" id="f-521" unitRef="usd">6800000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-86" decimals="-5" id="f-522" unitRef="usd">12700000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromDividendsReceived contextRef="c-86" decimals="-5" id="f-523" unitRef="usd">4500000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestments contextRef="c-87" decimals="-5" id="f-524" unitRef="usd">8300000</us-gaap:EquityMethodInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-88" decimals="-5" id="f-525" unitRef="usd">8400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-89"
      decimals="INF"
      id="f-526"
      unitRef="shares">1141234</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-90" decimals="-5" id="f-527" unitRef="usd">30600000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-91"
      decimals="INF"
      id="f-528"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-92" decimals="-5" id="f-529" unitRef="usd">25900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 contextRef="c-93" decimals="-5" id="f-530" unitRef="shares">15000000</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued contextRef="c-93" decimals="-5" id="f-531" unitRef="usd">400000</rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-94"
      decimals="INF"
      id="f-532"
      unitRef="shares">67658000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-95" decimals="-3" id="f-533" unitRef="usd">2000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-96" decimals="-5" id="f-534" unitRef="usd">400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-97" decimals="-5" id="f-535" unitRef="usd">300000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-98" decimals="-5" id="f-536" unitRef="usd">100000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-537">NATURE OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2023, we operated directly or indirectly through joint ventures with hospitals, 366 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting. In June 2023, we completed a public offering of 8,711,250 shares of our common stock at a price to the public of $29.75 per share. The gross proceeds as a result of this public offering was $259.2&#160;million before underwriting discounts, commissions, and expenses totaling $13.4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc. as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group (the "Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $205.6 million, $189.1 million, and $179.6 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2023, 2022, and 2021, respectively and $205.6 million, $189.1 million, and $179.6 million of operating expenses for the years ended December 31, 2023, 2022, and 2021, respectively. RadNet, Inc. recognized $849.4 million, $786.5 million, and $749.2 million of total billed net service fee revenue for the years ended December 31, 2023, 2022, and 2021, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31, 2023 and December 31, 2022, we have included approximately $94.1 million and $110.3 million, respectively, of accounts receivable and approximately $16.7 million and $16.2 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters contextRef="c-4" decimals="INF" id="f-538" unitRef="center">366</rdnt:NumberOfCenters>
    <us-gaap:NumberOfReportableSegments contextRef="c-1" decimals="INF" id="f-539" unitRef="loan">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-99"
      decimals="INF"
      id="f-540"
      unitRef="shares">8711250</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-100"
      decimals="2"
      id="f-541"
      unitRef="usdPerShare">29.75</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-101" decimals="-5" id="f-542" unitRef="usd">259200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <rdnt:SaleOfStockCost contextRef="c-101" decimals="-5" id="f-543" unitRef="usd">13400000</rdnt:SaleOfStockCost>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues contextRef="c-1" decimals="-5" id="f-544" unitRef="usd">205600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues contextRef="c-14" decimals="-5" id="f-545" unitRef="usd">189100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues contextRef="c-15" decimals="-5" id="f-546" unitRef="usd">179600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense contextRef="c-1" decimals="-5" id="f-547" unitRef="usd">205600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense contextRef="c-14" decimals="-5" id="f-548" unitRef="usd">189100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense contextRef="c-15" decimals="-5" id="f-549" unitRef="usd">179600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax contextRef="c-1" decimals="-5" id="f-550" unitRef="usd">849400000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax contextRef="c-14" decimals="-5" id="f-551" unitRef="usd">786500000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax contextRef="c-15" decimals="-5" id="f-552" unitRef="usd">749200000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets contextRef="c-102" decimals="-5" id="f-553" unitRef="usd">94100000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-103" decimals="-5" id="f-554" unitRef="usd">110300000</us-gaap:Assets>
    <us-gaap:Liabilities contextRef="c-102" decimals="-5" id="f-555" unitRef="usd">16700000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-103" decimals="-5" id="f-556" unitRef="usd">16200000</us-gaap:Liabilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-557">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the fees for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by the Group as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and co-payment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service fee revenues for the years ended December 31, 2023, 2022, and 2021 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In Thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software and teleradiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging center segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020. As part of the CARES act, we received $39.6 million total of accelerated Medicare payments which were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed. Through December 31, 2023, all of the accelerated Medicare payments have been applied to revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.   Amounts remaining to be collected on these agreements were $14.3 million and $15.4 million at December 31, 2023 and December 31, 2022, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS PAYABLE AND ACCRUED EXPENSES - Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.665%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.953%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; We have developed and sell Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2023, 2022 and 2021, we recorded approximately $20.2 million, $13.2 million, and $10.5 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statements of operations. At December 31, 2023 we had deferred revenue of approximately $1.3 million associated with these sales which we expect to recognize into revenue over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. The cash in the financial institution is in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Deferred financing costs, net of accumulated amortization, were $1.6 million and $2.3 million for the twelve months ended at December 31, 2023 and 2022, respectively.  See Note 8, Credit Facilities and Notes Payable for more information on our revolving lines of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATIONS &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES &#x2013; Goodwill totaled $679.5 million and $677.7 million at December 31, 2023 and December 31, 2022, respectively. Indefinite lived intangible assets were $9.0 million at December 31, 2023 and $24.1 million at December 31, 2022 and are associated with the value of certain trade name intangibles and in process research and development ("IPR&amp;amp;D"). Goodwill, trade name intangibles and IPR&amp;amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We tested goodwill, trade name and IPR&amp;amp;D for impairment&#160;on October 1, 2023.  In September 2023, we determined that an IPR&amp;amp;D indefinite-lived intangible asset related to Aidence's Ai Veye Lung Nodule and Veye Clinic would not receive FDA approval for sale in the US without a new submission and additional expenditures for rework in the original projected timeline. The additional expenditures, delay and reduction of US sales affected the estimated fair value of the related IPR&amp;amp;D intangible asset and resulted in impairment charges of $3.9 million within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The estimated fair value of the IPR&amp;amp;D intangible asset was determined using the multi-period excess earnings method under the income approach, which estimates the present value of the free cash flows associated with the asset and tax amortization benefit to arrive at the fair value of the asset. Our annual impairment test as of October 1, 2023 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2023.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2023 and December 31, 2021 we recorded lease abandonment of $2.5 million and $7.1 million, respectively in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2023. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers to maximize utilization rates. We may abandon low utilization leases and divert the patients to nearby centers. During 2023, we experienced lower utilization at two imaging centers. To complete the closure of these locations, we took a lease abandonment charge of approximately $5.1&#160;million and $19.7 million at December 31, 2023 and December 31, 2021, respectively. Of these amounts, $2.7 million and $12.6 million were related to right-of-use assets impairment and $2.5 million and $7.1 million were related to the write-off of leasehold improvements for the years ending December 31, 2023 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UNINSURED RISKS &#x2013; We maintain a high-deductible workers&#x2019; compensation insurance policy. We have recorded liabilities of $3.4 million and $3.9 million at December 31, 2023 and December 31, 2022, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for all years covered by this report.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2023, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2023 and 2022 of $7.2 million and $7.4 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contributions.  We contributed $0.0 million and $3.0 million in matching for each of the twelve months ended December 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, third on April 15, 2021 and currently as of April 27, 2023 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023. We have reserved 20,100,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric. We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options generally vest over &lt;span style="-sec-ix-hidden:f-664"&gt;three&lt;/span&gt; years to five years and expire &lt;span style="-sec-ix-hidden:f-666"&gt;five&lt;/span&gt; years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FOREIGN CURRENCY TRANSLATION &#x2013; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.  The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2023, 2022 and 2021 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.148%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.339%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;OTHER COMPREHENSIVE INCOME (LOSS) &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2023, December 31, 2022, and December 31, 2021 are included in the consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They matured in October 2023 for the two smaller notional and will mature in October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month Term SOFR rates at 1.89% for the $100,000,000 notional and at 1.98% for the $400,000,000 notional. In October of 2023, the two agreements of $50,000,000 each matured and the remaining 2019 swaps have a total notional amount of $400,000,000 as of December 31, 2023. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of other accumulated comprehensive income (loss) in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 1.98% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.89% did not match the cash flows for our Barclays term loans and so we determined that they were not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional was recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million per month through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (loss) recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(8,185)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-703"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,576)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39,621&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-706"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,687)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-709"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,695)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Aidence Holding B.V.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we agreed to pay up to $10.0 million consideration upon the completion of two identified milestones in RadNet common shares or cash at our election.  The contingency had a fair value of approximately $7.2 million on December 31, 2022. The fair value is based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of meeting the milestones which were tied to FDA approval of artificial intelligence screening solutions. In September 2023, we determined that the milestones could not be achieved under the contractual terms of the stock purchase agreement because the original submissions of artificial intelligence screening solutions did not receive regulatory clearance. A new submission would be required; and therefore, the probability of the milestones being achieved became zero. Accordingly, management recognized a gain of $7.2 million in 2023 representing the change in fair value of contingent consideration within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In addition, there was a general holdback of $4.0 million for any indemnification claims, which was settled on April 30, 2023 by the issuance of 144,227 shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Quantib B.V. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we agreed to issue 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. In addition, there is a general holdback of $1.6 million to be issued in cash subject to adjustment for any indemnification claims. On July 7, 2023, we settled the stock holdback contingent liabilities by issuing 113,303 shares of our common stock at an ascribed value of $3.5 million and also settled the general holdback for $1.6 million in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Montclair. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $1.2 million in contingent consideration which was based on the anticipated achievement of specific EBITDA targets within a defined time frame. In June 2023, we determined that the contingent consideration thresholds were not achieved and, as such, we recognized a gain of $1.2 million representing the change in fair value of the contingent consideration within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heart &amp;amp; Lung Imaging Limited. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed our acquisition of 75% of the equity interests of Heart &amp;amp; Lung Imaging Limited. The purchase included $10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in subsequent periods.  The milestone contingencies had a value of approximately $6.2 million and $11.1 million as of December 31, 2023 and 2022, respectively.   The contingent consideration is determined by the achievement of a specific number of physician reads. On September 20, 2023, we settled a milestone contingent liability by issuing 56,600 shares of our common stock at an ascribed value of $1.6 million and cash of $1.8 million. On December 12, 2023, we settled a milestone contingent liability by issuing 64,569 shares of our common stock at an ascribed value of $2.3 million and cash of $2.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular roll-forward of contingent consideration is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Valuation of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Valuation of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of contingent consideration at December 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Current Assets and Deposits and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Current Assets and Deposits and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward SOFR curve in 2023 and forward LIBOR curve in 2022. respectively. The forward SOFR curve and forward LIBOR curve are readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs. For Heart &amp;amp; Lung Imaging Limited, the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Heart &amp;amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. Holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs. For Aidence Holding B.V., the milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval. For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares. For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame. For Heart &amp;amp; Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads. As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart &amp;amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data, they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our Barclays Term Loans and Trust Term Loan long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Barclays Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Barclays Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2023 and December 31, 2022, respectively.  Our Truist revolving credit facility had no aggregate principal amount outstanding as of December 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily relate to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations and other notes payable to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.243%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,580,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,580,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options, warrants and holdback shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,658,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,320,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,421,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value associated with contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to RadNet, Inc's common stockholders for diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3,044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9,926&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24,727&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight average shares for which the exercise price exceeds the average market price of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENTS IN EQUITY SECURITIES- Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million, represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was identified as of December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired 2,315,350 shares of Series A Preferred Stock interest at a cost of $1.0 million and also loaned the company $2.5 million in support of its operations. On October 6, 2023, WhiteRabbit.ai Inc. commenced another offering of preferred shares and the Company converted its note receivable outstanding principal and accrued interest in exchange for 20,325,203 shares of Series C-1 Preferred Stock at an exchange rate of $0.123 per share. No observable price changes or impairment in our investment was identified as of December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2023 and December 31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.090%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.710%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the imaging centers underlying these joint ventures of approximately $17.9 million , $22.2 million, and $19.6 million for the years ended December 31, 2023, 2022 and 2021, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures. As we have the ability to exercise significant influence over our joint venture entities, we consider them related parties. Amounts transacted between ourselves and the entities in the ordinary course of business are disclosed on our balance sheet in the due from/to affiliate accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key financial data for these joint ventures as of December 31, 2023 and 2022, respectively, and for the years ended December 31, 2023, 2022 and 2021, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2023 and 2022, we made additional equity contributions of $2.4 million and $1.4 million, respectively, to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we contributed eight of our imaging centers to ADRG of $12.7 million and recorded a loss of $0.5 million which was calculated as the difference between the sale price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $4.5 million of the sale price as an offset to due to affiliates while the remaining $8.3 million was recorded as investment in joint venture on our balance sheet.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our 49% economic interest in ADRG, we received a distribution from the partnership of $4.5 million to reduce our overall investment to $8.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Formation of majority owned subsidiary and sale of economic interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Los Angeles Imaging Group, LLC. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2023, we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of three locations in Los Angeles, California. We contributed the operations of 3 centers to the subsidiary. Cedars-Sinai Medical Center ("CSMC") purchased from us a 35% noncontrolling interest in LAIG for a cash payment of $5.9 million. As a result of the transaction, we retain a 65% controlling economic interest in LAIG.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Joint venture investment contribution&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Santa Monica Imaging Group, LLC. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2017, we formed, in conjunction with Cedars-Sinai Medical Center ("CSMC") the Santa Monica Imaging Group, LLC ("SMIG"), consisting of two multi-modality imaging centers located in Santa Monica, California with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest. RadNet accounted for its share of the venture under the equity method. On January 1, 2019, CSMC purchased an additional 5% economic interest in SMIG from us and, as a result, of our economic interest in SMIG was reduced to 35%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2023, RadNet contributed an additional multi-modality imaging center and a newly constructed imaging center located in Beverly Hills, California valued at $27.2 million and purchased an additional economic interest in SMIG for cash payment of $11.3 million. Simultaneously, CSMC contributed five additional multi-modality imaging centers located in Santa Monica, California. As a result of the transaction, our economic interest in SMIG has been increased to 49%. We recorded a gain of $16.8 million, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Gain) on contribution of imaging centers into joint venture &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, representing the difference between the fair value and carrying value of the business contributed. The related gain on disposal of business was calculated as the difference between the fair value and carrying value of such imaging centers which included equipment, other assets, accrued liabilities, and an allocation of goodwill to such imaging centers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the fair value of the imaging centers contributed to SMIG, we used an income approach which is considered a level 3 valuation technique. See Fair Value Measurements above for further detail on the valuation hierarchy. Key assumptions used in measuring the fair value are financial forecasts and a discount rate. We also utilized the cash paid for an additional interest in the joint venture to substantiate the fair value of the contributed assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-558">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-559">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-560">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the fees for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by the Group as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and co-payment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock contextRef="c-1" id="f-561">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service fee revenues for the years ended December 31, 2023, 2022, and 2021 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In Thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software and teleradiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging center segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-104" decimals="-3" id="f-562" unitRef="usd">897948000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-105" decimals="-3" id="f-563" unitRef="usd">785128000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-106" decimals="-3" id="f-564" unitRef="usd">743462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-565" unitRef="usd">363863000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-108" decimals="-3" id="f-566" unitRef="usd">311124000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-3" id="f-567" unitRef="usd">280911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-110" decimals="-3" id="f-568" unitRef="usd">43175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-569" unitRef="usd">38279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-112" decimals="-3" id="f-570" unitRef="usd">34731000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-571" unitRef="usd">47364000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-3" id="f-572" unitRef="usd">51339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-573" unitRef="usd">44235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-574" unitRef="usd">42249000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-3" id="f-575" unitRef="usd">31849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-3" id="f-576" unitRef="usd">19398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-119" decimals="-3" id="f-577" unitRef="usd">17936000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-120" decimals="-3" id="f-578" unitRef="usd">22235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-121" decimals="-3" id="f-579" unitRef="usd">19630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-122" decimals="-3" id="f-580" unitRef="usd">18082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-123" decimals="-3" id="f-581" unitRef="usd">14238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-124" decimals="-3" id="f-582" unitRef="usd">10525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-125" decimals="-3" id="f-583" unitRef="usd">20111000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-126" decimals="-3" id="f-584" unitRef="usd">19428000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-127" decimals="-3" id="f-585" unitRef="usd">12436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-586" unitRef="usd">153433000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-587" unitRef="usd">152045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-588" unitRef="usd">148334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-128" decimals="-3" id="f-589" unitRef="usd">1604161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-129" decimals="-3" id="f-590" unitRef="usd">1425665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-130" decimals="-3" id="f-591" unitRef="usd">1313662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-131" decimals="-3" id="f-592" unitRef="usd">12469000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-132" decimals="-3" id="f-593" unitRef="usd">4396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-133" decimals="-3" id="f-594" unitRef="usd">1415000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-595" unitRef="usd">1616630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-596" unitRef="usd">1430061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-15" decimals="-3" id="f-597" unitRef="usd">1315077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <rdnt:AdvanceMedicarePayments contextRef="c-134" decimals="-5" id="f-598" unitRef="usd">39600000</rdnt:AdvanceMedicarePayments>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-599">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoringReceivable contextRef="c-4" decimals="-5" id="f-600" unitRef="usd">14300000</rdnt:ContractsReceivableFactoringReceivable>
    <rdnt:ContractsReceivableFactoringReceivable contextRef="c-5" decimals="-5" id="f-601" unitRef="usd">15400000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-602">Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.665%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.953%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-603" unitRef="usd">122888000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-604" unitRef="usd">102678000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-605" unitRef="usd">124059000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-606" unitRef="usd">181574000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-607" unitRef="usd">71297000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-608" unitRef="usd">62072000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-609" unitRef="usd">24696000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-610" unitRef="usd">23271000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-611" unitRef="usd">342940000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-612" unitRef="usd">369595000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-613">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; We have developed and sell Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-135" decimals="-5" id="f-614" unitRef="usd">20200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-136" decimals="-5" id="f-615" unitRef="usd">13200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-137" decimals="-5" id="f-616" unitRef="usd">10500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-138" decimals="-5" id="f-617" unitRef="usd">1300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-138" id="f-618">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="c-1" id="f-619">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-620">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. The cash in the financial institution is in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-621">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c-1" id="f-622">DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Notes Payable for more information on our revolving lines of credit.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-4" decimals="-5" id="f-623" unitRef="usd">1600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-5" decimals="-5" id="f-624" unitRef="usd">2300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-625">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-139" id="f-626">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-140" id="f-627">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-141" id="f-628">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-142" id="f-629">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-630">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATIONS &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy contextRef="c-1" id="f-631">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill, trade name intangibles and IPR&amp;amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-632" unitRef="usd">679500000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-5" id="f-633" unitRef="usd">677700000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-5" id="f-634" unitRef="usd">9000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-5" id="f-635" unitRef="usd">24100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-143" decimals="-5" id="f-636" unitRef="usd">3900000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-637">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2023 and December 31, 2021 we recorded lease abandonment of $2.5 million and $7.1 million, respectively in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-144" decimals="-5" id="f-638" unitRef="usd">2500000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-145" decimals="-5" id="f-639" unitRef="usd">7100000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-640">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-641">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2023. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers to maximize utilization rates. We may abandon low utilization leases and divert the patients to nearby centers. During 2023, we experienced lower utilization at two imaging centers. To complete the closure of these locations, we took a lease abandonment charge of approximately $5.1&#160;million and $19.7 million at December 31, 2023 and December 31, 2021, respectively. Of these amounts, $2.7 million and $12.6 million were related to right-of-use assets impairment and $2.5 million and $7.1 million were related to the write-off of leasehold improvements for the years ending December 31, 2023 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <rdnt:OperatingLeaseLeaseAbandonmentCharge contextRef="c-1" decimals="-5" id="f-642" unitRef="usd">5100000</rdnt:OperatingLeaseLeaseAbandonmentCharge>
    <rdnt:OperatingLeaseLeaseAbandonmentCharge contextRef="c-15" decimals="-5" id="f-643" unitRef="usd">19700000</rdnt:OperatingLeaseLeaseAbandonmentCharge>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-144" decimals="-5" id="f-644" unitRef="usd">2700000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-145" decimals="-5" id="f-645" unitRef="usd">12600000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-144" decimals="-5" id="f-646" unitRef="usd">2500000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-145" decimals="-5" id="f-647" unitRef="usd">7100000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <rdnt:UninsuredRisksPolicyTextBlock contextRef="c-1" id="f-648">UNINSURED RISKS &#x2013; We maintain a high-deductible workers&#x2019; compensation insurance policy. We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2023, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.</rdnt:UninsuredRisksPolicyTextBlock>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-4" decimals="-5" id="f-649" unitRef="usd">3400000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-5" decimals="-5" id="f-650" unitRef="usd">3900000</us-gaap:WorkersCompensationLiabilityCurrent>
    <rdnt:MedicalMalpracticeDeductiblePerIncidence contextRef="c-4" decimals="INF" id="f-651" unitRef="usd">10000</rdnt:MedicalMalpracticeDeductiblePerIncidence>
    <us-gaap:SelfInsuranceReserve contextRef="c-146" decimals="-5" id="f-652" unitRef="usd">7200000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-147" decimals="-5" id="f-653" unitRef="usd">7400000</us-gaap:SelfInsuranceReserve>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount contextRef="c-148" decimals="INF" id="f-654" unitRef="usd">250000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount contextRef="c-149" decimals="INF" id="f-655" unitRef="usd">1000000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="c-1" id="f-656">EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="c-1" decimals="INF" id="f-657" unitRef="number">0.010</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c-1" decimals="INF" id="f-658" unitRef="number">0.040</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-1" decimals="-5" id="f-659" unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-14" decimals="-5" id="f-660" unitRef="usd">3000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c-1" id="f-661">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, third on April 15, 2021 and currently as of April 27, 2023 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023. We have reserved 20,100,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric. We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options generally vest over &lt;span style="-sec-ix-hidden:f-664"&gt;three&lt;/span&gt; years to five years and expire &lt;span style="-sec-ix-hidden:f-666"&gt;five&lt;/span&gt; years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="c-4"
      decimals="INF"
      id="f-662"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-150"
      decimals="INF"
      id="f-663"
      unitRef="shares">20100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-152" id="f-665">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-152" id="f-667">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-668">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FOREIGN CURRENCY TRANSLATION &#x2013; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a &lt;/span&gt;&lt;/div&gt;component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <rdnt:ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock contextRef="c-1" id="f-669">The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2023, 2022 and 2021 is provided below (in thousands):&lt;div style="padding-left:72pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.148%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.339%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-22" decimals="-3" id="f-670" unitRef="usd">-377000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="c-15" decimals="-3" id="f-671" unitRef="usd">-65000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-43" decimals="-3" id="f-672" unitRef="usd">-442000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="c-14" decimals="-3" id="f-673" unitRef="usd">-3943000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-674" unitRef="usd">-4385000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-675" unitRef="usd">4617000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-4" decimals="-3" id="f-676" unitRef="usd">232000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-677">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;OTHER COMPREHENSIVE INCOME (LOSS) &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2023, December 31, 2022, and December 31, 2021 are included in the consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c-1" id="f-678">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-679">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS &lt;/span&gt;&lt;/div&gt; The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They matured in October 2023 for the two smaller notional and will mature in October 2025 for the two larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of other accumulated comprehensive income (loss) in the consolidated statement of equity.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="c-153"
      decimals="INF"
      id="f-680"
      unitRef="agreement">4000</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-153" decimals="INF" id="f-681" unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="c-154"
      decimals="INF"
      id="f-682"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-154" decimals="INF" id="f-683" unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="c-155"
      decimals="INF"
      id="f-684"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-155" decimals="INF" id="f-685" unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="c-156"
      decimals="INF"
      id="f-686"
      unitRef="number">0.0189</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-157" decimals="INF" id="f-687" unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="c-158"
      decimals="INF"
      id="f-688"
      unitRef="number">0.0198</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-159" decimals="INF" id="f-689" unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-154" decimals="INF" id="f-690" unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-159" decimals="INF" id="f-691" unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-159" decimals="INF" id="f-692" unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="c-158"
      decimals="INF"
      id="f-693"
      unitRef="number">0.0198</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-157" decimals="INF" id="f-694" unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="c-156"
      decimals="INF"
      id="f-695"
      unitRef="number">0.0189</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-159" decimals="INF" id="f-696" unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-157" decimals="INF" id="f-697" unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:StockholdersEquity contextRef="c-160" decimals="-5" id="f-698" unitRef="usd">24400000</us-gaap:StockholdersEquity>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains contextRef="c-161" decimals="-5" id="f-699" unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains contextRef="c-162" decimals="-5" id="f-700" unitRef="usd">300000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-701">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (loss) recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(8,185)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-703"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,576)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39,621&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-706"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,687)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-709"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,695)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-163" decimals="-3" id="f-702" unitRef="usd">-8185000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-164" decimals="-3" id="f-704" unitRef="usd">-3576000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-165" decimals="-3" id="f-705" unitRef="usd">39621000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-166" decimals="-3" id="f-707" unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-167" decimals="-3" id="f-708" unitRef="usd">21670000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-168" decimals="-3" id="f-710" unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="c-90" decimals="-5" id="f-711" unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones contextRef="c-90" decimals="INF" id="f-712" unitRef="loan">2</rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-169" decimals="-5" id="f-713" unitRef="usd">7200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-170" decimals="-5" id="f-714" unitRef="usd">7200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-171" decimals="-5" id="f-715" unitRef="usd">4000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-81"
      decimals="INF"
      id="f-716"
      unitRef="shares">144227</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod contextRef="c-91" id="f-717">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="c-92"
      decimals="INF"
      id="f-718"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution contextRef="c-92" decimals="-5" id="f-719" unitRef="usd">3000000</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-172" decimals="-5" id="f-720" unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="c-80"
      decimals="INF"
      id="f-721"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-80" decimals="-5" id="f-722" unitRef="usd">3500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-173" decimals="-5" id="f-723" unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-174" decimals="-5" id="f-724" unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-175" decimals="-3" id="f-725" unitRef="usd">-1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-176" decimals="2" id="f-726" unitRef="number">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-177" decimals="-5" id="f-727" unitRef="usd">10200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-178" decimals="-5" id="f-728" unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod contextRef="c-179" id="f-729">P24M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-180" decimals="-5" id="f-730" unitRef="usd">6200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-181" decimals="-5" id="f-731" unitRef="usd">11100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="c-182"
      decimals="INF"
      id="f-732"
      unitRef="shares">56600</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-182" decimals="-5" id="f-733" unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="c-182" decimals="-5" id="f-734" unitRef="usd">1800000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-183"
      decimals="INF"
      id="f-735"
      unitRef="shares">64569</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-183" decimals="-5" id="f-736" unitRef="usd">2300000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-184" decimals="-5" id="f-737" unitRef="usd">2100000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock contextRef="c-1" id="f-738">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular roll-forward of contingent consideration is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Valuation of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Valuation of Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-185" decimals="-3" id="f-739" unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-143" decimals="-3" id="f-740" unitRef="usd">-4000000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-143" decimals="-3" id="f-741" unitRef="usd">-7158000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-143" decimals="-3" id="f-742" unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-186" decimals="-3" id="f-743" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-187" decimals="-3" id="f-744" unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-188" decimals="-3" id="f-745" unitRef="usd">-5110000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-188" decimals="-3" id="f-746" unitRef="usd">1401000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-188" decimals="-3" id="f-747" unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-189" decimals="-3" id="f-748" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-190" decimals="-3" id="f-749" unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-191" id="f-750" unitRef="usd" xsi:nil="true"/>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-175" decimals="-3" id="f-751" unitRef="usd">-1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-191" decimals="-3" id="f-752" unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-192" decimals="-3" id="f-753" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-193" decimals="-3" id="f-754" unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-194" decimals="-3" id="f-755" unitRef="usd">-7854000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-194" decimals="-3" id="f-756" unitRef="usd">2477000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-194" decimals="-3" id="f-757" unitRef="usd">600000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-195" decimals="-3" id="f-758" unitRef="usd">6879000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-196" decimals="-3" id="f-759" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-197" decimals="-3" id="f-760" unitRef="usd">11453000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-197" decimals="-3" id="f-761" unitRef="usd">-362000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-197" decimals="-3" id="f-762" unitRef="usd">67000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-185" decimals="-3" id="f-763" unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-198" decimals="-3" id="f-764" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-199" decimals="-3" id="f-765" unitRef="usd">4581000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-199" decimals="-3" id="f-766" unitRef="usd">-903000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-199" decimals="-3" id="f-767" unitRef="usd">31000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-187" decimals="-3" id="f-768" unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-200" decimals="-3" id="f-769" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-201" decimals="-3" id="f-770" unitRef="usd">1200000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-201" decimals="-3" id="f-771" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-201" decimals="-3" id="f-772" unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-190" decimals="-3" id="f-773" unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-202" decimals="-3" id="f-774" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements contextRef="c-203" decimals="-3" id="f-775" unitRef="usd">10814000</rdnt:BusinessCombinationContingentConsiderationArrangementsSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-203" decimals="-3" id="f-776" unitRef="usd">566000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation contextRef="c-203" decimals="-3" id="f-777" unitRef="usd">276000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-193" decimals="-3" id="f-778" unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-779">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward SOFR curve in 2023 and forward LIBOR curve in 2022. respectively. The forward SOFR curve and forward LIBOR curve are readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs. For Heart &amp;amp; Lung Imaging Limited, the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Heart &amp;amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. Holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs. For Aidence Holding B.V., the milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval. For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares. For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame. For Heart &amp;amp; Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads. As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart &amp;amp; Lung Imaging Limited are not observable and cannot be corroborated by observable market data, they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily relate to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations and other notes payable to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="c-1" id="f-780">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Current Assets and Deposits and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Current Assets and Deposits and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of contingencies and holdback relating to our acquisitions that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our Barclays Term Loans and Trust Term Loan long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Barclays Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Barclays Term Loans and Truist Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets contextRef="c-204" decimals="-3" id="f-781" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-205" decimals="-3" id="f-782" unitRef="usd">15118000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-206" decimals="-3" id="f-783" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-207" decimals="-3" id="f-784" unitRef="usd">15118000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-208" decimals="-3" id="f-785" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-209" decimals="-3" id="f-786" unitRef="usd">23302000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-210" decimals="-3" id="f-787" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-211" decimals="-3" id="f-788" unitRef="usd">23302000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-212" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-213" decimals="-3" id="f-790" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-214" decimals="-3" id="f-791" unitRef="usd">6879000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-215" decimals="-3" id="f-792" unitRef="usd">6879000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <rdnt:ScheuldeOfEstimatedFairValuesTableTextBlock contextRef="c-1" id="f-793">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. Holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:ScheuldeOfEstimatedFairValuesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-216" decimals="-3" id="f-794" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-217" decimals="-3" id="f-795" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-218" decimals="-3" id="f-796" unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-219" decimals="-3" id="f-797" unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="c-92"
      decimals="INF"
      id="f-798"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-220" decimals="-3" id="f-799" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-221" decimals="-3" id="f-800" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-222" decimals="-3" id="f-801" unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-223" decimals="-3" id="f-802" unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-224" decimals="-3" id="f-803" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-225" decimals="-3" id="f-804" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-226" decimals="-3" id="f-805" unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-227" decimals="-3" id="f-806" unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-228" decimals="-3" id="f-807" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-229" decimals="-3" id="f-808" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-230" decimals="-3" id="f-809" unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-231" decimals="-3" id="f-810" unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <rdnt:ValueOfEstimatedSharesIssuable
      contextRef="c-5"
      decimals="2"
      id="f-811"
      unitRef="usdPerShare">18.83</rdnt:ValueOfEstimatedSharesIssuable>
    <us-gaap:DebtInstrumentFairValue contextRef="c-232" decimals="-3" id="f-812" unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-233" decimals="-3" id="f-813" unitRef="usd">824759000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-234" decimals="-3" id="f-814" unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-235" decimals="-3" id="f-815" unitRef="usd">824759000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-4" decimals="-3" id="f-816" unitRef="usd">823063000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-236" decimals="-3" id="f-817" unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-237" decimals="-3" id="f-818" unitRef="usd">843594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-238" decimals="-3" id="f-819" unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-239" decimals="-3" id="f-820" unitRef="usd">843594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-5" decimals="-3" id="f-821" unitRef="usd">864125000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit contextRef="c-240" decimals="INF" id="f-822" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-241" decimals="INF" id="f-823" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-242" decimals="INF" id="f-824" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-243" decimals="INF" id="f-825" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-826">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-827">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.243%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,580,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,580,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options, warrants and holdback shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,658,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,320,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,421,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value associated with contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to RadNet, Inc's common stockholders for diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3,044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9,926&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24,727&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight average shares for which the exercise price exceeds the average market price of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-828" unitRef="usd">3044000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-829" unitRef="usd">10650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-830" unitRef="usd">24727000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-831" unitRef="shares">63580059</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-832" unitRef="shares">56293336</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-15" decimals="0" id="f-833" unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-834"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-835"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-15"
      decimals="2"
      id="f-836"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-837" unitRef="shares">63580059</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-838" unitRef="shares">56293336</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-15" decimals="0" id="f-839" unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-1" decimals="0" id="f-840" unitRef="shares">202995</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-14" decimals="0" id="f-841" unitRef="shares">172139</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-15" decimals="0" id="f-842" unitRef="shares">259539</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-1" decimals="0" id="f-843" unitRef="shares">875245</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-14" decimals="0" id="f-844" unitRef="shares">855395</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-15" decimals="0" id="f-845" unitRef="shares">664815</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-846" unitRef="shares">64658299</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-847" unitRef="shares">57320870</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-15" decimals="0" id="f-848" unitRef="shares">53421033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements contextRef="c-1" decimals="-3" id="f-849" unitRef="usd">0</rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements>
    <rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements contextRef="c-14" decimals="-3" id="f-850" unitRef="usd">-724000</rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements>
    <rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements contextRef="c-15" decimals="-3" id="f-851" unitRef="usd">0</rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-3" id="f-852" unitRef="usd">3044000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-14" decimals="-3" id="f-853" unitRef="usd">9926000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-15" decimals="-3" id="f-854" unitRef="usd">24727000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-855"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-856"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-15"
      decimals="2"
      id="f-857"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-244" decimals="0" id="f-858" unitRef="shares">754131</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-245" decimals="0" id="f-859" unitRef="shares">152723</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-246" decimals="0" id="f-860" unitRef="shares">47792</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-247" decimals="0" id="f-861" unitRef="shares">70760</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-248" decimals="0" id="f-862" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-249" decimals="0" id="f-863" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="c-1" id="f-864">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENTS IN EQUITY SECURITIES- Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost as follows:&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments
      contextRef="c-4"
      decimals="INF"
      id="f-865"
      unitRef="investment">3</rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c-250" decimals="-5" id="f-866" unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-250" decimals="4" id="f-867" unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:EquityMethodInvestmentSharesPurchased
      contextRef="c-251"
      decimals="-5"
      id="f-868"
      unitRef="shares">2100000</rdnt:EquityMethodInvestmentSharesPurchased>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-251" decimals="-5" id="f-869" unitRef="usd">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ShortTermBorrowings contextRef="c-252" decimals="-3" id="f-870" unitRef="usd">100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="c-253"
      decimals="INF"
      id="f-871"
      unitRef="shares">80000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <rdnt:EquityMethodInvestmentSharesAcquired
      contextRef="c-254"
      decimals="INF"
      id="f-872"
      unitRef="shares">2315350</rdnt:EquityMethodInvestmentSharesAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-254" decimals="-5" id="f-873" unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-254" decimals="-5" id="f-874" unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-255"
      decimals="INF"
      id="f-875"
      unitRef="shares">20325203</us-gaap:PreferredStockSharesIssued>
    <rdnt:PreferredStockExchangeRatePerShare
      contextRef="c-255"
      decimals="4"
      id="f-876"
      unitRef="usdPerShare">0.123</rdnt:PreferredStockExchangeRatePerShare>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-877">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="c-4"
      decimals="INF"
      id="f-878"
      unitRef="jointventure">13</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage contextRef="c-256" decimals="2" id="f-879" unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage contextRef="c-257" decimals="2" id="f-880" unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="c-1" id="f-881">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2023 and December 31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.090%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.710%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-43" decimals="-3" id="f-882" unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures contextRef="c-14" decimals="-3" id="f-883" unitRef="usd">9712000</rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-14" decimals="-3" id="f-884" unitRef="usd">10390000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="c-14" decimals="-3" id="f-885" unitRef="usd">4438000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-5" decimals="-3" id="f-886" unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-887" unitRef="usd">6427000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures contextRef="c-1" decimals="-3" id="f-888" unitRef="usd">43993000</rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="c-1" decimals="-3" id="f-889" unitRef="usd">15603000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-4" decimals="-3" id="f-890" unitRef="usd">92710000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees contextRef="c-1" decimals="-5" id="f-891" unitRef="usd">17900000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees contextRef="c-14" decimals="-5" id="f-892" unitRef="usd">22200000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees contextRef="c-15" decimals="-5" id="f-893" unitRef="usd">19600000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock contextRef="c-1" id="f-894">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key financial data for these joint ventures as of December 31, 2023 and 2022, respectively, and for the years ended December 31, 2023, 2022 and 2021, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent contextRef="c-258" decimals="-3" id="f-895" unitRef="usd">39819000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-259" decimals="-3" id="f-896" unitRef="usd">39304000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-258" decimals="-3" id="f-897" unitRef="usd">224936000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-259" decimals="-3" id="f-898" unitRef="usd">134694000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-258" decimals="-3" id="f-899" unitRef="usd">46587000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-259" decimals="-3" id="f-900" unitRef="usd">29588000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-258" decimals="-3" id="f-901" unitRef="usd">70834000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-259" decimals="-3" id="f-902" unitRef="usd">37952000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c-260" decimals="-3" id="f-903" unitRef="usd">147334000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost contextRef="c-261" decimals="-3" id="f-904" unitRef="usd">106458000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:Revenues contextRef="c-262" decimals="-3" id="f-905" unitRef="usd">184194000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-263" decimals="-3" id="f-906" unitRef="usd">145256000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-264" decimals="-3" id="f-907" unitRef="usd">129023000</us-gaap:Revenues>
    <us-gaap:ProfitLoss contextRef="c-262" decimals="-3" id="f-908" unitRef="usd">12968000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-263" decimals="-3" id="f-909" unitRef="usd">21169000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-264" decimals="-3" id="f-910" unitRef="usd">21893000</us-gaap:ProfitLoss>
    <rdnt:EquityMethodInvestmentAdditionalContribution contextRef="c-265" decimals="-5" id="f-911" unitRef="usd">2400000</rdnt:EquityMethodInvestmentAdditionalContribution>
    <rdnt:EquityMethodInvestmentAdditionalContribution contextRef="c-266" decimals="-5" id="f-912" unitRef="usd">1400000</rdnt:EquityMethodInvestmentAdditionalContribution>
    <rdnt:NumberOfAssetsSold
      contextRef="c-87"
      decimals="INF"
      id="f-913"
      unitRef="center">8</rdnt:NumberOfAssetsSold>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-86" decimals="-5" id="f-914" unitRef="usd">12700000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity contextRef="c-87" decimals="-5" id="f-915" unitRef="usd">-500000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:ProceedsFromDividendsReceived contextRef="c-86" decimals="-5" id="f-916" unitRef="usd">4500000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestments contextRef="c-87" decimals="-5" id="f-917" unitRef="usd">8300000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-87" decimals="2" id="f-918" unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromDividendsReceived contextRef="c-86" decimals="-5" id="f-919" unitRef="usd">4500000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestments contextRef="c-87" decimals="-5" id="f-920" unitRef="usd">8300000</us-gaap:EquityMethodInvestments>
    <rdnt:NumberOfLocationOfferingMultiModalityServices
      contextRef="c-267"
      decimals="INF"
      id="f-921"
      unitRef="location">3</rdnt:NumberOfLocationOfferingMultiModalityServices>
    <rdnt:NumberOfCentersContributed
      contextRef="c-267"
      decimals="INF"
      id="f-922"
      unitRef="center">3</rdnt:NumberOfCentersContributed>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest contextRef="c-268" decimals="2" id="f-923" unitRef="number">0.35</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:LimitedPartnersContributedCapital contextRef="c-267" decimals="-5" id="f-924" unitRef="usd">5900000</us-gaap:LimitedPartnersContributedCapital>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest contextRef="c-269" decimals="2" id="f-925" unitRef="number">0.65</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest contextRef="c-270" decimals="2" id="f-926" unitRef="number">0.40</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest contextRef="c-271" decimals="2" id="f-927" unitRef="number">0.60</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <rdnt:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed contextRef="c-272" decimals="2" id="f-928" unitRef="number">0.05</rdnt:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestDisposed>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest contextRef="c-273" decimals="2" id="f-929" unitRef="number">0.35</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:LimitedPartnersContributedCapital contextRef="c-274" decimals="-5" id="f-930" unitRef="usd">27200000</us-gaap:LimitedPartnersContributedCapital>
    <us-gaap:LimitedPartnersContributedCapital contextRef="c-275" decimals="-5" id="f-931" unitRef="usd">11300000</us-gaap:LimitedPartnersContributedCapital>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest contextRef="c-276" decimals="2" id="f-932" unitRef="number">0.49</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-276" decimals="-5" id="f-933" unitRef="usd">16800000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-935">RECENT ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-07 ("ASU 2023-07"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance requires entities to provide enhanced disclosures about significant segment expenses. For entities that have adopted the amendments in ASU 2023-07, the updated guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2023-07 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-09 ("ASU 2023-09"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Tax (Topic 740) Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; primarily related to the rate reconciliation and income taxes paid information. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is currently evaluating the impact of the adoption of ASU 2023-09 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="c-1" id="f-934">RECENT ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-07 ("ASU 2023-07"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance requires entities to provide enhanced disclosures about significant segment expenses. For entities that have adopted the amendments in ASU 2023-07, the updated guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2023-07 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued Accounting Standards Updates (ASUs) 2023-09 ("ASU 2023-09"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Tax (Topic 740) Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; primarily related to the rate reconciliation and income taxes paid information. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2024, and is applicable to the Company in fiscal 2025. Early adoption is permitted. The &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is currently evaluating the impact of the adoption of ASU 2023-09 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="c-1" id="f-936">BUSINESS COMBINATIONS AND RELATED ACTIVITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended 2023, 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the California, Delaware, Maryland, New Jersey and New York markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.113%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C.C.D.G.L.R. &amp;amp; S Services Inc.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,689)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Southern California Diagnostic Imaging, Inc.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,184)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inglewood Imaging Center, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ramapo Radiology Associates, P.C.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,775)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Madison Radiology Medical Group, Inc.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delaware Diagnostic Imaging, P.A.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$10,765&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$3,942&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$8,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$6,473&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(8,173)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.113%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*&#x5e;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*&#x5e;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates, P.A.*#&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,665&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,690&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,168)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chelsea Diagnostic Radiology, P.C.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North Jersey Imaging Center, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/9/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$142,781&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$22,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$7,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$106,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$16,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(2,145)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(6,684)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x5e; IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;#&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;+See detailed description of the Heart &amp;amp; Lung Imaging Limited acquisition below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heart &amp;amp; Lung Imaging Limited.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we acquired a 75% controlling interest in Heart &amp;amp; Lung Imaging Limited (&#x201c;HLI&#x201d;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#x2019;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $31.9 million, including: i) shares with a fair value of $6.8 million (359,002 shares issued at $19.06 per share), ii) cash of $6.3 million, iii) contingent consideration of $10.8 million ($10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $8.0 million. We recorded $0.6 million in current assets, $15.8 million in intangible assets, $0.6 million current liabilities and $16.2 million in goodwill in connection with this transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 19.0%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Aidence Holding B.V. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2&#160;million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0&#160;million, ii) cash of $1.8&#160;million, iii) contingent consideration of $11.9&#160;million ($7.4&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $4.5&#160;million), and iv) a settlement of a loan from RadNet of $1.5&#160;million.  In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6&#160;million.  As a result of this transaction, we recorded $1.0&#160;million in current assets, $0.2&#160;million in property and equipment, $27.7&#160;million in intangible assets (including developed technology of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$21.1&#160;million and IPR&amp;amp;D of $5.5&#160;million), $3.2&#160;million in current liabilities, a deferred tax liability of $3.5&#160;million, and $22.9&#160;million in goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15% to 17%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IPR&amp;amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company originally expected to complete the project following twelve months of acquisition. Subsequently, in September 2023, we determined that the In-process Research and Development ("IPR&amp;amp;D") related to Aidence's Ai Veye Lung and Veye Clinic would not achieve FDA approval for sale in the US without a new submission and additional expenditures for rework.  The additional expenditures, delay, and reduction of US sales affected the estimated fair value of the associated IPR&amp;amp;D intangible asset and resulted in impairment charges of $3.9&#160;million within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The useful lives for the developed technology asset was set at 7 years, for customer relationships 5.4 years, and trade names was 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Quantib B.V. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3&#160;million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9&#160;million, ii) cash of $11.8&#160;million, and iii)  contingent consideration consisting of 113,303 shares with a fair value at the date of close of $3.0&#160;million and cash of $1.6&#160;million both to be released 18 months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $2.4&#160;million in current assets, $0.1&#160;million in property and equipment, $21.3&#160;million in intangible assets (including developed technology of $19.6&#160;million and IPR&amp;amp;D of $0.7&#160;million), $0.7&#160;million in current liabilities, $6.7&#160;million in long-term debt and deferred tax liabilities, and $26.4&#160;million in goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 50% to 55%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The useful lives for the developed technology asset was set at seven years, customer relationships three years, and trade names seven years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As disclosed above, for the acquisitions of Aidence and Quantib, the Company uses the income approach to determine the fair value of developed technology and IPR&amp;amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsidiary activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Formation of majority owned subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Frederick County Radiology, LLC.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc.  The operation offers multi-modality services out of six locations in Frederick, Maryland.  We contributed the operations of four centers to the enterprise and Frederick Health Hospital, Inc.  contributed $5.4 million in fixed assets, $3.0 million in equipment, and  $11.0 million in goodwill.  As a result of the transaction, we recognized a gain of $6.6 million to additional paid in capital and retained a 65% controlling economic interest in FCR and Frederick Health Hospital, Inc. retains an $11.1 million or 35% noncontrolling economic interest in FCR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Formation of majority owned subsidiary and sale of ownership interest&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Los Angeles Imaging Group, LLC. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2023 we formed a wholly-owned subsidiary, Los Angeles Imaging Group, LLC ("LAIG"). The operation offers multi-modality imaging services out of three locations in Los Angeles, California. We contributed the operations of 3 centers to the subsidiary. Cedars-Sinai Medical Center purchased from us a 35% noncontrolling economic interest in LAIG for a cash payment of $5.9 million. As a result of the transaction, we retain a 65% controlling economic interest in LAIG.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of ownership interest  in a majority owned subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tarzana Medical Center, LLC.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-937">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.113%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C.C.D.G.L.R. &amp;amp; S Services Inc.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,689)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Southern California Diagnostic Imaging, Inc.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,184)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inglewood Imaging Center, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ramapo Radiology Associates, P.C.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,775)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Madison Radiology Medical Group, Inc.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delaware Diagnostic Imaging, P.A.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/1/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$10,765&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$3,942&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$8,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$6,473&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(8,173)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.113%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.914%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*&#x5e;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*&#x5e;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates, P.A.*#&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,665&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,690&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,168)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart &amp;amp; Lung Imaging Limited+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chelsea Diagnostic Radiology, P.C.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North Jersey Imaging Center, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/9/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$142,781&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$22,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$7,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$106,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$16,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(2,145)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(6,684)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x5e; IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;#&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.&lt;/span&gt;&lt;/div&gt;+See detailed description of the Heart &amp;amp; Lung Imaging Limited acquisition below.</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-277" decimals="-3" id="f-938" unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-277" decimals="-3" id="f-939" unitRef="usd">435000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-277" decimals="-3" id="f-940" unitRef="usd">1689000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-277" decimals="-3" id="f-941" unitRef="usd">3015000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-277" decimals="-3" id="f-942" unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-277" decimals="-3" id="f-943" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-277" decimals="-3" id="f-944" unitRef="usd">1689000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-278" decimals="-3" id="f-945" unitRef="usd">1815000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-278" decimals="-3" id="f-946" unitRef="usd">466000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-278" decimals="-3" id="f-947" unitRef="usd">1184000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-278" decimals="-3" id="f-948" unitRef="usd">1272000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-278" decimals="-3" id="f-949" unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-278" decimals="-3" id="f-950" unitRef="usd">27000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-278" decimals="-3" id="f-951" unitRef="usd">1184000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-279" decimals="-3" id="f-952" unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-279" decimals="-3" id="f-953" unitRef="usd">877000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-279" decimals="-3" id="f-954" unitRef="usd">1188000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-279" decimals="-3" id="f-955" unitRef="usd">1658000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-279" decimals="-3" id="f-956" unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-279" decimals="-3" id="f-957" unitRef="usd">15000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-279" decimals="-3" id="f-958" unitRef="usd">1188000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-280" decimals="-3" id="f-959" unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-280" decimals="-3" id="f-960" unitRef="usd">1663000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-280" decimals="-3" id="f-961" unitRef="usd">3775000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-280" decimals="-3" id="f-962" unitRef="usd">229000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-280" decimals="-3" id="f-963" unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-280" decimals="-3" id="f-964" unitRef="usd">8000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-280" decimals="-3" id="f-965" unitRef="usd">3775000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-281" decimals="-3" id="f-966" unitRef="usd">250000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-281" decimals="-3" id="f-967" unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-281" decimals="-3" id="f-968" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-281" decimals="-3" id="f-969" unitRef="usd">150000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-281" decimals="-3" id="f-970" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-281" decimals="-3" id="f-971" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-281" decimals="-3" id="f-972" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-282" decimals="-3" id="f-973" unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-282" decimals="-3" id="f-974" unitRef="usd">401000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-282" decimals="-3" id="f-975" unitRef="usd">337000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-282" decimals="-3" id="f-976" unitRef="usd">149000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-282" decimals="-3" id="f-977" unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-282" decimals="-3" id="f-978" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-282" decimals="-3" id="f-979" unitRef="usd">337000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-283" decimals="-3" id="f-980" unitRef="usd">10765000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-283" decimals="-3" id="f-981" unitRef="usd">3942000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-283" decimals="-3" id="f-982" unitRef="usd">8173000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-283" decimals="-3" id="f-983" unitRef="usd">6473000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-283" decimals="-3" id="f-984" unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-283" decimals="-3" id="f-985" unitRef="usd">50000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-283" decimals="-3" id="f-986" unitRef="usd">8173000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-284" decimals="-3" id="f-987" unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-284" decimals="-3" id="f-988" unitRef="usd">2910000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-284" decimals="-3" id="f-989" unitRef="usd">1703000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-284" decimals="-3" id="f-990" unitRef="usd">5271000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-284" decimals="-3" id="f-991" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-284" decimals="-3" id="f-992" unitRef="usd">19000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-284" decimals="-3" id="f-993" unitRef="usd">1703000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-285" decimals="-3" id="f-994" unitRef="usd">4800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-285" decimals="-3" id="f-995" unitRef="usd">2103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-285" decimals="-3" id="f-996" unitRef="usd">857000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-285" decimals="-3" id="f-997" unitRef="usd">2697000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-285" decimals="-3" id="f-998" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-285" decimals="-3" id="f-999" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-285" decimals="-3" id="f-1000" unitRef="usd">857000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-286" decimals="-3" id="f-1001" unitRef="usd">94877000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-286" decimals="-3" id="f-1002" unitRef="usd">16414000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-286" decimals="-3" id="f-1003" unitRef="usd">4665000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-286" decimals="-3" id="f-1004" unitRef="usd">79690000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-286" decimals="-3" id="f-1005" unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-286" decimals="-3" id="f-1006" unitRef="usd">-2168000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-286" decimals="-3" id="f-1007" unitRef="usd">4124000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-176" decimals="-3" id="f-1008" unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-176" decimals="-3" id="f-1009" unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-176" decimals="-3" id="f-1010" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-176" decimals="-3" id="f-1011" unitRef="usd">16200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-176" decimals="-3" id="f-1012" unitRef="usd">15800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-176" decimals="-3" id="f-1013" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-176" decimals="-3" id="f-1014" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-287" decimals="-3" id="f-1015" unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-287" decimals="-3" id="f-1016" unitRef="usd">568000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-287" decimals="-3" id="f-1017" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-287" decimals="-3" id="f-1018" unitRef="usd">2132000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-287" decimals="-3" id="f-1019" unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-287" decimals="-3" id="f-1020" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-287" decimals="-3" id="f-1021" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-288" decimals="-3" id="f-1022" unitRef="usd">104000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-288" decimals="-3" id="f-1023" unitRef="usd">20000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-288" decimals="-3" id="f-1024" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-288" decimals="-3" id="f-1025" unitRef="usd">55000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-288" decimals="-3" id="f-1026" unitRef="usd">25000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-288" decimals="-3" id="f-1027" unitRef="usd">4000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-288" decimals="-3" id="f-1028" unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-289" decimals="-3" id="f-1029" unitRef="usd">142781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-289" decimals="-3" id="f-1030" unitRef="usd">22015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset contextRef="c-289" decimals="-3" id="f-1031" unitRef="usd">7225000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-289" decimals="-3" id="f-1032" unitRef="usd">106045000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-289" decimals="-3" id="f-1033" unitRef="usd">16325000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther contextRef="c-289" decimals="-3" id="f-1034" unitRef="usd">-2145000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-289" decimals="-3" id="f-1035" unitRef="usd">6684000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationNumberOfSubsidiariesAcquired
      contextRef="c-290"
      decimals="INF"
      id="f-1036"
      unitRef="loan">3</rdnt:BusinessCombinationNumberOfSubsidiariesAcquired>
    <rdnt:BusinessCombinationNumberOfSubsidiariesAcquired
      contextRef="c-291"
      decimals="INF"
      id="f-1037"
      unitRef="loan">1</rdnt:BusinessCombinationNumberOfSubsidiariesAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-286" decimals="-5" id="f-1038" unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-176"
      decimals="2"
      id="f-1039"
      unitRef="number">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-179" decimals="-5" id="f-1040" unitRef="usd">31900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-179" decimals="-5" id="f-1041" unitRef="usd">6800000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-179"
      decimals="INF"
      id="f-1042"
      unitRef="shares">359002</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c-176"
      decimals="2"
      id="f-1043"
      unitRef="usdPerShare">19.06</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-179" decimals="-5" id="f-1044" unitRef="usd">6300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-176" decimals="-5" id="f-1045" unitRef="usd">10800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-177" decimals="-5" id="f-1046" unitRef="usd">10200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-178" decimals="-5" id="f-1047" unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod contextRef="c-179" id="f-1048">P24M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue contextRef="c-176" decimals="-5" id="f-1049" unitRef="usd">8000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="c-176" decimals="-5" id="f-1050" unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-176" decimals="-5" id="f-1051" unitRef="usd">15800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="c-176" decimals="-5" id="f-1052" unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:Goodwill contextRef="c-176" decimals="-5" id="f-1053" unitRef="usd">16200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="c-292"
      decimals="3"
      id="f-1054"
      unitRef="number">0.190</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-89" decimals="-5" id="f-1055" unitRef="usd">45200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-293"
      decimals="INF"
      id="f-1056"
      unitRef="shares">1117872</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c-294"
      decimals="2"
      id="f-1057"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-293" decimals="-5" id="f-1058" unitRef="usd">30000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-89" decimals="-5" id="f-1059" unitRef="usd">1800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-90" decimals="-5" id="f-1060" unitRef="usd">11900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-295" decimals="-5" id="f-1061" unitRef="usd">7400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-296" decimals="-5" id="f-1062" unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities contextRef="c-90" decimals="-5" id="f-1063" unitRef="usd">1500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-297"
      decimals="INF"
      id="f-1064"
      unitRef="shares">23362</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-297" decimals="-5" id="f-1065" unitRef="usd">600000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="c-90" decimals="-5" id="f-1066" unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-90" decimals="-5" id="f-1067" unitRef="usd">200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-90" decimals="-5" id="f-1068" unitRef="usd">27700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-298" decimals="-5" id="f-1069" unitRef="usd">21100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-299" decimals="-5" id="f-1070" unitRef="usd">5500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="c-90" decimals="-5" id="f-1071" unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-90" decimals="-5" id="f-1072" unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill contextRef="c-90" decimals="-5" id="f-1073" unitRef="usd">22900000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="c-300"
      decimals="2"
      id="f-1074"
      unitRef="number">0.15</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="c-301"
      decimals="2"
      id="f-1075"
      unitRef="number">0.17</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-143" decimals="-5" id="f-1076" unitRef="usd">3900000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-302" id="f-1077">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-303" id="f-1078">P5Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-304" id="f-1079">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-91" decimals="-5" id="f-1080" unitRef="usd">42300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-91"
      decimals="INF"
      id="f-1081"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c-305"
      decimals="2"
      id="f-1082"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-91" decimals="-5" id="f-1083" unitRef="usd">25900000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-91" decimals="-5" id="f-1084" unitRef="usd">11800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-306"
      decimals="INF"
      id="f-1085"
      unitRef="shares">113303</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-306" decimals="-5" id="f-1086" unitRef="usd">3000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-307" decimals="-5" id="f-1087" unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod contextRef="c-91" id="f-1088">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="c-92" decimals="-5" id="f-1089" unitRef="usd">2400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-92" decimals="-5" id="f-1090" unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-92" decimals="-5" id="f-1091" unitRef="usd">21300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-308" decimals="-5" id="f-1092" unitRef="usd">19600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-309" decimals="-5" id="f-1093" unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="c-92" decimals="-5" id="f-1094" unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities contextRef="c-92" decimals="-5" id="f-1095" unitRef="usd">6700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:Goodwill contextRef="c-92" decimals="-5" id="f-1096" unitRef="usd">26400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="c-310"
      decimals="2"
      id="f-1097"
      unitRef="number">0.50</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="c-311"
      decimals="2"
      id="f-1098"
      unitRef="number">0.55</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-312" id="f-1099">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-313" id="f-1100">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-314" id="f-1101">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <rdnt:NumberOfLocationOfferingMultiModalityServices
      contextRef="c-315"
      decimals="INF"
      id="f-1102"
      unitRef="location">6</rdnt:NumberOfLocationOfferingMultiModalityServices>
    <rdnt:NumberOfCentersContributed
      contextRef="c-316"
      decimals="INF"
      id="f-1103"
      unitRef="center">4</rdnt:NumberOfCentersContributed>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-317" decimals="-5" id="f-1104" unitRef="usd">5400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-318" decimals="-5" id="f-1105" unitRef="usd">3000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-88" decimals="-5" id="f-1106" unitRef="usd">11000000</us-gaap:Goodwill>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-319" decimals="-5" id="f-1107" unitRef="usd">6600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="c-320"
      decimals="2"
      id="f-1108"
      unitRef="number">0.65</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:EquityMethodInvestments contextRef="c-321" decimals="-5" id="f-1109" unitRef="usd">11100000</us-gaap:EquityMethodInvestments>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest
      contextRef="c-322"
      decimals="2"
      id="f-1110"
      unitRef="number">0.35</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest>
    <rdnt:NumberOfLocationOfferingMultiModalityServices
      contextRef="c-267"
      decimals="INF"
      id="f-1111"
      unitRef="location">3</rdnt:NumberOfLocationOfferingMultiModalityServices>
    <rdnt:NumberOfCentersContributed
      contextRef="c-267"
      decimals="INF"
      id="f-1112"
      unitRef="center">3</rdnt:NumberOfCentersContributed>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="c-268"
      decimals="2"
      id="f-1113"
      unitRef="number">0.35</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:LimitedPartnersContributedCapital contextRef="c-267" decimals="-5" id="f-1114" unitRef="usd">5900000</us-gaap:LimitedPartnersContributedCapital>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="c-269"
      decimals="2"
      id="f-1115"
      unitRef="number">0.65</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <rdnt:NoncontrollingInterestPercentOfOwnershipSold
      contextRef="c-323"
      decimals="3"
      id="f-1116"
      unitRef="number">0.249</rdnt:NoncontrollingInterestPercentOfOwnershipSold>
    <rdnt:ProceedsFromSaleOfInterestInMinorityShareholders contextRef="c-323" decimals="-5" id="f-1117" unitRef="usd">13100000</rdnt:ProceedsFromSaleOfInterestInMinorityShareholders>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-324"
      decimals="3"
      id="f-1118"
      unitRef="number">0.750</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-325"
      decimals="3"
      id="f-1119"
      unitRef="number">0.501</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-326" decimals="-5" id="f-1120" unitRef="usd">4200000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-327" decimals="-5" id="f-1121" unitRef="usd">5200000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1122">SEGMENT REPORTING&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our reportable segments are described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  We also provide teleradiology services in the United Kingdom though our majority-owned Heart &amp;amp; Lung Imaging Limited subsidiary.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence ("AI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.305%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,610,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,610,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.305%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,604,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,371,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,240,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,117,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,395,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,264,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,123,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Gain on contribution of imaging centers into joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Lease abandonment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;120,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;109,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;128,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;115,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss on Disposal of Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Income from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;119,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;77,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(21,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(25,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;98,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;73,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;In the first quarter of 2024, we revised our reportable segments to combine our eRad business, which was included in the Imaging Center segment, with our AI segment to form a new Digital Health reportable segment. As a result of the change, beginning with our Quarterly Report on Form 10-Q for the quarter ending March 31, 2024, we will report our results in these two reportable segments. The change in reportable segments will be reflected retrospectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1123">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.305%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,610,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,610,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.931%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.300%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.305%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,604,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,616,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,371,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,240,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,117,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,395,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,264,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,123,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Gain on contribution of imaging centers into joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Lease abandonment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;120,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;109,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;128,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;115,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss on Disposal of Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Income from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;119,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;77,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(21,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(25,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;98,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;73,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues contextRef="c-328" decimals="-3" id="f-1124" unitRef="usd">1610707000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-329" decimals="-3" id="f-1125" unitRef="usd">5923000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-330" decimals="-3" id="f-1126" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-331" decimals="-3" id="f-1127" unitRef="usd">1616630000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-332" decimals="-3" id="f-1128" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-333" decimals="-3" id="f-1129" unitRef="usd">6546000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-334" decimals="-3" id="f-1130" unitRef="usd">-6546000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-335" decimals="-3" id="f-1131" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-336" decimals="-3" id="f-1132" unitRef="usd">1610707000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-337" decimals="-3" id="f-1133" unitRef="usd">12469000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-338" decimals="-3" id="f-1134" unitRef="usd">-6546000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-1135" unitRef="usd">1616630000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-339" decimals="-3" id="f-1136" unitRef="usd">1425665000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-340" decimals="-3" id="f-1137" unitRef="usd">4396000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-341" decimals="-3" id="f-1138" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-342" decimals="-3" id="f-1139" unitRef="usd">1430061000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-343" decimals="-3" id="f-1140" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-344" decimals="-3" id="f-1141" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-345" decimals="-3" id="f-1142" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-346" decimals="-3" id="f-1143" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-347" decimals="-3" id="f-1144" unitRef="usd">1425665000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-348" decimals="-3" id="f-1145" unitRef="usd">4396000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-349" decimals="-3" id="f-1146" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-14" decimals="-3" id="f-1147" unitRef="usd">1430061000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-350" decimals="-3" id="f-1148" unitRef="usd">1604161000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-351" decimals="-3" id="f-1149" unitRef="usd">1425665000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-352" decimals="-3" id="f-1150" unitRef="usd">1313662000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-353" decimals="-3" id="f-1151" unitRef="usd">12469000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-354" decimals="-3" id="f-1152" unitRef="usd">4396000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-355" decimals="-3" id="f-1153" unitRef="usd">1415000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-1154" unitRef="usd">1616630000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-14" decimals="-3" id="f-1155" unitRef="usd">1430061000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-15" decimals="-3" id="f-1156" unitRef="usd">1315077000</us-gaap:Revenues>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-350" decimals="-3" id="f-1157" unitRef="usd">1371036000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-351" decimals="-3" id="f-1158" unitRef="usd">1240593000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-352" decimals="-3" id="f-1159" unitRef="usd">1117941000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-353" decimals="-3" id="f-1160" unitRef="usd">24203000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-354" decimals="-3" id="f-1161" unitRef="usd">23753000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-355" decimals="-3" id="f-1162" unitRef="usd">5333000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-1" decimals="-3" id="f-1163" unitRef="usd">1395239000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-14" decimals="-3" id="f-1164" unitRef="usd">1264346000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-15" decimals="-3" id="f-1165" unitRef="usd">1123274000</us-gaap:OperatingCostsAndExpenses>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-350" decimals="-3" id="f-1166" unitRef="usd">-16808000</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-351" decimals="-3" id="f-1167" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-352" decimals="-3" id="f-1168" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-353" decimals="-3" id="f-1169" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-354" decimals="-3" id="f-1170" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-355" decimals="-3" id="f-1171" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-1" decimals="-3" id="f-1172" unitRef="usd">-16808000</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-14" decimals="-3" id="f-1173" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <rdnt:GainOnContributionOfImagingCentersIntoJointVenture contextRef="c-15" decimals="-3" id="f-1174" unitRef="usd">0</rdnt:GainOnContributionOfImagingCentersIntoJointVenture>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-350" decimals="-3" id="f-1175" unitRef="usd">-5146000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-351" decimals="-3" id="f-1176" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-352" decimals="-3" id="f-1177" unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-353" decimals="-3" id="f-1178" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-354" decimals="-3" id="f-1179" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-355" decimals="-3" id="f-1180" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-1" decimals="-3" id="f-1181" unitRef="usd">-5146000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-14" decimals="-3" id="f-1182" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c-15" decimals="-3" id="f-1183" unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-350" decimals="-3" id="f-1184" unitRef="usd">120776000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-351" decimals="-3" id="f-1185" unitRef="usd">109524000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-352" decimals="-3" id="f-1186" unitRef="usd">96174000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-353" decimals="-3" id="f-1187" unitRef="usd">7615000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-354" decimals="-3" id="f-1188" unitRef="usd">6353000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-355" decimals="-3" id="f-1189" unitRef="usd">520000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-1190" unitRef="usd">128391000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-14" decimals="-3" id="f-1191" unitRef="usd">115877000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-15" decimals="-3" id="f-1192" unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-350" decimals="-3" id="f-1193" unitRef="usd">-2191000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-351" decimals="-3" id="f-1194" unitRef="usd">-2506000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-352" decimals="-3" id="f-1195" unitRef="usd">-1246000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-353" decimals="-3" id="f-1196" unitRef="usd">4000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-354" decimals="-3" id="f-1197" unitRef="usd">-23000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-355" decimals="-3" id="f-1198" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-1199" unitRef="usd">-2187000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-14" decimals="-3" id="f-1200" unitRef="usd">-2529000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-15" decimals="-3" id="f-1201" unitRef="usd">-1246000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:SeveranceCosts1 contextRef="c-350" decimals="-3" id="f-1202" unitRef="usd">1973000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-351" decimals="-3" id="f-1203" unitRef="usd">926000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-352" decimals="-3" id="f-1204" unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-353" decimals="-3" id="f-1205" unitRef="usd">1805000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-354" decimals="-3" id="f-1206" unitRef="usd">20000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-355" decimals="-3" id="f-1207" unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-3" id="f-1208" unitRef="usd">3778000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-14" decimals="-3" id="f-1209" unitRef="usd">946000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-15" decimals="-3" id="f-1210" unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-350" decimals="-3" id="f-1211" unitRef="usd">119847000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-351" decimals="-3" id="f-1212" unitRef="usd">72116000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-352" decimals="-3" id="f-1213" unitRef="usd">77882000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-353" decimals="-3" id="f-1214" unitRef="usd">-21150000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-354" decimals="-3" id="f-1215" unitRef="usd">-25753000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-355" decimals="-3" id="f-1216" unitRef="usd">-4438000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-1" decimals="-3" id="f-1217" unitRef="usd">98697000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-14" decimals="-3" id="f-1218" unitRef="usd">46363000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding contextRef="c-15" decimals="-3" id="f-1219" unitRef="usd">73444000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-356"
      decimals="INF"
      id="f-1220"
      unitRef="loan">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-1221">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is recorded as a result of business combinations. The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2022 and December 31, 2023 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2023 is $142.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization expense was $12.2 million, $10.1 million, and $4.4 million for the years ended December 31, 2023, 2022 and 2021, respectively. Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.464%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="c-1" id="f-1222">The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2022 and December 31, 2023 is provided below (in thousands):&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill contextRef="c-357" decimals="-3" id="f-1223" unitRef="usd">489210000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-358" decimals="-3" id="f-1224" unitRef="usd">24610000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-43" decimals="-3" id="f-1225" unitRef="usd">513820000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-351" decimals="-3" id="f-1226" unitRef="usd">120551000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-354" decimals="-3" id="f-1227" unitRef="usd">48697000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-14" decimals="-3" id="f-1228" unitRef="usd">169248000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-351" decimals="-3" id="f-1229" unitRef="usd">4200000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-354" decimals="-3" id="f-1230" unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-14" decimals="-3" id="f-1231" unitRef="usd">4200000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-351" decimals="-3" id="f-1232" unitRef="usd">-106000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-354" decimals="-3" id="f-1233" unitRef="usd">147000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-14" decimals="-3" id="f-1234" unitRef="usd">41000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-351" decimals="-3" id="f-1235" unitRef="usd">1028000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-354" decimals="-3" id="f-1236" unitRef="usd">-2272000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-14" decimals="-3" id="f-1237" unitRef="usd">-1244000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-359" decimals="-3" id="f-1238" unitRef="usd">606483000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-360" decimals="-3" id="f-1239" unitRef="usd">71182000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-1240" unitRef="usd">677665000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-350" decimals="-3" id="f-1241" unitRef="usd">6473000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-353" decimals="-3" id="f-1242" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-1243" unitRef="usd">6473000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-350" decimals="-3" id="f-1244" unitRef="usd">9235000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-353" decimals="-3" id="f-1245" unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="c-1" decimals="-3" id="f-1246" unitRef="usd">9235000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-350" decimals="-3" id="f-1247" unitRef="usd">1603000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-353" decimals="-3" id="f-1248" unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-1" decimals="-3" id="f-1249" unitRef="usd">1603000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-350" decimals="-3" id="f-1250" unitRef="usd">1233000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-353" decimals="-3" id="f-1251" unitRef="usd">1724000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-3" id="f-1252" unitRef="usd">2957000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-361" decimals="-3" id="f-1253" unitRef="usd">606557000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-362" decimals="-3" id="f-1254" unitRef="usd">72906000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-1255" unitRef="usd">679463000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-4" decimals="-5" id="f-1256" unitRef="usd">142700000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:AdjustmentForAmortization contextRef="c-1" decimals="-5" id="f-1257" unitRef="usd">12200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-14" decimals="-5" id="f-1258" unitRef="usd">10100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-15" decimals="-5" id="f-1259" unitRef="usd">4400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-363" id="f-1260">P25Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-1261">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.464%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-364" decimals="-3" id="f-1262" unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-364" decimals="-3" id="f-1263" unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-364" decimals="-3" id="f-1264" unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-364" decimals="-3" id="f-1265" unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-364" decimals="-3" id="f-1266" unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-364" decimals="-3" id="f-1267" unitRef="usd">6671000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-364" decimals="-3" id="f-1268" unitRef="usd">18106000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-364" id="f-1269">P7Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-365" decimals="-3" id="f-1270" unitRef="usd">946000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-365" decimals="-3" id="f-1271" unitRef="usd">714000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-365" decimals="-3" id="f-1272" unitRef="usd">427000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-365" decimals="-3" id="f-1273" unitRef="usd">132000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-365" decimals="-3" id="f-1274" unitRef="usd">45000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-365" decimals="-3" id="f-1275" unitRef="usd">6000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-365" decimals="-3" id="f-1276" unitRef="usd">2270000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-365" id="f-1277">P3Y4M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-366" decimals="-3" id="f-1278" unitRef="usd">1234000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-366" decimals="-3" id="f-1279" unitRef="usd">1104000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-366" decimals="-3" id="f-1280" unitRef="usd">981000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-366" decimals="-3" id="f-1281" unitRef="usd">797000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-366" decimals="-3" id="f-1282" unitRef="usd">764000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-366" decimals="-3" id="f-1283" unitRef="usd">10564000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-366" decimals="-3" id="f-1284" unitRef="usd">15444000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-366" id="f-1285">P17Y8M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-367" decimals="-3" id="f-1286" unitRef="usd">316000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-367" decimals="-3" id="f-1287" unitRef="usd">316000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-367" decimals="-3" id="f-1288" unitRef="usd">316000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-367" decimals="-3" id="f-1289" unitRef="usd">315000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-367" decimals="-3" id="f-1290" unitRef="usd">300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-367" decimals="-3" id="f-1291" unitRef="usd">164000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-367" decimals="-3" id="f-1292" unitRef="usd">1727000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-367" id="f-1293">P5Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-368" decimals="-3" id="f-1294" unitRef="usd">7785000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-368" decimals="-3" id="f-1295" unitRef="usd">7785000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-368" decimals="-3" id="f-1296" unitRef="usd">7745000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-368" decimals="-3" id="f-1297" unitRef="usd">7210000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-368" decimals="-3" id="f-1298" unitRef="usd">7046000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-368" decimals="-3" id="f-1299" unitRef="usd">6117000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-368" decimals="-3" id="f-1300" unitRef="usd">43688000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-368" id="f-1301">P5Y8M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-369" decimals="-3" id="f-1302" unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-369" decimals="-3" id="f-1303" unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-369" decimals="-3" id="f-1304" unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-369" decimals="-3" id="f-1305" unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-369" decimals="-3" id="f-1306" unitRef="usd">63000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-369" decimals="-3" id="f-1307" unitRef="usd">27000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-369" decimals="-3" id="f-1308" unitRef="usd">398000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-369" id="f-1309">P5Y3M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-370" decimals="-3" id="f-1310" unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-370" decimals="-3" id="f-1311" unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-371" decimals="-3" id="f-1312" unitRef="usd">1882000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-371" decimals="-3" id="f-1313" unitRef="usd">1882000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1314" unitRef="usd">12645000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-3" id="f-1315" unitRef="usd">12283000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-3" id="f-1316" unitRef="usd">11833000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-3" id="f-1317" unitRef="usd">10818000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-4" decimals="-3" id="f-1318" unitRef="usd">10505000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-4" decimals="-3" id="f-1319" unitRef="usd">32531000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-1320" unitRef="usd">90615000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-1321">PROPERTY AND EQUIPMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment originally acquired under finance/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(836,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our property and equipment at December 31, 2023  is approximately $42.7 million total of construction in process amounts consisting of $12.2 million in medical equipment, $1.9 million in computer and office equipment, $6.0 million in software costs and $22.6 million in leasehold improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our property and equipment at December 31, 2022 is approximately $73.4 million total of construction in process amounts consisting of $26.6 million in medical equipment, $5.3 million in computer and office equipment, $0.4 million in software costs and $41.1 million in leasehold improvements.&lt;/span&gt;&lt;/div&gt;Depreciation and amortization expense of property and equipment, including amortization of equipment under finance leases, for the years ended December 31, 2023, 2022 and 2021 was $116.2 million, $105.6 million, and $92.3 million, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-1322">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment originally acquired under finance/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(836,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-372" decimals="-3" id="f-1323" unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-373" decimals="-3" id="f-1324" unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-374" decimals="-3" id="f-1325" unitRef="usd">714400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-375" decimals="-3" id="f-1326" unitRef="usd">649034000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-376" decimals="-3" id="f-1327" unitRef="usd">127540000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-377" decimals="-3" id="f-1328" unitRef="usd">119467000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-378" decimals="-3" id="f-1329" unitRef="usd">47286000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-379" decimals="-3" id="f-1330" unitRef="usd">36015000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-380" decimals="-3" id="f-1331" unitRef="usd">537853000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-381" decimals="-3" id="f-1332" unitRef="usd">501963000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-1333" unitRef="usd">13971000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-1334" unitRef="usd">13971000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-1335" unitRef="usd">1441300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-1336" unitRef="usd">1320700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-1337" unitRef="usd">836899000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-1338" unitRef="usd">754739000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-1339" unitRef="usd">604401000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-1340" unitRef="usd">565961000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-382" decimals="-5" id="f-1341" unitRef="usd">42700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-383" decimals="-5" id="f-1342" unitRef="usd">12200000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-384" decimals="-5" id="f-1343" unitRef="usd">1900000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-378" decimals="-5" id="f-1344" unitRef="usd">6000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-380" decimals="-5" id="f-1345" unitRef="usd">22600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-385" decimals="-5" id="f-1346" unitRef="usd">73400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-386" decimals="-5" id="f-1347" unitRef="usd">26600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-387" decimals="-5" id="f-1348" unitRef="usd">5300000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-379" decimals="-5" id="f-1349" unitRef="usd">400000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-381" decimals="-5" id="f-1350" unitRef="usd">41100000</us-gaap:ConstructionInProgressGross>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-5" id="f-1351" unitRef="usd">116200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-14" decimals="-5" id="f-1352" unitRef="usd">105600000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-15" decimals="-5" id="f-1353" unitRef="usd">92300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1354">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023 and December 31, 2022 our term loan debt and other obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Barclays Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on Barclays Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Truist Term Loan collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on Truist Term Loan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.090%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.710%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2023 and had reserved an additional $7.6 million for certain letters of credit.  The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2023.  We also had no balance under our $50.0 million Truist Revolving Credit Facility, related to our consolidated subsidiary NJIN, at December 31, 2023, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2023 we were in compliance with all covenants under our credit facilities. On February 1, 2023, we issued a promissory note in the amount of $19.8 million to acquire radiology equipment previously leased under operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Amendments to Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays: First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2023, we entered into the First Amendment to Second Amended and Restated First Lien Credit and Guaranty Agreement related to our Barclays credit facility (the "Barclays Amendment"), which replaces the interest rate benchmark, from the London Interbank Offered Rate ("LIBOR") to the Secured Overnight Financing Rate ("SOFR") and includes applicable credit spread adjustments of 0.11448%, 0.26161%, and 0.42826% for interest periods of one month, three months, and six months, respectively. The replacement of LIBOR with SOFR and the credit spread adjustments were effective as of March 31, 2023, which was the last day of the last-ending existing interest period of currently outstanding loan bearing interest at LIBOR. Other than the foregoing, the material terms of the Barclays credit facility remained unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Barclays Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "Barclays Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the Barclays Term Loans were used to refinance loans outstanding under our prior Barclays credit agreement and provide funding for current and future operations. Total costs of the Barclays Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs, $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the  Barclays Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Truist Restated Credit Agreement") which provides for a $150.0 million of a secured term loan (the "Truist Term Loan") and a $50.0 million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior Truist term loan agreement and provide funding for current and future operations. Total costs of the Truist Restated Credit Agreement amounted to approximately $2.7 million segregated as follows: $2.0 million capitalized to discount and deferred finance cost and $0.7 million expensed to loss on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Truist Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Truist Restated Credit Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Truist Restated Credit Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.790%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.226%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.226%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;Barclays Term Loans:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through March 31, 2023, the Barclays Term Loans bore interest at either a Eurodollar Rate or an Alternative Base Rate (in each such case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin. The applicable margin for Eurodollar Rate and Alternative Base Rate was 3% and 2%, respectively, with an effective Eurodollar Rate and the Alternative Base Rate of 4.63% and 8.00%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Barclays Amendment, effective March 31, 2023, the Barclays Term Loans bear interest either at a SOFR or Alternative Base Rate (in each such case, as defined in the Restated Barclays Credit Agreement) plus an applicable margin. The applicable margin for Eurodollar Rate and Alternative Base Rate was 3% and 2%, respectively. At December 31, 2023, we have an effective SOFR of 8.38%, with an applicable credit spread adjustment of 0.26161%, and an Alternative Base Rate of 10.5%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Restated Credit Agreement provides for quarterly payments of principal for the Barclays Term Loans in the amount of approximately $1.8 million. The  Barclays Term Loans will mature on April 23, 2028 unless otherwise accelerated under the terms of the Barclays Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist Term Loan:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Truist Term Loan currently bears interest at a three month SOFR election of 5.33% plus an applicable margin and fees based on Pricing Level V described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the Truist Term Loan began March 31, 2023 with quarterly payments of $1.9 million, representing 1.00% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $0.9 million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the Truist Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Barclays Revolving Credit Facility is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $1.1 million at December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin which adjusts depending on our  net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.850%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Alternative Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, the effective interest rate for borrowings on revolving loans under the Barclays Revolving Credit Facility was 10.3%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for SOFR revolving loans which is currently 3.00% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Barclays Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Barclays Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Associated with the Truist Revolving Credit Facility of $50.0 million are deferred financing costs, net of accumulated amortization, of  $0.5 million at December 31, 2023.  As of December 31, 2023, NJIN had no borrowings under the Truist Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level V as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent Amendments to prior Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;Truist Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On August 31, 2018, under an Amended and Restated Revolving Credit and Term Loan Agreement, our NJIN subsidiary secured a term loan commitment of $60.0 million and established revolving credit facility of $30.0 million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Truist Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-1355">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023 and December 31, 2022 our term loan debt and other obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Barclays Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on Barclays Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Truist Term Loan collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on Truist Term Loan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment notes payable at 6.0%, due 2028, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt contextRef="c-388" decimals="-3" id="f-1356" unitRef="usd">678687000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-389" decimals="-3" id="f-1357" unitRef="usd">714125000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-388" decimals="-3" id="f-1358" unitRef="usd">9041000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-389" decimals="-3" id="f-1359" unitRef="usd">11127000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt contextRef="c-390" decimals="-3" id="f-1360" unitRef="usd">144375000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-391" decimals="-3" id="f-1361" unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-390" decimals="-3" id="f-1362" unitRef="usd">990000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-391" decimals="-3" id="f-1363" unitRef="usd">1254000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-392"
      decimals="INF"
      id="f-1364"
      unitRef="number">0.060</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:OtherNotesPayable contextRef="c-392" decimals="-3" id="f-1365" unitRef="usd">17011000</us-gaap:OtherNotesPayable>
    <us-gaap:OtherNotesPayable contextRef="c-393" decimals="-3" id="f-1366" unitRef="usd">0</us-gaap:OtherNotesPayable>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-1367" unitRef="usd">830042000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-5" decimals="-3" id="f-1368" unitRef="usd">851744000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-1369" unitRef="usd">17974000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-1370" unitRef="usd">12400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-1371" unitRef="usd">812068000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-1372" unitRef="usd">839344000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-1373">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.090%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.710%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1374" unitRef="usd">20324000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-4" decimals="-3" id="f-1375" unitRef="usd">22431000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-4" decimals="-3" id="f-1376" unitRef="usd">22676000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-4" decimals="-3" id="f-1377" unitRef="usd">124188000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="c-4" decimals="-3" id="f-1378" unitRef="usd">650454000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-4" decimals="-3" id="f-1379" unitRef="usd">840073000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCredit contextRef="c-394" decimals="INF" id="f-1380" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-395" decimals="INF" id="f-1381" unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-396" decimals="-5" id="f-1382" unitRef="usd">7600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-397" decimals="-5" id="f-1383" unitRef="usd">187400000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-398" decimals="INF" id="f-1384" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-399" decimals="INF" id="f-1385" unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-83" decimals="-5" id="f-1386" unitRef="usd">19800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-400"
      decimals="INF"
      id="f-1387"
      unitRef="number">0.0011448</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-401"
      decimals="INF"
      id="f-1388"
      unitRef="number">0.0026161</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-402"
      decimals="INF"
      id="f-1389"
      unitRef="number">0.0042826</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCredit contextRef="c-403" decimals="-5" id="f-1390" unitRef="usd">725000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-395" decimals="INF" id="f-1391" unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-404" decimals="-5" id="f-1392" unitRef="usd">14900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="c-404" decimals="-5" id="f-1393" unitRef="usd">8800000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-404" decimals="-5" id="f-1394" unitRef="usd">4500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-405" decimals="-5" id="f-1395" unitRef="usd">-1500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfDeferredCharges contextRef="c-405" decimals="-5" id="f-1396" unitRef="usd">100000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:LineOfCredit contextRef="c-406" decimals="-5" id="f-1397" unitRef="usd">150000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-407" decimals="INF" id="f-1398" unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-408" decimals="-5" id="f-1399" unitRef="usd">2700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="c-408" decimals="-5" id="f-1400" unitRef="usd">2000000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-409" decimals="-5" id="f-1401" unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock contextRef="c-1" id="f-1402">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Truist Restated Credit Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Truist Restated Credit Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.790%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.226%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.226%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a SOFR or an Alternate Base Rate (in each case, as defined in the Barclays Restated Credit Agreement) plus an applicable margin which adjusts depending on our  net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.850%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Alternative Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="c-410"
      decimals="INF"
      id="f-1403"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-411"
      decimals="INF"
      id="f-1404"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-412"
      decimals="INF"
      id="f-1405"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-413"
      decimals="INF"
      id="f-1406"
      unitRef="number">0.0250</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-413"
      decimals="INF"
      id="f-1407"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-414"
      decimals="INF"
      id="f-1408"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="c-414"
      decimals="INF"
      id="f-1409"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-415"
      decimals="INF"
      id="f-1410"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-416"
      decimals="INF"
      id="f-1411"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-417"
      decimals="INF"
      id="f-1412"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-417"
      decimals="INF"
      id="f-1413"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-418"
      decimals="INF"
      id="f-1414"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="c-418"
      decimals="INF"
      id="f-1415"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-419"
      decimals="INF"
      id="f-1416"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-420"
      decimals="INF"
      id="f-1417"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-421"
      decimals="INF"
      id="f-1418"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-421"
      decimals="INF"
      id="f-1419"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-422"
      decimals="INF"
      id="f-1420"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="c-422"
      decimals="INF"
      id="f-1421"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-423"
      decimals="INF"
      id="f-1422"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-424"
      decimals="INF"
      id="f-1423"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-425"
      decimals="INF"
      id="f-1424"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-425"
      decimals="INF"
      id="f-1425"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-426"
      decimals="INF"
      id="f-1426"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-427"
      decimals="INF"
      id="f-1427"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-428"
      decimals="INF"
      id="f-1428"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-429"
      decimals="INF"
      id="f-1429"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-429"
      decimals="INF"
      id="f-1430"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-430"
      decimals="INF"
      id="f-1431"
      unitRef="number">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-431"
      decimals="INF"
      id="f-1432"
      unitRef="number">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-432"
      decimals="4"
      id="f-1433"
      unitRef="number">0.0463</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-433"
      decimals="4"
      id="f-1434"
      unitRef="number">0.0800</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-430"
      decimals="INF"
      id="f-1435"
      unitRef="number">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-431"
      decimals="INF"
      id="f-1436"
      unitRef="number">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-434"
      decimals="4"
      id="f-1437"
      unitRef="number">0.0838</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-434"
      decimals="INF"
      id="f-1438"
      unitRef="number">0.0026161</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-435"
      decimals="3"
      id="f-1439"
      unitRef="number">0.105</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-436" decimals="-5" id="f-1440" unitRef="usd">1800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-437"
      decimals="INF"
      id="f-1441"
      unitRef="number">0.0533</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="c-438" decimals="-5" id="f-1442" unitRef="usd">1900000</us-gaap:DebtInstrumentPeriodicPayment>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="c-438"
      decimals="INF"
      id="f-1443"
      unitRef="number">0.0100</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease contextRef="c-439" decimals="-5" id="f-1444" unitRef="usd">900000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-395" decimals="INF" id="f-1445" unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-397" decimals="-5" id="f-1446" unitRef="usd">1100000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="c-440"
      decimals="INF"
      id="f-1447"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-441"
      decimals="INF"
      id="f-1448"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-442"
      decimals="INF"
      id="f-1449"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="c-443"
      decimals="INF"
      id="f-1450"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="c-444"
      decimals="INF"
      id="f-1451"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-445"
      decimals="INF"
      id="f-1452"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-446"
      decimals="INF"
      id="f-1453"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="c-447"
      decimals="INF"
      id="f-1454"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-448"
      decimals="INF"
      id="f-1455"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-449"
      decimals="INF"
      id="f-1456"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-397"
      decimals="3"
      id="f-1457"
      unitRef="number">0.103</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-450"
      decimals="INF"
      id="f-1458"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-451"
      decimals="INF"
      id="f-1459"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-451"
      decimals="INF"
      id="f-1460"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-407" decimals="INF" id="f-1461" unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-452" decimals="-5" id="f-1462" unitRef="usd">500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-453" decimals="INF" id="f-1463" unitRef="usd">60000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-454" decimals="INF" id="f-1464" unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-1465">LEASES&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our material lease contracts are for facilities and advanced radiology equipment.  In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from 5 to 8 years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our incremental borrowing rate used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our incremental borrowing rate is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.826%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) Operating lease cost above for the year ended December 31, 2023 and 2021 included $2.7 million and $12.6 million, respectively in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.568%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1511"&gt;&lt;span style="-sec-ix-hidden:f-1512"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.904%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.896%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $4.6 million.  These operating leases will commence in 2024 with lease terms of 1 to 15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-455" id="f-1466">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-456" id="f-1467">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-455" id="f-1468">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-456" id="f-1469">P35Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <rdnt:LesseeLeaseTermofContract contextRef="c-457" id="f-1470">P5Y</rdnt:LesseeLeaseTermofContract>
    <rdnt:LesseeLeaseTermofContract contextRef="c-458" id="f-1471">P8Y</rdnt:LesseeLeaseTermofContract>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1472">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.826%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) Operating lease cost above for the year ended December 31, 2023 and 2021 included $2.7 million and $12.6 million, respectively in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-1473" unitRef="usd">106954000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-14" decimals="-3" id="f-1474" unitRef="usd">107475000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-15" decimals="-3" id="f-1475" unitRef="usd">121578000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-1476" unitRef="usd">1204000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-14" decimals="-3" id="f-1477" unitRef="usd">2896000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-15" decimals="-3" id="f-1478" unitRef="usd">3068000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-1479" unitRef="usd">0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-14" decimals="-3" id="f-1480" unitRef="usd">0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-15" decimals="-3" id="f-1481" unitRef="usd">46000</us-gaap:FinanceLeaseInterestExpense>
    <rdnt:FinanceLeaseCost contextRef="c-1" decimals="-3" id="f-1482" unitRef="usd">1204000</rdnt:FinanceLeaseCost>
    <rdnt:FinanceLeaseCost contextRef="c-14" decimals="-3" id="f-1483" unitRef="usd">2896000</rdnt:FinanceLeaseCost>
    <rdnt:FinanceLeaseCost contextRef="c-15" decimals="-3" id="f-1484" unitRef="usd">3114000</rdnt:FinanceLeaseCost>
    <rdnt:OperatingLeaseLeaseAbandonmentCharges contextRef="c-1" decimals="-5" id="f-1485" unitRef="usd">2700000</rdnt:OperatingLeaseLeaseAbandonmentCharges>
    <rdnt:OperatingLeaseLeaseAbandonmentCharges contextRef="c-15" decimals="-5" id="f-1486" unitRef="usd">12600000</rdnt:OperatingLeaseLeaseAbandonmentCharges>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c-1" id="f-1487">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.568%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-1488" unitRef="usd">101516000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-14" decimals="-3" id="f-1489" unitRef="usd">108004000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-15" decimals="-3" id="f-1490" unitRef="usd">110288000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-1491" unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-14" decimals="-3" id="f-1492" unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-15" decimals="-3" id="f-1493" unitRef="usd">46000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-1494" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-14" decimals="-3" id="f-1495" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-15" decimals="-3" id="f-1496" unitRef="usd">3304000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-1497" unitRef="usd">55852000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-14" decimals="-3" id="f-1498" unitRef="usd">88080000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-15" decimals="-3" id="f-1499" unitRef="usd">186695000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <rdnt:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-1500">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1511"&gt;&lt;span style="-sec-ix-hidden:f-1512"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-1501" unitRef="usd">596032000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-1502" unitRef="usd">603524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1503" unitRef="usd">55981000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-1504" unitRef="usd">57607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-1505" unitRef="usd">605097000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-1506" unitRef="usd">604117000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1507" unitRef="usd">661078000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-1508" unitRef="usd">661724000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-1509" unitRef="usd">13971000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-1510" unitRef="usd">13971000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-1513" unitRef="usd">13374000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-1514" unitRef="usd">12171000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-1515" unitRef="usd">597000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-1516" unitRef="usd">1801000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1517">P10Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1518">P10Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-1519" unitRef="number">0.067</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-1520" unitRef="number">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1521">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.904%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.896%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1522" unitRef="usd">97603000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-1523" unitRef="usd">92092000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-1524" unitRef="usd">91400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-1525" unitRef="usd">88977000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-1526" unitRef="usd">85633000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <rdnt:LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter contextRef="c-4" decimals="-3" id="f-1527" unitRef="usd">482594000</rdnt:LesseeOperatingLeaseLiabilityToBePaidYearSixThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-1528" unitRef="usd">938299000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-1529" unitRef="usd">277221000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1530" unitRef="usd">661078000</us-gaap:OperatingLeaseLiability>
    <rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount contextRef="c-4" decimals="-5" id="f-1531" unitRef="usd">4600000</rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1 contextRef="c-455" id="f-1532">P1Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1 contextRef="c-456" id="f-1533">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1534">INCOME TAXES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2023, 2022 and 2021, we have the following income (loss) before income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2023, 2022 and 2021, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Officer Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax rate adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets and liabilities comprise the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, we had federal net operating loss carryforwards of approximately $128.9 million, which is comprised of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $63.9 million, which expire at various intervals from the years 2026 to 2037, and had carryforwards of $65.0 million of net operating losses which do not expire. Federal net operating losses generated in tax years following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  We also had state net operating loss carryforwards of approximately $145.3 million, which expire at various intervals from the years 2024 through 2042. As of December 31, 2023, $24.9 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code. We also had foreign net operating loss carryforwards of approximately $45.8 million, which do not expire and are carried over indefinitely.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2023, we have determined that deferred tax assets of $196.2 million are more likely-than-not to be realized. We have also determined deferred tax liabilities of $42.4 million are related to book basis in goodwill that has an indefinite life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018. We do not anticipate the results of any open examinations would result in a material change to our financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2023, we had unrecognized tax benefits of $3.1 million of which $2.5 million will affect the effective tax rate if recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2023 the Company accrued approximately $47 thousand of interest and penalties. As of December 31, 2023, accrued interest and penalties amounted to approximately $0.4 million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In 2021, the Organization for Economic Co-operation and Development ("OECD") announced an inclusive framework on base erosion and profit shifting including Pillar Two Model Rules defining the global minimum tax, which calls for taxation of large multinational corporations at a minimum rate of 15%. Subsequently multiple sets of administrative guidance have been issued. Many non-US tax jurisdictions have either recently enacted legislation to adopt certain components of Pillar Two Model Rules beginning in 2024 (including the European Union Member States) with the adoption of additional components in later years or announced their plans to enact legislation in future years. We are continuing to evaluate the impacts of enacted legislation and pending legislation to enact Pillar Two Model Rules in the jurisdictions that we operate in outside of the US.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 was signed into law on August 9, 2022 to boost domestic semiconductor manufacturing and encourage US research activities.  The act provided a 25% investment credit intended to promote domestic production of semiconductors. This act is not expected to have a material impact for us.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-1535">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2023, 2022 and 2021, we have the following income (loss) before income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-3" id="f-1536" unitRef="usd">60374000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-14" decimals="-3" id="f-1537" unitRef="usd">59529000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-15" decimals="-3" id="f-1538" unitRef="usd">58806000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-3" id="f-1539" unitRef="usd">-21564000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-14" decimals="-3" id="f-1540" unitRef="usd">-16560000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-15" decimals="-3" id="f-1541" unitRef="usd">73000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-1542" unitRef="usd">38810000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-1543" unitRef="usd">42969000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-1544" unitRef="usd">58879000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1545">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2023, 2022 and 2021, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1546" unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1547" unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1548" unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-1" decimals="-3" id="f-1549" unitRef="usd">3442000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-14" decimals="-3" id="f-1550" unitRef="usd">371000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-15" decimals="-3" id="f-1551" unitRef="usd">-2191000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1552" unitRef="usd">638000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1553" unitRef="usd">87000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1554" unitRef="usd">18000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <rdnt:CurrentOtherTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1555" unitRef="usd">0</rdnt:CurrentOtherTaxExpenseBenefit>
    <rdnt:CurrentOtherTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1556" unitRef="usd">0</rdnt:CurrentOtherTaxExpenseBenefit>
    <rdnt:CurrentOtherTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1557" unitRef="usd">0</rdnt:CurrentOtherTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1558" unitRef="usd">8960000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1559" unitRef="usd">6470000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1560" unitRef="usd">9831000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1561" unitRef="usd">-2724000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1562" unitRef="usd">5863000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1563" unitRef="usd">6902000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1564" unitRef="usd">-1843000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1565" unitRef="usd">-3430000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1566" unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <rdnt:ForeignCurrencyTranslationAdjustments contextRef="c-1" decimals="-3" id="f-1567" unitRef="usd">0</rdnt:ForeignCurrencyTranslationAdjustments>
    <rdnt:ForeignCurrencyTranslationAdjustments contextRef="c-14" decimals="-3" id="f-1568" unitRef="usd">0</rdnt:ForeignCurrencyTranslationAdjustments>
    <rdnt:ForeignCurrencyTranslationAdjustments contextRef="c-15" decimals="-3" id="f-1569" unitRef="usd">0</rdnt:ForeignCurrencyTranslationAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1570" unitRef="usd">8473000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1571" unitRef="usd">9361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1572" unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1573">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Officer Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax rate adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-1574" unitRef="usd">8150000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-14" decimals="-3" id="f-1575" unitRef="usd">9023000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-15" decimals="-3" id="f-1576" unitRef="usd">12365000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-3" id="f-1577" unitRef="usd">3730000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-14" decimals="-3" id="f-1578" unitRef="usd">595000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-15" decimals="-3" id="f-1579" unitRef="usd">4198000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="-3" id="f-1580" unitRef="usd">196000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-14" decimals="-3" id="f-1581" unitRef="usd">305000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-15" decimals="-3" id="f-1582" unitRef="usd">-93000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-1" decimals="-3" id="f-1583" unitRef="usd">1199000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-14" decimals="-3" id="f-1584" unitRef="usd">759000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-15" decimals="-3" id="f-1585" unitRef="usd">291000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="c-1" decimals="-3" id="f-1586" unitRef="usd">5752000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="c-14" decimals="-3" id="f-1587" unitRef="usd">4821000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="c-15" decimals="-3" id="f-1588" unitRef="usd">4114000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-1589" unitRef="usd">-2569000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-14" decimals="-3" id="f-1590" unitRef="usd">6124000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-15" decimals="-3" id="f-1591" unitRef="usd">-249000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c-1" decimals="-3" id="f-1592" unitRef="usd">5987000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c-14" decimals="-3" id="f-1593" unitRef="usd">234000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c-15" decimals="-3" id="f-1594" unitRef="usd">-2530000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-3" id="f-1595" unitRef="usd">483000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-14" decimals="-3" id="f-1596" unitRef="usd">-1451000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-15" decimals="-3" id="f-1597" unitRef="usd">5009000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-1598" unitRef="usd">-1083000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-14" decimals="-3" id="f-1599" unitRef="usd">-737000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-15" decimals="-3" id="f-1600" unitRef="usd">4000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-1" decimals="-3" id="f-1601" unitRef="usd">-884000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-14" decimals="-3" id="f-1602" unitRef="usd">-749000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-15" decimals="-3" id="f-1603" unitRef="usd">-321000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-1" decimals="-3" id="f-1604" unitRef="usd">-984000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-14" decimals="-3" id="f-1605" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-15" decimals="-3" id="f-1606" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-1" decimals="-3" id="f-1607" unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-14" decimals="-3" id="f-1608" unitRef="usd">79000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-15" decimals="-3" id="f-1609" unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1610" unitRef="usd">8473000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-1611" unitRef="usd">9361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-15" decimals="-3" id="f-1612" unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1613">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets and liabilities comprise the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-1614" unitRef="usd">43247000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-1615" unitRef="usd">68124000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-4" decimals="-3" id="f-1616" unitRef="usd">4432000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-5" decimals="-3" id="f-1617" unitRef="usd">3941000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities contextRef="c-4" decimals="-3" id="f-1618" unitRef="usd">136097000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities contextRef="c-5" decimals="-3" id="f-1619" unitRef="usd">142347000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="c-4" decimals="-3" id="f-1620" unitRef="usd">4179000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="c-5" decimals="-3" id="f-1621" unitRef="usd">4387000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-4" decimals="-3" id="f-1622" unitRef="usd">2198000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-5" decimals="-3" id="f-1623" unitRef="usd">3071000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-3" id="f-1624" unitRef="usd">15755000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-1625" unitRef="usd">6541000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1626" unitRef="usd">9688000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1627" unitRef="usd">12095000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-1628" unitRef="usd">196220000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-1629" unitRef="usd">216316000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1630" unitRef="usd">7851000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-1631" unitRef="usd">9214000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-4" decimals="-3" id="f-1632" unitRef="usd">42419000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-5" decimals="-3" id="f-1633" unitRef="usd">38820000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="c-4" decimals="-3" id="f-1634" unitRef="usd">15578000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="c-5" decimals="-3" id="f-1635" unitRef="usd">18640000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets contextRef="c-4" decimals="-3" id="f-1636" unitRef="usd">122840000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets contextRef="c-5" decimals="-3" id="f-1637" unitRef="usd">129802000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <rdnt:DeferredTaxLiabilitiesOutsideBasisDifference contextRef="c-4" decimals="-3" id="f-1638" unitRef="usd">18547000</rdnt:DeferredTaxLiabilitiesOutsideBasisDifference>
    <rdnt:DeferredTaxLiabilitiesOutsideBasisDifference contextRef="c-5" decimals="-3" id="f-1639" unitRef="usd">20015000</rdnt:DeferredTaxLiabilitiesOutsideBasisDifference>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-4" decimals="-3" id="f-1640" unitRef="usd">4761000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-5" decimals="-3" id="f-1641" unitRef="usd">9081000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-1642" unitRef="usd">211996000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-3" id="f-1643" unitRef="usd">225572000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-4" decimals="-3" id="f-1644" unitRef="usd">15776000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-5" decimals="-3" id="f-1645" unitRef="usd">9256000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-459" decimals="-5" id="f-1646" unitRef="usd">128900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-459" decimals="-5" id="f-1647" unitRef="usd">63900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-459" decimals="-5" id="f-1648" unitRef="usd">65000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards contextRef="c-460" decimals="-5" id="f-1649" unitRef="usd">145300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-461" decimals="-5" id="f-1650" unitRef="usd">24900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-4" decimals="-5" id="f-1651" unitRef="usd">45800000</rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration>
    <rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized contextRef="c-4" decimals="-5" id="f-1652" unitRef="usd">196200000</rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-4" decimals="-5" id="f-1653" unitRef="usd">42400000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-1654">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-1655" unitRef="usd">4144000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-43" decimals="-3" id="f-1656" unitRef="usd">5088000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-22" decimals="-3" id="f-1657" unitRef="usd">5484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1658" unitRef="usd">54000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-14" decimals="-3" id="f-1659" unitRef="usd">55000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-15" decimals="-3" id="f-1660" unitRef="usd">317000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1661" unitRef="usd">62000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-14" decimals="-3" id="f-1662" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-15" decimals="-3" id="f-1663" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-3" id="f-1664" unitRef="usd">1180000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-14" decimals="-3" id="f-1665" unitRef="usd">999000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-15" decimals="-3" id="f-1666" unitRef="usd">713000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate contextRef="c-1" decimals="-3" id="f-1667" unitRef="usd">2000</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate contextRef="c-14" decimals="-3" id="f-1668" unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate contextRef="c-15" decimals="-3" id="f-1669" unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-1670" unitRef="usd">3082000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-1671" unitRef="usd">4144000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-43" decimals="-3" id="f-1672" unitRef="usd">5088000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-5" id="f-1673" unitRef="usd">3100000</us-gaap:UnrecognizedTaxBenefits>
    <rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized contextRef="c-4" decimals="-5" id="f-1674" unitRef="usd">2500000</rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized>
    <rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod contextRef="c-1" decimals="-3" id="f-1675" unitRef="usd">-47000</rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="-5" id="f-1676" unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1677">STOCK-BASED COMPENSATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, second on March 9, 2017, third on April 15, 2021, and currently as of April 27, 2023 (the "Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 7, 2023.  We have reserved for issuance under the Restated Plan 20,100,000 shares of common stock.  We can issue options (incentive and nonstatutory), performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over &lt;span style="-sec-ix-hidden:f-1680"&gt;one&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:f-1682"&gt;five&lt;/span&gt; to ten years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all of our option transactions for the twelve months ended December 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Restated Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled, forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,561,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,387,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2023 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2023. As of December 31, 2023, total unrecognized stock-based compensation expense related to non-vested employee awards was $1.4 million which is expected to be recognized over a weighted average period of approximately 1.23 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2023, total unrecognized stock based compensation expense related to non-vested DeepHealth options was insignificant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.197%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,749,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards (&#x201c;RSA&#x2019;s&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of restricted stock awards (&#x201c;RSA&#x2019;s&#x201d;). As of December 31, 2023, we have issued a total of 8,718,185 RSA&#x2019;s of which 537,358 were unvested at December 31, 2023. The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785,656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSA&#x2019;s based on the closing price of our common stock on award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2023 we issued 50,765 shares relating to these awards, amounting to approximately $1.3 million of compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock units ("PSUs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022. In January of 2023, based on the performance condition achieved, the board of directors issued 12,843 units with a fair value of $29.44 per unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, we granted certain employees PSUs with a target award of 60,685 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2023 through December 31, 2023. As of December 31, 2023, 121,370 shares are expected to vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock options ("PSOs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we granted certain employees PSOs to purchase a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022. In January of 2023, based on the performance condition achieved, the board of directors issued 27,981 options with a strike price of $29.44 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, we granted certain employees PSOs with a potential to purchase a maximum of 235,227 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 235,227 shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period January 1, 2023 through December 31, 2023. As of December 31, 2023, all 235,227 shares are expected to vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AI Long Term Incentive Plan shares ("AI LTIPs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a &lt;span style="-sec-ix-hidden:f-1757"&gt;two&lt;/span&gt; to four year period, conditioned on continued employment through the vesting periods. We determine the fair value of all AI LTIPs based on the closing price of our common stock on the award date.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all unvested AI LTIPs activities during the twelve months ended December 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LTIPs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In summary, of the 20,100,000 shares of common stock reserved for issuance under the Restated Plan at December 31, 2023, there remain 4,069,349 shares available for future issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="c-4"
      decimals="INF"
      id="f-1678"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-150"
      decimals="INF"
      id="f-1679"
      unitRef="shares">20100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-458" id="f-1681">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-458" id="f-1683">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1684">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all of our option transactions for the twelve months ended December 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Restated Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled, forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,561,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,387,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.197%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,749,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-5"
      decimals="INF"
      id="f-1685"
      unitRef="shares">678914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-1686"
      unitRef="usdPerShare">15.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-462"
      decimals="INF"
      id="f-1687"
      unitRef="shares">261220</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-462"
      decimals="2"
      id="f-1688"
      unitRef="usdPerShare">18.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-1"
      decimals="INF"
      id="f-1689"
      unitRef="shares">12723</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1690"
      unitRef="usdPerShare">11.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-462"
      decimals="INF"
      id="f-1691"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-462"
      decimals="2"
      id="f-1692"
      unitRef="usdPerShare">17.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-4"
      decimals="INF"
      id="f-1693"
      unitRef="shares">911411</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1694"
      unitRef="usdPerShare">16.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1695">P6Y2M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-1696" unitRef="usd">16561659000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-4"
      decimals="INF"
      id="f-1697"
      unitRef="shares">668809</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1698"
      unitRef="usdPerShare">14.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1699">P5Y2M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-1700" unitRef="usd">13387921000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-463" decimals="-5" id="f-1701" unitRef="usd">1400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-464" id="f-1702">P1Y2M23D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-465"
      decimals="INF"
      id="f-1703"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-466"
      decimals="2"
      id="f-1704"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-467"
      decimals="INF"
      id="f-1705"
      unitRef="shares">116982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-467"
      id="f-1706"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-468"
      decimals="INF"
      id="f-1707"
      unitRef="shares">37909</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-468"
      decimals="2"
      id="f-1708"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-469"
      decimals="INF"
      id="f-1709"
      unitRef="shares">79073</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-469"
      decimals="2"
      id="f-1710"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-468" id="f-1711">P5Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-469" decimals="-3" id="f-1712" unitRef="usd">2749368000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-469"
      decimals="INF"
      id="f-1713"
      unitRef="shares">76612</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-469"
      decimals="2"
      id="f-1714"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-468" id="f-1715">P5Y9M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-469" decimals="-3" id="f-1716" unitRef="usd">2663803000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-470"
      decimals="INF"
      id="f-1717"
      unitRef="shares">8718185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-471"
      decimals="INF"
      id="f-1718"
      unitRef="shares">537358</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-1719">The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2023:&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785,656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-472"
      decimals="INF"
      id="f-1720"
      unitRef="shares">536767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-472"
      decimals="2"
      id="f-1721"
      unitRef="usdPerShare">23.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-470"
      decimals="INF"
      id="f-1722"
      unitRef="shares">825255</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-470"
      decimals="2"
      id="f-1723"
      unitRef="usdPerShare">21.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-470"
      decimals="INF"
      id="f-1724"
      unitRef="shares">785656</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-470"
      decimals="2"
      id="f-1725"
      unitRef="usdPerShare">22.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-470"
      decimals="INF"
      id="f-1726"
      unitRef="shares">39008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-470"
      decimals="2"
      id="f-1727"
      unitRef="usdPerShare">18.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-471"
      decimals="INF"
      id="f-1728"
      unitRef="shares">537358</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-470" id="f-1729">P0Y10M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-471"
      decimals="2"
      id="f-1730"
      unitRef="usdPerShare">22.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-473"
      decimals="INF"
      id="f-1731"
      unitRef="shares">50765</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue contextRef="c-473" decimals="-5" id="f-1732" unitRef="usd">1300000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-474"
      decimals="INF"
      id="f-1733"
      unitRef="shares">25683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="c-474"
      decimals="INF"
      id="f-1734"
      unitRef="tranche">2</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-474" id="f-1735">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-475"
      decimals="INF"
      id="f-1736"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-476"
      decimals="INF"
      id="f-1737"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharesIssued
      contextRef="c-477"
      decimals="INF"
      id="f-1738"
      unitRef="shares">12843</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-477"
      decimals="2"
      id="f-1739"
      unitRef="usdPerShare">29.44</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-478"
      decimals="INF"
      id="f-1740"
      unitRef="shares">60685</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-479"
      decimals="INF"
      id="f-1741"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-480"
      decimals="INF"
      id="f-1742"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-481"
      decimals="INF"
      id="f-1743"
      unitRef="shares">121370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-482"
      decimals="INF"
      id="f-1744"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="c-482"
      decimals="INF"
      id="f-1745"
      unitRef="tranche">3</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-482" id="f-1746">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-483"
      decimals="INF"
      id="f-1747"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-484"
      decimals="INF"
      id="f-1748"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharesIssued
      contextRef="c-485"
      decimals="INF"
      id="f-1749"
      unitRef="shares">27981</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-485"
      decimals="2"
      id="f-1750"
      unitRef="usdPerShare">29.44</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-486"
      decimals="INF"
      id="f-1751"
      unitRef="shares">235227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="c-486"
      decimals="INF"
      id="f-1752"
      unitRef="tranche">3</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-486" id="f-1753">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-487"
      decimals="INF"
      id="f-1754"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-488"
      decimals="INF"
      id="f-1755"
      unitRef="shares">235227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-488"
      decimals="INF"
      id="f-1756"
      unitRef="shares">235227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-490" id="f-1758">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="c-1" id="f-1759">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all unvested AI LTIPs activities during the twelve months ended December 31, 2023:&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LTIPs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-491"
      decimals="INF"
      id="f-1760"
      unitRef="shares">169471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-491"
      decimals="2"
      id="f-1761"
      unitRef="usdPerShare">19.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-492"
      decimals="INF"
      id="f-1762"
      unitRef="shares">216460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-492"
      decimals="2"
      id="f-1763"
      unitRef="usdPerShare">20.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-493"
      decimals="INF"
      id="f-1764"
      unitRef="shares">66309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-493"
      decimals="2"
      id="f-1765"
      unitRef="usdPerShare">19.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod
      contextRef="c-492"
      decimals="INF"
      id="f-1766"
      unitRef="shares">94897</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue
      contextRef="c-492"
      decimals="2"
      id="f-1767"
      unitRef="usdPerShare">19.82</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-494"
      decimals="INF"
      id="f-1768"
      unitRef="shares">224725</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-492" id="f-1769">P2Y8M23D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-494"
      decimals="2"
      id="f-1770"
      unitRef="usdPerShare">20.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-150"
      decimals="INF"
      id="f-1771"
      unitRef="shares">20100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="c-495"
      decimals="INF"
      id="f-1772"
      unitRef="shares">4069349</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1773">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Proposed acquisitions of imaging centers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2023, we acquired Houston Medical Imaging, LLC for a purchase consideration of approximately $29.0 million. Houston Medical Imaging consists of seven multi modality imaging centers located in Houston, Texas.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2024, we acquired Antelope Valley Outpatient Imaging Center, LLC for a purchase consideration of approximately $3.5 million. Antelope Valley Outpatient Imaging consists of four multi modality imaging centers located in Palmdale, California.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-496" decimals="-5" id="f-1774" unitRef="usd">29000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-497" decimals="-5" id="f-1775" unitRef="usd">3500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-498" id="f-1776">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-498" id="f-1777">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-498" id="f-1778">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-498" id="f-1779">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-1780">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
